head;tail;relation
renal cell carcinoma associated with neuroblastoma;renal cell cancer associated with neuroblastoma;exactmatch
benign female reproductive system neoplasm;benign female reproductive system neoplasm;exactmatch
malignant neck neoplasm;cancer of neck;exactmatch
benign lymphoproliferative disorder;benign lymphoproliferative disorder;exactmatch
localized lymphoma;localized lymphoma;exactmatch
recurrent hodgkin lymphoma;recurrent hodgkin lymphoma;exactmatch
ileal neuroendocrine tumor g1;carcinoid tumor of ileum;exactmatch
cerebral white matter;cerebral white matter;exactmatch
brain nucleus;brain nucleus;exactmatch
brain white matter;brain white matter;exactmatch
stage 0 pharyngeal cancer;carcinoma in situ of pharynx;exactmatch
epiglottis neoplasm;epiglottic neoplasm;exactmatch
retina layer;eye, retina;exactmatch
duodenal adenoma;duodenal adenoma;exactmatch
pseudostratified columnar epithelium;pseudostratified columnar epithelium;exactmatch
vaginal squamous epithelium;vaginal squamous epithelium;exactmatch
vaginal epithelium;vaginal epithelium;exactmatch
gland of littre;gland of littre;exactmatch
soft palate squamous cell carcinoma;scc of soft palate;exactmatch
pyriform fossa squamous cell carcinoma;epidermoid carcinoma of pyriform fossa;exactmatch
chest wall neoplasm;chest wall neoplasm;exactmatch
cerebral astrocytoma;astrocytoma of cerebral hemispheres;exactmatch
leptomeningeal neoplasm;leptomeningeal disease;exactmatch
benign neoplasm of the meninges;benign meningeal neoplasm;exactmatch
desmoplastic/nodular medulloblastoma;desmoplastic medulloblastoma;exactmatch
benign cerebellar neoplasm;benign cerebellar neoplasm;exactmatch
localized malignant brain neoplasm;localized malignant brain neoplasm;exactmatch
intracranial neoplasm;intracranial central nervous system neoplasm;exactmatch
localized brain neoplasm;localized brain neoplasm;exactmatch
colon non-hodgkin lymphoma;colon non-hodgkin lymphoma;exactmatch
sellar region neoplasm;neoplasm of sella turcica;exactmatch
liver lymphoma;hepatic lymphoma;exactmatch
vaginal fibroepithelial polyp;fibroepithelial polyp of vagina;exactmatch
convoluted tubule;convoluted tubule;exactmatch
intestinal wall tissue;intestinal wall tissue;exactmatch
vaginal condyloma;condylomata acuminata of vagina;exactmatch
thyroid gland hurthle cell carcinoma;hurthle cell carcinoma of thyroid;exactmatch
supraglottic squamous cell carcinoma;epidermoid carcinoma of supraglottis;exactmatch
tongue epithelium;tongue epithelium;exactmatch
hilar area of the lung;hilar area of the lung;exactmatch
malignant chromaffin cell;malignant chromaffin cell;exactmatch
malignant skeletal muscle cell;malignant skeletal muscle cell;exactmatch
anaplastic embryonal rhabdomyosarcoma;anaplastic embryonal rhabdomyosarcoma;exactmatch
fibrovascular septa present;fibrovascular septa present;exactmatch
primitive malignant skeletal muscle cell;primitive malignant skeletal muscle cell;exactmatch
primitive malignant skeletal spindle cell;primitive malignant skeletal spindle cell;exactmatch
primitive skeletal muscle cell;primitive skeletal muscle cell;exactmatch
cambium layer;cambium layer;exactmatch
malignant rhabdomyoblast;malignant rhabdomyoblast;exactmatch
rectal villous adenoma;rectal villous adenoma;exactmatch
cervix epithelium;cervix epithelium;exactmatch
malignant nasal cavity neoplasm;malignant nasal cavity neoplasm;exactmatch
conventional cardiac rhabdomyoma;conventional cardiac rhabdomyoma;exactmatch
primitive skeletal spindle cell;primitive skeletal spindle cell;exactmatch
neoplastic striated muscle cell with eosinophilic granular cytoplasm;neoplastic striated muscle cell with eosinophilic granular cytoplasm;exactmatch
lung small cell carcinoma;lung oat cell carcinoma;exactmatch
neoplastic large striated muscle cell with clear cytoplasm;neoplastic large striated muscle cell with clear cytoplasm;exactmatch
neoplastic skeletal muscle cell;neoplastic skeletal muscle cell;exactmatch
retinal cavernous hemangioma;cavernous angioma of retina;exactmatch
cervix squamous epithelium;cervix squamous epithelium;exactmatch
renal tubule epithelium;renal tubule epithelium;exactmatch
malignant germ cell tumor;germ cell cancer, nos;exactmatch
renal tubule;renal tubule;exactmatch
benign ovarian cyst;benign cyst of ovary;exactmatch
oropharynx epithelium;oropharynx epithelium;exactmatch
nasopharynx epithelium;nasopharynx epithelium;exactmatch
nasal cavity epithelium;nasal cavity epithelium;exactmatch
metastatic undifferentiated pleomorphic sarcoma;malignant fibrous histiocytoma metastatic;exactmatch
lymphatic vessel endothelium;lymphatic vessel endothelium;exactmatch
laryngeal epithelium;laryngeal epithelium;exactmatch
esophageal epithelium;esophageal epithelium;exactmatch
laryngeal mucosa;laryngeal mucosa;exactmatch
intestinal mucosa;intestinal mucosa;exactmatch
gingival epithelium;gingival epithelium;exactmatch
candidate tumor suppressor gene;candidate tumor suppressor gene;exactmatch
glottis carcinoma;cancer of glottis;exactmatch
gallbladder epithelium;gallbladder epithelium;exactmatch
esophageal squamous epithelium;esophageal squamous epithelium;exactmatch
cerebral convexity meningioma;cerebral convexity meningioma;exactmatch
oral cavity epithelium;oral cavity epithelium;exactmatch
parasagittal meningioma;parasagittal meningioma;exactmatch
stage 0 rectosigmoid cancer ajcc v6 and v7;stage 0 rectosigmoid cancer;exactmatch
prostate well differentiated neuroendocrine tumor;carcinoid tumor of prostate;exactmatch
stage 0 esophageal squamous cell carcinoma ajcc v7;esophageal squamous cell carcinoma stage 0;exactmatch
stage i esophageal squamous cell carcinoma ajcc v7;esophageal squamous cell carcinoma stage i;exactmatch
stage ii esophageal squamous cell carcinoma ajcc v7;esophageal squamous cell carcinoma stage ii;exactmatch
stage iii esophageal squamous cell carcinoma ajcc v7;esophageal squamous cell carcinoma stage iii;exactmatch
stage iv esophageal squamous cell carcinoma ajcc v7;esophageal squamous cell carcinoma stage iv;exactmatch
unresectable pancreatic carcinoma;non-resectable carcinoma of pancreas;exactmatch
stage i rectosigmoid cancer ajcc v6 and v7;stage i rectosigmoid cancer;exactmatch
malignant testicular non-seminomatous germ cell tumor;malignant non-seminomatous germ cell cancer of testis;exactmatch
stage ii rectosigmoid cancer ajcc v6;stage ii rectosigmoid cancer;exactmatch
recurrent lung squamous cell carcinoma;recurrent lung squamous cell carcinoma;exactmatch
ann arbor stage i subdiaphragmatic hodgkin lymphoma;ann arbor stage i subdiaphragmatic hodgkin lymphoma;exactmatch
ann arbor stage i supradiaphragmatic hodgkin lymphoma;ann arbor stage i supradiaphragmatic hodgkin lymphoma;exactmatch
ann arbor stage ii subdiaphragmatic hodgkin lymphoma;ann arbor stage ii subdiaphragmatic hodgkin lymphoma;exactmatch
ann arbor stage ii supradiaphragmatic hodgkin lymphoma;ann arbor stage ii supradiaphragmatic hodgkin lymphoma;exactmatch
recurrent burkitt lymphoma;recurrent burkitt lymphoma;exactmatch
recurrent nasal type extranodal nk/t-cell lymphoma;recurrent angiocentric lymphoma;exactmatch
verrucous lesion;verruca;exactmatch
spinal nerve plexus;spinal nerve plexus;exactmatch
visual manifestations;visual manifestations;exactmatch
cancer other;cancer other;exactmatch
aids-related malignant anal neoplasm;aids-related malignant anal neoplasm;exactmatch
airway obstruction;airway obstruction;exactmatch
erosion;erosion;exactmatch
fluid and electrolyte manifestation;fluid and electrolyte manifestation;exactmatch
body substance discharge;body substance discharge;exactmatch
ventilation or perfusion signs and symptoms;ventilation or perfusion signs and symptoms;exactmatch
thin bands of collagen present;thin bands of collagen present;exactmatch
extrahepatic bile duct sarcoma;extrahepatic bile duct sarcoma;exactmatch
myopericytoma;hemangiopericytoma;exactmatch
sensory manifestations;sensory manifestations;exactmatch
motor manifestations;motor manifestations;exactmatch
alterations in hearing;alterations in hearing;exactmatch
integumentary system signs and symptoms;integumentary system signs and symptoms;exactmatch
genitourinary signs and symptoms;genital or reproductive signs and symptoms;exactmatch
disturbance in bowel function;disturbance in bowel function;exactmatch
recurrent follicular lymphoma;recurrent follicular lymphoma;exactmatch
ann arbor stage iv follicular lymphoma;ann arbor stage iv follicular lymphoma;exactmatch
high grade burkitt-like lymphoma;high grade burkitt-like lymphoma;exactmatch
therapy-related malignant neoplasm;iatrogenic cancer;exactmatch
splenic marginal zone;spleen marginal zone;exactmatch
marginal zone;marginal zone;exactmatch
central nervous system vascular malformation;cns vascular malformation;exactmatch
primary brain stem neoplasm;primary brain stem neoplasm;exactmatch
perineurioma;perineurioma;exactmatch
nerve sheath neoplasm;neoplasm of nerve sheath;exactmatch
cerebral embryonal tumor, not otherwise specified;cerebral embryonal tumor, nos;exactmatch
secondary malignant neoplasm;development of smn;exactmatch
recurrent high grade burkitt-like lymphoma;recurrent high grade burkitt-like lymphoma;exactmatch
adult acute lymphoblastic leukemia;acute lymphoblastic leukemia (all);exactmatch
malignant infratentorial neoplasm;infratentorial neoplasms, malignant;exactmatch
benign infratentorial neoplasm;benign infratentorial neoplasm;exactmatch
malignant supratentorial neoplasm;malignant supratentorial brain tumor;exactmatch
benign supratentorial neoplasm;benign supratentorial neoplasm;exactmatch
malignant thymus neoplasm;cancer of thymus;exactmatch
malignant peripheral nervous system neoplasm;malignant neoplasm of pns;exactmatch
malignant colorectal neoplasm;malignant colorectal neoplasm;exactmatch
carcinoma unspecified site;carcinoma unspecified site;exactmatch
aleukemic leukemia;aleukemic leukemia;exactmatch
aleukemic leukemia cutis;aleukemic leukemia cutis;exactmatch
refractory high grade burkitt-like lymphoma;refractory high grade burkitt-like lymphoma;exactmatch
stage i high grade burkitt-like lymphoma;stage i high grade burkitt-like lymphoma;exactmatch
stage ii high grade burkitt-like lymphoma;stage ii high grade burkitt-like lymphoma;exactmatch
stage iii high grade burkitt-like lymphoma;stage iii high grade burkitt-like lymphoma;exactmatch
stage iv high grade burkitt-like lymphoma;stage iv high grade burkitt-like lymphoma;exactmatch
recurrent nodal marginal zone lymphoma;recurrent nodal marginal zone b-cell lymphoma;exactmatch
refractory nodal marginal zone lymphoma;nodal marginal zone b-cell lymphoma refractory;exactmatch
stage i extragonadal seminoma;stage i extragonadal primary seminoma;exactmatch
recurrent bladder adenocarcinoma;bladder adenocarcinoma, recurrent;exactmatch
stage ii bladder squamous cell carcinoma ajcc v6 and v7;stage ii bladder squamous cell cancer;exactmatch
occupational malignant neoplasm;occupational cancer;exactmatch
environment-related malignant neoplasm;environment-related cancer;exactmatch
aids-related disorder;aids-related disorder;exactmatch
childhood leukemia;childhood leukemia;exactmatch
ovarian neoplasm;neoplasm of ovary;exactmatch
extracardiac rhabdomyoma;extracardiac rhabdomyoma;exactmatch
focal nodular hyperplasia of the liver;fnh;exactmatch
embryonal tumor with multilayered rosettes, c19mc-altered;etmr, c19mc-altered;exactmatch
metastatic malignant neoplasm in the spine;metastases to spine;exactmatch
metastatic malignant neoplasm in the trachea;metastasis to the trachea;exactmatch
benign pyriform fossa neoplasm;benign neoplasm of pyriform fossa;exactmatch
benign neck neoplasm;benign neck neoplasm;exactmatch
malignant muscle neoplasm;malignant muscle neoplasm;exactmatch
lumbosacral region;lumbosacral region;exactmatch
jaw bone;jaw;exactmatch
benign muscle neoplasm;benign muscle neoplasm;exactmatch
benign bone neoplasm;benign bone neoplasm;exactmatch
cartilage-like elements present;cartilage-like elements present;exactmatch
benign sweat gland neoplasm;benign neoplasm of sweat gland;exactmatch
malignant connective and soft tissue cell;malignant connective and soft tissue cell;exactmatch
lung carcinoma;cancer of lung;exactmatch
rectosigmoid neoplasm;neoplasm of rectosigmoid junction;exactmatch
bone cell;bone cell;exactmatch
symptom;symptom;exactmatch
reproductive system disorder;disorder of reproductive system;exactmatch
splenic lymphoma;primary splenic lymphoma;exactmatch
dedifferentiated chordoma;dedifferentiated chordoma;exactmatch
benign urinary system neoplasm;benign neoplasm of urinary tract;exactmatch
painful mass;painful mass;exactmatch
delicate arborizing vascular channel formation;delicate arborizing vascular channel formation;exactmatch
primitive mesenchymal round to oval cell;primitive mesenchymal round to oval cell;exactmatch
non lipogenic sarcomatous stroma present;non lipogenic sarcomatous stroma present;exactmatch
benign submandibular gland neoplasm;benign neoplasm of submandibular gland;exactmatch
floret-like pattern;floret-like pattern;exactmatch
neoplastic spindle-shaped adipocyte;neoplastic spindle-shaped adipocyte;exactmatch
intravascular fibrin thrombus formation;intravascular fibrin thrombus formation;exactmatch
malignant digestive system neoplasm;gastrointestinal system cancer;exactmatch
malignant lipocyte;malignant lipocyte;exactmatch
hiv lipodystrophy;hiv lipodystrophy;exactmatch
painless mass;painless mass;exactmatch
neoplastic mature adipocyte;neoplastic mature adipocyte;exactmatch
metastatic malignant neoplasm in the heart;metastases to heart;exactmatch
clinical tnm finding;clinical tnm finding;exactmatch
benign lung hilum neoplasm;benign hilar lung neoplasm;exactmatch
neoplastic lipoblast;neoplastic lipoblast;exactmatch
cerebral neoplasm;cerebral hemispheric neoplasm;exactmatch
pathologic tnm finding;pathologic tnm finding;exactmatch
rare disorder;rare disease;exactmatch
satellite nodule;satellite nodule;exactmatch
desmoplastic neurotropic melanoma;desmoplastic neurotropic melanoma;exactmatch
melanoma in congenital melanocytic nevus;cutaneous (skin) melanoma in congenital melanocytic nevus;exactmatch
minimal deviation melanoma;minimal deviation cutaneous (skin) melanoma;exactmatch
acute monocytic leukemia;acute monocytic leukemia;exactmatch
invasive cutaneous melanoma;infiltrating melanoma;exactmatch
focal pattern;focal pattern;exactmatch
lung sarcoma;lung sarcoma;exactmatch
invasive prostate carcinoma;infiltrating prostate carcinoma;exactmatch
breast carcinoma;breast cancer;exactmatch
ganglion cell-like elements present;ganglion cell-like elements present;exactmatch
neoplastic schwann-like cell;neoplastic schwann-like cell;exactmatch
neoplastic epithelioid neuroendocrine cell;neoplastic epithelioid neuroendocrine cell;exactmatch
gastrointestinal hemorrhage;gi bleed;exactmatch
base of the heart;base of the heart;exactmatch
slow growing painless mass;slow growing painless mass;exactmatch
placental neoplasm;neoplasm of placenta;exactmatch
lesion by focality;lesion by focality;exactmatch
unifocal lesion;unifocal;exactmatch
ovarian sex cord-stromal tumor;ovarian sex cord-stromal neoplasm;exactmatch
mucosal lentiginous melanoma;mucosal lentiginous malignant melanoma;exactmatch
complete hydatidiform mole;classical hydatidiform mole;exactmatch
cancer tnm finding category;cancer tnm finding category;exactmatch
neoplastic cartilage cell;neoplastic cartilage cell;exactmatch
cartilage cell;cartilage cell;exactmatch
brain stem neoplasm;brain stem neoplasm;exactmatch
remnants of the notochord;remnants of the notochord;exactmatch
skeletal muscle cell;skeletal muscle cell;exactmatch
neoplastic lipocyte;neoplastic lipocyte;exactmatch
neoplastic fibroblast;neoplastic fibroblast;exactmatch
placental hemangioma;angioma of placenta;exactmatch
malignant soft tissue neoplasm;malignant neoplasm of soft tissue;exactmatch
vulvar carcinoma;cancer of vulva;exactmatch
prostate carcinoma;cancer of prostate;exactmatch
mccune-albright syndrome;mas;exactmatch
neoplastic parathyroid gland water-clear cell;neoplastic parathyroid gland water-clear cell;exactmatch
stage 0 small intestinal cancer ajcc v7;small intestine cancer stage 0;exactmatch
benign endometrial neoplasm;benign endometrial neoplasm;exactmatch
skin carcinoma;carcinoma of skin;exactmatch
xanthomatous fibrohistiocytic cell;xanthomatous fibrohistiocytic cell;exactmatch
conventional dermatofibrosarcoma protuberans;conventional dermatofibrosarcoma protuberans;exactmatch
fibroblastoma-like differentiation;fibroblastoma-like differentiation;exactmatch
fibrosarcomatous component present;fibrosarcomatous component present;exactmatch
myofibroblastic differentiation;myofibroblastic differentiation;exactmatch
colon carcinoma;carcinoma of colon;exactmatch
melanin-pigmented dendritic cells present;melanin-pigmented dendritic cells present;exactmatch
wide vessel-like spaces formation;wide vessel-like spaces formation;exactmatch
neoplastic epithelioid fibrohistiocytic cell;neoplastic epithelioid fibrohistiocytic cell;exactmatch
gastric carcinoma;cancer of stomach;exactmatch
ovarian carcinoma;carcinoma of ovary;exactmatch
skin fibrous histiocytoma, epithelioid variant;cutaneous epithelioid fibrous histiocytoma;exactmatch
skin fibrous histiocytoma, cellular variant;cutaneous fibrous histiocytoma, cellular variant;exactmatch
skin fibrous histiocytoma, histiocytic variant;cutaneous fibrous histiocytoma, histiocytic variant;exactmatch
skin fibrous histiocytoma, fibroblastic variant;cutaneous fibrous histiocytoma, fibroblastic variant;exactmatch
neoplastic spindle-shaped fibrohistiocytic cell;neoplastic spindle-shaped fibrohistiocytic cell;exactmatch
malignant large hyperchromatic fibrohistiocytic cell;malignant large hyperchromatic fibrohistiocytic cell;exactmatch
giant cell tumor of soft tissue;gct-st;exactmatch
solid angioleiomyoma;solid angioleiomyoma;exactmatch
bladder wall;bladder wall;exactmatch
bladder carcinoma;bladder cancer;exactmatch
malignant female reproductive system neoplasm;female reproductive cancer;exactmatch
malignant smooth muscle cell with granular cytoplasmic change;malignant smooth muscle cell with granular cytoplasmic change;exactmatch
malignant epithelioid smooth muscle cell;malignant epithelioid smooth muscle cell;exactmatch
malignant spindle-shaped smooth muscle cell;malignant spindle-shaped smooth muscle cell;exactmatch
intersecting sharply marginated clusters of spindle cells present;intersecting sharply marginated clusters of spindle cells present;exactmatch
malignant smooth muscle cell;malignant smooth muscle cell;exactmatch
lipomatous metaplasia;lipomatous metaplasia;exactmatch
alternative fascicle (bundle) pattern;alternative fascicle (bundle) pattern;exactmatch
venous angioleiomyoma;venous angioleiomyoma;exactmatch
hydropic change;hydropic change;exactmatch
neoplastic epithelioid smooth muscle cell;epithelioid smooth muscle cell;exactmatch
dartoic muscle;dartoic muscle;exactmatch
cavernous angioleiomyoma;cavernous angioleiomyoma;exactmatch
cavernous vascular space formation;cavernous vascular space formation;exactmatch
slit-like vascular channel formation;slit-like vascular channel formation;exactmatch
venous type vascular channel formation;venous type vascular channel formation;exactmatch
malignant spindle-shaped fibrohistiocytic cell;malignant spindle-shaped fibrohistiocytic cell;exactmatch
xanthomatous cell;xanthomatous cell;exactmatch
malignant ovoid to spindle-shaped fibrohistiocytic cell;malignant ovoid to spindle-shaped fibrohistiocytic cell;exactmatch
myofibroblastoma;myofibroblastoma;exactmatch
malignant spindle-shaped fibroblast;malignant spindle-shaped fibroblast;exactmatch
benign splenic neoplasm;benign neoplasm of spleen;exactmatch
regional lymph node;lymph node, regional;exactmatch
gardner fibroma;desmoid precursor lesion;exactmatch
angiomyofibroblastoma;angiomyofibroblastoma;exactmatch
nuclear palisading;nuclear palisading;exactmatch
numerous stromal mast cells present;numerous stromal mast cells present;exactmatch
intracytoplasmic eosinophilic spherical inclusion;intracytoplasmic eosinophilic spherical inclusion;exactmatch
cellular pleomorphism;cellular pleomorphism;exactmatch
lymphoid leukemia in remission;lymphoid leukemia (in remission);exactmatch
myeloid leukemia in remission;myelocytic leukemia in remission;exactmatch
chronic leukemia in remission;chronic leukemia (in remission);exactmatch
acute leukemia in remission;acute leukemia (in remission);exactmatch
subcutaneous nodular fasciitis;subcutaneous nodular fasciitis;exactmatch
leukemia in remission;leukemia (in remission);exactmatch
benign adrenal medulla neoplasm;benign adrenal medulla neoplasm;exactmatch
low grade myofibroblastic sarcoma;low grade myofibroblastic sarcoma;exactmatch
myxoinflammatory fibroblastic sarcoma;acral myxoinflammatory fibroblastic sarcoma;exactmatch
inclusion-like nucleoli;inclusion-like nucleoli;exactmatch
sclerosing epithelioid fibrosarcoma;sef;exactmatch
malignant fibrohistiocytic cell;malignant fibrohistiocytic cell;exactmatch
parathyroid gland carcinoma;adenocarcinoma of parathyroid;exactmatch
malignant mesenchymal spindle cell;malignant mesenchymal spindle cell;exactmatch
neoplastic mononuclear stromal cell;neoplastic mononuclear stromal cell;exactmatch
neoplastic elongated mononuclear stromal cell;neoplastic elongated mononuclear stromal cell;exactmatch
neoplastic ovoid mononuclear stromal cell;neoplastic ovoid mononuclear stromal cell;exactmatch
joint effusion;joint effusion;exactmatch
malignant histiocyte-like cell;malignant histiocyte-like cell;exactmatch
skin hemangioma;angioma of skin;exactmatch
metastatic malignant neoplasm in the lymph nodes;metastases to lymph nodes;exactmatch
curvilinear thin-walled vascular pattern;curvilinear thin-walled vascular pattern;exactmatch
vacuolated malignant fibroblast;pseudolipoblast;exactmatch
metastatic malignant neoplasm in the thymus;metastasis to the thymus;exactmatch
malignant epithelioid fibroblast;malignant epithelioid fibroblast;exactmatch
malignant fibroblast;malignant fibroblast;exactmatch
aids-related non-hodgkin lymphoma;aids-related non-hodgkin lymphoma;exactmatch
aids-related malignant cervical neoplasm;aids-related malignant cervical neoplasm;exactmatch
childhood testicular neoplasm;childhood neoplasm of testis;exactmatch
gastric mucosa-associated lymphoid tissue lymphoma;gastric malt lymphoma;exactmatch
metaphysis;long bone metaphysis;exactmatch
skull base meningioma;meningioma of skull base;exactmatch
petrous apex meningioma;meningioma of petrous apex;exactmatch
cerebellar papillary meningioma;cerebellar papillary meningioma;exactmatch
intracerebral cystic meningioma;intracerebral cystic meningioma;exactmatch
cavernous sinus meningioma;cavernous sinus meningioma;exactmatch
falx cerebri meningioma;cerebral falx meningioma;exactmatch
thyroid gland lymphoma;lymphoma of thyroid;exactmatch
metastatic meningioma;metastatic meningioma;exactmatch
bronchial mucosa-associated lymphoid tissue lymphoma;balt lymphoma;exactmatch
childhood acute lymphoblastic leukemia in complete remission;acute lymphoblastic leukemia (all) in complete remission;exactmatch
childhood acute lymphoblastic leukemia in partial remission;acute lymphoblastic leukemia (all) in partial remission;exactmatch
mature gastric teratoma;mature gastric teratoma;exactmatch
gastric teratoma;gastric teratoma;exactmatch
gastric lipoma;gastric lipoma;exactmatch
immature gastric teratoma;immature gastric teratoma;exactmatch
intraventricular meningioma;intraventricular meningioma;exactmatch
multiple intraspinal meningiomas;multiple intraspinal meningiomas;exactmatch
jugular foramen meningioma;jugular foramen meningioma;exactmatch
tuberculum sellae meningioma;meningioma of tuberculum sellae;exactmatch
radiation-induced intracranial meningioma;radiation-induced intracranial meningioma;exactmatch
upper clivus meningioma;meningioma of upper clivus;exactmatch
clivus meningioma;clivus meningioma;exactmatch
lower clivus meningioma;lower clivus meningioma;exactmatch
spinal multifocal clear cell meningioma;multifocal clear cell meningioma of spine;exactmatch
anterior cranial fossa meningioma;anterior cranial fossa meningioma;exactmatch
sphenoorbital meningioma;sphenoorbital meningioma;exactmatch
diaphragma sellae meningioma;diaphragm sellae meningioma;exactmatch
head skin;head skin;exactmatch
posterior foramen magnum meningioma;meningioma of posterior foramen magnum;exactmatch
anterior foramen magnum meningioma;anterior foramen magnum meningioma;exactmatch
foramen magnum meningioma;foramen magnum meningioma;exactmatch
multiple skull base meningiomas;multiple skull base meningiomas;exactmatch
petroclival meningioma;petroclival meningioma;exactmatch
primary cutaneous meningioma;primary cutaneous meningioma;exactmatch
primary lung meningioma;primary lung meningioma;exactmatch
labium;labium;exactmatch
gastric t-cell non-hodgkin lymphoma;gastric t-cell non-hodgkin lymphoma;exactmatch
gastric diffuse large b-cell lymphoma;gastric diffuse large b-cell lymphoma;exactmatch
stage ia ovarian cancer ajcc v6 and v7;ajcc stage ia ovarian cancer;exactmatch
ovarian cystadenocarcinoma;cystadenocarcinoma of ovary;exactmatch
borderline ovarian serous tumor;borderline ovarian serous neoplasm;exactmatch
stage iic ovarian cancer ajcc v6 and v7;ajcc stage iic ovarian cancer;exactmatch
stage iib ovarian cancer ajcc v6 and v7;ajcc stage iib ovarian cancer;exactmatch
stage iia ovarian cancer ajcc v6 and v7;ajcc stage iia ovarian cancer;exactmatch
stage ic ovarian cancer ajcc v6 and v7;ajcc stage ic ovarian cancer;exactmatch
stage ib ovarian cancer ajcc v6 and v7;ajcc stage ib ovarian cancer;exactmatch
benign ovarian thecoma;benign ovarian thecal cell neoplasm;exactmatch
gastric burkitt lymphoma;gastric burkitt lymphoma;exactmatch
breast adenocarcinoma;adenocarcinoma of breast;exactmatch
malignant nipple neoplasm;malignant neoplasm of nipple;exactmatch
nipple neoplasm;neoplasm of nipple;exactmatch
breast epithelioid hemangioma;breast epithelioid hemangioma;exactmatch
breast capillary hemangioma;breast capillary angioma;exactmatch
breast vascular neoplasm;breast vascular neoplasm;exactmatch
breast papillary neoplasm;breast papillary neoplasm;exactmatch
ovarian carcinoid tumor;carcinoid tumor of ovary;exactmatch
ovarian leydig cell tumor;leydig cell neoplasm of ovary;exactmatch
ovarian angiosarcoma;angiosarcoma of ovary;exactmatch
ovarian fibrosarcoma;fibrosarcoma of ovary;exactmatch
gastric signet ring cell adenocarcinoma;gastric signet ring cell adenocarcinoma;exactmatch
gastric mucinous adenocarcinoma;gastric mucinous adenocarcinoma;exactmatch
gastric cardia adenocarcinoma;adenocarcinoma of cardia of stomach;exactmatch
benign ovarian partly luteinized thecoma;benign ovarian partly luteinized thecoma;exactmatch
ovarian myxoma;myxoma of ovary;exactmatch
ovarian soft tissue neoplasm;ovarian soft tissue neoplasm;exactmatch
ovarian mucinous adenocarcinoma;mucinous adenocarcinoma of ovary;exactmatch
ovarian mucinous tumor;mucinous neoplasm of ovary;exactmatch
mixed germ cell-sex cord-stromal tumor;mixed germ cell-sex cord neoplasm;exactmatch
ovarian transitional cell carcinoma;ovarian transitional cell cancer;exactmatch
ovarian large cell neuroendocrine carcinoma;large cell neuroendocrine carcinoma of ovary;exactmatch
ovarian neuroendocrine neoplasm;neuroendocrine neoplasm of ovary;exactmatch
ovarian rhabdomyosarcoma;ovarian rhabdomyosarcoma;exactmatch
ovarian myxoid liposarcoma;myxoid liposarcoma of ovary;exactmatch
ovarian leiomyosarcoma;leiomyosarcoma of ovary;exactmatch
frontal convexity meningioma;frontal convexity meningioma;exactmatch
deletion of the short arm of chromosome 1 (1p) associated meningioma;deletion of short arm of chromosome 1 (1p) associated meningioma;exactmatch
breast intraductal papillomatosis;breast intraductal papillomatosis;exactmatch
cavernous lymphangioma;cavernous lymphangioma;exactmatch
blood vessel endothelium;blood vessel endothelium;exactmatch
small intestinal lipoma;lipoma of small bowel;exactmatch
duodenal villous adenoma;duodenal villous adenoma;exactmatch
small intestinal hodgkin lymphoma;hodgkin's disease of small bowel;exactmatch
small intestinal fibrosarcoma;fibrosarcoma of small bowel;exactmatch
small intestinal sarcoma;sarcoma of small bowel;exactmatch
esophageal leiomyosarcoma;esophageal leiomyosarcoma;exactmatch
collagen bundles formation;collagen bundles formation;exactmatch
malignant epithelioid endothelial cell;malignant epithelioid endothelial cell;exactmatch
neoplastic plump endothelial cell;neoplastic plump endothelial cell;exactmatch
skin red dot;skin red dot;exactmatch
congenital lesion;congenital lesion;exactmatch
acquired lesion;acquired lesion;exactmatch
spontaneous regression;spontaneous regression;exactmatch
epidermal hyperplasia;epidermal hyperplasia;exactmatch
red papular lesion;red papular lesion;exactmatch
small intestinal adenoma;adenoma of small bowel;exactmatch
malignant spindle endothelial cell;malignant spindle endothelial cell;exactmatch
brain stem intraparenchymal clear cell meningioma;brain stem intraparenchymal clear cell meningioma;exactmatch
telangiectatic glomangioma;telangiectatic glomangioma;exactmatch
medullary bone;medullary bone;exactmatch
chicken wire calcification;chicken wire calcification;exactmatch
endocardial neoplasm;endocardial neoplasm;exactmatch
chondroma;chondroma, benign;exactmatch
sign;sign;exactmatch
multiple osteochondromas;multiple osteochondromas;exactmatch
solitary osteochondroma;solitary osteochondroma;exactmatch
cartilaginous differentiation;cartilaginous differentiation;exactmatch
esophageal sarcoma;esophageal sarcoma;exactmatch
osseous differentiation;osseous differentiation;exactmatch
esophageal squamous cell papilloma;esophageal squamous cell papilloma;exactmatch
esophageal mucoepidermoid carcinoma;esophageal mucoepidermoid cancer;exactmatch
esophageal adenoid cystic carcinoma;adenoid cystic carcinoma of esophagus;exactmatch
rarely metastasizing lesion;rarely metastasizing lesion;exactmatch
locally aggressive lesion;locally aggressive lesion;exactmatch
malignant oval endothelial cell;malignant oval endothelial cell;exactmatch
familial paraganglioma;familial paraganglioma;exactmatch
advanced unfavorable non-hodgkin lymphoma;advanced unfavorable non-hodgkin lymphoma;exactmatch
advanced favorable non-hodgkin lymphoma;advanced favorable non-hodgkin lymphoma;exactmatch
bilateral optic nerve meningioma;bilateral meningioma of optic nerve;exactmatch
pituitary stalk meningioma;meningioma of pituitary stalk;exactmatch
epidural spinal canal meningioma;epidural spinal canal meningioma;exactmatch
ethmoid sinus primary ectopic meningioma;ethmoid sinus primary ectopic meningioma;exactmatch
ectopic meningioma;ectopic meningioma;exactmatch
internal auditory canal meningioma;internal auditory canal meningioma;exactmatch
deletion of chromosome 3p associated meningioma;deletion of chromosome 3p associated meningioma;exactmatch
deletion of chromosome 22 associated meningioma;deletion of chromosome 22 associated meningioma;exactmatch
primary parapharyngeal meningioma;primary parapharyngeal meningioma;exactmatch
early unfavorable non-hodgkin lymphoma;early unfavorable non-hodgkin lymphoma;exactmatch
lateral ventricle meningioma;lateral ventricle meningioma;exactmatch
hereditary meningioma;familial meningioma;exactmatch
cerebellopontine angle meningioma;c-p angle meningioma;exactmatch
sacral intraspinal meningioma;meningioma of sacral spinal canal and spinal cord;exactmatch
lumbar intraspinal meningioma;lumbar intraspinal meningioma;exactmatch
thoracic intraspinal meningioma;meningioma of thoracic spinal canal and spinal cord;exactmatch
cervical intraspinal meningioma;cervical intraspinal meningioma;exactmatch
recurrent meningioma;recurrent meningioma;exactmatch
sphenocavernous meningioma;sphenocavernous meningioma;exactmatch
primary low grade b-cell dural lymphoma;primary low grade b-cell dural lymphoma;exactmatch
borderline breast phyllodes tumor;borderline breast phyllodes neoplasm;exactmatch
early favorable non-hodgkin lymphoma;early favorable non-hodgkin lymphoma;exactmatch
extra-adrenal retroperitoneal paraganglioma;extra-adrenal retroperitoneal paraganglioma;exactmatch
skin of the extremity;skin of the extremity;exactmatch
dendritic melanoma cell;dendritic melanoma cell;exactmatch
head and neck paraganglioma;head and neck paraganglioma;exactmatch
intra-abdominal paraganglioma;intra-abdominal paraganglioma;exactmatch
intestinal gangliocytic paraganglioma;gangliocytic intestinal paraganglioma;exactmatch
spinal paraganglioma;cauda equina paraganglioma;exactmatch
jugular foramen schwannoma;jugular foramen neurilemmoma;exactmatch
central nervous system anaplastic large cell lymphoma;anaplastic cns large cell lymphoma;exactmatch
microcystic/reticular schwannoma;microcystic/reticular schwannoma;exactmatch
peripheral intraneural angiosarcoma;peripheral intraneural angiosarcoma;exactmatch
adult meningeal melanoma;adult leptomeningeal melanoma;exactmatch
childhood meningeal melanoma;childhood leptomeningeal melanoma;exactmatch
meningeal melanoma;leptomeningeal melanoma;exactmatch
non-proliferating breast lesion;non-proliferating breast lesion;exactmatch
breast papillary ductal hyperplasia;breast papillary ductal hyperplasia;exactmatch
cerebral lymphoma in immunocompetent host;cerebral lymphoma in immunocompetent host;exactmatch
stage ii splenic marginal zone lymphoma;splenic marginal zone lymphoma stage ii;exactmatch
resectable pancreatic carcinoma;pancreatic carcinoma, resectable;exactmatch
brain stem ependymoma;brain stem ependymoma;exactmatch
brain stem glioblastoma;brain stem glioblastoma;exactmatch
refractory splenic marginal zone lymphoma;refractory splenic marginal zone b-cell lymphoma;exactmatch
recurrent splenic marginal zone lymphoma;recurrent splenic marginal zone b-cell lymphoma;exactmatch
stage iv splenic marginal zone lymphoma;splenic marginal zone lymphoma stage iv;exactmatch
stage iii splenic marginal zone lymphoma;splenic marginal zone lymphoma stage iii;exactmatch
stage i splenic marginal zone lymphoma;splenic marginal zone lymphoma stage i;exactmatch
renomedullary interstitial cell tumor;fibroma of renal medulla;exactmatch
refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;extranodal marginal zone b-cell lymphoma (malt type) refractory;exactmatch
recurrent extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;recurrent extranodal marginal zone b-cell lymphoma (malt type);exactmatch
ann arbor stage iv extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;ann arbor stage iv extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;exactmatch
ann arbor stage iii extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;ann arbor stage iii extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;exactmatch
ann arbor stage ii extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;ann arbor stage ii extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;exactmatch
ann arbor stage i extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;ann arbor stage i extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;exactmatch
skin erosion;erosion;exactmatch
disease response;disease response;exactmatch
kidney lipoma;kidney lipoma;exactmatch
myopericyte;myopericyte;exactmatch
huge vascular channel formation;huge vascular channel formation;exactmatch
malignant intracranial neoplasm;intracranial cancer;exactmatch
marked nuclear atypia present;marked nuclear atypia present;exactmatch
lesion with diameter greater than 2 cm;lesion with diameter greater than 2 cm;exactmatch
deep lesion;deep lesion;exactmatch
capillary sized vascular channel formation;capillary sized vascular channel formation;exactmatch
solid glomus tumor;solid glomus tumor;exactmatch
vascular channel formation with muscular walls;vascular channel formation with muscular walls;exactmatch
dilated vascular space formation;dilated vascular space formation;exactmatch
lacrimal system neoplasm;lacrimal apparatus neoplasm;exactmatch
autonomic nervous system neoplasm;autonomic nervous system neoplasm;exactmatch
benign intracranial neoplasm;benign intracranial neoplasm;exactmatch
colorectal adenocarcinoma;adenocarcinoma of large bowel;exactmatch
cell defense process;cell defense process;exactmatch
ann arbor stage ii supradiaphragmatic mixed cellularity classic hodgkin lymphoma;ann arbor stage ii supradiaphragmatic mixed cellularity classic hodgkin lymphoma;exactmatch
regulation of cell death process;regulation of cell death;exactmatch
recurrent pharyngeal carcinoma;pharyngeal cancer, recurrent;exactmatch
ann arbor stage iv burkitt lymphoma;ann arbor stage iv burkitt lymphoma;exactmatch
ann arbor stage ii supradiaphragmatic nodular sclerosis classic hodgkin lymphoma;ann arbor stage ii supradiaphragmatic nodular sclerosis classic hodgkin lymphoma;exactmatch
ann arbor stage ii subdiaphragmatic nodular sclerosis classic hodgkin lymphoma;ann arbor stage ii subdiaphragmatic nodular sclerosis classic hodgkin lymphoma;exactmatch
endobronchial lipoma;endobronchial lipoma;exactmatch
ann arbor stage ii supradiaphragmatic lymphocyte-depleted classic hodgkin lymphoma;ann arbor stage ii supradiaphragmatic lymphocyte-depleted classic hodgkin lymphoma;exactmatch
ann arbor stage ii subdiaphragmatic lymphocyte-depleted classic hodgkin lymphoma;ann arbor stage ii subdiaphragmatic lymphocyte-depleted classic hodgkin lymphoma;exactmatch
ann arbor stage ii lymphocyte-depleted classic hodgkin lymphoma;ann arbor stage ii lymphocyte-depleted classic hodgkin lymphoma;exactmatch
nasal obstruction;nasal obstruction;exactmatch
ann arbor stage i supradiaphragmatic lymphocyte-depleted classic hodgkin lymphoma;ann arbor stage i supradiaphragmatic lymphocyte-depleted classic hodgkin lymphoma;exactmatch
ann arbor stage i subdiaphragmatic lymphocyte-depleted classic hodgkin lymphoma;ann arbor stage i subdiaphragmatic lymphocyte-depleted classic hodgkin lymphoma;exactmatch
ann arbor stage i lymphocyte-depleted classic hodgkin lymphoma;ann arbor stage i lymphocyte-depleted classic hodgkin lymphoma;exactmatch
urethral urothelial papilloma;urethral urothelial papilloma;exactmatch
ann arbor stage ii nodular sclerosis classic hodgkin lymphoma;ann arbor stage ii nodular sclerosis classic hodgkin lymphoma;exactmatch
localized fibrosarcoma;localized fibrosarcoma;exactmatch
recurrent epithelioid sarcoma;epithelioid sarcoma, recurrent;exactmatch
heart failure;cardiac failure;exactmatch
hearing impairment;hearing impairment;exactmatch
alopecia;alopecia;exactmatch
secondary cerebral hodgkin lymphoma;metastatic hodgkin lymphoma in the cerebral hemisphere;exactmatch
cerebral hodgkin lymphoma;cerebral hodgkin lymphoma;exactmatch
ann arbor stage ii nodular lymphocyte predominant hodgkin lymphoma;ann arbor stage ii nodular lymphocyte predominant hodgkin lymphoma;exactmatch
ann arbor stage ii subdiaphragmatic nodular lymphocyte predominant hodgkin lymphoma;ann arbor stage ii subdiaphragmatic nodular lymphocyte predominant hodgkin lymphoma;exactmatch
ann arbor stage ii supradiaphragmatic nodular lymphocyte predominant hodgkin lymphoma;ann arbor stage ii supradiaphragmatic nodular lymphocyte predominant hodgkin lymphoma;exactmatch
regurgitation;regurgitation;exactmatch
visual disturbance;visual disturbance;exactmatch
ann arbor stage i supradiaphragmatic nodular sclerosis classic hodgkin lymphoma;ann arbor stage i supradiaphragmatic nodular sclerosis classic hodgkin lymphoma;exactmatch
abnormal vaginal discharge;abnormal vaginal discharge;exactmatch
urinary retention;bladder distention;exactmatch
ann arbor stage i subdiaphragmatic nodular sclerosis classic hodgkin lymphoma;ann arbor stage i subdiaphragmatic nodular sclerosis classic hodgkin lymphoma;exactmatch
ann arbor stage ii subdiaphragmatic mixed cellularity classic hodgkin lymphoma;ann arbor stage ii subdiaphragmatic mixed cellularity classic hodgkin lymphoma;exactmatch
tissue damage;tissue damage;exactmatch
tinnitus;tinnitus;exactmatch
ann arbor stage ii mixed cellularity classic hodgkin lymphoma;ann arbor stage ii mixed cellularity classic hodgkin lymphoma;exactmatch
lymphadenopathy;adenopathy;exactmatch
ann arbor stage i supradiaphragmatic mixed cellularity classic hodgkin lymphoma;ann arbor stage i supradiaphragmatic mixed cellularity classic hodgkin lymphoma;exactmatch
ann arbor stage i subdiaphragmatic mixed cellularity classic hodgkin lymphoma;ann arbor stage i subdiaphragmatic mixed cellularity classic hodgkin lymphoma;exactmatch
sore throat;sore throat;exactmatch
ann arbor stage i supradiaphragmatic nodular lymphocyte predominant hodgkin lymphoma;ann arbor stage i supradiaphragmatic nodular lymphocyte predominant hodgkin lymphoma;exactmatch
ann arbor stage i subdiaphragmatic nodular lymphocyte predominant hodgkin lymphoma;ann arbor stage i subdiaphragmatic nodular lymphocyte predominant hodgkin lymphoma;exactmatch
concentric perivascular arrangement of tumor cells;concentric perivascular arrangement of tumor cells;exactmatch
cd34-positive neoplastic cells present;cd34-positive neoplastic cells present;exactmatch
benign nipple neoplasm;benign neoplasm of nipple;exactmatch
breast pleomorphic carcinoma;anaplastic breast carcinoma;exactmatch
breast neuroendocrine neoplasm;breast endocrine neoplasm;exactmatch
low grade breast mucoepidermoid carcinoma;low grade breast mucoepidermoid carcinoma;exactmatch
high grade breast mucoepidermoid carcinoma;high grade breast mucoepidermoid carcinoma;exactmatch
breast mucoepidermoid carcinoma;breast mucoepidermoid carcinoma;exactmatch
childhood lymphoma;childhood lymphoma;exactmatch
breast metaplastic carcinoma; mpbc;exactmatch
breast adenocarcinoma with squamous metaplasia;adenoacanthoma of breast;exactmatch
breast mixed ductal and lobular carcinoma;breast mixed ductal and lobular carcinoma;exactmatch
metastatic breast neuroendocrine tumor g1;metastatic breast carcinoid tumor;exactmatch
spinal cord melanoma;melanoma of spinal cord;exactmatch
spinal cord lymphoma;lymphoma of spinal cord;exactmatch
spinal chordoma;chordoma of spinal column;exactmatch
spinal cord neuroblastoma;neuroblastoma of spinal cord;exactmatch
brain sarcoma;brain sarcoma;exactmatch
central nervous system sarcoma;cns sarcoma;exactmatch
spinal cord sarcoma;sarcoma of spinal cord;exactmatch
breast neuroendocrine tumor g1;breast carcinoid tumor;exactmatch
breast signet ring cell carcinoma;breast signet ring cell carcinoma;exactmatch
malignant spindle-shaped to round cell;malignant spindle-shaped to round cell;exactmatch
breast leiomyosarcoma;breast leiomyosarcoma;exactmatch
benign breast phyllodes tumor;benign breast phyllodes tumor;exactmatch
breast atypical hyperplasia;atypical breast hyperplasia;exactmatch
breast complex fibroadenoma;breast complex fibroadenoma;exactmatch
breast spiradenoma;benign breast eccrine spiradenoma;exactmatch
breast rhabdomyosarcoma;breast rhabdomyosarcoma;exactmatch
breast extraskeletal osteosarcoma;breast extraskeletal osteosarcoma;exactmatch
breast liposarcoma;breast liposarcoma;exactmatch
breast fibrosarcoma;breast fibrosarcoma;exactmatch
metastatic breast signet ring cell carcinoma;metastatic breast signet ring cell carcinoma;exactmatch
breast angiosarcoma;angiosarcoma of breast;exactmatch
hereditary multiple exostoses;hereditary multiple exostoses;exactmatch
breast t-cell non-hodgkin lymphoma;breast t-cell non-hodgkin lymphoma;exactmatch
breast non-hodgkin lymphoma;breast non-hodgkin lymphoma;exactmatch
malignant breast spiradenoma;malignant breast eccrine spiradenoma;exactmatch
metastatic breast squamous cell carcinoma;metastatic breast squamous cell carcinoma;exactmatch
breast squamous cell carcinoma;breast squamous cell carcinoma;exactmatch
cerebral glioblastoma;cerebral glioblastoma;exactmatch
cerebellar glioblastoma;cerebellar glioblastoma;exactmatch
supratentorial glioblastoma;grade iv supratentorial astrocytic neoplasm;exactmatch
hemispheric anaplastic astrocytoma;anaplastic astrocytoma of cerebral hemisphere;exactmatch
breast adenoid cystic carcinoma;adenocystic breast carcinoma;exactmatch
diencephalic glioblastoma;diencephalic gbm;exactmatch
diencephalic astrocytoma;astrocytoma of diencephalon;exactmatch
benign diencephalic neoplasm;benign diencephalic neoplasm;exactmatch
malignant diencephalic neoplasm;malignant diencephalic neoplasm;exactmatch
diencephalic neoplasm;diencephalic neoplasm;exactmatch
anaplastic diencephalic astrocytoma;anaplastic astrocytoma of diencephalon;exactmatch
trigeminal nerve neoplasm;cranial nerve v neoplasms;exactmatch
infratentorial glioblastoma;grade iv infratentorial astrocytic neoplasm;exactmatch
olfactory nerve neoplasm;cranial nerve i neoplasms;exactmatch
vestibulocochlear nerve neoplasm;acoustic nerve neoplasm;exactmatch
nerve root neoplasm;neoplasm of nerve root;exactmatch
spiradenocarcinoma;carcinoma ex eccrine spiradenoma;exactmatch
benign adult brain neoplasm;benign adult brain neoplasm;exactmatch
flcn gene mutation;bhd gene mutation;exactmatch
malignant adult brain neoplasm;brain neoplasms, adult, malignant;exactmatch
hereditary leiomyomatosis and renal cell carcinoma;fh deficiency;exactmatch
fh gene mutation;fh gene mutation;exactmatch
adult central nervous system neoplasm;adult cns neoplasm;exactmatch
childhood central nervous system neoplasm;central nervous system neoplasm;exactmatch
brain stem hemangioblastoma;angioblastoma of brain stem;exactmatch
cerebellar hemangioblastoma;angioblastoma of cerebellum;exactmatch
spinal cord neurofibroma;neurofibroma of spinal cord;exactmatch
benign breast adenomyoepithelioma;benign adenomyoepithelioma of breast;exactmatch
malignant breast adenomyoepithelioma;adenomyoepithelioma with carcinoma;exactmatch
invasive breast cribriform carcinoma;infiltrating cribriform breast carcinoma;exactmatch
breast apocrine carcinoma;apocrine breast carcinoma;exactmatch
breast apocrine carcinoma in situ;apocrine breast carcinoma in situ;exactmatch
breast micropapillary ductal carcinoma in situ;breast intraductal micropapillary carcinoma;exactmatch
breast ductal carcinoma in situ, cribriform pattern;breast ductal carcinoma in situ with cribriform pattern;exactmatch
breast ductal carcinoma in situ, non-comedo type;breast ductal carcinoma in situ, non-comedo type;exactmatch
childhood glioblastoma;childhood glioblastoma;exactmatch
intradural extramedullary spinal canal neoplasm;intradural extramedullary neoplasm of spinal canal;exactmatch
intraspinal meningioma;intraspinal meningioma;exactmatch
benign intracranial meningioma;benign intracranial meningioma;exactmatch
extra-adrenal sympathetic paraganglioma;extra-adrenal chromaffin neoplasm;exactmatch
adrenal medulla neoplasm;adrenal medulla neoplasm;exactmatch
neoplastic stellate chondrocyte;neoplastic stellate chondrocyte;exactmatch
totipotent primordial germ cell;totipotent primordial germ cell;exactmatch
mediastinal paraganglioma;mediastinal paraganglioma;exactmatch
mediastinal myeloid sarcoma;mediastinal myeloid sarcoma;exactmatch
mediastinal t lymphoblastic lymphoma;mediastinal precursor t-lymphoblastic lymphoma;exactmatch
malignant dermal neoplasm;malignant dermal neoplasm;exactmatch
mediastinal t acute lymphoblastic leukemia;mediastinal precursor t-lymphoblastic leukemia;exactmatch
mediastinal t lymphoblastic leukemia/lymphoma;mediastinal precursor t-lymphoblastic lymphoma/leukemia;exactmatch
pluripotent primordial germ cell;pluripotent primordial germ cell;exactmatch
malignant mediastinal germ cell tumor with associated hematologic malignancy;malignant mediastinal germ cell tumor with associated hematologic malignancy;exactmatch
hamartoma of mature cardiac myocytes;hamartoma of mature cardiac myocytes;exactmatch
mediastinal germ cell tumor with somatic-type malignancy;mediastinal germ cell tumor with somatic-type malignancy;exactmatch
malignant skin appendage neoplasm;malignant cutaneous adnexal neoplasm;exactmatch
thymic epithelial stem cell;thymic epithelial stem cell;exactmatch
combined thymic epithelial neoplasm;combined thymic carcinoma;exactmatch
thymic typical carcinoid tumor;thymic typical carcinoid tumor;exactmatch
malignant intestinal neoplasm;bowel cancer;exactmatch
thymic atypical carcinoid tumor;thymic atypical carcinoid tumor;exactmatch
mediastinal solitary fibrous tumor;mediastinal solitary fibrous tumor;exactmatch
adult cardiac cellular rhabdomyoma;adult cardiac cellular rhabdomyoma;exactmatch
"t(15;19)(q13;p13.1)";"t(15;19)(q13;p13.1)";exactmatch
cardiac synovial sarcoma;cardiac synovial sarcoma;exactmatch
malignant cerebral neoplasm;cerebral cancer;exactmatch
metastatic malignant neoplasm in the pericardium;metastatic malignant neoplasm in the pericardium;exactmatch
pericardial germ cell tumor;pericardial germ cell tumor;exactmatch
malignant thalamic neoplasm;malignant neoplasm of thalamus;exactmatch
cardiac rhabdomyosarcoma;cardiac rhabdomyosarcoma;exactmatch
cardiac monophasic synovial sarcoma;cardiac monophasic synovial sarcoma;exactmatch
cardiac biphasic synovial sarcoma;cardiac biphasic synovial sarcoma;exactmatch
heart undifferentiated pleomorphic sarcoma;cardiac malignant fibrous histiocytoma;exactmatch
ventricular myxoma;ventricular myxoma;exactmatch
cystic tumor of the atrioventricular node;benign mesothelioma of mahaim;exactmatch
cardiac inflammatory myofibroblastic tumor;cardiac inflammatory myofibroblastic tumor;exactmatch
cardiac intramuscular hemangioma;cardiac intramuscular hemangioma;exactmatch
cardiac capillary hemangioma;cardiac capillary hemangioma;exactmatch
cardiac cavernous hemangioma;cardiac cavernous hemangioma;exactmatch
malignant great vessel neoplasm;great vessel cancer;exactmatch
cardiac hemangioma;cardiac hemangioma;exactmatch
brd4-nut fusion protein expression;brd4-c15orf55 fusion protein expression;exactmatch
nut carcinoma;"carcinoma with t(15;19)(q13;p13.1) translocation";exactmatch
neoplastic chromaffin cell;neoplastic chromaffin cell;exactmatch
malignant pericardial neoplasm;malignant neoplasm of pericardium;exactmatch
pleural mass;pleural mass;exactmatch
pyothorax;pulmonary empyema;exactmatch
pyothorax-associated lymphoma;pal;exactmatch
malignant myocardial neoplasm;malignant myocardial neoplasm;exactmatch
pleural lymphoma;pleural lymphoma;exactmatch
malignant epicardial neoplasm;malignant epicardial neoplasm;exactmatch
industrial aid;industrial additive;exactmatch
nf2 gene mutation;acn gene mutation;exactmatch
pleural epithelioid hemangioendothelioma;pleural epithelioid hemangioendothelioma;exactmatch
gpc3 gene inactivation;gpc3 gene inactivation;exactmatch
localized pleural malignant mesothelioma;localized pleural malignant mesothelioma;exactmatch
pleural biphasic mesothelioma;pleural biphasic mesothelioma;exactmatch
pleural desmoplastic mesothelioma;pleural desmoplastic mesothelioma;exactmatch
pleural sarcomatoid mesothelioma;pleural sarcomatoid mesothelioma;exactmatch
pleural epithelioid mesothelioma;pleural epithelioid mesothelioma;exactmatch
peritoneal well differentiated papillary mesothelioma;peritoneal wdpm;exactmatch
ebv-transformed late germinal center/post-germinal center b-lymphocyte;ebv-transformed late germinal center/post-germinal center b-lymphocyte;exactmatch
pleural synovial sarcoma;pleural synovial sarcoma;exactmatch
glandular epithelial tissue;glandular epithelial tissue;exactmatch
micronodular thymoma with lymphoid stroma;micronodular thymoma;exactmatch
epithelial tissue;epithelial tissue;exactmatch
thymic epithelial tissue;thymic epithelial tissue;exactmatch
thymus lipofibroadenoma;thymic lipofibroadenoma;exactmatch
malignant respiratory system neoplasm;malignant respiratory system neoplasm;exactmatch
sclerosing thymoma;ancient thymoma;exactmatch
microscopic thymoma;microscopic thymoma;exactmatch
metaplastic thymoma;biphasic thymoma;exactmatch
thymic epithelial cell capable of differentiating towards cortical cell type;thymic epithelial cell capable of differentiating towards cortical cell type;exactmatch
pleural monophasic synovial sarcoma;pleural monophasic synovial sarcoma;exactmatch
thymic epithelial cell capable of differentiating towards both cortical and medullary cell type;thymic epithelial cell capable of differentiating towards both cortical and medullary cell type;exactmatch
"t(15;22)(p11;q11)";"t(15;22)(p11;q11)";exactmatch
thymic medullary epithelial cell;thymic medullary epithelial cell;exactmatch
widely invasive thymoma;widely invasive thymoma;exactmatch
malignant endocardial neoplasm;malignant endocardial neoplasm;exactmatch
minimally invasive thymoma;minimally invasive thymoma;exactmatch
pleural biphasic synovial sarcoma;pleural biphasic synovial sarcoma;exactmatch
conjunctival kaposi sarcoma;conjunctival kaposi sarcoma;exactmatch
corneal kaposi sarcoma;corneal kaposi sarcoma;exactmatch
malignant chest wall neoplasm;malignant chest wall neoplasm;exactmatch
cecum carcinoma in situ;carcinoma in situ of cecum;exactmatch
neoplastic lactotroph cell with large secretory granules;neoplastic lactotroph cell with large secretory granules;exactmatch
malignant lactotroph cell;malignant lactotroph cell;exactmatch
anal intraepithelial neoplasia;ain;exactmatch
malignant thyrotroph cell;malignant thyrotroph cell;exactmatch
malignant corticotroph cell;malignant corticotroph cell;exactmatch
malignant somatotroph cell;malignant somatotroph cell;exactmatch
neoplastic somatotroph cell with scarce secretory granules;neoplastic somatotroph cell with scarce secretory granules;exactmatch
neoplastic somatotroph cell with abundant secretory granules;neoplastic somatotroph cell with abundant secretory granules;exactmatch
misplaced exocytosis present;misplaced exocytosis present;exactmatch
pituitary gland oncocytic adenoma;null cell pituitary gland adenoma, oncocytic variant;exactmatch
hras gene mutation;c-h-ras gene mutation;exactmatch
gain of chromosome 4q;gain of chromosome 4q;exactmatch
sparsely granulated lactotroph adenoma;sparsely granulated lactotroph adenoma;exactmatch
densely granulated lactotroph adenoma;densely granulated lactotroph adenoma;exactmatch
gnas gene mutation;gnas complex locus gene mutation;exactmatch
stage 0 appendix carcinoma ajcc v7;carcinoma in situ of appendix;exactmatch
neoplastic lactotroph cell with small secretory granules;neoplastic lactotroph cell with small secretory granules;exactmatch
well developed rough endoplasmic reticulum present;well developed rer present;exactmatch
gain of chromosome 13q;gain of chromosome 13q;exactmatch
malignant adenohypophysial cell;malignant adenohypophysial cell;exactmatch
benign salivary gland neoplasm;benign neoplasm of salivary gland;exactmatch
benign palate neoplasm;benign neoplasm of palate;exactmatch
presence of a hormonal syndrome;presence of a hormonal syndrome;exactmatch
absence of a hormonal syndrome;absence of a hormonal syndrome;exactmatch
benign gingival neoplasm;benign gingival neoplasm;exactmatch
lesion less than 5 mm in diameter;lesion less than 5 mm in diameter;exactmatch
fungating mass;fungating mass;exactmatch
stage 0is renal pelvis cancer ajcc v7;carcinoma in situ of kidney pelvis;exactmatch
concentric aggregates of intermediate filaments present;concentric aggregates of intermediate filaments present;exactmatch
lesion with diameter greater than 10 mm;lesion with diameter greater than 10 mm;exactmatch
lesion with diameter of 10 mm or less;lesion with diameter of 10 mm or less;exactmatch
neoplastic adenohypophysial cell;neoplastic adenohypophysial cell;exactmatch
multihormonal immunoreactivity present;multihormonal immunoreactivity present;exactmatch
giant mitochondria present;giant mitochondria present;exactmatch
no evidence of hormonal immunoreactivity present;no evidence of hormonal immunoreactivity present;exactmatch
penile intraepithelial neoplasia;pein;exactmatch
acidophil stem cell pituitary gland adenoma;asca;exactmatch
mammosomatotroph adenoma;mammosomatotrope adenoma;exactmatch
mixed somatotroph and lactotroph adenoma;mixed gh-prl cell adenoma;exactmatch
non-functioning pancreatic neuroendocrine tumor g2;non-functional pancreatic neuroendocrine tumor g2;exactmatch
loss of chromosome 3q;3q deletion;exactmatch
gain of chromosome 4;gain of chromosome 4;exactmatch
metastatic malignant neoplasm in the spinal cord;metastasis to spinal cord;exactmatch
pancreatic mixed adenoneuroendocrine carcinoma;mixed exocrine-endocrine carcinoma of the pancreas;exactmatch
functioning pancreatic neuroendocrine tumor g2;functional pancreatic neuroendocrine tumor g2;exactmatch
functioning pancreatic neuroendocrine tumor;functional neuroendocrine tumor;exactmatch
metastatic malignant neoplasm in the testis;metastatic malignant neoplasm in the testis;exactmatch
non-functioning pancreatic neuroendocrine tumor;inactive pancreatic endocrine tumor;exactmatch
sparsely granulated somatotroph adenoma;sparsely granulated pituitary gland somatotroph adenoma;exactmatch
pancreatic neuroendocrine tumor g2;pancreatic net g2;exactmatch
pancreatic neuroendocrine microadenoma;pancreatic endocrine microadenoma;exactmatch
metastatic malignant neoplasm in the peritoneum;metastases to peritoneum, nos;exactmatch
metastatic malignant neoplasm in the bone marrow;metastases to the bone marrow;exactmatch
metastatic malignant neoplasm in the large intestine;metastases to large intestine;exactmatch
gain of chromosome 11q13;gain of chromosome 11q13;exactmatch
gain of chromosome 22q;gain of chromosome 22q;exactmatch
metastatic malignant neoplasm in the eye;eye metastasis;exactmatch
del(18q21);loss of chromosome 18q21;exactmatch
stage 0 oral cavity cancer ajcc v6 and v7;carcinoma in situ of mouth;exactmatch
stage 0 lip cancer ajcc v6 and v7;carcinoma in situ of lip;exactmatch
densely granulated somatotroph adenoma;densely granulated pituitary gland somatotroph adenoma;exactmatch
null cell pituitary gland adenoma;hormone immunonegative adenoma;exactmatch
pituitary gland neoplasm (antiquated);pituitary gland neoplasm (antiquated);exactmatch
anterior pituitary gland neoplasm;anterior pituitary gland neoplasm;exactmatch
adenohypophysial cell;adenohypophysial cell;exactmatch
stage 0 epiglottic carcinoma ajcc v6, v7, and v8;carcinoma in situ of epiglottis;exactmatch
pituicyte;pituicyte;exactmatch
hypothalamic gangliocytoma;hypothalamic gangliocytoma;exactmatch
pituitary gland gangliocytoma;adenohypophysial choristoma;exactmatch
plurihormonal pituitary gland adenoma;multihormonal adenoma;exactmatch
gonadotroph adenoma;gonadotrope adenoma;exactmatch
pituitary stalk;pituitary stalk;exactmatch
tuberculum sellae;tuberculum sellae;exactmatch
stage 0 oropharyngeal carcinoma ajcc v6 and v7;carcinoma in situ of oropharynx;exactmatch
stage 0 nasal cavity cancer ajcc v6, v7, and v8;carcinoma in situ of nasal cavity;exactmatch
pleural well differentiated papillary mesothelioma;pleural wdpm;exactmatch
malignant lung hilum neoplasm;malignant hilar lung neoplasm;exactmatch
absence of invasion;absence of invasion;exactmatch
activated mature gamma/delta t-lymphocyte with a cytotoxic phenotype;activated mature gamma/delta t-lymphocyte with a cytotoxic phenotype;exactmatch
thymic mucosa-associated lymphoid tissue lymphoma;thymic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;exactmatch
optic nerve sheath meningioma;meningioma of optic nerve sheath;exactmatch
multilocular thymic cyst;multilocular thymic cyst;exactmatch
optic nerve glioma;glioma of optic nerve;exactmatch
primary cutaneous cd4-positive small/medium t-cell lymphoproliferative disorder;primary cutaneous cd4-positive small/medium t-cell lymphoproliferative disorder;exactmatch
pituitary gland carcinoma;cancer of pituitary;exactmatch
spinal cord oligodendroglioma;oligodendroglioma of spinal cord;exactmatch
primary cutaneous gamma-delta t-cell lymphoma;cutaneous gamma/delta t-cell lymphoma;exactmatch
malignant vestibulocochlear nerve neoplasm;cancer of vestibulocochlear nerve;exactmatch
spinal cord glioma;glial neoplasm spinal cord;exactmatch
primary cutaneous cd8-positive aggressive epidermotropic cytotoxic t-cell lymphoma;primary cutaneous aggressive epidermotropic cd8-positive t-cell lymphoma;exactmatch
rimming of adipose tissue cells present;rimming of adipose tissue cells present;exactmatch
primary cutaneous peripheral t-cell lymphoma, rare subtype;primary cutaneous peripheral t-cell lymphoma, rare subtype;exactmatch
neoplastic immunoblast-like t-lymphocyte;neoplastic immunoblast-like t-lymphocyte;exactmatch
malignant choroid plexus neoplasm;malignant choroid plexus neoplasm;exactmatch
papulovesicular lesion;papulovesicular lesion;exactmatch
cd15-positive neoplastic cells present;cd15-positive neoplastic cells present;exactmatch
v-mll fusion protein expression;v-mll fusion protein expression;exactmatch
orbit cavernous hemangioma;cavernous angioma of orbit;exactmatch
"t(2;17)(p23;q35)";"t(2;17)(p23;q35)";exactmatch
orbit capillary hemangioma;capillary angioma of orbit;exactmatch
vulvar angiomyofibroblastoma;vulvar angiomyofibroblastoma;exactmatch
vaginal angiomyofibroblastoma;vaginal angiomyofibroblastoma;exactmatch
myh9-alk fusion protein expression;myh9-alk fusion protein expression;exactmatch
alo17-alk fusion protein expression;alo17-alk fusion protein expression;exactmatch
tpm4-alk fusion protein expression;tpm4-alk fusion protein expression;exactmatch
"t(2;22)(p23;q11)";"t(2;22)(p23;q11)";exactmatch
malignant orbit hemangiopericytoma;malignant hemangiopericytoma of orbit;exactmatch
lacrimal gland adenoid cystic carcinoma;adenoid cystic carcinoma of lacrimal gland;exactmatch
"t(2;19)(p23;p13)";"t(2;19)(p23;p13)";exactmatch
pdcd1lg2 gene;pdcd1lg2;exactmatch
orbit rhabdomyosarcoma;orbit rhabdomyosarcoma;exactmatch
colon intramucosal adenocarcinoma;colon intramucosal adenocarcinoma;exactmatch
lacrimal gland pleomorphic adenoma;benign mixed tumor of lacrimal gland;exactmatch
lacrimal gland adenocarcinoma;adenocarcinoma of lacrimal gland;exactmatch
notch1 gene mutation;notch1 gene mutation;exactmatch
hydroa vacciniforme-like lymphoproliferative disorder;hv-like lpd;exactmatch
cd8-positive neoplastic cells present;cd8 antigen positive neoplastic cells present;exactmatch
dermal involvement;dermal involvement;exactmatch
respiratory system finding;respiratory system;exactmatch
cutaneous mature b-cell neoplasm;cutaneous mature b-cell lymphocytic neoplasm;exactmatch
cutaneous t lymphoblastic leukemia/lymphoma;cutaneous precursor t-lymphoblastic lymphoma/leukemia;exactmatch
cutaneous b lymphoblastic leukemia/lymphoma;cutaneous b lymphoblastic leukemia/lymphoma;exactmatch
cutaneous hematopoietic and lymphoid cell neoplasm;cutaneous hematopoietic and lymphoid cell neoplasm;exactmatch
multilocular cystic renal neoplasm of low malignant potential;multilocular clear cell renal cell carcinoma;exactmatch
cutaneous precursor lymphoid neoplasm;cutaneous precursor lymphoblastic lymphoma/leukemia;exactmatch
precursor of plasmacytoid dendritic cell;pdcs;exactmatch
diffuse large b-cell lymphoma unclassifiable;dlbcl unclassifiable;exactmatch
benign accessory urethral gland neoplasm;benign accessory urethral gland neoplasm;exactmatch
neoplasm by obsolete classification;neoplasm by obsolete classification;exactmatch
stage 0 testicular cancer ajcc v6 and v7;stage 0;exactmatch
stage 0 vulvar cancer ajcc v6;ajcc stage 0 vulvar cancer v6;exactmatch
diffuse large b-cell lymphoma, not otherwise specified by gene expression profile;diffuse large b-cell lymphoma, not otherwise specified by gene expression profile;exactmatch
primary cutaneous plasmablastic lymphoma;primary cutaneous plasmablastic lymphoma;exactmatch
primary cutaneous t-cell/histiocyte-rich large b-cell lymphoma;primary cutaneous t-cell/histiocyte rich lymphoma;exactmatch
primary cutaneous intravascular large b-cell lymphoma;primary cutaneous intravascular large b-cell lymphoma;exactmatch
kidney sarcoma;kidney sarcoma;exactmatch
cutaneous mature t-cell and nk-cell neoplasm;cutaneous mature t-cell and nk-cell neoplasm;exactmatch
kidney oncocytoma;kidney oncocytoma;exactmatch
cutaneous chronic lymphocytic leukemia;cutaneous chronic lymphocytic leukemia;exactmatch
confluent sheets of neoplastic b-lymphocytes present;confluent sheets of neoplastic b-lymphocytes present;exactmatch
neoplastic follicle center b-cell;neoplastic follicle center b-cell;exactmatch
neoplastic small to medium-sized b-lymphocyte resembling a centrocyte;neoplastic small to medium-sized b-lymphocyte resembling a centrocyte;exactmatch
stage 0is urethral cancer ajcc v7;carcinoma in situ of urethra;exactmatch
ureter polyp;polyp of ureter;exactmatch
cd56-positive neoplastic cells present;cd56-positive neoplastic cells present;exactmatch
cd4-positive neoplastic cells present;cd4 antigen-positive neoplastic cells present;exactmatch
stage 0is ureter cancer ajcc v7;carcinoma in situ of ureter;exactmatch
renal pelvis urothelial papilloma;renal pelvis urothelial papilloma;exactmatch
cutaneous adult t-cell leukemia/lymphoma;cutaneous adult t-cell leukemia/lymphoma;exactmatch
cutaneous angioimmunoblastic t-cell lymphoma;cutaneous angioimmunoblastic t-cell lymphoma;exactmatch
kidney hemangiopericytoma;hemangiopericytoma of kidney;exactmatch
cutaneous nasal type extranodal nk/t-cell lymphoma;cutaneous nasal type extranodal nk/t-cell lymphoma;exactmatch
cutaneous lymphomatoid granulomatosis;cutaneous lymphomatoid granulomatosis;exactmatch
cutaneous mantle cell lymphoma;cutaneous mantle cell lymphoma;exactmatch
fus-erg fusion protein expression;fus-erg fusion protein expression;exactmatch
tfg-nr4a3 fusion protein expression;tfg-chn fusion protein expression;exactmatch
sarcomatoid mesothelioma;sarcomatoid mesothelioma;exactmatch
adenomatous hyperplasia of the ciliary body;adenomatous hyperplasia of the ciliary body;exactmatch
pulmonary lymphomatoid granulomatosis;pulmonary lymphomatoid granulomatosis;exactmatch
primary pulmonary diffuse large b-cell lymphoma;high grade malt lymphoma of the lung;exactmatch
lung mucinous cystadenoma;lung mucinous cystadenoma;exactmatch
lung pleomorphic adenoma;lung pleomorphic adenoma;exactmatch
lung mixed squamous cell and glandular papilloma;lung mixed squamous cell and glandular papilloma;exactmatch
lung glandular papilloma;lung glandular papilloma;exactmatch
ciliary body leiomyoma;ciliary body leiomyoma;exactmatch
gene fusion abnormality;gene fusion;exactmatch
lung soft tissue neoplasm;lung soft tissue neoplasm;exactmatch
gene duplication abnormality;duplication;exactmatch
gene amplification abnormality;amplification;exactmatch
ciliary body melanoma;ciliary body malignant melanoma;exactmatch
mutation abnormality;genetic alteration;exactmatch
lung squamous cell papilloma;lung squamous cell papilloma;exactmatch
ciliary body malignant medulloepithelioma;ciliary body malignant medulloepithelioma;exactmatch
lung neuroendocrine carcinoma;high grade lung neuroendocrine neoplasm;exactmatch
choroid melanoma;choroid malignant melanoma;exactmatch
choroid hemangioma;angioma of choroid;exactmatch
"t(3;9)(q11-12;q22)";"t(3;9)(q11-12;q22)";exactmatch
lung monophasic synovial sarcoma;lung monophasic synovial sarcoma;exactmatch
lung melanoma;lung melanoma;exactmatch
benign thoracic neoplasm;benign neoplasm of thorax;exactmatch
splenic angiosarcoma;angiosarcoma of spleen;exactmatch
mediastinal thymoma;mediastinal thymoma;exactmatch
intrapulmonary thymoma;intrapulmonary thymoma;exactmatch
lung teratoma;lung teratoma;exactmatch
lung germ cell tumor;lung germ cell neoplasm;exactmatch
lung biphasic synovial sarcoma;lung biphasic synovial sarcoma;exactmatch
malignant lung and pleural neoplasm;malignant lung and pleural neoplasm;exactmatch
lung synovial sarcoma;lung synovial sarcoma;exactmatch
diffuse pulmonary lymphangiomatosis;diffuse pulmonary lymphangiomatosis;exactmatch
chronic eosinophilic leukemia, not otherwise specified;cel;exactmatch
lung chondroma;lung chondroma;exactmatch
type iii pleuropulmonary blastoma;type iii pleuropulmonary blastoma;exactmatch
type ii pleuropulmonary blastoma;type ii pleuropulmonary blastoma;exactmatch
type i pleuropulmonary blastoma;type i pleuropulmonary blastoma;exactmatch
intermediate grade lung neuroendocrine neoplasm;intermediate grade lung neuroendocrine neoplasm;exactmatch
low grade lung neuroendocrine neoplasm;low grade lung neuroendocrine neoplasm;exactmatch
gain of chromosome 3q24-qter;gain of chromosome 3q24-qter;exactmatch
vascular ectasia;vascular ectasia;exactmatch
lung basaloid squamous cell  carcinoma;basaloid squamous cell lung carcinoma;exactmatch
lung squamous cell carcinoma, small cell variant;lung squamous cell carcinoma, small cell variant;exactmatch
lung squamous cell carcinoma, clear cell variant;lung squamous cell carcinoma, clear cell variant;exactmatch
lung squamous cell carcinoma, papillary variant;lung squamous cell carcinoma, papillary variant;exactmatch
conjunctival melanoma;conjunctiva melanoma;exactmatch
conjunctival squamous cell carcinoma;conjunctiva epidermoid carcinoma;exactmatch
lymphangioma circumscriptum;lymphangioma circumscriptum;exactmatch
orbit dermoid cyst;dermoid cyst of orbit;exactmatch
iris nevus;iris nevus;exactmatch
reactive vascular proliferation;reactive vascular proliferation;exactmatch
polymorphus hemangioendothelioma;polymorphus hemangioendothelioma;exactmatch
composite hemangioendothelioma;che;exactmatch
intermediate (rarely metastasizing) blood vessel neoplasm;intermediate (rarely metastasizing) blood vessel neoplasm;exactmatch
intermediate (locally aggressive) blood vessel neoplasm;intermediate (locally aggressive) blood vessel neoplasm;exactmatch
ewsr1-ddit3 fusion protein expression;ews-chop fusion protein expression;exactmatch
orbit hemangiopericytoma;hemangiopericytoma of orbit;exactmatch
lung adenocarcinoma, mixed subtype;lung adenocarcinoma, mixed subtype;exactmatch
lung fetal adenocarcinoma;fetal adenocarcinoma;exactmatch
conjunctival nevus;conjunctival nevus;exactmatch
lung colloid adenocarcinoma;lung colloid adenocarcinoma;exactmatch
lung atypical carcinoid tumor;lung atypical carcinoid tumor;exactmatch
lung typical carcinoid tumor;lung typical carcinoid tumor;exactmatch
benign iris neoplasm;benign iris neoplasm;exactmatch
lung epithelial-myoepithelial carcinoma;lung epithelial-myoepithelial cancer;exactmatch
lung mucoepidermoid carcinoma;lung mucoepidermoid cancer;exactmatch
lung carcinosarcoma;lung carcinosarcoma;exactmatch
lung pleomorphic carcinoma;lung pleomorphic carcinoma;exactmatch
lung spindle cell carcinoma;lung spindle cell carcinoma;exactmatch
lung sarcomatoid carcinoma;lung sarcomatoid carcinoma;exactmatch
malignant iris neoplasm;malignant iris neoplasm;exactmatch
corneal melanoma;cornea melanoma;exactmatch
corneal squamous cell carcinoma;cornea epidermoid carcinoma;exactmatch
lung lymphoepithelioma-like carcinoma;lung lymphoepithelioma-like carcinoma;exactmatch
lung clear cell adenocarcinoma;lung clear cell adenocarcinoma;exactmatch
lung signet ring cell carcinoma;lung signet ring cell carcinoma;exactmatch
thyroid gland papillary microcarcinoma;papillary microcarcinoma of the thyroid;exactmatch
ret/ptc rearrangement;positive;exactmatch
ntrk1 gene rearrangement;mtc gene rearrangement;exactmatch
neoplastic thyroid gland follicular cell with large and hyperchromatic nucleus;neoplastic thyroid gland follicular cell with large and hyperchromatic nucleus;exactmatch
breast paget disease without invasive carcinoma;breast paget disease without invasive carcinoma;exactmatch
breast paget disease;breast paget disease;exactmatch
breast carcinoma with osseous metaplasia;breast carcinoma with osseous metaplasia;exactmatch
breast carcinoma with chondroid metaplasia;breast carcinoma with cartilaginous metaplasia;exactmatch
cardiovascular neoplasm;cardiovascular neoplasm;exactmatch
nesting (zellballen) growth pattern;alveolar (zellballen) growth pattern;exactmatch
malignant endothelial cell;malignant endothelial cell;exactmatch
neoplastic thyroid gland follicular clear cell;neoplastic thyroid gland follicular clear cell;exactmatch
benign digestive system neoplasm;benign digestive system neoplasm;exactmatch
neoplastic thyroid gland follicular signet ring cell;neoplastic thyroid gland follicular signet ring cell;exactmatch
pseudostratified columnar tumor cells present;pseudostratified columnar tumor cells present;exactmatch
borderline ovarian epithelial tumor;borderline epithelial neoplasm of ovary;exactmatch
nuclear grooves;nuclear grooves;exactmatch
nuclear clearing;nuclear clearing;exactmatch
nuclear pseudoinclusion;nuclear pseudoinclusion;exactmatch
diffuse lesion;diffuse lesion;exactmatch
dementia;dementia;exactmatch
malignant nervous system neoplasm;malignant neoplasm of nervous system;exactmatch
recurrent malignant neoplasm;recurrence;exactmatch
optic nerve neoplasm;cranial nerve ii neoplasms;exactmatch
fibromatosis colli;congenital muscular torticollis;exactmatch
malignant sweat gland neoplasm;malignant neoplasm of sweat gland;exactmatch
residual disease;residual disease;exactmatch
cerebral meningioma;cerebral hemispheric meningioma;exactmatch
breast hyperplasia;breast hyperplasia;exactmatch
duodenal carcinoma;cancer of duodenum;exactmatch
central nervous system degenerative disorder;central nervous system degenerative disorder;exactmatch
retinal neoplasm;neoplasm of retina;exactmatch
benign nervous system neoplasm;benign neoplasm of nervous system;exactmatch
deficiency of humoral immunity;b-cell deficiency;exactmatch
recurrent neoplasm;neoplasm recurrence;exactmatch
prostate adenoma;adenoma of prostate;exactmatch
lung lymphoma;lung lymphoma;exactmatch
colon lymphoma;colon lymphoma;exactmatch
right atrial myxoma;myxoma of right atrium;exactmatch
left atrial myxoma;left atrial myxoma;exactmatch
malignant thyroid gland follicular clear cell;malignant thyroid gland follicular clear cell;exactmatch
microfollicular structures present;microfollicular structures present;exactmatch
benign pituitary gland neoplasm;benign neoplasm of pituitary;exactmatch
malignant pituitary gland neoplasm;malignant neoplasm of pituitary;exactmatch
benign extrahepatic bile duct neoplasm;benign extrahepatic bile duct neoplasm;exactmatch
benign duodenal neoplasm;benign duodenal neoplasm;exactmatch
benign rectal neoplasm;benign neoplasm of rectum;exactmatch
benign appendix neoplasm;benign appendix neoplasm;exactmatch
benign cecum neoplasm;benign cecum neoplasm;exactmatch
benign major salivary gland neoplasm;benign major salivary gland neoplasm;exactmatch
benign parotid gland neoplasm;benign neoplasm of parotid;exactmatch
malignant olfactory nerve neoplasm;malignant first cranial nerve neoplasm;exactmatch
macrofollicular structures present;macrofollicular structures present;exactmatch
malignant eye neoplasm;cancer of eye;exactmatch
malignant ciliary body neoplasm;malignant ciliary body neoplasm;exactmatch
malignant middle ear neoplasm;malignant middle ear neoplasm;exactmatch
malignant neoplasm of the abdominal esophagus;malignant neoplasm of abdominal esophagus;exactmatch
malignant neoplasm of the cervical esophagus;malignant neoplasm of cervical esophagus;exactmatch
malignant major salivary gland neoplasm;malignant major salivary gland neoplasm;exactmatch
vulvar high grade squamous intraepithelial lesion;grade 2 vin;exactmatch
benign male reproductive system neoplasm;benign male reproductive system neoplasm;exactmatch
benign kidney neoplasm;benign kidney neoplasm;exactmatch
benign ciliary body neoplasm;benign ciliary body neoplasm;exactmatch
benign eye neoplasm;benign eye neoplasm;exactmatch
follicular structures present;follicular structures present;exactmatch
follicular cell differentiation;follicular cell differentiation;exactmatch
non-neoplastic osteoclast-like giant cell;non-neoplastic osteoclast-like giant cell;exactmatch
vocal cord paralysis;vocal cord palsy;exactmatch
hoarseness;dysphonia;exactmatch
malignant goblet-like mucous cell;malignant goblet-like mucous cell;exactmatch
malignant cuboidal mucous cell;malignant cuboidal mucous cell;exactmatch
benign brain neoplasm;benign brain neoplasm;exactmatch
thyroid gland epithelial tissue;thyroid gland epithelial tissue;exactmatch
malignant squamoid cell;malignant squamoid cell;exactmatch
calcitonin positive neoplastic cells present;calcitonin positive neoplastic cells present;exactmatch
thyroglobulin-positive neoplastic cells present;thyroglobulin-positive neoplastic cells present;exactmatch
malignant neuroendocrine small round cell;malignant neuroendocrine small round cell;exactmatch
serum calcitonin level increased;serum calcitonin level increased;exactmatch
neoplastic c-cell;neoplastic c-cell;exactmatch
malignant odontogenic neoplasm;malignant odontogenic neoplasm;exactmatch
thyroid gland carcinoma;cancer of thyroid;exactmatch
oral cavity cyst;cyst of mouth;exactmatch
primary bone osteosarcoma;primary bone osteosarcoma;exactmatch
malignant adrenal cortical cell;malignant adrenal cortical cell;exactmatch
neoplastic adrenal cortical clear cell;neoplastic adrenal clear cell;exactmatch
neoplastic adrenal cortical cell;neoplastic adrenal cortical cell;exactmatch
malignant epiglottis neoplasm;malignant epiglottic neoplasm;exactmatch
adrenal cortical cell;adrenal cortical cell;exactmatch
abundant intracytoplasmic lipofuscin present;abundant intracytoplasmic lipofuscin present;exactmatch
ewing sarcoma of bone;bone ewing's sarcoma;exactmatch
oral cavity squamous cell carcinoma;mouth scc;exactmatch
esophageal intraepithelial neoplasia;esophageal dysplasia;exactmatch
primary site unknown;primary site unknown;exactmatch
adrenal gland angiosarcoma;adrenal gland angiosarcoma;exactmatch
retroperitoneal sarcoma;retroperitoneal sarcoma;exactmatch
adrenal cortex adenomatoid tumor;adrenal cortex adenomatoid tumor;exactmatch
cerebellar paraganglioma;cerebellar paraganglioma;exactmatch
superior and inferior paraaortic paraganglioma;superior and inferior paraaortic paraganglioma;exactmatch
nasopharyngeal paraganglioma;nasopharyngeal paraganglioma;exactmatch
neuroendocrine tissue;neuroendocrine tissue;exactmatch
esophageal low grade intraepithelial neoplasia;esophageal low grade dysplasia;exactmatch
ewing sarcoma;es;exactmatch
estrogen-producing adrenal cortex adenoma;estrogen producing adrenal cortex adenoma;exactmatch
no evidence of metastatic disease;no evidence of metastatic disease;exactmatch
laryngeal carcinoma;cancer of larynx;exactmatch
stage 0 rectal cancer ajcc v6 and v7;carcinoma in situ of rectum;exactmatch
mild colon dysplasia;low grade colon dysplasia;exactmatch
colon dysplasia;colon dysplasia;exactmatch
pancreatic intraepithelial neoplasia-2;grade 2 pancreatic intraepithelial neoplasia;exactmatch
non-functioning adrenal cortex adenoma;adrenal cortical incidentaloma;exactmatch
androgen-producing adrenal cortex adenoma;androgen producing adrenal cortex adenoma;exactmatch
biliary intraepithelial neoplasia;bilin;exactmatch
sex hormone-producing adrenal cortex adenoma;sex hormone producing adrenal cortex adenoma;exactmatch
aldosterone-producing adrenal cortex adenoma;aldosterone producing adrenal cortex adenoma;exactmatch
pancreatic intraepithelial neoplasia;panin;exactmatch
cortisol-producing adrenal cortex adenoma;cortisol producing adrenal cortex adenoma;exactmatch
neoplastic adrenal cortical oncocyte;neoplastic adrenal cortex oncocyte;exactmatch
adrenal cortex oncocytic adenoma;adrenal cortex oncocytic adenoma;exactmatch
neural crest-derived cell;neural crest-derived cell;exactmatch
benign paraganglioma;benign neuroendocrine cell tumor;exactmatch
gingival hemangioma;angioma of gingiva;exactmatch
adrenal gland composite pheochromocytoma;adrenal gland composite pheochromocytoma;exactmatch
tonsillar carcinoma;cancer of tonsil;exactmatch
malignant parathyroid gland cell;malignant parathyroid gland cell;exactmatch
neoplastic parathyroid gland cell;neoplastic parathyroid gland cell;exactmatch
perineural invasion;perineural invasion;exactmatch
central nervous system neuroblastoma;central nervous system neuroblastoma;exactmatch
hyperparathyroidism;hyperparathyroidism;exactmatch
parathyroid gland epithelial tissue;parathyroid gland epithelial tissue;exactmatch
parathyroid gland parenchymal cell;parathyroid gland parenchymal cell;exactmatch
tongue carcinoma;cancer of tongue;exactmatch
benign adrenal gland pheochromocytoma;benign adrenal gland pheochromocytoma;exactmatch
cancer tnm finding;cancer tnm finding;exactmatch
malignant glioma;glioma, malignant;exactmatch
anogenital human papillomavirus infection;anogenital human papilloma virus infection;exactmatch
skin squamous cell carcinoma;cutaneous squamous cell carcinoma;exactmatch
genomic instability;genomic instability;exactmatch
calcifying aponeurotic fibroma;aponeurotic fibroma;exactmatch
lesion less than 10 mm in diameter;lesion less than 10 mm in diameter;exactmatch
neoplastic parathyroid gland chief cell;neoplastic parathyroid gland chief cell;exactmatch
malignant parathyroid gland chief cell;malignant parathyroid gland chief cell;exactmatch
adrenal gland neuroblastoma;adrenal gland neuroblastoma;exactmatch
malignant parathyroid gland clear cell;malignant parathyroid gland clear cell;exactmatch
sdhd gene mutation;cii-4 gene mutation;exactmatch
sdhc gene mutation;cyb560 gene mutation;exactmatch
sdhb gene mutation;ip gene mutation;exactmatch
sdh complex gene mutation;mitochondrial complex ii gene mutation;exactmatch
familial paraganglioma-pheochromocytoma syndrome;familial paraganglioma-pheochromocytoma syndrome;exactmatch
ureter urothelial carcinoma;transitional cell carcinoma of ureter;exactmatch
disseminated squamous cell carcinoma;disseminated squamous cell carcinoma;exactmatch
hyperparathyroidism-jaw tumor syndrome;hpt-jt;exactmatch
broad fibrous bands formation;broad fibrous bands formation;exactmatch
parathyroid gland atypical adenoma;parathyroid gland atypical adenoma;exactmatch
parathyroid gland lipoadenoma;parathyroid gland hamartoma;exactmatch
primary hyperparathyroidism;primary hyperparathyroidism;exactmatch
neoplastic parathyroid gland clear cell;neoplastic parathyroid gland clear cell;exactmatch
malignant parathyroid gland oncocyte;malignant parathyroid gland oncocyte;exactmatch
neoplastic parathyroid gland oncocyte;neoplastic parathyroid gland oncocyte;exactmatch
vulvar low grade squamous intraepithelial lesion;grade 1 vin;exactmatch
metastatic malignant neoplasm in the liver;liver metastases;exactmatch
pparg gene rearrangement;ppar-gamma rearrangement;exactmatch
benign male breast neoplasm;benign male breast neoplasm;exactmatch
dermoid cyst of the skin;cutaneous dermoid cyst;exactmatch
low grade cervical intraepithelial neoplasia;cervical intraepithelial neoplasia, low grade;exactmatch
malignant neoplasm of the meninges;cancer of meninges;exactmatch
malignant central nervous system neoplasm;cns cancer;exactmatch
malignant coccygeal body neoplasm;malignant coccygeal body neoplasm;exactmatch
malignant jugulotympanic paraganglioma;malignant glomus jugulare neoplasm;exactmatch
benign endocrine neoplasm;benign endocrine gland neoplasm;exactmatch
spinal cord lipoma;lipoma of spinal cord;exactmatch
skin fibroblastic neoplasm;cutaneous fibroblastic neoplasm;exactmatch
external ear lipoma;external auditory meatus lipoma;exactmatch
skin lipoma;cutaneous lipoma;exactmatch
benign skin appendage neoplasm;benign cutaneous adnexal neoplasm;exactmatch
skin papilloma;basosquamous tumor, benign;exactmatch
benign exocrine pancreas neoplasm;benign exocrine pancreas neoplasm;exactmatch
capsular invasion;capsular invasion;exactmatch
thyroid gland paraganglioma;thyroid gland paraganglioma;exactmatch
amelanotic cutaneous melanoma;amelanotic cutaneous (skin) melanoma;exactmatch
gastric neuroendocrine tumor g1;gastric carcinoid tumor;exactmatch
atypical endometrial hyperplasia;atypical endometrial hyperplasia;exactmatch
grade 2 vaginal intraepithelial neoplasia;grade 2 vain;exactmatch
external ear neoplasm;external auditory canal neoplasm;exactmatch
pericardial neoplasm;neoplasm of pericardium;exactmatch
parotid gland pleomorphic adenoma;benign mixed tumor of parotid gland;exactmatch
palate squamous cell carcinoma;palate scc;exactmatch
tongue squamous cell carcinoma;scc of tongue;exactmatch
breast lipoma;breast lipoma;exactmatch
gestational choriocarcinoma;gestational choriocarcinoma;exactmatch
low grade vaginal intraepithelial neoplasia;grade 1 vaginal intraepithelial neoplasia;exactmatch
gastric lymphoma;gastric lymphoma;exactmatch
scrotal squamous cell carcinoma;scrotal squamous cell carcinoma;exactmatch
brain glioblastoma;brain glioblastoma;exactmatch
spinal cord astrocytoma;astrocytoma of spinal cord;exactmatch
rectal melanoma;malignant melanoma of rectum;exactmatch
anal melanoma;anal malignant melanoma;exactmatch
small intestinal neuroendocrine tumor g1;carcinoid tumor of small bowel;exactmatch
intestinal neuroendocrine tumor g1;carcinoid tumor of intestine;exactmatch
thyroid gland teratoma;primary thyroid gland teratoma;exactmatch
thyroid gland follicular adenoma with bizarre nuclei;thyroid gland follicular adenoma with bizarre nuclei;exactmatch
thyroid gland hyperfunctioning adenoma;thyroid gland hot adenoma;exactmatch
thyroid gland hurthle (oncocytic) cell neoplasm;hurthle cell neoplasm;exactmatch
oncocytic variant thyroid gland papillary carcinoma;oncocytic variant thyroid gland papillary cancer;exactmatch
macrofollicular variant thyroid gland papillary carcinoma;macrofollicular variant thyroid gland papillary carcinoma;exactmatch
benign intestinal neoplasm;benign intestinal neoplasm;exactmatch
nonestrogen-dependent malignant neoplasm;nonestrogen-dependent cancer;exactmatch
benign endocardial neoplasm;benign endocardial neoplasm;exactmatch
unilateral breast carcinoma;unilateral breast cancer;exactmatch
benign myocardial neoplasm;benign myocardial neoplasm;exactmatch
presymptomatic cancer;presymptomatic cancer;exactmatch
benign pancreatic neoplasm;benign neoplasm of pancreas;exactmatch
benign epiglottis neoplasm;benign epiglottic neoplasm;exactmatch
benign glottis neoplasm;benign glottis neoplasm;exactmatch
benign oropharyngeal neoplasm;benign neoplasm of oropharynx;exactmatch
benign nasal cavity neoplasm;benign nasal cavity neoplasm;exactmatch
benign middle ear neoplasm;benign middle ear neoplasm;exactmatch
benign sublingual gland neoplasm;benign neoplasm of sublingual gland;exactmatch
thyroid gland squamous cell carcinoma;squamous cell thyroid gland carcinoma;exactmatch
clear cell variant thyroid gland papillary carcinoma;clear cell variant thyroid gland papillary carcinoma;exactmatch
solid/trabecular variant thyroid gland papillary carcinoma;follicular adenocarcinoma, trabecular;exactmatch
clear cell variant thyroid gland follicular carcinoma;clear cell variant thyroid gland follicular carcinoma;exactmatch
sporadic thyroid gland medullary carcinoma;sporadic thyroid gland medullary carcinoma;exactmatch
thyroid gland clear cell follicular adenoma;adenoma, light cell, benign;exactmatch
thyroid gland lipoadenoma;thyroid gland adenolipoma;exactmatch
thyroid gland mucinous follicular adenoma;thyroid gland mucinous follicular adenoma;exactmatch
thyroid gland signet ring cell follicular adenoma;thyroid gland signet ring cell follicular adenoma;exactmatch
thyroid gland follicular adenoma with papillary hyperplasia;papillary variant thyroid gland follicular adenoma;exactmatch
benign anal neoplasm;benign anal neoplasm;exactmatch
intrathyroid thymic carcinoma;castle;exactmatch
thyroid gland spindle cell tumor with thymus-like differentiation;settle;exactmatch
thyroid gland mixed medullary and follicular cell carcinoma;mmftc;exactmatch
sporadic thyroid gland micromedullary carcinoma;sporadic thyroid gland micromedullary carcinoma;exactmatch
reactive c-cell hyperplasia;reactive c-cell hyperplasia;exactmatch
neoplastic c-cell hyperplasia;adenoma, c-cell, benign;exactmatch
c-cell hyperplasia;c-cell hyperplasia;exactmatch
benign colorectal neoplasm;benign colorectal neoplasm;exactmatch
hereditary thyroid gland medullary carcinoma;familial medullary thyroid cancer;exactmatch
malignant external ear neoplasm;malignant external auditory canal neoplasm;exactmatch
trigeminal schwannoma;fifth cranial nerve neurilemmoma;exactmatch
vulvar intraepithelial neoplasia;intraepithelial neoplasia of vulva;exactmatch
cellular schwannoma;cellular neurilemmoma;exactmatch
peutz-jeghers polyp;peutz jeghers polyp;exactmatch
neuropathy;neuropathy;exactmatch
breast atypical lobular hyperplasia;alh;exactmatch
proliferative fasciitis;proliferative fasciitis;exactmatch
post-transplant lymphoproliferative disorder;ptld;exactmatch
adamantinomatous craniopharyngioma;acp;exactmatch
papillary craniopharyngioma;craniopharyngioma, papillary;exactmatch
atypical meningioma;atypical meningioma;exactmatch
low grade t-cell lymphoma;low grade t-cell lymphoma;exactmatch
clear cell meningioma;clear cell meningioma;exactmatch
microcystic meningioma;microcystic meningioma;exactmatch
lymphoplasmacyte-rich meningioma;lymphoplasmacyte-rich meningioma;exactmatch
choroid plexus meningioma;choroid plexus meningioma;exactmatch
secretory meningioma;secretory meningioma;exactmatch
anaplastic ganglioglioma;anaplastic ganglioglioma;exactmatch
ectomesenchymoma;ectomesenchymoma;exactmatch
non-secretory plasma cell myeloma;non-secretory multiple myeloma;exactmatch
high grade t-cell lymphoma;high grade t-cell lymphoma;exactmatch
intracranial meningioma;intracranial meningioma;exactmatch
malignant melanotic peripheral nerve sheath tumor;malignant melanocytic neoplasm of peripheral nerve sheath;exactmatch
chondrogenic neoplasm;cartilaginous neoplasm;exactmatch
spindle cell hemangioma;sch;exactmatch
b-cell prolymphocytic leukemia;b prolymphocytic leukemia;exactmatch
t-cell prolymphocytic leukemia;prolymphocytic leukemia, t-cell type;exactmatch
pigmented spindle cell nevus;pscn;exactmatch
skin cavernous hemangioma;skin cavernous hemangioma;exactmatch
basal cell nevus with comedones;basal cell nevus with comedones;exactmatch
neuronal and mixed neuronal-glial tumors;neuronal and glio-neuronal neoplasm;exactmatch
enteropathy-associated t-cell lymphoma;eatl, type i;exactmatch
benign ovarian brenner tumor;benign brenner neoplasm of ovary;exactmatch
coccygeal body neoplasm;coccygeal body neoplasm;exactmatch
benign basal cell neoplasm;benign basal cell neoplasm;exactmatch
benign squamous cell neoplasm;benign epidermoid cell neoplasm;exactmatch
neoplasm by morphology;neoplasm by morphology;exactmatch
porokeratotic eccrine ostial and dermal duct nevus;linear eccrine nevus with comedones;exactmatch
desmoplastic infantile ganglioglioma;dig;exactmatch
choroid plexus carcinoma;anaplastic choroid plexus papilloma;exactmatch
clear cell ependymoma;clear cell ependymoma;exactmatch
cellular ependymoma;cellular ependymoma;exactmatch
skin spindle cell squamous cell carcinoma;skin pseudosarcomatous squamous cell carcinoma;exactmatch
skull base neoplasm;neoplasm of skull base;exactmatch
acute biphenotypic leukemia;acute biphenotypic leukemia;exactmatch
testicular sertoli cell tumor;sertoli cell neoplasm of testis;exactmatch
breast lymphoma;breast lymphoma;exactmatch
breast sarcoma;breast sarcoma;exactmatch
bladder sarcoma;bladder sarcoma;exactmatch
mediastinal immature teratoma;immature teratoma of mediastinum;exactmatch
plasma cell neoplasm;plasma cell tumor, malignant;exactmatch
adenocarcinoma with metaplasia;adenocarcinoma with metaplasia;exactmatch
t-cell large granular lymphocyte leukemia;leukemia, large granular lymphocytic, malignant;exactmatch
splenic marginal zone lymphoma;marginal zone lymphoma of spleen;exactmatch
meningeal melanocytoma;leptomeningeal melanocytoma;exactmatch
primary melanocytic lesion of meninges;cns primary melanocytic lesions;exactmatch
meningeal solitary fibrous tumor/hemangiopericytoma;hemangiopericytoma of meninges;exactmatch
pineal region germ cell tumor;pineal area germ cell neoplasm;exactmatch
central nervous system cyst;cns cyst;exactmatch
organoid nevus;linear sebaceous nevus;exactmatch
laryngeal keratosis;keratosis of larynx;exactmatch
plantar fibromatosis;ledderhose disease;exactmatch
dermatofibrosarcoma protuberans;dfsp;exactmatch
borderline cystadenoma;borderline cystadenoma;exactmatch
interarytenoid leukoplakia;interarytenoid leukoplakia;exactmatch
eruptive collagenoma;eruptive collagenoma;exactmatch
sclerotic fibroma;circumscribed storiform collagenoma;exactmatch
carney complex;atrial myxoma with lentigines;exactmatch
moniliform hamartoma;hamartoma moniliformis;exactmatch
eccrine angiomatous hamartoma;angiomatous hamartoma, eccrine;exactmatch
encephalocraniocutaneous lipomatosis;eccl;exactmatch
giant cell fibroblastoma;gcf;exactmatch
gestational trophoblastic tumor;gtt;exactmatch
proliferative verrucous leukoplakia;pvl;exactmatch
speckled oral leukoplakia;speckled oral leukoplakia;exactmatch
ulcerated oral leukoplakia;ulcerated oral leukoplakia;exactmatch
gingival fibroepithelial polyp;fibroepithelial polyp of gingiva;exactmatch
nasal type extranodal nk/t-cell lymphoma;angiocentric t-cell lymphoma;exactmatch
epicardial neoplasm;epicardial neoplasm;exactmatch
neoplastic spindle-shaped chondrocyte;neoplastic spindle-shaped chondrocyte;exactmatch
malignant squamous cell;malignant squamous cell;exactmatch
stage iva hypopharyngeal carcinoma ajcc v7;stage iva carcinoma of hypopharynx;exactmatch
stage iib nasopharyngeal carcinoma;stage iib carcinoma of nasopharynx;exactmatch
stage iia nasopharyngeal carcinoma;stage iia carcinoma of nasopharynx;exactmatch
stage iva nasopharyngeal carcinoma ajcc v7;stage iva carcinoma of nasopharynx;exactmatch
stage ivb nasopharyngeal carcinoma ajcc v7;stage ivb carcinoma of nasopharynx;exactmatch
stage ivc nasopharyngeal carcinoma ajcc v7;stage ivc carcinoma of nasopharynx;exactmatch
stage ivc hypopharyngeal carcinoma ajcc v7;stage ivc carcinoma of hypopharynx;exactmatch
stage ivb hypopharyngeal carcinoma ajcc v7;stage ivb carcinoma of hypopharynx;exactmatch
posterior tongue adenoid cystic carcinoma;adenoid cystic carcinoma of base of tongue;exactmatch
stage ivb pharyngeal cancer;pharyngeal cancer stage ivb;exactmatch
posterior tongue mucoepidermoid carcinoma;base of tongue mucoepidermoid carcinoma;exactmatch
tonsillar lipoma;lipoma of tonsil;exactmatch
oropharyngeal polyp;oropharyngeal polyp;exactmatch
stage ivc oropharyngeal carcinoma ajcc v7;stage ivc carcinoma of oropharynx;exactmatch
stage ivb oropharyngeal carcinoma ajcc v7;stage ivb carcinoma of oropharynx;exactmatch
stage iva oropharyngeal carcinoma ajcc v7;stage iva carcinoma of oropharynx;exactmatch
major salivary gland sarcoma;major salivary gland sarcoma;exactmatch
stage iva pharyngeal cancer;pharyngeal cancer stage iva;exactmatch
stage ivc pharyngeal cancer;pharyngeal cancer stage ivc;exactmatch
major salivary gland non-hodgkin lymphoma;major salivary gland non-hodgkin lymphoma;exactmatch
stage ii nasal cavity cancer ajcc v6 and v7;stage ii carcinoma of nasal cavity;exactmatch
paranasal sinus adenoid cystic carcinoma;accessory sinus adenoid cystic carcinoma;exactmatch
paranasal sinus mucoepidermoid carcinoma;accessory sinus mucoepidermoid carcinoma;exactmatch
paranasal sinus adenocarcinoma;accessory sinus adenocarcinoma;exactmatch
paranasal sinus olfactory neuroblastoma;accessory sinus esthesioneuroblastoma;exactmatch
nasal cavity adenocarcinoma;adenocarcinoma of nasal cavity;exactmatch
paranasal sinus carcinoma;accessory sinus cancer;exactmatch
stage i nasal cavity cancer ajcc v6 and v7;stage i carcinoma of nasal cavity;exactmatch
stage iii nasal cavity cancer ajcc v6 and v7;stage iii carcinoma of nasal cavity;exactmatch
stage ivc laryngeal cancer ajcc v7;laryngeal cancer stage ivc;exactmatch
stage iv nasal cavity cancer;stage iv carcinoma of nasal cavity;exactmatch
stage iv paranasal sinus cancer ajcc v7;paranasal sinus cancer stage iv;exactmatch
stage iii paranasal sinus cancer ajcc v6 and v7;paranasal sinus cancer stage iii;exactmatch
stage ii paranasal sinus cancer ajcc v6 and v7;paranasal sinus cancer stage ii;exactmatch
stage i paranasal sinus cancer;paranasal sinus cancer stage i;exactmatch
stage iva laryngeal cancer ajcc v7;laryngeal cancer stage iva;exactmatch
stage ivb laryngeal cancer ajcc v7;laryngeal cancer stage ivb;exactmatch
parotid gland lipoma;lipoma of parotid;exactmatch
salivary gland cystadenocarcinoma;cystadenocarcinoma of salivary gland;exactmatch
liver leiomyosarcoma;hepatic leiomyosarcoma;exactmatch
parotid gland non-hodgkin lymphoma;non-hodgkin's lymphoma of parotid;exactmatch
sublingual gland adenocarcinoma;adenocarcinoma of sublingual gland;exactmatch
minor salivary gland carcinoma;carcinoma of minor salivary gland;exactmatch
minor salivary gland small cell neuroendocrine carcinoma;minor salivary gland neuroendocrine carcinoma;exactmatch
malignant mixed tumor of the minor salivary gland;malignant minor salivary gland mixed neoplasm;exactmatch
minor salivary gland undifferentiated carcinoma;anaplastic carcinoma of minor salivary gland;exactmatch
minor salivary gland mucoepidermoid carcinoma;minor salivary gland mucoepidermoid carcinoma;exactmatch
parotid gland kaposi sarcoma;kaposi's sarcoma of parotid;exactmatch
salivary gland basal cell adenoma;basal cell adenoma;exactmatch
childhood supratentorial neoplasm;childhood supratentorial neoplasm;exactmatch
parotid gland sebaceous lymphadenoma;parotid gland sebaceous lymphadenoma;exactmatch
minor salivary gland adenocarcinoma;adenocarcinoma of minor salivary gland;exactmatch
submandibular gland undifferentiated carcinoma;anaplastic carcinoma of submandibular gland;exactmatch
parotid gland undifferentiated carcinoma;anaplastic carcinoma of parotid;exactmatch
malignant parotid gland mixed tumor;malignant mixed neoplasm of parotid;exactmatch
malignant submandibular gland mixed tumor;malignant mixed neoplasm of submandibular gland;exactmatch
submandibular gland squamous cell carcinoma;squamous cell carcinoma of submandibular gland;exactmatch
minor salivary gland squamous cell carcinoma;epidermoid carcinoma of minor salivary gland;exactmatch
childhood central nervous system embryonal tumor, not otherwise specified;central nervous system embryonal tumor, nos;exactmatch
salivary gland canalicular adenoma;canalicular adenoma of salivary gland;exactmatch
ear polyp;aural polyp;exactmatch
salivary gland myoepithelioma;benign myoepithelioma of the salivary gland;exactmatch
submandibular gland carcinoma ex pleomorphic adenoma;submandibular gland carcinoma ex pleomorphic adenoma;exactmatch
minor salivary gland carcinoma ex pleomorphic adenoma;carcinoma ex pleomorphic adenoma of minor salivary gland;exactmatch
major salivary gland carcinoma ex pleomorphic adenoma;carcinoma ex pleomorphic adenoma of major salivary gland;exactmatch
parotid gland carcinoma ex pleomorphic adenoma;carcinoma ex pleomorphic adenoma of parotid;exactmatch
supraglottic carcinoma;cancer of supraglottis;exactmatch
subglottic carcinoma;cancer of subglottis;exactmatch
childhood cerebellar neoplasm;childhood cerebellar neoplasm;exactmatch
prolactin-producing pituitary gland carcinoma;malignant pituitary gland prolactinoma;exactmatch
childhood brain stem neoplasm;brain stem neoplasm;exactmatch
adult cerebellar neoplasm;adult cerebellar neoplasm;exactmatch
adult brain stem neoplasm;adult brain stem neoplasm;exactmatch
anaplastic brain stem astrocytoma;anaplastic brain stem astrocytoma;exactmatch
tsh-producing pituitary gland carcinoma;malignant pituitary gland thyrotropinoma;exactmatch
acth-producing pituitary gland carcinoma;acth producing pituitary gland carcinoma;exactmatch
growth hormone-producing pituitary gland carcinoma;growth hormone producing pituitary gland carcinoma;exactmatch
laryngeal sarcoma;laryngeal sarcoma;exactmatch
laryngeal liposarcoma;laryngeal liposarcoma;exactmatch
laryngeal leiomyosarcoma;laryngeal leiomyosarcoma;exactmatch
stage 0 nasopharyngeal undifferentiated carcinoma ajcc v6, v7, and v8;nasopharyngeal undifferentiated carcinoma stage o;exactmatch
rat benign schwannoma;rat benign schwannoma;exactmatch
rat benign pinealoma;pinealoma, benign (reni);exactmatch
rat benign oligodendroglioma;oligodendroglioma, benign (reni);exactmatch
rat benign odontogenic tumor;rat benign odontogenic tumor;exactmatch
rat benign neuroendocrine cell tumor;rat benign neuroendocrine cell tumor;exactmatch
rat benign mixed tumor;rat benign mixed tumor;exactmatch
rat benign mixed sex cord stromal tumor;rat benign mixed sex cord stromal tumor;exactmatch
rat benign mixed muellerian tumor;mixed muellerian tumor, benign (reni);exactmatch
rat benign teratoma;rat benign teratoma;exactmatch
rat benign mixed glioma;glioma, mixed, benign (reni);exactmatch
rat benign mesothelioma;mesothelioma, benign (reni);exactmatch
rat benign meningioma;meningioma, benign (reni);exactmatch
rat benign medullary tumor;rat benign adrenal medullary tumor;exactmatch
rat benign luteoma;benign luteoma of the rat;exactmatch
rat benign hibernoma;hibernoma, benign (reni);exactmatch
rat benign hemangiopericytoma;hemangiopericytoma, benign (reni);exactmatch
rat benign sertoli cell tumor;rat benign sertoli cell tumor;exactmatch
prostatic crystalloids present;prostatic crystalloids present;exactmatch
laryngeal neuroendocrine neoplasm;laryngeal neuroendocrine neoplasm;exactmatch
nasopharyngeal squamous cell papilloma;nasopharyngeal papilloma;exactmatch
rat choroid plexus carcinoma;carcinoma, choroid plexus (reni);exactmatch
rat choriocarcinoma;choriocarcinoma (reni);exactmatch
rat chondrosarcoma;chondrosarcoma (reni);exactmatch
rat chondroma;chondroma (reni);exactmatch
rat cholangioma;cholangioma (reni);exactmatch
rat cholangiocarcinoma;cholangiocarcinoma (reni);exactmatch
absence of basal cell layer;absence of basal cell layer;exactmatch
rat c-cell carcinoma;carcinoma, c-cell (reni);exactmatch
stage 0 nasopharyngeal keratinizing squamous cell carcinoma ajcc v6, v7, and v8;keratinizing epidermoid carcinoma in situ of nasopharynx;exactmatch
rat c-cell adenoma;adenoma, c-cell (reni);exactmatch
rat carcinoma, nos;carcinoma, nos (reni);exactmatch
rat carcinoma;carcinoma (reni);exactmatch
rat bronchiolo-alveolar carcinoma;bronchiolo-alveolar carcinoma of the rat;exactmatch
rat bronchiolo-alveolar adenoma;adenoma, bronchiolo-alveolar (reni);exactmatch
rat benign thymoma;rat benign thymoma;exactmatch
rat benign thecoma;rat benign thecoma;exactmatch
rat benign hair follicle tumor;rat benign hair follicle tumor;exactmatch
rat benign granulosa cell tumor;granulosa cell tumor, benign;exactmatch
nasopharyngeal polyp;nasopharyngeal polyp;exactmatch
two to 10 mitoses per 10hpf;two to 10 mitoses per 10hpf;exactmatch
secretory adenocarcinoma cell;acinar carcinoma cell;exactmatch
serum prostate specific antigen increased;serum psa increased;exactmatch
rat histopathology diagnoses for proliferative changes;rat histopathologic diagnoses;exactmatch
lung mature b-cell neoplasm;lung mature b-cell lymphocytic neoplasm;exactmatch
metastatic malignant neoplasm in the larynx;metastatic malignant neoplasm in the larynx;exactmatch
more than 10 mitoses per 10hpf;more than 10 mitoses per 10hpf;exactmatch
less than 2 mitoses per 10hpf;less than 2 mitoses per 10hpf;exactmatch
malignant spindle transitional cell;malignant spindle transitional cell;exactmatch
rat benign granular cell tumor;rat benign granular cell tumor;exactmatch
metastatic malignant neoplasm in the nasopharynx;metastasis to the nasopharynx;exactmatch
metastatic malignant neoplasm in the oropharynx;metastasis to the oropharynx;exactmatch
metastatic malignant neoplasm in the hypopharynx;metastatic malignant neoplasm in the hypopharynx;exactmatch
laryngeal leiomyoma;laryngeal leiomyoma;exactmatch
subglottic hemangioma;angioma of subglottis;exactmatch
laryngeal small cell neuroendocrine carcinoma;laryngeal small cell carcinoma;exactmatch
laryngeal carcinoid tumor;carcinoid tumor of larynx;exactmatch
tissue autolysed diagnosis not possible;tissue autolysed diagnosis not possible;exactmatch
rat acinar cell adenocarcinoma;adenocarcinoma, acinar cell (reni);exactmatch
rat acinar cell adenoma;adenoma, acinar cell (reni);exactmatch
rat acinar islet cell adenoma;adenoma, acinar-islet cell (reni);exactmatch
rat benign fibrous histiocytoma;histiocytoma, fibrous, benign (reni);exactmatch
rat benign ependymoma;ependymoma, benign (reni);exactmatch
rat benign endocardial schwannoma;rat benign endocardial schwannoma;exactmatch
rat benign craniopharyngioma;craniopharyngioma, benign (reni);exactmatch
rat benign chordoma;chordoma, benign;exactmatch
rat benign basal cell tumor;rat benign basal cell tumor;exactmatch
rat benign atriocaval mesothelioma;mesothelioma, atriocaval, benign (reni);exactmatch
rat benign astrocytoma;astrocytoma, benign (reni);exactmatch
rat basal cell carcinoma;carcinoma, basal cell (reni);exactmatch
rat ameloblastoma;ameloblastoma (reni);exactmatch
rat ameloblastic odontoma;odontoma, ameloblastic (reni);exactmatch
rat adenosquamous carcinoma;carcinoma, adenosquamous (reni);exactmatch
rat adenoma;adenoma (reni);exactmatch
rat adenocarcinoma arising in fibroadenoma;adenocarcinoma arising in fibroadenoma (reni);exactmatch
rat adenocarcinoma;adenocarcinoma (reni);exactmatch
parotid gland squamous cell carcinoma;parotid gland squamous cell carcinoma;exactmatch
parotid gland adenocarcinoma;adenocarcinoma of parotid;exactmatch
submandibular gland adenocarcinoma;adenocarcinoma of submandibular gland;exactmatch
nerve plexus neoplasm;neoplasm of nerve plexus;exactmatch
accessory nerve neoplasm;accessory nerve neoplasm;exactmatch
glossopharyngeal nerve neoplasm;glossopharyngeal nerve neoplasm;exactmatch
facial nerve neoplasm;facial nerve neoplasm;exactmatch
abducens nerve neoplasm;abducens nerve neoplasm;exactmatch
trochlear nerve neoplasm;fourth cranial nerve neoplasm;exactmatch
lumbar plexus neoplasm;lumbar plexus neoplasm;exactmatch
brachial plexus neoplasm;brachial plexus neoplasm;exactmatch
esophageal neuroendocrine neoplasm;esophageal neuroendocrine neoplasm;exactmatch
vagus nerve neoplasm;neoplasm of tenth cranial nerve;exactmatch
esophageal neuroendocrine tumor g1;carcinoid tumor of esophagus;exactmatch
buccal squamous cell papilloma;buccal mucosa papilloma;exactmatch
pharyngeal adenoid cystic carcinoma;adenoid cystic carcinoma of pharynx;exactmatch
intracranial embryonal tumor, not otherwise specified;intracranial embryonal tumor, nos;exactmatch
metastatic malignant neoplasm in the adult brain;brain metastases, adult;exactmatch
small intestinal gastrointestinal stromal tumor;digestive stromal neoplasm of small intestine;exactmatch
stage iv small intestinal cancer ajcc v7;small intestine cancer stage iv;exactmatch
hypoglossal nerve neoplasm;hypoglossal nerve neoplasm;exactmatch
liver fibrosarcoma;fibrosarcoma of liver;exactmatch
extrahepatic bile duct leiomyoma;extrahepatic bile duct leiomyoma;exactmatch
extrahepatic bile duct mucinous adenocarcinoma;bile duct colloid carcinoma;exactmatch
extrahepatic bile duct fibroma;extrahepatic bile duct fibroma;exactmatch
extrahepatic bile duct benign granular cell tumor;benign extrahepatic bile duct granular cell myoblastoma;exactmatch
extrahepatic bile duct mucinous cystic neoplasm;cystadenoma of extrahepatic bile duct;exactmatch
extrahepatic bile duct tubular adenoma;extrahepatic bile duct tubular adenoma;exactmatch
extrahepatic bile duct papillary adenoma;extrahepatic bile duct papillary adenoma;exactmatch
extrahepatic bile duct leiomyosarcoma;bile duct leiomyosarcoma;exactmatch
extrahepatic bile duct embryonal rhabdomyosarcoma;embryonal extrahepatic bile duct rhabdomyosarcoma;exactmatch
extrahepatic bile duct small cell neuroendocrine carcinoma;extrahepatic bile duct small cell carcinoma;exactmatch
liver extraskeletal osteosarcoma;hepatic extraskeletal osteosarcoma;exactmatch
gallbladder kaposi sarcoma;gallbladder kaposi sarcoma;exactmatch
gallbladder leiomyosarcoma;gallbladder leiomyosarcoma;exactmatch
gallbladder angiosarcoma;angiosarcoma of gallbladder;exactmatch
gallbladder rhabdomyosarcoma;gallbladder rhabdomyosarcoma;exactmatch
gallbladder undifferentiated carcinoma, spindle and giant cell type;gallbladder undifferentiated carcinoma, spindle and giant cell type;exactmatch
gallbladder lipoma;gallbladder lipoma;exactmatch
liver rhabdomyosarcoma;hepatic rhabdomyosarcoma;exactmatch
stage iii small intestinal cancer ajcc v7;small intestine cancer stage iii;exactmatch
stage ii small intestinal cancer ajcc v7;small intestine cancer stage ii;exactmatch
stage i small intestinal cancer ajcc v7;small intestine cancer stage i;exactmatch
liver mucosa-associated lymphoid tissue lymphoma;hepatic maltoma;exactmatch
extrahepatic bile duct clear cell adenocarcinoma;bile duct clear cell adenocarcinoma;exactmatch
stage ivb extrahepatic bile duct cancer;extrahepatic bile duct cancer stage ivb;exactmatch
stage iva extrahepatic bile duct cancer;extrahepatic bile duct cancer stage iva;exactmatch
stage iv extrahepatic bile duct cancer;extrahepatic bile duct cancer stage iv;exactmatch
stage iii extrahepatic bile duct cancer;extrahepatic bile duct cancer stage iii;exactmatch
stage ii extrahepatic bile duct cancer;extrahepatic bile duct cancer stage ii;exactmatch
stage i extrahepatic bile duct cancer;extrahepatic bile duct cancer stage i;exactmatch
liver non-hodgkin lymphoma;hepatic non-hodgkin lymphoma;exactmatch
gastric gastrointestinal stromal tumor;digestive stromal neoplasm of stomach;exactmatch
stage ivb hepatocellular carcinoma ajcc v7;stage ivb carcinoma of liver cells;exactmatch
stage iva hepatocellular carcinoma ajcc v7;stage iva hepatocellular cancer;exactmatch
stage iv hepatocellular carcinoma ajcc v6;hepatocellular cancer stage iv ajcc v6;exactmatch
stage iiib hepatocellular carcinoma ajcc v7;stage iiib carcinoma of liver cells;exactmatch
stage iiia hepatocellular carcinoma ajcc v7;stage iiia carcinoma of liver cells;exactmatch
stage iii hepatocellular carcinoma ajcc v6;hepatocellular cancer stage iii ajcc v6;exactmatch
stage ii hepatocellular carcinoma ajcc v6 and v7;hepatocullular cancer stage ii;exactmatch
extrahepatic bile duct signet ring cell carcinoma;bile duct signet ring cell carcinoma;exactmatch
extrahepatic bile duct squamous cell carcinoma;bile duct squamous cell carcinoma;exactmatch
extrahepatic bile duct adenosquamous carcinoma;adenosquamous bile duct carcinoma;exactmatch
extrahepatic bile duct undifferentiated carcinoma;anaplastic carcinoma of extrahepatic bile duct;exactmatch
small intestinal neuroendocrine neoplasm;small intestinal neuroendocrine neoplasm;exactmatch
childhood infratentorial neoplasm;childhood infratentorial neoplasm;exactmatch
childhood choroid plexus papilloma;childhood choroid plexus papilloma;exactmatch
benign childhood supratentorial neoplasm;benign childhood supratentorial neoplasm;exactmatch
benign childhood brain neoplasm;benign childhood brain neoplasm;exactmatch
benign adult brain stem neoplasm;adult benign brain stem neoplasms;exactmatch
benign adult cerebellar neoplasm;adult benign cerebellar neoplasms;exactmatch
childhood brain germ cell tumor;brain germ cell tumor;exactmatch
adult central nervous system teratoma;adult cns teratoma;exactmatch
adult central nervous system choriocarcinoma;adult cns choriocarcinoma;exactmatch
adult central nervous system germinoma;adult cns germinoma;exactmatch
adult central nervous system embryonal carcinoma;adult cns embryonal carcinoma;exactmatch
pancreatic non-hodgkin lymphoma;pancreatic non-hodgkin lymphoma;exactmatch
jejunal somatostatin-producing neuroendocrine tumor;delta cell tumor of jejunum;exactmatch
liver neuroendocrine tumor;carcinoid tumor of liver;exactmatch
extrahepatic bile duct lipoma;extrahepatic bile duct lipoma;exactmatch
benign extrahepatic bile duct soft tissue neoplasm;benign extrahepatic bile duct soft tissue neoplasm;exactmatch
submandibular gland mucoepidermoid carcinoma;mucoepidermoid carcinoma of submandibular gland;exactmatch
oral cavity lipoma;lipoma of mouth;exactmatch
tonsillar lymphoma;lymphoma of tonsil;exactmatch
upper gingival verrucous carcinoma;upper gingival verrucous carcinoma;exactmatch
oral cavity sarcoma;mouth sarcoma;exactmatch
oral cavity mucosal melanoma;mouth mucosal melanoma;exactmatch
oral cavity adenocarcinoma;adenocarcinoma of mouth;exactmatch
oral cavity adenoma;adenoma of mouth;exactmatch
oral cavity granular cell tumor;granular cell neoplasm of mouth;exactmatch
oral cavity leiomyoma;leiomyoma of mouth;exactmatch
astler-coller b3 rectal carcinoma;astler-coller b3 carcinoma of rectum;exactmatch
salivary gland mucoepidermoid carcinoma;mucoepidermoid carcinoma of salivary gland;exactmatch
major salivary gland carcinoma;carcinoma of major salivary gland;exactmatch
major salivary gland mucoepidermoid carcinoma;major salivary gland mucoepidermoid cancer;exactmatch
major salivary gland adenoid cystic carcinoma;adenoid cystic carcinoma of major salivary gland;exactmatch
salivary duct carcinoma;carcinoma of salivary duct;exactmatch
major salivary gland adenocarcinoma;adenocarcinoma of major salivary gland;exactmatch
malignant mixed tumor of the major salivary gland;malignant major salivary gland mixed neoplasm;exactmatch
astler-coller b3 colon carcinoma;astler-coller b3 carcinoma of colon;exactmatch
astler-coller c3 rectal carcinoma;astler-coller c3 carcinoma of rectum;exactmatch
extrahepatic bile duct adenoma;adenoma of extrahepatic bile duct;exactmatch
astler-coller c1 colorectal carcinoma;astler-coller c1 colorectal carcinoma;exactmatch
parotid gland mucoepidermoid carcinoma;mucoepidermoid carcinoma of parotid;exactmatch
parotid gland adenoid cystic carcinoma;adenoid cystic carcinoma of parotid;exactmatch
minor salivary gland adenoid cystic carcinoma;adenoid cystic carcinoma of minor salivary gland;exactmatch
submandibular gland adenoid cystic carcinoma;adenoid cystic carcinoma of submandibular gland;exactmatch
submandibular gland acinic cell carcinoma;acinic cell carcinoma of submandibular gland;exactmatch
parotid gland acinic cell carcinoma;acinic cell carcinoma of parotid;exactmatch
salivary gland oncocytoma;oncocytoma of salivary gland;exactmatch
astler-coller c2 colorectal carcinoma;astler-coller c2 colorectal carcinoma;exactmatch
astler-coller c1 rectal carcinoma;astler-coller c1 carcinoma of rectum;exactmatch
astler-coller c3 colorectal carcinoma;astler-coller c3 colorectal carcinoma;exactmatch
astler-coller b3 colorectal carcinoma;astler-coller b3 colorectal carcinoma;exactmatch
astler-coller a colorectal carcinoma;astler-coller a colorectal carcinoma;exactmatch
stage iiib anal canal cancer ajcc v6 and v7;stage iiib anal canal cancer;exactmatch
stage iiia anal canal cancer ajcc v6 and v7;stage iiia anal canal cancer;exactmatch
astler-coller a rectal carcinoma;astler-coller a carcinoma of rectum;exactmatch
astler-coller c2 rectal carcinoma;astler-coller c2 carcinoma of rectum;exactmatch
major salivary gland acinic cell carcinoma;acinic cell adenocarcinoma of major salivary gland;exactmatch
stage iv major salivary gland carcinoma without metastasis;stage iv carcinoma of major salivary gland without metastasis;exactmatch
stage iv major salivary gland carcinoma with metastasis;stage iv carcinoma of major salivary gland with metastasis;exactmatch
stage ivb oral cavity mucoepidermoid carcinoma ajcc v6 and v7;stage ivb mouth mucoepidermoid carcinoma;exactmatch
stage iva basal cell lip carcinoma;stage iva basal cell carcinoma of lip;exactmatch
stage ivb basal cell lip carcinoma;stage ivb basal cell carcinoma of lip;exactmatch
stage ivc basal cell lip carcinoma;stage ivc basal cell carcinoma of lip;exactmatch
stage ivc oral cavity verrucous carcinoma;stage ivc mouth verrucous carcinoma;exactmatch
stage ivb oral cavity verrucous carcinoma;stage ivb mouth verrucous carcinoma;exactmatch
stage iva oral cavity verrucous carcinoma;stage iva mouth verrucous carcinoma;exactmatch
stage iva oral cavity mucoepidermoid carcinoma ajcc v6 and v7;stage iva mouth mucoepidermoid carcinoma;exactmatch
stage ivc oral cavity mucoepidermoid carcinoma ajcc v6 and v7;stage ivc mouth mucoepidermoid carcinoma;exactmatch
stage iv major salivary gland cancer ajcc v7;stage iv carcinoma of major salivary gland;exactmatch
stage ivc oral cavity adenoid cystic carcinoma ajcc v6 and v7;stage ivc adenoid cystic carcinoma of mouth;exactmatch
stage ivb oral cavity adenoid cystic carcinoma ajcc v6 and v7;stage ivb adenoid cystic carcinoma of mouth;exactmatch
stage iva oral cavity adenoid cystic carcinoma ajcc v6 and v7;stage iva adenoid cystic carcinoma of mouth;exactmatch
extrahepatic bile duct mucoepidermoid carcinoma;bile duct mucoepidermoid carcinoma;exactmatch
extrahepatic bile duct neuroendocrine tumor g1;carcinoid tumor of extrahepatic bile duct;exactmatch
extrahepatic bile duct rhabdomyosarcoma;extrahepatic bile duct rhabdomyosarcoma;exactmatch
liver inflammatory myofibroblastic tumor;hepatic inflammatory myofibroblastic tumor;exactmatch
stage i lip cancer ajcc v6 and v7;stage i cancer of lip;exactmatch
stage ii lip cancer ajcc v6 and v7;stage ii cancer of lip;exactmatch
stage iii lip cancer ajcc v6 and v7;stage iii cancer of lip;exactmatch
stage iv lip cancer ajcc v6 and v7;stage iv cancer of lip;exactmatch
stage iii major salivary gland cancer ajcc v7;stage iii carcinoma of major salivary gland;exactmatch
stage ii major salivary gland cancer ajcc v7;stage ii carcinoma of major salivary gland;exactmatch
stage i major salivary gland cancer ajcc v7;stage i carcinoma of major salivary gland;exactmatch
stage 0 lip basal cell carcinoma ajcc v6 and v7;basal cell carcinoma in situ of lip;exactmatch
stage 0 oral cavity verrucous carcinoma;mouth verrucous carcinoma in situ;exactmatch
stage ivc oral cavity cancer ajcc v6 and v7;stage ivc carcinoma of mouth;exactmatch
stage ivb oral cavity cancer ajcc v6 and v7;stage ivb carcinoma of mouth;exactmatch
stage iva oral cavity cancer ajcc v6 and v7;stage iva carcinoma of mouth;exactmatch
stage iv oral cavity cancer ajcc v6 and v7;stage iv carcinoma of mouth;exactmatch
stage iii oral cavity cancer ajcc v6 and v7;stage iii carcinoma of mouth;exactmatch
stage ii oral cavity cancer ajcc v6 and v7;stage ii carcinoma of mouth;exactmatch
stage i oral cavity cancer ajcc v6 and v7;stage i carcinoma of mouth;exactmatch
stage ivc lip cancer ajcc v6 and v7;stage ivc carcinoma of lip;exactmatch
stage ivb lip cancer ajcc v6 and v7;stage ivb carcinoma of lip;exactmatch
stage iva lip cancer ajcc v6 and v7;stage iva carcinoma of lip;exactmatch
rat choroid plexus papilloma;papilloma, choroid plexus (reni);exactmatch
oropharyngeal squamous cell papilloma;oropharyngeal papilloma;exactmatch
rat cortical adenoma;adenoma of the rat adrenal cortex;exactmatch
rectal small cell neuroendocrine carcinoma;rectal small cell carcinoma;exactmatch
sphenoid sinus squamous cell carcinoma;epidermoid carcinoma of sphenoid sinus;exactmatch
ethmoid sinus squamous cell carcinoma;epidermoid carcinoma of ethmoid sinus;exactmatch
childhood lesion;childhood lesion;exactmatch
adulthood lesion;adulthood lesion;exactmatch
colon medullary carcinoma;colon medullary carcinoma;exactmatch
rectal medullary carcinoma;rectal medullary carcinoma;exactmatch
maxillary sinus squamous cell carcinoma;epidermoid carcinoma of maxillary sinus;exactmatch
rat zymbal gland;rat zymbal gland;exactmatch
intramucosal lesion;intramucosal lesion;exactmatch
rat vagina;rat vagina;exactmatch
rat uterus;rat uterus;exactmatch
rat uterine cervix;rat cervix;exactmatch
rat urinary bladder;rat bladder;exactmatch
rat urethra;rat urethra;exactmatch
rat ureter;rat ureter;exactmatch
rat trachea;rat trachea;exactmatch
tenesmus;tenesmus;exactmatch
malignant epithelial cell with vesicular nucleus, distinct nucleolus, and abundant pink cytoplasm;malignant epithelial cell with vesicular nucleus, distinct nucleolus, and abundant pink cytoplasm;exactmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat hematopoietic and mononuclear phagocytic system neoplasms;exactmatch
enterochromaffin type granules present;ec type granules present;exactmatch
rat female genital system neoplasms;rat female genital system neoplasms;exactmatch
rat endocrine system neoplasms;rat endocrine system neoplasms;exactmatch
rat digestive system neoplasms;rat digestive system neoplasms;exactmatch
rat nervous system and sensory organs neoplasms;rat nervous system and sensory organs neoplasms;exactmatch
rat cardiovascular system neoplasms;rat cardiovascular system neoplasms;exactmatch
paranasal sinus lymphoma;accessory sinus lymphoma;exactmatch
rat neoplasms by location;rat neoplasms by location;exactmatch
enterochromaffin-like type granules present;ecl type granules present;exactmatch
rassf1 gene;rassf1;exactmatch
serotonin-positive neoplastic cells present;serotonin-positive neoplastic cells present;exactmatch
argentaffin positive neoplastic cells present;argentaffin positive neoplastic cells present;exactmatch
chromogranin-a positive neoplastic cells present;chga positive neoplastic cells present;exactmatch
malt1 wt allele;dkfzp434l132;exactmatch
malt1 gene;malt1;exactmatch
frontal sinus squamous cell carcinoma;epidermoid carcinoma of frontal sinus;exactmatch
ras association domain-containing protein 1;cardiac-specific ras association domain family 1 protein;exactmatch
rat tooth;rat tooth;exactmatch
benign anterior tongue neoplasm;benign anterior tongue neoplasm;exactmatch
rat tongue;rat tongue;exactmatch
rat oviduct;oviduct (reni);exactmatch
rat peritoneum;peritoneum (reni);exactmatch
rat pericardium;pericardium (reni);exactmatch
rat parotid gland;parotid gland (reni);exactmatch
recurrent oral cavity squamous cell carcinoma;recurrent epidermoid carcinoma of mouth;exactmatch
rat parathyroid gland;parathyroid gland (reni);exactmatch
rat paranasal sinus;paranasal sinus (reni);exactmatch
rat pancreas;pancreas (reni);exactmatch
rat ovary;ovary (reni);exactmatch
rat thyroid gland;rat thyroid;exactmatch
rat oral cavity;oral cavity, nos (reni);exactmatch
rat nasopharynx;nasopharynx (reni);exactmatch
rat nasal cavity;nasal cavity (reni);exactmatch
stage ivc oral cavity squamous cell carcinoma ajcc v6 and v7;stage ivc epidermoid carcinoma of mouth;exactmatch
rat mononuclear phagocytic tissue;mononuclear phagocytic tissue (reni);exactmatch
rat mandibular gland;mandibular gland (reni);exactmatch
rat mammary gland;mammary gland (reni);exactmatch
rat pineal gland;pineal gland (reni);exactmatch
rat pituitary gland;pituitary gland (reni);exactmatch
rat pleura;pleura (reni);exactmatch
rat preputial gland;preputial gland (reni);exactmatch
rat thymus;rat thymus;exactmatch
rat testis;rat testicle;exactmatch
rat sublingual gland;rat sublingual gland;exactmatch
anterior tongue neoplasm;anterior tongue neoplasm;exactmatch
rat spinal meninx;rat spinal meninges;exactmatch
rat spinal cord;rat medulla spinalis;exactmatch
rat soft tissue;rat soft tissue;exactmatch
rat skin/subcutaneous tissue;rat skin and subcutaneous tissue;exactmatch
rat skeletal system;rat skeletal system;exactmatch
rat skeletal muscle;rat skeletal muscle;exactmatch
rat seminal vesicle;rat seminal sac;exactmatch
rat salivary gland;rat salivary gland;exactmatch
rat renal pelvis;rat renal pelvis;exactmatch
malignant anterior tongue neoplasm;malignant anterior tongue neoplasm;exactmatch
rat prostate;prostate (reni);exactmatch
rat genital system neoplasms;rat genital system neoplasms;exactmatch
rat integumentary system neoplasms;rat integumentary system neoplasms;exactmatch
rat liver;liver (reni);exactmatch
malignant cutaneous basal cell;malignant cutaneous basal cell;exactmatch
proliferation of small ducts present;proliferation of small ducts present;exactmatch
distal common bile duct;distal common bile duct;exactmatch
external ear actinic keratosis;actinic keratosis of external ear;exactmatch
cysts containing proteinaceous fluid present;cysts containing proteinaceous fluid present;exactmatch
eye carcinoma;carcinoma of eye;exactmatch
anorectal fistula;anal fistula;exactmatch
anal mucosa;anal mucosa;exactmatch
fibrovascular stalks present;fibrovascular stalks present;exactmatch
malignant small round cell with scant amount of dark granular cytoplasm;malignant small round cell with scant amount of dark granular cytoplasm;exactmatch
astrocytoma;astrocytoma;exactmatch
brain astrocytoma;brain astrocytoma;exactmatch
eyelid carcinoma;carcinoma of eyelid;exactmatch
neck carcinoma;carcinoma of neck;exactmatch
recurrent oral cavity carcinoma;recurrent carcinoma of mouth;exactmatch
osseous metaplasia of malignant cells present;osseous metaplasia of malignant cells present;exactmatch
cartilaginous metaplasia of malignant cells present;cartilaginous metaplasia of malignant cells present;exactmatch
small cuboidal cell resembling fetal hepatocyte;small cuboidal cell resembling fetal hepatocyte;exactmatch
melanin pigment present;melanin pigment present;exactmatch
rat male genital system neoplasms;rat male genital system neoplasms;exactmatch
single cell necrosis;single cell necrosis;exactmatch
histiocytoid differentiation;histiocytoid differentiation;exactmatch
lacrimal drainage system squamous cell carcinoma;lacrimal drainage system squamous cell carcinoma;exactmatch
malignant spindle mesothelial cell;malignant spindle mesothelial cell;exactmatch
microglandular pattern;adenomatoid pattern;exactmatch
lacrimal gland mucoepidermoid carcinoma;lacrimal gland mucoepidermoid carcinoma;exactmatch
middle ear carcinoma;carcinoma of middle ear;exactmatch
cytoplasmic membrane-bound granules present;cytoplasmic membrane-bound granules present;exactmatch
ceruminous adenoma;adenoma, ceruminous gland, benign;exactmatch
external ear carcinoma;carcinoma of external ear;exactmatch
ectopic thyroid tissue present;ectopic thyroid tissue present;exactmatch
middle ear squamous cell carcinoma;epidermoid carcinoma of middle ear;exactmatch
middle ear paraganglioma;middle ear paraganglioma;exactmatch
external ear squamous cell carcinoma;epidermoid carcinoma of external ear;exactmatch
squamoid corpuscle;squamoid corpuscle;exactmatch
lipase hypersecretion syndrome;lipase hypersecretion syndrome;exactmatch
external ear basal cell carcinoma;basal cell carcinoma of external ear;exactmatch
mesenchymal metaplasia of malignant cells present;mesenchymal metaplasia of malignant cells present;exactmatch
spindle cell metaplasia of malignant cells present;spindle cell metaplasia of malignant cells present;exactmatch
squamous metaplasia of malignant cells present;squamous metaplasia of malignant cells present;exactmatch
stage iva paranasal sinus cancer ajcc v7;paranasal sinus cancer stage iva;exactmatch
stage ivb paranasal sinus cancer ajcc v7;stage ivb accessory sinus carcinoma;exactmatch
appendix neuroendocrine neoplasm;appendix neuroendocrine neoplasm;exactmatch
neuron-specific enolase positive neoplastic cells present;nse positive neoplastic cells present;exactmatch
glucagon-like peptide positive neoplastic cells present;glucagon-like peptide positive neoplastic cells present;exactmatch
vip-positive neoplastic cells present;vip-positive neoplastic cells present;exactmatch
somatostatin-positive neoplastic cells present;somatostatin-positive neoplastic cells present;exactmatch
gastrin-positive neoplastic cells present;gastrin-positive neoplastic cells present;exactmatch
periampullary region;periampullary region;exactmatch
nasal cavity non-hodgkin lymphoma;nasal cavity non-hodgkin lymphoma;exactmatch
biliary obstruction;biliary obstruction;exactmatch
rat neoplasms by morphology;rat neoplasms by morphology;exactmatch
rat special sensory organ neoplasms;rat special sensory organ neoplasms;exactmatch
rat urinary system neoplasms;rat urinary system neoplasms;exactmatch
rat soft tissue and musculoskeletal system neoplasms;rat soft tissue and musculoskeletal system neoplasms;exactmatch
paranasal sinus non-hodgkin lymphoma;accessory sinus non-hodgkin's lymphoma;exactmatch
rat respiratory system neoplasms;rat respiratory system neoplasms;exactmatch
submucosal tumor growth;submucosal tumor growth;exactmatch
stage ivc paranasal sinus cancer ajcc v7;paranasal sinus cancer stage ivc;exactmatch
absence of invasion of the muscularis externa;absence of invasion of the muscularis externa;exactmatch
paranasal sinus diffuse large b-cell lymphoma;accessory sinus diffuse large b-cell lymphoma;exactmatch
metaplasia of malignant cells present;metaplasia of malignant cells present;exactmatch
rat male reproductive system part;rat male reproductive system;exactmatch
rat female reproductive system part;rat female reproductive system;exactmatch
rat urinary system part;rat urinary system;exactmatch
rat special sensory organ part;rat special sensory organ;exactmatch
rat respiratory system part;rat respiratory system;exactmatch
rat reproductive system part;rat reproductive system;exactmatch
rat nervous system part;rat nervous system;exactmatch
nasal cavity lymphoma;lymphoma of nasal cavity;exactmatch
rat musculoskeletal system part;rat musculoskeletal system;exactmatch
rat lymphohematopoietic system part;rat lymphohematopoietic system;exactmatch
rat integument system part;rat integument system;exactmatch
rat endocrine system part;rat endocrine system;exactmatch
rat digestive system part;rat digestive system;exactmatch
rat cardiovascular system part;rat cardiovascular system;exactmatch
rat lung;lung (reni);exactmatch
rat larynx;larynx (reni);exactmatch
rat cortical carcinoma;carcinoma of the rat adrenal cortex;exactmatch
thyroid gland non-hodgkin lymphoma;non-hodgkin's lymphoma of thyroid;exactmatch
rat malignant intraocular schwannoma;rat malignant intraocular schwannoma;exactmatch
rat malignant hibernoma;hibernoma, malignant (reni);exactmatch
rat malignant hemangiopericytoma;hemangiopericytoma, malignant (reni);exactmatch
rat malignant granulosa cell tumor;rat malignant granulosa cell tumor;exactmatch
rat malignant fibrous histiocytoma;histiocytoma, fibrous, malignant (reni);exactmatch
rat malignant ependymoma;ependymoma, malignant (reni);exactmatch
rat malignant endocardial schwannoma;rat malignant endocardial schwannoma;exactmatch
rat malignant craniopharyngioma;craniopharyngioma, malignant (reni);exactmatch
rat malignant mast cell tumor;rat malignant mast cell tumor;exactmatch
rat malignant chordoma;chordoma, malignant (reni);exactmatch
rat malignant atriocaval mesothelioma;mesothelioma, atriocaval, malignant (reni);exactmatch
rat malignant astrocytoma;astrocytoma, malignant (reni);exactmatch
rat lymphangioma;lymphangioma (reni);exactmatch
rat liposarcoma;liposarcoma (reni);exactmatch
adenocarcinoma cell with abundant cytoplasm;adenocarcinoma cell with abundant cytoplasm;exactmatch
rat lipoma;lipoma (reni);exactmatch
rat malignant lymphoma;lymphoma, malignant (reni);exactmatch
rat malignant medullary tumor;rat malignant medullary tumor;exactmatch
rat malignant thecoma;rat malignant thecoma;exactmatch
thyroid gland diffuse large b-cell lymphoma;diffuse large b-cell lymphoma of thyroid;exactmatch
rat malignant sertoli cell tumor;rat malignant sertoli cell tumor;exactmatch
rat malignant seminoma;rat malignant seminoma;exactmatch
rat malignant schwannoma;rat malignant schwannoma;exactmatch
rat malignant reticulosis;rat malignant reticulosis;exactmatch
rat malignant pinealoma;pinealoma, malignant (reni);exactmatch
rat malignant oligodendroglioma;oligodendroglioma, malignant (reni);exactmatch
rat malignant odontogenic tumor;rat malignant odontogenic tumor;exactmatch
rat malignant neuromyoblastoma;neuromyoblastoma, malignant (reni);exactmatch
rat malignant melanoma;melanoma, malignant (reni);exactmatch
rat malignant neuroendocrine cell tumor;rat malignant neuroendocrine cell tumor;exactmatch
rat malignant mixed tumor;rat malignant mixed tumor;exactmatch
rat malignant mixed sertoli-leydig cell tumor;mixed sertoli-leydig cell tumor, malignant (reni);exactmatch
rat malignant mixed muellerian tumor;mixed muellerian tumor, malignant (reni);exactmatch
rat malignant mixed glioma;glioma, mixed, malignant (reni);exactmatch
rat malignant mesothelioma;mesothelioma, malignant (reni);exactmatch
rat malignant mesenchymoma;mesenchymoma, malignant (reni);exactmatch
rat leydig cell carcinoma;carcinoma, leydig cell (reni);exactmatch
thyroid gland angiosarcoma;angiosarcoma of thyroid;exactmatch
rat leydig cell adenoma;adenoma, leydig cell (reni);exactmatch
rat endometrial stromal sarcoma;rat endometrial stromal sarcoma;exactmatch
rat follicular cell adenoma;adenoma, follicular cell (reni);exactmatch
rat fibrosarcoma;fibrosarcoma (reni);exactmatch
rat fibroma;fibroma (reni);exactmatch
rat fibroadenoma;fibroadenoma (reni);exactmatch
rat erythroid leukemia;leukemia, erythroid (reni);exactmatch
poorly differentiated thyroid gland carcinoma;insular carcinoma;exactmatch
mucinous fibroplasia;mucinous fibroplasia;exactmatch
rat endometrial stromal polyp;polyp, endometrial stromal (reni);exactmatch
rat leukemia;leukemia, nos (reni);exactmatch
rat embryonal carcinoma;carcinoma, embryonal (reni);exactmatch
glomerulations;glomerulations;exactmatch
stage 0 oropharyngeal squamous cell carcinoma ajcc v6 and v7;epidermoid carcinoma in situ of oropharynx;exactmatch
rat ductal cell adenoma;adenoma, ductal cell (reni);exactmatch
rat ductal cell adenocarcinoma;adenocarcinoma, ductal cell (reni);exactmatch
rat cystadenoma;cystadenoma (reni);exactmatch
rat cystadenocarcinoma;cystadenocarcinoma (reni);exactmatch
rat follicular cell carcinoma;carcinoma, follicular cell (reni);exactmatch
rat glandular polyp;polyp, glandular (reni);exactmatch
thyroid gland sarcoma;sarcoma of thyroid;exactmatch
rat granulocytic leukemia;leukemia, granulocytic (reni);exactmatch
rat leiomyosarcoma;leiomyosarcoma (reni);exactmatch
rat leiomyoma;leiomyoma (reni);exactmatch
rat keratoacanthoma;keratoacanthoma (reni);exactmatch
rat keratinizing cystic epithelioma;epithelioma, cystic, keratinizing (reni);exactmatch
rat islet cell carcinoma;carcinoma, islet cell (reni);exactmatch
rat islet cell adenoma;adenoma, islet cell (reni);exactmatch
rat hyperplasia;hyperplasia (reni);exactmatch
thyroid gland hurthle cell adenoma;benign oncocytoma of thyroid;exactmatch
rat histiocytic sarcoma;histiocytic sarcoma of the rat mononuclear phagocytic tissue;exactmatch
rat hepatocholangiocellular carcinoma;carcinoma, hepatocholangiocellular (reni);exactmatch
rat hepatocholangiocellular adenoma;adenoma, hepatocholangiocellular (reni);exactmatch
rat hepatocellular carcinoma;carcinoma, hepatocellular (reni);exactmatch
rat hepatocellular adenoma;adenoma, hepatocellular (reni);exactmatch
rat hemangiosarcoma;hemangiosarcoma (reni);exactmatch
rat hemangioma;hemangioma (reni);exactmatch
rat malignant teratoma;rat malignant teratoma;exactmatch
rat malignant thymoma;rat malignant thymoma;exactmatch
stage ivb oral cavity squamous cell carcinoma ajcc v6 and v7;stage ivb epidermoid carcinoma of mouth;exactmatch
polarization of nuclei towards the glandular lumen;polarization of nuclei towards the glandular lumen;exactmatch
rat bronchus;bronchus (reni);exactmatch
rat bronchiole;bronchiole (reni);exactmatch
rat brain;brain (reni);exactmatch
rat adrenal gland;adrenal gland (reni);exactmatch
stage ii oral cavity squamous cell carcinoma ajcc v6 and v7;stage ii epidermoid carcinoma of mouth;exactmatch
rat anatomy concepts;rat anatomy;exactmatch
neoplastic neuroendocrine small cell;neoplastic neuroendocrine small cell;exactmatch
intraluminal masses of mucin present;intraluminal masses of mucin present;exactmatch
rat cerebellum;cerebellum (reni);exactmatch
tall columnar adenocarcinoma cell;tall columnar adenocarcinoma cell;exactmatch
rat yolk sac carcinoma;carcinoma, yolk sac (reni);exactmatch
stage i oral cavity squamous cell carcinoma ajcc v6 and v7;stage i epidermoid carcinoma of mouth;exactmatch
rat uveal leiomyoma;leiomyoma, uveal (reni);exactmatch
rat unclassifiable malignant tumor;rat unclassifiable malignant tumor;exactmatch
rat unclassifiable benign tumor;rat unclassifiable benign tumor;exactmatch
adenocarcinoma cell with foamy cytoplasm;adenocarcinoma cell with foamy cytoplasm;exactmatch
stage iii oral cavity squamous cell carcinoma ajcc v6 and v7;stage iii epidermoid carcinoma of mouth;exactmatch
rat cerebral meninx;cerebral meninx (reni);exactmatch
rat medulloblastoma;medulloblastoma (reni);exactmatch
rat eyelid;eyelid (reni);exactmatch
rat kidney;kidney (reni);exactmatch
rat joint;joint (reni);exactmatch
rat hematopoietic tissue;hematopoietic tissue (reni);exactmatch
rat heart;heart (reni);exactmatch
stage iva oral cavity squamous cell carcinoma ajcc v6 and v7;stage iva epidermoid carcinoma of mouth;exactmatch
rat glandular stomach;glandular stomach (reni);exactmatch
rat forestomach;forestomach (reni);exactmatch
rat eyeball;eyeball (reni);exactmatch
rat clitoral gland;clitoral gland (reni);exactmatch
rat esophagus;esophagus (reni);exactmatch
rat epididymis;epididymis (reni);exactmatch
stage iv oral cavity squamous cell carcinoma ajcc v6 and v7;stage iv epidermoid carcinoma of mouth;exactmatch
rat external ear;ear, external (reni);exactmatch
rat cranial nerve;cranial nerve (reni);exactmatch
rat conjunctiva;conjunctiva (reni);exactmatch
rat coagulating gland;coagulating gland (reni);exactmatch
rat tubulostromal adenoma;adenoma, tubulostromal (reni);exactmatch
rat tubulostromal adenocarcinoma;adenocarcinoma, tubulostromal (reni);exactmatch
rat transitional cell papilloma;papilloma, transitional cell (reni);exactmatch
rat odontoma;odontoma (reni);exactmatch
rat pars distalis adenoma;adenoma, pars distalis, benign;exactmatch
tracheal leiomyoma;leiomyoma of trachea;exactmatch
rat papilloma;papilloma (reni);exactmatch
rat osteosarcoma;osteosarcoma (reni);exactmatch
rat osteoma;osteoma (reni);exactmatch
rat osteochondroma;osteochondroma (reni);exactmatch
rat olfactory neuroblastoma;neuroblastoma, olfactory (reni);exactmatch
rat odontogenic fibroma;fibroma, odontogenic (reni);exactmatch
stage 0 oral cavity squamous cell carcinoma ajcc v6 and v7;epidermoid carcinoma in situ of mouth;exactmatch
rat ocular dermoid;dermoid, ocular (reni);exactmatch
rat non-keratinizing epithelioma;epithelioma, non-keratinizing (reni);exactmatch
stage 0 hypopharyngeal squamous cell carcinoma ajcc v6, v7, and v8;epidermoid carcinoma in situ of hypopharynx;exactmatch
rat neuroendocrine cell hyperplasia;hyperplasia, neuroendocrine cell (reni);exactmatch
rat nephroblastoma;nephroblastoma (reni);exactmatch
rat myelolipoma;myelolipoma (reni);exactmatch
rat meningeal sarcoma;rat meningeal sarcoma;exactmatch
rat pars distalis carcinoma;carcinoma, pars distalis, malignant;exactmatch
rat pars intermedia adenoma;adenoma, pars intermedia, benign;exactmatch
rat pituicytoma;pituicytoma (reni);exactmatch
lipoma of the rat kidney;lipoma of the rat kidney;exactmatch
rat transitional cell carcinoma;carcinoma, transitional cell (reni);exactmatch
rat synovial sarcoma;rat synovial sarcoma;exactmatch
rat squamous cell papilloma;papilloma, squamous cell (reni);exactmatch
large neoplastic glands with branching and papillary infolding present;large neoplastic glands with branching and papillary infolding present;exactmatch
rat squamous cell carcinoma;carcinoma, squamous cell (reni);exactmatch
tracheal adenoid cystic carcinoma;adenoid cystic carcinoma of trachea;exactmatch
rat sebaceous cell carcinoma;carcinoma, sebaceous cell (reni);exactmatch
rat sebaceous cell adenoma;adenoma, sebaceous cell (reni);exactmatch
rat sarcoma;rat sarcoma;exactmatch
rat rhabdomyosarcoma;rat rhabdomyosarcoma;exactmatch
rat retinoblastoma;rat retinoblastoma;exactmatch
rat rete testis carcinoma;carcinoma, rete testis (reni);exactmatch
rat rete testis adenoma;adenoma of the rat rete testis;exactmatch
tracheal sarcoma;sarcoma of trachea;exactmatch
liposarcoma of the rat kidney;liposarcoma of the rat kidney;exactmatch
stage i hepatocellular carcinoma ajcc v6 and v7;hepatocellular cancer stage i;exactmatch
clear cell hepatocellular carcinoma;clear cell carcinoma of liver cells;exactmatch
hyaline cartilage differentiation;hyaline cartilage differentiation;exactmatch
mesenchymal component present;mesenchymal component present;exactmatch
columnar cell change of the breast with atypia;columnar cell change of breast with atypia;exactmatch
columnar cell change of the breast;blunt duct adenosis of breast;exactmatch
breast columnar cell lesion;breast columnar cell lesion;exactmatch
pleural schwannoma;neurilemmoma of pleura;exactmatch
carcinomatous component present;carcinomatous component present;exactmatch
osseous component present;osseous component present;exactmatch
cartilaginous component present;cartilaginous component present;exactmatch
medium size melanoma cell;medium size melanoma cell;exactmatch
breast columnar cell hyperplasia with atypia;breast columnar cell hyperplasia with atypia;exactmatch
lesion with diameter greater than 15 mm;lesion with diameter greater than 15 mm;exactmatch
secondary supratentorial anaplastic astrocytoma;anaplastic secondary supratentorial astrocytoma;exactmatch
spindle b melanoma cell;spindle b melanoma cell;exactmatch
spindle a melanoma cell;spindle a melanoma cell;exactmatch
mixture of germ cell neoplastic components present;mixture of germ cell neoplastic components present;exactmatch
cerebellopontine angle neoplasm;c-p angle neoplasm;exactmatch
cerebellopontine angle schwannoma;c-p angle neurinoma;exactmatch
breast columnar cell hyperplasia;breast columnar cell hyperplasia;exactmatch
floor of mouth;floor of mouth;exactmatch
schiller-duval body;schiller-duval body;exactmatch
peripheral nuclear palisading;peripheral nuclear palisading;exactmatch
mucin-producing malignant epithelial cell;mucin-producing malignant epithelial cell;exactmatch
crtc1-maml2 fusion protein expression;crtc1-maml2 fusion protein expression;exactmatch
"t(11;19)(q21;p13)";"t(11;19)(q21;p13)";exactmatch
horny masses of keratin present;horny masses of keratin present;exactmatch
early stromal invasion present;early stromal invasion present;exactmatch
urachal epithelium;urachal epithelium;exactmatch
sympathetic schwannoma;sympathetic neurilemmoma;exactmatch
malignant hyperchromatic squamous cell;malignant hyperchromatic squamous cell;exactmatch
rectosigmoid region;rectosigmoid junction;exactmatch
malignant small squamous cell;malignant basaloid squamous cell;exactmatch
endophytic tumor growth;endophytic tumor growth;exactmatch
upper gingiva;upper gingiva;exactmatch
lower gingiva;lower gingiva;exactmatch
exophytic papillary lesion;exophytic papillary lesion;exactmatch
gliofibroma;gliofibroma;exactmatch
colorectal region;colorectal region;exactmatch
malignant large germ cell with abundant cytoplasm;malignant large germ cell with abundant cytoplasm;exactmatch
sinusoidal growth pattern;sinusoidal growth pattern;exactmatch
liver leiomyoma;hepatic leiomyoma;exactmatch
hereditary lesion;hereditary lesion;exactmatch
neoplastic vacuolated stromal cell;neoplastic vacuolated stromal cell;exactmatch
central nervous system t-cell non-hodgkin lymphoma;cns t-cell lymphoma;exactmatch
intradural extramedullary cauda equina astrocytoma;intradural extramedullary astrocytoma of cauda equina;exactmatch
polyhedral melanocyte;polyhedral melanocyte;exactmatch
fusiform melanocyte;fusiform melanocyte;exactmatch
nevoid polygonal cell;nevoid polygonal cell;exactmatch
medulloblastoma with extensive nodularity;cerebellar neuroblastoma;exactmatch
spinal cord embryonal tumor, not otherwise specified;primitive neuroectodermal neoplasm of spinal cord;exactmatch
aggravated disease;aggravated disease;exactmatch
cerebellopontine angle;cerebellopontine angle;exactmatch
preexisting condition;pre-existing condition;exactmatch
nevoid basal cell carcinoma syndrome associated medulloblastoma;nevoid basal cell carcinoma syndrome associated medulloblastoma;exactmatch
striated muscle component present;striated muscle component present;exactmatch
melanin-forming neuroepithelial cells present;melanin-forming neuroepithelial cells present;exactmatch
malignant neuroectodermal small cell;malignant neuroectodermal small cell;exactmatch
malignant neuroectodermal large cell;malignant neuroectodermal large cell;exactmatch
gastric granular cell tumor;gastric granular cell tumor;exactmatch
nodules of compact keratin present;nodules of compact keratin present;exactmatch
cytoplasmic hyaline globules present;cytoplasmic hyaline globules present;exactmatch
malignant germ cell;malignant germ cell;exactmatch
clivus chordoma;chordoma of clivus;exactmatch
malignant syncytiotrophoblastic giant cell;malignant syncytiotrophoblastic giant cell;exactmatch
malignant cytotrophoblastic cell;malignant cytotrophoblastic cell;exactmatch
sarcomatous or carcinomatous component present;sarcomatous or carcinomatous component present;exactmatch
mesodermal differentiation;mesodermal differentiation;exactmatch
endodermal differentiation;endodermal differentiation;exactmatch
ectodermal differentiation;ectodermal differentiation;exactmatch
adult central nervous system embryonal tumor, not otherwise specified;adult cns pnet;exactmatch
cholesterol deposit;cholesterol deposit;exactmatch
"undifferentiated ""fetal-type"" tissues present";"undifferentiated ""fetal-type"" tissues present";exactmatch
"fully differentiated ""adult-type"" tissues present";"fully differentiated ""adult-type"" tissues present";exactmatch
germinal layer;germinal layer;exactmatch
abnormal germ cell;abnormal germ cell;exactmatch
parinaud syndrome;dorsal midbrain syndrome;exactmatch
malignant central nervous system germ cell tumor;malignant central nervous system germ cell neoplasm;exactmatch
rathke pouch epithelium;rathke pouch epithelium;exactmatch
odontogenic cyst;odontogenic cyst;exactmatch
postcricoid region;lower hypopharyngeal region;exactmatch
posterior wall of the pharynx;posterior pharyngeal wall;exactmatch
laryngeal papillary squamous cell carcinoma;laryngeal papillary squamous cell carcinoma;exactmatch
laryngeal giant cell carcinoma;laryngeal anaplastic carcinoma;exactmatch
laryngeal lymphoepithelial carcinoma;laryngeal lymphoepithelial carcinoma;exactmatch
schwannoma of the twelfth cranial nerve;hypoglossal nerve neurilemmoma;exactmatch
laryngeal undifferentiated carcinoma;laryngeal undifferentiated carcinoma;exactmatch
laryngeal adenosquamous carcinoma;laryngeal adenosquamous carcinoma;exactmatch
laryngeal acantholytic squamous cell carcinoma;laryngeal acantholytic squamous cell carcinoma;exactmatch
laryngeal squamous cell carcinoma, spindle cell variant;laryngeal carcinosarcoma;exactmatch
laryngeal basaloid carcinoma;laryngeal basaloid carcinoma;exactmatch
nasal cavity exophytic papilloma;nasal cavity exophytic papilloma;exactmatch
cerebral hemangioma;angioma of cerebral hemispheres;exactmatch
dentinogenic ghost cell tumor;calcifying ghost cell odontogenic tumor;exactmatch
intracranial cavernous hemangioma;intracranial cavernoma;exactmatch
calcifying cystic odontogenic tumor;calcifying cystic odontogenic tumor;exactmatch
odontoameloblastoma;ameloblastic odontoma;exactmatch
primary intraosseous squamous cell carcinoma derived from keratocystic odontogenic tumor;primary intraosseous carcinoma ex keratocystic odontogenic tumor;exactmatch
odontogenic keratocyst;kcot;exactmatch
sinonasal oncocytic papilloma;oncocytic schneiderian papilloma;exactmatch
kadish stage c olfactory neuroblastoma;kadish stage c olfactory neuroblastoma;exactmatch
retromolar trigone;retromolar trigone;exactmatch
central nervous system leukemia;cns leukemia;exactmatch
renal pelvis and ureter;renal pelvis and ureter;exactmatch
intraluminal necrosis;intraluminal necrosis;exactmatch
round adenocarcinoma cell;round adenocarcinoma cell;exactmatch
cervix glandular epithelium;cervix columnar epithelium;exactmatch
rassf1a gene inactivation;rassf1 gene inactivation;exactmatch
central nervous system teratoma;cns teratoma;exactmatch
nasopharyngeal papillary adenocarcinoma;nasopharyngeal papillary adenocarcinoma;exactmatch
cellular stratification;cellular stratification;exactmatch
cerebellopontine angle embryonal tumor, not otherwise specified;c-p angle pnet;exactmatch
drop metastasis in the spinal cord;drop metastasis in the spinal cord;exactmatch
nasopharyngeal differentiated carcinoma;differentiated nasopharyngeal cancer;exactmatch
malignant epithelial large cell with vesicular nucleus and distinct nucleolus;malignant epithelial large cell with vesicular nucleus and distinct nucleolus;exactmatch
corpus callosum lipoma;corpus callosum lipoma;exactmatch
extracranial neuroblastoma;extracranial neuroblastoma;exactmatch
transcription regulation gene;transcription regulation gene;exactmatch
nasopharyngeal basaloid carcinoma;nasopharyngeal basaloid carcinoma;exactmatch
calcifying epithelial odontogenic tumor;ceot;exactmatch
clear cell odontogenic carcinoma;clear cell ameloblastoma;exactmatch
intracranial germinoma;intracranial germinoma;exactmatch
malignant hyperchromatic epithelial cell;malignant hyperchromatic epithelial cell;exactmatch
dome-shaped lesion;dome-shaped lesion;exactmatch
acantholysis;acantholysis;exactmatch
windblown appearance of atypical keratinocytes;windblown appearance of atypical keratinocytes;exactmatch
skin adenosquamous carcinoma;skin adenosquamous cancer;exactmatch
angiosarcoma-like areas present;angiosarcoma-like areas present;exactmatch
skin ulcer;skin ulcer;exactmatch
solar radiation toxicity;solar radiation toxicity;exactmatch
basaloid squamous cell carcinoma;basaloid squamous cell carcinoma;exactmatch
ameloblastic carcinoma-secondary type (dedifferentiated), peripheral;ameloblastic carcinoma-secondary type (dedifferentiated), peripheral;exactmatch
no evidence of radiologic finding;no evidence of radiologic finding;exactmatch
bronchial epithelial cell;bronchial epithelial cell;exactmatch
mixture of morphologic patterns;mixture of morphologic patterns;exactmatch
epidural spinal canal angiolipoma;angiolipoma of epidural spinal canal;exactmatch
malignant large squamous cell;malignant large squamous cell;exactmatch
cervicomedullary junction neoplasm;cervicomedullary junction neoplasm;exactmatch
lip and oral cavity;lip and oral cavity;exactmatch
clivus chondroid chordoma;chondroid chordoma of clivus;exactmatch
ear carcinoma;ear carcinoma;exactmatch
retroperitoneal ganglioneuroma;ganglioneuroma of retroperitoneum;exactmatch
throat;throat;exactmatch
ameloblastic carcinoma-secondary type (dedifferentiated), intraosseous;ameloblastic carcinoma-secondary type (dedifferentiated), intraosseous;exactmatch
metastasizing ameloblastoma;ameloblastoma, malignant;exactmatch
odontogenic epithelium;odontogenic epithelium;exactmatch
primary intraosseous squamous cell carcinoma;pioscc;exactmatch
sinonasal undifferentiated carcinoma;sinonasal anaplastic carcinoma;exactmatch
sinonasal carcinoma;nasal cavity and paranasal sinus cancer;exactmatch
sinonasal tract;nasal cavity and paranasal sinuses;exactmatch
childhood mediastinal neurogenic neoplasm;childhood mediastinal neurogenic neoplasm;exactmatch
sinonasal non-keratinizing squamous cell carcinoma;non-keratinizing sinonasal squamous cell carcinoma;exactmatch
nasal cavity keratinizing squamous cell carcinoma;keratinizing nasal cavity squamous cell carcinoma;exactmatch
paranasal sinus keratinizing squamous cell carcinoma;keratinizing paranasal sinus squamous cell carcinoma;exactmatch
head and neck keratinizing squamous cell carcinoma;head and neck keratinizing squamous cell carcinoma;exactmatch
rhinorrhea;nasal discharge;exactmatch
paranasal sinus epithelium;paranasal sinus epithelium;exactmatch
intramedullary spinal cord teratoma;intramedullary spinal cord teratoma;exactmatch
malignant neuroectodermal round cell;malignant neuroectodermal round cell;exactmatch
nodular, reticulin-free zones present;nodular, reticulin-free zones present;exactmatch
malignant neuroectodermal cell with hyperchromatic nucleus and scanty cytoplasm;malignant neuroectodermal cell with hyperchromatic nucleus and scanty cytoplasm;exactmatch
cardiac kaposi sarcoma;cardiac kaposi sarcoma;exactmatch
spindle cell pattern;spindle cell pattern;exactmatch
cord-like pattern;cord-like pattern;exactmatch
malignant polygonal cell with eosinophilic cytoplasm;malignant polygonal cell with eosinophilic cytoplasm;exactmatch
wreath-like multinucleated giant cell;wreath-like multinucleated giant cell;exactmatch
cardiac leiomyosarcoma;cardiac leiomyosarcoma;exactmatch
epithelioid component present;epithelioid component present;exactmatch
malignant spindle cell;malignant spindle cell;exactmatch
pseudoalveolar pattern;pseudoalveolar pattern;exactmatch
malignant cardiac hemangiopericytoma;malignant cardiac hemangiopericytoma;exactmatch
pseudogranulomatous pattern;pseudogranulomatous pattern;exactmatch
spindle cell component present;spindle cell component present;exactmatch
cardiac epithelioid hemangioendothelioma;cardiac epithelioid angioendothelioma;exactmatch
cardiac fibrosarcoma;cardiac fibrosarcoma;exactmatch
cardiac granular cell tumor;cardiac granular cell neoplasm;exactmatch
lipomatous component present;lipomatous component present;exactmatch
epithelial component present;epithelial component present;exactmatch
malignant cell with eosinophilic cytoplasm;malignant cell with eosinophilic cytoplasm;exactmatch
glucose metabolism disorder;disorder of glucose metabolism;exactmatch
cardiac myeloid sarcoma;cardiac extramedullary myeloid neoplasm;exactmatch
neoplastic perivascular epithelioid cell;neoplastic perivascular epithelioid cell;exactmatch
osteoid formation;osteoid formation;exactmatch
nidus formation;nidus formation;exactmatch
secondary heart lymphoma;metastatic lymphoma in the heart;exactmatch
atypical choroid plexus papilloma;atypical choroid plexus papilloma;exactmatch
benign connective and soft tissue neoplasm;benign connective and soft tissue neoplasm;exactmatch
smooth muscle component present;smooth muscle component present;exactmatch
thick-walled vessels present;thick-walled vessels present;exactmatch
gain of chromosome 12q13-14;gain of chromosome 12q13-14;exactmatch
intermediate filaments present;intermediate filaments present;exactmatch
heart lymphoma;heart lymphoma;exactmatch
intraluminal tumor growth;intraluminal tumor growth;exactmatch
arterial embolic tumor spread;arterial embolic tumor spread;exactmatch
intimal sarcoma;intimal sarcoma;exactmatch
cardiac malignant peripheral nerve sheath tumor;cardiac schwannoma, malignant;exactmatch
intracytoplasmic eosinophilic inclusion;intracytoplasmic eosinophilic inclusion;exactmatch
malignant cell with large nucleus and abundant eosinophilic cytoplasm;malignant cell with large nucleus and abundant eosinophilic cytoplasm;exactmatch
ectopic hamartomatous thymoma;branchial anlage mixed tumor;exactmatch
pleomorphic hyalinizing angiectatic tumor of soft parts;phat;exactmatch
cardiac neurofibroma;cardiac neurofibroma;exactmatch
mesenchymal chondrosarcoma of bone;mesenchymal chondrosarcoma of bone;exactmatch
benign orbit hemangiopericytoma;benign hemangiopericytoma of orbit;exactmatch
metastatic jugulotympanic paraganglioma;metastatic glomus jugulare neoplasm;exactmatch
non-neoplastic pancreatic disorder;non-neoplastic pancreatic disorder;exactmatch
non-neoplastic stomach disorder;non-neoplastic stomach disorder;exactmatch
non-neoplastic intestinal disorder;non-neoplastic intestinal disorder;exactmatch
hereditary glomangioma;familial glomangioma;exactmatch
non-neoplastic esophageal disorder;non-neoplastic esophageal disorder;exactmatch
malignant chondrocyte with clear cytoplasm;malignant chondrocyte with clear cytoplasm;exactmatch
cellular myxoma;cellular myxoma;exactmatch
myocardial neoplasm;myocardial neoplasm;exactmatch
well differentiated hyaline cartilage present;well differentiated hyaline cartilage present;exactmatch
malignant small round cell;malignant small round cell;exactmatch
low grade cartilaginous component present;low grade cartilaginous component present;exactmatch
high grade non cartilaginous sarcomatous stroma present;high grade non cartilaginous sarcomatous stroma present;exactmatch
great vessel neoplasm;great vessel neoplasm;exactmatch
malignant chondrocyte;malignant chondrocyte;exactmatch
non-neoplastic disorder;non-neoplastic;exactmatch
breast hemangioma;angioma of breast;exactmatch
non-neoplastic disorder by site;non-neoplastic disease by site;exactmatch
non-neoplastic vision disorder;non-neoplastic vision disorder;exactmatch
tissue differentiation uncertain;tissue differentiation uncertain;exactmatch
cardiac schwannoma;benign cardiac neurilemmoma;exactmatch
benign cardiac germ cell tumor;benign cardiac germ cell neoplasm;exactmatch
uterine corpus intravenous leiomyomatosis;intravascular leiomyomatosis of uterus;exactmatch
basal-like breast carcinoma;basal-like breast cancer;exactmatch
normal breast-like subtype of breast carcinoma;normal breast-like subtype of breast cancer;exactmatch
her2 positive breast carcinoma;erbb2 overexpressing subtype of breast carcinoma;exactmatch
luminal b breast carcinoma;luminal b;exactmatch
luminal a breast carcinoma;luminal a;exactmatch
breast carcinoma by gene expression profile;breast carcinoma by gene expression profile;exactmatch
non-neoplastic liver and intrahepatic bile duct disorder;non-neoplastic hepatic disease;exactmatch
intravascular angioleiomyoma;intravascular angioleiomyoma;exactmatch
non-neoplastic disorder by special category;non-neoplastic disease by special category;exactmatch
rare non-neoplastic disorder;rare non-neoplastic disorder;exactmatch
skin vascular neoplasm;blood vessel tumor of skin;exactmatch
lesion with diameter of 2 cm or less;lesion with diameter of 2 cm or less;exactmatch
secondary osteosarcoma;secondary bone osteosarcoma;exactmatch
classic medulloblastoma;classic medulloblastoma;exactmatch
pushing tumor margin;pushing;exactmatch
heparan sulfate;heparan sulfate (porcine 5500 mw);exactmatch
malignant gastrointestinal stromal tumor;gastrointestinal stroma tumor, malignant;exactmatch
benign gastrointestinal stromal tumor;benign gastrointestinal stromal tumor;exactmatch
endometrioid stromal cell;endometrioid stromal cell;exactmatch
undifferentiated stromal sarcoma;undifferentiated stromal sarcoma;exactmatch
plexiform vasculature present;plexiform vasculature present;exactmatch
infiltrating tumor margins present;infiltrating tumor margins present;exactmatch
cytoplasmic eosinophilic globules present;cytoplasmic eosinophilic globules present;exactmatch
gastrointestinal stromal tumor of uncertain malignant potential;gastrointestinal stromal tumor of uncertain malignant potential;exactmatch
medulloblastoma with leptomeningeal spread;medulloblastoma with leptomeningeal spread;exactmatch
malignant stellate cell;malignant stellate cell;exactmatch
malignant neuroectodermal cell;malignant neuroectodermal cell;exactmatch
primitive round to oval cell;primitive round to oval cell;exactmatch
central nervous system embryonal tumor, not otherwise specified;cns embryonal tumor, nos;exactmatch
neuroectodermal differentiation;neuroectodermal differentiation;exactmatch
non-hereditary lesion;non-hereditary lesion;exactmatch
central nervous system embryonal tumor, not otherwise specified with leptomeningeal spread;central nervous system embryonal tumor, nos with leptomeningeal spread;exactmatch
neoplastic spindle stromal cell;neoplastic spindle stromal cell;exactmatch
radiation-related osteosarcoma;postradiation osteosarcoma;exactmatch
amorphous, eosinophilic, and acellular deposit;amorphous, eosinophilic, and acellular deposit;exactmatch
pseudostratified tumor cells present;pseudostratified tumor cells present;exactmatch
pseudostratified neuroepithelial tumor cells present;pseudostratified neuroepithelial tumor cells present;exactmatch
drop metastasis;drop metastasis;exactmatch
malignant intracranial germ cell tumor;malignant intracranial germ cell neoplasm;exactmatch
nerve root;nerve root;exactmatch
region 17p13 allelic loss associated medulloblastoma;region 17p13 allelic loss associated medulloblastoma;exactmatch
apple green dichromism present in polarized congo-red stained sections;apple green dichromism present in polarized congo-red stained sections;exactmatch
elastin fibers present;elastin fibers present;exactmatch
neoplastic epithelioid stromal cell;neoplastic epithelioid stromal cell;exactmatch
dermal nodule;dermal nodule;exactmatch
cerebellar vermis medulloblastoma;cerebellar vermis medulloblastoma;exactmatch
distortion of the hair follicle;distortion of the hair follicle;exactmatch
more than 5 mitoses per 50hpf;more than 5 mitoses per 50hpf;exactmatch
five or less mitoses per 50hpf;five or less mitoses per 50hpf;exactmatch
lesion with diameter greater than 10 cm;lesion with diameter greater than 10 cm;exactmatch
lesion with diameter of 5 cm or less;lesion with diameter of 5 cm or less;exactmatch
erdheim-chester disease;ecd;exactmatch
parotid gland hemangioma;angioma of parotid;exactmatch
blue bone formation;blue bone formation;exactmatch
superior vena cava angiosarcoma;angiosarcoma of superior vena cava;exactmatch
retroperitoneal hemangiopericytoma;retroperitoneal hemangiopericytoma;exactmatch
uterine angiosarcoma;angiosarcoma of uterus;exactmatch
recurrent angiosarcoma;recurrent angiosarcoma;exactmatch
malignant pulmonary vein neoplasm;malignant neoplasm of pulmonary vein;exactmatch
pulmonary artery choriocarcinoma;choriocarcinoma of pulmonary artery;exactmatch
malignant pulmonary artery neoplasm;malignant neoplasm of pulmonary artery;exactmatch
malignant superior vena cava neoplasm;malignant neoplasm of superior vena cava;exactmatch
malignant inferior vena cava neoplasm;malignant inferior vena cava neoplasm;exactmatch
fibrous septa present;fibrous septa present;exactmatch
aortic angiosarcoma;angiosarcoma of aorta;exactmatch
malignant aortic neoplasm;aortic malignant neoplasm;exactmatch
pulmonary vein leiomyosarcoma;leiomyosarcoma of pulmonary vein;exactmatch
pulmonary artery leiomyosarcoma;leiomyosarcoma of pulmonary artery;exactmatch
inferior vena cava leiomyosarcoma;inferior vena cava leiomyosarcoma;exactmatch
malignant cardiac germ cell tumor;malignant cardiac germ cell neoplasm;exactmatch
bone osteosarcoma;bone osteosarcoma;exactmatch
leiomyosarcoma of vessels;leiomyosarcoma of vessels;exactmatch
renal vein leiomyosarcoma;leiomyosarcoma of renal vein;exactmatch
benign atrial neoplasm;benign atrial neoplasm;exactmatch
atrial paraganglioma;atrial paraganglioma;exactmatch
zonal pattern;zonal pattern;exactmatch
spindle cell osteo-fibrous component present;spindle cell osteo-fibrous component present;exactmatch
bone leiomyoma;bone leiomyoma;exactmatch
fibrous histiocytoma of bone;benign fibrous histiocytoma of bone;exactmatch
bone epithelioid hemangioma;bone epithelioid angioma;exactmatch
high grade surface osteosarcoma;high grade surface osteosarcoma;exactmatch
malignant spindle-shaped osteoblast;malignant spindle-shaped osteoblast;exactmatch
malignant small osteoblast;malignant small osteoblast;exactmatch
large spaces filled with blood present;large spaces filled with blood present;exactmatch
new bone formation;new bone formation;exactmatch
osteoblastic osteosarcoma;osteoblastic osteosarcoma;exactmatch
colon cavernous hemangioma;cavernous angioma of colon;exactmatch
solitary adult fibroma;solitary adult cutaneous fibroma;exactmatch
parotid gland lymphangioma;lymphangioma of parotid;exactmatch
malignant cardiac paraganglioma;malignant cardiac paraganglioma;exactmatch
intracranial melanoma;intracranial melanoma;exactmatch
conus medullaris neoplasm;conus medullaris neoplasm;exactmatch
intracranial lipoma;intracranial lipoma;exactmatch
small intestinal mucosa-associated lymphoid tissue lymphoma;malt lymphoma of small bowel;exactmatch
stage ib lung cancer ajcc v7;stage ib carcinoma of lung;exactmatch
stage ia lung cancer ajcc v7;stage ia carcinoma of lung;exactmatch
occult lung carcinoma;occult carcinoma of lung;exactmatch
childhood t lymphoblastic leukemia/lymphoma;childhood precursor t-lymphoblastic lymphoma/leukemia;exactmatch
gastric hodgkin lymphoma;gastric hodgkin lymphoma;exactmatch
childhood mature t-cell and nk-cell non-hodgkin lymphoma;childhood mature t- and nk-cell lymphoma;exactmatch
childhood anaplastic large cell lymphoma;anaplastic large cell lymphoma;exactmatch
ann arbor stage i nodular lymphocyte predominant hodgkin lymphoma;ann arbor stage i nodular lymphocyte predominant hodgkin lymphoma;exactmatch
stage iib lung cancer ajcc v7;stage iib carcinoma of lung;exactmatch
ann arbor stage ivb hodgkin lymphoma;ann arbor stage ivb hodgkin lymphoma;exactmatch
ann arbor stage ib hodgkin lymphoma;ann arbor stage ib hodgkin lymphoma;exactmatch
aleukemic acute lymphoblastic leukemia cutis;aleukemic acute lymphoblastic leukemia cutis;exactmatch
aleukemic monocytic leukemia cutis;aleukemic monocytic leukemia cutis;exactmatch
metastatic malignant neoplasm in the skin;metastases to skin;exactmatch
metastatic carcinoma in the skin;carcinoma metastatic in the skin;exactmatch
rectal rhabdomyosarcoma;rectal rhabdomyosarcoma;exactmatch
stage iia lung cancer ajcc v7;stage iia carcinoma of lung;exactmatch
stage iiia lung cancer ajcc v7;stage iiia carcinoma of lung;exactmatch
lung leiomyosarcoma;leiomyosarcoma of lung;exactmatch
lung myolipoma;lung myolipoma;exactmatch
atypical adenomatous lung hyperplasia;aah;exactmatch
lung mucous gland adenoma;adenoma of bronchial mucous gland;exactmatch
multiple pulmonary hamartomas;multiple chondromatous hamartoma of lung;exactmatch
endobronchial hamartoma;endobronchial hamartoma;exactmatch
endobronchial leiomyoma;endobronchial leiomyoma;exactmatch
lung leiomyoma;leiomyoma of lung;exactmatch
lung fibroma;fibroma of lung;exactmatch
sclerosing pneumocytoma;lung sclerosing angioma;exactmatch
stage iiib lung cancer ajcc v7;stage iiib carcinoma of lung;exactmatch
stage iia lung non-small cell carcinoma ajcc v7;stage iia lung non-small cell carcinoma ajcc v7;exactmatch
stage iib lung non-small cell carcinoma ajcc v7;stage iib lung non-small cell carcinoma ajcc v7;exactmatch
stage ib lung non-small cell carcinoma ajcc v7;stage ib lung non-small cell carcinoma ajcc v7;exactmatch
stage ia lung non-small cell carcinoma ajcc v7;stage ia lung non-small cell carcinoma ajcc v7;exactmatch
solid lung adenocarcinoma;lung solid adenocarcinoma with mucin;exactmatch
lung papillary adenocarcinoma;lung papillary adenocarcinoma;exactmatch
lung acinar adenocarcinoma;acinar adenocarcinoma of lung;exactmatch
aids-related gastric kaposi sarcoma;aids-related gastric kaposi sarcoma;exactmatch
adult acute lymphoblastic leukemia in partial remission;acute lymphoblastic leukemia (all) in partial remission;exactmatch
adult acute lymphoblastic leukemia in complete remission;acute lymphoblastic leukemia (all) in complete remission;exactmatch
skin sarcoma;cutaneous sarcoma;exactmatch
prostate acinar adenocarcinoma;acinar adenocarcinoma of prostate;exactmatch
chordoid glioma of the third ventricle;chordoid glioma;exactmatch
benign childhood central nervous system neoplasm;benign central nervous system neoplasm;exactmatch
jugular foramen neoplasm;jugular foramen neoplasm;exactmatch
recurrent medulloblastoma;recurrent medulloblastoma;exactmatch
visual pathway meningioma;meningioma of visual pathway;exactmatch
middle cranial fossa meningioma;meningioma of middle cranial fossa;exactmatch
stage iv skin cancer;carcinoma of skin stage iv;exactmatch
rectal adenoma with severe dysplasia;adenoma of rectum with marked dysplasia;exactmatch
stage iii skin cancer;carcinoma of skin stage iii;exactmatch
tubular structures of glycogen-rich non-ciliated cells present;tubular structures of glycogen-rich non-ciliated cells present;exactmatch
type ii cell differentiation;type ii cell differentiation;exactmatch
club cell differentiation;clara cell differentiation;exactmatch
lepidic growth pattern;lepidic growth pattern;exactmatch
stage ii skin cancer;carcinoma of skin stage ii;exactmatch
solitary pulmonary nodule;coin lesion;exactmatch
prostate undifferentiated carcinoma;prostate undifferentiated carcinoma;exactmatch
anal paget disease;anal paget disease;exactmatch
anal leiomyosarcoma;anal leiomyosarcoma;exactmatch
anal adenocarcinoma;adenocarcinoma of anus;exactmatch
rectal tubulovillous adenoma;rectal tubulovillous adenoma;exactmatch
cutaneous granular cell tumor;cutaneous granular cell neoplasm;exactmatch
skin nodular solid basal cell carcinoma;skin nodular solid basal cell carcinoma;exactmatch
skin liposarcoma;cutaneous liposarcoma;exactmatch
malignant cutaneous granular cell tumor;cutaneous malignant granular cell tumor;exactmatch
metastatic anal canal carcinoma;metastatic anal canal carcinoma;exactmatch
anal sarcoma;anal sarcoma;exactmatch
anal rhabdomyosarcoma;anal rhabdomyosarcoma;exactmatch
anal glands adenocarcinoma;adenocarcinoma of anal gland;exactmatch
anal leiomyoma;anal leiomyoma;exactmatch
benign anal granular cell tumor;benign anal granular cell neoplasm;exactmatch
anal mucinous adenocarcinoma;anal colloid adenocarcinoma;exactmatch
anal canal neuroendocrine neoplasm;anal canal neuroendocrine neoplasm;exactmatch
anal kaposi sarcoma;anal kaposi sarcoma;exactmatch
anal lymphoma;anal lymphoma;exactmatch
lung adenoid cystic carcinoma;adenocystic carcinoma of lung;exactmatch
lung meningioma;lung meningioma;exactmatch
asbestos exposure;asbestos exposure;exactmatch
pancreatic undifferentiated carcinoma;pancreatic carcinosarcoma;exactmatch
stage 0 pancreatic cancer ajcc v6 and v7;pancreatic cancer stage 0;exactmatch
solid pseudopapillary carcinoma of the pancreas;pancreatic solid pseudopapillary carcinoma;exactmatch
pancreatic acinar cell cystadenocarcinoma;acinar cell cystadenocarcinoma;exactmatch
pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma;intraductal papillary mucinous neoplasm with an associated invasive carcinoma;exactmatch
pancreatic intraductal papillary-mucinous carcinoma;intraductal papillary-colloid carcinoma of pancreas;exactmatch
pancreatic serous cystadenocarcinoma;pancreatic serous cystadenocarcinoma;exactmatch
pancreatic undifferentiated carcinoma with osteoclast-like giant cells;osteoclast-like giant cell neoplasm of pancreas;exactmatch
pancreatic adenosquamous carcinoma;adenosquamous carcinoma of pancreas;exactmatch
duodenal gastrin-producing neuroendocrine tumor;duodenal g-cell gastrin producing tumor;exactmatch
pancreatic signet ring cell carcinoma;pancreatic signet ring cell carcinoma;exactmatch
pancreatic intraductal papillary-mucinous neoplasm with intermediate grade dysplasia;pancreatic borderline intraductal papillary-mucinous neoplasm;exactmatch
pancreatic mucinous cystadenoma;colloid cystadenoma of pancreas;exactmatch
borderline exocrine pancreatic neoplasm;borderline exocrine pancreatic neoplasm;exactmatch
pancreatic sarcoma;pancreatic sarcoma;exactmatch
pancreatic lymphoma;lymphoma of pancreas;exactmatch
pancreatic mucinous cystadenocarcinoma;colloid cystadencarcinoma of pancreas;exactmatch
stage iva pancreatic cancer;stage iva carcinoma of pancreas;exactmatch
gallbladder lymphoma;gallbladder lymphoma;exactmatch
pleuropulmonary blastoma;pleuropulmonary blastoma;exactmatch
gallbladder mucinous adenocarcinoma;colloid carcinoma of gallbladder;exactmatch
liver solitary fibrous tumor;fibroma of liver;exactmatch
liver mesenchymal hamartoma;hepatic mesenchymal hamartoma;exactmatch
liver lipoma;hepatic lipoma;exactmatch
liver and intrahepatic bile duct benign non-epithelial neoplasm;benign non-epithelial hepatic neoplasm;exactmatch
gallbladder leiomyoma;gallbladder leiomyoma;exactmatch
gallbladder neurofibroma;gallbladder neurofibroma;exactmatch
gallbladder signet ring cell carcinoma;gallbladder signet ring cell carcinoma;exactmatch
gallbladder intracholecystic papillary neoplasm with an associated invasive carcinoma;gallbladder icpn with an associated invasive carcinoma;exactmatch
gallbladder melanoma;gallbladder malignant melanoma;exactmatch
stage ivb gallbladder cancer ajcc v7;gallbladder cancer stage ivb ajcc v7;exactmatch
stage iva gallbladder cancer ajcc v7;gallbladder cancer stage iva ajcc v7;exactmatch
stage iv gallbladder cancer ajcc v6;gallbladder cancer stage iv ajcc v6;exactmatch
stage iii gallbladder cancer ajcc v6;gallbladder cancer stage iii ajcc v6;exactmatch
stage ii gallbladder cancer ajcc v6;gallbladder cancer stage ii ajcc v6;exactmatch
stage i gallbladder cancer ajcc v6;gallbladder cancer stage i ajcc v6;exactmatch
gallbladder sarcoma;gallbladder sarcoma;exactmatch
pancreatic serous cystadenoma;pancreatic microcystic adenoma;exactmatch
stage iv pancreatic cancer ajcc v6 and v7;pancreatic cancer stage iv;exactmatch
stage i childhood hepatocellular carcinoma ajcc v6 and v7;stage i childhood hepatocellular carcinoma ajcc v6;exactmatch
colorectal lipoma;colorectal lipoma;exactmatch
esophageal non-hodgkin lymphoma;esophageal non-hodgkin lymphoma;exactmatch
esophageal lymphoma;esophageal lymphoma;exactmatch
colorectal adenoma with severe dysplasia;colorectal adenoma with marked dysplasia;exactmatch
lung non-hodgkin lymphoma;lung non-hodgkin lymphoma;exactmatch
colorectal hyperplastic polyp;colorectal hp;exactmatch
colorectal juvenile polyp;colorectal juvenile polyp;exactmatch
colorectal polyp;colorectal polyp;exactmatch
colorectal leiomyoma;colorectal leiomyoma;exactmatch
stage ii childhood hepatocellular carcinoma ajcc v6 and v7;stage ii childhood hepatocellular carcinoma ajcc v6;exactmatch
colorectal villous adenoma;colorectal villous adenoma;exactmatch
colorectal tubulovillous adenoma;colorectal tubulovillous adenoma;exactmatch
colorectal traditional serrated adenoma;colorectal serrated adenoma;exactmatch
colorectal adenoma;adenoma of large bowel;exactmatch
lung large cell neuroendocrine carcinoma;lcnec of the lung;exactmatch
lung hilum neoplasm;hilar lung neoplasm;exactmatch
lung neuroendocrine neoplasm;lung neuroendocrine neoplasm;exactmatch
esophageal hodgkin lymphoma;esophageal hodgkin lymphoma;exactmatch
stage iia esophageal cancer ajcc v7;esophageal cancer stage iia;exactmatch
stage iib esophageal cancer ajcc v7;esophageal cancer stage iib;exactmatch
stage ivb esophageal cancer;esophageal cancer stage ivb;exactmatch
stage iii childhood hepatocellular carcinoma ajcc v7;stage iii childhood hepatocellular carcinoma;exactmatch
esophageal melanoma;esophageal melanoma;exactmatch
esophageal kaposi sarcoma;esophageal kaposi sarcoma;exactmatch
esophageal liposarcoma;esophageal liposarcoma;exactmatch
esophageal neurofibroma;esophageal neurofibroma;exactmatch
esophageal schwannoma;benign esophageal neurilemmoma;exactmatch
esophageal fibroma;esophageal fibroma;exactmatch
esophageal lipoma;esophageal lipoma;exactmatch
esophageal granular cell tumor;esophageal granular cell myoblastoma;exactmatch
giant fibrovascular esophageal polyp;giant fibrovascular esophageal polyp;exactmatch
rectal neuroendocrine neoplasm;neuroendocrine neoplasm of rectum;exactmatch
colon neuroendocrine neoplasm;colon neuroendocrine neoplasm;exactmatch
gastric neuroendocrine neoplasm;gastric neuroendocrine neoplasm;exactmatch
intestinal neuroendocrine neoplasm;intestinal neuroendocrine neoplasm;exactmatch
stage iva esophageal cancer;esophageal cancer stage iva;exactmatch
nuclear molding;nuclear molding;exactmatch
pancoast syndrome;pancoast syndrome;exactmatch
meningeal gliomatosis;gliomatosis of meninges;exactmatch
neoplastic syndrome;cancer-related syndrome;exactmatch
malignant epithelial cells with abundant clear cytoplasm containing glycogen present;malignant epithelial cells with abundant clear cytoplasm containing glycogen present;exactmatch
acinar cell differentiation;acinar cell differentiation;exactmatch
malignant epithelial cells with abundant cytoplasmic neutral lipids present;malignant epithelial cells with abundant cytoplasmic neutral lipids present;exactmatch
mesenchymal metaplasia;mesenchymal metaplasia;exactmatch
stage iiia gastric cancer ajcc v7;carcinoma of stomach stage iiia;exactmatch
spindle cell metaplasia;spindle cell metaplasia;exactmatch
blood pressure finding;blood pressure;exactmatch
stage iiib gastric cancer ajcc v7;carcinoma of stomach stage iiib;exactmatch
gastric papillary adenocarcinoma;gastric papillary adenocarcinoma;exactmatch
tumor replacement;tumor replacement;exactmatch
invasive breast lobular carcinoma, signet ring variant;invasive breast lobular carcinoma, signet ring variant;exactmatch
mucinous tall columnar adenocarcinoma cell;mucinous tall columnar adenocarcinoma cell;exactmatch
stage ib gastric cancer ajcc v7;carcinoma of stomach stage ib;exactmatch
round adenocarcinoma cell with abundant cytoplasm and vesicular nucleus;round adenocarcinoma cell with abundant cytoplasm and vesicular nucleus;exactmatch
prominent in situ component present;prominent in situ component present;exactmatch
prominent intraductal component present;eic;exactmatch
sebaceous differentiation;sebaceous differentiation;exactmatch
intracytoplasmic and extracytoplasmic eosinophilic material present;intracytoplasmic and extracytoplasmic eosinophilic material present;exactmatch
colon adenosquamous carcinoma;adenosquamous carcinoma of colon;exactmatch
cauda equina neoplasm;cauda equina neoplasm;exactmatch
gastric liposarcoma;gastric liposarcoma;exactmatch
gastric soft tissue neoplasm;gastric soft tissue neoplasm;exactmatch
malignant gastric germ cell tumor;malignant gastric germ cell neoplasm;exactmatch
malignant gastric granular cell tumor;malignant gastric granular cell neoplasm;exactmatch
benign gastric granular cell tumor;benign gastric granular cell neoplasm;exactmatch
gastric lymphangioma;gastric lymphangioma;exactmatch
gastric hemangioma;angioma of stomach;exactmatch
adult intracranial neoplasm;adult intracranial neoplasm;exactmatch
adenocarcinoma cell with abundant pale cytoplasm;adenocarcinoma cell with abundant pale cytoplasm;exactmatch
gastric undifferentiated carcinoma;anaplastic carcinoma of stomach;exactmatch
gastric squamous cell carcinoma;gastric (stomach) squamous cell cancer;exactmatch
gastric adenosquamous carcinoma;adenosquamous carcinoma of stomach;exactmatch
gastric tubular adenocarcinoma;gastric tubular adenocarcinoma;exactmatch
intracanalicular growth pattern;intracanalicular growth pattern;exactmatch
sarcomatous component present;sarcomatous component;exactmatch
fibrotic stroma with finger-like projections present;fibrotic stroma with finger-like projections present;exactmatch
melanoma cells present;melanoma cells present;exactmatch
stage ia gastric cancer ajcc v7;carcinoma of stomach stage ia;exactmatch
skin keratotic basal cell carcinoma;keratotic basal cell carcinoma;exactmatch
stage iib breast cancer ajcc v6 and v7;breast cancer stage iib;exactmatch
human chorionic gonadotropin-positive neoplastic cells present;human chorionic gonadotropin-positive neoplastic cells present;exactmatch
heterologous elements present;heterologous elements present;exactmatch
renal pelvis urothelial cell;renal pelvis transitional cell;exactmatch
renal pelvis urothelium;renal pelvis transitional epithelium;exactmatch
malignant transitional cell with eccentrically placed large nucleus and small nucleolus;malignant transitional cell with eccentrically placed large nucleus and small nucleolus;exactmatch
malignant transitional cell with large nucleus and small nucleolus;malignant transitional cell with large nucleus and small nucleolus;exactmatch
single malignant cells present;single malignant cells present;exactmatch
stage iia breast cancer ajcc v6 and v7;breast cancer stage iia;exactmatch
hidradenocarcinoma;clear cell eccrine carcinoma;exactmatch
skull base chordoma;chordoma of skull base;exactmatch
inner ear lipoma;inner ear lipoma;exactmatch
central nervous system lipoma;cns lipoma;exactmatch
central nervous system angiosarcoma;angiosarcoma of cns;exactmatch
central nervous system mesenchymal, non-meningothelial neoplasm;cns soft tissue neoplasm;exactmatch
malignant childhood central nervous system neoplasm;childhood malignant cns neoplasms;exactmatch
childhood anaplastic oligodendroglioma;anaplastic childhood oligodendroglioma;exactmatch
malignant transitional cell with clear cytoplasm;malignant transitional cell with clear cytoplasm;exactmatch
lipoblast-like malignant transitional cell;lipoblast-like malignant transitional cell;exactmatch
preserved nuclear polarity;preserved nuclear polarity;exactmatch
invasive breast apocrine carcinoma;infiltrating apocrine breast carcinoma;exactmatch
signet ring melanoma;signet ring cutaneous (skin) melanoma;exactmatch
nevoid melanoma;nevoid cutaneous (skin) melanoma;exactmatch
head and neck nevus;head and neck nevus;exactmatch
flexural skin nevus;flexural skin nevus;exactmatch
central nervous system paraganglioma;cns paraganglioma;exactmatch
acral nevus;acral nevus;exactmatch
breast nevus;breast nevus;exactmatch
central nervous system fibrosarcoma;cns fibrosarcoma;exactmatch
central nervous system rhabdomyosarcoma;cns rhabdomyosarcoma;exactmatch
primary site unspecified;primary site unspecified;exactmatch
synchronous lesion;synchronous lesion;exactmatch
intracranial extraskeletal myxoid chondrosarcoma;intracranial extraskeletal myxoid chondrosarcoma;exactmatch
central nervous system germ cell tumor;cns germ cell neoplasm;exactmatch
malignant epithelial cell with ground glass cytoplasm;malignant epithelial cell with ground glass cytoplasm;exactmatch
gastric hemorrhage;gastric hemorrhage;exactmatch
colon squamous cell carcinoma;colon epidermoid carcinoma;exactmatch
colon leiomyoma;colon leiomyoma;exactmatch
stage i skin cancer;carcinoma of skin stage i;exactmatch
rectal neuroendocrine tumor g1;carcinoid tumor of rectum;exactmatch
rectal squamous cell carcinoma;rectal squamous carcinoma;exactmatch
rectal lymphoma;lymphoma of rectum;exactmatch
rectal leiomyoma;leiomyoma of rectum;exactmatch
rectal lipoma;lipoma of rectum;exactmatch
rectal kaposi sarcoma;kaposi's sarcoma of rectum;exactmatch
rectal leiomyosarcoma;leiomyosarcoma of rectum;exactmatch
rectal sarcoma;rectal sarcoma;exactmatch
rectal adenoma;adenoma of rectum;exactmatch
rectal sarcomatoid carcinoma;rectal sarcomatoid cancer;exactmatch
prostate neuroendocrine neoplasm;neuroendocrine neoplasm of prostate;exactmatch
prostate leiomyoma;leiomyoma of prostate;exactmatch
cecum adenocarcinoma;adenocarcinoma of cecum;exactmatch
low grade prostatic intraepithelial neoplasia;grade 1 pin;exactmatch
high grade prostatic intraepithelial neoplasia;hgpin;exactmatch
prostate adenoid cystic carcinoma;adenoid cystic carcinoma of prostate;exactmatch
prostate adenosquamous carcinoma;adenosquamous carcinoma of prostate;exactmatch
rectal cloacogenic carcinoma;cloacogenic carcinoma of rectum;exactmatch
ceruminous neoplasm;ceruminous neoplasm;exactmatch
colon lipoma;colon lipoma;exactmatch
frontal lobe neoplasm;frontal lobe neoplasm;exactmatch
stage iv uveal melanoma ajcc v7;iv;exactmatch
stage iii uveal melanoma ajcc v7;stage iii malignant melanoma of uvea;exactmatch
stage ii uveal melanoma ajcc v7;stage ii malignant melanoma of uvea;exactmatch
stage i uveal melanoma ajcc v7;i;exactmatch
skin undifferentiated pleomorphic sarcoma;cutaneous malignant fibrous histiocytoma;exactmatch
occipital lobe neoplasm;neoplasm of occipital lobe;exactmatch
parietal lobe neoplasm;neoplasm of parietal lobe;exactmatch
cutaneous schwannoma;benign dermal neurilemmoma;exactmatch
malignant eccrine neoplasm;malignant eccrine neoplasm;exactmatch
skin nodulo-ulcerative basal cell carcinoma;nodulo-ulcerative basal cell carcinoma;exactmatch
temporal lobe neoplasm;neoplasm of temporal lobe;exactmatch
skin lipomatous neoplasm;cutaneous lipomatous neoplasm;exactmatch
pilosebaceous hamartoma;pilosebaceous hamartoma;exactmatch
eccrine sweat gland hamartoma;eccrine sweat gland hamartoma;exactmatch
skin appendage hamartoma;hamartoma of skin appendage;exactmatch
porocarcinoma;eccrine porocarcinoma;exactmatch
prostate acinar mucinous adenocarcinoma;acinar colloid prostate adenocarcinoma;exactmatch
prostate squamous cell carcinoma;prostate squamous cell carcinoma;exactmatch
prostate acinar adenocarcinoma, signet ring-like cell variant;acinar prostate adenocarcinoma, signet ring variant;exactmatch
benign peripheral nerve granular cell tumor;benign granular cell neoplasm of peripheral nerve;exactmatch
appendix mucinous cystadenocarcinoma;appendiceal colloid cystadenocarcinoma;exactmatch
appendix mucinous cystadenoma;appendix mucinous cystadenoma;exactmatch
central nervous system hamartoma;cns hamartoma;exactmatch
central nervous system dermoid cyst;cns dermoid cyst;exactmatch
central nervous system melanoma;cns melanoma;exactmatch
central nervous system melanocytic neoplasm;cns melanocytic neoplasm;exactmatch
central nervous system hematopoietic neoplasm;cns hematopoietic neoplasm;exactmatch
cecum neuroendocrine tumor g1;caecal carcinoid tumor;exactmatch
prostate non-hodgkin lymphoma;non-hodgkin's lymphoma of prostate;exactmatch
colon lymphangioma;colon lymphangioma;exactmatch
colon hodgkin lymphoma;colon hodgkin lymphoma;exactmatch
colon mucosa-associated lymphoid tissue lymphoma;colon malt lymphoma;exactmatch
colon neuroendocrine tumor g1;carcinoid tumor of colon;exactmatch
colon tubulovillous adenoma;colon tubulovillous adenoma;exactmatch
colon sarcoma;colon sarcoma;exactmatch
colon leiomyosarcoma;colon leiomyosarcoma;exactmatch
appendix villous adenoma;appendix villous adenoma;exactmatch
appendix lymphoma;appendiceal lymphoma;exactmatch
appendix leiomyoma;appendiceal leiomyoma;exactmatch
cecum lymphoma;cecal lymphoma;exactmatch
prostate lymphoma;lymphoma of prostate;exactmatch
benign prostate phyllodes tumor;benign phyllodes neoplasm of prostate;exactmatch
malignant prostate phyllodes tumor;malignant phyllodes neoplasm of prostate;exactmatch
prostate acinar adenocarcinoma, sarcomatoid variant;acinar prostate adenocarcinoma, sarcomatoid variant;exactmatch
gastric kaposi sarcoma;gastric kaposi sarcoma;exactmatch
prostate angiosarcoma;angiosarcoma of prostate;exactmatch
prostate myeloid sarcoma;extramedullary myeloid neoplasm of prostate;exactmatch
prostate leiomyosarcoma;leiomyosarcoma of prostate;exactmatch
prostate embryonal rhabdomyosarcoma;embryonal rhabdomyosarcoma of prostate;exactmatch
prostate stromal sarcoma;prostate stromal sarcoma;exactmatch
prostate kaposi sarcoma;kaposi's sarcoma of prostate;exactmatch
prostate rhabdomyosarcoma;prostate rhabdomyosarcoma;exactmatch
cecum non-hodgkin lymphoma;cecal non-hodgkin's lymphoma;exactmatch
cecum villous adenoma;cecal villous adenoma;exactmatch
colon kaposi sarcoma;colon kaposi sarcoma;exactmatch
primary cutaneous diffuse large b-cell lymphoma, other;primary cutaneous diffuse large b-cell lymphoma, other;exactmatch
pdcd1lg2 gene overexpression;pdcd1lg2 gene overexpression;exactmatch
classical low grade fibromyxoid sarcoma;classical low grade fibromyxoid sarcoma;exactmatch
segmentation clock pathway;segmentation clock;exactmatch
igf1r antiapoptosis pathway;igf1r antiapoptosis pathway;exactmatch
igf-1 signaling pathway;igf-1 signaling pathway;exactmatch
skeletal muscle hypertrophy pathway;skeletal muscle hypertrophy pathway;exactmatch
ifn gamma signaling pathway;ifn gamma signaling pathway;exactmatch
ann arbor stage ia hodgkin lymphoma;ann arbor stage ia hodgkin lymphoma;exactmatch
hswi-snf pathway;chromatin remodeling by hswi/snf atp-dependent complexes;exactmatch
hiv-i nef in apoptosis pathway;hiv-i nef in apoptosis pathway;exactmatch
erbb2 signaling pathway;erbb2 signaling pathway;exactmatch
ann arbor stage iia hodgkin lymphoma;ann arbor stage iia hodgkin lymphoma;exactmatch
skeletal myogenesis pathway;control of skeletal myogenesis by hdac & calcium/calmodulin-dependent kinase (camk);exactmatch
human cytomegalovirus infection pathway;human cytomegalovirus infection pathway;exactmatch
molecular abnormality;chromosomal, gene, or protein abnormality;exactmatch
beta-catenin accumulation pathway;beta-catenin accumulation pathway;exactmatch
inhibition of cellular proliferation by gleevec pathway;inhibition of cellular proliferation by gleevec;exactmatch
growth hormone signaling pathway;growth hormone signaling pathway;exactmatch
corticosteroid cardioprotection pathway;corticosteroid cardioprotection pathway;exactmatch
il12 signaling pathway;il12 signaling pathway;exactmatch
il22 signaling pathway;il22 signaling pathway;exactmatch
g2/m checkpoint pathway;cell cycle: g2/m checkpoint;exactmatch
longevity pathway;longevity pathway;exactmatch
nfat pathway;nfat pathway;exactmatch
parathyroid gland adenoma;adenoma of parathyroid;exactmatch
mtor signaling pathway biocarta;mtor signaling pathway;exactmatch
hepatocyte growth factor receptor signaling pathway biocarta;hepatocyte growth factor receptor signaling pathway biocarta;exactmatch
small cell neuroendocrine carcinoma;oat cell cancer;exactmatch
calpain-2 cell motility pathway;calpain-2 cell motility pathway;exactmatch
mapkinase signaling pathway;mapkinase signaling pathway;exactmatch
ann arbor stage iiia hodgkin lymphoma;ann arbor stage iiia hodgkin lymphoma;exactmatch
il2rb pathway;il-2 receptor beta chain in t cell activation;exactmatch
keratinocyte differentiation pathway;keratinocyte differentiation;exactmatch
insulin signaling pathway;insulin signaling pathway;exactmatch
ann arbor stage iib hodgkin lymphoma;ann arbor stage iib hodgkin lymphoma;exactmatch
il7 signaling pathway;il-7 signal transduction;exactmatch
il6 signaling pathway;il 6 signaling pathway;exactmatch
il4 signaling pathway;il 4 signaling pathway;exactmatch
il3 signaling pathway;il 3 signaling pathway;exactmatch
gallbladder polyp;gallbladder polyp;exactmatch
g1/s checkpoint pathway;cell cycle: g1/s check point;exactmatch
"del(7)(q11;q36)";"del(7)(q11;q36)";exactmatch
telangiectatic osteosarcoma;malignant bone aneurysm;exactmatch
papillary meningioma;papillary meningioma;exactmatch
creb activation signaling pathway;creb activation signaling pathway;exactmatch
mixed glioma;glioma, mixed, malignant;exactmatch
apoptosis dna damage pathway;apoptosis dna damage pathway;exactmatch
cyclin regulation of cell cycle pathway;cyclin regulation of cell cycle pathway;exactmatch
cell to cell adhesion signaling pathway;cell to cell adhesion signaling;exactmatch
cell migration pathway;cell migration pathway;exactmatch
egf receptor downregulation by cbl pathway;cbl mediated ligand-induced downregulation of egf receptors;exactmatch
t-cell activation co-stimulatory signaling pathway;t-cell activation co-stimulatory signaling pathway;exactmatch
estrogen receptor regulation by carm1 pathway;carm1 and regulation of the estrogen receptor;exactmatch
cardiac hypertrophy pathway;cardiac hypertrophy pathway;exactmatch
compound nevus;compound nevus;exactmatch
btg cell cycle regulation pathway;btg cell cycle regulation pathway;exactmatch
bioactive peptide signaling pathway;bioactive peptide induced signaling pathway;exactmatch
b-cell survival pathway;b cell survival pathway;exactmatch
bard1 pathway;bard1 pathway;exactmatch
ctcf pathway;ctcf pathway;exactmatch
dicer pathway;dicer pathway;exactmatch
ampulla of vater carcinoma;ampulla of vater cancer;exactmatch
erbb3 receptor recycling pathway;erbb3 receptor recycling pathway;exactmatch
fc epsilon receptor i signaling pathway biocarta;fc epsilon receptor i signaling pathway biocarta;exactmatch
cyclin e degradation pathway;cyclin e degradation pathway;exactmatch
fas signaling pathway biocarta;fas signaling pathway ( cd95 );exactmatch
electron transport pathway;electron transport pathway;exactmatch
erythrocyte differentiation pathway;erythrocyte differentiation pathway;exactmatch
erk1/erk2 mapk signaling pathway;erk1/erk2 mapk signaling pathway;exactmatch
neuronal survival pathway;neuronal survival pathway;exactmatch
epo signaling pathway;epo signaling pathway;exactmatch
extracellular matrix binding pathway;erk and pi-3 kinase are necessary for collagen binding in corneal epithelia;exactmatch
erythropoietin neuroprotection pathway;erythropoietin neuroprotection pathway;exactmatch
eif4 regulation pathway;regulation of eif4e and p70 s6 kinase;exactmatch
map kinase inactivation of smrt corepressor pathway;map kinase inactivation of smrt corepressor;exactmatch
egf signaling pathway;egf signaling pathway;exactmatch
efp cell cycle pathway;efp cell cycle pathway;exactmatch
vesicle transport pathway;the role of fyve-finger proteins in vesicle transport;exactmatch
phospholipid signaling pathway;phospholipid signaling pathway;exactmatch
nerve growth factor pathway;nerve growth factor pathway;exactmatch
nitric oxide pathway;actions of nitric oxide in the heart;exactmatch
no2-dependent il12 pathway;no2-dependent il12 pathway;exactmatch
sphenoid sinus polyp;polyp of sphenoid sinus;exactmatch
mongolian spot;blue sacral spot;exactmatch
congenital melanocytic nevus;congenital melanocytic nevi;exactmatch
fibrous hamartoma of infancy;fibrous hamartoma;exactmatch
bannayan syndrome;bannayan syndrome;exactmatch
turcot syndrome;turcot syndrome;exactmatch
non-neoplastic nevus;non-neoplastic nevus;exactmatch
leukoplakia of vocal cords;keratotic vocal cord;exactmatch
ethmoid sinus polyp;ethmoid sinus polyp;exactmatch
gingival polyp;gingival polyp;exactmatch
maxillary sinus polyp;maxillary antral polyp;exactmatch
cd4+/cd56+ neoplastic medium-sized cell;cd4+/cd56+ neoplastic medium-sized cell;exactmatch
precursor natural killer cell;precursor nk-cell;exactmatch
opisthorchis viverrini infection;opisthorchis viverrini infection;exactmatch
schistosoma hematobium infection;schistosoma hematobium infection;exactmatch
helicobacter pylori infection;h. pylori infection;exactmatch
htlv-1 infection;htlv-1 infection;exactmatch
nevus comedonicus;acne nevus;exactmatch
oral mucosa lobular capillary hemangioma;oral mucosa lobular capillary hemangioma;exactmatch
vaginal carcinoma;cancer of vagina;exactmatch
peripheral (post-thymic) t-lymphocyte and natural killer cell;peripheral (post-thymic) t-lymphocyte and nk-cell;exactmatch
type 3 autoimmune lymphoproliferative syndrome;alps-u;exactmatch
t-lymphocyte with a post-thymic immunophenotype;t-lymphocyte with a post-thymic immunophenotype;exactmatch
neoplastic cerebriform t-prolymphocyte;neoplastic cerebriform t-prolymphocyte;exactmatch
neoplastic small t-prolymphocyte;neoplastic small t-prolymphocyte;exactmatch
cutaneous involvement;cutaneous involvement;exactmatch
anal polyp;anal polyp;exactmatch
cytoplasmic protrusions present;cytoplasmic blebs present;exactmatch
t-lymphocyte and natural killer cell;t-lymphocyte and nk-cell;exactmatch
leukoplakia of lip;leukoplakia of lip;exactmatch
neoplastic t-lymphocyte and neoplastic natural killer cell;neoplastic t-lymphocyte and neoplastic natural killer cell;exactmatch
coarse azurophilic granules present;coarse azurophilic granules present;exactmatch
intestinal metaplasia of gastric mucosa;gastric intestinal metaplasia;exactmatch
gastric intraepithelial neoplasia;gastric glandular intraepithelial dysplasia;exactmatch
gastric polyp;gastric polyp;exactmatch
esophageal leukoplakia;esophageal epidermoid metaplasia;exactmatch
hairy leukoplakia of tongue;hairy leukoplakia of tongue;exactmatch
hhv8 infection;hhv8 infection;exactmatch
thrombin/protease-activated receptor signaling pathway;thrombin signaling and protease-activated receptors;exactmatch
wnt signaling pathway biocarta;wnt signaling pathway;exactmatch
cell cycle progression pathway;cell cycle progression pathway;exactmatch
ion channels in vascular endothelium pathway;ion channels and their functional role in vascular endothelium;exactmatch
rac1 cell motility signaling pathway;rac 1 cell motility signaling pathway;exactmatch
pten-dependent cell cycle arrest and apoptosis pathway;pten dependent cell cycle arrest and apoptosis;exactmatch
phosphoinositide pathway;phosphoinositide pathway;exactmatch
ptc1 regulation of cell cycle pathway;ptc1 regulation of cell cycle pathway;exactmatch
notch and wnt signaling pathway;notch and wnt signaling pathway;exactmatch
ppar-alpha gene regulation pathway;mechanism of gene regulation by peroxisome proliferators via ppara(alpha);exactmatch
phospholipase c signaling pathway;phospholipase c signaling pathway;exactmatch
angiokeratoma of mibelli;angiokeratoma of mibelli;exactmatch
pitx2 transcription regulation pathway;multi-step regulation of transcription by pitx2;exactmatch
pdgf signaling pathway;pdgf signaling pathway;exactmatch
p53 signaling pathway biocarta;p53 signaling pathway;exactmatch
extragonadal germ cell tumor;extragonadal gct, nos;exactmatch
hypoxia pathway;hypoxia pathway;exactmatch
p27 regulation pathway;regulation of p27 phosphorylation during cell cycle progression;exactmatch
notch proteolysis and signaling pathway;notch proteolysis and signaling pathway;exactmatch
g1 to s transition pathway;g1 to s transition pathway;exactmatch
ras signaling pathway;ras signaling pathway;exactmatch
rb checkpoint signaling pathway;rb checkpoint signaling pathway;exactmatch
dsrna induction pathway;double stranded rna induced gene expression;exactmatch
angiogenesis pathway;angiogenesis pathway;exactmatch
angioma serpiginosum;angioma serpiginosum;exactmatch
trka receptor signaling pathway;trka receptor signaling pathway;exactmatch
tpo signaling pathway;tpo signaling pathway;exactmatch
tnfr1 signaling pathway;tnfr1 signaling pathway;exactmatch
interferon signaling modulation pathway;chaperones modulate interferon signaling pathway;exactmatch
tgf beta signaling pathway biocarta;tgf beta signaling pathway biocarta;exactmatch
mucosal healing pathway;mucosal healing pathway;exactmatch
tert regulation pathway;overview of telomerase protein component gene htert transcriptional regulation;exactmatch
terc regulation pathway;overview of telomerase rna component gene hterc transcriptional regulation;exactmatch
telomere pathway;telomere pathway;exactmatch
t cell receptor signaling pathway biocarta;t cell receptor signaling pathway;exactmatch
sprouty regulation of tyrosine kinase signaling pathway;sprouty regulation of tyrosine kinase signaling pathway;exactmatch
e2f1 degradation pathway;e2f1 degradation pathway;exactmatch
sonic hedgehog pathway;sonic hedgehog (shh) pathway;exactmatch
bad regulation pathway;bad regulation pathway;exactmatch
cancer susceptibility pathway;cancer susceptibility pathway;exactmatch
atm signaling pathway;atm signaling pathway;exactmatch
male breast carcinoma;carcinoma of male breast;exactmatch
tonsil part;tonsil part;exactmatch
extremity part;extremity part;exactmatch
breast intraductal papilloma;breast intracystic papilloma;exactmatch
lower extremity part;lower extremity part;exactmatch
upper extremity part;upper extremity part;exactmatch
organ of special sense part;organ of special sense part;exactmatch
integumentary system part;integumentary system part;exactmatch
head and neck part;head and neck part;exactmatch
delta cell of the pancreas;delta cell of the pancreas;exactmatch
ependymal tumor of brain;ependymal tumor of brain;exactmatch
extrahepatic bile duct carcinoma;carcinoma of extrahepatic bile duct;exactmatch
mental and behavioral signs and symptoms;mental and behavioral signs and symptoms;exactmatch
ovarian dermoid cyst;dermoid cyst of ovary;exactmatch
creb1 gene;creb1;exactmatch
creb family gene;creb family gene;exactmatch
tonsillar tissue;tonsillar tissue;exactmatch
inv(22q12);inv(22)(q12q12);exactmatch
colon adenoma;adenoma of colon;exactmatch
composite lymphoma;composite lymphoma;exactmatch
vacuolated plasma cells in the bone marrow;vacuolated plasma cells in the bone marrow;exactmatch
esophageal leiomyoma;esophageal leiomyoma;exactmatch
transformed peripheral b-lymphocyte;transformed peripheral b-lymphocyte;exactmatch
neoplastic immunoblast-like b-lymphocyte;neoplastic immunoblast-like b-lymphocyte;exactmatch
alk kinase overexpression;alk kinase overexpression;exactmatch
bulky disease;bulky disease;exactmatch
bone marrow and blood involvement;bone marrow and blood involvement;exactmatch
defective mu heavy chain present;defective igh mu chain present;exactmatch
negative bone marrow and peripheral blood;negative bone marrow and peripheral blood;exactmatch
neoplastic b-lymphocyte;neoplastic b-lymphocyte;exactmatch
prolymphocytes exceed 55 percent of lymphoid cells in the peripheral blood;prolymphocytes exceed 55 percent of lymphoid cells in the peripheral blood;exactmatch
fried-egg appearance of the bone marrow;fried-egg appearance of the bone marrow;exactmatch
tartrate resistant acid phosphatase positive cells present;trap positivite cells present;exactmatch
bone pain;bone pain;exactmatch
extensive bone marrow and blood involvement;extensive bone marrow and blood involvement;exactmatch
lymphoblasts 25 percent or less of bone marrow nucleated cells;lymphoblasts 25 percent or less of bone marrow nucleated cells;exactmatch
neoplastic t-lymphocyte;neoplastic t-lymphocyte;exactmatch
spleen part;spleen part;exactmatch
aggravated malignant neoplasm;aggravated malignant neoplasm;exactmatch
pancreatic carcinoma;cancer of pancreas;exactmatch
congenital non-progressive hemangioma;congenital angioma;exactmatch
gallbladder carcinoma;cancer of gallbladder;exactmatch
mature lymphocyte;mature lymphocyte;exactmatch
mature b-lymphocyte at the germinal center stage of differentiation;mature b-lymphocyte at the germinal center stage of differentiation;exactmatch
peripheral (post-thymic) t-lymphocyte;peripheral (post-thymic) t-lymphocyte;exactmatch
malignant ovarian cyst;malignant ovarian cyst;exactmatch
pleomorphic reed-sternberg cell;pleomorphic reed-sternberg cell;exactmatch
urothelial papilloma;papilloma of bladder;exactmatch
prkaca gene;prkaca;exactmatch
benign female breast neoplasm;benign female breast neoplasm;exactmatch
progressive transformation of germinal centers;progressive transformation of germinal centers;exactmatch
c-kit somatic point mutation;c-kit somatic point mutation;exactmatch
kmt2a-een fusion protein expression;kmt2a-een fusion protein expression;exactmatch
kmt2a-ell fusion protein expression;kmt2a-ell fusion protein expression;exactmatch
kmt2a-enl fusion protein expression;kmt2a-enl fusion protein expression;exactmatch
mllt3-kmt2a fusion protein expression;mll-af9 fusion protein expression;exactmatch
kmt2a-af10 fusion protein expression;kmt2a-af10 fusion protein expression;exactmatch
abnormal immunology test result;abnormal immunology test result;exactmatch
interleukin-2 overexpression;il-2 overexpression;exactmatch
interleukin-5 overexpression;il-5 overexpression;exactmatch
interleukin-6 overexpression;il-6 overexpression;exactmatch
constitutional symptom;constitutional finding;exactmatch
interfollicular area of the lymph node;interfollicular area of the lymph node;exactmatch
lymph node part;lymph node part;exactmatch
hair part;hair part;exactmatch
aggravated neurofibromatosis;aggravated neurofibromatosis;exactmatch
api2-mlt fusion protein expression;api2-mlt fusion protein expression;exactmatch
traditional serrated adenoma;serrated adenoma;exactmatch
clonal bcl3 gene rearrangement;clonal bcl-3 gene rearrangement;exactmatch
colony-stimulating factor overexpression;colony-stimulating factor overexpression;exactmatch
neonatal leukemia;neonatal leukemia;exactmatch
lymphotoxin-alpha overexpression;lymphotoxin-alpha overexpression;exactmatch
interleukin-13 overexpression;il-13 overexpression;exactmatch
interleukin-10 overexpression;il-10 overexpression;exactmatch
interleukin-9 overexpression;il-9 overexpression;exactmatch
interleukin-7 overexpression;il-7 overexpression;exactmatch
neoplastic large b-lymphocyte with pale cytoplasm;neoplastic large b-lymphocyte with pale cytoplasm;exactmatch
pericardial cavity;body cavity, pericardial;exactmatch
angiotensin ii signaling pathway;angiotensin ii signaling pathway;exactmatch
cell cycle pathway;cell cycle;exactmatch
mapk signaling pathway;mapk signaling pathway;exactmatch
focal adhesion pathway;focal adhesion;exactmatch
inositol phosphate metabolism pathway;inositol metabolism;exactmatch
huntington's disease pathway;huntington's disease;exactmatch
leukoplakia of gingiva;gingival leukoplakia;exactmatch
eyelid nevus;eyelid nevus;exactmatch
citrate cycle (tca cycle) pathway;citrate cycle (tca cycle) pathway;exactmatch
thyroid gland medullary carcinoma;c cell carcinoma;exactmatch
skin cyst;cutaneous cyst;exactmatch
apoptosis pathway;apoptosis;exactmatch
amyotrophic lateral sclerosis pathway;amyotrophic lateral sclerosis (als);exactmatch
thyroid gland anaplastic carcinoma;atc;exactmatch
alzheimer's disease pathway kegg;alzheimer's disease;exactmatch
malignant neoplasms of mouse liver;malignant neoplasms of mouse liver;exactmatch
benign neoplasms of mouse liver;benign neoplasms of mouse liver;exactmatch
squamous differentiation;squamous differentiation;exactmatch
mrna biosynthesis pathway;mrna biosynthesis (eukaryotes);exactmatch
oxidative phosphorylation pathway;oxidative phosphorylation;exactmatch
chest pain;chest pain;exactmatch
minimal residual disease;detectable residual disease;exactmatch
ribosomal biogenesis pathway;ribosomal biogenesis pathway;exactmatch
alk pathway;alk pathway;exactmatch
akt signaling pathway;akt signaling pathway;exactmatch
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue;exactmatch
agrin pathway;agrin pathway;exactmatch
regulation of apoptosis pathway;regulation of apoptosis pathway;exactmatch
isochromosome;isochromosome;exactmatch
grade iii meningioma;grade 3 meningioma;exactmatch
parkinson's disease pathway kegg;parkinson's disease;exactmatch
grade ii meningioma;grade 2 meningioma;exactmatch
grade i meningioma;grade 1 meningioma;exactmatch
mu heavy chain disease;mu heavy chain disease;exactmatch
kidney angiomyolipoma;angiomyolipoma of kidney;exactmatch
leukoplakia of tongue;leukoplakia of tongue;exactmatch
prion disease pathway;prion disease;exactmatch
phosphatidylinositol signaling system pathway;phosphatidylinositol signaling system;exactmatch
testicular teratoma;teratoma of testis;exactmatch
lymphocytic thyroiditis;lymphocytic thyroiditis;exactmatch
squamoid differentiation;squamoid differentiation;exactmatch
neoplastic small b-lymphocyte;neoplastic small b-lymphocyte;exactmatch
lymphoepithelial lesion;lymphoepithelial lesion;exactmatch
ovarian germ cell tumor;germ cell neoplasm of ovary;exactmatch
marginal zone b-lymphocyte;marginal zone b-lymphocyte;exactmatch
villous lymphocyte;villous lymphocyte;exactmatch
nuclear pleomorphism;nuclear pleomorphism;exactmatch
ovarian brenner tumor;brenner neoplasm of ovary;exactmatch
nasopharyngeal carcinoma;cancer of nasopharynx;exactmatch
lymphangitic carcinomatosis;lymphangitic carcinomatosis;exactmatch
scaffolding protein;scaffolding protein;exactmatch
hyperviscosity;blood hyperviscosity;exactmatch
liver hemangioma;angioma of liver;exactmatch
gastrointestinal stromal tumor;gist;exactmatch
widespread disease;extensive disease;exactmatch
fallopian tube carcinoma;cancer of fallopian tube;exactmatch
polymorphic cellular infiltrate;polymorphic cellular infiltrate;exactmatch
monomorphic cellular infiltrate;monomorphic cellular infiltrate;exactmatch
villous atrophy;villous atrophy;exactmatch
defective alpha heavy chain present;defective alpha heavy chain present;exactmatch
mouse hepatic system neoplasm;mouse hepatic system neoplasm;exactmatch
mouse cholangiocarcinoma;bile duct carcinoma of mouse;exactmatch
thyroid gland sclerosing mucoepidermoid carcinoma with eosinophilia;sclerosing mucoepidermoid thyroid carcinoma with eosinophilia;exactmatch
thyroid gland mucoepidermoid carcinoma;mucoepidermoid thyroid carcinoma;exactmatch
submucosal invasive colon adenocarcinoma;submucosal invasive colon adenocarcinoma;exactmatch
gastric leiomyoma;gastric leiomyoma;exactmatch
ebv infection;ebv infection;exactmatch
hepatocellular carcinoma of the mouse;hepatocellular carcinoma of the mouse;exactmatch
hepatocellular adenoma of the mouse;hepatocellular adenoma of the mouse;exactmatch
mouse liver disorder;mouse liver disorder;exactmatch
non-neoplastic proliferation of the mouse liver;non-neoplastic proliferation of the mouse liver;exactmatch
mouse ito cell tumor, benign;lipoma of mouse;exactmatch
spinal cord ependymoma;ependymoma of spinal cord;exactmatch
mouse hepatocholangiocellular adenocarcinoma;mouse hepatocholangiocellular adenocarcinoma;exactmatch
mouse hepatocholangiocellular adenoma;mouse hepatocholangiocellular adenoma;exactmatch
mouse cholangioma;bile duct adenoma of mouse;exactmatch
pancreatic cystadenocarcinoma;cystadenocarcinoma - pancreas;exactmatch
autoimmune lymphoproliferative syndrome-associated lymphoma;alps-associated lymphoma;exactmatch
disseminated peritoneal leiomyomatosis;diffuse peritoneal leiomyomatosis;exactmatch
fas apoptosis pathway deregulation;cd95 apoptotic pathway deregulation;exactmatch
infiltrating renal pelvis and ureter urothelial carcinoma;infiltrating renal pelvis and ureter transitional cell carcinoma;exactmatch
high grade prostatic intraepithelial neoplasia, mucinous variant;high grade prostatic intraepithelial neoplasia, mucinous variant;exactmatch
high grade prostatic intraepithelial neoplasia, signet ring variant;high grade prostatic intraepithelial neoplasia, signet ring variant;exactmatch
prostate acinar adenocarcinoma, lymphoepithelioma-like variant;acinar prostate adenocarcinoma, lymphoepithelioma-like variant;exactmatch
prostate acinar adenocarcinoma, oncocytic variant;acinar prostate adenocarcinoma, oncocytic variant;exactmatch
prostate acinar adenocarcinoma, foamy gland variant;acinar prostate adenocarcinoma, foamy gland variant;exactmatch
prostate acinar adenocarcinoma, pseudohyperplastic variant;acinar prostate adenocarcinoma, pseudohyperplastic variant;exactmatch
prostate acinar adenocarcinoma, atrophic variant;acinar prostate adenocarcinoma, atrophic variant;exactmatch
bladder mucosa-associated lymphoid tissue lymphoma;bladder malt lymphoma;exactmatch
parathyroid hyperplasia;hyperplasia of parathyroid;exactmatch
fgfr3 gene mutation;cd333 gene mutation;exactmatch
loss of chromosome 9q;loss of chromosome 9q;exactmatch
urethral verrucous carcinoma;urethral verrucous carcinoma;exactmatch
urethral glandular metaplasia;urethral glandular metaplasia;exactmatch
urethral villous adenoma;urethral villous adenoma;exactmatch
prostatic urethral malignant neoplasm;prostatic urethral malignant neoplasm;exactmatch
bulbomembranous urethral malignant neoplasm;bulbomembranous urethral malignant neoplasm;exactmatch
high grade prostatic intraepithelial neoplasia, foamy variant;high grade prostatic intraepithelial neoplasia, foamy variant;exactmatch
high grade prostatic intraepithelial neoplasia, inverted variant;high grade prostatic intraepithelial neoplasia, inverted variant;exactmatch
testicular gonadoblastoma;testicular gonadoblastoma;exactmatch
prostate adenocarcinoma with neuroendocrine differentiation;prostate adenocarcinoma with neuroendocrine differentiation;exactmatch
thrombocytopenia due to immune destruction;immune thrombocytopenia;exactmatch
gain of chromosome 18q;gain of chromosome 18q;exactmatch
seminal vesicle neoplasm;seminal vesicle neoplasm;exactmatch
seminal vesicle cystadenoma;seminal vesicle cystadenoma;exactmatch
seminal vesicle adenocarcinoma;seminal vesicle adenocarcinoma;exactmatch
prostate stromal tumor of uncertain malignant potential;prostate stromal proliferation of uncertain malignant potential;exactmatch
tumor of specialized prostatic stroma;tumor of specialized prostatic stroma;exactmatch
prostate basal cell carcinoma;basal cell carcinoma of the prostate;exactmatch
high grade prostatic intraepithelial neoplasia, small cell neuroendocrine variant;high grade prostatic intraepithelial neoplasia, small cell neuroendocrine variant;exactmatch
prostatic duct urothelial carcinoma;prostatic duct urothelial carcinoma;exactmatch
prostatic urethra urothelial carcinoma;prostatic urethra urothelial carcinoma;exactmatch
secondary prostate urothelial carcinoma;secondary prostate urothelial carcinoma;exactmatch
primary prostate urothelial carcinoma;primary prostate urothelial cancer;exactmatch
prostate ductal adenocarcinoma, solid pattern;prostate ductal adenocarcinoma, solid pattern;exactmatch
prostate ductal adenocarcinoma, papillary pattern;prostate ductal adenocarcinoma, papillary pattern;exactmatch
prostate ductal adenocarcinoma, cribriform pattern;prostate ductal adenocarcinoma, cribriform pattern;exactmatch
penile urethral malignant neoplasm;penile urethral malignant neoplasm;exactmatch
male urethral malignant neoplasm;male urethral malignant neoplasm;exactmatch
female urethral malignant neoplasm;female urethral malignant neoplasm;exactmatch
bladder adenocarcinoma, not otherwise specified;bladder adenocarcinoma nos;exactmatch
bladder urachal adenocarcinoma;bladder urachal adenocarcinoma;exactmatch
bladder urachal carcinoma;bladder urachal cancer;exactmatch
intestinal metaplasia of bladder urothelium;intestinal metaplasia of bladder urothelium;exactmatch
urinary tract precancerous condition;urinary tract precancerous condition;exactmatch
bladder mixed adenocarcinoma;bladder mixed adenocarcinoma;exactmatch
bladder hepatoid adenocarcinoma;bladder hepatoid adenocarcinoma;exactmatch
bladder mucinous adenocarcinoma;bladder colloid adenocarcinoma;exactmatch
bladder enteric type adenocarcinoma;bladder colonic type adenocarcinoma;exactmatch
carcinoma of littre glands;adenocarcinoma of littre glands;exactmatch
bladder squamous cell papilloma;bladder keratotic papilloma;exactmatch
schistosoma hematobium-related bladder verrucous carcinoma;schistosoma hematobium-related bladder verrucous carcinoma;exactmatch
bladder verrucous carcinoma;bladder verrucous carcinoma;exactmatch
bladder non-invasive papillary urothelial neoplasm;bladder non-invasive papillary urothelial neoplasm;exactmatch
infiltrating bladder urothelial carcinoma with giant cells;infiltrating bladder urothelial carcinoma with giant cells;exactmatch
infiltrating bladder urothelial carcinoma, lipid-rich variant;infiltrating bladder urothelial carcinoma, lipid-cell variant;exactmatch
infiltrating bladder urothelial carcinoma, clear cell variant;clear cell (glycogen-rich) urothelial carcinoma;exactmatch
bladder urachal urothelial carcinoma;bladder urachal urothelial carcinoma;exactmatch
bladder urachal squamous cell carcinoma;bladder urachal squamous cell carcinoma;exactmatch
intestinal metaplasia of bladder urachal epithelium;intestinal metaplasia of bladder urachal epithelium;exactmatch
bladder tubulo-cystic clear cell adenocarcinoma;bladder tubulo-cystic clear cell adenocarcinoma;exactmatch
carcinoma of cowper glands;adenocarcinoma of cowper glands;exactmatch
carcinoma of skene glands;adenocarcinoma of skene gland;exactmatch
human papillomavirus-related urethral squamous cell carcinoma;human papilloma virus-related urethral squamous cell carcinoma;exactmatch
cystitis glandularis;cystitis glandularis;exactmatch
bladder inverted papilloma;bladder inverted papilloma;exactmatch
bladder urothelial papilloma;bladder transitional cell papilloma;exactmatch
bladder papillary urothelial neoplasm;bladder papillary transitional cell neoplasm;exactmatch
urothelial dysplasia;transitional cell dysplasia of the urinary tract;exactmatch
non-invasive urothelial neoplasm;non-invasive transitional cell neoplasm of the urinary tract;exactmatch
infiltrating urothelial carcinoma;infiltrating transitional cell carcinoma of the urinary tract;exactmatch
urothelial neoplasm;transitional cell neoplasm of the urinary tract;exactmatch
bladder urothelial carcinoma;blca;exactmatch
stage 0 renal pelvis and ureter cancer ajcc v7;stage 0 renal pelvis and ureter cancer;exactmatch
bladder diffuse clear cell adenocarcinoma;bladder diffuse clear cell adenocarcinoma;exactmatch
bladder papillary clear cell adenocarcinoma;bladder papillary clear cell adenocarcinoma;exactmatch
gain of chromosome y;gain of chromosome y;exactmatch
testicular mixed germ cell-sex cord-stromal tumor, unclassified;testicular mixed germ cell-sex cord-stromal tumor, unclassified;exactmatch
infiltrating bladder urothelial carcinoma, sarcomatoid variant with heterologous elements;infiltrating bladder urothelial carcinoma, sarcomatoid variant with heterologous elements;exactmatch
moderately differentiated ovarian sertoli-leydig cell tumor;intermediate differentiated ovarian sertoli-leydig cell tumor;exactmatch
sertoli cell tumor;sertoli cell tumor;exactmatch
ovarian sertoli-leydig cell tumor with retiform elements;ovarian sertoli-leydig cell tumor with retiform elements;exactmatch
poorly differentiated ovarian sertoli-leydig cell tumor, variant with heterologous elements;poorly differentiated ovarian sertoli-leydig cell tumor, variant with heterologous elements;exactmatch
moderately differentiated ovarian sertoli-leydig cell tumor, variant with heterologous elements;intermediate differentiated ovarian sertoli-leydig cell tumor, variant with heterologous elements;exactmatch
ovarian retiform sertoli-leydig cell tumor;ovarian retiform sertoli-leydig cell tumor;exactmatch
ovarian sertoli-leydig cell tumor with heterologous elements;ovarian sertoli-leydig cell tumor with heterologous elements;exactmatch
childhood medulloblastoma;childhood medulloblastoma;exactmatch
ovarian sertoli-stromal cell tumor;ovarian sertoli-stromal cell tumor;exactmatch
ovarian sex cord-stromal tumor of mixed or unclassified cell types;ovarian sex cord-stromal tumor of mixed or unclassified cell types;exactmatch
ovarian signet ring stromal tumor;ovarian signet ring stromal tumor;exactmatch
typical ovarian thecoma;typical ovarian thecoma;exactmatch
penile bowenoid papulosis;penile bowenoid papulosis;exactmatch
penile basal cell carcinoma;basal cell carcinoma of the penis;exactmatch
monoclonal gammopathy of undetermined significance;mgus;exactmatch
mixed squamous cell carcinoma of the penis;mixed squamous cell carcinoma of the penis;exactmatch
epididymal neoplasm;epididymal neoplasm;exactmatch
ovarian stromal-leydig cell tumor;ovarian stromal-leydig cell tumor;exactmatch
ovarian steroid cell tumor, not otherwise specified;ovarian steroid cell tumor, nos;exactmatch
i(12p);i(12p);exactmatch
ovarian yolk sac tumor, hepatoid pattern;ovarian yolk sac tumor, hepatoid pattern;exactmatch
ovarian fetiform teratoma;homunculus;exactmatch
malignant ovarian teratoma;grade 3 ovarian teratoma;exactmatch
grade 1 ovarian teratoma;grade 1 ovarian teratoma;exactmatch
ovarian biphasic or triphasic teratoma;ovarian biphasic or triphasic teratoma;exactmatch
non-gestational ovarian choriocarcinoma;non-gestational ovarian choriocarcinoma;exactmatch
ovarian polyembryoma;ovarian polyembryoma;exactmatch
recurrent esophageal carcinoma;esophageal carcinoma, recurrent;exactmatch
ovarian yolk sac tumor, glandular pattern;ovarian yolk sac tumor, glandular pattern;exactmatch
recurrent colon carcinoma;recurrent cancer of colon;exactmatch
ovarian yolk sac tumor, polyvesicular vitelline pattern;ovarian yolk sac tumor, polyvesicular vitelline pattern;exactmatch
ovarian primitive germ cell tumor;ovarian primitive germ cell tumor;exactmatch
ovarian gonadoblastoma;ovarian gonadoblastoma;exactmatch
ovarian leydig cell tumor, not otherwise specified;ovarian leydig cell tumor, not otherwise specified;exactmatch
ovarian leydig cell tumor, non-hilar type;ovarian leydig cell tumor, non-hilar type;exactmatch
malignant ovarian steroid cell tumor;malignant ovarian steroid cell tumor;exactmatch
well differentiated ovarian steroid cell tumor;well differentiated ovarian steroid cell tumor;exactmatch
epididymal adenocarcinoma;adenocarcinoma of the epididymis;exactmatch
rete testis adenoma;adenoma, rete testis, benign;exactmatch
rete testis neoplasm;rete testis neoplasm;exactmatch
testicular yolk sac tumor, macrocystic pattern;testicular yolk sac tumor, macrocystic pattern;exactmatch
testicular yolk sac tumor, polyvesicular vitelline pattern;testicular yolk sac tumor, polyvesicular vitelline pattern;exactmatch
stage ii colon cancer ajcc v6;ajcc stage ii colon cancer v6;exactmatch
testicular yolk sac tumor, myxomatous pattern;testicular yolk sac tumor, myxomatous pattern;exactmatch
testicular yolk sac tumor, papillary pattern;testicular yolk sac tumor, papillary pattern;exactmatch
testicular yolk sac tumor, endodermal sinus/perivascular pattern;testicular yolk sac tumor, endodermal sinus pattern;exactmatch
testicular yolk sac tumor, glandular-alveolar pattern;testicular yolk sac tumor, glandular-alveolar pattern;exactmatch
testicular yolk sac tumor, solid pattern;testicular yolk sac tumor, solid pattern;exactmatch
testicular yolk sac tumor, microcystic pattern;testicular yolk sac tumor, microcystic pattern;exactmatch
brenner tumor;brenner tumor;exactmatch
testicular spermatocytic tumor with sarcoma;spermatocytic tumor with sarcoma;exactmatch
testicular spermatocytic tumor;spermatocytic seminoma;exactmatch
testicular seminoma with high mitotic index;anaplastic seminoma;exactmatch
aids-related kaposi sarcoma;aids related kaposi's sarcoma;exactmatch
testicular seminoma with syncytiotrophoblastic cells;testicular seminoma with syncytiotrophoblastic cells;exactmatch
testicular pure germ cell tumor;testicular pure germ cell tumor;exactmatch
gain of chromosome 12p;gain of chromosome 12p;exactmatch
testicular yolk sac tumor, hepatoid pattern;testicular yolk sac tumor, hepatoid pattern;exactmatch
testicular yolk sac tumor, enteric pattern;testicular yolk sac tumor, enteric pattern;exactmatch
testicular trophoblastic tumor;testicular trophoblastic tumor;exactmatch
testicular monophasic choriocarcinoma;testicular monophasic choriocarcinoma;exactmatch
testicular brenner tumor;testicular brenner tumor;exactmatch
testicular thecoma;testicular thecoma;exactmatch
testicular fibroma;testicular fibroma;exactmatch
tumor of the thecoma/fibroma group;tumor of the thecoma/fibroma group;exactmatch
stage iv breast cancer ajcc v6 and v7;breast cancer stage iv;exactmatch
testicular tumor of the thecoma/fibroma group;testicular tumor of the thecoma/fibroma group;exactmatch
malignant testicular sex cord-stromal tumor;malignant testicular sex cord-stromal tumor;exactmatch
juvenile type testicular granulosa cell tumor;juvenile type testicular granulosa cell tumor;exactmatch
adult type testicular granulosa cell tumor;adult type testicular granulosa cell tumor;exactmatch
testicular sclerosing sertoli cell tumor;testicular sclerosing sertoli cell tumor;exactmatch
testicular large cell calcifying sertoli cell tumor;large cell calcifying sertoli cell tumor;exactmatch
testicular sertoli cell tumor, lipid rich variant;testicular sertoli cell tumor, lipid rich variant;exactmatch
malignant testicular leydig cell tumor;malignant testicular leydig cell tumor;exactmatch
stage iv colon cancer ajcc v6;ajcc stage iv colon cancer v6;exactmatch
monodermal testicular teratoma;monodermal testicular teratoma;exactmatch
infiltrating bladder urothelial carcinoma, sarcomatoid variant without heterologous elements;infiltrating bladder urothelial carcinoma, sarcomatoid variant without heterologous elements;exactmatch
infiltrating bladder urothelial carcinoma, sarcomatoid variant;bladder carcinosarcoma;exactmatch
t-cell large granular lymphocyte leukemia, common variant;t-cell large granular lymphocyte leukemia, common variant;exactmatch
anaplastic large cell lymphoma, giant cell rich subtype;anaplastic large cell lymphoma, giant cell rich subtype;exactmatch
flower-like t-lymphocyte;flower-like t-lymphocyte;exactmatch
neoplastic small to medium-sized t-lymphocyte with irregular nucleus;neoplastic small to medium-sized t-lymphocyte with irregular nucleus;exactmatch
doughnut cell;doughnut cell;exactmatch
hallmark cell;anaplastic t-lymphocyte with horseshoe-shaped nucleus;exactmatch
anaplastic t-lymphocyte;anaplastic t-cell;exactmatch
anaplastic large cell lymphoma, signet ring-like subtype;anaplastic large cell lymphoma, signet ring-like subtype;exactmatch
anaplastic large cell lymphoma, sarcomatoid subtype;anaplastic large cell lymphoma, sarcomatoid subtype;exactmatch
neoplastic t-lymphocyte with clear cytoplasm;neoplastic t-lymphocyte with clear cytoplasm;exactmatch
activated skin-homing t-lymphocyte;activated skin-homing t-lymphocyte;exactmatch
proliferation of follicular dendritic cells present;proliferation of follicular dendritic cells present;exactmatch
proliferation of high endothelial venules present;proliferation of high endothelial venules present;exactmatch
serpine1 gene;serpine1;exactmatch
erythroderma;erythroderma;exactmatch
mycosis fungoides variant;mycosis fungoides variant;exactmatch
mucinous degeneration;mucinous degeneration;exactmatch
cdkn2a gene inactivation;cdkn2a gene inactivation;exactmatch
signet ring-like neoplastic t-lymphocyte;signet ring-like neoplastic t-lymphocyte;exactmatch
activated mature cytotoxic t-lymphocyte;activated mature cytotoxic t-lymphocyte;exactmatch
solitary skin tumor;solitary skin tumor;exactmatch
kidney cyst;cyst of kidney;exactmatch
cerebriform-like lymphocyte;cerebriform-like lymphocyte;exactmatch
dna repair pathway;dna repair pathway;exactmatch
cell differentiation or development pathway;cell differentiation or development pathway;exactmatch
cell motility pathway;cell motility pathway;exactmatch
degradation pathway;degradation pathway;exactmatch
disease pathway;disease pathway;exactmatch
cell cycle regulation pathway;cell cycle regulation pathway;exactmatch
apoptosis regulation pathway;apoptosis regulation pathway;exactmatch
localized skin lesion;localized skin lesion;exactmatch
immune response regulation pathway;immune response regulation pathway;exactmatch
extranodal disease;extranodal disease;exactmatch
sarcomatoid features;sarcomatoid differentiation;exactmatch
complete regression;complete regression;exactmatch
partial regression;partial regression;exactmatch
papular lesion;papular lesion;exactmatch
multicentric cutaneous involvement;multicentric cutaneous involvement;exactmatch
single cell exocytosis;single cell exocytosis;exactmatch
pautrier microabscess present;pautrier microabscess present;exactmatch
epidermotropic lymphocytic infiltrate;epidermotropic lymphocytic infiltrate;exactmatch
ccnd2 gene;ccnd2;exactmatch
osteoclastic activity present;osteoclastic activity present;exactmatch
pleomorphic medium-sized to large t-lymphocyte;pleomorphic medium-sized to large t-lymphocyte;exactmatch
pleomorphic small t-lymphocyte;pleomorphic small t-lymphocyte;exactmatch
neoplastic medium-sized t-lymphocyte;neoplastic medium-sized t-lymphocyte;exactmatch
polylobated t-lymphocyte;flower cell;exactmatch
cebpa gene;ccaat enhancer binding protein alpha gene;exactmatch
prkcb gene;prkcb;exactmatch
skin rash;cutaneous eruption;exactmatch
extracutaneous dissemination of disease;extracutaneous dissemination of disease;exactmatch
peripheral blood involvement;peripheral blood involvement;exactmatch
chronic lymphoproliferative disorder of nk-cells;clpd-nk;exactmatch
hepatobiliary disorder;hepatobiliary disorder;exactmatch
angioinvasion;angioinvasion;exactmatch
serum soluble fas ligand level increased;serum soluble fas ligand level increased;exactmatch
t-cell large granular lymphocyte leukemia expressing the t-cell receptor gamma-delta;t-cell large granular lymphocyte leukemia expressing the t-cell receptor gamma-delta;exactmatch
gamma/delta t-lymphocyte;gamma delta t cell;exactmatch
pautrier-like microabscess present;pautrier-like microabscess present;exactmatch
neoplastic small t-lymphocyte;neoplastic small t-lymphocyte;exactmatch
neoplastic small to medium-sized t-lymphocyte;neoplastic small to medium-sized t-lymphocyte;exactmatch
coagulative necrosis;coagulative necrosis;exactmatch
skin plaque;plaque;exactmatch
skin patch;skin patch;exactmatch
scaly skin eruption;scaly skin eruption;exactmatch
cerebriform lymphocyte;cerebriform lymphocyte;exactmatch
dermatopathic lymphadenopathy;dermatopathic lymphadenopathy;exactmatch
subcutaneous nodule;subcutaneous nodule;exactmatch
subcutaneous involvement;subcutaneous involvement;exactmatch
karyorrhexis;karyorrhexis;exactmatch
sinusoidal infiltration;sinusoidal infiltration;exactmatch
neoplastic medium-sized to large t-lymphocyte;neoplastic medium-sized to large t-lymphocyte;exactmatch
intraepithelial t-lymphocyte of the intestine;intraepithelial t-lymphocyte of the intestine;exactmatch
intestinal ulcerated mass;intestinal ulcerated mass;exactmatch
intestinal perforation;bowel perforation;exactmatch
small intestinal enteropathy-associated t-cell lymphoma;small intestinal eatl;exactmatch
activated natural killer cell;activated natural killer cell;exactmatch
confluent sheets of anaplastic t-lymphocytes present;confluent sheets of anaplastic t-lymphocytes present;exactmatch
c-kit tyrosine kinase protein overexpression;c-kit tyrosine kinase protein overexpression;exactmatch
infiltrating bladder urothelial carcinoma, plasmacytoid variant;infiltrating bladder urothelial carcinoma, plasmacytoid variant;exactmatch
"t(3;8)(p14;q24)";"t(3;8)(p14;q24)";exactmatch
"inv(x)(p11;q12)";"inv(x)(p11;q12)";exactmatch
sickle cell trait;sickle cell trait;exactmatch
loss of chromosome 21;loss of chromosome 21;exactmatch
loss of chromosome 2;loss of chromosome 2;exactmatch
loss of chromosome 14q;loss of chromosome 14q;exactmatch
"t(3;12)(q13;q24)";"t(3;12)(q13;q24)";exactmatch
"t(3;6)(p13;q25)";"t(3;6)(p13;q25)";exactmatch
renal cell carcinoma with constitutional chromosome 3 translocations;renal cell carcinoma with constitutional chromosome 3 translocations;exactmatch
prcc-tfe3 fusion protein expression;prcc-tfe3 fusion protein expression;exactmatch
hereditary renal cell carcinoma;familial renal cancer;exactmatch
met gene mutation;hgfr gene mutation;exactmatch
multiple tumor masses;multiple masses;exactmatch
bilateral disease;bilateral disease;exactmatch
inner ear neoplasm;inner ear neoplasm;exactmatch
retinal hemangioblastoma;retinal capillary hemangioma;exactmatch
vulvar polyp;polyp of vulva;exactmatch
"renal cell carcinoma associated with inv(x)(p11;q12)";"renal cell carcinoma associated with inv(x)(p11;q12)";exactmatch
psf-tfe3 fusion protein expression;psf-tfe3 fusion protein expression;exactmatch
kit gene mutation;c-kit mutation;exactmatch
cellular congenital mesoblastic nephroma;cellular congenital mesoblastic nephroma;exactmatch
infiltrating bladder urothelial carcinoma, lymphoma-like variant;infiltrating bladder urothelial carcinoma, lymphoma-like variant;exactmatch
infiltrating bladder lymphoepithelioma-like carcinoma;infiltrating bladder lymphoepithelioma-like carcinoma;exactmatch
infiltrating bladder urothelial carcinoma, microcystic variant;infiltrating bladder urothelial carcinoma, microcystic variant;exactmatch
infiltrating bladder urothelial carcinoma, nested variant;infiltrating bladder urothelial carcinoma, nested variant;exactmatch
infiltrating bladder urothelial carcinoma with trophoblastic differentiation;infiltrating bladder urothelial carcinoma with trophoblastic differentiation;exactmatch
infiltrating bladder urothelial carcinoma with glandular differentiation;infiltrating bladder urothelial carcinoma with glandular differentiation;exactmatch
infiltrating bladder urothelial carcinoma with squamous differentiation;infiltrating bladder urothelial carcinoma with squamous;exactmatch
classic congenital mesoblastic nephroma;classic congenital mesoblastic nephroma;exactmatch
nono-tfe3 fusion protein expression;nono-tfe3 fusion protein expression;exactmatch
smarcb1 gene inactivation;inactivating baf47 gene mutation;exactmatch
metanephric adenofibroma;metanephric adenofibroma;exactmatch
"t(5;11)(q35;q13)";"t(5;11)(q35;q13)";exactmatch
type 2 renal papillary adenoma;type 2 papillary adenoma of the kidney;exactmatch
type 1 renal papillary adenoma;type 1 papillary adenoma of the kidney;exactmatch
asymptomatic mass;asymptomatic mass;exactmatch
mucinous tubular and spindle cell carcinoma of the kidney;carcinoma, renal, tubular, malignant;exactmatch
non-contiguous disease;non-contiguous disease;exactmatch
contiguous disease;contiguous disease;exactmatch
below the diaphragm disease;below the diaphragm disease;exactmatch
defective heavy chain present;defective heavy chain present;exactmatch
infectious disease pathway;infectious disease;exactmatch
neurodegenerative disorders pathway;neurodegenerative disorders;exactmatch
genetic information processing pathway;genetic information processing;exactmatch
energy metabolism pathway;energy metabolism - reference pathway;exactmatch
carbohydrate metabolism pathway;carbohydrate metabolism - reference pathway;exactmatch
immunodeficiency;immunodeficiency;exactmatch
immune system finding;immune system;exactmatch
abundance of small lymphocytes;abundance of small lymphocytes;exactmatch
above the diaphragm disease;above the diaphragm disease;exactmatch
classical reed-sternberg cell;classical reed-sternberg cell;exactmatch
prostate fibroma;fibroma of prostate;exactmatch
pdgfralpha protein overexpression;pdgfra protein overexpression;exactmatch
pdgfra gene mutation;cd140a gene mutation;exactmatch
mdm2 gene mutation;actfs gene mutation;exactmatch
egfr protein overexpression;egfr overexpression;exactmatch
cd30-positive neoplastic cells present;cd30+ neoplastic cells present;exactmatch
negative peripheral blood;negative peripheral blood;exactmatch
lung inflammatory myofibroblastic tumor;lung inflammatory myofibroblastic tumor;exactmatch
retroperitoneal inflammatory myofibroblastic tumor;retroperitoneal inflammatory myofibroblastic tumor;exactmatch
fascicular pattern;fascicular pattern;exactmatch
cervical leukoplakia;cervical leukoplakia;exactmatch
desmoplastic ameloblastoma;desmoplastic ameloblastoma;exactmatch
basal cell ameloblastoma;basal cell ameloblastoma;exactmatch
unicystic ameloblastoma;ameloblastoma, unicystic type;exactmatch
solid/multicystic ameloblastoma;conventional ameloblastoma;exactmatch
acanthomatous ameloblastoma;acanthomatous ameloblastoma;exactmatch
plexiform ameloblastoma;plexiform ameloblastoma;exactmatch
refractory disease;refractory disease;exactmatch
secondary glioblastoma;secondary glioblastoma;exactmatch
glioblastoma, idh-wildtype;glioblastoma, idh-wildtype;exactmatch
cervical atypia;cellular cervical abnormality;exactmatch
type ii endometrial adenocarcinoma;type ii endometrial adenocarcinoma;exactmatch
lymphoblast-like neoplastic b-lymphocyte;lymphoblast-like neoplastic b-lymphocyte;exactmatch
pleomorphic variant mantle cell lymphoma;pleomorphic variant mantle cell lymphoma;exactmatch
myxoid changes present;myxoid changes present;exactmatch
del(20)(q11);del(20)(q11);exactmatch
aneuploid dysplastic oral leukoplakia;aneuploid dysplastic oral leukoplakia;exactmatch
vaginal intraepithelial neoplasia;intraepithelial neoplasia of vagina;exactmatch
mummified cell;mummified cell;exactmatch
abnormal eosinophil;abnormal eosinophil;exactmatch
dysplastic neutrophil;dysplastic neutrophil;exactmatch
toxic neutrophil;toxic neutrophil;exactmatch
pleomorphic lipoma;pl;exactmatch
abnormal neutrophil;abnormal neutrophil;exactmatch
popcorn cell;l&h cell;exactmatch
hodgkin-like cell;hodgkin's-like cell;exactmatch
reed-sternberg-like cell;r-s-like cell;exactmatch
abnormal platelet;abnormal platelet;exactmatch
lacunar reed-sternberg cell;lacunar reed-sternberg cell;exactmatch
hodgkin cell;hodgkin cell;exactmatch
neoplastic large cleaved follicle center cell;neoplastic large centrocyte;exactmatch
hibernoma;brown fat neoplasm;exactmatch
neoplastic t-cell large granular lymphocyte;neoplastic t-cell large granular lymphocyte;exactmatch
anaplastic large lymphocyte;anaplastic large lymphocyte;exactmatch
anaplastic large t-lymphocyte;anaplastic large t-lymphocyte;exactmatch
neoplastic epithelial polygonal cell;neoplastic epithelial polygonal cell;exactmatch
large atypical platelet;large atypical platelet;exactmatch
anaplastic large b-lymphocyte;anaplastic large b-lymphocyte;exactmatch
monolobed megakaryocyte;monolobed megakaryocyte;exactmatch
dysplastic erythroid precursor;dysplastic erythroid precursor;exactmatch
abnormal erythroid precursor;abnormal erythroid precursor;exactmatch
faggot cell;faggot cell;exactmatch
dysplastic granulocyte;dysplastic granulocyte;exactmatch
abnormal granulocyte;abnormal granulocyte;exactmatch
pleomorphic liposarcoma;pleomorphic liposarcoma;exactmatch
hyperchromatic megakaryocyte;hyperchromatic megakaryocyte;exactmatch
hypolobated megakaryocyte;hypolobated megakaryocyte;exactmatch
dedifferentiated liposarcoma;ddlps;exactmatch
dysplastic megakaryocyte;dysplastic megakaryocyte;exactmatch
giant megakaryocyte;giant megakaryocyte;exactmatch
large megakaryocyte;large megakaryocyte;exactmatch
abnormal megakaryocyte;abnormal megakaryocyte;exactmatch
abnormal myeloid cell;abnormal myeloid cell;exactmatch
neoplastic monocyte;myelomonocyte;exactmatch
abnormal monocyte;abnormal monocyte;exactmatch
neoplastic large t-lymphocyte;neoplastic large t-lymphocyte;exactmatch
neoplastic centroblast;neoplastic centroblast;exactmatch
stat5b-rara fusion protein expression;stat5-raralpha fusion protein expression;exactmatch
neoplastic chondrocyte;neoplastic chondrocyte;exactmatch
neoplastic small to medium-sized b-lymphocyte with pale cytoplasm;neoplastic small to medium-sized b-lymphocyte with pale cytoplasm;exactmatch
neoplastic small to medium-sized lymphocyte;neoplastic small to medium-sized lymphocyte;exactmatch
intramuscular hemangioma;intramuscular angioma;exactmatch
neoplastic lymphocyte;neoplastic lymphocyte;exactmatch
abnormal hematopoietic and lymphoid cell;abnormal hematopoietic and lymphoid cell;exactmatch
neoplastic chondroblast;neoplastic chondroblast;exactmatch
atypical chondrocyte;atypical chondrocyte;exactmatch
chondrocyte-like cell;chondrocyte-like cell;exactmatch
neoplastic natural killer cell;neoplastic nk-cell;exactmatch
ganglion-like cell;ganglion-like cell;exactmatch
hyperchromatic stromal cell;hyperchromatic stromal cell;exactmatch
choroid plexus papilloma;choroid plexus papilloma;exactmatch
hyperchromatic adipocyte;hyperchromatic adipocyte;exactmatch
atypical adipocyte;atypical adipocyte;exactmatch
signet ring lipoblast;signet ring lipoblast;exactmatch
pleomorphic lipoblast;pleomorphic lipoblast;exactmatch
neoplastic medium-sized to large lymphocyte;neoplastic medium-sized to large lymphocyte;exactmatch
pleomorphic lymphocyte;pleomorphic lymphocyte;exactmatch
neoplastic large b-lymphocyte;neoplastic large b-lymphocyte;exactmatch
neoplastic medium-sized b-lymphocyte with basophilic cytoplasm;neoplastic medium-sized b-lymphocyte with basophilic cytoplasm;exactmatch
neoplastic t-immunoblast;neoplastic t-immunoblast;exactmatch
plasmablastic immunoblast;plasmablastic immunoblast;exactmatch
neoplastic b-immunoblast;neoplastic b-immunoblast;exactmatch
myxoid leiomyosarcoma;myxoid leiomyosarcoma;exactmatch
neoplastic immunoblast;neoplastic immunoblast;exactmatch
neoplastic large lymphocyte;neoplastic large lymphocyte;exactmatch
neoplastic medium-sized b-lymphocyte with eccentric basophilic cytoplasm;neoplastic medium-sized b-lymphocyte with eccentric basophilic cytoplasm;exactmatch
neoplastic medium-sized lymphocyte;neoplastic medium-sized lymphocyte;exactmatch
pleomorphic t-lymphocyte;pleomorphic t-lymphocyte;exactmatch
neoplastic monocytoid b-lymphocyte;neoplastic monocytoid b-lymphocyte;exactmatch
neoplastic small cleaved follicle center cell;neoplastic small centrocyte;exactmatch
centrocyte-like cell;centrocyte-like cell;exactmatch
lymphoplasmacytoid cell;lymphoplasmacytoid cell;exactmatch
epithelioid leiomyosarcoma;epithelioid leiomyosarcoma;exactmatch
neoplastic small lymphocyte with clumped chromatin;neoplastic small lymphocyte with clumped chromatin;exactmatch
neoplastic small lymphocyte;neoplastic small lymphocyte;exactmatch
large multinucleated erythroid cell;large multinucleated erythroid cell;exactmatch
dysplastic erythroblast;dysplastic erythroblast;exactmatch
abnormal erythroblast;abnormal erythroblast;exactmatch
pleomorphic connective and soft tissue cell;pleomorphic connective and soft tissue cell;exactmatch
neoplastic blastemal cell;neoplastic blastemal cell;exactmatch
squamous cell papilloma;epidermoid cell papilloma;exactmatch
atypical epithelioid cell;atypical epithelioid cell;exactmatch
adenocarcinoma cell with intracytoplasmic mucin;adenocarcinoma cell with intracytoplasmic mucin;exactmatch
neoplastic epithelial cell with intracytoplasmic mucin;neoplastic epithelial cell with intracytoplasmic mucin;exactmatch
serous adenocarcinoma cell;serous adenocarcinoma cell;exactmatch
neoplastic serous epithelial cell;neoplastic serous epithelial cell;exactmatch
pleomorphic cell;pleomorphic cell;exactmatch
neoplastic multinucleated stromal cell;neoplastic multinucleated stromal cell;exactmatch
compound odontoma;compound odontoma;exactmatch
malignant epithelial spindle cell;malignant epithelial spindle cell;exactmatch
adenocarcinoma spindle cell;adenocarcinoma spindle cell;exactmatch
neoplastic large cell with abundant cytoplasm;neoplastic large cell with abundant cytoplasm;exactmatch
neoplastic large cell with abundant eosinophilic cytoplasm;neoplastic large cell with abundant eosinophilic cytoplasm;exactmatch
neoplastic cell with eosinophilic cytoplasm;neoplastic cell with eosinophilic cytoplasm;exactmatch
neoplastic epithelioid cell;neoplastic epithelioid cell;exactmatch
neoplastic spindle-shaped to round cell;neoplastic spindle-shaped to round cell;exactmatch
neoplastic neuroepithelial cell;neoplastic neuroepithelial cell;exactmatch
ring sideroblast;ring sideroblast;exactmatch
neoplastic piloid astrocyte;neoplastic bipolar astrocyte;exactmatch
neoplastic elongated glial cell;neoplastic elongated glial cell;exactmatch
neoplastic ependymal cell;neoplastic ependymal cell;exactmatch
neoplastic intermediate type trophoblastic cell;neoplastic intermediate type trophoblastic cell;exactmatch
neoplastic oligodendrocyte;neoplastic oligodendrocyte;exactmatch
neoplastic cytotrophoblastic cell;neoplastic cytotrophoblastic cell;exactmatch
epithelioid sarcoma;es;exactmatch
xanthomatous astrocyte;xanthomatous astrocyte;exactmatch
poorly differentiated neoplastic astrocyte;poorly differentiated neoplastic astrocyte;exactmatch
neoplastic glial cell;neoplastic glial cell;exactmatch
anaplastic astrocyte;anaplastic astrocyte;exactmatch
neoplastic astrocyte with few flaccid processes;neoplastic astrocyte with few flaccid processes;exactmatch
giant neoplastic germ cell;giant neoplastic germ cell;exactmatch
gemistocytic neoplastic astrocyte;gemistocyte;exactmatch
papillomatosis;papillomatosis;exactmatch
fibrillary neoplastic astrocyte;fibrillary neoplastic astrocyte;exactmatch
neoplastic astrocyte;neoplastic astrocyte;exactmatch
neoplastic small round cell;neoplastic small round cell;exactmatch
ameloblastic fibro-odontoma;ameloblastic fibro-odontoma;exactmatch
neoplastic round cell;neoplastic round cell;exactmatch
neoplastic myeloid blast;neoplastic myeloid blast;exactmatch
hypogranular promyelocyte;hypogranular promyelocyte;exactmatch
hypergranular promyelocyte;hypergranular promyelocyte;exactmatch
neoplastic promyelocyte;neoplastic promyelocyte;exactmatch
neoplastic t-lymphoblast;neoplastic t-lymphoblast;exactmatch
neoplastic b-lymphoblast;neoplastic b-lymphoblast;exactmatch
meningiomatosis;meningiomas, multiple;exactmatch
neoplastic megakaryoblast;neoplastic megakaryoblast;exactmatch
neoplastic myeloblast with basophilic cytoplasm;neoplastic myeloblast with basophilic cytoplasm;exactmatch
malignant thyroid gland oncocyte;malignant hurthle cell;exactmatch
neoplastic myeloblast;neoplastic myeloblast;exactmatch
neoplastic blast;neoplastic blast;exactmatch
immature malignant mast cell;immature malignant mast cell;exactmatch
neoplastic mast cell;neoplastic mast cell;exactmatch
neoplastic hematopoietic and lymphoid cell;neoplastic hematopoietic and lymphoid cell;exactmatch
medullomyoblastoma with myogenic differentiation;medullomyoblastoma;exactmatch
neoplastic large erythroblast;neoplastic large erythroblast;exactmatch
neoplastic promonocyte;neoplastic promonocyte;exactmatch
neoplastic neutrophilic precursor;neoplastic neutrophilic precursor;exactmatch
neoplastic plasma cell;neoplastic plasma cell;exactmatch
pseudo-gaucher cell;pseudo-gaucher cell;exactmatch
neoplastic thyroid gland oncocyte;neoplastic hurthle cell;exactmatch
epithelioid endothelial cell;epithelioid endothelial cell;exactmatch
spindle endothelial cell;spindle endothelial cell;exactmatch
vacuolated endothelial cell;vacuolated endothelial cell;exactmatch
epithelial neoplasm;epithelial neoplasm;exactmatch
neoplastic endothelial cell;neoplastic endothelial cell;exactmatch
abnormal endothelial cell;abnormal endothelial cell;exactmatch
undifferentiated carcinoma cell;undifferentiated carcinoma cell;exactmatch
hyperchromatic spindle cell;hyperchromatic spindle cell;exactmatch
pleomorphic plasma cell;pleomorphic plasma cell;exactmatch
plasmablast;plasmablast;exactmatch
anaplastic plasma cell;anaplastic plasma cell;exactmatch
flame cell;flame cell;exactmatch
germ cell tumor;germ cell neoplasm;exactmatch
mott cell;mott cell;exactmatch
multivacuolated lipoblast;multivacuolated lipoblast;exactmatch
monovacuolated lipoblast;monovacuolated lipoblast;exactmatch
multilobated lipoblast-like cell;multilobated lipoblast-like cell;exactmatch
lipid-laden macrophage;lipid-laden macrophage;exactmatch
hemosiderin-laden macrophage;hemosiderin-laden macrophage;exactmatch
abnormal connective and soft tissue cell;abnormal connective and soft tissue cell;exactmatch
giant astrocyte;giant astrocyte;exactmatch
granular adenocarcinoma cell;granular adenocarcinoma cell;exactmatch
malignant thyroid gland follicular cell;malignant thyroid follicular cell;exactmatch
neoplastic thyroid gland follicular cell;neoplastic thyroid follicular cell;exactmatch
tingible body macrophage;tangible body macrophage;exactmatch
abnormal macrophage;abnormal macrophage;exactmatch
neoplastic epithelial spindle cell;neoplastic epithelial spindle cell;exactmatch
malignant mesothelial cell;malignant mesothelial cell;exactmatch
abnormal mesothelial cell;abnormal mesothelial cell;exactmatch
giant cell with myoblastic differentiation;giant cell with myoblastic differentiation;exactmatch
osteoclast-like giant cell;osteoclast-like giant cell;exactmatch
malignant neuroendocrine cell;malignant neuroendocrine cell;exactmatch
malignant epithelial giant cell;malignant epithelial giant cell;exactmatch
neoplastic spindle cell;neoplastic spindle cell;exactmatch
anaplastic carcinoma cell;anaplastic carcinoma cell;exactmatch
microcystic adenoma;microcystic adenoma;exactmatch
spindle melanoma cell;spindle melanoma cell;exactmatch
malignant small cell;malignant small cell;exactmatch
epithelioid melanoma cell;epithelioid melanoma cell;exactmatch
epithelioid melanocyte;epithelioid melanocyte;exactmatch
spindle melanocyte;spindle melanocyte;exactmatch
atypical melanocyte;atypical melanocyte;exactmatch
balloon nevus cell;balloon nevus cell;exactmatch
neoplastic melanocyte;neoplastic melanocyte;exactmatch
malignant small hyperchromatic cell;malignant small hyperchromatic cell;exactmatch
salivary gland monomorphic adenoma;salivary gland monomorphic adenoma;exactmatch
polygonal adenocarcinoma cell with eosinophilic cytoplasm;polygonal adenocarcinoma cell with eosinophilic cytoplasm;exactmatch
ductal carcinoma cell;ductal carcinoma cell;exactmatch
giant adenocarcinoma cell;giant adenocarcinoma cell;exactmatch
mucin-producing adenocarcinoma cell;mucin-producing adenocarcinoma cell;exactmatch
malignant neuroendocrine polygonal cell;malignant neuroendocrine polygonal cell;exactmatch
malignant neuroendocrine spindle cell;malignant neuroendocrine spindle cell;exactmatch
neoplastic polygonal cell with abundant granular cytoplasm;neoplastic polygonal cell with abundant granular cytoplasm;exactmatch
neoplastic polygonal cell;neoplastic polygonal cell;exactmatch
malignant epithelial large cell;malignant epithelial large cell;exactmatch
malignant neuroendocrine large cell;malignant neuroendocrine large cell;exactmatch
malignant neuroendocrine small cell;malignant neuroendocrine small cell;exactmatch
neoplastic cutaneous basal cell;neoplastic cutaneous basal cell;exactmatch
non-keratinizing malignant small squamous cell;non-keratinizing malignant small squamous cell;exactmatch
oncocytic adenocarcinoma;hurthle cell adenocarcinoma;exactmatch
dysplastic squamous cell;dysplastic squamous cell;exactmatch
giant epithelial cell;giant epithelial cell;exactmatch
malignant epithelial clear cell;malignant epithelial clear cell;exactmatch
malignant non-cutaneous basaloid cell;malignant non-cutaneous basaloid cell;exactmatch
neoplastic non-cutaneous basaloid cell;neoplastic non-cutaneous basaloid cell;exactmatch
malignant myoepithelial cell;malignant myoepithelial cell;exactmatch
sweat gland tubular carcinoma;sweat gland tubular adenocarcinoma;exactmatch
salivary gland basal cell adenocarcinoma;basal cell adenocarcinoma;exactmatch
malignant epithelial cell;carcinoma cell;exactmatch
malignant transitional cell;malignant transitional cell;exactmatch
signet ring adenocarcinoma cell;signet ring adenocarcinoma cell;exactmatch
malignant spindle squamous cell;malignant spindle squamous cell;exactmatch
multinucleated malignant squamous cell;multinucleated malignant squamous cell;exactmatch
adenocarcinoma cell;adenocarcinoma cell;exactmatch
keratinizing malignant squamous cell;keratinizing malignant squamous cell;exactmatch
non-keratinizing malignant squamous cell;non-keratinizing malignant squamous cell;exactmatch
non-keratinizing malignant large squamous cell;moderately differentiated malignant squamous cell;exactmatch
dysplastic glandular cell;dysplastic glandular cell;exactmatch
neoplastic multinucleated giant cell;giant cell, neoplastic multinucleated;exactmatch
large osteoclastic giant cell;giant cell, large osteoclastic;exactmatch
adenocarcinoma clear cell;adenocarcinoma clear cell;exactmatch
malignant clear squamous cell;malignant clear squamous cell;exactmatch
warthin-finkeldey polykaryocyte;warthin-finkeldey polykaryocyte;exactmatch
granular cell carcinoma;granular cell adenocarcinoma;exactmatch
dysplastic epithelial cell;dysplastic epithelial cell;exactmatch
neoplastic trophoblastic cell;neoplastic trophoblastic cell;exactmatch
abnormal intermediate type trophoblastic cell;abnormal intermediate type trophoblastic cell;exactmatch
abnormal cytotrophoblastic cell;abnormal cytotrophoblastic cell;exactmatch
abnormal syncytiotrophoblastic cell;abnormal syncytiotrophoblastic cell;exactmatch
cribriform carcinoma;cribriform carcinoma;exactmatch
abnormal trophoblastic cell;abnormal trophoblastic cell;exactmatch
poorly differentiated adenocarcinoma cell;poorly differentiated adenocarcinoma cell;exactmatch
malignant epithelial small cell;malignant epithelial small cell;exactmatch
melanoma cell;melanoma cell;exactmatch
neoplastic ductal epithelial cell;neoplastic ductal epithelial cell;exactmatch
pale brown fat cell;pale brown fat cell;exactmatch
neoplastic oncocyte;neoplastic oncocyte;exactmatch
primitive striated muscle cell;primitive striated muscle cell;exactmatch
strap-like skeletal muscle cell;strap-like skeletal muscle cell;exactmatch
neoplastic striated muscle cell;neoplastic striated muscle cell;exactmatch
neoplastic spindle-shaped smooth muscle cell;neoplastic spindle-shaped smooth muscle cell;exactmatch
malignant small undifferentiated cell;malignant small undifferentiated cell;exactmatch
neoplastic acinar cell;neoplastic acinar cell;exactmatch
malignant oncocyte;malignant oncocyte;exactmatch
dysplastic nevus;atypical nevus;exactmatch
round striated muscle cell;round striated muscle cell;exactmatch
neoplastic smooth muscle cell;neoplastic smooth muscle cell;exactmatch
neoplastic muscle cell;neoplastic muscle cell;exactmatch
neoplastic neuroendocrine spindle cell;neoplastic neuroendocrine spindle cell;exactmatch
neoplastic neuroendocrine polygonal cell;neoplastic neuroendocrine polygonal cell;exactmatch
neoplastic adrenal cortical compact cell;neoplastic adrenal compact cell;exactmatch
neoplastic endocrine clear cell;neoplastic endocrine clear cell;exactmatch
carcinomatosis;carcinomatosis;exactmatch
papillary fibroelastoma;fibroelastic papilloma;exactmatch
round cell with primitive myoblastic differentiation;round cell with primitive myoblastic differentiation;exactmatch
neoplastic lobular epithelial cell;neoplastic lobular epithelial cell;exactmatch
neoplastic fusiform cell;neoplastic fusiform cell;exactmatch
myxopapillary ependymoma;ependymoma, benign;exactmatch
eosinophilic brown fat cell;eosinophilic brown fat cell;exactmatch
multivacuolated brown fat cell;multivacuolated brown fat cell;exactmatch
polygonal brown fat cell;polygonal brown fat cell;exactmatch
malignant glomus cell;malignant glomus cell;exactmatch
glomus cell;glomus cell;exactmatch
neoplastic myoid cell;neoplastic myoid cell;exactmatch
neoplastic fibrohistiocytic cell;neoplastic fibrohistiocytic cell;exactmatch
spindle cell myoblast;spindle cell myoblast;exactmatch
neoplastic histiocyte-like cell;neoplastic histiocyte-like cell;exactmatch
subependymal giant cell astrocytoma;sega;exactmatch
neoplastic fibroblast-like cell;neoplastic fibroblast-like cell;exactmatch
neoplastic spindle-shaped myofibroblast;neoplastic spindle-shaped myofibroblast;exactmatch
neoplastic spindle-shaped fibroblast;neoplastic spindle-shaped fibroblast;exactmatch
neoplastic connective and soft tissue spindle cell;neoplastic connective and soft tissue spindle cell;exactmatch
bizarre cell with evidence of skeletal muscle differentiation;bizarre cell with evidence of skeletal muscle differentiation;exactmatch
malignant endocrine cell;malignant endocrine cell;exactmatch
neoplastic glomerulosa cell;neoplastic glomerulosa cell;exactmatch
neoplastic endocrine cell;neoplastic endocrine cell;exactmatch
appendix goblet cell adenocarcinoma;appendix adenocarcinoid tumor;exactmatch
neoplastic leydig cell;neoplastic leydig cell;exactmatch
neoplastic sertoli cell;neoplastic sertoli cell;exactmatch
neoplastic granulosa cell;neoplastic granulosa cell;exactmatch
neoplastic follicular dendritic cell;neoplastic follicular dendritic cell;exactmatch
neoplastic interdigitating dendritic cell;neoplastic interdigitating dendritic cell;exactmatch
mucin-producing neoplastic epithelial cell;mucin-producing neoplastic epithelial cell;exactmatch
malignant langerhans cell;malignant langerhans cell;exactmatch
neoplastic langerhans cell;neoplastic langerhans cell;exactmatch
neoplastic endocrine null cell;neoplastic endocrine null cell;exactmatch
neoplastic histiocyte;neoplastic histiocyte;exactmatch
neoplastic connective and soft tissue cell;neoplastic connective and soft tissue cell;exactmatch
malignant polygonal cell with abundant granular cytoplasm;malignant polygonal cell with abundant granular cytoplasm;exactmatch
neoplastic glandular cell with eosinophilic granular cytoplasm;neoplastic glandular cell with eosinophilic granular cytoplasm;exactmatch
adenocarcinoma cell with eosinophilic granular cytoplasm;adenocarcinoma cell with eosinophilic granular cytoplasm;exactmatch
trabecular adenoma;trabecular adenoma;exactmatch
lobular carcinoma cell;lobular carcinoma cell;exactmatch
malignant primitive germ cell;malignant primitive germ cell;exactmatch
neoplastic sex cord-stromal cell;neoplastic sex cord-stromal cell;exactmatch
neoplastic stellate cell;neoplastic stellate cell;exactmatch
neoplastic osteoblast;neoplastic osteoblast;exactmatch
neoplastic thyrotroph cell;neoplastic thyrotroph cell;exactmatch
neoplastic gonadotroph cell;neoplastic gonadotroph cell;exactmatch
neoplastic corticotroph cell;neoplastic corticotroph cell;exactmatch
undifferentiated carcinoma;anaplastic carcinoma;exactmatch
neoplastic somatotroph cell;neoplastic growth hormone cell;exactmatch
neoplastic lactotroph cell;neoplastic lactotroph cell;exactmatch
atypical epithelial cell;atypical epithelial cell;exactmatch
primitive mesenchymal round cell;primitive mesenchymal round cell;exactmatch
apocrine carcinoma cell;apocrine carcinoma cell;exactmatch
primitive mesenchymal cell;primitive mesenchymal cell;exactmatch
neoplastic syncytiotrophoblastic cell;neoplastic syncytiotrophoblastic cell;exactmatch
neoplastic large germ cell;neoplastic large germ cell;exactmatch
neoplastic germ cell;neoplastic germ cell;exactmatch
signet ring stromal cell;signet ring stromal cell;exactmatch
malignant osteoblast;malignant osteoblast;exactmatch
neoplastic neuroblast;neoplastic neuroblast;exactmatch
neoplastic ganglion cell;neoplastic ganglion cell;exactmatch
neoplastic oligodendrocyte-like cell;neoplastic oligodendrocyte-like cell;exactmatch
dizziness;dizziness;exactmatch
malignant peripheral nerve sheath tumor;mpnst;exactmatch
hypophosphatemia;hypophosphatemia;exactmatch
hypokalemia;hypokalemia;exactmatch
hypocalcemia;hypocalcemia;exactmatch
plexiform neurofibroma;plexiform neurofibroma;exactmatch
gliosarcoma;glioblastoma with a sarcomatous component;exactmatch
subependymoma;subependymoma, benign;exactmatch
sex cord-stromal tumor;gonadal stromal tumor, nos;exactmatch
palpitation;palpitation;exactmatch
cough;cough;exactmatch
constipation;constipation;exactmatch
inverted papilloma;inverted papilloma;exactmatch
squamous cell neoplasm;epidermoid cell neoplasm;exactmatch
central neurocytoma;central neurocytoma;exactmatch
gain of chromosome 14;gain of chromosome 14;exactmatch
intestinal mass;intestinal mass;exactmatch
angiofibroma;angiofibroma, benign;exactmatch
epithelioid hemangioendothelioma;epithelioid angioendothelioma;exactmatch
carcinoma of unknown primary;cup;exactmatch
connective and soft tissue neoplasm;connective and soft tissue neoplasm;exactmatch
skin signet ring cell basal cell carcinoma;signet ring cell basal cell carcinoma;exactmatch
malignant salivary gland neoplasm;cancer of salivary gland;exactmatch
skin basal cell carcinoma with adnexal differentiation;skin basal cell carcinoma with adnexal differentiation;exactmatch
dermatofibrosarcoma protuberans with giant cell fibroblastoma-like differentiation;dermatofibrosarcoma protuberans with giant cell fibroblastoma-like differentiation;exactmatch
dedifferentiated dermatofibrosarcoma protuberans;dedifferentiated dermatofibrosarcoma protuberans;exactmatch
myxoid dermatofibrosarcoma protuberans;myxoid dermatofibrosarcoma protuberans;exactmatch
dermatofibrosarcoma protuberans with myoid differentiation;dermatofibrosarcoma protuberans with myoid differentiation;exactmatch
neuroendocrine neoplasm;nen;exactmatch
pneumothorax;pneumothorax;exactmatch
rhabdoid tumor;rhabdoid sarcoma;exactmatch
typhlitis;neutropenic colitis;exactmatch
dermal nevus;dermal nevus;exactmatch
tremor;shaking;exactmatch
blue nevus;blue nevus;exactmatch
amelanotic melanoma;amelanotic melanoma;exactmatch
hemangioblastoma;angioblastoma;exactmatch
ganglioneuroblastoma;ganglioneuroblastoma, malignant;exactmatch
"t(9;22)(p24;q11)";"t(9;22)(p24;q11)";exactmatch
olfactory neuroblastoma;esthesioneuroblastoma;exactmatch
verrucous carcinoma;condylomatous carcinoma;exactmatch
trisomy 17;trisomy 17;exactmatch
autoimmune lymphoproliferative syndrome;alps;exactmatch
mesothelial neoplasm;mesothelial neoplasm;exactmatch
intraductal papilloma;duct adenoma;exactmatch
basal cell neoplasm;basal cell neoplasm;exactmatch
serous cystadenoma;serous cystadenoma;exactmatch
cervical intraepithelial neoplasia;cin;exactmatch
large cell carcinoma;carcinoma, large cell;exactmatch
bcr-jak2 fusion protein expression;bcr-jak2 fusion protein expression;exactmatch
giant cell carcinoma;carcinoma, giant cell;exactmatch
serous cystadenocarcinoma;serous adenocarcinoma;exactmatch
papillary cystadenocarcinoma;cystadenocarcinoma, papillary, malignant;exactmatch
mucinous cystadenocarcinoma;mucinous cystadenocarcinoma;exactmatch
adnexal carcinoma;adnexal carcinoma;exactmatch
signet ring cell carcinoma;signet ring cell adenocarcinoma;exactmatch
neuroendocrine carcinoma;nec;exactmatch
trisomy 16;trisomy 16;exactmatch
tetrasomy 7;tetrasomy 7;exactmatch
b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classic hodgkin lymphoma;b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classic hodgkin lymphoma;exactmatch
neuroepithelial neoplasm;neoplasm of neuroepithelial tissue;exactmatch
"t(9;12)(p24;p13)";"t(9;12)(p24;p13)";exactmatch
tel-jak2 fusion protein expression;etv6-jak2 fusion protein expression;exactmatch
"t(9;12)(q34;p13)";"t(9;12)(q34;p13)";exactmatch
tel-abl fusion protein expression;etv6-abl1 fusion protein expression;exactmatch
bcr-pdgfralpha fusion protein expression;bcr-pdgfra fusion protein expression;exactmatch
"t(4;22)(q12;q11)";"t(4;22)(q12;q11)";exactmatch
bcr-fgfr1 fusion protein expression;bcr-fgfr1 fusion protein expression;exactmatch
"t(8;22)(p11;q11)";"t(8;22)(p11;q11)";exactmatch
ganglioglioma;ganglioglioma;exactmatch
"renal cell carcinoma associated with t(x;17)(p11.2;q25)";"renal cell carcinoma associated with t(x;17)(p11.2;q25)";exactmatch
"t(x;1)(p11.2;p34)";"t(x;1)(p11.2;p34)";exactmatch
"renal cell carcinoma associated with t(x;1)(p11.2;p34)";"renal cell carcinoma associated with t(x;1)(p11.2;p34)";exactmatch
"t(x;1)(p11.2;q21)";"t(x;1)(p11.2;q21)";exactmatch
"renal cell carcinoma associated with t(x;1)(p11.2;q21)";"renal cell carcinoma associated with t(x;1)(p11.2;q21)";exactmatch
mediastinal b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classic hodgkin lymphoma;mediastinal b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classic hodgkin lymphoma;exactmatch
skin basal cell carcinoma with sarcomatoid differentiation;skin basal cell carcinoma with sarcomatoid differentiation;exactmatch
metastatic malignant neoplasm in the brain;brain metastases;exactmatch
breast lobular carcinoma;breast lobular carcinoma;exactmatch
thymic b-lymphocyte;thymic b-lymphocyte;exactmatch
interdigitating dendritic cell;interdigitating cell;exactmatch
germinal center b-lymphocyte;germinal center b-lymphocyte;exactmatch
postgerminal center marginal zone b-lymphocyte;postgerminal center marginal zone b-lymphocyte;exactmatch
activated b-lymphocyte;activated b-lymphocyte;exactmatch
peripheral b-lymphocyte of inner mantle zone;peripheral b-lymphocyte of inner mantle zone;exactmatch
intraepithelial t-lymphocyte;intraepithelial t-lymphocyte;exactmatch
peripheral b-lymphocyte;peripheral b-lymphocyte;exactmatch
unfavorable clinical outcome;unfavorable clinical outcome;exactmatch
postgerminal center memory b-lymphocyte;postgerminal center memory b-lymphocyte;exactmatch
immature peripheral alpha/beta cell of cytotoxic type;immature peripheral alpha/beta cell of cytotoxic type;exactmatch
immature peripheral gamma/delta cell of cytotoxic type;immature peripheral gamma/delta cell of cytotoxic type;exactmatch
immature t-lymphocyte;immature t-lymphocyte;exactmatch
mature cytotoxic t-lymphocyte;mature cytotoxic t-lymphocyte;exactmatch
peripheral epidermotropic t-lymphocyte;peripheral epidermotropic t-lymphocyte;exactmatch
marginal zone b-lymphocyte of nodal type;marginal zone b-lymphocyte of nodal type;exactmatch
malaise;malaise;exactmatch
naive pregerminal center b-lymphocyte;naive b cell;exactmatch
ataxic gait;ataxic gait;exactmatch
metastatic malignant neoplasm in the leptomeninges;leptomeningeal metastases;exactmatch
del(4)(q12);del(4)(q12);exactmatch
"t(17;17)(q21;q21)";"t(17;17)(q21;q21)";exactmatch
"acute myeloid leukemia with t(17;17)(q21;q21)";"apl with t(17;17)(q21;q21); stat5b-rara";exactmatch
rbm15-mkl1 fusion protein expression;ott-mal fusion protein expression;exactmatch
cebpa gene mutation;c/ebp-alpha gene mutation;exactmatch
neurological signs and symptoms;neurological signs and symptoms;exactmatch
runx1 gene mutation;aml1 gene mutation;exactmatch
infertility;fertility disorders;exactmatch
msn-alk fusion protein expression;msn-alk fusion protein expression;exactmatch
postgerminal center b-lymphocyte;postgerminal center b-lymphocyte;exactmatch
pi3k-akt pathway deregulation;pi3k-akt pathway deregulation;exactmatch
myc pathway deregulation;myc pathway deregulation;exactmatch
jun pathway deregulation;jun pathway deregulation;exactmatch
ras-raf pathway deregulation;ras-raf pathway deregulation;exactmatch
jak-stat pathway deregulation;jak-stat pathway deregulation;exactmatch
pancreatic intraductal papillary-mucinous neoplasm;ipmn;exactmatch
postgerminal center b-lymphocyte of unknown differentiation stage;postgerminal center b-lymphocyte of unknown differentiation stage;exactmatch
gnas gene;gnas;exactmatch
gnaq gene;g protein subunit alpha q gene;exactmatch
chondromyxoid fibroma;chondromyxoid fibroma;exactmatch
metachronous osteosarcoma;metachronous osteosarcoma;exactmatch
male reproductive system precancerous condition;male reproductive system precancerous condition;exactmatch
digestive system hodgkin lymphoma;digestive system hodgkin lymphoma;exactmatch
digestive system lymphoma;digestive system lymphoma;exactmatch
digestive system non-hodgkin lymphoma;digestive system non-hodgkin lymphoma;exactmatch
aids-related plasmablastic lymphoma of mucosa site;aids-related plasmablastic lymphoma of mucosa site;exactmatch
plasmablastic lymphoma of mucosa site;plasmablastic lymphoma of mucosa site;exactmatch
metachronous kidney wilms tumor;metachronous kidney nephroblastoma;exactmatch
metachronous malignant neoplasm;metachronous malignant neoplasm;exactmatch
benign synovial neoplasm;benign neoplasm of synovium;exactmatch
recurrent disease;disease relapse;exactmatch
clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres;ccmmt;exactmatch
lung lymphangioleiomyomatosis;lung lymphangioleiomyomatosis;exactmatch
lung clear cell tumor;ccstl;exactmatch
epithelioid angiomyolipoma;epithelioid angiomyolipoma;exactmatch
pecoma;neoplasm with perivascular epithelioid cell differentiation;exactmatch
malignant ascites;ascites, malignant;exactmatch
cd10 messenger rna overexpression;cd10 messenger rna overexpression;exactmatch
bcl-6 messenger rna overexpression;bcl-6 messenger rna overexpression;exactmatch
a-myb messenger rna overexpression;a-myb messenger rna overexpression;exactmatch
lmo2 messenger rna overexpression;lmo2 messenger rna overexpression;exactmatch
combined hepatocellular carcinoma and cholangiocarcinoma;carcinoma of liver and intrahepatic biliary tract;exactmatch
nodular fasciitis;nodular fasciitis;exactmatch
juvenile polyp;juvenile polyp;exactmatch
pseudolymphoma;pseudolymphoma;exactmatch
lesion;gross lesion;exactmatch
hemangiomatosis with thrombocytopenia;hemangioma-hemorrhage syndrome;exactmatch
primary amyloidosis;primary amyloidosis;exactmatch
alk gene;alk;exactmatch
secondary amyloidosis;secondary amyloidosis;exactmatch
bcl2 gene translocation;b-cell cll-lymphoma 2 gene translocation;exactmatch
cd44 messenger rna overexpression;cd44 messenger rna overexpression;exactmatch
irf4/mum1 messenger rna overexpression;irf4 gene mrna overexpression;exactmatch
bcl2 gene mrna overexpression;bcl-2 messenger rna overexpression;exactmatch
cyclin d2 messenger rna overexpression;ccnd2 mrna overexpression;exactmatch
pkcbeta1 messenger rna overexpression;pkcbeta1 messenger rna overexpression;exactmatch
mucoepidermoid carcinoma;mec;exactmatch
pancreatic neuroendocrine carcinoma;carcinoma, islet cell, malignant;exactmatch
rhabdoid cell;rhabdoid cell;exactmatch
"t(16;17)(q22;p13)";"t(16;17)(q22;p13)";exactmatch
zap70 messenger rna overexpression;zap-70 mrna overexpression;exactmatch
small lymphocytic lymphoma with unmutated immunoglobulin heavy chain variable-region gene;pregerminal center small lymphocytic lymphoma;exactmatch
chronic lymphocytic leukemia with unmutated immunoglobulin heavy chain variable-region gene;cll with unmutated igvh;exactmatch
chronic lymphocytic leukemia/small lymphocytic lymphoma with unmutated immunoglobulin heavy chain variable-region gene;cll/sll with unmutated igvh;exactmatch
small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation;postgerminal center small lymphocytic lymphoma;exactmatch
chronic lymphocytic leukemia with immunoglobulin heavy chain variable-region gene somatic hypermutation;cll with igvh shm;exactmatch
chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation;cll/sll with igvh shm;exactmatch
anaplastic large cell lymphoma;alcl;exactmatch
diffuse blastoid b-cell lymphoma;blastoid follicular lymphoma;exactmatch
primary systemic anaplastic large cell lymphoma, alk-negative;primary systemic alk-negative anaplastic large cell lymphoma;exactmatch
primary systemic anaplastic large cell lymphoma, alk-positive;primary systemic alk-positive alcl;exactmatch
anaplastic large cell lymphoma, alk-negative;alcl, alk-;exactmatch
anaplastic large cell lymphoma, alk-positive;alcl, alk+;exactmatch
intravascular metastasis;intravascular metastasis;exactmatch
trisomy 11;trisomy 11;exactmatch
"t(9;22)(q22-31;q12)";"t(9;22)(q22-31;q12)";exactmatch
rearrangement of 2p23;rearrangement of 2p23;exactmatch
lymphomatoid papulosis;lyp;exactmatch
lymphatic vessel neoplasm;lymph vessel neoplasm;exactmatch
zbtb16-rara fusion protein expression;plzf-raralpha fusion protein expression;exactmatch
kmt2a-af4 fusion protein expression;kmt2a-af4 fusion protein expression;exactmatch
etv6-runx1 fusion protein expression;etv6-cbfalpha2 fusion protein expression;exactmatch
tcf3-pbx1 fusion protein expression;e2a-pbx1 fusion protein expression;exactmatch
ewsr1-fli1 fusion protein expression;ews-fli1 fusion protein expression;exactmatch
pml-rara fusion protein expression;pml-rar;exactmatch
numa1-rara fusion protein expression;numa1-rara fusion protein expression;exactmatch
npm1-rara fusion protein expression;npm-raralpha fusion protein expression;exactmatch
oral cavity hairy leukoplakia;hairy leukoplakia of mouth;exactmatch
"renal cell carcinoma with t(6;11);(p21;q12); malat1-tfeb";"renal cell carcinoma with t(6;11);(p21;q12); malat1-tfeb";exactmatch
cbfb-myh11 fusion protein expression;cbfb-myh11 fusion protein expression;exactmatch
aml1-eto fusion protein expression;aml1-eto fusion protein expression;exactmatch
fip1l1-pdgfralpha fusion protein expression;fip1l1-pdgfra fusion protein expression;exactmatch
cltc-alk fusion protein expression;cltc-alk fusion protein expression;exactmatch
pancreatic colloid carcinoma;colloid carcinoma of the pancreas;exactmatch
solid pseudopapillary neoplasm of the pancreas;frantz tumor;exactmatch
"t(6;11)(p21;q12)";"t(6;11)(p21;q12)";exactmatch
del(17q25);del(17q25);exactmatch
del(6q25-27);del(6q25-27);exactmatch
gain of chromosome 12q13;gain in chromosome 12(q13);exactmatch
eosinophilic meningothelial cell;eosinophilic meningothelial cell;exactmatch
atypical lymphocyte;atypical lymphocyte;exactmatch
neoplastic polygonal cell with eosinophilic cytoplasm;neoplastic polygonal cell with eosinophilic cytoplasm;exactmatch
neoplastic large cell with abundant pale cytoplasm;neoplastic large cell with abundant pale cytoplasm;exactmatch
neoplastic large cell;large cell;exactmatch
small meningothelial cell;small meningothelial cell;exactmatch
meningothelial cell with clear cytoplasm;meningothelial cell with clear cytoplasm;exactmatch
primitive neuroectodermal tumor;neuroectodermal neoplasm;exactmatch
meningothelial cell with elongated processes;meningothelial cell with elongated processes;exactmatch
neoplastic t-prolymphocyte;neoplastic t-prolymphocyte;exactmatch
spindle-shaped meningothelial cell;spindle-shaped meningothelial cell;exactmatch
neoplastic meningothelial cell;neoplastic arachnoidal cell;exactmatch
neoplastic perineurial cell;neoplastic perineurial cell;exactmatch
malignant stromal cell;malignant stromal cell;exactmatch
neoplastic perineurial-like cell;neoplastic perineurial-like cell;exactmatch
neoplastic schwann cell;neoplastic schwann cell;exactmatch
neoplastic stromal cell;neoplastic stromal cell;exactmatch
neoplastic eosinophilic cell oncocyte;neoplastic eosinophilic cell oncocyte;exactmatch
malignant eosinophilic cell oncocyte;malignant eosinophilic cell oncocyte;exactmatch
multilobated neoplastic b-lymphocyte;multilobated neoplastic b-lymphocyte;exactmatch
melanotic neuroectodermal tumor;infantile melanotic neuroectodermal neoplasm;exactmatch
neoplastic b-prolymphocyte;neoplastic b-prolymphocyte;exactmatch
neoplastic prolymphocyte;neoplastic prolymphocyte;exactmatch
neoplastic monoblast;neoplastic monoblast;exactmatch
medium-sized neoplastic myeloblast with coarse cytoplasmic basophilic granules;medium-sized neoplastic myeloblast with coarse cytoplasmic basophilic granules;exactmatch
wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome;11p partial monosomy syndrome;exactmatch
neoplastic myeloblast without azurophilic granules;neoplastic myeloblast without azurophilic granules;exactmatch
neoplastic myeloblast with azurophilic granules;neoplastic myeloblast with azurophilic granules;exactmatch
neoplastic medium-sized myeloblast with basophilic agranular cytoplasm;neoplastic medium-sized myeloblast with basophilic agranular cytoplasm;exactmatch
neoplastic myeloblast with abundant basophilic cytoplasm;neoplastic myeloblast with abundant basophilic cytoplasm;exactmatch
neutrophil with pseudo chediak-higashi granules;neutrophil with pseudo chediak-higashi granules;exactmatch
neutrophil with cytoplasmic hypogranularity;neutrophil with cytoplasmic hypogranularity;exactmatch
neutrophil with abnormal cytoplasmic granulation;neutrophil with abnormal cytoplasmic granulation;exactmatch
hypolobated neutrophil;hypolobated neutrophil;exactmatch
pleomorphic adenocarcinoma cell;pleomorphic adenocarcinoma cell;exactmatch
pleomorphic epithelial cell;pleomorphic epithelial cell;exactmatch
ewsr1-erg fusion protein expression;ews-erg fusion protein expression;exactmatch
ewsr1-etv1 fusion protein expression;ews-etv1 fusion protein expression;exactmatch
endometrioid adenocarcinoma;endometrioid adenocarcinoma;exactmatch
fibrous histiocytoma;benign fibrous histiocytoma;exactmatch
small cell sarcoma;small cell sarcoma;exactmatch
clear cell sarcoma of soft tissue;chordoid sarcoma;exactmatch
breast fibroadenoma;breast fibroadenoma;exactmatch
fibroepithelial neoplasm;fibroepithelial neoplasm;exactmatch
myofibromatosis;infantile hemangiopericytoma;exactmatch
abdominal (mesenteric) fibromatosis;abdominal (mesenteric) fibromatosis;exactmatch
desmoplastic fibroma;bone desmoplastic fibroma;exactmatch
osteoclastic giant cell-rich tumor of bone;osteoclastic giant cell-rich tumor of bone;exactmatch
leiomyomatosis;leiomyomatosis;exactmatch
mesenchymal chondrosarcoma;mesenchymal chondrosarcoma;exactmatch
adrenal gland myelolipoma;adrenal gland myelolipoma;exactmatch
angiomyolipoma;angiomyolipoma;exactmatch
angiolipoma;angiolipoma, benign;exactmatch
pulmonary blastoma;blastoma of lung;exactmatch
loss of chromosome 11q;11q deletion;exactmatch
multicentric thyroid gland papillary carcinoma;multicentric papillary thyroid carcinoma;exactmatch
angioleiomyoma;angioleiomyoma;exactmatch
alveolar rhabdomyosarcoma;arms;exactmatch
ewsr1-etv4 fusion protein expression;ews-e1af fusion protein expression;exactmatch
hidrocystoma;hidrocystoma;exactmatch
acinar cell carcinoma;acinar adenocarcinoma;exactmatch
clear cell adenocarcinoma;adenocarcinoma, clear cell, malignant;exactmatch
multicystic mesothelioma;cystic mesothelioma;exactmatch
adenomatous polyp;adenomatous polyp;exactmatch
pulmonary adenomatosis;pulmonary adenomatosis;exactmatch
adenomatoid tumor;adenomatoid tumor;exactmatch
syringoma;eccrine syringoma;exactmatch
oncocytic adenoma;oncocytic adenoma;exactmatch
alveolar soft part sarcoma;asps;exactmatch
hepatocellular adenoma;adenoma, hepatocellular, benign;exactmatch
placental-site gestational trophoblastic tumor;placental site gestational trophoblastic tumor;exactmatch
mixed embryonal carcinoma and teratoma;mixed embryonal carcinoma and teratoma;exactmatch
gonadoblastoma;gonadoblastoma;exactmatch
germinoma;germinoma;exactmatch
embryonal carcinoma;carcinoma, embryonal, malignant;exactmatch
smooth muscle neoplasm;neoplasm of smooth muscle;exactmatch
mixed mesodermal (mullerian) tumor;mesodermal mixed tumor;exactmatch
head and neck basaloid carcinoma;basaloid squamous cell carcinoma of head and neck;exactmatch
malignant mixed neoplasm;malignant mixed neoplasm;exactmatch
pax7-foxo1 fusion protein expression;pax7-fkhr fusion protein expression;exactmatch
ss18-ssx4 fusion protein expression;ss18-ssx4 fusion protein expression;exactmatch
ss18-ssx2 fusion protein expression;ss18-ssx2 fusion protein expression;exactmatch
ss18-ssx1 fusion protein expression;ss18-ssx1 fusion protein expression;exactmatch
fus-atf1 fusion protein expression;fus-atf1 fusion protein expression;exactmatch
etv6-ntrk3 fusion protein expression;etv6-ntrk3 fusion protein expression;exactmatch
has2-plag1 fusion protein expression;has2-plag1 fusion protein expression;exactmatch
col1a2-plag1 fusion protein expression;col1a2-plag1 fusion protein expression;exactmatch
cystic hygroma;cystic hygroma;exactmatch
hepatoblastoma;hbl;exactmatch
pax3-foxo1 fusion protein expression;pax3-fkhr fusion protein expression;exactmatch
fus-ddit3 fusion protein expression;fus-chop fusion protein expression;exactmatch
ewsr1-wt1 fusion protein expression;ews-wt1 fusion protein expression;exactmatch
tcf12-nr4a3 fusion protein expression;tcf12-chn fusion protein expression;exactmatch
taf15-nr4a3 fusion protein expression;rbp56-chn fusion protein expression;exactmatch
ewsr1-nr4a3 fusion protein expression;ews-chn fusion protein expression;exactmatch
ewsr1-atf1 fusion protein expression;ews-atf1 fusion protein expression;exactmatch
aspl-tfe3 fusion protein expression;aspl-tfe3 fusion protein expression;exactmatch
"t(2;22)(q33;q12)";"t(2;22)(q33;q12)";exactmatch
lymphangioleiomyomatosis;lam;exactmatch
ewsr1-fev fusion protein expression;ews-fev fusion protein expression;exactmatch
vulvar intraepithelial neoplasia, differentiated type;differentiated vulvar intraepithelial neoplasia;exactmatch
adenosquamous carcinoma;adenosquamous carcinoma;exactmatch
atypical small acinar proliferation of the prostate gland;asap;exactmatch
bladder urothelial carcinoma in situ;bladder flat intraepithelial lesion;exactmatch
malignant mixed epithelial and stromal tumor of the kidney;kidney malignant mixed epithelial and stromal tumor;exactmatch
benign kidney mixed epithelial and stromal tumor;benign kidney mixed epithelial and stromal tumor;exactmatch
kidney mixed epithelial and stromal tumor;kidney mixed epithelial and stromal tumor;exactmatch
adenomyoma;adenomyoma, benign;exactmatch
paraganglioma-like dermal melanocytic tumor;paraganglioma-like dermal melanocytic tumor;exactmatch
desmoplastic melanoma;desmoplastic cutaneous (skin) melanoma;exactmatch
pancreatic foamy gland adenocarcinoma;pancreatic foamy gland adenocarcinoma;exactmatch
cardiovascular system signs and symptoms;cardiovascular system signs and symptoms;exactmatch
hmga2-lpp fusion protein expression;hmga2-lpp fusion protein expression;exactmatch
ewsr1-patz1 fusion protein expression;ews-zsg fusion protein expression;exactmatch
"t(1;22)(p36.1;q12)";"t(1;22)(p36.1;q12)";exactmatch
ovarian dermoid cyst with secondary carcinoma;ovarian dermoid cyst with secondary carcinoma;exactmatch
ovarian dermoid cyst with squamous cell carcinoma;ovarian dermoid cyst with squamous cell carcinoma;exactmatch
ovarian dermoid cyst with adenocarcinoma;ovarian dermoid cyst with adenocarcinoma;exactmatch
pleomorphic rhabdomyosarcoma;pleomorphic rhabdomyosarcoma;exactmatch
sporadic retinoblastoma;sporadic retinoblastoma;exactmatch
rhabdomyosarcoma with mixed embryonal and alveolar features;mixed alveolar rhabdomyosarcoma;exactmatch
chondroid hamartoma;chondroid hamartoma;exactmatch
sheet-like growth pattern;sheet-like growth pattern;exactmatch
pseudo-psammoma body formation;pseudo-psammoma body formation;exactmatch
epithelial differentiation;epithelial differentiation;exactmatch
ossified mass;ossified mass;exactmatch
bizarre leiomyoma;atypical leiomyoma;exactmatch
serrated glandular architecture;serrated glandular architecture;exactmatch
cellular leiomyoma;cellular leiomyoma;exactmatch
lipoblastomatosis;fetal lipomatosis;exactmatch
spindle cell lipoma;scl;exactmatch
mixed liposarcoma;mixed liposarcoma;exactmatch
round cell liposarcoma;cellular myxoid liposarcoma;exactmatch
fibromyxolipoma;fibromyxolipoma;exactmatch
fibrolipoma;fibrolipoma, benign;exactmatch
low grade appendix mucinous neoplasm;appendix well differentiated mucinous adenocarcinoma;exactmatch
fetal rhabdomyoma;fetal rhabdomyoma;exactmatch
undifferentiated pleomorphic sarcoma;fibrosarcoma, pleomorphic, malignant;exactmatch
low grade endometrioid stromal sarcoma;endolymphatic stromal myosis;exactmatch
uterine carcinosarcoma;carcinosarcoma of the uterus;exactmatch
malignant ovarian brenner tumor;brenner tumor, malignant;exactmatch
lip and oral cavity squamous cell carcinoma;lip and oral cavity squamous cell cancer;exactmatch
malignant mesenchymoma;mesenchymoma, malignant;exactmatch
benign mesenchymoma;benign mesenchymoma;exactmatch
pancreatoblastoma;pancreatoblastoma;exactmatch
clear cell sarcoma of the kidney;ccsk;exactmatch
premalignant lesion;premalignant lesion;exactmatch
rb-e2f pathway deregulation;rb-e2f pathway deregulation;exactmatch
endometrial stromal nodule;endometrial stromal nodule;exactmatch
adult extracardiac rhabdomyoma;adult extracardiac rhabdomyoma;exactmatch
therapy-related toxicity;therapy-related toxicity;exactmatch
chemotherapeutic agent toxicity;chemotherapeutic agent toxicity;exactmatch
neoplastic retinal ganglion cell;neoplastic retinal ganglion cell;exactmatch
suprasellar region;suprasellar;exactmatch
extraocular dissemination of disease;extraocular dissemination of disease;exactmatch
lipomatous neoplasm;adipose tissue neoplasm;exactmatch
atypical fibroxanthoma;atypical cutaneous fibroxanthoma;exactmatch
stage 0 cervical cancer ajcc v6;cin 3 ajcc v6;exactmatch
sympathetic paraganglioma;chromaffin neoplasm;exactmatch
glomangiomyoma;glomangiomyoma;exactmatch
glomangioma;glomangioma;exactmatch
malignant glomus tumor;glomangiosarcoma;exactmatch
malignant adrenal gland pheochromocytoma;adrenal medullary paraganglioma, malignant;exactmatch
malignant extra-adrenal paraganglioma;extra-adrenal paraganglioma, malignant;exactmatch
aorticopulmonary paraganglioma;aortic body neoplasm;exactmatch
parasympathetic paraganglioma;parasympathetic extra-adrenal paraganglioma;exactmatch
ovarian steroid cell tumor;lipid cell neoplasm of ovary;exactmatch
balloon cell nevus;balloon cell nevus;exactmatch
ovarian hilus cell tumor;hilar cell neoplasm;exactmatch
malignant leydig cell tumor;carcinoma, leydig cell;exactmatch
benign leydig cell tumor;adenoma, interstitial;exactmatch
ovarian sertoli cell tumor with lipid storage;ovarian sertoli cell tumor with lipid storage;exactmatch
poorly differentiated ovarian sertoli-leydig cell tumor;poorly differentiated ovarian sertoli-leydig cell tumor;exactmatch
tissue differentiation;tissue differentiation;exactmatch
rare lesion;rare lesion;exactmatch
cutaneous nodular melanoma;cutaneous nodular melanoma;exactmatch
balloon cell melanoma;balloon cell cutaneous (skin) melanoma;exactmatch
elastofibroma;elastofibroma;exactmatch
spindle cell melanoma;malignant spindle cell melanoma;exactmatch
infantile fibrosarcoma;congenital fibrosarcoma;exactmatch
sarcomatosis;sarcomatosis;exactmatch
benign soft tissue neoplasm;benign neoplasm of soft tissue;exactmatch
cellular blue nevus;cellular blue nevus;exactmatch
melanoma arising from blue nevus;blue nevus-like melanoma;exactmatch
type b spindle cell melanoma;malignant spindle cell type b melanoma;exactmatch
type a spindle cell melanoma;malignant spindle cell type a melanoma;exactmatch
epithelioid cell melanoma;epithelioid cell malignant melanoma;exactmatch
regressing melanoma;malignant melanoma, regressing;exactmatch
melanoma arising in giant congenital nevus;malignant melanoma in congenital melanocytic nevus;exactmatch
giant congenital nevus;bathing trunk nevus;exactmatch
precancerous melanosis;precancerous melanosis;exactmatch
melanoma in junctional nevus;cutaneous (skin) melanoma in junctional nevus;exactmatch
junctional nevus;intraepidermal nevus;exactmatch
optic disc melanocytoma;melanocytoma of eyeball;exactmatch
neuronevus;neural nevus;exactmatch
breast intracanalicular fibroadenoma;breast intracanalicular fibroadenoma;exactmatch
bone marrow stem cell with potential to differentiate to granulocytic lineage;bone marrow stem cell with potential to differentiate to granulocytic lineage;exactmatch
cells of monocytic lineage 80 percent or more of bone marrow leukemic cells;cells of monocytic lineage 80 percent or more of bone marrow leukemic cells;exactmatch
ameloblastic fibroma;ameloblastic fibroma;exactmatch
neoplastic medium to large size erythroblast;neoplastic medium to large size erythroblast;exactmatch
neoplastic erythroblast;neoplastic erythroblast;exactmatch
gemistocytic astrocytoma;gemistocytic astrocytoma;exactmatch
protoplasmic astrocytoma;protoplasmic astrocytoma;exactmatch
papillary ependymoma;papillary ependymoma;exactmatch
gliomatosis cerebri;astrocytosis cerebri;exactmatch
ameloblastic fibrosarcoma;afs;exactmatch
peripheral odontogenic fibroma;peripheral odontogenic fibroma;exactmatch
bone marrow myeloid stem cell with some degree of commitment to the erythroid lineage;bone marrow myeloid stem cell with some degree of commitment to the erythroid lineage;exactmatch
odontogenic fibroma;central odontogenic fibroma;exactmatch
ameloblastoma;ameloblastoma;exactmatch
ghost cell odontogenic carcinoma;ghost cell odontogenic carcinoma;exactmatch
adenomatoid odontogenic tumor;adenomatoid odontogenic neoplasm;exactmatch
complex odontoma;complex odontoma;exactmatch
cementoblastoma;benign cementoblastoma;exactmatch
benign odontogenic neoplasm;benign odontogenic neoplasm;exactmatch
fibrillary astrocytoma;fibrillary astrocytoma;exactmatch
bone marrow stem cell committed to the megakaryocytic lineage;bone marrow stem cell committed to the megakaryocytic lineage;exactmatch
breast pericanalicular fibroadenoma;breast pericanalicular fibroadenoma;exactmatch
mature tissue histiocyte;mature tissue histiocyte;exactmatch
multifocal unisystem disease;multifocal unisystem disease;exactmatch
unifocal disease;unifocal disease;exactmatch
large multinucleated malignant histiocyte;large multinucleated malignant histiocyte;exactmatch
large malignant histiocyte;large malignant histiocyte;exactmatch
neoplastic histiocytic and dendritic cell;neoplastic histiocytic and dendritic cell;exactmatch
histiocytic and dendritic cell;histiocytic and dendritic cell;exactmatch
giant cell glioblastoma;giant cell glioblastoma;exactmatch
astroblastoma;astroblastoma;exactmatch
myeloid leukemia associated with down syndrome;aml occurring in children with down syndrome;exactmatch
neoplastic eosinophilic precursor;neoplastic eosinophilic precursor;exactmatch
mature neutrophils present;mature neutrophils present;exactmatch
neoplastic granulocyte;neoplastic granulocyte;exactmatch
pleomorphic xanthoastrocytoma;pleomorphic xantho-astrocytoma;exactmatch
rapidly progressive clinical course;rapidly progressing clinical course;exactmatch
bone marrow stem cell committed to the basophil lineage;bone marrow stem cell committed to the basophil lineage;exactmatch
trisomy 21;trisomy 21;exactmatch
malignancy in giant cell tumor of bone;dedifferentiated giant cell tumor;exactmatch
myxoid chondrosarcoma;myxoid chondrosarcoma;exactmatch
periosteal chondroma;juxtacortical chondroma;exactmatch
neoplastic promyelocytes in bone marrow markedly increased;neoplastic promyelocytes in bone marrow markedly increased;exactmatch
biphasic mesothelioma;biphasic mesothelioma;exactmatch
pericardial solitary fibrous tumor;benign pericardial mesothelial neoplasm;exactmatch
biphasic synovial sarcoma;biphasic sarcoma of synovium;exactmatch
bone marrow stem cell with some commitment to monocytic differentiation;bone marrow stem cell with some commitment to monocytic differentiation;exactmatch
epithelial synovial sarcoma;epithelial sarcoma of synovium;exactmatch
acute myelomonocytic leukemia without abnormal eosinophils;acute myelomonocytic leukemia without abnormal eosinophils;exactmatch
immature myeloid cells increased in bone marrow;immature myeloid cells increased in bone marrow;exactmatch
spindle cell synovial sarcoma;spindle cell synovial sarcoma;exactmatch
malignant hemangiopericytoma;hemangiopericytoma, malignant;exactmatch
granulocyte-monocyte progenitor cell;bone marrow stem cell with potential to differentiate to granulocytic and monocytic lineages;exactmatch
abnormal eosinophilic granules present;abnormal eosinophilic granules present;exactmatch
breast juvenile fibroadenoma;breast juvenile fibroadenoma;exactmatch
malignant phyllodes tumor;cystosarcoma phyllodes, malignant;exactmatch
benign phyllodes tumor;benign cystosarcoma phyllodes;exactmatch
breast giant fibroadenoma;breast giant fibroadenoma;exactmatch
neoplastic granulocytes and precursors 20 percent or more of bone marrow cells;neoplastic granulocytes and precursors 20 percent or more of bone marrow cells;exactmatch
immature teratoma;embryonal teratoma;exactmatch
malignant teratoma;grade 3 teratoma;exactmatch
undifferentiated neoplastic blast;undifferentiated neoplastic blast;exactmatch
neoplastic blast coexpressing myeloid and lymphoid lineage antigens;neoplastic blast co-expressing myeloid and lymphoid lineage antigens;exactmatch
myeloblasts 90 percent or more of bone marrow non-erythroid cells;myeloblasts 90 percent or more of bone marrow non-erythroid cells;exactmatch
dek-nup214 fusion protein expression;dek-can fusion protein expression;exactmatch
benign hemangiopericytoma;benign hemangiopericytoma;exactmatch
verrucous hemangioma;verrucous hemangioma;exactmatch
epithelioid hemangioma;angiolymphoid hyperplasia with eosinophilia;exactmatch
venous hemangioma;venous angioma;exactmatch
mesonephric neoplasm;mesonephric neoplasm;exactmatch
benign mesonephroma;benign mesonephroma;exactmatch
partial hydatidiform mole;incomplete hydatid mole;exactmatch
strumal carcinoid;struma ovarii and carcinoid;exactmatch
malignant struma ovarii;malignant struma ovarii;exactmatch
mixed germ cell tumor;combined germ cell neoplasm;exactmatch
teratoma with somatic-type malignancy;dermoid cyst with malignant transformation;exactmatch
intermediate immature teratoma;intermediate immature teratoma;exactmatch
dual population of bone marrow blasts present;dual population of bone marrow blasts present;exactmatch
neoplastic maturing ganglion cell;neoplastic maturing ganglion cell;exactmatch
neoplastic round neuroepithelial cell;neoplastic round neuroepithelial cell;exactmatch
lipomatous differentiation;lipomatous differentiation;exactmatch
mixed cellular population;mixed cellular population;exactmatch
juxtaglomerular cell tumor;juxtaglomerular cell tumor;exactmatch
signet ring cell intrahepatic cholangiocarcinoma;signet ring cell intrahepatic cholangiocarcinoma;exactmatch
mucin-producing intrahepatic cholangiocarcinoma;mucin-producing intrahepatic cholangiocarcinoma;exactmatch
cholangiolocellular carcinoma;clc;exactmatch
cdkn2a gene deletion;cdk4i gene deletion;exactmatch
extensive necrosis;extensive necrosis;exactmatch
precise histogenesis unknown;precise histogenesis unknown;exactmatch
thyroid gland macrofollicular adenoma;colloid adenoma;exactmatch
ependyma and remnants of the central canal of the spinal cord;ependyma and remnants of the central canal of the spinal cord;exactmatch
endocrine reproductive tissue;endocrine reproductive tissue;exactmatch
endocrine-stromal cell;endocrine-stromal cell;exactmatch
neoplastic mesothelial cell;neoplastic mesothelial cell;exactmatch
thyroid gland microfollicular adenoma;fetal adenoma;exactmatch
lipoadenoma;adenolipoma, benign;exactmatch
mixed cell adenocarcinoma;mixed cell adenocarcinoma;exactmatch
mixed cell adenoma;mixed cell adenoma;exactmatch
sarcomatoid intrahepatic cholangiocarcinoma;intrahepatic cholangiocarcinoma with extensive sarcomatous changes;exactmatch
remnants of the central canal of the spinal cord;remnants of the central canal of the spinal cord;exactmatch
borderline papillary cystadenoma;borderline malignancy papillary cystadenoma;exactmatch
apocrine adenoma;apocrine adenoma;exactmatch
ceruminous adenocarcinoma;carcinoma, ceruminous gland, malignant;exactmatch
sebaceous adenoma;adenoma, sebaceous, benign;exactmatch
papillary eccrine adenoma;eccrine papillary adenoma;exactmatch
syringocystadenoma papilliferum;papillary syringadenoma;exactmatch
hidradenoma papilliferum;hidradenoma papilliferum;exactmatch
spiradenoma;benign eccrine spiradenoma;exactmatch
apocrine carcinoma;apocrine carcinoma;exactmatch
adrenal cortex mixed cell adenoma;adrenal cortex mixed cell adenoma;exactmatch
protein kinase b;akt;exactmatch
adrenal cortex glomerulosa cell adenoma;adrenal cortex glomerulosa cell adenoma;exactmatch
adrenal cortex clear cell adenoma;adrenal cortex clear cell adenoma;exactmatch
pigmented adrenal cortex adenoma;adrenal cortical adenoma, pigmented;exactmatch
fascicles of spindly tumor cells present;fascicles of spindly tumor cells present;exactmatch
adrenal cortex compact cell adenoma;adrenal cortex compact cell adenoma;exactmatch
clear perinuclear halo present;clear perinuclear halo present;exactmatch
perivascular pseudorosette formation;perivascular pseudorosette formation;exactmatch
water-clear cell adenocarcinoma;water-clear cell adenocarcinoma;exactmatch
parathyroid gland water-clear cell adenoma;parathyroid gland water-clear cell adenoma;exactmatch
resistance process;resistance;exactmatch
hyalinized vessels present;hyalinized vessels present;exactmatch
neoplastic large ganglioid astrocyte;neoplastic large ganglioid astrocyte;exactmatch
intracellular accumulation of lipids;intracellular accumulation of lipids;exactmatch
dense intercellular reticulin network present;dense intercellular reticulin network present;exactmatch
multinodular lesion;multinodular lesion;exactmatch
rosenthal fibers present;rosenthal fibers present;exactmatch
macrocystic change;macrocystic change;exactmatch
eosinophilic granular bodies present;eosinophilic granular bodies present;exactmatch
low cellularity present;low cellularity present;exactmatch
nucleotide biosynthesis process;nucleotide biosynthesis;exactmatch
chromophobe renal cell carcinoma;chromophobe adenocarcinoma;exactmatch
neoplastic protoplasmic astrocyte;neoplastic multipolar astrocyte;exactmatch
slow growing mass;slow growing mass;exactmatch
well-circumscribed lesion;well-circumscribed lesion;exactmatch
microcystic change;microcystic change;exactmatch
microvascular proliferation;mvp;exactmatch
cystic change;cystic degeneration;exactmatch
pituitary gland acidophil carcinoma;acidophil adenocarcinoma;exactmatch
perivascular pseudopalisading;perivascular pseudopalisading;exactmatch
glial differentiation;glial differentiation;exactmatch
collagenous stroma formation;collagenous stroma formation;exactmatch
dna maintenance process;dna maintenance process;exactmatch
parathyroid gland chief cell adenoma;chief cell adenoma;exactmatch
leukotriene activity induction;leukotriene activity induction;exactmatch
eicosanoid activity induction;eicosanoid activity induction;exactmatch
glycogen-rich carcinoma;glycogen-rich carcinoma;exactmatch
lipid-rich carcinoma;lipid-rich carcinoma;exactmatch
cell movement process;cell movement process;exactmatch
cell death process;cell death;exactmatch
cell adhesion process;cell adhesion;exactmatch
circulatory process;circulation;exactmatch
clear cell adenoma;adenoma, clear cell, benign;exactmatch
basophilic adenocarcinoma;basophil adenocarcinoma;exactmatch
pituitary gland mixed acidophil-basophil carcinoma;mixed acidophil-basophil adenocarcinoma;exactmatch
musculoskeletal process;musculoskeletal process;exactmatch
pituitary gland mixed acidophil-basophil adenoma;mixed acidophil-basophil adenoma;exactmatch
borderline serous cystadenoma;borderline malignancy serous cystadenoma;exactmatch
papillary cystic neoplasm;papillary cystic neoplasm;exactmatch
well differentiated ovarian sertoli-leydig cell tumor;sertoli-leydig cell tumor, well differentiated;exactmatch
composite ganglioneuroblastoma, stroma-dominant and stroma-poor;composite ganglioneuroblastoma, stroma-dominant and stroma-poor;exactmatch
ganglioneuroma component present;ganglioneuroma component present;exactmatch
ganglioneuroblastoma component present;ganglioneuroblastoma component present;exactmatch
hemorrhagic neuroblastic nodules present;hemorrhagic neuroblastic nodules present;exactmatch
mature ganglioneuroma;mature ganglioneuroma;exactmatch
maturing ganglioneuroma;maturing ganglioneuroma;exactmatch
schwannian stroma predominant component of the tumor volume;schwannian stroma predominant component of the tumor volume;exactmatch
schwannian stroma more than 50 percent of the tumor volume;schwannian stroma more than 50 percent of the tumor volume;exactmatch
composite ganglioneuroblastoma, schwannian stroma-rich and stroma-poor;composite ganglioneuroblastoma, schwannian stroma-rich and stroma-poor;exactmatch
mature schwannian stroma present;mature schwannian stroma present;exactmatch
ganglioneuroblastoma, nodular;ganglioneuroblastoma, nodular;exactmatch
ganglioneuroblastoma, intermixed;ganglioneuroblastoma, intermixed;exactmatch
differentiating neuroblasts present;differentiating neuroblasts present;exactmatch
differentiating neuroblasts more than 5 percent of the tumor cells;differentiating neuroblasts more than 5 percent of the tumor cells;exactmatch
differentiating neuroblasts under 5 percent of the tumor cells;differentiating neuroblasts under 5 percent of the tumor cells;exactmatch
neuropil present;neuropil present;exactmatch
neuroectodermal cell;neuroectodermal cell;exactmatch
juvenile type granulosa cell tumor;granulosa cell tumor, juvenile;exactmatch
ganglion cells present;ganglion cells present;exactmatch
papillary serous cystadenoma;papillary serous cystadenoma;exactmatch
neoplastic cuboidal cell;neoplastic cuboidal cell;exactmatch
pale eosinophilic stroma formation;pale eosinophilic stroma formation;exactmatch
cortical dysplasia;cortical dysplasia;exactmatch
aggregates of poorly differentiated neuroepithelial cells present;aggregates of poorly differentiated neuroepithelial cells present;exactmatch
downward ocular deviation;downward ocular deviation;exactmatch
dysplastic ganglion cell;dysplastic ganglion cell;exactmatch
neoplastic mature ganglion cell;neoplastic mature ganglion cell;exactmatch
neuronal differentiation;neuronal differentiation;exactmatch
cauliflower-like mass;cauliflower-like mass;exactmatch
scattered collections of differentiating neuroblasts present;scattered collections of differentiating neuroblasts present;exactmatch
childhood choroid plexus neoplasm;childhood choroid plexus neoplasm;exactmatch
ovarian sex cord tumor with annular tubules;ovarian sertoli cell tumor, annular tubular variant;exactmatch
choroid plexus epithelium;choroid plexus epithelium;exactmatch
lesion by morphology;lesion by morphology;exactmatch
cellular infiltrate;cellular infiltrate;exactmatch
abnormal cells present;abnormal cells present;exactmatch
abnormal tissue present;abnormal tissue present;exactmatch
malignant granulosa cell tumor;granulosa cell tumor, malignant;exactmatch
prominent schwannian stroma present;prominent schwannian stroma present;exactmatch
differentiating neuroblastoma;differentiating;exactmatch
neoplastic small immature neuroepithelial cell;neoplastic small immature neuroepithelial cell;exactmatch
gliomatosis cerebri type ii;gliomatosis cerebri type ii;exactmatch
gliomatosis cerebri type i;gliomatosis cerebri type i;exactmatch
clusters and cords of gfap positive epithelioid tumor cells present;clusters and cords of gfap positive epithelioid tumor cells present;exactmatch
papillary mucinous cystadenoma;papillary mucinous cystadenoma;exactmatch
perivascular arrangement of tumor cells;perivascular arrangement of tumor cells;exactmatch
large pineocytomatous rosette formation;large pineocytomatous rosette formation;exactmatch
neoplastic small mature neuroepithelial cell;neoplastic small mature neuroepithelial cell;exactmatch
neoplastic small neuroepithelial cell;neoplastic small neuroepithelial cell;exactmatch
poorly differentiated neuroblastoma;poorly differentiated;exactmatch
pineal parenchyma;pineal parenchyma;exactmatch
nests of tumor cell nuclei in a fibrillary matrix;nests of tumor cell nuclei in a fibrillary matrix;exactmatch
back pain;back pain;exactmatch
borderline papillary serous cystadenoma;borderline malignancy papillary serous cystadenoma;exactmatch
pseudopalisading necrosis;pseudopalisading necrosis;exactmatch
serous surface papillary carcinoma;serous surface papillary carcinoma;exactmatch
serous surface papilloma;serous surface papilloma;exactmatch
regional disease;regional;exactmatch
borderline papillary mucinous cystadenoma;borderline malignancy papillary mucinous cystadenoma;exactmatch
comedocarcinoma;comedocarcinoma;exactmatch
breast secretory carcinoma;breast secretory carcinoma;exactmatch
undifferentiated neuroblastoma;undifferentiated;exactmatch
ovarian sclerosing stromal tumor;ovarian sclerosing stromal neoplasm;exactmatch
ovarian luteinized thecoma;luteinized ovarian thecoma;exactmatch
adenocarcinoma with apocrine metaplasia;adenocarcinoma with apocrine metaplasia;exactmatch
adenocarcinoma with spindle cell metaplasia;adenocarcinoma with spindle cell metaplasia;exactmatch
adenocarcinoma with squamous metaplasia;adenoacanthoma, malignant;exactmatch
epithelial-myoepithelial carcinoma;epithelial-myoepithelial carcinoma;exactmatch
complex epithelial neoplasm;complex epithelial neoplasm;exactmatch
acinar cell neoplasm;acinar cell neoplasm;exactmatch
acinar cell adenoma;adenoma, acinar cell, benign;exactmatch
breast ductal carcinoma in situ and lobular carcinoma in situ;breast ductal carcinoma in situ and lobular carcinoma in situ;exactmatch
invasive breast carcinoma of no special type;ibc nst;exactmatch
thyroid gland medullary carcinoma with amyloid stroma;c cell adenocarcinoma with amyloid stroma;exactmatch
nipple adenoma;adenoma of nipple;exactmatch
breast papillary ductal carcinoma in situ;breast intracystic papillary carcinoma;exactmatch
anaplastic oligodendroglioma;anaplastic oligodendroglioma;exactmatch
bone lesion;bone lesion;exactmatch
multiple destructive bone lesions;multiple destructive bone lesions;exactmatch
benign minor salivary gland neoplasm;benign minor salivary gland neoplasm;exactmatch
benign frontal sinus neoplasm;benign frontal sinus neoplasm;exactmatch
frontal sinus neoplasm;frontal sinus neoplasm;exactmatch
benign ethmoid sinus neoplasm;benign ethmoid sinus neoplasm;exactmatch
ethmoid sinus neoplasm;ethmoid sinus neoplasm;exactmatch
benign maxillary sinus neoplasm;benign maxillary sinus neoplasm;exactmatch
nasal cavity neoplasm;nasal cavity neoplasm;exactmatch
middle ear neoplasm;middle ear neoplasm;exactmatch
malignant minor salivary gland neoplasm;malignant minor salivary gland neoplasm;exactmatch
pyriform fossa neoplasm;neoplasm of pyriform fossa;exactmatch
minor salivary gland neoplasm;minor salivary gland neoplasm;exactmatch
benign posterior tongue neoplasm;benign base of tongue neoplasm;exactmatch
major salivary gland neoplasm;major salivary gland neoplasm;exactmatch
benign buccal mucosa neoplasm;benign buccal mucosa neoplasm;exactmatch
buccal mucosa neoplasm;buccal mucosa neoplasm;exactmatch
benign soft palate neoplasm;benign neoplasm of soft palate;exactmatch
benign hard palate neoplasm;benign hard palate neoplasm;exactmatch
benign sphenoid sinus neoplasm;benign neoplasm of sphenoid sinus;exactmatch
glottis neoplasm;glottis neoplasm;exactmatch
pancreatic exocrine neoplasm;exocrine pancreas neoplasm;exactmatch
cholangiocarcinoma;cc;exactmatch
ampulla of vater neoplasm;ampulla of vater neoplasm;exactmatch
stage 0 extrahepatic bile duct cancer;carcinoma in situ of extrahepatic bile duct;exactmatch
extrahepatic bile duct neoplasm;extrahepatic bile duct neoplasm;exactmatch
gallbladder benign neoplasm;benign gallbladder neoplasm;exactmatch
stage 0 gallbladder cancer ajcc v6 and v7;carcinoma in situ of gallbladder;exactmatch
liver angiosarcoma;angiosarcoma of liver;exactmatch
liver sarcoma;hepatic sarcoma;exactmatch
appendix neoplasm;appendix neoplasm;exactmatch
subglottis neoplasm;neoplasm of subglottis;exactmatch
cecum neoplasm;cecum neoplasm;exactmatch
small intestinal neoplasm;neoplasm of small bowel;exactmatch
gastric pylorus carcinoma in situ ajcc v6 and v7;carcinoma in situ of gastric pylorus;exactmatch
gastric body carcinoma in situ ajcc v6 and v7;carcinoma in situ of body of stomach;exactmatch
gastric fundus carcinoma in situ ajcc v6 and v7;carcinoma in situ of fundus of stomach;exactmatch
gastric cardia carcinoma in situ ajcc v6 and v7;carcinoma in situ of cardia of stomach;exactmatch
benign subglottis neoplasm;benign neoplasm of subglottis;exactmatch
palate neoplasm;neoplasm of palate;exactmatch
floor of the mouth neoplasm;floor of mouth neoplasm;exactmatch
posterior tongue neoplasm;base of tongue neoplasm;exactmatch
extrahepatic bile duct epithelium;extrahepatic bile duct epithelium;exactmatch
external ear polyp;external auditory canal polyp;exactmatch
primary retinal non-hodgkin lymphoma;lymphoma of retina;exactmatch
ciliary body neoplasm;ciliary body neoplasm;exactmatch
hilar portion of the hepatic duct;hilar portion of the hepatic duct;exactmatch
sarcomatoid hepatocellular carcinoma;hepatocellular carcinoma, spindle cell variant;exactmatch
lamellar pattern;lamellar;exactmatch
pleomorphic hepatocellular carcinoma;hepatocellular carcinoma, pleomorphic type;exactmatch
intrahepatic bile duct epithelium;intrahepatic bile duct epithelium;exactmatch
carcinoma ex pleomorphic adenoma;carcinoma ex pleomorphic adenoma;exactmatch
bile duct epithelium;bile duct epithelium;exactmatch
bile duct tissue;bile duct tissue;exactmatch
hepatobiliary tissue;hepatobiliary tissue;exactmatch
hepatobiliary system;hepatobiliary system;exactmatch
corneal neoplasm;cornea neoplasm;exactmatch
gallbladder papillary biliary intraepithelial neoplasia;gallbladder papillary bilin;exactmatch
gallbladder flat biliary intraepithelial neoplasia;gallbladder flat bilin;exactmatch
frontal sinus polyp;frontal sinus polyp;exactmatch
nasal vestibule squamous cell papilloma;nasal vestibule papilloma;exactmatch
skin lymphangioleiomyomatosis;lymphangioleiomyomatosis of skin;exactmatch
cherry hemangioma of lip;cherry hemangioma of lip;exactmatch
malignant adrenal medulla neoplasm;malignant adrenal medulla neoplasm;exactmatch
anogenital papillomaviral intraepithelial neoplasia;anogenital papillomaviral intraepithelial neoplasia;exactmatch
cervical symmetrical lipomatosis;cervical symmetrical lipomatosis;exactmatch
intravascular papillary endothelial hyperplasia;intravascular papillary endothelial hyperplasia;exactmatch
bile pigment present;bile pigment present;exactmatch
neutral epithelial mucin present;neutral epithelial mucin present;exactmatch
cherry hemangioma;campbell de morgan spot;exactmatch
clear cell intrahepatic cholangiocarcinoma;clear cell intrahepatic cholangiocarcinoma;exactmatch
vulvar condyloma;condylomata acuminata of vulva;exactmatch
ovarian epithelial tumor;epithelial neoplasm of ovary;exactmatch
scrotal neoplasm;neoplasm of scrotum;exactmatch
accessory urethral gland neoplasm;accessory urethral gland neoplasm;exactmatch
renal failure;kidney failure;exactmatch
pancreatic cystadenoma;cystadenoma of pancreas;exactmatch
gastric hamartomatous polyp;gastric hamartomatous polyp;exactmatch
stage 0 ampulla of vater cancer ajcc v7;ampulla of vater cancer stage 0;exactmatch
pancreatic serotonin-producing neuroendocrine tumor;carcinoid neoplasm of pancreas;exactmatch
gallbladder clear cell adenocarcinoma;gallbladder clear cell adenocarcinoma;exactmatch
hereditary breast carcinoma;familial breast carcinoma;exactmatch
ovarian mucinous cystadenoma;benign mucinous cystadenoma of ovary;exactmatch
ovarian serous cystadenoma;benign ovarian serous cystadenoma;exactmatch
benign ovarian epithelial tumor;benign epithelial neoplasm of ovary;exactmatch
ovarian undifferentiated carcinoma;anaplastic carcinoma of ovary;exactmatch
ovarian seromucinous tumor;ovarian seromucinous tumor;exactmatch
benign breast neoplasm;benign breast neoplasm;exactmatch
malignant breast phyllodes tumor;malignant breast phyllodes neoplasm;exactmatch
benign lipomatous neoplasm;benign adipose tissue neoplasm;exactmatch
ovarian choriocarcinoma;choriocarcinoma of ovary;exactmatch
pleural adenomatoid tumor;benign mesothelioma of pleura;exactmatch
nevus spilus;nevus spilus;exactmatch
desmoplastic nevus;desmoplastic nevus;exactmatch
chlamydia psittaci-associated ocular adnexal mucosa-associated lymphoid tissue lymphoma;chlamydia psittaci-associated ocular adnexal mucosa-associated lymphoid tissue lymphoma;exactmatch
common blue nevus;common blue nevus;exactmatch
chlamydophila psittaci infection;chlamydia psittaci;exactmatch
cockade nevus;cockade nevus;exactmatch
malignant ovarian germ cell tumor;malignant germ cell neoplasm of ovary;exactmatch
benign ovarian germ cell tumor;benign germ cell neoplasm of ovary;exactmatch
benign retroperitoneal neoplasm;benign retroperitoneal neoplasm;exactmatch
low grade fibromyxoid sarcoma;low grade fibromyxoid sarcoma;exactmatch
poor collagen rosette formation;poor collagen rosette formation;exactmatch
fus-creb3l1 fusion protein expression;fus-creb3l1 fusion protein expression;exactmatch
fus-creb3l2 fusion protein expression;fus-creb3l2 fusion protein expression;exactmatch
"t(7;16)(q33;p11)";"t(7;16)(q33;p11)";exactmatch
prominent collagen rosette formation;prominent collagen rosette formation;exactmatch
collagen rosette formation;collagen rosette formation;exactmatch
low grade fibromyxoid sarcoma with giant collagen rosettes;hyalinizing spindle cell tumor with giant rosettes;exactmatch
cervical adenocarcinoma in situ;adenocarcinoma in situ of cervix;exactmatch
borrelia burgdorferi infection;borrelia;exactmatch
primary cutaneous diffuse large b-cell lymphoma, leg type;primary cutaneous diffuse large b-cell lymphoma, leg type;exactmatch
primary cutaneous diffuse large b-cell lymphoma;primary cutaneous diffuse large b-cell lymphoma;exactmatch
cervical adenosquamous carcinoma;adenosquamous carcinoma;exactmatch
intravenous leiomyomatosis;intravenous leiomyomatosis;exactmatch
benign fallopian tube neoplasm;benign fallopian tube neoplasm;exactmatch
campylobacter jejuni-associated small intestinal mucosa-associated lymphoid tissue lymphoma;campylobacter jejuni-associated small intestinal mucosa-associated lymphoid tissue lymphoma;exactmatch
borrelia burgdoferi-associated cutaneous marginal zone lymphoma of mucosa-associated lymphoid tissue;borrelia burgdoferi-associated cutaneous marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue;exactmatch
skin hemangioendothelioma;angioendothelioma of skin;exactmatch
malignant skin hemangiopericytoma;malignant hemangiopericytoma of skin;exactmatch
skin hemangiopericytoma;hemangiopericytoma of skin;exactmatch
malignant mesothelioma;mesothelioma, malignant;exactmatch
skin appendage neoplasm;adnexal neoplasm of skin;exactmatch
skin squamous cell papilloma;dyskeratotic papilloma of skin;exactmatch
multiple self healing epithelioma of ferguson-smith;ferguson-smith tumor;exactmatch
skin acantholytic squamous cell carcinoma;acantholytic squamous cell carcinoma of skin;exactmatch
skin clear cell squamous cell carcinoma;clear cell squamous cell carcinoma of skin;exactmatch
benign thymus neoplasm;benign neoplasm of thymus;exactmatch
pleural solitary fibrous tumor;fibroma of pleura;exactmatch
lung adenoma;adenoma of lung;exactmatch
skin glomus tumor;glomus neoplasm of skin;exactmatch
benign lung neoplasm;benign lung neoplasm;exactmatch
lung epithelioid hemangioendothelioma;epithelioid angioendothelioma of lung;exactmatch
"t(3;14)(p14.1;q32)";"t(3;14)(p14.1;q32)";exactmatch
lung giant cell carcinoma;giant cell carcinoma of lung;exactmatch
lung large cell carcinoma, clear cell variant;clear cell carcinoma of lung, large cell type;exactmatch
lung large cell carcinoma;anaplastic lung carcinoma;exactmatch
tracheal squamous cell carcinoma;epidermoid carcinoma of trachea;exactmatch
pilar sheath acanthoma;acanthoma of pilar sheath;exactmatch
tumor of the follicular infundibulum;basal cell hamartoma with follicular differentiation;exactmatch
perifollicular fibroma;perifollicular fibroma;exactmatch
adenoid cystic skin carcinoma;adenoid cystic carcinoma of skin;exactmatch
skin lymphangiosarcoma;lymphangiosarcoma of skin;exactmatch
skin angiosarcoma;angiosarcoma of skin;exactmatch
skin angiokeratoma;angiokeratoma of skin;exactmatch
tufted angioma;acquired tufted hemangioma;exactmatch
atypical intradermal smooth muscle neoplasm;aismn;exactmatch
dartoic leiomyoma;dartoic leiomyoma;exactmatch
skin leiomyoma;cutaneous (skin) leiomyoma;exactmatch
cutaneous ganglioneuroma;cutaneous ganglioneuroma;exactmatch
skin smooth muscle neoplasm;cutaneous neoplasm of smooth muscle origin;exactmatch
cutaneous neural neoplasm;cutaneous neural neoplasm;exactmatch
cutaneous verruciform xanthoma;cutaneous verruciform xanthoma;exactmatch
dermal neoplasm;dermal neoplasm;exactmatch
benign mixed tumor of the skin;benign mixed tumor of skin;exactmatch
dermal duct tumor;dermal duct neoplasm;exactmatch
mucoepidermoid skin carcinoma;mucoepidermoid carcinoma of skin;exactmatch
gallbladder biliary intraepithelial neoplasia;gallbladder bilin;exactmatch
gallbladder adenocarcinoma, intestinal-type;gallbladder adenocarcinoma, intestinal-type;exactmatch
diabetes insipidus;diabetes insipidus;exactmatch
trichoadenoma;trichoadenoma;exactmatch
pilar leiomyoma;pilar leiomyoma;exactmatch
fibrofolliculoma;fibrofolliculoma;exactmatch
transitional meningioma;mixed meningioma;exactmatch
trichofollicular carcinoma;trichofollicular carcinoma;exactmatch
trichoepithelial carcinoma;trichoepithelial carcinoma;exactmatch
malignant proliferating pilar tumor;malignant pilar tumor;exactmatch
trichilemmal carcinoma;trichilemmal carcinoma;exactmatch
outer hair sheath and infundibulum neoplasm;neoplasm of the outer hair sheath and infundibulum;exactmatch
superficial epithelioma with sebaceous differentiation;superficial epithelioma with sebaceous differentiation;exactmatch
benign pilar-associated mesenchyme neoplasm;benign pilar-associated mesenchyme neoplasm;exactmatch
benign mixed epithelial and mesenchymal hair follicle neoplasm;benign mixed epithelial and mesenchymal hair follicle neoplasm;exactmatch
malignant germinative follicular epithelium neoplasm;malignant germinative follicular epithelium neoplasm;exactmatch
angiomatous meningioma;angiomatous meningioma;exactmatch
benign germinative follicular epithelium neoplasm;benign germinative follicular epithelium neoplasm;exactmatch
malignant outer hair sheath and infundibulum neoplasm;malignant outer hair sheath and infundibulum neoplasm;exactmatch
benign outer hair sheath and infundibulum neoplasm;benign outer hair sheath and infundibulum neoplasm;exactmatch
spindle-cell predominant trichodiscoma;neurofollicular hamartoma;exactmatch
sebaceoma;infundibular adenoma;exactmatch
syringofibroadenoma;acrosyringeal adenomatosis;exactmatch
ductal eccrine carcinoma with spindle cell elements;ductal eccrine carcinoma with spindle cell elements;exactmatch
porocarcinoma in situ;hidroacanthoma simplex;exactmatch
classical poroma;classical eccrine poroma;exactmatch
turban tumor;ancell-spiegler syndrome;exactmatch
sporadic cylindroma;sporadic cylindroma;exactmatch
malignant triton tumor;mpnst with rhabdomyosarcoma;exactmatch
ductal eccrine carcinoma with abundant fibromyxoid stroma;ductal eccrine carcinoma with abundant fibromyxoid stroma;exactmatch
squamoid eccrine ductal carcinoma;ductal eccrine carcinoma with squamous metaplasia;exactmatch
ductal eccrine adenocarcinoma;ductal eccrine adenocarcinoma;exactmatch
sebocyte;sebocyte;exactmatch
cylindrocarcinoma;carcinoma ex cylindroma;exactmatch
apocrine hidrocystoma;apocrine hidrocystoma;exactmatch
extraocular cutaneous sebaceous carcinoma;extraocular cutaneous sebaceous carcinoma;exactmatch
eye sebaceous carcinoma;eye sebaceous carcinoma;exactmatch
meningeal sarcomatosis;meningeal sarcomatosis;exactmatch
malignant sebocyte;malignant sebaceous cell;exactmatch
neoplastic sebocyte;neoplastic sebocyte;exactmatch
pilar-associated mesenchyme neoplasm;pilar-associated mesenchyme neoplasm;exactmatch
mixed epithelial and mesenchymal hair follicle neoplasm;mixed epithelial and mesenchymal hair follicle neoplasm;exactmatch
germinative follicular epithelium neoplasm;germinative follicular epithelium neoplasm;exactmatch
neoplastic dendritic cell;neoplastic dendritic cell;exactmatch
peau chagrine lesion;grain leather skin;exactmatch
pacinian neurofibroma;pacinian neurofibroma;exactmatch
macular lesion;macular lesion;exactmatch
pure cutaneous mastocytosis;pure cutaneous mastocytosis;exactmatch
serum total tryptase levels increased;serum total tryptase levels increased;exactmatch
leukemic mast cell;leukemic mast cell;exactmatch
paracortical involvement with residual follicles present;paracortical involvement with residual follicles present;exactmatch
cd35-positive neoplastic cells present;cd35-positive neoplastic cells present;exactmatch
malignant hair follicle neoplasm;hair follicle neoplasm, malignant;exactmatch
central nervous system medulloepithelioma;central nervous system medulloepithelioma;exactmatch
cd21-positive neoplastic cells present;cd21-positive neoplastic cells present;exactmatch
hmb-45-positive neoplastic cells present;hmb-45 positive neoplastic cells present;exactmatch
cd1a-positive neoplastic cells present;antigen cd1a-positive neoplastic cells present;exactmatch
birbeck granules present;birbeck granules present;exactmatch
ultrastructural finding;ultrastructural finding;exactmatch
monoclonal langerhans cells present;clonal langerhans cells present;exactmatch
mast cells 20 percent or more of bone marrow nucleated cells;mast cells 20 percent or more of bone marrow nucleated cells;exactmatch
mast cells 10 percent or more of peripheral blood white cells;mast cells 10 percent or more of peripheral blood white cells;exactmatch
primary systemic mastocytosis;primary systemic mastocytosis;exactmatch
unifocal disease at presentation;unifocal disease at presentation;exactmatch
psammomatous meningioma;psammomatous meningioma;exactmatch
gain of chromosome 10p;gain of chromosome 10p;exactmatch
"t(3;8)(p12;q21)";"t(3;8)(p12;q21)";exactmatch
neoplastic connective and soft tissue epithelioid cell;neoplastic connective and soft tissue epithelioid cell;exactmatch
ss18-ssx fusion protein expression;ss18-ssx fusion protein expression;exactmatch
monosomy 3;monosomy 3;exactmatch
col1a1-pdgfbeta fusion protein expression;col1a1-pdgfb fusion protein expression;exactmatch
campylobacter jejuni infection;campylobacter jejuni infection;exactmatch
fibrous meningioma;fibroblastic meningioma;exactmatch
hereditary pancreatic carcinoma;familial pancreatic cancer;exactmatch
hereditary gastric diffuse adenocarcinoma;hereditary diffuse gastric adenocarcinoma;exactmatch
ret gene mutation;ret gene mutation;exactmatch
cdkn1c gene mutation;cdkn1c gene mutation;exactmatch
meningothelial meningioma;meningothelial meningioma;exactmatch
monoclonal myeloid or lymphoid cells present;clonal myeloid or lymphoid cells present;exactmatch
syringoacanthoma;syringoacanthoma;exactmatch
malignant granular cell tumor;granular cell tumor, malignant;exactmatch
gallbladder tubulopapillary adenoma;gallbladder tubulopapillary adenoma;exactmatch
eyelid seborrheic keratosis;basal cell papilloma of eyelid;exactmatch
neuroendocrine differentiation;neuroendocrine differentiation;exactmatch
glandular differentiation;glandular differentiation;exactmatch
parafibromin;cdc73;exactmatch
eyelid capillary hemangioma;capillary angioma of eyelid;exactmatch
cdc73 gene;cdc73;exactmatch
appendix tubular carcinoid;appendix tubular carcinoid;exactmatch
appendix mixed adenoneuroendocrine carcinoma;appendix manec;exactmatch
appendix mucinous adenocarcinoma;appendix mucinous adenocarcinoma;exactmatch
colon traditional serrated adenoma;colon serrated adenoma;exactmatch
appendix undifferentiated carcinoma;appendix undifferentiated carcinoma;exactmatch
appendix small cell neuroendocrine carcinoma;appendix small cell carcinoma;exactmatch
appendix signet ring cell carcinoma;appendix signet ring cell carcinoma;exactmatch
small intestinal tubulovillous adenoma;small intestinal tubulovillous adenoma;exactmatch
small intestinal tubular adenoma;small intestinal tubular adenoma;exactmatch
small intestinal villous adenoma;small intestinal villous adenoma;exactmatch
appendix adenoma;appendix adenoma;exactmatch
appendix lipoma;appendix lipoma;exactmatch
eyelid melanoma;eyelid melanoma;exactmatch
anus;anus;exactmatch
rectosigmoid signet ring cell carcinoma;rectosigmoid signet ring cell carcinoma;exactmatch
gallbladder papillary adenoma;gallbladder papillary adenoma;exactmatch
gallbladder tubular adenoma;gallbladder tubular adenoma;exactmatch
lacrimal gland neoplasm;lacrimal gland neoplasm;exactmatch
perianal intraepithelial neoplasia;anal margin bowen disease;exactmatch
myc gene mutation;mrtl gene mutation;exactmatch
protoplasm;protoplasm;exactmatch
rectal adenosquamous carcinoma;rectal adenosquamous cancer;exactmatch
rectosigmoid mucinous adenocarcinoma;rectosigmoid mucinous adenocarcinoma;exactmatch
rectosigmoid adenocarcinoma;rectosigmoid adenocarcinoma;exactmatch
colorectal undifferentiated carcinoma;colorectal undifferentiated carcinoma;exactmatch
colorectal medullary carcinoma;colorectal medullary carcinoma;exactmatch
colorectal adenosquamous carcinoma;colorectal (colon or rectal) adenosquamous cancer;exactmatch
colorectal squamous cell carcinoma;colorectal (colon or rectal) squamous cell cancer;exactmatch
colorectal small cell neuroendocrine carcinoma;colorectal small cell carcinoma;exactmatch
colorectal signet ring cell carcinoma;colorectal signet ring cell carcinoma;exactmatch
colorectal mucinous adenocarcinoma;colorectal mucinous adenocarcinoma;exactmatch
eyelid squamous cell papilloma;epidermoid papilloma of eyelid;exactmatch
appendix traditional serrated adenoma;appendix serrated adenoma;exactmatch
appendix tubulovillous adenoma;appendix tubulovillous adenoma;exactmatch
peripheral t-cell lymphoma, not otherwise specified;peripheral t-cell lymphoma, nos;exactmatch
acute panmyelosis with myelofibrosis;apmf;exactmatch
activity;activity;exactmatch
aleukemic lymphoid leukemia;aleukemic lymphatic leukemia;exactmatch
epithelial stem cell;epithelial stem cell;exactmatch
intravascular large b-cell lymphoma;angiotropic large cell lymphoma;exactmatch
multipotent stem cell;multipotent stem cell;exactmatch
marginal zone lymphoma;mzbcl;exactmatch
multifocal lymphomatous polyposis;multifocal lymphomatous polyposis;exactmatch
appendix tubular adenoma;appendix tubular adenoma;exactmatch
diffuse centroblastic-centrocytic lymphoma;cb/cc;exactmatch
cdc73 gene mutation;c1orf28 gene mutation;exactmatch
apocrine cell;apocrine;exactmatch
eccrine cell;eccrine cell;exactmatch
lentigo maligna;hutchinson melanotic freckle;exactmatch
glandular epithelium;glandular epithelium;exactmatch
mantle cell lymphoma;classical mantle cell lymphoma;exactmatch
myeloproliferative neoplasm;cmpd;exactmatch
skin basal cell carcinoma with sebaceous differentiation;basal cell carcinoma with sebaceous differentiation;exactmatch
childhood cerebral astrocytoma;cerebral astrocytoma;exactmatch
non-functioning pituitary gland adenoma;functionless adenoma of pituitary;exactmatch
small intestinal signet ring cell carcinoma;small intestinal signet ring cell carcinoma;exactmatch
pituitary gland macroadenoma;pituitary gland macroadenoma;exactmatch
pituitary gland microadenoma;pituitary gland microadenoma;exactmatch
benign eyelid neoplasm;benign eyelid neoplasm;exactmatch
pituitary tumor transforming gene overexpression;pttg1 overexpression;exactmatch
small intestinal undifferentiated carcinoma;small intestinal undifferentiated carcinoma;exactmatch
small intestinal medullary carcinoma;small intestinal medullary cancer;exactmatch
small intestinal mucinous adenocarcinoma;small intestinal mucinous adenocarcinoma;exactmatch
small intestinal adenosquamous carcinoma;small intestinal adenosquamous cancer;exactmatch
small intestinal squamous cell carcinoma;small intestinal squamous cell cancer;exactmatch
c-met gene amplification;hgfr gene amplification;exactmatch
sporadic gastric diffuse adenocarcinoma;sporadic diffuse gastric adenocarcinoma;exactmatch
sporadic gastric adenocarcinoma;sporadic gastric adenocarcinoma;exactmatch
gastric pyloric gland adenoma;gastric pyloric gland adenoma;exactmatch
colon adenocarcinoma;adenocarcinoma - colon;exactmatch
infiltrative growth pattern;infiltrative growth;exactmatch
subependymal cell;subependymal cell;exactmatch
neoplastic subependymal glial cell;neoplastic subependymal glial cell;exactmatch
cervical adenomyoma, endometrial type;cervical adenomyoma, endometrial type;exactmatch
cervical disorder;cervical disorder;exactmatch
cervical blue nevus;blue nevus of the cervix;exactmatch
esophageal squamous cell carcinoma;escc;exactmatch
cervical melanoma;cervical melanoma;exactmatch
cervical wilms tumor;cervical nephroblastoma;exactmatch
uterine corpus atypical polypoid adenomyoma;uterine corpus atypical polypoid adenomyoma;exactmatch
cervical atypical polypoid adenomyoma;cervical atypical polypoid adenomyoma;exactmatch
cervical adenomyoma, endocervical type;cervical adenomyoma, endocervical type;exactmatch
vaginal keratinizing squamous cell carcinoma;vaginal keratinizing squamous cell carcinoma;exactmatch
cervical adenomyoma;cervical adenomyoma;exactmatch
cervical adenofibroma;cervical adenofibroma;exactmatch
small cell osteosarcoma;small cell osteogenic sarcoma;exactmatch
cervical adenosarcoma;cervical adenosarcoma;exactmatch
malignant mixed epithelial and mesenchymal neoplasm of the cervix;malignant cervical mixed epithelial and mesenchymal neoplasm;exactmatch
benign cervical mixed epithelial and mesenchymal neoplasm;benign cervical mixed epithelial and mesenchymal neoplasm;exactmatch
cervical mixed epithelial and mesenchymal neoplasm;cervical mixed epithelial and mesenchymal neoplasm;exactmatch
vaginal squamous neoplasm;vaginal squamous neoplasm;exactmatch
vaginal non-keratinizing squamous cell carcinoma;vaginal non-keratinizing squamous cell carcinoma;exactmatch
vaginal undifferentiated carcinoma;undifferentiated vaginal cancer;exactmatch
vaginal adenoma;vaginal adenoma;exactmatch
vaginal adenoid basal carcinoma;vaginal adenoid basal cancer;exactmatch
vaginal adenoid cystic carcinoma;vaginal adenoid cystic cancer;exactmatch
vaginal adenosquamous carcinoma;vaginal adenosquamous cancer;exactmatch
ovarian mucinous cystadenocarcinoma;mucinous cystadenocarcinoma of ovary;exactmatch
vaginal villous adenoma;vaginal villous adenoma;exactmatch
vaginal tubulovillous adenoma;vaginal tubulovillous adenoma;exactmatch
vaginal tubular adenoma;vaginal tubular adenoma;exactmatch
vaginal mullerian papilloma;vaginal mullerian papilloma;exactmatch
vaginal basaloid carcinoma;vaginal basaloid carcinoma;exactmatch
cervical mesonephric adenocarcinoma;cervical mesonephric adenocarcinoma;exactmatch
vaginal mesonephric adenocarcinoma;gartner duct adenocarcinoma;exactmatch
vaginal mucinous adenocarcinoma;vaginal mucinous adenocarcinoma;exactmatch
vaginal endometrioid adenocarcinoma;vaginal endometrioid adenocarcinoma;exactmatch
vaginal glandular neoplasm;vaginal glandular neoplasm;exactmatch
esophageal adenocarcinoma;adenocarcinoma;exactmatch
vaginal warty carcinoma;vaginal warty carcinoma;exactmatch
cervical alveolar soft part sarcoma;cervical alveolar soft part sarcoma;exactmatch
undifferentiated endocervical sarcoma;undifferentiated endocervical sarcoma;exactmatch
uterine corpus low grade endometrial stromal sarcoma;jazf1-suz12 ess;exactmatch
cervical lymphoepithelioma-like carcinoma;cervical lymphoepithelioma-like carcinoma;exactmatch
fibroblastic osteosarcoma;fibrosarcoma, osteogenic, malignant;exactmatch
cervical squamous intraepithelial neoplasia 1;cin 1;exactmatch
cervical squamous intraepithelial neoplasia 2;cin 2;exactmatch
high grade cervical squamous intraepithelial neoplasia;hsil of cervix;exactmatch
low grade cervical squamous intraepithelial neoplasia;cervical squamous intraepithelial neoplasia 1;exactmatch
cervical squamous neoplasm;cervical squamous neoplasm;exactmatch
cervical squamotransitional carcinoma;cervical squamotransitional carcinoma;exactmatch
cervical papillary squamous cell carcinoma;cervical papillary squamous cell carcinoma;exactmatch
low grade endometrioid stromal sarcoma of the cervix;low grade endometrioid stromal sarcoma of the cervix;exactmatch
cervical warty carcinoma;cervical condylomatous squamous cell carcinoma;exactmatch
cervical verrucous carcinoma;cervical verrucous carcinoma;exactmatch
breast paget disease and intraductal carcinoma;breast paget disease and intraductal carcinoma;exactmatch
cervical basaloid carcinoma;cervical basaloid carcinoma;exactmatch
cervical non-keratinizing squamous cell carcinoma;cervical non-keratinizing squamous cell carcinoma;exactmatch
cervical keratinizing squamous cell carcinoma;cervical keratinizing squamous cell carcinoma;exactmatch
digit;digit;exactmatch
cervical serous adenocarcinoma;cervical serous adenocarcinoma;exactmatch
cervical mucinous adenocarcinoma, endocervical type;cervical adenocarcinoma, endocervical type;exactmatch
cervical mucinous adenocarcinoma, intestinal-type;cervical mucinous adenocarcinoma, intestinal variant;exactmatch
cervical mucinous adenocarcinoma, signet ring cell type;cervical mucinous adenocarcinoma, signet ring cell type;exactmatch
endometrioid stromal sarcoma of the cervix;endometrioid stromal sarcoma of the cervix;exactmatch
acral lentiginous melanoma;acral lentiginous malignant melanoma;exactmatch
uterine corpus endometrial stromal sarcoma;uterine corpus ess;exactmatch
endometrioid stromal and related neoplasms of the cervix;endometrioid stromal and related neoplasms of the cervix;exactmatch
uterine corpus endometrial stromal and related neoplasms;uterine corpus endometrial stromal and related neoplasms;exactmatch
cervical soft tissue neoplasm;cervical soft tissue neoplasm;exactmatch
cervical mullerian papilloma;cervical mullerian papilloma;exactmatch
cervical large cell neuroendocrine carcinoma;cervical large cell neuroendocrine carcinoma;exactmatch
cervical adenoid basal carcinoma;cervical adenoid basal cancer;exactmatch
cervical adenosquamous carcinoma, glassy cell variant;cervical adenosquamous carcinoma, glassy cell variant;exactmatch
cervical glandular neoplasm;cervical glandular neoplasm;exactmatch
chondroblastic osteosarcoma;chondroblastic osteogenic sarcoma;exactmatch
cervical glandular dysplasia;cervical glandular dysplasia;exactmatch
cervical villoglandular adenocarcinoma;cervical adenocarcinoma, villoglandular variant;exactmatch
cervical mucinous adenocarcinoma, minimal deviation type;cervical adenoma malignum;exactmatch
vaginal small cell neuroendocrine carcinoma;vaginal small cell carcinoma;exactmatch
vaginal soft tissue neoplasm;vaginal soft tissue neoplasm;exactmatch
non-neoplastic, non-molar trophoblastic disorder;non-neoplastic, non-molar trophoblastic disorder;exactmatch
sebaceous carcinoma;adenocarcinoma, sebaceous, malignant;exactmatch
vulvar leiomyosarcoma;vulvar leiomyosarcoma;exactmatch
vulvar sarcoma;vulvar sarcoma;exactmatch
vulvar soft tissue neoplasm;vulvar soft tissue neoplasm;exactmatch
pilomyxoid astrocytoma;pilomyxoid astrocytoma;exactmatch
vulvar trichoepithelioma;vulvar trichoblastoma;exactmatch
vulvar nodular hidradenoma;vulvar nodular hidradenoma;exactmatch
vulvar syringoma;vulvar syringoma;exactmatch
bladder squamous cell carcinoma;bladder epidermoid carcinoma;exactmatch
bladder adenocarcinoma;adenocarcinoma of bladder;exactmatch
vulvar sebaceous carcinoma;vulvar sebaceous carcinoma;exactmatch
vulvar apocrine adenocarcinoma;vulvar apocrine adenocarcinoma;exactmatch
vulvar clear cell hidradenocarcinoma;vulvar clear cell hidradenocarcinoma;exactmatch
vulvar porocarcinoma;vulvar eccrine porocarcinoma;exactmatch
vulvar eccrine adenocarcinoma;vulvar eccrine adenocarcinoma;exactmatch
malignant vulvar sweat gland neoplasm;malignant vulvar sweat gland neoplasm;exactmatch
vulvar neoplasm of skin appendage origin;vulvar neoplasm of skin appendage origin;exactmatch
vulvar proximal-type epithelioid sarcoma;vulvar proximal-type epithelioid sarcoma;exactmatch
vulvar alveolar soft part sarcoma;vulvar alveolar soft part sarcoma;exactmatch
cervical rhabdomyoma;cervical rhabdomyoma;exactmatch
clear cell renal cell carcinoma;ccrcc;exactmatch
retroperitoneal gastrointestinal stromal tumor;retroperitoneal gastrointestinal stromal tumor;exactmatch
vulvar melanocytic neoplasm;vulvar melanocytic neoplasm;exactmatch
vulvar dysplastic melanocytic nevus;vulvar dysplastic melanocytic nevus;exactmatch
atypical melanocytic nevus, genital type;atypical melanocytic nevus of genital type;exactmatch
vulvar blue nevus;vulvar blue nevus;exactmatch
vulvar acquired melanocytic nevus;vulvar acquired melanocytic nevus;exactmatch
vulvar congenital melanocytic nevus;vulvar congenital melanocytic nevus;exactmatch
vulvar melanoma;vulvar melanoma;exactmatch
vulvar liposarcoma;vulvar liposarcoma;exactmatch
vulvar granular cell tumor;vulvar granular cell tumor;exactmatch
vulvar cellular angiofibroma;vulvar cellular angiofibroma;exactmatch
vulvar leiomyoma;vulvar leiomyoma;exactmatch
vulvar angiomyxoma;vulvar angiomyxoma;exactmatch
vulvar superficial angiomyxoma;vulvar superficial angiomyxoma;exactmatch
superficial angiomyxoma;superficial angiomyxoma;exactmatch
"vulvar deep ""aggressive"" angiomyxoma";vulvar aggressive angiomyxoma;exactmatch
benign mixed tumor of the vulva;benign mixed tumor of the vulva;exactmatch
adenoma of minor vestibular glands;adenoma of minor vestibular glands;exactmatch
bartholin gland adenomyoma;bartholin gland adenomyoma;exactmatch
vaginal mixed epithelial and mesenchymal neoplasm;vaginal mixed epithelial and mesenchymal neoplasm;exactmatch
benign vaginal mixed tumor;benign vaginal mixed tumor;exactmatch
cervical squamous cell carcinoma, not otherwise specified;cervical squamous cell cancer;exactmatch
malignant vaginal mixed tumor resembling synovial sarcoma;malignant vaginal mixed tumor resembling synovial sarcoma;exactmatch
vaginal carcinosarcoma;vaginal carcinosarcoma;exactmatch
vaginal adenosarcoma;vaginal adenosarcoma;exactmatch
malignant vaginal mixed epithelial and mesenchymal neoplasm;malignant vaginal mixed epithelial and mesenchymal neoplasm;exactmatch
benign vaginal mixed epithelial and mesenchymal neoplasm;benign vaginal mixed epithelial and mesenchymal neoplasm;exactmatch
"vaginal deep ""aggressive"" angiomyxoma";vaginal aggressive angiomyxoma;exactmatch
urothelial carcinoma;conventional urothelial carcinoma;exactmatch
vaginal undifferentiated sarcoma;vaginal undifferentiated sarcoma;exactmatch
low grade endometrioid stromal sarcoma of the vagina;low grade endometrioid stromal sarcoma of the vagina;exactmatch
endometrioid stromal sarcoma of the vagina;endometrioid stromal sarcoma of the vagina;exactmatch
vulvar paget disease;paget disease of the vulva;exactmatch
endometrioid stromal and related neoplasms of the vagina;endometrioid stromal and related neoplasms of the vagina;exactmatch
botryoid-type embryonal rhabdomyosarcoma of the vagina;botryoid-type embryonal rhabdomyosarcoma of the vagina;exactmatch
adult botryoid-type embryonal rhabdomyosarcoma of the vagina;adult botryoid-type embryonal rhabdomyosarcoma of the vagina;exactmatch
benign vaginal melanocytic nevus;benign vaginal melanocytic nevus;exactmatch
vaginal blue nevus;vaginal blue nevus;exactmatch
vulvar squamous neoplasm;vulvar squamous neoplasm;exactmatch
vulvar keratinizing squamous cell carcinoma;vulvar keratinizing squamous cell carcinoma;exactmatch
bartholin gland adenoma;bartholin gland adenoma;exactmatch
bartholin gland small cell neuroendocrine carcinoma;bartholin gland small cell carcinoma;exactmatch
bartholin gland transitional cell carcinoma;bartholin gland transitional cell carcinoma;exactmatch
bartholin gland adenosquamous carcinoma;bartholin gland adenosquamous carcinoma;exactmatch
bartholin gland adenoid cystic carcinoma;bartholin gland adenoid cystic carcinoma;exactmatch
bartholin gland squamous cell carcinoma;bartholin gland squamous cell carcinoma;exactmatch
vulvar glandular neoplasm;vulvar glandular neoplasm;exactmatch
vulvar inverted follicular keratosis;vulvar inverted follicular keratosis;exactmatch
vulvar squamous cell papillomatosis;micropapillomatosis labialis;exactmatch
cervical adenocarcinoma;adenocarcinoma;exactmatch
vulvar squamous cell carcinoma with tumor giant cells;vulvar squamous cell carcinoma with tumor giant cells;exactmatch
vulvar squamous cell carcinoma, keratoacanthoma type;vulvar keratoacanthoma-like carcinoma;exactmatch
vulvar warty carcinoma;vulvar condylomatous carcinoma;exactmatch
vulvar basaloid carcinoma;vulvar basaloid carcinoma;exactmatch
vulvar non-keratinizing squamous cell carcinoma;vulvar non-keratinizing squamous cell carcinoma;exactmatch
forebrain;brain, forebrain;exactmatch
uterine corpus carcinofibroma;uterine corpus carcinofibroma;exactmatch
mesenteric gastrointestinal stromal tumor;mesenteric gastrointestinal stromal tumor;exactmatch
childhood malignant neoplasm;childhood cancer;exactmatch
undifferentiated ovarian sarcoma;undifferentiated ovarian sarcoma;exactmatch
ovarian endometrioid stromal and related neoplasms;ovarian endometrioid stromal and related neoplasms;exactmatch
ovarian low grade endometrioid stromal sarcoma;ovarian low grade endometrioid stromal sarcoma;exactmatch
ovarian endometrioid adenocarcinoma with squamous differentiation;ovarian adenoacanthoma;exactmatch
ovarian endometrioid adenocarcinofibroma;endometrioid adenofibroma, malignant;exactmatch
stage iv uterine corpus cancer ajcc v6;stage iv cancer of uterine corpus ajcc v6;exactmatch
malignant ovarian endometrioid tumor;malignant ovarian endometrioid tumor;exactmatch
ovarian mucinous cystic tumor associated with pseudomyxoma peritonei;ovarian mucinous cystic tumor associated with pseudomyxoma peritonei;exactmatch
small intestinal lymphoma;lymphoma of small bowel;exactmatch
ovarian mucinous cystic tumor with mural nodules;ovarian mucinous cystic tumor with mural nodules;exactmatch
ovarian mucinous cystadenofibroma;ovarian mucinous cystadenofibroma;exactmatch
ovarian mucinous adenofibroma;ovarian mucinous adenofibroma;exactmatch
gastric adenocarcinoma;adenocarcinoma;exactmatch
benign ovarian mucinous tumor;benign ovarian mucinous neoplasm;exactmatch
borderline ovarian mucinous tumor, endocervical-like;borderline ovarian mucinous tumor, endocervical-like;exactmatch
borderline ovarian mucinous tumor, intestinal type;borderline ovarian mucinous tumor, intestinal type;exactmatch
borderline ovarian endometrioid adenofibroma;borderline ovarian endometrioid adenofibroma;exactmatch
benign ovarian endometrioid tumor;benign ovarian endometrioid tumor;exactmatch
ovarian squamous cell tumor;ovarian squamous cell neoplasm;exactmatch
borderline ovarian clear cell cystadenofibroma;borderline ovarian clear cell cystadenofibroma;exactmatch
non-functioning pituitary gland neoplasm;non-functioning neoplasm of pituitary;exactmatch
malignant ovarian transitional cell tumor;malignant ovarian transitional cell neoplasm;exactmatch
borderline ovarian transitional cell tumor;borderline ovarian transitional cell neoplasm;exactmatch
benign ovarian transitional cell tumor;benign ovarian transitional cell neoplasm;exactmatch
ovarian clear cell cystadenofibroma;ovarian clear cell cystadenofibroma;exactmatch
ovarian clear cell adenofibroma;ovarian clear cell adenofibroma;exactmatch
benign ovarian clear cell tumor;benign ovarian clear cell neoplasm;exactmatch
borderline ovarian clear cell tumor/atypical proliferative ovarian clear cell tumor with intraepithelial carcinoma;borderline ovarian clear cell adenofibroma with intraepithelial carcinoma;exactmatch
ovarian endometrioid cystadenoma;ovarian endometrioid cystadenoma;exactmatch
borderline ovarian clear cell adenofibroma;borderline ovarian clear cell adenofibroma;exactmatch
borderline ovarian clear cell tumor;borderline ovarian clear cell neoplasm;exactmatch
recurrent gallbladder carcinoma;gallbladder cancer, recurrent;exactmatch
ovarian clear cell adenocarcinofibroma;clear cell adenocarcinofibroma;exactmatch
ovarian clear cell adenocarcinoma;ovarian clear cell adenocarcinoma;exactmatch
malignant ovarian clear cell tumor;malignant ovarian clear cell neoplasm;exactmatch
ovarian clear cell tumor;ovarian clear cell neoplasm;exactmatch
borderline ovarian mucinous tumor;borderline ovarian mucinous neoplasm;exactmatch
adenocarcinofibroma;adenocarcinofibroma;exactmatch
ovarian mucinous adenocarcinofibroma;mucinous adenocarcinofibroma;exactmatch
ovarian dermoid cyst with prolactin secreting adenoma;ovarian dermoid cyst with prolactin secreting adenoma;exactmatch
ovarian trabecular carcinoid tumor;ovarian trabecular carcinoid tumor;exactmatch
ovarian insular carcinoid tumor;ovarian insular carcinoid tumor;exactmatch
benign struma ovarii;benign struma ovarii;exactmatch
ovarian dermoid cyst with angiosarcoma;ovarian dermoid cyst with angiosarcoma;exactmatch
ovarian dermoid cyst with leiomyosarcoma;ovarian dermoid cyst with leiomyosarcoma;exactmatch
breast inflammatory carcinoma;breast inflammatory carcinoma;exactmatch
ovarian dermoid cyst with secondary sarcoma;ovarian dermoid cyst with secondary sarcoma;exactmatch
ovarian dermoid cyst with corticotropin secreting adenoma;ovarian dermoid cyst with corticotropin secreting adenoma;exactmatch
malignant ovarian mucinous tumor;malignant ovarian mucinous neoplasm;exactmatch
ovarian dermoid cyst with secondary pituitary-type tumor;ovarian dermoid cyst with secondary pituitary-type tumor;exactmatch
ovarian dermoid cyst with sebaceous adenoma;ovarian dermoid cyst with sebaceous adenoma;exactmatch
ovarian dermoid cyst with sebaceous carcinoma;ovarian dermoid cyst with sebaceous carcinoma;exactmatch
ovarian dermoid cyst with secondary sebaceous tumor;ovarian dermoid cyst with secondary sebaceous tumor;exactmatch
ovarian dermoid cyst with melanocytic nevus;ovarian dermoid cyst with melanocytic nevus;exactmatch
ovarian dermoid cyst with melanoma;ovarian dermoid cyst with melanoma;exactmatch
ovarian dermoid cyst with secondary melanocytic lesion;ovarian dermoid cyst with secondary melanocytic lesion;exactmatch
ovarian mucinous carcinoid tumor;ovarian mucinous carcinoid tumor;exactmatch
rete ovarii neoplasm;rete ovarii neoplasm;exactmatch
rete ovarii adenocarcinoma;adenocarcinoma of rete ovarii;exactmatch
rete ovarii adenoma;adenoma, rete ovarii, benign;exactmatch
ovarian serous cystadenofibroma;ovarian serous cystadenofibroma;exactmatch
ovarian serous adenofibroma;ovarian serous adenofibroma;exactmatch
stage iv renal cell cancer ajcc v6;renal cell cancer stage iv ajcc v6;exactmatch
borderline ovarian serous cystadenofibroma;borderline ovarian serous cystadenofibroma;exactmatch
borderline ovarian serous adenofibroma;borderline ovarian serous adenofibroma;exactmatch
borderline ovarian serous tumor/atypical proliferative ovarian serous tumor with microinvasion;borderline ovarian serous neoplasm with microinvasion;exactmatch
malignant ovarian epithelial tumor;malignant ovarian epithelial tumor;exactmatch
malignant ovarian serous tumor;malignant ovarian serous tumor;exactmatch
primary peritoneal serous borderline tumor/ primary peritoneal atypical proliferative serous tumor;primary borderline peritoneal epithelial neoplasm;exactmatch
primary peritoneal serous adenocarcinoma;primary peritoneal serous adenocarcinoma;exactmatch
primary peritoneal carcinoma;ppc;exactmatch
ovarian lymphoma;ovarian lymphoma;exactmatch
rete ovarii cystadenofibroma;rete ovarii cystadenofibroma;exactmatch
extraosseous plasmacytoma;extramedullary plasmacytoma;exactmatch
rete ovarii cystadenoma;rete ovarii cystadenoma;exactmatch
ovarian seromucinous carcinoma;ovarian seromucinous carcinoma;exactmatch
ovarian squamous cell carcinoma;ovarian squamous cell cancer;exactmatch
uterine corpus mixed epithelial and mesenchymal neoplasm;uterine corpus mixed epithelial and mesenchymal neoplasm;exactmatch
figo grade 3 endometrial mucinous adenocarcinoma;figo grade 3 endometrial mucinous adenocarcinoma;exactmatch
"t(7;17)(p15;q21)";"t(7;17)(p15;q21)";exactmatch
malignant bone neoplasm;bone cancer;exactmatch
endometrial undifferentiated carcinoma;endometrial undifferentiated carcinoma;exactmatch
endometrial small cell neuroendocrine carcinoma;endometrial small cell carcinoma;exactmatch
endometrial transitional cell carcinoma;endometrial transitional cell carcinoma;exactmatch
endometrial mixed cell adenocarcinoma;endometrial mixed cell adenocarcinoma;exactmatch
serous endometrial intraepithelial carcinoma;eic;exactmatch
figo grade 2 endometrial mucinous adenocarcinoma;figo grade 2 endometrial mucinous adenocarcinoma;exactmatch
uterine corpus leiomyoma, mitotically active variant;uterine corpus leiomyoma, mitotically active variant;exactmatch
metastatic malignant neoplasm in the central nervous system;cns metastases;exactmatch
figo grade 1 endometrial mucinous adenocarcinoma;figo grade 1 endometrial mucinous adenocarcinoma;exactmatch
figo grade 3 endometrial endometrioid adenocarcinoma;figo grade 3 endometrial endometrioid adenocarcinoma;exactmatch
figo grade 2 endometrial endometrioid adenocarcinoma;figo grade 2 endometrial endometrioid adenocarcinoma;exactmatch
figo grade 1 endometrial endometrioid adenocarcinoma;figo grade 1 endometrial endometrioid adenocarcinoma;exactmatch
type i endometrial adenocarcinoma;type i endometrial adenocarcinoma;exactmatch
endometrial mucinous adenocarcinoma;endometrial mucinous adenocarcinoma;exactmatch
jazf1-suz12 fusion protein expression;jazf1-jjaz1 fusion protein expression;exactmatch
uterine corpus cellular leiomyoma;uterine corpus cellular leiomyoma;exactmatch
fallopian tube serous adenocarcinoma;fallopian tube serous adenocarcinoma;exactmatch
uterine corpus epithelioid leiomyosarcoma;uterine corpus epithelioid leiomyosarcoma;exactmatch
uterine corpus pecoma;uterine corpus pecoma;exactmatch
breast lobular carcinoma in situ;breast lobular carcinoma in situ;exactmatch
uterine corpus soft tissue neoplasm;uterine corpus soft tissue neoplasm;exactmatch
mixed endometrial stromal and smooth muscle neoplasm;mixed endometrial stromal and smooth muscle neoplasm;exactmatch
uterine corpus smooth muscle tumor of uncertain malignant potential;borderline uterine corpus smooth muscle neoplasm;exactmatch
uterine corpus smooth muscle neoplasm;uterine corpus smooth muscle neoplasm;exactmatch
uterine corpus myxoid leiomyosarcoma;uterine corpus myxoid leiomyosarcoma;exactmatch
benign metastasizing leiomyoma of the uterine corpus;benign metastasizing leiomyoma of the uterine corpus;exactmatch
uterine corpus epithelioid leiomyoma;uterine corpus epithelioid leiomyoma;exactmatch
uterine corpus dissecting leiomyoma;cotyledonoid dissecting leiomyoma;exactmatch
uterine corpus diffuse leiomyomatosis;uterine corpus diffuse leiomyomatosis;exactmatch
breast ductal carcinoma;breast ductal carcinoma;exactmatch
uterine corpus lipoleiomyoma;uterine corpus lipoleiomyoma;exactmatch
uterine corpus bizarre leiomyoma;uterine corpus bizarre leiomyoma;exactmatch
uterine corpus myxoid leiomyoma;uterine corpus myxoid leiomyoma;exactmatch
uterine corpus apoplectic leiomyoma;uterine corpus apoplectic leiomyoma;exactmatch
uterine ligament papillary cystadenoma associated with von hippel-lindau disease;uterine ligament papillary cystadenoma associated with von hippel-lindau disease;exactmatch
wolffian adnexal tumor;wolffian adnexal neoplasm;exactmatch
borderline uterine ligament neoplasm;borderline uterine ligament neoplasm;exactmatch
borderline fallopian tube mucinous tumor;borderline fallopian tube mucinous neoplasm;exactmatch
fallopian tube serous cystadenofibroma;fallopian tube cystadenofibroma;exactmatch
fallopian tube serous adenofibroma;fallopian tube adenofibroma;exactmatch
fallopian tube papilloma;fallopian tube papilloma;exactmatch
fallopian tube endometrioid tumor;fallopian tube endometrioid neoplasm;exactmatch
borderline fallopian tube endometrioid tumor;borderline fallopian tube endometrioid neoplasm;exactmatch
adult medulloblastoma;adult brain medulloblastoma;exactmatch
fallopian tube mucinous neoplasm;fallopian tube mucinous neoplasm;exactmatch
borderline fallopian tube serous tumor/atypical proliferative serous tumor;borderline fallopian tube serous neoplasm;exactmatch
adult oligodendroglioma;adult oligodendroglioma;exactmatch
borderline fallopian tube neoplasm;borderline fallopian tube neoplasm;exactmatch
stage 0 fallopian tube cancer ajcc v7;fallopian tube carcinoma in situ;exactmatch
fallopian tube transitional cell carcinoma;fallopian tube transitional cell cancer;exactmatch
fallopian tube mucinous adenocarcinoma;fallopian tube mucinous adenocarcinoma;exactmatch
fallopian tube serous neoplasm;fallopian tube serous neoplasm;exactmatch
serous adenocarcinoma;serous adenocarcinoma;exactmatch
adult craniopharyngioma;adult craniopharyngioma;exactmatch
fallopian tube endometrioid polyp;fallopian tube endometrioid adenomatous polyp;exactmatch
fallopian tube metaplastic papillary tumor;fallopian tube metaplastic papillary tumor;exactmatch
stage iv lung non-small cell cancer ajcc v7;stage iv lung non-small cell cancer ajcc v7;exactmatch
pelvic pain;pelvic pain;exactmatch
uterine ligament clear cell adenocarcinoma;uterine ligament clear cell adenocarcinoma;exactmatch
uterine ligament endometrioid adenocarcinoma;uterine ligament endometrioid adenocarcinoma;exactmatch
uterine ligament mucinous adenocarcinoma;uterine ligament mucinous adenocarcinoma;exactmatch
uterine ligament serous adenocarcinoma;uterine ligament serous adenocarcinoma;exactmatch
uterine ligament adenocarcinoma;uterine ligament adenocarcinoma;exactmatch
uterine ligament neoplasm;neoplasm of the uterine ligament;exactmatch
fallopian tube teratoma;fallopian tube teratoma;exactmatch
fallopian tube germ cell tumor;fallopian tube germ cell neoplasm;exactmatch
malignant head and neck neoplasm;cancer of head and neck;exactmatch
fallopian tube adenomatoid tumor;fallopian tube adenomatoid tumor;exactmatch
fallopian tube leiomyosarcoma;fallopian tube leiomyosarcoma;exactmatch
fallopian tube leiomyoma;fallopian tube leiomyoma;exactmatch
fallopian tube soft tissue neoplasm;fallopian tube soft tissue neoplasm;exactmatch
fallopian tube adenosarcoma;fallopian tube adenosarcoma;exactmatch
fallopian tube carcinosarcoma;fallopian tube carcinosarcoma;exactmatch
peritoneal gastrointestinal stromal tumor;peritoneal gastrointestinal stromal tumor;exactmatch
recurrent laryngeal carcinoma;recurrent carcinoma of larynx;exactmatch
intradural extramedullary spinal canal space;intradural extramedullary spinal canal space;exactmatch
trichilemmoma;tricholemmoma, benign;exactmatch
hematopoietic and lymphoid tissue;hemolymphoreticular tissue;exactmatch
hematopoietic and lymphatic system part;hematopoietic and lymphatic system part;exactmatch
hematopoietic and lymphatic system;hematopoietic and lymphatic system;exactmatch
stage 0 transitional cell carcinoma;stage 0 transitional cell carcinoma;exactmatch
transitional cell papilloma;papilloma, transitional cell, benign;exactmatch
pilomatrical carcinoma;invasive pilomatrixoma;exactmatch
amyloidoma;amyloidoma;exactmatch
trichofolliculoma;trichofolliculoma;exactmatch
immature granulocytes in peripheral blood under 10 percent;immature granulocytes in peripheral blood less than 10 percent;exactmatch
intraepidermal epithelioma of jadassohn;borst-jadassohn intraepidermal carcinoma;exactmatch
skin fibroepithelial basal cell carcinoma;basal cell carcinoma, fibroepithelial;exactmatch
superficial multifocal basal cell carcinoma;multicentric basal cell carcinoma;exactmatch
evi1-aml1 fusion protein expression;evi1-aml1 fusion protein expression;exactmatch
leukemic lymphocyte;leukemic lymphocyte;exactmatch
leukemic plasma cell;leukemic plasma cell;exactmatch
leukemic natural killer cell;leukemic natural killer cell;exactmatch
sinonasal papilloma;schneiderian papilloma;exactmatch
monoclonal eosinophils present;clonal eosinophils present;exactmatch
granulocytes increased in bone marrow;granulocytes increased in bone marrow;exactmatch
increased red cell mass;increased rcm;exactmatch
marked bone marrow fibrosis;marked bone marrow fibrosis;exactmatch
metastatic adenocarcinoma;adenocarcinoma, metastatic, nos;exactmatch
minimal reticulin fibrosis of the bone marrow;minimal reticulin fibrosis of the bone marrow;exactmatch
overt primary myelofibrosis;chronic idiopathic myelofibrosis, fibrotic stage;exactmatch
prefibrotic/early primary myelofibrosis;chronic idiopathic myelofibrosis, cellular phase;exactmatch
osteosclerosis;osteosclerosis;exactmatch
extramedullary hematopoiesis;extramedullary hematopoiesis;exactmatch
polycythemia vera, post-polycythemic myelofibrosis phase;"polycythemia vera, ""spent"" phase";exactmatch
monoclonal cellular population present;clonal;exactmatch
polycythemia vera, polycythemic phase;polycythemia vera, polycythemic phase;exactmatch
charcot-leyden crystals formation;charcot-leyden crystals formation;exactmatch
adenocarcinoma in situ;ais;exactmatch
papillary transitional cell carcinoma;papillary transitional carcinoma;exactmatch
basaloid carcinoma;basaloid carcinoma;exactmatch
sarcomatoid transitional cell carcinoma;sarcomatoid transitional cell carcinoma;exactmatch
inverted transitional cell papilloma;inverted transitional cell papilloma;exactmatch
nasopharyngeal-type undifferentiated carcinoma;lymphoepithelial carcinoma;exactmatch
leukemic medium-sized b-lymphocyte with basophilic cytoplasm;leukemic medium-sized b-lymphocyte with basophilic cytoplasm;exactmatch
leukemic small lymphocyte with clumped chromatin;leukemic small lymphocyte with clumped chromatin;exactmatch
germinal centers with prominent hyalinized vessels present;germinal centers with prominent hyalinized vessels present;exactmatch
neoplastic plasma cells under 10 percent of bone marrow nucleated cells;neoplastic plasma cells less than 10 percent of bone marrow nucleated cells;exactmatch
neoplastic plasma cells present in bone marrow;neoplastic plasma cells present in bone marrow;exactmatch
papillary squamous cell carcinoma;papillary epidermoid carcinoma;exactmatch
osteosclerotic lesion;osteosclerotic lesion;exactmatch
verrucous papilloma;verrucous papilloma;exactmatch
qualifier;modifier;exactmatch
sheets of interfollicular plasma cells present;sheets of interfollicular plasma cells present;exactmatch
reactive germinal centers present;reactive germinal centers present;exactmatch
neoplastic myeloid cell;neoplastic myeloid cell;exactmatch
atypical histiocyte;atypical histiocyte;exactmatch
immunophenotypic finding;immunophenotypic finding;exactmatch
cd14-positive neoplastic cells present;cd14-positive neoplastic cells present;exactmatch
cd68-positive neoplastic cells present;cd68-positive neoplastic cells present;exactmatch
s-100-positive neoplastic cells present;s-100-positive neoplastic cells present;exactmatch
massive sinusoidal histiocytic infiltrate;massive sinusoidal histiocytic infiltrate;exactmatch
plasmacytic infiltrate;plasmacytic infiltrate;exactmatch
neoplastic plasma cells between 10 and 30 percent of bone marrow nucleated cells;neoplastic plasma cells between 10 and 30 percent of bone marrow nucleated cells;exactmatch
neoplastic plasma cells more than 30 percent of bone marrow nucleated cells;neoplastic plasma cells greater than 30 percent of bone marrow nucleated cells;exactmatch
monoclonal paraproteinemia present in lower than myeloma levels;monoclonal paraproteinemia present in lower than myeloma levels;exactmatch
neoplastic plasma cells 10 percent or more of bone marrow nucleated cells;neoplastic plasma cells 10 percent or more of bone marrow nucleated cells;exactmatch
bone marrow stem cell at the earliest stage of myeloid differentiation;bone marrow stem cell at the earliest stage of myeloid differentiation;exactmatch
bone marrow stem cell with predominant neutrophil differentiation;bone marrow stem cell with predominant neutrophil differentiation;exactmatch
pseudoglandular squamous cell carcinoma;adenoid squamous carcinoma;exactmatch
multipotent bone marrow stem cell;bone marrow stem cell with variable lineage potential;exactmatch
solitary mass;solitary mass;exactmatch
keratinizing squamous cell carcinoma;keratinizing squamous cell carcinoma;exactmatch
immunoglobulin heavy chain deposition;immunoglobulin heavy chain deposition;exactmatch
immunoglobulin light chain deposition;immunoglobulin light chain deposition;exactmatch
immunoglobulin deposition;immunoglobulin deposition;exactmatch
solitary lytic metastatic bone lesion;solitary lytic metastatic bone lesion;exactmatch
lytic bone lesion;lytic bone lesion;exactmatch
metastatic squamous cell carcinoma;metastatic squamous cell carcinoma;exactmatch
localized lesion;localized lesion;exactmatch
neoplastic plasma cells under 20 percent of bone marrow nucleated cells;neoplastic plasma cells less than 20 percent of bone marrow nucleated cells;exactmatch
bone marrow-homing plasma cell;bone marrow-homing plasma cell;exactmatch
blasts under 10 percent of peripheral blood white cells;blasts less than 10 percent of peripheral blood white cells;exactmatch
pancreatic non-invasive mucinous cystadenocarcinoma;mucinous cystadenocarcinoma, non-invasive;exactmatch
cervical lymphadenopathy;cervical lymphadenopathy;exactmatch
perineural cell;perineural cell;exactmatch
nodular lesion;nodular lesion;exactmatch
loss of merlin expression;loss of merlin expression;exactmatch
unicystic lesion;unicystic lesion;exactmatch
multilocular lesion;multicystic lesion;exactmatch
cystic lesion;cystic lesion;exactmatch
villous adenocarcinoma;villous adenocarcinoma;exactmatch
vater-pacini corpuscles-like structures present;vater-pacini corpuscles-like structures present;exactmatch
melanosomes present;melanosomes present;exactmatch
cellular neurofibroma;cellular neurofibroma;exactmatch
pseudo-onion bulbs formation;pseudo-onion bulbs formation;exactmatch
neoplastic perineural cell;neoplastic perineural cell;exactmatch
neuroepithelial cell;neuroepithelial cell;exactmatch
adenocarcinoma in villous adenoma;adenocarcinoma in villous adenoma;exactmatch
neuroepithelial tissue;neuroepithelial tissue;exactmatch
neoplastic neuroepithelial cell and neoplastic perineural cell;neoplastic neuroepithelial cell and neoplastic perineural cell;exactmatch
perineural tissue;perineural tissue;exactmatch
atypical neurofibroma;atypical neurofibroma;exactmatch
increased cellularity present;cellularity, increased;exactmatch
pancreatic mucinous-cystic neoplasm with an associated invasive carcinoma;pancreatic invasive mucinous cystadenocarcinoma;exactmatch
adenocarcinoma in situ in tubulovillous adenoma;adenocarcinoma in situ in tubulovillous adenoma;exactmatch
adenocarcinoma in tubulovillous adenoma;adenocarcinoma in tubulovillous adenoma;exactmatch
epidural spinal canal space;epidural space;exactmatch
subependymal tissue;subependymal tissue;exactmatch
visual pathway;visual pathway;exactmatch
secondary lesion;secondary lesion;exactmatch
nerve tissue and nerve sheaths;nerve tissue and nerve sheaths;exactmatch
perineurial cell;perineurial cell;exactmatch
nerve sheath;nerve sheath;exactmatch
absence of malignant features;absence of malignant features;exactmatch
malignant epithelioid cell;malignant epithelioid cell;exactmatch
malignant perineural cell;malignant perineural cell;exactmatch
geographic necrosis;geographic necrosis;exactmatch
pseudoencapsulated mass;pseudoencapsulated mass;exactmatch
thick-walled hyalinized vessels present;thick-walled hyalinized vessels present;exactmatch
peripheral nerve schwannoma;peripheral nerve schwannoma;exactmatch
tubulovillous adenoma;gi tract tubulovillous adenoma;exactmatch
nerve tissue, neuroepithelial tissue, and nerve sheaths;nerve tissue, neuroepithelial tissue, and nerve sheaths;exactmatch
neuron, neuroepithelial cell, and supporting cell of the nervous system;nerve cell, neuroepithelial cell, and supporting cell of the nervous system;exactmatch
absence of bone marrow dysplasia;absence of bone marrow dysplasia;exactmatch
bile duct mucinous cystic neoplasm with an associated invasive carcinoma;bile duct cystadenocarcinoma;exactmatch
kras gene mutation;k-ras mutation;exactmatch
adenocarcinoma in multiple adenomatous polyps;adenocarcinoma in multiple adenomatous polyps;exactmatch
multiple adenomatous polyps;gi tract multiple adenomatous polyps;exactmatch
adenocarcinoma in adenomatous polyposis coli;adenocarcinoma in adenomatous polyposis coli;exactmatch
tubular adenoma;adenoma, tubular cell, benign;exactmatch
electrocardiographic finding;ecg finding;exactmatch
fibrolamellar carcinoma;flc;exactmatch
bile duct mucinous cystic neoplasm;bile duct cystadenoma;exactmatch
elevated serum lysozyme;elevated serum lysozyme;exactmatch
diffuse type adenocarcinoma;adenocarcinoma, diffuse type;exactmatch
intestinal-type adenocarcinoma;adenocarcinoma, intestinal type;exactmatch
pancreatic intraductal papillary-mucinous neoplasm, high grade;pancreatic intraductal papillary mucinous neoplasm with high grade dysplasia;exactmatch
superficial spreading adenocarcinoma;superficial spreading adenocarcinoma;exactmatch
pancreatic intraductal papillary-mucinous neoplasm, low grade;pancreatic intraductal papillary mucinous neoplasm with low grade dysplasia;exactmatch
pancreatic serous neoplasm;pancreatic serous cystic neoplasm;exactmatch
pancreatic mucinous-cystic neoplasm;pancreatic mucinous cystic neoplasm;exactmatch
drug exposure;drug exposure;exactmatch
map2k4 gene inactivation;map2k4 gene inactivation;exactmatch
akt2 gene amplification;akt2 gene amplification;exactmatch
solid carcinoma;solid carcinoma;exactmatch
myeloblasts under 10 percent of peripheral blood white cells;myeloblasts less than 10 percent of peripheral blood white cells;exactmatch
blasts 10-19 percent of bone marrow nucleated cells;blasts 10-19 percent of bone marrow nucleated cells;exactmatch
blasts 5-19 percent of peripheral blood white cells;blasts 5-19 percent of peripheral blood white cells;exactmatch
alveolar adenoma;adenoma, bronchioloalveolar, benign;exactmatch
blasts under 5 percent of peripheral blood white cells;blasts less than 5 percent of peripheral blood white cells;exactmatch
blasts under 10 percent of bone marrow nucleated cells;blasts less than 10 percent of bone marrow nucleated cells;exactmatch
blasts under 20 percent of bone marrow nucleated cells;blasts less than 20 percent of bone marrow nucleated cells;exactmatch
combined carcinoid and adenocarcinoma;adenocarcinoid neoplasm;exactmatch
etv6-pdgfrb fusion protein expression;etv6-pdgfrb fusion protein expression;exactmatch
nras gene mutation;n-ras gene mutation;exactmatch
fgf6 gene amplification;fgf6 gene amplification;exactmatch
appendix neuroendocrine tumor g1;appendiceal carcinoid tumor;exactmatch
fgf4 gene amplification;fgf-4 gene amplification;exactmatch
del(3p25);del(3p25);exactmatch
loss of chromosome 12;loss of chromosome 12;exactmatch
small cell intermediate cell carcinoma;small cell cancer, intermediate cell type;exactmatch
abnormal large granular lymphocyte;abnormal large granular lymphocyte;exactmatch
omentum gastrointestinal stromal tumor;omentum gastrointestinal stromal tumor;exactmatch
breast malignant myoepithelioma;breast malignant myoepithelioma;exactmatch
breast fibroepithelial neoplasm;breast fibroepithelial neoplasm;exactmatch
breast granular cell tumor;breast granular cell tumor;exactmatch
buccal mucosa squamous cell carcinoma;buccal mucosa squamous cell carcinoma;exactmatch
breast leiomyoma;breast leiomyoma;exactmatch
breast inflammatory myofibroblastic tumor;breast inflammatory myofibroblastic tumor;exactmatch
breast myofibroblastoma;breast myofibroblastoma;exactmatch
breast hemangiopericytoma;breast hemangiopericytoma;exactmatch
salivary gland myoepithelial tumor;salivary gland myoepithelial neoplasm;exactmatch
kidney wilms tumor;embryonal nephroma;exactmatch
myoepithelial tumor;myoepithelial neoplasm;exactmatch
adenocarcinoma of unknown primary;adenocarcinoma of unknown primary;exactmatch
breast myoepithelial tumor;breast myoepithelial neoplasm;exactmatch
breast periductal myoepitheliosis;breast periductal myoepitheliosis;exactmatch
breast intraductal myoepitheliosis;breast intraductal myoepitheliosis;exactmatch
breast atypical myoepitheliosis;atypical breast myoepitheliosis;exactmatch
breast myoepitheliosis;breast myoepitheliosis;exactmatch
breast soft tissue neoplasm;breast soft tissue neoplasm;exactmatch
breast pleomorphic adenoma;breast pleomorphic adenoma;exactmatch
ovarian malignant mesothelioma;ovarian malignant mesothelioma;exactmatch
braf gene mutation;b-raf gene mutation;exactmatch
gestational ovarian choriocarcinoma;gestational ovarian choriocarcinoma;exactmatch
ovarian small cell carcinoma, pulmonary-type;ovarian small cell carcinoma, pulmonary-type;exactmatch
laryngeal squamous cell carcinoma;epidermoid carcinoma of larynx;exactmatch
ovarian small cell carcinoma, hypercalcemic type;ovarian small cell carcinoma, hypercalcemic type;exactmatch
ovarian sex cord-stromal tumor associated with peutz-jeghers syndrome;ovarian sex cord-stromal tumor associated with peutz-jeghers syndrome;exactmatch
potter syndrome;oligohydramnios sequence;exactmatch
juvenile type bilateral ovarian granulosa cell tumor;juvenile type bilateral ovarian granulosa cell tumor;exactmatch
hypopharyngeal squamous cell carcinoma;epidermoid carcinoma of hypopharynx;exactmatch
salivary gland pleomorphic adenoma;benign mixed salivary gland neoplasm;exactmatch
mesenchymal hamartoma;mesenchymal hamartoma;exactmatch
cartilaginous hamartoma;cartilaginous hamartoma;exactmatch
protein cycling pathway;protein cycling pathway;exactmatch
lip squamous cell carcinoma;lip scc;exactmatch
salivary gland myoepithelial cell;salivary gland myoepithelial cell;exactmatch
salivary gland carcinoma ex pleomorphic adenoma;salivary gland carcinoma ex pleomorphic adenoma;exactmatch
floor of mouth squamous cell carcinoma;floor of mouth scc;exactmatch
breast ductal adenoma;breast ductal adenoma;exactmatch
breast apocrine adenoma;breast apocrine adenoma;exactmatch
breast adenoma;breast adenoma;exactmatch
breast carcinoma with melanotic features;breast carcinoma with melanotic features;exactmatch
myelodysplastic syndrome with ring sideroblasts;mds-rs;exactmatch
breast squamous cell carcinoma, acantholytic variant;breast squamous cell carcinoma, acantholytic variant;exactmatch
breast squamous cell carcinoma, spindle cell variant;breast squamous cell carcinoma, spindle cell variant;exactmatch
breast squamous cell carcinoma, large cell keratinizing variant;breast squamous cell carcinoma, large cell keratinizing variant;exactmatch
breast large cell neuroendocrine carcinoma;breast large cell neuroendocrine carcinoma;exactmatch
breast columnar cell mucinous carcinoma;breast columnar cell mucinous adenocarcinoma;exactmatch
breast mucinous cystadenocarcinoma;breast mucinous cystadenocarcinoma;exactmatch
breast carcinoma with choriocarcinomatous features;breast carcinoma with choriocarcinomatous features;exactmatch
breast angiomatosis;breast angiomatosis;exactmatch
thyroid gland papillary carcinoma;ptc;exactmatch
breast carcinoma with osteoclast-like stromal giant cells;breast carcinoma with osteoclast-like stromal giant cells;exactmatch
breast mixed carcinoma;breast mixed carcinoma;exactmatch
testicular germ cell neoplasia in situ;gcnis;exactmatch
hypertriploidy;hypertriploidy;exactmatch
hypotriploidy;hypotriploidy;exactmatch
hypospadias;hypospadias;exactmatch
breast adenocarcinoma with spindle cell metaplasia;breast adenocarcinoma with spindle cell metaplasia;exactmatch
breast adenosquamous carcinoma;adenosquamous breast carcinoma;exactmatch
low grade breast adenosquamous carcinoma;infiltrating breast syringomatous adenoma;exactmatch
nipple syringomatous tumor;infiltrating nipple syringomatous adenoma;exactmatch
lung carcinoid tumor;carcinoid tumor of lung;exactmatch
angiosarcoma of the skin of the arm after radical mastectomy followed by lymphedema;angiosarcoma of the skin of the arm after radical mastectomy followed by lymphedema;exactmatch
postradiation breast angiosarcoma;post-radiotherapy breast angiosarcoma;exactmatch
breast follicular lymphoma;breast follicular lymphoma;exactmatch
breast burkitt lymphoma;breast burkitt lymphoma;exactmatch
breast diffuse large b-cell lymphoma;breast dlbcl;exactmatch
microinvasive breast carcinoma;dcism;exactmatch
synchronous bilateral breast carcinoma;synchronous bilateral breast carcinoma;exactmatch
acute myeloid leukemia arising from previous myelodysplastic syndrome;aml/mds;exactmatch
breast sebaceous carcinoma;breast sebaceous carcinoma;exactmatch
glycogen-rich, clear cell breast carcinoma;breast glycogen-rich carcinoma;exactmatch
breast acinic cell carcinoma;acinic cell breast carcinoma;exactmatch
breast oncocytic carcinoma;breast oncocytic carcinoma;exactmatch
breast lipid-rich carcinoma;breast lipid-rich carcinoma;exactmatch
breast mixed epithelial/mesenchymal metaplastic carcinoma;breast carcinosarcoma;exactmatch
ovarian wilms tumor;ovarian nephroblastoma;exactmatch
childhood oligodendroglioma;childhood oligodendroglioma;exactmatch
angiocentric immunoproliferative lesion;ail;exactmatch
ovarian endometriotic cyst;endometrioma of ovary;exactmatch
cell migration inhibition process;cell migration inhibition;exactmatch
centroblastic lymphoma;centroblastic lymphoma;exactmatch
meningeal sarcoma;meningeal sarcoma;exactmatch
negative regulation of cell death;cell death inhibition;exactmatch
mesonephric adenocarcinoma;malignant mesonephroma;exactmatch
positive regulation of cell death;cell death induction;exactmatch
xanthoma;xanthoma;exactmatch
protein degradation inhibition;protein degradation inhibition;exactmatch
cell membrane process;cell membrane alteration;exactmatch
trabecular adenocarcinoma;trabecular adenocarcinoma;exactmatch
ectopic hormone secretion syndrome associated with neoplasia;ectopic hormone secretion syndrome associated with neoplasia;exactmatch
eicosanoid modulation;eicosanoid modulation;exactmatch
prostatic intraepithelial neoplasia;pin;exactmatch
myomatous neoplasm;muscle neoplasm;exactmatch
eyelid papilloma;eyelid papilloma;exactmatch
ovarian cystadenoma;benign cystadenoma of ovary;exactmatch
intercellular communication induction;intercellular communication induction;exactmatch
cytoskeletal process;cytoskeletal process;exactmatch
hereditary fallopian tube carcinoma;familial fallopian tube carcinoma;exactmatch
polyposis;multiple polyps;exactmatch
testicular polyembryoma;polyembryoma of testis;exactmatch
testicular seminoma, tubular variant;testicular seminoma, tubular variant;exactmatch
testicular seminoma, pseudoglandular variant;testicular seminoma, pseudoglandular variant;exactmatch
testicular seminoma, cribriform variant;testicular seminoma, cribriform variant;exactmatch
pleomorphic carcinoma;pleomorphic carcinoma;exactmatch
benign epithelial neoplasm;benign epithelial neoplasm;exactmatch
malignant giant cell neoplasm;giant cell tumor, malignant;exactmatch
dysplasia;dyscrasia;exactmatch
perforation;perforation;exactmatch
antimicrobial effect;antimicrobial effect;exactmatch
lymphocyte activation process;lymphocyte activation;exactmatch
hyperplastic polyp;hp;exactmatch
signal transduction induction;signal transduction induction;exactmatch
glucose transport induction;glucose transport induction;exactmatch
lipogranuloma;lipogranuloma;exactmatch
chromatin structural process;chromatin structural process;exactmatch
ann arbor stage iva hodgkin lymphoma;ann arbor stage iva hodgkin lymphoma;exactmatch
ann arbor stage iiib hodgkin lymphoma;ann arbor stage iiib hodgkin lymphoma;exactmatch
enzyme inhibition;enzyme inhibition;exactmatch
alkylation process;alkylation;exactmatch
oligoastrocytoma;glioma, mixed, benign;exactmatch
anaplastic ependymoma;anaplastic ependymal neoplasm;exactmatch
cytokine receptor binding;cytokine receptor binding;exactmatch
chelating activity;chelating;exactmatch
childhood pilocytic astrocytoma;childhood pilocytic astrocytoma;exactmatch
antigen binding;antigen binding;exactmatch
pilocytic astrocytoma;grade i astrocytic neoplasm;exactmatch
calcifying odontogenic cyst;coc;exactmatch
enzyme activity alteration;enzyme activity alteration;exactmatch
turcot syndrome type 2;turcot syndrome type 2;exactmatch
turcot syndrome type 1;turcot syndrome type 1;exactmatch
tsc1 gene inactivation;hamartin gene inactivation;exactmatch
cerebral calcification;cerebral calcification;exactmatch
cafe au lait spot;cafe au lait patch;exactmatch
aids-related malignant neoplasm;aids related cancer;exactmatch
atm gene mutation;a-t mutated gene mutation;exactmatch
anaplastic (malignant) meningioma;anaplastic (malignant) meningioma;exactmatch
ion transport process;ion transport alteration;exactmatch
leukotriene receptor binding;leukotriene receptor binding;exactmatch
vulvar squamous cell carcinoma;epidermoid carcinoma of vulva;exactmatch
rel gene amplification;rel gene amplification;exactmatch
esophageal polyp;esophageal polyp;exactmatch
transformed neoplastic lymphocyte;transformed neoplastic lymphocyte;exactmatch
transformed phase of disease;transformed phase of disease;exactmatch
exophytic polypoid lesion;exophytic polypoid lesion;exactmatch
intraocular lesion;intraocular lesion;exactmatch
primary lesion;primary lesion;exactmatch
metastatic lesion;metastatic lesion;exactmatch
morphologic overlap;morphologic overlap;exactmatch
composite lesion;composite lesion;exactmatch
cdk4 gene inactivation;cdk4 gene inactivation;exactmatch
benign meningioma;benign meningioma;exactmatch
anal condyloma;anal condyloma;exactmatch
receptor binding;receptor binding;exactmatch
nucleic acid binding;nucleic acid binding;exactmatch
dense collagenized tissue present;dense collagenized tissue present;exactmatch
absence of invasion or limited invasion present;absence of invasion or limited invasion present;exactmatch
flattened neoplastic mesothelial cell;flattened neoplastic mesothelial cell;exactmatch
secondary central nervous system lymphoma;secondary central nervous system lymphoma;exactmatch
stage iiib appendix carcinoma ajcc v7;stage iiib appendix cancer;exactmatch
stage iiia appendix carcinoma ajcc v7;stage iiia appendix cancer;exactmatch
stage iic appendix carcinoma ajcc v7;stage iic appendix cancer;exactmatch
stage iib appendix carcinoma ajcc v7;stage iib appendix cancer;exactmatch
recurrent chondrosarcoma;chondrosarcoma, recurrent;exactmatch
stage iia appendix carcinoma ajcc v7;stage iia appendix cancer;exactmatch
stage i appendix carcinoma ajcc v7;stage i appendix cancer;exactmatch
stage iiib small intestinal cancer ajcc v7;stage iiib small intestinal cancer;exactmatch
stage iva appendix carcinoma ajcc v7;stage iva appendix cancer;exactmatch
stage iiia small intestinal cancer ajcc v7;stage iiia small intestinal cancer;exactmatch
stage iib small intestinal cancer ajcc v7;stage iib small intestinal cancer;exactmatch
stage iia small intestinal cancer ajcc v7;stage iia small intestinal cancer;exactmatch
metastatic chondrosarcoma;chondrosarcoma, metastatic;exactmatch
stage iiic esophageal squamous cell carcinoma ajcc v7;stage iiic esophageal squamous cell cancer;exactmatch
stage iiib esophageal squamous cell carcinoma ajcc v7;stage iiib esophageal squamous cell cancer;exactmatch
stage iiia esophageal squamous cell carcinoma ajcc v7;stage iiia esophageal squamous cell cancer;exactmatch
stage iiic appendix carcinoma ajcc v7;stage iiic appendix cancer;exactmatch
stage ivb appendix carcinoma ajcc v7;stage ivb appendix cancer;exactmatch
stage iiib esophageal adenocarcinoma ajcc v7;stage iiib esophageal adenocarcinoma;exactmatch
stage iiia colorectal cancer ajcc v7;stage iiia colorectal (colon or rectal) cancer;exactmatch
stage ib gastric gastrointestinal stromal tumor;stage ib gastric (stomach) gastrointestinal stromal tumor (gist);exactmatch
stage ia gastric gastrointestinal stromal tumor;stage ia gastric (stomach) gastrointestinal stromal tumor (gist);exactmatch
stage ivb colorectal cancer ajcc v7;stage ivb colorectal (colon or rectal) cancer;exactmatch
stage ii acral lentiginous melanoma ajcc v6 and v7;stage ii acral lentiginous melanoma;exactmatch
stage iva colorectal cancer ajcc v7;stage iva colorectal (colon or rectal) cancer;exactmatch
stage iiic colorectal cancer ajcc v7;stage iiic colorectal (colon or rectal) cancer;exactmatch
stage iiib colorectal cancer ajcc v7;stage iiib colorectal (colon or rectal) cancer;exactmatch
stage iic colorectal cancer ajcc v7;stage iic colorectal (colon or rectal) cancer;exactmatch
stage ivc appendix carcinoma ajcc v7;stage ivc appendix cancer;exactmatch
stage iib colorectal cancer ajcc v7;stage iib colorectal (colon or rectal) cancer;exactmatch
stage iia colorectal cancer ajcc v7;stage iia colorectal (colon or rectal) cancer;exactmatch
stage iv appendix neuroendocrine tumor ajcc v7;stage iv appendix carcinoid tumor;exactmatch
stage iii appendix neuroendocrine tumor ajcc v7;stage iii appendix carcinoid tumor;exactmatch
stage ii appendix neuroendocrine tumor ajcc v7;stage ii appendix carcinoid tumor;exactmatch
stage i acral lentiginous melanoma ajcc v7;stage i acral lentiginous melanoma;exactmatch
stage i appendix neuroendocrine tumor ajcc v7;stage i appendix carcinoid tumor;exactmatch
stage iiic esophageal adenocarcinoma ajcc v7;stage iiic esophageal adenocarcinoma;exactmatch
stage iiia esophageal adenocarcinoma ajcc v7;stage iiia esophageal adenocarcinoma;exactmatch
stage iv chronic lymphocytic leukemia;cll stage iv;exactmatch
stage iv lung large cell carcinoma ajcc v7;stage iv large cell carcinoma of lung;exactmatch
stage 0 lung squamous cell carcinoma ajcc v6 and v7;epidermoid cell carcinoma in situ of lung;exactmatch
stage iv lung adenocarcinoma ajcc v7;lung adenocarcinoma, stage iv;exactmatch
stage iii lung adenocarcinoma ajcc v7;lung adenocarcinoma stage iii;exactmatch
stage ii lung adenocarcinoma ajcc v7;lung adenocarcinoma stage ii;exactmatch
stage i lung adenocarcinoma ajcc v7;lung adenocarcinoma, stage i;exactmatch
stage 0 lung adenocarcinoma ajcc v6 and v7;adenocarcinoma in situ of lung;exactmatch
recurrent lung adenocarcinoma;lung adenocarcinoma, recurrent;exactmatch
stage ivc thyroid gland anaplastic carcinoma ajcc v7;stage ivc thyroid gland anaplastic carcinoma ajcc v7;exactmatch
stage ii lung squamous cell carcinoma ajcc v7;lung squamous cell carcinoma stage ii;exactmatch
stage ivb thyroid gland anaplastic carcinoma ajcc v7;stage ivb thyroid gland anaplastic carcinoma ajcc v7;exactmatch
stage iva thyroid gland anaplastic carcinoma ajcc v7;stage iva thyroid gland anaplastic carcinoma ajcc v7;exactmatch
stage ivc thyroid gland medullary carcinoma ajcc v7;stage ivc thyroid gland medullary cancer;exactmatch
stage ivb thyroid gland medullary carcinoma ajcc v7;stage ivb thyroid gland medullary cancer;exactmatch
stage i lung large cell carcinoma ajcc v7;stage i large cell carcinoma of lung;exactmatch
stage iva thyroid gland medullary carcinoma ajcc v7;stage iva thyroid gland medullary cancer;exactmatch
stage ivc differentiated thyroid gland carcinoma ajcc v7;stage ivc differentiated thyroid gland cancer;exactmatch
stage i lung squamous cell carcinoma ajcc v7;stage i epidermoid cell carcinoma of lung;exactmatch
stage iii lung squamous cell carcinoma ajcc v7;lung squamous cell carcinoma stage iii;exactmatch
stage ib esophageal adenocarcinoma ajcc v7;stage ib esophageal adenocarcinoma;exactmatch
stage iia gastric cancer ajcc v7;stage iia gastric (stomach) cancer;exactmatch
stage ia esophageal adenocarcinoma ajcc v7;stage ia esophageal adenocarcinoma;exactmatch
stage ib esophageal squamous cell carcinoma ajcc v7;stage ib esophageal squamous cell cancer;exactmatch
stage ia esophageal squamous cell carcinoma ajcc v7;stage ia esophageal squamous cell cancer;exactmatch
localized chondrosarcoma;chondrosarcoma, localized;exactmatch
cancer stage (antiquated);cancer stage (antiquated);exactmatch
stage iiic gastric cancer ajcc v7;stage iiic gastric (stomach) cancer;exactmatch
stage iib gastric cancer ajcc v7;stage iib gastric (stomach) cancer;exactmatch
peripheral primitive neuroectodermal tumor of bone;bone peripheral neuroepithelioma;exactmatch
stage iv lung squamous cell carcinoma ajcc v7;stage iv epidermoid cell carcinoma of lung;exactmatch
stage iv lung cancer ajcc v6;stage iv carcinoma of lung ajcc v6;exactmatch
stage iii lung cancer ajcc v6;stage iii carcinoma of lung ajcc v6;exactmatch
stage i lung cancer ajcc v6;stage i carcinoma of lung ajcc v6;exactmatch
stage iv pharyngeal cancer;pharyngeal cancer stage iv;exactmatch
stage iii pharyngeal cancer;pharyngeal cancer stage iii;exactmatch
stage ii pharyngeal cancer;pharyngeal cancer stage ii;exactmatch
stage i pharyngeal cancer;pharyngeal cancer stage i;exactmatch
stage ii gastric gastrointestinal stromal tumor;stage ii gastric (stomach) gastrointestinal stromal tumor (gist);exactmatch
stage iiia gastric gastrointestinal stromal tumor;stage iiia gastric (stomach) gastrointestinal stromal tumor (gist);exactmatch
stage iiib gastric gastrointestinal stromal tumor;stage iiib gastric (stomach) gastrointestinal stromal tumor (gist);exactmatch
stage iva hilar cholangiocarcinoma ajcc v7;stage iva hilar cholangiocarcinoma;exactmatch
stage ib distal bile duct cancer ajcc v7;stage ib distal bile duct cancer;exactmatch
stage ia distal bile duct cancer ajcc v7;stage ia distal bile duct cancer;exactmatch
localized extraskeletal osteosarcoma;extraskeletal osteosarcoma, nonmetastatic;exactmatch
stage 0 distal bile duct cancer ajcc v7;stage 0 distal bile duct cancer;exactmatch
metastatic extraskeletal osteosarcoma;extraskeletal osteosarcoma, metastatic;exactmatch
recurrent extraskeletal myxoid chondrosarcoma;extraskeletal myxoid chondrosarcoma, recurrent;exactmatch
stage ivb hilar cholangiocarcinoma ajcc v7;stage ivb hilar cholangiocarcinoma;exactmatch
stage iiib hilar cholangiocarcinoma ajcc v7;stage iiib hilar cholangiocarcinoma;exactmatch
stage iib distal bile duct cancer ajcc v7;stage iib distal bile duct cancer;exactmatch
stage iiia hilar cholangiocarcinoma ajcc v7;stage iiia hilar cholangiocarcinoma;exactmatch
stage ii hilar cholangiocarcinoma ajcc v7;stage ii hilar cholangiocarcinoma;exactmatch
stage i hilar cholangiocarcinoma ajcc v7;stage i hilar cholangiocarcinoma;exactmatch
stage 0 hilar cholangiocarcinoma ajcc v7;stage 0 hilar cholangiocarcinoma;exactmatch
stage iiib gallbladder cancer ajcc v7;stage iiib gallbladder cancer;exactmatch
stage iiia gallbladder cancer ajcc v7;stage iiia gallbladder cancer;exactmatch
stage ivb intrahepatic cholangiocarcinoma ajcc v7;stage ivb intrahepatic bile duct cancer (cholangiocarcinoma);exactmatch
stage iia distal bile duct cancer ajcc v7;stage iia distal bile duct cancer;exactmatch
stage iii distal bile duct cancer ajcc v7;stage iii distal bile duct cancer;exactmatch
stage iii acral lentiginous melanoma ajcc v7;stage iii acral lentiginous melanoma;exactmatch
stage iib pancreatic cancer ajcc v6 and v7;stage iib exocrine and endocrine pancreatic cancer ajcc v6 and v7;exactmatch
stage 0 eyelid carcinoma ajcc v7;stage 0 eyelid carcinoma;exactmatch
metastatic fibrosarcoma;metastatic fibrosarcoma;exactmatch
recurrent extraskeletal osteosarcoma;extraskeletal osteosarcoma, recurrent;exactmatch
stage iib prostate cancer ajcc v7;stage iib prostate cancer;exactmatch
stage iia prostate cancer ajcc v7;stage iia prostate cancer;exactmatch
stage iiib penile cancer ajcc v7;stage iiib penile cancer;exactmatch
stage iiia penile cancer ajcc v7;stage iiia penile cancer;exactmatch
stage iia pancreatic cancer ajcc v6 and v7;stage iia exocrine and endocrine pancreatic cancer ajcc v6 and v7;exactmatch
stage iv distal bile duct cancer ajcc v7;stage iv distal bile duct cancer;exactmatch
stage ib pancreatic cancer ajcc v6 and v7;stage ib exocrine and endocrine pancreatic cancer ajcc v6 and v7;exactmatch
stage ia pancreatic cancer ajcc v6 and v7;stage ia exocrine and endocrine pancreatic cancer ajcc v6 and v7;exactmatch
extraskeletal osteosarcoma;extraosseous osteosarcoma;exactmatch
stage iib ampulla of vater cancer ajcc v7;stage iib ampulla of vater cancer;exactmatch
stage iia ampulla of vater cancer ajcc v7;stage iia ampulla of vater cancer;exactmatch
stage ib ampulla of vater cancer ajcc v7;stage ib ampulla of vater cancer;exactmatch
stage ia ampulla of vater cancer ajcc v7;stage ia ampulla of vater cancer;exactmatch
stage iva intrahepatic cholangiocarcinoma ajcc v7;stage iva intrahepatic bile duct cancer (cholangiocarcinoma);exactmatch
stage iii intrahepatic cholangiocarcinoma ajcc v7;stage iii intrahepatic bile duct cancer (cholangiocarcinoma);exactmatch
stage ii intrahepatic cholangiocarcinoma ajcc v7;stage ii intrahepatic bile duct cancer (cholangiocarcinoma);exactmatch
stage i lentigo maligna melanoma ajcc v7;stage i lentigo maligna ajcc v7;exactmatch
stage iv low-csd melanoma ajcc v7;stage iv low-csd melanoma ajcc v7;exactmatch
stage iii low-csd melanoma ajcc v7;stage iii low-csd melanoma ajcc v7;exactmatch
stage ii low-csd melanoma ajcc v7;stage ii low-csd melanoma ajcc v7;exactmatch
stage i low-csd melanoma ajcc v7;stage i low-csd melanoma ajcc v7;exactmatch
stage iv lentigo maligna melanoma ajcc v6 and v7;stage iv lentigo maligna;exactmatch
stage iii lentigo maligna melanoma ajcc v7;stage iii lentigo maligna ajcc v7;exactmatch
stage ii lentigo maligna melanoma ajcc v6 and v7;stage ii lentigo maligna;exactmatch
recurrent lentigo maligna melanoma;lentigo maligna recurrent;exactmatch
stage i intrahepatic cholangiocarcinoma ajcc v7;stage i intrahepatic bile duct cancer (cholangiocarcinoma);exactmatch
stage iv acral lentiginous melanoma ajcc v6 and v7;stage iv acral lentiginous melanoma;exactmatch
stage iv small intestinal gastrointestinal stromal tumor;stage iv small intestinal gastrointestinal stromal tumor;exactmatch
stage iiib small intestinal gastrointestinal stromal tumor;stage iiib small intestinal gastrointestinal stromal tumor;exactmatch
stage iiia small intestinal gastrointestinal stromal tumor;stage iiia small intestinal gastrointestinal stromal tumor;exactmatch
stage ii small intestinal gastrointestinal stromal tumor;stage ii small intestinal gastrointestinal stromal tumor;exactmatch
stage i small intestinal gastrointestinal stromal tumor;stage i small intestinal gastrointestinal stromal tumor;exactmatch
stage iv gastric gastrointestinal stromal tumor;stage iv gastric (stomach) gastrointestinal stromal tumor (gist);exactmatch
recurrent undifferentiated pleomorphic sarcoma;malignant fibrous histiocytoma recurrent;exactmatch
metastatic alveolar soft part sarcoma;alveolar soft part sarcoma metastatic;exactmatch
localized alveolar soft part sarcoma;alveolar soft part sarcoma nonmetastatic;exactmatch
recurrent alveolar soft part sarcoma;alveolar soft part sarcoma recurrent;exactmatch
stage 0 intrahepatic cholangiocarcinoma ajcc v7;stage 0 intrahepatic bile duct cancer (cholangiocarcinoma);exactmatch
stage iiic hepatocellular carcinoma ajcc v7;stage iiic hepatocellular cancer;exactmatch
metastatic extraskeletal myxoid chondrosarcoma;extraskeletal myxoid chondrosarcoma, metastatic;exactmatch
stage iv digestive system neuroendocrine tumor ajcc v7;stage iv digestive system neuroendocrine neoplasm;exactmatch
stage iiib digestive system neuroendocrine tumor ajcc v7;stage iiib digestive system neuroendocrine neoplasm;exactmatch
stage iiia digestive system neuroendocrine tumor ajcc v7;stage iiia digestive system neuroendocrine neoplasm;exactmatch
stage iib digestive system neuroendocrine tumor ajcc v7;stage iib digestive system neuroendocrine neoplasm;exactmatch
recurrent extraskeletal ewing sarcoma;extra-osseous ewing's sarcoma, recurrent;exactmatch
stage iia digestive system neuroendocrine tumor ajcc v7;stage iia digestive system neuroendocrine neoplasm;exactmatch
stage i digestive system neuroendocrine tumor ajcc v7;stage i digestive system neuroendocrine neoplasm;exactmatch
stage 0 digestive system neuroendocrine tumor ajcc v7;stage 0 digestive system neuroendocrine neoplasm;exactmatch
localized extraskeletal ewing sarcoma;extra-osseous ewing's sarcoma, nonmetastatic;exactmatch
metastatic extraskeletal ewing sarcoma;extra-osseous ewing's sarcoma, metastatic;exactmatch
localized epithelioid sarcoma;epithelioid sarcoma, nonmetastatic;exactmatch
metastatic epithelioid sarcoma;epithelioid sarcoma, metastatic;exactmatch
stage ivb differentiated thyroid gland carcinoma ajcc v7;stage ivb differentiated thyroid gland cancer;exactmatch
stage iva differentiated thyroid gland carcinoma ajcc v7;stage iva differentiated thyroid gland cancer;exactmatch
stage iii differentiated thyroid gland carcinoma ajcc v7;stage iii differentiated thyroid gland cancer;exactmatch
t lymphoblastic leukemia/lymphoma;precursor t lymphoblastic leukemia/lymphoma;exactmatch
stage iiia vulvar cancer ajcc v7;stage iiia vulvar cancer;exactmatch
stage iv t lymphoblastic leukemia/lymphoma;precursor t-lymphoblastic lymphoma/leukemia stage iv;exactmatch
stage iii t lymphoblastic leukemia/lymphoma;precursor t-lymphoblastic lymphoma/leukemia stage iii;exactmatch
stage ii t lymphoblastic leukemia/lymphoma;precursor t-lymphoblastic lymphoma/leukemia stage ii;exactmatch
stage i t lymphoblastic leukemia/lymphoma;precursor t-lymphoblastic lymphoma/leukemia stage i;exactmatch
refractory t lymphoblastic leukemia/lymphoma;precursor t lymphoblastic lymphoma/leukemia refractory;exactmatch
recurrent t lymphoblastic leukemia/lymphoma;recurrent precursor t-lymphoblastic lymphoma/leukemia;exactmatch
ann arbor stage iv mature t- and nk-cell lymphoma;ann arbor stage iv mature t- and nk-cell lymphoma;exactmatch
stage iiic vulvar cancer ajcc v7;stage iiic vulvar cancer;exactmatch
ann arbor stage iii mature t- and nk-cell lymphoma;ann arbor stage iii mature t- and nk-cell lymphoma;exactmatch
steatorrhea;steatorrhea;exactmatch
ann arbor stage ii mature t- and nk-cell lymphoma;ann arbor stage ii mature t- and nk-cell lymphoma;exactmatch
ann arbor stage i mature t- and nk-cell lymphoma;ann arbor stage i mature t- and nk-cell lymphoma;exactmatch
refractory mature t-cell and nk-cell non-hodgkin lymphoma;peripheral t-cell lymphoma refractory;exactmatch
recurrent mature t-cell and nk-cell non-hodgkin lymphoma;recurrent mature t- and nk-cell lymphoma;exactmatch
refractory mycosis fungoides;mycosis fungoides refractory;exactmatch
stage iiib vulvar cancer ajcc v7;stage iiib vulvar cancer;exactmatch
refractory non-hodgkin lymphoma;non-hodgkin's lymphoma refractory;exactmatch
stage iiic uterine sarcoma ajcc v7;stage iiic uterine sarcoma;exactmatch
primary malignant hemangiopericytoma;malignant hemangiopericytoma nonmetastatic;exactmatch
stage iiia uterine sarcoma ajcc v7;stage iiia uterine sarcoma;exactmatch
stage ic uterine sarcoma ajcc v7;stage ic uterine sarcoma;exactmatch
stage ib uterine sarcoma ajcc v7;stage ib uterine sarcoma;exactmatch
stage ia uterine sarcoma ajcc v7;stage ia uterine sarcoma;exactmatch
bilateral retinoblastoma;bilateral retinoblastoma;exactmatch
pineal region germinoma;pineal germinoma;exactmatch
non-cutaneous melanoma;extracutaneous melanoma;exactmatch
metastatic malignant hemangiopericytoma;metastatic malignant hemangiopericytoma;exactmatch
recurrent transformed non-hodgkin lymphoma;non-hodgkin's lymphoma transformed recurrent;exactmatch
metastatic angiosarcoma;metastatic angiosarcoma;exactmatch
recurrent pleural malignant mesothelioma;malignant pleural mesothelioma recurrent;exactmatch
advanced pleural malignant mesothelioma;advanced malignant mesothelioma of pleura;exactmatch
oropharyngeal human papillomavirus-positive squamous cell carcinoma;hpv-associated oropharyngeal squamous cell carcinoma;exactmatch
recurrent peritoneal malignant mesothelioma;malignant peritoneal mesothelioma recurrent;exactmatch
advanced peritoneal malignant mesothelioma;advanced malignant mesothelioma of peritoneum;exactmatch
advanced pericardial malignant mesothelioma;advanced pericardial malignant mesothelioma;exactmatch
recurrent mycosis fungoides;mycosis fungoides recurrent;exactmatch
ann arbor stage iv enteropathy-associated t-cell lymphoma;ann arbor stage iv enteropathy-associated t-cell lymphoma;exactmatch
ann arbor stage iii enteropathy-associated t-cell lymphoma;ann arbor stage iii enteropathy-associated t-cell lymphoma;exactmatch
ann arbor stage iv lymphoplasmacytic lymphoma;ann arbor stage iv lymphoplasmacytic lymphoma;exactmatch
recurrent t-cell non-hodgkin lymphoma;recurrent t-cell lymphoma;exactmatch
ann arbor stage iv noncutaneous anaplastic large cell lymphoma;anaplastic large cell lymphoma stage iv;exactmatch
ann arbor stage iii noncutaneous anaplastic large cell lymphoma;anaplastic large cell lymphoma stage iii;exactmatch
ann arbor stage ii noncutaneous anaplastic large cell lymphoma;anaplastic large cell lymphoma stage ii;exactmatch
ann arbor stage i noncutaneous anaplastic large cell lymphoma;anaplastic large cell lymphoma stage i;exactmatch
refractory anaplastic large cell lymphoma;anaplastic large cell lymphoma t- and null-cell types refractory;exactmatch
refractory adult t-cell leukemia/lymphoma;adult t-cell lymphoma/leukemia refractory;exactmatch
ann arbor stage iii lymphoplasmacytic lymphoma;ann arbor stage iii lymphoplasmacytic lymphoma;exactmatch
ann arbor stage ii enteropathy-associated t-cell lymphoma;ann arbor stage ii enteropathy-associated t-cell lymphoma;exactmatch
ann arbor stage ii lymphoplasmacytic lymphoma;ann arbor stage ii lymphoplasmacytic lymphoma;exactmatch
ann arbor stage i lymphoplasmacytic lymphoma;ann arbor stage i lymphoplasmacytic lymphoma;exactmatch
refractory lymphoplasmacytic lymphoma;refractory lymphoplasmacytic lymphoma;exactmatch
ann arbor stage iv lymphocyte-depleted classic hodgkin lymphoma;ann arbor stage iv lymphocyte-depleted classic hodgkin lymphoma;exactmatch
refractory lymphocyte-depleted classic hodgkin lymphoma;refractory hodgkin's disease lymphocyte depleted;exactmatch
recurrent lymphocyte-depleted classic hodgkin lymphoma;recurrent hodgkin's disease lymphocyte depletion type;exactmatch
myelodysplastic syndrome, unclassifiable;mds, u;exactmatch
refractory t-cell non-hodgkin lymphoma;refractory t-cell lymphoma;exactmatch
ann arbor stage i t-cell non-hodgkin lymphoma;ann arbor stage i t-cell non-hodgkin lymphoma;exactmatch
ann arbor stage ii t-cell non-hodgkin lymphoma;ann arbor stage ii t-cell non-hodgkin lymphoma;exactmatch
ann arbor stage iii t-cell non-hodgkin lymphoma;ann arbor stage iii t-cell non-hodgkin lymphoma;exactmatch
ann arbor stage i enteropathy-associated t-cell lymphoma;ann arbor stage i enteropathy-associated t-cell lymphoma;exactmatch
refractory enteropathy-associated t-cell lymphoma;intestinal t-cell lymphoma refractory;exactmatch
recurrent enteropathy-associated t-cell lymphoma;recurrent enteropathy-associated t-cell lymphoma;exactmatch
ann arbor stage iv angioimmunoblastic t-cell lymphoma;angioimmunoblastic t-cell lymphoma stage iv;exactmatch
ann arbor stage iii angioimmunoblastic t-cell lymphoma;angioimmunoblastic t-cell lymphoma stage iii;exactmatch
ann arbor stage ii angioimmunoblastic t-cell lymphoma;angioimmunoblastic t-cell lymphoma stage ii;exactmatch
recurrent angioimmunoblastic t-cell lymphoma;recurrent angioimmunoblastic t-cell lymphoma;exactmatch
ann arbor stage iv nasal type nk/t-cell lymphoma;angiocentric lymphoma stage iv;exactmatch
ann arbor stage iii nasal type nk/t-cell lymphoma;angiocentric lymphoma stage iii;exactmatch
ann arbor stage ii nasal type nk/t-cell lymphoma;angiocentric lymphoma stage ii;exactmatch
ann arbor stage i angioimmunoblastic t-cell lymphoma;angioimmunoblastic t-cell lymphoma stage i;exactmatch
refractory angioimmunoblastic t-cell lymphoma;angioimmunoblastic t-cell lymphoma refractory;exactmatch
ann arbor stage i nasal type nk/t-cell lymphoma;angiocentric lymphoma stage i;exactmatch
refractory nasal type extranodal nk/t-cell lymphoma;angiocentric lymphoma refractory;exactmatch
ann arbor stage iv t-cell non-hodgkin lymphoma;ann arbor stage iv t-cell non-hodgkin lymphoma;exactmatch
stage iiib uterine sarcoma ajcc v7;stage iiib uterine sarcoma;exactmatch
unilateral retinoblastoma;unilateral retinoblastoma;exactmatch
stage ii differentiated thyroid gland carcinoma ajcc v7;stage ii differentiated thyroid gland cancer;exactmatch
stage i ovarian yolk sac tumor ajcc v6 and v7;ovarian yolk sac tumor stage i;exactmatch
stage iv ovarian polyembryoma ajcc v6 and v7;ovarian polyembryoma stage iv;exactmatch
stage iii ovarian polyembryoma ajcc v6 and v7;ovarian polyembryoma stage iii;exactmatch
stage ii ovarian polyembryoma ajcc v6 and v7;ovarian polyembryoma stage ii;exactmatch
stage i ovarian polyembryoma ajcc v6 and v7;ovarian polyembryoma stage i;exactmatch
stage iv ovarian yolk sac tumor ajcc v6 and v7;ovarian yolk sac tumor stage iv;exactmatch
stage iii ovarian yolk sac tumor ajcc v6 and v7;ovarian yolk sac tumor stage iii;exactmatch
stage ii ovarian yolk sac tumor ajcc v6 and v7;ovarian yolk sac tumor stage ii;exactmatch
stage i ovarian embryonal carcinoma ajcc v6 and v7;ovarian embryonal carcinoma, stage i;exactmatch
stage ii ovarian teratoma ajcc v6 and v7;ovarian germ cell teratoma stage ii;exactmatch
stage iv ovarian choriocarcinoma;ovarian germ cell choriocarcinoma stage iv;exactmatch
stage iii ovarian choriocarcinoma;ovarian germ cell choriocarcinoma stage iii;exactmatch
stage ii ovarian choriocarcinoma;ovarian germ cell choriocarcinoma stage ii;exactmatch
stage ivc lip and oral cavity cancer ajcc v6 and v7;stage ivc lip and oral cavity cancer;exactmatch
stage ivb lip and oral cavity cancer ajcc v6 and v7;stage ivb lip and oral cavity cancer;exactmatch
stage iva lip and oral cavity cancer ajcc v6 and v7;stage iva lip and oral cavity cancer;exactmatch
stage i ovarian choriocarcinoma;stage i ovarian choriocarcinoma;exactmatch
stage i ovarian teratoma ajcc v6 and v7;stage i ovarian germ cell teratoma;exactmatch
stage iii ovarian teratoma ajcc v6 and v7;ovarian germ cell teratoma stage iii;exactmatch
stage iva uterine sarcoma ajcc v7;stage iva uterine sarcoma;exactmatch
stage iii lung adenosquamous carcinoma ajcc v7;stage iii adenosquamous cell carcinoma of lung;exactmatch
stage i differentiated thyroid gland carcinoma ajcc v7;stage i differentiated thyroid gland cancer;exactmatch
stage ivc mucosal melanoma of the head and neck ajcc v7;stage ivc mucosal melanoma of the head and neck;exactmatch
stage ivb mucosal melanoma of the head and neck ajcc v7;stage ivb mucosal melanoma of the head and neck;exactmatch
stage iva mucosal melanoma of the head and neck ajcc v7;stage iva mucosal melanoma of the head and neck;exactmatch
stage iii mucosal melanoma of the head and neck ajcc v7;stage iii mucosal melanoma of the head and neck;exactmatch
recurrent lung large cell carcinoma;recurrent large cell carcinoma of lung;exactmatch
stage iv lung adenosquamous carcinoma ajcc v7;stage iv adenosquamous cell carcinoma of lung;exactmatch
stage ivc sinonasal cancer ajcc v7;stage ivc nasal cavity and paranasal sinus cancer;exactmatch
stage iv ovarian teratoma ajcc v6 and v7;ovarian germ cell teratoma stage iv;exactmatch
stage ivb sinonasal cancer ajcc v7;stage ivb nasal cavity and paranasal sinus cancer;exactmatch
stage iva sinonasal cancer ajcc v7;stage iva nasal cavity and paranasal sinus cancer;exactmatch
stage ii lung adenosquamous  carcinoma ajcc v7;stage ii adenosquamous cell carcinoma of lung;exactmatch
stage 0 sinonasal cancer ajcc v6, v7, and v8;stage 0 nasal cavity and paranasal sinus cancer;exactmatch
stage i lung adenosquamous carcinoma ajcc v7;stage i adenosquamous cell carcinoma of lung;exactmatch
stage 0 lung adenosquamous carcinoma ajcc v6 and v7;adenosquamous cell carcinoma in situ of lung;exactmatch
recurrent lung adenosquamous carcinoma;adenosquamous cell lung carcinoma recurrent;exactmatch
stage iv ovarian embryonal carcinoma ajcc v6 and v7;ovarian embryonal carcinoma stage iv;exactmatch
stage iii ovarian embryonal carcinoma ajcc v6 and v7;ovarian embryonal carcinoma, stage iii;exactmatch
stage iv ovarian dysgerminoma ajcc v6 and v7;stage iv ovarian dysgerminoma;exactmatch
stage iii gestational trophoblastic tumor ajcc v7;stage iii gestational trophoblastic tumor;exactmatch
mucin-rich endometrial endometrioid adenocarcinoma;mucin-rich endometrial endometrioid adenocarcinoma;exactmatch
stage ivb gestational trophoblastic tumor ajcc v7;stage ivb gestational trophoblastic tumor;exactmatch
stage iva gestational trophoblastic tumor ajcc v7;stage iva gestational trophoblastic tumor;exactmatch
regional malignant ureter neoplasm;local malignant ureter neoplasm;exactmatch
stage iv gestational trophoblastic tumor ajcc v7;stage iv gestational trophoblastic tumor;exactmatch
stage iiib gestational trophoblastic tumor ajcc v7;stage iiib gestational trophoblastic tumor;exactmatch
stage iiia gestational trophoblastic tumor ajcc v7;stage iiia gestational trophoblastic tumor;exactmatch
stage iib gestational trophoblastic tumor ajcc v7;stage iib gestational trophoblastic tumor;exactmatch
stage iii ovarian dysgerminoma ajcc v6 and v7;stage iii ovarian dysgerminoma;exactmatch
stage iia gestational trophoblastic tumor ajcc v7;stage iia gestational trophoblastic tumor;exactmatch
stage ii gestational trophoblastic tumor ajcc v7;stage ii gestational trophoblastic tumor;exactmatch
stage ib gestational trophoblastic tumor ajcc v7;stage ib gestational trophoblastic tumor;exactmatch
stage ia gestational trophoblastic tumor ajcc v7;stage ia gestational trophoblastic tumor;exactmatch
stage i gestational trophoblastic tumor ajcc v7;stage i gestational trophoblastic tumor;exactmatch
rhabdoid tumor of the kidney;kidney rhabdoid tumor;exactmatch
stage ivb uterine sarcoma ajcc v7;stage ivb uterine sarcoma;exactmatch
stage i bone cancer  ajcc v7;stage i bone cancer;exactmatch
stage ia bone cancer  ajcc v7;stage ia bone cancer;exactmatch
stage ib bone cancer  ajcc v7;stage ib bone cancer;exactmatch
stage ii bone cancer  ajcc v7;stage ii bone cancer;exactmatch
stage ii ovarian embryonal carcinoma ajcc v6 and v7;ovarian embryonal carcinoma, stage ii;exactmatch
stage ii ovarian dysgerminoma ajcc v6 and v7;stage ii ovarian dysgerminoma;exactmatch
stage i ovarian dysgerminoma ajcc v6 and v7;stage i ovarian dysgerminoma;exactmatch
stage iii fallopian tube cancer ajcc v6;ajcc stage iii fallopian tube cancer v6;exactmatch
stage ii fallopian tube cancer ajcc v6 and v7;ajcc stage ii fallopian tube cancer;exactmatch
stage i fallopian tube cancer ajcc v6 and v7;ajcc stage i fallopian tube cancer;exactmatch
stage ib pleural malignant mesothelioma ajcc v7;stage ib pleural malignant mesothelioma;exactmatch
stage ia pleural malignant mesothelioma ajcc v7;stage ia pleural malignant mesothelioma;exactmatch
endometrial squamous cell carcinoma;endometrial squamous cell carcinoma;exactmatch
stage ivb bone cancer  ajcc v7;stage ivb bone cancer;exactmatch
stage iva bone cancer  ajcc v7;stage iva bone cancer;exactmatch
stage iv bone cancer  ajcc v7;stage iv bone cancer;exactmatch
stage iii bone cancer  ajcc v7;stage iii bone cancer;exactmatch
stage iib bone cancer  ajcc v7;stage iib bone cancer;exactmatch
stage iia bone cancer  ajcc v7;stage iia bone cancer;exactmatch
stage ia eyelid carcinoma ajcc v7;stage ia eyelid carcinoma;exactmatch
stage ib eyelid carcinoma ajcc v7;stage ib eyelid carcinoma;exactmatch
stage ic eyelid carcinoma ajcc v7;stage ic eyelid carcinoma;exactmatch
stage ii lung cancer ajcc v6;stage ii carcinoma of lung ajcc v6;exactmatch
stage iv penile cancer ajcc v6;penile cancer stage iv ajcc v6;exactmatch
cutaneous precancerous condition;cutaneous precancerous condition;exactmatch
stage iv gastric cancer without metastasis;carcinoma of stomach stage iv without metastasis;exactmatch
stage iia cervical cancer ajcc v7;stage iia cervical cancer;exactmatch
stage ii cervical cancer ajcc v7;stage ii cervical cancer;exactmatch
stage 0 cervical cancer ajcc v7;cin 3;exactmatch
rete testis adenocarcinoma;adenocarcinoma of rete testis;exactmatch
recurrent lung carcinoma;recurrent lung cancer;exactmatch
fundic gland polyp;fundic gland polyp;exactmatch
stage iiib lung adenosquamous carcinoma ajcc v7;stage iiib adenosquamous cell carcinoma of lung;exactmatch
stage iiia lung adenosquamous carcinoma ajcc v7;stage iiia adenosquamous cell carcinoma of lung;exactmatch
stage iv prostate adenocarcinoma ajcc v7;stage iv prostate adenocarcinoma;exactmatch
stage iii prostate adenocarcinoma ajcc v7;stage iii prostate adenocarcinoma;exactmatch
stage ii prostate adenocarcinoma ajcc v7;stage ii prostate adenocarcinoma;exactmatch
stage 0 vaginal cancer ajcc v7;grade iii vaginal intraepithelial neoplasia;exactmatch
stage i prostate adenocarcinoma ajcc v7;stage i prostate adenocarcinoma;exactmatch
hereditary kidney oncocytoma;familial renal oncocytoma;exactmatch
digestive system intraepithelial neoplasia;digestive system intraepithelial neoplasia;exactmatch
alveolar ridge;alveolar margin;exactmatch
parosteal osteosarcoma;juxtacortical osteogenic sarcoma;exactmatch
uterine corpus undifferentiated sarcoma;undifferentiated uterine sarcoma;exactmatch
gna11 gene;g protein subunit alpha 11 gene;exactmatch
gna11 gene mutation;g protein subunit alpha 11 gene mutation;exactmatch
gnaq gene mutation;cmc1 gene mutation;exactmatch
embryonal rhabdomyosarcoma;erms;exactmatch
periosteal osteosarcoma;juxtacortical chondroblastic osteosarcoma;exactmatch
stage iii fallopian tube cancer ajcc v7;stage iii fallopian tube cancer;exactmatch
grade 2 follicular lymphoma;follicular lymphoma grade 2;exactmatch
stage iv fallopian tube cancer ajcc v6 and v7;ajcc stage iv fallopian tube cancer;exactmatch
lymphangioma;capillary lymphangioma;exactmatch
synovial neoplasm;neoplasm of synovium;exactmatch
stage iv uterine corpus cancer ajcc v7;stage iv uterine (including endometrial) cancer;exactmatch
stage iii uterine corpus cancer ajcc v7;stage iii uterine (including endometrial) cancer;exactmatch
stage ii uterine corpus cancer ajcc v7;stage ii uterine (including endometrial) cancer;exactmatch
stage i uterine corpus cancer ajcc v7;stage i uterine (including endometrial) cancer;exactmatch
stage 0 uterine corpus cancer ajcc v7;stage 0 uterine (including endometrial) cancer;exactmatch
metastatic prostate carcinoma;metastatic prostate cancer;exactmatch
stage iva vulvar cancer ajcc v7;stage iva vulvar cancer;exactmatch
stage iv vulvar cancer ajcc v7;stage iv vulvar cancer;exactmatch
ann arbor stage iii centroblastic lymphoma;ann arbor stage iii centroblastic lymphoma;exactmatch
metastatic pancreatic adenocarcinoma;metastatic pancreatic adenocarcinoma;exactmatch
pediatric disorder;pediatric disease;exactmatch
stage 0 colorectal cancer ajcc v6 and v7;colorectal cancer, stage 0;exactmatch
ann arbor stage iv centroblastic lymphoma;ann arbor stage iv centroblastic lymphoma;exactmatch
stage iv renal cell cancer ajcc v7;stage iv renal cell cancer;exactmatch
stage iii renal cell cancer ajcc v7;stage iii renal cell cancer;exactmatch
stage ii renal cell cancer ajcc v7;stage ii renal cell cancer;exactmatch
ann arbor stage ii centroblastic lymphoma;ann arbor stage ii centroblastic lymphoma;exactmatch
stage iii vulvar cancer ajcc v7;stage iii vulvar cancer;exactmatch
ann arbor stage i centroblastic lymphoma;ann arbor stage i centroblastic lymphoma;exactmatch
refractory centroblastic lymphoma;refractory centroblastic lymphoma;exactmatch
recurrent centroblastic lymphoma;recurrent centroblastic lymphoma;exactmatch
metastatic melanoma;metastatic melanoma;exactmatch
stage iv prostate cancer ajcc v7;stage iv prostate cancer;exactmatch
stage iii prostate cancer ajcc v7;stage iii prostate cancer;exactmatch
stage ii prostate cancer ajcc v7;stage ii prostate cancer;exactmatch
developmental disorder;developmental disorder;exactmatch
eating disorder;eating disorder;exactmatch
metastatic small intestinal adenocarcinoma;metastatic small intestinal adenocarcinoma;exactmatch
b lymphoblastic leukemia/lymphoma;b lymphoblastic leukemia/lymphoma;exactmatch
stage ii vulvar cancer ajcc v7;stage ii vulvar cancer;exactmatch
metastatic prostate adenocarcinoma;metastatic prostate adenocarcinoma;exactmatch
stage ib vulvar cancer ajcc v7;stage ib vulvar cancer;exactmatch
stage ia vulvar cancer ajcc v7;stage ia vulvar cancer;exactmatch
stage i vulvar cancer ajcc v7;stage i vulvar cancer;exactmatch
stage 0 vulvar cancer ajcc v7;stage 0 vulvar cancer;exactmatch
metastatic vaginal adenocarcinoma;metastatic vaginal adenocarcinoma;exactmatch
metastatic endometrioid adenocarcinoma;metastatic endometrioid adenocarcinoma;exactmatch
metastatic endometrial adenocarcinoma;metastatic endometrial adenocarcinoma;exactmatch
stage iv bladder urothelial carcinoma ajcc v7;stage iv bladder urothelial cancer;exactmatch
stage iii bladder urothelial carcinoma ajcc v6 and v7;stage iii bladder urothelial cancer;exactmatch
stage ii bladder urothelial carcinoma ajcc v6 and v7;stage ii bladder urothelial cancer;exactmatch
refractory primary cutaneous t-cell non-hodgkin lymphoma;refractory cutaneous t-cell non-hodgkin lymphoma;exactmatch
ann arbor stage ii b lymphoblastic lymphoma;ann arbor stage ii b lymphoblastic lymphoma;exactmatch
stage iv bladder cancer ajcc v7;stage iv bladder cancer;exactmatch
endometrioid stromal sarcoma;ess;exactmatch
malignant mixed mesodermal (mullerian) tumor;carcinosarcoma, embryonal;exactmatch
acute erythroid leukemia;ael;exactmatch
adult teratoma;adult teratoma;exactmatch
stage iv hepatocellular carcinoma ajcc v7;stage iv hepatocellular cancer;exactmatch
stage iii hepatocellular carcinoma ajcc v7;stage iii hepatocellular cancer;exactmatch
"acute myeloid leukemia with inv(16)(p13.1q22); cbfb-myh11";"acute myeloid leukemia with inv(16)(p13.1q22); cbfb-myh11";exactmatch
aids-related primary effusion lymphoma;aids-related primary effusion lymphoma;exactmatch
aids-related plasmablastic lymphoma of the oral mucosa;aids-related plasmablastic lymphoma of oral mucosa;exactmatch
mature teratoma;grade 0 teratoma;exactmatch
cystic teratoma;cystic teratoma;exactmatch
adult cystic teratoma;adult cystic teratoma;exactmatch
acute myelomonocytic leukemia with abnormal eosinophils;amml eo;exactmatch
dermoid cyst;benign cystic teratoma;exactmatch
myeloid differentiation primary response protein myd88;myd88;exactmatch
mixed teratoma and seminoma;mixed teratoma and seminoma;exactmatch
squamous papillomatosis;squamous papillomatosis;exactmatch
myd88 gene;myd88;exactmatch
inverted follicular keratosis;inverted follicular keratosis;exactmatch
seborrheic keratosis;basal cell papilloma;exactmatch
"acute myeloid leukemia with t(16;16)(p13.1;q22); cbfb-myh11";"acute myeloid leukemia with t(16;16)(p13.1;q22); cbfb-myh11";exactmatch
stage i gallbladder cancer ajcc v7;stage i gallbladder cancer;exactmatch
stage 0 esophageal cancer ajcc v7;esophageal carcinoma in situ;exactmatch
fnclcc sarcoma grade 2;fnclcc sarcoma grade 2;exactmatch
renal cell cancer by ajcc v6 stage;renal cell cancer by ajcc v6 stage;exactmatch
ann arbor stage iii adult hodgkin lymphoma;adult hodgkin's disease stage iii;exactmatch
ann arbor stage ii adult hodgkin lymphoma;adult hodgkin's disease stage ii;exactmatch
ann arbor stage i adult hodgkin lymphoma;adult hodgkin's disease stage i;exactmatch
poorly differentiated angiosarcoma;poorly differentiated angiosarcoma;exactmatch
high grade malignant peripheral nerve sheath tumor;high grade malignant peripheral nerve sheath tumor;exactmatch
fnclcc sarcoma grade 3;fnclcc sarcoma grade 3;exactmatch
grade i chondrosarcoma;atypical cartilaginous tumor/grade i chondrosarcoma;exactmatch
stage ii gallbladder cancer ajcc v7;stage ii gallbladder cancer;exactmatch
low grade malignant peripheral nerve sheath tumor;low grade malignant peripheral nerve sheath tumor;exactmatch
well differentiated fibrosarcoma;well differentiated fibrosarcoma;exactmatch
fnclcc sarcoma grade 1;fnclcc sarcoma grade 1;exactmatch
sarcoma by fnclcc grade;fnclcc tumor grade in sarcoma;exactmatch
childhood astrocytic tumor;astrocytic tumor;exactmatch
stage iv gallbladder cancer ajcc v7;stage iv gallbladder cancer;exactmatch
stage iii gallbladder cancer ajcc v7;stage iii gallbladder cancer;exactmatch
malignant pancreatic neoplasm;malignant neoplasm of pancreas;exactmatch
benign adrenal cortex neoplasm;adrenal cortical tumor, benign;exactmatch
adrenal cortex adenoma;adenoma, adrenocortical, benign;exactmatch
cystadenofibroma;cystadenofibroma;exactmatch
clear cell cystadenofibroma;clear cell cystadenofibroma;exactmatch
clear cell adenofibroma;clear cell adenofibroma;exactmatch
stage iv gastric cancer ajcc v7;stage iv gastric (stomach) cancer;exactmatch
stage iii gastric cancer ajcc v7;stage iii gastric (stomach) cancer;exactmatch
papillary adenofibroma;papillary adenofibroma;exactmatch
stage ii gastric cancer ajcc v7;stage ii gastric (stomach) cancer;exactmatch
stage i gastric cancer ajcc v7;stage i gastric (stomach) cancer;exactmatch
female reproductive system adenofibroma;adenofibroma, benign;exactmatch
stage iv rectosigmoid cancer ajcc v7;stage iv rectosigmoid cancer;exactmatch
colon carcinoma metastatic in the lung;colon carcinoma metastatic in the lung;exactmatch
stage iv esophageal cancer ajcc v7;stage iv esophageal cancer;exactmatch
stage iii esophageal cancer ajcc v7;stage iii esophageal cancer;exactmatch
stage ii esophageal cancer ajcc v7;stage ii esophageal cancer;exactmatch
stage i esophageal cancer ajcc v7;stage i esophageal cancer;exactmatch
mucinous cystadenofibroma;mucinous cystadenofibroma;exactmatch
mucinous adenofibroma;mucinous adenofibroma;exactmatch
oral neoplasm;lip and oral cavity neoplasm;exactmatch
oral cavity carcinoma;carcinoma of mouth;exactmatch
malignant mastocytosis;mast cell tumor, malignant;exactmatch
ureter carcinoma;carcinoma of ureter;exactmatch
stage iv rectal cancer ajcc v7;stage iv rectal cancer;exactmatch
stage iv colon cancer ajcc v7;stage iv colon cancer;exactmatch
stage iv colorectal cancer ajcc v7;stage iv colorectal (colon or rectal) cancer;exactmatch
stage iii rectosigmoid cancer ajcc v7;stage iii rectosigmoid cancer;exactmatch
stage iii rectal cancer ajcc v7;stage iii rectal cancer;exactmatch
stage iii colon cancer ajcc v7;stage iii colon cancer;exactmatch
stage iii colorectal cancer ajcc v7;stage iii colorectal (colon or rectal) cancer;exactmatch
stage ii rectosigmoid cancer ajcc v7;stage ii rectosigmoid cancer;exactmatch
stage ii rectal cancer ajcc v7;stage ii rectal cancer;exactmatch
stage ii colon cancer ajcc v7;stage ii colon cancer;exactmatch
stage ii colorectal cancer ajcc v7;stage ii colorectal (colon or rectal) cancer;exactmatch
blastoma;blastoma;exactmatch
malignant lymphoma follicular, large cleaved cell type;malignant lymphoma follicular, large cleaved cell type;exactmatch
malignant lymphoma follicular, large noncleaved cell type;malignant lymphoma follicular, large noncleaved cell type;exactmatch
malignant lymphoma centroblastic, follicular;malignant lymphoma centroblastic, follicular;exactmatch
stage i prostate cancer ajcc v7;stage i prostate cancer;exactmatch
stage iii testicular yolk sac tumor ajcc v6 and v7;stage iii testicular yolk sac tumor;exactmatch
stage ii eyelid carcinoma ajcc v7;stage ii eyelid carcinoma;exactmatch
stage iii breast cancer ajcc v7;stage iii breast cancer;exactmatch
stage iii cutaneous melanoma ajcc v7;stage iii cutaneous (skin) melanoma;exactmatch
stage i cutaneous melanoma ajcc v7;stage i cutaneous (skin) melanoma;exactmatch
recurrent b-cell non-hodgkin lymphoma;b-cell lymphoma recurrent;exactmatch
ann arbor stage iv nodular sclerosis classic hodgkin lymphoma;ann arbor stage iv nodular sclerosis classic hodgkin lymphoma;exactmatch
ann arbor stage i nodular sclerosis classic hodgkin lymphoma;ann arbor stage i nodular sclerosis classic hodgkin lymphoma;exactmatch
refractory nodular sclerosis classic hodgkin lymphoma;refractory nodular sclerosis classic hodgkin lymphoma;exactmatch
stage iiic breast cancer ajcc v7;stage iiic breast cancer;exactmatch
stage i breast cancer ajcc v7;stage i breast cancer;exactmatch
ann arbor stage ii b-cell non-hodgkin lymphoma;ann arbor stage ii b-cell non-hodgkin lymphoma;exactmatch
recurrent nodular sclerosis classic hodgkin lymphoma;recurrent hodgkin's nodular sclerosis;exactmatch
refractory hodgkin lymphoma;refractory hodgkin lymphoma;exactmatch
ann arbor stage iv mixed cellularity classic hodgkin lymphoma;ann arbor stage iv mixed cellularity classic hodgkin lymphoma;exactmatch
ann arbor stage i mixed cellularity classic hodgkin lymphoma;ann arbor stage i mixed cellularity classic hodgkin lymphoma;exactmatch
refractory mixed cellularity classic hodgkin lymphoma;refractory mixed cellularity classic hodgkin lymphoma;exactmatch
recurrent mixed cellularity classic hodgkin lymphoma;recurrent mixed cellularity classic hodgkin lymphoma;exactmatch
stage iv hodgkin's disease lymphocyte predominance type;stage iv hodgkin's disease lymphocyte predominance type;exactmatch
refractory b-cell non-hodgkin lymphoma;b-cell lymphoma refractory;exactmatch
ann arbor stage iii b-cell non-hodgkin lymphoma;ann arbor stage iii b-cell non-hodgkin lymphoma;exactmatch
nodal marginal zone lymphoma;monocytoid b-cell lymphoma;exactmatch
ann arbor stage i diffuse large b-cell lymphoma;ann arbor stage i diffuse large b-cell lymphoma;exactmatch
ann arbor stage iii follicular lymphoma;ann arbor stage iii follicular lymphoma;exactmatch
ann arbor stage ii follicular lymphoma;ann arbor stage ii follicular lymphoma;exactmatch
ann arbor stage i follicular lymphoma;ann arbor stage i follicular lymphoma;exactmatch
refractory follicular lymphoma;refractory follicular lymphoma;exactmatch
ann arbor stage iv diffuse large b-cell lymphoma;ann arbor stage iv diffuse large b-cell lymphoma;exactmatch
ann arbor stage iii diffuse large b-cell lymphoma;ann arbor stage iii diffuse large b-cell lymphoma;exactmatch
ann arbor stage ii diffuse large b-cell lymphoma;ann arbor stage ii diffuse large b-cell lymphoma;exactmatch
refractory diffuse large b-cell lymphoma;diffuse large b-cell lymphoma refractory;exactmatch
ann arbor stage iv b-cell non-hodgkin lymphoma;ann arbor stage iv b-cell non-hodgkin lymphoma;exactmatch
recurrent diffuse large b-cell lymphoma;recurrent diffuse large b-cell lymphoma;exactmatch
diffuse large b-cell lymphoma;dlbcl;exactmatch
ann arbor stage iii burkitt lymphoma;ann arbor stage iii burkitt lymphoma;exactmatch
ann arbor stage ii burkitt lymphoma;ann arbor stage ii burkitt lymphoma;exactmatch
ann arbor stage i burkitt lymphoma;ann arbor stage i burkitt lymphoma;exactmatch
refractory burkitt lymphoma;burkitt's lymphoma refractory;exactmatch
refractory small lymphocytic lymphoma;b-cell small lymphocytic lymphoma refractory;exactmatch
stage iii hodgkin's disease lymphocyte predominance type;stage iii hodgkin's disease lymphocyte predominance type;exactmatch
refractory hodgkin's disease lymphocyte predominance type;refractory hodgkin's disease lymphocyte predominance type;exactmatch
recurrent hodgkin's disease lymphocyte predominance type;recurrent hodgkin's disease lymphocyte predominance type;exactmatch
stage iiib uveal melanoma ajcc v7;iiib;exactmatch
stage ib mycosis fungoides and sezary syndrome ajcc v7;stage ib mycosis fungoides and sezary syndrome;exactmatch
stage ia mycosis fungoides and sezary syndrome ajcc v7;stage ia mycosis fungoides and sezary syndrome;exactmatch
stage i mycosis fungoides and sezary syndrome ajcc v7;stage i mycosis fungoides and sezary syndrome;exactmatch
recurrent leiomyosarcoma;leiomyosarcoma recurrent;exactmatch
ocular adnexal non-hodgkin lymphoma;oal;exactmatch
localized leiomyosarcoma;leiomyosarcoma nonmetastatic;exactmatch
stage iiic uveal melanoma ajcc v7;iiic;exactmatch
stage iiia uveal melanoma ajcc v7;iiia;exactmatch
recurrent synovial sarcoma;recurrent synovial sarcoma;exactmatch
stage iib uveal melanoma ajcc v7;iib;exactmatch
stage iia uveal melanoma ajcc v7;iia;exactmatch
stage iv eyelid carcinoma ajcc v7;stage iv eyelid carcinoma;exactmatch
stage iiic eyelid carcinoma ajcc v7;stage iiic eyelid carcinoma;exactmatch
stage iiib eyelid carcinoma ajcc v7;stage iiib eyelid carcinoma;exactmatch
metastatic leiomyosarcoma;leiomyosarcoma metastatic;exactmatch
stage iiia eyelid carcinoma ajcc v7;stage iiia eyelid carcinoma;exactmatch
stage ii mycosis fungoides and sezary syndrome ajcc v7;stage ii mycosis fungoides and sezary syndrome;exactmatch
stage iia mycosis fungoides and sezary syndrome ajcc v7;stage iia mycosis fungoides and sezary syndrome;exactmatch
stage iib mycosis fungoides and sezary syndrome ajcc v7;stage iib mycosis fungoides and sezary syndrome;exactmatch
leukemia cutis;leukemia cutis;exactmatch
localized synovial sarcoma;localized synovial sarcoma;exactmatch
metastatic synovial sarcoma;metastatic synovial sarcoma;exactmatch
recurrent rhabdomyosarcoma;recurrent rhabdomyosarcoma;exactmatch
recurrent malignant peripheral nerve sheath tumor;recurrent mpnst;exactmatch
metastatic malignant peripheral nerve sheath tumor;metastatic mpnst;exactmatch
recurrent liposarcoma;liposarcoma recurrent;exactmatch
gpc3 gene;gpc3;exactmatch
localized liposarcoma;liposarcoma nonmetastatic;exactmatch
stage ivb mycosis fungoides and sezary syndrome ajcc v7;stage ivb mycosis fungoides and sezary syndrome;exactmatch
stage iva mycosis fungoides and sezary syndrome ajcc v7;stage iva mycosis fungoides and sezary syndrome;exactmatch
stage iv mycosis fungoides and sezary syndrome ajcc v7;stage iv mycosis fungoides and sezary syndrome;exactmatch
metastatic liposarcoma;liposarcoma metastatic;exactmatch
stage iiib mycosis fungoides and sezary syndrome ajcc v7;stage iiib mycosis fungoides and sezary syndrome;exactmatch
stage iiia mycosis fungoides and sezary syndrome ajcc v7;stage iiia mycosis fungoides and sezary syndrome;exactmatch
stage iii mycosis fungoides and sezary syndrome ajcc v7;stage iii mycosis fungoides and sezary syndrome;exactmatch
refractory mantle cell lymphoma;mantle cell lymphoma refractory;exactmatch
ann arbor stage i nodal marginal zone lymphoma;ann arbor stage i nodal marginal zone lymphoma;exactmatch
stage ii testicular yolk sac tumor ajcc v6 and v7;stage ii testicular yolk sac tumor;exactmatch
stage 0 bladder squamous cell carcinoma ajcc v6 and v7;stage 0 bladder squamous cell cancer;exactmatch
stage i testicular choriocarcinoma ajcc v6 and v7;stage i testicular choriocarcinoma;exactmatch
stage iv bladder squamous cell carcinoma ajcc v7;stage iv bladder squamous cell cancer;exactmatch
stage iii bladder squamous cell carcinoma ajcc v6 and v7;stage iii bladder squamous cell cancer;exactmatch
stage iv hypopharyngeal carcinoma ajcc v7;stage iv hypopharyngeal carcinoma;exactmatch
stage iii hypopharyngeal carcinoma ajcc v7;stage iii hypopharyngeal carcinoma;exactmatch
stage i hypopharyngeal carcinoma ajcc v7;stage i hypopharyngeal carcinoma;exactmatch
stage i squamous cell carcinoma of the bladder ajcc v6 and v7;bladder squamous cell carcinoma stage i;exactmatch
stage iv oropharyngeal carcinoma ajcc v7;stage iv oropharyngeal carcinoma;exactmatch
stage ii testicular embryonal carcinoma ajcc v6 and v7;stage ii testicular embryonal carcinoma;exactmatch
stage iii oropharyngeal carcinoma ajcc v7;stage iii oropharyngeal carcinoma;exactmatch
recurrent bladder squamous cell carcinoma;recurrent bladder epidermoid carcinoma;exactmatch
stage i bladder cancer without carcinoma in situ;stage i bladder cancer without cancer in situ;exactmatch
stage iii testicular choriocarcinoma ajcc v6 and v7;stage iii testicular choriocarcinoma;exactmatch
stage i bladder cancer with carcinoma in situ;stage i bladder cancer with cancer in situ;exactmatch
stage iv nasopharyngeal carcinoma ajcc v7;stage iv nasopharyngeal carcinoma;exactmatch
stage iii nasopharyngeal carcinoma ajcc v7;stage iii nasopharyngeal carcinoma;exactmatch
stage i testicular embryonal carcinoma ajcc v6 and v7;stage i testicular embryonal carcinoma;exactmatch
stage iv laryngeal cancer ajcc v7;stage iv laryngeal cancer;exactmatch
ann arbor stage ii nodal marginal zone lymphoma;ann arbor stage ii nodal marginal zone lymphoma;exactmatch
stage ii testicular seminoma ajcc v6 and v7;stage ii seminoma;exactmatch
stage i testicular yolk sac tumor ajcc v6 and v7;stage i testicular yolk sac tumor;exactmatch
stage iv penile cancer ajcc v7;stage iv penile cancer;exactmatch
stage iii penile cancer ajcc v7;stage iii penile cancer;exactmatch
stage ii penile cancer ajcc v7;stage ii penile cancer;exactmatch
stage i penile cancer ajcc v7;stage i penile cancer;exactmatch
stage 0 penile cancer ajcc v7;stage 0 penile cancer;exactmatch
stage iii testicular seminoma ajcc v6 and v7;stage iii seminoma;exactmatch
stage i testicular seminoma ajcc v6 and v7;stage i seminoma;exactmatch
stage iii testicular embryonal carcinoma ajcc v6 and v7;stage iii testicular embryonal carcinoma;exactmatch
stage iii immature testicular teratoma ajcc v6 and v7;stage iii immature testicular teratoma;exactmatch
stage ii immature testicular teratoma ajcc v6 and v7;stage ii immature testicular teratoma;exactmatch
stage i immature testicular teratoma ajcc v6 and v7;stage i immature testicular teratoma;exactmatch
stage iii testicular mixed germ cell tumor ajcc v6 and v7;stage iii testicular mixed germ cell tumor;exactmatch
stage i testicular mixed germ cell tumor ajcc v6 and v7;stage i testicular mixed germ cell tumor;exactmatch
stage iv sinonasal cancer ajcc v7;stage iv nasal cavity and paranasal sinus cancer;exactmatch
stage ii testicular mixed germ cell tumor ajcc v6 and v7;stage ii testicular mixed germ cell tumor;exactmatch
stage ii nasopharyngeal carcinoma ajcc v7;stage ii nasopharyngeal carcinoma;exactmatch
stage i nasopharyngeal carcinoma ajcc v7;stage i nasopharyngeal carcinoma;exactmatch
stage iv bladder adenocarcinoma ajcc v7;stage iv bladder adenocarcinoma;exactmatch
recurrent primary mediastinal (thymic) large b-cell lymphoma;recurrent mediastinal (thymic) large b-cell lymphoma;exactmatch
malignant extragonadal germ cell tumor;malignant extragonadal germ cell tumor;exactmatch
extragonadal embryonal carcinoma;extragonadal embryonal carcinoma;exactmatch
ann arbor stage iv primary mediastinal (thymic) large b-cell lymphoma;ann arbor stage iv primary mediastinal (thymic) large b-cell lymphoma;exactmatch
ann arbor stage iii primary mediastinal (thymic) large b-cell lymphoma;ann arbor stage iii primary mediastinal (thymic) large b-cell lymphoma;exactmatch
ann arbor stage ii primary mediastinal (thymic) large b-cell lymphoma;ann arbor stage ii primary mediastinal (thymic) large b-cell lymphoma;exactmatch
ann arbor stage i primary mediastinal (thymic) large b-cell lymphoma;ann arbor stage i primary mediastinal (thymic) large b-cell lymphoma;exactmatch
refractory primary mediastinal (thymic) large b-cell lymphoma;refractory mediastinal (thymic) large b-cell lymphoma;exactmatch
ann arbor stage iv b lymphoblastic lymphoma;ann arbor stage iv b lymphoblastic lymphoma;exactmatch
stage iii bladder adenocarcinoma ajcc v6 and v7;stage iii bladder adenocarcinoma;exactmatch
ann arbor stage iii b lymphoblastic lymphoma;ann arbor stage iii b lymphoblastic lymphoma;exactmatch
ann arbor stage i b lymphoblastic lymphoma;ann arbor stage i b lymphoblastic lymphoma;exactmatch
refractory b lymphoblastic lymphoma;precursor b-lymphoblastic lymphoma refractory;exactmatch
recurrent b lymphoblastic lymphoma;recurrent b lymphoblastic lymphoma;exactmatch
b lymphoblastic lymphoma;b lymphoblastic lymphoma;exactmatch
ann arbor stage iv nodal marginal zone lymphoma;ann arbor stage iv nodal marginal zone lymphoma;exactmatch
ann arbor stage iii nodal marginal zone lymphoma;ann arbor stage iii nodal marginal zone lymphoma;exactmatch
stage i extragonadal mixed germ cell tumor;stage i extragonadal mixed germ cell tumor;exactmatch
stage iii extragonadal mixed germ cell tumor;stage iii extragonadal mixed germ cell tumor;exactmatch
immature extragonadal teratoma;immature extragonadal teratoma;exactmatch
malignant extragonadal non-seminomatous germ cell tumor;cancer of extragonadal non-seminomatous germ cell;exactmatch
stage ii bladder adenocarcinoma ajcc v6 and v7;stage ii bladder adenocarcinoma;exactmatch
stage i bladder adenocarcinoma ajcc v6 and v7;bladder adenocarcinoma stage i;exactmatch
stage 0 bladder adenocarcinoma ajcc v6 and v7;stage 0 bladder adenocarcinoma;exactmatch
placental choriocarcinoma;choriocarcinoma of placenta;exactmatch
stage iv extragonadal seminoma;stage iv extragonadal primary seminoma;exactmatch
stage iii extragonadal seminoma;stage iii extragonadal primary seminoma;exactmatch
stage ii extragonadal seminoma;stage ii extragonadal primary seminoma;exactmatch
stage iv lung cancer ajcc v7;stage iv lung cancer;exactmatch
stage iii lung cancer ajcc v7;stage iii lung cancer;exactmatch
stage iv extragonadal non-seminomatous germ cell tumor;stage iv extragonadal non-seminomatous germ cell tumor;exactmatch
stage ii lung cancer ajcc v7;stage ii lung cancer;exactmatch
stage i lung cancer ajcc v7;stage i lung cancer;exactmatch
stage iii extragonadal non-seminomatous germ cell tumor;stage iii extragonadal non-seminomatous germ cell tumor;exactmatch
stage ii extragonadal non-seminomatous germ cell tumor;stage ii extragonadal non-seminomatous germ cell tumor;exactmatch
stage i extragonadal non-seminomatous germ cell tumor;stage i extragonadal non-seminomatous germ cell tumor;exactmatch
aggressive nk-cell leukemia;aggressive nk-cell leukemia;exactmatch
recurrent chronic lymphocytic leukemia;chronic lymphocytic leukemia recurrent;exactmatch
regional adrenal gland pheochromocytoma;regional adrenal gland chromaffin neoplasm;exactmatch
stage i hypopharyngeal squamous cell carcinoma ajcc v7;stage i epidermoid carcinoma of hypopharynx;exactmatch
gata1 gene mutation;eryf1 gene mutation;exactmatch
stage iii hypopharyngeal squamous cell carcinoma ajcc v7;stage iii epidermoid carcinoma of hypopharynx;exactmatch
transient abnormal myelopoiesis associated with down syndrome;tam;exactmatch
myeloid proliferations associated with down syndrome;myeloid proliferations associated with down syndrome;exactmatch
stage ii hypopharyngeal squamous cell carcinoma ajcc v6 and v7;stage ii epidermoid carcinoma of hypopharynx;exactmatch
sonic hedgehog/patch pathway activated;shh/ptch pathway activated;exactmatch
signaling pathway status;signaling pathway status;exactmatch
recurrent nasopharyngeal undifferentiated carcinoma;recurrent lymphoepithelioma of nasopharynx;exactmatch
recurrent hypopharyngeal squamous cell carcinoma;recurrent epidermoid carcinoma of hypopharynx;exactmatch
recurrent nasopharyngeal keratinizing squamous cell carcinoma;recurrent keratinizing epidermoid carcinoma of nasopharynx;exactmatch
stage iv nasopharyngeal undifferentiated carcinoma ajcc v7;nasopharyngeal undifferentiated carcinoma stage iv;exactmatch
stage iv nasopharyngeal keratinizing squamous cell carcinoma ajcc v7;stage iv keratinizing epidermoid carcinoma of nasopharynx;exactmatch
stage iii nasopharyngeal undifferentiated carcinoma ajcc v7;nasopharyngeal undifferentiated carcinoma stage iii;exactmatch
stage iii nasopharyngeal keratinizing squamous cell carcinoma ajcc v7;stage iii keratinizing epidermoid carcinoma of nasopharynx;exactmatch
stage ii nasopharyngeal undifferentiated carcinoma ajcc v7;nasopharyngeal undifferentiated carcinoma stage ii;exactmatch
stage ii nasopharyngeal keratinizing squamous cell carcinoma ajcc v7;stage ii keratinizing epidermoid carcinoma of nasopharynx;exactmatch
stage iv hypopharyngeal squamous cell carcinoma ajcc v7;stage iv epidermoid carcinoma of hypopharynx;exactmatch
tmprss2-erg fusion protein expression;tmprss2-erg fusion protein expression;exactmatch
stage i nasopharyngeal keratinizing squamous cell carcinoma ajcc v7;stage i keratinizing epidermoid carcinoma of nasopharynx;exactmatch
"acute myeloid leukemia with t(6;9) (p23;q34.1); dek-nup214";"aml with t(6;9)(p23;q34); dek-nup214";exactmatch
acute myeloid leukemia with mutated cebpa;aml with mutated cebpa;exactmatch
acute myeloid leukemia with mutated npm1;aml with mutated npm1;exactmatch
acute myeloid leukemia with gene mutations;aml with gene mutations;exactmatch
stage iv laryngeal squamous cell carcinoma ajcc v7;stage iv epidermoid carcinoma of larynx;exactmatch
npm1 gene mutation;mutation of the nucleophosmin gene;exactmatch
"acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13.3;q13.1); rbm15-mkl1";"aml (megakaryoblastic) with t(1;22)(p13;q13); rbm15-mkl1";exactmatch
"acute myeloid leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); gata2, mecom";"aml with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); gata2, mecom";exactmatch
stage iii laryngeal verrucous carcinoma ajcc v6 and v7;stage iii laryngeal throat verrucous cancer;exactmatch
erg gene rearrangement;erg gene rearrangement;exactmatch
stage iii laryngeal squamous cell carcinoma ajcc v6 and v7;stage iii epidermoid carcinoma of larynx;exactmatch
"acute myeloid leukemia with t(9;11)(p21.3;q23.3); mllt3-mll";"aml with t(9;11)(p21.3;q23.3); kmt2a-mllt3";exactmatch
stage ii laryngeal verrucous carcinoma ajcc v6 and v7;stage ii laryngeal throat verrucous cancer;exactmatch
therapy-related myelodysplastic/myeloproliferative neoplasm;therapy-related myelodysplastic/myeloproliferative disease;exactmatch
stage ii laryngeal squamous cell carcinoma ajcc v6 and v7;stage ii epidermoid carcinoma of larynx;exactmatch
stage i laryngeal verrucous carcinoma ajcc v6 and v7;stage i laryngeal throat verrucous cancer;exactmatch
stage i laryngeal squamous cell carcinoma ajcc v6 and v7;stage i epidermoid carcinoma of larynx;exactmatch
stage i nasopharyngeal undifferentiated carcinoma ajcc v7;nasopharyngeal undifferentiated carcinoma stage i;exactmatch
natural killer cell lymphoblastic leukemia/lymphoma;nk cell lymphoblastic leukemia/lymphoma;exactmatch
b acute lymphoblastic leukemia;acute b cell lymphocytic leukemia;exactmatch
stage ii oral cavity verrucous carcinoma;stage ii mouth verrucous carcinoma;exactmatch
stage iv lip basal cell carcinoma;stage iv basal cell carcinoma of lip;exactmatch
stage iii oral cavity adenoid cystic carcinoma ajcc v6 and v7;stage iii adenoid cystic carcinoma of mouth;exactmatch
stage iii oral cavity mucoepidermoid carcinoma ajcc v6 and v7;stage iii mouth mucoepidermoid carcinoma;exactmatch
stage iii oral cavity verrucous carcinoma;stage iii mouth verrucous carcinoma;exactmatch
stage iii lip basal cell carcinoma;stage iii basal cell carcinoma of lip;exactmatch
stage ii oral cavity adenoid cystic carcinoma;stage ii adenoid cystic carcinoma of mouth;exactmatch
stage ii oral cavity mucoepidermoid carcinoma;stage ii mouth mucoepidermoid carcinoma;exactmatch
stage ii lip basal cell carcinoma;stage ii basal cell carcinoma of lip;exactmatch
stage iv oral cavity mucoepidermoid carcinoma ajcc v6 and v7;stage iv mouth mucoepidermoid carcinoma;exactmatch
stage i oral cavity adenoid cystic carcinoma ajcc v6 and v7;stage i adenoid cystic carcinoma of mouth;exactmatch
stage i oral cavity mucoepidermoid carcinoma ajcc v6 and v7;stage i mouth mucoepidermoid carcinoma;exactmatch
stage i oral cavity verrucous carcinoma;stage i mouth verrucous carcinoma;exactmatch
stage i lip basal cell carcinoma;stage i basal cell carcinoma of lip;exactmatch
nasal cavity and paranasal sinus lethal midline granuloma;midfacial necrotising lesion;exactmatch
paranasal sinus inverted papilloma;accessory sinus inverted papilloma;exactmatch
alk fusion protein expression;alk fusion protein expression;exactmatch
stage iv oral cavity verrucous carcinoma;stage iv mouth verrucous carcinoma;exactmatch
stage iv oral cavity adenoid cystic carcinoma ajcc v6 and v7;stage iv adenoid cystic carcinoma of mouth;exactmatch
blasts expressing cd56 and immature t-cell markers present;blasts expressing cd56 and immature t-cell markers present;exactmatch
"mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2); bcr-abl1";"mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2); bcr-abl1";exactmatch
blasts expressing t-lymphoid and myeloid markers present;blasts expressing t-lymphoid and myeloid markers present;exactmatch
blasts expressing b-lymphoid and myeloid markers present;blasts expressing b-lymphoid and myeloid markers present;exactmatch
mixed phenotype acute leukemia, t/myeloid, not otherwise specified;mixed phenotype acute leukemia, t/myeloid, nos;exactmatch
mixed phenotype acute leukemia, b/myeloid, not otherwise specified;mixed phenotype acute leukemia, b/myeloid, nos;exactmatch
recurrent oropharyngeal squamous cell carcinoma;recurrent epidermoid carcinoma of oropharynx;exactmatch
"mixed phenotype acute leukemia with t(v;11q23.3); mll rearranged";"mixed phenotype acute leukemia with t(v;11q23); mll rearranged";exactmatch
stage iv oropharyngeal squamous cell carcinoma ajcc v7;stage iv epidermoid carcinoma of oropharynx;exactmatch
stage iii oropharyngeal squamous cell carcinoma ajcc v7;stage iii epidermoid carcinoma of oropharynx;exactmatch
recurrent lip basal cell carcinoma;recurrent basal cell carcinoma of lip;exactmatch
blasts of mixed phenotype present;blasts of mixed phenotype present;exactmatch
stage ii oropharyngeal squamous cell carcinoma ajcc v6 and v7;stage ii epidermoid carcinoma of oropharynx;exactmatch
mixed phenotype acute leukemia;mpal;exactmatch
stage i oropharyngeal squamous cell carcinoma ajcc v6 and v7;stage i epidermoid carcinoma of oropharynx;exactmatch
recurrent oral cavity adenoid cystic carcinoma;recurrent adenoid cystic carcinoma of mouth;exactmatch
recurrent oral cavity mucoepidermoid carcinoma;recurrent mouth mucoepidermoid carcinoma;exactmatch
recurrent oral cavity verrucous carcinoma;recurrent mouth verrucous carcinoma;exactmatch
stage iv laryngeal verrucous carcinoma ajcc v7;stage iv laryngeal throat verrucous cancer;exactmatch
recurrent laryngeal squamous cell carcinoma;recurrent epidermoid carcinoma of larynx;exactmatch
recurrent laryngeal verrucous carcinoma;recurrent laryngeal throat verrucous cancer;exactmatch
adult embryonal tumor with multilayered rosettes, c19mc-altered;adult embryonal tumor with multilayered rosettes, c19mc-altered;exactmatch
hyperchromasia;hyperchromasia;exactmatch
lung papilloma;lung papilloma;exactmatch
pancreatic adenocarcinoma;adenocarcinoma - pancreas;exactmatch
adult papillary meningioma;adult papillary meningioma;exactmatch
adult pineoblastoma;adult pineoblastoma;exactmatch
adult pineocytoma;adult pineocytoma;exactmatch
mild chronic inflammation;mild chronic inflammation;exactmatch
hepatocellular large cell change;hepatocellular large cell change;exactmatch
aids-related diffuse mixed cell lymphoma;aids associated diffuse mixed cell lymphoma;exactmatch
cystic oncocytic neoplasm;cystic oncocytic neoplasm;exactmatch
adult infiltrating astrocytic tumor;adult infiltrating astrocytic neoplasm;exactmatch
bone marrow involvement;bone marrow involvement;exactmatch
bilateral breast carcinoma;bilateral breast cancer;exactmatch
desmoplastic spitz nevus;desmoplastic spitz nevus;exactmatch
meyerson nevus;halo dermatitis;exactmatch
aids-related burkitt lymphoma;aids related burkitt's lymphoma;exactmatch
odontogenesis;odontogenesis;exactmatch
aids-related diffuse small cleaved cell lymphoma;aids associated diffuse small cleaved cell lymphoma;exactmatch
ann arbor stage i adult t-cell leukemia/lymphoma;adult t-cell lymphoma/leukemia stage i;exactmatch
small lymphocytic lymphoma variant;small lymphocytic lymphoma variant;exactmatch
stage ii childhood large cell lymphoma;childhood large cell lymphoma stage ii;exactmatch
stage i childhood large cell lymphoma;childhood large cell lymphoma stage i;exactmatch
childhood acute myeloid leukemia with minimal differentiation;acute myeloid leukemia (aml) with minimal differentiation;exactmatch
adult acute myeloid leukemia with minimal differentiation;acute myeloid leukemia (aml) with minimal differentiation;exactmatch
desmoplastic small round cell tumor;dsrct;exactmatch
hypocellular tissue;hypocellular tissue;exactmatch
glandular hyperplasia;glandular hyperplasia;exactmatch
macrovesicular steatosis;hepatic macrovesicular steatosis;exactmatch
focal mammary duct ectasia;focal mammary duct ectasia;exactmatch
primary systemic amyloidosis;primary systemic amyloidosis;exactmatch
architectural distortion;architectural distortion;exactmatch
aids-related lymphoblastic lymphoma;aids associated lymphoblastic lymphoma;exactmatch
chronic viral hepatitis;chronic viral hepatitis;exactmatch
chronic hepatitis;chronic hepatitis;exactmatch
subcapsular adrenal tumor;subcapsular adrenal tumor;exactmatch
duodenal extraskeletal osteosarcoma;duodenal extraskeletal osteosarcoma;exactmatch
aids-related immunoblastic lymphoma;aids associated immunoblastic lymphoma;exactmatch
aids-related primary central nervous system lymphoma;aids related lymphoma of primary central nervous system;exactmatch
sexual dysfunction and infertility;sexual dysfunction and infertility;exactmatch
anal canal cloacogenic carcinoma;anal canal cloacogenic cancer;exactmatch
refractory neutropenia;rn;exactmatch
unilineage dysplasia present;bone marrow unilineage dysplasia present;exactmatch
myelodysplastic syndrome with single lineage dysplasia;mds-sld;exactmatch
stage ii uterine sarcoma ajcc v7;stage ii uterine sarcoma;exactmatch
stage i uterine sarcoma ajcc v7;stage i uterine sarcoma;exactmatch
adult anaplastic astrocytoma;adult anaplastic astrocytoma;exactmatch
anal basaloid carcinoma;anal basaloid carcinoma;exactmatch
abnormal finding;abnormal finding;exactmatch
cancer-related condition;cancer related condition;exactmatch
recurrent renal pelvis and ureter urothelial carcinoma;recurrent renal pelvis and ureter urothelial carcinoma;exactmatch
de novo myelodysplastic syndrome;untreated myelodysplastic syndrome;exactmatch
therapy-related acute myeloid leukemia;high-grade treatment-related myeloid neoplasm;exactmatch
recurrent adult t-cell leukemia/lymphoma;adult t-cell lymphoma/leukemia recurrent;exactmatch
ann arbor stage iv adult t-cell leukemia/lymphoma;adult t-cell lymphoma/leukemia stage iv;exactmatch
ann arbor stage iii adult t-cell leukemia/lymphoma;adult t-cell lymphoma/leukemia stage iii;exactmatch
ann arbor stage ii adult t-cell leukemia/lymphoma;adult t-cell lymphoma/leukemia stage ii;exactmatch
refractory thrombocytopenia;rt;exactmatch
myelodysplastic syndrome with excess blasts and fibrosis;myelodysplastic syndrome with excess blasts and fibrosis;exactmatch
refractory cytopenia of childhood;rcc;exactmatch
stage iii uterine sarcoma ajcc v7;stage iii uterine sarcoma;exactmatch
localized unresectable neuroblastoma;localized unresectable neuroblastoma;exactmatch
adult anaplastic (malignant) meningioma;adult anaplastic (malignant) meningioma;exactmatch
pineal gland astrocytoma;astrocytoma of pineal gland;exactmatch
adult pineal parenchymal cell neoplasm;adult pineal gland neoplasm;exactmatch
mixed astrocytoma-ependymoma-oligodendroglioma;mixed astrocytoma-ependymoma-oligodendroglioma;exactmatch
mixed astrocytoma-ependymoma;mixed astrocytoma-ependymoma;exactmatch
adult anaplastic oligodendroglioma;adult anaplastic oligodendroglioma;exactmatch
adult anaplastic ependymoma;adult anaplastic ependymoma;exactmatch
ovarian sarcoma;ovarian sarcoma;exactmatch
adult cholangiocarcinoma;adult cholangiocarcinoma;exactmatch
childhood meningioma;childhood meningioma;exactmatch
adult acute monocytic leukemia;acute monocytic leukemia;exactmatch
myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis;essential thrombocythemia with ring sideroblasts;exactmatch
ptpn11 gene mutation;bptp3 gene mutation;exactmatch
recurrent uterine corpus sarcoma;recurrent sarcoma of uterine corpus;exactmatch
alk gene mutation;alk gene mutation;exactmatch
nasal cavity inverted papilloma;inverting papilloma of nasal cavity;exactmatch
paranasal sinus squamous cell carcinoma;epidermoid carcinoma of paranasal sinus;exactmatch
childhood liposarcoma;childhood liposarcoma;exactmatch
squamous cell carcinoma of unknown primary;epidermoid carcinoma of unknown primary origin;exactmatch
recurrent adult non-hodgkin lymphoma;adult recurrent non-hodgkin's lymphoma;exactmatch
childhood malignant mesenchymoma;childhood malignant mesenchymoma;exactmatch
childhood epithelioid sarcoma;childhood epithelioid sarcoma;exactmatch
childhood malignant peripheral nerve sheath tumor;childhood mpnst;exactmatch
childhood leiomyosarcoma;childhood leiomyosarcoma;exactmatch
childhood alveolar soft part sarcoma;alveolar soft part sarcoma;exactmatch
malignant childhood hemangiopericytoma;childhood malignant hemangiopericytoma;exactmatch
adult solid neoplasm;adult solid neoplasm;exactmatch
childhood synovial sarcoma;childhood synovial sarcoma;exactmatch
childhood fibrosarcoma;childhood fibrosarcoma;exactmatch
recurrent ovarian germ cell tumor;recurrent germ cell neoplasm of ovary;exactmatch
stage iv ovarian germ cell tumor ajcc v6 and v7;stage iv malignant germ cell neoplasm of ovary;exactmatch
stage iii ovarian germ cell tumor ajcc v6 and v7;stage iii malignant germ cell neoplasm of ovary;exactmatch
stage ii ovarian germ cell tumor ajcc v6 and v7;stage ii malignant germ cell neoplasm of ovary;exactmatch
stage i ovarian germ cell tumor ajcc v6 and v7;stage i malignant germ cell neoplasm of ovary;exactmatch
undifferentiated carcinoma of unknown primary;undifferentiated carcinoma of unknown primary;exactmatch
ann arbor stage i adult non-hodgkin lymphoma;ann arbor stage i adult non-hodgkin lymphoma;exactmatch
stage ii adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma stage ii;exactmatch
ovarian monodermal and highly specialized teratoma;ovarian germ cell monodermal and highly specialized teratoma;exactmatch
immunosuppression-related post-transplant toxicity;immunosuppression-related post-transplant toxicity;exactmatch
ann arbor stage ii grade 3 follicular lymphoma;ann arbor stage ii grade 3 follicular lymphoma;exactmatch
stage ii intermediate grade adult non-hodgkin's lymphoma;stage ii intermediate grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage ii grade 2 follicular lymphoma;ann arbor stage ii grade 2 follicular lymphoma;exactmatch
ann arbor stage ii grade 1 follicular lymphoma;ann arbor stage ii grade 1 follicular lymphoma;exactmatch
ann arbor stage ii small lymphocytic lymphoma;ann arbor stage ii small lymphocytic lymphoma;exactmatch
ovarian mixed germ cell tumor;mixed germ cell neoplasm of ovary;exactmatch
mature ovarian teratoma;mature ovarian teratoma;exactmatch
ann arbor stage ii adult non-hodgkin lymphoma;adult non-hodgkin's lymphoma stage ii;exactmatch
immature ovarian teratoma;grade 2 ovarian teratoma;exactmatch
ovarian teratoma;germ cell teratoma of ovary;exactmatch
ovarian embryonal carcinoma;embryonal carcinoma of ovary;exactmatch
ovarian yolk sac tumor;endodermal sinus neoplasm of ovary;exactmatch
ovarian dysgerminoma;dysgerminoma of ovary;exactmatch
ann arbor stage iv adult non-hodgkin lymphoma;adult non-hodgkin's lymphoma stage iv;exactmatch
ann arbor stage iii adult non-hodgkin lymphoma;adult non-hodgkin's lymphoma stage iii;exactmatch
stage ii low grade adult non-hodgkin's lymphoma;stage ii low grade adult non-hodgkin's lymphoma;exactmatch
stage i high grade adult non-hodgkin's lymphoma;stage i high grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage i adult burkitt lymphoma;adult diffuse small non-cleaved cell lymphoma stage i;exactmatch
ann arbor stage ii childhood hodgkin lymphoma;ann arbor stage ii childhood hodgkin lymphoma;exactmatch
childhood nodular sclerosis classic hodgkin lymphoma;childhood hodgkin's nodular sclerosis;exactmatch
childhood lymphocyte-depleted classic hodgkin lymphoma;childhood ldhd;exactmatch
childhood nodular lymphocyte predominant hodgkin lymphoma;childhood nlphd;exactmatch
recurrent childhood hodgkin lymphoma;recurrent childhood hodgkin lymphoma;exactmatch
ann arbor stage iv childhood hodgkin lymphoma;ann arbor stage iv childhood hodgkin lymphoma;exactmatch
ann arbor stage iii childhood hodgkin lymphoma;ann arbor stage iii childhood hodgkin lymphoma;exactmatch
ann arbor stage i childhood hodgkin lymphoma;ann arbor stage i childhood hodgkin lymphoma;exactmatch
thyroid gland follicular carcinoma;carcinoma, follicular cell, malignant;exactmatch
ann arbor stage i adult lymphoblastic lymphoma;adult lymphoblastic lymphoma stage i;exactmatch
malignant ovarian sex cord-stromal tumor;malignant ovarian sex cord-stromal neoplasm;exactmatch
biological model;biological model;exactmatch
recurrent oropharyngeal carcinoma;oropharyngeal cancer, recurrent;exactmatch
stage iii oropharyngeal carcinoma ajcc v6;oropharyngeal cancer, stage iii ajcc v6;exactmatch
stage ii oropharyngeal carcinoma ajcc v6 and v7;oropharyngeal cancer, stage ii;exactmatch
stage i oropharyngeal carcinoma ajcc v6 and v7;oropharyngeal cancer, stage i;exactmatch
recurrent adrenal gland pheochromocytoma;recurrent adrenal gland chromaffin neoplasm;exactmatch
childhood mixed cellularity classic hodgkin lymphoma;childhood mchd;exactmatch
metastatic renal pelvis and ureter urothelial carcinoma;metastatic renal pelvis and ureter urothelial carcinoma;exactmatch
localized childhood rhabdomyosarcoma;localized childhood rhabdomyosarcoma;exactmatch
metastatic childhood soft tissue sarcoma;metastatic childhood sarcoma of soft tissue;exactmatch
ann arbor stage i adult immunoblastic lymphoma;adult immunoblastic large cell lymphoma stage i;exactmatch
stage i adult diffuse large cell lymphoma;adult diffuse large cell lymphoma stage i;exactmatch
stage i adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma stage i;exactmatch
stage i adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma stage i;exactmatch
stage i intermediate grade adult non-hodgkin's lymphoma;stage i intermediate grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage i grade 3 follicular lymphoma;ann arbor stage i grade 3 follicular lymphoma;exactmatch
ann arbor stage i grade 2 follicular lymphoma;ann arbor stage i grade 2 follicular lymphoma;exactmatch
ann arbor stage i grade 1 follicular lymphoma;ann arbor stage i grade 1 follicular lymphoma;exactmatch
ann arbor stage i small lymphocytic lymphoma;ann arbor stage i small lymphocytic lymphoma;exactmatch
bone marrow failure;bone marrow failure;exactmatch
chemotherapy-related leukemia;chemotherapy-related leukemia;exactmatch
stage i low grade adult non-hodgkin's lymphoma;stage i low grade adult non-hodgkin's lymphoma;exactmatch
therapy-related leukemia;therapy related leukemia;exactmatch
adult non-hodgkin's lymphoma stage;adult non-hodgkin's lymphoma stage;exactmatch
recurrent childhood soft tissue sarcoma;recurrent childhood sarcoma of soft tissue;exactmatch
ribonucleic acid;r;exactmatch
stage ii adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma stage ii;exactmatch
nasal cavity squamous cell carcinoma;nasal cavity squamous cell carcinoma;exactmatch
hard palate squamous cell carcinoma;hard palate scc;exactmatch
lower gingival verrucous carcinoma;lower gingival verrucous carcinoma;exactmatch
fibroblastic reticular cell tumor;fibroblastic reticular cell tumor;exactmatch
buccal mucosa verrucous carcinoma;buccal mucosa verrucous carcinoma;exactmatch
oral cavity verrucous carcinoma;ackerman tumor;exactmatch
upper gingival squamous cell carcinoma;scc of upper gingiva;exactmatch
retromolar trigone squamous cell carcinoma;retromolar trigone squamous cell carcinoma;exactmatch
lower gingival squamous cell carcinoma;lower gingival scc;exactmatch
anterior tongue squamous cell carcinoma;anterior tongue scc;exactmatch
indeterminate dendritic cell tumor;indeterminate cell histiocytosis;exactmatch
regional renal pelvis and ureter urothelial carcinoma;regional renal pelvis and ureter urothelial carcinoma;exactmatch
localized renal pelvis and ureter urothelial carcinoma;localized renal pelvis and ureter urothelial carcinoma;exactmatch
adult non-hodgkin's lymphoma grade;adult non-hodgkin's lymphoma grade;exactmatch
recurrent adult lymphoblastic lymphoma;adult recurrent lymphoblastic lymphoma;exactmatch
recurrent adult immunoblastic lymphoma;recurrent adult immunoblastic large cell lymphoma;exactmatch
recurrent high grade adult non-hodgkin's lymphoma;recurrent high grade adult non-hodgkin's lymphoma;exactmatch
recurrent adult diffuse large cell lymphoma;recurrent adult diffuse large cell lymphoma;exactmatch
cytokeratin-positive neoplastic cells present;cytokeratin-positive neoplastic cells present;exactmatch
oral cavity mucoepidermoid carcinoma;mucoepidermoid carcinoma of oral cavity;exactmatch
stage ii adult diffuse large cell lymphoma;adult diffuse large cell lymphoma stage ii;exactmatch
benign epithelioid cell type gastrointestinal stromal tumor;benign epithelioid cell type gastrointestinal stromal tumor;exactmatch
supraglottic verrucous carcinoma;supraglottic verrucous carcinoma;exactmatch
subglottic verrucous carcinoma;subglottic verrucous carcinoma;exactmatch
glottis verrucous carcinoma;glottic verrucous carcinoma;exactmatch
laryngeal verrucous carcinoma;laryngeal throat verrucous cancer;exactmatch
subglottic squamous cell carcinoma;epidermoid carcinoma of subglottis;exactmatch
glottic squamous cell carcinoma;epidermoid carcinoma of glottis;exactmatch
malignant epithelioid cell type gastrointestinal stromal tumor;leiomyoblastoma, malignant;exactmatch
postcricoid squamous cell carcinoma;epidermoid carcinoma of postcricoid area;exactmatch
disseminated juvenile xanthogranuloma;disseminated jxg;exactmatch
tonsillar undifferentiated carcinoma;tonsillar lymphoepithelioma;exactmatch
tonsillar squamous cell carcinoma;scc of tonsil;exactmatch
posterior tongue squamous cell carcinoma;posterior tongue scc;exactmatch
oropharyngeal squamous cell carcinoma;epidermoid carcinoma of oropharynx;exactmatch
floor of mouth adenoid cystic carcinoma;adenoid cystic carcinoma of floor of mouth;exactmatch
oral cavity adenoid cystic carcinoma;adenoid cystic carcinoma of mouth;exactmatch
floor of mouth mucoepidermoid carcinoma;floor of mouth mucoepidermoid carcinoma;exactmatch
recurrent adult diffuse mixed cell lymphoma;recurrent adult diffuse mixed cell lymphoma;exactmatch
recurrent adult burkitt lymphoma;recurrent adult burkitt lymphoma;exactmatch
recurrent grade 3 follicular lymphoma;recurrent follicular large cell lymphoma;exactmatch
stage iii intermediate grade adult non-hodgkin's lymphoma;stage iii intermediate grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage iii adult immunoblastic lymphoma;adult immunoblastic large cell lymphoma stage iii;exactmatch
stage iii high grade adult non-hodgkin's lymphoma;stage iii high grade adult non-hodgkin's lymphoma;exactmatch
stage iii adult diffuse large cell lymphoma;adult diffuse large cell lymphoma stage iii;exactmatch
stage iii adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma stage iii;exactmatch
stage iii adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma stage iii;exactmatch
elevated test result;elevated test result;exactmatch
ann arbor stage iii grade 3 follicular lymphoma;ann arbor stage iii grade 3 follicular lymphoma;exactmatch
ann arbor stage iii grade 2 follicular lymphoma;ann arbor stage iii grade 2 follicular lymphoma;exactmatch
recurrent intermediate grade adult non-hodgkin's lymphoma;recurrent intermediate grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage iii grade 1 follicular lymphoma;ann arbor stage iii grade 1 follicular lymphoma;exactmatch
ann arbor stage iii small lymphocytic lymphoma;ann arbor stage iii small lymphocytic lymphoma;exactmatch
stage iii low grade adult non-hodgkin's lymphoma;stage iii low grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage ii adult burkitt lymphoma;adult diffuse small non-cleaved cell lymphoma stage ii;exactmatch
ann arbor stage ii adult lymphoblastic lymphoma;adult lymphoblastic lymphoma stage ii;exactmatch
ann arbor stage ii adult immunoblastic lymphoma;adult immunoblastic large cell lymphoma stage ii;exactmatch
stage ii high grade adult non-hodgkin's lymphoma;stage ii high grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage iii adult lymphoblastic lymphoma;adult lymphoblastic lymphoma stage iii;exactmatch
ann arbor stage iii adult burkitt lymphoma;adult diffuse small non-cleaved cell lymphoma stage iii;exactmatch
stage iv low grade adult non-hodgkin's lymphoma;stage iv low grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage iv small lymphocytic lymphoma;ann arbor stage iv small lymphocytic lymphoma;exactmatch
recurrent grade 2 follicular lymphoma;recurrent follicular mixed cell lymphoma;exactmatch
recurrent grade 1 follicular lymphoma;recurrent follicular small cleaved cell lymphoma;exactmatch
recurrent small lymphocytic lymphoma;recurrent b-cell small lymphocytic lymphoma;exactmatch
recurrent low grade adult non-hodgkin's lymphoma;recurrent low grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage iv adult burkitt lymphoma;adult diffuse small non-cleaved cell lymphoma stage iv;exactmatch
ann arbor stage iv adult lymphoblastic lymphoma;adult lymphoblastic lymphoma stage iv;exactmatch
ann arbor stage iv adult immunoblastic lymphoma;adult immunoblastic large cell lymphoma stage iv;exactmatch
stage iv high grade adult non-hodgkin's lymphoma;stage iv high grade adult non-hodgkin's lymphoma;exactmatch
stage iv adult diffuse large cell lymphoma;adult diffuse large cell lymphoma stage iv;exactmatch
stage iv adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma stage iv;exactmatch
stage iv adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma stage iv;exactmatch
ann arbor stage iv grade 3 follicular lymphoma;ann arbor stage iv grade 3 follicular lymphoma;exactmatch
stage iv intermediate grade adult non-hodgkin's lymphoma;stage iv intermediate grade adult non-hodgkin's lymphoma;exactmatch
ann arbor stage iv grade 2 follicular lymphoma;ann arbor stage iv grade 2 follicular lymphoma;exactmatch
ann arbor stage iv grade 1 follicular lymphoma;ann arbor stage iv grade 1 follicular lymphoma;exactmatch
stage iii childhood large cell lymphoma;childhood large cell lymphoma stage iii;exactmatch
stage iv childhood large cell lymphoma;childhood large cell lymphoma stage iv;exactmatch
recurrent childhood large cell lymphoma;recurrent childhood large cell lymphoma;exactmatch
metastatic malignant neoplasm in the epididymis;metastatic malignant neoplasm in the epididymis;exactmatch
metastatic malignant neoplasm in the ciliary body;metastasis to the ciliary body;exactmatch
metastatic malignant neoplasm in the brain stem;metastatic malignant neoplasm in the brain stem;exactmatch
benign brain stem neoplasm;benign brain stem neoplasm;exactmatch
benign cerebral neoplasm;benign cerebral hemispheric neoplasm;exactmatch
metastatic malignant neoplasm in the nervous system;metastases to nervous system;exactmatch
metastatic malignant neoplasm in the placenta;metastasis to placenta;exactmatch
benign placental neoplasm;benign neoplasm of placenta;exactmatch
metastatic malignant neoplasm in the pancreas;metastatic cancer to the pancreas;exactmatch
metastatic malignant neoplasm in the retina;metastasis to the retina;exactmatch
metastatic malignant neoplasm in the lip;metastasis to the lip;exactmatch
splenic hemangioma;angioma of spleen;exactmatch
respiratory system signs and symptoms;respiratory system signs and symptoms;exactmatch
subcutaneous hemangioma;angioma of subcutaneous tissue;exactmatch
benign great vessel neoplasm;benign great vessel neoplasm;exactmatch
malignant blood vessel neoplasm;malignant blood vessel neoplasm;exactmatch
benign blood vessel neoplasm;benign blood vessel neoplasm;exactmatch
metastatic malignant neoplasm in the choroid;metastatic malignant neoplasm in the choroid;exactmatch
metastatic malignant neoplasm in the orbit;metastasis to the orbit;exactmatch
localized malignant neoplasm;local cancer;exactmatch
visual pathway glioma;glioma of visual pathway;exactmatch
myelodysplastic syndrome with multilineage dysplasia;mds-mld;exactmatch
stage iic adult soft tissue sarcoma;stage iic adult sarcoma of soft tissue;exactmatch
stage iib adult soft tissue sarcoma ajcc v7;stage iib adult sarcoma of soft tissue;exactmatch
stage iia adult soft tissue sarcoma ajcc v7;stage iia adult sarcoma of soft tissue;exactmatch
stage ib adult soft tissue sarcoma ajcc v7;stage ib adult sarcoma of soft tissue;exactmatch
stage ia adult soft tissue sarcoma ajcc v7;stage ia adult sarcoma of soft tissue;exactmatch
adult choroid plexus neoplasm;adult choroid plexus neoplasm;exactmatch
metastatic malignant neoplasm of unknown primary;cancer of unknown primary site;exactmatch
metastatic malignant neoplasm in the parathyroid glands;metastasis to the parathyroid gland;exactmatch
ann arbor stage ii adult non-contiguous immunoblastic lymphoma;ann arbor stage ii adult non-contiguous immunoblastic lymphoma;exactmatch
ann arbor stage ii adult contiguous immunoblastic lymphoma;ann arbor stage ii adult contiguous immunoblastic lymphoma;exactmatch
undifferentiated high grade pleomorphic sarcoma of bone;malignant bone fibrous histiocytoma;exactmatch
ocular melanoma;eye melanoma;exactmatch
malignant male reproductive system neoplasm;male reprod. system cancer, nos;exactmatch
erythroleukemia in remission;erythroleukemia in remission;exactmatch
malignant paraganglioma;malignant neoplasm of paraganglion;exactmatch
benign pericardial neoplasm;benign neoplasm of pericardium;exactmatch
benign epicardial neoplasm;benign epicardial neoplasm;exactmatch
stage iv hypopharyngeal carcinoma ajcc v6;stage iv carcinoma of hypopharynx ajcc v6;exactmatch
invasive malignant neoplasm;infiltrating malignant neoplasm;exactmatch
malignant neoplasm with regional lymph node involvement;cancer with regional lymph node involvement;exactmatch
refractory carcinoma;refractory carcinoma;exactmatch
progressive neoplastic disease;pd-progressive disease;exactmatch
primary neoplasm;primary;exactmatch
positive axillary lymph node;positive axillary lymph node;exactmatch
sinus histiocytosis;sinus histiocytosis;exactmatch
malignant leptomeningeal neoplasm;malignant leptomeningeal neoplasm;exactmatch
indolent non-hodgkin lymphoma;indolent non-hodgkin lymphoma;exactmatch
benign paranasal sinus neoplasm;benign accessory sinus neoplasm;exactmatch
proteus syndrome;proteus syndrome;exactmatch
chronic lymphoblastic lymphoma;chronic lymphoblastic lymphoma;exactmatch
brain stem glioma;brain stem glioma;exactmatch
bilateral carcinoma;bilateral cancer;exactmatch
isocitrate dehydrogenase [nadp], mitochondrial;ec 1.1.1.42;exactmatch
hereditary melanoma;familial cutaneous melanoma;exactmatch
neurofibromatosis 1 and 2 (nf1 and nf2);neurofibromatosis 1 and 2 (nf1 and nf2);exactmatch
stage i colorectal cancer ajcc v6 and v7;colorectal cancer, stage i;exactmatch
stage ii colorectal cancer ajcc v6;colorectal cancer, stage ii ajcc v6;exactmatch
stage iii colorectal cancer ajcc v6;colorectal cancer, stage iii ajcc v6;exactmatch
stage iv colorectal cancer ajcc v6;astler-coller d colorectal cancer;exactmatch
benign respiratory system neoplasm;benign respiratory system neoplasm;exactmatch
metastatic malignant neoplasm in the chest wall;metastasis to the chest wall;exactmatch
benign chest wall neoplasm;benign chest wall neoplasm;exactmatch
metastatic malignant neoplasm in the neck;metastases to neck;exactmatch
metastatic malignant neoplasm in the sternum;metastasis to the sternum;exactmatch
benign sebaceous neoplasm;benign neoplasm of sebaceous gland;exactmatch
locally advanced malignant neoplasm;locally advanced cancer;exactmatch
47,xyy syndrome;47,xyy;exactmatch
ann arbor stage iv non-hodgkin lymphoma;ann arbor stage iv non-hodgkin lymphoma;exactmatch
ann arbor stage iii non-hodgkin lymphoma;ann arbor stage iii non-hodgkin lymphoma;exactmatch
ann arbor stage ii non-hodgkin lymphoma;ann arbor stage ii non-hodgkin lymphoma;exactmatch
ann arbor stage i non-hodgkin lymphoma;ann arbor stage i non-hodgkin lymphoma;exactmatch
ann arbor stage iv hodgkin lymphoma;ann arbor stage iv hodgkin lymphoma;exactmatch
ann arbor stage ii hodgkin lymphoma;ann arbor stage ii hodgkin lymphoma;exactmatch
ann arbor stage i hodgkin lymphoma;ann arbor stage i hodgkin lymphoma;exactmatch
stage ivb pancreatic cancer;pancreatic cancer stage ivb;exactmatch
infiltrating cervical carcinoma;infiltrating cervical cancer;exactmatch
hereditary retinoblastoma;familial retinoblastoma;exactmatch
recurrent breast inflammatory carcinoma;recurrent breast inflammatory carcinoma;exactmatch
chronic myelomonocytic leukemia in remission;cmml in remission;exactmatch
metastatic malignant neoplasm in the abdominal cavity;metastases to the abdominal cavity;exactmatch
hepatobiliary neoplasm;hepatic and biliary neoplasms;exactmatch
myeloid sarcoma in remission;chloroma (in remission);exactmatch
benign peritoneal neoplasm;benign peritoneal neoplasm;exactmatch
metastatic malignant neoplasm in the adrenal gland;metastases to adrenals;exactmatch
malignant hepatobiliary neoplasm;malignant hepato-biliary neoplasm;exactmatch
stage ii testicular choriocarcinoma ajcc v6 and v7;stage ii testicular choriocarcinoma;exactmatch
recurrent colorectal carcinoma;colorectal cancer, recurrent;exactmatch
stage iiic cutaneous melanoma ajcc v7;stage iiic cutaneous (skin) melanoma;exactmatch
stage iiib cutaneous melanoma ajcc v7;stage iiib cutaneous (skin) melanoma;exactmatch
anaplastic (malignant) intraspinal meningioma;anaplastic (malignant) intraspinal meningioma;exactmatch
stage iiia cutaneous melanoma ajcc v7;stage iiia cutaneous (skin) melanoma;exactmatch
recurrent lymphoplasmacytic lymphoma;recurrent lymphoplasmacytic lymphoma;exactmatch
stage iic cutaneous melanoma ajcc v6 and v7;stage iic cutaneous (skin) melanoma;exactmatch
stage iia cutaneous melanoma ajcc v6 and v7;stage iia cutaneous (skin) melanoma;exactmatch
pure erythroid leukemia in remission;pure erythroid leukemia in remission;exactmatch
stage iv gastric cancer with metastasis;stage iv gastric cancer with metastasis;exactmatch
childhood ependymoma;childhood ependymoma;exactmatch
stage iv rectosigmoid cancer ajcc v6;stage iv rectosigmoid cancer;exactmatch
recurrent hepatoblastoma;hepatoblastoma, recurrent;exactmatch
resectable hepatoblastoma;hepatoblastoma, resectable;exactmatch
unresectable hepatoblastoma;hepatoblastoma, nonresectable;exactmatch
resectable extrahepatic bile duct carcinoma;bile duct cancer, resectable;exactmatch
resectable small intestinal carcinoma;resectable carcinoma of small bowel;exactmatch
unresectable small intestinal carcinoma;non-resectable carcinoma of small bowel;exactmatch
metastatic small intestinal carcinoma;metastatic carcinoma from the small bowel;exactmatch
stage iii rectosigmoid cancer ajcc v6;stage iii rectosigmoid cancer;exactmatch
recurrent esophageal adenocarcinoma;esophageal adenocarcinoma, recurrent;exactmatch
recurrent rectosigmoid carcinoma;rectosigmoid cancer, recurrent;exactmatch
recurrent esophageal squamous cell carcinoma;recurrent esophageal squamous cell cancer;exactmatch
stage iv esophageal adenocarcinoma ajcc v7;esophageal adenocarcinoma, stage iv;exactmatch
stage iii esophageal adenocarcinoma ajcc v7;esophageal adenocarcinoma, stage iii;exactmatch
stage i esophageal adenocarcinoma ajcc v7;esophageal adenocarcinoma, stage i;exactmatch
stage 0 esophageal adenocarcinoma ajcc v7;adenocarcinoma in situ of esophagus;exactmatch
stage ii esophageal adenocarcinoma ajcc v7;esophageal adenocarcinoma, stage ii;exactmatch
stage ib cutaneous melanoma ajcc v7;stage ib cutaneous (skin) melanoma;exactmatch
renal pelvis papillary urothelial neoplasm;papillary neoplasm of renal pelvis;exactmatch
stage ia cutaneous melanoma ajcc v7;stage ia cutaneous (skin) melanoma;exactmatch
stage iii soft tissue sarcoma ajcc v7;stage iii sarcoma of soft tissue;exactmatch
acute myelomonocytic leukemia in remission;acute myelomonocytic leukemia in remission;exactmatch
stage i merkel cell carcinoma ajcc v7;stage i merkel cell cancer;exactmatch
stage 0 merkel cell carcinoma ajcc v7;stage 0 merkel cell carcinoma;exactmatch
fanconi anemia complementation group protein;fanconi anemia complementation group protein;exactmatch
childhood ovarian germ cell tumor;childhood ovarian germ cell neoplasm;exactmatch
precancerous polyp;precancerous polyp;exactmatch
stage iv soft tissue sarcoma ajcc v7;stage iv sarcoma of soft tissue;exactmatch
stage iic soft tissue sarcoma;stage iic sarcoma of soft tissue;exactmatch
pleomorphic adenoma;pleomorphic adenoma;exactmatch
stage ib breast cancer ajcc v7;stage ib breast cancer;exactmatch
stage ia breast cancer ajcc v7;stage ia breast cancer;exactmatch
stage ia soft tissue sarcoma ajcc v7;stage ia sarcoma of soft tissue;exactmatch
stage iib soft tissue sarcoma ajcc v7;stage iib sarcoma of soft tissue;exactmatch
stage iia soft tissue sarcoma ajcc v7;stage iia sarcoma of soft tissue;exactmatch
stage ib soft tissue sarcoma ajcc v7;stage ib sarcoma of soft tissue;exactmatch
recurrent childhood ependymoma;recurrent childhood ependymoma;exactmatch
stage ia merkel cell carcinoma ajcc v7;stage ia merkel cell carcinoma;exactmatch
stage ib merkel cell carcinoma ajcc v7;stage ib merkel cell carcinoma;exactmatch
stage ii merkel cell carcinoma ajcc v7;stage ii merkel cell cancer;exactmatch
stage iia merkel cell carcinoma ajcc v7;stage iia merkel cell carcinoma;exactmatch
retinal melanoma;malignant melanoma of retina;exactmatch
stage ii extragonadal mixed germ cell tumor;stage ii extragonadal mixed germ cell tumor;exactmatch
retro-orbital neoplasm;retro-orbital neoplasm;exactmatch
vulvar angiokeratoma;vulvar angiokeratoma;exactmatch
postcricoid carcinoma;cancer of postcricoid area;exactmatch
leukemic phase of lymphoma;leukemic lymphoma;exactmatch
benign chondrogenic neoplasm;benign cartilaginous neoplasm;exactmatch
testicular germ cell tumor;germ cell neoplasm of testis;exactmatch
stage iv merkel cell carcinoma ajcc v7;stage iv merkel cell cancer;exactmatch
lymphocyte predominant type hodgkin's disease;lymphocyte predominant type hodgkin's disease;exactmatch
stage iiib merkel cell carcinoma ajcc v7;stage iiib merkel cell carcinoma;exactmatch
stage iiia merkel cell carcinoma ajcc v7;stage iiia merkel cell carcinoma;exactmatch
stage iii merkel cell carcinoma ajcc v7;stage iii merkel cell cancer;exactmatch
stage iic merkel cell carcinoma ajcc v7;stage iic merkel cell carcinoma;exactmatch
stage iib merkel cell carcinoma ajcc v7;stage iib merkel cell carcinoma;exactmatch
hereditary kidney wilms tumor;familial kidney wilms tumor;exactmatch
idh2 gene;idh2;exactmatch
childhood large cell lymphoma;childhood large cell lymphoma;exactmatch
functioning pituitary gland adenoma;functioning adenoma of pituitary;exactmatch
soft palate carcinoma;carcinoma of soft palate;exactmatch
hard palate carcinoma;carcinoma of hard palate;exactmatch
lower gingival carcinoma;carcinoma of lower gingiva;exactmatch
upper gingival carcinoma;carcinoma of upper gingiva;exactmatch
tbxt gene duplication;t (brachyury) gene duplication;exactmatch
squamous metaplasia of bladder;squamous metaplasia of bladder;exactmatch
recurrent childhood cerebellar astrocytoma;recurrent cerebellar astrocytoma;exactmatch
childhood cerebral diffuse astrocytoma;childhood cerebral diffuse astrocytoma;exactmatch
sublingual gland carcinoma;carcinoma of sublingual gland;exactmatch
endometrioid stromal and related neoplasms;endometrioid stromal and related neoplasms;exactmatch
kidney adenoma;adenoma, renal cell, benign;exactmatch
florid cemento-osseous dysplasia;florid cod;exactmatch
undifferentiated pleomorphic sarcoma with osteoclast-like giant cells;giant cell fibrous histiocytoma;exactmatch
papillary serous cystadenocarcinoma;papillary serous adenocarcinoma;exactmatch
adenocarcinoma in situ in villous adenoma;adenocarcinoma in situ in villous adenoma;exactmatch
bowenoid papulosis;bowenoid papulosis;exactmatch
submandibular gland carcinoma;carcinoma of submandibular gland;exactmatch
gastric fundus carcinoma;cancer of fundus of stomach;exactmatch
dysplastic cerebellar gangliocytoma;dysplastic cerebellar gangliocytoma;exactmatch
malignant sebaceous neoplasm;malignant neoplasm of sebaceous gland;exactmatch
benign ear neoplasm;aural neoplasms, benign;exactmatch
benign sternal neoplasm;benign neoplasm of sternum;exactmatch
benign supraglottis neoplasm;benign neoplasm of supraglottis;exactmatch
stage iv rectal cancer ajcc v6;ajcc stage iv rectal cancer v6;exactmatch
metastatic malignant neoplasm in the colon;metastatic malignant neoplasm in the colon;exactmatch
breast melanoma;breast melanoma;exactmatch
fgfr4 gene mutation;cd334 gene mutation;exactmatch
malignant sternal neoplasm;malignant neoplasm of sternum;exactmatch
gastric body carcinoma;cancer of body of stomach;exactmatch
posterior tongue carcinoma;base of tongue carcinoma;exactmatch
benign choroid plexus neoplasm;benign choroid plexus neoplasm;exactmatch
renal pelvis neoplasm;kidney pelvis neoplasm;exactmatch
malignant ovarian granulosa cell tumor;malignant granulosa cell neoplasm of ovary;exactmatch
fibrohistiocytic neoplasm;fibrohistiocytic neoplasm;exactmatch
jejunal neoplasm;jejunal neoplasm;exactmatch
gastric antrum carcinoma in situ ajcc v6 and v7;carcinoma in situ of the antrum;exactmatch
lymphangiomatosis;lymphangiomatosis;exactmatch
hamartomatous polyp;hamartomatous polyp;exactmatch
connective tissue nevus;collagen hamartoma;exactmatch
ann arbor stage ii lymphoma;ann arbor stage ii lymphoma;exactmatch
severe cytologic atypia;severe cytologic atypia;exactmatch
moderate cytologic atypia;moderate cytologic atypia;exactmatch
mild cytologic atypia;mild cytologic atypia;exactmatch
cytologic atypia;atypical;exactmatch
soft tissue amyloid neoplasm;soft tissue amyloid neoplasm;exactmatch
ann arbor stage iv lymphoma;ann arbor stage iv lymphoma;exactmatch
ann arbor stage iii lymphoma;ann arbor stage iii lymphoma;exactmatch
ann arbor stage i lymphoma;ann arbor stage i lymphoma;exactmatch
grade ii intraepithelial neoplasia;grade 2 intraepithelial neoplasia;exactmatch
colorectal serrated lesions and polyps;colorectal mixed hyperplastic adenomatous polyp;exactmatch
cellular pleomorphic adenoma;cellular pleomorphic adenoma;exactmatch
malignant cells with nuclei of various sizes and shapes present;malignant cells with nuclei of various sizes and shapes present;exactmatch
breast classic lobular carcinoma in situ type b;breast classic lobular carcinoma in situ type b;exactmatch
breast classic lobular carcinoma in situ type a;breast classic lobular carcinoma in situ type a;exactmatch
leptomeningeal sarcoma;leptomeningeal sarcoma;exactmatch
fibrous polyp;fibrous polyp;exactmatch
squamous cell atypia;squamous cell atypia;exactmatch
squamous cell intraepithelial neoplasia;sil;exactmatch
low grade squamous intraepithelial neoplasia;grade 1 squamous intraepithelial neoplasia;exactmatch
high grade squamous intraepithelial neoplasia;hsil;exactmatch
low grade intraepithelial neoplasia;grade 1 intraepithelial neoplasia;exactmatch
intraepithelial neoplasia;epithelial dysplasia;exactmatch
severe dysplasia;severe;exactmatch
moderate dysplasia;moderate;exactmatch
mild dysplasia;mild;exactmatch
intestinal metaplasia;intestinal metaplasia;exactmatch
apocrine metaplasia;apocrine metaplasia;exactmatch
glandular metaplasia;glandular metaplasia;exactmatch
atypical glandular hyperplasia;atypical glandular hyperplasia;exactmatch
atypical hyperplasia;atypical hyperplasia;exactmatch
koilocytotic atypia;koilocytosis;exactmatch
microscopic finding;microscopic finding;exactmatch
malignant subcapsular adrenal tumor;adrenal tumor, subcapsular, malignant;exactmatch
benign subcapsular adrenal tumor;adrenal tumor, subcapsular, benign;exactmatch
glandular cell atypia;glandular cell atypia;exactmatch
benign bartholin gland neoplasm;benign bartholin gland neoplasm;exactmatch
diffuse malignant mesothelioma;diffuse malignant mesothelioma;exactmatch
palb2 gene;palb2;exactmatch
ann arbor stage ii grade 3 contiguous follicular lymphoma;ann arbor stage ii grade 3 contiguous follicular lymphoma;exactmatch
ann arbor stage ii non-contiguous adult non-hodgkin lymphoma;adult non-contiguous non-hodgkin's lymphoma stage ii;exactmatch
ann arbor stage ii contiguous adult lymphoblastic lymphoma;adult contiguous lymphoblastic lymphoma stage ii;exactmatch
stage ii contiguous adult diffuse large cell lymphoma;contiguous adult diffuse large cell lymphoma stage ii;exactmatch
stage ii contiguous adult diffuse mixed cell lymphoma;contiguous adult diffuse mixed cell lymphoma stage ii;exactmatch
ann arbor stage ii contiguous mantle cell lymphoma;ann arbor stage ii contiguous mantle cell lymphoma;exactmatch
ann arbor stage ii contiguous adult aggressive non-hodgkin lymphoma;adult aggressive contiguous non-hodgkin's lymphoma stage ii;exactmatch
stage ii contiguous adult diffuse small cleaved cell lymphoma;contiguous stage ii adult diffuse small cleaved cell lymphoma;exactmatch
ann arbor stage ii grade 2 contiguous follicular lymphoma;ann arbor stage ii grade 2 contiguous follicular lymphoma;exactmatch
ann arbor stage ii non-contiguous aggressive adult non-hodgkin lymphoma;aggressive non-contiguous adult non-hodgkin's lymphoma stage ii;exactmatch
ann arbor stage ii grade 1 contiguous follicular lymphoma;ann arbor stage ii grade 1 contiguous follicular lymphoma;exactmatch
ann arbor stage ii contiguous adult indolent non-hodgkin lymphoma;adult indolent contiguous non-hodgkin's lymphoma stage ii;exactmatch
denys-drash syndrome;dds;exactmatch
ann arbor stage ii contiguous adult non-hodgkin lymphoma;adult contiguous non-hodgkin's lymphoma stage ii;exactmatch
costello syndrome;costello syndrome;exactmatch
ann arbor stage i mantle cell lymphoma;ann arbor stage i mantle cell lymphoma;exactmatch
ann arbor stage i indolent adult non-hodgkin lymphoma;ann arbor stage i indolent adult non-hodgkin lymphoma;exactmatch
ann arbor stage ii non-contiguous adult indolent non-hodgkin lymphoma;adult indolent non-contiguous non-hodgkin's lymphoma stage ii;exactmatch
stage ii non-contiguous adult diffuse large cell lymphoma;non-contiguous adult diffuse large cell lymphoma stage ii;exactmatch
cervical condyloma;cervical condyloma;exactmatch
recurrent mantle cell lymphoma;recurrent mantle cell lymphoma;exactmatch
lynch syndrome;familial non-polyposis colon cancer (hmsh2, hmlh1, hpms1, hpms2);exactmatch
brca1/2-associated hereditary breast and ovarian cancer syndrome;brca1/2-associated hereditary breast and ovarian cancer syndrome;exactmatch
aggressive adult non-hodgkin lymphoma;adult aggressive non-hodgkin's lymphoma;exactmatch
nelson syndrome;nelson syndrome;exactmatch
indolent adult non-hodgkin lymphoma;adult indolent non-hodgkin's lymphoma;exactmatch
muir-torre syndrome;muir-torre syndrome;exactmatch
recurrent aggressive adult non-hodgkin lymphoma;aggressive recurrent adult non-hodgkin's lymphoma;exactmatch
marek disease;marek disease;exactmatch
ann arbor stage ii non-contiguous adult lymphoblastic lymphoma;adult non-contiguous lymphoblastic lymphoma stage ii;exactmatch
recurrent indolent adult non-hodgkin lymphoma;recurrent adult indolent non-hodgkin's lymphoma;exactmatch
ann arbor stage iv aggressive adult non-hodgkin lymphoma;aggressive adult non-hodgkin's lymphoma stage iv;exactmatch
ann arbor stage iv mantle cell lymphoma;ann arbor stage iv mantle cell lymphoma;exactmatch
ann arbor stage iv indolent adult non-hodgkin lymphoma;ann arbor stage iv indolent adult non-hodgkin lymphoma;exactmatch
ann arbor stage iii aggressive adult non-hodgkin lymphoma;aggressive adult non-hodgkin's lymphoma stage iii;exactmatch
ann arbor stage iii mantle cell lymphoma;ann arbor stage iii mantle cell lymphoma;exactmatch
ann arbor stage iii indolent adult non-hodgkin lymphoma;ann arbor stage iii indolent adult non-hodgkin lymphoma;exactmatch
palate carcinoma;carcinoma of palate;exactmatch
central nervous system cavernous hemangioma;central nervous system cavernous hemangioma;exactmatch
tibial adamantinoma;tibial adamantinoma;exactmatch
myeloid/lymphoid neoplasms with eosinophilia and rearrangement of pdgfra, pdgfrb, or fgfr1, or with pcm1-jak2;myeloid and lymphoid neoplasms with eosinophilia and abnormalities of pdgfra, pdgfrb, or fgfr1;exactmatch
tympanic paraganglioma;tympanic paraganglioma;exactmatch
myeloid/lymphoid neoplasms with fgfr1 rearrangement;8p11 myeloproliferative syndrome;exactmatch
myeloid/lymphoid neoplasms with pdgfrb rearrangement;myeloid neoplasms with pdgfrb rearrangement;exactmatch
myeloid/lymphoid neoplasms with pdgfra rearrangement;myeloid and lymphoid neoplasms with pdgfra rearrangement;exactmatch
fgfr1 gene rearrangement;bfgfr gene rearrangement;exactmatch
pdgfrb gene rearrangement;cd140b gene rearrangement;exactmatch
pdgfra gene rearrangement;cd140a gene rearrangement;exactmatch
vagal paraganglioma;paraganglioma of vagal body;exactmatch
acute myeloid leukemia with minimal differentiation;aml with minimal differentiation;exactmatch
mastocytosis;mast cell disease;exactmatch
diffuse neurofibroma;diffuse neurofibroma;exactmatch
renal benign mesenchymoma;renal benign mesenchymoma;exactmatch
jak2 gene mutation;jak-2 gene mutation;exactmatch
leukoplakia of buccal mucosa;leukoplakia of buccal mucosa;exactmatch
stage 0 cutaneous melanoma ajcc v6 and v7;cutaneous melanoma in situ;exactmatch
cemento-ossifying fibroma;cof;exactmatch
papillary epithelial neoplasm;papillary epithelial neoplasm;exactmatch
ovarian papillary tumor;ovarian papillary neoplasm;exactmatch
ovarian serous tumor;ovarian serous neoplasm;exactmatch
microcalcification;microcalcification;exactmatch
hepatosplenic t-cell lymphoma;hepatosplenic gamma/delta t-cell lymphoma;exactmatch
aniridia;aniridia;exactmatch
familial amyloidosis;amyloidosis, familial;exactmatch
acromegaly;acromegaly;exactmatch
primary malignant neoplasm;primary malignant neoplasm;exactmatch
asbestos-related lung disorder;asbestos-related lung disease;exactmatch
mllt10 gene;af10;exactmatch
tbxt gene;brachyury gene;exactmatch
mental retardation;mental retardation;exactmatch
joint capsule;articular capsule;exactmatch
distant intracranial metastasis;distant intracranial metastasis;exactmatch
breast atypical ductal hyperplasia;adh;exactmatch
yolk sac adenoma;yolk sac adenoma;exactmatch
phakomatosis;neurocutaneous syndrome;exactmatch
anaplastic astroblastoma;anaplastic astroblastoma;exactmatch
bladder cancer by ajcc v6 stage;bladder cancer by ajcc v6 stage;exactmatch
vulvar cancer by ajcc v6 stage;vulvar cancer by ajcc v6 stage;exactmatch
vaginal cancer by ajcc v6 stage;vaginal cancer by ajcc v6 stage;exactmatch
di guglielmo syndrome;di guglielmo syndrome;exactmatch
small intestinal high grade b-cell lymphoma, not otherwise specified;small intestinal b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and burkitt lymphoma;exactmatch
small intestinal follicular lymphoma;primary small intestinal follicular lymphoma;exactmatch
small intestinal diffuse large b-cell lymphoma;small intestinal diffuse large b-cell lymphoma;exactmatch
small intestinal t-cell non-hodgkin lymphoma;small intestinal t-cell non-hodgkin lymphoma;exactmatch
small intestinal b-cell non-hodgkin lymphoma;small intestinal b-cell non-hodgkin lymphoma;exactmatch
nr4a3 gene;nr4a3;exactmatch
taf15 gene;taf15;exactmatch
dural extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;dural extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;exactmatch
small intestinal kaposi sarcoma;small intestinal kaposi sarcoma;exactmatch
ampulla of vater gangliocytic paraganglioma;ampulla of vater gangliocytic paraganglioma;exactmatch
ampulla of vater somatostatin-producing neuroendocrine tumor;ampulla of vater somatostatin producing net;exactmatch
ampulla of vater enterochromaffin cell serotonin-producing neuroendocrine tumor;ampulla of vater ec cell serotonin-producing net;exactmatch
ampulla of vater mixed adenoneuroendocrine carcinoma;ampulla of vater manec;exactmatch
ampulla of vater large cell neuroendocrine carcinoma;ampulla of vater large cell nec;exactmatch
ampulla of vater neuroendocrine carcinoma;ampulla of vater high grade neuroendocrine carcinoma;exactmatch
ampulla of vater neuroendocrine tumor g2;ampulla of vater neuroendocrine tumor g2;exactmatch
monomorphic epitheliotropic intestinal t-cell lymphoma;meitl;exactmatch
small intestinal angiosarcoma;small intestinal angiosarcoma;exactmatch
ampulla of vater neuroendocrine tumor;ampulla of vater net;exactmatch
colorectal neuroendocrine carcinoma;colorectal (colon or rectal) neuroendocrine cancer;exactmatch
colorectal neuroendocrine tumor g2;colorectal net g2;exactmatch
colorectal enterochromaffin cell serotonin-producing neuroendocrine tumor;colorectal enterochromaffin cell serotonin-producing neuroendocrine tumor;exactmatch
colorectal l-cell glucagon-like peptide-producing neuroendocrine tumor;colorectal l-cell glucagon-like peptide-producing net;exactmatch
colorectal neuroendocrine tumor g1;colorectal carcinoid tumor;exactmatch
colorectal neuroendocrine tumor;colorectal net;exactmatch
colorectal mixed adenoneuroendocrine carcinoma;colorectal (colon or rectal) mixed adenoneuroendocrine cancer;exactmatch
colorectal large cell neuroendocrine carcinoma;colorectal large cell neuroendocrine carcinoma;exactmatch
colorectal neuroendocrine neoplasm;colorectal neuroendocrine neoplasm;exactmatch
small intestinal neuroendocrine tumor;small intestinal net;exactmatch
small intestinal gangliocytic paraganglioma;small intestinal gangliocytic paraganglioma;exactmatch
small intestinal neuroendocrine tumor g2;small intestinal net g2;exactmatch
small intestinal mixed adenoneuroendocrine carcinoma;small intestinal manec;exactmatch
small intestinal large cell neuroendocrine carcinoma;small intestinal large cell neuroendocrine carcinoma;exactmatch
small intestinal neuroendocrine carcinoma;small intestinal high grade neuroendocrine carcinoma;exactmatch
intestinal neuroendocrine carcinoma;intestinal high grade neuroendocrine carcinoma;exactmatch
intestinal neuroendocrine tumor;intestinal net;exactmatch
ampulla of vater neuroendocrine tumor g1;ampulla of vater net g1;exactmatch
ampulla of vater neuroendocrine neoplasm;ampulla of vater neuroendocrine neoplasm;exactmatch
ann arbor stage iv adult hodgkin lymphoma;adult hodgkin's disease stage iv;exactmatch
gastric adenoma, intestinal-type;gastric adenoma, intestinal-type;exactmatch
gastric neuroendocrine tumor g2;gastric net g2;exactmatch
gastric neuroendocrine tumor;gastric net;exactmatch
kcnj5 gene;kcnj5;exactmatch
foveolar-type adenoma;foveolar-type adenoma;exactmatch
foveolar-type epithelium present;foveolar-type epithelium present;exactmatch
gastric adenoma, gastric-type;gastric adenoma, gastric-type;exactmatch
gastric-type epithelial differentiation;gastric-type epithelial differentiation;exactmatch
gastric non-neoplastic polyp;gastric non-neoplastic polyp;exactmatch
gastric large cell neuroendocrine carcinoma;gastric large cell neuroendocrine carcinoma;exactmatch
gastric intramucosal adenocarcinoma;gastric intramucosal adenocarcinoma;exactmatch
gastric dysplasia;gastric dysplasia;exactmatch
gastric choriocarcinoma;gastric choriocarcinoma;exactmatch
gastric carcinoma with lymphoid stroma;gastric carcinoma with lymphoid stroma;exactmatch
gastric hepatoid adenocarcinoma;gastric hepatoid adenocarcinoma;exactmatch
poorly cohesive malignant cellular infiltrate;poorly cohesive malignant cellular infiltrate;exactmatch
gastric poorly cohesive adenocarcinoma;gastric poorly cohesive adenocarcinoma;exactmatch
gastric neuroendocrine carcinoma;gastric (stomach) neuroendocrine cancer;exactmatch
gastric mixed adenoneuroendocrine carcinoma;gastric (stomach) mixed adenoneuroendocrine cancer;exactmatch
ampulla of vater invasive papillary adenocarcinoma;ampulla of vater invasive papillary adenocarcinoma;exactmatch
ampullary noninvasive papillary neoplasm, pancreatobiliary type;ampullary noninvasive papillary neoplasm, pancreatobiliary type;exactmatch
ampulla of vater hepatoid adenocarcinoma;ampulla of vater hepatoid adenocarcinoma;exactmatch
ampulla of vater undifferentiated carcinoma with osteoclast-like giant cells;ampulla of vater undifferentiated carcinoma with osteoclast-like giant cells;exactmatch
pancreatobiliary-type malignant cells present;pancreatobiliary-type malignant cells present;exactmatch
ampulla of vater pancreatobiliary type adenocarcinoma;ampulla of vater pancreatobiliary type adenocarcinoma;exactmatch
ampullary flat intraepithelial neoplasia, high grade;ampullary flat intraepithelial neoplasia (dysplasia), high grade;exactmatch
ampullary noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia;ampullary high grade intraepithelial neoplasia;exactmatch
ampullary noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia;ampullary low grade intraepithelial neoplasia;exactmatch
preinvasive neoplasm of the ampullary region;preinvasive neoplasm of the ampullary region;exactmatch
benign gastric gastrointestinal stromal tumor;benign gastric gastrointestinal stromal tumor;exactmatch
metastatic malignant neoplasm in the stomach;metastatic malignant neoplasm in the stomach;exactmatch
gastric plexiform fibromyxoma;gastric plexiform fibromyxoma;exactmatch
gastric schwannoma;gastric schwannoma;exactmatch
gastric glomus tumor;gastric glomus tumor;exactmatch
gastric synovial sarcoma;gastric synovial sarcoma;exactmatch
gastric gastrointestinal stromal tumor of uncertain malignant potential;gastric gastrointestinal stromal tumor of uncertain malignant potential;exactmatch
malignant gastric gastrointestinal stromal tumor;malignant gastric gastrointestinal stromal tumor;exactmatch
intestinal neuroendocrine tumor g2;intestinal net g2;exactmatch
digestive system neuroendocrine tumor g2;digestive system neuroendocrine tumor g2;exactmatch
cystitis cystica and glandularis;cystitis cystica and glandularis;exactmatch
villous projections of the neoplastic epithelium present;villous projections of the neoplastic epithelium present;exactmatch
gastrointestinal hamartoma;gastrointestinal hamartoma;exactmatch
colorectal hamartoma;colorectal hamartoma;exactmatch
colorectal microvesicular hyperplastic polyp;colorectal mvhp;exactmatch
colorectal goblet cell rich hyperplastic polyp;colorectal gchp;exactmatch
colon serrated polyposis;colon serrated polyposis;exactmatch
colorectal sporadic serrated polyp;colorectal sporadic serrated polyp;exactmatch
colorectal filiform serrated adenoma;colorectal fsa;exactmatch
digestive system filiform serrated adenoma;digestive system filiform serrated adenoma;exactmatch
rectal tubular adenoma;rectal tubular adenoma;exactmatch
rectal serrated lesions and polyps;rectal ssa;exactmatch
colon serrated lesions and polyps;colon ssa;exactmatch
rectal traditional serrated adenoma;rectal serrated adenoma;exactmatch
appendix neuroma;appendix fibrous obliteration;exactmatch
appendix leiomyosarcoma;appendix leiomyosarcoma;exactmatch
appendix kaposi sarcoma;appendix kaposi sarcoma;exactmatch
appendix large cell neuroendocrine carcinoma;appendix large cell neuroendocrine carcinoma;exactmatch
colorectal cowden-associated polyp;colorectal cowden-associated polyp;exactmatch
colorectal adenomatous polyp;adenomatous polyp of large bowel;exactmatch
stage ib cervix;stage ib cervix;exactmatch
colon micropapillary adenocarcinoma;colon micropapillary adenocarcinoma;exactmatch
colorectal hodgkin lymphoma;colorectal hodgkin lymphoma;exactmatch
colorectal non-hodgkin lymphoma;colorectal non-hodgkin lymphoma;exactmatch
colorectal lymphoma;colorectal lymphoma;exactmatch
crohn disease-associated colorectal adenocarcinoma;crohn disease-associated colorectal adenocarcinoma;exactmatch
ulcerative colitis-associated colorectal adenocarcinoma;uc-associated crc;exactmatch
colorectal sarcomatoid carcinoma;colorectal (colon or rectal) sarcomatoid cancer;exactmatch
rectal micropapillary adenocarcinoma;rectal micropapillary adenocarcinoma;exactmatch
colorectal micropapillary adenocarcinoma;colorectal micropapillary adenocarcinoma;exactmatch
colon adenomatous polyp;adenomatous polyp of colon;exactmatch
rectal cribriform comedo-type adenocarcinoma;rectal cribriform comedo-type adenocarcinoma;exactmatch
colon cribriform comedo-type adenocarcinoma;colon cribriform comedo-type adenocarcinoma;exactmatch
colorectal cribriform comedo-type adenocarcinoma;colorectal cribriform comedo-type adenocarcinoma;exactmatch
rectal serrated adenocarcinoma;rectal serrated adenocarcinoma;exactmatch
colon serrated adenocarcinoma;colon serrated adenocarcinoma;exactmatch
colorectal serrated adenocarcinoma;colorectal serrated adenocarcinoma;exactmatch
rectal adenomatous polyp;adenomatous polyp of rectum;exactmatch
appendix neuroendocrine carcinoma;appendix high grade neuroendocrine carcinoma;exactmatch
appendix enterochromaffin cell serotonin-producing neuroendocrine tumor;appendix ec cell serotonin-producing carcinoid tumor;exactmatch
appendix neuroendocrine tumor g2;appendix net g2;exactmatch
figo stage ib2;figo stage ib2;exactmatch
figo stage iiib;figo stage iiib;exactmatch
figo stage iiia;figo stage iiia;exactmatch
figo stage iii;figo stage iii;exactmatch
figo stage iib;figo stage iib;exactmatch
figo stage iia;figo stage iia;exactmatch
figo stage ii;figo stage ii;exactmatch
figo stage ic;figo stage ic;exactmatch
figo stage ib1;figo stage ib1;exactmatch
appendix neuroendocrine tumor;appendix net;exactmatch
figo stage ib;figo stage ib;exactmatch
figo stage ia2;figo stage ia2;exactmatch
figo stage ia1;figo stage ia1;exactmatch
figo stage ia;figo stage ia;exactmatch
figo stage i;figo stage i;exactmatch
stage iia cervix;stage iia cervix;exactmatch
stage ii cervix;stage ii cervix;exactmatch
figo stage iiic;figo stage iiic;exactmatch
figo stage iiic1;figo stage iiic1;exactmatch
figo stage iiic2;figo stage iiic2;exactmatch
figo stage iv;figo stage iv;exactmatch
high grade appendix mucinous adenocarcinoma;high grade appendix mucinous adenocarcinoma;exactmatch
appendix high grade intraepithelial neoplasia;appendiceal high grade dysplasia;exactmatch
appendix low grade intraepithelial neoplasia;appendiceal low grade dysplasia;exactmatch
appendix intraepithelial neoplasia;appendiceal dysplasia;exactmatch
generalized dysplasia;generalized dysplasia;exactmatch
appendix serrated lesions and polyps;appendix ssa;exactmatch
serrated lesions and polyps;ssa;exactmatch
brain disorder;brain disorder;exactmatch
epithelial metaplasia;epithelial metaplasia;exactmatch
small cell component present;small cell component present;exactmatch
perinuclear halo present;perinuclear halo present;exactmatch
pik3ca gene mutation;pi3k gene mutation;exactmatch
intracytoplasmic lipofuscin present;intracytoplasmic lipofuscin present;exactmatch
figo stage ivb;figo stage ivb;exactmatch
figo stage iva;figo stage iva;exactmatch
esophageal mucosa-associated lymphoid tissue lymphoma;esophageal malt lymphoma;exactmatch
esophageal diffuse large b-cell lymphoma;esophageal dlbcl;exactmatch
esophageal synovial sarcoma;esophageal synovial sarcoma;exactmatch
ann arbor stage i childhood non-hodgkin lymphoma;ann arbor stage i childhood non-hodgkin lymphoma;exactmatch
ann arbor stage iii aids-related lymphoma;ann arbor stage iii aids-related lymphoma;exactmatch
ann arbor stage ii aids-related lymphoma;ann arbor stage ii aids-related lymphoma;exactmatch
ann arbor stage i aids-related lymphoma;ann arbor stage i aids-related lymphoma;exactmatch
locally recurrent malignant neoplasm;locally recurrent cancer;exactmatch
ann arbor stage iv childhood non-hodgkin lymphoma;ann arbor stage iv childhood non-hodgkin lymphoma;exactmatch
ann arbor stage iii childhood non-hodgkin lymphoma;ann arbor stage iii childhood non-hodgkin lymphoma;exactmatch
ann arbor stage ii childhood non-hodgkin lymphoma;ann arbor stage ii childhood non-hodgkin lymphoma;exactmatch
hereditary malignant neoplasm;familial cancer;exactmatch
ann arbor stage iv aids-related lymphoma;ann arbor stage iv aids-related lymphoma;exactmatch
stage iv adult liver cancer ajcc v7;stage iv adult liver cancer ajcc v7;exactmatch
stage iiic adult liver cancer ajcc v7;stage iii liver cancer;exactmatch
stage iiib adult liver cancer ajcc v7;stage iii liver cancer;exactmatch
atypia;atypia;exactmatch
stage iiia adult liver cancer ajcc v7;stage iii liver cancer;exactmatch
stage iii adult liver cancer ajcc v7;stage iii adult liver cancer ajcc v7;exactmatch
stage ii adult liver cancer ajcc v7;stage ii adult liver cancer ajcc v7;exactmatch
invasive carcinoma;invasive carcinoma;exactmatch
inherited bone marrow failure syndrome;ibmfs;exactmatch
dysembryoplastic neuroepithelial tumor;dnet;exactmatch
medulloblastoma with melanotic differentiation;medulloblastoma with melanotic differentiation;exactmatch
thymus solitary fibrous tumor;thymic solitary fibrous tumor;exactmatch
stage 4s neuroblastoma;neuroblastoma stage ivs;exactmatch
thymoliposarcoma;thymoliposarcoma;exactmatch
juvenile breast papillomatosis;juvenile breast papillomatosis;exactmatch
myolipoma;extrauterine lipoleiomyoma;exactmatch
melanomatosis;melanomatosis;exactmatch
melanocytoma;magnocellular nevus;exactmatch
t-cell/histiocyte-rich large b-cell lymphoma;t-cell rich/histiocyte-rich large b-cell lymphoma;exactmatch
soft tissue chondroma;chondroma of soft parts;exactmatch
breast ductal hyperplasia;breast ductal hyperplasia;exactmatch
chromosomal deletion;chromosomal deletion;exactmatch
familial isolated hyperparathyroidism;cdc73 parathyroid cancer syndrome;exactmatch
stage iv borderline ovarian surface epithelial-stromal tumor;stage iv borderline ovarian surface epithelial-stromal tumor;exactmatch
stage iii borderline ovarian surface epithelial-stromal tumor;stage iii borderline ovarian surface epithelial-stromal tumor;exactmatch
stage ii borderline ovarian surface epithelial-stromal tumor;stage ii borderline ovarian surface epithelial-stromal tumor;exactmatch
stage i borderline ovarian surface epithelial-stromal tumor;stage i borderline ovarian surface epithelial-stromal tumor;exactmatch
stage i adult liver cancer ajcc v7;stage i adult liver cancer ajcc v7;exactmatch
early-stage breast carcinoma;early-stage breast cancer;exactmatch
multicentric breast carcinoma;multicentric breast cancer;exactmatch
breast ductal carcinoma in situ, low grade;breast ductal carcinoma in situ, low grade;exactmatch
hypopharyngeal carcinoma;cancer of hypopharynx;exactmatch
grade 1 diffuse follicular lymphoma;grade 1 diffuse follicular lymphoma;exactmatch
laryngeal mucoepidermoid carcinoma;laryngeal mucoepidermoid carcinoma;exactmatch
laryngeal adenoid cystic carcinoma;adenoid cystic carcinoma of larynx;exactmatch
bladder small cell neuroendocrine carcinoma;bladder small cell carcinoma;exactmatch
bcr/abl1 fusion gene;bcr-abl;exactmatch
borderline ovarian brenner tumor/atypical proliferative ovarian brenner tumor;borderline brenner neoplasm of ovary;exactmatch
breast ductal carcinoma in situ, intermediate grade;breast ductal carcinoma in situ, intermediate grade;exactmatch
multicentric lesion;multicentric lesion;exactmatch
neoplastic eosinophilic spindle cell;neoplastic eosinophilic spindle cell;exactmatch
anterior pituitary gland endocrine neoplasm;anterior pituitary gland endocrine neoplasm;exactmatch
grade 3 colon adenocarcinoma;grade 3 colon adenocarcinoma;exactmatch
spindle cell oncocytoma;folliculo-stellate cell tumor of the pituitary;exactmatch
grade 2 colon adenocarcinoma;grade 2 colon adenocarcinoma;exactmatch
pituicytoma;pituicytoma, benign;exactmatch
grade 1 colon adenocarcinoma;grade 1 colon adenocarcinoma;exactmatch
pharyngeal carcinoma;cancer of pharynx;exactmatch
cervical intraepithelial neoplasia grade 2/3;cin 2/3;exactmatch
grade 2/3;grade 2/3;exactmatch
systemic anaplastic large cell lymphoma;alcl, systemic;exactmatch
multifocal breast carcinoma;multifocal breast cancer;exactmatch
anaplastic astrocytoma;anaplastic astrocytoma;exactmatch
stage 0 paranasal sinus cancer ajcc v6, v7, and v8;stage 0 paranasal sinus cancer;exactmatch
diffuse intrinsic pontine glioma;dipg;exactmatch
tfeb gene;tfeb;exactmatch
non-functioning endocrine neoplasm;non-functioning endocrine neoplasm;exactmatch
desmoplastic infantile astrocytoma;dia;exactmatch
functioning endocrine neoplasm;functioning endocrine neoplasm;exactmatch
meningeal lymphoma;leptomeningeal lymphoma;exactmatch
meningeal leukemia;leukemic leptomeningitis;exactmatch
cerebellar astrocytoma;astrocytoma of cerebellum;exactmatch
adenosarcoma;adenosarcoma;exactmatch
lactating adenoma;lactating adenoma;exactmatch
atypical gastric lymphoid hyperplasia;atypical gastric lymphoid hyperplasia;exactmatch
childhood systemic anaplastic large cell lymphoma;childhood systemic anaplastic large cell lymphoma;exactmatch
ectopic cervical thymoma;ectopic cervical thymoma;exactmatch
thymic hodgkin lymphoma;thymic hodgkin lymphoma;exactmatch
esophageal rhabdomyosarcoma;esophageal rhabdomyosarcoma;exactmatch
pancreatic intraductal papillary mucinous neoplasm, oncocytic-type;iopn;exactmatch
pancreatic large cell neuroendocrine carcinoma;pancreatic large cell nec;exactmatch
mature pancreatic teratoma;mature pancreatic teratoma;exactmatch
pancreatic teratoma;pancreatic teratoma;exactmatch
vaginal bleeding;vaginal bleeding;exactmatch
acinar cystic transformation of the pancreas;acinar cystic transformation of the pancreas;exactmatch
pancreatic acinar cell neoplasm;pancreatic acinar cell neoplasm;exactmatch
hemoglobin trait;hemoglobin trait;exactmatch
thin-branching papillae present;thin-branching papillae present;exactmatch
pancreatic neuroendocrine tumor g1;pancreatic net g1;exactmatch
pancreatic intraductal papillary mucinous neoplasm, pancreatobiliary-type;pancreatic intraductal papillary mucinous neoplasm, pancreatobiliary-type;exactmatch
tall papillae present;tall papillae present;exactmatch
pancreatic intraductal papillary mucinous neoplasm, intestinal-type;pancreatic intraductal papillary mucinous neoplasm, intestinal-type;exactmatch
cellular changes resembling foveolar epithelium cells;cellular changes resembling foveolar epithelium cells;exactmatch
pancreatic intraductal papillary mucinous neoplasm, gastric-type;gastric foveolar;exactmatch
pancreatic intraductal tubulopapillary neoplasm with an associated invasive carcinoma;pancreatic intraductal tubulopapillary neoplasm with an associated invasive carcinoma;exactmatch
pancreatic intraductal tubulopapillary neoplasm;itpn;exactmatch
pancreatic small cell neuroendocrine carcinoma;pancreatic small cell carcinoma;exactmatch
non-functioning pancreatic neuroendocrine tumor g1;non-functional pancreatic neuroendocrine tumor g1;exactmatch
stage iia1 cervical cancer ajcc v7;figo stage iia1 cervical carcinoma;exactmatch
esophageal poorly differentiated squamous cell carcinoma;esophageal poorly differentiated squamous cell carcinoma;exactmatch
esophageal hemangioma;esophageal hemangioma;exactmatch
esophageal mixed adenoneuroendocrine carcinoma;esophageal manec;exactmatch
esophageal large cell neuroendocrine carcinoma;esophageal large cell nec;exactmatch
esophageal neuroendocrine carcinoma;esophageal high grade neuroendocrine carcinoma;exactmatch
esophageal neuroendocrine tumor g2;esophageal neuroendocrine tumor g2;exactmatch
esophageal neuroendocrine tumor;esophageal net;exactmatch
intraepithelial neoplasia in barrett esophagus;intraepithelial neoplasia in barrett esophagus;exactmatch
esophageal moderately differentiated squamous cell carcinoma;esophageal moderately differentiated squamous cell carcinoma;exactmatch
pancreatic somatostatinoma;pancreatic somatostatinoma;exactmatch
esophageal well differentiated squamous cell carcinoma;esophageal well differentiated squamous cell carcinoma;exactmatch
esophageal spindle cell carcinoma;esophageal carcinoma with mesenchymal stroma;exactmatch
second primary malignant neoplasm;second primary cancer;exactmatch
pancreatic vipoma;pancreatic vipoma;exactmatch
pancreatic insulinoma;insulinoma;exactmatch
pancreatic glucagonoma;glucagonoma;exactmatch
pancreatic gastrinoma;pancreatic gastrinoma;exactmatch
pancreatic intraductal neoplasm;pancreatic intraductal neoplasm;exactmatch
pancreatic mucinous-cystic neoplasm, high grade;mucinous cystic neoplasm with high-grade dysplasia;exactmatch
non-invasive pancreatic mucinous-cystic neoplasm;non-invasive pancreatic mucinous cystic neoplasm;exactmatch
fh gene;fh;exactmatch
pancreatic moderately differentiated ductal adenocarcinoma;pancreatic moderately differentiated ductal adenocarcinoma;exactmatch
pancreatic well differentiated ductal adenocarcinoma;pancreatic well differentiated ductal adenocarcinoma;exactmatch
digestive system mixed adenoneuroendocrine carcinoma;digestive system mixed adenoneuroendocrine cancer;exactmatch
digestive system neuroendocrine carcinoma;digestive system neuroendocrine carcinoma;exactmatch
digestive system neuroendocrine tumor;digestive system net;exactmatch
intramucosal adenocarcinoma;intramucosal adenocarcinoma;exactmatch
digestive system dysplasia;digestive system dysplasia;exactmatch
prkd2 gene;prkd2;exactmatch
pancreatic mucinous-cystic neoplasm, low grade;pancreatic mucinous cystic neoplasm with low grade dysplasia;exactmatch
stage iiic2;stage iiic2;exactmatch
stage iiic1;stage iiic1;exactmatch
stage iia2;stage iia2;exactmatch
stage iia1;stage iia1;exactmatch
stage iiic2 uterine corpus cancer ajcc v7;stage iiic2 uterine (including endometrial) cancer;exactmatch
stage iiic1 uterine corpus cancer ajcc v7;stage iiic1 uterine (including endometrial) cancer;exactmatch
stage iia2 cervical cancer ajcc v7;figo stage iia2 cervical carcinoma;exactmatch
pancreatic poorly differentiated ductal adenocarcinoma;pancreatic poorly differentiated ductal adenocarcinoma;exactmatch
pancreatic intraepithelial neoplasia-1a;panin-1a;exactmatch
pancreatic intraepithelial neoplasia-1b;panin-1b;exactmatch
high grade pancreatic intraepithelial neoplasia;grade 3 pancreatic intraepithelial neoplasia;exactmatch
creb3l2 gene;creb3l2;exactmatch
creb3l1 gene;creb3l1;exactmatch
von hippel-lindau syndrome-associated pancreatic serous adenoma;vhl-associated pancreatic serous adenoma;exactmatch
pancreatic solid serous adenoma;pancreatic solid serous adenoma;exactmatch
pancreatic macrocystic serous cystadenoma;pancreatic macrocystic serous cystadenoma;exactmatch
pancreatic serous adenoma;pancreatic serous adenoma;exactmatch
pancreatic medullary carcinoma;medullary carcinoma;exactmatch
pancreatic hepatoid adenocarcinoma;hepatoid carcinoma;exactmatch
pancreatic mixed acinar-ductal neuroendocrine carcinoma;mixed acinar-neuroendocrine-ductal carcinoma of the pancreas;exactmatch
mastermind-like protein 2;maml2;exactmatch
pancreatic mixed acinar-ductal carcinoma;mixed acinar-ductal carcinoma of the pancreas;exactmatch
maml2 gene;maml2;exactmatch
creb-regulated transcription coactivator 1;creb-regulated transcription coactivator 1;exactmatch
crtc1 gene;creb regulated transcription coactivator 1 gene;exactmatch
internal auditory canal;internal auditory canal;exactmatch
colorectal high grade b-cell lymphoma, not otherwise specified;colorectal b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and burkitt lymphoma;exactmatch
colorectal burkitt lymphoma;colorectal burkitt lymphoma;exactmatch
colorectal diffuse large b-cell lymphoma;colorectal dlbcl;exactmatch
mediator of rna polymerase ii transcription subunit 12;arc240;exactmatch
braf protein variant;braf protein variant;exactmatch
akt1 gene mutation;akt gene mutation;exactmatch
akt1 protein variant;akt1 protein variant;exactmatch
gonadal teratoma;gonadal teratoma;exactmatch
splicing factor 3b subunit 1;pre-mrna-splicing factor sf3b 155 kda subunit;exactmatch
sf3b1 gene;sf3b1;exactmatch
tumor mass;tumor;exactmatch
med12 gene;med12;exactmatch
braf nm_004333.4:c.1799_1800deltginsaa;b-raf1 c.1799_1800tg>aa;exactmatch
ighg1 wt allele;ighg1 wt allele;exactmatch
ighg1 gene;ighg1;exactmatch
has2 gene;has2;exactmatch
breast solid neuroendocrine carcinoma;breast solid neuroendocrine carcinoma;exactmatch
gene product sequence variation;aa_mutation;exactmatch
gene variant;genetic_seq;exactmatch
molecular sequence variation;molecular sequence variation;exactmatch
braf np_004324.2:p.v600e;activating braf v600e mutation;exactmatch
braf nm_004333.4:c.1799t>a;b-raf1 c.1799t>a;exactmatch
dek/nup214 fusion gene;dek-can fusion gene;exactmatch
zymbal's gland adenoma;adenoma, zymbal's gland, benign;exactmatch
pml/rara fusion gene;pml-rar;exactmatch
lipofibromatosis;infantile fibromatosis, non-desmoid type;exactmatch
sacrococcygeal teratoma;pre-sacral teratoma;exactmatch
neonatal disorder;neonatal disorder;exactmatch
connective and soft tissue injury;connective and soft tissue injury;exactmatch
congenital urinary system abnormality;congenital abnormality of the urinary system;exactmatch
zymbal's gland carcinoma;carcinoma, zymbal's gland;exactmatch
undetermined sertoli cell tumor;undetermined sertoli cell tumor;exactmatch
egfr protein variant;egfr protein variant;exactmatch
experimental organism pituitary gland adenoma;adenoma, pituitary gland, benign;exactmatch
experimental organism benign melanocytoma;benign melanocytoma;exactmatch
benign histiocytoma;benign histiocytoma;exactmatch
pik3ca protein variant;pi3kalpha protein variant;exactmatch
nras protein variant;gtpase nras protein variant;exactmatch
kras protein variant;gtpase kras protein variant;exactmatch
egfr gene mutation;egfr gene mutation;exactmatch
cic gene;cic;exactmatch
patz1 gene;patz1;exactmatch
tpm4 gene;tpm4;exactmatch
kdm5a gene;jarid1a;exactmatch
notch2 gene;notch2;exactmatch
map2k4 gene;map2k4;exactmatch
mlf1 gene;mlf1;exactmatch
myh9 gene;myh9;exactmatch
moesin;msn;exactmatch
msn gene;msn;exactmatch
lpp gene;lim domain containing preferred translocation partner in lipoma gene;exactmatch
mnx1 gene;hlxb9;exactmatch
tpm3 gene;tpm3;exactmatch
gata2 gene;gata binding protein 2 gene;exactmatch
ell gene;ell;exactmatch
fev gene;fev;exactmatch
dux4 gene;dux4;exactmatch
fip1l1 gene;fip1 like 1 (s. cerevisiae) gene;exactmatch
crlf2 gene;crlf2;exactmatch
cd79b gene;cd79b;exactmatch
neurogenic locus notch homolog protein 2;notch2;exactmatch
phox2b gene;phox2b;exactmatch
prkar1a gene;prkar1a;exactmatch
sdhaf2 gene;sdhaf2;exactmatch
tfg gene;tfg;exactmatch
tcf12 gene;tcf12;exactmatch
hnf1a gene;hnf1 homeobox a gene;exactmatch
ssx4 gene;ssx4;exactmatch
ssx2 gene;ssx family member 2 gene;exactmatch
ssx1 gene;ssx1;exactmatch
ss18 gene;ss18;exactmatch
sh3gl1 gene;sh3-domain grb2-like 1 gene;exactmatch
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial;cii-4;exactmatch
sdhd gene;sdhd;exactmatch
succinate dehydrogenase cytochrome b560 subunit, mitochondrial;cybl;exactmatch
sdhc gene;sdhc;exactmatch
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial;ec 1.3.5.1;exactmatch
sdhb gene;sdhb;exactmatch
succinate dehydrogenase assembly factor 2, mitochondrial;sdh assembly factor 2;exactmatch
col1a1/pdgfb fusion gene;col1a1-pdgfb fusion gene;exactmatch
ewsr1/ddit3 fusion gene;chop/ews fusion gene;exactmatch
atic gene;5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase gene;exactmatch
nup98/nsd1 fusion gene;nup98-nsd1 fusion gene;exactmatch
sfpq/tfe3 fusion gene;psf-tfe3 fusion gene;exactmatch
tfe3/aspscr1 fusion gene;tfe3-aspscr1 fusion gene;exactmatch
stat5b/rara fusion gene;stat5b-rara fusion gene;exactmatch
tfg/nr4a3 fusion gene;nor1/tfg fusion gene;exactmatch
mllt10/clp1 fusion gene;af10-heab fusion gene;exactmatch
mll/sh3gl1 fusion gene;een/mll fusion gene;exactmatch
taf15/nr4a3 fusion gene;nr4a3/rbp56 fusion gene;exactmatch
hmga2/lpp long fusion gene;hmga2-lpp long fusion gene;exactmatch
aspscr1/tfe3 fusion gene;aspl-tfe3 fusion gene;exactmatch
hmga2/lpp short fusion gene;hmga2-lpp short fusion gene;exactmatch
etv6/jak2 fusion gene;etv6-jak2 fusion gene;exactmatch
etv6/ntrk3 fusion gene;etv6-ntrk3 fusion gene;exactmatch
etv6/pdgfrb fusion gene;etv6-pdgfrb fusion gene;exactmatch
tcf12/nr4a3 fusion gene;nr4a3/tcf12 fusion gene;exactmatch
pcm1/ret fusion gene;pcm1-ret fusion gene;exactmatch
ss18/ssx4 fusion gene;ss18-ssx4 fusion gene;exactmatch
rbm15/mkl1 fusion gene;ott-mal fusion gene;exactmatch
jazf1/suz12 fusion gene;jazf1-jjaz1 fusion gene;exactmatch
ewsr1/fli1 fusion gene;ews-fli1 fusion gene;exactmatch
ncoa4/ret fusion gene;ele1-ret fusion gene;exactmatch
birc3/malt1 fusion gene;api2-malt1 fusion gene;exactmatch
cltc/alk fusion gene;alk/cltc fusion gene;exactmatch
rnf213/alk fusion gene;alk/alo17 fusion gene;exactmatch
ctnnb1/plag1 fusion gene;ctnnb1-plag1 fusion gene;exactmatch
golga5/ret fusion gene;golga5-ret fusion gene;exactmatch
trim33/ret fusion gene;ptc7 chimeric oncogene;exactmatch
trim24/ret fusion gene;htif1-ret fusion gene;exactmatch
prkar1a/ret fusion gene;prkar1a-ret fusion gene;exactmatch
pax3/foxo1 fusion gene;pax3-fkhr fusion gene;exactmatch
brd4/nutm1 fusion gene;brd4-c15orf55 fusion gene;exactmatch
malat1/tfeb fusion gene;alpha-tfeb fusion gene;exactmatch
fip1l1/pdgfra fusion gene;fip1l1-pdgfra fusion gene;exactmatch
crtc1/maml2 fusion gene;crtc1-maml2 fusion gene;exactmatch
eml4/alk fusion gene;alk/eml4 fusion gene;exactmatch
erc1/ret fusion gene;elks-ret fusion gene;exactmatch
nsd1/nup98 fusion gene;nsd1-nup98 fusion gene;exactmatch
ss18/ssx2 fusion gene;ss18-ssx2 fusion gene;exactmatch
ss18/ssx1 fusion gene;ss18-ssx1 fusion gene;exactmatch
tfe3/prcc fusion gene;tfe3-prcc fusion gene;exactmatch
ewsr1/etv1 fusion gene;etv1/ews fusion gene;exactmatch
runx1/runx1t1 fusion gene;aml-eto fusion gene;exactmatch
tcf3/pbx1 fusion gene;e2a-pbx1 fusion gene;exactmatch
fus/creb3l2 fusion gene;creb3l2/fus fusion gene;exactmatch
fus/erg fusion gene;erg/fus fusion gene;exactmatch
fus/ddit3 fusion gene;chop/fus fusion gene;exactmatch
fus/atf1 fusion gene;atf1/fus fusion gene;exactmatch
ewsr1/etv4 fusion gene;etv4/ews fusion gene;exactmatch
ewsr1/nr4a3 fusion gene;ews-chn fusion gene;exactmatch
contralateral breast carcinoma;contralateral breast carcinoma;exactmatch
ewsr1/creb1 fusion gene;ews-creb1 fusion gene;exactmatch
ewsr1/patz1 fusion gene;ews-znf278 fusion gene;exactmatch
ewsr1/fev fusion gene;ews-fev fusion gene;exactmatch
ewsr1/atf1 fusion gene;atf1-ewsr1 fusion gene;exactmatch
ewsr1/wt1 fusion gene;ews-wt1 fusion gene;exactmatch
ewsr1/erg fusion gene;erg-ewsr1 fusion gene;exactmatch
eye finding;eye finding;exactmatch
runx1/mecom fusion gene;ame fusion gene;exactmatch
bcr/abl1 fusion gene p190;bcr-abl1 fusion gene p190;exactmatch
bcr/abl1 fusion gene p210;bcr-abl1 fusion gene p210;exactmatch
bcr/abl1 fusion gene p230;bcr-abl1 fusion gene p230;exactmatch
tpm3/ntrk1 fusion gene;tpm3-ntrk1 fusion gene;exactmatch
autoimmune nervous system disorder;autoimmune nervous system disorder;exactmatch
prcc/tfe3 fusion gene;prcc-tfe3 fusion gene;exactmatch
zbtb16/rara fusion gene;plzf-rar-alpha fusion gene;exactmatch
pax8/pparg fusion gene;pax8-pparg fusion gene;exactmatch
pax7/foxo1 fusion gene;pax7-fkhr fusion gene;exactmatch
npm1/alk fusion gene;alk/npm1 fusion gene;exactmatch
numa1/rara fusion gene;numa-rara fusion gene;exactmatch
mll/mllt4 fusion gene;af6/mll fusion gene;exactmatch
mll/mllt10 fusion gene;af10/mll fusion gene;exactmatch
mll/mllt3 fusion gene;mll-af9 fusion gene;exactmatch
mll/mllt1 fusion gene;kmt2a-mllt1 fusion gene;exactmatch
mll/aff1 fusion gene;mll-af4 fusion gene;exactmatch
bcr/pdgfra fusion gene;bcr-pdgfra fusion gene;exactmatch
bcr/fgfr1 fusion gene;bcr-fgfr fusion gene;exactmatch
cltc gene;cltc;exactmatch
rnf213 gene;rnf213;exactmatch
colon diffuse large b-cell lymphoma;colon dlbcl;exactmatch
bile duct intraductal papillary neoplasm with an associated invasive carcinoma;bile duct ipn with an associated invasive carcinoma;exactmatch
thrombocyte differentiation;thrombocyte differentiation;exactmatch
erythrocyte differentiation;erythrocyte differentiation;exactmatch
myeloid cell differentiation;myeloid cell differentiation;exactmatch
calcifying nested stromal-epithelial tumor of the liver;cnset;exactmatch
biliary adenofibroma;baf;exactmatch
megakaryopoiesis;megakaryocytopoiesis;exactmatch
extrahepatic bile duct tubulopapillary adenoma;extrahepatic bile duct tubulopapillary adenoma;exactmatch
bile duct intraductal papillary neoplasm, high grade;bile duct ipn with high grade intraepithelial neoplasia;exactmatch
bile duct mucinous cystic neoplasm, low grade;bile duct mcn with low grade intraepithelial neoplasia;exactmatch
bile duct intraductal papillary neoplasm with intermediate grade intraepithelial neoplasia;bile duct intraductal papillary neoplasm with intermediate grade intraepithelial neoplasia;exactmatch
bile duct intraductal papillary neoplasm, low grade;bile duct ipn with low grade intraepithelial neoplasia;exactmatch
small duct intrahepatic cholangiocarcinoma;peripheral cholangiocarcinoma, malignant;exactmatch
large duct intrahepatic cholangiocarcinoma;large duct intrahepatic cholangiocarcinoma;exactmatch
intrahepatic large bile duct;intrahepatic large bile duct;exactmatch
liver undifferentiated carcinoma;liver undifferentiated carcinoma;exactmatch
poorly differentiated hepatocellular carcinoma;poorly differentiated hepatocellular cancer;exactmatch
intrahepatic bile duct mucinous cystic neoplasm;intrahepatic bile duct cystadenoma;exactmatch
bile duct mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia;bile duct mcn with intermediate grade intraepithelial neoplasia;exactmatch
gallbladder intracholecystic papillary (tubular) neoplasm with intermediate grade intraepithelial neoplasia;gallbladder intracholecystic papillary (tubular) neoplasm with intermediate grade intraepithelial neoplasia;exactmatch
extrarenal rhabdoid tumor of the liver;extrarenal malignant rhabdoid tumor of the liver;exactmatch
pdgfra gene amplification;cd140a gene amplification;exactmatch
akt family gene mutation;akt family gene mutation;exactmatch
non-neoplastic hepatobiliary disorder;non-neoplastic hepatobiliary disorder;exactmatch
liver yolk sac tumor;hepatic yolk sac tumor;exactmatch
liver teratoma;hepatic teratoma;exactmatch
liver germ cell tumor;hepatic germ cell tumor;exactmatch
liver carcinosarcoma;hepatic carcinosarcoma;exactmatch
liver epithelioid hemangioendothelioma;hepatic epithelioid hemangioendothelioma;exactmatch
bile duct mucinous cystic neoplasm, high grade;bile duct mcn with high grade intraepithelial neoplasia;exactmatch
liver synovial sarcoma;hepatic synovial sarcoma;exactmatch
liver kaposi sarcoma;hepatic kaposi sarcoma;exactmatch
liver diffuse large b-cell lymphoma;hepatic diffuse large b-cell lymphoma;exactmatch
liver lymphangiomatosis;liver lymphangiomatosis;exactmatch
liver lymphangioma;liver lymphangioma;exactmatch
liver infantile hemangioma;liver infantile hemangioendothelioma;exactmatch
liver cavernous hemangioma;liver cavernous hemangioma;exactmatch
moderately differentiated hepatocellular carcinoma;moderately differentiated hepatocellular cancer;exactmatch
well differentiated hepatocellular carcinoma;well differentiated hepatocellular cancer;exactmatch
lymphocyte-rich hepatocellular carcinoma;lymphocyte-rich hepatocellular carcinoma;exactmatch
colorectal ganglioneuroma;colorectal ganglioneuroma;exactmatch
anal canal neuroendocrine tumor g1;anal canal carcinoid tumor;exactmatch
anal canal neuroendocrine tumor;anal canal net;exactmatch
anal canal undifferentiated carcinoma;anal canal undifferentiated carcinoma;exactmatch
bmpr1a gene mutation;acvrlk3 gene mutation;exactmatch
mutyh gene mutation;mutyh gene mutation;exactmatch
mutyh-associated polyposis;map;exactmatch
colorectal benign granular cell tumor;colorectal benign granular cell tumor;exactmatch
colorectal perineurioma;colorectal fibroblastic polyp;exactmatch
liver neuroendocrine carcinoma;hnec;exactmatch
colorectal schwannoma;colorectal schwannoma;exactmatch
colorectal angiosarcoma;colorectal angiosarcoma;exactmatch
colorectal kaposi sarcoma;colorectal kaposi sarcoma;exactmatch
colorectal leiomyosarcoma;colorectal leiomyosarcoma;exactmatch
colorectal sarcoma;colorectal sarcoma;exactmatch
colorectal mucosa-associated lymphoid tissue lymphoma;colorectal malt lymphoma;exactmatch
colorectal mantle cell lymphoma;colorectal mantle cell lymphoma;exactmatch
anal canal neuroendocrine tumor g2;anal canal net g2;exactmatch
anal canal neuroendocrine carcinoma;anal canal high grade neuroendocrine carcinoma;exactmatch
anal canal large cell neuroendocrine carcinoma;anal canal large cell nec;exactmatch
anal canal small cell neuroendocrine carcinoma;anal canal small cell carcinoma;exactmatch
liver neuroendocrine neoplasm;hepatic neuroendocrine neoplasm;exactmatch
early hepatocellular carcinoma;early hepatocellular cancer;exactmatch
low grade liver dysplastic nodule;lgdn;exactmatch
high grade liver dysplastic nodule;hgdn;exactmatch
metastatic carcinoma in the liver;metastatic carcinoma in the liver;exactmatch
hnf1a gene mutation;hnf1a gene mutation;exactmatch
unclassified hepatocellular adenoma;unclassified hepatocellular adenoma;exactmatch
inflammatory hepatocellular adenoma;ihca;exactmatch
beta-catenin-activated hepatocellular adenoma;beta-catenin-activated hepatocellular adenoma;exactmatch
hnf1alpha-inactivated hepatocellular adenoma;h-hca;exactmatch
benign liver and intrahepatic bile duct epithelial neoplasm;benign liver and intrahepatic bile duct epithelial neoplasm;exactmatch
bile duct disorder;bile duct disorder;exactmatch
anal hidradenoma papilliferum;anal hidradenoma papilliferum;exactmatch
anal canal squamous cell papilloma;anal canal squamous cell papilloma;exactmatch
anal canal mixed adenoneuroendocrine carcinoma;anal canal manec;exactmatch
gallbladder intracholecystic papillary neoplasm, low grade;gallbladder icpn with low grade intraepithelial neoplasia;exactmatch
gallbladder intracholecystic papillary neoplasm, high grade;gallbladder icpn with high grade intraepithelial neoplasia;exactmatch
hepatosplenomegaly;hepatosplenomegaly;exactmatch
condyloma with dysplasia;condyloma acuminatum with dysplasia;exactmatch
calcium oxalate crystal deposition;calcium oxalate crystal deposition;exactmatch
lipodystrophy;lipodsystrophic syndromes;exactmatch
carbohydrate metabolism disorder;carbohydrate metabolism disorder;exactmatch
benign lymphoid hyperplasia;benign lymphoid hyperplasia;exactmatch
giant cell angioblastoma;giant cell angioblastoma;exactmatch
hereditary connective tissue disorder;connective tissue hereditary disorder;exactmatch
mixed congenital mesoblastic nephroma;mixed congenital mesoblastic nephroma;exactmatch
invasive breast lobular carcinoma, tubulolobular variant;invasive breast lobular carcinoma, tubulolobular variant;exactmatch
blindness;blindness;exactmatch
invasive breast lobular carcinoma, solid variant;invasive breast lobular carcinoma, solid variant;exactmatch
invasive breast lobular carcinoma, pleomorphic variant;invasive breast lobular carcinoma, pleomorphic variant;exactmatch
invasive breast lobular carcinoma, alveolar variant;invasive breast lobular carcinoma, alveolar variant;exactmatch
human papillomavirus-related adenosquamous carcinoma;hpv-related adenosquamous carcinoma;exactmatch
metabolic bone disorder;mbd;exactmatch
basal cells with pale cytoplasm present;basal cells with pale cytoplasm present;exactmatch
clear cell acanthoma;clear cell acanthoma;exactmatch
nephrogenic metaplasia;nephrogenic metaplasia;exactmatch
spinal cord disorder;spinal cord disorder;exactmatch
gallbladder mucinous cystic neoplasm;gallbladder mcn;exactmatch
myelodysplastic syndrome with somatic mutations;myelodysplastic syndrome with point mutations;exactmatch
conjunctival melanocytic intraepithelial neoplasia;c-min;exactmatch
manufactured object;manufactured object;exactmatch
asxl1 gene;asxl transcriptional regulator 1 gene;exactmatch
pbx1 gene;pbx1;exactmatch
asxl1 gene mutation;asxl transcriptional regulator 1 gene mutation;exactmatch
etv6 gene mutation;ets variant 6 gene mutation;exactmatch
ezh2 gene mutation;enx-1 gene mutation;exactmatch
mrtfa gene;mkl1;exactmatch
sclerosing polycystic adenosis;salivary gland sclerosing polycystic adenosis;exactmatch
rbm15 gene;rbm15;exactmatch
low vision;low vision;exactmatch
congenital nervous system disorder;congenital abnormality of the nervous system;exactmatch
non-neoplastic brain disorder;non-neoplastic brain disorder;exactmatch
congenital systemic disorder;congenital systemic disorder;exactmatch
unmutated immunoglobulin heavy chain variable region gene;ighv mutation negative;exactmatch
complex karyotype;complex;exactmatch
digestive system carcinoma;carcinoma of the gastrointestinal system;exactmatch
extrahepatic bile duct mixed adenoneuroendocrine carcinoma;extrahepatic bile duct manec;exactmatch
extrahepatic bile duct large cell neuroendocrine carcinoma;extrahepatic bile duct large cell nec;exactmatch
gallbladder adenocarcinoma, gastric foveolar type;gallbladder adenocarcinoma, gastric foveolar type;exactmatch
gallbladder mixed adenoneuroendocrine carcinoma;gallbladder manec;exactmatch
gallbladder neuroendocrine tumor g2;gallbladder net g2;exactmatch
gallbladder neuroendocrine tumor g1;gallbladder carcinoid tumor;exactmatch
gallbladder large cell neuroendocrine carcinoma;gallbladder large cell nec;exactmatch
gallbladder neuroendocrine carcinoma;gallbladder g3;exactmatch
gallbladder neuroendocrine tumor;gallbladder net;exactmatch
gallbladder neuroendocrine neoplasm;gallbladder neuroendocrine neoplasm;exactmatch
gallbladder adenocarcinoma, biliary type;gallbladder adenocarcinoma, biliary type;exactmatch
extrahepatic bile duct neuroendocrine tumor g2;extrahepatic bile duct net g2;exactmatch
gallbladder cribriform carcinoma;gallbladder cribriform carcinoma;exactmatch
gallbladder hepatoid adenocarcinoma;gallbladder hepatoid adenocarcinoma;exactmatch
gallbladder carcinosarcoma;gallbladder carcinosarcoma;exactmatch
gallbladder mucinous cystic neoplasm with an associated invasive carcinoma;gallbladder cystadenocarcinoma;exactmatch
gallbladder mucinous cystic neoplasm, high grade;gallbladder mcn with high grade intraepithelial neoplasia;exactmatch
gallbladder mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia;gallbladder mcn with intermediate grade intraepithelial neoplasia;exactmatch
gallbladder mucinous cystic neoplasm, low grade;gallbladder mcn with low grade intraepithelial neoplasia;exactmatch
gallbladder goblet cell carcinoid;gallbladder goblet cell carcinoid;exactmatch
gallbladder tubular carcinoid;gallbladder tubular carcinoid;exactmatch
extrahepatic bile duct adenocarcinoma, biliary type;extrahepatic bile duct adenocarcinoma, biliary type;exactmatch
extrahepatic bile duct adenocarcinoma, gastric foveolar type;extrahepatic bile duct adenocarcinoma, gastric foveolar type;exactmatch
extrahepatic bile duct neuroendocrine carcinoma;extrahepatic bile duct g3;exactmatch
extrahepatic bile duct neuroendocrine tumor;extrahepatic bile duct net;exactmatch
extrahepatic bile duct neuroendocrine neoplasm;extrahepatic bile duct neuroendocrine neoplasm;exactmatch
metastatic malignant neoplasm in the extrahepatic bile ducts;metastatic malignant neoplasm in the extrahepatic bile ducts;exactmatch
extrahepatic bile duct lymphoma;extrahepatic bile duct lymphoma;exactmatch
extrahepatic bile duct kaposi sarcoma;extrahepatic bile duct kaposi sarcoma;exactmatch
intrahepatic bile duct intraductal papillary neoplasm with an associated invasive carcinoma;intrahepatic bile duct ipn with an associated invasive carcinoma;exactmatch
extrahepatic bile duct intraductal papillary neoplasm with an associated invasive carcinoma;extrahepatic bile duct ipn with an associated invasive carcinoma;exactmatch
intrahepatic bile duct mucinous cystic neoplasm with an associated invasive carcinoma;intrahepatic bile duct cystadenocarcinoma;exactmatch
extrahepatic bile duct mucinous cystic neoplasm with an associated invasive carcinoma;extrahepatic bile duct cystadenocarcinoma;exactmatch
bile duct biliary intraepithelial neoplasia;bile duct bilin;exactmatch
intrahepatic bile duct biliary intraepithelial neoplasia;intrahepatic bile duct bilin;exactmatch
extrahepatic bile duct biliary intraepithelial neoplasia;extrahepatic bile duct bilin;exactmatch
extrahepatic bile duct carcinosarcoma;extrahepatic bile duct carcinosarcoma;exactmatch
extrahepatic bile duct adenocarcinoma, intestinal type;extrahepatic bile duct adenocarcinoma, intestinal type;exactmatch
grade 1 rectal adenocarcinoma;grade 1 rectal adenocarcinoma;exactmatch
grade 2 rectal adenocarcinoma;grade 2 rectal adenocarcinoma;exactmatch
grade 3 rectal adenocarcinoma;grade 3 rectal adenocarcinoma;exactmatch
toll-like receptor signaling pathway;toll-like receptor signaling pathway;exactmatch
low-csd melanoma;cutaneous superficial spreading melanoma;exactmatch
jak-stat signaling pathway;jak/stat;exactmatch
prostate cancer pathway;prostate cancer pathway;exactmatch
hedgehog signaling pathway;hedgehog signaling pathway;exactmatch
erbb family signaling pathway;erbb family signaling pathway;exactmatch
basal cell carcinoma pathway;basal cell carcinoma pathway;exactmatch
lentigo maligna melanoma;lentigo maligna melanoma;exactmatch
aldosterone-regulated sodium reabsorption pathway;aldosterone-regulated sodium reabsorption pathway;exactmatch
vascular smooth muscle contraction pathway;vascular smooth muscle contraction pathway;exactmatch
small cell lung cancer pathway;sclc pathway;exactmatch
renal cell carcinoma pathway;renal cell carcinoma pathway;exactmatch
botryoid-type embryonal rhabdomyosarcoma;botryoid sarcoma;exactmatch
fc gamma receptor-mediated phagocytosis pathway;fc gamma receptor-mediated phagocytosis pathway;exactmatch
papillary thyroid carcinoma pathway;ptc pathway;exactmatch
progesterone-mediated oocyte maturation pathway;progesterone-mediated oocyte maturation pathway;exactmatch
leishmaniasis infection pathway;leishmaniasis;exactmatch
notch signaling pathway;notch signaling pathway;exactmatch
vegf signaling pathway;vegf signaling pathway;exactmatch
bcr immune response signaling pathway;bcr immune response signaling pathway;exactmatch
androgen-mediated signaling pathway;androgen-mediated signaling pathway;exactmatch
aurora a signaling pathway;aurora a signaling pathway;exactmatch
aurora kinase signaling pathway;aurora kinase signaling pathway;exactmatch
atypical nf-kappab signaling pathway;atypical nf-kappab signaling pathway;exactmatch
atf-2 transcription factor signaling pathway;atf-2 transcription factor signaling pathway;exactmatch
arf6 pathway;arf6 pathway;exactmatch
adult acute myeloid leukemia;acute myeloid leukemia (aml);exactmatch
angiopoietin-1 receptor signaling pathway;angiopoietin receptor tie2-mediated signaling;exactmatch
alpham/beta2 integrin signaling pathway;alpham/beta2 integrin signaling pathway;exactmatch
chagas disease pathway;chagas disease pathway;exactmatch
alpha6/beta1 and alpha6/beta4 integrin signaling pathway;alpha6/beta1 and alpha6/beta4 integrin signaling pathway;exactmatch
hedgehog family-mediated signaling pathway;hedgehog family-mediated signaling pathway;exactmatch
wnt signaling pathway kegg;wnt signaling pathway kegg;exactmatch
adult acute erythroid leukemia;acute erythroid leukemia;exactmatch
endometrial cancer pathway;endometrial cancer pathway;exactmatch
epithelial cell signaling pathway in helicobacter pylori infection;epithelial cell signaling pathway in helicobacter pylori infection;exactmatch
acute myeloid leukemia pathway;aml pathway;exactmatch
type ii diabetes mellitus pathway;type ii diabetes mellitus pathway;exactmatch
mixed cell type kidney wilms tumor;mixed cell type kidney adenosarcoma;exactmatch
insulin/insulin receptor signaling pathway;insulin signaling pathway;exactmatch
arrhythmogenic right ventricular cardiomyopathy pathway;arvc pathway;exactmatch
calcium-mediated signaling pathway;calcium signaling pathway;exactmatch
epithelial predominant kidney wilms tumor;epithelial predominant kidney adenosarcoma;exactmatch
hematopoietic cell lineage pathway;hematopoietic cell lineage pathway;exactmatch
bladder cancer pathway;bladder cancer pathway;exactmatch
base excision repair pathway;base excision repair pathway;exactmatch
b cell receptor signaling pathway;b cell receptor signaling pathway;exactmatch
axon guidance pathway;axon guidance pathway;exactmatch
spliceosome pathway;spliceosome;exactmatch
chemokine signaling pathway;chemokine signaling pathway;exactmatch
t cell receptor signaling pathway kegg;t cell receptor signaling pathway kegg;exactmatch
osteosarcoma;osteosarcoma, malignant;exactmatch
pancreatic cancer pathway;pancreatic cancer pathway;exactmatch
non-small cell lung cancer pathway;nsclc pathway;exactmatch
neurotrophin signaling pathway;neurotrophin signaling pathway;exactmatch
natural killer cell-mediated cytotoxicity pathway;nk cell cytotoxicity;exactmatch
non-t non-b calla positive adult acute lymphoblastic leukemia;non-t non-b calla positive acute lymphoblastic leukemia;exactmatch
adherens junction assembly pathway;adherens junction assembly pathway;exactmatch
long-term depression pathway;long-term depression pathway;exactmatch
chronic myeloid leukemia pathway;cml pathway;exactmatch
colorectal cancer pathway;crc pathway;exactmatch
adipocytokine signaling pathway;adipocytokine signaling pathway;exactmatch
long-term potentiation pathway;ltp pathway;exactmatch
gonadotropin-releasing hormone signaling pathway;gnrh signaling pathway;exactmatch
stromal predominant kidney wilms tumor;stromal predominant kidney adenosarcoma;exactmatch
glioblastoma multiforme pathway;gbm pathway;exactmatch
gap junction assembly pathway;gap junction assembly pathway;exactmatch
melanoma pathway;melanoma;exactmatch
fc epsilon receptor i signaling pathway kegg;fc epsilon receptor i signaling pathway kegg;exactmatch
tight junction assembly pathway;tight junction assembly pathway;exactmatch
pathogenic escherichia coli infection pathway;pathogenic e. coli infection pathway;exactmatch
endocytosis pathway;endocytosis;exactmatch
mismatch repair pathway;dna mismatch repair pathway;exactmatch
blastema predominant kidney wilms tumor;blastema predominant kidney adenosarcoma;exactmatch
cytokine-cytokine receptor signaling pathway;cytokine-cytokine receptor signaling pathway;exactmatch
melanogenesis pathway;melanogenesis;exactmatch
adult acute promyelocytic leukemia with pml-rara;acute promyelocytic leukemia with pml-rara;exactmatch
t-cell receptor signaling pathway in naive cd4+ t cells;t-cell receptor signaling pathway in naive cd4+ t cells;exactmatch
cancer pathway;cancer pathway;exactmatch
il23-mediated signaling pathway;il23-mediated signaling pathway;exactmatch
insulin pathway;insulin pathway;exactmatch
il6-mediated signaling pathway;il6-mediated signaling pathway;exactmatch
il4-mediated signaling pathway;il4-mediated signaling pathway;exactmatch
il2/stat5 signaling pathway;il2 signaling events mediated by stat5;exactmatch
il2/pi3k signaling pathway;il2 signaling events mediated by pi3k;exactmatch
il2-mediated signaling pathway;il2-mediated signaling pathway;exactmatch
childhood acute monoblastic leukemia;acute monoblastic leukemia;exactmatch
il1-mediated signaling pathway;il1-mediated signaling pathway;exactmatch
integrin angiogenesis pathway;integrin angiogenesis pathway;exactmatch
igf1 pathway;igf1 pathway;exactmatch
interferon-gamma signaling pathway;ifn-gamma pathway;exactmatch
hif-1-alpha transcription factor pathway;hif-1-alpha transcription factor pathway;exactmatch
anal squamous cell carcinoma;anal squamous cell cancer;exactmatch
hypoxia and oxygen homeostasis regulation of hif-1-alpha pathway;hypoxia and oxygen homeostasis regulation of hif-1-alpha pathway;exactmatch
hedgehog signaling events mediated by gli family proteins;hedgehog signaling events mediated by gli family proteins;exactmatch
glucocorticoid receptor regulatory network;glucocorticoid receptor regulatory network;exactmatch
insulin-mediated glucose transport pathway;insulin-mediated glucose transport pathway;exactmatch
internalization pathway for epidermal growth factor receptor;internalization pathway for epidermal growth factor receptor;exactmatch
t-cell receptor signaling pathway in naive cd8+ t cells;t-cell receptor signaling pathway in naive cd8+ t cells;exactmatch
osteopontin-mediated signaling pathway;osteopontin-mediated signaling pathway;exactmatch
presenilin action in notch and wnt signaling pathways;presenilin action in notch and wnt signaling pathways;exactmatch
childhood acute eosinophilic leukemia;acute eosinophilic leukemia;exactmatch
plasma membrane estrogen receptor signaling pathway;plasma membrane estrogen receptor signaling pathway;exactmatch
pdgfr-beta signaling pathway;beta-type platelet-derived growth factor receptor signaling pathway;exactmatch
pdgfr-alpha signaling pathway;alpha-type platelet-derived growth factor receptor signaling pathway;exactmatch
nerve growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;exactmatch
p38 mapk signaling pathway pid;p38 mapk signaling pathway pid;exactmatch
nongenotropic androgen signaling pathway;nongenotropic androgen signaling pathway;exactmatch
childhood acute monocytic leukemia;acute monocytic leukemia;exactmatch
childhood acute erythroid leukemia;acute erythroid leukemia;exactmatch
neurotrophic factor-mediated ntrk1 signaling pathway;high affinity nerve growth factor receptor signaling pathway;exactmatch
nephrin signaling pathway in the kidney podocyte;nephrin signaling pathway in the kidney podocyte;exactmatch
nectin adhesion pathway;nectin adhesion pathway;exactmatch
n-cadherin signaling pathway;n-cadherin signaling pathway;exactmatch
mtor signaling pathway pid;mtor signaling pathway pid;exactmatch
lysophosphatidic acid receptor signaling pathway;lpa receptor mediated events;exactmatch
glucocorticoid receptor signaling pathway;glucocorticoid receptor signaling pathway;exactmatch
foxo transcription factor family signaling pathway;foxo transcription factor family signaling pathway;exactmatch
foxm1 transcription factor signaling pathway;foxm1 transcription factor signaling pathway;exactmatch
gastric intestinal-type adenocarcinoma;gastric intestinal type adenocarcinoma;exactmatch
adherens junction formation pathway;adherens junction formation pathway;exactmatch
e-cadherin signaling pathway in keratinocytes;e-cadherin signaling pathway in keratinocytes;exactmatch
e-cadherin signaling pathway;e-cadherin signaling pathway;exactmatch
e2f transcription factor pathway;e2f transcription factor pathway;exactmatch
p53 effector pathway;direct p53 effectors;exactmatch
p53 pathway for transcriptional regulation;p53 pathway for transcriptional regulation;exactmatch
cxcr4-mediated signaling pathway;cxcr4-mediated signaling pathway;exactmatch
cxcr3-mediated signaling pathway;cxcr3-mediated signaling pathway;exactmatch
childhood acute myeloid leukemia;acute myeloid leukemia (aml);exactmatch
coregulation pathway for androgen receptor activity;coregulation pathway for androgen receptor activity;exactmatch
class i pi3k signaling pathway;class i pi3k signaling pathway;exactmatch
ceramide signaling pathway pid;ceramide signaling pathway pid;exactmatch
cd40/cd40l signaling pathway;cd40/cd40l signaling pathway;exactmatch
adult acute monoblastic leukemia;acute monoblastic leukemia;exactmatch
canonical wnt signaling pathway;canonical wnt signaling pathway;exactmatch
wnt signaling pathway pid;wnt signaling pathway pid;exactmatch
epidermal growth factor receptor pathway;egf receptor (erbb1) signaling pathway;exactmatch
childhood acute myeloid leukemia without maturation;acute myeloid leukemia (aml) without maturation;exactmatch
endothelin pathway;endothelin pathway;exactmatch
egfr-dependent endothelin signaling pathway;egfr-dependent endothelin signaling pathway;exactmatch
foxa2 and foxa3 transcription factor signaling pathway;foxa2 and foxa3 transcription factor signaling pathway;exactmatch
foxa transcription factor signaling pathway;foxa transcription factor signaling pathway;exactmatch
fgf signaling pathway;fgf signaling pathway;exactmatch
fc-epsilon receptor i signaling pathway pid;fc-epsilon receptor i signaling pathway pid;exactmatch
fas signaling pathway pid;fas signaling pathway pid;exactmatch
erbb2/erbb3 signaling pathway;erbb2/erbb3 signaling pathway;exactmatch
epidermal growth factor receptor downstream signaling pathway;epidermal growth factor receptor downstream signaling pathway;exactmatch
epidermal growth factor receptor family pathway;epidermal growth factor receptor family pathway;exactmatch
gastric diffuse adenocarcinoma;adenocarcinoma of linitis plastica type;exactmatch
erythropoietin signaling pathway;epo signaling pathway;exactmatch
ephrin b reverse signaling pathway;ephrin b reverse signaling pathway;exactmatch
ephrin b forward signaling pathway;ephb forward signaling;exactmatch
ephrin a2 forward signaling pathway;epha2 forward signaling;exactmatch
ephrin b signaling pathway;ephb signaling pathway;exactmatch
ephrin a signaling pathway;epha signaling pathway;exactmatch
leukocyte transendothelial migration pathway;leukocyte transendothelial migration pathway;exactmatch
actin cytoskeleton regulation pathway;actin cytoskeleton regulation pathway;exactmatch
ras signaling in the cd4+ tcr pathway;ras signaling in the cd4+ tcr pathway;exactmatch
ann arbor stage iv childhood lymphoblastic lymphoma;ann arbor stage iv childhood lymphoblastic lymphoma;exactmatch
recurrent adult hepatocellular carcinoma;recurrent adult hepatocellular carcinoma;exactmatch
localized unresectable adult hepatocellular carcinoma;localized non-resectable adult hepatocellular carcinoma;exactmatch
localized resectable adult hepatocellular carcinoma;localized resectable adult hepatocellular carcinoma;exactmatch
malignant testicular germ cell tumor;malignant germ cell neoplasm of testis;exactmatch
adult burkitt lymphoma;adult burkitt lymphoma;exactmatch
penile carcinoma;cancer of penis;exactmatch
recurrent childhood lymphoblastic lymphoma;recurrent childhood lymphoblastic lymphoma;exactmatch
ann arbor stage iii childhood lymphoblastic lymphoma;ann arbor stage iii childhood lymphoblastic lymphoma;exactmatch
pancreatic gastrin-producing neuroendocrine tumor;pancreatic gastrin producing net;exactmatch
ann arbor stage ii childhood lymphoblastic lymphoma;ann arbor stage ii childhood lymphoblastic lymphoma;exactmatch
ann arbor stage i childhood lymphoblastic lymphoma;ann arbor stage i childhood lymphoblastic lymphoma;exactmatch
bartholin gland carcinoma;bartholin gland cancer;exactmatch
recurrent vulvar carcinoma;recurrent cancer of vulva;exactmatch
ajcc v7 stage;7th;exactmatch
stage iv vulvar cancer ajcc v6;ajcc stage iv vulva cancer v6;exactmatch
ajcc v6 stage;6th;exactmatch
recurrent childhood acute myeloid leukemia;recurrent acute myeloid leukemia (aml);exactmatch
recurrent chronic myelogenous leukemia, bcr-abl1 positive;recurrent chronic myelogenous leukemia;exactmatch
medium/large size posterior uveal melanoma;medium/large size ciliary body and choroid melanoma;exactmatch
stage i thyroid gland papillary carcinoma ajcc v7;stage i papillary carcinoma of thyroid;exactmatch
iris melanoma;iris malignant melanoma;exactmatch
kaposi sarcoma;ks;exactmatch
stage iv thyroid gland follicular carcinoma ajcc v7;stage iv thyroid gland follicular cancer;exactmatch
stage ii thyroid gland follicular carcinoma ajcc v7;stage ii follicular carcinoma of thyroid;exactmatch
stage i thyroid gland follicular carcinoma ajcc v7;stage i follicular carcinoma of thyroid;exactmatch
stage iv thyroid gland papillary carcinoma ajcc v7;stage iv papillary carcinoma of thyroid;exactmatch
stage ii thyroid gland papillary carcinoma ajcc v7;stage ii papillary carcinoma of thyroid;exactmatch
noninvasive malignant thymoma;malignant thymoma, noninvasive;exactmatch
stage 0 uterine corpus cancer ajcc v6;endometrial carcinoma in situ ajcc v6;exactmatch
childhood immunoblastic lymphoma;childhood immunoblastic large cell lymphoma;exactmatch
refractory malignant testicular germ cell tumor;refractory cancer of testis;exactmatch
childhood diffuse large cell lymphoma;childhood diffuse large cell lymphoma;exactmatch
stage iv prostate cancer ajcc v6;cancer of prostate stage iv ajcc v6;exactmatch
stage iii testicular cancer ajcc v6 and v7;stage iii;exactmatch
stage ii testicular cancer ajcc v6 and v7;stage ii;exactmatch
recurrent uterine corpus cancer;recurrent corpus uteri cancer;exactmatch
sinonasal cancer by ajcc v6 stage;nasal cavity and paranasal sinus cancer by ajcc v6 stage;exactmatch
laryngeal cancer by ajcc v6 stage;laryngeal cancer by ajcc v6 stage;exactmatch
pharyngeal carcinoma by ajcc v6 stage;pharyngeal carcinoma by ajcc v6 stage;exactmatch
metastatic parathyroid gland carcinoma;metastatic parathyroid cancer;exactmatch
uterine corpus cancer by ajcc v6 stage;uterine corpus cancer by ajcc v6 stage;exactmatch
cervical cancer by ajcc v6 stage;cervical cancer by ajcc v6 stage;exactmatch
extensive stage lung small cell carcinoma;extensive disease small cell lung cancer;exactmatch
childhood extraocular retinoblastoma;childhood extraocular retinoblastoma;exactmatch
childhood intraocular retinoblastoma;childhood intraocular retinoblastoma;exactmatch
recurrent childhood hepatocellular carcinoma;recurrent childhood hepatocellular carcinoma;exactmatch
recurrent childhood central nervous system neoplasm;recurrent central nervous system neoplasm;exactmatch
childhood supratentorial ependymoma;childhood supratentorial ependymoma;exactmatch
hypopharyngeal carcinoma by ajcc v6 stage;hypopharyngeal carcinoma by ajcc v6 stage;exactmatch
childhood brain stem glioma;brain stem glioma;exactmatch
childhood infratentorial ependymoma;childhood infratentorial ependymoma;exactmatch
adult angiosarcoma;adult angiosarcoma;exactmatch
cervical carcinoma;cancer of cervix;exactmatch
occult lung non-small cell carcinoma;occult lung non-small cell carcinoma;exactmatch
stage i anal canal cancer ajcc v6 and v7;stage i anal canal cancer;exactmatch
stage iv gastric cancer ajcc v6;carcinoma of stomach stage iv ajcc v6;exactmatch
fallopian tube cancer by ajcc v6 stage;fallopian tube cancer by ajcc v6 stage;exactmatch
recurrent lung small cell carcinoma;recurrent lung small cell carcinoma;exactmatch
esophageal cancer by ajcc v6 stage;esophageal cancer by ajcc v6 stage;exactmatch
gastric cancer by ajcc v6 stage;gastric cancer by ajcc v6 stage;exactmatch
oropharyngeal carcinoma by ajcc v6 stage;oropharyngeal carcinoma by ajcc v6 stage;exactmatch
nasopharyngeal carcinoma by ajcc v6 stage;nasopharyngeal carcinoma by ajcc v6 stage;exactmatch
prostate cancer by ajcc v6 stage;prostate cancer by ajcc v6 stage;exactmatch
penile cancer by ajcc v6 stage;penile cancer by ajcc v6 stage;exactmatch
stage iii vulvar cancer ajcc v6;ajcc stage iii vulva cancer ajcc v6;exactmatch
lung cancer by ajcc v6 stage;lung cancer by ajcc v6 stage;exactmatch
cutaneous melanoma by ajcc v6 stage;cutaneous melanoma by ajcc v6 stage;exactmatch
breast cancer by ajcc v6 stage;breast cancer by ajcc v6 stage;exactmatch
gallbladder cancer by ajcc v6 stage;gallbladder cancer by ajcc v6 stage;exactmatch
hepatocellular carcinoma by ajcc v6 stage;hepatocellular carcinoma by ajcc v6 stage;exactmatch
stage ii vulvar cancer ajcc v6;ajcc stage ii vulva cancer v6;exactmatch
rectosigmoid cancer by ajcc v6 stage;rectosigmoid cancer by ajcc v6 stage;exactmatch
rectal cancer by ajcc v6 stage;rectal cancer by ajcc v6 stage;exactmatch
colon cancer by ajcc v6 stage;colon cancer by ajcc v6 stage;exactmatch
colorectal cancer by ajcc v6 stage;colorectal cancer by ajcc v6 stage;exactmatch
small size posterior uveal melanoma;small size ciliary body and choroid melanoma;exactmatch
adult brain stem glioma;adult brain stem glioma;exactmatch
dorso-ventral axis formation pathway;dorso-ventral axis formation pathway;exactmatch
lung cancer by ajcc v7 stage;lung cancer by ajcc v7 stage;exactmatch
hypopharyngeal carcinoma by ajcc v7 stage;hypopharyngeal carcinoma by ajcc v7 stage;exactmatch
adult lymphocyte-depleted classic hodgkin lymphoma;adult hdld;exactmatch
oropharyngeal carcinoma by ajcc v7 stage;oropharyngeal carcinoma by ajcc v7 stage;exactmatch
nasopharyngeal carcinoma by ajcc v7 stage;nasopharyngeal carcinoma by ajcc v7 stage;exactmatch
childhood lymphoblastic lymphoma;childhood lymphoblastic lymphoma;exactmatch
penile cancer by ajcc v7 stage;penile cancer by ajcc v7 stage;exactmatch
prostate cancer by ajcc v7 stage;prostate cancer by ajcc v7 stage;exactmatch
cutaneous melanoma by ajcc v7 stage;cutaneous melanoma by ajcc v7 stage;exactmatch
sinonasal cancer by ajcc v7 stage;nasal cavity and paranasal sinus cancer by ajcc v7 stage;exactmatch
breast cancer by ajcc v7 stage;breast cancer by ajcc v7 stage;exactmatch
gallbladder cancer by ajcc v7 stage;gallbladder cancer by ajcc v7 stage;exactmatch
hepatocellular carcinoma by ajcc v7 stage;hepatocellular carcinoma by ajcc v7 stage;exactmatch
rectosigmoid cancer by ajcc v7 stage;rectosigmoid cancer by ajcc v7 stage;exactmatch
rectal cancer by ajcc v7 stage;rectal cancer by ajcc v7 stage;exactmatch
colon cancer by ajcc v7 stage;colon cancer by ajcc v7 stage;exactmatch
colorectal cancer by ajcc v7 stage;colorectal cancer by ajcc v7 stage;exactmatch
pharyngeal carcinoma by ajcc v7 stage;pharyngeal carcinoma by ajcc v7 stage;exactmatch
laryngeal cancer by ajcc v7 stage;laryngeal cancer by ajcc v7 stage;exactmatch
adult ependymoma;adult ependymoma;exactmatch
breast tubular carcinoma;breast tubular carcinoma;exactmatch
mtor signaling pathway kegg;mtor signaling pathway kegg;exactmatch
adult b acute lymphoblastic leukemia;adult b acute lymphoblastic leukemia;exactmatch
adult t acute lymphoblastic leukemia;adult precursor t-lymphoblastic leukemia;exactmatch
non-t non-b calla positive childhood acute lymphoblastic leukemia;non-t non-b calla positive acute lymphoblastic leukemia;exactmatch
childhood b acute lymphoblastic leukemia;b acute lymphoblastic leukemia;exactmatch
combined lung small cell carcinoma;combined lung small cell carcinoma;exactmatch
invasive breast lobular carcinoma with predominant in situ component;infiltrating lobular breast carcinoma with predominant in situ component;exactmatch
breast papillary  carcinoma;breast papillary  carcinoma;exactmatch
adult nodular sclerosis classic hodgkin lymphoma;adult hodgkin's nodular sclerosis;exactmatch
lung adenosquamous carcinoma;adenosquamous cell lung carcinoma;exactmatch
invasive breast carcinoma of no special type with predominant intraductal component;infiltrating ductal breast carcinoma with predominant intraductal component;exactmatch
breast mucinous carcinoma;breast mucinous carcinoma;exactmatch
adult rhabdomyosarcoma;adult rhabdomyosarcoma;exactmatch
philadelphia chromosome negative, bcr-abl1 positive chronic myelogenous leukemia;ph negative cml;exactmatch
philadelphia chromosome positive, bcr-abl1 positive chronic myelogenous leukemia;cml - philadelphia chromosome;exactmatch
adult mixed cellularity classic hodgkin lymphoma;adult mchd;exactmatch
gastric cancer by ajcc v7 stage;gastric cancer by ajcc v7 stage;exactmatch
esophageal cancer by ajcc v7 stage;esophageal cancer by ajcc v7 stage;exactmatch
stage iii thyroid gland papillary carcinoma ajcc v7;stage iii papillary carcinoma of thyroid;exactmatch
stage 0 hypopharyngeal carcinoma ajcc v6, v7, and v8;carcinoma in situ of the hypopharynx;exactmatch
intermediate grade adult non-hodgkin's lymphoma;intermediate grade adult non-hodgkin's lymphoma;exactmatch
childhood solid neoplasm;childhood solid neoplasm;exactmatch
urethral carcinoma;carcinoma of urethra;exactmatch
oropharyngeal carcinoma;cancer of oropharynx;exactmatch
stage 0 lung non-small cell cancer ajcc v6 and v7;lung non-small cell carcinoma in situ;exactmatch
stage iiib lung non-small cell cancer ajcc v7;non small cell lung cancer stage iiib;exactmatch
stage iiia lung non-small cell cancer ajcc v7;non small cell lung cancer stage iiia;exactmatch
stage 0 laryngeal cancer ajcc v6, v7, and v8;carcinoma in situ of larynx;exactmatch
fallopian tube cancer by ajcc v7 stage;fallopian tube cancer by ajcc v7 stage;exactmatch
stage 0 nasopharyngeal carcinoma ajcc v6, v7, and v8;carcinoma in situ of nasopharynx;exactmatch
low grade adult non-hodgkin's lymphoma;low grade adult non-hodgkin's lymphoma;exactmatch
recurrent cutaneous melanoma;recurrent cutaneous (skin) melanoma;exactmatch
stage iv cutaneous melanoma ajcc v6 and v7;malignant melanoma (of skin), stage iv;exactmatch
childhood burkitt lymphoma;burkitt lymphoma;exactmatch
adult glioblastoma;adult glioblastoma;exactmatch
adult meningioma;adult meningioma;exactmatch
high grade adult non-hodgkin's lymphoma;high grade adult non-hodgkin's lymphoma;exactmatch
blast phase chronic myelogenous leukemia, bcr-abl1 positive;blast phase cml;exactmatch
meningeal chronic myelogenous leukemia, bcr-abl1 positive;meningeal chronic myelogenous leukemia;exactmatch
classic kaposi sarcoma;classic kaposi sarcoma;exactmatch
uterine corpus cancer by ajcc v7 stage;uterine corpus cancer by ajcc v7 stage;exactmatch
stage iii thyroid gland follicular carcinoma ajcc v7;stage iii follicular carcinoma of thyroid;exactmatch
cervical cancer by ajcc v7 stage;cervical cancer by ajcc v7 stage;exactmatch
vaginal cancer by ajcc v7 stage;vaginal cancer by ajcc v7 stage;exactmatch
vulvar cancer by ajcc v7 stage;vulvar cancer by ajcc v7 stage;exactmatch
bladder cancer by ajcc v7 stage;bladder cancer by ajcc v7 stage;exactmatch
renal cell cancer by ajcc v7 stage;renal cell cancer by ajcc v7 stage;exactmatch
pancreatic ductal adenocarcinoma;ductal adenocarcinoma of pancreas;exactmatch
breast medullary carcinoma;breast medullary carcinoma;exactmatch
sarcoma;mesenchymal tumor, malignant;exactmatch
recurrent neck squamous cell carcinoma of unknown primary;recurrent metastatic epidermoid carcinoma to the neck with occult primary;exactmatch
childhood acute leukemia in remission;acute leukemia in remission;exactmatch
childhood acute myeloid leukemia in remission;acute myeloid leukemia (aml) in remission;exactmatch
adult acute leukemia in remission;acute leukemia in remission;exactmatch
kaposi sarcoma related to immunosuppressive treatment;immunosuppressive treatment related kaposi sarcoma;exactmatch
syndecan-mediated signaling pathway;proteogylcan syndecan-mediated signaling events;exactmatch
reelin signaling pathway pid;reelin signaling pathway pid;exactmatch
grade 3 colorectal adenocarcinoma;grade 3 colorectal adenocarcinoma;exactmatch
advanced stage;advanced stage;exactmatch
malignant bladder neoplasm;malignant bladder neoplasm;exactmatch
malignant appendix neoplasm;malignant appendix neoplasm;exactmatch
in-transit metastasis;in-transit metastasis;exactmatch
maxillary sinus carcinoma;maxillary sinus cancer;exactmatch
malignant gastric neoplasm;malignant gastric neoplasm;exactmatch
appendix carcinoma;appendiceal cancer;exactmatch
malignant cecum neoplasm;malignant cecum neoplasm;exactmatch
malignant duodenal neoplasm;malignant duodenal neoplasm;exactmatch
nasal cavity carcinoma;cancer of nasal cavity;exactmatch
malignant adrenal cortex neoplasm;adrenal cortical tumor, malignant;exactmatch
rhabdoid tumor predisposition syndrome;familial posterior fossa brain tumor syndrome of infancy;exactmatch
adrenal cortex carcinoma;adenocarcinoma, adrenocortical, malignant;exactmatch
malignant postcricoid neoplasm;malignant neoplasm of postcricoid area;exactmatch
psa failure;psa failure;exactmatch
malignant parathyroid gland neoplasm;malignant neoplasm of parathyroid;exactmatch
inflammatory disorder;inflammatory disease;exactmatch
malignant breast neoplasm;malignant breast neoplasm;exactmatch
malignant ear neoplasm;malignant ear neoplasm;exactmatch
stage i colon cancer ajcc v6 and v7;ajcc stage i colon cancer;exactmatch
plasmacytoma;plasmacytoma;exactmatch
regional ureter carcinoma;regional ureter carcinoma;exactmatch
stage ivb vaginal cancer ajcc v6 and v7;ajcc stage ivb vaginal cancer;exactmatch
recurrent malignant gastric neoplasm;recurrent malignant gastric neoplasm;exactmatch
recurrent malignant hypopharyngeal neoplasm;recurrent malignant hypopharyngeal neoplasm;exactmatch
recurrent duodenal carcinoma;recurrent duodenal cancer;exactmatch
pleural mesothelioma;mesothelioma of pleura;exactmatch
peritoneal malignant mesothelioma;malignant mesothelioma of peritoneum;exactmatch
mast cell sarcoma;mcs;exactmatch
malignant adrenal gland neoplasm;malignant adrenal gland neoplasm;exactmatch
tracheal carcinoma;cancer of trachea;exactmatch
malignant tracheal neoplasm;malignant neoplasm of trachea;exactmatch
malignant tongue neoplasm;malignant neoplasm of tongue;exactmatch
pineoblastoma;pineoblastoma, malignant;exactmatch
bone neoplasm;bone neoplasm;exactmatch
peripheral primitive neuroectodermal tumor;neuro-differentiated ewing tumor;exactmatch
refractory peripheral t-cell lymphoma, not otherwise specified;refractory peripheral t-cell lymphoma, not otherwise specified;exactmatch
malignant nasopharyngeal neoplasm;malignant nasopharyngeal neoplasm;exactmatch
malignant buccal mucosa neoplasm;malignant buccal mucosa neoplasm;exactmatch
floor of the mouth carcinoma;carcinoma of floor of mouth;exactmatch
myeloid neoplasm;myeloid malignancy;exactmatch
gastroesophageal junction adenocarcinoma;adenocarcinoma - gej;exactmatch
mast cell neoplasm;mast cell neoplasm;exactmatch
central nervous system histiocytic and dendritic cell neoplasm;central nervous system histiocytic and dendritic cell neoplasm;exactmatch
histiocytic and dendritic cell neoplasm;histiocytic and dendritic cell neoplasm;exactmatch
central nervous system neoplasm;brain/spinal cord tumor;exactmatch
solid neoplasm;solid neoplasm;exactmatch
anal carcinoma;anal cancer;exactmatch
acute myeloid leukemia with multilineage dysplasia;aml with multilineage dysplasia;exactmatch
malignant floor of the mouth neoplasm;malignant floor of mouth neoplasm;exactmatch
"acute myeloid leukemia with t(8;21); (q22; q22.1); runx1-runx1t1";"aml with t(8;21)(q22;q22), runx1 runx1t1";exactmatch
"acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); cbfb-myh11";"aml with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); cbfb-myh11";exactmatch
indolent systemic mastocytosis;ism;exactmatch
aggressive systemic mastocytosis;asm;exactmatch
systemic mastocytosis with an associated hematological neoplasm;sm-ahn;exactmatch
lymphocyte-depleted classic hodgkin lymphoma;classical hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis;exactmatch
interdigitating dendritic cell sarcoma;interdigitating cell sarcoma/tumor;exactmatch
malignant urinary system neoplasm;malignant urinary system neoplasm;exactmatch
acute undifferentiated leukemia;acute leukemia not otherwise specified;exactmatch
acute leukemia;acute leukemia;exactmatch
central nervous system lymphoma;cns lymphoma;exactmatch
malignant gingival neoplasm;malignant gingival neoplasm;exactmatch
malignant oral neoplasm;malignant lip and oral cavity neoplasm;exactmatch
lip and oral cavity carcinoma;lip and oral cavity cancer;exactmatch
malignant oral cavity neoplasm;malignant mouth neoplasm;exactmatch
testicular non-seminomatous germ cell tumor;testicular germ cell tumor non-seminomatous;exactmatch
radiation-related sarcoma;radiation-related sarcoma;exactmatch
bone sarcoma;bone sarcoma;exactmatch
malignant cervical neoplasm;malignant cervical neoplasm;exactmatch
deleterious mutation;deleterious;exactmatch
seminoma;seminoma, malignant;exactmatch
lymphoproliferative disorder;lymphoproliferative disorder;exactmatch
soft tissue sarcoma;connective tissue sarcoma;exactmatch
malignant neoplasm;ca;exactmatch
paratesticular soft tissue;paratesticular soft tissue;exactmatch
mastocytoma;mastocytoma;exactmatch
hodgkin lymphoma;hl;exactmatch
location description;location description;exactmatch
primary mediastinal (thymic) large b-cell lymphoma;b-cell diffuse large cell lymphoma of mediastinum;exactmatch
epithelioid sarcoma nci grade 2;epithelioid sarcoma nci grade 2;exactmatch
sarcoma by ajcc grade;ajcc tumor grade in sarcoma;exactmatch
sarcoma nci grade 3;sarcoma nci grade 3;exactmatch
kaposi sarcoma nci grade 3;kaposi sarcoma nci grade 3;exactmatch
kaposi sarcoma nci grade 2;kaposi sarcoma nci grade 2;exactmatch
angiosarcoma nci grade 3;angiosarcoma nci grade 3;exactmatch
angiosarcoma nci grade 2;angiosarcoma nci grade 2;exactmatch
epithelioid sarcoma nci grade 3;epithelioid sarcoma nci grade 3;exactmatch
inflammatory malignant fibrous histiocytoma nci grade 3;inflammatory malignant fibrous histiocytoma nci grade 3;exactmatch
high grade sarcoma;high grade sarcoma;exactmatch
inflammatory malignant fibrous histiocytoma nci grade 2;inflammatory malignant fibrous histiocytoma nci grade 2;exactmatch
storiform-pleomorphic malignant fibrous histiocytoma nci grade 3;storiform-pleomorphic malignant fibrous histiocytoma nci grade 3;exactmatch
storiform-pleomorphic malignant fibrous histiocytoma nci grade 2;storiform-pleomorphic malignant fibrous histiocytoma nci grade 2;exactmatch
poorly differentiated fibrosarcoma;poorly differentiated fibrosarcoma;exactmatch
fibrosarcoma nci grade 2;fibrosarcoma nci grade 2;exactmatch
round cell liposarcoma nci grade 3;round cell liposarcoma nci grade 3;exactmatch
round cell liposarcoma nci grade 2;round cell liposarcoma nci grade 2;exactmatch
low grade sarcoma;low grade sarcoma;exactmatch
ajcc grade 1 sarcoma;ajcc g1 sarcoma;exactmatch
skin pigmented basal cell carcinoma;pigmented basal cell carcinoma;exactmatch
pigmented dermatofibrosarcoma protuberans;bednar tumor;exactmatch
grade 2 colorectal adenocarcinoma;grade 2 colorectal adenocarcinoma;exactmatch
grade 1 colorectal adenocarcinoma;grade 1 colorectal adenocarcinoma;exactmatch
deposit;deposit;exactmatch
chronic kidney disease, stage 5;chronic kidney disease, stage 5;exactmatch
granuloma by site;granuloma by site;exactmatch
malignant pleural effusion;malignant pleural effusion;exactmatch
childhood hematopoietic neoplasm;childhood hematopoietic neoplasm;exactmatch
receptor status;receptor status;exactmatch
ajcc grade 2 sarcoma;ajcc g2 sarcoma;exactmatch
conventional fibrosarcoma;classic fibrosarcoma;exactmatch
conventional leiomyosarcoma;classic leiomyosarcoma;exactmatch
conventional angiosarcoma;conventional angiosarcoma;exactmatch
conventional malignant hemangiopericytoma;conventional malignant hemangiopericytoma;exactmatch
combined lung small cell and squamous cell carcinoma;combined lung small cell and squamous cell carcinoma;exactmatch
ajcc grade 4 sarcoma;ajcc g4 sarcoma;exactmatch
ajcc grade 3 sarcoma;ajcc g3 sarcoma;exactmatch
sarcoma nci grade 2;sarcoma nci grade 2;exactmatch
myxoid chondrosarcoma nci grade 2;myxoid chondrosarcoma nci grade 2;exactmatch
myxoid chondrosarcoma nci grade 1;myxoid chondrosarcoma nci grade 1;exactmatch
stage ivb bladder cancer;jewett-marshall stage d2 bladder cancer;exactmatch
adult brain oligodendroglioma;adult brain oligodendroglioma;exactmatch
adult brain glioblastoma;adult brain glioblastoma;exactmatch
adult intracranial meningioma;adult brain meningioma;exactmatch
adult brain ependymoma;adult brain ependymoma;exactmatch
adult brain stem mixed glioma;adult brain stem mixed glioma;exactmatch
adult brain stem gliosarcoma;adult brain stem gliosarcoma;exactmatch
recurrent malignant testicular germ cell tumor;recurrent cancer of testis;exactmatch
stage iva bladder cancer;jewett-marshall stage d1 bladder cancer;exactmatch
chondrosarcoma nci grade 1;chondrosarcoma nci grade 1;exactmatch
stage iib bladder cancer;jewett-marshall stage b2 bladder cancer;exactmatch
stage iia bladder cancer;jewett-marshall stage b1 bladder cancer;exactmatch
labia minora carcinoma;carcinoma of labia minora;exactmatch
labia majora carcinoma;carcinoma of labia majora;exactmatch
clitoral carcinoma;carcinoma of clitoris;exactmatch
adult lymphoblastic lymphoma;adult lymphoblastic lymphoma;exactmatch
lymphoblastic lymphoma;lymphoma, lymphoblastic, malignant;exactmatch
brain oligodendroglioma;brain oligodendroglioma;exactmatch
childhood myeloid leukemia in remission;childhood myeloid leukemia in remission;exactmatch
combined lung small cell carcinoma and lung adenocarcinoma;adenocarcinoma and small cell carcinoma of lung;exactmatch
adult acute myeloid leukemia without maturation;acute myeloid leukemia (aml) without maturation;exactmatch
chondrosarcoma nci grade 2;chondrosarcoma nci grade 2;exactmatch
chondrosarcoma nci grade 3;chondrosarcoma nci grade 3;exactmatch
malignant hemangiopericytoma nci grade 3;malignant hemangiopericytoma nci grade 3;exactmatch
malignant hemangiopericytoma nci grade 2;malignant hemangiopericytoma nci grade 2;exactmatch
well differentiated malignant hemangiopericytoma;well differentiated malignant hemangiopericytoma;exactmatch
leiomyosarcoma nci grade 2;leiomyosarcoma nci grade 2;exactmatch
leiomyosarcoma nci grade 3;leiomyosarcoma nci grade 3;exactmatch
well differentiated leiomyosarcoma;well differentiated leiomyosarcoma;exactmatch
sarcoma nci grade 1;sarcoma nci grade 1;exactmatch
sarcoma by nci grade;nci tumor grade in sarcoma;exactmatch
renal cell carcinoma;adenocarcinoma of kidney;exactmatch
kidney carcinoma;kidney (including renal cell) cancer;exactmatch
rectal adenocarcinoma;adenocarcinoma - rectum;exactmatch
rectal carcinoma;cancer of rectum;exactmatch
childhood acute myeloid leukemia with maturation;acute myeloid leukemia (aml) with maturation;exactmatch
follicular dendritic cell sarcoma;follicular dendritic cell sarcoma;exactmatch
aids-related hodgkin lymphoma;aids-associated hodgkin's disease;exactmatch
gallbladder adenocarcinoma;adenocarcinoma of gallbladder;exactmatch
ann arbor stage i childhood burkitt lymphoma;ann arbor stage i childhood burkitt lymphoma;exactmatch
recurrent childhood cerebral astrocytoma;recurrent cerebral astrocytoma;exactmatch
recurrent childhood brain stem glioma;recurrent brain stem glioma;exactmatch
recurrent childhood burkitt lymphoma;recurrent burkitt lymphoma;exactmatch
ann arbor stage iv childhood burkitt lymphoma;ann arbor stage iv childhood burkitt lymphoma;exactmatch
ann arbor stage iii childhood burkitt lymphoma;ann arbor stage iii childhood burkitt lymphoma;exactmatch
ann arbor stage ii childhood burkitt lymphoma;ann arbor stage ii childhood burkitt lymphoma;exactmatch
fus gene;fus;exactmatch
primary intraocular non-hodgkin lymphoma;intraocular lymphoma;exactmatch
ann arbor stage ii contiguous adult burkitt lymphoma;ann arbor stage ii contiguous adult burkitt lymphoma;exactmatch
adult intracranial solitary fibrous tumor/hemangiopericytoma, grade 3;adult intracranial anaplastic hemangiopericytoma;exactmatch
homeostasis regulation pathway;homeostasis regulation pathway;exactmatch
drug pathway;drug pathway;exactmatch
desmoid fibromatosis;aggressive fibromatosis;exactmatch
recurrent carcinoma of unknown primary;recurrent carcinoma of unknown primary;exactmatch
amoebiasis pathway;amoebiasis;exactmatch
malaria pathway;malaria;exactmatch
ovarian carcinosarcoma;carcinosarcoma of ovary;exactmatch
ann arbor stage ii grade 1 non-contiguous follicular lymphoma;ann arbor stage ii grade 1 non-contiguous follicular lymphoma;exactmatch
stage ii adrenal cortex carcinoma ajcc v7;stage ii adrenal cortex cancer;exactmatch
stage iv cervical cancer ajcc v6 and v7;ajcc stage iv cervical cancer;exactmatch
stage iv esophageal cancer ajcc v6;stage iv carcinoma of esophagus ajcc v6;exactmatch
stage iii esophageal cancer ajcc v6;esophageal cancer stage iii ajcc v6;exactmatch
stage ii esophageal cancer ajcc v6;esophageal cancer stage ii ajcc v6;exactmatch
stage i esophageal cancer ajcc v6;esophageal cancer stage i ajcc v6;exactmatch
stage iii uterine corpus cancer ajcc v6;stage iii cancer of uterine corpus ajcc v6;exactmatch
stage ii uterine corpus cancer ajcc v6;stage ii cancer of uterine corpus ajcc v6;exactmatch
stage i uterine corpus cancer ajcc v6;stage i cancer of uterine corpus ajcc v6;exactmatch
stage iii cervical cancer ajcc v6 and v7;cervical cancer stage iii;exactmatch
ann arbor stage ii grade 2 non-contiguous follicular lymphoma;ann arbor stage ii grade 2 non-contiguous follicular lymphoma;exactmatch
stage i cervical cancer ajcc v6 and v7;ajcc stage i cervical cancer;exactmatch
ann arbor stage ii mantle cell lymphoma;ann arbor stage ii mantle cell lymphoma;exactmatch
ann arbor stage ii non-contiguous adult burkitt lymphoma;ann arbor stage ii non-contiguous adult burkitt lymphoma;exactmatch
stage ii non-contiguous adult diffuse mixed cell lymphoma;non-contiguous adult diffuse mixed cell lymphoma stage ii;exactmatch
ann arbor stage ii non-contiguous mantle cell lymphoma;ann arbor stage ii non-contiguous mantle cell lymphoma;exactmatch
stage ii non-contiguous adult diffuse small cleaved cell lymphoma;non-contiguous adult diffuse small cleaved cell lymphoma stage ii;exactmatch
ann arbor stage ii grade 3 non-contiguous follicular lymphoma;ann arbor stage ii grade 3 non-contiguous follicular lymphoma;exactmatch
bacterial invasion of epithelial cell pathway;bacterial invasion of epithelial cell pathway;exactmatch
uterine corpus carcinosarcoma;carcinosarcoma of corpus uteri;exactmatch
stage iv uterine sarcoma ajcc v7;stage iv uterine sarcoma;exactmatch
sphingosine 1-phosphate receptor 3 signaling pathway;edg3 signaling pathway;exactmatch
p38-alpha and p38-beta signaling pathway;signaling mediated by p38-alpha and p38-beta;exactmatch
proto-oncogene tyrosine-protein kinase receptor ret signaling pathway;proto-oncogene tyrosine-protein kinase receptor ret signaling pathway;exactmatch
vegfr1 and vegfr2 signaling;signaling events mediated by vegfr1 and vegfr2;exactmatch
rectal signet ring cell adenocarcinoma;rectal signet ring cell adenocarcinoma;exactmatch
mast/stem cell growth factor receptor signaling pathway;kit signaling pathway;exactmatch
ptpn1 signaling pathway;ptp1b signaling pathway;exactmatch
hepatocyte growth factor receptor signaling pathway pid;hepatocyte growth factor receptor signaling pathway pid;exactmatch
gallbladder undifferentiated carcinoma;anaplastic carcinoma of gallbladder;exactmatch
immune hemolytic anemia;immune hemolytic anemia;exactmatch
sphingosine 1-phosphate receptor 2 signaling pathway;edg2 signaling pathway;exactmatch
sphingosine 1-phosphate signaling pathway;sphingosine 1-phosphate signaling pathway;exactmatch
retinoic acid receptor family-mediated signaling pathway;retinoic acid receptor family-mediated signaling pathway;exactmatch
telomerase regulation pathway;regulation of telomerase;exactmatch
regulation of retinoblastoma protein pathway;regulation of retinoblastoma protein pathway;exactmatch
regulation of nuclear smad2/3 signaling pathway;regulation of nuclear smad2/3 signaling pathway;exactmatch
regulation of cytoplasmic and nuclear smad2/3 signaling pathway;regulation of cytoplasmic and nuclear smad2/3 signaling pathway;exactmatch
adherens junction stabilization pathway;adherens junction stabilization pathway;exactmatch
syndecan-2-mediated signaling pathway;syndecan-2-mediated signaling pathway;exactmatch
syndecan-3-mediated signaling pathway;syndecan-3-mediated signaling pathway;exactmatch
gallbladder adenocarcinoma with squamous metaplasia;adenocarcinoma of gallbladder with squamous metaplasia;exactmatch
poor prognosis metastatic gestational trophoblastic tumor;poor prognosis metastatic gestational trophoblastic tumor;exactmatch
good prognosis metastatic gestational trophoblastic tumor;good prognosis metastatic gestational trophoblastic tumor;exactmatch
transport pathway;transport pathway;exactmatch
non-metastatic gestational trophoblastic tumor;non-metastatic gtt;exactmatch
bowel obstruction;bowel obstruction;exactmatch
middle ear carcinoma in situ;middle ear carcinoma in situ;exactmatch
childhood angiosarcoma;angiosarcoma;exactmatch
testicular mixed choriocarcinoma and seminoma;mixed choriocarcinoma and seminoma of testis;exactmatch
testicular mixed embryonal carcinoma and yolk sac tumor with seminoma;mixed embryonal carcinoma and endodermal sinus neoplasm with seminoma of testis;exactmatch
gallbladder squamous cell carcinoma;epidermoid carcinoma of gallbladder;exactmatch
vegfr3 lymphatic signaling pathway;flt4 signaling pathway;exactmatch
vegfr1 signaling pathway;flt1 signaling pathway;exactmatch
ntrk1/mapk signaling pathway;ntrk1/mapk signaling pathway;exactmatch
ntrk1/pi3k/plc-gamma signaling pathway;ntrk1/pi3k/plc-gamma signaling pathway;exactmatch
thromboxane a2 receptor family signaling pathway;thromboxane a2 receptor family signaling pathway;exactmatch
stage i adrenal cortex carcinoma ajcc v7;stage i adrenal cortex cancer;exactmatch
stage iii adrenal cortex carcinoma ajcc v7;stage iii adrenal cortex cancer;exactmatch
aids-related anal carcinoma;aids-related anal cancer;exactmatch
angiocentric glioma;angiocentric glioma;exactmatch
anaplastic medulloblastoma;anaplastic medulloblastoma;exactmatch
papillary tumor of the pineal region;papillary tumor of the pineal region;exactmatch
recurrent malignant oral neoplasm;recurrent malignant lip and oral cavity neoplasm;exactmatch
stage iii lung large cell carcinoma ajcc v7;stage iii large cell carcinoma of lung;exactmatch
extraventricular neurocytoma;extraventricular neurocytoma;exactmatch
papillary glioneuronal tumor;papillary glioneuronal tumor;exactmatch
ependymal differentiation;ependymal differentiation;exactmatch
islands of neuropil-like matrix present;islands of neuropil-like matrix present;exactmatch
recurrent malignant duodenal neoplasm;recurrent malignant duodenal neoplasm;exactmatch
glioneuronal tumor with neuropil-like islands;glioneuronal tumor with neuropil-like islands;exactmatch
recurrent ureter carcinoma;recurrent ureter cancer;exactmatch
multifocal glioblastomas;multifocal glioblastomas;exactmatch
recurrent malignant hemangiopericytoma;malignant hemangiopericytoma recurrent;exactmatch
ddit3 gene;chop;exactmatch
arid1a gene;arid1a;exactmatch
recurrent pericardial malignant mesothelioma;recurrent pericardial malignant mesothelioma;exactmatch
central nervous system ganglioneuroblastoma;central nervous system ganglioneuroblastoma;exactmatch
recurrent hepatocellular carcinoma;hepatocellular carcinoma, recurrent;exactmatch
stage iv adrenal cortex carcinoma ajcc v7;stage iv adrenal cortex cancer;exactmatch
advanced malignant neoplasm;advanced cancer;exactmatch
testicular leukemia;testicular leukemia;exactmatch
metastatic carcinoma in the adrenal medulla;metastatic carcinoma in the adrenal medulla;exactmatch
localized angiosarcoma;angiosarcoma nonmetastatic;exactmatch
pregnancy finding;pregnancy finding;exactmatch
salivary gland carcinoma;carcinoma of salivary gland;exactmatch
nutm1 gene;c15orf55;exactmatch
brd4 gene;brd4;exactmatch
malat1 gene;malat1;exactmatch
malignant peripheral nerve sheath tumor with mesenchymal differentiation;malignant peripheral nerve sheath tumor with mesenchymal differentiation;exactmatch
recurrent malignant endocervical neoplasm;recurrent malignant endocervical neoplasm;exactmatch
recurrent malignant nasopharyngeal neoplasm;recurrent malignant nasopharyngeal neoplasm;exactmatch
stage 0a bladder urothelial carcinoma ajcc v6 and v7;non-invasive papillary carcinoma of bladder;exactmatch
microrna synthesis;microrna biosynthesis;exactmatch
recurrent malignant bladder neoplasm;recurrent malignant bladder neoplasm;exactmatch
meningeal solitary fibrous tumor/hemangiopericytoma, grade 3;meningeal anaplastic hemangiopericytoma;exactmatch
mycosis fungoides and sezary syndrome;mycosis fungoides and sezary syndrome;exactmatch
ann arbor stage i aggressive adult non-hodgkin lymphoma;aggressive adult non-hodgkin's lymphoma stage i;exactmatch
recurrent non-hodgkin lymphoma;non-hodgkin's lymphoma relapsed;exactmatch
recurrent anaplastic large cell lymphoma;recurrent anaplastic large cell lymphoma;exactmatch
intraocular malignant peripheral nerve sheath tumor;intraocular malignant peripheral nerve sheath tumor;exactmatch
esophagitis;esophagitis;exactmatch
hereditary papillary renal cell carcinoma;familial renal papillary carcinoma;exactmatch
recurrent childhood malignant germ cell tumor;recurrent childhood malignant germ cell neoplasm;exactmatch
extraperitoneal space;body cavity, extraperitoneal;exactmatch
stage iii renal cell cancer ajcc v6;renal cell cancer stage iii ajcc v6;exactmatch
cognitive disorder;cognitive disorder;exactmatch
pericardial adenomatoid tumor;pericardial adenomatoid tumor;exactmatch
esophageal malignant peripheral nerve sheath tumor;esophageal malignant peripheral nerve sheath tumor;exactmatch
recurrent aids-related anal canal carcinoma;recurrent aids-related anal canal cancer;exactmatch
malignant adrenal gland composite pheochromocytoma;malignant adrenal gland composite pheochromocytoma;exactmatch
rat pars intermedia carcinoma;carcinoma, pars intermedia, malignant;exactmatch
intraocular schwannoma;benign intraocular schwannoma;exactmatch
benign adrenal gland composite pheochromocytoma;benign adrenal gland composite pheochromocytoma;exactmatch
rat sertoliform tubular adenoma;rat sertoliform tubular adenoma;exactmatch
stage iv oropharyngeal carcinoma ajcc v6;oropharyngeal cancer stage iv ajcc v6;exactmatch
atf1 gene;atf1;exactmatch
non-hematologic malignancy;non-hematologic cancer;exactmatch
systemic disease;systemic disease;exactmatch
merkel cell carcinoma;cutaneous apudoma;exactmatch
weight change;weight change;exactmatch
endobronchial lesion;endobronchial lesion;exactmatch
silicon granuloma;silicon granuloma;exactmatch
stage iiib breast  inflammatory carcinoma;stage iiib breast  inflammatory carcinoma;exactmatch
invasive breast carcinoma;infiltrating breast carcinoma;exactmatch
aggressive non-hodgkin lymphoma;aggressive non-hodgkin lymphoma;exactmatch
hypertension-associated pregnancy disorder;hypertension associated disorders of pregnancy;exactmatch
malignant colon neoplasm;colon neoplasm, malignant;exactmatch
recurrent hypopharyngeal carcinoma;recurrent cancer of hypopharynx;exactmatch
recurrent nasopharyngeal carcinoma;nasopharyngeal cancer, recurrent;exactmatch
localized malignant mesothelioma;localized malignant mesothelioma;exactmatch
recurrent rectal carcinoma;rectal cancer, recurrent;exactmatch
recurrent gastric carcinoma;gastric carcinoma, recurrent;exactmatch
systemic mastocytosis;systemic mastocytosis;exactmatch
childhood spinal cord neoplasm;childhood spinal cord neoplasm;exactmatch
juvenile myelomonocytic leukemia;chronic myelomonocytic leukemia;exactmatch
metastatic adrenal gland pheochromocytoma;metastatic adrenal gland chromaffin neoplasm;exactmatch
stage iii laryngeal cancer ajcc v6 and v7;laryngeal cancer, stage iii;exactmatch
cuboidal neoplastic mesothelial cell;cuboidal neoplastic mesothelial cell;exactmatch
benign mediastinal germ cell tumor;benign germ cell neoplasm of mediastinum;exactmatch
thymolipoma;thymolipoma;exactmatch
thymic lymphoma;lymphoma of thymus;exactmatch
thymic epithelial neoplasm;epithelial neoplasm of thymus;exactmatch
benign germ cell tumor;benign germ cell neoplasm;exactmatch
gastric germ cell tumor;gastric germ cell neoplasm;exactmatch
retroperitoneal germ cell tumor;germ cell neoplasm of retroperitoneum;exactmatch
malignant mediastinal germ cell tumor;malignant germ cell neoplasm of mediastinum;exactmatch
mediastinal mixed non-seminomatous germ cell tumor;mediastinal mixed non-seminomatous germ cell neoplasm;exactmatch
thymoma type a;medullary thymoma;exactmatch
mediastinal yolk sac tumor;endodermal sinus neoplasm of mediastinum;exactmatch
mediastinal mixed embryonal carcinoma and teratoma;mediastinal mixed embryonal carcinoma and teratoma;exactmatch
mediastinal embryonal carcinoma;embryonal carcinoma of mediastinum;exactmatch
mediastinal choriocarcinoma;choriocarcinoma of mediastinum;exactmatch
malignant mediastinal non-seminomatous germ cell tumor;malignant mediastinal non-seminomatous germ cell tumor;exactmatch
mediastinal teratoma;mediastinal teratoma;exactmatch
mediastinal germ cell tumor;germ cell neoplasm of mediastinum;exactmatch
invasive thymoma;infiltrating thymoma;exactmatch
thymic squamous cell carcinoma;epidermoid thymic carcinoma;exactmatch
endometrial polyp;endometrial polyp;exactmatch
stage ib bone sarcoma  ajcc v7;stage ib bone sarcoma;exactmatch
asynchronous multifocal osteosarcoma;asynchronous multifocal osteogenic sarcoma;exactmatch
synchronous multifocal osteosarcoma;synchronous multifocal osteogenic sarcoma;exactmatch
multifocal osteosarcoma;multicentric osteosarcoma;exactmatch
osteosarcoma arising in paget disease of bone;osteosarcoma arising in bone paget's disease;exactmatch
stage iii bone sarcoma  ajcc v7;stage iii bone sarcoma;exactmatch
stage iia bone sarcoma  ajcc v7;stage iia bone sarcoma;exactmatch
stage iib bone sarcoma  ajcc v7;stage iib bone sarcoma;exactmatch
stage ia bone sarcoma  ajcc v7;stage ia bone sarcoma;exactmatch
thymic basaloid carcinoma;basaloid carcinoma of thymus;exactmatch
thymic sarcomatoid carcinoma;sarcomatoid carcinoma of thymus;exactmatch
thymic clear cell carcinoma;clear cell carcinoma of thymus;exactmatch
thymic large cell neuroendocrine carcinoma;large cell neuroendocrine carcinoma of thymus;exactmatch
thymic small cell neuroendocrine carcinoma;small cell carcinoma of thymus;exactmatch
thymic adenocarcinoma;adenocarcinoma of thymus;exactmatch
thymic adenosquamous carcinoma;adenosquamous carcinoma of thymus;exactmatch
thymic mucoepidermoid carcinoma;mucoepidermoid carcinoma of thymus;exactmatch
bartholin gland neoplasm;bartholin gland neoplasm;exactmatch
multiple endocrine neoplasia;endocrine adenomatosis;exactmatch
squamous cell papilloma of the rat uterus;rat uterus squamous cell papilloma;exactmatch
squamous cell papilloma of the rat urethra;rat urethral squamous cell papilloma;exactmatch
transitional cell carcinoma of the rat urethra;rat urethral transitional cell carcinoma;exactmatch
malignant bladder paraganglioma;malignant bladder paraganglioma;exactmatch
transitional cell carcinoma of the rat ureter;rat ureteral transitional cell carcinoma;exactmatch
transitional cell carcinoma of the rat renal pelvis;rat renal pelvis transitional cell carcinoma;exactmatch
squamous cell papilloma of the rat skin;rat cutaneous squamous cell papilloma;exactmatch
squamous cell carcinoma of the rat skin;rat cutaneous squamous cell carcinoma;exactmatch
squamous cell papilloma of the rat urinary bladder;rat urinary bladder squamous cell papilloma;exactmatch
squamous cell papilloma of the rat trachea;rat tracheal squamous cell papilloma;exactmatch
transitional cell papilloma of the rat renal pelvis;rat renal pelvis transitional cell papilloma;exactmatch
squamous cell papilloma of the rat paranasal sinus;rat paranasal sinus squamous cell papilloma;exactmatch
squamous cell papilloma of the rat nasopharynx;rat nasopharyngeal squamous cell papilloma;exactmatch
squamous cell papilloma of the rat nasal cavity;rat nasal cavity squamous cell papilloma;exactmatch
squamous cell papilloma of the rat larynx;rat laryngeal squamous cell papilloma;exactmatch
squamous cell papilloma of the rat bronchus;rat bronchial squamous cell papilloma;exactmatch
squamous cell papilloma of the rat bronchiole;rat bronchiolar squamous cell papilloma;exactmatch
squamous cell carcinoma of the rat urinary bladder;rat urinary bladder squamous cell carcinoma;exactmatch
transitional cell carcinoma of the rat urinary bladder;rat urinary bladder transitional cell carcinoma;exactmatch
transitional cell papilloma of the rat ureter;rat ureteral transitional cell papilloma;exactmatch
metastatic carcinoid tumor;metastatic carcinoid tumor;exactmatch
hindgut carcinoid tumor;hindgut carcinoid tumor;exactmatch
thymic carcinoid tumor;carcinoid tumor of thymus;exactmatch
jejunal neuroendocrine tumor g1;carcinoid tumor of jejunum;exactmatch
descending colon neuroendocrine tumor g1;carcinoid tumor of descending colon;exactmatch
ascending colon neuroendocrine tumor g1;ascending colon carcinoid tumor;exactmatch
transverse colon neuroendocrine tumor g1;carcinoid tumor of transverse colon;exactmatch
duodenal neuroendocrine tumor g1;carcinoid tumor of duodenum;exactmatch
meckel diverticulum neuroendocrine tumor g1;carcinoid tumor of meckel's diverticulum;exactmatch
midgut neuroendocrine tumor g1;midgut carcinoid tumor;exactmatch
transitional cell papilloma of the rat urethra;rat urethral transitional cell papilloma;exactmatch
foregut carcinoid tumor;foregut carcinoid tumor;exactmatch
ovarian liposarcoma;liposarcoma of ovary;exactmatch
teratoma of the rat ovary;rat ovary teratoma;exactmatch
recurrent adrenal cortex carcinoma;recurrent adrenal cortex cancer;exactmatch
squamous cell carcinoma of the rat tongue;rat tongue carcinoma cell papilloma;exactmatch
squamous cell papilloma of the rat tongue;rat tongue squamous cell papilloma;exactmatch
transitional cell papilloma of the rat urinary bladder;rat urinary bladder transitional cell papilloma;exactmatch
low grade central osteosarcoma;intraosseous well-differentiated osteogenic sarcoma;exactmatch
clear cell chondrosarcoma;clear cell chondrosarcoma;exactmatch
dedifferentiated chondrosarcoma;dedifferentiated chondrosarcoma;exactmatch
squamous cell carcinoma in situ with questionable stromal invasion;squamous cell carcinoma in situ with questionable stromal invasion;exactmatch
islet cell adenoma;islet cell adenoma;exactmatch
micropapillary transitional cell carcinoma;micropapillary transitional cell carcinoma;exactmatch
non-invasive papillary transitional cell carcinoma;non-invasive papillary transitional cell carcinoma;exactmatch
squamous cell carcinoma, clear cell type;squamous cell carcinoma, clear cell type;exactmatch
intermediate rhabdomyoma;cellular rhabdomyoma;exactmatch
squamous cell carcinoma with horn formation;squamous cell carcinoma with horn formation;exactmatch
microinvasive squamous cell carcinoma;microinvasive squamous cell carcinoma;exactmatch
non-keratinizing small cell squamous cell carcinoma;epidermoid carcinoma, small cell, nonkeratinizing;exactmatch
malignant pancreatic glucagonoma;alpha cell tumor, malignant;exactmatch
keratin present;keratin present;exactmatch
non-keratinizing large cell squamous cell carcinoma;non-keratinizing large cell squamous cell carcinoma;exactmatch
genital rhabdomyoma;genital rhabdomyoma;exactmatch
inverted squamous cell papilloma;inverted squamous cell papilloma;exactmatch
non-invasive papillary squamous cell carcinoma;non-invasive papillary squamous cell carcinoma;exactmatch
papillary carcinoma in situ;papillary carcinoma in situ;exactmatch
tumorlet;benign tumorlet;exactmatch
malignant pancreatic insulinoma;beta cell tumor, malignant;exactmatch
malignant gastrinoma;g cell tumor, malignant;exactmatch
bone hemangioma;angioma of bone;exactmatch
lung adenocarcinoma with mixed bronchioloalveolar and invasive components;lung adenocarcinoma with mixed bronchioloalveolar and invasive components;exactmatch
malignant testicular sertoli cell tumor;malignant sertoli cell neoplasm of testis;exactmatch
benign testicular sertoli cell tumor;benign sertoli cell neoplasm of testis;exactmatch
papillary mucinous cystadenocarcinoma;papillary mucinous cystadenocarcinoma;exactmatch
clear cell papillary cystadenoma;clear cell papillary cystadenoma;exactmatch
minimal invasion present;minimal invasion present;exactmatch
thyroid gland follicular carcinoma, minimally invasive;ftc, minimally invasive;exactmatch
glandular papillomatosis;glandular papillomatosis;exactmatch
carcinoid tumor of uncertain malignant potential;carcinoid tumor of uncertain malignant potential;exactmatch
malignant vipoma;malignant vipoma;exactmatch
carcinoma simplex;carcinoma simplex;exactmatch
gastric parietal cell adenocarcinoma;gastric parietal cell adenocarcinoma;exactmatch
flat adenoma;flat adenoma;exactmatch
tubular adenocarcinoma;carcinoma, tubular cell, malignant;exactmatch
malignant enteroglucagonoma;malignant enteroglucagonoma;exactmatch
malignant somatostatinoma;delta cell carcinoma;exactmatch
spindle cell rhabdomyosarcoma;spindle cell rhabdomyosarcoma;exactmatch
polygonal cell carcinoma;polygonal cell carcinoma;exactmatch
giant cell and spindle cell carcinoma;giant cell and spindle cell carcinoma;exactmatch
malignant skeletal muscle neoplasm;malignant neoplasm of skeletal muscle;exactmatch
extraabdominal fibromatosis;extra-abdominal desmoid;exactmatch
undifferentiated pleomorphic sarcoma, inflammatory variant;inflammatory mfh;exactmatch
myxofibrosarcoma;fibromyxosarcoma;exactmatch
angiomatoid fibrous histiocytoma;afh;exactmatch
plexiform fibrohistiocytic tumor;pfht;exactmatch
deep fibrous histiocytoma;benign deep fibrous histiocytoma;exactmatch
intermediate fibrohistiocytic neoplasm;intermediate fibrohistiocytic neoplasm;exactmatch
benign fibrohistiocytic neoplasm;benign fibrohistiocytic neoplasm;exactmatch
calcifying fibrous tumor;cft;exactmatch
glassy cell carcinoma;glassy cell carcinoma;exactmatch
nuchal-type fibroma;nuchal fibroma;exactmatch
tendon sheath fibroma;fibroma of tendon sheath;exactmatch
dermal fibroma;dermal fibroma;exactmatch
inflammatory myofibroblastic tumor;imt;exactmatch
bone glomus tumor;bone glomus neoplasm;exactmatch
bone angiosarcoma;bone angioendothelial sarcoma;exactmatch
vascular bone neoplasm;bone vascular neoplasm;exactmatch
deep lipoma;deep fatty neoplasm;exactmatch
tendon sheath lipoma;lipoma of tendon sheath;exactmatch
lumbosacral lipoma;lumbosacral lipoma;exactmatch
chondroid lipoma;chondroid lipoma;exactmatch
neoplasm, uncertain whether benign or malignant;neoplasm, uncertain whether benign or malignant;exactmatch
clear cell malignant neoplasm;clear cell malignant neoplasm;exactmatch
malignant tumor, small cell type;malignant tumor, small cell type;exactmatch
malignant neoplasm, uncertain whether primary or metastatic;malignant neoplasm, uncertain whether primary or metastatic;exactmatch
non-small cell carcinoma;non-small cell carcinoma;exactmatch
benign skeletal muscle neoplasm;benign neoplasm of skeletal muscle;exactmatch
skeletal muscle neoplasm;neoplasm of skeletal muscle;exactmatch
deep leiomyoma;deep leiomyoma;exactmatch
malignant smooth muscle neoplasm;cancer of smooth muscle;exactmatch
benign smooth muscle neoplasm;benign neoplasm of smooth muscle;exactmatch
fibroblastic liposarcoma;fibroblastic liposarcoma;exactmatch
inflammatory atypical lipomatous tumor/well differentiated liposarcoma;inflammatory alt/wdlps;exactmatch
sclerosing atypical lipomatous tumor/well differentiated liposarcoma;sclerosing alt/wdlps;exactmatch
atypical lipomatous tumor/well differentiated liposarcoma;alt;exactmatch
diffuse lipomatosis;diffuse lipomatosis;exactmatch
squamous cell carcinoma of the rat urethra;rat urethral squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat ureter;rat ureteral squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat trachea;rat tracheal squamous cell carcinoma;exactmatch
malignant astrocytoma of the rat brain;malignant astrocytoma of the rat brain;exactmatch
malignant melanoma of the rat spinal meninx;malignant melanoma of the rat spinal meninx;exactmatch
malignant melanoma of the rat cerebral meninx;malignant melanoma of the rat cerebral meninx;exactmatch
malignant intraocular schwannoma of the rat eyeball;malignant intraocular schwannoma of the rat eyeball;exactmatch
malignant glioma of the rat spinal cord;malignant glioma of the rat spinal cord;exactmatch
malignant ependymoma of the rat spinal cord;malignant ependymoma of the rat spinal cord;exactmatch
malignant ependymoma of the rat brain;malignant ependymoma of the rat brain;exactmatch
malignant astrocytoma of the rat spinal cord;malignant astrocytoma of the rat spinal cord;exactmatch
keratoacanthoma of the rat external ear;keratoacanthoma of the rat external ear;exactmatch
malignant mixed glioma of the rat spinal cord;malignant mixed glioma of the rat spinal cord;exactmatch
fibroadenoma of the rat mammary gland;fibroadenoma of the rat mammary gland;exactmatch
figo stage iv gestational trophoblastic tumor;figo stage iv gtt;exactmatch
carcinosarcoma of the rat mammary gland;carcinosarcoma of the rat mammary gland;exactmatch
carcinoma of the rat rete testis;carcinoma of the rat rete testis;exactmatch
carcinoma of the rat choroid plexus;carcinoma of the rat choroid plexus;exactmatch
benign oligodendroglioma of the rat spinal cord;benign oligodendroglioma of the rat spinal cord;exactmatch
benign mixed tumor of the rat mammary gland;benign mixed tumor of the rat mammary gland;exactmatch
figo stage iva gestational trophoblastic tumor;figo stage iva gtt;exactmatch
malignant mixed tumor of the rat mammary gland;malignant mixed tumor of the rat mammary gland;exactmatch
rat malignant glioma;glioma, nos, malignant (reni);exactmatch
meningeal sarcoma of the rat cerebral meninx;meningeal sarcoma of the rat cerebral meninx;exactmatch
rat lymphoblastic lymphoma;rat lymphoblastic lymphoma;exactmatch
rat large granular lymphocyte leukemia;rat large granular lymphocyte leukemia;exactmatch
rat eosinophilic leukemia;rat eosinophilic leukemia;exactmatch
rat basophilic leukemia;rat basophilic leukemia;exactmatch
papilloma of the rat choroid plexus;papilloma of the rat choroid plexus;exactmatch
ocular dermoid of the rat eyeball;ocular dermoid of the rat eyeball;exactmatch
meningeal sarcoma of the rat spinal meninx;meningeal sarcoma of the rat spinal meninx;exactmatch
figo stage ivb gestational trophoblastic tumor;figo stage ivb gtt;exactmatch
malignant neuromyoblastoma of the rat brain;malignant neuromyoblastoma of the rat brain;exactmatch
malignant uveal melanoma of the rat eyeball;malignant uveal melanoma of the rat eyeball;exactmatch
malignant sertoli cell tumor of the rat testis;malignant sertoli cell tumor of the rat testis;exactmatch
malignant reticulosis of the rat spinal cord;malignant reticulosis of the rat spinal cord;exactmatch
malignant reticulosis of the rat brain;malignant reticulosis of the rat brain;exactmatch
malignant oligodendroglioma of the rat spinal cord;malignant oligodendroglioma of the rat spinal cord;exactmatch
malignant oligodendroglioma of the rat brain;malignant oligodendroglioma of the rat brain;exactmatch
malignant neuromyoblastoma of the rat cranial nerve;malignant neuromyoblastoma of the rat cranial nerve;exactmatch
benign mixed glioma of the rat spinal cord;benign mixed glioma of the rat spinal cord;exactmatch
benign meningioma of the rat spinal meninx;benign meningioma of the rat spinal meninx;exactmatch
benign meningioma of the rat cerebral meninx;benign meningioma of the rat cerebral meninx;exactmatch
adenocarcinoma of the rat coagulating gland;adenocarcinoma of the rat coagulating gland;exactmatch
adenocarcinoma of the rat preputial gland;adenocarcinoma of the rat preputial gland;exactmatch
adenocarcinoma of the rat mammary gland;adenocarcinoma of the rat mammary gland;exactmatch
adenocarcinoma of the rat lacrimal gland;adenocarcinoma of the rat lacrimal gland;exactmatch
figo stage iiia gestational trophoblastic tumor;figo stage iiia gtt;exactmatch
adenocarcinoma of the rat intraorbital lacrimal gland;adenocarcinoma of the rat intraorbital lacrimal gland;exactmatch
adenocarcinoma of the rat harderian gland;adenocarcinoma of the rat harderian gland;exactmatch
adenocarcinoma of the rat extraorbital lacrimal gland;adenocarcinoma of the rat extraorbital lacrimal gland;exactmatch
adenocarcinoma arising in fibroadenoma of the rat mammary gland;adenocarcinoma arising in fibroadenoma of the rat mammary gland;exactmatch
benign granulosa cell tumor of the rat testis;benign granulosa cell tumor of the rat testis;exactmatch
yolk sac carcinoma of the rat uterus;rat uterus yolk sac carcinoma;exactmatch
yolk sac carcinoma of the rat uterine cervix;rat uterine cervix yolk sac carcinoma;exactmatch
yolk sac carcinoma of the rat oviduct;rat oviduct yolk sac carcinoma;exactmatch
yolk sac carcinoma of the rat ovary;rat ovary yolk sac carcinoma;exactmatch
tubulostromal adenoma of the rat ovary;rat ovary tubulostromal adenoma;exactmatch
figo stage iii gestational trophoblastic tumor;figo stage iii gtt;exactmatch
tubulostromal adenocarcinoma of the rat ovary;rat ovary tubulostromal adenocarcinoma;exactmatch
adenocarcinoma of the rat prostate;adenocarcinoma of the rat prostate;exactmatch
adenocarcinoma of the rat seminal vesicle;adenocarcinoma of the rat seminal vesicle;exactmatch
adenolipoma of the rat mammary gland;adenolipoma of the rat mammary gland;exactmatch
adenoma of the rat coagulating gland;adenoma of the rat coagulating gland;exactmatch
benign ependymoma of the rat spinal cord;benign ependymoma of the rat spinal cord;exactmatch
figo stage iiic gestational trophoblastic tumor;figo stage iiic gtt;exactmatch
benign ependymoma of the rat brain;benign ependymoma of the rat brain;exactmatch
benign astrocytoma of the rat spinal cord;benign astrocytoma of the rat spinal cord;exactmatch
benign astrocytoma of the rat brain;benign astrocytoma of the rat brain;exactmatch
basal cell carcinoma of the rat preputial gland;basal cell carcinoma of the rat preputial gland;exactmatch
adenoma of the rat seminal vesicle;adenoma of the rat seminal vesicle;exactmatch
adenoma of the rat prostate;adenoma of the rat prostate;exactmatch
adenoma of the rat preputial gland;adenoma of the rat preputial gland;exactmatch
adenoma of the rat mammary gland;adenoma of the rat mammary gland;exactmatch
adenoma of the rat lacrimal gland;adenoma of the rat lacrimal gland;exactmatch
figo stage iiib gestational trophoblastic tumor;figo stage iiib gtt;exactmatch
adenoma of the rat intraorbital lacrimal gland;adenoma of the rat intraorbital lacrimal gland;exactmatch
adenoma of the rat harderian gland;adenoma of the rat harderian gland;exactmatch
adenoma of the rat extraorbital lacrimal gland;adenoma of the rat extraorbital lacrimal gland;exactmatch
rat lymphocytic lymphoma;rat lymphocytic lymphoma;exactmatch
figo stage ivc gestational trophoblastic tumor;figo stage ivc gtt;exactmatch
squamous cell carcinoma of the rat renal pelvis;rat renal pelvis squamous cell carcinoma;exactmatch
keratinizing cystic epithelioma of the rat lung;keratinizing cystic epithelioma of the rat lung;exactmatch
malignant melanoma of the rat skin;malignant melanoma of the rat skin;exactmatch
malignant neuroendocrine cell tumor of the rat trachea;malignant neuroendocrine cell tumor of the rat trachea;exactmatch
malignant mesothelioma of the rat pleura;malignant mesothelioma of the rat pleura;exactmatch
malignant mesothelioma of the rat peritoneum;malignant mesothelioma of the rat peritoneum;exactmatch
malignant mesothelioma of the rat pericardium;malignant mesothelioma of the rat pericardium;exactmatch
malignant mesenchymal tumor of the rat kidney;malignant mesenchymal tumor of the rat kidney;exactmatch
keratoacanthoma of the rat skin;keratoacanthoma of the rat skin;exactmatch
epithelioid mesothelioma of the rat pericardium;epithelioid mesothelioma of the rat pericardium;exactmatch
non-keratinizing epithelioma of the rat lung;non-keratinizing epithelioma of the rat lung;exactmatch
carcinoma of the rat lung;carcinoma of the rat lung;exactmatch
carcinoma of the rat kidney;carcinoma of the rat kidney;exactmatch
benign basosquamous tumor of the rat skin;benign basosquamous tumor of the rat skin;exactmatch
intrathoracic paravertebral paraganglioma;intrathoracic paravertebral paraganglioma;exactmatch
benign basal cell tumor of the rat skin;benign basal cell tumor of the rat skin;exactmatch
benign mesothelioma of the rat pleura;benign mesothelioma of the rat pleura;exactmatch
benign mesothelioma of the rat peritoneum;benign mesothelioma of the rat peritoneum;exactmatch
melanotic malignant melanoma of the rat skin;melanotic malignant melanoma of the rat skin;exactmatch
olfactory neuroblastoma of the rat nasal cavity;olfactory neuroblastoma of the rat nasal cavity;exactmatch
rat neutrophilic leukemia;rat neutrophilic leukemia;exactmatch
squamous cell carcinoma of the rat bronchiole;rat bronchiolar squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat paranasal sinus;rat paranasal sinus squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat nasopharynx;rat nasopharyngeal squamous cell carcinoma;exactmatch
bladder paraganglioma;bladder paraganglioma;exactmatch
squamous cell carcinoma of the rat nasal cavity;rat nasal cavity squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat lung;rat lung squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat larynx;rat laryngeal squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat bronchus;rat bronchial squamous cell carcinoma;exactmatch
sebaceous cell carcinoma of the rat skin;rat cutaneous sebaceous cell carcinoma;exactmatch
papilloma of the rat bronchiole;papilloma of the rat bronchiole;exactmatch
sebaceous cell adenoma of the rat skin;rat cutaneous sebaceous cell adenoma;exactmatch
rat myxolipomatous lipoma;myxolipomatous lipoma of the rat;exactmatch
rat angiolipomatous lipoma;angiolipomatous lipoma of the rat;exactmatch
papilloma of the rat trachea;papilloma of the rat trachea;exactmatch
malignant intrathoracic paravertebral paraganglioma;malignant intrathoracic paravertebral paraganglioma;exactmatch
papilloma of the rat larynx;papilloma of the rat larynx;exactmatch
papilloma of the rat bronchus;papilloma of the rat bronchus;exactmatch
benign mesothelioma of the rat pericardium;benign mesothelioma of the rat pericardium;exactmatch
basal cell carcinoma of the rat skin;basal cell carcinoma of the rat skin;exactmatch
amelanotic malignant melanoma of the rat skin;amelanotic malignant melanoma of the rat skin;exactmatch
squamous cell carcinoma of the rat conjunctiva;squamous cell carcinoma of the rat conjunctiva;exactmatch
squamous cell papilloma of the rat external ear;squamous cell papilloma of the rat external ear;exactmatch
squamous cell papilloma of the rat conjunctiva;squamous cell papilloma of the rat conjunctiva;exactmatch
squamous cell carcinoma of the rat zymbal gland;squamous cell carcinoma of the rat zymbal gland;exactmatch
squamous cell carcinoma of the rat preputial gland;squamous cell carcinoma of the rat preputial gland;exactmatch
squamous cell carcinoma of the rat eyelid;squamous cell carcinoma of the rat eyelid;exactmatch
squamous cell carcinoma of the rat external ear;squamous cell carcinoma of the rat external ear;exactmatch
orbit paraganglioma;orbit paraganglioma;exactmatch
sebaceous cell carcinoma of the rat zymbal gland;sebaceous cell carcinoma of the rat zymbal gland;exactmatch
adenosquamous carcinoma of the rat paranasal sinus;adenosquamous carcinoma of the rat paranasal sinus;exactmatch
sebaceous cell adenoma of the rat zymbal gland;sebaceous cell adenoma of the rat zymbal gland;exactmatch
rat tricholemmoma type benign follicle hair tumor;rat tricholemmoma type benign follicle hair tumor;exactmatch
rat trichofolliculoma type benign follicle hair tumor;rat trichofolliculoma type benign follicle hair tumor;exactmatch
rat trichoepithelioma type benign follicle hair tumor;rat trichoepithelioma type benign follicle hair tumor;exactmatch
rat pleomorphic lymphoma;rat pleomorphic lymphoma;exactmatch
rat plasmacytic lymphoma;rat plasmacytic lymphoma;exactmatch
rat pilomatricoma type benign follicle hair tumor;rat pilomatricoma type benign follicle hair tumor;exactmatch
squamous cell papilloma of the rat eyelid;squamous cell papilloma of the rat eyelid;exactmatch
squamous cell papilloma of the rat preputial gland;squamous cell papilloma of the rat preputial gland;exactmatch
adenocarcinoma of the rat bronchiole;adenocarcinoma of the rat bronchiole;exactmatch
adenocarcinoma of the rat bronchus;adenocarcinoma of the rat bronchus;exactmatch
adenosquamous carcinoma of the rat nasopharynx;adenosquamous carcinoma of the rat nasopharynx;exactmatch
adenosquamous carcinoma of the rat nasal cavity;adenosquamous carcinoma of the rat nasal cavity;exactmatch
adenosquamous carcinoma of the rat lung;adenosquamous carcinoma of the rat lung;exactmatch
cardiac paraganglioma;cardiac paraganglioma;exactmatch
adenoma of the rat paranasal sinus;adenoma of the rat paranasal sinus;exactmatch
adenoma of the rat nasopharynx;adenoma of the rat nasopharynx;exactmatch
adenoma of the rat nasal cavity;adenoma of the rat nasal cavity;exactmatch
adenoma of the rat kidney;adenoma of the rat kidney;exactmatch
adenocarcinoma of the rat urinary bladder;adenocarcinoma of the rat urinary bladder;exactmatch
adenocarcinoma of the rat trachea;adenocarcinoma of the rat trachea;exactmatch
adenocarcinoma of the rat paranasal sinus;adenocarcinoma of the rat paranasal sinus;exactmatch
adenocarcinoma of the rat nasopharynx;adenocarcinoma of the rat nasopharynx;exactmatch
adenocarcinoma of the rat nasal cavity;adenocarcinoma of the rat nasal cavity;exactmatch
adenocarcinoma of the rat larynx;adenocarcinoma of the rat larynx;exactmatch
laryngeal paraganglioma;laryngeal paraganglioma;exactmatch
benign lymphatic vessel neoplasm;benign lymph vessel neoplasm;exactmatch
synovial hemangioma;angioma of synovium;exactmatch
perineural hemangioma;perineural angioma;exactmatch
carotid body;carotid body;exactmatch
stage iiib lung squamous cell carcinoma ajcc v7;stage iiib lung squamous cell carcinoma ajcc v7;exactmatch
keratin horn pearls formation;keratin horn pearls formation;exactmatch
stage iiia lung squamous cell carcinoma ajcc v7;stage iiia lung squamous cell carcinoma ajcc v7;exactmatch
stage iia lung squamous cell carcinoma ajcc v7;stage iia lung squamous cell carcinoma ajcc v7;exactmatch
stage ia lung squamous cell carcinoma ajcc v7;stage ia lung squamous cell carcinoma ajcc v7;exactmatch
parotid gland warthin tumor;parotid gland adenolymphoma;exactmatch
occult lung squamous cell carcinoma;occult lung squamous cell carcinoma;exactmatch
diffuse hyperplastic perilobar nephroblastomatosis;dhpln;exactmatch
stage iib lung squamous cell carcinoma ajcc v7;stage iib lung squamous cell carcinoma ajcc v7;exactmatch
follicular variant thyroid gland papillary carcinoma, encapsulated subtype with invasion;follicular variant thyroid gland papillary carcinoma, encapsulated subtype with invasion;exactmatch
occult lung large cell carcinoma;occult large cell carcinoma of lung;exactmatch
hodgkin's disease, lymphocyte depletion, reticular;hodgkin's disease, lymphocyte depletion, reticular;exactmatch
hodgkin's disease, lymphocyte depletion, diffuse fibrosis;hodgkin's disease, lymphocyte depletion, diffuse fibrosis;exactmatch
malignant peripheral nerve sheath tumor with perineurial differentiation;malignant perineurioma;exactmatch
melanotic neurofibroma;melanotic neurofibroma;exactmatch
occult lung adenosquamous carcinoma;occult adenosquamous cell carcinoma of lung;exactmatch
skin metatypical carcinoma;skin metatypical basal cell carcinoma;exactmatch
stage ib lung squamous cell carcinoma ajcc v7;stage ib lung squamous cell carcinoma ajcc v7;exactmatch
stage iva osteosarcoma  ajcc v7;stage iva osteogenic sarcoma;exactmatch
stage iiib lung adenocarcinoma ajcc v7;stage iiib adenocarcinoma of lung;exactmatch
stage iv osteosarcoma  ajcc v7;stage iv osteogenic sarcoma;exactmatch
malignant sertoli cell tumor;malignant androblastoma;exactmatch
pyriform fossa carcinoma;carcinoma of pyriform fossa;exactmatch
mixed testicular sex cord-stromal tumor;mixed testicular sex cord-gonadal stromal tumor;exactmatch
occult lung adenocarcinoma;occult adenocarcinoma of lung;exactmatch
ovarian thecoma;ovarian theca cell neoplasm;exactmatch
stage iiia lung adenocarcinoma ajcc v7;stage iiia adenocarcinoma of lung;exactmatch
stage iib lung adenocarcinoma ajcc v7;stage iib adenocarcinoma of lung;exactmatch
enteroglucagonoma;enteroglucagonoma;exactmatch
mucinous adenocarcinoma, endocervical type;mucinous adenocarcinoma, endocervical type;exactmatch
adenocarcinoma, endocervical type;adenocarcinoma, endocervical type;exactmatch
hepatoid adenocarcinoma;hepatoid adenocarcinoma;exactmatch
stage iia lung adenocarcinoma ajcc v7;stage iia adenocarcinoma of lung;exactmatch
stage ia lung adenocarcinoma ajcc v7;stage ia adenocarcinoma of lung;exactmatch
breast ductal carcinoma in situ, solid type;breast ductal carcinoma in situ, solid type;exactmatch
stage ib lung adenocarcinoma ajcc v7;stage ib adenocarcinoma of lung;exactmatch
occult lung small cell carcinoma;occult lung small cell carcinoma;exactmatch
stage iv lung small cell carcinoma ajcc v7;stage iv lung small cell carcinoma ajcc v7;exactmatch
nervous system neoplasm (antiquated);nervous system neoplasm (antiquated);exactmatch
gonadal polyembryoma;gonadal polyembryoma;exactmatch
aggressive osteoblastoma;aggressive osteoblastoma;exactmatch
hemolymphangioma;hemolymphangioma;exactmatch
stage iii lung small cell carcinoma ajcc v7;stage iii lung small cell carcinoma ajcc v7;exactmatch
stage ii lung small cell carcinoma ajcc v7;stage ii lung small cell carcinoma ajcc v7;exactmatch
benign hemangioendothelioma;benign hemangioendothelioma;exactmatch
malignant trophoblastic teratoma;malignant trophoblastic teratoma;exactmatch
choriocarcinoma combined with other germ cell elements;choriocarcinoma combined with other germ cell elements;exactmatch
borderline ovarian mucinous adenofibroma;borderline ovarian mucinous adenofibroma;exactmatch
hemangioblastic meningioma;hemangioblastic meningioma;exactmatch
ossifying renal tumor of infancy;orti;exactmatch
benign stromal tumor;benign stromal tumor;exactmatch
angiomyosarcoma;angiomyosarcoma;exactmatch
stage iia lung small cell carcinoma ajcc v7;stage iia lung small cell carcinoma ajcc v7;exactmatch
fascial fibrosarcoma;fascial fibrosarcoma;exactmatch
fascial fibroma;fascial fibroma;exactmatch
periosteal fibrosarcoma;periosteal fibrosarcoma;exactmatch
metastasizing chondroblastoma;chondroblastoma, malignant;exactmatch
stage iiia lung small cell carcinoma ajcc v7;stage iiia lung small cell carcinoma ajcc v7;exactmatch
ameloblastic fibrodentinoma;ameloblastic fibrodentinoma;exactmatch
polar spongioblastoma;polar spongioblastoma;exactmatch
spontaneously regressed retinoblastoma;retinoblastoma, spontaneously regressed;exactmatch
diffuse retinoblastoma;diffuse retinoblastoma;exactmatch
undifferentiated retinoblastoma;retinoblastoma, undifferentiated;exactmatch
differentiated retinoblastoma;differentiated retinoblastoma;exactmatch
retinocytoma;retinocytoma;exactmatch
spongioneuroblastoma;spongioneuroblastoma;exactmatch
ciliary body teratoid medulloepithelioma;ciliary body teratoid medulloepithelioma;exactmatch
stage iiib lung small cell carcinoma ajcc v7;stage iiib lung small cell carcinoma ajcc v7;exactmatch
ciliary body benign teratoid medulloepithelioma;benign intraocular teratoid medulloepithelioma;exactmatch
medulloepithelioma not otherwise specified;medulloepithelioma not otherwise specified;exactmatch
ciliary body benign medulloepithelioma;benign ciliary body medulloepithelioma;exactmatch
ciliary body medulloepithelioma;ciliary body medulloepithelioma;exactmatch
ganglioneuromatosis;ganglioneuromatosis;exactmatch
cerebellar sarcoma;cerebellar sarcoma;exactmatch
oligodendroblastoma;oligodendroblastoma;exactmatch
benign sertoli cell tumor;benign androblastoma;exactmatch
stage ivb osteosarcoma  ajcc v7;stage ivb osteogenic sarcoma;exactmatch
fibromyxoid tumor;fibromyxoma, benign;exactmatch
mature pericardial teratoma;mature pericardial teratoma;exactmatch
pulmonary artery angiosarcoma;pulmonary artery angiosarcoma;exactmatch
pancreatic g-cell adenoma;pancreatic g-cell adenoma;exactmatch
malignant pancreatic gastrinoma;malignant pancreatic gastrinoma;exactmatch
pancreatic beta cell adenoma;pancreatic beta cell adenoma;exactmatch
pancreatic alpha cell adenoma;pancreatic alpha cell adenoma;exactmatch
pancreatic polypeptide tumor;ppoma;exactmatch
superior vena cava leiomyosarcoma;leiomyosarcoma of superior vena cava;exactmatch
pericardial leiomyoma;leiomyoma of pericardium;exactmatch
malignant pancreatic vipoma;malignant pancreatic vipoma;exactmatch
epicardial lipoma;epicardial lipoma;exactmatch
cardiac lipoma;cardiac lipoma;exactmatch
cardiac rhabdomyoma;cardiac rhabdomyoma;exactmatch
stage iia esophageal squamous cell carcinoma ajcc v7;stage iia esophageal squamous cell cancer;exactmatch
stage iib esophageal squamous cell carcinoma ajcc v7;stage iib esophageal squamous cell cancer;exactmatch
malignant pancreatic somatostatinoma;malignant pancreatic somatostatinoma;exactmatch
stage iva esophageal squamous cell carcinoma;stage iva esophageal squamous cell carcinoma;exactmatch
pancreatic delta cell adenoma;pancreatic delta cell adenoma;exactmatch
desmoplastic mesothelioma;desmoplastic mesothelioma;exactmatch
stage i bone sarcoma  ajcc v7;stage i bone sarcoma;exactmatch
pineal region yolk sac tumor;endodermal sinus tumor of pineal region;exactmatch
stage ii sinonasal cancer ajcc v6 and v7;stage ii nasal cavity and paranasal sinus cancer;exactmatch
stage i sinonasal cancer ajcc v6 and v7;stage i nasal cavity and paranasal sinus cancer;exactmatch
pineal region immature teratoma;atypical pineal teratoma;exactmatch
testicular mixed choriocarcinoma and yolk sac tumor;testicular mixed choriocarcinoma and yolk sac tumor;exactmatch
pineal region mature teratoma;mature teratoma of pineal area;exactmatch
pineal region teratoma;pineal area teratoma;exactmatch
gastric mixed adenocarcinoma;gastric mixed adenocarcinoma;exactmatch
tdt negative acute lymphoblastic leukemia;tdt negative acute lymphoblastic leukemia;exactmatch
benign glomus tumor;benign glomus neoplasm;exactmatch
benign extragonadal germ cell tumor;benign extragonadal germ cell neoplasm;exactmatch
skin glomangioma;cutaneous glomangioma;exactmatch
flt3 internal tandem duplication;activating flt3-itd gene mutation;exactmatch
high-grade biliary intraepithelial neoplasia;bilin-3;exactmatch
biliary intraepithelial neoplasia-2;bilin-2;exactmatch
biliary intraepithelial neoplasia-1;bilin-1;exactmatch
palate kaposi sarcoma;kaposi's sarcoma of palate;exactmatch
stage ivb esophageal squamous cell carcinoma;stage ivb esophageal squamous cell carcinoma;exactmatch
stage ivb esophageal adenocarcinoma;stage ivb adenocarcinoma of esophagus;exactmatch
stage iva esophageal adenocarcinoma;stage iva adenocarcinoma of esophagus;exactmatch
benign teratoma;benign teratoma;exactmatch
olfactory neurocytoma;olfactory neurocytoma;exactmatch
olfactory neurogenic tumor;olfactory neurogenic tumor;exactmatch
sternal chondromyxoid fibroma;chondromyxoid fibroma of sternum;exactmatch
chest wall fibromatosis;chest wall desmoid neoplasm;exactmatch
epithelioid osteoblast;epithelioid osteoblast;exactmatch
chest wall lymphoma;chest wall lymphoma;exactmatch
chest wall solitary plasmacytoma;chest wall solitary plasmacytoma;exactmatch
stage ii osteosarcoma  ajcc v7;stage ii osteogenic sarcoma;exactmatch
stage iib esophageal adenocarcinoma ajcc v7;stage iib adenocarcinoma of esophagus;exactmatch
ovarian serous adenocarcinofibroma;ovarian serous adenocarcinofibroma;exactmatch
serous adenofibroma;serous adenofibroma;exactmatch
stage i osteosarcoma  ajcc v7;stage i osteogenic sarcoma;exactmatch
stage ivb bone sarcoma  ajcc v7;stage ivb bone sarcoma;exactmatch
stage iva bone sarcoma  ajcc v7;stage iva bone sarcoma;exactmatch
stage iv bone sarcoma  ajcc v7;stage iv bone sarcoma;exactmatch
stage ii bone sarcoma  ajcc v7;stage ii bone sarcoma;exactmatch
sternal lymphoma;lymphoma of sternum;exactmatch
nodular sclerosis classic hodgkin lymphoma, cellular phase;classical hodgkin lymphoma, nodular sclerosis, cellular phase;exactmatch
sternal intraosseous schwannoma;intraosseous neurilemmoma of sternum;exactmatch
chest wall lipoma;chest wall lipoma;exactmatch
stage iia esophageal adenocarcinoma ajcc v7;stage iia adenocarcinoma of esophagus;exactmatch
sternal neoplasm;neoplasm of sternum;exactmatch
attenuated familial adenomatous polyposis;aapc;exactmatch
gardner syndrome;gardner syndrome;exactmatch
neurofibromatosis;neurofibromatosis;exactmatch
lynch 2 syndrome;familial non-polyposis colon cancer type 2;exactmatch
lynch 1 syndrome;familial non-polyposis colon cancer type 1;exactmatch
malignant chest wall bone neoplasm;malignant bone neoplasm of chest wall;exactmatch
phosphaturic mesenchymal tumor;phosphaturic mesenchymal tumor;exactmatch
phosphaturia;phosphaturia;exactmatch
oncogenic osteomalacia;oncogenic osteomalacia;exactmatch
chest wall hodgkin lymphoma;chest wall hodgkin lymphoma;exactmatch
peripheral primitive neuroectodermal tumor of the kidney;malignant neuroepithelial tumor of the kidney;exactmatch
chest wall plexiform fibrohistiocytic tumor;chest wall plexiform fibrohistiocytic neoplasm;exactmatch
chest wall parachordoma;chest wall parachordoma;exactmatch
periosteal fibroma;periosteal fibroma;exactmatch
stage iib lung small cell carcinoma ajcc v7;stage iib lung small cell carcinoma ajcc v7;exactmatch
pericytic neoplasm;pericytic neoplasm;exactmatch
parachordoma;parachordoma;exactmatch
malignant soft tissue tumor of uncertain differentiation;malignant soft tissue neoplasm of uncertain differentiation;exactmatch
benign soft tissue tumor of uncertain differentiation;benign soft tissue neoplasm of uncertain differentiation;exactmatch
extrarenal rhabdoid tumor;extrarenal rhabdoid tumor;exactmatch
childhood osteosarcoma;childhood osteogenic sarcoma;exactmatch
palisaded lymph node myofibroblastoma;palisaded lymph node myofibroblastoma;exactmatch
nonossifying fibromyxoid tumor;nonossifying fibromyxoid neoplasm;exactmatch
ossifying fibromyxoid tumor;ofmt;exactmatch
juxta-articular myxoma;juxta-articular myxoma;exactmatch
childhood conventional osteosarcoma;childhood conventional osteosarcoma;exactmatch
intramuscular myxoma;intramuscular myxoma;exactmatch
skin myxoma;cutaneous myxoma;exactmatch
myxoma;myxoma, benign;exactmatch
extraskeletal osteoma;extraskeletal osteoma;exactmatch
fibroosseous pseudotumor of digits;fp;exactmatch
malignant extraskeletal cartilaginous and osseous neoplasm;malignant extraskeletal cartilaginous and osseous neoplasm;exactmatch
benign extraskeletal cartilaginous and osseous neoplasm;benign extraskeletal cartilaginous and osseous neoplasm;exactmatch
childhood parosteal osteosarcoma;childhood parosteal osteogenic sarcoma;exactmatch
peripheral neuroblastoma;peripheral neuroblastoma;exactmatch
stage iia osteosarcoma  ajcc v7;stage iia osteogenic sarcoma;exactmatch
mediastinal granular cell tumor;granular cell myoblastoma of mediastinum;exactmatch
malignant mediastinal hemangiopericytoma;malignant hemangiopericytoma of mediastinum;exactmatch
stage ia osteosarcoma  ajcc v7;stage ia osteogenic sarcoma;exactmatch
mediastinal sarcoma;mediastinal sarcoma;exactmatch
soft tissue fibrosarcoma;fibrosarcoma of soft tissue;exactmatch
bone fibrosarcoma;bone fibrosarcoma;exactmatch
osteogenic neoplasm;osseous neoplasm;exactmatch
benign osteogenic neoplasm;benign osseous neoplasm;exactmatch
mediastinal rhabdomyoma;mediastinal rhabdomyoma;exactmatch
benign mediastinal soft tissue neoplasm;benign mediastinal soft tissue neoplasm;exactmatch
mitogen;mitogen;exactmatch
mediastinal lipoma;lipoma of mediastinum;exactmatch
mediastinal leiomyoma;leiomyoma of mediastinum;exactmatch
benign mediastinal hemangiopericytoma;benign hemangiopericytoma of mediastinum;exactmatch
mediastinal chondroma;chondroma of mediastinum;exactmatch
mediastinal lymphangioma;cystic hygroma of mediastinum;exactmatch
peripheral ganglioneuroblastoma;pns ganglioneuroblastoma;exactmatch
extraskeletal cartilaginous and osseous neoplasm;extraskeletal cartilaginous and osseous neoplasm;exactmatch
congenital mesoblastic nephroma;cmn;exactmatch
childhood renal cell carcinoma;childhood kidney cell carcinoma;exactmatch
stage i soft tissue sarcoma ajcc v7;stage i sarcoma of soft tissue;exactmatch
childhood testicular choriocarcinoma;childhood choriocarcinoma of testis;exactmatch
childhood testicular yolk sac tumor;childhood testicular endodermal sinus neoplasm;exactmatch
childhood testicular mixed germ cell tumor;childhood testicular mixed germ cell neoplasm;exactmatch
malignant childhood germ cell tumor;malignant childhood germ cell neoplasm;exactmatch
childhood testicular teratoma;childhood teratoma of testis;exactmatch
childhood testicular mixed embryonal carcinoma and teratoma;childhood teratocarcinoma of testis;exactmatch
stage ii soft tissue sarcoma ajcc v7;stage ii sarcoma of soft tissue;exactmatch
peritoneal multicystic mesothelioma;multicystic mesothelioma of peritoneum;exactmatch
childhood multilocular cystic renal neoplasm;childhood multilocular cystic kidney neoplasm;exactmatch
malignant tenosynovial giant cell tumor;giant cell tumor of tendon sheath, malignant;exactmatch
monophasic synovial sarcoma;monophasic sarcoma of synovium;exactmatch
fibrous synovial sarcoma;fibrous sarcoma of synovium;exactmatch
tenosynovial giant cell tumor, localized type;localized giant cell neoplasm of tendon sheath;exactmatch
malignant synovial neoplasm;malignant neoplasm of synovium;exactmatch
malignant pericytic neoplasm;malignant pericytic neoplasm;exactmatch
benign pericytic neoplasm;benign pericytic neoplasm;exactmatch
childhood testicular embryonal carcinoma;childhood embryonal carcinoma of testis;exactmatch
childhood ovarian embryonal carcinoma;childhood embryonal carcinoma of ovary;exactmatch
childhood ovarian immature teratoma;childhood immature teratoma of ovary;exactmatch
childhood ovarian mature teratoma;childhood mature teratoma of ovary;exactmatch
childhood kidney angiomyolipoma;childhood kidney angiomyolipoma;exactmatch
childhood kidney neoplasm;childhood kidney neoplasm;exactmatch
epithelioid malignant peripheral nerve sheath tumor;epithelioid mpnst;exactmatch
glandular malignant peripheral nerve sheath tumor;glandular mpnst;exactmatch
multiple mucosal neuromas;multiple mucosal neuromas;exactmatch
epithelioid neurofibroma;epithelioid neurofibroma;exactmatch
schwannomatosis;neurilemmomatosis;exactmatch
degenerated schwannoma;ancient neurilemmoma;exactmatch
deep hemangioma;deep angioma;exactmatch
childhood ovarian teratoma;childhood ovarian teratoma;exactmatch
benign childhood germ cell tumor;benign childhood germ cell neoplasm;exactmatch
childhood testicular germ cell tumor;childhood testicular germ cell neoplasm;exactmatch
childhood ovarian yolk sac tumor;childhood ovarian endodermal sinus neoplasm;exactmatch
childhood ovarian dysgerminoma;childhood dysgerminoma;exactmatch
childhood ovarian choriocarcinoma;childhood choriocarcinoma of ovary;exactmatch
stage ib osteosarcoma  ajcc v7;stage ib osteogenic sarcoma;exactmatch
stage iib osteosarcoma  ajcc v7;stage iib osteogenic sarcoma;exactmatch
giant cell sarcoma;giant cell sarcoma;exactmatch
stage iib lung large cell carcinoma ajcc v7;stage iib large cell carcinoma of lung;exactmatch
stage iib lung adenosquamous carcinoma ajcc v7;stage iib adenosquamous cell carcinoma of lung;exactmatch
stage ib lung adenosquamous carcinoma ajcc v7;stage ib adenosquamous cell carcinoma of lung;exactmatch
stage ia lung adenosquamous carcinoma ajcc v7;stage ia adenosquamous cell carcinoma of lung;exactmatch
stage iia lung adenosquamous carcinoma ajcc v7;stage iia adenosquamous cell carcinoma of lung;exactmatch
stage iia lung large cell carcinoma ajcc v7;stage iia large cell carcinoma of lung;exactmatch
stage iiia lung large cell carcinoma ajcc v7;stage iiia large cell carcinoma of lung;exactmatch
stage iiib lung large cell carcinoma ajcc v7;stage iiib large cell carcinoma of lung;exactmatch
stage ib lung large cell carcinoma ajcc v7;stage ib large cell carcinoma of lung;exactmatch
metastatic signet ring cell carcinoma;metastatic signet ring cell carcinoma;exactmatch
stage ia lung large cell carcinoma ajcc v7;stage ia large cell carcinoma of lung;exactmatch
stage ii lung large cell carcinoma ajcc v7;stage ii large cell carcinoma of lung;exactmatch
ampulla of vater tubular adenoma;ampulla of vater tubular adenoma;exactmatch
ampulla of vater villous adenoma;ampulla of vater villous adenoma;exactmatch
ampulla of vater adenoma, intestinal-type;ampulla of vater adenoma;exactmatch
ampulla of vater signet ring cell carcinoma;ampulla of vater signet ring cell carcinoma;exactmatch
ampulla of vater small cell neuroendocrine carcinoma;ampulla of vater small cell carcinoma;exactmatch
stage i lung non-small cell cancer ajcc v7;stage i lung non-small cell cancer ajcc v7;exactmatch
medullary carcinoma, not otherwise specified;medullary carcinoma, nos;exactmatch
stage iii osteosarcoma  ajcc v7;stage iii osteogenic sarcoma;exactmatch
granulosa cell-theca cell tumor;granulosa cell-theca cell tumor;exactmatch
spindle cell nevus;spindle cell nevus;exactmatch
epithelioid cell nevus;epithelioid cell nevus;exactmatch
mixed epithelioid and spindle cell melanoma;mixed epithelioid and spindle cell melanoma;exactmatch
proliferative nodules in congenital melanocytic nevus;proliferative dermal lesion in congenital nevus;exactmatch
small congenital melanocytic nevus;small congenital melanocytic nevus;exactmatch
malignant melanoma in precancerous melanosis;malignant cutaneous (skin) melanoma in precancerous melanosis;exactmatch
clear cell neoplasm;clear cell neoplasm;exactmatch
adult type granulosa cell tumor;adult type granulosa cell tumor;exactmatch
breast atypical medullary carcinoma;atypical medullary breast carcinoma;exactmatch
stage ib lung small cell carcinoma ajcc v7;stage ib lung small cell carcinoma ajcc v7;exactmatch
ovarian stromal tumor with minor sex cord elements;ovarian stromal tumor with minor sex cord elements;exactmatch
unclassified testicular sex cord-stromal tumor;sex cord-gonadal stromal tumor, incompletely differentiated;exactmatch
benign thymoma;benign thymoma;exactmatch
adenocarcinoma with neuroendocrine differentiation;adenocarcinoma with neuroendocrine differentiation;exactmatch
stage ia lung small cell carcinoma ajcc v7;stage ia lung small cell carcinoma ajcc v7;exactmatch
stage i lung small cell carcinoma ajcc v7;stage i lung small cell carcinoma ajcc v7;exactmatch
stage iv ampulla of vater cancer ajcc v7;ampulla of vater cancer stage iv;exactmatch
stage iii ampulla of vater cancer ajcc v7;ampulla of vater cancer stage iii;exactmatch
stage ii ampulla of vater cancer ajcc v7;ampulla of vater cancer stage ii;exactmatch
recurrent bone ewing sarcoma;recurrent bone ewing sarcoma;exactmatch
mediastinal neurofibroma;mediastinal neurofibroma;exactmatch
malignant melanotic peripheral nerve sheath tumor of the mediastinum;malignant mediastinal melanocytic peripheral nerve sheath tumor;exactmatch
mediastinal neuroblastoma;mediastinal neuroblastoma;exactmatch
mediastinal ganglioneuroblastoma;ganglioneuroblastoma of mediastinum;exactmatch
mediastinal malignant peripheral nerve sheath tumor;mpnst of mediastinum;exactmatch
mediastinal neurogenic neoplasm;mediastinal neural neoplasm;exactmatch
localized bone ewing sarcoma;localized bone ewing sarcoma;exactmatch
metastatic bone ewing sarcoma;metastatic bone ewing sarcoma;exactmatch
stage i ampulla of vater cancer ajcc v7;ampulla of vater cancer stage i;exactmatch
primary bone lymphoma;primary bone lymphoma;exactmatch
mediastinal leiomyosarcoma;leiomyosarcoma of mediastinum;exactmatch
mediastinal synovial sarcoma;mediastinal synovial sarcoma;exactmatch
mediastinal rhabdomyosarcoma;mediastinal rhabdomyosarcoma;exactmatch
mediastinal extraskeletal osteosarcoma;mediastinal extraskeletal osteosarcoma;exactmatch
mediastinal liposarcoma;liposarcoma of mediastinum;exactmatch
mediastinal angiosarcoma;angiosarcoma of mediastinum;exactmatch
mediastinal ganglioneuroma;ganglioneuroma of mediastinum;exactmatch
mediastinal lymphoma;lymphoma of mediastinum;exactmatch
mediastinal hodgkin lymphoma;hodgkin's disease of mediastinum;exactmatch
mediastinal melanotic schwannoma;mediastinal melanocytic neurilemmoma;exactmatch
ampulla of vater adenocarcinoma;adenocarcinoma of ampulla of vater;exactmatch
stage iv pleural malignant mesothelioma ajcc v7;stage iv mesothelioma;exactmatch
stage iii pleural malignant mesothelioma ajcc v7;stage iii mesothelioma;exactmatch
stage ii pleural malignant mesothelioma ajcc v7;stage ii mesothelioma;exactmatch
stage i pleural malignant mesothelioma ajcc v7;stage i mesothelioma;exactmatch
infantile hemangioma;cellular hemangioma;exactmatch
pleural lipoma;lipoma of pleura;exactmatch
mediastinal schwannoma;benign mediastinal neurilemmoma;exactmatch
malignant mediastinal soft tissue neoplasm;malignant mediastinal soft tissue neoplasm;exactmatch
stage 4 neuroblastoma;disseminated neuroblastoma;exactmatch
stage 3 neuroblastoma;stage 3 neuroblastoma;exactmatch
stage 2 neuroblastoma;stage 2 neuroblastoma;exactmatch
stage 1 neuroblastoma;stage 1 neuroblastoma;exactmatch
mediastinal soft tissue neoplasm;mediastinal soft tissue neoplasm;exactmatch
mediastinal psammomatous schwannoma;benign mediastinal psammomatous neurilemmoma;exactmatch
squamous cell papilloma of the rat vagina;rat vagina squamous cell papilloma;exactmatch
squamous cell papilloma of the rat uterine cervix;rat uterine cervix squamous cell papilloma;exactmatch
stage ii laryngeal cancer ajcc v6 and v7;laryngeal cancer, stage ii;exactmatch
urethral leiomyoma;leiomyoma of urethra;exactmatch
bladder leiomyoma;bladder leiomyoma;exactmatch
bladder inflammatory myofibroblastic tumor;bladder inflammatory myofibroblastic neoplasm;exactmatch
ureter small cell neuroendocrine carcinoma;small cell carcinoma of ureter;exactmatch
ureter lymphoma;lymphoma of ureter;exactmatch
ureter inverted papilloma;inverted papilloma of ureter;exactmatch
urethral inverted papilloma;inverted papilloma of urethra;exactmatch
urethral clear cell adenocarcinoma;clear cell adenocarcinoma of urethra;exactmatch
urethral condyloma;condylomata of urethra;exactmatch
adult kidney wilms tumor;adenosarcoma of adult kidney;exactmatch
urethral undifferentiated carcinoma;anaplastic carcinoma of urethra;exactmatch
urethral adenocarcinoma;adenocarcinoma of urethra;exactmatch
urethral urothelial carcinoma;transitional cell carcinoma of urethra;exactmatch
urethral squamous cell carcinoma;epidermoid carcinoma of urethra;exactmatch
bladder lymphoma;bladder lymphoma;exactmatch
bladder signet ring cell adenocarcinoma;bladder signet ring cell adenocarcinoma;exactmatch
ureter schwannoma;neurilemmoma of ureter;exactmatch
bladder clear cell adenocarcinoma;bladder clear cell adenocarcinoma;exactmatch
kidney extraskeletal osteosarcoma;kidney extraskeletal osteosarcoma;exactmatch
ureter leiomyoma;leiomyoma of ureter;exactmatch
stage 0 urethral cancer ajcc v7;stage 0 carcinoma of urethra;exactmatch
stage 0a ureter cancer ajcc v7;stage 0a carcinoma of ureter;exactmatch
stage 0a renal pelvis cancer ajcc v7;renal pelvis papillary noninvasive carcinoma;exactmatch
stage iv urethral cancer ajcc v7;stage iv carcinoma of urethra;exactmatch
stage iii urethral cancer ajcc v7;stage iii carcinoma of urethra;exactmatch
stage ii urethral cancer ajcc v7;stage ii carcinoma of urethra;exactmatch
stage i urethral cancer ajcc v7;stage i carcinoma of urethra;exactmatch
stage 0a urethral cancer ajcc v7;stage 0a carcinoma of urethra;exactmatch
collecting duct carcinoma;bdc;exactmatch
kidney leiomyosarcoma;kidney leiomyosarcoma;exactmatch
stage 0 renal pelvis cancer ajcc v7;stage 0 carcinoma of renal pelvis;exactmatch
inverted urothelial papilloma;inverted papilloma of urinary tract;exactmatch
stage i bladder urothelial carcinoma ajcc v6 and v7;stage i bladder urothelial cancer;exactmatch
stage 0 bladder urothelial carcinoma ajcc v6 and v7;non-invasive bladder urothelial carcinoma;exactmatch
renal pelvis inverted papilloma;inverted papilloma of kidney pelvis;exactmatch
infiltrating renal pelvis urothelial carcinoma, sarcomatoid variant;infiltrating renal pelvis urothelial carcinoma, sarcomatoid variant;exactmatch
kidney liposarcoma;kidney liposarcoma;exactmatch
tissue of mullerian origin present;tissue of mullerian origin present;exactmatch
fibromuscular stroma formation;fibromuscular stroma formation;exactmatch
squamous cell papilloma of the rat clitoral gland;rat clitoral gland squamous cell papilloma;exactmatch
gastrointestinal type epithelium present;gastrointestinal type epithelium present;exactmatch
mixed neoplastic epithelial cell population;mixed neoplastic epithelial cell population;exactmatch
malignant hobnail cell;malignant hobnail cell;exactmatch
neoplastic glandular epithelium resembling the normal endometrium present;neoplastic glandular epithelium resembling the normal endometrium present;exactmatch
atypical glandular epithelium resembling the normal endometrium present;atypical glandular epithelium resembling the normal endometrium present;exactmatch
ureter squamous cell carcinoma;epidermoid carcinoma of ureter;exactmatch
malignant glandular epithelium resembling the normal endometrium present;malignant glandular epithelium resembling the normal endometrium present;exactmatch
mural nodule;mural nodule;exactmatch
endocervical type epithelium present;endocervical type epithelium present;exactmatch
myomatous stroma formation;myomatous stroma formation;exactmatch
stage iv ureter cancer ajcc v7;stage iv carcinoma of ureter;exactmatch
stage iii ureter cancer ajcc v7;stage iii carcinoma of ureter;exactmatch
ovarian surface epithelium;ovarian surface epithelium;exactmatch
stage ii ureter cancer ajcc v7;stage ii carcinoma of ureter;exactmatch
stage i ureter cancer ajcc v7;stage i carcinoma of ureter;exactmatch
stage 0 ureter cancer ajcc v7;stage 0 carcinoma of ureter;exactmatch
renal pelvis papillary urothelial carcinoma;kidney pelvis papillary carcinoma;exactmatch
ureter adenocarcinoma;adenocarcinoma of ureter;exactmatch
degradation;degradated;exactmatch
basal cell of the squamous epithelium;basal cell of the squamous epithelium;exactmatch
malignant hyperchromatic small epithelial cell;malignant hyperchromatic small epithelial cell;exactmatch
prominent squamous eddies present;prominent squamous eddies present;exactmatch
female genitalia;female genitalia;exactmatch
ureter urothelial papilloma;ureter urothelial papilloma;exactmatch
lipid;lipid;exactmatch
vaginal mass;vaginal mass;exactmatch
endometrial type glands and stroma present;endometrial type glands and stroma present;exactmatch
ureter undifferentiated carcinoma;anaplastic carcinoma of ureter;exactmatch
mesonephric remnants;mesonephric duct remnant;exactmatch
infiltrating ureter urothelial carcinoma with squamous differentiation;infiltrating ureter urothelial carcinoma with squamous differentiation;exactmatch
infiltrating ureter urothelial carcinoma with mixed differentiation;infiltrating ureter urothelial carcinoma with mixed differentiation;exactmatch
malignant glandular epithelium resembling the endocervical epithelium present;malignant glandular epithelium resembling the endocervical epithelium present;exactmatch
complex glandular pattern;complex glandular pattern;exactmatch
ciliated adenocarcinoma cell;ciliated adenocarcinoma cell;exactmatch
uterine corpus cancer;cancer of the corpus uteri;exactmatch
infiltrating ureter urothelial carcinoma with glandular differentiation;infiltrating ureter urothelial carcinoma with glandular differentiation;exactmatch
rete ovarii;rete ovarii;exactmatch
ciliated respiratory mucosa;ciliated respiratory mucosa;exactmatch
childhood central nervous system teratoma;central nervous system teratoma;exactmatch
childhood central nervous system germ cell tumor;central nervous system germ cell tumor;exactmatch
benign thalamic neoplasm;benign neoplasm of thalamus;exactmatch
dilated terminal duct lobular units with acini lined by more than two layers of columnar epithelial cells present;dilated terminal duct lobular units with acini lined by more than two layers of columnar epithelial cells present;exactmatch
dilated terminal duct lobular units with acini lined by one or two layers of columnar epithelial cells present;dilated terminal duct lobular units with acini lined by one or two layers of columnar epithelial cells present;exactmatch
dilated terminal duct lobular units present;dilated terminal duct lobular units present;exactmatch
spaces lined by one to three layers of monotonous atypical cells present;spaces lined by one to three layers of monotonous atypical cells present;exactmatch
malignant basaloid cell;malignant basaloid cell;exactmatch
juvenile lesion;juvenile lesion;exactmatch
subareolar region;subareolar region;exactmatch
large mass;large mass;exactmatch
hyperplastic epithelial tissue present;hyperplastic epithelial tissue present;exactmatch
pericanalicular growth pattern;pericanalicular growth pattern;exactmatch
intraductal lesion;intraductal lesion;exactmatch
extensive secretory changes present;extensive secretory changes present;exactmatch
breast tubular adenoma;breast tubular adenoma;exactmatch
thalamic neoplasm;neoplasm of thalamus;exactmatch
eccrine differentiation;eccrine differentiation;exactmatch
neoplastic apocrine cell with eosinophilic granular cytoplasm;neoplastic apocrine cell with eosinophilic granular cytoplasm;exactmatch
hyperplastic tissue present;hyperplastic tissue present;exactmatch
conjunctival squamous papilloma;conjunctival squamous cell papilloma;exactmatch
childhood central nervous system choriocarcinoma;central nervous system choriocarcinoma;exactmatch
micronodular pattern;micronodular pattern;exactmatch
central nervous system carcinoma;central nervous system carcinoma;exactmatch
fenestrating pattern;fenestrating pattern;exactmatch
arborising network of cords of basaloid cells present;arborising network of cords of basaloid cells present;exactmatch
fibrovascular stroma formation;fibrovascular stroma formation;exactmatch
matrical differentiation;matrical differentiation;exactmatch
slit-like stromal retraction present;slit-like stromal retraction present;exactmatch
proliferation of basaloid cells parallel to the long axis of the epidermis present;proliferation of basaloid cells parallel to the long axis of the epidermis present;exactmatch
infundibular-like structures present;infundibular-like structures present;exactmatch
epithelial neoplasm (antiquated);epithelial neoplasm (antiquated);exactmatch
prominent keratin formation;prominent keratin formation;exactmatch
adnexal differentiation;adnexal differentiation;exactmatch
superficial basal cell carcinoma;superficial basal cell carcinoma;exactmatch
skin nodular basal cell carcinoma;nodular basal cell carcinoma;exactmatch
germ cell tumor (antiquated);germ cell tumor (antiquated);exactmatch
connective and soft tissue neoplasm (antiquated);connective and soft tissue neoplasm (antiquated);exactmatch
mixed neoplastic glandular and squamous cell population;mixed neoplastic glandular and squamous cell population;exactmatch
apocrine carcinoma cell with eosinophilic granular cytoplasm;apocrine carcinoma cell with eosinophilic granular cytoplasm;exactmatch
paucicellular stroma present;paucicellular stroma present;exactmatch
beaded anastomosing cords present;beaded anastomosing cords present;exactmatch
extraosseous lesion;extraosseous lesion;exactmatch
hard palate adenoid cystic carcinoma;adenoid cystic carcinoma of hard palate;exactmatch
tumor droplets present;tumor droplets present;exactmatch
rosette-like configurations present;rosette-like configurations present;exactmatch
duct-like structures present;duct-like structures present;exactmatch
hard palate pleomorphic adenoma;benign mixed salivary tumor of hard palate;exactmatch
neoplastic ghost cell;neoplastic ghost cell;exactmatch
soft palate pleomorphic adenoma;benign mixed tumor of soft palate;exactmatch
intraosseous lesion;intraosseous lesion;exactmatch
canalicular pattern;canalicular pattern;exactmatch
neoplastic epithelial cell with granular cytoplasm;neoplastic epithelial cell with granular cytoplasm;exactmatch
anastomosing strands of tumor cells present;anastomosing strands of tumor cells present;exactmatch
soft palate benign granular cell tumor;benign granular cell neoplasm of soft palate;exactmatch
islands of odontogenic epithelium present;islands of odontogenic epithelium present;exactmatch
childhood central nervous system yolk sac tumor;central nervous system yolk sac tumor;exactmatch
childhood central nervous system embryonal carcinoma;childhood cns embryonal cell carcinoma;exactmatch
childhood brain germinoma;childhood brain germinoma;exactmatch
hard palate mucoepidermoid carcinoma;hard palate mucoepidermoid carcinoma;exactmatch
dysplastic dentin formation;dentinoid formation;exactmatch
childhood anaplastic astrocytoma;anaplastic astrocytoma;exactmatch
childhood brain stem astrocytoma;childhood brain stem astrocytoma;exactmatch
neoplastic columnar epithelial cell;neoplastic columnar epithelial cell;exactmatch
point mutation;point mutation;exactmatch
cerebral hemisphere lipoma;cerebral hemisphere lipoma;exactmatch
salivary gland adenocarcinoma, not otherwise specified;salivary gland adenocarcinoma, nos;exactmatch
salivary gland oncocytic carcinoma;salivary gland oncocytic carcinoma;exactmatch
salivary gland mucinous adenocarcinoma;salivary gland mucinous adenocarcinoma;exactmatch
salivary gland intraductal carcinoma;low grade salivary duct carcinoma;exactmatch
salivary gland clear cell carcinoma;salivary gland clear cell carcinoma;exactmatch
benign childhood cerebral neoplasm;benign childhood cerebral hemispheric neoplasm;exactmatch
benign adult cerebral neoplasm;adult benign cerebral neoplasms;exactmatch
malignant cuboidal epithelial cell;malignant cuboidal epithelial cell;exactmatch
small to medium size adenocarcinoma cell with oval nucleus;small to medium size adenocarcinoma cell with oval nucleus;exactmatch
lobular pattern;lobular pattern;exactmatch
terminal duct cell;intercalated duct cell;exactmatch
recurrent childhood brain stem astrocytoma;recurrent childhood brain stem astrocytoma;exactmatch
localized hydropic villous change;localized hydropic villous change;exactmatch
generalized hydropic villous change;generalized hydropic villous change;exactmatch
first trimester bleeding;first trimester bleeding;exactmatch
rat proliferative change by location;rat disorder by site;exactmatch
proliferative change of the rat nervous system and sensory organs;proliferative change of the rat nervous system and sensory organs;exactmatch
proliferative change of the rat integumentary system;proliferative change of the rat integumentary system;exactmatch
proliferative change of the rat hematopoietic and mononuclear phagocytic system;proliferative change of the rat hematopoietic and mononuclear phagocytic system;exactmatch
proliferative change of the rat genital system;proliferative change of the rat genital system;exactmatch
proliferative change of the rat endocrine system;proliferative change of the rat endocrine system;exactmatch
proliferative change of the rat digestive system;proliferative change of the rat digestive system;exactmatch
proliferative change of the rat cardiovascular system;proliferative change of the rat cardiovascular system;exactmatch
large adenocarcinoma cell with eosinophilic cytoplasm;large adenocarcinoma cell with eosinophilic cytoplasm;exactmatch
stage iic retinoblastoma;stage iic retinoblastoma;exactmatch
stage iib retinoblastoma;stage iib retinoblastoma;exactmatch
non-specific glandular pattern;non-specific glandular pattern;exactmatch
absence of muscle invasion;absence of muscle invasion;exactmatch
kidney and ureter;kidney and ureter;exactmatch
stage iia retinoblastoma;stage iia retinoblastoma;exactmatch
stage ii retinoblastoma;stage ii retinoblastoma;exactmatch
stage ib retinoblastoma;stage ib retinoblastoma;exactmatch
proliferative change of the rat respiratory system;proliferative change of the rat respiratory system;exactmatch
proliferative change of the rat soft tissue and musculoskeletal system;proliferative change of the rat soft tissue and musculoskeletal system;exactmatch
stage 0 laryngeal squamous cell carcinoma ajcc v6, v7, and v8;epidermoid carcinoma in situ of larynx;exactmatch
small adenocarcinoma cell with scant amount of cytoplasm;small adenocarcinoma cell with scant amount of cytoplasm;exactmatch
ciliary body epithelioid cell melanoma;ciliary body epithelioid cell melanoma;exactmatch
intermediate cell type ciliary body melanoma;intermediate cell type ciliary body melanoma;exactmatch
ciliary body spindle cell melanoma;ciliary body spindle cell melanoma;exactmatch
stage iv retinoblastoma;stage iv retinoblastoma;exactmatch
stage iiib retinoblastoma;stage iiib retinoblastoma;exactmatch
renal tubular epithelial cell;renal tubular epithelial cell;exactmatch
adenocarcinoma cell with eosinophilic cytoplasm;adenocarcinoma cell with eosinophilic cytoplasm;exactmatch
delicate vascular network formation;delicate vascular network formation;exactmatch
proliferative change of the rat urinary system;proliferative change of the rat urinary system;exactmatch
stage iiia retinoblastoma;stage iiia retinoblastoma;exactmatch
stage iii retinoblastoma;stage iii retinoblastoma;exactmatch
posterior portion of the urethra;posterior portion of the urethra;exactmatch
anterior portion of the urethra;anterior portion of the urethra;exactmatch
bulbomembranous urethra;bulbomembranous urethra;exactmatch
penile portion of the urethra;penile portion of the urethra;exactmatch
skene gland;paraurethral skene gland;exactmatch
stage ia retinoblastoma;stage ia retinoblastoma;exactmatch
hemorrhagic pattern;hemorrhagic pattern;exactmatch
sclerotic pattern;sclerotic pattern;exactmatch
choroid spindle cell melanoma;choroid spindle cell melanoma;exactmatch
intermediate cell type choroid melanoma;intermediate cell type choroid melanoma;exactmatch
malignant epithelial small oval cell;malignant epithelial small oval cell;exactmatch
neoplastic epithelial small oval cell;neoplastic epithelial small oval cell;exactmatch
malignant epithelial small polygonal cell;malignant epithelial small polygonal cell;exactmatch
neoplastic epithelial small polygonal cell;neoplastic epithelial small polygonal cell;exactmatch
malignant epithelial oval cell;malignant epithelial oval cell;exactmatch
neoplastic epithelial oval cell;neoplastic epithelial oval cell;exactmatch
myasthenia gravis;myasthenia gravis;exactmatch
entrapped respiratory epithelium present;entrapped respiratory epithelium present;exactmatch
widely invasive lesion;widely invasive lesion;exactmatch
minimally invasive lesion;minimally invasive lesion;exactmatch
iris spindle cell melanoma;iris spindle cell melanoma;exactmatch
low grade conjunctival squamous intraepithelial neoplasia;grade 1 conjunctival intraepithelial neoplasia;exactmatch
orbit sarcoma;orbit sarcoma;exactmatch
low grade corneal squamous intraepithelial neoplasia;grade 1 corneal intraepithelial neoplasia;exactmatch
corneal squamous intraepithelial neoplasia;cornea intraepithelial neoplasia;exactmatch
neoplastic epithelial large polygonal cell;neoplastic epithelial large polygonal cell;exactmatch
malignant epithelial large polygonal cell;malignant epithelial large polygonal cell;exactmatch
malignant epithelial medium-sized polygonal cell;malignant epithelial medium-sized polygonal cell;exactmatch
multifocal epithelial proliferations less than 1mm in diameter present;multifocal epithelial proliferations less than 1mm in diameter present;exactmatch
malignant round germ cell with glycogen-rich cytoplasm and round nucleus;malignant round germ cell with glycogen-rich cytoplasm and round nucleus;exactmatch
stage i retinoblastoma;stage i retinoblastoma;exactmatch
adenine dna glycosylase;a/g-specific adenine dna glycosylase;exactmatch
mutyh gene;mutyh;exactmatch
tobacco chewing toxicity;tobacco chewing toxicity;exactmatch
cigarette smoking toxicity;cigarette smoking toxicity;exactmatch
tobacco toxicity;tobacco toxicity;exactmatch
alcohol toxicity;alcohol toxicity;exactmatch
basophilic adenocarcinoma cell;basophilic adenocarcinoma cell;exactmatch
malignant uveal neoplasm;malignant neoplasm of uvea;exactmatch
benign uveal neoplasm;benign neoplasm of uvea;exactmatch
metastatic malignant neoplasm in the iris;metastatic malignant neoplasm in the iris;exactmatch
choroid epithelioid cell melanoma;choroid epithelioid cell melanoma;exactmatch
prominent elastic tissue cores present;prominent elastic tissue cores present;exactmatch
intermediate cell type iris melanoma;intermediate cell type iris melanoma;exactmatch
conjunctival squamous intraepithelial neoplasia;conjunctiva intraepithelial neoplasia;exactmatch
stage iva laryngeal squamous cell carcinoma ajcc v7;stage iva epidermoid carcinoma of larynx;exactmatch
tissues derived from two or three embryonic layers present;tissues derived from two or three embryonic layers present;exactmatch
neoplastic sertoli cell with clear cytoplasm;neoplastic sertoli cell with clear cytoplasm;exactmatch
neoplastic leutein cell;neoplastic leutein cell;exactmatch
renal pelvis adenocarcinoma;adenocarcinoma of kidney pelvis;exactmatch
sclerosing peritonitis;sclerosing peritonitis;exactmatch
neoplastic small sex cord-stromal cell;neoplastic small sex cord-stromal cell;exactmatch
lipid-rich neoplastic spindle cell;lipid-rich neoplastic spindle cell;exactmatch
gonadal dysgenesis;dysgenetic_gonad;exactmatch
renal pelvis carcinoma;carcinoma of kidney pelvis;exactmatch
neoplastic large polygonal sertoli cell;neoplastic large polygonal sertoli cell;exactmatch
stage i renal pelvis cancer ajcc v7;stage i carcinoma of renal pelvis;exactmatch
malignant sex cord-stromal cell;malignant sex cord-stromal cell;exactmatch
embryoid bodies present;embryoid bodies present;exactmatch
seminomatous component present;seminomatous component present;exactmatch
one germ layer present;one germ layer present;exactmatch
stage iva oropharyngeal squamous cell carcinoma ajcc v7;stage iva epidermoid carcinoma of oropharynx;exactmatch
inconspicuous syncytiotrophoblastic cell component;inconspicuous syncytiotrophoblastic cell component;exactmatch
malignant intermediate type trophoblastic cell;malignant intermediate type trophoblastic cell;exactmatch
pseudolobular pattern;pseudolobular pattern;exactmatch
amenorrhea;amenorrhea;exactmatch
stage ivb laryngeal squamous cell carcinoma ajcc v7;stage ivb epidermoid carcinoma of larynx;exactmatch
annular tubules present;annular tubules present;exactmatch
single type of tissue derived from one embryonic layer present;single type of tissue derived from one embryonic layer present;exactmatch
stage iv renal pelvis cancer ajcc v7;stage iv carcinoma of renal pelvis;exactmatch
thyrotoxicosis;thyrotoxicosis;exactmatch
aberrant thyroid tissue present;aberrant thyroid tissue present;exactmatch
malignant component present;malignant component present;exactmatch
fetiform mass;fetiform mass;exactmatch
stage iii renal pelvis cancer ajcc v7;stage iii carcinoma of renal pelvis;exactmatch
small lesion;small lesion;exactmatch
hirsutism;hirsutism;exactmatch
neoplastic sex cord-stromal cell resembling steroid hormone-secreting cell;neoplastic sex cord-stromal cell resembling steroid hormone-secreting cell;exactmatch
stage ii renal pelvis cancer ajcc v7;stage ii carcinoma of renal pelvis;exactmatch
ovarian hilus;ovarian hilus;exactmatch
retiform structures comprise more than 10% and less than 90% of the tumor;retiform structures comprise more than 10% and less than 90% of the tumor;exactmatch
retiform structures comprise 90% or more of the tumor;retiform structures comprise 90% or more of the tumor;exactmatch
retiform structures present;retiform structures present;exactmatch
sarcomatoid stroma formation;sarcomatoid stroma formation;exactmatch
stage ivc oropharyngeal squamous cell carcinoma ajcc v7;stage ivc epidermoid carcinoma of oropharynx;exactmatch
radiation exposure;radiation exposure;exactmatch
polyvesicular vitelline pattern;polyvesicular vitelline pattern;exactmatch
blastemal pattern;blastemal pattern;exactmatch
neoplastic epithelial cell with eosinophilic cytoplasm;neoplastic epithelial cell with eosinophilic cytoplasm;exactmatch
tubular structures present;tubular;exactmatch
malignant blastemal cell;malignant blastemal cell;exactmatch
serpentine blastemal pattern;serpentine blastemal pattern;exactmatch
nodular blastemal pattern;nodular blastemal pattern;exactmatch
diffuse blastemal pattern;diffuse blastemal pattern;exactmatch
lacrimal gland carcinoma;carcinoma of lacrimal gland;exactmatch
blastemal cell;blastemal cell;exactmatch
testicular mass;testicular mass;exactmatch
nephrogenic blastemal cell;nephrogenic blastemal cell;exactmatch
stage 0 laryngeal verrucous carcinoma ajcc v6, v7, and v8;laryngeal verrucous carcinoma in situ;exactmatch
stage iva laryngeal verrucous carcinoma ajcc v7;stage iva laryngeal throat verrucous cancer;exactmatch
stage ivb laryngeal verrucous carcinoma ajcc v7;stage ivb laryngeal throat verrucous cancer;exactmatch
stage ivc laryngeal verrucous carcinoma ajcc v7;stage ivc laryngeal throat verrucous cancer;exactmatch
x-linked lymphoproliferative syndrome;duncan disease;exactmatch
stage ivc laryngeal squamous cell carcinoma ajcc v7;stage ivc epidermoid carcinoma of larynx;exactmatch
neoplastic small epithelial cell with scant amount of cytoplasm;neoplastic small epithelial cell with scant amount of cytoplasm;exactmatch
high plasma renin activity;high plasma renin activity;exactmatch
stage ivc hypopharyngeal squamous cell carcinoma ajcc v7;stage ivc epidermoid carcinoma of hypopharynx;exactmatch
stage ivb hypopharyngeal squamous cell carcinoma ajcc v7;stage ivb epidermoid carcinoma of hypopharynx;exactmatch
stage ivb oropharyngeal squamous cell carcinoma ajcc v7;stage ivb epidermoid carcinoma of oropharynx;exactmatch
malignant round germ cell;malignant round germ cell;exactmatch
malignant small germ cell;malignant small germ cell;exactmatch
malignant giant germ cell;malignant giant germ cell;exactmatch
testicular typical seminoma;testicular typical seminoma;exactmatch
painless testicular mass;painless testicular mass;exactmatch
stage ivb nasopharyngeal keratinizing squamous cell carcinoma ajcc v7;stage ivb keratinizing epidermoid carcinoma of nasopharynx;exactmatch
tissue breakdown;tissue breakdown;exactmatch
stage iva nasopharyngeal keratinizing squamous cell carcinoma ajcc v7;stage iva keratinizing epidermoid carcinoma of nasopharynx;exactmatch
uterine ligament;uterine ligament;exactmatch
stage iv thyroid gland medullary carcinoma ajcc v7;stage iv medullary carcinoma of thyroid;exactmatch
stage iii thyroid gland medullary carcinoma ajcc v7;stage iii medullary carcinoma of thyroid;exactmatch
stage ii thyroid gland medullary carcinoma ajcc v7;stage ii medullary carcinoma of thyroid;exactmatch
stage i thyroid gland medullary carcinoma ajcc v7;stage i medullary carcinoma of thyroid;exactmatch
stage iva hypopharyngeal squamous cell carcinoma ajcc v7;stage iva epidermoid carcinoma of hypopharynx;exactmatch
melanoma cell with large nucleus and abundant pale cytoplasm;melanoma cell with large nucleus and abundant pale cytoplasm;exactmatch
giant melanoma cell;giant melanoma cell;exactmatch
dermo-epidermal junction;dermo-epidermal junction;exactmatch
benign mixed tumor of the rat sublingual gland;benign mixed tumor of the rat sublingual gland;exactmatch
squamous cell carcinoma of the rat salivary gland;rat salivary gland squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat parotid gland;rat parotid gland squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat mandibular gland;rat mandibular gland squamous cell carcinoma;exactmatch
malignant mixed tumor of the rat sublingual gland;malignant mixed tumor of the rat sublingual gland;exactmatch
malignant mixed tumor of the rat salivary gland;malignant mixed tumor of the rat salivary gland;exactmatch
malignant mixed tumor of the rat parotid gland;malignant mixed tumor of the rat parotid gland;exactmatch
malignant mixed tumor of the rat mandibular gland;malignant mixed tumor of the rat mandibular gland;exactmatch
benign mixed tumor of the rat salivary gland;benign mixed tumor of the rat salivary gland;exactmatch
squamous cell carcinoma of the rat sublingual gland;rat sublingual gland squamous cell carcinoma;exactmatch
benign mixed tumor of the rat parotid gland;benign mixed tumor of the rat parotid gland;exactmatch
vulvar verrucous carcinoma;verrucous carcinoma of vulva;exactmatch
benign mixed tumor of the rat mandibular gland;benign mixed tumor of the rat mandibular gland;exactmatch
adenoma of the rat sublingual gland;adenoma of the rat sublingual gland;exactmatch
adenoma of the rat salivary gland;adenoma of the rat salivary gland;exactmatch
adenoma of the rat parotid gland;adenoma of the rat parotid gland;exactmatch
adenoma of the rat mandibular gland;adenoma of the rat mandibular gland;exactmatch
paratesticular lipoma;paratesticular lipoma;exactmatch
squamous cell metaplasia of the rat mandibular gland;rat mandibular gland squamous cell metaplasia;exactmatch
adenoma of the rat colon;adenoma of the rat colon;exactmatch
adenocarcinoma of the rat duodenum;adenocarcinoma of the rat duodenum;exactmatch
adenocarcinoma of the rat small intestine;adenocarcinoma of the rat small intestine;exactmatch
adenocarcinoma of the rat rectum;adenocarcinoma of the rat rectum;exactmatch
adenocarcinoma of the rat large intestine;adenocarcinoma of the rat large intestine;exactmatch
adenocarcinoma of the rat jejunum;adenocarcinoma of the rat jejunum;exactmatch
scrotal hemangioma;angioma of scrotum;exactmatch
adenocarcinoma of the rat ileum;adenocarcinoma of the rat ileum;exactmatch
adenocarcinoma of the rat glandular stomach;adenocarcinoma of the rat glandular stomach;exactmatch
adenocarcinoma of the rat colon;adenocarcinoma of the rat colon;exactmatch
squamous cell metaplasia of the rat parotid gland;rat parotid gland squamous cell metaplasia;exactmatch
adenocarcinoma of the rat cecum;adenocarcinoma of the rat cecum;exactmatch
rat intestinal neoplasm;intestinal neoplasm of the rat;exactmatch
rat salivary gland neoplasm;rat salivary gland neoplasm;exactmatch
scrotal basal cell carcinoma;basal cell carcinoma of scrotum;exactmatch
metastatic malignant neoplasm in the uterine cervix;metastasis to the cervix;exactmatch
squamous cell metaplasia of the rat sublingual gland;rat sublingual gland squamous cell metaplasia;exactmatch
squamous cell metaplasia of the rat salivary gland;rat salivary gland squamous cell metaplasia;exactmatch
adenocarcinoma of the rat sublingual gland;adenocarcinoma of the rat sublingual gland;exactmatch
adenocarcinoma of the rat salivary gland;adenocarcinoma of the rat salivary gland;exactmatch
adenocarcinoma of the rat parotid gland;adenocarcinoma of the rat parotid gland;exactmatch
testicular well differentiated neuroendocrine tumor;carcinoid tumor of testis;exactmatch
stage iic testicular cancer ajcc v6 and v7;stage iic;exactmatch
stage iib testicular cancer ajcc v6 and v7;stage iib;exactmatch
stage iia testicular cancer ajcc v6 and v7;stage iia;exactmatch
stage is testicular cancer ajcc v6 and v7;stage is;exactmatch
undifferentiated carcinoma with osteoclast-like giant cells;carcinoma with osteoclast-like giant cells;exactmatch
stage ib testicular cancer ajcc v6 and v7;stage ib;exactmatch
stage ia testicular cancer ajcc v6 and v7;stage ia;exactmatch
testicular sarcoma;sarcoma of testis;exactmatch
adenocarcinoma of the rat mandibular gland;adenocarcinoma of the rat mandibular gland;exactmatch
testicular sex cord-stromal tumor;sex cord-stromal neoplasm of testis;exactmatch
testicular granulosa cell tumor;granulosa cell neoplasm of testis;exactmatch
testicular leydig cell tumor;leydig cell neoplasm of testis;exactmatch
mature testicular teratoma;mature teratoma of testis;exactmatch
kidney diffuse large b-cell lymphoma;diffuse large b-cell lymphoma of the kidney;exactmatch
kidney lymphoma;kidney lymphoma;exactmatch
immature testicular teratoma;immature teratoma of testis;exactmatch
stage iiic testicular cancer ajcc v6 and v7;stage iiic;exactmatch
stage iiib testicular cancer ajcc v6 and v7;stage iiib;exactmatch
stage iiia testicular cancer ajcc v6 and v7;stage iiia;exactmatch
giant condyloma;buschke-lowenstein neoplasm;exactmatch
rat acanthomatous ameloblastoma;acanthomatous ameloblastomaof the rat;exactmatch
epididymal adenomatoid tumor;adenomatoid neoplasm of epididymis;exactmatch
rat compound odontoma;compound odontoma of the rat;exactmatch
rat complex odontoma;complex odontoma of the rat;exactmatch
vulvar basal cell carcinoma;basal cell carcinoma of vulva;exactmatch
vulvar adenocarcinoma;adenocarcinoma of vulva;exactmatch
rat cavity;rat cavity;exactmatch
vaginal yolk sac tumor;vaginal endodermal sinus neoplasm;exactmatch
testicular rhabdomyosarcoma;rhabdomyosarcoma of testis;exactmatch
penile kaposi sarcoma;kaposi's sarcoma of penis;exactmatch
vulvar squamous cell papilloma;vestibular papilloma;exactmatch
vulvar seborrheic keratosis;seborrheic keratosis of vulva;exactmatch
vaginal squamous cell papilloma;squamous papilloma of vagina;exactmatch
vaginal leiomyoma;leiomyoma of vagina;exactmatch
vaginal rhabdomyoma;rhabdomyoma of vagina;exactmatch
adenoma of the rat cecum;adenoma of the rat cecum;exactmatch
adenoma of the rat duodenum;adenoma of the rat duodenum;exactmatch
flcn gene;flcn;exactmatch
figo stage iia gestational trophoblastic tumor;figo stage iia gtt;exactmatch
cystadenocarcinoma of the rat ovary;cystadenocarcinoma of the rat ovary;exactmatch
choriocarcinoma of the rat uterus;choriocarcinoma of the rat uterus;exactmatch
choriocarcinoma of the rat uterine cervix;choriocarcinoma of the rat uterine cervix;exactmatch
choriocarcinoma of the rat oviduct;choriocarcinoma of the rat oviduct;exactmatch
choriocarcinoma of the rat ovary;choriocarcinoma of the rat ovary;exactmatch
benign thecoma of the rat ovary;benign thecoma of the rat ovary;exactmatch
benign sertoli cell tumor of the rat ovary;benign sertoli cell tumor of the rat ovary;exactmatch
benign mixed muellerian tumor of the rat uterus;benign mixed muellerian tumor of the rat uterus;exactmatch
decidual reaction of the rat uterine cervix;decidual reaction of the rat uterine cervix;exactmatch
benign mixed muellerian tumor of the rat uterine cervix;benign mixed muellerian tumor of the rat uterine cervix;exactmatch
benign granulosa cell tumor of the rat ovary;benign granulosa cell tumor of the rat ovary;exactmatch
adenosquamous carcinoma of the rat uterus;adenosquamous carcinoma of the rat uterus;exactmatch
adenosquamous carcinoma of the rat uterine cervix;adenosquamous carcinoma of the rat uterine cervix;exactmatch
adenoma of the rat uterus;adenoma of the rat uterus;exactmatch
adenoma of the rat oviduct;adenoma of the rat oviduct;exactmatch
adenoma of the rat clitoral gland;adenoma of the rat clitoral gland;exactmatch
cystadenoma of the rat ovary;cystadenoma of the rat ovary;exactmatch
decidual reaction of the rat uterus;decidual reaction of the rat uterus;exactmatch
adenoma of the rat glandular stomach;adenoma of the rat glandular stomach;exactmatch
malignant mixed muellerian tumor of the rat uterus;malignant mixed muellerian tumor of the rat uterus;exactmatch
squamous cell carcinoma of the rat vagina;rat vagina squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat uterus;rat uterus squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat uterine cervix;rat uterine cervix squamous cell carcinoma;exactmatch
squamous cell carcinoma of the rat clitoral gland;rat clitoral gland squamous cell carcinoma;exactmatch
malignant thecoma of the rat ovary;malignant thecoma of the rat ovary;exactmatch
figo stage iic gestational trophoblastic tumor;figo stage iic gtt;exactmatch
malignant sertoli cell tumor of the rat ovary;malignant sertoli cell tumor of the rat ovary;exactmatch
malignant mixed muellerian tumor of the rat uterine cervix;malignant mixed muellerian tumor of the rat uterine cervix;exactmatch
figo stage iib gestational trophoblastic tumor;figo stage iib gtt;exactmatch
malignant granulosa cell tumor of the rat ovary;malignant granulosa cell tumor of the rat ovary;exactmatch
keratoacanthoma of the rat vagina;keratoacanthoma of the rat vagina;exactmatch
keratoacanthoma of the rat uterine cervix;keratoacanthoma of the rat uterine cervix;exactmatch
endometrial stromal sarcoma of the rat uterus;endometrial stromal sarcoma of the rat uterus;exactmatch
endometrial stromal sarcoma of the rat uterine cervix;endometrial stromal sarcoma of the rat uterine cervix;exactmatch
endometrial stromal polyp of the rat uterus;endometrial stromal polyp of the rat uterus;exactmatch
endometrial stromal polyp of the rat uterine cervix;endometrial stromal polyp of the rat uterine cervix;exactmatch
adenocarcinoma of the rat uterus;adenocarcinoma of the rat uterus;exactmatch
adenocarcinoma of the rat oviduct;adenocarcinoma of the rat oviduct;exactmatch
figo stage ii gestational trophoblastic tumor;figo stage ii gtt;exactmatch
benign neuroendocrine cell tumor of the rat glandular stomach;benign neuroendocrine cell tumor of the rat glandular stomach;exactmatch
squamous cell carcinoma of the rat esophagus;rat esophagus squamous cell carcinoma;exactmatch
signet ring cell adenocarcinoma of the rat glandular stomach;rat glandular stomach signet ring cell adenocarcinoma;exactmatch
neuroendocrine cell hyperplasia of the rat glandular stomach;neuroendocrine cell hyperplasia of the rat glandular stomach;exactmatch
scrotal carcinoma;cancer of scrotum;exactmatch
malignant neuroendocrine cell tumor of the rat glandular stomach;malignant neuroendocrine cell tumor of the rat glandular stomach;exactmatch
exophytic squamous cell carcinoma of the rat esophagus;exophytic squamous cell carcinoma of the rat esophagus;exactmatch
endophytic squamous cell carcinoma of the rat esophagus;endophytic squamous cell carcinoma of the rat esophagus;exactmatch
benign basal cell tumor of the rat forestomach;benign basal cell tumor of the rat forestomach;exactmatch
adenocarcinoma of the rat clitoral gland;adenocarcinoma of the rat clitoral gland;exactmatch
basal cell carcinoma of the rat forestomach;basal cell carcinoma of the rat forestomach;exactmatch
basal cell carcinoma of the rat esophagus;basal cell carcinoma of the rat esophagus;exactmatch
adenoma of the rat small intestine;adenoma of the rat small intestine;exactmatch
adenoma of the rat rectum;adenoma of the rat rectum;exactmatch
adenoma of the rat large intestine;adenoma of the rat large intestine;exactmatch
adenoma of the rat jejunum;adenoma of the rat jejunum;exactmatch
adenoma of the rat ileum;adenoma of the rat ileum;exactmatch
squamous cell carcinoma of the rat forestomach;rat forestomach squamous cell carcinoma;exactmatch
squamous cell papilloma of the rat esophagus;rat esophagus squamous cell papilloma;exactmatch
squamous cell papilloma of the rat forestomach;rat forestomach squamous cell papilloma;exactmatch
rat hepatic neoplasm;hepatic neoplasm of the rat;exactmatch
figo stage ic gestational trophoblastic tumor;figo stage ic gtt;exactmatch
figo stage ib gestational trophoblastic tumor;figo stage ib gtt;exactmatch
invasive breast ductal carcinoma and invasive lobular carcinoma;infiltrating ductal and infiltrating lobular breast carcinoma;exactmatch
figo stage ia gestational trophoblastic tumor;figo stage ia gtt;exactmatch
malignant medullary tumor of the rat adrenal gland;malignant medullary tumor of the rat adrenal gland;exactmatch
benign medullary tumor of the rat adrenal gland;benign medullary tumor of the rat adrenal gland;exactmatch
rat c-cell ganglioneuroma;c-cell ganglioneuroma of the rat thyroid gland;exactmatch
adenoma of the rat parathyroid gland;adenoma of the rat parathyroid gland;exactmatch
adenocarcinoma of the rat parathyroid gland;adenocarcinoma of the rat parathyroid gland;exactmatch
figo stage i gestational trophoblastic tumor;figo stage i gtt;exactmatch
acinar cell adenocarcinoma of the rat pancreas;acinar cell adenocarcinoma of the rat pancreas;exactmatch
ductal cell adenocarcinoma of the rat pancreas;ductal cell adenocarcinoma of the rat pancreas;exactmatch
acinar cell adenoma of the rat pancreas;acinar cell adenoma of the rat pancreas;exactmatch
ductal cell adenoma of the rat pancreas;ductal cell adenoma of the rat pancreas;exactmatch
gestational trophoblastic tumor by figo stage;gestational trophoblastic tumor by figo stage;exactmatch
testicular mixed embryonal carcinoma and teratoma with seminoma;mixed embryonal carcinoma and teratoma with seminoma of testis;exactmatch
testicular mixed embryonal carcinoma and teratoma;mixed embryonal carcinoma and teratoma of testis;exactmatch
stage ivc nasopharyngeal keratinizing squamous cell carcinoma ajcc v7;nasopharyngeal keratinizing squamous cell carcinoma stage ivc;exactmatch
fenestrated pattern;fenestrated pattern;exactmatch
stage iiib ovarian cancer ajcc v6 and v7;ajcc stage iiib ovarian cancer;exactmatch
stage iiia ovarian cancer ajcc v6 and v7;ajcc stage iiia ovarian cancer;exactmatch
bowen disease of the skin;bowen disease;exactmatch
ovarian endometrioid tumor;endometrioid neoplasm of ovary;exactmatch
epidermolytic ichthyosis;bcie;exactmatch
tricholemmal differentiation;tricholemmal differentiation;exactmatch
shadow cells present;shadow cells present;exactmatch
ovarian serous surface papillary adenocarcinoma;ovarian serous surface papillary adenocarcinoma;exactmatch
stage iiic ovarian cancer ajcc v6 and v7;ajcc stage iiic ovarian cancer;exactmatch
follicular differentiation;follicular differentiation;exactmatch
trichoblastic differentiation;trichoblastic differentiation;exactmatch
stage iib nasopharyngeal keratinizing squamous cell carcinoma;nasopharyngeal keratinizing squamous cell carcinoma stage iib;exactmatch
stage iia nasopharyngeal keratinizing squamous cell carcinoma;nasopharyngeal keratinizing squamous cell carcinoma stage iia;exactmatch
childhood intracranial meningioma;brain meningioma;exactmatch
childhood brain anaplastic astrocytoma;anaplastic childhood astrocytoma of brain;exactmatch
anterior tongue adenoid cystic carcinoma;adenoid cystic carcinoma of anterior tongue;exactmatch
hypopituitarism;hypopituitarism;exactmatch
ovarian granulosa cell tumor;granulosa cell neoplasm of ovary;exactmatch
stage ib fallopian tube cancer ajcc v6 and v7;ajcc stage ib fallopian tube cancer;exactmatch
petrous apex;petrous apex;exactmatch
childhood cerebral ependymoma;childhood cerebral ependymoma;exactmatch
fallopian tube papillary adenocarcinoma;fallopian tube papillary adenocarcinoma;exactmatch
fallopian tube adenocarcinoma;adenocarcinoma of fallopian tube;exactmatch
sphenocavernous region;sphenocavernous region;exactmatch
sphenoorbital region;sphenoorbital region;exactmatch
periocular region;periocular region;exactmatch
petroclival region;petroclival region;exactmatch
trigeminal ganglion;ganglion, trigeminal;exactmatch
visual pathway neoplasm;neoplasm of visual pathway;exactmatch
upper clivus;upper clivus;exactmatch
benign ovarian luteinized thecoma;benign luteinized ovarian thecoma;exactmatch
malignant ovarian luteinized thecoma;malignant luteinized thecal cell neoplasm of ovary;exactmatch
posterior foramen magnum;posterior foramen magnum;exactmatch
aflatoxins toxicity;aflatoxins toxicity;exactmatch
anterior visual pathway;anterior visual pathway;exactmatch
anterior foramen magnum;anterior foramen magnum;exactmatch
compartmentalized pattern;compartmentalized pattern;exactmatch
anastomosing cells connected to the basal layer of the epidermis present;anastomosing cells connected to the basal layer of the epidermis present;exactmatch
malignant apocrine cell;malignant apocrine cell;exactmatch
balloon melanoma cell;balloon melanoma cell;exactmatch
orbit hemangioma;angioma of orbit;exactmatch
flexural skin;flexural skin;exactmatch
orbit lymphoma;lymphoma of orbit;exactmatch
minor salivary gland acinic cell carcinoma;acinic cell adenocarcinoma of minor salivary gland;exactmatch
oral cavity pleomorphic adenoma;benign mixed salivary tumor of oral cavity;exactmatch
oropharyngeal adenoid cystic carcinoma;adenoid cystic carcinoma of oropharynx;exactmatch
ionizing radiation toxicity;ionizing radiation toxicity;exactmatch
signet ring melanoma cell;signet ring melanoma cell;exactmatch
anterior tongue mucoepidermoid carcinoma;anterior tongue mucoepidermoid carcinoma;exactmatch
small melanoma cell;small melanoma cell;exactmatch
large melanoma cell;large melanoma cell;exactmatch
maxillary sinus adenocarcinoma;adenocarcinoma of maxillary sinus;exactmatch
maxillary sinus adenoid cystic carcinoma;adenoid cystic carcinoma of maxillary sinus;exactmatch
ethmoid sinus adenoid cystic carcinoma;adenoid cystic carcinoma of ethmoid sinus;exactmatch
ethmoid sinus adenocarcinoma;adenocarcinoma of ethmoid sinus;exactmatch
actinic damage;actinic damage;exactmatch
lesion with diameter of 4 mm or more;lesion with diameter of 4 mm or more;exactmatch
melanocytes near the tips and sides of elongated rete ridges present;melanocytes near the tips and sides of elongated rete ridges present;exactmatch
orbit embryonal rhabdomyosarcoma;embryonal rhabdomyosarcoma of orbit;exactmatch
area of depigmentation at the periphery of the dermal melanocytic infiltrate present;area of depigmentation at the periphery of the dermal melanocytic infiltrate present;exactmatch
malignant eccrine cell;malignant eccrine cell;exactmatch
eccrine adenocarcinoma cell;eccrine adenocarcinoma cell;exactmatch
neoplastic eccrine cell;neoplastic eccrine cell;exactmatch
neoplastic apocrine cell;neoplastic apocrine cell;exactmatch
apocrine differentiation;apocrine differentiation;exactmatch
pilar sheath;pilar sheath;exactmatch
outer root sheath;outer root sheath;exactmatch
anterior tongue carcinoma;anterior tongue carcinoma;exactmatch
germinative follicular epithelium;germinative follicular epithelium;exactmatch
chest wall;chest wall;exactmatch
tracheal lymphoma;lymphoma of trachea;exactmatch
orbit alveolar rhabdomyosarcoma;alveolar rhabdomyosarcoma of orbit;exactmatch
nests of nevus cells resembling nerve bundles present;nests of nevus cells resembling nerve bundles present;exactmatch
wedge-shaped growth pattern;wedge-shaped growth pattern;exactmatch
epidermal involvement;epidermal involvement;exactmatch
stage ia fallopian tube cancer ajcc v6 and v7;ajcc stage ia fallopian tube cancer;exactmatch
stage ic fallopian tube cancer ajcc v6 and v7;ajcc stage ic fallopian tube cancer;exactmatch
testicular mixed embryonal carcinoma and seminoma;mixed embryonal carcinoma and seminoma of testis;exactmatch
stage iib cervical cancer ajcc v6 and v7;ajcc stage iib cervical cancer;exactmatch
stage ia vulvar carcinoma ajcc v6;stage ia carcinoma of vulva ajcc v6;exactmatch
vaginal leiomyosarcoma;leiomyosarcoma of vagina;exactmatch
vaginal verrucous carcinoma;vagina verrucous carcinoma;exactmatch
stage ivb cervical cancer ajcc v6 and v7;ajcc stage ivb cervical cancer;exactmatch
stage iva cervical cancer ajcc v6 and v7;ajcc stage iva cervical cancer;exactmatch
stage iiia cervical cancer ajcc v6 and v7;ajcc stage iiia cervical cancer;exactmatch
stage iiib cervical cancer ajcc v6 and v7;ajcc stage iiib cervical cancer;exactmatch
stage iia cervical cancer ajcc v6;ajcc stage iia cervical cancer v6;exactmatch
stage iva vulvar cancer ajcc v6;stage iva carcinoma of vulva ajcc v6;exactmatch
stage ib2 cervical cancer ajcc v6 and v7;ajcc stage ib2 cervical cancer;exactmatch
stage ib1 cervical cancer ajcc v6 and v7;ajcc stage ib1 cervical cancer;exactmatch
stage ib cervical cancer ajcc v6 and v7;ajcc stage ib cervical cancer;exactmatch
stage ia2 cervical cancer ajcc v6 and v7;ajcc stage ia2 cervical cancer;exactmatch
stage ia1 cervical cancer ajcc v6 and v7;ajcc stage ia1cervical cancer;exactmatch
stage ia cervical cancer ajcc v6 and v7;ajcc stage ia cervical cancer;exactmatch
malignant uterine corpus mixed epithelial and mesenchymal neoplasm;malignant body of uterus mixed neoplasm;exactmatch
stage ib vulvar carcinoma ajcc v6;stage ib carcinoma of vulva ajcc v6;exactmatch
metastatic malignant neoplasm in the vulva;metastasis to the vulva;exactmatch
stage iia fallopian tube cancer ajcc v6 and v7;ajcc stage iia fallopian tube cancer;exactmatch
cervical squamous cell papilloma;cervical squamous cell papilloma;exactmatch
testicular mixed choriocarcinoma and teratoma;mixed choriocarcinoma and teratoma of testis;exactmatch
testicular mixed choriocarcinoma and embryonal carcinoma;mixed choriocarcinoma and embryonal carcinoma of testis;exactmatch
testicular mixed germ cell tumor;mixed germ cell neoplasm of testis;exactmatch
cervical adenoid cystic carcinoma;adenoid cystic carcinoma of cervix;exactmatch
cervical undifferentiated carcinoma;cervical undifferentiated carcinoma;exactmatch
cervical clear cell adenocarcinoma;cervical clear cell adenocarcinoma;exactmatch
cervical endometrioid adenocarcinoma;cervical endometrioid adenocarcinoma;exactmatch
testicular embryonal carcinoma;embryonal carcinoma of testis;exactmatch
metastatic malignant neoplasm in the vagina;metastasis to vagina;exactmatch
uterine corpus leiomyosarcoma;body of uterus leiomyosarcoma;exactmatch
uterine corpus sarcoma;body of uterus sarcoma;exactmatch
uterine corpus adenomyoma;adenomyoma of body of uterus;exactmatch
uterine corpus adenofibroma;adenofibroma of body of uterus;exactmatch
uterine corpus adenosarcoma;adenosarcoma of body of uterus;exactmatch
benign uterine corpus mixed epithelial and mesenchymal neoplasm;benign corpus uteri mixed neoplasm;exactmatch
metastatic carcinoma in the uterine cervix;metastatic carcinoma in the uterine cervix;exactmatch
stage ivb uterine corpus cancer ajcc v7;stage ivb uterine (including endometrial) cancer;exactmatch
melanin;melanin;exactmatch
stage iva uterine corpus cancer ajcc v7;stage iva uterine (including endometrial) cancer;exactmatch
fallopian tube endometrioid adenocarcinoma;endometrioid adenocarcinoma of fallopian tube;exactmatch
childhood cerebellar astrocytoma;cerebellar astrocytoma;exactmatch
adult central nervous system germ cell tumor;adult cns germ cell neoplasm;exactmatch
brain germinoma;brain germinoma;exactmatch
childhood neoplasm;childhood neoplasm;exactmatch
fallopian tube squamous cell carcinoma;fallopian tube squamous cell cancer;exactmatch
fallopian tube undifferentiated carcinoma;fallopian tube undifferentiated carcinoma;exactmatch
fallopian tube clear cell adenocarcinoma;clear cell adenocarcinoma of fallopian tube;exactmatch
fallopian tube gestational choriocarcinoma;fallopian tube gestational choriocarcinoma;exactmatch
stage iiic uterine corpus cancer ajcc v7;stage iiic uterine (including endometrial) cancer;exactmatch
perivascular lymphocytic infiltrate;perivascular lymphocytic infiltrate;exactmatch
cutaneous pseudolymphoma;cutaneous pseudolymphoma;exactmatch
stage iib fallopian tube cancer ajcc v6 and v7;ajcc stage iib fallopian tube cancer;exactmatch
stage iic fallopian tube cancer ajcc v6 and v7;ajcc stage iic fallopian tube cancer;exactmatch
stage iiic fallopian tube cancer ajcc v7;ajcc stage iiic fallopian tube cancer;exactmatch
stage iiib fallopian tube cancer ajcc v7;ajcc stage iiib fallopian tube cancer;exactmatch
stage iiia fallopian tube cancer ajcc v7;ajcc stage iiia fallopian tube cancer;exactmatch
endometrial endometrioid adenocarcinoma;endometrial endometrioid adenocarcinoma;exactmatch
endometrial endometrioid adenocarcinoma, variant with squamous differentiation;adenocanthoma of endometrium;exactmatch
stage ia ovarian germ cell tumor ajcc v6 and v7;figo stage ia malignant germ cell neoplasm of ovary;exactmatch
stage ib ovarian germ cell tumor ajcc v6 and v7;figo stage ib malignant germ cell neoplasm of ovary;exactmatch
stage iiib uterine corpus cancer ajcc v7;stage iiib uterine (including endometrial) cancer;exactmatch
stage iiia uterine corpus cancer ajcc v7;stage iiia uterine (including endometrial) cancer;exactmatch
stage iib uterine corpus cancer ajcc v6;stage iib endometrial cancer ajcc v6;exactmatch
stage iia uterine corpus cancer ajcc v6;stage iia endometrial cancer ajcc v6;exactmatch
stage ic uterine corpus cancer ajcc v6;stage ic endometrial cancer ajcc v6;exactmatch
stage ib uterine corpus cancer ajcc v7;stage ib uterine (including endometrial) cancer;exactmatch
stage ia uterine corpus cancer ajcc v7;stage ia uterine (including endometrial) cancer;exactmatch
uterine corpus neoplasm;corpus uteri neoplasm;exactmatch
stage iiic ovarian germ cell tumor ajcc v6 and v7;figo stage iiic malignant germ cell neoplasm of ovary;exactmatch
stage iiib ovarian germ cell tumor ajcc v6 and v7;figo stage iiib malignant germ cell neoplasm of ovary;exactmatch
stage iiia ovarian germ cell tumor ajcc v6 and v7;figo stage iiia malignant germ cell neoplasm of ovary;exactmatch
stage iia ovarian germ cell tumor ajcc v6 and v7;figo stage iia malignant germ cell neoplasm of ovary;exactmatch
stage iib ovarian germ cell tumor ajcc v6 and v7;figo stage iib malignant germ cell neoplasm of ovary;exactmatch
stage iic ovarian germ cell tumor ajcc v6 and v7;figo stage iic malignant germ cell neoplasm of ovary;exactmatch
stage ic ovarian germ cell tumor ajcc v6 and v7;figo stage ic malignant germ cell neoplasm of ovary;exactmatch
stage iii sinonasal cancer ajcc v6 and v7;stage iii nasal cavity and paranasal sinus cancer;exactmatch
stage iv sinonasal cancer ajcc v6;stage iv nasal cavity and paranasal sinus cancer;exactmatch
recurrent sinonasal carcinoma;recurrent nasal cavity and paranasal sinus cancer;exactmatch
digestive system precancerous condition;digestive system precancerous condition;exactmatch
high grade penile intraepithelial neoplasia;high grade pein;exactmatch
low grade penile intraepithelial neoplasia;grade 1 penile intraepithelial neoplasia;exactmatch
grade ii penile intraepithelial neoplasia;grade 2 penile intraepithelial neoplasia;exactmatch
high grade vaginal intraepithelial neoplasia;high grade vain;exactmatch
high grade glandular intraepithelial neoplasia;high grade glandular intraepithelial neoplasia;exactmatch
low grade glandular intraepithelial neoplasia;glandular intraepithelial neoplasia, grade i;exactmatch
grade ii glandular intraepithelial neoplasia;glandular intraepithelial neoplasia, grade ii;exactmatch
intestinal intraepithelial neoplasia;bowel dysplasia;exactmatch
high grade corneal squamous intraepithelial neoplasia;high grade corneal intraepithelial neoplasia;exactmatch
intestinal precancerous condition;intestinal precancerous condition;exactmatch
liver dysplastic nodule;dn;exactmatch
hepatobiliary precancerous condition;hepato-biliary precancerous condition;exactmatch
intermediate soft tissue neoplasm;intermediate soft tissue neoplasm;exactmatch
metastatic malignant neoplasm in the bladder;metastases to bladder;exactmatch
localized gallbladder carcinoma;gallbladder cancer, localized;exactmatch
adrenal gland ganglioneuroblastoma;adrenal ganglioneuroblastoma;exactmatch
high grade conjunctival squamous intraepithelial neoplasia;high grade conjunctival intraepithelial neoplasia;exactmatch
high grade cervical intraepithelial neoplasia;high grade cervical intraepithelial neoplasia;exactmatch
adamantinoma;adamantinoma, malignant;exactmatch
carcinoma in a polyp;carcinoma in a polyp;exactmatch
resectable hepatocellular carcinoma;hepatocellular carcinoma, resectable;exactmatch
breast ductal carcinoma in situ and lobular carcinoma;breast ductal carcinoma in situ and lobular carcinoma;exactmatch
invasive breast ductal carcinoma and lobular carcinoma in situ;infiltrating ductal and lobular carcinoma in situ;exactmatch
invasive breast ductal carcinoma and lobular carcinoma;infiltrating ductal and lobular carcinoma;exactmatch
adenocarcinoma with cartilaginous metaplasia;adenocarcinoma with cartilaginous metaplasia;exactmatch
adenocarcinoma with osseous metaplasia;adenocarcinoma with osseous metaplasia;exactmatch
adenocarcinoma with cartilaginous and osseous metaplasia;adenocarcinoma with cartilaginous and osseous metaplasia;exactmatch
carcinoma in situ in a polyp;carcinoma in situ in a polyp;exactmatch
cervical glandular intraepithelial neoplasia;cgin;exactmatch
adenocarcinoma in situ in a polyp;adenocarcinoma in situ in a polyp;exactmatch
adenocarcinoma in situ in tubular adenoma;adenocarcinoma in situ in tubular adenoma;exactmatch
adenocarcinoma in situ in adenomatous polyp;adenocarcinoma in situ in adenomatous polyp;exactmatch
adenocarcinoma in tubular adenoma;adenocarcinoma in tubular adenoma;exactmatch
adenocarcinoma in adenomatous polyp;adenocarcinoma in adenomatous polyp;exactmatch
high grade cervical glandular intraepithelial neoplasia;high grade cervical glandular intraepithelial neoplasia;exactmatch
low grade cervical glandular intraepithelial neoplasia;low grade cervical glandular intraepithelial neoplasia;exactmatch
breast intracystic papillary carcinoma;breast intracystic papillary carcinoma;exactmatch
alkylating agent-related myelodysplastic syndrome;alkylating agent related myelodysplastic syndrome;exactmatch
rosette-forming glioneuronal tumor of the fourth ventricle;rosette-forming glioneuronal tumor of the fourth ventricle;exactmatch
malignant thymoma;malignant thymoma;exactmatch
recurrent male reproductive system carcinoma;recurrent male reproductive system cancer;exactmatch
recurrent female reproductive system carcinoma;recurrent female reproductive system cancer;exactmatch
recurrent carcinoma;recurrent cancer;exactmatch
benign reproductive system neoplasm;benign reproductive system neoplasm;exactmatch
childhood diffuse large b-cell lymphoma;childhood dlbcl;exactmatch
adult diffuse large b-cell lymphoma;adult diffuse large b-cell lymphoma;exactmatch
cutaneous lymphoproliferative disorder;cld;exactmatch
cerebral lymphoma;cerebral lymphoma;exactmatch
recurrent urinary system carcinoma;recurrent urinary system carcinoma;exactmatch
cerebral non-hodgkin lymphoma;cerebral non-hodgkin lymphoma;exactmatch
benign oral neoplasm;benign oral neoplasm;exactmatch
benign oral cavity neoplasm;benign mouth neoplasm;exactmatch
oral cavity neoplasm;mouth neoplasm;exactmatch
oral cavity benign granular cell tumor;oral cavity benign granular cell neoplasm;exactmatch
nasal cavity olfactory neuroblastoma;nasal cavity olfactory neuroblastoma;exactmatch
regressing nevus;regressing nevus;exactmatch
recurrent digestive system carcinoma;recurrent digestive system carcinoma;exactmatch
recurrent head and neck carcinoma;recurrent head and neck carcinoma;exactmatch
epipodophyllotoxin-related myelodysplastic syndrome;epipodophyllotoxin related myelodysplastic syndrome;exactmatch
peritoneal mesothelioma;mesothelioma of peritoneum;exactmatch
anterior urethral malignant neoplasm;anterior urethra malignant neoplasm;exactmatch
posterior urethral malignant neoplasm;malignant neoplasm of posterior urethra;exactmatch
regional malignant urethral neoplasm;local malignant neoplasm of urethra;exactmatch
malignant labia majora neoplasm;malignant labia majora neoplasm;exactmatch
malignant labia minora neoplasm;malignant labia minora neoplasm;exactmatch
well differentiated papillary mesothelioma;benign/intermediate mesothelioma;exactmatch
solitary fibrous tumor;hemangiopericytoma;exactmatch
metastatic breast lobular carcinoma;metastatic breast lobular carcinoma;exactmatch
localized carcinoma;localized carcinoma;exactmatch
metastatic breast ductal carcinoma;metastatic breast ductal carcinoma;exactmatch
pericardial mesothelioma;pericardial mesothelioma;exactmatch
pericardial malignant mesothelioma;malignant mesothelioma of pericardium;exactmatch
intermediate lipomatous neoplasm;intermediate lipomatous neoplasm;exactmatch
refractory neoplasm;refractory neoplasm;exactmatch
bilateral malignant neoplasm;bilateral cancer;exactmatch
recurrent pancreatic carcinoma;pancreatic carcinoma, recurrent;exactmatch
resectable malignant liver neoplasm;resectable hepatic malignant neoplasm;exactmatch
precancerous atypia;precancerous atypia;exactmatch
primary peritoneal serous papillary adenocarcinoma;primary peritoneal serous papillary adenocarcinoma;exactmatch
juvenile polyposis syndrome;juvenile multiple polyps syndrome;exactmatch
stage iii colon cancer ajcc v6;ajcc stage iii colon cancer v6;exactmatch
osteosclerotic plasma cell myeloma;osteosclerotic multiple myeloma;exactmatch
atypical lymphoproliferative disorder;atypical lymphoid hyperplasia;exactmatch
cranial cavity;body cavity, cranial;exactmatch
oral mucosa;mucosa, oral;exactmatch
dna repair disorder;dna repair deficiency;exactmatch
peutz-jeghers polyp of the small intestine;peutz-jeghers hamartoma of small bowel;exactmatch
angiokeratoma of fordyce;angiokeratoma of fordyce;exactmatch
stage ii breast cancer ajcc v6 and v7;breast cancer stage ii;exactmatch
skin fibrohistiocytic neoplasm;cutaneous fibrohistiocytic neoplasm;exactmatch
cardiac myxoma;cardiac myxoma;exactmatch
mucous membrane leukoplakia;mucous membrane leukoplakia;exactmatch
mucous membrane hemangioma;mucous membrane hemangioma;exactmatch
mouth mucous membrane leukoplakia;mouth mucous membrane leukoplakia;exactmatch
laryngeal squamous cell papilloma;laryngeal papilloma;exactmatch
digestive system hemangioma;angioma of digestive system;exactmatch
stage i breast cancer ajcc v6;breast cancer stage i ajcc v6;exactmatch
stage iii breast cancer ajcc v6;breast cancer stage iii ajcc v6;exactmatch
stage iv breast  inflammatory carcinoma;inflammatory carcinoma of breast stage iv;exactmatch
superior sulcus lung carcinoma;superior sulcus carcinoma of lung;exactmatch
stage ii pancreatic cancer ajcc v6 and v7;pancreatic cancer stage ii;exactmatch
stage i pancreatic cancer ajcc v6 and v7;pancreatic cancer stage i;exactmatch
recurrent childhood acute lymphoblastic leukemia;recurrent acute lymphoblastic leukemia (all);exactmatch
recurrent lung non-small cell carcinoma;non small cell lung cancer recurrent;exactmatch
stage iiib breast cancer ajcc v7;breast cancer stage iiib;exactmatch
metastatic osteosarcoma;metastatic osteogenic sarcoma;exactmatch
localized osteosarcoma;localized osteogenic sarcoma;exactmatch
stage iii lung non-small cell cancer ajcc v7;stage iii lung non-small cell cancer ajcc v7;exactmatch
stage iiia breast cancer ajcc v7;breast cancer stage iiia;exactmatch
stage ii lung non-small cell cancer ajcc v7;non -small cell lung cancer stage ii;exactmatch
stage iii anal canal cancer ajcc v6 and v7;stage iii anal canal cancer;exactmatch
stage ii anal canal cancer ajcc v6 and v7;stage ii anal canal cancer;exactmatch
stage iii gastric cancer ajcc v6;carcinoma of stomach stage iii ajcc v6;exactmatch
stage ii gastric cancer ajcc v6;carcinoma of stomach stage ii ajcc v6;exactmatch
stage i gastric cancer ajcc v6;carcinoma of stomach stage i ajcc v6;exactmatch
recurrent breast carcinoma;breast cancer, recurrent;exactmatch
peau d'orange;peau d'orange;exactmatch
brain hemangioma;brain angioma;exactmatch
vaginal sarcoma;sarcoma of vagina;exactmatch
childhood malignant liver neoplasm;childhood cancer of liver;exactmatch
clinical test result;clinical test result;exactmatch
childhood hodgkin lymphoma;childhood hd;exactmatch
neck squamous cell carcinoma of unknown primary;epidermoid carcinoma metastatic to the neck with occult primary;exactmatch
uveal melanoma;intraocular melanoma;exactmatch
adult liver carcinoma;adult liver carcinoma;exactmatch
adult brain neoplasm;adult brain neoplasm;exactmatch
digestive system neuroendocrine tumor g1;carcinoid tumor of digestive system;exactmatch
adult soft tissue sarcoma;adult sarcoma of soft tissue;exactmatch
vaginal squamous cell carcinoma, not otherwise specified;epidermoid carcinoma of vagina;exactmatch
childhood non-hodgkin lymphoma;childhood nhl;exactmatch
childhood rhabdomyosarcoma;childhood rhabdomyosarcoma;exactmatch
adult non-hodgkin lymphoma;adult nhl;exactmatch
childhood brain neoplasm;brain neoplasm;exactmatch
adult hodgkin lymphoma;adult hd;exactmatch
ovarian adenocarcinoma;adenocarcinoma of ovary;exactmatch
gastric adenoma;adenoma of stomach;exactmatch
childhood soft tissue sarcoma;childhood sarcoma of soft tissue;exactmatch
renal pelvis and ureter urothelial carcinoma;renal pelvis and ureter tcc;exactmatch
appendix adenocarcinoma;adenocarcinoma of appendix;exactmatch
bartholin gland adenocarcinoma;adenocarcinoma of bartholin's gland;exactmatch
vaginal clear cell adenocarcinoma;clear cell adenocarcinoma of vagina;exactmatch
tongue lipoma;lipoma of tongue;exactmatch
testicular choriocarcinoma;choriocarcinoma of testis;exactmatch
renal pelvis squamous cell carcinoma;epidermoid carcinoma of kidney pelvis;exactmatch
prostate sarcoma;prostate sarcoma;exactmatch
penile sarcoma;penile sarcoma;exactmatch
squamous cell carcinoma of the penis;epidermoid carcinoma of penis;exactmatch
scrotal paget disease;paget disease of the scrotum;exactmatch
light chain deposition disease;bence jones myeloma;exactmatch
kidney fibrosarcoma;fibrosarcoma of kidney;exactmatch
small intestinal leiomyoma;leiomyoma of small bowel;exactmatch
small intestinal carcinoma;cancer of small bowel;exactmatch
cardiac sarcoma;cardiac sarcoma;exactmatch
gingival carcinoma;carcinoma of gingiva;exactmatch
gallbladder adenoma;adenoma of gallbladder;exactmatch
halo nevus;halo nevus;exactmatch
thyroid gland mucosa-associated lymphoid tissue lymphoma;thyroid gland mucosa-associated lymphoid tissue lymphoma;exactmatch
acute myeloid leukemia with myelodysplasia-related changes;aml with myelodysplasia-related changes;exactmatch
malignant esophageal neoplasm;malignant esophageal neoplasm;exactmatch
malignant lip neoplasm;malignant lip neoplasm;exactmatch
malignant laryngeal neoplasm;malignant laryngeal neoplasm;exactmatch
malignant extrahepatic bile duct neoplasm;malignant extrahepatic bile duct neoplasm;exactmatch
metastatic malignant neoplasm in the gallbladder;metastatic malignant neoplasm in the gallbladder;exactmatch
gallbladder malignant neoplasm;gallbladder malignant neoplasm;exactmatch
malignant fallopian tube neoplasm;fallopian tube malignant neoplasm;exactmatch
metastatic malignant neoplasm in the esophagus;esophageal metastasis;exactmatch
anal canal paget disease;anal canal paget disease;exactmatch
malignant paranasal sinus neoplasm;malignant accessory sinus neoplasm;exactmatch
anal margin paget disease;anal margin paget disease;exactmatch
anal adenocarcinoma within anorectal fistula;adenocarcinoma of anus within anorectal fistula;exactmatch
anal extramucosal (perianal) adenocarcinoma;anal extramucosal (perianal) adenocarcinoma;exactmatch
anal margin basal cell carcinoma;anal margin basal cell carcinoma;exactmatch
anal margin carcinoma;anal margin cancer;exactmatch
anal canal adenocarcinoma;adenocarcinoma arising in anal mucosa;exactmatch
anal verrucous carcinoma;anal buschke-lowenstein tumor;exactmatch
paranasal sinus polyp;accessory sinus polyp;exactmatch
paranasal sinus neoplasm;accessory sinus neoplasm;exactmatch
malignant thyroid gland neoplasm;malignant neoplasm of thyroid;exactmatch
primary intraosseous squamous cell carcinoma derived from odontogenic cyst;primary intraosseous carcinoma ex odontogenic cyst;exactmatch
recurrent urethral carcinoma;recurrent cancer of urethra;exactmatch
malignant urethral neoplasm;malignant neoplasm of urethra;exactmatch
myelodysplastic syndrome with excess blasts;mds-eb;exactmatch
adult cystic nephroma;adult cystic nephroma;exactmatch
borderline phyllodes tumor;borderline phyllodes neoplasm;exactmatch
malignant vulvar neoplasm;malignant neoplasm of vulva;exactmatch
odontogenic myxoma;odontogenic myxoma;exactmatch
non-keratinizing primary intraosseous squamous cell carcinoma -solid type;non-keratinizing primary intraosseous squamous cell carcinoma -solid type;exactmatch
anal canal carcinoma;anal canal cancer;exactmatch
keratinizing primary intraosseous squamous cell carcinoma -solid type;keratinizing primary intraosseous squamous cell carcinoma -solid type;exactmatch
ameloblastic carcinoma derived from odontogenic cyst;ameloblastic carcinoma derived from odontogenic cyst;exactmatch
ameloblastic carcinoma-secondary type (dedifferentiated);ameloblastic carcinoma ex ameloblastoma;exactmatch
ameloblastic carcinoma-primary type;ameloblastic carcinoma-primary type;exactmatch
ameloblastic carcinoma;ac;exactmatch
primary intraosseous squamous cell carcinoma-solid type;primary intraosseous squamous cell carcinoma arising de novo;exactmatch
anal canal intraepithelial neoplasia;acin;exactmatch
pigment;pigment;exactmatch
anal canal squamous cell carcinoma;anal canal squamous cell carcinoma;exactmatch
struma ovarii;struma ovarii;exactmatch
aids-related cervical kaposi sarcoma;aids-related cervical kaposi sarcoma;exactmatch
benign myoepithelioma;benign myoepithelioma;exactmatch
papilloma;papilloma, benign;exactmatch
breast papillary ductal carcinoma in situ with invasion;breast intraductal papillary adenocarcinoma with invasion;exactmatch
infiltrating papillary adenocarcinoma;infiltrating papillary adenocarcinoma;exactmatch
bronchial intraepithelial neoplasia;bronchial intraepithelial neoplasia;exactmatch
pulmonary precancerous condition;pulmonary precancerous condition;exactmatch
aids-related non-hodgkin lymphoma of the cervix;aids-related non-hodgkin lymphoma of the cervix;exactmatch
aids-related cervical carcinoma;aids related carcinoma of uterine cervix;exactmatch
pure erythroid leukemia;acute erythremic myelosis;exactmatch
malignant ovarian neoplasm;cancer of ovary;exactmatch
malignant exocrine pancreas neoplasm;malignant exocrine pancreas neoplasm;exactmatch
diffuse sclerosing variant thyroid gland papillary carcinoma;diffuse sclerosing variant thyroid gland papillary carcinoma;exactmatch
metastatic malignant neoplasm in the rectum;metastasis to the rectum;exactmatch
oral cavity and lip precancerous condition;opmds;exactmatch
gastric precancerous condition;gastric precancerous condition;exactmatch
esophageal precancerous condition;esophageal precancerous condition;exactmatch
brain stem astrocytoma;brain stem astrocytoma;exactmatch
anaplastic brain stem glioma;anaplastic brain stem glioma;exactmatch
granular cell odontogenic fibroma;granular cell odontogenic fibroma;exactmatch
hybrid odontogenic fibroma;hybrid odontogenic fibroma;exactmatch
acute erythroid leukemia in remission;acute erythroid leukemia in remission;exactmatch
aids-related anal non-hodgkin lymphoma;aids-related anal non-hodgkin lymphoma;exactmatch
acute leukemia of ambiguous lineage;acute leukemia of ambiguous lineage;exactmatch
acute myelomonocytic leukemia;amml;exactmatch
corticotroph adenoma;acth producing pituitary gland adenoma;exactmatch
somatotroph adenoma;gh cell adenoma;exactmatch
metastatic malignant neoplasm in the anus;metastatic malignant neoplasm in the anus;exactmatch
capillary hemangioma;capillary angioma;exactmatch
metastatic malignant neoplasm in the ovary;metastases to ovary;exactmatch
lung hilum carcinoma;hilar lung carcinoma;exactmatch
exocervical carcinoma;carcinoma of exocervix;exactmatch
odontogenic myxofibroma;odontogenic myxofibroma;exactmatch
infiltrating lipoma;infiltrating lipoma;exactmatch
intramuscular lipoma;intramuscular lipoma;exactmatch
infiltrating angiolipoma;infiltrating angiolipoma;exactmatch
metastatic malignant neoplasm in the thyroid gland;metastasis to the thyroid;exactmatch
metastatic malignant neoplasm in the breast;breast metastases;exactmatch
bone liposarcoma;bone liposarcoma;exactmatch
atypical adenoma;atypical adenoma;exactmatch
thymic carcinoma;thymic carcinoma;exactmatch
nodular hidradenoma;nodular hidradenoma;exactmatch
clear cell hidradenoma;clear cell hidradenoma;exactmatch
sporadic breast carcinoma;sporadic breast cancer;exactmatch
eccrine hidrocystoma;eccrine cystadenoma;exactmatch
hidradenoma;acrospiroma;exactmatch
sweat gland adenoma;adenoma, sweat gland, benign;exactmatch
endometrial carcinoma;carcinoma, endometrial, malignant;exactmatch
benign skin melanocytic nevus;benign melanocytic nevus;exactmatch
stage a prostate cancer;stage a prostate cancer;exactmatch
stage i prostate cancer ajcc v6;cancer of prostate stage i ajcc v6;exactmatch
stage b prostate cancer;stage b prostate cancer;exactmatch
stage ii prostate cancer ajcc v6;cancer of prostate stage ii ajcc v6;exactmatch
stage c prostate cancer;stage c prostate cancer;exactmatch
stage iii prostate cancer ajcc v6;cancer of prostate stage iii ajcc v6;exactmatch
ovarian serous adenocarcinoma;ovarian serous adenocarcinoma;exactmatch
melanocytic nevus;melanocytic nevus;exactmatch
kidney medullary carcinoma;kidney medullary carcinoma;exactmatch
trichorhinophalangeal syndrome type ii;langer-giedion syndrome;exactmatch
dysplastic nevus syndrome;atypical mole syndrome;exactmatch
stage iv vaginal cancer ajcc v6 and v7;figo stage iv vaginal carcinoma;exactmatch
malignant myoepithelioma;myoepithelioma, malignant;exactmatch
combined lung carcinoma;combined carcinoma of lung;exactmatch
nsd1 gene;nsd1;exactmatch
adult lymphoma;adult lymphoma;exactmatch
malignant basal cell neoplasm;malignant basal cell neoplasm;exactmatch
skin adamantinoid basal cell carcinoma;adamantinoid basal cell carcinoma;exactmatch
nevus of ota;nevus of ota;exactmatch
metastatic malignant neoplasm in the urethra;metastasis to the urethra;exactmatch
microcystic adnexal carcinoma;eccrine epithelioma;exactmatch
skin appendage adenoma;adenoma, adnexal, benign;exactmatch
nevus of female genitalia;nevus of female genitalia;exactmatch
recurrent nevus;persistent nevus;exactmatch
deep penetrating nevus;deep penetrating nevus;exactmatch
breast phyllodes tumor;breast cystosarcoma phyllodes;exactmatch
prostate phyllodes tumor;cystosarcoma phyllodes of prostate;exactmatch
metastatic malignant neoplasm in the kidney;metastases to kidney;exactmatch
malignant kidney neoplasm;malignant kidney neoplasm;exactmatch
foxl2 gene;foxl2;exactmatch
stage ii renal pelvis and ureter cancer ajcc v7;stage ii renal pelvis and ureter cancer;exactmatch
malignant superior sulcus neoplasm;malignant superior sulcus lung neoplasm;exactmatch
papillary intralymphatic angioendothelioma;dabska tumor;exactmatch
malignant renal pelvis neoplasm;malignant neoplasm of renal pelvis;exactmatch
metastatic malignant neoplasm in the small intestine;metastases to small intestine;exactmatch
malignant small intestinal neoplasm;malignant neoplasm of small bowel;exactmatch
stage iv renal pelvis and ureter cancer ajcc v7;stage iv renal pelvis and ureter cancer;exactmatch
stage iii renal pelvis and ureter cancer ajcc v7;stage iii renal pelvis and ureter cancer;exactmatch
stage i renal pelvis and ureter cancer ajcc v7;stage i renal pelvis and ureter cancer;exactmatch
col1a1 associated connective tissue disorder;col1a1 associated connective tissue disorder;exactmatch
stage 0is renal pelvis and ureter cancer ajcc v7;stage 0is renal pelvis and ureter cancer;exactmatch
stage 0a renal pelvis and ureter cancer ajcc v7;stage 0a renal pelvis and ureter cancer;exactmatch
renal pelvis and ureter carcinoma;carcinoma of the upper urinary tract;exactmatch
kidney and ureter neoplasm;kidney and ureter neoplasm;exactmatch
malignant esophageal neoplasm by topographic region;malignant esophageal neoplasm by topographic region;exactmatch
tuberous sclerosis 1;tuberous sclerosis 1;exactmatch
malignant esophageal neoplasm by anatomic region;malignant esophageal neoplasm by anatomic region;exactmatch
angioimmunoblastic t-cell lymphoma;aild;exactmatch
recurrent childhood visual pathway glioma;recurrent childhood optic tract glioma;exactmatch
recurrent childhood visual pathway astrocytoma;recurrent childhood visual pathway astrocytoma;exactmatch
recurrent childhood optic nerve glioma;recurrent childhood optic nerve glioma;exactmatch
malignant penile neoplasm;malignant neoplasm of penis;exactmatch
metastatic malignant neoplasm in the pharynx;metastasis to the pharynx;exactmatch
malignant pharyngeal neoplasm;malignant pharyngeal neoplasm;exactmatch
metastatic malignant neoplasm in the ureter;metastasis to the ureter;exactmatch
malignant ureter neoplasm;malignant neoplasm of ureter;exactmatch
askin tumor;askin tumor;exactmatch
retinoblastoma;rb;exactmatch
small lymphocytic lymphoma;b-cell small lymphocytic lymphoma;exactmatch
lymphoid leukemia;leukemia, lymphocytic, malignant;exactmatch
anterior visual pathway meningioma;anterior visual pathway meningioma;exactmatch
childhood visual pathway glioma;childhood visual pathway glioma;exactmatch
childhood visual pathway astrocytoma;childhood visual pathway astrocytoma;exactmatch
tuberous sclerosis 2;tuberous sclerosis 2;exactmatch
visual pathway astrocytoma;visual pathway astrocytoma;exactmatch
recurrent childhood optic nerve astrocytoma;recurrent childhood optic nerve astrocytoma;exactmatch
stage iii pancreatic cancer ajcc v6 and v7;pancreatic cancer stage iii;exactmatch
stage 0 gastric cancer ajcc v6 and v7;carcinoma in situ of stomach;exactmatch
recurrent adult hodgkin lymphoma;recurrent adult hodgkin lymphoma;exactmatch
ovarian serous cystadenocarcinoma;ovarian serous cystadenocarcinoma;exactmatch
abnormal virilization;abnormal virilization;exactmatch
epithelioid mesothelioma;epithelial mesothelioma;exactmatch
borderline ovarian endometrioid tumor/atypical proliferative ovarian endometrioid tumor;borderline endometrioid neoplasm of ovary;exactmatch
cervical small cell neuroendocrine carcinoma;cervical small cell cancer;exactmatch
vaginal adenocarcinoma;adenocarcinoma of vagina;exactmatch
ovarian clear cell cystadenocarcinoma;ovarian clear cell cystadenocarcinoma;exactmatch
ovarian endometrioid adenocarcinoma;endometrioid adenocarcinoma of ovary;exactmatch
pancreatic acinar cell carcinoma;acinar cell adenocarcinoma of pancreas;exactmatch
spindle cell type a uveal melanoma;spindle cell type a melanoma of uvea;exactmatch
distal bile duct adenocarcinoma;adenocarcinoma of the distal common bile duct;exactmatch
extrahepatic bile duct adenocarcinoma;adenocarcinoma of extrahepatic bile duct;exactmatch
hominidae;hominid;exactmatch
rectal undifferentiated carcinoma;anaplastic carcinoma of rectum;exactmatch
rectal mucinous adenocarcinoma;colloid adenocarcinoma of rectum;exactmatch
childhood acute megakaryoblastic leukemia;acute megakaryoblastic leukemia;exactmatch
childhood acute basophilic leukemia;acute basophilic leukemia;exactmatch
spindle cell uveal melanoma;spindle cell intraocular melanoma;exactmatch
spindle cell type b uveal melanoma;spindle cell type b melanoma of uvea;exactmatch
testicular mixed embryonal carcinoma and yolk sac tumor;mixed embryonal carcinoma and endodermal sinus neoplasm of testis;exactmatch
granular renal cell carcinoma;granular cell carcinoma of kidney;exactmatch
malignant type a thymoma;malignant type a thymoma;exactmatch
thymic lymphoepithelioma-like carcinoma;lymphoepithelial cancer of thymus;exactmatch
thymoma type b3;atypical thymoma;exactmatch
malignant type b1 thymoma;malignant type b1 thymoma;exactmatch
tubulostromal adenoma;adenoma, tubulostromal, benign;exactmatch
papillary adenoma;adenoma, papillary, benign;exactmatch
benign carotid body paraganglioma;benign carotid body paraganglioma;exactmatch
carcinoma arising from craniopharyngioma;craniopharyngioma, malignant;exactmatch
intermediate cell type uveal melanoma;intermediate cell type intraocular melanoma;exactmatch
dedifferentiated solitary fibrous tumor;dedifferentiated solitary fibrous tumor;exactmatch
parathyroid gland mixed cell type adenoma;mixed cell type adenoma of parathyroid;exactmatch
parathyroid gland clear cell adenoma;clear cell adenoma of parathyroid;exactmatch
nasopharyngeal keratinizing squamous cell carcinoma;keratinizing epidermoid carcinoma of nasopharynx;exactmatch
salivary gland squamous cell carcinoma;epidermoid carcinoma of salivary gland;exactmatch
tmprss2/erg fusion gene;erg/tmprss2 fusion gene;exactmatch
necrotic uveal melanoma;necrotic uveal melanoma;exactmatch
precocious puberty;precocious puberty;exactmatch
childhood acute myelomonocytic leukemia;acute myelomonocytic leukemia;exactmatch
optic nerve disorder;optic nerve disorder;exactmatch
adult alveolar soft part sarcoma;adult alveolar soft part sarcoma;exactmatch
breast ductal carcinoma in situ, high grade;breast comedocarcinoma;exactmatch
reproductive system hemorrhage;genital bleeding;exactmatch
digestive system perforation;digestive system perforation;exactmatch
adult malignant mesenchymoma;adult malignant mesenchymoma;exactmatch
digestive system obstruction;digestive system obstruction;exactmatch
malignant adult hemangiopericytoma;adult malignant hemangiopericytoma;exactmatch
adult epithelioid sarcoma;adult epithelioid sarcoma;exactmatch
adult nodular lymphocyte predominant hodgkin lymphoma;adult nlphd;exactmatch
ophthalmoplegia;ophthalmoplegia;exactmatch
body temperature associated symptom;alteration in body temperature;exactmatch
childhood acute monoblastic and monocytic leukemia;acute monoblastic and monocytic leukemia;exactmatch
stage 0 lip and oral cavity cancer ajcc v6 and v7;lip and oral cavity cancer stage 0;exactmatch
childhood acute lymphoblastic leukemia in remission;acute lymphoblastic leukemia (all) in remission;exactmatch
adult acute lymphoblastic leukemia in remission;acute lymphoblastic leukemia (all) in remission;exactmatch
adult acute myeloid leukemia in remission;acute myeloid leukemia (aml) in remission;exactmatch
recurrent kaposi sarcoma;recurrent kaposi sarcoma;exactmatch
invasive breast lobular carcinoma;classic invasive lobular carcinoma;exactmatch
breast paget disease with invasive ductal carcinoma;breast paget disease with invasive ductal carcinoma;exactmatch
childhood burkitt leukemia;burkitt leukemia;exactmatch
childhood t acute lymphoblastic leukemia;childhood precursor t-lymphoblastic leukemia;exactmatch
childhood acute promyelocytic leukemia with pml-rara;apl with pml-rara;exactmatch
colon signet ring cell adenocarcinoma;colon signet ring cell adenocarcinoma;exactmatch
colon mucinous adenocarcinoma;colloid adenocarcinoma of colon;exactmatch
adult acute megakaryoblastic leukemia;acute megakaryoblastic leukemia;exactmatch
adult acute basophilic leukemia;acute basophilic leukemia;exactmatch
adult acute eosinophilic leukemia;acute eosinophilic leukemia;exactmatch
adult acute myelomonocytic leukemia;acute myelomonocytic leukemia;exactmatch
adult acute myeloid leukemia with maturation;acute myeloid leukemia (aml) with maturation;exactmatch
childhood rhabdomyosarcoma with mixed embryonal and alveolar features;childhood mixed alveolar rhabdomyosarcoma;exactmatch
childhood pleomorphic rhabdomyosarcoma;childhood anaplastic rhabdomyosarcoma;exactmatch
childhood alveolar rhabdomyosarcoma;alveolar childhood rhabdomyosarcoma;exactmatch
childhood embryonal rhabdomyosarcoma;childhood embryonal rhabdomyosarcoma;exactmatch
adult hepatocellular carcinoma;adult hepatocellular carcinoma;exactmatch
childhood hepatocellular carcinoma;childhood carcinoma of liver cell;exactmatch
adult burkitt leukemia;adult burkitt leukemia;exactmatch
testicular yolk sac tumor;endodermal sinus neoplasm of testis;exactmatch
testicular mixed yolk sac tumor and teratoma;mixed endodermal sinus neoplasm and teratoma of testis;exactmatch
grade iii lymphomatoid granulomatosis;angiocentric immunoproliferative lesion grade iii;exactmatch
hypodiploidy;hypodiploid;exactmatch
hyperdiploid b acute lymphoblastic leukemia;hyperdiploid all;exactmatch
"b acute lymphoblastic leukemia with t(12;21)(p13.2;q22.1); etv6-runx1";"b acute lymphoblastic leukemia with t(12;21)(p13.2;q22.1); etv6-runx1";exactmatch
"b acute lymphoblastic leukemia with t(v;11q23.3); mll rearranged";"b acute lymphoblastic leukemia with t(v;11q23.3); kmt2a rearranged";exactmatch
"b lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); e2a-pbx1 (tcf3-pbx1)";"b lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); e2a-pbx1 (tcf3-pbx1)";exactmatch
"b lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3); il3-igh";"b lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3); il3-igh";exactmatch
stage ii lip and oral cavity cancer ajcc v6 and v7;lip and oral cavity cancer stage ii;exactmatch
b lymphoblastic leukemia/lymphoma with hypodiploidy;b lymphoblastic leukemia/lymphoma with hypodiploidy;exactmatch
hyperdiploidy;hyperdiploid;exactmatch
"b acute lymphoblastic leukemia with t(5;14)(q31.1;q32.3); il3-igh";"b acute lymphoblastic leukemia with t(5;14)(q31.1;q32.3); il3-igh";exactmatch
b lymphoblastic leukemia/lymphoma with hyperdiploidy;b lymphoblastic leukemia/lymphoma with hyperdiploidy;exactmatch
"b lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); etv6-runx1";"b lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); etv6-runx1";exactmatch
"b lymphoblastic leukemia/lymphoma with t(v;11q23.3); mll rearranged";"b lymphoblastic leukemia/lymphoma with t(v;11q23.3); kmt2a rearranged";exactmatch
"b lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2); bcr-abl1";"b lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2); bcr-abl1";exactmatch
stage i lip and oral cavity cancer ajcc v6 and v7;lip and oral cavity cancer stage i;exactmatch
recurrent genetic abnormalities present;recurrent genetic abnormalities present;exactmatch
b lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities;b lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities;exactmatch
hypodiploid b acute lymphoblastic leukemia;hypodiploid all;exactmatch
"b acute lymphoblastic leukemia with t(1;19)(q23;p13.3); e2a-pbx1 (tcf3-pbx1)";"b acute lymphoblastic leukemia with t(1;19)(q23;p13.3); e2a-pbx1 (tcf3-pbx1)";exactmatch
testicular mixed yolk sac tumor and teratoma with seminoma;mixed endodermal sinus neoplasm and teratoma with seminoma of testis;exactmatch
recurrent lip and oral cavity carcinoma;recurrent lip and oral cavity cancer;exactmatch
stage i laryngeal cancer ajcc v6 and v7;laryngeal cancer, stage i;exactmatch
stage iii hypopharyngeal carcinoma ajcc v6;stage iii carcinoma of hypopharynx ajcc v6;exactmatch
stage ii hypopharyngeal carcinoma ajcc v6 and v7;stage ii carcinoma of hypopharynx;exactmatch
stage i hypopharyngeal carcinoma ajcc v6;stage i carcinoma of hypopharynx ajcc v6;exactmatch
follicular t-cell lymphoma;ftcl;exactmatch
systemic ebv-positive t-cell lymphoma of childhood;systemic ebv-positive t-cell lymphoma of childhood;exactmatch
ebv-positive t-cell lymphoproliferative disorder of childhood;ebv-positive t-cell lymphoproliferative disease of childhood;exactmatch
stage iv lip and oral cavity cancer ajcc v6 and v7;lip and oral cavity cancer stage iv;exactmatch
choristoma;choristoma;exactmatch
neoplastic nodule;neoplastic nodule;exactmatch
tubulostromal adenocarcinoma;carcinoma, tubulostromal, malignant;exactmatch
malignant ito cell tumor;ito cell tumor, malignant;exactmatch
benign ito cell tumor;benign ito cell tumor;exactmatch
ito cell tumor;ito cell tumor;exactmatch
stage iii lip and oral cavity cancer ajcc v6 and v7;lip and oral cavity cancer stage iii;exactmatch
cystic keratinizing epithelioma;cystic keratinizing epithelioma;exactmatch
b lymphoblastic leukemia/lymphoma, not otherwise specified;b lymphoblastic leukemia/lymphoma, nos;exactmatch
monoclonal b-cell lymphocytosis;mbl;exactmatch
splenic diffuse red pulp small b-cell lymphoma;splenic diffuse red pulp small b-cell lymphoma;exactmatch
binet stage c;binet stage c;exactmatch
salivary gland poorly differentiated squamous cell carcinoma;poorly differentiated salivary gland squamous cell cancer;exactmatch
salivary gland adenocarcinoma;adenocarcinoma of salivary gland;exactmatch
high grade salivary gland mucoepidermoid carcinoma;grade iii mucoepidermoid carcinoma of salivary gland;exactmatch
high grade salivary gland carcinoma;high grade salivary gland cancer;exactmatch
intermediate grade salivary gland mucoepidermoid carcinoma;grade ii mucoepidermoid carcinoma of salivary gland;exactmatch
low grade salivary gland mucoepidermoid carcinoma;grade i mucoepidermoid carcinoma of salivary gland;exactmatch
lip basal cell carcinoma;basal cell carcinoma of lip;exactmatch
binet stage b;binet stage b;exactmatch
splenic b-cell lymphoma/leukemia, unclassifiable;splenic b-cell lymphoma/leukemia, unclassifiable;exactmatch
binet stage a;binet stage a;exactmatch
salivary gland acinic cell carcinoma;acinic cell carcinoma of salivary gland;exactmatch
merkel cell polyomavirus infection;mcpyv infection;exactmatch
low grade salivary gland carcinoma;low grade salivary gland cancer;exactmatch
thyrotroph adenoma;tsh producing adenoma of pituitary;exactmatch
chronic kidney disease;ckd - chronic kidney disease;exactmatch
pancreatic somatostatin-producing neuroendocrine tumor;pancreatic somatostatin producing net;exactmatch
nasopharyngeal undifferentiated carcinoma;lymphoepithelioma of nasopharynx;exactmatch
salivary gland undifferentiated carcinoma;anaplastic carcinoma of salivary gland;exactmatch
malignant mixed tumor of the salivary gland;malignant mixed cell type neoplasm of salivary gland;exactmatch
salivary gland adenoid cystic carcinoma;adenoid cystic carcinoma of salivary gland;exactmatch
waldenstrom macroglobulinemia;waldenstrom macroglobulinemia;exactmatch
poems syndrome;poems syndrome;exactmatch
refractory hairy cell leukemia;hairy cell leukemia, refractory;exactmatch
pediatric nodal marginal zone lymphoma;childhood nodal marginal zone lymphoma;exactmatch
intestinal follicular lymphoma;intestinal follicular lymphoma;exactmatch
pediatric-type follicular lymphoma;childhood follicular lymphoma;exactmatch
high grade b-cell lymphoma, not otherwise specified;b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and burkitt lymphoma;exactmatch
plasmablastic lymphoma of the oral mucosa;plasmablastic lymphoma of the oral cavity;exactmatch
progressive hairy cell leukemia initial treatment;progressive hairy cell leukemia initial treatment;exactmatch
diffuse large b-cell lymphoma associated with chronic inflammation;dlbcl-ci;exactmatch
ebv-transformed mature b-lymphocyte;ebv-transformed mature b-lymphocyte;exactmatch
ebv-positive diffuse large b-cell lymphoma, not otherwise specified;age-related ebv positive b-cell lymphoproliferative disorder;exactmatch
diffuse large b-cell lymphoma, not otherwise specified;diffuse large b-cell lymphoma, not otherwise specified;exactmatch
endometrial clear cell adenocarcinoma;clear cell carcinoma of endometrium;exactmatch
braf v600e mutation present;braf v600e mutation present;exactmatch
recurrent lymphomatoid granulomatosis;recurrent angiocentric immunoproliferative lesion;exactmatch
grade ii lymphomatoid granulomatosis;angiocentric immunoproliferative lesion grade ii;exactmatch
stage i rectal cancer ajcc v6 and v7;ajcc stage i rectal cancer;exactmatch
recurrent ovarian carcinoma;recurrent carcinoma of ovary;exactmatch
intra-abdominal hemorrhage;intra-abdominal hemorrhage;exactmatch
recurrent neuroblastoma;recurrent neuroblastoma;exactmatch
regional neuroblastoma;regional neuroblastoma;exactmatch
localized resectable neuroblastoma;localized resectable neuroblastoma;exactmatch
recurrent childhood brain neoplasm;recurrent brain neoplasm;exactmatch
hepatic infection;hepatic infection;exactmatch
hemoglobin increased;hemoglobin increased;exactmatch
stage iv ovarian cancer ajcc v6 and v7;ajcc stage iv ovarian cancer;exactmatch
recurrent childhood malignant liver neoplasm;recurrent childhood cancer of liver;exactmatch
digestive system fistula;digestive system fistula;exactmatch
gastric infection;gastric infection;exactmatch
stage iii ovarian cancer ajcc v6 and v7;ajcc stage iii ovarian cancer;exactmatch
gait disturbance;gait disturbance;exactmatch
stage ii ovarian cancer ajcc v6 and v7;ajcc stage ii ovarian cancer;exactmatch
stage i ovarian cancer ajcc v6 and v7;ajcc stage i ovarian cancer;exactmatch
recurrent parathyroid gland carcinoma;recurrent parathyroid cancer;exactmatch
stage iv childhood hepatocellular carcinoma ajcc v7;stage iv childhood hepatocellular carcinoma;exactmatch
trochlear nerve disorder;ivth cranial nerve disorder;exactmatch
stage 0 vaginal cancer ajcc v6;ajcc stage 0 vaginal cancer v6;exactmatch
stage 0 chronic lymphocytic leukemia;cll stage 0;exactmatch
limited stage lung small cell carcinoma;limited stage lung small cell carcinoma;exactmatch
ds stage iii plasma cell myeloma;ds stage iii multiple myeloma;exactmatch
pain in extremity;pain in extremity;exactmatch
ds stage ii plasma cell myeloma;ds stage ii multiple myeloma;exactmatch
ds stage i plasma cell myeloma;ds stage i multiple myeloma;exactmatch
recurrent retinoblastoma;recurrent retinoblastoma;exactmatch
extraocular retinoblastoma;extraocular retinoblastoma;exactmatch
intraocular retinoblastoma;intraocular retinoblastoma;exactmatch
stage i kidney wilms tumor;stage i kidney nephroblastoma;exactmatch
recurrent kidney wilms tumor;recurrent kidney adenosarcoma;exactmatch
stage v kidney wilms tumor;stage v kidney nephroblastoma;exactmatch
lower gastrointestinal hemorrhage;intestinal hemorrhage;exactmatch
decreased libido;decreased libido;exactmatch
stage iv kidney wilms tumor;stage iv kidney nephroblastoma;exactmatch
stage iii kidney wilms tumor;stage iii kidney nephroblastoma;exactmatch
stage ii kidney wilms tumor;stage ii kidney nephroblastoma;exactmatch
agent affecting blood or body fluid;agent affecting blood or body fluid;exactmatch
metastatic malignant parathyroid gland neoplasm;metastatic malignant parathyroid gland neoplasm;exactmatch
localized parathyroid gland carcinoma;localized parathyroid cancer;exactmatch
stage iii cutaneous t-cell non-hodgkin lymphoma;cutaneous t-cell lymphoma stage iii;exactmatch
localized ewing sarcoma;ewing's sarcoma, localized;exactmatch
recurrent primary cutaneous t-cell non-hodgkin lymphoma;recurrent cutaneous t-cell non-hodgkin lymphoma;exactmatch
recurrent cervical carcinoma;cervical carcinoma recurrent;exactmatch
stage ii cervical cancer ajcc v6;ajcc stage ii cervical cancer v6;exactmatch
stage iv mycosis fungoides ajcc v7;mycosis fungoides stage iv;exactmatch
stage iv cutaneous t-cell non-hodgkin lymphoma;cutaneous t-cell lymphoma stage iv;exactmatch
stage iii mycosis fungoides ajcc v7;mycosis fungoides stage iii;exactmatch
stage ii mycosis fungoides ajcc v7;mycosis fungoides stage ii;exactmatch
non-infectious cystitis;cystitis noninfective;exactmatch
stage ii cutaneous t-cell non-hodgkin lymphoma;cutaneous t-cell lymphoma stage ii;exactmatch
stage i mycosis fungoides ajcc v7;mycosis fungoides stage i;exactmatch
stage i cutaneous t-cell non-hodgkin lymphoma;cutaneous t-cell lymphoma stage i;exactmatch
stage 0 anal canal cancer ajcc v6 and v7;anal canal carcinoma in situ;exactmatch
recurrent anal canal carcinoma;recurrent anal canal cancer;exactmatch
stage iii rectal cancer ajcc v6;ajcc stage iii rectal cancer v6;exactmatch
stage ii rectal cancer ajcc v6;ajcc stage ii rectal cancer v6;exactmatch
metastatic ewing sarcoma;ewing's sarcoma, metastatic;exactmatch
recurrent ewing sarcoma;ewing's sarcoma, recurrent;exactmatch
adult fibrosarcoma;adult fibrosarcoma;exactmatch
adult leiomyosarcoma;adult leiomyosarcoma;exactmatch
recurrent renal cell carcinoma;recurrent renal cell cancer;exactmatch
stage ii renal cell cancer ajcc v6;renal cell cancer stage ii ajcc v6;exactmatch
stage i renal cell cancer ajcc v6 and v7;renal cell cancer stage i;exactmatch
recurrent adult soft tissue sarcoma;recurrent adult sarcoma of soft tissue;exactmatch
stage iv adult soft tissue sarcoma ajcc v7;stage iv adult sarcoma of soft tissue;exactmatch
stage iii adult soft tissue sarcoma ajcc v7;stage iii adult sarcoma of soft tissue;exactmatch
stage ii adult soft tissue sarcoma ajcc v7;stage ii adult sarcoma of soft tissue;exactmatch
stage i adult soft tissue sarcoma ajcc v7;stage i adult sarcoma of soft tissue;exactmatch
adult synovial sarcoma;adult synovial sarcoma;exactmatch
childhood craniopharyngioma;benign childhood neoplasm of rathke's pouch;exactmatch
recurrent childhood rhabdomyosarcoma;recurrent childhood rhabdomyosarcoma;exactmatch
adult malignant peripheral nerve sheath tumor;adult mpnst;exactmatch
refractory plasma cell neoplasm;refractory plasma cell neoplasm;exactmatch
solitary plasmacytoma of bone;isolated osseous plasmacytoma;exactmatch
adult liposarcoma;adult liposarcoma;exactmatch
stage i vulvar cancer ajcc v6;ajcc stage i vulvar cancer ajcc v6;exactmatch
stage i vaginal cancer ajcc v6 and v7;ajcc stage i vaginal cancer;exactmatch
grade i lymphomatoid granulomatosis;angiocentric immunoproliferative lesion grade i;exactmatch
recurrent prostate carcinoma;recurrent cancer of prostate;exactmatch
rearrangement of 3q;rearrangement of 3q;exactmatch
recurrent thyroid gland carcinoma;recurrent cancer of thyroid;exactmatch
thyroid gland undifferentiated small cell carcinoma;anaplastic small cell carcinoma of thyroid;exactmatch
thyroid gland anaplastic carcinoma, osteoclastic variant;thyroid gland anaplastic carcinoma, osteoclastic variant;exactmatch
recurrent malignant thymoma;malignant thymoma, recurrent;exactmatch
invasive malignant thymoma;invasive malignant thymoma;exactmatch
recurrent skin carcinoma;recurrent cancer of skin;exactmatch
stage i testicular cancer ajcc v6 and v7;stage i;exactmatch
rearrangement of 21q;rearrangement of 21q;exactmatch
stage iv bladder cancer ajcc v6;cancer of bladder stage iv ajcc v6;exactmatch
recurrent bladder carcinoma;bladder cancer, recurrent;exactmatch
stage iii bladder cancer ajcc v6 and v7;cancer of bladder stage iii;exactmatch
stage ii bladder cancer ajcc v6 and v7;cancer of bladder stage ii;exactmatch
stage i bladder cancer ajcc v6 and v7;bladder cancer stage i;exactmatch
stage 0 bladder cancer ajcc v6 and v7;bladder cancer stage 0;exactmatch
recurrent small intestinal carcinoma;recurrent cancer of small intestine;exactmatch
rearrangement of 11q;rearrangement of 11q;exactmatch
acth-producing pituitary gland neoplasm;acth producing pituitary gland neoplasm;exactmatch
pleural infection;pleural infection;exactmatch
stage iii cutaneous melanoma ajcc v6;malignant melanoma (of skin), stage iii ajcc v6;exactmatch
lymphomatoid granulomatosis;lyg;exactmatch
childhood germ cell tumor;childhood germ cell neoplasm;exactmatch
liver and intrahepatic bile duct carcinoma;biliary tract cancer;exactmatch
recurrent salivary gland carcinoma;recurrent cancer of salivary gland;exactmatch
adult extraskeletal osteosarcoma;adult extraosseous osteosarcoma;exactmatch
adult extraskeletal myxoid chondrosarcoma;adult extraosseous myxoid chondrosarcoma;exactmatch
stage ii nasopharyngeal carcinoma ajcc v6;nasopharyngeal cancer, stage ii ajcc v6;exactmatch
stage ii cutaneous melanoma ajcc v6 and v7;malignant melanoma (of skin), stage ii;exactmatch
1p/19q codeletion;1p/19q co-deletion;exactmatch
stage i cutaneous melanoma ajcc v6;malignant melanoma (of skin), stage i ajcc v6;exactmatch
tsh-producing pituitary gland neoplasm;tsh producing neoplasm of pituitary;exactmatch
recurrent uveal melanoma;recurrent melanoma of uvea;exactmatch
ocular melanoma with extraocular extension;extraocular extension melanoma;exactmatch
recurrent anterior pituitary gland neoplasm;recurrent anterior pituitary gland neoplasm;exactmatch
growth hormone-producing pituitary gland neoplasm;growth hormone producing neoplasm of pituitary;exactmatch
prolactin-producing pituitary gland neoplasm;prl producing pituitary gland neoplasm;exactmatch
recurrent extrahepatic bile duct carcinoma;recurrent cancer of extrahepatic bile duct;exactmatch
unresectable extrahepatic bile duct carcinoma;non-resectable extrahepatic bile duct carcinoma;exactmatch
localized extrahepatic bile duct carcinoma;localized cancer of extrahepatic bile duct;exactmatch
recurrent digestive system neuroendocrine tumor g1;recurrent digestive carcinoid tumor;exactmatch
recurrent penile carcinoma;recurrent carcinoma of penis;exactmatch
stage iii penile cancer ajcc v6;penile cancer stage iii ajcc v6;exactmatch
stage ii penile cancer ajcc v6;penile cancer stage ii ajcc v6;exactmatch
stage i penile cancer ajcc v6;penile cancer stage i ajcc v6;exactmatch
upper gastrointestinal hemorrhage;upper gastrointestinal hemorrhage;exactmatch
recurrent malignant mesothelioma;mesothelioma malignant recurrent;exactmatch
advanced malignant mesothelioma;advanced malignant mesothelioma;exactmatch
regional digestive system neuroendocrine tumor g1;regional digestive carcinoid tumor;exactmatch
unresectable gallbladder carcinoma;gallbladder cancer unresectable;exactmatch
small intestinal infection;small intestinal infection;exactmatch
small intestinal obstruction;small intestinal obstruction;exactmatch
localized digestive system neuroendocrine tumor g1;localized digestive carcinoid tumor;exactmatch
recurrent vaginal carcinoma;recurrent cancer of vagina;exactmatch
stage iva vaginal cancer ajcc v6 and v7;ajcc stage iva vaginal cancer;exactmatch
stage iii vaginal cancer ajcc v6 and v7;ajcc stage iii vaginal cancer;exactmatch
stage ii vaginal cancer ajcc v6 and v7;ajcc stage ii vaginal cancer;exactmatch
adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma;exactmatch
wheezing;wheeze;exactmatch
adult diffuse large cell lymphoma;adult diffuse histiocytic lymphoma;exactmatch
adult immunoblastic lymphoma;adult immunoblastic large cell lymphoma;exactmatch
duodenal adenocarcinoma;adenocarcinoma of duodenum;exactmatch
small intestinal adenocarcinoma;adenocarcinoma - small intest.;exactmatch
recurrent gestational trophoblastic tumor;recurrent gtt;exactmatch
refractory chronic lymphocytic leukemia;chronic lymphocytic leukemia refractory;exactmatch
refractory chronic myelogenous leukemia, bcr-abl1 positive;refractory cgl;exactmatch
recurrent adult brain neoplasm;recurrent adult brain neoplasm;exactmatch
recurrent adult acute lymphoblastic leukemia;recurrent acute lymphoblastic leukemia (all);exactmatch
recurrent adult acute myeloid leukemia;recurrent acute myeloid leukemia (aml);exactmatch
recurrent osteosarcoma;osteosarcoma, recurrent;exactmatch
recurrent adult liver carcinoma;recurrent adult liver cancer;exactmatch
localized unresectable adult liver carcinoma;localized non-resectable adult liver cancer;exactmatch
localized resectable adult liver carcinoma;localized resectable adult liver cancer;exactmatch
stage iii chronic lymphocytic leukemia;cll stage iii;exactmatch
stage ii chronic lymphocytic leukemia;cll stage ii;exactmatch
stage i chronic lymphocytic leukemia;cll stage i;exactmatch
precancerous condition by site;precancerous condition by site;exactmatch
rectosigmoid carcinoma;rectosigmoid cancer;exactmatch
malignant rectosigmoid neoplasm;malignant neoplasm of rectosigmoid junction;exactmatch
"deep ""aggressive"" angiomyxoma";aggressive angiomyxoma;exactmatch
nonanaplastic kidney wilms tumor;nonanaplastic kidney wilms tumor;exactmatch
benign kidney hemangiopericytoma;benign hemangiopericytoma of kidney;exactmatch
postoperative spindle cell nodule of the bladder;postoperative spindle cell nodule of bladder;exactmatch
postoperative spindle cell nodule;postoperative spindle cell nodule;exactmatch
cardiac fibroma;cardiac fibroelastic hamartoma;exactmatch
breast ductal carcinoma in situ and invasive lobular carcinoma;breast ductal carcinoma in situ and invasive lobular carcinoma;exactmatch
sweat gland carcinoma;carcinoma, sweat gland, malignant;exactmatch
spinal cord meningioma;meningioma of spinal cord;exactmatch
adult brain stem astrocytoma;adult brain stem astrocytoma;exactmatch
gangliocytoma;gangliocytoma;exactmatch
middle ear polyp;middle ear polyp;exactmatch
solitary plasmacytoma;solitary plasmacytoma;exactmatch
thoracic spine;t spine;exactmatch
lumbar spine;l spine;exactmatch
cervical spine;c spine;exactmatch
sclerosis;sclerosis;exactmatch
anaplastic kidney wilms tumor;anaplastic kidney wilms tumor;exactmatch
retinal neuroblastoma;neuroblastoma of retina;exactmatch
warty carcinoma of the penis;condylomatous carcinoma of penis;exactmatch
supratentorial embryonal tumor, not otherwise specified;cns/supratentorial pnet;exactmatch
squamous cell carcinoma of the penis, usual type;epidermoid carcinoma of the penis;exactmatch
papillary renal cell carcinoma;chromophil carcinoma of kidney;exactmatch
neoplasm of uncertain histogenesis;neoplasm of uncertain histogenesis;exactmatch
intracranial liposarcoma;intracranial liposarcoma;exactmatch
meningothelial cell neoplasm;meningothelial cell neoplasm;exactmatch
melanotic schwannoma;melanocytic neurilemmoma;exactmatch
plexiform schwannoma;plexiform neurilemmoma;exactmatch
pineal parenchymal tumor of intermediate differentiation;pineal parenchymal tumor of intermediate differentiation;exactmatch
childhood cerebral embryonal tumor with multilayered rosettes, c19mc-altered;childhood cerebral embryonal tumor with multilayered rosettes, c19mc-altered;exactmatch
pineocytoma;benign pinealoma;exactmatch
pineal parenchymal cell neoplasm;neoplasm of pineal gland;exactmatch
neuroblastoma of the adrenal gland and sympathetic nervous system;neuroblastoma of the adrenal gland and sympathetic nervous system;exactmatch
neuroblastic tumor;neuroblastic tumor;exactmatch
oligodendroglial tumor;oligodendroglial neoplasm;exactmatch
anaplastic oligoastrocytoma;anaplastic mixed glioma;exactmatch
astrocytic tumor;astrocytic neoplasm;exactmatch
mixed neoplasm;mixed neoplasm;exactmatch
malignant ovarian thecoma;malignant ovarian thecal cell neoplasm;exactmatch
stromal sarcoma;stromal sarcoma, malignant;exactmatch
breast adenomyoepithelioma;adenomyoepithelioma;exactmatch
metaplastic meningioma;metaplastic meningioma;exactmatch
atypical teratoid/rhabdoid tumor;at/rt;exactmatch
cerebellar liponeurocytoma;cerebellar liponeurocytoma;exactmatch
large cell medulloblastoma;large cell medulloblastoma;exactmatch
tanycytic ependymoma;tanycytic ependymoma;exactmatch
chondroid chordoma;chondroid chordoma;exactmatch
epithelioid trophoblastic tumor;epithelioid trophoblastic tumor;exactmatch
cystic partially differentiated kidney nephroblastoma;cystic partially differentiated kidney nephroblastoma;exactmatch
anal margin squamous cell carcinoma;anal margin squamous cell carcinoma;exactmatch
atypical polypoid adenomyoma;atypical polypoid adenomyoma;exactmatch
malignant solitary fibrous tumor;malignant hemangiopericytoma;exactmatch
cellular fibroma;cellular fibroma;exactmatch
meningeal melanomatosis;leptomeningeal melanomatosis;exactmatch
meningeal melanocytosis;diffuse melanocytosis;exactmatch
malignant type b2 thymoma;malignant type b2 thymoma;exactmatch
thymoma type b2;cortical thymoma;exactmatch
chordoid meningioma;chordoid meningioma;exactmatch
rhabdoid meningioma;rhabdoid meningioma;exactmatch
melanotic psammomatous malignant peripheral nerve sheath tumor;melanocytic psammomatous mpnst;exactmatch
intraneural perineurioma;intraneural perineurioma;exactmatch
acute myeloid leukemia with variant mll translocations;aml with variant mll translocations;exactmatch
acute bilineal leukemia;acute bilineal leukemia;exactmatch
langerhans cell sarcoma;langerhans cell sarcoma;exactmatch
hand-schuller-christian disease;classic multifocal langerhans cell histiocytosis;exactmatch
t lymphoblastic lymphoma;precur. t-lymphoblastic lymphoma;exactmatch
subcutaneous panniculitis-like t-cell lymphoma;sptcl;exactmatch
atypical burkitt/burkitt-like lymphoma;atypical burkitt's/burkitt's-like lymphoma;exactmatch
anaplastic lymphoma;anaplastic large b-cell lymphoma;exactmatch
primary effusion lymphoma;pel;exactmatch
recurrent grade iii lymphomatoid granulomatosis;recurrent grade iii lymphomatoid granulomatosis;exactmatch
childhood classic hodgkin lymphoma;childhood classic hodgkin lymphoma;exactmatch
hodgkin's granuloma;hodgkin granuloma;exactmatch
adult classic hodgkin lymphoma;adult classic hodgkin lymphoma;exactmatch
lymphocyte-rich classic hodgkin lymphoma;classical hodgkin lymphoma, lymphocyte-rich;exactmatch
soft tissue perineurioma;soft tissue perineurioma;exactmatch
basaloid squamous cell carcinoma of the penis;basaloid carcinoma of penis;exactmatch
verrucous carcinoma of the penis;squamous carcinoma of penis, verrucous type;exactmatch
malignant type ab thymoma;malignant type ab thymoma;exactmatch
precursor lymphoid neoplasm;precursor lymphoblastic leukemia/lymphoma;exactmatch
retinal cell neoplasm;retinal cell neoplasm;exactmatch
nucleic acids;nucleic acid substance;exactmatch
mesenchymal cell neoplasm;mesenchymal cell neoplasm;exactmatch
recurrent adult diffuse small cleaved cell lymphoma;recurrent adult diffuse small cleaved cell lymphoma;exactmatch
melanocytic neoplasm;melanocytic neoplasm;exactmatch
disease, disorder or finding;disease, disorder or finding;exactmatch
mature b-cell non-hodgkin lymphoma;mature b-cell lymphoma;exactmatch
childhood lymphocyte-rich classic hodgkin lymphoma;childhood lymphocyte rich classical hodgkin lymphoma;exactmatch
notochordal tumor;notochordal neoplasm;exactmatch
cavernous hemangioma of the face;cavernous hemangioma of face;exactmatch
myofibroma;infantile hemangiopericytoma;exactmatch
meningioma by site;meningioma by site;exactmatch
adult astrocytic tumor;adult astrocytic neoplasm;exactmatch
supratentorial meningioma;supratentorial meningioma;exactmatch
functioning pituitary gland neoplasm;functioning pituitary gland neoplasm;exactmatch
urinary system paraganglioma;urinary system paraganglioma;exactmatch
neoplasm by special category;neoplasm by special category;exactmatch
erythroid neoplasm;erythroid neoplasm;exactmatch
papillary carcinoma of the penis;papillary carcinoma of penis;exactmatch
oncocytic neoplasm;oncocytoma, benign;exactmatch
metastatic malignant neoplasm in the prostate gland;metastases to prostate;exactmatch
nucleic acids, nucleosides, and nucleotides;nucleic acids, nucleosides, and nucleotides;exactmatch
prostate cancer by whitmore-jewett stage;prostate cancer by jewett stage;exactmatch
hemangiopericytic neoplasm;hemangiopericytic neoplasm;exactmatch
fibroblastic neoplasm;fibroblastic neoplasm;exactmatch
serous neoplasm;serous neoplasm;exactmatch
paget disease;paget cell neoplasm;exactmatch
mucinous neoplasm;mucinous neoplasm;exactmatch
t-cell chronic lymphocytic leukemia;cll, t-cell;exactmatch
giant cell neoplasm;giant cell neoplasm;exactmatch
neoplastic polyp;neoplastic polyp;exactmatch
iss stage iii plasma cell myeloma;iii;exactmatch
megakaryocytic neoplasm;megakaryocytic neoplasm;exactmatch
iss stage ii plasma cell myeloma;ii;exactmatch
iss stage i plasma cell myeloma;i;exactmatch
lymphocytic neoplasm;lymphocytic neoplasm;exactmatch
malignant intracranial neoplasm by morphology;malignant intracranial neoplasm by morphology;exactmatch
colon ganglioneuroma;colon ganglioneuroma;exactmatch
colon tubular adenoma;colon tubular adenoma;exactmatch
central nervous system leiomyosarcoma;cns leiomyosarcoma;exactmatch
intracranial myeloid sarcoma;intracranial chloroma;exactmatch
central nervous system hemangioblastoma;cns hemangioblastoma;exactmatch
central nervous system kaposi sarcoma;cns kaposi sarcoma;exactmatch
central nervous system hemangioma;central nervous system hemangioma;exactmatch
central nervous system extraskeletal osteosarcoma;central nervous system extraskeletal osteosarcoma;exactmatch
central nervous system chondroma;cns chondroma;exactmatch
central nervous system rhabdomyoma;central nervous system rhabdomyoma;exactmatch
central nervous system leiomyoma;central nervous system leiomyoma;exactmatch
gastric villous adenoma;gastric villous adenoma;exactmatch
central nervous system hibernoma;central nervous system hibernoma;exactmatch
malignant oculomotor nerve neoplasm;iiird cranial nerve neoplasm, malignant;exactmatch
oculomotor nerve neoplasm;cranial nerve iii tumor;exactmatch
central nervous system embryonal neoplasm;cns embryonal neoplasm;exactmatch
breast ductal carcinoma with squamous metaplasia;breast ductal carcinoma with squamous metaplasia;exactmatch
invasive hydatidiform mole;chorioadenoma;exactmatch
sarcomatoid carcinoma of the penis;sarcomatoid carcinoma of the penis;exactmatch
central nervous system germinoma;central nervous system germinoma;exactmatch
central nervous system embryonal carcinoma;central nervous system embryonal carcinoma;exactmatch
central nervous system yolk sac tumor;cns yolk sac tumor;exactmatch
central nervous system choriocarcinoma;central nervous system choriocarcinoma;exactmatch
gastric tubulovillous adenoma;gastric tubulovillous adenoma;exactmatch
gastric tubular adenoma;gastric tubular adenoma;exactmatch
esophageal basaloid carcinoma;basaloid squamous carcinoma of esophagus;exactmatch
barrett adenocarcinoma;adenocarcinoma arising in barrett's mucosa;exactmatch
recurrent plasma cell myeloma;recurrent multiple myeloma;exactmatch
refractory plasma cell myeloma;refractory multiple myeloma;exactmatch
gastric inflammatory myofibroblastic tumor;gastric inflammatory myofibroblastic neoplasm;exactmatch
central nervous system inflammatory myofibroblastic tumor;central nervous system inflammatory myofibroblastic tumor;exactmatch
trilateral retinoblastoma;trilateral retinoblastoma;exactmatch
nerve sheath myxoma;nerve sheath myxoma;exactmatch
granular cell tumor of the sellar region;granular cell tumor of neurohypophysis;exactmatch
central nervous system mixed germ cell tumor;cns mixed germ cell tumor;exactmatch
central nervous system teratoma with malignant transformation;cns teratoma with malignant transformation;exactmatch
central nervous system immature teratoma;cns immature teratoma;exactmatch
central nervous system mature teratoma;cns mature teratoma;exactmatch
thymoma type b1;lymphocyte-predominant thymoma;exactmatch
thymoma type ab;mixed type thymoma;exactmatch
colon cancer by astler-coller stage;colon cancer by astler-coller stage;exactmatch
cerebellar pilocytic astrocytoma;cerebellar pilocytic astrocytoma;exactmatch
high grade b-cell non-hodgkin's lymphoma;high grade b-cell non-hodgkin's lymphoma;exactmatch
low grade b-cell non-hodgkin's lymphoma;low grade b-cell non-hodgkin's lymphoma;exactmatch
superficial fibromatosis;superficial fibromatosis;exactmatch
prostate ductal adenocarcinoma;ductal adenocarcinoma of prostate;exactmatch
mediastinal seminoma;mediastinal seminoma;exactmatch
plantar verrucous carcinoma;epithelioma cuniculatum of the sole;exactmatch
testicular lymphoma;lymphoma of testis;exactmatch
dermoid cyst of the spinal cord;dermoid cyst of spinal cord;exactmatch
pancreatic intraepithelial neoplasia-1;grade 1 pancreatic intraepithelial neoplasia;exactmatch
benign external ear neoplasm;benign external auditory canal neoplasm;exactmatch
benign skin fibroblastic neoplasm;benign cutaneous fibroblastic neoplasm;exactmatch
metastatic malignant neoplasm in the pituitary gland;metastasis to pituitary gland;exactmatch
lacrimal gland carcinoma ex pleomorphic adenoma;carcinoma ex pleomorphic adenoma of lacrimal gland;exactmatch
benign ovarian sex cord-stromal tumor;benign ovarian sex cord-stromal neoplasm;exactmatch
skin fibrous histiocytoma;benign cutaneous fibrous histiocytoma;exactmatch
malignant apocrine neoplasm;malignant apocrine neoplasm;exactmatch
intermediate grade b-cell non-hodgkin's lymphoma;intermediate grade b-cell non-hodgkin's lymphoma;exactmatch
balanced chromosomal translocation;balanced chromosomal aberration/rearrangement;exactmatch
oral cavity monomorphic adenoma;monomorphic adenoma of oral cavity;exactmatch
ethmoid sinus papilloma;ethmoid sinus papilloma;exactmatch
ethmoid sinus inverted papilloma;ethmoid sinus inverted papilloma;exactmatch
frontal sinus inverted papilloma;frontal sinus inverted papilloma;exactmatch
sphenoid sinus inverted papilloma;inverted papilloma of sphenoid sinus;exactmatch
maxillary sinus inverted papilloma;inverted papilloma of maxillary sinus;exactmatch
maxillary sinus papilloma;maxillary sinus papilloma;exactmatch
sphenoid sinus papilloma;schneiderian papilloma of sphenoid sinus;exactmatch
frontal sinus papilloma;frontal sinus papilloma;exactmatch
paranasal sinus papilloma;accessory sinus schneiderian papilloma;exactmatch
unbalanced translocation;unbalanced chromosomal alteration;exactmatch
middle ear adenoma;adenoma of middle ear;exactmatch
double minutes;dm;exactmatch
homogeneously staining region;homogeneously staining region;exactmatch
derivative chromosome;derivative chromosome;exactmatch
chromosomal insertion;chromosomal insertion;exactmatch
chromosomal inversion;chromosomal inversion;exactmatch
numerical chromosomal abnormality;numerical chromosomal abnormalities;exactmatch
benign apocrine neoplasm;benign apocrine neoplasm;exactmatch
apocrine neoplasm;apocrine neoplasm;exactmatch
benign eccrine neoplasm;benign eccrine neoplasm;exactmatch
colon small cell neuroendocrine carcinoma;colon oat cell carcinoma;exactmatch
ependymal tumor;ependymal neoplasm;exactmatch
optic nerve astrocytoma;astrocytoma of optic nerve;exactmatch
malignant pineal region germ cell tumor;malignant germ cell neoplasm of pineal gland;exactmatch
prostate small cell neuroendocrine carcinoma;oat cell carcinoma of prostate;exactmatch
gastric small cell neuroendocrine carcinoma;gastric oat cell carcinoma;exactmatch
gallbladder small cell neuroendocrine carcinoma;gallbladder oat cell carcinoma;exactmatch
esophageal small cell neuroendocrine carcinoma;esophageal oat cell carcinoma;exactmatch
breast small cell neuroendocrine carcinoma;breast small cell carcinoma;exactmatch
eccrine neoplasm;eccrine neoplasm;exactmatch
pineal region choriocarcinoma;choriocarcinoma of pineal area;exactmatch
malignant central nervous system mesenchymal, non-meningothelial neoplasm;malignant cns soft tissue neoplasm;exactmatch
benign central nervous system mesenchymal, non-meningothelial neoplasm;benign cns soft tissue neoplasm;exactmatch
myxoid leiomyoma;myxoid leiomyoma;exactmatch
malignant sex cord-stromal tumor;malignant sex cord-stromal tumor;exactmatch
endolymphatic sac tumor;elst;exactmatch
pineal region meningioma;meningioma of pineal area;exactmatch
olfactory groove meningioma;meningioma of olfactory groove;exactmatch
childhood supratentorial embryonal tumor with multilayered rosettes, c19mc-altered;childhood supratentorial embryonal tumor with multilayered rosettes, c19mc-altered;exactmatch
childhood infratentorial embryonal tumor with multilayered rosettes, c19mc-altered;childhood infratentorial embryonal tumor with multilayered rosettes, c19mc-altered;exactmatch
recurrent childhood medulloblastoma;recurrent childhood medulloblastoma;exactmatch
gastric pylorus carcinoma;cancer of gastric pylorus;exactmatch
gastric cardia carcinoma;cancer of gastric cardia;exactmatch
supraglottis neoplasm;neoplasm of supraglottis;exactmatch
sphenoid sinus neoplasm;neoplasm of sphenoid sinus;exactmatch
parotid gland carcinoma;carcinoma of parotid;exactmatch
malignant eyelid neoplasm;malignant eyelid neoplasm;exactmatch
cystic neoplasm;cystic neoplasm;exactmatch
transitional cell neoplasm;transitional cell neoplasm;exactmatch
stromal neoplasm;stromal neoplasm;exactmatch
pituitary gland acidophil adenoma;acidophil adenoma;exactmatch
gasserian meningioma;gasserian ganglion meningioma;exactmatch
intraorbital meningioma;intraorbital meningioma;exactmatch
periocular meningioma;periocular meningioma;exactmatch
suprasellar meningioma;suprasellar meningioma;exactmatch
posterior cranial fossa meningioma;meningioma of posterior cranial fossa;exactmatch
hard palate monomorphic adenoma;hard palate monomorphic adenoma;exactmatch
thyroid gland hyalinizing trabecular tumor;hyalinizing trabecular adenoma of thyroid;exactmatch
unfavorable non-hodgkin lymphoma;unfavorable non-hodgkin lymphoma;exactmatch
childhood nasal type extranodal nk/t-cell lymphoma;childhood nasal type extranodal nk/t-cell lymphoma;exactmatch
neurotransmitter;neurotransmitter;exactmatch
"adult acute myeloid leukemia with t(8;21); (q22; q22.1); runx1-runx1t1";"acute myeloid leukemia (aml) with t(8;21); (q22; q22.1); runx1-runx1t1";exactmatch
"adult acute myeloid leukemia with t(16;16)(p13.1;q22); cbfb-myh11";"acute myeloid leukemia (aml) with t(16;16)(p13.1;q22); cbfb-myh11";exactmatch
"adult acute myeloid leukemia with inv(16)(p13.1q22); cbfb-myh11";"acute myeloid leukemia (aml) with inv(16)(p13.1q22); cbfb-myh11";exactmatch
"adult acute myeloid leukemia with t(9;11)(p21.3;q23.3); mllt3-mll";"acute myeloid leukemia (aml) with t(9;11)(p21.3;q23.3); mllt3-kmt2a";exactmatch
adult erythroleukemia;adult erythroleukemia;exactmatch
adult pure erythroid leukemia;adult pure erythroid leukemia;exactmatch
adult oligodendroglial tumor;adult oligodendroglial tumor;exactmatch
adult acute myeloid leukemia with recurrent genetic abnormalities;acute myeloid leukemia (aml) with recurrent genetic abnormalities;exactmatch
adult ependymal tumor;adult ependymal tumor;exactmatch
tdt positive acute lymphoblastic leukemia;tdt positive acute lymphoblastic leukemia;exactmatch
ann arbor stage ii indolent adult non-hodgkin lymphoma;ann arbor stage ii indolent adult non-hodgkin lymphoma;exactmatch
ann arbor stage ii aggressive adult non-hodgkin lymphoma;ann arbor stage ii aggressive adult non-hodgkin lymphoma;exactmatch
recurrent marginal zone lymphoma;recurrent marginal zone b-cell lymphoma;exactmatch
ann arbor stage iv marginal zone lymphoma;ann arbor stage iv marginal zone lymphoma;exactmatch
ann arbor stage iii marginal zone lymphoma;ann arbor stage iii marginal zone lymphoma;exactmatch
breast solid papillary carcinoma;breast solid papillary carcinoma;exactmatch
adult gliosarcoma;adult gliosarcoma;exactmatch
parotid gland monomorphic adenoma;monomorphic adenoma of parotid;exactmatch
grade iii glandular intraepithelial neoplasia;glandular intraepithelial neoplasia, grade iii;exactmatch
favorable non-hodgkin lymphoma;favorable non-hodgkin lymphoma;exactmatch
pancreatic mucinous-cystic neoplasm with intermediate grade dysplasia;mucinous cystic tumor with moderate dysplasia;exactmatch
micropapillary serous carcinoma;mpsc;exactmatch
bile duct intraductal papillary neoplasm;bile duct ipn;exactmatch
glandular papilloma;glandular papilloma;exactmatch
pancreatic mixed ductal-neuroendocrine carcinoma;mixed ductal-endocrine carcinoma;exactmatch
pancreatic mixed acinar-neuroendocrine carcinoma;acinar-islet cell tumor, malignant;exactmatch
oligodendroglial component present;oligodendroglial component present;exactmatch
adult giant cell glioblastoma;adult giant cell glioblastoma;exactmatch
lung large cell carcinoma with rhabdoid phenotype;large cell carcinoma with rhabdoid phenotype;exactmatch
large cell neuroendocrine carcinoma;lcnec;exactmatch
her2/neu negative;erbb2 negative;exactmatch
childhood myelodysplastic syndrome;childhood mds;exactmatch
stage iv anal canal cancer ajcc v6 and v7;stage iv anal canal cancer;exactmatch
sinonasal inverted papilloma;inverted schneiderian papilloma;exactmatch
adult supratentorial embryonal tumor, not otherwise specified;adult supratentorial embryonal tumor, nos;exactmatch
stage iv laryngeal cancer ajcc v6;laryngeal cancer, stage iv ajcc v6;exactmatch
ann arbor stage ii marginal zone lymphoma;ann arbor stage ii marginal zone lymphoma;exactmatch
ann arbor stage i marginal zone lymphoma;ann arbor stage i marginal zone lymphoma;exactmatch
primary cutaneous b-cell non-hodgkin lymphoma;cbcl;exactmatch
childhood teratoma;childhood teratoma;exactmatch
choroid spindle cell type b melanoma;choroid spindle cell type b melanoma;exactmatch
sinonasal squamous cell carcinoma;nasal cavity and paranasal sinus squamous cell cancer;exactmatch
oropharyngeal undifferentiated carcinoma;oropharyngeal lymphoepithelioma;exactmatch
choroid spindle cell type a melanoma;choroid spindle cell type a melanoma;exactmatch
primary cutaneous anaplastic large cell lymphoma;alcl, cutaneous;exactmatch
grade 3 cutaneous follicular lymphoma;cutaneous large b cell follicular lymphoma;exactmatch
cervical microglandular polyp;cervical microglandular polyp;exactmatch
myelodysplastic syndrome with isolated del(5q);5q minus syndrome;exactmatch
kadish stage b olfactory neuroblastoma;kadish stage b olfactory neuroblastoma;exactmatch
kadish stage a olfactory neuroblastoma;kadish stage a olfactory neuroblastoma;exactmatch
adult atypical meningioma;adult atypical meningioma;exactmatch
low grade paranasal sinus sarcoma;low grade accessory sinus sarcoma;exactmatch
high grade paranasal sinus sarcoma;high grade accessory sinus sarcoma;exactmatch
paranasal sinus sarcoma;accessory sinus sarcoma;exactmatch
middle ear adenocarcinoma;adenocarcinoma of middle ear;exactmatch
childhood extracranial germ cell tumor;childhood extracranial germ cell tumor;exactmatch
childhood malignant testicular germ cell tumor;childhood malignant testicular germ cell tumor;exactmatch
childhood malignant ovarian germ cell tumor;childhood malignant ovarian germ cell tumor;exactmatch
ciliary body spindle cell type b melanoma;ciliary body spindle cell type b melanoma;exactmatch
hodgkin lymphoma by clinical course;hodgkin lymphoma by clinical course;exactmatch
advanced unfavorable hodgkin lymphoma;advanced unfavorable hodgkin lymphoma;exactmatch
early unfavorable hodgkin lymphoma;early unfavorable hodgkin lymphoma;exactmatch
unfavorable hodgkin lymphoma;unfavorable hodgkin lymphoma;exactmatch
advanced favorable hodgkin lymphoma;advanced favorable hodgkin lymphoma;exactmatch
early favorable hodgkin lymphoma;early favorable hodgkin lymphoma;exactmatch
favorable hodgkin lymphoma;favorable hodgkin lymphoma;exactmatch
"childhood b acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1";"b acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1";exactmatch
malignant trophoblastic cell;malignant trophoblastic cell;exactmatch
choroid necrotic melanoma;choroid necrotic melanoma;exactmatch
anaplastic adrenal cortex carcinoma;anaplastic adrenal cortex cancer;exactmatch
ciliary body spindle cell type a melanoma;ciliary body spindle cell type a melanoma;exactmatch
well differentiated adrenal cortex carcinoma;well differentiated adrenal cortex cancer;exactmatch
childhood atypical teratoid/rhabdoid tumor;atypical teratoid/rhabdoid tumor;exactmatch
childhood extragonadal malignant germ cell tumor;childhood extragonadal malignant germ cell tumor;exactmatch
colorectal cancer by astler-coller stage;colorectal cancer by astler-coller stage;exactmatch
rectal cancer by astler-coller stage;rectal cancer by astler-coller stage;exactmatch
acanthoma;acanthoma;exactmatch
ovarian monodermal teratoma;monodermal teratoma;exactmatch
splenic non-hodgkin lymphoma;non-hodgkin lymphoma of spleen;exactmatch
malignant splenic soft tissue neoplasm;malignant soft tissue neoplasm of spleen;exactmatch
ovarian cellular fibroma;ovarian cellular fibroma;exactmatch
ovarian tumor of the thecoma/fibroma group;ovarian tumor of the thecoma/fibroma group;exactmatch
juvenile type ovarian granulosa cell tumor;juvenile type ovarian granulosa cell tumor;exactmatch
adult type ovarian granulosa cell tumor;adult type ovarian granulosa cell tumor;exactmatch
ovarian granulosa-stromal cell tumor;ovarian granulosa-stromal cell tumor;exactmatch
ovarian solid teratoma;ovarian solid teratoma;exactmatch
splenic manifestation of leukemia;splenic manifestation of leukemia;exactmatch
ovarian dermoid cyst with secondary tumor;ovarian dermoid cyst with secondary tumor;exactmatch
ovarian cystic teratoma;ovarian cystic teratoma;exactmatch
benign ovarian seromucinous tumor;benign ovarian seromucinous tumor;exactmatch
borderline ovarian seromucinous tumor/atypical proliferative ovarian seromucinous tumor;borderline ovarian seromucinous tumor/atypical proliferative ovarian seromucinous tumor;exactmatch
ovarian transitional cell tumor;ovarian transitional cell neoplasm;exactmatch
ovarian surface papilloma;ovarian surface papilloma;exactmatch
ovarian papillary cystadenoma;ovarian papillary cystadenoma;exactmatch
splenic hodgkin lymphoma;hodgkin's disease of spleen;exactmatch
splenic manifestation of prolymphocytic leukemia;splenic manifestation of prolymphocytic leukemia;exactmatch
acute monoblastic and monocytic leukemia;acute monoblastic leukemia and acute monocytic leukemia;exactmatch
splenic follicular lymphoma;primary splenic follicular lymphoma;exactmatch
borderline ovarian serous surface papillary tumor;borderline ovarian serous surface papillary neoplasm;exactmatch
benign ovarian serous tumor;benign ovarian serous neoplasm;exactmatch
splenic lymphoblastic lymphoma;splenic lymphoblastic lymphoma;exactmatch
splenic t lymphoblastic lymphoma;splenic precursor t-lymphoblastic lymphoma;exactmatch
splenic b lymphoblastic lymphoma;splenic b lymphoblastic lymphoma;exactmatch
splenic burkitt lymphoma;primary splenic burkitt's lymphoma;exactmatch
splenic diffuse large b-cell lymphoma;primary splenic diffuse large b-cell lymphoma;exactmatch
splenic mantle cell lymphoma;splenic mantle cell lymphoma;exactmatch
splenic manifestation of t-cell prolymphocytic leukemia;splenic manifestation of t-cell prolymphocytic leukemia;exactmatch
splenic lymphoplasmacytic lymphoma;splenic lymphoplasmacytic lymphoma;exactmatch
splenic small lymphocytic lymphoma;splenic small lymphocytic lymphoma;exactmatch
splenic manifestation of chronic myelogenous leukemia, bcr-abl1 positive;splenic manifestation of cml;exactmatch
splenic manifestation of t-cell large granular lymphocyte leukemia;splenic manifestation of lgl;exactmatch
splenic manifestation of hairy cell leukemia;splenic manifestation of hairy cell leukemia;exactmatch
splenic manifestation of chronic lymphocytic leukemia;splenic manifestation of cll;exactmatch
splenic manifestation of b-cell prolymphocytic leukemia;splenic manifestation of b-cell prolymphocytic leukemia;exactmatch
borderline ovarian serous papillary cystic tumor;borderline ovarian serous papillary cystic tumor;exactmatch
mixed mucinous and non-mucinous bronchioloalveolar carcinoma;indeterminate bronchioloalveolar carcinoma;exactmatch
minimally invasive lung non-mucinous adenocarcinoma;minimally invasive lung non-mucinous adenocarcinoma;exactmatch
monomorphic t/nk-cell post-transplant lymphoproliferative disorder;monomorphic t-cell ptld;exactmatch
burkitt-like lymphoma post-transplant lymphoproliferative disorder;burkitt's-like lymphoma post-transplant lymphoproliferative disorder;exactmatch
burkitt lymphoma post-transplant lymphoproliferative disorder;burkitt lymphoma ptld;exactmatch
classic hodgkin lymphoma type post-transplant lymphoproliferative disorder;classic hodgkin lymphoma type post-transplant lymphoproliferative disorder;exactmatch
plasma cell myeloma post-transplant lymphoproliferative disorder;plasma cell myeloma ptld;exactmatch
plasmacytoma-like post-transplant lymphoproliferative disorder;plasmacytoma-like post-transplant lymphoproliferative disorder;exactmatch
plasma cell post-transplant lymphoproliferative disorder;plasma cell ptld;exactmatch
hodgkin-like post-transplant lymphoproliferative disorder;hodgkin lymphoma - like ptld;exactmatch
monomorphic b-cell post-transplant lymphoproliferative disorder;monomorphic b-cell ptld;exactmatch
minimally invasive lung mucinous adenocarcinoma;minimally invasive lung mucinous adenocarcinoma;exactmatch
infectious mononucleosis-like post-transplant lymphoproliferative disorder;infectious mononucleosis-like post-transplant lymphoproliferative disorder;exactmatch
non-destructive post-transplant lymphoproliferative disorder;non-destructive ptld;exactmatch
monomorphic post-transplant lymphoproliferative disorder;monomorphic ptld;exactmatch
neoplastic post-transplant lymphoproliferative disorder;neoplastic ptld;exactmatch
small intestinal non-hodgkin lymphoma;primary small intestinal non-hodgkin's lymphoma;exactmatch
primary cutaneous marginal zone lymphoma of mucosa-associated lymphoid tissue;c-malt;exactmatch
blastoid variant mantle cell lymphoma;blastoid variant mantle cell lymphoma;exactmatch
diffuse large b-cell lymphoma post-transplant lymphoproliferative disorder;diffuse large b-cell lymphoma ptld;exactmatch
anaplastic lymphoma post-transplant lymphoproliferative disorder;anaplastic diffuse large b-cell lymphoma ptld;exactmatch
centroblastic lymphoma post-transplant lymphoproliferative disorder;centroblastic diffuse large b-cell lymphoma ptld;exactmatch
immunoblastic lymphoma post-transplant lymphoproliferative disorder;immunoblastic diffuse large b-cell lymphoma ptld;exactmatch
combined lung large cell neuroendocrine carcinoma;combined large cell lung neuroendocrine carcinoma;exactmatch
lung basaloid large cell carcinoma;lung basaloid large cell carcinoma;exactmatch
diffuse follicular lymphoma;diffuse follicle centre lymphoma;exactmatch
thyroid gland immunoblastic lymphoma;immunoblastic lymphoma of thyroid;exactmatch
ann arbor stage iii nodular lymphocyte predominant hodgkin lymphoma;ann arbor stage iii nodular lymphocyte predominant hodgkin lymphoma;exactmatch
ann arbor stage iv nodular lymphocyte predominant hodgkin lymphoma;ann arbor stage iv nodular lymphocyte predominant hodgkin lymphoma;exactmatch
refractory nodular lymphocyte predominant hodgkin lymphoma;refractory nodular lymphocyte predominant hodgkin lymphoma;exactmatch
recurrent nodular lymphocyte predominant hodgkin lymphoma;recurrent nodular lymphocyte predominant hodgkin lymphoma;exactmatch
nodular lymphocyte predominant hodgkin lymphoma;hodgkin lymphoma nodular lp, nos;exactmatch
methotrexate-associated hodgkin lymphoma;methotrexate-associated hodgkin lymphoma;exactmatch
methotrexate-associated burkitt lymphoma;methotrexate-associated burkitt lymphoma;exactmatch
methotrexate-associated follicular lymphoma;methotrexate-associated follicular lymphoma;exactmatch
methotrexate-associated diffuse large b-cell lymphoma;methotrexate-associated diffuse large b-cell lymphoma;exactmatch
methotrexate-associated peripheral t-cell lymphoma;methotrexate-associated peripheral t-cell lymphoma;exactmatch
malignant testicular neoplasm;malignant neoplasm of testis;exactmatch
ovarian adenosarcoma;ovarian adenosarcoma;exactmatch
adult acute monoblastic and monocytic leukemia;acute monoblastic and monocytic leukemia;exactmatch
refractory t lymphoblastic lymphoma;refractory precursor t-lymphoblastic lymphoma;exactmatch
thyroid gland papillary and follicular carcinoma;papillary and follicular adenocarcinoma;exactmatch
malignant vascular neoplasm;cancerous tumor of blood vessel;exactmatch
benign vascular neoplasm;benign vascular neoplasm;exactmatch
vascular neoplasm;neoplasm of vascular tissue;exactmatch
blood vessel neoplasm;blood vessel neoplasm;exactmatch
encapsulated thymoma;encapsulated thymoma;exactmatch
bladder papillary urothelial carcinoma;bladder papillary urothelial carcinoma;exactmatch
follicular variant thyroid gland papillary carcinoma, infiltrative subtype;follicular variant thyroid gland papillary carcinoma, infiltrative subtype;exactmatch
malignant anal neoplasm;malignant anal neoplasm;exactmatch
skin epithelioid hemangioma;angiolymphoid cutaneous hyperplasia;exactmatch
malignant prostate neoplasm;malignant neoplasm of prostate;exactmatch
malignant lung neoplasm;malignant lung neoplasm;exactmatch
pleural malignant mesothelioma;malignant mesothelioma of pleura;exactmatch
nasopharyngeal nonkeratinizing carcinoma;ebv positive nasopharyngeal carcinoma;exactmatch
cerebellar neuronal and mixed neuronal-glial tumor;cerebellar neuronal and mixed neuronal-glial tumor;exactmatch
accessory urethral gland carcinoma;accessory urethral gland adenocarcinoma;exactmatch
pilomatricoma;benign hair follicle neoplasm;exactmatch
intermediate blood vessel neoplasm;intermediate blood vessel neoplasm;exactmatch
ebv-positive neoplastic cells present;ebv-positive neoplastic cells present;exactmatch
childhood chronic myelogenous leukemia, bcr-abl1 positive;childhood cml;exactmatch
anal precancerous condition;anal precancerous condition;exactmatch
malignant rectal neoplasm;malignant neoplasm of rectum;exactmatch
bladder nephrogenic adenoma;bladder nephrogenic adenoma;exactmatch
bladder villous adenoma;bladder villous adenoma;exactmatch
nephrogenic adenoma;nephrogenic adenoma;exactmatch
pancreatic precancerous condition;pancreatic precancerous condition;exactmatch
laryngeal precancerous condition;laryngeal precancerous condition;exactmatch
malignant vaginal neoplasm;malignant neoplasm of vagina;exactmatch
malignant tonsillar neoplasm;malignant neoplasm of tonsil;exactmatch
stage i nasopharyngeal carcinoma ajcc v6;nasopharyngeal cancer, stage i ajcc v6;exactmatch
hairy cell leukemia;hcl;exactmatch
hairy cell leukemia variant;hcl-v;exactmatch
burkitt leukemia;burkitt leukemia;exactmatch
villous adenoma;gi tract villous adenoma;exactmatch
malignant oropharyngeal neoplasm;malignant neoplasm of oropharynx;exactmatch
stage iv nasopharyngeal carcinoma ajcc v6;nasopharyngeal cancer, stage iv ajcc v6;exactmatch
stage iii nasopharyngeal carcinoma ajcc v6;nasopharyngeal cancer, stage iii ajcc v6;exactmatch
hair follicle neoplasm;hair follicle neoplasm;exactmatch
focal intraductal papillomatosis;focal intraductal papillomatosis;exactmatch
diffuse intraductal papillomatosis;diffuse intraductal papillomatosis;exactmatch
intermediate vascular neoplasm;intermediate vascular neoplasm;exactmatch
benign epithelial skin neoplasm;benign epithelial skin neoplasm;exactmatch
hematopoietic and lymphoid neoplasm (antiquated);blood borne cancer;exactmatch
heavy chain deposition disease;hcdd;exactmatch
adult b lymphoblastic lymphoma;adult b lymphoblastic lymphoma;exactmatch
peritoneal and retroperitoneal neoplasm;peritoneal and retroperitoneal neoplasm;exactmatch
sinonasal neoplasm;nasal cavity and paranasal sinus neoplasm;exactmatch
reproductive endocrine neoplasm;reproductive endocrine neoplasm;exactmatch
intermediate fibroblastic neoplasm;intermediate fibroblastic neoplasm;exactmatch
intraductal papillomatosis;intraductal papillomatosis;exactmatch
intratubular seminoma;intratubular seminoma;exactmatch
testicular seminoma;seminoma of testis;exactmatch
extragonadal seminoma;extragonadal primary seminoma;exactmatch
testicular germ cell neoplasia in situ with extratubular extension;testicular germ cell neoplasia in situ with extratubular extension;exactmatch
intratubular non-seminoma;intratubular embryonal carcinoma;exactmatch
testicular mixed germ cell-sex cord-stromal tumor;testicular mixed germ cell-sex cord neoplasm;exactmatch
ovarian mixed germ cell-sex cord-stromal tumor;ovarian mixed germ cell-sex cord neoplasm;exactmatch
epithelial skin neoplasm;epithelial skin neoplasm;exactmatch
benign skin fibrohistiocytic neoplasm;benign cutaneous fibrohistiocytic neoplasm;exactmatch
skin intermediate fibrohistiocytic neoplasm;intermediate cutaneous fibrohistiocytic neoplasm;exactmatch
cervical squamous intraepithelial neoplasia;cin;exactmatch
breast scirrhous carcinoma;breast scirrhous carcinoma;exactmatch
scrotal melanoma;melanoma of scrotum;exactmatch
grade ii prostatic intraepithelial neoplasia;grade ii pin;exactmatch
endometrial adenocarcinoma;adenocarcinoma, endometrial, malignant;exactmatch
periosteal chondrosarcoma;juxtacortical chondrosarcoma;exactmatch
gallbladder adenosquamous carcinoma;adenosquamous carcinoma of gallbladder;exactmatch
renal pelvis urothelial carcinoma;renal pelvis transitional cell carcinoma;exactmatch
suz12 gene;suz12;exactmatch
jazf1 gene;jazf zinc finger 1 gene;exactmatch
peritoneal adenomatoid tumor;benign peritoneal mesothelioma;exactmatch
retroperitoneal lymphoma;primary retroperitoneal lymphoma;exactmatch
retroperitoneal carcinoma;carcinoma of retroperitoneum;exactmatch
grade ii squamous intraepithelial neoplasia;grade 2 squamous intraepithelial lesion;exactmatch
high grade intraepithelial neoplasia;high grade intraepithelial neoplasia;exactmatch
cervical squamous cell carcinoma in situ;cin 3;exactmatch
refractory mature b-cell non-hodgkin lymphoma;refractory mature b-cell lymphoma;exactmatch
adult t lymphoblastic lymphoma;adult precursor t-lymphoblastic lymphoma;exactmatch
small intestinal leiomyosarcoma;leiomyosarcoma of small bowel;exactmatch
childhood grade ii meningioma;childhood grade ii meningioma;exactmatch
bone surface (peripheral) osteosarcoma;bone surface (peripheral) osteosarcoma;exactmatch
ovarian sertoli cell tumor;ovarian sertoli cell tumor;exactmatch
glandular cell neoplasm;glandular cell epithelial neoplasm;exactmatch
gallbladder benign granular cell tumor;benign gallbladder granular cell neoplasm;exactmatch
adult grade iii meningioma;adult grade iii meningioma;exactmatch
adult grade ii meningioma;adult grade ii meningioma;exactmatch
childhood grade iii meningioma;childhood grade iii meningioma;exactmatch
childhood grade i meningioma;childhood grade i meningioma;exactmatch
extracutaneous mastocytoma;extracutaneous mastocytoma;exactmatch
gallbladder intracholecystic papillary neoplasm;gallbladder icpn;exactmatch
adult grade i meningioma;adult grade i meningioma;exactmatch
gallbladder benign non-epithelial neoplasm;benign non-epithelial gallbladder neoplasm;exactmatch
benign extrahepatic bile duct non-epithelial neoplasm;benign extrahepatic bile duct non-epithelial neoplasm;exactmatch
intrahepatic bile duct microcystic adenoma;intrahepatic bile duct microcystic adenoma;exactmatch
intrahepatic bile duct adenoma;adenoma, hepatocholangiocellular, benign;exactmatch
intrahepatic bile duct intraductal papillary neoplasm;intrahepatic bile duct ipn;exactmatch
extraskeletal ewing sarcoma;eoe;exactmatch
cutaneous mastocytosis;cm;exactmatch
differentiated thyroid gland carcinoma;differentiated thyroid cancer;exactmatch
postsurgical stage iii hepatoblastoma;postsurgical stage iii hepatoblastoma;exactmatch
monoclonal immunoglobulin deposition disease;immunoglobulin deposition disease;exactmatch
indolent plasma cell myeloma;indolent multiple myeloma;exactmatch
smoldering plasma cell myeloma;asymptomatic myeloma;exactmatch
soft tissue tumor of uncertain differentiation;soft tissue neoplasm of uncertain differentiation;exactmatch
benign fibroblastic neoplasm;benign fibroblastic neoplasm;exactmatch
postsurgical stage i hepatoblastoma;postsurgical stage i hepatoblastoma;exactmatch
postsurgical stage ii hepatoblastoma;postsurgical stage ii hepatoblastoma;exactmatch
postsurgical stage iv hepatoblastoma;postsurgical stage iv hepatoblastoma;exactmatch
solitary mastocytoma of the skin;cutaneous solitary mastocytoma;exactmatch
plag1 gene;plag1;exactmatch
pretext stage 4 hepatoblastoma;pretext stage 4 hepatoblastoma;exactmatch
nono gene;nono;exactmatch
sfpq gene;sfpq;exactmatch
pretext stage 3 hepatoblastoma;pretext stage 3 hepatoblastoma;exactmatch
pretext stage 2 hepatoblastoma;pretext stage 2 hepatoblastoma;exactmatch
pretext stage 1 hepatoblastoma;pretext stage 1 hepatoblastoma;exactmatch
extrahepatic bile duct intraductal papillary neoplasm;extrahepatic bile duct ipn;exactmatch
stage ivb liver cancer;stage ivb liver cancer;exactmatch
stage iva liver cancer;stage iva liver cancer;exactmatch
hepatoblastoma with combined fetal and embryonal epithelial differentiation;hepatoblastoma with combined fetal and embryonal epithelial differentiation;exactmatch
prcc gene;prcc;exactmatch
aspscr1 gene;aspscr1;exactmatch
stage d prostate cancer;cancer of prostate stage d;exactmatch
mixed hepatoblastoma with teratoid features;mixed hepatoblastoma with teratoid features;exactmatch
mixed epithelial and mesenchymal hepatoblastoma;hepatoblastoma, mixed epithelial-mesenchymal;exactmatch
small cell undifferentiated hepatoblastoma;small cell undifferentiated hepatoblastoma;exactmatch
macrotrabecular hepatoblastoma;macrotrabecular hepatoblastoma;exactmatch
hepatoblastoma with pure fetal epithelial differentiation;hepatoblastoma with pure fetal epithelial differentiation;exactmatch
stage iv liver cancer;stage iv liver cancer;exactmatch
metastatic non-cutaneous melanoma;metastatic non-cutaneous melanoma;exactmatch
mucosal melanoma of the digestive system;digestive system melanoma;exactmatch
regressing non-cutaneous melanoma;regressing non-cutaneous melanoma;exactmatch
nucleotide;base;exactmatch
regressing cutaneous melanoma;regressing cutaneous (skin) melanoma;exactmatch
recurrent non-cutaneous melanoma;recurrent non-cutaneous melanoma;exactmatch
recurrent melanoma;recurrent malignant melanoma;exactmatch
colon undifferentiated carcinoma;carcinoma simplex of the colon.;exactmatch
adult pilocytic astrocytoma;adult pilocytic astrocytoma;exactmatch
adult subependymal giant cell astrocytoma;adult subependymal giant cell astrocytoma;exactmatch
adult spinal cord neoplasm;adult spinal cord neoplasm;exactmatch
stage iii liver cancer;stage iii liver cancer;exactmatch
stage ii liver cancer;stage ii liver cancer;exactmatch
stage i liver cancer;stage i liver cancer;exactmatch
liver and intrahepatic bile duct malignant non-epithelial neoplasm;liver and intrahepatic bile duct malignant non-epithelial neoplasm;exactmatch
thymoma type b;dendritic cell thymoma;exactmatch
endometrioid tumor;endometrioid neoplasm;exactmatch
squamous odontogenic tumor;squamous odontogenic neoplasm;exactmatch
benign ameloblastoma;ameloblastoma, benign;exactmatch
recurrent liver carcinoma;recurrent cancer of liver;exactmatch
distal bile duct carcinoma;distal bile duct carcinoma;exactmatch
liver and intrahepatic bile duct non-epithelial neoplasm;hepatic and intrahepatic bile duct non-epithelial neoplasm;exactmatch
liver and intrahepatic bile duct epithelial neoplasm;epithelial hepatic and intrahepatic bile duct neoplasm;exactmatch
exaggerated placental site;exaggerated placental site;exactmatch
mature mediastinal teratoma;mature mediastinal teratoma;exactmatch
liver and intrahepatic bile duct neoplasm;hepatic and intrahepatic bile duct neoplasm;exactmatch
erythroleukemia;erythroleukemia;exactmatch
bone leiomyosarcoma;bone leiomyosarcoma;exactmatch
alk-positive large b-cell lymphoma;alk positive large b-cell lymphoma;exactmatch
borderline primary cutaneous cd30-positive t-cell lymphoproliferative disorder;borderline primary cutaneous cd30+ t-cell lymphoproliferative disorder;exactmatch
blastic plasmacytoid dendritic cell neoplasm;agranular cd4+ cd56+ hematodermic neoplasm/tumor;exactmatch
malignant histiocytosis;histiocytic medullary reticulosis;exactmatch
infrequent neoplasm;infrequent neoplasm;exactmatch
anaplastic large cell lymphoma, lymphomatoid papulosis-like histology;anaplastic large cell lymphoma, lymphomatoid papulosis-like histology;exactmatch
type c lymphomatoid papulosis;diffuse large cell type lyp;exactmatch
type b lymphomatoid papulosis;type b lyp;exactmatch
type a lymphomatoid papulosis;type a lyp;exactmatch
primary cutaneous cd30-positive t-cell lymphoproliferative disorder;primary cutaneous cd30+ t-cell lymphoproliferative disorder;exactmatch
lymphoepithelioid variant peripheral t-cell lymphoma;lennert lymphoma;exactmatch
grade 2 diffuse follicular lymphoma;grade 2 diffuse follicular lymphoma;exactmatch
grade 3b follicular lymphoma;follicular lymphoma grade 3b;exactmatch
grade 3a follicular lymphoma;follicular lymphoma grade 3a;exactmatch
malignant hypopharyngeal neoplasm;malignant hypopharyngeal neoplasm;exactmatch
burkitt lymphoma with plasmacytoid differentiation;burkitt lymphoma with plasmacytoid differentiation;exactmatch
classical burkitt lymphoma;classical burkitt lymphoma;exactmatch
non-burkitt's lymphoma;non-burkitt's lymphoma;exactmatch
t-zone variant peripheral t-cell lymphoma;t-zone lymphoma;exactmatch
common variant anaplastic large cell lymphoma;common variant anaplastic large cell lymphoma;exactmatch
primary central chondrosarcoma;conventional chondrosarcoma;exactmatch
non-hodgkin lymphoma with variable clinical course;non-hodgkin lymphoma with variable clinical course;exactmatch
plasmablastic lymphoma;pbl;exactmatch
adult lymphocyte-rich classic hodgkin lymphoma;adult lymphocyte rich classical hodgkin lymphoma;exactmatch
primary cutaneous hodgkin lymphoma;pchl;exactmatch
grade 1 cutaneous follicular lymphoma;grade 1 cutaneous follicular lymphoma;exactmatch
grade 2 cutaneous follicular lymphoma;grade 2 cutaneous follicular lymphoma;exactmatch
cutaneous follicular lymphoma;cutaneous follicular lymphoma;exactmatch
primary cutaneous follicle center lymphoma;crosti's disease;exactmatch
non-hodgkin lymphoma by clinical course;non-hodgkin lymphoma by clinical course;exactmatch
lymphohistiocytic variant anaplastic large cell lymphoma;lymphohistiocytic variant anaplastic large cell lymphoma;exactmatch
aids-related diffuse large cell lymphoma;aids associated diffuse large cell lymphoma;exactmatch
aids-related diffuse large b-cell lymphoma;aids-related diffuse large b-cell lymphoma;exactmatch
childhood primary cutaneous anaplastic large cell lymphoma;childhood primary cutaneous anaplastic large cell lymphoma;exactmatch
childhood t lymphoblastic lymphoma;childhood precursor t-lymphoblastic lymphoma;exactmatch
childhood b lymphoblastic lymphoma;b lymphoblastic lymphoma;exactmatch
small cell variant anaplastic large cell lymphoma;small cell variant anaplastic large cell lymphoma;exactmatch
atypical carcinoid tumor;atypical carcinoid tumor;exactmatch
lymphoma by working formulation (antiquated);lymphoma by working formulation (antiquated);exactmatch
lymphoma by site;lymphoma by site;exactmatch
methotrexate-associated lymphoproliferative disorder;methotrexate-associated lymphoproliferation;exactmatch
myelodysplastic syndrome with excess blasts-1;mds-eb-1;exactmatch
refractory brain neoplasm;refractory brain neoplasm;exactmatch
refractory primary central nervous system neoplasm;refractory central nervous system neoplasm;exactmatch
recurrent primary central nervous system neoplasm;recurrent primary central nervous system neoplasm;exactmatch
recurrent spinal cord neoplasm;recurrent spinal cord neoplasm;exactmatch
recurrent brain neoplasm;recurrent brain neoplasm;exactmatch
pineal region dysgerminoma;pineal dysgerminoma;exactmatch
myelodysplastic syndrome with excess blasts-2;mds-eb-2;exactmatch
grade 2 nodular sclerosis classic hodgkin lymphoma;classical hodgkin lymphoma, nodular sclerosis, grade 2;exactmatch
polymorphic post-transplant lymphoproliferative disorder;polymorphic b-cell lymphoma;exactmatch
grade 1 nodular sclerosis classic hodgkin lymphoma;grade 1 nodular sclerosis classic hodgkin lymphoma;exactmatch
classic hodgkin lymphoma;chl;exactmatch
primary cutaneous lymphoma;cutaneous (skin) lymphoma;exactmatch
skin melanocytic neoplasm;cutaneous melanocytic neoplasm;exactmatch
subepidermal nodular fibrosis;subepidermal nodular fibrosis;exactmatch
benign dermal neoplasm;benign dermal neoplasm;exactmatch
posterior pituitary gland neoplasm;neurohypophysis neoplasm;exactmatch
refractory spinal cord neoplasm;refractory spinal cord neoplasm;exactmatch
acute monoblastic leukemia;acute monoblastic leukemia;exactmatch
recurrent childhood spinal cord neoplasm;recurrent childhood spinal cord neoplasm;exactmatch
recurrent adult spinal cord neoplasm;recurrent adult spinal cord neoplasm;exactmatch
b-cell proliferation of uncertain malignant potential;b-cell proliferation of uncertain malignant potential;exactmatch
spindle cell/pleomorphic lipoma;scl/pl;exactmatch
organic chemical;organic chemical;exactmatch
chronic adult t-cell leukemia/lymphoma;chronic adult t-cell leukemia/lymphoma;exactmatch
smoldering adult t-cell leukemia/lymphoma;smoldering adult t-cell leukemia/lymphoma;exactmatch
aleukemic acute lymphoblastic leukemia;aleukemic acute lymphoblastic leukemia;exactmatch
aleukemic chronic lymphocytic leukemia;aleukemic chronic lymphocytic leukemia;exactmatch
acute myeloid leukemia with recurrent genetic abnormalities;aml with recurrent genetic abnormalities;exactmatch
adult diffuse astrocytoma;adult diffuse astrocytoma;exactmatch
triple-negative breast carcinoma;triple-negative breast cancer;exactmatch
diffuse astrocytoma;astrocytoma, diffuse, malignant;exactmatch
primary diffuse large b-cell lymphoma of the central nervous system;cns dlbcl;exactmatch
central nervous system neuroepithelial neoplasm of uncertain origin;central nervous system neuroepithelial neoplasm of uncertain origin;exactmatch
refractory adult spinal cord neoplasm;refractory adult spinal cord neoplasm;exactmatch
refractory childhood spinal cord neoplasm;refractory childhood spinal cord neoplasm;exactmatch
abnormal squamous cell;abnormal squamous cell;exactmatch
intellectual property;intellectual product;exactmatch
neoplastic myoepithelial cell;neoplastic myoepithelial cell;exactmatch
langerhans cell histiocytosis, polyostotic;langerhans cell histiocytosis, polyostotic;exactmatch
acute myeloid leukemia with germline cebpa mutation;acute myeloid leukemia with germline biallelic cebpa mutations;exactmatch
myeloid neoplasms with germline predisposition without a preexisting disorder or organ dysfunction;myeloid neoplasms with germline predisposition without a preexisting disorder or organ dysfunction;exactmatch
unresectable gastrointestinal stromal tumor;unresectable gastrointestinal stromal tumor;exactmatch
locally advanced gastrointestinal stromal tumor;locally advanced gastrointestinal stromal tumor;exactmatch
metastatic gastrointestinal stromal tumor;metastatic gastrointestinal stromal tumor;exactmatch
ebv-positive inflammatory follicular dendritic cell sarcoma of the digestive system;ebv-positive inflammatory follicular dendritic cell sarcoma of the digestive system;exactmatch
langerhans cell histiocytosis, disseminated;langerhans cell histiocytosis, disseminated;exactmatch
langerhans cell histiocytosis, monostotic;langerhans cell histiocytosis, monostotic;exactmatch
myeloid neoplasms with germline ddx41 mutation;myeloid neoplasms with germline ddx41 mutation;exactmatch
tumors derived from langerhans cells;tumors derived from langerhans cells;exactmatch
med12 gene mutation;arc240 gene mutation;exactmatch
other iatrogenic immunodeficiency-associated lymphoproliferative disorders;other iatrogenic immunodeficiency-associated lymphoproliferative disorders;exactmatch
methotrexate-associated lymphoma;methotrexate-associated lymphoma;exactmatch
lymphoproliferative disease associated with primary immune disorder;lymphoproliferative disease associated with pid;exactmatch
immunodeficiency-associated lymphoproliferative disorder;immunodeficiency-associated lymphoproliferative disorder;exactmatch
activating flt3 gene mutation;activating cd135 gene mutation;exactmatch
ddx41 gene mutation;abs gene mutation;exactmatch
myeloid neoplasms with germline predisposition and preexisting platelet disorders;myeloid neoplasms with germline predisposition and preexisting platelet disorders;exactmatch
resectable neuroblastoma;resectable neuroblastoma;exactmatch
myeloid neoplasms with germline gata2 mutation;myeloid neoplasms with germline gata2 mutation;exactmatch
transformed non-hodgkin lymphoma;transformed non-hodgkin lymphoma;exactmatch
extracranial solid neoplasm;extracranial solid neoplasm;exactmatch
ankrd26 gene;ankrd26;exactmatch
myeloid neoplasms with germline predisposition associated with inherited bone marrow failure syndromes;myeloid neoplasms with germline predisposition associated with inherited bone marrow failure syndromes;exactmatch
myeloid neoplasms with germline predisposition associated with telomerase biology disorders;myeloid neoplasms with germline predisposition associated with telomerase biology disorders;exactmatch
telomere maintenance gene mutation;telomere maintenance gene mutation;exactmatch
ddx41 gene;ddx41;exactmatch
myeloid neoplasms with germline etv6 mutation;etv6 syndrome with thrombocytopenia, all and aml;exactmatch
myeloid neoplasms with germline runx1 mutation;myeloid neoplasms with germline runx1 mutation;exactmatch
myeloid neoplasms with germline predisposition associated with other organ dysfunction;myeloid neoplasms with germline predisposition associated with other organ dysfunction;exactmatch
ankrd26 gene mutation;ankrd26 gene mutation;exactmatch
myeloid neoplasms with germline ankrd26 mutation;ankrd26-related thrombocytopenia and leukemia predisposition;exactmatch
refractory head and neck carcinoma;refractory head and neck carcinoma;exactmatch
refractory digestive system carcinoma;refractory digestive system carcinoma;exactmatch
recurrent metastatic digestive system carcinoma;recurrent metastatic digestive system carcinoma;exactmatch
refractory metastatic digestive system carcinoma;refractory metastatic digestive system carcinoma;exactmatch
unresectable neuroblastoma;unresectable neuroblastoma;exactmatch
resectable undifferentiated pleomorphic sarcoma;resectable undifferentiated pleomorphic sarcoma;exactmatch
recurrent childhood malignant solid neoplasm;childhood recurrent malignant solid neoplasm;exactmatch
refractory malignant skin neoplasm;refractory malignant skin neoplasm;exactmatch
bladder carcinoma infiltrating the muscle of the bladder wall;bladder carcinoma infiltrating the muscle of the bladder wall;exactmatch
muscle invasion;muscle invasion;exactmatch
infiltrating bladder carcinoma;infiltrating bladder cancer;exactmatch
bone marrow lymphoplasmacytic infiltration of less than 10%;bone marrow lymphoplasmacytic infiltration of less than 10%;exactmatch
serum igm monoclonal gammopathy of less than 30g/l;serum igm monoclonal gammopathy of less than 30g/l;exactmatch
igm monoclonal gammopathy of undetermined significance;igm mgus;exactmatch
prostate adenocarcinoma without neuroendocrine differentiation;prostate adenocarcinoma without evidence of neuroendocrine differentiation;exactmatch
recurrent malignant skin neoplasm;recurrent malignant skin neoplasm;exactmatch
metastatic gastroesophageal junction adenocarcinoma;metastatic gastroesophageal junction adenocarcinoma;exactmatch
refractory cutaneous melanoma;refractory cutaneous (skin) melanoma;exactmatch
refractory malignant urinary system neoplasm;refractory malignant urinary system neoplasm;exactmatch
recurrent malignant urinary system neoplasm;recurrent malignant urinary system neoplasm;exactmatch
refractory malignant endocrine neoplasm;refractory malignant endocrine neoplasm;exactmatch
recurrent malignant endocrine neoplasm;recurrent malignant endocrine neoplasm;exactmatch
refractory malignant thyroid gland neoplasm;refractory malignant thyroid gland neoplasm;exactmatch
recurrent malignant thyroid gland neoplasm;recurrent malignant thyroid gland neoplasm;exactmatch
localized cerebral neoplasm;localized cerebral neoplasm;exactmatch
unresectable gastroesophageal junction adenocarcinoma;unresectable gastroesophageal junction adenocarcinoma;exactmatch
unresectable undifferentiated pleomorphic sarcoma;unresectable undifferentiated pleomorphic sarcoma;exactmatch
hepatic steatosis;hepatic steatosis;exactmatch
resectable dedifferentiated liposarcoma;resectable dedifferentiated liposarcoma;exactmatch
resectable liposarcoma;resectable liposarcoma;exactmatch
resectable sarcoma;resectable sarcoma;exactmatch
resectable carcinoma;resectable carcinoma;exactmatch
resectable malignant neoplasm;resectable malignant neoplasm;exactmatch
unresectable dedifferentiated liposarcoma;unresectable dedifferentiated liposarcoma;exactmatch
metastatic malignant neoplasm in the viscera;metastatic malignant neoplasm in the viscera;exactmatch
metastatic renal cell carcinoma;metastatic renal cell cancer;exactmatch
recurrent myxoid liposarcoma;recurrent myxoid liposarcoma;exactmatch
refractory liposarcoma;refractory liposarcoma;exactmatch
refractory dedifferentiated liposarcoma;refractory dedifferentiated liposarcoma;exactmatch
recurrent dedifferentiated liposarcoma;recurrent dedifferentiated liposarcoma;exactmatch
testicular follicular lymphoma;testicular follicular lymphoma;exactmatch
non-igm monoclonal gammopathy of undetermined significance;non-igm mgus;exactmatch
refractory lung small cell carcinoma;refractory lung small cell carcinoma;exactmatch
unresectable adrenal cortex carcinoma;unresectable adrenal cortex carcinoma;exactmatch
locally advanced bile duct carcinoma;locally advanced bile duct cancer;exactmatch
acute leukemia of ambiguous lineage, not otherwise specified;acute leukemia of ambiguous lineage, nos;exactmatch
recurrent burkitt leukemia;recurrent burkitt leukemia;exactmatch
locally advanced lung non-squamous non-small cell carcinoma;locally advanced lung non-squamous non-small cell carcinoma;exactmatch
colorectal carcinoma metastatic in the lung;colorectal carcinoma metastatic in the lung;exactmatch
cd4 positive;cd4 antigen positive;exactmatch
locally advanced head and neck carcinoma;locally advanced head and neck carcinoma;exactmatch
locally advanced lung carcinoma;locally advanced lung carcinoma;exactmatch
advanced lung carcinoma;advanced lung carcinoma;exactmatch
metastatic lung carcinoma;metastatic lung carcinoma;exactmatch
advanced lung non-small cell squamous carcinoma;advanced lung non-small cell squamous carcinoma;exactmatch
advanced sarcoma;advanced sarcoma;exactmatch
breast carcinoma metastatic in the lymph nodes;breast carcinoma metastatic in lymph node;exactmatch
advanced synovial sarcoma;advanced synovial sarcoma;exactmatch
locally advanced skin squamous cell carcinoma;locally advanced cutaneous squamous cell carcinoma;exactmatch
refractory mediastinal lymphoma;refractory mediastinal lymphoma;exactmatch
recurrent mediastinal lymphoma;recurrent mediastinal lymphoma;exactmatch
advanced lymphoma;advanced lymphoma;exactmatch
advanced carcinoma;advanced carcinoma;exactmatch
advanced renal cell carcinoma;advanced renal cell carcinoma;exactmatch
breast carcinoma metastatic in the spine;breast carcinoma metastatic in the spine;exactmatch
metastatic breast carcinoma;metastatic breast carcinoma;exactmatch
refractory burkitt leukemia;refractory burkitt leukemia;exactmatch
metastatic unresectable gastric adenocarcinoma;metastatic unresectable gastric (stomach) adenocarcinoma;exactmatch
recurrent ebv-positive diffuse large b-cell lymphoma, not otherwise specified;recurrent ebv-positive diffuse large b-cell lymphoma, nos;exactmatch
unresectable chordoma;unresectable chordoma;exactmatch
locally advanced chordoma;locally advanced chordoma;exactmatch
metastatic chordoma;metastatic chordoma;exactmatch
metastatic gastric carcinoma;metastatic gastric carcinoma;exactmatch
metastatic gastric adenocarcinoma;metastatic gastric adenocarcinoma;exactmatch
advanced unresectable gastric adenocarcinoma;advanced unresectable gastric adenocarcinoma;exactmatch
metastatic unresectable carcinoma;metastatic unresectable carcinoma;exactmatch
fgfr gene rearrangement;fgf receptor gene family rearrangement;exactmatch
refractory ewing sarcoma/peripheral primitive neuroectodermal tumor;refractory ewing sarcoma/peripheral primitive neuroectodermal tumor;exactmatch
metastatic unresectable malignant neoplasm;metastatic unresectable malignant neoplasm;exactmatch
locally advanced unresectable malignant neoplasm;locally advanced unresectable malignant neoplasm;exactmatch
tfeb gene translocation;bhlhe35 gene translocation;exactmatch
tfe3 gene translocation;rccp2 gene translocation;exactmatch
nutm1 gene rearrangement;c15orf55 gene rearrangement;exactmatch
homologous recombination repair gene;hhr gene;exactmatch
advanced melanoma;advanced melanoma;exactmatch
refractory hepatosplenic t-cell lymphoma;refractory hepatosplenic t-cell lymphoma;exactmatch
recurrent hepatosplenic t-cell lymphoma;recurrent hepatosplenic t-cell lymphoma;exactmatch
blasts expressing b-lymphoid, t-lymphoid, and myeloid markers present;blasts expressing b-lymphoid, t-lymphoid, and myeloid markers present;exactmatch
distal esophagus adenocarcinoma;adenocarcinoma of the lower third of the esophagus;exactmatch
resectable pancreatic ductal adenocarcinoma;resectable pancreatic ductal adenocarcinoma;exactmatch
locally advanced pancreatic ductal adenocarcinoma;locally advanced pancreatic ductal adenocarcinoma;exactmatch
mixed phenotype acute leukemia, b/t, not otherwise specified;mixed phenotype acute leukemia, b/t, nos;exactmatch
mixed phenotype acute leukemia, b/t/myeloid, not otherwise specified;mixed phenotype acute leukemia, b/t/myeloid, nos;exactmatch
mixed phenotype acute leukemia, not otherwise specified, rare subtypes;mixed phenotype acute leukemia, nos, rare subtypes;exactmatch
blasts expressing b-lymphoid and t-lymphoid markers present;blasts expressing b-lymphoid and t-lymphoid markers present;exactmatch
abdominal undifferentiated pleomorphic sarcoma;abdominal undifferentiated pleomorphic sarcoma;exactmatch
resectable soft tissue sarcoma;resectable soft tissue sarcoma;exactmatch
pelvic undifferentiated high grade pleomorphic sarcoma;pelvic undifferentiated high grade pleomorphic sarcoma;exactmatch
unresectable rhabdomyosarcoma;unresectable rhabdomyosarcoma;exactmatch
abdominal rhabdomyosarcoma;abdominal rhabdomyosarcoma;exactmatch
pelvic rhabdomyosarcoma;pelvic rhabdomyosarcoma;exactmatch
recurrent high grade b-cell lymphoma with myc and bcl2 or bcl6 rearrangements;recurrent double-hit lymphoma;exactmatch
refractory high grade b-cell lymphoma with myc and bcl2 or bcl6 rearrangements;refractory double-hit lymphoma;exactmatch
refractory lymphoblastic lymphoma;refractory lymphoblastic lymphoma;exactmatch
refractory primary peritoneal carcinoma;refractory primary peritoneal cancer;exactmatch
refractory fallopian tube carcinoma;refractory fallopian tube cancer;exactmatch
refractory female reproductive system carcinoma;refractory female reproductive system cancer;exactmatch
metastatic unresectable sarcoma;metastatic unresectable sarcoma;exactmatch
refractory lung non-small cell carcinoma;refractory lung non-small cell carcinoma;exactmatch
unresectable carcinoid tumor;unresectable carcinoid tumor;exactmatch
unresectable pancreatic neuroendocrine carcinoma;unresectable pancreatic neuroendocrine cancer;exactmatch
metastatic pancreatic neuroendocrine carcinoma;metastatic pancreatic neuroendocrine cancer;exactmatch
unresectable synovial sarcoma;unresectable synovial sarcoma;exactmatch
metastatic bone sarcoma;metastatic bone sarcoma;exactmatch
unresectable bone sarcoma;unresectable bone sarcoma;exactmatch
locally advanced sarcoma;locally advanced sarcoma;exactmatch
locally advanced bone sarcoma;locally advanced bone sarcoma;exactmatch
metastatic soft tissue sarcoma;metastatic soft tissue sarcoma;exactmatch
unresectable soft tissue sarcoma;unresectable soft tissue sarcoma;exactmatch
locally advanced soft tissue sarcoma;locally advanced soft tissue sarcoma;exactmatch
refractory malignant head and neck neoplasm;refractory head and neck cancer;exactmatch
recurrent malignant head and neck neoplasm;recurrent head and neck cancer;exactmatch
metastatic sarcoma;metastatic sarcoma;exactmatch
refractory malignant soft tissue neoplasm;refractory malignant soft tissue neoplasm;exactmatch
recurrent malignant soft tissue neoplasm;recurrent malignant soft tissue neoplasm;exactmatch
refractory malignant mesothelioma;refractory malignant mesothelioma;exactmatch
diffuse large b-cell lymphoma, not otherwise specified molecular subtypes;dlbcl, nos genetic subtypes;exactmatch
pdgfr protein overexpression;pdgf receptor protein overexpression;exactmatch
pdgfr gene amplification;pdgf receptor gene amplification;exactmatch
refractory sinonasal squamous cell carcinoma;refractory nasal cavity and paranasal sinus squamous cell carcinoma;exactmatch
ezb diffuse large b-cell lymphoma;ezb dlbcl;exactmatch
n1 diffuse large b-cell lymphoma;n1 dlbcl;exactmatch
bn2 diffuse large b-cell lymphoma;bn2 dlbcl;exactmatch
mcd diffuse large b-cell lymphoma;mcd dlbcl;exactmatch
cd79b gene mutation;agm6 gene mutation;exactmatch
recurrent leukemia;recurrent leukemia;exactmatch
notch2 gene mutation;ags2 gene mutation;exactmatch
bcl6 gene fusion;b-cell cll/lymphoma 6 gene fusion;exactmatch
recurrent paranasal sinus squamous cell carcinoma;recurrent paranasal sinus squamous cell cancer;exactmatch
refractory paranasal sinus squamous cell carcinoma;refractory paranasal sinus squamous cell cancer;exactmatch
refractory oropharyngeal squamous cell carcinoma;refractory oropharyngeal squamous cell carcinoma;exactmatch
refractory oral cavity squamous cell carcinoma;refractory oral cavity squamous cell cancer;exactmatch
refractory laryngeal squamous cell carcinoma;refractory laryngeal squamous cell carcinoma;exactmatch
recurrent mixed phenotype acute leukemia;recurrent mixed phenotype acute leukemia;exactmatch
refractory leukemia;advanced leukemia;exactmatch
thoracic esophagus adenocarcinoma;thoracic esophagus adenocarcinoma;exactmatch
advanced urothelial carcinoma;advanced urothelial cancer;exactmatch
castration-naive prostate carcinoma;cnpc;exactmatch
unresectable melanoma;unresectable melanoma;exactmatch
advanced uveal melanoma;advanced uveal melanoma;exactmatch
metastatic uveal melanoma;metastatic uveal melanoma;exactmatch
refractory human papillomavirus-related malignant neoplasm;refractory human papillomavirus-related malignant neoplasm;exactmatch
recurrent human papillomavirus-related malignant neoplasm;recurrent human papillomavirus-related malignant neoplasm;exactmatch
locally advanced melanoma;locally advanced melanoma;exactmatch
refractory soft tissue sarcoma, excluding rhabdomyosarcoma;refractory soft tissue sarcoma, excluding rhabdomyosarcoma;exactmatch
recurrent acute myeloid leukemia;recurrent acute myeloid leukemia;exactmatch
recurrent soft tissue sarcoma, excluding rhabdomyosarcoma;recurrent soft tissue sarcoma, excluding rhabdomyosarcoma;exactmatch
soft tissue sarcoma, excluding rhabdomyosarcoma;soft tissue sarcoma, excluding rhabdomyosarcoma;exactmatch
refractory nasopharyngeal carcinoma;refractory nasopharyngeal carcinoma;exactmatch
unresectable intrahepatic cholangiocarcinoma;unresectable intrahepatic bile duct cancer (cholangiocarcinoma);exactmatch
refractory acute leukemia;refractory acute leukemia;exactmatch
refractory mixed phenotype acute leukemia;refractory mixed phenotype acute leukemia;exactmatch
recurrent acute leukemia;recurrent acute leukemia;exactmatch
refractory hypopharyngeal squamous cell carcinoma;refractory hypopharyngeal squamous cell carcinoma;exactmatch
recurrent myelodysplastic syndrome;recurrent myelodysplastic syndrome;exactmatch
refractory myelodysplastic syndrome;refractory myelodysplastic syndrome;exactmatch
refractory malignant thymoma;refractory malignant thymoma;exactmatch
metastatic thymic carcinoma;metastatic thymic carcinoma;exactmatch
recurrent thymic carcinoma;recurrent thymic carcinoma;exactmatch
locally advanced thymic carcinoma;locally advanced thymic carcinoma;exactmatch
unresectable thymic carcinoma;unresectable thymic carcinoma;exactmatch
unresectable carcinoma;unresectable carcinoma;exactmatch
somatic kit gene mutation;c-kit somatic mutation;exactmatch
hedgehog pathway mutation;hedgehog pathway gene mutation;exactmatch
recurrent craniopharyngioma;recurrent craniopharyngioma;exactmatch
unresectable sarcoma;unresectable sarcoma;exactmatch
unresectable craniopharyngioma;unresectable craniopharyngioma;exactmatch
cd34 positive;cd34 antigen positive;exactmatch
advanced b-cell neoplasm;advanced b-cell neoplasm;exactmatch
recurrent who grade iii glioma;recurrent grade iii glioma;exactmatch
recurrent who grade ii glioma;recurrent grade ii glioma;exactmatch
unresectable malignant solid neoplasm;unresectable malignant solid neoplasm;exactmatch
childhood malignant solid neoplasm;childhood malignant solid neoplasm;exactmatch
refractory mycosis fungoides and sezary syndrome;refractory mycosis fungoides and sezary syndrome;exactmatch
locally advanced carcinoma;locally advanced carcinoma;exactmatch
refractory head and neck squamous cell carcinoma;refractory head and neck squamous cell cancer;exactmatch
metastatic head and neck squamous cell carcinoma;metastatic head and neck squamous cell cancer;exactmatch
recurrent sarcoma;recurrent sarcoma;exactmatch
refractory sarcoma;refractory sarcoma;exactmatch
metastatic round cell liposarcoma;metastatic round cell liposarcoma;exactmatch
refractory round cell liposarcoma;refractory round cell liposarcoma;exactmatch
metastatic myxoid liposarcoma;metastatic myxoid liposarcoma;exactmatch
refractory myxoid liposarcoma;refractory myxoid liposarcoma;exactmatch
refractory synovial sarcoma;refractory synovial sarcoma;exactmatch
refractory undifferentiated pleomorphic sarcoma;refractory undifferentiated pleomorphic sarcoma;exactmatch
refractory leiomyosarcoma;refractory leiomyosarcoma;exactmatch
refractory stage 0 bladder cancer ajcc v6 and v7;refractory bladder carcinoma in situ ajcc v6 and v7;exactmatch
unresectable cutaneous melanoma;unresectable cutaneous (skin) melanoma;exactmatch
recurrent grade 3a follicular lymphoma;recurrent grade 3a follicular lymphoma;exactmatch
refractory indolent adult non-hodgkin lymphoma;refractory indolent adult non-hodgkin lymphoma;exactmatch
histone gene;histone gene;exactmatch
refractory thymic carcinoma;refractory thymic carcinoma;exactmatch
castration-naive;castration-naive;exactmatch
thoracic esophagus squamous cell carcinoma;thoracic esophagus squamous cell carcinoma;exactmatch
refractory malignant male reproductive system neoplasm;refractory malignant male reproductive system neoplasm;exactmatch
blasts 5 percent or less of peripheral blood white cells;blasts 5 percent or less of peripheral blood white cells;exactmatch
intestinal t-cell lymphoma;intestinal t-cell lymphoma;exactmatch
chromosome 7 rearrangement;chromosome 7 rearrangement;exactmatch
chromosome 5 rearrangement;chromosome 5 rearrangement;exactmatch
cdkn1b gene mutation;cdkn1b gene mutation;exactmatch
cdk4 gene mutation;cdk4 gene mutation;exactmatch
cdh1 gene mutation;arc-1 gene mutation;exactmatch
blasts more than 10 percent of peripheral blood white cells;blasts greater than 10 percent of peripheral blood white cells;exactmatch
alk gene product;alk gene product;exactmatch
intestinal t-cell lymphoma, not otherwise specified;intestinal t-cell lymphoma, nos;exactmatch
hmb45-positive cells present;hmb-45 positive;exactmatch
body cavity primary effusion lymphoma;body cavity pel;exactmatch
extracavitary primary effusion lymphoma;extracavitary pel;exactmatch
hhv8-positive germinotropic lymphoproliferative disorder;glpd;exactmatch
hhv8-positive multicentric castleman disease;hhv8-positive multicentric castleman disease;exactmatch
hhv8-related lymphoproliferative disorder;hhv8-associated lymphoproliferative disorder;exactmatch
fibrin-associated diffuse large b-cell lymphoma;fibrin-associated diffuse large b-cell lymphoma;exactmatch
small intestinal monomorphic epitheliotropic t-cell lymphoma;small intestinal monomorphic epitheliotropic t-cell lymphoma;exactmatch
refractory t acute lymphoblastic leukemia;refractory t acute lymphoblastic leukemia;exactmatch
cervical esophagus adenocarcinoma;cervical esophagus adenocarcinoma;exactmatch
recurrent malignant female reproductive system neoplasm;recurrent malignant female reproductive system neoplasm;exactmatch
recurrent malignant male reproductive system neoplasm;recurrent malignant male reproductive system neoplasm;exactmatch
refractory malignant pharyngeal neoplasm;refractory malignant pharyngeal neoplasm;exactmatch
recurrent malignant pharyngeal neoplasm;recurrent malignant pharyngeal neoplasm;exactmatch
refractory malignant oral neoplasm;refractory malignant lip and oral cavity neoplasm;exactmatch
refractory malignant neoplasm of multiple primary sites;refractory malignant neoplasm of multiple primary sites;exactmatch
recurrent malignant neoplasm of multiple primary sites;recurrent malignant neoplasm of multiple primary sites;exactmatch
refractory malignant female reproductive system neoplasm;refractory malignant female reproductive system neoplasm;exactmatch
refractory malignant bone neoplasm;refractory malignant bone neoplasm;exactmatch
metastatic urethral urothelial carcinoma;metastatic urethral urothelial cancer;exactmatch
recurrent malignant bone neoplasm;recurrent malignant bone neoplasm;exactmatch
unresectable urothelial carcinoma;unresectable urothelial carcinoma;exactmatch
recurrent renal pelvis urothelial carcinoma;recurrent renal pelvis urothelial cancer;exactmatch
recurrent ureter urothelial carcinoma;recurrent ureter urothelial cancer;exactmatch
metastatic ureter urothelial carcinoma;metastatic ureter urothelial cancer;exactmatch
metastatic renal pelvis urothelial carcinoma;metastatic renal pelvis urothelial cancer;exactmatch
metastatic bladder urothelial carcinoma;metastatic bladder urothelial cancer;exactmatch
small aggregates of tumor cells present;small aggregates of tumor cells present;exactmatch
fibrinous material present;fibrinous material present;exactmatch
platinum-resistant urothelial carcinoma;platinum-refractory urothelial carcinoma;exactmatch
refractory uterine corpus cancer;refractory uterine corpus cancer;exactmatch
high grade myeloid neoplasm;high grade myeloid neoplasm;exactmatch
refractory endometrial endometrioid adenocarcinoma;refractory endometrial endometrioid adenocarcinoma;exactmatch
recurrent endometrial endometrioid adenocarcinoma;recurrent endometrial endometrioid adenocarcinoma;exactmatch
refractory ovarian endometrioid adenocarcinoma;refractory ovarian endometrioid adenocarcinoma;exactmatch
recurrent ovarian endometrioid adenocarcinoma;recurrent ovarian endometrioid adenocarcinoma;exactmatch
recurrent endometrial carcinoma;recurrent endometrial carcinoma;exactmatch
refractory endometrial carcinoma;refractory endometrial carcinoma;exactmatch
refractory ovarian carcinoma;refractory ovarian carcinoma;exactmatch
refractory urothelial carcinoma;refractory urothelial carcinoma;exactmatch
refractory chronic myelomonocytic leukemia;refractory chronic myelomonocytic leukemia;exactmatch
recurrent chronic myelomonocytic leukemia;recurrent chronic myelomonocytic leukemia;exactmatch
refractory chronic leukemia;refractory chronic leukemia;exactmatch
recurrent chronic leukemia;recurrent chronic leukemia;exactmatch
distal esophagus squamous cell carcinoma;distal esophagus squamous cell carcinoma;exactmatch
gastric cardia squamous cell carcinoma;gastric cardia squamous cell carcinoma;exactmatch
cervical esophagus squamous cell carcinoma;cervical esophagus squamous cell carcinoma;exactmatch
biomarker positive malignant neoplasm;biomarker positive cancer;exactmatch
uveal melanoma metastatic in the liver;metastatic uveal melanoma in the liver;exactmatch
recurrent t acute lymphoblastic leukemia;recurrent t acute lymphoblastic leukemia;exactmatch
recurrent monomorphic epitheliotropic intestinal t-cell lymphoma;recurrent monomorphic epitheliotropic intestinal t-cell lymphoma;exactmatch
bilateral synchronous sporadic renal cell carcinoma;bssrcc;exactmatch
refractory bladder carcinoma;refractory bladder cancer;exactmatch
samd9 gene;samd9;exactmatch
high risk neuroblastoma;high risk neuroblastoma;exactmatch
metastatic laryngeal squamous cell carcinoma;metastatic laryngeal squamous cell carcinoma;exactmatch
metastatic hypopharyngeal squamous cell carcinoma;metastatic hypopharyngeal squamous cell carcinoma;exactmatch
advanced laryngeal squamous cell carcinoma;advanced laryngeal squamous cell carcinoma;exactmatch
advanced hypopharyngeal squamous cell carcinoma;advanced hypopharyngeal squamous cell carcinoma;exactmatch
metastatic nasopharyngeal squamous cell carcinoma;metastatic nasopharyngeal squamous cell carcinoma;exactmatch
advanced nasopharyngeal squamous cell carcinoma;advanced nasopharyngeal squamous cell carcinoma;exactmatch
metastatic oral cavity squamous cell carcinoma;metastatic oral cavity squamous cell cancer;exactmatch
advanced oral cavity squamous cell carcinoma;advanced oral cavity squamous cell cancer;exactmatch
metastatic oropharyngeal squamous cell carcinoma;metastatic oropharyngeal squamous cell carcinoma;exactmatch
advanced oropharyngeal squamous cell carcinoma;advanced oropharyngeal squamous cell carcinoma;exactmatch
recurrent t-cell prolymphocytic leukemia;recurrent t-cell prolymphocytic leukemia;exactmatch
refractory ebv-positive diffuse large b-cell lymphoma, not otherwise specified;refractory ebv-positive diffuse large b-cell lymphoma, nos;exactmatch
castration-sensitive;castration-sensitive;exactmatch
castration-sensitive prostate carcinoma;cspc;exactmatch
refractory digestive system neuroendocrine carcinoma;refractory digestive system neuroendocrine carcinoma;exactmatch
broad ligament papillary cystadenoma;broad ligament papillary cystadenoma;exactmatch
chromophobe renal cell carcinoma associated with birt-hogg-dube syndrome;chromophobe renal cell carcinoma associated with birt-hogg-dube syndrome;exactmatch
hereditary malignant urinary system neoplasm;hereditary malignant urinary system neoplasm;exactmatch
medullary hemangioblastoma;medullary hemangioblastoma;exactmatch
spinal hemangioblastoma;spinal hemangioblastoma;exactmatch
cerebral hemangioblastoma;cerebral hemangioblastoma;exactmatch
recurrent digestive system neuroendocrine carcinoma;recurrent digestive system neuroendocrine carcinoma;exactmatch
metastatic digestive system neuroendocrine carcinoma;metastatic digestive system neuroendocrine carcinoma;exactmatch
intestinal polyposis syndrome;intestinal polyposis syndrome;exactmatch
unresectable digestive system neuroendocrine carcinoma;unresectable digestive system neuroendocrine carcinoma;exactmatch
locally advanced digestive system neuroendocrine carcinoma;locally advanced digestive system neuroendocrine carcinoma;exactmatch
locally advanced pancreatic neuroendocrine carcinoma;locally advanced pancreatic neuroendocrine carcinoma;exactmatch
metastatic malignant neoplasm in the thoracic cavity;metastatic malignant neoplasm in the thoracic cavity;exactmatch
bone marrow lymphoplasmacytic infiltrate;bone marrow lymphoplasmacytic infiltrate;exactmatch
smoldering waldenstrom macroglobulinemia;asymptomatic waldenstrom macroglobulinemia;exactmatch
metastatic lung adenocarcinoma;metastatic lung adenocarcinoma;exactmatch
epididymal papillary cystadenoma;epididymal papillary cystadenoma;exactmatch
thyroid gland spindle cell follicular adenoma;thyroid gland spindle cell follicular adenoma;exactmatch
temporal lobe anaplastic astrocytoma;temporal lobe anaplastic astrocytoma;exactmatch
refractory neurofibromatosis type 1;refractory neurofibromatosis type 1;exactmatch
encapsulated variant thyroid gland papillary carcinoma;encapsulated variant thyroid gland papillary carcinoma;exactmatch
receptor tyrosine kinase gene amplification;rtk amplification;exactmatch
receptor tyrosine kinase gene rearrangement;rtk family gene rearrangement;exactmatch
myeloblasts present;myeloblasts positive;exactmatch
blasts 2 percent or more of peripheral blood white cells;blasts 2 percent or more of peripheral blood white cells;exactmatch
etv6 gene rearrangement;ets variant 6 gene rearrangement;exactmatch
refractory malignant peripheral nerve sheath tumor;refractory malignant peripheral nerve sheath tumor;exactmatch
recurrent neurofibromatosis type 1;recurrent neurofibromatosis type 1;exactmatch
thyroid gland black follicular adenoma;thyroid gland black follicular adenoma;exactmatch
refractory visual pathway glioma;refractory visual pathway glioma;exactmatch
recurrent visual pathway glioma;recurrent visual pathway glioma;exactmatch
questionable invasive lesion;questionable invasive lesion;exactmatch
thyroid gland follicular tumor of uncertain malignant potential;ft-ump;exactmatch
recurrent chordoma;recurrent chordoma;exactmatch
cytoplasmic accumulation of black pigment;cytoplasmic accumulation of black pigment;exactmatch
black discoloration;black discoloration;exactmatch
unresectable digestive system carcinoma;unresectable digestive system carcinoma;exactmatch
unresectable lung carcinoma;unresectable lung carcinoma;exactmatch
unresectable lung non-small cell carcinoma;unresectable lung non-small cell carcinoma;exactmatch
sellar germ cell tumor;germ cell tumor of the sellar region;exactmatch
sellar mature teratoma;mature teratoma of the sellar region;exactmatch
sellar teratoma;sellar teratoma;exactmatch
sellar choriocarcinoma;choriocarcinoma of the sellar region;exactmatch
sellar embryonal carcinoma;embryonal carcinoma of the sellar region;exactmatch
sellar yolk sac tumor;sellar yolk sac tumor;exactmatch
suprasellar germinoma;germinoma of the suprasellar region;exactmatch
sellar germinoma;germinoma of the sellar region;exactmatch
pituitary gland diffuse large b-cell lymphoma;pituitary gland diffuse large b-cell lymphoma;exactmatch
unresectable desmoid fibromatosis;unresectable desmoid fibromatosis;exactmatch
pituitary gland non-hodgkin lymphoma;pituitary gland non-hodgkin lymphoma;exactmatch
benign skull base neoplasm;benign skull base neoplasm;exactmatch
benign skull neoplasm;benign skull neoplasm;exactmatch
malignant skull base neoplasm;malignant skull base neoplasm;exactmatch
malignant skull neoplasm;malignant skull neoplasm;exactmatch
metastatic malignant neoplasm in the sellar region;metastatic malignant neoplasm in the sellar region;exactmatch
sellar solitary fibrous tumor/hemangiopericytoma;sellar hemangiopericytoma/ solitary fibrous tumor;exactmatch
sellar immature teratoma;immature teratoma of the sellar region;exactmatch
sellar teratoma with malignant transformation;sellar teratoma with malignant transformation;exactmatch
sellar mixed germ cell tumor;mixed germ cell tumor of the sellar region;exactmatch
recurrent endometrial clear cell adenocarcinoma;recurrent endometrial clear cell adenocarcinoma;exactmatch
recurrent desmoid fibromatosis;recurrent desmoid fibromatosis;exactmatch
locally advanced unresectable gastric adenocarcinoma;locally advanced unresectable gastric adenocarcinoma;exactmatch
chest wall sarcoma;chest wall sarcoma;exactmatch
advanced neuroendocrine carcinoma;advanced neuroendocrine carcinoma;exactmatch
metastatic neuroendocrine carcinoma;metastatic neuroendocrine carcinoma;exactmatch
low grade neuroendocrine lesion;low grade neuroendocrine lesion;exactmatch
poorly differentiated neuroendocrine lesion;poorly differentiated neuroendocrine lesion;exactmatch
intermediate grade neuroendocrine lesion;intermediate grade neuroendocrine lesion;exactmatch
well differentiated neuroendocrine lesion;neuroendocrine tumor, well differentiated;exactmatch
metastatic malignant pancreatic neoplasm;metastatic malignant pancreatic neoplasm;exactmatch
unresectable low grade glioma;unresectable low grade glioma;exactmatch
aerodigestive invasive malignancy;aerodigestive invasive malignancy;exactmatch
recurrent endometrial mixed cell adenocarcinoma;recurrent endometrial mixed cell adenocarcinoma;exactmatch
recurrent uterine corpus carcinosarcoma;recurrent uterine corpus carcinosarcoma;exactmatch
recurrent endometrial undifferentiated carcinoma;recurrent endometrial undifferentiated carcinoma;exactmatch
frontal lobe anaplastic astrocytoma;frontal lobe anaplastic astrocytoma;exactmatch
third ventricle pilocytic astrocytoma;third ventricle pilocytic astrocytoma;exactmatch
sellar chondroid chordoma;sellar chondroid chordoma;exactmatch
creb3l2/pparg fusion gene;creb3l2-pparg fusion gene;exactmatch
locally advanced pancreatic adenocarcinoma;locally advanced pancreatic adenocarcinoma;exactmatch
ectopic thyroid gland thymoma;ectopic thyroid gland thymoma;exactmatch
thyroid gland mucinous carcinoma;thyroid gland mucinous carcinoma;exactmatch
refractory aggressive non-hodgkin lymphoma;refractory aggressive non-hodgkin lymphoma;exactmatch
recurrent aggressive non-hodgkin lymphoma;recurrent aggressive non-hodgkin lymphoma;exactmatch
localized gastric carcinoma;localized gastric carcinoma;exactmatch
localized gastroesophageal junction adenocarcinoma;localized gastroesophageal junction adenocarcinoma;exactmatch
thyroid gland follicular carcinoma, widely invasive;ftc, widely invasive;exactmatch
tongue sarcoma;tongue sarcoma;exactmatch
thyroid gland follicular carcinoma, encapsulated angioinvasive;ftc, encapsulated angioinvasive;exactmatch
frontal lobe anaplastic oligodendroglioma;frontal lobe anaplastic oligodendroglioma;exactmatch
refractory blastic plasmacytoid dendritic cell neoplasm;refractory blastic plasmacytoid dendritic cell neoplasm;exactmatch
recurrent blastic plasmacytoid dendritic cell neoplasm;recurrent blastic plasmacytoid dendritic cell neoplasm;exactmatch
metastatic neuroblastoma;metastatic neuroblastoma;exactmatch
metastatic thyroid gland papillary carcinoma;metastatic thyroid gland papillary carcinoma;exactmatch
metastatic thyroid gland follicular carcinoma;metastatic thyroid gland follicular carcinoma;exactmatch
tongue alveolar soft part sarcoma';tongue alveolar soft part sarcoma';exactmatch
orbital alveolar soft part sarcoma;orbital alveolar soft part sarcoma;exactmatch
hypothalamic-chiasmatic pilomyxoid astrocytoma;hypothalamic-chiasmatic pilomyxoid astrocytoma;exactmatch
advanced prostate adenocarcinoma;advanced prostate adenocarcinoma;exactmatch
locally advanced cervical carcinoma;locally advanced cervical carcinoma;exactmatch
advanced cervical carcinoma;advanced cervical carcinoma;exactmatch
high risk chronic myelomonocytic leukemia;high risk chronic myelomonocytic leukemia;exactmatch
high risk acute myeloid leukemia;high risk acute myeloid leukemia;exactmatch
locally advanced unresectable prostate adenocarcinoma;locally advanced unresectable prostate adenocarcinoma;exactmatch
locally advanced unresectable prostate carcinoma;locally advanced unresectable prostate carcinoma;exactmatch
locally advanced prostate adenocarcinoma;locally advanced prostate adenocarcinoma;exactmatch
locally advanced prostate carcinoma;locally advanced prostate carcinoma;exactmatch
bladder alveolar soft part sarcoma;bladder alveolar soft part sarcoma;exactmatch
advanced prostate carcinoma;advanced prostate carcinoma;exactmatch
scrotal sarcoma;scrotal sarcoma;exactmatch
scrotal liposarcoma;scrotal liposarcoma;exactmatch
parotid gland liposarcoma;parotid gland liposarcoma;exactmatch
parotid gland sarcoma;parotid gland sarcoma;exactmatch
colon liposarcoma;colon liposarcoma;exactmatch
cellular nerve sheath myxoma;cellular nerve sheath myxoma;exactmatch
metastatic rectal carcinoma;metastatic rectal carcinoma;exactmatch
metastatic colon carcinoma;metastatic colon carcinoma;exactmatch
metastatic colorectal carcinoma;metastatic colorectal carcinoma;exactmatch
metastatic ovarian carcinoma;metastatic ovarian carcinoma;exactmatch
metastatic cutaneous melanoma;metastatic cutaneous melanoma;exactmatch
metastatic adult soft tissue sarcoma;metastatic adult soft tissue sarcoma;exactmatch
metastatic adrenal cortex carcinoma;metastatic adrenal cortex carcinoma;exactmatch
metastatic pancreatic carcinoma;metastatic pancreatic carcinoma;exactmatch
metastatic endometrial carcinoma;metastatic endometrial carcinoma;exactmatch
metastatic vulvar carcinoma;metastatic vulvar carcinoma;exactmatch
metastatic vaginal carcinoma;metastatic vaginal carcinoma;exactmatch
metastatic fallopian tube carcinoma;metastatic fallopian tube carcinoma;exactmatch
metastatic lung small cell carcinoma;metastatic lung small cell carcinoma;exactmatch
metastatic bladder carcinoma;metastatic bladder carcinoma;exactmatch
hobnail variant thyroid gland papillary carcinoma;hobnail variant thyroid gland papillary carcinoma;exactmatch
spindle cell variant thyroid gland papillary carcinoma;spindle cell variant thyroid gland papillary carcinoma;exactmatch
temporal lobe pleomorphic xanthoastrocytoma;temporal lobe pleomorphic xanthoastrocytoma;exactmatch
supratentorial pleomorphic xanthoastrocytoma;supratentorial pleomorphic xanthoastrocytoma;exactmatch
third ventricle germinoma;third ventricle germinoma;exactmatch
fourth ventricle medulloblastoma;fourth ventricle medulloblastoma;exactmatch
metastatic esophageal carcinoma;metastatic esophageal carcinoma;exactmatch
metastatic esophageal adenocarcinoma;metastatic esophageal adenocarcinoma;exactmatch
metastatic esophageal squamous cell carcinoma;metastatic esophageal squamous cell carcinoma;exactmatch
metastatic nasopharyngeal keratinizing squamous cell carcinoma;metastatic nasopharyngeal keratinizing squamous cell carcinoma;exactmatch
metastatic lung non-small cell carcinoma;metastatic lung non-small cell carcinoma;exactmatch
metastatic lung adenosquamous carcinoma;metastatic lung adenosquamous carcinoma;exactmatch
metastatic lung squamous cell carcinoma;metastatic lung squamous cell carcinoma;exactmatch
metastatic lip squamous cell carcinoma;metastatic lip squamous cell carcinoma;exactmatch
metastatic oral cavity mucoepidermoid carcinoma;metastatic oral cavity mucoepidermoid carcinoma;exactmatch
metastatic oral cavity adenoid cystic carcinoma;metastatic oral cavity adenoid cystic carcinoma;exactmatch
metastatic lip carcinoma;metastatic lip carcinoma;exactmatch
metastatic oral cavity carcinoma;metastatic oral cavity carcinoma;exactmatch
metastatic lip and oral cavity carcinoma;metastatic lip and oral cavity carcinoma;exactmatch
metastatic laryngeal carcinoma;metastatic laryngeal carcinoma;exactmatch
metastatic oropharyngeal carcinoma;metastatic oropharyngeal carcinoma;exactmatch
metastatic hypopharyngeal carcinoma;metastatic hypopharyngeal carcinoma;exactmatch
metastatic pharyngeal carcinoma;metastatic pharyngeal carcinoma;exactmatch
metastatic nasopharyngeal carcinoma;metastatic nasopharyngeal carcinoma;exactmatch
metastatic nasopharyngeal undifferentiated carcinoma;metastatic nasopharyngeal undifferentiated carcinoma;exactmatch
sellar dedifferentiated chordoma;sellar dedifferentiated chordoma;exactmatch
sellar chordoma;sellar chordoma;exactmatch
recurrent ovarian carcinosarcoma;recurrent ovarian carcinosarcoma;exactmatch
recurrent ovarian clear cell adenocarcinoma;recurrent ovarian clear cell adenocarcinoma;exactmatch
recurrent skin angiosarcoma;recurrent skin angiosarcoma;exactmatch
recurrent thyroid gland anaplastic carcinoma;recurrent thyroid gland anaplastic carcinoma;exactmatch
recurrent thyroid gland medullary carcinoma;recurrent thyroid gland medullary carcinoma;exactmatch
recurrent thyroid gland follicular carcinoma;recurrent thyroid gland follicular carcinoma;exactmatch
recurrent thyroid gland papillary carcinoma;recurrent thyroid gland papillary carcinoma;exactmatch
recurrent pancreatic cystadenocarcinoma;recurrent pancreatic cystadenocarcinoma;exactmatch
recurrent pancreatic ductal adenocarcinoma;recurrent pancreatic ductal adenocarcinoma;exactmatch
recurrent ovarian cystadenocarcinoma;recurrent ovarian cystadenocarcinoma;exactmatch
recurrent submandibular gland carcinoma;recurrent submandibular gland carcinoma;exactmatch
recurrent ovarian mucinous adenocarcinoma;recurrent ovarian mucinous adenocarcinoma;exactmatch
recurrent ovarian serous adenocarcinoma;recurrent ovarian serous adenocarcinoma;exactmatch
recurrent ovarian adenocarcinoma;recurrent ovarian adenocarcinoma;exactmatch
recurrent fallopian tube serous adenocarcinoma;recurrent fallopian tube serous adenocarcinoma;exactmatch
recurrent minor salivary gland adenocarcinoma;recurrent minor salivary gland adenocarcinoma;exactmatch
recurrent salivary duct carcinoma;recurrent salivary duct carcinoma;exactmatch
recurrent chromophobe renal cell carcinoma;recurrent chromophobe renal cell carcinoma;exactmatch
recurrent parotid gland carcinoma;recurrent parotid gland carcinoma;exactmatch
recurrent appendix carcinoma;recurrent appendix carcinoma;exactmatch
cd1a positive;antigen cd1a positive;exactmatch
recurrent parotid gland undifferentiated carcinoma;recurrent parotid gland undifferentiated carcinoma;exactmatch
refractory malignant brain neoplasm;refractory malignant brain neoplasm;exactmatch
refractory primary malignant central nervous system neoplasm;refractory malignant central nervous system neoplasm;exactmatch
recurrent malignant brain neoplasm;recurrent malignant brain neoplasm;exactmatch
recurrent primary malignant central nervous system neoplasm;recurrent malignant central nervous system neoplasm;exactmatch
recurrent ovarian transitional cell carcinoma;recurrent ovarian transitional cell carcinoma;exactmatch
recurrent malignant ovarian brenner tumor;recurrent malignant ovarian brenner tumor;exactmatch
recurrent malignant ovarian transitional cell tumor;recurrent malignant ovarian transitional cell tumor;exactmatch
recurrent submandibular gland undifferentiated carcinoma;recurrent submandibular gland undifferentiated carcinoma;exactmatch
recurrent parotid gland adenoid cystic carcinoma;recurrent parotid gland adenoid cystic carcinoma;exactmatch
recurrent submandibular gland squamous cell carcinoma;recurrent submandibular gland squamous cell carcinoma;exactmatch
recurrent parotid gland squamous cell carcinoma;recurrent parotid gland squamous cell carcinoma;exactmatch
recurrent submandibular gland adenoid cystic carcinoma;recurrent submandibular gland adenoid cystic carcinoma;exactmatch
recurrent submandibular gland carcinoma ex pleomorphic adenoma;recurrent submandibular gland carcinoma ex pleomorphic adenoma;exactmatch
recurrent submandibular gland mucoepidermoid carcinoma;recurrent submandibular gland mucoepidermoid carcinoma;exactmatch
recurrent parotid gland mucoepidermoid carcinoma;recurrent parotid gland mucoepidermoid carcinoma;exactmatch
recurrent parotid gland carcinoma ex pleomorphic adenoma;recurrent parotid gland carcinoma ex pleomorphic adenoma;exactmatch
recurrent clear cell renal cell carcinoma;recurrent clear cell renal cell carcinoma;exactmatch
recurrent breast paget disease;recurrent breast paget disease;exactmatch
recurrent invasive breast carcinoma of no special type;recurrent invasive breast carcinoma of no special type;exactmatch
recurrent bile duct carcinoma;recurrent bile duct carcinoma;exactmatch
metastatic cervical adenocarcinoma;metastatic cervical adenocarcinoma;exactmatch
metastatic cervical squamous cell carcinoma, not otherwise specified;metastatic cervical squamous cell carcinoma;exactmatch
metastatic cervical carcinoma;metastatic cervical carcinoma;exactmatch
neoplastic plasma cells under 50 percent of bone marrow nucleated cells;neoplastic plasma cells less than 50 percent of bone marrow nucleated cells;exactmatch
locally advanced soft tissue sarcoma, excluding liposarcoma;locally advanced soft tissue sarcoma, excluding liposarcoma;exactmatch
metastatic soft tissue sarcoma, excluding liposarcoma;metastatic soft tissue sarcoma, excluding liposarcoma;exactmatch
soft tissue sarcoma, excluding liposarcoma;soft tissue sarcoma, excluding liposarcoma;exactmatch
recurrent gastroesophageal junction adenocarcinoma;recurrent gastroesophageal junction adenocarcinoma;exactmatch
recurrent lobular breast carcinoma;recurrent lobular breast carcinoma;exactmatch
locally advanced digestive system carcinoma;locally advanced digestive system carcinoma;exactmatch
locally advanced small intestinal carcinoma;locally advanced small intestinal carcinoma;exactmatch
refractory small intestinal carcinoma;refractory small intestinal carcinoma;exactmatch
refractory bile duct carcinoma;refractory bile duct carcinoma;exactmatch
refractory liver carcinoma;refractory liver carcinoma;exactmatch
refractory colon carcinoma;refractory colon carcinoma;exactmatch
metastatic triple-negative breast carcinoma;metastatic triple-negative breast carcinoma;exactmatch
metastatic cervical adenosquamous carcinoma;metastatic cervical adenosquamous carcinoma;exactmatch
pmel positive;me20 positive;exactmatch
locally advanced unresectable bone sarcoma;locally advanced unresectable bone sarcoma;exactmatch
locally advanced unresectable soft tissue sarcoma;locally advanced unresectable soft tissue sarcoma;exactmatch
recurrent appendix mucinous adenocarcinoma;recurrent appendix mucinous adenocarcinoma;exactmatch
recurrent paget disease of the anal canal;recurrent paget disease of the anal canal;exactmatch
recurrent anal mucinous adenocarcinoma;recurrent anal mucinous adenocarcinoma;exactmatch
recurrent anal adenocarcinoma;recurrent anal adenocarcinoma;exactmatch
recurrent ampulla of vater adenocarcinoma;recurrent ampulla of vater adenocarcinoma;exactmatch
recurrent cervical mucinous adenocarcinoma, endocervical type;recurrent cervical mucinous adenocarcinoma, endocervical type;exactmatch
recurrent submandibular gland acinic cell carcinoma;recurrent submandibular gland acinic cell carcinoma;exactmatch
recurrent parotid gland acinic cell carcinoma;recurrent parotid gland acinic cell carcinoma;exactmatch
recurrent prostate acinar adenocarcinoma;recurrent prostate acinar adenocarcinoma;exactmatch
recurrent pancreatic acinar cell carcinoma;recurrent pancreatic acinar cell carcinoma;exactmatch
recurrent breast acinic cell carcinoma;recurrent acinic cell breast carcinoma;exactmatch
mgmt gene promoter methylation;mgmt gene methylation;exactmatch
xp11.2 translocation;xp11.2 translocation;exactmatch
t-cell receptor gene rearrangement;t cell receptor family gene rearrangement;exactmatch
locally advanced unresectable sarcoma;locally advanced unresectable sarcoma;exactmatch
refractory who grade iii glioma;refractory who grade iii glioma;exactmatch
metastatic fibrolamellar carcinoma;metastatic flc;exactmatch
sellar schwannoma;sellar neurilemmoma;exactmatch
experimental organism adenocarcinoma arising in fibroadenoma;adenocarcinoma arising in fibroadenoma, malignant;exactmatch
pituitary gland blastoma;pituitary blastoma;exactmatch
gain of chromosome 14q;gain of chromosome 14q;exactmatch
progesterone receptor negative;negative;exactmatch
progesterone receptor positive;pgr positive;exactmatch
estrogen receptor negative;er alpha negative;exactmatch
estrogen receptor positive;er alpha positive;exactmatch
cytoplasmic alteration;cytoplasmic alteration;exactmatch
transplant-related squamous cell carcinoma;transplant-associated squamous cell carcinoma;exactmatch
recurrent cutaneous melanoma of the extremity;recurrent cutaneous melanoma of the extremity;exactmatch
digestive system small cell neuroendocrine carcinoma;digestive system small cell carcinoma;exactmatch
recurrent gastric adenocarcinoma;recurrent gastric adenocarcinoma;exactmatch
advanced well differentiated neuroendocrine neoplasm;advanced well differentiated neuroendocrine neoplasm;exactmatch
digestive system large cell neuroendocrine carcinoma;digestive system large cell neuroendocrine carcinoma;exactmatch
recurrent metastatic malignant neoplasm;recurrent metastatic malignant neoplasm;exactmatch
resectable renal cell carcinoma;resectable renal cell carcinoma;exactmatch
unresectable renal cell carcinoma;unresectable renal cell carcinoma;exactmatch
cutaneous melanoma of the extremity;cutaneous melanoma of the extremity;exactmatch
advanced cutaneous melanoma of the extremity;advanced cutaneous melanoma of the extremity;exactmatch
recurrent fibrolamellar carcinoma;recurrent flc;exactmatch
sellar neurocytoma;extraventricular neurocytoma of the sellar region;exactmatch
intrasellar region;intrasellar region;exactmatch
intrasellar meningioma;intrasellar meningioma;exactmatch
sellar region;sellar region;exactmatch
sellar meningioma;sellar meningioma;exactmatch
sellar ependymoma;sellar ependymoma;exactmatch
sellar neuroblastoma;sellar esthesioneuroblastoma;exactmatch
pituitary gland paraganglioma;pituitary gland paraganglioma;exactmatch
pituitary gland mixed gangliocytoma-adenoma;pituitary gland adenoma with gangliocytic component;exactmatch
sarcoma of the extremity;extremity sarcoma;exactmatch
locally advanced unresectable pancreatic adenocarcinoma;locally advanced unresectable pancreatic adenocarcinoma;exactmatch
recurrent pancreatic adenocarcinoma;recurrent pancreatic adenocarcinoma;exactmatch
locally advanced unresectable renal cell carcinoma;locally advanced unresectable renal cell carcinoma;exactmatch
locally advanced unresectable carcinoma;locally advanced unresectable carcinoma;exactmatch
primitive mesenchymal stroma formation;primitive mesenchymal stroma formation;exactmatch
advanced sarcoma of the extremity;advanced extremity sarcoma;exactmatch
recurrent sarcoma of the extremity;recurrent extremity sarcoma;exactmatch
more than two separate tumor masses present in the same organ;more than two separate tumor masses present in the same organ;exactmatch
two separate tumor masses present in the same organ;two separate tumor masses present in the same organ;exactmatch
pituitary gland multiple adenomas;pituitary gland multiple adenomas;exactmatch
locally advanced sinonasal squamous cell carcinoma;locally advanced nasal cavity and paranasal sinus squamous cell carcinoma;exactmatch
sparsely granulated corticotroph adenoma;sparsely granulated corticotroph adenoma;exactmatch
densely granulated corticotroph adenoma;densely granulated corticotroph adenoma;exactmatch
neoplastic corticotroph cell with scarce secretory granules;neoplastic corticotroph cell with scarce secretory granules;exactmatch
neoplastic corticotroph cell with abundant secretory granules;neoplastic corticotroph cell with abundant secretory granules;exactmatch
mgmt-methylated glioblastoma;mgmt-methylated glioblastoma;exactmatch
recurrent peripheral t-cell lymphoma, not otherwise specified;recurrent peripheral t-cell lymphoma, not otherwise specified;exactmatch
sinonasal poorly differentiated carcinoma;nasal cavity and paranasal sinus poorly differentiated carcinoma;exactmatch
locally advanced squamous cell carcinoma;locally advanced squamous cell carcinoma;exactmatch
pituitary gland double adenomas;pituitary gland double adenomas;exactmatch
histone h3 gene;h3 gene;exactmatch
unresectable gastric adenocarcinoma;unresectable gastric adenocarcinoma;exactmatch
myeloblasts 5 percent or less of bone marrow nucleated cells;myeloblasts 5 percent or less of bone marrow nucleated cells;exactmatch
squamous dysplasia;squamous dysplasia;exactmatch
blasts 20 percent or less of peripheral blood white cells;blasts 20 percent or less of peripheral blood white cells;exactmatch
metastatic hepatocellular carcinoma;metastatic hepatocellular carcinoma;exactmatch
metastatic liver carcinoma;metastatic liver carcinoma;exactmatch
crooke hyaline change;crooke hyaline change;exactmatch
crooke cell adenoma;crooke cell adenoma;exactmatch
usp8 gene mutation;humorf8 gene mutation;exactmatch
non-functioning corticotroph adenoma;non-functioning corticotroph adenoma;exactmatch
plurimorphous plurihormonal pituitary gland adenoma;plurimorphous plurihormonal pituitary gland adenoma;exactmatch
monomorphous plurihormonal pituitary gland adenoma;monomorphous plurihormonal pituitary gland adenoma;exactmatch
multihormonal immunoreactivity present in two or more cell types;multihormonal immunoreactivity present in two or more cell types;exactmatch
multihormonal immunoreactivity present in a single cell type;multihormonal immunoreactivity present in a single cell type;exactmatch
anaplastic sarcoma of the kidney;ask;exactmatch
mit family translocation;mit family translocation;exactmatch
mit family translocation-associated renal cell carcinoma;mit family translocation-associated renal cell carcinoma;exactmatch
tfeb protein overexpression;class e basic helix-loop-helix protein 35 overexpression;exactmatch
melanoma of unknown primary;melanoma of unknown primary;exactmatch
unresectable pleural malignant mesothelioma;unresectable pleural malignant mesothelioma;exactmatch
unresectable malignant mesothelioma;unresectable malignant mesothelioma;exactmatch
resectable malignant mesothelioma;resectable malignant mesothelioma;exactmatch
resectable pleural malignant mesothelioma;resectable malignant pleural mesothelioma;exactmatch
sparsely granulated non-functioning corticotroph adenoma;nonfunctional corticotroph adenoma type 2;exactmatch
densely granulated non-functioning corticotroph adenoma;densely granulated non-functioning corticotroph adenoma;exactmatch
refractory childhood malignant solid neoplasm;childhood refractory malignant solid neoplasm;exactmatch
recurrent brca- associated ovarian carcinoma;recurrent brca- associated ovarian carcinoma;exactmatch
stage ii vaginal cancer ajcc v8;stage ii vaginal cancer;exactmatch
stage iv renal pelvis and ureter cancer ajcc v8;stage iv renal pelvis and ureter cancer;exactmatch
stage 0a bladder cancer ajcc v8;0a;exactmatch
bladder cancer by ajcc v8 stage;bladder cancer by ajcc v8 stage;exactmatch
ureter cancer by ajcc v7 stage;ureter cancer by ajcc v7 stage;exactmatch
renal pelvis cancer by ajcc v7 stage;renal pelvis cancer by ajcc v7 stage;exactmatch
renal pelvis and ureter cancer by ajcc v7 stage;renal pelvis and ureter cancer by ajcc v7 stage;exactmatch
stage iv ureter cancer ajcc v8;stage iv ureter cancer;exactmatch
stage iv renal pelvis cancer ajcc v8;stage iv renal pelvis cancer;exactmatch
stage iii ureter cancer ajcc v8;stage iii ureter cancer;exactmatch
stage i bladder cancer ajcc v8;i;exactmatch
stage iii renal pelvis cancer ajcc v8;stage iii renal pelvis cancer;exactmatch
stage iii renal pelvis and ureter cancer ajcc v8;stage iii renal pelvis and ureter cancer;exactmatch
stage ii ureter cancer ajcc v8;stage ii ureter cancer;exactmatch
stage ii renal pelvis cancer ajcc v8;stage ii renal pelvis cancer;exactmatch
stage ii renal pelvis and ureter cancer ajcc v8;stage ii renal pelvis and ureter cancer;exactmatch
stage i ureter cancer ajcc v8;stage i ureter cancer;exactmatch
stage i renal pelvis cancer ajcc v8;stage i renal pelvis cancer;exactmatch
stage 0is bladder cancer ajcc v8;0is;exactmatch
brct domain;brct domain;exactmatch
stage 0is ureter cancer ajcc v8;stage 0is ureter cancer;exactmatch
stage 0a urethral cancer ajcc v8;stage 0a urethral cancer;exactmatch
eyelid carcinoma by ajcc v7 stage;eyelid carcinoma by ajcc v7 stage;exactmatch
urethral cancer by ajcc v7 stage;urethral cancer by ajcc v7 stage;exactmatch
stage iv urethral cancer ajcc v8;stage iv urethral cancer;exactmatch
stage iii urethral cancer ajcc v8;stage iii urethral cancer;exactmatch
stage ii urethral cancer ajcc v8;stage ii urethral cancer;exactmatch
stage i urethral cancer ajcc v8;stage i urethral cancer;exactmatch
stage 0is urethral cancer ajcc v8;stage 0is urethral cancer;exactmatch
urethral cancer by ajcc v8 stage;urethral cancer by ajcc v8 stage;exactmatch
stage ii bladder cancer ajcc v8;ii;exactmatch
walker-a motif;walker-a domain;exactmatch
stage ivb bladder cancer ajcc v8;ivb;exactmatch
stage iva bladder cancer ajcc v8;iva;exactmatch
stage iv bladder cancer ajcc v8;stage iv bladder cancer;exactmatch
stage iiib bladder cancer ajcc v8;iiib;exactmatch
stage iiia bladder cancer ajcc v8;iiia;exactmatch
stage iii bladder cancer ajcc v8;stage iii bladder cancer;exactmatch
stage i renal pelvis and ureter cancer ajcc v8;stage i renal pelvis and ureter cancer;exactmatch
stage 0is renal pelvis cancer ajcc v8;stage 0is renal pelvis cancer;exactmatch
brca-associated ovarian carcinoma;brca-associated ovarian carcinoma;exactmatch
testicular cancer by ajcc v8 stage;testicular cancer by ajcc v8 stage;exactmatch
stage iia testicular cancer ajcc v8;stage iia testicular cancer;exactmatch
stage ii testicular cancer ajcc v8;stage ii testicular cancer;exactmatch
stage is testicular cancer ajcc v8;stage is testicular cancer;exactmatch
stage ib testicular cancer ajcc v8;stage ib testicular cancer;exactmatch
stage ia testicular cancer ajcc v8;stage ia testicular cancer;exactmatch
stage i testicular cancer ajcc v8;stage i testicular cancer;exactmatch
stage 0 testicular cancer ajcc v8;stage 0 testicular cancer;exactmatch
stage ivb prostate cancer ajcc v8;ivb;exactmatch
stage iic testicular cancer ajcc v8;stage iic testicular cancer;exactmatch
stage iva prostate cancer ajcc v8;iva;exactmatch
stage iv prostate cancer ajcc v8;stage iv prostate cancer;exactmatch
stage iiic prostate cancer ajcc v8;iiic;exactmatch
stage iiib prostate cancer ajcc v8;iiib;exactmatch
stage iiia prostate cancer ajcc v8;iiia;exactmatch
stage iii prostate cancer ajcc v8;stage iii prostate cancer;exactmatch
stage iic prostate cancer ajcc v8;iic;exactmatch
stage iib testicular cancer ajcc v8;stage iib testicular cancer;exactmatch
stage iii testicular cancer ajcc v8;stage iii testicular cancer;exactmatch
stage 0is renal pelvis and ureter cancer ajcc v8;stage 0is renal pelvis and ureter cancer;exactmatch
advanced non-functioning well differentiated neuroendocrine neoplasm;advanced non-functioning well differentiated neuroendocrine neoplasm;exactmatch
stage 0a ureter cancer ajcc v8;stage 0a ureter cancer;exactmatch
stage 0a renal pelvis cancer ajcc v8;stage 0a renal pelvis cancer;exactmatch
stage 0a renal pelvis and ureter cancer ajcc v8;stage 0a renal pelvis and ureter cancer;exactmatch
ureter cancer by ajcc v8 stage;ureter cancer by ajcc v8 stage;exactmatch
renal pelvis cancer by ajcc v8 stage;renal pelvis cancer by ajcc v8 stage;exactmatch
renal pelvis and ureter cancer by ajcc v8 stage;renal pelvis and ureter cancer by ajcc v8 stage;exactmatch
metastatic non-functioning well differentiated neuroendocrine neoplasm;metastatic non-functioning well differentiated neuroendocrine neoplasm;exactmatch
stage iv renal cell cancer ajcc v8;stage iv;exactmatch
stage iiia testicular cancer ajcc v8;stage iiia testicular cancer;exactmatch
stage iii renal cell cancer ajcc v8;stage iii;exactmatch
stage ii renal cell cancer ajcc v8;stage ii;exactmatch
stage i renal cell cancer ajcc v8;stage i;exactmatch
renal cell cancer by ajcc v8 stage;renal cell cancer by ajcc v8 stage;exactmatch
testicular cancer by ajcc v6 and v7 stage;testicular cancer by ajcc v6 and v7 stage;exactmatch
stage iiic testicular cancer ajcc v8;stage iiic testicular cancer;exactmatch
stage iiib testicular cancer ajcc v8;stage iiib testicular cancer;exactmatch
eyelid carcinoma by ajcc v8 stage;eyelid carcinoma by ajcc v8 stage;exactmatch
stage 0 eyelid carcinoma ajcc v8;stage 0 eyelid carcinoma ajcc v8;exactmatch
stage i eyelid carcinoma ajcc v8;stage i eyelid carcinoma ajcc v8;exactmatch
stage i differentiated thyroid gland carcinoma 55 years and older ajcc v8;stage i differentiated thyroid gland cancer 55 years and older;exactmatch
stage ivb differentiated thyroid gland carcinoma ajcc v8;stage ivb differentiated thyroid gland cancer;exactmatch
stage iva differentiated thyroid gland carcinoma ajcc v8;stage iva differentiated thyroid gland cancer;exactmatch
stage iv differentiated thyroid gland carcinoma ajcc v8;stage iv differentiated thyroid gland cancer;exactmatch
stage iii differentiated thyroid gland carcinoma ajcc v8;stage iii differentiated thyroid gland cancer;exactmatch
stage ii differentiated thyroid gland carcinoma 55 years and older ajcc v8;stage ii differentiated thyroid gland cancer 55 years and older;exactmatch
stage ii differentiated thyroid gland carcinoma under 55 years ajcc v8;stage ii differentiated thyroid gland cancer under 55 years;exactmatch
stage ii differentiated thyroid gland carcinoma ajcc v8;stage ii differentiated thyroid gland cancer;exactmatch
stage i differentiated thyroid gland carcinoma under 55 years ajcc v8;stage i differentiated thyroid gland cancer under 55 years;exactmatch
stage i thyroid gland papillary carcinoma ajcc v8;i;exactmatch
stage i differentiated thyroid gland carcinoma ajcc v8;stage i differentiated thyroid gland cancer;exactmatch
differentiated thyroid gland carcinoma by ajcc v8 stage;differentiated thyroid gland carcinoma by ajcc v8 stage;exactmatch
differentiated thyroid gland carcinoma 55 years and older ajcc v8 stage;differentiated thyroid gland carcinoma 55 years and older ajcc v8 stage;exactmatch
differentiated thyroid gland carcinoma 45 years and older ajcc v7 stage;differentiated thyroid gland carcinoma 45 years and older ajcc v7 stage;exactmatch
differentiated thyroid gland carcinoma under 55 years ajcc v8 stage;differentiated thyroid gland carcinoma under 55 years ajcc v8 stage;exactmatch
differentiated thyroid gland carcinoma under 45 years ajcc v7 stage;differentiated thyroid gland carcinoma under 45 years ajcc v7 stage;exactmatch
thyroid gland papillary carcinoma by ajcc v7 stage;thyroid gland papillary carcinoma by ajcc v7 stage;exactmatch
thyroid gland papillary carcinoma by ajcc v8 stage;thyroid gland papillary carcinoma by ajcc v8 stage;exactmatch
stage i thyroid gland papillary carcinoma under 55 years ajcc v8;i under 55 years;exactmatch
stage ia eyelid carcinoma ajcc v8;stage ia eyelid carcinoma ajcc v8;exactmatch
stage i thyroid gland follicular carcinoma ajcc v8;stage i thyroid gland follicular cancer;exactmatch
stage iv thyroid gland follicular carcinoma ajcc v8;stage iv thyroid gland follicular cancer;exactmatch
stage iii thyroid gland follicular carcinoma ajcc v8;stage iii thyroid gland follicular cancer;exactmatch
stage ii thyroid gland follicular carcinoma 55 years and older ajcc v8;stage ii thyroid gland follicular cancer 55 years and older;exactmatch
stage ii thyroid gland follicular carcinoma under 55 years ajcc v8;stage ii thyroid gland follicular cancer under 55 years;exactmatch
stage ii thyroid gland follicular carcinoma ajcc v8;stage ii thyroid gland follicular cancer;exactmatch
stage i thyroid gland follicular carcinoma 55 years and older ajcc v8;stage i thyroid gland follicular cancer 55 years and older;exactmatch
stage i thyroid gland follicular carcinoma under 55 years ajcc v8;stage i thyroid gland follicular cancer under 55 years;exactmatch
thyroid gland follicular carcinoma by ajcc v8 stage;thyroid gland follicular carcinoma by ajcc v8 stage;exactmatch
stage i thyroid gland papillary carcinoma 55 years and older ajcc v8;ii 55 years and older;exactmatch
stage ivb thyroid gland papillary carcinoma ajcc v8;ivb;exactmatch
stage iva thyroid gland papillary carcinoma ajcc v8;iva;exactmatch
stage iv thyroid gland papillary carcinoma ajcc v8;iv;exactmatch
stage iii thyroid gland papillary carcinoma ajcc v8;iii;exactmatch
stage ii thyroid gland papillary carcinoma 55 years and older ajcc v8;ii 55 years and older;exactmatch
stage ii thyroid gland papillary carcinoma under 55 years ajcc v8;ii under years;exactmatch
stage ii thyroid gland papillary carcinoma ajcc v8;ii;exactmatch
differentiated thyroid gland carcinoma by ajcc v7 stage;differentiated thyroid gland carcinoma by ajcc v7 stage;exactmatch
thyroid gland follicular carcinoma by ajcc v7 stage;thyroid gland follicular carcinoma by ajcc v7 stage;exactmatch
nuclear localization signal;nls;exactmatch
choroidal and ciliary body melanoma by ajcc v8 stage;choroidal and ciliary body melanoma by ajcc v8 stage;exactmatch
stage iiib choroidal and ciliary body melanoma ajcc v8;stage iiib choroidal and ciliary body melanoma;exactmatch
stage iiia choroidal and ciliary body melanoma ajcc v8;stage iiia choroidal and ciliary body melanoma;exactmatch
stage iii choroidal and ciliary body melanoma ajcc v8;stage iii choroidal and ciliary body melanoma;exactmatch
stage iib choroidal and ciliary body melanoma ajcc v8;stage iib choroidal and ciliary body melanoma;exactmatch
stage iia choroidal and ciliary body melanoma ajcc v8;stage iia choroidal and ciliary body melanoma;exactmatch
stage ii choroidal and ciliary body melanoma ajcc v8;stage ii choroidal and ciliary body melanoma;exactmatch
stage i choroidal and ciliary body melanoma ajcc v8;stage i choroidal and ciliary body melanoma;exactmatch
stage iv eyelid carcinoma ajcc v8;stage iv eyelid carcinoma ajcc v8;exactmatch
gtp binding domain;gtp binding domain;exactmatch
stage iiib eyelid carcinoma ajcc v8;stage iiib eyelid carcinoma ajcc v8;exactmatch
stage iiia eyelid carcinoma ajcc v8;stage iiia eyelid carcinoma ajcc v8;exactmatch
stage iii eyelid carcinoma ajcc v8;stage iii eyelid carcinoma ajcc v8;exactmatch
stage iib eyelid carcinoma ajcc v8;stage iib eyelid carcinoma ajcc v8;exactmatch
stage iia eyelid carcinoma ajcc v8;stage iia eyelid carcinoma ajcc v8;exactmatch
stage ii eyelid carcinoma ajcc v8;stage ii eyelid carcinoma ajcc v8;exactmatch
stage ib eyelid carcinoma ajcc v8;stage ib eyelid carcinoma ajcc v8;exactmatch
stage iiic choroidal and ciliary body melanoma ajcc v8;stage iiic choroidal and ciliary body melanoma;exactmatch
stage iv choroidal and ciliary body melanoma ajcc v8;stage iv choroidal and ciliary body melanoma;exactmatch
progressive disease in neuroblastoma;progressive disease in neuroblastoma;exactmatch
uveal melanoma by ajcc v7 stage;tumor stage (pathologic);exactmatch
dag/pe-binding domain;c1 domain;exactmatch
pathologic stage iv retinoblastoma ajcc v8;pathologic stage iv retinoblastoma ajcc v8;exactmatch
pathologic stage iii retinoblastoma ajcc v8;pathologic stage iii retinoblastoma ajcc v8;exactmatch
pathologic stage ii retinoblastoma ajcc v8;pathologic stage ii retinoblastoma ajcc v8;exactmatch
pathologic stage i retinoblastoma ajcc v8;pathologic stage i retinoblastoma ajcc v8;exactmatch
retinoblastoma by ajcc v8 pathologic stage;retinoblastoma by ajcc v8 pathologic stage;exactmatch
clinical stage iv retinoblastoma ajcc v8;clinical stage iv retinoblastoma ajcc v8;exactmatch
clinical stage iii retinoblastoma ajcc v8;clinical stage iii retinoblastoma ajcc v8;exactmatch
clinical stage ii retinoblastoma ajcc v8;clinical stage ii retinoblastoma ajcc v8;exactmatch
clinical stage i retinoblastoma ajcc v8;clinical stage i retinoblastoma ajcc v8;exactmatch
retinoblastoma by ajcc v8 clinical stage;retinoblastoma by ajcc v8 clinical stage;exactmatch
retinoblastoma by ajcc v8 stage;retinoblastoma by ajcc v8 stage;exactmatch
tyrosine kinase domain;tyrosine kinase domain;exactmatch
substrate interaction domain;substrate domain;exactmatch
cellular membrane;cell membrane;exactmatch
stage iib prostate cancer ajcc v8;iib;exactmatch
stage iia prostate cancer ajcc v8;iia;exactmatch
stage ii prostate cancer ajcc v8;stage ii prostate cancer;exactmatch
uterine corpus leiomyosarcoma by ajcc v8 stage;uterine corpus leiomyosarcoma by ajcc v8 stage;exactmatch
stage iiib uterine corpus leiomyosarcoma ajcc v8;stage iiib uterine corpus leiomyosarcoma;exactmatch
stage iiia uterine corpus leiomyosarcoma ajcc v8;stage iiia uterine corpus leiomyosarcoma;exactmatch
stage iii uterine corpus leiomyosarcoma ajcc v8;stage iii uterine corpus leiomyosarcoma;exactmatch
stage ii uterine corpus leiomyosarcoma ajcc v8;stage ii uterine corpus leiomyosarcoma;exactmatch
stage ib uterine corpus leiomyosarcoma ajcc v8;stage ib uterine corpus leiomyosarcoma;exactmatch
stage ia uterine corpus leiomyosarcoma ajcc v8;stage ia uterine corpus leiomyosarcoma;exactmatch
stage i uterine corpus leiomyosarcoma ajcc v8;stage i uterine corpus leiomyosarcoma;exactmatch
uterine corpus sarcoma by ajcc v8 stage;uterine corpus sarcoma by ajcc v8 stage;exactmatch
stage iv uterine corpus leiomyosarcoma ajcc v8;stage iv uterine corpus leiomyosarcoma;exactmatch
anchoring junction;adhering junction;exactmatch
cell junction;cell junction;exactmatch
stage ivb uterine corpus cancer ajcc v8;stage ivb uterine (including endometrial) cancer;exactmatch
stage iva uterine corpus cancer ajcc v8;stage iva uterine (including endometrial) cancer;exactmatch
stage iv uterine corpus cancer ajcc v8;stage iv;exactmatch
stage iiic2 uterine corpus cancer ajcc v8;stage iiic2 uterine (including endometrial) cancer;exactmatch
stage iiic1 uterine corpus cancer ajcc v8;stage iiic1 uterine (including endometrial) cancer;exactmatch
stage iiic uterine corpus leiomyosarcoma ajcc v8;stage iiic uterine corpus leiomyosarcoma;exactmatch
stage iva uterine corpus leiomyosarcoma ajcc v8;stage iva uterine corpus leiomyosarcoma;exactmatch
stage ii uterine corpus adenosarcoma ajcc v8;stage ii uterine corpus adenosarcoma;exactmatch
stage iiic uterine corpus endometrial stromal sarcoma ajcc v8;stage iiic uterine corpus endometrial stromal sarcoma;exactmatch
stage ib uterine corpus adenosarcoma ajcc v8;stage ib uterine corpus adenosarcoma;exactmatch
stage ia uterine corpus adenosarcoma ajcc v8;stage ia uterine corpus adenosarcoma;exactmatch
stage i uterine corpus adenosarcoma ajcc v8;stage i uterine corpus adenosarcoma;exactmatch
uterine corpus adenosarcoma by ajcc v8 stage;uterine corpus adenosarcoma by ajcc v8 stage;exactmatch
stage ivb uterine corpus endometrial stromal sarcoma ajcc v8;stage ivb uterine corpus endometrial stromal sarcoma;exactmatch
stage iva uterine corpus endometrial stromal sarcoma ajcc v8;stage iva uterine corpus endometrial stromal sarcoma;exactmatch
stage iv uterine corpus endometrial stromal sarcoma ajcc v8;stage iv uterine corpus endometrial stromal sarcoma;exactmatch
stage iiib uterine corpus endometrial stromal sarcoma ajcc v8;stage iiib uterine corpus endometrial stromal sarcoma;exactmatch
stage ivb uterine corpus leiomyosarcoma ajcc v8;stage ivb uterine corpus leiomyosarcoma;exactmatch
stage iiia uterine corpus endometrial stromal sarcoma ajcc v8;stage iiia uterine corpus endometrial stromal sarcoma;exactmatch
stage iii uterine corpus endometrial stromal sarcoma ajcc v8;stage iii uterine corpus endometrial stromal sarcoma;exactmatch
stage ii uterine corpus endometrial stromal sarcoma ajcc v8;stage ii uterine corpus endometrial stromal sarcoma;exactmatch
stage ib uterine corpus endometrial stromal sarcoma ajcc v8;stage ib uterine corpus endometrial stromal sarcoma;exactmatch
stage ia uterine corpus endometrial stromal sarcoma ajcc v8;stage ia uterine corpus endometrial stromal sarcoma;exactmatch
stage i uterine corpus endometrial stromal sarcoma ajcc v8;stage i uterine corpus endometrial stromal sarcoma;exactmatch
uterine corpus endometrial stromal sarcoma by ajcc v8 stage;uterine corpus endometrial stromal sarcoma by ajcc v8 stage;exactmatch
stage iiic uterine corpus cancer ajcc v8;stage iiic uterine (including endometrial) cancer;exactmatch
stage iiib uterine corpus cancer ajcc v8;stage iiib uterine (including endometrial) cancer;exactmatch
stage iiia uterine corpus cancer ajcc v8;stage iiia uterine (including endometrial) cancer;exactmatch
stage i cervical cancer ajcc v8;i;exactmatch
stage ii cervical cancer ajcc v8;ii;exactmatch
stage ib2 cervical cancer ajcc v8;ib2;exactmatch
stage ib1 cervical cancer ajcc v8;ib1;exactmatch
stage ib cervical cancer ajcc v8;ib;exactmatch
stage ia2 cervical cancer ajcc v8;ia2;exactmatch
stage ia1 cervical cancer ajcc v8;ia1;exactmatch
stage ia cervical cancer ajcc v8;ia;exactmatch
cervical cancer by ajcc v8 stage;cervical cancer by ajcc v8 stage;exactmatch
stage iii uterine corpus cancer ajcc v8;stage iii;exactmatch
transformed follicular lymphoma to diffuse large b-cell lymphoma;transformed follicular lymphoma to diffuse large b-cell lymphoma;exactmatch
stage ivb vaginal cancer ajcc v8;stage ivb vaginal cancer;exactmatch
stage iva vaginal cancer ajcc v8;stage iva vaginal cancer;exactmatch
stage iv vaginal cancer ajcc v8;stage iv vaginal cancer;exactmatch
stage iii vaginal cancer ajcc v8;stage iii vaginal cancer;exactmatch
stage iib vaginal cancer ajcc v8;stage iib vaginal cancer;exactmatch
cic/dux4 fusion gene;cic-dux4;exactmatch
stage iia cervical cancer ajcc v8;iia;exactmatch
stage iia1 cervical cancer ajcc v8;iia1;exactmatch
stage iia2 cervical cancer ajcc v8;iia2;exactmatch
stage iib cervical cancer ajcc v8;iib;exactmatch
stage ii uterine corpus cancer ajcc v8;stage ii;exactmatch
stage ib uterine corpus cancer ajcc v8;stage ib uterine (including endometrial) cancer;exactmatch
stage ia uterine corpus cancer ajcc v8;stage ia uterine (including endometrial) cancer;exactmatch
stage i uterine corpus cancer ajcc v8;stage i;exactmatch
uterine corpus cancer by ajcc v8 stage;tumor stage (pathological);exactmatch
activating hras mutation;activating hras mutation;exactmatch
activating braf mutation;activating braf gene mutation;exactmatch
cd8 positive;cd8 antigen positive;exactmatch
blasts 50 percent or less of bone marrow nucleated cells;blasts 50 percent or less of bone marrow nucleated cells;exactmatch
stage ivb cervical cancer ajcc v8;ivb;exactmatch
stage iva cervical cancer ajcc v8;iva;exactmatch
stage iv cervical cancer ajcc v8;iv;exactmatch
stage iiib cervical cancer ajcc v8;iiib;exactmatch
stage iiia cervical cancer ajcc v8;iiia;exactmatch
stage iii cervical cancer ajcc v8;iii;exactmatch
stage ic uterine corpus adenosarcoma ajcc v8;stage ic uterine corpus adenosarcoma;exactmatch
stage iii uterine corpus adenosarcoma ajcc v8;stage iii uterine corpus adenosarcoma;exactmatch
stage i prostate cancer ajcc v8;i;exactmatch
stage iiia primary peritoneal cancer ajcc v8;stage iiia primary peritoneal cancer;exactmatch
gestational trophoblastic neoplasm by ajcc v8 stage;gestational trophoblastic neoplasm by ajcc v8 stage;exactmatch
gestational trophoblastic tumor by ajcc v7 stage;gestational trophoblastic tumor by ajcc v7 stage;exactmatch
stage ivb primary peritoneal cancer ajcc v8;stage ivb primary peritoneal cancer;exactmatch
stage iva primary peritoneal cancer ajcc v8;stage iva primary peritoneal cancer;exactmatch
stage iv primary peritoneal cancer ajcc v8;stage iv primary peritoneal cancer;exactmatch
stage iiic primary peritoneal cancer ajcc v8;stage iiic primary peritoneal cancer;exactmatch
stage iiib primary peritoneal cancer ajcc v8;stage iiib primary peritoneal cancer;exactmatch
stage iii primary peritoneal cancer ajcc v8;stage iii primary peritoneal cancer;exactmatch
stage ii gestational trophoblastic neoplasm ajcc v8;stage ii gestational trophoblastic neoplasm ajcc v8;exactmatch
stage iib primary peritoneal cancer ajcc v8;stage iib primary peritoneal cancer;exactmatch
stage iia primary peritoneal cancer ajcc v8;stage iia primary peritoneal cancer;exactmatch
stage ii primary peritoneal cancer ajcc v8;stage ii primary peritoneal cancer;exactmatch
primary peritoneal cancer by ajcc v8 stage;primary peritoneal cancer by ajcc v8 stage;exactmatch
primary peritoneal cancer by ajcc v7 stage;primary peritoneal cancer by ajcc v7 stage;exactmatch
stage ivb fallopian tube cancer ajcc v8;stage ivb fallopian tube cancer;exactmatch
stage iva fallopian tube cancer ajcc v8;stage iva fallopian tube cancer;exactmatch
stage i gestational trophoblastic neoplasm ajcc v8;stage i gestational trophoblastic neoplasm ajcc v8;exactmatch
stage iii gestational trophoblastic neoplasm ajcc v8;stage iii gestational trophoblastic neoplasm ajcc v8;exactmatch
stage iiia uterine corpus adenosarcoma ajcc v8;stage iiia uterine corpus adenosarcoma;exactmatch
stage iib penile cancer ajcc v8;stage iib penile cancer;exactmatch
prostate cancer by ajcc v8 stage;prostate cancer by ajcc v8 stage;exactmatch
whitmore-jewett stage;whitmore-jewett stage;exactmatch
refractory transformed non-hodgkin lymphoma;refractory transformed lymphoma;exactmatch
stage iv penile cancer ajcc v8;stage iv penile cancer;exactmatch
stage iiib penile cancer ajcc v8;stage iiib penile cancer;exactmatch
stage iiia penile cancer ajcc v8;stage iiia penile cancer;exactmatch
stage iii penile cancer ajcc v8;stage iii penile cancer;exactmatch
stage iia penile cancer ajcc v8;stage iia penile cancer;exactmatch
stage iv gestational trophoblastic neoplasm ajcc v8;stage iv gestational trophoblastic neoplasm ajcc v8;exactmatch
stage ii penile cancer ajcc v8;stage ii penile cancer;exactmatch
stage i penile cancer ajcc v8;stage i penile cancer;exactmatch
stage 0a penile cancer ajcc v8;stage 0a penile cancer;exactmatch
stage 0is penile cancer ajcc v8;stage 0is penile cancer;exactmatch
stage 0 penile cancer ajcc v8;stage 0 penile cancer;exactmatch
penile cancer by ajcc v8 stage;penile cancer by ajcc v8 stage;exactmatch
2p12;2p12;exactmatch
stage iv fallopian tube cancer ajcc v8;stage iv fallopian tube cancer;exactmatch
stage iiic fallopian tube cancer ajcc v8;stage iiic fallopian tube cancer;exactmatch
stage iiib fallopian tube cancer ajcc v8;stage iiib fallopian tube cancer;exactmatch
stage ib ovarian cancer ajcc v8;stage ib ovarian cancer;exactmatch
stage iiia1 ovarian cancer ajcc v8;stage iiia1 ovarian cancer;exactmatch
stage iiia ovarian cancer ajcc v8;stage iiia ovarian cancer;exactmatch
stage iii ovarian cancer ajcc v8;stage iii ovarian cancer;exactmatch
stage iib ovarian cancer ajcc v8;stage iib ovarian cancer;exactmatch
stage iia ovarian cancer ajcc v8;stage iia ovarian cancer;exactmatch
stage ii ovarian cancer ajcc v8;stage ii ovarian cancer;exactmatch
stage ic ovarian cancer ajcc v8;stage ic ovarian cancer;exactmatch
stage ia ovarian cancer ajcc v8;stage ia ovarian cancer;exactmatch
stage iiia2 fallopian tube cancer ajcc v8;stage iiia2 fallopian tube cancer;exactmatch
stage i ovarian cancer ajcc v8;stage i ovarian cancer;exactmatch
ovarian cancer by ajcc v8 stage;ovarian cancer by ajcc v8 stage;exactmatch
stage ivb uterine corpus adenosarcoma ajcc v8;stage ivb uterine corpus adenosarcoma;exactmatch
stage iva uterine corpus adenosarcoma ajcc v8;stage iva uterine corpus adenosarcoma;exactmatch
stage iv uterine corpus adenosarcoma ajcc v8;stage iv uterine corpus adenosarcoma;exactmatch
stage iiic uterine corpus adenosarcoma ajcc v8;stage iiic uterine corpus adenosarcoma;exactmatch
stage iiib uterine corpus adenosarcoma ajcc v8;stage iiib uterine corpus adenosarcoma;exactmatch
stage iiia2 ovarian cancer ajcc v8;stage iiia2 ovarian cancer;exactmatch
stage iiib ovarian cancer ajcc v8;stage iiib ovarian cancer;exactmatch
stage iiic ovarian cancer ajcc v8;stage iiic ovarian cancer;exactmatch
stage iv ovarian cancer ajcc v8;stage iv ovarian cancer;exactmatch
stage iiia1 fallopian tube cancer ajcc v8;stage iiia1 fallopian tube cancer;exactmatch
stage iiia fallopian tube cancer ajcc v8;stage iiia fallopian tube cancer;exactmatch
stage iii fallopian tube cancer ajcc v8;stage iii fallopian tube cancer;exactmatch
stage iib fallopian tube cancer ajcc v8;stage iib fallopian tube cancer;exactmatch
stage iia fallopian tube cancer ajcc v8;stage iia fallopian tube cancer;exactmatch
stage ii fallopian tube cancer ajcc v8;stage ii fallopian tube cancer;exactmatch
stage ic fallopian tube cancer ajcc v8;stage ic fallopian tube cancer;exactmatch
stage ib fallopian tube cancer ajcc v8;stage ib fallopian tube cancer;exactmatch
stage ia fallopian tube cancer ajcc v8;stage ia fallopian tube cancer;exactmatch
stage i fallopian tube cancer ajcc v8;stage i fallopian tube cancer;exactmatch
fallopian tube cancer by ajcc v8 stage;fallopian tube cancer by ajcc v8 stage;exactmatch
stage iiia2;stage iiia2;exactmatch
stage iiia1;stage iiia1;exactmatch
stage ivb ovarian cancer ajcc v8;stage ivb ovarian cancer;exactmatch
stage iva ovarian cancer ajcc v8;stage iva ovarian cancer;exactmatch
stage iva thyroid gland follicular carcinoma ajcc v8;stage iva thyroid gland follicular cancer;exactmatch
stage ivb thyroid gland follicular carcinoma ajcc v8;stage ivb thyroid gland follicular cancer;exactmatch
thyroid gland anaplastic carcinoma by ajcc v7 stage;thyroid gland anaplastic carcinoma by ajcc v7 stage;exactmatch
pulmonary myxoid sarcoma with ewsr1-creb1 translocation;low-grade malignant myxoid endobronchial tumor;exactmatch
refractory rhabdomyosarcoma;refractory rhabdomyosarcoma;exactmatch
refractory peripheral primitive neuroectodermal tumor;refractory peripheral primitive neuroectodermal tumor;exactmatch
recurrent rhabdoid tumor;recurrent rhabdoid tumor;exactmatch
recurrent malignant glioma;recurrent high grade glioma;exactmatch
lung myoepithelial carcinoma;lung myoepithelial carcinoma;exactmatch
lung myoepithelioma;benign lung myoepithelioma;exactmatch
lung myoepithelial tumor;lung myoepithelial tumor;exactmatch
pulmonary artery intimal sarcoma;intimal sarcoma of the pulmonary artery;exactmatch
refractory hepatoblastoma;refractory hepatoblastoma;exactmatch
peribronchial proliferation of neoplastic cells present;peribronchial proliferation of neoplastic cells present;exactmatch
congenital peribronchial myofibroblastic tumor;congenital bronchopulmonary leiomyosarcoma;exactmatch
vertebrata;vertebrata;exactmatch
refractory b acute lymphoblastic leukemia;refractory b acute lymphoblastic leukemia;exactmatch
recurrent b acute lymphoblastic leukemia;recurrent b acute lymphoblastic leukemia;exactmatch
recurrent acute lymphoblastic leukemia;recurrent acute lymphoblastic leukemia;exactmatch
refractory pancreatic carcinoma;refractory pancreatic carcinoma;exactmatch
refractory ewing sarcoma;refractory ewing sarcoma;exactmatch
refractory malignant glioma;refractory malignant glioma;exactmatch
neurofibromatosis type 1 with inoperable, progressive, symptomatic plexiform neurofibromas;nf type 1 with inoperable, progressive, symptomatic plexiform neurofibromas;exactmatch
recurrent primary cutaneous lymphoma;recurrent primary cutaneous (skin) lymphoma;exactmatch
recurrent skin squamous cell carcinoma;recurrent cutaneous squamous cell carcinoma;exactmatch
refractory thyroid gland carcinoma;refractory thyroid cancer;exactmatch
refractory lymphocyte-rich classic hodgkin lymphoma;refractory lymphocyte-rich classic hodgkin lymphoma;exactmatch
recurrent hairy cell leukemia;recurrent hairy cell leukemia;exactmatch
recurrent alveolar rhabdomyosarcoma;recurrent alveolar rhabdomyosarcoma;exactmatch
refractory alveolar rhabdomyosarcoma;refractory alveolar rhabdomyosarcoma;exactmatch
refractory primary cutaneous lymphoma;refractory primary cutaneous (skin) lymphoma;exactmatch
advanced bile duct carcinoma;advanced bile duct cancer;exactmatch
refractory medulloblastoma;refractory medulloblastoma;exactmatch
metastatic bile duct carcinoma;metastatic bile duct cancer;exactmatch
advanced microsatellite stable colorectal carcinoma;advanced microsatellite stable colorectal cancer;exactmatch
metastatic microsatellite stable colorectal carcinoma;metastatic microsatellite stable colorectal cancer;exactmatch
recurrent anaplastic oligodendroglioma;recurrent anaplastic oligodendroglioma;exactmatch
recurrent anaplastic oligoastrocytoma;recurrent anaplastic oligoastrocytoma;exactmatch
refractory rhabdoid tumor;refractory rhabdoid tumor;exactmatch
refractory osteosarcoma;refractory osteosarcoma;exactmatch
lung malignant pecoma;lung malignant pecoma;exactmatch
benign lung pecoma;benign lung pecoma;exactmatch
lung pecoma;lung pecoma;exactmatch
recurrent acute biphenotypic leukemia;acute biphenotypic leukemia in relapse;exactmatch
myoepithelial;myoepithelial;exactmatch
mucinous;mucinous;exactmatch
moderately differentiated;g2;exactmatch
low grade;low grade;exactmatch
invasive;invasive;exactmatch
high grade;high grade;exactmatch
recurrent acute undifferentiated leukemia;acute undifferentiated leukemia in relapse;exactmatch
anaplastic;anaplastic;exactmatch
thoracic nut carcinoma;thoracic nmc;exactmatch
malignant;malignant;exactmatch
ddit3 gene rearrangement;c/ebpzeta gene rearrangement;exactmatch
riss stage iii plasma cell myeloma;riss stage iii plasma cell myeloma;exactmatch
riss stage ii plasma cell myeloma;riss stage ii plasma cell myeloma;exactmatch
riss stage i plasma cell myeloma;riss stage i plasma cell myeloma;exactmatch
plasma cell myeloma by riss stage;plasma cell myeloma by riss stage;exactmatch
riss stage;riss stage;exactmatch
papillary;papillary;exactmatch
poorly differentiated;g3;exactmatch
tubular;tubular;exactmatch
villous;villous;exactmatch
primate;mammals, primates;exactmatch
organism;biologicentity;exactmatch
experimental organism benign mesoblastic nephroma;experimental organism benign mesoblastic nephroma;exactmatch
mammalia;mammal;exactmatch
human;homo sapiens;exactmatch
c11orf95/mkl2 fusion gene;c11orf95-mkl2 fusion gene;exactmatch
mrtfb gene;mkl2;exactmatch
refractory waldenstrom macroglobulinemia;refractory waldenstrom macroglobulinemia;exactmatch
activating akt1 gene mutation;akt1 activating mutation;exactmatch
blasts more than 5 percent of bone marrow nucleated cells;blasts greater than 5 percent of bone marrow nucleated cells;exactmatch
animal;animal;exactmatch
undifferentiated;g4;exactmatch
diffuse;diffuse;exactmatch
benign;benign;exactmatch
well differentiated;g1;exactmatch
metastatic skin squamous cell carcinoma;metastatic cutaneous squamous cell carcinoma;exactmatch
inoperable disease;inoperable disease;exactmatch
stage ivb mycosis fungoides and sezary syndrome ajcc v8;stage ivb mycosis fungoides and sezary syndrome ajcc v8;exactmatch
pericardial angiosarcoma;pericardial angiosarcoma;exactmatch
refractory ependymoma;refractory ependymoma;exactmatch
refractory glioma;refractory glioma;exactmatch
benign pericardial germ cell tumor;benign pericardial germ cell tumor;exactmatch
pericardial yolk sac tumor;pericardial yolk sac tumor;exactmatch
malignant pericardial germ cell tumor;malignant pericardial germ cell tumor;exactmatch
pericardial teratoma;pericardial teratoma;exactmatch
pericardial synovial sarcoma;pericardial synovial sarcoma;exactmatch
pericardial sarcoma;pericardial sarcoma;exactmatch
refractory medulloblastoma, shh-activated;refractory medulloblastoma, shh-activated;exactmatch
cardiac angiosarcoma;cardiac angiosarcoma;exactmatch
chromogranin-positive neoplastic cells present;chg-positive neoplastic cells present;exactmatch
chromogranin positive;chg positive;exactmatch
canine mammary adenoma;canine mammary adenoma;exactmatch
metastatic well differentiated neuroendocrine neoplasm;metastatic well differentiated neuroendocrine neoplasm;exactmatch
blasts 1 percent or more of peripheral blood white cells;blasts 1 percent or more of peripheral blood white cells;exactmatch
cardiac teratoma;cardiac teratoma;exactmatch
recurrent medulloblastoma, shh-activated;recurrent medulloblastoma, shh-activated;exactmatch
progressive medulloblastoma;progressive medulloblastoma;exactmatch
cysltr2 gene;cysltr2;exactmatch
childhood brain glioblastoma;brain glioblastoma;exactmatch
refractory gastric carcinoma;refractory gastric (stomach) cancer;exactmatch
refractory melanoma;refractory melanoma;exactmatch
refractory colorectal carcinoma;refractory colorectal cancer;exactmatch
refractory breast carcinoma;refractory breast cancer;exactmatch
central nervous system b-cell non-hodgkin lymphoma;b-cell primary central nervous system non-hodgkin lymphoma;exactmatch
advanced lung non-squamous non-small cell carcinoma;advanced lung non-squamous non-small cell carcinoma;exactmatch
oropharyngeal p16ink4a-negative squamous cell carcinoma;oropharyngeal squamous cell carcinoma, p16ink4a negative;exactmatch
recurrent ebv-related lymphoma;recurrent ebv-associated lymphoma;exactmatch
progressive ependymoma;progressive ependymoma;exactmatch
recurrent lymphoproliferative disorder;recurrent lymphoproliferative disorder;exactmatch
hormone resistance;hormone resistance;exactmatch
platinum-resistant ovarian carcinoma;platinum-refractory ovarian carcinoma;exactmatch
platinum resistance;platinum resistance;exactmatch
sheep lung adenocarcinoma;sheep lung adenocarcinoma;exactmatch
progressive medulloblastoma, shh-activated;progressive medulloblastoma, shh-activated;exactmatch
progressive central nervous system neoplasm;progressive central nervous system neoplasm;exactmatch
cardiac yolk sac tumor;cardiac yolk sac tumor;exactmatch
cardiac germ cell tumor;cardiac germ cell tumor;exactmatch
cardiac myxofibrosarcoma;cardiac myxofibrosarcoma;exactmatch
myeloblasts 5 percent or more of bone marrow nucleated cells;myeloblasts 5 percent or more of bone marrow nucleated cells;exactmatch
refractory glioblastoma;refractory glioblastoma;exactmatch
wt1 gene mutation;gud gene mutation;exactmatch
thymic hepatoid adenocarcinoma;thymic hepatoid adenocarcinoma;exactmatch
human papillomavirus-16 negative;hpv-16 negative;exactmatch
fgfr gene mutation;fgf receptor gene family mutation;exactmatch
mediastinal/thymic nut carcinoma;mediastinal/thymic nmc;exactmatch
blasts 30 percent or less of peripheral blood white cells;blasts 30 percent or less of peripheral blood white cells;exactmatch
blasts more than 5 percent of peripheral blood white cells;blasts greater than 5 percent of peripheral blood white cells;exactmatch
cardiac extraskeletal osteosarcoma;cardiac extraskeletal osteosarcoma;exactmatch
rb1 gene deletion;rb gene deletion;exactmatch
atypical type a thymoma;atypical type a thymoma;exactmatch
blasts under 30 percent of peripheral blood white cells;blasts less than 30 percent of peripheral blood white cells;exactmatch
blasts under 15 percent of bone marrow nucleated cells;blasts less than 15 percent of bone marrow nucleated cells;exactmatch
blasts under 15 percent of peripheral blood white cells;blasts less than 15 percent of peripheral blood white cells;exactmatch
masaoka-koga stage;masaoka-koga stage;exactmatch
refractory marginal zone lymphoma;refractory marginal zone lymphoma;exactmatch
mediastinal malignant germ cell tumor stage;mediastinal malignant germ cell tumor stage;exactmatch
malignant mediastinal germ cell tumor stage grouping of the pediatric study group;malignant mediastinal germ cell tumor stage grouping of the pediatric study group;exactmatch
stage i malignant mediastinal germ cell tumor;stage i malignant mediastinal germ cell tumor;exactmatch
stage ii malignant mediastinal germ cell tumor;stage ii malignant mediastinal germ cell tumor;exactmatch
recurrent central nervous system non-hodgkin lymphoma;recurrent central nervous system non-hodgkin lymphoma;exactmatch
refractory central nervous system non-hodgkin lymphoma;refractory central nervous system non-hodgkin lymphoma;exactmatch
mediastinal epithelioid hemangioendothelioma;mediastinal epithelioid hemangioendothelioma;exactmatch
mediastinal hemangioma;mediastinal hemangioma;exactmatch
gnas protein variant;gnas complex locus protein variant;exactmatch
cdkn2a protein variant;cdk4i protein variant;exactmatch
metastatic genitourinary system carcinoma;metastatic genitourinary cancer;exactmatch
tp53 protein variant;antigen ny-co-13 protein variant;exactmatch
mediastinal granulocytic sarcoma;mediastinal granulocytic sarcoma;exactmatch
mediastinal mixed germ cell tumor;mediastinal mixed germ cell tumor;exactmatch
metastatic epithelioid hemangioendothelioma;metastatic epithelioid hemangioendothelioma;exactmatch
locally advanced epithelioid hemangioendothelioma;locally advanced epithelioid hemangioendothelioma;exactmatch
locally advanced angiosarcoma;locally advanced angiosarcoma;exactmatch
stage iv malignant mediastinal germ cell tumor;stage iv malignant mediastinal germ cell tumor;exactmatch
stage iii malignant mediastinal germ cell tumor;stage iii malignant mediastinal germ cell tumor;exactmatch
porcine leukemia;porcine leukemia;exactmatch
stage iva2 mycosis fungoides and sezary syndrome ajcc v8;stage iva2 mycosis fungoides and sezary syndrome ajcc v8;exactmatch
ankyrin repeat;ank domain;exactmatch
lugano classification stage i adult non-hodgkin lymphoma ajcc v8;lugano classification stage i adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iv adult non-hodgkin lymphoma ajcc v8;lugano classification stage iv adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iii adult non-hodgkin lymphoma ajcc v8;lugano classification stage iii adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification advanced stage adult non-hodgkin lymphoma ajcc v8;lugano classification advanced stage adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ii bulky adult non-hodgkin lymphoma ajcc v8;lugano classification stage ii bulky adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iie adult non-hodgkin lymphoma ajcc v8;lugano classification stage iie adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ii adult non-hodgkin lymphoma ajcc v8;lugano classification stage ii adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ie adult non-hodgkin lymphoma ajcc v8;lugano classification stage ie adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification limited stage adult non-hodgkin lymphoma ajcc v8;lugano classification limited stage adult non-hodgkin lymphoma ajcc v8;exactmatch
lugano classification limited stage hodgkin lymphoma ajcc v8;lugano classification limited stage hodgkin lymphoma ajcc v8;exactmatch
lugano classification adult non-hodgkin lymphoma by ajcc v8 stage;lugano classification adult non-hodgkin lymphoma by ajcc v8 stage;exactmatch
lugano classification stage iv adult lymphoma ajcc v8;lugano classification stage iv adult lymphoma ajcc v8;exactmatch
lugano classification stage iii adult lymphoma ajcc v8;lugano classification stage iii adult lymphoma ajcc v8;exactmatch
lugano classification advanced stage adult lymphoma ajcc v8;lugano classification advanced stage adult lymphoma ajcc v8;exactmatch
lugano classification stage ii bulky adult lymphoma ajcc v8;lugano classification stage ii bulky adult lymphoma ajcc v8;exactmatch
lugano classification stage iie adult lymphoma ajcc v8;lugano classification stage iie adult lymphoma ajcc v8;exactmatch
lugano classification stage ii adult lymphoma ajcc v8;lugano classification stage ii adult lymphoma ajcc v8;exactmatch
lugano classification hodgkin lymphoma by ajcc v8 stage;lugano classification hodgkin lymphoma by ajcc v8 stage;exactmatch
lugano classification stage i hodgkin lymphoma ajcc v8;lugano classification stage i hodgkin lymphoma ajcc v8;exactmatch
lugano classification limited stage adult hodgkin lymphoma ajcc v8;lugano classification limited stage adult hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage i childhood hodgkin lymphoma ajcc v8;lugano classification stage i childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iv childhood hodgkin lymphoma ajcc v8;lugano classification stage iv childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iii childhood hodgkin lymphoma ajcc v8;lugano classification stage iii childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification advanced stage childhood hodgkin lymphoma ajcc v8;lugano classification advanced stage childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ii bulky childhood hodgkin lymphoma ajcc v8;lugano classification stage ii bulky childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iie childhood hodgkin lymphoma ajcc v8;lugano classification stage iie childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ii childhood hodgkin lymphoma ajcc v8;lugano classification stage ii childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ie childhood hodgkin lymphoma ajcc v8;lugano classification stage ie childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification limited stage childhood hodgkin lymphoma ajcc v8;lugano classification limited stage childhood hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ie hodgkin lymphoma ajcc v8;lugano classification stage ie hodgkin lymphoma ajcc v8;exactmatch
lugano classification childhood hodgkin lymphoma by ajcc v8 stage;lugano classification childhood hodgkin lymphoma by ajcc v8 stage;exactmatch
lugano classification stage iv hodgkin lymphoma ajcc v8;lugano classification stage iv hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iii hodgkin lymphoma ajcc v8;lugano classification stage iii hodgkin lymphoma ajcc v8;exactmatch
lugano classification advanced stage hodgkin lymphoma ajcc v8;lugano classification advanced stage hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ii bulky hodgkin lymphoma ajcc v8;lugano classification stage ii bulky hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iie hodgkin lymphoma ajcc v8;lugano classification stage iie hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ii hodgkin lymphoma ajcc v8;lugano classification stage ii hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ie adult lymphoma ajcc v8;lugano classification stage ie adult lymphoma ajcc v8;exactmatch
lugano classification stage i adult lymphoma ajcc v8;lugano classification stage i adult lymphoma ajcc v8;exactmatch
lugano classification limited stage adult lymphoma ajcc v8;lugano classification limited stage adult lymphoma ajcc v8;exactmatch
stage iii thyroid gland medullary carcinoma ajcc v8;stage iii thyroid gland medullary cancer;exactmatch
refractory extensive stage lung small cell carcinoma;refractory extensive stage lung small cell carcinoma;exactmatch
recurrent extensive stage lung small cell carcinoma;recurrent extensive stage lung small cell carcinoma;exactmatch
refractory lung carcinoma;refractory lung carcinoma;exactmatch
stage ivc thyroid gland medullary carcinoma ajcc v8;stage ivc thyroid gland medullary cancer;exactmatch
stage ivb thyroid gland medullary carcinoma ajcc v8;stage ivb thyroid gland medullary cancer;exactmatch
stage iva thyroid gland medullary carcinoma ajcc v8;stage iva thyroid gland medullary cancer;exactmatch
stage iv thyroid gland medullary carcinoma ajcc v8;stage iv thyroid gland medullary cancer;exactmatch
stage ii thyroid gland medullary carcinoma ajcc v8;stage ii thyroid gland medullary cancer;exactmatch
lugano classification adult lymphoma by ajcc v8 stage;lugano classification adult lymphoma by ajcc v8 stage;exactmatch
stage i thyroid gland medullary carcinoma ajcc v8;stage i thyroid gland medullary cancer;exactmatch
thyroid gland medullary carcinoma by ajcc v8 stage;thyroid gland medullary carcinoma by ajcc v8 stage;exactmatch
thyroid gland medullary carcinoma by ajcc v7 stage;thyroid gland medullary carcinoma by ajcc v7 stage;exactmatch
stage ivc thyroid gland anaplastic carcinoma ajcc v8;stage ivc thyroid gland anaplastic carcinoma ajcc v8;exactmatch
stage ivb thyroid gland anaplastic carcinoma ajcc v8;stage ivb thyroid gland anaplastic carcinoma ajcc v8;exactmatch
stage iva thyroid gland anaplastic carcinoma ajcc v8;stage iva thyroid gland anaplastic carcinoma ajcc v8;exactmatch
thyroid gland anaplastic carcinoma by ajcc v8 stage;thyroid gland anaplastic carcinoma by ajcc v8 stage;exactmatch
adrenal cortex carcinoma by ajcc v7 stage;adrenal cortex carcinoma by ajcc v7 stage;exactmatch
ensat stage;ensat stage;exactmatch
adrenal cortex carcinoma by ajcc v8 stage;adrenal cortex carcinoma by ajcc v8 stage;exactmatch
stage i adrenal cortex carcinoma ajcc v8;stage i adrenal cortex cancer;exactmatch
lugano stage;lugano stage;exactmatch
mycosis fungoides by ajcc v7 stage;mycosis fungoides by ajcc v7 stage;exactmatch
mycosis fungoides and sezary syndrome by ajcc v7 stage;mycosis fungoides and sezary syndrome by ajcc v7 stage;exactmatch
hodgkin lymphoma by ann arbor stage;hodgkin lymphoma by ann arbor stage;exactmatch
non-hodgkin lymphoma by ann arbor stage;non-hodgkin lymphoma by ann arbor stage;exactmatch
lymphoma by ann arbor stage;lymphoma by ann arbor stage;exactmatch
ann arbor stage;ann arbor stage;exactmatch
stage iv adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8;stage iv adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8;exactmatch
stage iii adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8;stage iii adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8;exactmatch
stage ii adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8;stage ii adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8;exactmatch
stage i adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8;stage i adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8;exactmatch
adrenal gland pheochromocytoma and sympathetic paraganglioma by ajcc v8 stage;adrenal gland pheochromocytoma and sympathetic paraganglioma by ajcc v8 stage;exactmatch
stage iv adrenal cortex carcinoma ajcc v8;stage iv adrenal cortex cancer;exactmatch
stage iii adrenal cortex carcinoma ajcc v8;stage iii adrenal cortex cancer;exactmatch
stage ii adrenal cortex carcinoma ajcc v8;stage ii adrenal cortex cancer;exactmatch
lugano classification adult hodgkin lymphoma by ajcc v8 stage;lugano classification adult hodgkin lymphoma by ajcc v8 stage;exactmatch
lugano classification stage i adult hodgkin lymphoma ajcc v8;lugano classification stage i adult hodgkin lymphoma ajcc v8;exactmatch
stage iva1 mycosis fungoides and sezary syndrome ajcc v8;stage iva1 mycosis fungoides and sezary syndrome ajcc v8;exactmatch
nodal marginal zone lymphoma by ann arbor stage;nodal marginal zone lymphoma by ann arbor stage;exactmatch
angioimmunoblastic t-cell lymphoma by ann arbor stage;angioimmunoblastic t-cell lymphoma by ann arbor stage;exactmatch
noncutaneous childhood anaplastic large cell lymphoma by ann arbor stage;noncutaneous childhood anaplastic large cell lymphoma by ann arbor stage;exactmatch
noncutaneous anaplastic large cell lymphoma by ann arbor stage;noncutaneous anaplastic large cell lymphoma by ann arbor stage;exactmatch
adult t-cell leukemia/lymphoma by ann arbor stage;adult t-cell leukemia/lymphoma by ann arbor stage;exactmatch
mature t- and nk-cell lymphoma by ann arbor stage;mature t- and nk-cell lymphoma by ann arbor stage;exactmatch
centroblastic lymphoma by ann arbor stage;centroblastic lymphoma by ann arbor stage;exactmatch
primary mediastinal (thymic) large b-cell lymphoma by ann arbor stage;primary mediastinal (thymic) large b-cell lymphoma by ann arbor stage;exactmatch
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue by ann arbor stage;extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue by ann arbor stage;exactmatch
nasal type nk/t-cell lymphoma by ann arbor stage;nasal type nk/t-cell lymphoma by ann arbor stage;exactmatch
small lymphocytic lymphoma by ann arbor stage;small lymphocytic lymphoma by ann arbor stage;exactmatch
marginal zone lymphoma by ann arbor stage;marginal zone lymphoma by ann arbor stage;exactmatch
mantle cell lymphoma by ann arbor stage;mantle cell lymphoma by ann arbor stage;exactmatch
lymphoplasmacytic lymphoma by ann arbor stage;lymphoplasmacytic lymphoma by ann arbor stage;exactmatch
follicular lymphoma by ann arbor stage;follicular lymphoma by ann arbor stage;exactmatch
diffuse large b-cell lymphoma by ann arbor stage;diffuse large b-cell lymphoma by ann arbor stage;exactmatch
burkitt lymphoma by ann arbor stage;burkitt lymphoma by ann arbor stage;exactmatch
enteropathy-associated t-cell lymphoma by ann arbor stage;enteropathy-associated t-cell lymphoma by ann arbor stage;exactmatch
blasts 30 percent or less of bone marrow nucleated cells;blasts 30 percent or less of bone marrow nucleated cells;exactmatch
lugano classification stage ie adult hodgkin lymphoma ajcc v8;lugano classification stage ie adult hodgkin lymphoma ajcc v8;exactmatch
cell structure;cell structure;exactmatch
stage iv mycosis fungoides and sezary syndrome ajcc v8;stage iv mycosis fungoides and sezary syndrome ajcc v8;exactmatch
stage iiib mycosis fungoides and sezary syndrome ajcc v8;stage iiib mycosis fungoides and sezary syndrome ajcc v8;exactmatch
stage iiia mycosis fungoides and sezary syndrome ajcc v8;stage iiia mycosis fungoides and sezary syndrome ajcc v8;exactmatch
stage iii mycosis fungoides and sezary syndrome ajcc v8;stage iii mycosis fungoides and sezary syndrome ajcc v8;exactmatch
stage iib mycosis fungoides and sezary syndrome ajcc v8;stage iib mycosis fungoides and sezary syndrome ajcc v8;exactmatch
stage iia mycosis fungoides and sezary syndrome ajcc v8;stage iia mycosis fungoides and sezary syndrome ajcc v8;exactmatch
stage ii mycosis fungoides and sezary syndrome ajcc v8;stage ii mycosis fungoides and sezary syndrome ajcc v8;exactmatch
stage ib mycosis fungoides and sezary syndrome ajcc v8;stage ib mycosis fungoides and sezary syndrome ajcc v8;exactmatch
blasts 5 percent or more of peripheral blood white cells;blasts 5 percent or more of peripheral blood white cells;exactmatch
stage ia mycosis fungoides and sezary syndrome ajcc v8;stage ia mycosis fungoides and sezary syndrome ajcc v8;exactmatch
stage i mycosis fungoides and sezary syndrome ajcc v8;stage i mycosis fungoides and sezary syndrome ajcc v8;exactmatch
mycosis fungoides and sezary syndrome by ajcc v8 stage;mycosis fungoides and sezary syndrome by ajcc v8 stage;exactmatch
stage iva2;iva2;exactmatch
stage iva1;iva2;exactmatch
macromolecular structure;macromolecular structure;exactmatch
epstein-barr virus negative;ebv negative;exactmatch
ccaat enhancer binding protein gene mutation;c/ebp gene mutation;exactmatch
b lymphoblastic lymphoma by ann arbor stage;b lymphoblastic lymphoma by ann arbor stage;exactmatch
deleterious homologous recombination pathway gene mutation;deleterious hhr gene mutation;exactmatch
childhood lymphoma by ajcc v8 stage;childhood lymphoma by ajcc v8 stage;exactmatch
stage c chronic lymphocytic leukemia;stage c chronic lymphocytic leukemia;exactmatch
stage b chronic lymphocytic leukemia;stage b chronic lymphocytic leukemia;exactmatch
stage a chronic lymphocytic leukemia;stage a chronic lymphocytic leukemia;exactmatch
chronic lymphocytic leukemia- binet staging system;chronic lymphocytic leukemia- binet staging system;exactmatch
rai stage;rai stage;exactmatch
chronic lymphocytic leukemia- modified rai staging system;chronic lymphocytic leukemia- modified rai staging system;exactmatch
lymphoma by ajcc v8 stage;lymphoma by ajcc v8 stage;exactmatch
stage iie;stage iie;exactmatch
t-cell non-hodgkin lymphoma by ann arbor stage;t-cell non-hodgkin lymphoma by ann arbor stage;exactmatch
stage ie;stage ie;exactmatch
lugano classification stage iv adult hodgkin lymphoma ajcc v8;lugano classification stage iv adult hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iii adult hodgkin lymphoma ajcc v8;lugano classification stage iii adult hodgkin lymphoma ajcc v8;exactmatch
lugano classification advanced stage adult hodgkin lymphoma ajcc v8;lugano classification advanced stage adult hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ii bulky adult hodgkin lymphoma ajcc v8;lugano classification stage ii bulky adult hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage iie adult hodgkin lymphoma ajcc v8;lugano classification stage iie adult hodgkin lymphoma ajcc v8;exactmatch
lugano classification stage ii adult hodgkin lymphoma ajcc v8;lugano classification stage ii adult hodgkin lymphoma ajcc v8;exactmatch
binet stage;binet stage;exactmatch
st. jude stage;st. jude stage;exactmatch
st. jude childhood non-hodgkin lymphoma by ajcc v8 stage;st. jude childhood non-hodgkin lymphoma by ajcc v8 stage;exactmatch
st. jude stage i childhood non-hodgkin lymphoma ajcc v8;st. jude stage i childhood non-hodgkin lymphoma ajcc v8;exactmatch
b-cell non-hodgkin lymphoma by ann arbor stage;b-cell non-hodgkin lymphoma by ann arbor stage;exactmatch
receptor tyrosine kinase gene mutation;rtk family gene mutation;exactmatch
chromosome 13 abnormality;chromosome 13 abnormality;exactmatch
childhood non-hodgkin lymphoma by ann arbor stage;childhood non-hodgkin lymphoma by ann arbor stage;exactmatch
adult non-hodgkin lymphoma by ann arbor stage;adult non-hodgkin lymphoma by ann arbor stage;exactmatch
deleterious brca gene mutation;deleterious brca family mutation;exactmatch
childhood hodgkin lymphoma by ann arbor stage;childhood hodgkin lymphoma by ann arbor stage;exactmatch
adult hodgkin lymphoma by ann arbor stage;adult hodgkin lymphoma by ann arbor stage;exactmatch
nodular lymphocyte predominant hodgkin lymphoma by ann arbor stage;nodular lymphocyte predominant hodgkin lymphoma by ann arbor stage;exactmatch
mixed cellularity classic hodgkin lymphoma by ann arbor stage;mixed cellularity classic hodgkin lymphoma by ann arbor stage;exactmatch
nodular sclerosis classic hodgkin lymphoma by ann arbor stage;nodular sclerosis classic hodgkin lymphoma by ann arbor stage;exactmatch
lymphocyte-depleted classic hodgkin lymphoma by ann arbor stage;lymphocyte-depleted classic hodgkin lymphoma by ann arbor stage;exactmatch
st. jude stage iv childhood non-hodgkin lymphoma ajcc v8;st. jude stage iv childhood non-hodgkin lymphoma ajcc v8;exactmatch
st. jude stage iii childhood non-hodgkin lymphoma ajcc v8;st. jude stage iii childhood non-hodgkin lymphoma ajcc v8;exactmatch
st. jude stage ii childhood non-hodgkin lymphoma ajcc v8;st. jude stage ii childhood non-hodgkin lymphoma ajcc v8;exactmatch
locally advanced cervical adenocarcinoma;locally advanced cervical adenocarcinoma;exactmatch
locally advanced unresectable cervical adenocarcinoma;locally advanced unresectable cervical adenocarcinoma;exactmatch
locally advanced unresectable cervical carcinoma;locally advanced unresectable cervical carcinoma;exactmatch
recurrent primary peritoneal high grade serous adenocarcinoma;recurrent primary peritoneal high grade serous adenocarcinoma;exactmatch
refractory endometrial transitional cell carcinoma;refractory endometrial transitional cell carcinoma;exactmatch
refractory endometrial squamous cell carcinoma;refractory endometrial squamous cell carcinoma;exactmatch
refractory endometrial dedifferentiated carcinoma;refractory endometrial dedifferentiated carcinoma;exactmatch
recurrent endometrial transitional cell carcinoma;recurrent endometrial transitional cell carcinoma;exactmatch
recurrent endometrial squamous cell carcinoma;recurrent endometrial squamous cell carcinoma;exactmatch
recurrent endometrial dedifferentiated carcinoma;recurrent endometrial dedifferentiated carcinoma;exactmatch
recurrent primary peritoneal endometrioid adenocarcinoma;recurrent endometrioid primary peritoneal carcinoma;exactmatch
recurrent high grade fallopian tube serous adenocarcinoma;recurrent high grade fallopian tube serous adenocarcinoma;exactmatch
refractory endometrial mucinous adenocarcinoma;refractory endometrial mucinous adenocarcinoma;exactmatch
recurrent fallopian tube endometrioid adenocarcinoma;recurrent fallopian tube endometrioid adenocarcinoma;exactmatch
recurrent high grade ovarian serous adenocarcinoma;recurrent high grade ovarian serous adenocarcinoma;exactmatch
solid pseudopapillary neoplasm of the ovary;primary ovarian solid pseudopapillary neoplasm;exactmatch
primary peritoneal endometrioid adenocarcinoma;primary peritoneal endometrioid adenocarcinoma;exactmatch
upper aerodigestive invasive malignancy;upper aerodigestive invasive malignancy;exactmatch
recurrent neuroendocrine carcinoma;recurrent neuroendocrine carcinoma;exactmatch
metastatic malignant mesothelioma;metastatic malignant mesothelioma;exactmatch
refractory endometrial adenocarcinoma;refractory endometrial adenocarcinoma;exactmatch
recurrent endometrial mucinous adenocarcinoma;recurrent endometrial mucinous adenocarcinoma;exactmatch
refractory diffuse large b-cell lymphoma, not otherwise specified;refractory diffuse large b-cell lymphoma, not otherwise specified;exactmatch
metastatic pancreatic neuroendocrine neoplasm;metastatic pancreatic neuroendocrine neoplasm;exactmatch
unresectable digestive system neuroendocrine neoplasm;unresectable digestive system neuroendocrine neoplasm;exactmatch
unresectable lung neuroendocrine neoplasm;unresectable lung neuroendocrine neoplasm;exactmatch
unresectable well differentiated neuroendocrine neoplasm;unresectable well differentiated neuroendocrine neoplasm;exactmatch
advanced pancreatic carcinoma;advanced pancreatic carcinoma;exactmatch
refractory pancreatic ductal adenocarcinoma;refractory pancreatic ductal adenocarcinoma;exactmatch
unresectable clear cell renal cell carcinoma;unresectable clear cell renal cell carcinoma;exactmatch
advanced pancreatic neuroendocrine neoplasm;advanced pancreatic neuroendocrine neoplasm;exactmatch
advanced lung neuroendocrine neoplasm;advanced lung neuroendocrine neoplasm;exactmatch
resectable liver and intrahepatic bile duct carcinoma;resectable liver and intrahepatic bile duct carcinoma;exactmatch
endocytotic process;endocytic process;exactmatch
advanced merkel cell carcinoma;advanced merkel cell carcinoma;exactmatch
advanced gastric carcinoma;advanced gastric carcinoma;exactmatch
refractory endometrial undifferentiated carcinoma;refractory endometrial undifferentiated carcinoma;exactmatch
refractory very high risk myelodysplastic syndrome;refractory very high risk myelodysplastic syndrome;exactmatch
recurrent very high risk myelodysplastic syndrome;recurrent very high risk myelodysplastic syndrome;exactmatch
very high risk myelodysplastic syndrome;very high risk myelodysplastic syndrome;exactmatch
nutm1 gene translocation;c15orf55 gene translocation;exactmatch
recurrent diffuse large b-cell lymphoma, not otherwise specified;recurrent diffuse large b-cell lymphoma, not otherwise specified;exactmatch
advanced cervical adenocarcinoma;advanced cervical adenocarcinoma;exactmatch
sinonasal exophytic papilloma;sinonasal exophytic papilloma;exactmatch
ctnnb1 protein variant;beta catenin protein variant;exactmatch
cdc73 protein variant;cdc73 protein variant;exactmatch
nasal cavity papilloma;nasal cavity papilloma;exactmatch
mixed neuroendocrine non-neuroendocrine neoplasm;minen;exactmatch
neuroendocrine and non-neuroendocrine neoplastic components present;neuroendocrine and non-neuroendocrine neoplastic components present;exactmatch
gastrointestinal tract adenoma, intestinal-type;adenoma, intestinal-type;exactmatch
infiltrating urothelial carcinoma, sarcomatoid variant;infiltrating urothelial carcinoma, sarcomatoid variant;exactmatch
human papillomavirus-negative squamous cell carcinoma;hpv-negative squamous cell carcinoma;exactmatch
unresectable malignant peripheral nerve sheath tumor;unresectable malignant peripheral nerve sheath tumor;exactmatch
differentiated intraepithelial neoplasia;differentiated intraepithelial neoplasia;exactmatch
warty carcinoma;warty carcinoma;exactmatch
locally advanced unresectable malignant pecoma;locally advanced unresectable malignant pecoma;exactmatch
advanced malignant pecoma;advanced malignant pecoma;exactmatch
metastatic malignant pecoma;metastatic malignant pecoma;exactmatch
refractory clear cell renal cell carcinoma;refractory clear cell renal cell carcinoma;exactmatch
hereditary colon carcinoma;hereditary colon carcinoma;exactmatch
dicer1 protein variant;dicer1 protein variant;exactmatch
nf1-associated malignant peripheral nerve sheath tumor;nf1-associated malignant peripheral nerve sheath tumor;exactmatch
expression negative;absent;exactmatch
unresectable ampulla of vater carcinoma;unresectable ampulla of vater carcinoma;exactmatch
transcriptional repression;gene down-regulation;exactmatch
trunk and extremities;trunk and extremities;exactmatch
soft tissue sarcoma of the trunk and extremities;soft tissue sarcoma of the trunk and extremities;exactmatch
dna binding protein;dna binding protein;exactmatch
unresectable nasopharyngeal carcinoma;unresectable nasopharyngeal carcinoma;exactmatch
unresectable head and neck carcinoma;unresectable head and neck carcinoma;exactmatch
unresectable periampullary adenocarcinoma;unresectable periampullary adenocarcinoma;exactmatch
unresectable liver and intrahepatic bile duct carcinoma;unresectable liver and intrahepatic bile duct carcinoma;exactmatch
sporadic malignant peripheral nerve sheath tumor;sporadic malignant peripheral nerve sheath tumor;exactmatch
dna replication;dna replication;exactmatch
dna repair;dna damage repair;exactmatch
cytoskeletal protein;cytoskeletal protein;exactmatch
cytokinesis;cytokinesis;exactmatch
conception;conception;exactmatch
cloudman s91 malignant melanoma;cloudman s91 malignant melanoma;exactmatch
radiation-induced malignant peripheral nerve sheath tumor;radiation-induced malignant peripheral nerve sheath tumor;exactmatch
unresectable pancreatic neuroendocrine neoplasm;unresectable pancreatic neuroendocrine neoplasm;exactmatch
advanced ovarian carcinoma;advanced ovarian carcinoma;exactmatch
skin verrucous carcinoma;skin verrucous carcinoma;exactmatch
high-csd melanoma;cutaneous melanoma with a high degree of cumulative sun damage;exactmatch
cic gene rearrangement;cic gene rearrangement;exactmatch
ewsr1 gene rearrangement;ews gene rearrangement;exactmatch
cic-dux4l sarcoma;cic-dux4l sarcoma;exactmatch
cic-dux4 sarcoma;cic-dux4 sarcoma;exactmatch
nail matrix nevus;nmn;exactmatch
nail matrix;nail matrix;exactmatch
excision repair;excision repair;exactmatch
skin with high degree of cumulative sun damage;skin with high degree of cumulative sun damage;exactmatch
ewsr1-negative small round cell tumor;ewsr1-negative small blue round cell tumor;exactmatch
localized malignant pancreatic neoplasm;localized malignant pancreatic neoplasm;exactmatch
metastatic proximal gastric adenocarcinoma;metastatic proximal gastric adenocarcinoma;exactmatch
proximal gastric adenocarcinoma;proximal gastric adenocarcinoma;exactmatch
proximal stomach;proximal stomach;exactmatch
bone marrow failure syndrome;bone marrow failure syndrome;exactmatch
recurrent differentiated thyroid gland carcinoma;recurrent differentiated thyroid gland carcinoma;exactmatch
refractory thyroid gland hurthle cell carcinoma;refractory thyroid gland hurthle cell carcinoma;exactmatch
cic/dux4l fusion gene;cic-dux4l fusion gene;exactmatch
metastatic breast adenocarcinoma;metastatic breast adenocarcinoma;exactmatch
skin squamous cell carcinoma with osteoclast-like giant cells;skin squamous cell carcinoma with osteoclast-like giant cells;exactmatch
refractory skin squamous cell carcinoma;refractory skin squamous cell carcinoma;exactmatch
refractory neuroendocrine carcinoma;refractory neuroendocrine carcinoma;exactmatch
refractory merkel cell carcinoma;refractory merkel cell carcinoma;exactmatch
locally recurrent merkel cell carcinoma;locally recurrent merkel cell carcinoma;exactmatch
recurrent metastatic merkel cell carcinoma;recurrent metastatic merkel cell carcinoma;exactmatch
locally advanced merkel cell carcinoma;locally advanced merkel cell carcinoma;exactmatch
locally recurrent skin squamous cell carcinoma;locally recurrent skin squamous cell carcinoma;exactmatch
recurrent metastatic skin squamous cell carcinoma;recurrent metastatic skin squamous cell carcinoma;exactmatch
mixed malignant epithelial cell population;mixed malignant epithelial cell population;exactmatch
locally advanced breast adenocarcinoma;locally advanced breast adenocarcinoma;exactmatch
mixed carcinoma;mixed carcinoma;exactmatch
infiltrating bladder mixed carcinoma;infiltrating bladder mixed carcinoma;exactmatch
atypical vascular lesion;avl;exactmatch
refractory breast adenocarcinoma;refractory breast adenocarcinoma;exactmatch
refractory bladder urothelial carcinoma;refractory bladder urothelial carcinoma;exactmatch
locally advanced hypopharyngeal squamous cell carcinoma;locally advanced hypopharyngeal squamous cell carcinoma;exactmatch
advanced breast adenocarcinoma;advanced breast adenocarcinoma;exactmatch
esterase;ec 3.1;exactmatch
refractory thyroid gland follicular carcinoma;refractory thyroid gland follicular carcinoma;exactmatch
refractory thyroid gland papillary carcinoma;refractory thyroid gland papillary carcinoma;exactmatch
lichen planus-like keratosis;lichen planus-like keratosis;exactmatch
bap1-inactivated skin melanocytic neoplasm;bap1-deficient tumor;exactmatch
mixture of melanocytic neoplastic components present;mixture of melanocytic neoplastic components present;exactmatch
sinonasal tract and oral cavity;sinonasal tract and oral cavity;exactmatch
melanin-pigmented epithelioid cells present;melanin-pigmented epithelioid cells present;exactmatch
pigmented epithelioid melanocytoma;epithelioid blue nevus;exactmatch
spitz melanoma;mst;exactmatch
unresectable triple-negative breast carcinoma;unresectable triple-negative breast carcinoma;exactmatch
locally advanced squamous cell carcinoma of unknown primary;locally advanced squamous cell carcinoma of unknown primary;exactmatch
refractory differentiated thyroid gland carcinoma;refractory differentiated thyroid gland carcinoma;exactmatch
locally advanced laryngeal squamous cell carcinoma;locally advanced laryngeal squamous cell carcinoma;exactmatch
locally advanced oral cavity squamous cell carcinoma;locally advanced oral cavity squamous cell carcinoma;exactmatch
hereditary colorectal cancer syndrome;hereditary colorectal cancer syndrome;exactmatch
energy metabolism process;energy metabolism;exactmatch
colorectal serrated polyposis;colorectal serrated polyposis;exactmatch
skin squamous cell carcinoma with sarcomatoid differentiation;skin carcinosarcoma;exactmatch
skin lymphoepithelioma-like carcinoma;skin lymphoepithelioma-like carcinoma;exactmatch
combined bap1-inactivated nevus;combined bap1-inactivated nevus;exactmatch
bap1-inactivated melanocytoma;bap1-inactivated cutaneous melanocytoma;exactmatch
combined nevus;clonal nevus;exactmatch
unresectable acral lentiginous melanoma;unresectable acral lentiginous melanoma;exactmatch
erythropoiesis;erythropoiesis;exactmatch
pten protein variant;mutated in multiple advanced cancers 1 protein variant;exactmatch
locally advanced paranasal sinus carcinoma;locally advanced paranasal sinus carcinoma;exactmatch
locally advanced lip and oral cavity carcinoma;locally advanced lip and oral cavity carcinoma;exactmatch
locally advanced pharyngeal carcinoma;locally advanced pharyngeal carcinoma;exactmatch
locally advanced laryngeal carcinoma;locally advanced laryngeal carcinoma;exactmatch
shared neoantigen-positive malignant solid neoplasm;shared neoantigen-positive malignant solid neoplasm;exactmatch
patient-specific neoantigen-positive malignant solid neoplasm;patient-specific neoantigen-positive malignant solid neoplasm;exactmatch
neoantigen-positive malignant solid neoplasm;neoantigen-positive malignant solid neoplasm;exactmatch
patient-specific neoantigen-positive;patient-specific neoantigen-positive;exactmatch
enzyme;enzyme;exactmatch
shared neoantigen-positive;shared neoantigen-positive;exactmatch
neoantigen-positive;neoantigen-positive;exactmatch
metastatic non-small cell carcinoma;metastatic non-small cell carcinoma;exactmatch
unresectable mucosal melanoma;unresectable mucosal melanoma;exactmatch
advanced pancreatic ductal adenocarcinoma;advanced pancreatic ductal adenocarcinoma;exactmatch
pax3 gene rearrangement;pax3 gene rearrangement;exactmatch
brd4 gene translocation;brd4 gene translocation;exactmatch
refractory epithelioid malignant peripheral nerve sheath tumor;refractory epithelioid malignant peripheral nerve sheath tumor;exactmatch
recurrent malignant myoepithelioma;recurrent malignant myoepithelioma;exactmatch
refractory rhabdoid tumor of the kidney;refractory rhabdoid tumor of the kidney;exactmatch
recurrent rhabdoid tumor of the kidney;recurrent rhabdoid tumor of the kidney;exactmatch
refractory dedifferentiated chordoma;refractory dedifferentiated chordoma;exactmatch
recurrent dedifferentiated chordoma;recurrent dedifferentiated chordoma;exactmatch
refractory kidney medullary carcinoma;refractory kidney medullary carcinoma;exactmatch
recurrent kidney medullary carcinoma;recurrent kidney medullary carcinoma;exactmatch
recurrent epithelioid malignant peripheral nerve sheath tumor;recurrent epithelioid malignant peripheral nerve sheath tumor;exactmatch
non-m3 acute myeloid leukemia;non-m3 acute myeloid leukemia;exactmatch
refractory atypical teratoid/rhabdoid tumor;refractory atypical teratoid/rhabdoid tumor;exactmatch
refractory epithelioid sarcoma;refractory epithelioid sarcoma;exactmatch
refractory chordoma;refractory chordoma;exactmatch
refractory urinary system carcinoma;refractory urinary system carcinoma;exactmatch
metastatic thyroid gland medullary carcinoma;metastatic thyroid gland medullary carcinoma;exactmatch
refractory childhood malignant neoplasm;refractory childhood malignant neoplasm;exactmatch
recurrent childhood malignant neoplasm;recurrent childhood malignant neoplasm;exactmatch
refractory malignant myoepithelioma;refractory malignant myoepithelioma;exactmatch
normal karyotype intermediate risk acute myeloid leukemia;normal karyotype intermediate risk acute myeloid leukemia;exactmatch
acute myeloid leukemia with trisomy 8;acute myeloid leukemia with trisomy 8;exactmatch
advanced papillary renal cell carcinoma;advanced papillary renal cell carcinoma;exactmatch
asph-positive head and neck squamous cell carcinoma;asph-positive head and neck squamous cell carcinoma;exactmatch
asph-positive neoplastic cells present;asp beta-hydroxylase-positive neoplastic cells present;exactmatch
metastatic clear cell renal cell carcinoma;metastatic clear cell renal cell carcinoma;exactmatch
locally advanced gastric adenocarcinoma;locally advanced gastric adenocarcinoma;exactmatch
locally advanced colorectal carcinoma;locally advanced colorectal carcinoma;exactmatch
advanced myxoid liposarcoma;advanced myxoid liposarcoma;exactmatch
advanced bone sarcoma;advanced bone sarcoma;exactmatch
metastatic papillary renal cell carcinoma;metastatic papillary renal cell carcinoma;exactmatch
refractory biliary tract carcinoma;refractory biliary tract carcinoma;exactmatch
locally advanced gastroesophageal junction adenocarcinoma;locally advanced gastroesophageal junction adenocarcinoma;exactmatch
locally advanced head and neck squamous cell carcinoma;locally advanced head and neck squamous cell carcinoma;exactmatch
advanced gallbladder carcinoma;advanced gallbladder carcinoma;exactmatch
metastatic gallbladder carcinoma;metastatic gallbladder carcinoma;exactmatch
refractory gallbladder carcinoma;refractory gallbladder carcinoma;exactmatch
advanced cholangiocarcinoma;advanced cholangiocarcinoma;exactmatch
metastatic biliary tract carcinoma;metastatic biliary tract carcinoma;exactmatch
aging;aging;exactmatch
refractory systemic anaplastic large cell lymphoma;refractory systemic anaplastic large cell lymphoma;exactmatch
recurrent systemic anaplastic large cell lymphoma;recurrent systemic anaplastic large cell lymphoma;exactmatch
penile epithelioid hemangioma;penile epithelioid hemangioma;exactmatch
penile neurofibroma;penile neurofibroma;exactmatch
penile schwannoma;penile schwannoma;exactmatch
penile leiomyosarcoma;penile leiomyosarcoma;exactmatch
penile malignant peripheral nerve sheath tumor;penile malignant peripheral nerve sheath tumor;exactmatch
penile leiomyoma;penile leiomyoma;exactmatch
penile glomus tumor;penile glomus tumor;exactmatch
penile epithelioid hemangioendothelioma;penile epithelioid hemangioendothelioma;exactmatch
penile hemangioma;penile hemangioma;exactmatch
resectable osteosarcoma;resectable osteosarcoma;exactmatch
penile angiosarcoma;penile angiosarcoma;exactmatch
penile soft tissue neoplasm;penile mesenchymal neoplasm;exactmatch
metastatic merkel cell carcinoma;metastatic merkel cell carcinoma;exactmatch
localized lung carcinoma;localized lung carcinoma;exactmatch
actin-binding protein;abp;exactmatch
localized head and neck carcinoma;localized head and neck carcinoma;exactmatch
primary peritoneal clear cell adenocarcinoma;primary peritoneal clear cell adenocarcinoma;exactmatch
penile rhabdomyosarcoma;penile rhabdomyosarcoma;exactmatch
penile undifferentiated pleomorphic sarcoma;penile undifferentiated pleomorphic sarcoma;exactmatch
penile myointimoma;myointimoma;exactmatch
intravascular myofibroblastic proliferation;intravascular myofibroblastic proliferation;exactmatch
advanced squamous cell carcinoma;advanced squamous cell carcinoma;exactmatch
recurrent squamous cell carcinoma;recurrent squamous cell carcinoma;exactmatch
advanced breast carcinoma;advanced breast carcinoma;exactmatch
unresectable lung non-squamous non-small cell carcinoma;unresectable lung non-squamous non-small cell carcinoma;exactmatch
atpase;atp hydrolase;exactmatch
locally advanced urethral urothelial carcinoma;locally advanced urethral urothelial carcinoma;exactmatch
locally advanced bladder urothelial carcinoma;locally advanced bladder urothelial carcinoma;exactmatch
locally advanced renal pelvis urothelial carcinoma;locally advanced renal pelvis urothelial carcinoma;exactmatch
locally advanced ureter urothelial carcinoma;locally advanced ureter urothelial carcinoma;exactmatch
recurrent adamantinomatous craniopharyngioma;recurrent adamantinomatous craniopharyngioma;exactmatch
unresectable fibrolamellar carcinoma;unresectable fibrolamellar carcinoma;exactmatch
unresectable colorectal carcinoma;unresectable colorectal carcinoma;exactmatch
head and neck carcinoma of unknown primary;head and neck cup;exactmatch
metastatic malignant neoplasm in the head and neck;metastatic malignant neoplasm in the head and neck;exactmatch
penile lymphangioma;penile lymphangioma;exactmatch
locally advanced gastric carcinoma;locally advanced gastric carcinoma;exactmatch
"b acute lymphoblastic leukemia with t(4;11)(q21;23)";"acute lymphoblastic leukemia with t(4;11)(q21;23)";exactmatch
biphenotypic sinonasal sarcoma;bsns;exactmatch
cell cycle process;cell cycle;exactmatch
cell motility;cell motility;exactmatch
cell growth;cell growth;exactmatch
unresectable adenoid cystic carcinoma;unresectable adenoid cystic carcinoma;exactmatch
advanced adenoid cystic carcinoma;advanced adenoid cystic carcinoma;exactmatch
cell differentiation process;cell differentiation;exactmatch
neuroendocrine carcinoma of unknown primary;neuroendocrine carcinoma of unknown primary;exactmatch
unresectable thyroid gland medullary carcinoma;unresectable thyroid gland medullary carcinoma;exactmatch
metastatic digestive system mixed adenoneuroendocrine carcinoma;metastatic digestive system mixed adenoneuroendocrine carcinoma;exactmatch
cell survival;cell survival;exactmatch
advanced renal pelvis carcinoma;advanced renal pelvis carcinoma;exactmatch
metastatic renal pelvis carcinoma;metastatic renal pelvis carcinoma;exactmatch
advanced thyroid gland medullary carcinoma;advanced thyroid gland medullary carcinoma;exactmatch
advanced urethral urothelial carcinoma;advanced urethral urothelial carcinoma;exactmatch
refractory gliosarcoma;refractory gliosarcoma;exactmatch
recurrent small cell glioblastoma;recurrent small cell glioblastoma;exactmatch
refractory small cell glioblastoma;refractory small cell glioblastoma;exactmatch
dysplasia negative;dysplasia negative;exactmatch
metastatic dedifferentiated liposarcoma;metastatic dedifferentiated liposarcoma;exactmatch
metastatic malignant colorectal neoplasm;metastatic malignant colorectal neoplasm;exactmatch
fumarate hydratase-deficient renal cell carcinoma;fh-deficient rcc;exactmatch
head and neck sarcoma;head and neck sarcoma;exactmatch
prostate adenocarcinoma by ajcc v7 stage;prostate adenocarcinoma by ajcc v7 stage;exactmatch
aggressive prostate adenocarcinoma;aggressive prostate adenocarcinoma;exactmatch
abdominal neoplasm, excluding pancreas neoplasm;abdominal neoplasm, excluding pancreas neoplasm;exactmatch
apc protein variant;apc protein variant;exactmatch
unresectable renal pelvis and ureter urothelial carcinoma;unresectable renal pelvis and ureter urothelial carcinoma;exactmatch
locally advanced renal pelvis and ureter urothelial carcinoma;locally advanced renal pelvis and ureter urothelial carcinoma;exactmatch
hodgkin's sarcoma;hodgkin's sarcoma;exactmatch
locally advanced dedifferentiated liposarcoma;locally advanced dedifferentiated liposarcoma;exactmatch
micropapillary carcinoma;micropapillary carcinoma;exactmatch
advanced genitourinary system carcinoma;advanced genitourinary system carcinoma;exactmatch
genitourinary system carcinoma;genitourinary system carcinoma;exactmatch
locally advanced ewing sarcoma;locally advanced ewing sarcoma;exactmatch
unresectable alveolar soft part sarcoma;unresectable alveolar soft part sarcoma;exactmatch
locally advanced alveolar soft part sarcoma;locally advanced alveolar soft part sarcoma;exactmatch
locally advanced malignant peripheral nerve sheath tumor;locally advanced malignant peripheral nerve sheath tumor;exactmatch
unresectable pituitary gland carcinoma;unresectable pituitary gland carcinoma;exactmatch
locally advanced parathyroid gland carcinoma;locally advanced parathyroid gland carcinoma;exactmatch
metastatic pituitary gland carcinoma;metastatic pituitary gland carcinoma;exactmatch
retropharyngeal space;retropharyngeal space;exactmatch
metastatic paranasal sinus squamous cell carcinoma;metastatic paranasal sinus squamous cell carcinoma;exactmatch
digital papillary adenoma;aggressive digital papillary adenoma;exactmatch
unresectable malignant digestive system neoplasm;unresectable malignant digestive system neoplasm;exactmatch
unresectable oropharyngeal squamous cell carcinoma;unresectable oropharyngeal squamous cell carcinoma;exactmatch
malignant retropharyngeal neoplasm;malignant retropharyngeal neoplasm;exactmatch
benign retropharyngeal neoplasm;benign retropharyngeal neoplasm;exactmatch
retropharyngeal neoplasm;retropharyngeal neoplasm;exactmatch
malignant parapharyngeal neoplasm;malignant parapharyngeal neoplasm;exactmatch
locally advanced pituitary gland carcinoma;locally advanced pituitary gland carcinoma;exactmatch
benign parapharyngeal neoplasm;benign parapharyngeal neoplasm;exactmatch
parapharyngeal neoplasm;parapharyngeal neoplasm;exactmatch
lateral pharyngeal space;lateral pharyngeal space;exactmatch
cdkn2a-p16 status;cdkn2a-p16 status;exactmatch
resectable oropharyngeal squamous cell carcinoma;resectable oropharyngeal squamous cell carcinoma;exactmatch
unresectable merkel cell carcinoma;unresectable merkel cell carcinoma;exactmatch
localized breast carcinoma;localized breast carcinoma;exactmatch
locally advanced oropharyngeal squamous cell carcinoma;locally advanced oropharyngeal squamous cell carcinoma;exactmatch
metastatic sinonasal squamous cell carcinoma;metastatic nasal cavity and paranasal sinus squamous cell carcinoma;exactmatch
peritoneal epithelioid mesothelioma;peritoneal epithelioid mesothelioma;exactmatch
recurrent cutaneous squamous cell carcinoma of the head and neck;recurrent cutaneous squamous cell carcinoma of the head and neck;exactmatch
advanced ureter urothelial carcinoma;advanced ureter urothelial carcinoma;exactmatch
advanced bladder urothelial carcinoma;advanced bladder urothelial carcinoma;exactmatch
intercellular communication process;cell to cell communication and signaling;exactmatch
cell aging;aging, cellular;exactmatch
biology;biologic;exactmatch
biological sciences;biological sciences;exactmatch
biomarker;biological marker;exactmatch
b16 malignant melanoma;b16 malignant melanoma;exactmatch
unresectable meningioma;unresectable meningioma;exactmatch
asph positive;asp beta-hydroxylase positive;exactmatch
non-malignant neoplasm;non-malignant neoplasm;exactmatch
malignant brain glioma;brain high grade glioma;exactmatch
non-invasive cribriform carcinoma;non-invasive cribriform carcinoma;exactmatch
testicular signet ring stromal tumor;psrstt;exactmatch
resectable cutaneous squamous cell carcinoma of the head and neck;resectable cutaneous squamous cell carcinoma of the head and neck;exactmatch
hormone receptor negative breast adenocarcinoma;er and pr negative breast carcinoma;exactmatch
hormone receptor negative;hormone receptor negative;exactmatch
refractory renal cell carcinoma;refractory renal cell carcinoma;exactmatch
advanced her2 negative breast adenocarcinoma;advanced her2 negative breast adenocarcinoma;exactmatch
abnormal karyotype;abnormal karyotype;exactmatch
myc gene;myc;exactmatch
peritoneal biphasic mesothelioma;peritoneal biphasic mesothelioma;exactmatch
peritoneal sarcomatoid mesothelioma;peritoneal sarcomatoid mesothelioma;exactmatch
morphogenesis;morphogenesis;exactmatch
refractory her2 negative breast adenocarcinoma;refractory her2 negative breast adenocarcinoma;exactmatch
recurrent her2 negative breast adenocarcinoma;recurrent her2 negative breast adenocarcinoma;exactmatch
refractory follicular t-cell lymphoma;refractory follicular t-cell lymphoma;exactmatch
locally advanced esophageal carcinoma;locally advanced esophageal carcinoma;exactmatch
recurrent follicular t-cell lymphoma;recurrent follicular t-cell lymphoma;exactmatch
refractory nodal peripheral t-cell lymphoma with tfh phenotype;refractory nodal peripheral t-cell lymphoma with tfh phenotype;exactmatch
recurrent nodal peripheral t-cell lymphoma with tfh phenotype;recurrent nodal peripheral t-cell lymphoma with tfh phenotype;exactmatch
metastatic her2 negative breast adenocarcinoma;metastatic her2 negative breast adenocarcinoma;exactmatch
gata2/mecom fusion gene;gata2-mecom fusion gene;exactmatch
samd9l-associated familial myelodysplastic syndrome;samd9l-associated familial mds;exactmatch
samd9-associated familial myelodysplastic syndrome;samd9- associated familial mds;exactmatch
unresectable neuroendocrine neoplasm;unresectable neuroendocrine neoplasm;exactmatch
locally advanced anal carcinoma;locally advanced anal carcinoma;exactmatch
metastatic bladder urachal urothelial carcinoma;metastatic bladder urachal urothelial carcinoma;exactmatch
locally advanced renal cell carcinoma;locally advanced renal cell carcinoma;exactmatch
sdhd protein variant;cii-4 protein variant;exactmatch
sdhb protein variant;ip protein variant;exactmatch
rb1 protein variant;rb1 protein variant;exactmatch
ptpn11 protein variant;ptp-1d protein variant;exactmatch
platinum-resistant malignant female reproductive system neoplasm;platinum-resistant malignant female reproductive system neoplasm;exactmatch
ptch1 protein variant;ptc protein variant;exactmatch
neovascularization;neovascularization;exactmatch
locally advanced cholangiocarcinoma;locally advanced cholangiocarcinoma;exactmatch
locally advanced adenocarcinoma;locally advanced adenocarcinoma;exactmatch
cutaneous erdheim-chester disease;cutaneous erdheim-chester disease;exactmatch
locally advanced pancreatic carcinoma;locally advanced pancreatic carcinoma;exactmatch
cutaneous indeterminate dendritic cell tumor;cutaneous indeterminate cell histiocytosis;exactmatch
cutaneous langerhans cell histiocytosis;cutaneous langerhans cell histiocytosis;exactmatch
locally advanced biliary tract carcinoma;locally advanced biliary tract carcinoma;exactmatch
cutaneous histiocytic and dendritic cell neoplasm;cutaneous histiocytic and dendritic cell neoplasm;exactmatch
locally advanced hepatocellular carcinoma;locally advanced hepatocellular carcinoma;exactmatch
samd9l gene mutation;atxpc gene mutation;exactmatch
samd9 gene mutation;c7orf5 gene mutation;exactmatch
familial myelodysplastic syndrome;familial mds;exactmatch
myeloblasts 1 percent or less of peripheral blood white cells;myeloblasts 1 percent or less of peripheral blood white cells;exactmatch
spinal region;spinal region;exactmatch
high risk acute lymphoblastic leukemia;high risk acute lymphoblastic leukemia;exactmatch
very high risk prostate carcinoma;very high risk prostate carcinoma;exactmatch
high risk prostate carcinoma;high risk prostate carcinoma;exactmatch
very high risk chronic myelogenous leukemia, bcr-abl1 positive;very high risk chronic myelogenous leukemia, bcr-abl1 positive;exactmatch
high risk chronic myelogenous leukemia, bcr-abl1 positive;high risk chronic myelogenous leukemia, bcr-abl1 positive;exactmatch
myelodysplastic syndrome, unclassifiable, with single lineage dysplasia;myelodysplastic syndrome, unclassifiable, with single lineage dysplasia;exactmatch
bone marrow dysplasia present in less than 10 percent of myeloid cells;bone marrow dysplasia present in less than 10 percent of myeloid cells;exactmatch
samd9l gene;samd9l;exactmatch
myelodysplastic syndrome, unclassifiable, based on defining cytogenetic abnormality;myelodysplastic syndrome, unclassifiable, based on defining cytogenetic abnormality;exactmatch
myelodysplastic syndrome, unclassifiable, with 1 percent blasts;myelodysplastic syndrome, unclassifiable, with 1 percent blasts;exactmatch
myeloblasts 1 percent of peripheral blood white cells;myeloblasts 1 percent of peripheral blood white cells;exactmatch
sacral spine neoplasm;sacral spine neoplasm;exactmatch
lumbar spine neoplasm;lumbar spine neoplasm;exactmatch
thoracic spine neoplasm;thoracic spine neoplasm;exactmatch
locally advanced myxofibrosarcoma;locally advanced myxofibrosarcoma;exactmatch
thoracic region;thoracic region;exactmatch
spinal neoplasm;spinal neoplasm;exactmatch
lumbosacral spine neoplasm;lumbosacral spine neoplasm;exactmatch
cervical spine neoplasm;cervical spine neoplasm;exactmatch
unresectable soft tissue leiomyosarcoma;unresectable soft tissue leiomyosarcoma;exactmatch
advanced soft tissue leiomyosarcoma;advanced soft tissue leiomyosarcoma;exactmatch
metastatic soft tissue leiomyosarcoma;metastatic soft tissue leiomyosarcoma;exactmatch
unresectable round cell liposarcoma;unresectable round cell liposarcoma;exactmatch
unresectable epithelioid hemangioendothelioma;unresectable epithelioid hemangioendothelioma;exactmatch
advanced round cell liposarcoma;advanced round cell liposarcoma;exactmatch
advanced epithelioid hemangioendothelioma;advanced epithelioid hemangioendothelioma;exactmatch
advanced angiosarcoma;advanced angiosarcoma;exactmatch
unresectable myxoid liposarcoma;unresectable myxoid liposarcoma;exactmatch
unresectable angiosarcoma;unresectable angiosarcoma;exactmatch
unresectable fibrosarcoma;unresectable fibrosarcoma;exactmatch
advanced fibrosarcoma;advanced fibrosarcoma;exactmatch
advanced dedifferentiated liposarcoma;advanced dedifferentiated liposarcoma;exactmatch
advanced malignant peripheral nerve sheath tumor;advanced malignant peripheral nerve sheath tumor;exactmatch
advanced liposarcoma;advanced liposarcoma;exactmatch
localized pancreatic adenocarcinoma;localized pancreatic adenocarcinoma;exactmatch
recurrent soft tissue sarcoma of the trunk and extremities;recurrent soft tissue sarcoma of the trunk and extremities;exactmatch
metastatic malignant neoplasm in the digestive system;metastatic malignant neoplasm in the digestive system;exactmatch
benign periampullary neoplasm;benign periampullary neoplasm;exactmatch
pleomorphic fibroma;pleomorphic fibroma;exactmatch
usp6 gene rearrangement;hrp1 gene rearrangement;exactmatch
appendix mucinous neoplasm;appendix mucinous neoplasm;exactmatch
primary peritoneal adenocarcinoma;primary peritoneal adenocarcinoma;exactmatch
metastatic malignant breast neoplasm;metastatic malignant breast neoplasm;exactmatch
recurrent breast sarcoma;recurrent breast sarcoma;exactmatch
recurrent malignant breast neoplasm;recurrent malignant breast neoplasm;exactmatch
epidermal growth factor receptor;cell growth inhibiting protein 40;exactmatch
fosl1 protein overexpression;fos-like antigen 1 protein overexpression;exactmatch
cell surface receptor;cell surface receptor;exactmatch
hras gene;h-ras gene;exactmatch
advanced thyroid gland carcinoma;advanced thyroid gland carcinoma;exactmatch
advanced anal carcinoma;advanced anal carcinoma;exactmatch
metastatic anal carcinoma;metastatic anal carcinoma;exactmatch
refractory cervical carcinoma;refractory cervical carcinoma;exactmatch
skin angiolipoma;skin angiolipoma;exactmatch
11q12 translocation;11q12 translocation;exactmatch
recurrent platinum-resistant ovarian carcinoma;recurrent platinum-resistant ovarian carcinoma;exactmatch
refractory anaplastic oligodendroglioma;refractory anaplastic oligodendroglioma;exactmatch
recurrent fallopian tube adenocarcinoma;recurrent fallopian tube adenocarcinoma;exactmatch
upper alveolar ridge squamous cell carcinoma;upper alveolar ridge squamous cell carcinoma;exactmatch
alveolar ridge squamous cell carcinoma;alveolar ridge squamous cell carcinoma;exactmatch
recurrent superficial bladder urothelial carcinoma;recurrent superficial bladder transitional cell carcinoma;exactmatch
superficial bladder urothelial carcinoma;superficial bladder transitional cell carcinoma;exactmatch
lower alveolar ridge;lower alveolar ridge;exactmatch
upper alveolar ridge;upper alveolar ridge;exactmatch
recurrent primary peritoneal adenocarcinoma;recurrent primary peritoneal adenocarcinoma;exactmatch
recurrent primary peritoneal clear cell adenocarcinoma;recurrent primary peritoneal clear cell adenocarcinoma;exactmatch
recurrent platinum-resistant fallopian tube carcinoma;recurrent platinum-resistant fallopian tube carcinoma;exactmatch
recurrent fallopian tube clear cell adenocarcinoma;recurrent fallopian tube clear cell adenocarcinoma;exactmatch
recurrent primary peritoneal transitional cell carcinoma;recurrent primary peritoneal transitional cell carcinoma;exactmatch
recurrent fallopian tube transitional cell carcinoma;recurrent fallopian tube transitional cell carcinoma;exactmatch
recurrent primary peritoneal undifferentiated carcinoma;recurrent primary peritoneal undifferentiated carcinoma;exactmatch
recurrent fallopian tube undifferentiated carcinoma;recurrent fallopian tube undifferentiated carcinoma;exactmatch
recurrent ovarian undifferentiated carcinoma;recurrent ovarian undifferentiated carcinoma;exactmatch
recurrent platinum-resistant primary peritoneal carcinoma;recurrent platinum-resistant primary peritoneal carcinoma;exactmatch
prkd2 gene mutation;pkd2 gene mutation;exactmatch
skin pleomorphic lipoma;skin pleomorphic lipoma;exactmatch
skin spindle cell lipoma;skin spindle cell lipoma;exactmatch
metastatic anal squamous cell carcinoma;metastatic anal squamous cell carcinoma;exactmatch
phosphatase;ec 3.1.3.-;exactmatch
pathologic process;pathologic process;exactmatch
oxidoreductase;ec 1;exactmatch
oxidation/reduction;oxidation/reduction;exactmatch
left-sided breast carcinoma;left-sided breast carcinoma;exactmatch
resectable periampullary adenocarcinoma;resectable periampullary adenocarcinoma;exactmatch
recurrent acute promyelocytic leukemia with pml-rara;recurrent acute promyelocytic leukemia with pml-rara;exactmatch
recurrent anal squamous cell carcinoma;recurrent anal squamous cell carcinoma;exactmatch
skin spindle cell/pleomorphic lipoma;skin spindle cell/pleomorphic lipoma;exactmatch
skin soft tissue neoplasm;skin soft tissue neoplasm;exactmatch
locally advanced clear cell renal cell carcinoma;locally advanced clear cell renal cell carcinoma;exactmatch
mutyh protein variant;a/g-specific adenine dna glycosylase protein variant;exactmatch
med12 protein variant;arc240 protein variant;exactmatch
metastatic mucosal melanoma;metastatic mucosal melanoma;exactmatch
metastatic choroid melanoma;metastatic choroid melanoma;exactmatch
refractory anaplastic astrocytoma;refractory anaplastic astrocytoma;exactmatch
phosphoprotein;phosphoprotein;exactmatch
phosphorylation process;phosphorylation;exactmatch
phosphotransferase;ec 2.7;exactmatch
protein kinase;protein kinase;exactmatch
skin pleomorphic liposarcoma;skin pleomorphic liposarcoma;exactmatch
skin atypical lipomatous tumor/well differentiated liposarcoma;skin alt/wdlps;exactmatch
locally advanced malignant head and neck neoplasm;locally advanced malignant head and neck neoplasm;exactmatch
advanced malignant head and neck neoplasm;advanced malignant head and neck neoplasm;exactmatch
metastatic malignant head and neck neoplasm;metastatic malignant head and neck neoplasm;exactmatch
resectable skin carcinoma;resectable skin carcinoma;exactmatch
resectable skin squamous cell carcinoma;resectable skin squamous cell carcinoma;exactmatch
locally advanced gallbladder carcinoma;locally advanced gallbladder carcinoma;exactmatch
locally advanced endometrial carcinoma;locally advanced endometrial carcinoma;exactmatch
locally advanced malignant female reproductive system neoplasm;locally advanced malignant female reproductive system neoplasm;exactmatch
locally advanced pancreatobiliary carcinoma;locally advanced pancreatobiliary carcinoma;exactmatch
metastatic pancreatobiliary carcinoma;metastatic pancreatobiliary carcinoma;exactmatch
protein;protein;exactmatch
protein tyrosine kinase;ec 2.7.10;exactmatch
post-translational modification;post translational modification;exactmatch
metastatic myxofibrosarcoma;metastatic myxofibrosarcoma;exactmatch
locally advanced high grade sarcoma;locally advanced high grade sarcoma;exactmatch
diffuse large b-cell lymphoma with associated monoclonal small b-cell population in bone marrow;diffuse large b-cell lymphoma with associated monoclonal small b-cell population in bone marrow;exactmatch
hematopoietic process;hematopoiesis;exactmatch
locally advanced genitourinary system carcinoma;locally advanced genitourinary system carcinoma;exactmatch
notch1 protein variant;notch1 protein variant;exactmatch
nf1 protein variant;nf1 protein variant;exactmatch
hydrolysis;hydrolysis;exactmatch
hydrolase;ec 3;exactmatch
histone;histone;exactmatch
histone h3;h3;exactmatch
harding-passey malignant melanoma;harding-passey malignant melanoma;exactmatch
locally advanced ovarian carcinoma;locally advanced ovarian carcinoma;exactmatch
gtpase;gtpase;exactmatch
embryogenesis;embryogenesis;exactmatch
tissue growth;growth;exactmatch
pancreatobiliary carcinoma;pancreaticobiliary cancer;exactmatch
pancreatobiliary system;pancreaticobiliary system;exactmatch
locally advanced rhabdomyosarcoma;locally advanced rhabdomyosarcoma;exactmatch
metastatic rhabdomyosarcoma;metastatic rhabdomyosarcoma;exactmatch
locally advanced bladder carcinoma;locally advanced bladder carcinoma;exactmatch
unresectable ovarian carcinoma;unresectable ovarian carcinoma;exactmatch
brca-associated malignant neoplasm;brca-associated malignant neoplasm;exactmatch
acute myeloid leukemia with ram immunophenotype;aml with ram immunophenotype;exactmatch
blasts 2 percent or more of bone marrow nucleated cells;blasts 2 percent or more of bone marrow nucleated cells;exactmatch
mll gene translocation;kmt2a gene translocation;exactmatch
sf3b1 protein variant;pre-mrna-splicing factor sf3b 155 kda subunit protein variant;exactmatch
humoral immunity;humoral immune response;exactmatch
cell-mediated immunity;cell mediated immunity;exactmatch
immunity;immunity;exactmatch
inactivating brca gene mutation;brca family gene inactivation;exactmatch
hla-dr-negative neoplastic cells present;hla-dr-negative neoplastic cells present;exactmatch
refractory gastric adenocarcinoma;refractory gastric adenocarcinoma;exactmatch
neoplastic cells with cd38 dim-to-negative expression present;neoplastic cells with cd38 dim-to-negative expression present;exactmatch
neoplastic cells with cd45 dim-to-negative expression present;neoplastic cells with cd45 dim-to-negative expression present;exactmatch
neoplastic cells with bright cd56 expression present;neoplastic cells with bright cd56 expression present;exactmatch
recurrent oligoastrocytoma;recurrent oligoastrocytoma;exactmatch
recurrent diffuse astrocytoma;recurrent diffuse astrocytoma;exactmatch
refractory triple-negative breast carcinoma;refractory triple-negative breast carcinoma;exactmatch
unresectable bladder carcinoma;unresectable bladder carcinoma;exactmatch
mucosal nodular melanoma;mucosal nodular melanoma;exactmatch
sinonasal mucosal melanoma;nasal cavity and paranasal sinus melanoma;exactmatch
malignant musculoskeletal neoplasm;malignant musculoskeletal neoplasm;exactmatch
recurrent transformed t-cell non-hodgkin lymphoma;recurrent transformed t-cell non-hodgkin lymphoma;exactmatch
gene;gene;exactmatch
gene expression;expressed;exactmatch
gene deletion;gene deletion;exactmatch
gametogenesis;gametogenesis;exactmatch
recurrent mature b-cell non-hodgkin lymphoma;recurrent mature b-cell non-hodgkin lymphoma;exactmatch
refractory transformed t-cell non-hodgkin lymphoma;refractory transformed t-cell non-hodgkin lymphoma;exactmatch
fertilization;fertilization;exactmatch
refractory transformed mycosis fungoides;refractory t-mf;exactmatch
benign musculoskeletal neoplasm;benign musculoskeletal neoplasm;exactmatch
recurrent transformed mycosis fungoides;recurrent t-mf;exactmatch
transformed mycosis fungoides;t-mf;exactmatch
advanced undifferentiated pleomorphic sarcoma;advanced undifferentiated pleomorphic sarcoma;exactmatch
advanced leiomyosarcoma;advanced leiomyosarcoma;exactmatch
second primary squamous cell carcinoma of the head and neck;second primary squamous cell carcinoma of the head and neck;exactmatch
resectable lung non-small cell carcinoma;resectable lung non-small cell carcinoma;exactmatch
fgfr4 protein variant;cd334 antigen protein variant;exactmatch
oligometastatic esophageal adenocarcinoma;oligometastatic esophageal adenocarcinoma;exactmatch
oligometastatic gastric adenocarcinoma;oligometastatic gastric adenocarcinoma;exactmatch
recurrent myeloproliferative neoplasm;recurrent myeloproliferative neoplasm;exactmatch
recurrent myelodysplastic/myeloproliferative neoplasm;recurrent myelodysplastic/myeloproliferative neoplasm;exactmatch
non-neoplastic musculoskeletal disorder;non-neoplastic musculoskeletal disorder;exactmatch
musculoskeletal neoplasm;musculoskeletal neoplasm;exactmatch
advanced colorectal adenocarcinoma;advanced colorectal adenocarcinoma;exactmatch
advanced esophageal adenocarcinoma;advanced esophageal adenocarcinoma;exactmatch
advanced gastric adenocarcinoma;advanced gastric adenocarcinoma;exactmatch
locally advanced primary malignant central nervous system neoplasm;locally advanced primary malignant central nervous system neoplasm;exactmatch
metastatic primary malignant central nervous system neoplasm;metastatic primary malignant central nervous system neoplasm;exactmatch
advanced anaplastic large cell lymphoma;advanced anaplastic large cell lymphoma;exactmatch
localized anaplastic large cell lymphoma;localized anaplastic large cell lymphoma;exactmatch
non-recurrent lung carcinoma;non-recurrent lung carcinoma;exactmatch
non-recurrent esophageal carcinoma;non-recurrent esophageal carcinoma;exactmatch
localized esophageal carcinoma;localized esophageal carcinoma;exactmatch
mhc class i gene;class i mhc;exactmatch
resectable glioblastoma;resectable glioblastoma;exactmatch
homeobox gene;homeobox family gene;exactmatch
obesity-related malignant neoplasm;obesity-related malignant neoplasm;exactmatch
brca-associated breast carcinoma;brca-associated breast carcinoma;exactmatch
metastatic high grade sarcoma;metastatic high grade sarcoma;exactmatch
lymphoma finding;lymphoma finding;exactmatch
detoxification;detoxification;exactmatch
membrane protein;membrane protein;exactmatch
experimental malignant melanoma;experimental malignant melanoma;exactmatch
major histocompatibility complex gene;hla complex gene;exactmatch
interphase process;interphase;exactmatch
transmembrane protein;integral membrane protein;exactmatch
high risk plasma cell myeloma;high risk plasma cell myeloma;exactmatch
leukemia finding;leukemia finding;exactmatch
methylation;methylation;exactmatch
myeloid neoplasm finding;myeloid neoplasm finding;exactmatch
plasma cell neoplasm finding;plasma cell neoplasm finding;exactmatch
refractory high risk chronic myelomonocytic leukemia;refractory high risk chronic myelomonocytic leukemia;exactmatch
recurrent high risk chronic myelomonocytic leukemia;recurrent high risk chronic myelomonocytic leukemia;exactmatch
advanced primary peritoneal carcinoma;advanced primary peritoneal carcinoma;exactmatch
advanced fallopian tube carcinoma;advanced fallopian tube carcinoma;exactmatch
trichoblastic carcinosarcoma;trichoblastic carcinosarcoma;exactmatch
metaphase process;metaphase;exactmatch
her2 negative breast adenocarcinoma;her2 negative breast adenocarcinoma;exactmatch
recurrent non-muscle invasive bladder urothelial carcinoma (nmibc) with a prior history of low or intermediate risk nmibc;recurrent nmibc with a prior history of low or intermediate risk nmibc;exactmatch
melanocytic matricoma;melanocytic matricoma;exactmatch
gastrointestinal carcinomatosis;gastrointestinal carcinomatosis;exactmatch
model;model;exactmatch
cutaneous burkitt lymphoma;cutaneous burkitt lymphoma;exactmatch
mitosis;mitosis;exactmatch
microtubule associated protein;map;exactmatch
phyllodes tumor of anogenital mammary-type glands;phyllodes tumor of anogenital mammary-like glands;exactmatch
pigmented dendritic melanocytes present;pigmented dendritic melanocytes present;exactmatch
refractory metastatic pancreatic adenocarcinoma;refractory metastatic pancreatic adenocarcinoma;exactmatch
fus gene translocation;fus gene translocation;exactmatch
liver fibrosis;liver fibrosis;exactmatch
resectable glioma;resectable glioma;exactmatch
unresectable differentiated thyroid gland carcinoma;unresectable differentiated thyroid gland carcinoma;exactmatch
squamous cell carcinoma of the mouse tongue;squamous cell carcinoma of the mouse tongue;exactmatch
metastatic pleural malignant mesothelioma;metastatic pleural malignant mesothelioma;exactmatch
locally advanced thyroid gland medullary carcinoma;locally advanced thyroid gland medullary carcinoma;exactmatch
advanced skin squamous cell carcinoma;advanced skin squamous cell carcinoma;exactmatch
trichoblastic carcinoma;trichoblastic carcinoma;exactmatch
advanced epithelioid sarcoma;advanced epithelioid sarcoma;exactmatch
unresectable epithelioid sarcoma;unresectable epithelioid sarcoma;exactmatch
refractory prostate adenocarcinoma;refractory prostate adenocarcinoma;exactmatch
metastatic midgut neuroendocrine tumor;metastatic midgut neuroendocrine tumor;exactmatch
midgut neuroendocrine tumor g2;midgut neuroendocrine tumor g2;exactmatch
midgut neuroendocrine tumor;midgut neuroendocrine tumor;exactmatch
locally advanced pancreatic neuroendocrine tumor;locally advanced pancreatic neuroendocrine tumor;exactmatch
recurrent nasopharyngeal squamous cell carcinoma;recurrent nasopharyngeal squamous cell carcinoma;exactmatch
nasopharyngeal squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;exactmatch
advanced malignant female reproductive system neoplasm;advanced malignant female reproductive system neoplasm;exactmatch
refractory prostate carcinoma;refractory prostate carcinoma;exactmatch
locally advanced epithelioid sarcoma;locally advanced epithelioid sarcoma;exactmatch
advanced colon carcinoma;advanced colon carcinoma;exactmatch
resectable colon carcinoma;resectable colon carcinoma;exactmatch
metastatic nasal cavity squamous cell carcinoma;metastatic nasal cavity squamous cell carcinoma;exactmatch
locally advanced primary peritoneal carcinoma;locally advanced primary peritoneal carcinoma;exactmatch
metastatic primary peritoneal carcinoma;metastatic primary peritoneal carcinoma;exactmatch
locally advanced fallopian tube carcinoma;locally advanced fallopian tube carcinoma;exactmatch
palb2-associated breast carcinoma;palb2-associated breast carcinoma;exactmatch
locally advanced midgut neuroendocrine tumor;locally advanced midgut neuroendocrine tumor;exactmatch
unresectable midgut neuroendocrine tumor;unresectable midgut neuroendocrine tumor;exactmatch
locally advanced neuroendocrine neoplasm;locally advanced neuroendocrine neoplasm;exactmatch
locally advanced well differentiated neuroendocrine neoplasm;locally advanced well differentiated neuroendocrine neoplasm;exactmatch
skin myoepithelioma;cutaneous myoepithelioma;exactmatch
signet ring cell/histiocytoid carcinoma;signet ring cell/histiocytoid carcinoma;exactmatch
adnexal secretory carcinoma;adnexal secretory carcinoma;exactmatch
adnexal cribriform carcinoma;adnexal cribriform carcinoma;exactmatch
syringocystadenocarcinoma papilliferum;syringocystadenocarcinoma papilliferum;exactmatch
endocrine mucin-producing sweat gland carcinoma;empsgc;exactmatch
microinvasive anal carcinoma;microinvasive anal carcinoma;exactmatch
locally advanced nasopharyngeal squamous cell carcinoma;locally advanced nasopharyngeal squamous cell carcinoma;exactmatch
malignant mixed tumor of the skin;cutaneous malignant mixed tumor;exactmatch
spiradenocylindrocarcinoma;carcinoma ex spiradenocylindroma;exactmatch
spiradenocylindroma;spiradenocylindroma;exactmatch
adnexal adenocarcinoma, not otherwise specified;adnexal adenocarcinoma, nos;exactmatch
advanced bladder carcinoma;advanced bladder carcinoma;exactmatch
advanced hepatocellular carcinoma;advanced hepatocellular carcinoma;exactmatch
glioblastoma, idh-mutant;glioblastoma, idh-mutant;exactmatch
primary peritoneal transitional cell carcinoma;primary peritoneal transitional cell carcinoma;exactmatch
primary peritoneal undifferentiated carcinoma;primary peritoneal undifferentiated carcinoma;exactmatch
metastatic malignant neoplasm in the penis;metastatic malignant neoplasm in the penis;exactmatch
refractory aggressive nk-cell leukemia;refractory aggressive nk-cell leukemia;exactmatch
hiv-associated lymphoproliferative disorder;hiv-associated lymphoproliferative disorder;exactmatch
microcystic growth pattern;microcystic growth pattern;exactmatch
reticular growth pattern;reticular growth pattern;exactmatch
refractory b-cell prolymphocytic leukemia;refractory b-cell prolymphocytic leukemia;exactmatch
refractory subcutaneous panniculitis-like t-cell lymphoma;refractory subcutaneous panniculitis-like t-cell lymphoma;exactmatch
recurrent subcutaneous panniculitis-like t-cell lymphoma;recurrent subcutaneous panniculitis-like t-cell lymphoma;exactmatch
refractory monomorphic epitheliotropic intestinal t-cell lymphoma;refractory monomorphic epitheliotropic intestinal t-cell lymphoma;exactmatch
recurrent aggressive nk-cell leukemia;recurrent aggressive nk-cell leukemia;exactmatch
acquired cystic disease-associated renal cell carcinoma;acquired cystic disease-associated renal cell carcinoma;exactmatch
refractory t-cell prolymphocytic leukemia;refractory t-cell prolymphocytic leukemia;exactmatch
refractory nk-cell lymphoma, unclassifiable;refractory nk-cell lymphoma, unclassifiable;exactmatch
recurrent nk-cell lymphoma, unclassifiable;recurrent nk-cell lymphoma, unclassifiable;exactmatch
refractory hiv-associated lymphoproliferative disorder;refractory hiv-associated lymphoproliferative disorder;exactmatch
refractory lymphoproliferative disorder;refractory lymphoproliferative disorder;exactmatch
recurrent hiv-associated lymphoproliferative disorder;recurrent hiv-associated lymphoproliferative disorder;exactmatch
refractory plasmablastic lymphoma;refractory plasmablastic lymphoma;exactmatch
malignant epithelial cells with cytoplasmic vacuoles or flocculent cytoplasmic inclusions containing wispy eosinophilic material present;malignant epithelial cells with cytoplasmic vacuoles or flocculent cytoplasmic inclusions containing wispy eosinophilic material present;exactmatch
intra or intercytoplasmic lumina present;intra or intercytoplasmic lumina present;exactmatch
metastatic prostate small cell neuroendocrine carcinoma;metastatic prostate small cell carcinoma;exactmatch
metastatic infiltrating bladder urothelial carcinoma, plasmacytoid variant;metastatic infiltrating bladder urothelial carcinoma, plasmacytoid variant;exactmatch
metastatic bladder large cell neuroendocrine carcinoma;metastatic bladder large cell neuroendocrine carcinoma;exactmatch
bladder large cell neuroendocrine carcinoma;bladder large cell neuroendocrine carcinoma;exactmatch
bladder neuroendocrine carcinoma;bladder neuroendocrine carcinoma;exactmatch
bladder neuroendocrine neoplasm;bladder neuroendocrine neoplasm;exactmatch
metastatic sarcomatoid renal cell carcinoma;metastatic sarcomatoid renal cell carcinoma;exactmatch
metastatic kidney medullary carcinoma;metastatic kidney medullary carcinoma;exactmatch
metastatic infiltrating bladder urothelial carcinoma, lipid-rich variant;metastatic infiltrating bladder urothelial carcinoma, lipid-cell variant;exactmatch
metastatic bladder squamous cell carcinoma;metastatic bladder squamous cell carcinoma;exactmatch
laryngeal papillomatosis;laryngeal papillomatosis;exactmatch
metanephric stromal tumor;metanephric stromal tumor;exactmatch
metanephric tumor;metanephric tumor;exactmatch
tsc2 monoallelic inactivation;monoallelic tsc2 gene inactivation;exactmatch
childhood cystic nephroma;childhood cystic nephroma;exactmatch
kidney neuroendocrine neoplasm;kidney neuroendocrine neoplasm;exactmatch
smooth muscle metaplasia;smooth muscle metaplasia;exactmatch
kidney synovial sarcoma;kidney synovial sarcoma;exactmatch
recurrent plasmablastic lymphoma;recurrent plasmablastic lymphoma;exactmatch
refractory primary bone lymphoma;refractory primary bone lymphoma;exactmatch
recurrent primary bone lymphoma;recurrent primary bone lymphoma;exactmatch
short somatic mutation;short somatic mutation;exactmatch
transformed chronic lymphocytic leukemia to diffuse large b-cell lymphoma;transformed chronic lymphocytic leukemia to diffuse large b-cell lymphoma;exactmatch
metastatic cholangiocarcinoma;metastatic cholangiocarcinoma;exactmatch
platinum-resistant primary peritoneal carcinoma;platinum-refractory primary peritoneal carcinoma;exactmatch
platinum-resistant fallopian tube carcinoma;platinum-refractory fallopian tube carcinoma;exactmatch
bap1-mutant clear cell renal cell carcinoma;bap1-mutant clear cell renal cell carcinoma;exactmatch
variably-sized cysts filled with clear, serous, or gelatinous fluid;variably-sized cysts filled with clear, serous, or gelatinous fluid;exactmatch
refractory barrett esophagus;refractory barrett dysplasia;exactmatch
metastatic lung neuroendocrine neoplasm;metastatic lung neuroendocrine neoplasm;exactmatch
refractory primary effusion lymphoma;refractory hhv8-positive primary effusion lymphoma;exactmatch
recurrent ependymoma;recurrent ependymoma;exactmatch
recurrent giant cell glioblastoma;recurrent giant cell glioblastoma;exactmatch
hif1a overexpression positive;hif-1a overexpression positive;exactmatch
anal intraepithelial neoplasia 3;ain iii;exactmatch
anal intraepithelial neoplasia 2;ain2;exactmatch
low grade anal intraepithelial neoplasia;ain1;exactmatch
pi3k gene mutation;1-phosphatidylinositol 3-kinase gene mutation;exactmatch
transformed small lymphocytic lymphoma to diffuse large b-cell lymphoma;transformed small lymphocytic lymphoma to diffuse large b-cell lymphoma;exactmatch
chromosome arm 1p loss of heterozygosity;1p loh;exactmatch
chromosome arm 5q loss of heterozygosity;5q loh;exactmatch
chromosome 6 loss of heterozygosity;chromosome 6 loh;exactmatch
recurrent primary effusion lymphoma;recurrent hhv8-positive primary effusion lymphoma;exactmatch
refractory t-cell/histiocyte-rich large b-cell lymphoma;refractory t-cell/histiocyte-rich large b-cell lymphoma;exactmatch
unresectable lymphoma;unresectable lymphoma;exactmatch
blasts 0.01 percent or more of bone marrow nucleated cells;blasts 0.01 percent or more of bone marrow nucleated cells;exactmatch
pelvic sarcoma;pelvic sarcoma;exactmatch
chromosome 22 loss of heterozygosity;chromosome 22 loh;exactmatch
chromosome 18 loss of heterozygosity;chromosome 18 loh;exactmatch
chromosome 15 loss of heterozygosity;chromosome 15 loh;exactmatch
chromosome 11 loss of heterozygosity;chromosome 11 loh;exactmatch
chromosome 10 loss of heterozygosity;chromosome 10 loh;exactmatch
recurrent adenoid cystic carcinoma;recurrent adenoid cystic cancer;exactmatch
metastatic adenoid cystic carcinoma;metastatic adenoid cystic cancer;exactmatch
locally advanced urothelial carcinoma;locally advanced urothelial cancer;exactmatch
recurrent urothelial carcinoma;recurrent urothelial cancer;exactmatch
chromosome 8 loss of heterozygosity;chromosome 8 loh;exactmatch
metastatic bladder small cell neuroendocrine carcinoma;metastatic bladder small cell carcinoma;exactmatch
metastatic infiltrating bladder urothelial carcinoma, sarcomatoid variant;metastatic infiltrating bladder urothelial carcinoma, sarcomatoid variant;exactmatch
recurrent high risk non-muscle invasive bladder urothelial carcinoma;recurrent high risk nmibc;exactmatch
unresectable ureter urothelial carcinoma;unresectable ureter urothelial carcinoma;exactmatch
prostate large cell neuroendocrine carcinoma;prostate large cell neuroendocrine carcinoma;exactmatch
bladder soft tissue neoplasm;bladder soft tissue neoplasm;exactmatch
borderline serous cystadenofibroma;borderline serous cystadenofibroma;exactmatch
endometrioid tumor, variant with squamous differentiation;endometrioid tumor, variant with squamous differentiation;exactmatch
borderline ovarian mixed epithelial tumor/atypical proliferative ovarian mixed epithelial tumor;borderline ovarian mixed epithelial tumor/atypical proliferative ovarian mixed epithelial tumor;exactmatch
endometrioid adenocarcinoma, variant with squamous differentiation;endometrioid adenocarcinoma, variant with squamous differentiation;exactmatch
unresectable renal pelvis urothelial carcinoma;unresectable renal pelvis urothelial carcinoma;exactmatch
unresectable bladder urothelial carcinoma;unresectable bladder urothelial carcinoma;exactmatch
scattered neuroendocrine cells by immunohistochemistry present;scattered neuroendocrine cells by immunohistochemistry present;exactmatch
unresectable urethral urothelial carcinoma;unresectable urethral urothelial carcinoma;exactmatch
hodgkin lymphoma in remission;hodgkin lymphoma in remission;exactmatch
non-hodgkin lymphoma in remission;non-hodgkin lymphoma in remission;exactmatch
lymphoma in remission;lymphoma in remission;exactmatch
platinum-sensitive lung small cell carcinoma;platinum-sensitive lung small cell carcinoma;exactmatch
platinum sensitivity;platinum sensitivity;exactmatch
platinum-resistant lung small cell carcinoma;platinum-resistant lung small cell carcinoma;exactmatch
usual prostate adenocarcinoma with neuroendocrine differentiation;usual prostate adenocarcinoma with neuroendocrine cells;exactmatch
prostate adenocarcinoma with paneth cell-like neuroendocrine differentiation;prostate adenocarcinoma with paneth cell-like neuroendocrine differentiation;exactmatch
metastatic infiltrating bladder urothelial carcinoma, micropapillary variant;metastatic infiltrating bladder urothelial carcinoma, micropapillary variant;exactmatch
3q abnormality;3q;exactmatch
prostate neuroendocrine carcinoma;prostate neuroendocrine carcinoma;exactmatch
metastatic small cell neuroendocrine carcinoma;metastatic small cell carcinoma;exactmatch
locally advanced large cell neuroendocrine carcinoma;locally advanced large cell neuroendocrine carcinoma;exactmatch
locally advanced neuroendocrine carcinoma;locally advanced neuroendocrine carcinoma;exactmatch
metastatic large cell neuroendocrine carcinoma;metastatic large cell neuroendocrine carcinoma;exactmatch
primary site of disease;primary site of disease;exactmatch
braf exon 15 mutation;b-raf exon 15 mutation;exactmatch
canine nephroblastoma;canine nephroblastoma;exactmatch
11q23 abnormality;11q23 aberration;exactmatch
canine langerhans cell histiocytosis;canine langerhans cell histiocytosis;exactmatch
canine granular cell tumor;canine granular cell tumor;exactmatch
canine gastrointestinal stromal tumor;canine gastrointestinal stromal tumor;exactmatch
unresectable breast carcinoma;unresectable breast carcinoma;exactmatch
unresectable breast inflammatory carcinoma;unresectable breast inflammatory carcinoma;exactmatch
foxl2 gene mutation;bpes gene mutation;exactmatch
dense eosinophilic basement membrane deposit;dense eosinophilic basement membrane deposit;exactmatch
locally advanced salivary gland carcinoma;locally advanced salivary gland carcinoma;exactmatch
metastatic salivary gland carcinoma;metastatic salivary gland carcinoma;exactmatch
recurrent endometrial adenocarcinoma;recurrent endometrial adenocarcinoma;exactmatch
recurrent b-cell prolymphocytic leukemia;recurrent b-cell prolymphocytic leukemia;exactmatch
refractory transformed b-cell non-hodgkin lymphoma;refractory transformed b-cell non-hodgkin lymphoma;exactmatch
recurrent transformed b-cell non-hodgkin lymphoma;recurrent transformed b-cell non-hodgkin lymphoma;exactmatch
refractory who grade ii glioma;refractory who grade ii glioma;exactmatch
refractory cholangiocarcinoma;refractory cholangiocarcinoma;exactmatch
locally advanced unresectable digestive system neuroendocrine neoplasm;locally advanced unresectable digestive system neuroendocrine neoplasm;exactmatch
advanced digestive system neuroendocrine neoplasm;advanced digestive system neuroendocrine neoplasm;exactmatch
refractory digestive system neuroendocrine neoplasm;refractory digestive system neuroendocrine neoplasm;exactmatch
kidney mixed epithelial and stromal tumor family;kidney mixed epithelial and stromal tumor family;exactmatch
refractory spindle cell sarcoma;refractory spindle cell sarcoma;exactmatch
nf1 mutation positive malignant peripheral nerve sheath tumor;mpnst with nf1 mutation;exactmatch
kidney epithelioid angiomyolipoma;kidney epithelioid angiomyolipoma;exactmatch
subcutaneous disorder;subcutaneous disorder;exactmatch
metastatic malignant genitourinary system neoplasm;metastatic genitourinary system malignant neoplasm;exactmatch
metastatic infiltrating bladder urothelial carcinoma, nested variant;metastatic infiltrating bladder urothelial carcinoma, nested variant;exactmatch
metastatic infiltrating bladder urothelial carcinoma with giant cells;metastatic giant cell  bladder urothelial carcinoma;exactmatch
metastatic infiltrating bladder urothelial carcinoma, clear cell variant;metastatic clear cell bladder urothelial carcinoma;exactmatch
recurrent transformed chronic lymphocytic leukemia;recurrent richter syndrome;exactmatch
refractory transformed chronic lymphocytic leukemia;refractory richter syndrome;exactmatch
bladder non-invasive urothelial neoplasm;bladder non-invasive urothelial neoplasm;exactmatch
refractory endometrial serous adenocarcinoma;refractory endometrial serous adenocarcinoma;exactmatch
recurrent spindle cell sarcoma;recurrent spindle cell sarcoma;exactmatch
refractory fibrosarcoma;refractory fibrosarcoma;exactmatch
recurrent fibrosarcoma;recurrent fibrosarcoma;exactmatch
refractory desmoplastic small round cell tumor;refractory desmoplastic small round cell tumor;exactmatch
recurrent desmoplastic small round cell tumor;recurrent desmoplastic small round cell tumor;exactmatch
recurrent endometrioid adenocarcinoma;recurrent endometrioid adenocarcinoma;exactmatch
translocase gene;translocase gene;exactmatch
refractory adrenal gland pheochromocytoma;refractory adrenal gland pheochromocytoma;exactmatch
refractory paraganglioma;refractory paraganglioma;exactmatch
marked thickening of the bladder urothelium present;marked thickening of the bladder urothelium present;exactmatch
advanced uterine corpus carcinosarcoma;advanced endometrial carcinosarcoma;exactmatch
bladder non-invasive papillary urothelial carcinoma;bladder non-invasive papillary urothelial carcinoma;exactmatch
refractory uterine corpus carcinosarcoma;refractory endometrial carcinosarcoma;exactmatch
refractory endometrial clear cell adenocarcinoma;refractory endometrial clear cell adenocarcinoma;exactmatch
refractory endometrial mixed cell adenocarcinoma;refractory endometrial mixed cell adenocarcinoma;exactmatch
cdk gene mutation;cdk family gene mutation;exactmatch
high risk non-muscle invasive bladder urothelial carcinoma;high risk nmibc;exactmatch
locally advanced prostate neuroendocrine carcinoma;locally advanced prostate neuroendocrine carcinoma;exactmatch
metastatic gastric neuroendocrine carcinoma;metastatic gastric neuroendocrine carcinoma;exactmatch
advanced small intestinal large cell neuroendocrine carcinoma;advanced small intestinal large cell neuroendocrine carcinoma;exactmatch
advanced small intestinal small cell neuroendocrine carcinoma;advanced small intestinal small cell carcinoma;exactmatch
advanced small intestinal neuroendocrine carcinoma;advanced small intestinal neuroendocrine carcinoma;exactmatch
metastatic small intestinal neuroendocrine carcinoma;metastatic small intestinal neuroendocrine carcinoma;exactmatch
advanced gastric small cell neuroendocrine carcinoma;advanced gastric small cell carcinoma;exactmatch
advanced gastric large cell neuroendocrine carcinoma;advanced gastric large cell neuroendocrine carcinoma;exactmatch
advanced gastric neuroendocrine carcinoma;advanced gastric neuroendocrine carcinoma;exactmatch
non-neoplastic genitourinary system disorder;non-neoplastic genitourinary system disorder;exactmatch
transformed marginal zone lymphoma to diffuse large b-cell lymphoma;diffuse large b-cell lymphoma transformed from underlying marginal zone lymphoma;exactmatch
genitourinary system disorder;genitourinary system disorder;exactmatch
experimental organism malignant thecoma;experimental organism malignant thecoma;exactmatch
experimental organism benign thecoma;experimental organism benign thecoma;exactmatch
experimental organism brunner's gland carcinoma;carcinoma, brunner's gland, malignant;exactmatch
experimental organism ductal cell adenoma;adenoma, ductal cell, benign;exactmatch
experimental organism ductal cell adenocarcinoma;adenocarcinoma, ductal cell, malignant;exactmatch
experimental organism intramural schwannoma;experimental organism intramural schwannoma;exactmatch
recurrent t-cell/histiocyte-rich large b-cell lymphoma;recurrent t-cell/histiocyte-rich large b-cell lymphoma;exactmatch
malignant peritoneal and retroperitoneal neoplasm;malignant peritoneal and retroperitoneal neoplasm;exactmatch
basal cell carcinoma;basal cell carcinoma;exactmatch
recurrent acute monoblastic and monocytic leukemia;recurrent acute monoblastic and monocytic leukemia;exactmatch
sdhb negative;ip negative;exactmatch
advanced digestive system carcinoma;advanced digestive system carcinoma;exactmatch
locally advanced microsatellite stable colorectal carcinoma;locally advanced microsatellite stable colorectal carcinoma;exactmatch
recurrent acute megakaryoblastic leukemia;recurrent acute megakaryoblastic leukemia;exactmatch
acute monoblastic and monocytic leukemia in remission;acute monoblastic and monocytic leukemia in remission;exactmatch
acute myeloid leukemia with multilineage dysplasia in remission;acute myeloid leukemia with multilineage dysplasia in remission;exactmatch
recurrent acute erythroid leukemia;recurrent acute erythroid leukemia;exactmatch
recurrent acute myeloid leukemia with multilineage dysplasia;recurrent acute myeloid leukemia with multilineage dysplasia;exactmatch
peritoneum and retroperitoneum;peritoneum and retroperitoneum;exactmatch
"recurrent acute myeloid leukemia with t (9;11) (p21.3; q23.3); mllt3-mll";"recurrent acute myeloid leukemia with t (9;11) (p21.3; q23.3); mllt3 (af9)-kmt2a";exactmatch
recurrent acute myeloid leukemia with recurrent genetic abnormalities;recurrent acute myeloid leukemia with recurrent genetic abnormalities;exactmatch
recurrent acute myelomonocytic leukemia;recurrent acute myelomonocytic leukemia;exactmatch
recurrent acute myeloid leukemia not otherwise specified;recurrent acute myeloid leukemia not otherwise specified;exactmatch
malignant pelvic neoplasm;malignant pelvic neoplasm;exactmatch
malignant abdominal neoplasm;malignant abdominal neoplasm;exactmatch
benign peritoneal and retroperitoneal neoplasm;benign peritoneal and retroperitoneal neoplasm;exactmatch
experimental organism endocardial schwannoma;experimental organism endocardial schwannoma;exactmatch
metastatic breast neuroendocrine neoplasm;metastatic breast neuroendocrine neoplasm;exactmatch
metastatic digestive system neuroendocrine neoplasm;metastatic digestive system neuroendocrine neoplasm;exactmatch
thyroid gland solitary fibrous tumor;thyroid gland solitary fibrous tumor;exactmatch
grade 1 teratoma;grade 1 teratoma;exactmatch
thyroid gland follicular lymphoma;thyroid gland follicular lymphoma;exactmatch
thyroid gland follicular dendritic cell sarcoma;thyroid gland follicular dendritic cell sarcoma;exactmatch
thyroid gland langerhans cell histiocytosis;thyroid gland langerhans cell histiocytosis;exactmatch
thyroid gland histiocytic and dendritic cell neoplasm;thyroid gland histiocytic and dendritic cell neoplasm;exactmatch
feline melanoma;feline melanoma;exactmatch
rara gene translocation;nr1b1 gene translocation;exactmatch
thyroid gland leiomyosarcoma;thyroid gland leiomyosarcoma;exactmatch
advanced pancreatic neuroendocrine tumor;advanced pancreatic islet cell tumor;exactmatch
thyroid gland leiomyoma;thyroid gland leiomyoma;exactmatch
thyroid gland lymphangioma;thyroid gland lymphangioma;exactmatch
thyroid gland cavernous hemangioma;thyroid gland cavernous hemangioma;exactmatch
thyroid gland hemangioma;thyroid gland hemangioma;exactmatch
thyroid gland benign vascular neoplasm;thyroid gland benign vascular neoplasm;exactmatch
thyroid gland malignant peripheral nerve sheath tumor;thyroid gland malignant peripheral nerve sheath tumor;exactmatch
thyroid gland schwannoma;thyroid gland schwannoma;exactmatch
recurrent primary peritoneal serous adenocarcinoma;recurrent primary peritoneal serous adenocarcinoma;exactmatch
recurrent primary peritoneal low grade serous adenocarcinoma;recurrent primary peritoneal low grade serous adenocarcinoma;exactmatch
recurrent low grade ovarian serous adenocarcinoma;recurrent low grade ovarian serous adenocarcinoma;exactmatch
recurrent low grade fallopian tube serous adenocarcinoma;recurrent low grade fallopian tube serous adenocarcinoma;exactmatch
metastatic pancreatic neuroendocrine tumor;metastatic pancreatic islet cell tumor;exactmatch
advanced carcinoid tumor;advanced carcinoid tumor;exactmatch
advanced neuroendocrine neoplasm;advanced neuroendocrine neoplasm;exactmatch
metastatic neuroendocrine neoplasm;metastatic neuroendocrine neoplasm;exactmatch
malignant genitourinary system neoplasm;genitourinary cancer;exactmatch
benign genitourinary system neoplasm;benign genitourinary system neoplasm;exactmatch
genitourinary system neoplasm;genitourinary system neoplasm;exactmatch
advanced kaposi sarcoma;advanced kaposi sarcoma;exactmatch
metastatic kaposi sarcoma;metastatic kaposi sarcoma;exactmatch
refractory kaposi sarcoma;refractory kaposi sarcoma;exactmatch
succinate dehydrogenase-deficient renal cell carcinoma;sdh-rcc;exactmatch
loss of immunohistochemical expression of succinate dehydrogenase (sdh) b;loss of immunohistochemical expression of sdhb;exactmatch
brain ependymoma;brain ependymoma;exactmatch
malignant primitive cellular infiltrate;malignant primitive cellular infiltrate;exactmatch
extrapulmonary small cell neuroendocrine carcinoma;escc;exactmatch
benign parathyroid gland adenoma;adenoma, parathyroid gland, benign;exactmatch
malignant basal cell;malignant basal cell;exactmatch
feline histiocytic sarcoma;feline histiocytic sarcoma;exactmatch
familial adrenal gland pheochromocytoma;familial adrenal gland pheochromocytoma;exactmatch
advanced extracranial malignant solid neoplasm;advanced extracranial malignant solid neoplasm;exactmatch
metastatic extracranial malignant solid neoplasm;metastatic extracranial malignant solid neoplasm;exactmatch
unresectable skin basal cell carcinoma;unresectable skin basal cell carcinoma;exactmatch
unresectable basal cell carcinoma;unresectable basal cell carcinoma;exactmatch
unresectable skin carcinoma;unresectable skin carcinoma;exactmatch
unresectable skin squamous cell carcinoma;unresectable skin squamous cell carcinoma;exactmatch
blasts 0.1 percent or more of bone marrow nucleated cells;blasts 0.1 percent or more of bone marrow nucleated cells;exactmatch
composite paraganglioma;composite paraganglioma;exactmatch
borderline resectable malignant neoplasm;borderline resectable malignant neoplasm;exactmatch
adrenal gland ganglioneuroma;adrenal gland ganglioneuroma;exactmatch
adrenal gland ganglioneuroblastoma, nodular;adrenal gland ganglioneuroblastoma, nodular;exactmatch
adrenal gland ganglioneuroblastoma, intermixed;adrenal gland ganglioneuroblastoma, intermixed;exactmatch
breast histiocytoid carcinoma;breast histiocytoid carcinoma;exactmatch
afp level finding;afp level finding;exactmatch
refractory neuroendocrine neoplasm;refractory neuroendocrine neoplasm;exactmatch
recurrent neuroendocrine neoplasm;recurrent neuroendocrine neoplasm;exactmatch
monoclonal gammopathy of renal significance;monoclonal gammopathy of renal significance;exactmatch
borderline resectable mass;borderline resectable mass;exactmatch
metastatic basal cell carcinoma;metastatic basal cell carcinoma;exactmatch
sdhaf2 gene mutation;c11orf79 gene mutation;exactmatch
resistance to second-generation androgen receptor axis-targeted agents;resistance to second-generation androgen receptor axis-targeted agents;exactmatch
castration-resistant prostate carcinoma refractory to second-generation androgen receptor axis-targeted agents;castration-resistant prostate carcinoma refractory to second-generation arat agents;exactmatch
refractory polymorphic post-transplant lymphoproliferative disorder;refractory polymorphic post-transplant lymphoproliferative disorder;exactmatch
recurrent polymorphic post-transplant lymphoproliferative disorder;recurrent polymorphic post-transplant lymphoproliferative disorder;exactmatch
refractory monomorphic post-transplant lymphoproliferative disorder;refractory monomorphic post-transplant lymphoproliferative disorder;exactmatch
recurrent monomorphic post-transplant lymphoproliferative disorder;recurrent monomorphic post-transplant lymphoproliferative disorder;exactmatch
metastatic squamous cell carcinoma in the cervical lymph nodes;metastatic squamous cell carcinoma in cervical lymph node;exactmatch
peripheral hemangioblastoma;peripheral hemangioblastoma;exactmatch
borderline resectable pancreatic carcinoma;borderline resectable pancreatic carcinoma;exactmatch
multiple endocrine neoplasia type 4;men 4;exactmatch
colorectal carcinoma metastatic in the liver;colorectal carcinoma metastatic in the liver;exactmatch
locally advanced lung non-small cell squamous carcinoma;locally advanced lung non-small cell squamous carcinoma;exactmatch
metastatic lung non-small cell squamous carcinoma;metastatic lung non-small cell squamous carcinoma;exactmatch
colorectal adenocarcinoma metastatic in the liver;colorectal adenocarcinoma metastatic in the liver;exactmatch
borderline resectable pancreatic adenocarcinoma;borderline resectable pancreatic adenocarcinoma;exactmatch
borderline resectable carcinoma;borderline resectable carcinoma;exactmatch
locally advanced adrenal gland pheochromocytoma;locally advanced adrenal gland pheochromocytoma;exactmatch
unresectable adrenal gland pheochromocytoma;unresectable adrenal gland pheochromocytoma;exactmatch
unresectable paraganglioma;unresectable paraganglioma;exactmatch
malignant bronchial neoplasm;malignant bronchial neoplasm;exactmatch
kcnj5 gene mutation;cir gene mutation;exactmatch
resectable extrahepatic bile duct adenocarcinoma;resectable extrahepatic bile duct adenocarcinoma;exactmatch
resectable bile duct adenocarcinoma;resectable bile duct adenocarcinoma;exactmatch
resectable digestive system carcinoma;resectable digestive system carcinoma;exactmatch
resectable intrahepatic cholangiocarcinoma;resectable intrahepatic cholangiocarcinoma;exactmatch
resectable pancreatic acinar cell carcinoma;resectable pancreatic acinar cell carcinoma;exactmatch
resectable pancreatic adenocarcinoma;resectable pancreatic adenocarcinoma;exactmatch
medical condition;medical condition;exactmatch
recurrent paraganglioma;recurrent paraganglioma;exactmatch
metastatic human papillomavirus-related malignant neoplasm;metastatic human papillomavirus-related malignant neoplasm;exactmatch
locally advanced unresectable basal cell carcinoma;locally advanced unresectable basal cell carcinoma;exactmatch
metastatic unresectable basal cell carcinoma;metastatic unresectable basal cell carcinoma;exactmatch
recurrent biliary tract carcinoma;recurrent biliary tract carcinoma;exactmatch
biliary tract carcinoma;biliary tract carcinoma;exactmatch
biochemically recurrent prostate carcinoma;bcr prostate carcinoma;exactmatch
locally advanced basal cell carcinoma;locally advanced basal cell carcinoma;exactmatch
atp1a1 gene mutation;atp1a1 gene mutation;exactmatch
atp2b3 gene mutation;atp2b3 gene mutation;exactmatch
cacna1d gene mutation;cach3 gene mutation;exactmatch
prkaca gene mutation;pkaca gene mutation;exactmatch
refractory primary diffuse large b-cell lymphoma of the central nervous system;refractory primary diffuse large b-cell lymphoma of the central nervous system;exactmatch
recurrent primary diffuse large b-cell lymphoma of the central nervous system;recurrent primary diffuse large b-cell lymphoma of the central nervous system;exactmatch
refractory primary vitreoretinal diffuse large b-cell lymphoma;refractory pvrl dlbcl;exactmatch
recurrent primary vitreoretinal diffuse large b-cell lymphoma;recurrent pvrl dlbcl;exactmatch
refractory primary vitreoretinal non-hodgkin lymphoma;refractory pvrl;exactmatch
recurrent primary vitreoretinal non-hodgkin lymphoma;recurrent pvrl;exactmatch
primary vitreoretinal diffuse large b-cell lymphoma;pvrl dlbcl;exactmatch
vitreoretinal area;vitreoretinal area;exactmatch
primary vitreoretinal non-hodgkin lymphoma;pvrl;exactmatch
refractory hormone receptor positive breast adenocarcinoma;refractory hormone receptor positive breast adenocarcinoma;exactmatch
hormone receptor positive breast adenocarcinoma;hormone receptor positive breast adenocarcinoma;exactmatch
adrenal gland sarcoma;adrenal gland sarcoma;exactmatch
adrenal gland lymphoma;adrenal gland lymphoma;exactmatch
adrenal gland schwannoma;adrenal gland schwannoma;exactmatch
adrenal cortex sex cord-stromal tumor;adrenal cortex sex cord-stromal tumor;exactmatch
metastatic prostate neuroendocrine carcinoma;metastatic prostate neuroendocrine carcinoma;exactmatch
locally advanced small cell neuroendocrine carcinoma;locally advanced small cell carcinoma;exactmatch
penile lymphoma;lymphoma of the penis;exactmatch
cd15 positive;3-fucosyl-n-acetyl-lactosamine positive;exactmatch
advanced pancreatic adenocarcinoma;advanced pancreatic adenocarcinoma;exactmatch
advanced colon adenocarcinoma;advanced colon adenocarcinoma;exactmatch
regressed testicular germ cell tumor;burnt-out germ cell tumor;exactmatch
unresectable rectal adenocarcinoma;unresectable rectal adenocarcinoma;exactmatch
unresectable colon adenocarcinoma;unresectable colon adenocarcinoma;exactmatch
locally advanced unresectable gastroesophageal junction adenocarcinoma;locally advanced unresectable gastroesophageal junction adenocarcinoma;exactmatch
locally advanced unresectable esophageal adenocarcinoma;locally advanced unresectable esophageal adenocarcinoma;exactmatch
cd14 positive;cd14 antigen positive;exactmatch
refractory colon adenocarcinoma;refractory colon adenocarcinoma;exactmatch
eno2 positive;eno2 positive;exactmatch
hla-dr negative;hla-dr antigen negative;exactmatch
unresectable pancreatic adenocarcinoma;unresectable pancreatic adenocarcinoma;exactmatch
refractory pancreatic adenocarcinoma;refractory pancreatic adenocarcinoma;exactmatch
esophageal intramucosal adenocarcinoma;esophageal intramucosal adenocarcinoma;exactmatch
hepatocellular malignant neoplasm, not otherwise specified;hcn-nos;exactmatch
metastatic brca-associated breast carcinoma;brca-mutated metastatic breast carcinoma;exactmatch
refractory colorectal adenocarcinoma;refractory colorectal adenocarcinoma;exactmatch
refractory rectal carcinoma;refractory rectal carcinoma;exactmatch
stage iia cervical cancer figo 2018;stage iia cervical cancer figo 2018;exactmatch
stage i cervical cancer figo 2018;stage i cervical cancer figo 2018;exactmatch
stage ib3 cervical cancer figo 2018;stage ib3 cervical cancer figo 2018;exactmatch
stage ib2 cervical cancer figo 2018;stage ib2 cervical cancer figo 2018;exactmatch
stage ib1 cervical cancer figo 2018;stage ib1 cervical cancer figo 2018;exactmatch
stage ib cervical cancer figo 2018;stage ib cervical cancer figo 2018;exactmatch
stage ia2 cervical cancer figo 2018;stage ia2 cervical cancer figo 2018;exactmatch
stage ia1 cervical cancer figo 2018;stage ia1 cervical cancer figo 2018;exactmatch
stage ia cervical cancer figo 2018;stage ia cervical cancer figo 2018;exactmatch
cervical cancer by figo stage 2018;cervical cancer by figo stage 2018;exactmatch
refractory rectal adenocarcinoma;refractory rectal adenocarcinoma;exactmatch
figo stage iia2;figo stage iia2;exactmatch
figo stage iia1;figo stage iia1;exactmatch
figo stage ib3;figo stage ib3;exactmatch
advanced soft tissue sarcoma;advanced soft tissue sarcoma;exactmatch
clonal hematopoiesis;clonal hematopoiesis;exactmatch
locally advanced unresectable breast carcinoma;locally advanced unresectable breast carcinoma;exactmatch
advanced lung non-small cell carcinoma;advanced lung non-small cell carcinoma;exactmatch
progressive thyroid carcinoma;progressive thyroid carcinoma;exactmatch
metastatic malignant neoplasm in the seminal vesicle;metastatic malignant neoplasm in the seminal vesicle;exactmatch
malignant seminal vesicle neoplasm;malignant seminal vesicle neoplasm;exactmatch
prostate hemangioma;prostate hemangioma;exactmatch
elevated ldh;elevated;exactmatch
prostate carcinoma metastatic in the lymph nodes;prostate carcinoma metastatic in lymph node;exactmatch
advanced clear cell sarcoma of soft tissue;advanced clear cell sarcoma of soft tissue;exactmatch
metastatic clear cell sarcoma of soft tissue;metastatic clear cell sarcoma of soft tissue;exactmatch
prostate carcinoma metastatic in the pelvic cavity;prostate carcinoma metastatic in the pelvic cavity;exactmatch
metastatic malignant neoplasm in the pelvic cavity;metastatic malignant neoplasm in the pelvic cavity;exactmatch
prostate granular cell tumor;prostate granular cell tumor;exactmatch
prostate malignant solitary fibrous tumor;prostate malignant solitary fibrous tumor;exactmatch
benign seminal vesicle neoplasm;benign seminal vesicle neoplasm;exactmatch
prostate solitary fibrous tumor;prostate solitary fibrous tumor;exactmatch
her2/neu status;erbb2 status;exactmatch
estrogen receptor status;er alpha status;exactmatch
progesterone receptor status;pgr status;exactmatch
metastatic colorectal adenocarcinoma;metastatic colorectal adenocarcinoma;exactmatch
prostate soft tissue neoplasm;prostate mesenchymal neoplasm;exactmatch
prostate inflammatory myofibroblastic tumor;prostate inflammatory myofibroblastic tumor;exactmatch
prostate diffuse large b-cell lymphoma;prostate diffuse large b-cell lymphoma;exactmatch
prostate follicular lymphoma;prostate follicular lymphoma;exactmatch
prostate mantle cell lymphoma;prostate mantle cell lymphoma;exactmatch
prostate small lymphocytic lymphoma;prostate small lymphocytic lymphoma;exactmatch
seminal vesicle angiosarcoma;seminal vesicle angiosarcoma;exactmatch
seminal vesicle leiomyosarcoma;seminal vesicle leiomyosarcoma;exactmatch
seminal vesicle mammary-type myofibroblastoma;seminal vesicle mammary-type myofibroblastoma;exactmatch
seminal vesicle schwannoma;seminal vesicle schwannoma;exactmatch
seminal vesicle leiomyoma;seminal vesicle leiomyoma;exactmatch
seminal vesicle soft tissue neoplasm;seminal vesicle soft tissue neoplasm;exactmatch
seminal vesicle mixed epithelial and stromal tumor;seminal vesicle mixed epithelial and stromal tumor;exactmatch
seminal vesicle squamous cell carcinoma;seminal vesicle squamous cell carcinoma;exactmatch
increased fibroblast growth factor pathway activation;elevated fibroblast growth factor pathway activation;exactmatch
prostate paraganglioma;prostate paraganglioma;exactmatch
prostate melanoma;prostate melanoma;exactmatch
double-negative prostate carcinoma;double negative prostate cancer;exactmatch
extrarenal rhabdoid tumor of the prostate;extrarenal malignant rhabdoid tumor of the prostate;exactmatch
prostate wilms tumor;prostate nephroblastoma;exactmatch
prostate cystadenoma;prostate cystadenoma;exactmatch
stage ii cervical cancer figo 2018;stage ii cervical cancer figo 2018;exactmatch
stage iia1 cervical cancer figo 2018;stage iia1 cervical cancer figo 2018;exactmatch
prostate osteosarcoma;prostate osteosarcoma;exactmatch
paratesticular neoplasm;neoplasm of paratesticular structures;exactmatch
paratesticular soft tissue neoplasm;paratesticular mesenchymal neoplasm;exactmatch
paratesticular region;paratesticular region;exactmatch
paratesticular paraganglioma;paratesticular paraganglioma;exactmatch
paratesticular wilms tumor;paratesticular nephroblastoma;exactmatch
epididymal melanotic neuroectodermal tumor;epididymal melanotic neuroectodermal tumor;exactmatch
paratesticular melanotic neuroectodermal tumor;paratesticular melanotic neuroectodermal tumor;exactmatch
paratesticular squamous cell carcinoma;paratesticular squamous cell carcinoma;exactmatch
polymerase proofreading associated polyposis;ppap;exactmatch
paratesticular leiomyoma;paratesticular leiomyoma;exactmatch
epididymal cystadenoma;epididymal cystadenoma;exactmatch
paratesticular malignant mesothelioma;paratesticular malignant mesothelioma;exactmatch
paratesticular adenomatoid tumor;paratesticular adenomatoid tumor;exactmatch
advanced colorectal carcinoma;advanced colorectal carcinoma;exactmatch
canine transmissible venereal tumor;ctvt;exactmatch
testicular plasmacytoma;testicular plasmacytoma;exactmatch
testicular myeloid sarcoma;testicular myeloid sarcoma;exactmatch
paratesticular liposarcoma;paratesticular liposarcoma;exactmatch
paratesticular leiomyosarcoma;paratesticular leiomyosarcoma;exactmatch
stage iia2 cervical cancer figo 2018;stage iia2 cervical cancer figo 2018;exactmatch
non-human papillomavirus-related penile intraepithelial neoplasia;non-hpv-related pein;exactmatch
penile melanoma;melanoma of the penis;exactmatch
warty-basaloid penile intraepithelial neoplasia;warty-basaloid pein;exactmatch
warty (bowenoid) penile intraepithelial neoplasia;warty (bowenoid) pein;exactmatch
basaloid (undifferentiated) penile intraepithelial neoplasia;basaloid (undifferentiated) pein;exactmatch
human papillomavirus-related penile intraepithelial neoplasia;hpv-related pein;exactmatch
differentiated (simplex) penile intraepithelial neoplasia;differentiated (simplex) pein;exactmatch
refractory gastroesophageal junction adenocarcinoma;refractory gastroesophageal junction adenocarcinoma;exactmatch
invasive adenocarcinoma in adenomatous polyp;invasive adenocarcinoma in adenomatous polyp;exactmatch
paratesticular rhabdomyoma;paratesticular rhabdomyoma;exactmatch
blasts 1 percent or more of bone marrow nucleated cells;blasts 1 percent or more of bone marrow nucleated cells;exactmatch
paratesticular hemangioma;paratesticular hemangioma;exactmatch
paratesticular schwannoma;paratesticular schwannoma;exactmatch
"paratesticular deep ""aggressive"" angiomyxoma";"paratesticular deep ""aggressive"" angiomyxoma";exactmatch
paratesticular mammary-type myofibroblastoma;paratesticular mammary-type myofibroblastoma;exactmatch
paratesticular cellular angiofibroma;paratesticular cellular angiofibroma;exactmatch
paratesticular rhabdomyosarcoma;paratesticular rhabdomyosarcoma;exactmatch
testicular nasal type extranodal nk/t-cell lymphoma;testicular nasal type extranodal nk/t-cell lymphoma;exactmatch
testicular diffuse large b-cell lymphoma;testicular diffuse large b-cell lymphoma;exactmatch
intratubular large cell hyalinizing sertoli cell neoplasia;intratubular large cell hyalinizing sertoli cell neoplasia;exactmatch
stage iva cervical cancer figo 2018;stage iva cervical cancer figo 2018;exactmatch
locally advanced unresectable colorectal adenocarcinoma;locally advanced unresectable colorectal adenocarcinoma;exactmatch
hypermutated sample;hypermutated sample;exactmatch
resectable colorectal carcinoma;resectable colorectal carcinoma;exactmatch
hypermutated colorectal carcinoma;hypermutated colorectal cancer;exactmatch
metastatic malignant digestive system neoplasm;metastatic malignant digestive system neoplasm;exactmatch
metastatic malignant female reproductive system neoplasm;metastatic malignant female reproductive system neoplasm;exactmatch
stage ivb cervical cancer figo 2018;stage ivb cervical cancer figo 2018;exactmatch
stage iv cervical cancer figo 2018;stage iv cervical cancer figo 2018;exactmatch
metastatic thymic neuroendocrine neoplasm;metastatic thymic neuroendocrine neoplasm;exactmatch
stage iiic2 cervical cancer figo 2018;stage iiic2 cervical cancer figo 2018;exactmatch
stage iiic1 cervical cancer figo 2018;stage iiic1 cervical cancer figo 2018;exactmatch
stage iiic cervical cancer figo 2018;stage iiic cervical cancer figo 2018;exactmatch
stage iiib cervical cancer figo 2018;stage iiib cervical cancer figo 2018;exactmatch
stage iiia cervical cancer figo 2018;stage iiia cervical cancer figo 2018;exactmatch
stage iii cervical cancer figo 2018;stage iii cervical cancer figo 2018;exactmatch
stage iib cervical cancer figo 2018;stage iib cervical cancer figo 2018;exactmatch
locally advanced unresectable colon adenocarcinoma;locally advanced unresectable colon adenocarcinoma;exactmatch
locally advanced unresectable rectal adenocarcinoma;locally advanced unresectable rectal adenocarcinoma;exactmatch
metastatic colorectal mucinous adenocarcinoma;metastatic colorectal mucinous adenocarcinoma;exactmatch
metastatic appendix mucinous adenocarcinoma;metastatic appendix mucinous adenocarcinoma;exactmatch
thymic neuroendocrine neoplasm;thymic neuroendocrine neoplasm;exactmatch
refractory intermediate risk acute myeloid leukemia;refractory intermediate risk acute myeloid leukemia;exactmatch
refractory high risk acute myeloid leukemia;refractory high risk acute myeloid leukemia;exactmatch
intermediate risk acute myeloid leukemia;intermediate risk acute myeloid leukemia;exactmatch
refractory high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements;refractory high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements;exactmatch
recurrent high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements;recurrent high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements;exactmatch
refractory hepatocellular carcinoma;refractory hepatocellular carcinoma;exactmatch
recurrent rectal adenocarcinoma;recurrent rectal adenocarcinoma;exactmatch
recurrent colon adenocarcinoma;recurrent colon adenocarcinoma;exactmatch
recurrent colorectal adenocarcinoma;recurrent colorectal adenocarcinoma;exactmatch
exonuclease;exonuclease;exactmatch
ebv-related leiomyosarcoma;ebv lms;exactmatch
ebv-related sarcoma;ebv-associated sarcoma;exactmatch
ebv-related gastric carcinoma;ebv-associated gastric carcinoma;exactmatch
metastatic appendix carcinoma;metastatic appendix carcinoma;exactmatch
prostate undifferentiated pleomorphic sarcoma;prostate undifferentiated pleomorphic sarcoma;exactmatch
prostate synovial sarcoma;prostate synovial sarcoma;exactmatch
rearrangement detected;chromosomal rearrangement detected;exactmatch
borderline ovarian seromucinous tumor/atypical proliferative ovarian seromucinous tumor with microinvasion;borderline ovarian seromucinous tumor/atypical proliferative ovarian seromucinous tumor with microinvasion;exactmatch
advanced adenocarcinoma;advanced adenocarcinoma;exactmatch
advanced gastroesophageal junction adenocarcinoma;advanced gastroesophageal junction adenocarcinoma;exactmatch
bladder endometrioid adenocarcinoma;bladder endometrioid adenocarcinoma;exactmatch
primary peritoneal carcinosarcoma;primary peritoneal carcinosarcoma;exactmatch
borderline ovarian endometrioid tumor/atypical proliferative ovarian endometrioid tumor with microinvasion;borderline ovarian endometrioid tumor/atypical proliferative ovarian endometrioid tumor with microinvasion;exactmatch
chromosome 7 abnormality;-7, del(7q) or t(7q);exactmatch
chromosome 5 abnormality;-5, del(5q) or t(5q);exactmatch
borderline ovarian mucinous tumor/atypical proliferative ovarian mucinous tumor with intraepithelial carcinoma;borderline ovarian mucinous tumor/atypical proliferative ovarian mucinous tumor with intraepithelial carcinoma;exactmatch
refractory adenocarcinoma;refractory adenocarcinoma;exactmatch
borderline ovarian mucinous tumor/atypical proliferative ovarian mucinous tumor with microinvasion;borderline ovarian mucinous tumor/atypical proliferative ovarian mucinous tumor with microinvasion;exactmatch
growth phase;growth phase;exactmatch
lymphoepithelioma-like carcinoma of the penis;lymphoepithelioma-like carcinoma of the penis;exactmatch
clear cell squamous cell carcinoma of the penis;clear cell squamous cell carcinoma of the penis;exactmatch
warty-basaloid carcinoma of the penis;warty-basaloid carcinoma of the penis;exactmatch
papillary-basaloid carcinoma of the penis;papillary-basaloid carcinoma of the penis;exactmatch
adenosquamous carcinoma of the penis;adenosquamous carcinoma of the penis;exactmatch
advanced clear cell renal cell carcinoma;advanced clear cell renal cell carcinoma;exactmatch
recurrent adenocarcinoma;recurrent adenocarcinoma;exactmatch
unresectable gastric carcinoma;unresectable gastric carcinoma;exactmatch
bladder benign pecoma;bladder benign pecoma;exactmatch
bladder neurofibroma;bladder neurofibroma;exactmatch
bladder granular cell tumor;bladder granular cell tumor;exactmatch
bladder hemangioma;bladder hemangioma;exactmatch
bladder solitary fibrous tumor;bladder solitary fibrous tumor;exactmatch
bladder malignant pecoma;bladder malignant pecoma;exactmatch
advanced endometrial carcinoma;advanced endometrial carcinoma;exactmatch
refractory pleural malignant mesothelioma;refractory pleural malignant mesothelioma;exactmatch
bladder pecoma;bladder pecoma;exactmatch
bladder well differentiated neuroendocrine tumor;bladder neuroendocrine tumor;exactmatch
bladder angiosarcoma;bladder angiosarcoma;exactmatch
bladder leiomyosarcoma;bladder leiomyosarcoma;exactmatch
bladder alveolar rhabdomyosarcoma;bladder alveolar rhabdomyosarcoma;exactmatch
bladder embryonal rhabdomyosarcoma;bladder embryonal rhabdomyosarcoma;exactmatch
bladder rhabdomyosarcoma;bladder rhabdomyosarcoma;exactmatch
urethral melanoma;urethral melanoma;exactmatch
bladder melanoma;bladder melanoma;exactmatch
carcinoma cuniculatum of the penis;carcinoma cuniculatum of the penis;exactmatch
pseudoglandular carcinoma of the penis;pseudoglandular carcinoma of the penis;exactmatch
pseudohyperplastic carcinoma of the penis;pseudohyperplastic carcinoma of the penis;exactmatch
labyrinthine growth pattern;labyrinthine growth pattern;exactmatch
lung parenchyma tumor location;lung parenchyma tumor location;exactmatch
kidney leiomyoma;kidney leiomyoma;exactmatch
kidney ewing sarcoma;kidney ewing sarcoma;exactmatch
fa complementation group gene;fa complementation group gene;exactmatch
kidney rhabdomyosarcoma;kidney rhabdomyosarcoma;exactmatch
kidney angiosarcoma;kidney angiosarcoma;exactmatch
fanconi anemia complementation group gene mutation;brca2 and fanc gene mutations;exactmatch
proliferation of squamous nests with little stromal reaction;proliferation of squamous nests with little stromal reaction;exactmatch
non-human papillomavirus-related squamous cell carcinoma of the penis;non-human papillomavirus-related squamous cell carcinoma of the penis;exactmatch
light and heavy chain deposition disease;lhcdd;exactmatch
ahl amyloidosis;ahl amyloidosis;exactmatch
al amyloidosis;al amyloidosis;exactmatch
ah amyloidosis;ah amyloidosis;exactmatch
early stage pancreatic ductal adenocarcinoma;early stage pancreatic ductal adenocarcinoma;exactmatch
metastatic pancreatic ductal adenocarcinoma;metastatic pancreatic ductal adenocarcinoma;exactmatch
rearrangement negative;chromosomal rearrangement negative;exactmatch
kidney hemangioma;kidney hemangioma;exactmatch
peripheral lung parenchyma tumor;peripheral lung;exactmatch
central lung parenchyma tumor;central lung;exactmatch
kidney lymphangioma;kidney lymphangioma;exactmatch
diffuse large b-cell lymphoma in partial remission;diffuse large b-cell lymphoma in partial remission;exactmatch
diffuse large b-cell lymphoma in complete remission;diffuse large b-cell lymphoma in complete remission;exactmatch
kidney tumor, middle section;kidney tumor, middle section;exactmatch
kidney tumor, lower pole;kidney tumor, lower pole;exactmatch
kidney tumor, upper pole;kidney tumor, upper pole;exactmatch
acute bilineal leukemia in remission;acute bilineal leukemia in remission;exactmatch
kidney germ cell tumor;kidney germ cell tumor;exactmatch
kidney paraganglioma;kidney paraganglioma;exactmatch
kidney large cell neuroendocrine carcinoma;kidney large cell neuroendocrine carcinoma;exactmatch
kidney neuroendocrine carcinoma;kidney neuroendocrine carcinoma;exactmatch
kidney well differentiated neuroendocrine tumor;kidney neuroendocrine tumor;exactmatch
kidney solitary fibrous tumor;kidney solitary fibrous tumor;exactmatch
kidney schwannoma;kidney schwannoma;exactmatch
small, stellate, or spindled cells present;small, stellate, or spindled cells present;exactmatch
renomedullary interstitial cell;rmic;exactmatch
ebv-related lymphoproliferative disorder;ebv lymphoproliferation;exactmatch
platinum-sensitive ovarian carcinoma;platinum sensitive ovarian cancer;exactmatch
intraductal prostate carcinoma;intraductal prostate adenocarcinoma;exactmatch
recurrent anaplastic ependymoma;recurrent anaplastic ependymoma;exactmatch
locally advanced breast carcinoma;locally advanced breast carcinoma;exactmatch
locally advanced undifferentiated pleomorphic sarcoma;locally advanced undifferentiated pleomorphic sarcoma;exactmatch
locally advanced leiomyosarcoma;locally advanced leiomyosarcoma;exactmatch
locally advanced liposarcoma;locally advanced liposarcoma;exactmatch
refractory anaplastic ganglioglioma;refractory anaplastic ganglioglioma;exactmatch
recurrent anaplastic ganglioglioma;recurrent anaplastic ganglioglioma;exactmatch
refractory anaplastic ependymoma;refractory anaplastic ependymoma;exactmatch
refractory anaplastic pleomorphic xanthoastrocytoma;refractory anaplastic pleomorphic xanthoastrocytoma;exactmatch
sinonasal adenocarcinoma;nasal cavity and paranasal sinus adenocarcinoma;exactmatch
recurrent anaplastic pleomorphic xanthoastrocytoma;recurrent anaplastic pleomorphic xanthoastrocytoma;exactmatch
plcb4 gene mutation;arcnd2 gene mutation;exactmatch
plcb4 gene;plcb4;exactmatch
platinum-sensitive fallopian tube carcinoma;platinum-sensitive fallopian tube cancer;exactmatch
platinum-sensitive primary peritoneal carcinoma;platinum-sensitive peritoneal cancer;exactmatch
advanced adrenal gland pheochromocytoma;advanced adrenal gland pheochromocytoma;exactmatch
advanced paraganglioma;advanced paraganglioma;exactmatch
cribriform adenocarcinoma of minor salivary gland;camsg;exactmatch
sinonasal adenocarcinoma, non-intestinal-type ;nasal cavity and paranasal sinus adenocarcinoma, non-intestinal-type;exactmatch
advanced thymic carcinoma;advanced thymic carcinoma;exactmatch
sinonasal adenocarcinoma, intestinal-type with mucinous pattern;sinonasal adenocarcinoma, intestinal-type with mucinous pattern;exactmatch
oligometastatic disease;oligometastatic disease;exactmatch
oligometastatic malignant solid neoplasm;oligometastatic malignant solid neoplasm;exactmatch
morphologic features resembling salivary gland adenocarcinoma;morphologic features resembling salivary gland adenocarcinoma;exactmatch
sinonasal adenocarcinoma, non-salivary-type;nasal cavity and paranasal sinus adenocarcinoma, non-salivary-type;exactmatch
sinonasal adenocarcinoma, salivary-type;nasal cavity and paranasal sinus adenocarcinoma, salivary-type;exactmatch
canine thyroid gland medullary carcinoma;canine thyroid gland medullary carcinoma;exactmatch
sinonasal adenocarcinoma, intestinal-type with mixed pattern;sinonasal adenocarcinoma, intestinal-type with mixed pattern;exactmatch
nasal vestibule;nasal vestibule;exactmatch
head and neck sebaceous carcinoma;head and neck sebaceous carcinoma;exactmatch
sinonasal adenocarcinoma, intestinal-type with solid pattern;sinonasal adenocarcinoma, intestinal-type with solid pattern;exactmatch
sinonasal adenocarcinoma, intestinal-type with colonic pattern;sinonasal adenocarcinoma, intestinal-type with colonic pattern;exactmatch
tubuloglandular pattern;tubuloglandular pattern;exactmatch
sinonasal adenocarcinoma, intestinal-type with papillary pattern;sinonasal adenocarcinoma, intestinal-type with papillary pattern;exactmatch
head and neck large cell neuroendocrine carcinoma;head and neck large cell neuroendocrine carcinoma;exactmatch
head and neck small cell neuroendocrine carcinoma;head and neck small cell carcinoma;exactmatch
head and neck neuroendocrine carcinoma;head and neck neuroendocrine carcinoma;exactmatch
metastatic rectal adenocarcinoma;metastatic rectal adenocarcinoma;exactmatch
metastatic colon adenocarcinoma;metastatic colon adenocarcinoma;exactmatch
prostate acinar adenocarcinoma, pleomorphic giant cell variant;prostate acinar adenocarcinoma, pleomorphic giant cell variant;exactmatch
recurrent diffuse large b-cell lymphoma germinal center b-cell type;recurrent diffuse large b-cell lymphoma germinal center b-cell type;exactmatch
unresectable lung small cell carcinoma;unresectable lung small cell carcinoma;exactmatch
refractory transformed follicular lymphoma to diffuse large b-cell lymphoma;refractory transformed follicular lymphoma to diffuse large b-cell lymphoma;exactmatch
refractory diffuse large b-cell lymphoma activated b-cell type;refractory diffuse large b-cell lymphoma activated b-cell type;exactmatch
refractory diffuse large b-cell lymphoma germinal center b-cell type;refractory diffuse large b-cell lymphoma germinal center b-cell type;exactmatch
refractory high grade b-cell lymphoma;refractory high grade b-cell lymphoma;exactmatch
recurrent transformed follicular lymphoma to diffuse large b-cell lymphoma;recurrent transformed follicular lymphoma to diffuse large b-cell lymphoma;exactmatch
recurrent diffuse large b-cell lymphoma activated b-cell type;recurrent diffuse large b-cell lymphoma activated b-cell type;exactmatch
recurrent high grade b-cell lymphoma;recurrent high grade b-cell lymphoma;exactmatch
prostate acinar adenocarcinoma, microcystic variant;prostate acinar adenocarcinoma, microcystic variant;exactmatch
carcinoma arising in bladder diverticulum;carcinoma arising in bladder diverticulum;exactmatch
bladder diverticulum;bladder diverticulum;exactmatch
refractory epstein-barr virus-associated lymphoproliferative disease with primary immunodeficiency;refractory epstein-barr virus-associated lymphoproliferative disease with primary immunodeficiency;exactmatch
recurrent epstein-barr virus-associated lymphoproliferative disease with primary immunodeficiency;recurrent epstein-barr virus-associated lymphoproliferative disease with primary immunodeficiency;exactmatch
epstein-barr virus-associated lymphoproliferative disease with primary immunodeficiency;epstein-barr virus-associated lymphoproliferative disease with primary immunodeficiency;exactmatch
refractory ebv-related lymphoma;refractory ebv-associated lymphoma;exactmatch
advanced malignant thymoma;advanced malignant thymoma;exactmatch
advanced lung small cell carcinoma;advanced lung small cell carcinoma;exactmatch
metastatic nut carcinoma;metastatic nmc;exactmatch
advanced nut carcinoma;advanced nut carcinoma;exactmatch
unresectable nut carcinoma;unresectable nut carcinoma;exactmatch
high risk meningioma;high risk meningioma;exactmatch
locally advanced lung non-small cell carcinoma;locally advanced lung non-small cell carcinoma;exactmatch
metastatic ovarian serous adenocarcinoma;metastatic ovarian serous adenocarcinoma;exactmatch
unresectable ovarian serous adenocarcinoma;unresectable ovarian serous adenocarcinoma;exactmatch
recurrent oligodendroglioma;recurrent oligodendroglioma;exactmatch
hematologic malignancy-associated skin squamous cell carcinoma;hmcscc;exactmatch
recurrent malignant ovarian granulosa cell tumor;recurrent malignant ovarian granulosa cell tumor;exactmatch
urethra part;urethra part;exactmatch
advanced esophageal carcinoma;advanced esophageal carcinoma;exactmatch
rectal neuroendocrine tumor g2;rectal net g2;exactmatch
colon neuroendocrine tumor g2;colon net g2;exactmatch
duodenal neuroendocrine tumor g2;duodenal net g2;exactmatch
ileal neuroendocrine tumor g2;ileal net g2;exactmatch
jejunal neuroendocrine tumor g2;jejunal net g2;exactmatch
cysltr2 gene mutation;cyslt2 gene mutation;exactmatch
stage iia vaginal cancer ajcc v8;stage iia vaginal cancer;exactmatch
stage ib vaginal cancer ajcc v8;stage ib vaginal cancer;exactmatch
advanced rectal carcinoma;advanced rectal carcinoma;exactmatch
pathology result;pathologic examination result;exactmatch
endocrine cell of the digestive system;endocrine cell of gut;exactmatch
theca cell;ovarian interstitial cell;exactmatch
recurrent acute myeloid leukemia with myelodysplasia-related changes;recurrent acute myeloid leukemia (aml) with myelodysplasia-related changes;exactmatch
stromal cell;stromal cell;exactmatch
osteoblast;osteoblast;exactmatch
histiocyte;fixed macrophage;exactmatch
foam cell;foam cell;exactmatch
macrophage;macrophage;exactmatch
delta cell;d cell;exactmatch
chondrocyte;chondrocyte;exactmatch
adipocyte;adipocyte;exactmatch
connective and soft tissue cell;connective and soft tissue cell;exactmatch
chromaffin cell;chromaffin cell;exactmatch
megakaryocyte;megakaryocyte;exactmatch
bone marrow myeloid stem cell;bone marrow myeloid stem cell;exactmatch
hematopoietic stem cell;ferrata cell;exactmatch
figo stage;figo stage;exactmatch
epithelial cell;epithelial cell;exactmatch
cytotoxic t-lymphocyte;ctl;exactmatch
melanocyte;melanocyte;exactmatch
giant cell;giant cell;exactmatch
spermatozoon;spermatozoon;exactmatch
zygote;egg, fertilized;exactmatch
oocyte;egg;exactmatch
germ cell;gamete;exactmatch
sertoli cell;sertoli cell;exactmatch
parietal cell;gastric parietal cells;exactmatch
high grade b-cell lymphoma with myc and bcl2 or bcl6 rearrangements;dh lymphoma;exactmatch
ameloblast;ameloblast;exactmatch
small cell glioblastoma;small cell glioblastoma;exactmatch
keratinocyte;keratinocyte;exactmatch
hepatocyte;hepatic cells;exactmatch
granulosa cell;granulosa cell;exactmatch
enterocyte;enterocyte;exactmatch
langerhans cell;langerhans cell;exactmatch
dendritic cell;dendritic cell;exactmatch
myeloid cell;myeloid cell;exactmatch
cd8-positive t-lymphocyte;cd8 cell;exactmatch
childhood extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;childhood extranodal marginal zone lymphoma of malt;exactmatch
signet ring cell;signet ring cell;exactmatch
external acoustic meatus;auditory canal;exactmatch
sella turcica;sella turcica;exactmatch
jugular foramen;jugular foramen;exactmatch
foramen magnum;foramen magnum;exactmatch
clivus;clivus;exactmatch
base of the skull;base of skull;exactmatch
intrachromosomal amplification of chromosome 21;intrachromosomal amplification of chromosome 21;exactmatch
plasma cell;plasma cell;exactmatch
tympanic membrane;ear drum;exactmatch
neuroendocrine cell;neuroendocrine cell;exactmatch
fibroblast;fibroblast;exactmatch
endothelium;endothelial;exactmatch
mouse kidney carcinoma;mouse kidney carcinoma;exactmatch
terminal ductal lobular unit;tdlu;exactmatch
astrocyte;astrocyte;exactmatch
t-lymphocyte;t cell;exactmatch
inner ear;ear, inner;exactmatch
buccal mucosa;buccal mucosa;exactmatch
mouse plasma cell myeloma;mouse plasma cell myeloma;exactmatch
erythrocyte;blood corpuscles;exactmatch
rat plasma cell myeloma;rat plasma cell myeloma;exactmatch
rat malignant peripheral nerve sheath tumor;rat malignant peripheral nerve sheath tumor;exactmatch
cd4-positive t-lymphocyte;cd4 lymphocyte;exactmatch
natural killer cell;killer cell;exactmatch
lymphocyte;lymph cell;exactmatch
megaloblast;megaloblast;exactmatch
abnormal red blood cell;abnormal red blood cell;exactmatch
platelet;bizzozero corpuscle;exactmatch
tooth;tooth;exactmatch
peripheral blood cell;peripheral blood cell;exactmatch
superior sagittal sinus;greater sagittal sinus;exactmatch
sagittal sinus;sagittal sinus;exactmatch
supratentorial brain;supratentorial brain;exactmatch
pons varolii;brain, pons;exactmatch
infratentorial brain;infratentorial brain;exactmatch
cell;cell;exactmatch
islet of langerhans;endocrine pancreas;exactmatch
experimental organism benign mixed sertoli-leydig cell tumor;experimental organism benign mixed sertoli-leydig cell tumor;exactmatch
experimental organism benign mixed mullerian tumor;experimental organism benign mixed mullerian tumor;exactmatch
fallopian tube lymphoma;fallopian tube lymphoma;exactmatch
low grade broad ligament serous adenocarcinoma;low grade broad ligament serous adenocarcinoma;exactmatch
broad ligament serous adenocarcinoma;broad ligament serous adenocarcinoma;exactmatch
broad ligament serous adenofibroma;broad ligament serous adenofibroma;exactmatch
broad ligament serous cystadenofibroma;broad ligament serous cystadenofibroma;exactmatch
broad ligament serous cystadenoma;broad ligament serous cystadenoma;exactmatch
serous borderline broad ligament tumor/atypical proliferative serous broad ligament tumor;serous borderline broad ligament tumor/atypical proliferative serous broad ligament tumor;exactmatch
metastatic head and neck carcinoma;metastatic head and neck cancer;exactmatch
low grade fallopian tube serous adenocarcinoma;low grade fallopian tube serous adenocarcinoma;exactmatch
benign uterine ligament neoplasm;benign uterine ligament neoplasm;exactmatch
high grade fallopian tube serous adenocarcinoma;high grade fallopian tube serous adenocarcinoma;exactmatch
serous tubal intraepithelial carcinoma;stic;exactmatch
retinal ganglion cell;retinal ganglion cell;exactmatch
prominent stromal reaction;prominent stromal reaction;exactmatch
thyroid gland papillary carcinoma with fibromatosis/fasciitis-like stroma;nodular fasciitis-like stroma variant thyroid gland papillary carcinoma;exactmatch
warthin-like variant thyroid gland papillary carcinoma;warthin tumor-like variant thyroid gland papillary cancer;exactmatch
cribriform-morular variant thyroid gland papillary carcinoma;cribriform-morular variant thyroid gland papillary cancer;exactmatch
high grade broad ligament serous adenocarcinoma;high grade broad ligament serous adenocarcinoma;exactmatch
malignant uterine ligament neoplasm;malignant uterine ligament neoplasm;exactmatch
experimental organism benign neuroendocrine cell tumor;experimental organism benign neuroendocrine cell tumor;exactmatch
abdomen;abdominal cavity;exactmatch
axilla;axilla;exactmatch
autonomic nervous system;ans;exactmatch
arteriole;arteriole;exactmatch
upper extremity;limb, upper;exactmatch
aorta;aorta;exactmatch
adrenal gland;adrenal gland;exactmatch
abducens nerve;abducens nerve;exactmatch
stem cell;mother cells;exactmatch
c11orf95 gene;c11orf95;exactmatch
reed-sternberg cell;r-s cell;exactmatch
thyroid gland noninvasive follicular neoplasm with papillary-like nuclear features;follicular thyroid tumor;exactmatch
follicular variant thyroid gland papillary carcinoma;fvptc;exactmatch
phagocytic cell;phagocyte;exactmatch
pericyte;adventitial cell;exactmatch
apud cell;apud cell;exactmatch
gnas gene product;gnas gene product;exactmatch
peritoneal gliomatosis;gliomatosis peritonei;exactmatch
abdominal inflammatory myofibroblastic tumor;abdominal inflammatory myofibroblastic tumor;exactmatch
pelvic fibromatosis;pelvic desmoid tumor;exactmatch
glial cell;glia;exactmatch
sensory neuron;afferent neuron;exactmatch
myelinated nerve fiber;myelinated nerve fiber;exactmatch
neuron;nerve cell;exactmatch
follicular dendritic cell;follicular dendritic cell;exactmatch
antigen presenting cell;apc;exactmatch
schwann cell;neurilemma cell;exactmatch
oligodendrocyte;oligodendrocyte;exactmatch
muscle cell;muscle cell;exactmatch
peritoneal solitary fibrous tumor;peritoneal solitary fibrous tumor;exactmatch
infant t acute lymphoblastic leukemia;infant precursor t lymphoblastic leukemia;exactmatch
infant acute biphenotypic leukemia;acute biphenotypic leukemia;exactmatch
infant acute undifferentiated leukemia;acute undifferentiated leukemia;exactmatch
metastatic urothelial carcinoma;metastatic transitional cell carcinoma of the urinary tract;exactmatch
leydig cell;interstitial cell of testis;exactmatch
experimental organism malignant renal mesenchymal tumor;experimental organism malignant renal mesenchymal tumor;exactmatch
experimental organism malignant neuroendocrine cell tumor;experimental organism malignant neuroendocrine cell tumor;exactmatch
tubulocystic renal cell carcinoma;tubulocystic renal cell cancer;exactmatch
dilated cystic spaces present;dilated cystic spaces present;exactmatch
recurrent glioblastoma;recurrent glioblastoma;exactmatch
recurrent bladder urothelial carcinoma;recurrent bladder transitional cell carcinoma;exactmatch
peritoneal desmoplastic small round cell tumor;peritoneal desmoplastic small round cell tumor;exactmatch
primary peritoneal low grade serous adenocarcinoma;invasive micropapillary serous carcinoma of the peritoneum;exactmatch
primary peritoneal high grade serous adenocarcinoma;primary peritoneal high grade serous adenocarcinoma;exactmatch
chronic eosinophilic leukemia with fip1l1-pdgfra;chronic eosinophilic leukemia with fip1l1-pdgfra;exactmatch
photoreceptor cell;photoreceptor cell;exactmatch
ovarian adenomatoid tumor;ovarian adenomatoid tumor;exactmatch
gastroesophageal junction small cell neuroendocrine carcinoma;gastroesophageal junction small cell carcinoma;exactmatch
gastroesophageal junction neuroendocrine carcinoma;gastroesophageal junction neuroendocrine carcinoma;exactmatch
gastroesophageal junction large cell neuroendocrine carcinoma;gastroesophageal junction large cell neuroendocrine carcinoma;exactmatch
ovarian retiform sertoli-leydig cell tumor, variant with heterologous elements;ovarian retiform sertoli-leydig cell tumor, variant with heterologous elements;exactmatch
ovarian luteinized thecoma associated with sclerosing peritonitis;ovarian luteinized thecoma associated with sclerosing peritonitis;exactmatch
ovarian seromucinous adenofibroma;ovarian seromucinous adenofibroma;exactmatch
ovarian seromucinous cystadenoma;ovarian seromucinous cystadenoma;exactmatch
refractory adult acute lymphoblastic leukemia;refractory acute lymphoblastic leukemia (all);exactmatch
borderline ovarian clear cell tumor/atypical proliferative ovarian clear cell tumor;borderline ovarian clear cell tumor/atypical proliferative ovarian clear cell tumor;exactmatch
skin basal cell;basal cells;exactmatch
b-lymphocyte;b cell;exactmatch
synovial membrane;synovial membrane;exactmatch
sigmoid colon;colon, sigmoid;exactmatch
childhood mixed germ cell tumor;childhood mixed germ cell tumor;exactmatch
childhood embryonal carcinoma;childhood embryonal carcinoma;exactmatch
childhood choriocarcinoma;childhood choriocarcinoma;exactmatch
childhood testicular non-seminomatous germ cell tumor;childhood testicular non-germinomatous germ cell tumor;exactmatch
childhood ovarian nongerminomatous germ cell tumor;childhood ovarian non-germinomatous germ cell tumor;exactmatch
childhood nongerminomatous germ cell tumor;childhood non-germinomatous germ cell tumor;exactmatch
childhood seminoma;childhood seminoma;exactmatch
childhood germinomatous germ cell tumor;childhood germinomatous germ cell tumor;exactmatch
transverse colon;colon, transverse;exactmatch
childhood testicular mature teratoma;childhood testicular mature teratoma;exactmatch
childhood mature teratoma;childhood mature teratoma;exactmatch
childhood testicular immature teratoma;childhood testicular immature teratoma;exactmatch
childhood immature teratoma;childhood immature teratoma;exactmatch
colon;colon;exactmatch
cecum;cecum;exactmatch
appendix;appendix;exactmatch
childhood ovarian mixed germ cell tumor;childhood ovarian mixed germ cell tumor;exactmatch
small intestine;gastrointestinal tract, small intestine;exactmatch
pineal gland;gland, pineal;exactmatch
childhood malignant kidney neoplasm;childhood malignant kidney neoplasm;exactmatch
adrenal cortex;adrenal cortex;exactmatch
ear;ear;exactmatch
childhood small intestinal carcinoma;childhood small intestinal carcinoma;exactmatch
childhood small intestinal leiomyosarcoma;childhood small intestinal leiomyosarcoma;exactmatch
pancreas;gastrointestinal tract, pancreas;exactmatch
liver;body system, hepatic;exactmatch
stomach;gastric;exactmatch
childhood gastrointestinal stromal tumor;childhood gist;exactmatch
malignant germinomatous cells present;malignant germinomatous cells present;exactmatch
childhood thyroid gland medullary carcinoma;childhood medullary thyroid carcinoma;exactmatch
childhood thyroid gland follicular carcinoma;childhood follicular thyroid carcinoma;exactmatch
childhood thyroid gland papillary carcinoma;childhood papillary thyroid carcinoma;exactmatch
rectum;hemorrhoidal;exactmatch
esophagus;esophagus;exactmatch
jejunum;jejunum;exactmatch
ileum;ileum;exactmatch
large intestine;large intestine;exactmatch
digestive system;body system, gastrointestinal;exactmatch
gallbladder;gallbladder;exactmatch
lacrimal gland;gland, lacrimal;exactmatch
temporal lobe;temporal lobe;exactmatch
frontal lobe;frontal lobe;exactmatch
cerebral hemisphere;brain, cerebrum;exactmatch
spinal meninges;spinal meninges;exactmatch
cerebral meninges;cerebral meninges;exactmatch
meninges;meninges;exactmatch
orbit;body cavity, orbital;exactmatch
ciliary body;ciliary body;exactmatch
bile duct;bile duct;exactmatch
choroid;choroid;exactmatch
retina;retina;exactmatch
cornea;cornea;exactmatch
conjunctiva;conjunctiva;exactmatch
childhood periosteal osteosarcoma;childhood periosteal osteosarcoma;exactmatch
childhood spindle cell rhabdomyosarcoma;childhood spindle cell rhabdomyosarcoma;exactmatch
childhood langerhans cell histiocytosis without risk organ involvement;childhood langerhans cell histiocytosis without risk organ involvement;exactmatch
parietal lobe;parietal lobe;exactmatch
occipital lobe;occipital lobe;exactmatch
brain ventricle;brain ventricle;exactmatch
head and neck lymph node;head and neck lymph node;exactmatch
anal canal;anal canal;exactmatch
connective tissue;connective tissue;exactmatch
refractory malignant germ cell tumor;refractory malignant germ cell neoplasm;exactmatch
refractory childhood malignant germ cell tumor;refractory childhood malignant germ cell neoplasm;exactmatch
fusion-negative rhabdomyosarcoma;fusion-negative rhabdomyosarcoma;exactmatch
fusion-positive rhabdomyosarcoma;fusion-positive rhabdomyosarcoma;exactmatch
fusion-negative alveolar rhabdomyosarcoma;fusion gene negative alveolar rhabdomyosarcoma;exactmatch
fusion-positive alveolar rhabdomyosarcoma;fusion gene positive alveolar rhabdomyosarcoma;exactmatch
cartilage;cartilage;exactmatch
artery;artery;exactmatch
myocardium;cardiac muscle tissue;exactmatch
mammary gland tissue;breast tissue;exactmatch
mammary gland;gland, mammary;exactmatch
bone;bone;exactmatch
psa progression;elevated psa;exactmatch
adrenal medulla;adrenal medulla;exactmatch
pituitary gland;gland, pituitary;exactmatch
adipose tissue;adipose tissue;exactmatch
smooth muscle tissue;muscle, smooth;exactmatch
corpus callosum;brain, corpus callosum;exactmatch
cerebellum;brain, cerebellum;exactmatch
cerebral cortex;cerebral cortex;exactmatch
medulla oblongata;brain, medulla oblongata;exactmatch
brain stem;brain stem;exactmatch
brain;brain;exactmatch
central nervous system;central nervous system;exactmatch
striated muscle tissue;striated muscle tissue;exactmatch
diencephalon;diencephalon;exactmatch
muscle tissue;muscle tissue;exactmatch
blood;blood;exactmatch
thymus gland;reticuloendothelial system, thymus;exactmatch
spleen;reticuloendothelial system, spleen;exactmatch
bone marrow;bone marrow;exactmatch
childhood anaplastic ependymoma;anaplastic ependymoma;exactmatch
childhood choroid plexus carcinoma;childhood choroid plexus carcinoma;exactmatch
discoloration;discolored;exactmatch
hypothalamus;brain, hypothalamus;exactmatch
thyroid gland;gland, thyroid;exactmatch
experimental organism malignant mixed sex cord stromal tumor;experimental organism malignant mixed sex cord stromal tumor;exactmatch
soft tissue;soft tissue;exactmatch
skin;human skin;exactmatch
pleura;pleura;exactmatch
lung;lung;exactmatch
nerve;nerve;exactmatch
peripheral nervous system;peripheral nervous system;exactmatch
spinal cord;medulla spinalis;exactmatch
experimental organism benign mixed sex cord stromal tumor;experimental organism benign mixed sex cord stromal tumor;exactmatch
thalamus;brain, thalamus;exactmatch
experimental organism malignant sarcoma arising from fibroadenoma;experimental organism malignant sarcoma arising from fibroadenoma;exactmatch
experimental organism glandular polyp;experimental organism glandular polyp;exactmatch
experimental organism mesenchymal proliferative lesion;experimental organism mesenchymal proliferative lesion;exactmatch
experimental organism malignant mesovarial leiomyoma;experimental organism malignant mesovarial leiomyoma;exactmatch
experimental organism benign epithelial stromal tumor;epithelial-stromal tumor, benign;exactmatch
experimental organism malignant neuroepithelial carcinoma;carcinoma, neuroepithelial, malignant;exactmatch
experimental organism benign adenomyoepithelioma;adenomyoepithelioma, benign;exactmatch
childhood atypical choroid plexus papilloma;childhood atypical choroid plexus papilloma;exactmatch
limb;extremities;exactmatch
trachea;trachea;exactmatch
prostate gland;gland, prostate;exactmatch
urethra;urethra;exactmatch
ureter;ureter;exactmatch
kidney;kidney;exactmatch
bladder;bladder;exactmatch
childhood pineal parenchymal tumor of intermediate differentiation;childhood pineal parenchymal tumor of intermediate differentiation;exactmatch
urinary system;body system, renal/urologic;exactmatch
testis;genital system, male, testis;exactmatch
penis;genital system, male, penis;exactmatch
childhood astrocytoma;astrocytoma;exactmatch
vulva;external genitalia;exactmatch
vagina;genital system, female, vagina;exactmatch
uterus;genital system, female, uterus;exactmatch
ovary;genital system, female, ovary;exactmatch
fallopian tube;fallopian tube;exactmatch
female reproductive system;body system, gynecologic;exactmatch
eye;eye;exactmatch
head and neck;h and n;exactmatch
head;head;exactmatch
larynx;head and neck, larynx;exactmatch
oral cavity;body cavity, oral;exactmatch
childhood ganglioneuroblastoma, nodular;childhood ganglioneuroblastoma, nodular;exactmatch
childhood ganglioneuroblastoma, intermixed;childhood ganglioneuroblastoma, intermixed;exactmatch
childhood central nervous system ganglioneuroblastoma;central nervous system ganglioneuroblastoma;exactmatch
childhood ganglioneuroblastoma;childhood ganglioneuroblastoma;exactmatch
childhood neuroblastoma;childhood neuroblastoma;exactmatch
parotid gland;gland, salivary, parotid;exactmatch
childhood myxopapillary ependymoma;childhood myxopapillary ependymoma;exactmatch
salivary gland;gland, salivary;exactmatch
woodchuck hepatocellular carcinoma;woodchuck hepatocellular carcinoma;exactmatch
rat malignant meningioma;rat malignant meningioma;exactmatch
pharynx;pharynx;exactmatch
canine mammary carcinoma;canine mammary carcinoma;exactmatch
nasal cavity;body cavity, nasal;exactmatch
nasopharynx;nasopharynx;exactmatch
tongue;tongue;exactmatch
acute myeloid leukemia with flt3/itd mutation;acute myeloid leukemia (aml) with flt3/itd;exactmatch
bartholin gland;bartholin gland;exactmatch
oropharyngeal poorly differentiated carcinoma;oropharyngeal poorly differentiated carcinoma;exactmatch
squamous cell;squamous cell;exactmatch
endothelial cell;endothelial cell;exactmatch
ewsr1 gene translocation;ews gene translocation;exactmatch
recurrent respiratory papillomatosis;rrp;exactmatch
b acute lymphoblastic leukemia, philadelphia chromosome negative;acute lymphoblastic leukemia, philadelphia chromosome negative;exactmatch
unresectable esophageal carcinoma;esophageal cancer unresectable;exactmatch
sacral vertebra;sacral vertebra;exactmatch
female breast;breast, female;exactmatch
squamous epithelium;squamous epithelium;exactmatch
alveolar epithelium;alveolar epithelium;exactmatch
reactive lymphocyte;reactive lymphocyte;exactmatch
recurrent gastrointestinal stromal tumor;recurrent gastrointestinal stromal tumor;exactmatch
cutaneous neurofibroma;cutaneous (skin) neurofibroma;exactmatch
lumbar plexus;lumbar plexus;exactmatch
reproductive system;reproductive body system;exactmatch
pleural cavity;body cavity, pleural;exactmatch
lateral ventricle;brain ventricle, lateral;exactmatch
transitional cell;transitional cell;exactmatch
right atrium;heart, right atrium;exactmatch
bcr/abl1 fusion negative;bcr-abl fusion negative;exactmatch
recurrent intrahepatic cholangiocarcinoma;recurrent intrahepatic bile duct cancer (cholangiocarcinoma);exactmatch
pms1 gene mutation;hnpcc3 gene mutation;exactmatch
msh2 gene mutation;coca1 gene mutation;exactmatch
cdkn2a gene mutation;cdk4i gene mutation;exactmatch
deleterious brca2 gene mutation;deleterious brca2 gene mutation;exactmatch
deleterious brca1 gene mutation;deleterious brca1 gene mutation;exactmatch
bap1 gene mutation;bap1 gene mutation;exactmatch
igm monoclonal gammopathy;igm monoclonal gammopathy;exactmatch
cutaneous malignant melanoma 2;cmm2;exactmatch
left atrium;heart, left atrium;exactmatch
submucosal lesion;submucosal lesion;exactmatch
metastatic lung non-squamous non-small cell carcinoma;metastatic lung non-squamous non-small cell carcinoma;exactmatch
recurrent lung non-squamous non-small cell carcinoma;recurrent lung non-squamous non-small cell carcinoma;exactmatch
venous sinus;venous sinus;exactmatch
unclassifiable lesion;unclassifiable lesion;exactmatch
nk-cell lymphoma, unclassifiable;nk-cell lymphoma, unclassifiable;exactmatch
peripheral t-cell lymphoma, unclassifiable;peripheral t-cell lymphoma, unclassifiable;exactmatch
conus medullaris;conus medullaris;exactmatch
hypoploidy;hypoploid;exactmatch
vulvar yolk sac tumor;vulvar endodermal sinus tumor;exactmatch
inferior vena cava;inferior vena cava;exactmatch
vulvar keratoacanthoma;vulvar keratoacanthoma;exactmatch
vulvar adenocarcinoma, intestinal-type;primary villoglandular mucinous adenocarcinoma arising in the surface epithelium of the vulva;exactmatch
malignant vulvar phyllodes tumor;malignant vulvar phyllodes tumor;exactmatch
vulvar adenocarcinoma of sweat gland type;vulvar adenocarcinoma of sweat gland type;exactmatch
mammary gland type features present;mammary gland type features present;exactmatch
vulvar adenocarcinoma of mammary gland type;agmlgs;exactmatch
superior vena cava;superior vena cava;exactmatch
vulvar squamous intraepithelial lesion;vulvar squamous intraepithelial lesion;exactmatch
vulvar germ cell tumor;vulvar germ cell tumor;exactmatch
vein;vein;exactmatch
canine transitional cell carcinoma;canine transitional cell carcinoma;exactmatch
canine histiocytic sarcoma;canine histiocytic sarcoma;exactmatch
mouse testicular teratoma;mouse testicular teratoma;exactmatch
canine prostate carcinoma;canine prostate carcinoma;exactmatch
canine leukemia;canine leukemia;exactmatch
vagus nerve;cranial nerve x;exactmatch
vena cava;vein, vena cava;exactmatch
colon adenoma with severe dysplasia;colon adenoma with severe dysplasia;exactmatch
myd88 gene mutation;myd88 gene mutation;exactmatch
myd88 protein variant;myd88 protein variant;exactmatch
vulvar melanocytic nevus;vulvar melanocytic nevus;exactmatch
fourth ventricle;fourth ventricle;exactmatch
vulvar alveolar rhabdomyosarcoma;vulvar alveolar rhabdomyosarcoma;exactmatch
vulvar superficial myofibroblastoma;vulvar superficial myofibroblastoma;exactmatch
vulvar fibrolipoma;vulvar fibrolipoma;exactmatch
vulvar lipoma;vulvar lipoma;exactmatch
third ventricle;brain, third ventricle;exactmatch
vulvar merkel cell carcinoma;vulvar merkel cell carcinoma;exactmatch
vulvar large cell neuroendocrine carcinoma;vulvar large cell neuroendocrine carcinoma;exactmatch
vulvar small cell neuroendocrine carcinoma;vulvar small cell carcinoma;exactmatch
vulvar neuroendocrine carcinoma;vulvar high grade neuroendocrine carcinoma;exactmatch
vulvar ectopic fibroadenoma;vulvar ectopic fibroadenoma;exactmatch
vulvar hidradenoma papilliferum;vulvar hidradenoma papilliferum;exactmatch
canine sarcoma;canine sarcoma;exactmatch
venule;venule;exactmatch
stk11 gene mutation;lkb1 gene mutation;exactmatch
human papillomavirus positive;hpv positive;exactmatch
vaginal germ cell tumor;vaginal germ cell tumor;exactmatch
h3 k27m mutation;h3 k27m;exactmatch
oligoastrocytoma, not otherwise specified;oligoastrocytoma, nos;exactmatch
anaplastic oligodendroglioma, not otherwise specified;anaplastic oligodendroglioma, nos;exactmatch
anaplastic oligodendroglioma, idh-mutant and 1p/19q-codeleted;anaplastic oligodendroglioma, idh mutant and 1p/19q codeleted;exactmatch
1p/19q codeletion status unknown;1p/19q codeletion status unknown;exactmatch
oligodendroglioma, not otherwise specified;oligodendroglioma, nos;exactmatch
oligodendroglioma, idh-mutant and 1p/19q-codeleted;oligodendroglioma, idh mutant and 1p/19q codeleted;exactmatch
h3 protein variant;h3 protein variant;exactmatch
diffuse midline glioma, h3 k27m-mutant;diffuse midline glioma, h3 k27m-mutant;exactmatch
diffuse glioma;diffuse glioma;exactmatch
canine rhabdomyosarcoma;canine rhabdomyosarcoma;exactmatch
canine hepatocellular carcinoma;canine hepatocellular carcinoma;exactmatch
canine glioma;canine glioma;exactmatch
glioblastoma with primitive neuronal component;glioblastoma with pnet-like component;exactmatch
glioblastoma, not otherwise specified;glioblastoma, nos;exactmatch
epithelioid glioblastoma;epithelioid glioblastoma;exactmatch
anaplastic astrocytoma, not otherwise specified;anaplastic astrocytoma, nos;exactmatch
anaplastic oligoastrocytoma, not otherwise specified;anaplastic oligoastrocytoma, nos;exactmatch
anaplastic pleomorphic xanthoastrocytoma;apx;exactmatch
urothelium;transitional epithelium of the urinary tract;exactmatch
histone modification;histone modification;exactmatch
chromosome 17 abnormality;chromosome 17 abnormality;exactmatch
wnt pathway activated;wnt pathway activated;exactmatch
large cell/anaplastic medulloblastoma;large cell/anaplastic medulloblastoma;exactmatch
rosette-forming glioneuronal tumor;rgnt;exactmatch
multinodular and vacuolated tumor of the cerebrum;multinodular and vacuolated tumor of the cerebrum;exactmatch
multinodular and vacuolated pattern;multinodular and vacuolated pattern;exactmatch
diffuse leptomeningeal glioneuronal tumor;diffuse leptomeningeal glioneuronal tumor;exactmatch
mismatch repair protein;dna mismatch repair protein;exactmatch
vertebra;vertebra;exactmatch
core binding factor complex mutation;cbf mutation;exactmatch
janus kinase family;jak;exactmatch
mammary epithelium;mammary epithelium;exactmatch
gut-associated lymphoid tissue;galt;exactmatch
c11orf95/rela fusion gene;c11orf95-rela fusion gene;exactmatch
c11orf95-rela fusion protein expression;c11orf95-rela fusion protein expression;exactmatch
ependymoma, rela fusion-positive;ependymoma, rela fusion-positive;exactmatch
anaplastic astrocytoma, idh-wildtype;anaplastic astrocytoma, idh wild type;exactmatch
anaplastic astrocytoma, idh-mutant;anaplastic astrocytoma, idh mutant;exactmatch
nerve plexus;nerve plexi;exactmatch
flt3 protein variant;cd135 antigen protein variant;exactmatch
canine mastocytoma;canine mastocytoma;exactmatch
integumentary system;body system, dermatologic;exactmatch
thoracic cavity;body cavity, thoracic;exactmatch
thrombocytopenia 2;thc2;exactmatch
supraclavicular lymph node;lymph node(s) supraclavicular;exactmatch
bulbar conjunctiva;bulbar conjunctiva;exactmatch
thoracic spinal cord;spinal cord, thoracic;exactmatch
cervical spinal cord;cervical portion of spinal cord;exactmatch
gingival spindle cell carcinoma;gingival spindle cell carcinoma;exactmatch
flt3 gene mutation;cd135 gene mutation;exactmatch
fgfr3 protein variant;cd333 antigen protein variant;exactmatch
activating ras mutation;activating ras;exactmatch
falx cerebri;cerebral falx;exactmatch
renal pelvis;renal pelvis;exactmatch
lung micropapillary adenocarcinoma;lung micropapillary adenocarcinoma;exactmatch
philadelphia chromosome negative;ph negative;exactmatch
hematopoietic system;body system, hematologic;exactmatch
mucosa-associated lymphoid tissue;lymphoid tissue, mucosa-associated;exactmatch
abnormal cell;abnormal cell;exactmatch
neoplastic lymphoblast;atypical lymphoblast;exactmatch
idh gene family mutation status unknown;cannot be determined;exactmatch
corneal epithelium;corneal epithelium;exactmatch
diffuse astrocytoma, not otherwise specified;diffuse astrocytoma, nos;exactmatch
diffuse astrocytoma, idh-wildtype;diffuse astrocytoma, idh wild type;exactmatch
gemistocytic astrocytoma, idh-mutant;gemistocytic astrocytoma, idh mutant;exactmatch
diffuse astrocytoma, idh-mutant;diffuse astrocytoma, idh mutant;exactmatch
idh gene family mutation;idh family mutation;exactmatch
idh gene family;idh;exactmatch
tnfrsf8 positive;cd30 antigen positive;exactmatch
ncam1 positive;cd56 antigen positive;exactmatch
neoplastic cell;neoplastic cell;exactmatch
organ system;body systems;exactmatch
hematopoietic blast cell;blast cell;exactmatch
malignant cell;cancer cell;exactmatch
micromegakaryocyte;atypically small megakaryocyte;exactmatch
vaginal dermoid cyst;vaginal dermoid cyst;exactmatch
uvea;iris, ciliary body and choroid;exactmatch
oropharyngeal basaloid carcinoma;oropharyngeal basaloid carcinoma;exactmatch
unresectable solid neoplasm;unresectable solid neoplasm;exactmatch
glottis;glottis;exactmatch
glossopharyngeal nerve;cranial nerve ix;exactmatch
male reproductive system;body system, reproductive, male;exactmatch
growth hormone and prolactin-producing neoplastic cells present;growth hormone and prolactin-producing neoplastic cells present;exactmatch
somatotroph/lactotroph adenoma;growth hormone and prolactin-producing adenoma;exactmatch
ganglion;ganglion;exactmatch
macronodular adrenal hyperplasia;macronodular adrenal disease;exactmatch
metastatic malignant solid neoplasm;metastatic malignant solid neoplasm;exactmatch
inguinal region;groin;exactmatch
recurrent malignant solid neoplasm;recurrent malignant solid neoplasm;exactmatch
facial nerve;facial nerve;exactmatch
eyelid;eyelid;exactmatch
exocrine gland;apocrine;exactmatch
epithelium;epithelium;exactmatch
epiglottis;epiglottis;exactmatch
epidermis;epidermal tissue;exactmatch
gonad;gonad;exactmatch
heart;cardiac;exactmatch
occipital bone;occipital bone;exactmatch
lumbar vertebra;lumbar vertebra;exactmatch
nervous system;body system, neurologic;exactmatch
musculoskeletal system;musculoskeletal system;exactmatch
membrane;membrane;exactmatch
mediastinum;mediastinum;exactmatch
mast cell;mast cell;exactmatch
lymphatic system;lymphatic;exactmatch
lymph node;lymph node;exactmatch
lower extremity;limb, lower;exactmatch
cardiac atrium;atria of heart;exactmatch
renal medulla;kidney, medulla;exactmatch
renal cortex;cortical;exactmatch
iris;eye, iris;exactmatch
intestine;bowel;exactmatch
immune system;immune system;exactmatch
hypoglossal nerve;hypoglossal nerve;exactmatch
cardiac ventricle;cardiac ventricle;exactmatch
uterine corpus germ cell tumor;uterine corpus germ cell tumor;exactmatch
uterine corpus malignant pecoma;malignant uterine corpus pecoma;exactmatch
benign uterine corpus pecoma;benign uterine corpus pecoma;exactmatch
body region;anatomic region;exactmatch
carotid artery;artery, carotid;exactmatch
cardiovascular system;body system, cardiovascular;exactmatch
capillary;capillary;exactmatch
bronchus;bronchus;exactmatch
brachial plexus;brachial plexus;exactmatch
kit protein variant;cd117 antigen protein variant;exactmatch
myelofibrosis transformation in essential thrombocythemia;myelofibrosis transformation in essential thrombocythemia;exactmatch
blood vessel;blood vessel;exactmatch
endoderm;endoderm;exactmatch
biliary tract;biliary tract;exactmatch
uterine corpus carcinoid tumor;uterine corpus carcinoid tumor;exactmatch
endometrial large cell neuroendocrine carcinoma;endometrial large cell neuroendocrine carcinoma;exactmatch
uterine corpus neuroendocrine neoplasm;uterine corpus neuroendocrine neoplasm;exactmatch
dedifferentiated malignant infiltrate;dedifferentiated malignant infiltrate;exactmatch
intrahepatic bile duct;intrahepatic bile duct;exactmatch
endometrial dedifferentiated carcinoma;endometrial dedifferentiated carcinoma;exactmatch
epidermodysplasia verruciformis;ev;exactmatch
cauda equina;cauda equina;exactmatch
cavernous sinus;cavernous sinus;exactmatch
cervical vertebra;cervical vertebra;exactmatch
uterine corpus rhabdomyosarcoma;uterine corpus rhabdomyosarcoma;exactmatch
ywhae/fam22 fusion gene;ywhae-fam22 fusion gene;exactmatch
ywhae-fam22 fusion protein expression;ywhae-fam22 fusion protein expression;exactmatch
endocrine system;body system, endocrine/metabolic;exactmatch
"t(10;17)(q22;p13)";"t(10;17)(q22;p13)";exactmatch
endocrine gland;endocrine gland;exactmatch
ectoderm;ectoderm;exactmatch
dermis;corium;exactmatch
uterine corpus tumor resembling ovarian sex cord tumor;uterine corpus tumor resembling ovarian sex cord tumor;exactmatch
cranial nerve;cranial nerve;exactmatch
uterine corpus high grade endometrial stromal sarcoma;high grade ess;exactmatch
common bile duct;common bile duct;exactmatch
uterine corpus hydropic leiomyoma;uterine corpus hydropic leiomyoma;exactmatch
coccyx;coccyx;exactmatch
choroid plexus;brain, choroid plexus;exactmatch
nose;nose;exactmatch
oculomotor nerve;cranial nerve iii;exactmatch
ovarian cancer by ajcc v6 and v7 stage;ovarian cancer by ajcc v6 and v7 stage;exactmatch
vaginal neuroendocrine carcinoma;vaginal high grade neuroendocrine carcinoma;exactmatch
figo stage ic2 ovarian cancer;figo stage ic2 ovarian cancer;exactmatch
figo stage ic1 ovarian cancer;figo stage ic1 ovarian cancer;exactmatch
ovarian cancer by figo stage;ovarian cancer by figo stage;exactmatch
vaginal rhabdomyosarcoma;vaginal rhabdomyosarcoma;exactmatch
trochlear nerve;cranial nerve iv;exactmatch
vaginal myofibroblastoma;superficial cervicovaginal myofibroblastoma;exactmatch
vaginal large cell neuroendocrine carcinoma;vaginal large cell neuroendocrine carcinoma;exactmatch
vaginal papillary carcinoma;vaginal papillary carcinoma;exactmatch
figo stage ii ovarian cancer;figo stage ii ovarian cancer;exactmatch
trigeminal nerve;cranial nerve v;exactmatch
cervical yolk sac tumor;cervical endodermal sinus tumor;exactmatch
malignant cervical soft tissue neoplasm;malignant cervical soft tissue neoplasm;exactmatch
benign cervical soft tissue neoplasm;benign cervical soft tissue neoplasm;exactmatch
cervical malignant peripheral nerve sheath tumor;cervical malignant peripheral nerve sheath tumor;exactmatch
cervical angiosarcoma;cervical angiosarcoma;exactmatch
cervical rhabdomyosarcoma;cervical rhabdomyosarcoma;exactmatch
figo stage ic3 ovarian cancer;figo stage ic3 ovarian cancer;exactmatch
figo stage iii ovarian cancer;figo stage iii ovarian cancer;exactmatch
olfactory nerve;cranial nerve i;exactmatch
figo stage ic1;figo stage ic1;exactmatch
figo stage iiia2;figo stage iiia2;exactmatch
figo stage iiia1(ii);figo stage iiia1(ii);exactmatch
figo stage iiia1(i);figo stage iiia1(i);exactmatch
figo stage iiia1;figo stage iiia1;exactmatch
figo stage ic3;figo stage ic3;exactmatch
figo stage ic2;figo stage ic2;exactmatch
genitourinary system;genitourinary system;exactmatch
figo stage ivb ovarian cancer;figo stage ivb ovarian cancer;exactmatch
figo stage iiia ovarian cancer;figo stage iiia ovarian cancer;exactmatch
figo stage iva ovarian cancer;figo stage iva ovarian cancer;exactmatch
figo stage iiic ovarian cancer;figo stage iiic ovarian cancer;exactmatch
figo stage iiib ovarian cancer;figo stage iiib ovarian cancer;exactmatch
figo stage iiia2 ovarian cancer;figo stage iiia2 ovarian cancer;exactmatch
figo stage iiia1(ii) ovarian cancer;figo stage iiia1(ii) ovarian cancer;exactmatch
figo stage iiia1(i) ovarian cancer;figo stage iiia1(i) ovarian cancer;exactmatch
figo stage iiia1 ovarian cancer;figo stage iiia1 ovarian cancer;exactmatch
cervical leiomyosarcoma;cervical leiomyosarcoma;exactmatch
cervical leiomyoma;cervical leiomyoma;exactmatch
cervical neuroendocrine carcinoma;cervical high grade neuroendocrine neoplasm;exactmatch
peritoneum;human peritoneal membrane;exactmatch
who grade iii glioma;anaplastic glioma;exactmatch
experimental organism benign endometrial adenoma;adenoma, endometrial, benign;exactmatch
respiratory system;body system, pulmonary;exactmatch
pulmonary vein;pulmonary vein;exactmatch
pulmonary artery;artery, pulmonary;exactmatch
posterior lobe of the pituitary gland;neurohypophysis;exactmatch
anterior lobe of the pituitary gland;adenohypophysis;exactmatch
peripheral nerve;nerve, peripheral;exactmatch
cervical neuroendocrine tumor g2;cervical low grade neuroendocrine tumor, grade 2;exactmatch
pelvis;body cavity, pelvic;exactmatch
parathyroid gland;gland, parathyroid;exactmatch
parasympathetic nervous system;parasympathetic nervous system;exactmatch
paranasal sinus;accessory sinus;exactmatch
oropharynx;oropharynx;exactmatch
optic nerve;nerve, optic;exactmatch
optic disc;optic disc;exactmatch
recurrent waldenstrom macroglobulinemia;recurrent waldenstrom macroglobulinemia;exactmatch
scrotum;scrotum;exactmatch
seminal vesicle;gland, seminal vesicle;exactmatch
skeletal system;skeletal system;exactmatch
cervical neuroendocrine tumor g1;cervical carcinoid tumor;exactmatch
cervical neuroendocrine neoplasm;cervical neuroendocrine neoplasm;exactmatch
tonsil;tonsil;exactmatch
tissue;normal;exactmatch
tibia;bone, tibia;exactmatch
thorax;thorax;exactmatch
thoracic vertebra;thoracic vertebra;exactmatch
sympathetic nervous system;sns;exactmatch
sternum;bone, sternum;exactmatch
spinal nerve;nerve, spinal;exactmatch
cervical adenocarcinoma admixed with neuroendocrine carcinoma;cervical adenocarcinoma admixed with neuroendocrine carcinoma;exactmatch
spinal nerve root;spinal nerve root;exactmatch
endocervical adenocarcinoma, usual type;endocervical adenocarcinoma, usual type;exactmatch
cervical mucinous adenocarcinoma, gastric type;cervical mucinous adenocarcinoma, gastric type;exactmatch
skull;bone, skull;exactmatch
childhood langerhans cell histiocytosis with risk organ involvement;childhood langerhans cell histiocytosis with risk organ involvement;exactmatch
recurrent childhood lymphomatoid granulomatosis;recurrent childhood lymphomatoid granulomatosis;exactmatch
stage ia vaginal cancer ajcc v8;stage ia vaginal cancer;exactmatch
stage ivc thyroid gland follicular carcinoma ajcc v7;stage ivc thyroid gland follicular cancer;exactmatch
stage iia rectal cancer ajcc v7;stage iia rectal cancer;exactmatch
stage iic colon cancer ajcc v7;stage iic colon cancer;exactmatch
stage iib colon cancer ajcc v7;stage iib colon cancer;exactmatch
stage iia colon cancer ajcc v7;stage iia colon cancer;exactmatch
stage ivc thyroid gland papillary carcinoma ajcc v7;stage ivc thyroid gland papillary cancer;exactmatch
stage ivb thyroid gland papillary carcinoma ajcc v7;stage ivb thyroid gland papillary cancer;exactmatch
stage iva thyroid gland papillary carcinoma ajcc v7;stage iva thyroid gland papillary cancer;exactmatch
stage ivb thyroid gland follicular carcinoma ajcc v7;stage ivb thyroid gland follicular cancer;exactmatch
stage iic rectal cancer ajcc v7;stage iic rectal cancer;exactmatch
stage iva thyroid gland follicular carcinoma ajcc v7;stage iva thyroid gland follicular cancer;exactmatch
masaoka-koga stage iv;masaoka stage iv;exactmatch
masaoka-koga stage ii;masaoka stage ii;exactmatch
ann arbor stage iv noncutaneous childhood anaplastic large cell lymphoma;ann arbor stage iv childhood anaplastic large cell lymphoma;exactmatch
ann arbor stage iii noncutaneous childhood anaplastic large cell lymphoma;ann arbor stage iii childhood anaplastic large cell lymphoma;exactmatch
ann arbor stage ii noncutaneous childhood anaplastic large cell lymphoma;ann arbor stage ii childhood anaplastic large cell lymphoma;exactmatch
ann arbor stage i noncutaneous childhood anaplastic large cell lymphoma;ann arbor stage i childhood anaplastic large cell lymphoma;exactmatch
stage iib rectal cancer ajcc v7;stage iib rectal cancer;exactmatch
stage iiia colon cancer ajcc v7;stage iiia colon cancer;exactmatch
adult pleomorphic hepatocellular carcinoma;adult pleomorphic hepatocellular carcinoma;exactmatch
stage i lip and oral cavity squamous cell carcinoma ajcc v6 and v7;stage i lip and oral cavity squamous cell cancer;exactmatch
stage i sinonasal squamous cell carcinoma ajcc v6 and v7;stage i nasal cavity and paranasal sinus squamous cell cancer;exactmatch
stage ivc lip and oral cavity squamous cell carcinoma ajcc v6 and v7;stage ivc lip and oral cavity squamous cell cancer;exactmatch
stage ivb lip and oral cavity squamous cell carcinoma ajcc v6 and v7;stage ivb lip and oral cavity squamous cell cancer;exactmatch
stage iva lip and oral cavity squamous cell carcinoma ajcc v6 and v7;stage iva lip and oral cavity squamous cell cancer;exactmatch
stage iv lip and oral cavity squamous cell carcinoma ajcc v6 and v7;stage iv lip and oral cavity squamous cell cancer;exactmatch
stage iii lip and oral cavity squamous cell carcinoma ajcc v6 and v7;stage iii lip and oral cavity squamous cell cancer;exactmatch
stage ii lip and oral cavity squamous cell carcinoma ajcc v6 and v7;stage ii lip and oral cavity squamous cell cancer;exactmatch
stage ivb rectal cancer ajcc v7;stage ivb rectal cancer;exactmatch
stage iiib colon cancer ajcc v7;stage iiib colon cancer;exactmatch
stage iva rectal cancer ajcc v7;stage iva rectal cancer;exactmatch
stage ivb colon cancer ajcc v7;stage ivb colon cancer;exactmatch
stage iva colon cancer ajcc v7;stage iva colon cancer;exactmatch
stage iiic rectal cancer ajcc v7;stage iiic rectal cancer;exactmatch
stage iiib rectal cancer ajcc v7;stage iiib rectal cancer;exactmatch
stage iiia rectal cancer ajcc v7;stage iiia rectal cancer;exactmatch
stage iiic colon cancer ajcc v7;stage iiic colon cancer;exactmatch
untreated central nervous system neoplasm;untreated central nervous system neoplasm;exactmatch
adult fibrolamellar carcinoma;adult fibrolamellar carcinoma;exactmatch
childhood lymphomatoid granulomatosis;childhood lymphomatoid granulomatosis;exactmatch
childhood central nervous system embryonal neoplasm;central nervous system embryonal neoplasm;exactmatch
hormone-resistant breast adenocarcinoma;hormone-refractory breast cancer;exactmatch
adult langerhans cell histiocytosis;adult langerhans cell histiocytosis;exactmatch
childhood epithelioid hemangioendothelioma;childhood epithelioid hemangioendothelioma;exactmatch
adult epithelioid hemangioendothelioma;adult epithelioid hemangioendothelioma;exactmatch
jaw region;jaw region;exactmatch
osteolytic lesions of multiple myeloma;osteolytic lesions of multiple myeloma;exactmatch
recurrent childhood central nervous system embryonal neoplasm;recurrent central nervous system embryonal neoplasm;exactmatch
metastatic malignant neoplasm in the soft tissues;metastatic malignant neoplasm in the soft tissues;exactmatch
malignant cardiovascular neoplasm;malignant cardiovascular neoplasm;exactmatch
mucosal melanoma;mucosal melanoma;exactmatch
"adult b acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1";"adult b acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1";exactmatch
childhood pineoblastoma;childhood pineoblastoma;exactmatch
adult unfavorable prognosis hodgkin lymphoma;adult unfavorable prognosis hodgkin lymphoma;exactmatch
childhood unfavorable prognosis hodgkin lymphoma;childhood unfavorable prognosis hodgkin lymphoma;exactmatch
adult favorable prognosis hodgkin lymphoma;adult favorable prognosis hodgkin lymphoma;exactmatch
childhood favorable prognosis hodgkin lymphoma;childhood favorable prognosis hodgkin lymphoma;exactmatch
hormone-resistant prostate carcinoma;hormone-resistant prostate cancer;exactmatch
leukemic infiltration of brain;leukemic infiltration of brain;exactmatch
adult combined hepatocellular carcinoma and cholangiocarcinoma;adult combined hepatocellular carcinoma and cholangiocarcinoma;exactmatch
childhood diffuse astrocytoma;childhood diffuse astrocytoma;exactmatch
childhood oligoastrocytoma;childhood oligoastrocytoma;exactmatch
childhood anaplastic oligoastrocytoma;anaplastic oligoastrocytoma;exactmatch
childhood protoplasmic astrocytoma;childhood protoplasmic astrocytoma;exactmatch
childhood pleomorphic xanthoastrocytoma;childhood pleomorphic xanthoastrocytoma;exactmatch
childhood pilomyxoid astrocytoma;childhood pilomyxoid astrocytoma;exactmatch
childhood gliomatosis cerebri;childhood gliomatosis cerebri;exactmatch
childhood gliosarcoma;childhood gliosarcoma;exactmatch
childhood giant cell glioblastoma;childhood giant cell glioblastoma;exactmatch
secondary central nervous system hodgkin lymphoma;secondary central nervous system hodgkin lymphoma;exactmatch
childhood gemistocytic astrocytoma;childhood gemistocytic astrocytoma;exactmatch
childhood fibrillary astrocytoma;childhood fibrillary astrocytoma;exactmatch
untreated childhood high grade astrocytic tumor;untreated childhood high grade astrocytic tumor;exactmatch
untreated childhood low grade astrocytic tumor;untreated childhood low grade astrocytic tumor;exactmatch
recurrent childhood astrocytic tumor;recurrent astrocytic tumor;exactmatch
central nervous system hodgkin lymphoma;central nervous system hodgkin lymphoma;exactmatch
secondary central nervous system non-hodgkin lymphoma;secondary central nervous system non-hodgkin lymphoma;exactmatch
stage ii sinonasal squamous cell carcinoma ajcc v6 and v7;stage ii nasal cavity and paranasal sinus squamous cell cancer;exactmatch
stage iii sinonasal squamous cell carcinoma ajcc v6 and v7;stage iii nasal cavity and paranasal sinus squamous cell cancer;exactmatch
stage iv sinonasal squamous cell carcinoma ajcc v7;stage iv nasal cavity and paranasal sinus squamous cell cancer;exactmatch
familial testicular germ cell tumor;familial testicular germ cell tumor;exactmatch
newly diagnosed childhood ependymoma;ependymoma;exactmatch
adult myxopapillary ependymoma;adult myxopapillary ependymoma;exactmatch
adult primary melanocytic lesion of meninges;adult primary melanocytic lesion of meninges;exactmatch
adult mixed glioma;adult mixed glioma;exactmatch
metastatic digestive system neuroendocrine tumor g1;metastatic digestive system neuroendocrine tumor g1;exactmatch
familial neuroblastoma;familial neuroblastoma;exactmatch
familial waldenstrom macroglobulinemia;familial waldenstrom macroglobulinemia;exactmatch
distal urethral carcinoma;distal urethra carcinoma;exactmatch
adult pineal gland astrocytoma;adult pineal gland astrocytoma;exactmatch
untreated childhood pineoblastoma;untreated childhood pineoblastoma;exactmatch
childhood grade iii lymphomatoid granulomatosis;childhood grade iii lymphomatoid granulomatosis;exactmatch
childhood embryonal tumor with multilayered rosettes, c19mc-altered;childhood embryonal tumor with multilayered rosettes, c19mc-altered;exactmatch
childhood cerebral anaplastic astrocytoma;anaplastic hemispheric astrocytoma;exactmatch
childhood cerebellar anaplastic astrocytoma;cerebellar anaplastic astrocytoma;exactmatch
localized castleman disease;localized angiofollicular lymphoid hyperplasia;exactmatch
childhood pineal parenchymal cell neoplasm;childhood pineal parenchymal cell neoplasm;exactmatch
localized childhood soft tissue sarcoma;localized childhood soft tissue sarcoma;exactmatch
proximal urethral carcinoma;proximal urethral cancer;exactmatch
stage iva sinonasal squamous cell carcinoma ajcc v7;stage iva nasal cavity and paranasal sinus squamous cell cancer;exactmatch
recurrent childhood diffuse astrocytoma;recurrent childhood diffuse astrocytoma;exactmatch
recurrent childhood grade iii lymphomatoid granulomatosis;recurrent childhood grade iii lymphomatoid granulomatosis;exactmatch
recurrent childhood gliomatosis cerebri;recurrent childhood gliomatosis cerebri;exactmatch
recurrent childhood gliosarcoma;recurrent childhood gliosarcoma;exactmatch
recurrent childhood glioblastoma;recurrent childhood glioblastoma;exactmatch
recurrent childhood giant cell glioblastoma;recurrent childhood giant cell glioblastoma;exactmatch
recurrent childhood gemistocytic astrocytoma;recurrent childhood gemistocytic astrocytoma;exactmatch
recurrent childhood fibrillary astrocytoma;recurrent childhood fibrillary astrocytoma;exactmatch
recurrent childhood anaplastic oligodendroglioma;recurrent anaplastic oligodendroglioma;exactmatch
proximal urethra;proximal urethra;exactmatch
recurrent childhood anaplastic oligoastrocytoma;recurrent anaplastic oligoastrocytoma;exactmatch
recurrent childhood anaplastic large cell lymphoma;recurrent anaplastic large cell lymphoma;exactmatch
recurrent childhood anaplastic astrocytoma;recurrent anaplastic astrocytoma;exactmatch
recurrent borderline ovarian surface epithelial-stromal tumor;recurrent borderline ovarian surface epithelial-stromal tumor;exactmatch
recurrent adult undifferentiated high grade pleomorphic sarcoma of bone;recurrent adult undifferentiated high grade pleomorphic sarcoma;exactmatch
recurrent adult grade iii lymphomatoid granulomatosis;recurrent adult grade iii lymphomatoid granulomatosis;exactmatch
distal urethra;distal urethra;exactmatch
childhood mixed glioma;childhood mixed glioma;exactmatch
childhood ependymal tumor;childhood ependymal tumor;exactmatch
adult nasal type extranodal nk/t-cell lymphoma;adult nasal type extranodal nk/t-cell lymphoma;exactmatch
stage ivc oropharyngeal undifferentiated carcinoma ajcc v7;stage ivc oropharyngeal lymphoepithelioma;exactmatch
stage ia esophageal cancer ajcc v7;stage ia esophageal cancer;exactmatch
stage iv primary peritoneal cancer ajcc v7;stage iv primary peritoneal cancer;exactmatch
stage iiic primary peritoneal cancer ajcc v7;stage iiic primary peritoneal cancer;exactmatch
stage iiib primary peritoneal cancer ajcc v7;stage iiib primary peritoneal cancer;exactmatch
stage iiia primary peritoneal cancer ajcc v7;stage iiia primary peritoneal cancer;exactmatch
stage iii primary peritoneal cancer ajcc v7;stage iii primary peritoneal cancer;exactmatch
recurrent oropharyngeal undifferentiated carcinoma;recurrent oropharyngeal lymphoepithelioma;exactmatch
stage ivb oropharyngeal undifferentiated carcinoma ajcc v7;stage ivb oropharyngeal lymphoepithelioma;exactmatch
adult myelodysplastic syndrome;adult myelodysplastic syndrome;exactmatch
stage iva oropharyngeal undifferentiated carcinoma ajcc v7;stage iva oropharyngeal lymphoepithelioma;exactmatch
stage iv oropharyngeal undifferentiated carcinoma ajcc v7;stage iv oropharyngeal lymphoepithelioma;exactmatch
stage iii oropharyngeal undifferentiated carcinoma ajcc v7;stage iii oropharyngeal lymphoepithelioma;exactmatch
stage ii oropharyngeal undifferentiated carcinoma ajcc v6 and v7;stage ii oropharyngeal lymphoepithelioma;exactmatch
stage i oropharyngeal undifferentiated carcinoma ajcc v6 and v7;stage i oropharyngeal lymphoepithelioma;exactmatch
stage ivc sinonasal squamous cell carcinoma ajcc v7;stage ivc nasal cavity and paranasal sinus squamous cell cancer;exactmatch
stage ivb sinonasal squamous cell carcinoma ajcc v7;stage ivb nasal cavity and paranasal sinus squamous cell cancer;exactmatch
stage ib esophageal cancer ajcc v7;stage ib esophageal cancer;exactmatch
stage iiia esophageal cancer ajcc v7;stage iiia esophageal cancer;exactmatch
stage iiib esophageal cancer ajcc v7;stage iiib esophageal cancer;exactmatch
stage iiic esophageal cancer ajcc v7;stage iiic esophageal cancer;exactmatch
adult grade iii lymphomatoid granulomatosis;adult grade iii lymphomatoid granulomatosis;exactmatch
bclc stage d adult hepatocellular carcinoma;bclc stage d adult hepatocellular carcinoma;exactmatch
bclc stage c adult hepatocellular carcinoma;bclc stage c adult hepatocellular carcinoma;exactmatch
bclc stage b adult hepatocellular carcinoma;bclc stage b adult hepatocellular carcinoma;exactmatch
bclc stage a adult hepatocellular carcinoma;bclc stage a adult hepatocellular carcinoma;exactmatch
bclc stage 0 adult hepatocellular carcinoma;bclc stage 0 adult hepatocellular carcinoma;exactmatch
bclc stage d hepatocellular carcinoma;bclc stage d hepatocellular cancer;exactmatch
bclc stage c hepatocellular carcinoma;bclc stage c hepatocellular cancer;exactmatch
bclc stage b hepatocellular carcinoma;bclc stage b hepatocellular cancer;exactmatch
bclc stage a hepatocellular carcinoma;bclc stage a hepatocellular cancer;exactmatch
bclc stage;bclc stage;exactmatch
bclc stage 0 hepatocellular carcinoma;bclc stage 0 hepatocellular cancer;exactmatch
hepatocellular carcinoma by bclc stage;bclc staging for hepatocellular carcinoma;exactmatch
stage iib uterine sarcoma ajcc v7;stage iib uterine sarcoma;exactmatch
stage iia uterine sarcoma ajcc v7;stage iia uterine sarcoma;exactmatch
childhood gonadal germ cell tumor;childhood gonadal germ cell tumor;exactmatch
childhood subependymal giant cell astrocytoma;childhood subependymal giant cell astrocytoma;exactmatch
non-hodgkin lymphoma during pregnancy;non-hodgkin lymphoma during pregnancy;exactmatch
actb gene;actb;exactmatch
effector t-lymphocyte;effector t cell;exactmatch
ensat stage iv adrenal cortex carcinoma;ensat stage iv adrenal cortex cancer;exactmatch
ensat stage iii adrenal cortex carcinoma;ensat stage iii adrenal cortex cancer;exactmatch
ensat stage ii adrenal cortex carcinoma;ensat stage ii adrenal cortex cancer;exactmatch
ensat stage i adrenal cortex carcinoma;ensat stage i adrenal cortex cancer;exactmatch
adrenal cortex carcinoma by ensat stage;adrenal cortex carcinoma by ensat stage;exactmatch
congenital hematological disorder;congenital hematological disorder;exactmatch
hereditary prostate carcinoma;hereditary prostate cancer;exactmatch
high grade ovarian serous adenocarcinoma;high grade ovarian serous adenocarcinoma;exactmatch
experimental organism malignant hibernoma;experimental organism malignant hibernoma;exactmatch
experimental organism malignant hepatocholangiocellular carcinoma;carcinoma, hepatocholangiocellular, malignant;exactmatch
experimental organism benign bone osteofibroma;experimental organism benign bone osteofibroma;exactmatch
experimental organism benign basalioma;basalioma, benign;exactmatch
papillary carcinoma of the penis, not otherwise specified;papillary carcinoma of the penis, nos;exactmatch
ischemic necrosis;ischemic necrosis;exactmatch
genetic finding;genetic finding;exactmatch
egfr gene product;egfr gene product;exactmatch
low grade ovarian serous adenocarcinoma;invasive ovarian micropapillary serous carcinoma;exactmatch
musculoskeletal finding;musculoskeletal;exactmatch
pold1 gene;dna polymerase delta 1, catalytic subunit gene;exactmatch
serrated lesion of the mouse intestinal tract;serrated lesion of the mouse intestinal tract;exactmatch
intramucosal carcinoma of the mouse intestinal tract;intramucosal carcinoma of the mouse intestinal tract;exactmatch
pdgfra protein variant;cd140a antigen protein variant;exactmatch
musculoskeletal disorder;disorder of musculoskeletal system;exactmatch
non-receptor type protein tyrosine phosphatase;cytosolic protein tyrosine phosphatase;exactmatch
hyperploidy;hyperploidy;exactmatch
pole gene;dna polymerase epsilon, catalytic subunit gene;exactmatch
absence of signs or symptoms;absence of signs or symptoms;exactmatch
krt5 gene;krt5;exactmatch
krt17 gene;krt17;exactmatch
claudin-low;claudin-low;exactmatch
jak2 protein variant;jak-2 protein variant;exactmatch
braf np_004324.2:p.v600x;braf codon 600 mutation;exactmatch
cbfa2t3/glis2 fusion gene;cbfa2t3-glis2 fusion gene;exactmatch
mnx1/etv6 fusion gene;hlxb9-etv6 fusion gene;exactmatch
nup98/kdm5a fusion gene;nup98-kdm5a fusion gene;exactmatch
congenital reproductive system abnormality;congenital abnormality of the reproductive system;exactmatch
great blood vessel;great vessels;exactmatch
high grade astrocytic tumor;high grade astrocytic neoplasm;exactmatch
fus/creb3l1 fusion gene;fus-creb3l1 fusion gene;exactmatch
tpm3/alk fusion gene;tpm3-alk fusion gene;exactmatch
tfg/alk fusion gene;tfg-alk;exactmatch
npm1/rara long fusion gene;npm-rar long form;exactmatch
npm1/rara short fusion gene;npm-rar short form;exactmatch
nono/tfe3 fusion gene;nono-tfe3 fusion gene;exactmatch
msn/alk fusion gene;msn-alk fusion gene;exactmatch
mll/ell fusion gene;kmt2a-ell fusion gene;exactmatch
has2/plag1 fusion gene;has2-plag1 fusion gene;exactmatch
human papillomavirus-related malignant neoplasm in aids patient;aids-related hpv-related cancer;exactmatch
col1a2/plag1 fusion gene;col1a2-plag1 fusion gene;exactmatch
cbfb/myh11 fusion gene;cbfb/myh11 fusion gene;exactmatch
bcr/jak2 fusion gene;bcr-jak2 fusion gene;exactmatch
atic/alk fusion gene;atic-alk fusion gene;exactmatch
sign or symptom;clinical finding;exactmatch
central nervous system nongerminomatous germ cell tumor;central nervous system nongerminomatous germ cell tumor;exactmatch
benign neoplasm;benign neoplasm;exactmatch
tpm4/alk fusion gene;tpm4-alk fusion gene;exactmatch
bcor gene;bcl6 corepressor gene;exactmatch
ywhae gene;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide gene;exactmatch
myopathy;myopathy;exactmatch
miscellaneous neoplasm;miscellaneous neoplasm;exactmatch
pharyngeal squamous cell carcinoma;pharyngeal (including hypopharyngeal and oropharyngeal) squamous cell carcinoma;exactmatch
primary central nervous system neoplasm;cns primary tumor, nos;exactmatch
ovarian non-dysgerminomatous germ cell tumor;ovarian non-dysgerminomatous germ cell tumor;exactmatch
stage 2b neuroblastoma;stage 2b neuroblastoma;exactmatch
stage 2a neuroblastoma;stage 2a neuroblastoma;exactmatch
uterine ligament adenosarcoma;uterine ligament adenosarcoma;exactmatch
lymphoid hyperplasia;lymphoid hyperplasia;exactmatch
palb2 gene mutation;fancn gene mutation;exactmatch
stage ii differentiated thyroid gland carcinoma 45 years and older ajcc v7;stage ii differentiated thyroid gland cancer 45 years and older;exactmatch
stage ii differentiated thyroid gland carcinoma under 45 years ajcc v7;stage ii differentiated thyroid gland cancer under 45 years;exactmatch
stage i differentiated thyroid gland carcinoma 45 years and older ajcc v7;stage i differentiated thyroid gland cancer 45 years and older;exactmatch
stage i differentiated thyroid gland carcinoma under 45 years ajcc v7;stage i differentiated thyroid gland cancer under 45 years;exactmatch
camta1 gene;camta1;exactmatch
hormone receptor positive;er and/or pr +;exactmatch
metastatic carcinoma of the mouse intestinal tract;metastatic carcinoma of the mouse intestinal tract;exactmatch
musculoskeletal injury;muscle/tendon damage;exactmatch
hodgkin lymphoma during pregnancy;hodgkin lymphoma during pregnancy;exactmatch
adult undifferentiated pleomorphic sarcoma;adult malignant fibrous histiocytoma;exactmatch
adult l2 acute lymphoblastic leukemia;adult l2 acute lymphoblastic leukemia;exactmatch
non-t non-b calla negative adult acute lymphoblastic leukemia;non-t non-b calla negative acute lymphoblastic leukemia;exactmatch
non-t non-b calla negative childhood acute lymphoblastic leukemia;non-t non-b calla negative acute lymphoblastic leukemia;exactmatch
childhood non-t non-b acute lymphoblastic leukemia;childhood non-t non-b acute lymphoblastic leukemia;exactmatch
adult non-t non-b acute lymphoblastic leukemia;adult non-t non-b acute lymphoblastic leukemia;exactmatch
childhood l2 acute lymphoblastic leukemia;childhood l2 acute lymphoblastic leukemia;exactmatch
childhood l1 acute lymphoblastic leukemia;childhood l1 acute lymphoblastic leukemia;exactmatch
childhood langerhans cell histiocytosis;childhood langerhans cell histiocytosis;exactmatch
childhood tdt positive acute lymphoblastic leukemia;childhood tdt positive acute lymphoblastic leukemia;exactmatch
rare childhood malignant neoplasm;rare childhood malignant neoplasm;exactmatch
circulating plasma cell;cmmc;exactmatch
experimental organism benign nephroblastoma neoplasm;experimental organism benign nephroblastoma neoplasm;exactmatch
experimental organism benign thymoma neoplasm;experimental organism benign thymoma neoplasm;exactmatch
experimental organism benign teratoma neoplasm;experimental organism benign teratoma neoplasm;exactmatch
experimental organism benign stromal tumor neoplasm;experimental organism benign stromal tumor neoplasm;exactmatch
experimental organism lymphosarcoma neoplasm;experimental organism lymphosarcoma neoplasm;exactmatch
adult tdt positive acute lymphoblastic leukemia;adult tdt positive acute lymphoblastic leukemia;exactmatch
adult tdt negative acute lymphoblastic leukemia;adult tdt negative acute lymphoblastic leukemia;exactmatch
class 1 uveal melanoma;class 1 uveal melanoma;exactmatch
childhood brain stem mixed glioma;brain stem mixed glioma;exactmatch
adult undifferentiated high grade pleomorphic sarcoma of bone;adult malignant fibrous histiocytoma of bone;exactmatch
central nervous system non-hodgkin lymphoma;central nervous system non-hodgkin lymphoma;exactmatch
adult intracranial germ cell tumor;adult intracranial germ cell tumor;exactmatch
adult germ cell tumor;adult germ cell tumor;exactmatch
childhood central nervous system neuroblastoma;central nervous system neuroblastoma;exactmatch
childhood supratentorial embryonal tumor, not otherwise specified;childhood supratentorial embryonal tumor, nos;exactmatch
childhood brain oligodendroglioma;brain oligodendroglioma;exactmatch
childhood brain stem gliosarcoma;brain stem gliosarcoma;exactmatch
childhood tdt negative acute lymphoblastic leukemia;childhood tdt negative acute lymphoblastic leukemia;exactmatch
childhood undifferentiated high grade pleomorphic sarcoma of bone;childhood malignant fibrous histiocytoma of bone;exactmatch
childhood undifferentiated pleomorphic sarcoma;childhood malignant fibrous histiocytoma;exactmatch
urolithiasis;urinary stones;exactmatch
nephrolithiasis;kidney stone;exactmatch
endometrial adenosquamous carcinoma;endometrial adenosquamous cancer;exactmatch
adult pre-b acute lymphoblastic leukemia;adult pre-b acute lymphoblastic leukemia;exactmatch
mixed osteosarcoma;combined type osteosarcoma;exactmatch
experimental organism mixed lymphoma neoplasm;experimental organism mixed lymphoma neoplasm;exactmatch
experimental organism histiocytic lymphoma neoplasm;experimental organism histiocytic lymphoma neoplasm;exactmatch
experimental organism acidophil carcinoma;acidophil adenocarcinoma;exactmatch
proneural glioblastoma;proneural glioblastoma;exactmatch
masaoka-koga stage iia;masaoka stage iia;exactmatch
masaoka-koga stage i;masaoka stage i;exactmatch
thymoma by masaoka-koga stage;masaoka staging;exactmatch
inv(3);inv(3);exactmatch
mesenchymal glioblastoma;mesenchymal glioblastoma;exactmatch
classical glioblastoma;classical glioblastoma;exactmatch
neural glioblastoma;neural glioblastoma;exactmatch
glioblastoma by gene expression profile;glioblastoma by gene expression profile;exactmatch
experimental organism islet cell adenoma neoplasm;adenoma, islet cell, benign;exactmatch
experimental organism basal cell carcinoma;bcc;exactmatch
experimental organism basal cell adenoma;adenoma, basal cell, benign;exactmatch
arrhythmia by ecg finding;arrhythmia by ecg finding;exactmatch
minimal aneuploidy;minimal aneuploidy;exactmatch
uveal melanoma by gene expression profile;uveal melanoma by gene expression profile;exactmatch
class 1b uveal melanoma;class 1b uveal melanoma;exactmatch
class 1a uveal melanoma;class 1a uveal melanoma;exactmatch
masaoka-koga stage iib;masaoka stage iib;exactmatch
masaoka-koga stage iii;masaoka stage iii;exactmatch
masaoka-koga stage iva;masaoka stage iva;exactmatch
masaoka-koga stage ivb;masaoka stage ivb;exactmatch
cacna1d gene;cacna1d;exactmatch
atp2b3 gene;atp2b3;exactmatch
atp1a1 gene;atp1a1;exactmatch
paneth cell-like change;pclc;exactmatch
branch duct;branch duct;exactmatch
mixed type pancreatic intraductal papillary-mucinous neoplasm;mixed type ipmn;exactmatch
branch duct pancreatic intraductal papillary-mucinous neoplasm;bd-ipmn;exactmatch
main duct pancreatic intraductal papillary-mucinous neoplasm;md-ipmn;exactmatch
tmprss2/ets family fusion gene;tmprss2-ets family fusion gene;exactmatch
uterine carcinosarcoma, heterologous type;uterine carcinosarcoma, heterologous type;exactmatch
uterine carcinosarcoma, homologous type;uterine carcinosarcoma, homologous type;exactmatch
cushing disease;acth producing pituitary adenoma;exactmatch
experimental organism benign seminoma;experimental organism benign seminoma;exactmatch
vascular malformation;vascular malformation;exactmatch
succinate dehydrogenase;complex ii;exactmatch
recurrent childhood undifferentiated high grade pleomorphic sarcoma of bone;recurrent childhood undifferentiated high grade pleomorphic sarcoma;exactmatch
recurrent childhood non-hodgkin lymphoma;recurrent childhood non-hodgkin lymphoma;exactmatch
recurrent childhood oligoastrocytoma;recurrent childhood oligoastrocytoma;exactmatch
clear cell papillary renal neoplasm;clear cell papillary renal cell carcinoma;exactmatch
acute lymphoblastic leukemia by rose cluster;all gene expression cluster;exactmatch
ddit4l acute lymphoblastic leukemia;ddit4l;exactmatch
ph-like acute lymphoblastic leukemia;bcr-abl1-like all;exactmatch
acute lymphoblastic leukemia by gene expression profile;all gene expression cluster subtype;exactmatch
meningioangiomatosis;meningioangiomatosis;exactmatch
loss of ini 1 protein expression;loss of baf47 protein expression;exactmatch
cribriform neuroepithelial tumor;crinet;exactmatch
ovarian microcystic stromal tumor;ovarian microcystic stromal tumor;exactmatch
rose cluster 2;r2;exactmatch
bone epithelioid hemangioendothelioma;bone epithelioid hemangioendothelioma;exactmatch
malignant osteoclastic giant cell-rich tumor of bone;malignant osteoclastic giant cell-rich tumor of bone;exactmatch
giant cell tumor of bone;benign bone giant cell tumor;exactmatch
intermediate osteoclastic giant cell-rich tumor of bone;intermediate osteoclastic giant cell-rich tumor of bone;exactmatch
primary bone non-hodgkin lymphoma;primary bone non-hodgkin lymphoma;exactmatch
non-ossifying fibroma;nof;exactmatch
intermediate bone neoplasm;intermediate bone neoplasm;exactmatch
rose cluster 1;r1;exactmatch
rose cluster 3;r3;exactmatch
cervical esophagus;cervical esophagus;exactmatch
palate;palate;exactmatch
high risk acute leukemia;high risk;exactmatch
pulmonary nodule;lung nodule;exactmatch
sublingual salivary gland;gland, salivary, sublingual;exactmatch
submandibular gland;gland, salivary, submandibular;exactmatch
uvula;palatine uvula;exactmatch
soft palate;palate, soft;exactmatch
hard palate;hard palate;exactmatch
base of the tongue;base of tongue;exactmatch
rose cluster 4;r4;exactmatch
lip;lip;exactmatch
anatomic structure, system, or substance;anatomic structure, system, or substance;exactmatch
chemotherapy regimen or agent combination;chemotherapy regimen or agent combination;exactmatch
rose cluster 8;r8;exactmatch
rose cluster 7;r7;exactmatch
rose cluster 6;r6;exactmatch
rose cluster 5;r5;exactmatch
intermediate osteogenic neoplasm;intermediate osteogenic neoplasm;exactmatch
enostosis;enostosis;exactmatch
ivory exostosis;ivory exostosis;exactmatch
ewsr1-creb1 fusion protein expression;ewsr1-creb1 fusion protein expression;exactmatch
sclerosing pecoma;sclerosing pecoma;exactmatch
malignant phosphaturic mesenchymal tumor;malignant phosphaturic mesenchymal tumor;exactmatch
benign phosphaturic mesenchymal tumor;benign phosphaturic mesenchymal tumor;exactmatch
malignant mixed tumor, not otherwise specified;malignant mixed tumor, not otherwise specified;exactmatch
mixed tumor, not otherwise specified;mixed tumor, nos;exactmatch
ectomesenchymal chondromyxoid tumor;emcmt;exactmatch
malignant ossifying fibromyxoid tumor;malignant ossifying fibromyxoid tumor;exactmatch
hemosiderotic fibrolipomatous tumor;hflt;exactmatch
hey1/ncoa2 fusion gene;hey1-ncoa2 fusion gene;exactmatch
intermediate soft tissue tumor of uncertain differentiation;intermediate soft tissue neoplasm of uncertain differentiation;exactmatch
non-functioning pituitary gland macroadenoma;non-functioning pituitary gland macroadenoma;exactmatch
functioning pituitary gland macroadenoma;functional pituitary macroadenoma;exactmatch
acral fibromyxoma;acral fibromyxoma;exactmatch
nasal glial heterotopia;ectopic glial tissue;exactmatch
hybrid nerve sheath tumor;hybrid nerve sheath neoplasm;exactmatch
solitary circumscribed neuroma;palisaded encapsulated neuroma;exactmatch
benign pecoma;benign pecoma;exactmatch
malignant pecoma;malignant pecoma;exactmatch
undifferentiated/unclassified sarcoma;usts;exactmatch
undifferentiated spindle cell sarcoma;undifferentiated spindle cell sarcoma;exactmatch
benign notochordal cell tumor;bnct;exactmatch
giant cell lesion of small bones;gclsb;exactmatch
secondary peripheral chondrosarcoma;secondary peripheral chondrosarcoma;exactmatch
secondary central chondrosarcoma;secondary central chondrosarcoma;exactmatch
grade iii chondrosarcoma;grade iii chondrosarcoma;exactmatch
grade ii chondrosarcoma;grade ii chondrosarcoma;exactmatch
intermediate chondrogenic neoplasm;intermediate chondrogenic neoplasm;exactmatch
bizarre parosteal osteochondromatous proliferation;bpop;exactmatch
subungual exostosis;dupuytren exostosis;exactmatch
osteochondromyxoma;osteochondromyxoma;exactmatch
bone tumor of undefined neoplastic nature;bone tumor of undefined neoplastic nature;exactmatch
no identifiable line of differentiation;no identifiable line of differentiation;exactmatch
undifferentiated sarcoma, not otherwise specified;undifferentiated sarcoma, nos;exactmatch
undifferentiated epithelioid sarcoma;undifferentiated epithelioid sarcoma;exactmatch
undifferentiated round cell sarcoma;undifferentiated ewing tumor;exactmatch
hypopharynx;hypopharynx;exactmatch
thoracic esophagus;esophagus, thoracic;exactmatch
functioning pituitary gland microadenoma;functional pituitary microadenoma;exactmatch
nab2/stat6 fusion gene;nab2-stat6 fusion gene;exactmatch
clitoris;clitoris;exactmatch
labium minus;labium minus;exactmatch
labium majus;labium majus;exactmatch
nipple;nipple;exactmatch
retroperitoneum;retroperitoneum;exactmatch
external ear;auricle;exactmatch
mandible;bone, mandible;exactmatch
subglottis;subglottis;exactmatch
ectocervix;ectocervix;exactmatch
supraglottis;supraglottis;exactmatch
canine hemangiosarcoma;canine hemangiosarcoma;exactmatch
sphenoid sinus;sphenoid sinus;exactmatch
frontal sinus;frontal sinus;exactmatch
ethmoid sinus;ethmoid sinus;exactmatch
maxillary sinus;antrum highmori;exactmatch
middle ear;middle ear;exactmatch
endocervix;endocervix;exactmatch
cervix uteri;cervix;exactmatch
abdominal esophagus;abdominal esophagus;exactmatch
dicer1 syndrome;dicer1 syndrome;exactmatch
urethral gland;urethra gland;exactmatch
salivary gland secretory carcinoma;mammary analog secretory carcinoma of salivary gland;exactmatch
ureteric orifice;orifice of the ureter;exactmatch
invasive focus of carcinoma cells measuring more than 5 mm present;invasive focus of carcinoma cells measuring more than 5 mm present;exactmatch
lateral wall of the bladder;lateral wall of bladder;exactmatch
multiple endocrine neoplasia type 2;multiple endocrine neoplasia 2;exactmatch
dome of the bladder;bladder, dome;exactmatch
spermatic cord;spermatic cord;exactmatch
endometrium;endometrium;exactmatch
epididymis;epididymis;exactmatch
undescended testes;cryptorchidism;exactmatch
appendage of the uterus;appendage of the uterus;exactmatch
broad ligament;broad ligament;exactmatch
lepidic predominant adenocarcinoma;lpa;exactmatch
corpus uteri;corpus uteri;exactmatch
myometrium;myometrium;exactmatch
childhood acute myeloid leukemia with abnormalities of chromosome 7;acute myeloid leukemia (aml) with abnormalities of chromosome 7;exactmatch
childhood acute myeloid leukemia with abnormalities of chromosome 5q;acute myeloid leukemia (aml) with abnormalities of chromosome 5q;exactmatch
pancreatic duct;canal of wirsung;exactmatch
borderline ovarian serous tumor-micropapillary variant/non-invasive low grade ovarian serous carcinoma;borderline ovarian serous tumor-micropapillary variant/non-invasive low grade ovarian serous carcinoma;exactmatch
infantile lesion;infantile lesion;exactmatch
infant leukemia;infant leukemia;exactmatch
bone marrow and extramedullary involvement;bone marrow and extramedullary involvement;exactmatch
extramedullary involvement;extramedullary involvement;exactmatch
pylorus;pylorus;exactmatch
antrum pylori;antrum pylori;exactmatch
borderline ovarian mucinous tumor/atypical proliferative ovarian mucinous tumor;borderline ovarian mucinous tumor/atypical proliferative ovarian mucinous tumor;exactmatch
borderline ovarian serous tumor/atypical proliferative ovarian serous tumor;borderline ovarian serous tumor/atypical proliferative ovarian serous tumor;exactmatch
"acute myeloid leukemia with t(3;3) (q21.3;q26.2); gata2, mecom";"aml with inv(3)(q21;q26.2) or t(3;3) (q21;q26.2);rpni-evi1";exactmatch
body of stomach;body of stomach;exactmatch
fundus of the stomach;fundus of the stomach;exactmatch
gastric cardia;cardia;exactmatch
dnajb1/prkaca fusion gene;dnajb1-prkaca fusion gene;exactmatch
lower third of the esophagus;esophagus, lower third;exactmatch
middle third of the esophagus;esophagus, middle third;exactmatch
upper third of the esophagus;esophagus, upper third;exactmatch
neonatal lesion;neonatal lesion;exactmatch
infant acute lymphoblastic leukemia;infant all;exactmatch
infant acute lymphoblastic leukemia with mll rearrangement;infant all with mll rearrangement;exactmatch
infant acute lymphoblastic leukemia without mll gene rearrangement;infant all without mll rearrangement;exactmatch
"acute myeloid leukemia with inv(3) (q21.3;q26.2); gata2, mecom";"acute myeloid leukemia with inv(3) (q21.3;q26.2); gata2, mecom";exactmatch
nup98 gene rearrangement;adar2 gene rearrangement;exactmatch
childhood acute myeloid leukemia with nup98 rearrangement;childhood aml with nup98 rearrangement;exactmatch
"acute myeloid leukemia with t(7;12)(q36;p13); hlxb9-etv6";"aml with t(7;12)(q36;p13); hlxb9-etv6";exactmatch
"t(7;12)(q36;p13)";"t(7;12)(q36;p13)";exactmatch
core binding factor acute myeloid leukemia;cbf-aml;exactmatch
cytogenetically normal acute myeloid leukemia;cn-aml;exactmatch
hypocellular myelodysplastic syndrome;hypocellular myelodysplastic syndrome;exactmatch
descending colon;colon, descending;exactmatch
ascending colon;ascending colon;exactmatch
meckel diverticulum;meckel diverticulum;exactmatch
duodenum;duodenum;exactmatch
childhood acute myeloid leukemia not otherwise specified;childhood aml, nos;exactmatch
refractory childhood acute lymphoblastic leukemia;refractory acute lymphoblastic leukemia (all);exactmatch
mll gene rearrangement;kmt2a gene rearrangement;exactmatch
dermal nerve sheath myxoma;dermal nerve sheath myxoma;exactmatch
non-functioning pituitary gland microadenoma;non-functioning pituitary gland microadenoma;exactmatch
recurrent childhood oligodendroglioma;recurrent childhood oligodendroglioma;exactmatch
localized adult undifferentiated high grade pleomorphic sarcoma of bone;localized adult undifferentiated high grade pleomorphic sarcoma;exactmatch
low grade astrocytoma;low grade astrocytic neoplasm;exactmatch
sinonasal small cell neuroendocrine carcinoma;nasal cavity and paranasal sinus small cell carcinoma;exactmatch
kidney small cell neuroendocrine carcinoma;kidney small cell carcinoma;exactmatch
sinonasal adenocarcinoma, intestinal-type;enteric-type sinonasal adenocarcinoma;exactmatch
experimental organism benign acinar-islet cell tumor;acinar-islet cell tumor, benign;exactmatch
experimental organism malignant neuromyoblastoma;experimental organism malignant neuromyoblastoma;exactmatch
localized childhood undifferentiated high grade pleomorphic sarcoma of bone;localized childhood undifferentiated high grade pleomorphic sarcoma;exactmatch
infiltrating bladder urothelial carcinoma associated with urethral carcinoma;infiltrating bladder urothelial cancer associated with urethral cancer;exactmatch
congenital cystic hygroma;cervicofacial lymphatic malformation;exactmatch
untreated childhood supratentorial primitive neuroectodermal tumor;untreated childhood supratentorial primitive neuroectodermal tumor;exactmatch
untreated childhood subependymal giant cell astrocytoma;untreated childhood subependymal giant cell astrocytoma;exactmatch
untreated childhood protoplasmic astrocytoma;untreated childhood protoplasmic astrocytoma;exactmatch
untreated childhood pleomorphic xanthoastrocytoma;untreated childhood pleomorphic xanthoastrocytoma;exactmatch
untreated childhood pilomyxoid astrocytoma;untreated childhood pilomyxoid astrocytoma;exactmatch
untreated childhood pilocytic astrocytoma;untreated childhood pilocytic astrocytoma;exactmatch
untreated childhood oligodendroglioma;untreated childhood oligodendroglioma;exactmatch
movement disorder;movement disorder;exactmatch
liquid tumor;blood cancer;exactmatch
tsc2 gene mutation;tsc2 gene mutation;exactmatch
fgfr gene amplification;fgf receptor gene amplification;exactmatch
pms2 gene mutation;hnpcc4 gene mutation;exactmatch
tp53 gene mutation;abnormal;exactmatch
msh6 gene mutation;hnpcc5 gene mutation;exactmatch
mlh1 gene mutation;coca2 gene mutation;exactmatch
idh2 gene mutation;idh2 gene mutation;exactmatch
nf1 gene mutation;nf1 gene mutation;exactmatch
men1 gene mutation;mea i gene mutation;exactmatch
fgf gene amplification;fgf amplification;exactmatch
idh2 protein variant;idh2 protein variant;exactmatch
non-neoplastic muscle disorder;non-neoplastic muscle disorder;exactmatch
experimental organism benign keratoacanthoma;experimental organism benign keratoacanthoma;exactmatch
tracheobronchial tree;tracheobronchial tree;exactmatch
female reproductive system finding;female reproductive system finding;exactmatch
male reproductive system finding;male reproductive system finding;exactmatch
extranodal involvement;extranodal extension;exactmatch
idh2 np_002159.2:p.r172x;idh2 arg172xxx;exactmatch
untreated childhood oligoastrocytoma;untreated childhood oligoastrocytoma;exactmatch
untreated childhood gliosarcoma;untreated childhood gliosarcoma;exactmatch
untreated childhood gliomatosis cerebri;untreated childhood gliomatosis cerebri;exactmatch
recurrent malignant extragonadal germ cell tumor;recurrent malignant extragonadal germ cell tumor;exactmatch
recurrent pancreatic neuroendocrine carcinoma;recurrent pancreatic neuroendocrine cancer;exactmatch
recurrent sinonasal inverted papilloma;recurrent inverted schneiderian papilloma;exactmatch
recurrent grade ii lymphomatoid granulomatosis;recurrent grade ii lymphomatoid granulomatosis;exactmatch
recurrent grade i lymphomatoid granulomatosis;recurrent grade i lymphomatoid granulomatosis;exactmatch
recurrent fallopian tube carcinoma;recurrent fallopian tube cancer;exactmatch
recurrent extragonadal seminoma;recurrent extragonadal seminoma;exactmatch
recurrent malignant extragonadal non-seminomatous germ cell tumor;recurrent malignant extragonadal non-seminomatous germ cell tumor;exactmatch
recurrent olfactory neuroblastoma;recurrent olfactory neuroblastoma;exactmatch
untreated childhood glioblastoma;untreated childhood glioblastoma;exactmatch
recurrent childhood supratentorial embryonal tumor, not otherwise specified;recurrent childhood supratentorial embryonal tumor, nos;exactmatch
recurrent childhood subependymal giant cell astrocytoma;recurrent childhood subependymal giant cell astrocytoma;exactmatch
recurrent childhood protoplasmic astrocytoma;recurrent childhood protoplasmic astrocytoma;exactmatch
recurrent childhood pleomorphic xanthoastrocytoma;recurrent childhood pleomorphic xanthoastrocytoma;exactmatch
recurrent childhood pineoblastoma;recurrent childhood pineoblastoma;exactmatch
recurrent childhood pilomyxoid astrocytoma;recurrent childhood pilomyxoid astrocytoma;exactmatch
recurrent childhood pilocytic astrocytoma;recurrent childhood pilocytic astrocytoma;exactmatch
recurrent mycosis fungoides and sezary syndrome;recurrent mycosis fungoides and sezary syndrome;exactmatch
recurrent merkel cell carcinoma;recurrent merkel cell cancer;exactmatch
recurrent primary peritoneal carcinoma;recurrent primary peritoneal cancer;exactmatch
recurrent lip and oral cavity squamous cell carcinoma;recurrent lip and oral cavity squamous cell cancer;exactmatch
untreated childhood giant cell glioblastoma;untreated childhood giant cell glioblastoma;exactmatch
untreated childhood gemistocytic astrocytoma;untreated childhood gemistocytic astrocytoma;exactmatch
untreated childhood fibrillary astrocytoma;untreated childhood fibrillary astrocytoma;exactmatch
untreated childhood diffuse astrocytoma;untreated childhood diffuse astrocytoma;exactmatch
untreated childhood cerebral astrocytoma;untreated cerebral astrocytoma;exactmatch
untreated childhood anaplastic oligodendroglioma;untreated anaplastic oligodendroglioma;exactmatch
untreated childhood anaplastic oligoastrocytoma;untreated anaplastic oligoastrocytoma;exactmatch
untreated childhood anaplastic astrocytoma;untreated anaplastic astrocytoma;exactmatch
adult subependymoma;adult subependymoma;exactmatch
slowly progressive clinical course;slowly progressive clinical course;exactmatch
smoldering systemic mastocytosis;smoldering systemic mastocytosis;exactmatch
refractory childhood hodgkin lymphoma;refractory childhood hodgkin lymphoma;exactmatch
recurrent childhood kidney neoplasm;recurrent childhood kidney neoplasm;exactmatch
recurrent combined thymic epithelial neoplasm;recurrent combined thymic carcinoma;exactmatch
recurrent sinonasal squamous cell carcinoma;recurrent nasal cavity and paranasal sinus squamous cell cancer;exactmatch
tsc1 gene mutation;hamartin gene mutation;exactmatch
vhl gene mutation;hrca1 gene mutation;exactmatch
conventional schwannoma;conventional schwannoma;exactmatch
male malignant nipple neoplasm;male malignant nipple neoplasm;exactmatch
fsh-producing gonadotroph adenoma;fsh-producing gonadotroph adenoma;exactmatch
myh9/usp6 fusion gene;myh9-usp6 fusion gene;exactmatch
"t(11;16)(q13;p13)";"t(11;16)(q13;p13)";exactmatch
c11orf95-mkl2 fusion protein expression;c11orf95-mkl2 fusion protein expression;exactmatch
infiltrating intramuscular lipoma;infiltrating intramuscular lipoma;exactmatch
malignant kidney neoplasm except pelvis;malignant kidney neoplasm except pelvis;exactmatch
female malignant nipple neoplasm;female malignant nipple neoplasm;exactmatch
canine melanoma;canine melanoma;exactmatch
proliferative myositis;proliferative myositis;exactmatch
direct extension;contiguous spread;exactmatch
virilization;virilization;exactmatch
cic-dux sarcoma;cic-dux sarcoma;exactmatch
"t(10;19)(q26;q13)";"t(10;19)(q26;q13)";exactmatch
"t(4;19)(q35;q13)";"t(4;19)(q35;q13)";exactmatch
cic-dux4l fusion protein expression;cic-dux4l fusion protein expression;exactmatch
cic-dux4 fusion protein expression;cic-dux4 fusion protein expression;exactmatch
lh-producing gonadotroph adenoma;lh-producing gonadotroph adenoma;exactmatch
mammary-type myofibroblastoma;mammary-type myofibroblastoma;exactmatch
otolaryngologic disorder;otolaryngologic disorder;exactmatch
nongerminomatous germ cell tumor;germ cell tumor, nonseminomatous;exactmatch
wwtr1/camta1 fusion gene;taz-camta1 fusion gene;exactmatch
soft tissue angiosarcoma;angiosarcoma of soft tissue;exactmatch
wwtr1-camta1 fusion protein expression;wwtr1-camta1 fusion protein expression;exactmatch
pseudomyogenic hemangioendothelioma;epithelioid sarcoma-like hemangioendothelioma;exactmatch
mixture of embryonal and alveolar features present;mixture of embryonal and alveolar features present;exactmatch
sclerosing rhabdomyosarcoma;sclerosing rhabdomyosarcoma;exactmatch
spindle cell/sclerosing rhabdomyosarcoma;spindle cell/sclerosing rhabdomyosarcoma;exactmatch
germinomatous germ cell tumor;germinomatous germ cell tumor;exactmatch
pten gene mutation;mmac1 gene mutation;exactmatch
non-cutaneous leiomyosarcoma;leiomyosarcoma (excluding skin);exactmatch
leiomyosarcoma of deep soft tissue;leiomyosarcoma of deep soft tissue;exactmatch
rat adrenal gland pheochromocytoma;rat adrenal gland pheochromocytoma;exactmatch
rat neuroblastoma;rat neuroblastoma;exactmatch
rat insulinoma;rat insulinoma;exactmatch
malignant fibrohistiocytic neoplasm;malignant fibrohistiocytic neoplasm;exactmatch
"t(11;16)(p11;p11)";"t(11;16)(p11;p11)";exactmatch
refractory malignant neoplasm;refractory cancer;exactmatch
familial colorectal cancer type x;fcctx;exactmatch
hereditary nonpolyposis colorectal cancer syndrome;familial nonpolyposis colorectal cancer syndrome;exactmatch
childhood carcinoid tumor;childhood carcinoid tumor;exactmatch
childhood nasal cavity carcinoma;childhood nasal cavity carcinoma;exactmatch
childhood bladder carcinoma;bladder cancer;exactmatch
childhood lung small cell carcinoma;childhood lung small cell carcinoma;exactmatch
childhood lung non-small cell carcinoma;childhood lung non-small cell carcinoma;exactmatch
childhood gastric carcinoma;childhood carcinoma of the stomach;exactmatch
childhood esophageal carcinoma;childhood esophageal carcinoma;exactmatch
childhood laryngeal carcinoma;childhood laryngeal carcinoma;exactmatch
childhood breast carcinoma;breast cancer;exactmatch
canine osteosarcoma;canine osteosarcoma;exactmatch
childhood colorectal carcinoma;childhood colorectal carcinoma;exactmatch
exophthalmos;exophthalmos;exactmatch
liver adenosquamous carcinoma;liver adenosquamous cancer;exactmatch
cutaneous melanoma in-transit metastasis;cutaneous melanoma in-transit metastasis;exactmatch
satellite tumor;satellite tumor;exactmatch
catenin family protein;catenin;exactmatch
anaplastic plasmacytoma;anaplastic plasmacytoma;exactmatch
childhood paranasal sinus carcinoma;childhood paranasal sinus carcinoma;exactmatch
childhood parathyroid gland carcinoma;childhood parathyroid gland carcinoma;exactmatch
adult penile carcinoma;adult penile carcinoma;exactmatch
childhood malignant penile neoplasm;childhood malignant penile neoplasm;exactmatch
mouse colon adenocarcinoma;adenocarcinoma of mouse colon;exactmatch
peripheral neuropathy;peripheral nerve disorder;exactmatch
digestive system hemorrhage;digestive system hemorrhage;exactmatch
inv(16);inv(16);exactmatch
experimental organism malignant oligodendroglioma;experimental organism malignant oligodendroglioma;exactmatch
experimental organism benign ganglioglioma;experimental organism benign ganglioglioma;exactmatch
experimental organism malignant astrocytoma;astrocytoma, malignant;exactmatch
familial nonmedullary thyroid gland carcinoma;fnmtc;exactmatch
orbital melanoma;orbital melanoma;exactmatch
childhood thyroid gland carcinoma;childhood thyroid carcinoma;exactmatch
childhood malignant small intestinal neoplasm;childhood malignant small intestinal neoplasm;exactmatch
adult salivary gland carcinoma;adult salivary gland carcinoma;exactmatch
childhood salivary gland carcinoma;childhood salivary gland carcinoma;exactmatch
childhood rectal carcinoma;childhood rectal carcinoma;exactmatch
childhood adrenal gland pheochromocytoma;childhood adrenal gland pheochromocytoma;exactmatch
medulloblastoma, genetically defined;medulloblastoma, genetically defined;exactmatch
medulloblastoma, wnt-activated;medulloblastoma, wnt-activated;exactmatch
medulloblastoma, shh-activated;medulloblastoma, shh-activated;exactmatch
mouse leydig cell tumor;mouse leydig cell tumor;exactmatch
hemangioendothelioma of the mouse thyroid gland;hemangioendothelioma of the mouse thyroid gland;exactmatch
hamster chondrosarcoma;hamster chondrosarcoma;exactmatch
canine acanthomatous epulis;canine acanthomatous epulis;exactmatch
bat skin tumor;bat skin tumor;exactmatch
suncus murinus mammary tumor;suncus murinus mammary tumor;exactmatch
quail fibrosarcoma;quail fibrosarcoma;exactmatch
pike sarcoma;pike sarcoma;exactmatch
hamster insulinoma;hamster insulinoma;exactmatch
mouse adrenal gland pheochromocytoma;mouse adrenal gland pheochromocytoma;exactmatch
chicken monocytic leukemia;chicken monocytic leukemia;exactmatch
canine pancreatic carcinoma;canine pancreatic carcinoma;exactmatch
budgerigar fibrosarcoma;budgerigar fibrosarcoma;exactmatch
rat neoplasms;rat neoplasms;exactmatch
stage iv pancreatic cancer ajcc v8;stage iv;exactmatch
stage iii pancreatic cancer ajcc v8;stage iii;exactmatch
stage iib pancreatic cancer ajcc v8;stage iib;exactmatch
marmoset lymphoma;marmoset lymphoma;exactmatch
mouse submandibular gland neoplasm;mouse submandibular gland neoplasm;exactmatch
stage ii pancreatic cancer ajcc v8;stage ii exocrine pancreatic cancer ajcc v8;exactmatch
hamster small intestinal neoplasm;hamster small intestinal neoplasm;exactmatch
turtle neoplasm;turtle neoplasm;exactmatch
seal lymphosarcoma;seal lymphosarcoma;exactmatch
rattlesnake fibroma;rattlesnake fibroma;exactmatch
rabbit papilloma;rabbit papilloma;exactmatch
mouse thymic lymphoma;mouse thymic lymphoma;exactmatch
mouse histiocytic and dendritic cell neoplasm;mouse histiocytic and dendritic cell neoplasm;exactmatch
horse sarcoid;horse sarcoid;exactmatch
hamster pituitary carcinoma;hamster pituitary carcinoma;exactmatch
poeciliopsis lucida hepatocellular carcinoma;poeciliopsis lucida hepatocellular carcinoma;exactmatch
hamster fibrosarcoma;hamster fibrosarcoma;exactmatch
hamster lung carcinoma;hamster lung carcinoma;exactmatch
hamster adrenal carcinoma;hamster adrenal carcinoma;exactmatch
rabbit neoplasm;rabbit neoplasm;exactmatch
hamster neoplasm;hamster neoplasm;exactmatch
tamarin colon adenocarcinoma;tamarin colon adenocarcinoma;exactmatch
seal lymphoma;seal lymphoma;exactmatch
stage iia pancreatic cancer ajcc v8;stage iia;exactmatch
stage ib pancreatic cancer ajcc v8;stage ib;exactmatch
medulloblastoma, shh-activated, tp53-mutant;medulloblastoma, shh-activated, tp53-mutant;exactmatch
stage i distal bile duct cancer ajcc v8;i;exactmatch
stage iv distal bile duct cancer ajcc v8;iv;exactmatch
stage iiib distal bile duct cancer ajcc v8;iiib;exactmatch
stage iiia distal bile duct cancer ajcc v8;iiia;exactmatch
stage iii distal bile duct cancer ajcc v8;iii;exactmatch
stage iib distal bile duct cancer ajcc v8;iib;exactmatch
stage iia distal bile duct cancer ajcc v8;iia;exactmatch
stage ii distal bile duct cancer ajcc v8;ii;exactmatch
stage 0 distal bile duct cancer ajcc v8;0;exactmatch
recurrent ph-like acute lymphoblastic leukemia;recurrent ph-like acute lymphoblastic leukemia;exactmatch
distal bile duct cancer by ajcc v8 stage;distal bile duct cancer tumor stage (pathologic);exactmatch
distal bile duct cancer by ajcc v7 stage;distal bile duct cancer by ajcc v7 stage;exactmatch
7q34;7q34;exactmatch
porcine lymphoma;porcine lymphoma;exactmatch
zebra finch neoplasm;zebra finch neoplasm;exactmatch
rhesus monkey mammary tumor;rhesus monkey mammary tumor;exactmatch
rhesus monkey lymphoma;rhesus monkey lymphoma;exactmatch
eyelid sebaceous gland carcinoma;eyelid sgc;exactmatch
refractory ph-like acute lymphoblastic leukemia;refractory ph-like acute lymphoblastic leukemia;exactmatch
stage ia pancreatic cancer ajcc v8;stage ia;exactmatch
stage iii ampulla of vater cancer ajcc v8;stage iii ampulla of vater cancer;exactmatch
stage i pancreatic cancer ajcc v8;stage i exocrine pancreatic cancer ajcc v8;exactmatch
stage 0 pancreatic cancer ajcc v8;stage 0 exocrine pancreatic cancer ajcc v8;exactmatch
pancreatic cancer by ajcc v8 stage;exocrine pancreatic cancer by ajcc v8 stage;exactmatch
pancreatic cancer by ajcc v6 and v7 stage;exocrine and endocrine pancreatic cancer by ajcc v6 and v7 stage;exactmatch
stage iv ampulla of vater cancer ajcc v8;stage iv ampulla of vater cancer;exactmatch
stage iiib ampulla of vater cancer ajcc v8;stage iiib ampulla of vater cancer;exactmatch
stage iiia ampulla of vater cancer ajcc v8;stage iiia ampulla of vater cancer;exactmatch
stage iib ampulla of vater cancer ajcc v8;stage iib ampulla of vater cancer;exactmatch
ampulla of vater cancer by ajcc v7 stage;ampulla of vater cancer by ajcc v7 stage;exactmatch
stage iia ampulla of vater cancer ajcc v8;stage iia ampulla of vater cancer;exactmatch
stage ii ampulla of vater cancer ajcc v8;stage ii ampulla of vater cancer;exactmatch
stage ib ampulla of vater cancer ajcc v8;stage ib ampulla of vater cancer;exactmatch
stage ia ampulla of vater cancer ajcc v8;stage ia ampulla of vater cancer;exactmatch
stage i ampulla of vater cancer ajcc v8;stage i ampulla of vater cancer;exactmatch
stage 0 ampulla of vater cancer ajcc v8;stage 0 ampulla of vater cancer;exactmatch
ampulla of vater cancer by ajcc v8 stage;ampulla of vater cancer by ajcc v8 stage;exactmatch
walleye dermal sarcoma;walleye dermal sarcoma;exactmatch
budgerigar testicular carcinoma;budgerigar testicular carcinoma;exactmatch
chicken lymphoma;chicken lymphoma;exactmatch
colon neuroendocrine tumor by ajcc v8 stage;colon neuroendocrine tumor by ajcc v8 stage;exactmatch
stage iiib colon neuroendocrine tumor ajcc v8;stage iiib colon neuroendocrine tumor;exactmatch
stage iiia colon neuroendocrine tumor ajcc v8;stage iiia colon neuroendocrine tumor;exactmatch
2p;2p;exactmatch
14q;14q;exactmatch
stage iib colon neuroendocrine tumor ajcc v8;stage iib colon neuroendocrine tumor;exactmatch
stage iia colon neuroendocrine tumor ajcc v8;stage iia colon neuroendocrine tumor;exactmatch
stage i colon neuroendocrine tumor ajcc v8;stage i colon neuroendocrine tumor;exactmatch
rectal neuroendocrine tumor;rectal neuroendocrine tumor;exactmatch
rectal neuroendocrine tumor by ajcc v8 stage;rectal neuroendocrine tumor by ajcc v8 stage;exactmatch
colon neuroendocrine tumor;colon neuroendocrine tumor;exactmatch
stage iv colorectal neuroendocrine tumor ajcc v8;stage iv colorectal neuroendocrine tumor;exactmatch
stage iiib colorectal neuroendocrine tumor ajcc v8;stage iiib colorectal neuroendocrine tumor;exactmatch
stage iiia colorectal neuroendocrine tumor ajcc v8;stage iiia colorectal neuroendocrine tumor;exactmatch
stage iib colorectal neuroendocrine tumor ajcc v8;stage iib colorectal neuroendocrine tumor;exactmatch
stage iia colorectal neuroendocrine tumor ajcc v8;stage iia colorectal neuroendocrine tumor;exactmatch
stage i colorectal neuroendocrine tumor ajcc v8;stage i colorectal neuroendocrine tumor;exactmatch
stage iv colon neuroendocrine tumor ajcc v8;stage iv colon neuroendocrine tumor;exactmatch
stage i rectal neuroendocrine tumor ajcc v8;stage i rectal neuroendocrine tumor;exactmatch
chicken neoplasm;chicken neoplasm;exactmatch
stage iii pancreatic neuroendocrine tumor ajcc v8;stage iii pancreatic neuroendocrine tumor;exactmatch
rectal carcinoma metastatic in the liver;rectal carcinoma metastatic in the liver;exactmatch
feline large granular lymphocyte lymphoma;feline large granular lymphocyte lymphoma;exactmatch
hamster mammary carcinoma;hamster mammary carcinoma;exactmatch
rat erythroleukemia;rat erythroleukemia;exactmatch
mouse erythroleukemia;mouse erythroleukemia;exactmatch
7p;7p;exactmatch
stage iv pancreatic neuroendocrine tumor ajcc v8;stage iv pancreatic neuroendocrine tumor;exactmatch
stage ii pancreatic neuroendocrine tumor ajcc v8;stage ii pancreatic neuroendocrine tumor;exactmatch
stage iia rectal neuroendocrine tumor ajcc v8;stage iia rectal neuroendocrine tumor;exactmatch
stage i pancreatic neuroendocrine tumor ajcc v8;stage i pancreatic neuroendocrine tumor;exactmatch
pancreatic neuroendocrine tumor by ajcc v8 stage;pancreatic neuroendocrine tumor by ajcc v8 stage;exactmatch
stage iv rectal neuroendocrine tumor ajcc v8;stage iv rectal neuroendocrine tumor;exactmatch
stage iiib rectal neuroendocrine tumor ajcc v8;stage iiib rectal neuroendocrine tumor;exactmatch
stage iiia rectal neuroendocrine tumor ajcc v8;stage iiia rectal neuroendocrine tumor;exactmatch
stage iib rectal neuroendocrine tumor ajcc v8;stage iib rectal neuroendocrine tumor;exactmatch
22q;22q;exactmatch
colorectal neuroendocrine tumor by ajcc v8 stage;colorectal neuroendocrine tumor by ajcc v8 stage;exactmatch
stage iv appendix neuroendocrine tumor ajcc v8;stage iv appendix neuroendocrine tumor;exactmatch
stage iii appendix neuroendocrine tumor ajcc v8;stage iii appendix neuroendocrine tumor;exactmatch
duodenal neuroendocrine tumor by ajcc v8 stage;duodenal neuroendocrine tumor by ajcc v8 stage;exactmatch
stage i ampulla of vater neuroendocrine tumor ajcc v8;stage i ampulla of vater neuroendocrine tumor;exactmatch
ampulla of vater neuroendocrine tumor by ajcc v8 stage;ampulla of vater neuroendocrine tumor by ajcc v8 stage;exactmatch
duodenal neuroendocrine tumor;duodenal neuroendocrine tumor;exactmatch
stage iv duodenal neuroendocrine tumor ajcc v8;stage iv duodenal neuroendocrine tumor;exactmatch
stage iii duodenal neuroendocrine tumor ajcc v8;stage iii duodenal neuroendocrine tumor;exactmatch
stage ii duodenal neuroendocrine tumor ajcc v8;stage ii duodenal neuroendocrine tumor;exactmatch
stage i duodenal neuroendocrine tumor ajcc v8;stage i duodenal neuroendocrine tumor;exactmatch
stage iv gastric neuroendocrine tumor ajcc v8;stage iv gastric neuroendocrine tumor;exactmatch
stage ii appendix neuroendocrine tumor ajcc v8;stage ii appendix neuroendocrine tumor;exactmatch
stage iii gastric neuroendocrine tumor ajcc v8;stage iii gastric neuroendocrine tumor;exactmatch
stage ii gastric neuroendocrine tumor ajcc v8;stage ii gastric neuroendocrine tumor;exactmatch
stage i gastric neuroendocrine tumor ajcc v8;stage i gastric neuroendocrine tumor;exactmatch
gastric neuroendocrine tumor by ajcc v8 stage;gastric neuroendocrine tumor by ajcc v8 stage;exactmatch
lung non-squamous non-small cell carcinoma;lung non-squamous non-small cell carcinoma;exactmatch
feline reticulum cell sarcoma;feline reticulum cell sarcoma;exactmatch
fish melanoma;fish melanoma;exactmatch
stage ii ampulla of vater neuroendocrine tumor ajcc v8;stage ii ampulla of vater neuroendocrine tumor;exactmatch
stage iii ampulla of vater neuroendocrine tumor ajcc v8;stage iii ampulla of vater neuroendocrine tumor;exactmatch
stage iv ampulla of vater neuroendocrine tumor ajcc v8;stage iv ampulla of vater neuroendocrine tumor;exactmatch
jejunal neuroendocrine tumor;jejunal neuroendocrine tumor;exactmatch
stage i appendix neuroendocrine tumor ajcc v8;stage i appendix neuroendocrine tumor;exactmatch
appendix neuroendocrine tumor by ajcc v8 stage;appendix neuroendocrine tumor by ajcc v8 stage;exactmatch
appendix neuroendocrine tumor by ajcc v7 stage;appendix neuroendocrine tumor by ajcc v7 stage;exactmatch
digestive system neuroendocrine tumor by ajcc v7 stage;digestive system neuroendocrine neoplasm by ajcc v7 stage;exactmatch
stage iv ileal neuroendocrine tumor ajcc v8;stage iv ileal neuroendocrine tumor;exactmatch
stage iii ileal neuroendocrine tumor ajcc v8;stage iii ileal neuroendocrine tumor;exactmatch
stage ii ileal neuroendocrine tumor ajcc v8;stage ii ileal neuroendocrine tumor;exactmatch
stage i ileal neuroendocrine tumor ajcc v8;stage i ileal neuroendocrine tumor;exactmatch
ileal neuroendocrine tumor by ajcc v8 stage;ileal neuroendocrine tumor by ajcc v8 stage;exactmatch
stage iv jejunal neuroendocrine tumor ajcc v8;stage iv jejunal neuroendocrine tumor;exactmatch
stage iii jejunal neuroendocrine tumor ajcc v8;stage iii jejunal neuroendocrine tumor;exactmatch
stage ii jejunal neuroendocrine tumor ajcc v8;stage ii jejunal neuroendocrine tumor;exactmatch
stage i jejunal neuroendocrine tumor ajcc v8;stage i jejunal neuroendocrine tumor;exactmatch
jejunal neuroendocrine tumor by ajcc v8 stage;jejunal neuroendocrine tumor by ajcc v8 stage;exactmatch
ileal neuroendocrine tumor;ileal neuroendocrine tumor;exactmatch
ovine sinus tumor;ovine sinus tumor;exactmatch
mouse reticulum cell sarcoma;mouse reticulum cell sarcoma;exactmatch
mouse rectum carcinoma;mouse rectum carcinoma;exactmatch
stage ivb rectal cancer ajcc v8;stage ivb rectal cancer;exactmatch
apc gene mutation;apc gene mutation;exactmatch
nuclear structure;nuclear structure;exactmatch
gene feature;gene feature;exactmatch
anatomy qualifier;anatomy qualifier;exactmatch
chromosome band;chromosomal band;exactmatch
refractory acute myeloid leukemia;refractory aml;exactmatch
stage ivc rectal cancer ajcc v8;stage ivc rectal cancer;exactmatch
stage iva rectal cancer ajcc v8;stage iva rectal cancer;exactmatch
intrahepatic cholangiocarcinoma by ajcc v7 stage;intrahepatic cholangiocarcinoma by ajcc v7 stage;exactmatch
stage iv rectal cancer ajcc v8;stage iv rectal cancer;exactmatch
stage iiic rectal cancer ajcc v8;stage iiic rectal cancer;exactmatch
stage iiib rectal cancer ajcc v8;stage iiib rectal cancer;exactmatch
stage iiia rectal cancer ajcc v8;stage iiia rectal cancer;exactmatch
stage iii rectal cancer ajcc v8;stage iii rectal cancer;exactmatch
stage iic rectal cancer ajcc v8;stage iic rectal cancer;exactmatch
stage iib rectal cancer ajcc v8;stage iib rectal cancer;exactmatch
activating raf mutation;activating raf family gene mutation;exactmatch
hepatocellular carcinoma by ajcc v8 stage;hepatocellular carcinoma by ajcc v8 stage;exactmatch
chicken bursal lymphoma;chicken bursal lymphoma;exactmatch
stage ivb hepatocellular carcinoma ajcc v8;ivb;exactmatch
galline experimental organism diagnosis;galline experimental organism diagnosis;exactmatch
experimental organism neoplasm by organism;experimental organism neoplasm by organism;exactmatch
leporine experimental organism diagnosis;leporine experimental organism diagnosis;exactmatch
metal binding site;metal binding site;exactmatch
feline experimental organism diagnosis;feline experimental organism diagnosis;exactmatch
bovine neoplasm;bovine neoplasm;exactmatch
canine neoplasm;canine neoplasm;exactmatch
stage iva hepatocellular carcinoma ajcc v8;iva;exactmatch
stage i hepatocellular carcinoma ajcc v8;stage i hepatocellular cancer;exactmatch
stage iv hepatocellular carcinoma ajcc v8;stage iv hepatocellular cancer;exactmatch
stage iiib hepatocellular carcinoma ajcc v8;iiib;exactmatch
stage iiia hepatocellular carcinoma ajcc v8;iiia;exactmatch
stage iii hepatocellular carcinoma ajcc v8;stage iii hepatocellular cancer;exactmatch
stage ii hepatocellular carcinoma ajcc v8;ii;exactmatch
stage ib hepatocellular carcinoma ajcc v8;ib;exactmatch
stage ia hepatocellular carcinoma ajcc v8;ia;exactmatch
stage iia rectal cancer ajcc v8;stage iia rectal cancer;exactmatch
stage ii rectal cancer ajcc v8;stage ii rectal cancer;exactmatch
stage i rectal cancer ajcc v8;stage i rectal cancer;exactmatch
stage iii colorectal cancer ajcc v8;stage iii colorectal (colon or rectal) cancer;exactmatch
stage ivc colorectal cancer ajcc v8;stage ivc colorectal (colon or rectal) cancer;exactmatch
stage ivb colorectal cancer ajcc v8;stage ivb colorectal (colon or rectal) cancer;exactmatch
stage iva colorectal cancer ajcc v8;stage iva colorectal (colon or rectal) cancer;exactmatch
stage iv colorectal cancer ajcc v8;stage iv colorectal (colon or rectal) cancer;exactmatch
stage iiic colorectal cancer ajcc v8;stage iiic colorectal (colon or rectal) cancer;exactmatch
stage iiib colorectal cancer ajcc v8;stage iiib colorectal (colon or rectal) cancer;exactmatch
stage iiia colorectal cancer ajcc v8;stage iiia colorectal (colon or rectal) cancer;exactmatch
stage iic colorectal cancer ajcc v8;stage iic colorectal (colon or rectal) cancer;exactmatch
stage 0 rectal cancer ajcc v8;stage 0 rectal cancer;exactmatch
stage iib colorectal cancer ajcc v8;stage iib colorectal (colon or rectal) cancer;exactmatch
stage iia colorectal cancer ajcc v8;stage iia colorectal (colon or rectal) cancer;exactmatch
stage ii colorectal cancer ajcc v8;stage ii colorectal (colon or rectal) cancer;exactmatch
stage i colorectal cancer ajcc v8;stage i colorectal (colon or rectal) cancer;exactmatch
stage 0 colorectal cancer ajcc v8;stage 0 colorectal (colon or rectal) cancer;exactmatch
colorectal cancer by ajcc v8 stage;colorectal cancer by ajcc v8 stage;exactmatch
refractory langerhans cell histiocytosis;refractory langerhans cell histiocytosis;exactmatch
dna binding domain;dna binding domain;exactmatch
colon cancer by ajcc v8 stage;colon cancer by ajcc v8 stage;exactmatch
rectal cancer by ajcc v8 stage;rectal cancer by ajcc v8 stage;exactmatch
protein binding domain;protein binding domain;exactmatch
stage ivc colon cancer ajcc v8;stage ivc colon cancer;exactmatch
stage ivb colon cancer ajcc v8;stage ivb colon cancer;exactmatch
stage iva colon cancer ajcc v8;stage iva colon cancer;exactmatch
stage iv colon cancer ajcc v8;stage iv colon cancer;exactmatch
stage iiic colon cancer ajcc v8;stage iiic colon cancer;exactmatch
stage iiib colon cancer ajcc v8;stage iiib colon cancer;exactmatch
stage iiia colon cancer ajcc v8;stage iiia colon cancer;exactmatch
stage iii colon cancer ajcc v8;stage iii colon cancer;exactmatch
stage iic colon cancer ajcc v8;stage iic colon cancer;exactmatch
stage iib colon cancer ajcc v8;stage iib colon cancer;exactmatch
stage iia colon cancer ajcc v8;stage iia colon cancer;exactmatch
stage ii colon cancer ajcc v8;stage ii colon cancer;exactmatch
stage i colon cancer ajcc v8;stage i colon cancer;exactmatch
stage 0 colon cancer ajcc v8;stage 0 colon cancer;exactmatch
zinc-binding, dna-binding motif;zinc finger;exactmatch
equine experimental organism diagnosis;equine experimental organism diagnosis;exactmatch
chicken fibrosarcoma;chicken fibrosarcoma;exactmatch
horse lymphoma;horse lymphoma;exactmatch
stage iiia hilar cholangiocarcinoma ajcc v8;iiia;exactmatch
stage 0 intrahepatic cholangiocarcinoma ajcc v8;0;exactmatch
intrahepatic cholangiocarcinoma by ajcc v8 stage;intrahepatic cholangiocarcinoma by ajcc v8 stage;exactmatch
stage ivb hilar cholangiocarcinoma ajcc v8;ivb;exactmatch
stage iva hilar cholangiocarcinoma ajcc v8;iva;exactmatch
stage iv hilar cholangiocarcinoma ajcc v8;iv;exactmatch
stage iiic hilar cholangiocarcinoma ajcc v8;iiic;exactmatch
stage iiib hilar cholangiocarcinoma ajcc v8;iiib;exactmatch
stage iii hilar cholangiocarcinoma ajcc v8;iii;exactmatch
stage ia intrahepatic cholangiocarcinoma ajcc v8;ia;exactmatch
stage ii hilar cholangiocarcinoma ajcc v8;ii;exactmatch
stage i hilar cholangiocarcinoma ajcc v8;i;exactmatch
stage 0 hilar cholangiocarcinoma ajcc v8;0;exactmatch
hilar cholangiocarcinoma by ajcc v8 stage;hilar cholangiocarcinoma tumor stage (pathologic);exactmatch
hilar cholangiocarcinoma by ajcc v7 stage;hilar cholangiocarcinoma by ajcc v7 stage;exactmatch
stage ivb gallbladder cancer ajcc v8;stage ivb gallbladder cancer;exactmatch
stage iva gallbladder cancer ajcc v8;stage iva gallbladder cancer;exactmatch
stage i intrahepatic cholangiocarcinoma ajcc v8;i;exactmatch
stage ib intrahepatic cholangiocarcinoma ajcc v8;ib;exactmatch
chicken hepatoma;chicken hepatoma;exactmatch
feline erythroleukemia;feline erythroleukemia;exactmatch
hamster lymphosarcoma;hamster lymphosarcoma;exactmatch
hamster lymphoma;hamster lymphoma;exactmatch
hamster kidney tumor;hamster kidney tumor;exactmatch
gibbon lymphosarcoma;gibbon lymphosarcoma;exactmatch
gerbil melanoma;gerbil melanoma;exactmatch
gerbil fibrosarcoma;gerbil fibrosarcoma;exactmatch
frog pronephric kidney tumor;frog pronephric kidney tumor;exactmatch
duck neoplasm;duck neoplasm;exactmatch
stage ii intrahepatic cholangiocarcinoma ajcc v8;ii;exactmatch
bovine rectal myxoma;bovine rectal myxoma;exactmatch
bovine lymphosarcoma;bovine lymphosarcoma;exactmatch
baboon lymphoma;baboon lymphoma;exactmatch
stage iv intrahepatic cholangiocarcinoma ajcc v8;iv;exactmatch
stage iiib intrahepatic cholangiocarcinoma ajcc v8;iiib;exactmatch
stage iiia intrahepatic cholangiocarcinoma ajcc v8;iiia;exactmatch
stage iii intrahepatic cholangiocarcinoma ajcc v8;iii;exactmatch
stage iv gallbladder cancer ajcc v8;stage iv gallbladder cancer;exactmatch
stage iiib gallbladder cancer ajcc v8;stage iiib gallbladder cancer;exactmatch
stage iiia gallbladder cancer ajcc v8;stage iiia gallbladder cancer;exactmatch
hamster cholangiocarcinoma;hamster cholangiocarcinoma;exactmatch
rainbow trout hepatoma;oncorhynchus mykiss hepatoma;exactmatch
medaka melanoma;medaka melanoma;exactmatch
medaka hepatoma;medaka hepatoma;exactmatch
mouse basal cell carcinoma;mouse basal cell carcinoma;exactmatch
horse melanoma;horse melanoma;exactmatch
hamster uterine leiomyosarcoma;hamster uterine leiomyosarcoma;exactmatch
hamster ductus deferens leiomyosarcoma;hamster ductus deferens leiomyosarcoma;exactmatch
hamster buccal pouch carcinoma;hamster buccal pouch carcinoma;exactmatch
stage iii gallbladder cancer ajcc v8;stage iii gallbladder cancer;exactmatch
guinea pig leukemia;guinea pig leukemia;exactmatch
guinea pig colon adenocarcinoma;guinea pig colon adenocarcinoma;exactmatch
goldfish erythrophoroma;goldfish erythrophoroma;exactmatch
gerbil fibroma;gerbil fibroma;exactmatch
feline fibrosarcoma;feline fibrosarcoma;exactmatch
bone marrow stem cell;bone marrow blood-forming cell;exactmatch
feline bronchioloalveolar lung carcinoma;feline bronchioloalveolar lung carcinoma;exactmatch
xenopus neoplasm;xenopus neoplasm;exactmatch
xiphophorus melanoma;xiphophorus melanoma;exactmatch
experimental organism neoplasm;experimental organism neoplasm;exactmatch
intrahepatic bile duct cancer by ajcc v8 stage;intrahepatic bile duct cancer tumor stage (pathologic);exactmatch
stage iib gallbladder cancer ajcc v8;stage iib gallbladder cancer;exactmatch
stage iia gallbladder cancer ajcc v8;stage iia gallbladder cancer;exactmatch
stage ii gallbladder cancer ajcc v8;stage ii gallbladder cancer;exactmatch
stage i gallbladder cancer ajcc v8;stage i gallbladder cancer;exactmatch
stage 0 gallbladder cancer ajcc v8;stage 0 gallbladder cancer;exactmatch
gallbladder cancer by ajcc v8 stage;gallbladder cancer by ajcc v8 stage;exactmatch
stage iv intrahepatic bile duct cancer ajcc v8;stage iv intrahepatic bile duct cancer;exactmatch
stage iiib intrahepatic bile duct cancer ajcc v8;stage iiib intrahepatic bile duct cancer;exactmatch
stage iiia intrahepatic bile duct cancer ajcc v8;stage iiia intrahepatic bile duct cancer;exactmatch
stage iii intrahepatic bile duct cancer ajcc v8;stage iii intrahepatic bile duct cancer;exactmatch
stage ii intrahepatic bile duct cancer ajcc v8;stage ii intrahepatic bile duct cancer;exactmatch
stage ib intrahepatic bile duct cancer ajcc v8;stage ib intrahepatic bile duct cancer;exactmatch
stage ia intrahepatic bile duct cancer ajcc v8;stage ia intrahepatic bile duct cancer;exactmatch
stage i intrahepatic bile duct cancer ajcc v8;stage i intrahepatic bile duct cancer;exactmatch
stage 0 intrahepatic bile duct cancer ajcc v8;stage 0 intrahepatic bile duct cancer;exactmatch
met protein variant;c-met protein variant;exactmatch
thymic epithelial neoplasm by ajcc v8 stage;thymic epithelial neoplasm by ajcc v8 stage;exactmatch
stage i thymic epithelial neoplasm ajcc v8;stage i thymic epithelial neoplasm ajcc v8;exactmatch
refractory extranodal diffuse large b-cell lymphoma;refractory extranodal diffuse large b-cell lymphoma;exactmatch
recurrent intravascular large b-cell lymphoma;recurrent intravascular b-cell lymphoma;exactmatch
refractory breast lymphoma;refractory breast lymphoma;exactmatch
recurrent breast lymphoma;recurrent breast lymphoma;exactmatch
refractory testicular lymphoma;refractory testicular lymphoma;exactmatch
recurrent testicular lymphoma;recurrent testicular lymphoma;exactmatch
refractory central nervous system lymphoma;refractory central nervous system lymphoma;exactmatch
recurrent central nervous system lymphoma;recurrent central nervous system lymphoma;exactmatch
recurrent extranodal diffuse large b-cell lymphoma;recurrent extranodal diffuse large b-cell lymphoma;exactmatch
recurrent primary cutaneous diffuse large b-cell lymphoma, leg type;recurrent primary cutaneous (skin) diffuse large b-cell lymphoma, leg type;exactmatch
refractory b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classic hodgkin lymphoma;refractory b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classic hodgkin lymphoma;exactmatch
recurrent b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classic hodgkin lymphoma;recurrent b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classic hodgkin lymphoma;exactmatch
pi3k/mtor pathway mutation;pi3k/alk/mtor pathway mutation;exactmatch
refractory pancreatic neuroendocrine carcinoma;refractory pancreatic neuroendocrine cancer;exactmatch
refractory anal carcinoma;refractory anal cancer;exactmatch
breast pleomorphic lobular carcinoma in situ;breast pleomorphic lobular carcinoma in situ;exactmatch
experimental organism non-neoplastic disorder;experimental organism non-neoplastic disorder;exactmatch
refractory intravascular large b-cell lymphoma;refractory intravascular b-cell lymphoma;exactmatch
refractory primary cutaneous diffuse large b-cell lymphoma, leg type;refractory primary cutaneous (skin) diffuse large b-cell lymphoma, leg type;exactmatch
high grade b-cell lymphoma;hgbl;exactmatch
in situ follicular neoplasia;flis;exactmatch
leukemic nonnodal mantle cell lymphoma;leukemic nonnodal mantle cell lymphoma;exactmatch
in situ mantle cell neoplasia;ismcn;exactmatch
predominantly diffuse follicular lymphoma with 1p36 deletion;predominantly diffuse follicular lymphoma with 1p36 deletion;exactmatch
duodenal-type follicular lymphoma;duodenal-type follicular lymphoma;exactmatch
refractory abdominal neuroendocrine neoplasm;refractory abdominal neuroendocrine neoplasm;exactmatch
recurrent abdominal neuroendocrine neoplasm;recurrent abdominal neuroendocrine neoplasm;exactmatch
neoplastic plasma cells 30 percent or less of bone marrow nucleated cells;neoplastic plasma cells 30 percent or less of bone marrow nucleated cells;exactmatch
basal-like prostate carcinoma;basal-like prostate cancer;exactmatch
blasts 10 percent or more of peripheral blood white cells;blasts 10 percent or more of peripheral blood white cells;exactmatch
luminal b prostate carcinoma;luminal b prostate cancer;exactmatch
luminal a prostate carcinoma;luminal a prostate cancer;exactmatch
prostate carcinoma by gene expression profile;prostate cancer by gene expression profile;exactmatch
nucleosome core particle;core particle;exactmatch
tyrosine-protein phosphatase non-receptor type 2;ec 3.1.3.48;exactmatch
immunoglobulin domain;immunoglobulin domain;exactmatch
blasts under 30 percent of bone marrow nucleated cells;blasts less than 30 percent of bone marrow nucleated cells;exactmatch
tumor margin configuration;tumor border configuration;exactmatch
blasts under 25 percent of bone marrow nucleated cells;blasts less than 25 percent of bone marrow nucleated cells;exactmatch
blasts 5 percent or less of bone marrow nucleated cells;blasts 5 percent or less of bone marrow nucleated cells;exactmatch
clinical stage ia cutaneous melanoma ajcc v8;clinical stage ia cutaneous melanoma ajcc v8;exactmatch
clinical stage iv cutaneous melanoma ajcc v8;clinical stage iv cutaneous melanoma ajcc v8;exactmatch
clinical stage iii cutaneous melanoma ajcc v8;clinical stage iii cutaneous melanoma ajcc v8;exactmatch
clinical stage iic cutaneous melanoma ajcc v8;clinical stage iic cutaneous melanoma ajcc v8;exactmatch
clinical stage iib cutaneous melanoma ajcc v8;clinical stage iib cutaneous melanoma ajcc v8;exactmatch
clinical stage iia cutaneous melanoma ajcc v8;clinical stage iia cutaneous melanoma ajcc v8;exactmatch
clinical stage ii cutaneous melanoma ajcc v8;clinical stage ii cutaneous melanoma ajcc v8;exactmatch
clinical stage ib cutaneous melanoma ajcc v8;clinical stage ib cutaneous melanoma ajcc v8;exactmatch
clinical stage i cutaneous melanoma ajcc v8;clinical stage i cutaneous melanoma ajcc v8;exactmatch
myeloblasts 10 percent or more of bone marrow nucleated cells;myeloblasts 10 percent or more of bone marrow nucleated cells;exactmatch
clinical stage 0 cutaneous melanoma ajcc v8;clinical stage 0 cutaneous melanoma ajcc v8;exactmatch
cutaneous melanoma by ajcc v8 clinical stage;cutaneous melanoma by ajcc v8 clinical stage;exactmatch
cutaneous melanoma by ajcc v8 stage;cutaneous melanoma by ajcc v8 stage;exactmatch
zonula adherens;aj;exactmatch
plasma membrane;cell membrane;exactmatch
regulatory element;regulatory element;exactmatch
"t(12;21)(p13.2;q22.1)";"t(12;21)(p13.2;q22.1)";exactmatch
cutaneous melanoma by ajcc v8 pathologic stage;cutaneous melanoma by ajcc v8 pathologic stage;exactmatch
pathologic stage 0 cutaneous melanoma ajcc v8;pathologic stage 0 cutaneous melanoma ajcc v8;exactmatch
pathologic stage i cutaneous melanoma ajcc v8;pathologic stage i cutaneous melanoma ajcc v8;exactmatch
pathologic stage ia cutaneous melanoma ajcc v8;pathologic stage ia cutaneous melanoma ajcc v8;exactmatch
dicer1 gene mutation;dcr-1 gene mutation;exactmatch
blasts under 5 percent of bone marrow nucleated cells;blasts less than 5 percent of bone marrow nucleated cells;exactmatch
pathologic stage iv cutaneous melanoma ajcc v8;pathologic stage iv cutaneous melanoma ajcc v8;exactmatch
stage iiid;stage iiid;exactmatch
pathologic stage iiid cutaneous melanoma ajcc v8;pathologic stage iiid cutaneous melanoma ajcc v8;exactmatch
occult breast carcinoma;occult breast carcinoma;exactmatch
pathologic stage iiic cutaneous melanoma ajcc v8;pathologic stage iiic cutaneous melanoma ajcc v8;exactmatch
pathologic stage iiib cutaneous melanoma ajcc v8;pathologic stage iiib cutaneous melanoma ajcc v8;exactmatch
pathologic stage iiia cutaneous melanoma ajcc v8;pathologic stage iiia cutaneous melanoma ajcc v8;exactmatch
pathologic stage iii cutaneous melanoma ajcc v8;pathologic stage iii cutaneous melanoma ajcc v8;exactmatch
pathologic stage iic cutaneous melanoma ajcc v8;pathologic stage iic cutaneous melanoma ajcc v8;exactmatch
pathologic stage iib cutaneous melanoma ajcc v8;pathologic stage iib cutaneous melanoma ajcc v8;exactmatch
pathologic stage iia cutaneous melanoma ajcc v8;pathologic stage iia cutaneous melanoma ajcc v8;exactmatch
pathologic stage ii cutaneous melanoma ajcc v8;pathologic stage ii cutaneous melanoma ajcc v8;exactmatch
pathologic stage ib cutaneous melanoma ajcc v8;pathologic stage ib cutaneous melanoma ajcc v8;exactmatch
high grade b-cell lymphoma with myc and bcl2 and/or bcl6 rearrangements;hgbl with myc and bcl2 and/or bcl6 rearrangements;exactmatch
hhv8-positive diffuse large b-cell lymphoma, not otherwise specified;hhv8-positive dlbcl, nos;exactmatch
male genital system fluid or secretion;genital system, male, fluids, secretions;exactmatch
breast cancer by ajcc v8 prognostic stage;breast cancer by ajcc v8 prognostic stage;exactmatch
prognostic stage iia breast cancer ajcc v8;prognostic stage iia breast cancer ajcc v8;exactmatch
prognostic stage ii breast cancer ajcc v8;prognostic stage ii breast cancer ajcc v8;exactmatch
malignant neoplasm of lung - multiple primary sites;mplc;exactmatch
prognostic stage ib breast cancer ajcc v8;prognostic stage ib breast cancer ajcc v8;exactmatch
prognostic stage ia breast cancer ajcc v8;prognostic stage ia breast cancer ajcc v8;exactmatch
prognostic stage i breast cancer ajcc v8;prognostic stage i breast cancer ajcc v8;exactmatch
prognostic stage 0 breast cancer ajcc v8;prognostic stage 0 breast cancer ajcc v8;exactmatch
vulvar composite hidradenoma papilliferum and fibroadenoma;vulvar composite hidradenoma papilliferum and fibroadenoma;exactmatch
prognostic stage iii breast cancer ajcc v8;prognostic stage iii breast cancer ajcc v8;exactmatch
fibroadenoma of anogenital mammary-type glands;fibroadenoma of anogenital mammary-like glands;exactmatch
anal ectopic fibroadenoma;anal ectopic fibroadenoma;exactmatch
anatomic stage iv breast cancer ajcc v8;anatomic stage iv breast cancer ajcc v8;exactmatch
anatomic stage iiic breast cancer ajcc v8;anatomic stage iiic breast cancer ajcc v8;exactmatch
anatomic stage iiib breast cancer ajcc v8;anatomic stage iiib breast cancer ajcc v8;exactmatch
anatomic stage iiia breast cancer ajcc v8;anatomic stage iiia breast cancer ajcc v8;exactmatch
anatomic stage iii breast cancer ajcc v8;anatomic stage iii breast cancer ajcc v8;exactmatch
prognostic stage iib breast cancer ajcc v8;prognostic stage iib breast cancer ajcc v8;exactmatch
prognostic stage iiia breast cancer ajcc v8;prognostic stage iiia breast cancer ajcc v8;exactmatch
neoplastic plasma cells more than 20 percent of bone marrow nucleated cells;neoplastic plasma cells greater than 20 percent of bone marrow nucleated cells;exactmatch
stage iiia vulvar cancer ajcc v8;stage iiia vulvar cancer;exactmatch
stage i vaginal cancer ajcc v8;stage i vaginal cancer;exactmatch
vaginal cancer by ajcc v8 stage;vaginal cancer by ajcc v8 stage;exactmatch
stage ivb vulvar cancer ajcc v8;stage ivb vulvar cancer;exactmatch
stage iva vulvar cancer ajcc v8;stage iva vulvar cancer;exactmatch
stage iv vulvar cancer ajcc v8;stage iv vulvar cancer;exactmatch
stage iiic vulvar cancer ajcc v8;stage iiic vulvar cancer;exactmatch
stage iiib vulvar cancer ajcc v8;stage iiib vulvar cancer;exactmatch
stage iii vulvar cancer ajcc v8;stage iii vulvar cancer;exactmatch
prognostic stage iiib breast cancer ajcc v8;prognostic stage iiib breast cancer ajcc v8;exactmatch
stage ii vulvar cancer ajcc v8;stage ii vulvar cancer;exactmatch
stage ib vulvar cancer ajcc v8;stage ib vulvar cancer;exactmatch
stage ia vulvar cancer ajcc v8;stage ia vulvar cancer;exactmatch
stage i vulvar cancer ajcc v8;stage i vulvar cancer;exactmatch
vulvar cancer by ajcc v8 stage;vulvar cancer by ajcc v8 stage;exactmatch
prognostic stage iv breast cancer ajcc v8;prognostic stage iv breast cancer ajcc v8;exactmatch
prognostic stage iiic breast cancer ajcc v8;prognostic stage iiic breast cancer ajcc v8;exactmatch
anatomic stage iib breast cancer ajcc v8;anatomic stage iib breast cancer ajcc v8;exactmatch
anatomic stage iia breast cancer ajcc v8;anatomic stage iia breast cancer ajcc v8;exactmatch
anatomic stage ii breast cancer ajcc v8;anatomic stage ii breast cancer ajcc v8;exactmatch
nodal peripheral t-cell lymphoma of t follicular helper cell origin;nodal peripheral t-cell lymphoma of t follicular helper cell origin;exactmatch
breast implant-associated anaplastic large cell lymphoma;bia-alcl;exactmatch
nodal peripheral t-cell lymphoma with tfh phenotype;nodal ptcl with t follicular helper phenotype;exactmatch
neoplastic cells with tfh cell phenotype present;neoplastic cells with t follicular helper cell phenotype present;exactmatch
plasma cell myeloma by iss stage;plasma cell myeloma by iss stage;exactmatch
plasma cell myeloma by ds stage;plasma cell myeloma by ds stage;exactmatch
international staging system stage;iss stage;exactmatch
durie/salmon stage;ds stage;exactmatch
recurrent soft tissue sarcoma;recurrent soft tissue sarcoma;exactmatch
anatomic stage ib breast cancer ajcc v8;anatomic stage ib breast cancer ajcc v8;exactmatch
refractory soft tissue sarcoma;refractory soft tissue sarcoma;exactmatch
refractory high risk myelodysplastic syndrome;refractory high risk myelodysplastic syndrome;exactmatch
recurrent high risk myelodysplastic syndrome;recurrent high risk myelodysplastic syndrome;exactmatch
high risk myelodysplastic syndrome;high risk myelodysplastic syndrome;exactmatch
psa level finding;psa level finding;exactmatch
neoplastic cells with double expression of myc and bcl2 proteins present;neoplastic cells with double expression of myc and bcl2 proteins present;exactmatch
double-expressor lymphoma;del;exactmatch
breast implant-related lesion;breast implant-related lesion;exactmatch
type d lymphomatoid papulosis;type d lyp;exactmatch
type e lymphomatoid papulosis;angioinvasive lymphomatoid papulosis type e;exactmatch
rearrangement of 6p25.3;rearrangement of 6p25;exactmatch
anatomic stage ia breast cancer ajcc v8;anatomic stage ia breast cancer ajcc v8;exactmatch
anatomic stage i breast cancer ajcc v8;anatomic stage i breast cancer ajcc v8;exactmatch
anatomic stage 0 breast cancer ajcc v8;anatomic stage 0 breast cancer ajcc v8;exactmatch
breast cancer by ajcc v8 anatomic stage;breast cancer by ajcc v8 anatomic stage;exactmatch
breast cancer by ajcc v8 stage;breast cancer by ajcc v8 stage;exactmatch
breast cancer prognostic stage;breast cancer prognostic stage;exactmatch
breast cancer anatomic stage;breast cancer anatomic stage;exactmatch
egf-like domain;egf-like domain;exactmatch
advanced head and neck squamous cell carcinoma;advanced head and neck squamous cell cancer;exactmatch
primary ebv-positive nodal t-cell or nk-cell lymphoma;node-based ebv-positive peripheral t-cell lymphoma;exactmatch
acral lesion;acral lesion;exactmatch
primary cutaneous acral cd8-positive t-cell lymphoma;primary cutaneous acral cd8-positive t-cell lymphoma;exactmatch
superficial monoclonal gastrointestinal tract t-cell infiltrate present;superficial monoclonal gastrointestinal tract t-cell infiltrate present;exactmatch
indolent t-cell lymphoproliferative disorder of the gastrointestinal tract;indolent t-cell lymphoproliferative disorder of the gastrointestinal tract;exactmatch
lymphomatoid papulosis with dusp22-irf4 gene rearrangement;lyp with chromosome 6p25 rearrangement;exactmatch
rna recognition motif;putative rna-binding region;exactmatch
devil facial tumor disease;dftd;exactmatch
stage ii thymic epithelial neoplasm ajcc v8;stage ii thymic epithelial neoplasm ajcc v8;exactmatch
stage iva lung cancer ajcc v8;stage iva lung cancer;exactmatch
lung non-small cell cancer by ajcc v7 stage;lung non-small cell cancer by ajcc v7 stage;exactmatch
lung adenocarcinoma by ajcc v7 stage;lung adenocarcinoma by ajcc v7 stage;exactmatch
refractory erdheim-chester disease;refractory erdheim-chester disease;exactmatch
refractory acute lymphoblastic leukemia;refractory acute lymphoblastic leukemia;exactmatch
lung adenocarcinoma in situ;adenocarcinoma solitary lesion in situ of lung;exactmatch
stage ia3;stage ia3;exactmatch
stage ivb lung cancer ajcc v8;stage ivb lung cancer;exactmatch
stage iv lung cancer ajcc v8;stage iv;exactmatch
lung large cell carcinoma by ajcc v7 stage;lung large cell carcinoma by ajcc v7 stage;exactmatch
stage iiic lung cancer ajcc v8;stage iiic lung cancer;exactmatch
stage iiib lung cancer ajcc v8;stage iiib;exactmatch
stage iiia lung cancer ajcc v8;stage iiia;exactmatch
stage iii lung cancer ajcc v8;stage iii;exactmatch
stage iib lung cancer ajcc v8;stage iib;exactmatch
stage iia lung cancer ajcc v8;stage iia;exactmatch
stage ii lung cancer ajcc v8;stage ii;exactmatch
lung adenosquamous carcinoma by ajcc v7 stage;lung adenosquamous carcinoma by ajcc v7 stage;exactmatch
lung squamous cell carcinoma by ajcc v7 stage;lung squamous cell carcinoma by ajcc v7 stage;exactmatch
smarcb1 gene mutation;baf47 gene mutation;exactmatch
stage ia bone cancer ajcc v8;stage ia appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
stage iva bone cancer ajcc v8;stage iva appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
stage iv bone cancer ajcc v8;stage iv appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
stage iii bone cancer ajcc v8;stage iii appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
stage iib bone cancer ajcc v8;stage iib appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
stage iia bone cancer ajcc v8;stage iia appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
stage ii bone cancer ajcc v8;stage ii appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
stage ib bone cancer ajcc v8;stage ib appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
stage i bone cancer ajcc v8;stage i appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
lung small cell carcinoma by ajcc v7 stage;lung small cell carcinoma by ajcc v7 stage;exactmatch
bone cancer by ajcc v8 stage;appendicular skeleton, trunk, skull, and facial bones cancer by ajcc v8 stage;exactmatch
bone cancer by ajcc v7 stage;bone cancer by ajcc v7 stage;exactmatch
fish experimental organism diagnosis;fish experimental organism diagnosis;exactmatch
gerbil experimental organism diagnosis;gerbil experimental organism diagnosis;exactmatch
refractory diffuse intrinsic pontine glioma;refractory diffuse intrinsic pontine glioma;exactmatch
recurrent diffuse intrinsic pontine glioma;recurrent diffuse intrinsic pontine glioma;exactmatch
recurrent anaplastic astrocytoma;recurrent anaplastic astrocytoma;exactmatch
stage ib lung cancer ajcc v8;stage ib;exactmatch
stage ia3 lung cancer ajcc v8;stage ia3 lung cancer;exactmatch
stage ia2 lung cancer ajcc v8;stage ia2 lung cancer;exactmatch
stage ii thymoma ajcc v8;stage ii thymoma;exactmatch
pleural malignant mesothelioma by ajcc v7 stage;pleural malignant mesothelioma by ajcc v7 stage;exactmatch
stage ivb thymoma ajcc v8;stage ivb thymoma;exactmatch
stage iva thymoma ajcc v8;stage iva thymoma;exactmatch
stage iv thymoma ajcc v8;stage iv thymoma;exactmatch
stage iiib thymoma ajcc v8;stage iiib thymoma;exactmatch
stage iiia thymoma ajcc v8;stage iiia thymoma;exactmatch
stage iii thymoma ajcc v8;stage iii thymoma;exactmatch
stage i thymoma ajcc v8;stage i thymoma;exactmatch
stage ia1 lung cancer ajcc v8;stage ia1 lung cancer;exactmatch
thymoma by ajcc v8 stage;thymoma by ajcc v8 stage;exactmatch
stage ivb thymic epithelial neoplasm ajcc v8;stage ivb thymic epithelial neoplasm ajcc v8;exactmatch
stage iva thymic epithelial neoplasm ajcc v8;stage iva thymic epithelial neoplasm ajcc v8;exactmatch
stage iv thymic epithelial neoplasm ajcc v8;stage iv thymic epithelial neoplasm ajcc v8;exactmatch
stage iiib thymic epithelial neoplasm ajcc v8;stage iiib thymic epithelial neoplasm ajcc v8;exactmatch
stage iiia thymic epithelial neoplasm ajcc v8;stage iiia thymic epithelial neoplasm ajcc v8;exactmatch
stage iii thymic epithelial neoplasm ajcc v8;stage iii thymic epithelial neoplasm ajcc v8;exactmatch
pleural malignant mesothelioma by ajcc v8 stage;pleural malignant mesothelioma by ajcc v8 stage;exactmatch
stage i pleural malignant mesothelioma ajcc v8;stage i pleural malignant mesothelioma;exactmatch
stage ib pleural malignant mesothelioma ajcc v8;stage ib pleural malignant mesothelioma;exactmatch
stage ii pleural malignant mesothelioma ajcc v8;stage ii pleural malignant mesothelioma;exactmatch
stage i lung cancer ajcc v8;stage i;exactmatch
stage 0 lung cancer ajcc v8;stage 0 lung cancer;exactmatch
occult lung cancer ajcc v8;occult lung cancer;exactmatch
lung cancer by ajcc v8 stage;lung cancer by ajcc v8 stage;exactmatch
unresectable head and neck squamous cell carcinoma;unresectable head and neck squamous cell carcinoma;exactmatch
raf family gene mutation;mutant raf;exactmatch
jak family gene mutation;jak family gene mutation;exactmatch
pdgfr family gene mutation;mutant pdgfr;exactmatch
blasts 5 percent or more of bone marrow nucleated cells;blasts 5 percent or more of bone marrow nucleated cells;exactmatch
malignant peritoneal germ cell tumor;malignant peritoneal germ cell tumor;exactmatch
stage ia pleural malignant mesothelioma ajcc v8;stage ia pleural malignant mesothelioma;exactmatch
stage iv pleural malignant mesothelioma ajcc v8;stage iv pleural malignant mesothelioma;exactmatch
stage iiib pleural malignant mesothelioma ajcc v8;stage iiib pleural malignant mesothelioma;exactmatch
stage iiia pleural malignant mesothelioma ajcc v8;stage iiia pleural malignant mesothelioma;exactmatch
stage iii pleural malignant mesothelioma ajcc v8;stage iii pleural malignant mesothelioma;exactmatch
stage ivb bone cancer ajcc v8;stage ivb appendicular skeleton, trunk, skull, and facial bones cancer ajcc v8;exactmatch
bone sarcoma by ajcc v7 stage;bone sarcoma by ajcc v7 stage;exactmatch
rainbow trout mesothelioma;rainbow trout mesothelioma;exactmatch
stage ii retroperitoneal sarcoma ajcc v8;stage ii retroperitoneal sarcoma;exactmatch
merkel cell carcinoma by ajcc v8 stage;merkel cell carcinoma by ajcc v8 stage;exactmatch
merkel cell carcinoma by ajcc v7 stage;merkel cell carcinoma by ajcc v7 stage;exactmatch
atypical spitz nevus;atypical spitz nevus;exactmatch
stage iv retroperitoneal sarcoma ajcc v8;stage iv retroperitoneal sarcoma;exactmatch
stage iiib retroperitoneal sarcoma ajcc v8;stage iiib retroperitoneal sarcoma;exactmatch
stage iiia retroperitoneal sarcoma ajcc v8;stage iiia retroperitoneal sarcoma;exactmatch
stage iii retroperitoneal sarcoma ajcc v8;stage iii retroperitoneal sarcoma;exactmatch
stage ib retroperitoneal sarcoma ajcc v8;stage ib retroperitoneal sarcoma;exactmatch
clinical stage 0 merkel cell carcinoma ajcc v8;clinical stage 0 merkel cell carcinoma ajcc v8;exactmatch
stage ia retroperitoneal sarcoma ajcc v8;stage ia retroperitoneal sarcoma;exactmatch
stage i retroperitoneal sarcoma ajcc v8;stage i retroperitoneal sarcoma;exactmatch
retroperitoneal sarcoma by ajcc v8 stage;retroperitoneal sarcoma by ajcc v8 stage;exactmatch
stage iv small intestinal, esophageal, colorectal, mesenteric, and peritoneal gastrointestinal stromal tumor ajcc v8;stage iv small intestinal, esophageal, colorectal, mesenteric, and peritoneal gist ajcc v8;exactmatch
stage iiib small intestinal, esophageal, colorectal, mesenteric, and peritoneal gastrointestinal stromal tumor ajcc v8;stage iiib small intestinal, esophageal, colorectal, mesenteric, and peritoneal gist ajcc v8;exactmatch
stage iiia small intestinal, esophageal, colorectal, mesenteric, and peritoneal gastrointestinal stromal tumor ajcc v8;stage iiia small intestinal, esophageal, colorectal, mesenteric, and peritoneal gist ajcc v8;exactmatch
stage iii small intestinal, esophageal, colorectal, mesenteric, and peritoneal gastrointestinal stromal tumor ajcc v8;stage iii small intestinal, esophageal, colorectal, mesenteric, and peritoneal gist ajcc v8;exactmatch
merkel cell carcinoma by ajcc v8 clinical stage;merkel cell carcinoma by ajcc v8 clinical stage;exactmatch
clinical stage i merkel cell carcinoma ajcc v8;clinical stage i merkel cell carcinoma ajcc v8;exactmatch
osteosarcoma by ajcc v7 stage;osteosarcoma by ajcc v7 stage;exactmatch
pathologic stage iia merkel cell carcinoma ajcc v8;pathologic stage iia merkel cell carcinoma ajcc v8;exactmatch
intermediate atypical prostate carcinoma;iac;exactmatch
recurrent lymphocyte-rich classic hodgkin lymphoma;recurrent lymphocyte-rich classic hodgkin lymphoma;exactmatch
pathologic stage iv merkel cell carcinoma ajcc v8;pathologic stage iv merkel cell carcinoma ajcc v8;exactmatch
pathologic stage iiib merkel cell carcinoma ajcc v8;pathologic stage iiib merkel cell carcinoma ajcc v8;exactmatch
pathologic stage iiia merkel cell carcinoma ajcc v8;pathologic stage iiia merkel cell carcinoma ajcc v8;exactmatch
pathologic stage iii merkel cell carcinoma ajcc v8;pathologic stage iii merkel cell carcinoma ajcc v8;exactmatch
pathologic stage iib merkel cell carcinoma ajcc v8;pathologic stage iib merkel cell carcinoma ajcc v8;exactmatch
pathologic stage ii merkel cell carcinoma ajcc v8;pathologic stage ii merkel cell carcinoma ajcc v8;exactmatch
clinical stage ii merkel cell carcinoma ajcc v8;clinical stage ii merkel cell carcinoma ajcc v8;exactmatch
pathologic stage i merkel cell carcinoma ajcc v8;pathologic stage i merkel cell carcinoma ajcc v8;exactmatch
pathologic stage 0 merkel cell carcinoma ajcc v8;pathologic stage 0 merkel cell carcinoma ajcc v8;exactmatch
merkel cell carcinoma by ajcc v8 pathologic stage;merkel cell carcinoma by ajcc v8 pathologic stage;exactmatch
clinical stage iv merkel cell carcinoma ajcc v8;clinical stage iv merkel cell carcinoma ajcc v8;exactmatch
clinical stage iii merkel cell carcinoma ajcc v8;clinical stage iii merkel cell carcinoma ajcc v8;exactmatch
clinical stage iib merkel cell carcinoma ajcc v8;clinical stage iib merkel cell carcinoma ajcc v8;exactmatch
clinical stage iia merkel cell carcinoma ajcc v8;clinical stage iia merkel cell carcinoma ajcc v8;exactmatch
stage ii small intestinal, esophageal, colorectal, mesenteric, and peritoneal gastrointestinal stromal tumor ajcc v8;stage ii small intestinal, esophageal, colorectal, mesenteric, and peritoneal gist ajcc v8;exactmatch
stage i small intestinal, esophageal, colorectal, mesenteric, and peritoneal gastrointestinal stromal tumor ajcc v8;stage i small intestinal, esophageal, colorectal, mesenteric, and peritoneal gist ajcc v8;exactmatch
stage iv gastric and omental gastrointestinal stromal tumor ajcc v8;stage iv gastric (stomach) and omental gastrointestinal stromal tumor (gist);exactmatch
stage ia soft tissue sarcoma of the trunk and extremities ajcc v8;stage ia soft tissue sarcoma of the trunk and extremities;exactmatch
soft tissue sarcoma by ajcc v7 stage;soft tissue sarcoma by ajcc v7 stage;exactmatch
stage iv soft tissue sarcoma of the trunk and extremities ajcc v8;stage iv soft tissue sarcoma of the trunk and extremities;exactmatch
stage iiib soft tissue sarcoma of the trunk and extremities ajcc v8;stage iiib soft tissue sarcoma of the trunk and extremities;exactmatch
stage iiia soft tissue sarcoma of the trunk and extremities ajcc v8;stage iiia soft tissue sarcoma of the trunk and extremities;exactmatch
stage iii soft tissue sarcoma of the trunk and extremities ajcc v8;stage iii soft tissue sarcoma of the trunk and extremities;exactmatch
stage ii soft tissue sarcoma of the trunk and extremities ajcc v8;stage ii soft tissue sarcoma of the trunk and extremities;exactmatch
stage ib soft tissue sarcoma of the trunk and extremities ajcc v8;stage ib soft tissue sarcoma of the trunk and extremities;exactmatch
stage i soft tissue sarcoma of the trunk and extremities ajcc v8;stage i soft tissue sarcoma of the trunk and extremities;exactmatch
stage iiib gastric and omental gastrointestinal stromal tumor ajcc v8;stage iiib gastric (stomach) and omental gastrointestinal stromal tumor (gist);exactmatch
soft tissue sarcoma of the trunk and extremities by ajcc v8 stage;soft tissue sarcoma trunk and extremities by ajcc v8 stage;exactmatch
soft tissue sarcoma by ajcc v8 stage;soft tissue sarcoma by ajcc v8 stage;exactmatch
recurrent cervical adenocarcinoma;recurrent cervical adenocarcinoma;exactmatch
recurrent cervical adenosquamous carcinoma;recurrent cervical adenosquamous cancer;exactmatch
recurrent cervical squamous cell carcinoma, not otherwise specified;recurrent cervical squamous cell cancer, nos;exactmatch
blasts 10 percent or more of bone marrow nucleated cells;blasts 10 percent or more of bone marrow nucleated cells;exactmatch
notch family gene mutation;notch family gene mutation;exactmatch
uterine corpus sarcoma by ajcc v7 stage;uterine corpus sarcoma by ajcc v7 stage;exactmatch
invasive lung mucinous adenocarcinoma;invasive lung mucinous adenocarcinoma;exactmatch
ligand binding domain;binding site;exactmatch
lung enteric adenocarcinoma;enteric adenocarcinoma;exactmatch
stage iiia gastric and omental gastrointestinal stromal tumor ajcc v8;stage iiia gastric (stomach) and omental gastrointestinal stromal tumor (gist);exactmatch
stage iii gastric and omental gastrointestinal stromal tumor ajcc v8;stage iii gastric (stomach) and omental gastrointestinal stromal tumor (gist);exactmatch
stage ii gastric and omental gastrointestinal stromal tumor ajcc v8;stage ii gastric (stomach) and omental gastrointestinal stromal tumor (gist);exactmatch
stage ib gastric and omental gastrointestinal stromal tumor ajcc v8;stage ib gastric (stomach) and omental gastrointestinal stromal tumor (gist);exactmatch
stage ia gastric and omental gastrointestinal stromal tumor ajcc v8;stage ia gastric (stomach) and omental gastrointestinal stromal tumor (gist);exactmatch
stage i gastric and omental gastrointestinal stromal tumor ajcc v8;stage i gastric (stomach) and omental gastrointestinal stromal tumor (gist);exactmatch
small intestinal, esophageal, colorectal, mesenteric, and peritoneal gastrointestinal stromal tumor by ajcc v8 stage;small intestinal, esophageal, colorectal, mesenteric, and peritoneal gist by ajcc v8 stage;exactmatch
gastric and omental gastrointestinal stromal tumor by ajcc v8 stage;gastric and omental gist by ajcc v8 stage;exactmatch
gastrointestinal stromal tumor by ajcc v8 stage;gist by ajcc v8 stage;exactmatch
lung squamous cell carcinoma in situ;lusc-cis;exactmatch
lung mucinous adenocarcinoma in situ;lung mucinous adenocarcinoma in situ;exactmatch
lung non-mucinous adenocarcinoma in situ;lung non-mucinous adenocarcinoma in situ;exactmatch
intercellular bridges present;intercellular bridges present;exactmatch
lung non-keratinizing squamous cell carcinoma;lung non-keratinizing squamous cell carcinoma;exactmatch
lung keratinizing squamous cell carcinoma;keratinizing squamous cell lung carcinoma;exactmatch
recurrent langerhans cell histiocytosis;recurrent langerhans cell histiocytosis;exactmatch
recurrent histiocytic and dendritic cell neoplasm;recurrent histiocytic and dendritic cell neoplasm;exactmatch
refractory histiocytic and dendritic cell neoplasm;refractory histiocytic and dendritic cell neoplasm;exactmatch
epicardium;epicardium;exactmatch
pole gene mutation;dna polymerase epsilon catalytic subunit a exonuclease gene mutation;exactmatch
cdkn2a negative;cdkn2a loss;exactmatch
cdk4 gene amplification;cdk4 amplification;exactmatch
dna repair gene mutation;dna repair gene mutation;exactmatch
deleterious palb2 gene mutation;deleterious fancn gene mutation;exactmatch
anastomosing hemangioma;anastomosing hemangioma;exactmatch
mucosa;mucosa;exactmatch
platelet disorder;platelet abnormality;exactmatch
stratified squamous epithelium;stratified squamous epithelium;exactmatch
ventricular involvement only;ventricular involvement only;exactmatch
recurrent ependymal tumor;recurrent ependymal tumor;exactmatch
infratentorial and spinal cord ependymal tumor;infratentorial and spinal cord ependymal tumor;exactmatch
infratentorial ependymal tumor;infratentorial ependymal tumor;exactmatch
supratentorial ependymal tumor;supratentorial ependymal tumor;exactmatch
ependymal tumor of brain and spinal cord;ependymal tumor of brain and spinal cord;exactmatch
cervical, thoracic, and lumbosacral spinal cord ependymal tumor;cervical, thoracic, and lumbosacral spinal cord ependymal tumor;exactmatch
pold1 gene mutation;cdc2 gene mutation;exactmatch
pseudostratified columnar ciliated epithelium;pseudostratified columnar ciliated epithelium;exactmatch
chromosome 1;chromosome 1;exactmatch
high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements;high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements;exactmatch
bcl6 gene rearrangement;b-cell cll/lymphoma 6 gene rearrangement;exactmatch
chromosome;chromosome;exactmatch
bcl2 gene rearrangement;b-cell cll-lymphoma 2 gene rearrangement;exactmatch
myc gene rearrangement;c-myc gene rearrangement;exactmatch
resectable head and neck squamous cell carcinoma;resectable head and neck squamous cell cancer;exactmatch
chromatin;chromatin;exactmatch
nucleus;cell nucleus;exactmatch
11q aberration;11q aberration;exactmatch
columnar epithelium;columnar epithelium;exactmatch
burkitt-like lymphoma with 11q aberration;b-cell lymphoma with 11q aberration resembling burkitt lymphoma;exactmatch
ebv-positive mucocutaneous ulcer;ebv-positive mucocutaneous ulcer;exactmatch
childhood t acute lymphoblastic leukemia in remission;childhood t acute lymphoblastic leukemia in remission;exactmatch
recurrent childhood t acute lymphoblastic leukemia;recurrent childhood t acute lymphoblastic leukemia;exactmatch
recurrent chronic lymphocytic leukemia/small lymphocytic lymphoma;recurrent chronic lymphocytic leukemia/small lymphocytic lymphoma;exactmatch
amino acid sequence;amino acid sequence;exactmatch
periosteum;periosteum;exactmatch
cervical and lumbosacral spinal cord ependymal tumor;cervical and lumbosacral spinal cord ependymal tumor;exactmatch
thoracic and lumbosacral spinal cord ependymal tumor;thoracic and lumbosacral spinal cord ependymal tumor;exactmatch
cervical and thoracic spinal cord ependymal tumor;cervical and thoracic spinal cord ependymal tumor;exactmatch
bipolar neuron;bipolar neuron;exactmatch
ventricular ependymal tumor;ventricular ependymal tumor;exactmatch
cerebellar ependymal tumor;cerebellar ependymal tumor;exactmatch
parietal lobe ependymal tumor;parietal lobe ependymal tumor;exactmatch
temporal lobe ependymal tumor;temporal lobe ependymal tumor;exactmatch
frontal lobe ependymal tumor;frontal lobe ependymal tumor;exactmatch
cuboidal cell;cuboidal cell;exactmatch
ganglion cell;ganglion cell;exactmatch
ependymal tumor of spinal cord;ependymal tumor of spinal cord;exactmatch
lumbosacral spinal cord ependymal tumor;lumbosacral spinal cord ependymal tumor;exactmatch
olfactory receptor cell;olfactory receptor cell;exactmatch
childhood melanoma;childhood melanoma;exactmatch
"t(11;15)(p15;q35)";"t(11;15)(p15;q35)";exactmatch
"acute myeloid leukemia with t(11;15)(p15;q35); nup98-jarid1a";"aml with t(11;15)(p15;q35); nup98-jarid1a";exactmatch
"t(5;11)(q35;p15)";"t(5;11)(q35;p15)";exactmatch
"acute myeloid leukemia with t(5;11)(q35;p15); nup98-nsd1";"aml with t(5;11)(q35;p15); nup98-nsd1";exactmatch
recurrent subsequent malignant neoplasm;recurrent secondary malignancy;exactmatch
ventricular and brain stem ependymal tumor;ventricular and brain stem ependymal tumor;exactmatch
columnar cell;columnar cell;exactmatch
parietal lobe and occipital lobe ependymal tumor;parietal lobe and occipital lobe ependymal tumor;exactmatch
temporal lobe and parietal lobe ependymal tumor;temporal lobe and parietal lobe ependymal tumor;exactmatch
thoracic spinal cord ependymal tumor;thoracic spinal cord ependymal tumor;exactmatch
cervical spinal cord ependymal tumor;cervical spinal cord ependymal tumor;exactmatch
temporal lobe, parietal lobe, and lateral ventricle ependymal tumor;temporal lobe, parietal lobe, and lateral ventricle ependymal tumor;exactmatch
cerebellar and fourth ventricle ependymal tumor;cerebellar and fourth ventricle ependymal tumor;exactmatch
fourth ventricle and brain stem ependymal tumor;fourth ventricle and brain stem ependymal tumor;exactmatch
third ventricle ependymal tumor;third ventricle ependymal tumor;exactmatch
lateral ventricle ependymal tumor;lateral ventricle ependymal tumor;exactmatch
fourth ventricle ependymal tumor;fourth ventricle ependymal tumor;exactmatch
cerebellar, brain stem, and cervical spinal cord ependymal tumor;cerebellar, brain stem, and cervical spinal cord ependymal tumor;exactmatch
occipital lobe, parietal lobe, and ventricular ependymal tumor;occipital lobe, parietal lobe, and ventricular ependymal tumor;exactmatch
posterior cranial fossa ependymal tumor;posterior cranial fossa ependymal tumor;exactmatch
cerebellar, fourth ventricle, and brain stem ependymal tumor;cerebellar, fourth ventricle, and brain stem ependymal tumor;exactmatch
cerebellar and brain stem ependymal tumor;cerebellar and brain stem ependymal tumor;exactmatch
frontal lobe and parietal lobe ependymal tumor;frontal lobe and parietal lobe ependymal tumor;exactmatch
cerebellar and ventricular ependymal tumor;cerebellar and ventricular ependymal tumor;exactmatch
human chromosome;human chromosome;exactmatch
chromosome 10;chromosome 10;exactmatch
human papillomavirus negative;hpv negative;exactmatch
who grade ii glioma;grade ii glioma;exactmatch
stage iva unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy ajcc v8;stage iva unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy ajcc v8;exactmatch
stage iii unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy ajcc v8;stage iii unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy ajcc v8;exactmatch
unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy by ajcc v8 stage;unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy by ajcc v8 stage;exactmatch
nuclear membrane;nuclear envelope;exactmatch
mitochondrion;mitochondria;exactmatch
microtubule;micro tubule;exactmatch
recurrent glioma;recurrent glioma;exactmatch
body fluid or substance;body fluid or substance;exactmatch
nucleosome;nucleosome;exactmatch
endoplasmic reticulum;er;exactmatch
atypical pituitary gland adenoma;atypical pituitary gland adenoma;exactmatch
recurrent endometrial serous adenocarcinoma;recurrent endometrial serous adenocarcinoma;exactmatch
embryonic structure;embryologic structure;exactmatch
canine soft tissue sarcoma;canine soft tissue sarcoma;exactmatch
canine thyroid adenocarcinoma;canine thyroid adenocarcinoma;exactmatch
feline mammary carcinoma;feline mammary carcinoma;exactmatch
stage ivb unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy ajcc v8;stage ivb unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy ajcc v8;exactmatch
stage ivc unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy ajcc v8;stage ivc unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy ajcc v8;exactmatch
chromosome 11;chromosome 11;exactmatch
stage ivb lip and oral cavity cancer ajcc v8;stage ivb lip and oral cavity cancer;exactmatch
stage i major salivary gland cancer ajcc v8;stage i major salivary gland cancer;exactmatch
major salivary gland cancer by ajcc v8 stage;major salivary gland cancer by ajcc v8 stage;exactmatch
major salivary gland cancer by ajcc v7 stage;major salivary gland cancer by ajcc v7 stage;exactmatch
semen;human semen (sperm);exactmatch
ribosome;ribosomal;exactmatch
lip and oral cavity cancer by ajcc v6 and v7 stage;lip and oral cavity cancer by ajcc v6 and v7 stage;exactmatch
stage ivc lip and oral cavity cancer ajcc v8;stage ivc lip and oral cavity cancer;exactmatch
stage iva lip and oral cavity cancer ajcc v8;stage iva lip and oral cavity cancer;exactmatch
cytoplasmic organelle;cytoplasmic organelle;exactmatch
stage iv lip and oral cavity cancer ajcc v8;stage iv lip and oral cavity cancer;exactmatch
stage iii lip and oral cavity cancer ajcc v8;stage iii lip and oral cavity cancer;exactmatch
stage ii lip and oral cavity cancer ajcc v8;stage ii lip and oral cavity cancer;exactmatch
stage i lip and oral cavity cancer ajcc v8;stage i lip and oral cavity cancer;exactmatch
lip and oral cavity cancer by ajcc v8 stage;lip and oral cavity cancer by ajcc v8 stage;exactmatch
placenta;placenta;exactmatch
"t(9;22)(q34.1;q11.2)";"t(9;22)(q34.1;q11.2)";exactmatch
cytoskeleton;cellular matrix;exactmatch
small intestinal myeloid sarcoma;myeloid sarcoma of the small intestine;exactmatch
cytoplasm;cytoplasm;exactmatch
acute megakaryoblastic leukemia with cbfa2t3-glis2;acute megakaryoblastic leukemia with cbfa2t3-glis2;exactmatch
malignant solid neoplasm;malignant solid neoplasm;exactmatch
chromosome 19;chromosome 19;exactmatch
chromosome 18;chromosome 18;exactmatch
chromosome 17;chromosome 17;exactmatch
acute megakaryoblastic leukemia with nup98-kdm5a;acute megakaryoblastic leukemia with nup98-kdm5a;exactmatch
"t(11;12)(p15;p13)";"t(11;12)(p15;p13)";exactmatch
chromosome 16;chromosome 16;exactmatch
"acute myeloid leukemia with t(6;11)(q27;q23); mllt4-mll";"acute myeloid leukemia (aml) with t(6;11)(q27;q23); kmt2a-mllt4";exactmatch
chromosome 9;chromosome 9;exactmatch
"t(10;11)(p12;q23)";"t(10;11)(p12;q23)";exactmatch
"acute myeloid leukemia with t(10;11)(p12;q23); mllt10-mll";"acute myeloid leukemia (aml) with t(10;11)(p12;q23); mll-mllt10";exactmatch
chromosome 15;chromosome 15;exactmatch
chromosome 14;chromosome 14;exactmatch
chromosome 13;chromosome 13;exactmatch
chromosome 12;chromosome 12;exactmatch
low grade glioma;cns, low grade glioma (lgg);exactmatch
unresectable leiomyosarcoma;unresectable leiomyosarcoma;exactmatch
unresectable liposarcoma;unresectable liposarcoma;exactmatch
chromosome 2;chromosome 2;exactmatch
chromosome 20;chromosome 20;exactmatch
ajcc v8 stage;8th;exactmatch
chromosome arm 9p loss of heterozygosity;9p loh;exactmatch
chromosome arm 3p loss of heterozygosity;3p loh;exactmatch
chromosome 8;chromosome 8;exactmatch
chromosome 7;chromosome 7;exactmatch
ras family gene mutation;mutant ras;exactmatch
cdkn2a-p16 negative;cdkn2a-p16 negative;exactmatch
chromosome 6;chromosome 6;exactmatch
chromosome 5;chromosome 5;exactmatch
chromosome 4;chromosome 4;exactmatch
rat pituitary gland neoplasm;rat pituitary gland neoplasm;exactmatch
feline lymphoma;feline lymphoma;exactmatch
chromosome 3;chromosome 3;exactmatch
chromosome 22;chromosome 22;exactmatch
chromosome 21;chromosome 21;exactmatch
recurrent primary malignant neoplasm;recurrent primary malignancy;exactmatch
rb1 negative;rb negative;exactmatch
stage ii major salivary gland cancer ajcc v8;stage ii major salivary gland cancer;exactmatch
unresectable thyroid gland carcinoma;unresectable thyroid gland cancer;exactmatch
central nervous system histiocytic sarcoma;central nervous system histiocytic sarcoma;exactmatch
central nervous system langerhans cell histiocytosis;central nervous system langerhans cell histiocytosis;exactmatch
translocations involving tyrosine kinases or cytokine receptors present;translocations involving tyrosine kinases or cytokine receptors present;exactmatch
b acute lymphoblastic leukemia, bcr-abl1-like;b acute lymphoblastic leukemia with translocations involving tyrosine kinases or cytokine receptors;exactmatch
b lymphoblastic leukemia/lymphoma, bcr-abl1-like;b lymphoblastic leukemia/lymphoma with translocations involving tyrosine kinases or cytokine receptors;exactmatch
acute myeloid leukemia with mutated runx1;acute myeloid leukemia with mutated runx1;exactmatch
acute myeloid leukemia with bcr-abl1;acute myeloid leukemia with bcr-abl1;exactmatch
acute myeloid leukemia with monoallelic mutations of cebpa;acute myeloid leukemia with monoallelic mutations of cebpa;exactmatch
wall of the pharynx;pharyngeal wall;exactmatch
acute myeloid leukemia with biallelic mutations of cebpa;aml with biallelic mutations of cebpa;exactmatch
pluripotent stem cell;pluripotent stem cell;exactmatch
cervicomedullary junction;cervico-medullary junction;exactmatch
breast;breast;exactmatch
advanced malignant solid neoplasm;advanced malignant solid neoplasm;exactmatch
gata2 gene mutation;gata binding protein 2 gene mutation;exactmatch
xp11.2 translocations/tfe3 gene fusions present;xp11.2 translocations/tfe3 gene fusions present;exactmatch
central nervous system erdheim-chester disease;central nervous system erdheim-chester disease;exactmatch
bone of the lower extremity;bone of lower extremity;exactmatch
vestibulocochlear nerve;cranial nerve eight;exactmatch
rat ovarian adenocarcinoma;rat ovarian adenocarcinoma;exactmatch
splenic white pulp;splenic white pulp;exactmatch
sacral chordoma;sacral chordoma;exactmatch
neuroblast;neuroblast;exactmatch
floor of mouth basaloid squamous cell carcinoma;floor of mouth bscc;exactmatch
advanced head and neck carcinoma;advanced head and neck cancer;exactmatch
alveolus;alveolus;exactmatch
mouse teratocarcinoma;mouse teratocarcinoma;exactmatch
gingival squamous cell carcinoma;gingival scc;exactmatch
unresectable transitional cell carcinoma;unresectable transitional cell cancer;exactmatch
pcm1/jak2 fusion gene;pcm1-jak2 fusion gene;exactmatch
"t(8;9)(p22;p24.1)";"t(8;9)(p22;p24.1)";exactmatch
myeloid/lymphoid neoplasms with pcm1-jak2;"myeloid and lymphoid neoplasms with t(8;9)(p22;p24.1);pcm1-jak2";exactmatch
"chronic myelomonocytic leukemia with eosinophilia associated with t(5;12)(q31;p12)";"chronic myelomonocytic leukemia with eosinophilia associated with t(5;12)";exactmatch
monoallelic mutation;monoallelic mutation;exactmatch
biallelic mutation;biallelic mutation;exactmatch
metastatic transitional cell carcinoma;metastatic transitional cell cancer;exactmatch
unresectable digestive system adenocarcinoma;unresectable digestive system adenocarcinoma;exactmatch
connective and soft tissue;connective and soft tissue;exactmatch
gut epithelium;gut epithelium;exactmatch
duct;duct;exactmatch
nuclear expression of stat6 protein;gain of nuclear stat6;exactmatch
prkar1a gene mutation;prkar1a gene mutation;exactmatch
central nervous system embryonal tumor with rhabdoid features;cns embryonal tumor with rhabdoid features;exactmatch
loss of brg1 protein expression;loss of atp-dependent helicase smarca4 protein expression;exactmatch
embryonic tissue;embryonic tissue;exactmatch
embryonal tumor with multilayered rosettes, not otherwise specified;embryonal tumor with multilayered rosettes, nos;exactmatch
c19mc amplification;c19mc amplification;exactmatch
human papillomavirus-16 positive;hpv-16 positive;exactmatch
fgfr3 gene amplification;cd333 gene amplification;exactmatch
epstein-barr virus positive;ebv positive;exactmatch
small cell adenocarcinoma;small cell adenocarcinoma;exactmatch
medulloblastoma, not otherwise specified;medulloblastoma, nos;exactmatch
medulloblastoma, non-wnt/non-shh, group 4;medulloblastoma, non-wnt/non-shh, group 4;exactmatch
medulloblastoma, non-wnt/non-shh, group 3;medulloblastoma, non-wnt/non-shh, group 3;exactmatch
medulloblastoma, non-wnt/non-shh;medulloblastoma, non-wnt/non-shh;exactmatch
medulloblastoma, shh-activated, tp53-wildtype;medulloblastoma, shh-activated, tp53-wildtype;exactmatch
central nervous system solitary fibrous tumor/hemangiopericytoma;cns solitary fibrous tumor/hemangiopericytoma;exactmatch
central nervous system solitary fibrous tumor/hemangiopericytoma, grade 3;cns solitary fibrous tumor/hemangiopericytoma, grade 3;exactmatch
central nervous system solitary fibrous tumor/hemangiopericytoma, grade 2;cns solitary fibrous tumor/hemangiopericytoma, grade 2;exactmatch
central nervous system solitary fibrous tumor/hemangiopericytoma, grade 1;cns solitary fibrous tumor/hemangiopericytoma, grade 1;exactmatch
central nervous system intravascular large b-cell lymphoma;central nervous system intravascular large b-cell lymphoma;exactmatch
central nervous system mature t-cell and nk-cell non-hodgkin lymphoma;central nervous system mature t-cell and nk-cell non-hodgkin lymphoma;exactmatch
central nervous system anaplastic large cell lymphoma, alk-negative;central nervous system anaplastic large cell lymphoma, alk-negative;exactmatch
central nervous system anaplastic large cell lymphoma, alk-positive;central nervous system anaplastic large cell lymphoma, alk-positive;exactmatch
alk gene rearrangement;alk gene rearrangement;exactmatch
exocrine system;exocrine system;exactmatch
skull osteoma;skull osteoma;exactmatch
central nervous system undifferentiated pleomorphic sarcoma;central nervous system malignant fibrous histiocytoma;exactmatch
central nervous system myofibroblastoma;central nervous system myofibroblastoma;exactmatch
intracranial fibrous histiocytoma;intracranial benign fibrous histiocytoma;exactmatch
central nervous system desmoid fibromatosis;central nervous system desmoid fibromatosis;exactmatch
central nervous system angiolipoma;central nervous system angiolipoma;exactmatch
central nervous system ewing sarcoma/peripheral primitive neuroectodermal tumor;central nervous system ewing sarcoma/peripheral primitive neuroectodermal tumor;exactmatch
central nervous system epithelioid hemangioendothelioma;central nervous system epithelioid hemangioendothelioma;exactmatch
central nervous system mesenchymal chondrosarcoma;central nervous system mesenchymal chondrosarcoma;exactmatch
cdkn2a gene product;cdkn2a gene product;exactmatch
crlf2 gene rearrangement;crlf2 gene rearrangement;exactmatch
bovine leukemia;bovine leukemia;exactmatch
muscle;muscle;exactmatch
acinar cell;acinar cell;exactmatch
bone tissue;bone tissue;exactmatch
dentition;dentition;exactmatch
face;face;exactmatch
neck;cervical;exactmatch
sensory ganglion;sensory ganglia;exactmatch
synovial cell;synovial cell;exactmatch
secretory cell;secretory cell;exactmatch
neural pathway;neural pathway;exactmatch
embryonic cell;blastomere;exactmatch
vascular endothelium;vascular endothelium;exactmatch
nerve tissue;human nerve tissue;exactmatch
hematopoietic tissue;hematopoietic tissue;exactmatch
skeletal muscle tissue;muscle, skeletal;exactmatch
lymphoid tissue;lymphoid normal;exactmatch
nephron;nephron;exactmatch
ependyma;ependyma;exactmatch
alveolar wall;alveolar wall;exactmatch
vertebral column;spinal column;exactmatch
recurrent urethral urothelial carcinoma;recurrent urethral urothelial cancer;exactmatch
brca2 protein variant;brca1/brca2-containing complex, subunit 2 protein variant;exactmatch
brca1 protein variant;brca1 protein variant;exactmatch
msh2 protein variant;dna mismatch repair protein msh2 protein variant;exactmatch
microsatellite stable;msi stable;exactmatch
eif1ax gene;eif1ax;exactmatch
7p15-p14;7p15-p14;exactmatch
memory b-lymphocyte;memory b cell;exactmatch
recurrent gliosarcoma;recurrent gliosarcoma;exactmatch
posterior cranial fossa neoplasm;posterior cranial fossa neoplasm;exactmatch
immature lymphocyte;immature lymphocyte;exactmatch
tert gene mutation;dkca2 gene mutation;exactmatch
fascia;fascia;exactmatch
prostatic epithelium;prostatic epithelium;exactmatch
prostatic duct;prostatic duct;exactmatch
prostatic urethra;prostatic portion of the male urethra;exactmatch
stage ia mycosis fungoides ajcc v7;stage ia mycosis fungoides;exactmatch
seminiferous tubule;seminiferous tubule;exactmatch
ligament;human ligament;exactmatch
tendon;human tendon;exactmatch
endocardium;endocardium;exactmatch
lymphoblast;lymphoblast;exactmatch
ampulla of vater;ampulla;exactmatch
pericardium;human pericardium;exactmatch
multilineage dysplasia present;multilineage dysplasia present;exactmatch
limited early t-cell differentiation;limited early t-cell differentiation;exactmatch
early t acute lymphoblastic leukemia;etp all;exactmatch
b acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21;b acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21;exactmatch
b-lymphoblastic leukemia/lymphoma with intrachromosomal amplification of chromosome 21;b-lymphoblastic leukemia/lymphoma with intrachromosomal amplification of chromosome 21;exactmatch
joint;articular;exactmatch
myeloid neoplasms with germline predisposition;myeloid neoplasms with germline predisposition;exactmatch
myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia;mds-rs-sld;exactmatch
chronic myelomonocytic leukemia-0;cmml-0;exactmatch
ependymal cell;ependymal cell;exactmatch
cardiomyocyte;cardiocyte;exactmatch
smooth muscle cell;leiomyocyte;exactmatch
major salivary gland;major salivary gland;exactmatch
organ;organ;exactmatch
eye part;eye part;exactmatch
experimental organism benign plasma cell tumor;experimental organism benign plasma cell tumor;exactmatch
breast part;breast part;exactmatch
ear part;ear part;exactmatch
nervous system part;nervous system part;exactmatch
female reproductive system part;female reproductive system part;exactmatch
male reproductive system part;male reproductive system part;exactmatch
respiratory system part;respiratory system part;exactmatch
urinary system part;urinary system part;exactmatch
immune system part;immune system part;exactmatch
brain part;brain part;exactmatch
endocrine system part;endocrine system part;exactmatch
stage ib mycosis fungoides ajcc v7;stage ib mycosis fungoides;exactmatch
castration resistance;castration resistance;exactmatch
castration-resistant prostate carcinoma;crpc;exactmatch
heart part;heart part;exactmatch
skin part;skin part;exactmatch
constitutional mismatch repair deficiency syndrome;bmmrd;exactmatch
stage 0 major salivary gland cancer ajcc v8;stage 0 major salivary gland cancer;exactmatch
stage iii major salivary gland cancer ajcc v8;stage iii major salivary gland cancer;exactmatch
recurrent lymphoma;recurrent lymphoma;exactmatch
postneoadjuvant therapy stage ii gastroesophageal junction adenocarcinoma ajcc v8;postneoadjuvant therapy stage ii gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
recurrent classic hodgkin lymphoma;recurrent classic hodgkin lymphoma;exactmatch
postneoadjuvant therapy stage ivb gastroesophageal junction adenocarcinoma ajcc v8;postneoadjuvant therapy stage ivb gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iva gastroesophageal junction adenocarcinoma ajcc v8;postneoadjuvant therapy stage iva gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iv gastroesophageal junction adenocarcinoma ajcc v8;postneoadjuvant therapy stage iv gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iiib gastroesophageal junction adenocarcinoma ajcc v8;postneoadjuvant therapy stage iiib gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iiia gastroesophageal junction adenocarcinoma ajcc v8;postneoadjuvant therapy stage iiia gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iii gastroesophageal junction adenocarcinoma ajcc v8;postneoadjuvant therapy stage iii gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage i gastroesophageal junction adenocarcinoma ajcc v8;postneoadjuvant therapy stage i gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
gastric cancer by ajcc v8 clinical stage;gastric cancer by ajcc v8 clinical stage;exactmatch
gastroesophageal junction adenocarcinoma by ajcc v8 postneoadjuvant therapy stage;gastroesophageal junction adenocarcinoma by ajcc v8 postneoadjuvant therapy stage;exactmatch
pathologic stage ivb gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage ivb gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage iva gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage iva gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage iv gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage iv gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage iiib gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage iiib gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage iiia gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage iiia gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage iii gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage iii gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
gastric cancer by ajcc v8 stage;gastric cancer by ajcc v8 stage;exactmatch
gastric cancer by ajcc v8 pathologic stage;gastric cancer by ajcc v8 pathologic stage;exactmatch
pathologic stage iiic gastric cancer ajcc v8;iiic;exactmatch
pathologic stage i gastric cancer ajcc v8;pathologic stage i gastric cancer ajcc v8;exactmatch
pathologic stage iiia gastric cancer ajcc v8;iiia;exactmatch
pathologic stage iii gastric cancer ajcc v8;pathologic stage iii gastric cancer ajcc v8;exactmatch
pathologic stage iib gastric cancer ajcc v8;iib;exactmatch
pathologic stage iia gastric cancer ajcc v8;iia;exactmatch
pathologic stage ii gastric cancer ajcc v8;pathologic stage ii gastric cancer ajcc v8;exactmatch
pathologic stage ib gastric cancer ajcc v8;ib;exactmatch
pathologic stage ia gastric cancer ajcc v8;ia;exactmatch
pathologic stage 0 gastric cancer ajcc v8;0;exactmatch
gastric cancer by ajcc v8 postneoadjuvant therapy stage;gastric cancer by ajcc v8 postneoadjuvant therapy stage;exactmatch
clinical stage ivb gastric cancer ajcc v8;clinical stage ivb gastric cancer ajcc v8;exactmatch
clinical stage iva gastric cancer ajcc v8;clinical stage iva gastric cancer ajcc v8;exactmatch
clinical stage iv gastric cancer ajcc v8;clinical stage iv gastric cancer ajcc v8;exactmatch
clinical stage iii gastric cancer ajcc v8;clinical stage iii gastric cancer ajcc v8;exactmatch
clinical stage ii gastric cancer ajcc v8;clinical stage ii gastric cancer ajcc v8;exactmatch
clinical stage i gastric cancer ajcc v8;clinical stage i gastric cancer ajcc v8;exactmatch
clinical stage 0 gastric cancer ajcc v8;clinical stage 0 gastric cancer ajcc v8;exactmatch
pathologic stage iib gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage iib gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage iia gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage iia gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage ii gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage ii gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage ib esophageal squamous cell carcinoma ajcc v8;ib;exactmatch
pathologic stage iv esophageal squamous cell carcinoma ajcc v8;pathologic stage iv esophageal squamous cell carcinoma ajcc v8;exactmatch
pathologic stage iiib esophageal squamous cell carcinoma ajcc v8;iiib;exactmatch
pathologic stage iiia esophageal squamous cell carcinoma ajcc v8;iiia;exactmatch
pathologic stage iii esophageal squamous cell carcinoma ajcc v8;pathologic stage iii esophageal squamous cell carcinoma ajcc v8;exactmatch
pathologic stage iib esophageal squamous cell carcinoma ajcc v8;iib;exactmatch
pathologic stage iia esophageal squamous cell carcinoma ajcc v8;iia;exactmatch
pathologic stage ii esophageal squamous cell carcinoma ajcc v8;pathologic stage ii esophageal squamous cell carcinoma ajcc v8;exactmatch
pathologic stage ia esophageal squamous cell carcinoma ajcc v8;ia;exactmatch
pathologic stage ic gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage ic gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage i esophageal squamous cell carcinoma ajcc v8;pathologic stage i esophageal squamous cell carcinoma ajcc v8;exactmatch
pathologic stage 0 esophageal squamous cell carcinoma ajcc v8;0;exactmatch
melanoma metastatic in the central nervous system;melanoma metastatic in the cns;exactmatch
lung carcinoma metastatic in the central nervous system;lung carcinoma metastatic in the cns;exactmatch
breast carcinoma metastatic in the central nervous system;breast carcinoma metastatic in the cns;exactmatch
recurrent atypical teratoid/rhabdoid tumor;recurrent atypical teratoid/rhabdoid tumor;exactmatch
irf4 gene rearrangement;irf4 gene rearrangement;exactmatch
pathologic stage iva esophageal squamous cell carcinoma ajcc v8;iva;exactmatch
pathologic stage ivb esophageal squamous cell carcinoma ajcc v8;ivb;exactmatch
gastroesophageal junction adenocarcinoma by ajcc v8 stage;gastroesophageal junction adenocarcinoma by ajcc v8 stage;exactmatch
gastroesophageal junction adenocarcinoma by ajcc v8 clinical stage;gastroesophageal junction adenocarcinoma by ajcc v8 clinical stage;exactmatch
pathologic stage ib gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage ib gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage ia gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage ia gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage i gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage i gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
pathologic stage 0 gastroesophageal junction adenocarcinoma ajcc v8;pathologic stage 0 gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
gastroesophageal junction adenocarcinoma by ajcc v8 pathologic stage;gastroesophageal junction adenocarcinoma by ajcc v8 pathologic stage;exactmatch
clinical stage ivb gastroesophageal junction adenocarcinoma ajcc v8;clinical stage ivb gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
clinical stage iva gastroesophageal junction adenocarcinoma ajcc v8;clinical stage iva gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8;clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8;clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
clinical stage iib gastroesophageal junction adenocarcinoma ajcc v8;clinical stage iib gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
clinical stage iia gastroesophageal junction adenocarcinoma ajcc v8;clinical stage iia gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
clinical stage ii gastroesophageal junction adenocarcinoma ajcc v8;clinical stage ii gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
clinical stage i gastroesophageal junction adenocarcinoma ajcc v8;clinical stage i gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
clinical stage 0 gastroesophageal junction adenocarcinoma ajcc v8;clinical stage 0 gastroesophageal junction adenocarcinoma ajcc v8;exactmatch
chromosome arm;chromosome arm;exactmatch
pathologic stage iiib gastric cancer ajcc v8;iiib;exactmatch
pathologic stage iv gastric cancer ajcc v8;iv;exactmatch
alk protein variant;alk protein variant;exactmatch
stage ii small intestinal adenocarcinoma ajcc v8;stage ii small intestinal adenocarcinoma;exactmatch
"t(8;21)(q22;q22)";eight-twenty-one;exactmatch
stage iv small intestinal adenocarcinoma ajcc v8;stage iv small intestinal adenocarcinoma;exactmatch
stage iiib small intestinal adenocarcinoma ajcc v8;stage iiib small intestinal adenocarcinoma;exactmatch
stage iiia small intestinal adenocarcinoma ajcc v8;stage iiia small intestinal adenocarcinoma;exactmatch
stage iii small intestinal adenocarcinoma ajcc v8;stage iii small intestinal adenocarcinoma;exactmatch
stage iib small intestinal adenocarcinoma ajcc v8;stage iib small intestinal adenocarcinoma;exactmatch
stage iia small intestinal adenocarcinoma ajcc v8;stage iia small intestinal adenocarcinoma;exactmatch
stage i small intestinal adenocarcinoma ajcc v8;stage i small intestinal adenocarcinoma;exactmatch
transmembrane domain;tm domain;exactmatch
stage 0 small intestinal adenocarcinoma ajcc v8;stage 0 small intestinal adenocarcinoma;exactmatch
small intestinal adenocarcinoma by ajcc v8 stage;small intestinal adenocarcinoma by ajcc v8 stage;exactmatch
rabbit uterine carcinoma;rabbit uterine carcinoma;exactmatch
7q;7q;exactmatch
metastatic digestive system carcinoma;metastatic digestive system cancer;exactmatch
stage iv anal cancer ajcc v8;stage iv anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
stage iiic anal cancer ajcc v8;stage iiic anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
dna structure;dna structure;exactmatch
appendix carcinoma by ajcc v8 stage;appendiceal carcinoma by ajcc v8 stage;exactmatch
ptch1 gene mutation;ptc gene mutation;exactmatch
stage iiib appendix carcinoma ajcc v8;stage iiib appendiceal carcinoma ajcc v8;exactmatch
refractory lymphoma;refractory lymphoma;exactmatch
refractory neuroblastoma;refractory neuroblastoma;exactmatch
stage ivc appendix carcinoma ajcc v8;stage ivc appendiceal carcinoma ajcc v8;exactmatch
stage ivb appendix carcinoma ajcc v8;stage ivb appendiceal carcinoma ajcc v8;exactmatch
stage iva appendix carcinoma ajcc v8;stage iva appendiceal carcinoma ajcc v8;exactmatch
stage iv appendix carcinoma ajcc v8;stage iv appendiceal carcinoma ajcc v8;exactmatch
stage iiic appendix carcinoma ajcc v8;stage iiic appendiceal carcinoma ajcc v8;exactmatch
stage iiia appendix carcinoma ajcc v8;stage iiia appendiceal carcinoma ajcc v8;exactmatch
stage 0 appendix carcinoma ajcc v8;stage 0 appendiceal carcinoma ajcc v8;exactmatch
stage iii appendix carcinoma ajcc v8;stage iii appendiceal carcinoma ajcc v8;exactmatch
stage iic appendix carcinoma ajcc v8;stage iic appendiceal carcinoma ajcc v8;exactmatch
stage iib appendix carcinoma ajcc v8;stage iib appendiceal carcinoma ajcc v8;exactmatch
stage iia appendix carcinoma ajcc v8;stage iia appendiceal carcinoma ajcc v8;exactmatch
stage ii appendix carcinoma ajcc v8;stage ii appendiceal carcinoma ajcc v8;exactmatch
stage i appendix carcinoma ajcc v8;stage i appendiceal carcinoma ajcc v8;exactmatch
stage 0 low grade appendix mucinous neoplasm (lamn) ajcc v8;stage 0 low grade appendiceal mucinous neoplasm (lamn);exactmatch
stage iiib anal cancer ajcc v8;stage iiib anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
stage iiia anal cancer ajcc v8;stage iiia anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
stage iii anal cancer ajcc v8;stage iii anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
rb1 gene mutation;rb gene mutation;exactmatch
locally advanced paraganglioma;locally advanced malignant paraganglioma;exactmatch
metastatic paraganglioma;metastatic malignant paraganglioma;exactmatch
ubiquitin-transferase gene;e3 ubiquitin-transferase gene;exactmatch
recurrent head and neck squamous cell carcinoma;recurrent head and neck squamous cell cancer;exactmatch
mismatch repair gene mutation;dna mismatch repair gene mutation;exactmatch
sf3b1 gene mutation;hsh155 gene mutation;exactmatch
tfe3 gene rearrangement;rccp2 gene rearrangement;exactmatch
homologous recombination repair gene mutation;hhr gene mutation;exactmatch
stage iib anal cancer ajcc v8;stage iib anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
11q translocation;11q translocation;exactmatch
clinical stage iib gastric cancer ajcc v8;clinical stage iib gastric cancer ajcc v8;exactmatch
clinical stage iia gastric cancer ajcc v8;clinical stage iia gastric cancer ajcc v8;exactmatch
postneoadjuvant therapy stage iv gastric cancer ajcc v8;postneoadjuvant therapy stage iv gastric cancer ajcc v8;exactmatch
postneoadjuvant therapy stage iii gastric cancer ajcc v8;postneoadjuvant therapy stage iii gastric cancer ajcc v8;exactmatch
postneoadjuvant therapy stage ii gastric cancer ajcc v8;postneoadjuvant therapy stage ii gastric cancer ajcc v8;exactmatch
postneoadjuvant therapy stage i gastric cancer ajcc v8;postneoadjuvant therapy stage i gastric cancer ajcc v8;exactmatch
small intestinal cancer by ajcc v7 stage;small intestinal cancer by ajcc v7 stage;exactmatch
refractory primary amyloidosis;refractory primary amyloidosis;exactmatch
recurrent primary amyloidosis;recurrent primary amyloidosis;exactmatch
appendix carcinoma by ajcc v7 stage;appendiceal carcinoma by ajcc v7 stage;exactmatch
stage iia anal cancer ajcc v8;stage iia anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
stage ii anal cancer ajcc v8;stage ii anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
stage i anal cancer ajcc v8;stage i anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
stage 0 anal cancer ajcc v8;stage 0 anal canal and perianal (anal margin) carcinoma ajcc v8;exactmatch
anal cancer by ajcc v8 stage;anal canal and perianal (anal margin) carcinoma by ajcc v8 stage;exactmatch
protein domain;domain;exactmatch
anal canal cancer by ajcc v6 and v7 stage;anal canal cancer by ajcc v6 and v7 stage;exactmatch
chromosome structure;chromosomal organization;exactmatch
pterygium;pterygium;exactmatch
rabbit cutaneous lymphoma;rabbit cutaneous lymphoma;exactmatch
rabbit fibroma;rabbit fibroma;exactmatch
rabbit oral cavity squamous cell carcinoma;rabbit oral cavity squamous cell carcinoma;exactmatch
rabbit plasmacytoma;rabbit plasmacytoma;exactmatch
refractory malignant solid neoplasm;refractory malignant solid neoplasm;exactmatch
refractory classic hodgkin lymphoma;refractory classic hodgkin lymphoma;exactmatch
large b-cell lymphoma with irf4 rearrangement;lbcl with irf4 rearrangement;exactmatch
postneoadjuvant therapy stage ivb esophageal squamous cell carcinoma ajcc v8;postneoadjuvant therapy stage ivb esophageal squamous cell carcinoma ajcc v8;exactmatch
stage iv major salivary gland cancer ajcc v8;stage iv major salivary gland cancer;exactmatch
stage i hypopharyngeal carcinoma ajcc v8;stage i hypopharyngeal carcinoma ajcc v8;exactmatch
protein structure;protein structure;exactmatch
stage ivc hypopharyngeal carcinoma ajcc v8;stage ivc hypopharyngeal carcinoma ajcc v8;exactmatch
stage ivb hypopharyngeal carcinoma ajcc v8;stage ivb hypopharyngeal carcinoma ajcc v8;exactmatch
stage iva hypopharyngeal carcinoma ajcc v8;stage iva hypopharyngeal carcinoma ajcc v8;exactmatch
stage iv hypopharyngeal carcinoma ajcc v8;stage iv hypopharyngeal carcinoma ajcc v8;exactmatch
stage iii hypopharyngeal carcinoma ajcc v8;stage iii hypopharyngeal carcinoma ajcc v8;exactmatch
stage ii hypopharyngeal carcinoma ajcc v8;stage ii hypopharyngeal carcinoma ajcc v8;exactmatch
hypopharyngeal carcinoma by ajcc v8 stage;hypopharyngeal carcinoma by ajcc v8 stage;exactmatch
stage i sinonasal cancer ajcc v8;stage i nasal cavity and paranasal sinus cancer;exactmatch
stage ivc oropharyngeal (p16-negative) carcinoma ajcc v8;stage ivc oropharyngeal (p16-negative) carcinoma ajcc v8;exactmatch
stage ivb oropharyngeal (p16-negative) carcinoma ajcc v8;stage ivb oropharyngeal (p16-negative) carcinoma ajcc v8;exactmatch
stage iva oropharyngeal (p16-negative) carcinoma ajcc v8;stage iva oropharyngeal (p16-negative) carcinoma ajcc v8;exactmatch
stage iv oropharyngeal (p16-negative) carcinoma ajcc v8;stage iv oropharyngeal (p16-negative) carcinoma ajcc v8;exactmatch
stage iii oropharyngeal (p16-negative) carcinoma ajcc v8;stage iii oropharyngeal (p16-negative) carcinoma ajcc v8;exactmatch
stage ii oropharyngeal (p16-negative) carcinoma ajcc v8;stage ii oropharyngeal (p16-negative) carcinoma ajcc v8;exactmatch
stage i oropharyngeal (p16-negative) carcinoma ajcc v8;stage i oropharyngeal (p16-negative) carcinoma ajcc v8;exactmatch
sinonasal cancer by ajcc v8 stage;nasal cavity and paranasal sinus cancer by ajcc v8 stage;exactmatch
stage ii sinonasal cancer ajcc  v8;stage ii nasal cavity and paranasal sinus cancer;exactmatch
stage ivb laryngeal cancer ajcc v8;stage ivb laryngeal cancer ajcc v8;exactmatch
locally advanced malignant solid neoplasm;locally advanced malignant solid neoplasm;exactmatch
stage iv laryngeal cancer ajcc v8;stage iv laryngeal cancer ajcc v8;exactmatch
stage iii laryngeal cancer ajcc v8;stage iii laryngeal cancer ajcc v8;exactmatch
stage ii laryngeal cancer ajcc v8;stage ii laryngeal cancer ajcc v8;exactmatch
stage i laryngeal cancer ajcc v8;stage i laryngeal cancer ajcc v8;exactmatch
laryngeal cancer by ajcc v8 stage;laryngeal cancer by ajcc v8 stage;exactmatch
gene rearrangement abnormality;abnormal gene rearrangement;exactmatch
aids-related anal canal carcinoma;aids-related anal canal cancer;exactmatch
recurrent breast angiosarcoma;recurrent breast angiosarcoma;exactmatch
stage iii sinonasal cancer ajcc v8;stage iii nasal cavity and paranasal sinus cancer;exactmatch
lung adenofibroma;lung adenofibroma;exactmatch
hamster pancreatic ductal adenocarcinoma;hamster pancreatic ductal adenocarcinoma;exactmatch
hamster melanoma;hamster melanoma;exactmatch
stage ivc sinonasal cancer ajcc v8;stage ivc nasal cavity and paranasal sinus cancer;exactmatch
stage ivb sinonasal cancer ajcc v8;stage ivb nasal cavity and paranasal sinus cancer;exactmatch
stage iva sinonasal cancer ajcc v8;stage iva nasal cavity and paranasal sinus cancer;exactmatch
stage iv sinonasal cancer ajcc v8;stage iv nasal cavity and paranasal sinus cancer;exactmatch
stage 0 oropharyngeal (p16-negative) carcinoma ajcc v8;stage 0 oropharyngeal (p16-negative) carcinoma ajcc v8;exactmatch
oropharyngeal (p16-negative) carcinoma by ajcc v8 stage;oropharyngeal (p16-negative) carcinoma by ajcc v8 stage;exactmatch
telomere;telomere;exactmatch
subcellular structure;intracellular structure;exactmatch
unresectable ewing sarcoma;unresectable ewing sarcoma;exactmatch
feline osteosarcoma;feline osteosarcoma;exactmatch
feline oral squamous cell carcinoma;feline oral squamous cell carcinoma;exactmatch
canine oral squamous cell carcinoma;canine oral squamous cell carcinoma;exactmatch
stage ivb nasopharyngeal carcinoma ajcc v8;stage ivb nasopharyngeal carcinoma ajcc v8;exactmatch
stage iva nasopharyngeal carcinoma ajcc v8;stage iva nasopharyngeal carcinoma ajcc v8;exactmatch
stage iv nasopharyngeal carcinoma ajcc v8;stage iv nasopharyngeal carcinoma ajcc v8;exactmatch
stage iii nasopharyngeal carcinoma ajcc v8;stage iii nasopharyngeal carcinoma ajcc v8;exactmatch
c2h2 zinc finger;c2h2 zinc finger;exactmatch
stage ii nasopharyngeal carcinoma ajcc v8;stage ii nasopharyngeal carcinoma ajcc v8;exactmatch
stage i nasopharyngeal carcinoma ajcc v8;stage i nasopharyngeal carcinoma ajcc v8;exactmatch
nasopharyngeal carcinoma by ajcc v8 stage;nasopharyngeal carcinoma by ajcc v8 stage;exactmatch
pharyngeal carcinoma by ajcc v8 stage;pharyngeal carcinoma by ajcc v8 stage;exactmatch
stage ivc major salivary gland cancer ajcc v8;stage ivc major salivary gland cancer;exactmatch
stage ivb major salivary gland cancer ajcc v8;stage ivb major salivary gland cancer;exactmatch
stage iva major salivary gland cancer ajcc v8;stage iva major salivary gland cancer;exactmatch
chromosome x;chromosome x;exactmatch
unresectable osteosarcoma;unresectable osteosarcoma;exactmatch
recurrent malignant germ cell tumor;recurrent germ cell neoplasm;exactmatch
metastatic malignant germ cell tumor;metastatic germ cell neoplasm;exactmatch
mgmt-unmethylated glioblastoma;mgmt-unmethylated glioblastoma;exactmatch
pathologic stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;pathologic stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;exactmatch
pathologic stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;pathologic stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;exactmatch
pathologic stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;pathologic stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;exactmatch
pathologic stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;pathologic stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;exactmatch
clinical stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;clinical stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;exactmatch
unmethylated mgmt gene promoter;absent;exactmatch
clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;exactmatch
clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;exactmatch
clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8;exactmatch
hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 pathologic stage;hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 pathologic stage;exactmatch
hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 clinical stage;hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 clinical stage;exactmatch
hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 stage;hpv-mediated (p16-positive) oropharyngeal carcinoma by ajcc v8 stage;exactmatch
prostate carcinoma metastatic in the soft tissue;metastatic prostate cancer in the soft tissue;exactmatch
chromosome y;chromosome y;exactmatch
stage iva laryngeal cancer ajcc v8;stage iva laryngeal cancer ajcc v8;exactmatch
stage ivc laryngeal cancer ajcc v8;stage ivc laryngeal cancer ajcc v8;exactmatch
postneoadjuvant therapy stage iva esophageal squamous cell carcinoma ajcc v8;postneoadjuvant therapy stage iva esophageal squamous cell carcinoma ajcc v8;exactmatch
pathologic stage ivb esophageal adenocarcinoma ajcc v8;ivb;exactmatch
postneoadjuvant therapy stage iv esophageal adenocarcinoma ajcc v8;postneoadjuvant therapy stage iv esophageal adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iiib esophageal adenocarcinoma ajcc v8;postneoadjuvant therapy stage iiib esophageal adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iiia esophageal adenocarcinoma ajcc v8;postneoadjuvant therapy stage iiia esophageal adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iii esophageal adenocarcinoma ajcc v8;postneoadjuvant therapy stage iii esophageal adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage ii esophageal adenocarcinoma ajcc v8;postneoadjuvant therapy stage ii esophageal adenocarcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage i esophageal adenocarcinoma ajcc v8;postneoadjuvant therapy stage i esophageal adenocarcinoma ajcc v8;exactmatch
esophageal adenocarcinoma by ajcc v8 postneoadjuvant therapy stage;esophageal adenocarcinoma by ajcc v8 postneoadjuvant therapy stage;exactmatch
pathologic stage iva esophageal adenocarcinoma ajcc v8;iva;exactmatch
postneoadjuvant therapy stage ivb esophageal adenocarcinoma ajcc v8;postneoadjuvant therapy stage ivb esophageal adenocarcinoma ajcc v8;exactmatch
pathologic stage iv esophageal adenocarcinoma ajcc v8;iv;exactmatch
pathologic stage iiib esophageal adenocarcinoma ajcc v8;iiib;exactmatch
pathologic stage iiia esophageal adenocarcinoma ajcc v8;iiia;exactmatch
pathologic stage iii esophageal adenocarcinoma ajcc v8;iii;exactmatch
pathologic stage iib esophageal adenocarcinoma ajcc v8;iib;exactmatch
pathologic stage iia esophageal adenocarcinoma ajcc v8;iia;exactmatch
pathologic stage ii esophageal adenocarcinoma ajcc v8;ii;exactmatch
postneoadjuvant therapy stage iva esophageal adenocarcinoma ajcc v8;postneoadjuvant therapy stage iva esophageal adenocarcinoma ajcc v8;exactmatch
esophageal squamous cell carcinoma by ajcc v7 stage;esophageal squamous cell carcinoma by ajcc v7 stage;exactmatch
hair follicle;follicles;exactmatch
clinical stage iva esophageal squamous cell carcinoma ajcc v8;clinical stage iva esophageal squamous cell carcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iv esophageal squamous cell carcinoma ajcc v8;postneoadjuvant therapy stage iv esophageal squamous cell carcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iiib esophageal squamous cell carcinoma ajcc v8;postneoadjuvant therapy stage iiib esophageal squamous cell carcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iiia esophageal squamous cell carcinoma ajcc v8;postneoadjuvant therapy stage iiia esophageal squamous cell carcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage iii esophageal squamous cell carcinoma ajcc v8;postneoadjuvant therapy stage iii esophageal squamous cell carcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage ii esophageal squamous cell carcinoma ajcc v8;postneoadjuvant therapy stage ii esophageal squamous cell carcinoma ajcc v8;exactmatch
postneoadjuvant therapy stage i esophageal squamous cell carcinoma ajcc v8;postneoadjuvant therapy stage i esophageal squamous cell carcinoma ajcc v8;exactmatch
clinical stage ivb esophageal squamous cell carcinoma ajcc v8;clinical stage ivb esophageal squamous cell carcinoma ajcc v8;exactmatch
clinical stage iv esophageal squamous cell carcinoma ajcc v8;clinical stage iv esophageal squamous cell carcinoma ajcc v8;exactmatch
esophageal squamous cell carcinoma by ajcc v8 stage;esophageal squamous cell carcinoma by ajcc v8 stage;exactmatch
clinical stage iii esophageal squamous cell carcinoma ajcc v8;clinical stage iii esophageal squamous cell carcinoma ajcc v8;exactmatch
clinical stage ii esophageal squamous cell carcinoma ajcc v8;clinical stage ii esophageal squamous cell carcinoma ajcc v8;exactmatch
clinical stage i esophageal squamous cell carcinoma ajcc v8;clinical stage i esophageal squamous cell carcinoma ajcc v8;exactmatch
clinical stage 0 esophageal squamous cell carcinoma ajcc v8;clinical stage 0 esophageal squamous cell carcinoma ajcc v8;exactmatch
esophageal squamous cell carcinoma by ajcc v8 postneoadjuvant therapy stage;esophageal squamous cell carcinoma by ajcc v8 postneoadjuvant therapy stage;exactmatch
esophageal squamous cell carcinoma by ajcc v8 pathologic stage;esophageal squamous cell carcinoma tumor stage pathologic;exactmatch
esophageal squamous cell carcinoma by ajcc v8 clinical stage;esophageal squamous cell carcinoma by ajcc v8 clinical stage;exactmatch
pathologic stage ic esophageal adenocarcinoma ajcc v8;ic;exactmatch
pathologic stage ib esophageal adenocarcinoma ajcc v8;ib;exactmatch
pathologic stage ia esophageal adenocarcinoma ajcc v8;ia;exactmatch
lung non-small cell squamous carcinoma;lung non-small cell squamous carcinoma;exactmatch
inner mitochondrial membrane;inner mitochondrial membrane;exactmatch
rough endoplasmic reticulum;ergastoplasm;exactmatch
stage iv cutaneous squamous cell carcinoma of the head and neck ajcc v8;stage iv;exactmatch
stage iii cutaneous squamous cell carcinoma of the head and neck ajcc v8;stage iii;exactmatch
stage ii cutaneous squamous cell carcinoma of the head and neck ajcc v8;stage ii;exactmatch
stage i cutaneous squamous cell carcinoma of the head and neck ajcc v8;stage i;exactmatch
stage 0 cutaneous squamous cell carcinoma of the head and neck ajcc v8;stage 0 cutaneous squamous cell carcinoma of the head and neck ajcc v8;exactmatch
cutaneous squamous cell carcinoma of the head and neck by ajcc v8 stage;cutaneous squamous cell carcinoma of the head and neck by ajcc v8 stage;exactmatch
pathologic stage i esophageal adenocarcinoma ajcc v8;i;exactmatch
cutaneous squamous cell carcinoma of the head and neck;cutaneous squamous cell carcinoma of the head and neck;exactmatch
metastatic thyroid gland carcinoma;metastatic thyroid gland cancer;exactmatch
oral intraepithelial neoplasia;oral intraepithelial neoplasia;exactmatch
gland;gland;exactmatch
mucosal melanoma of the head and neck;mucosal melanoma of the head and neck;exactmatch
mucosal melanoma of the head and neck by ajcc v7 stage;mucosal melanoma of the head and neck by ajcc v7 stage;exactmatch
transitional epithelium;transitional epithelium;exactmatch
ocular tissue;human ocular tissue;exactmatch
germinal center;germinal center;exactmatch
sh2 domain;sh2 domain;exactmatch
postneoadjuvant therapy pathologic tnm finding;postneoadjuvant therapy pathologic tnm finding;exactmatch
pathologic stage 0 esophageal adenocarcinoma ajcc v8;0;exactmatch
esophageal adenocarcinoma by ajcc v8 pathologic stage;esophageal adenocarcinoma tumor stage pathologic;exactmatch
esophageal adenocarcinoma by ajcc v7 stage;esophageal adenocarcinoma by ajcc v7 stage;exactmatch
clinical stage ivb esophageal adenocarcinoma ajcc v8;clinical stage ivb esophageal adenocarcinoma ajcc v8;exactmatch
clinical stage iva esophageal adenocarcinoma ajcc v8;clinical stage iva esophageal adenocarcinoma ajcc v8;exactmatch
clinical stage iv esophageal adenocarcinoma ajcc v8;clinical stage iv esophageal adenocarcinoma ajcc v8;exactmatch
clinical stage iii esophageal adenocarcinoma ajcc v8;clinical stage iii esophageal adenocarcinoma ajcc v8;exactmatch
clinical stage iib esophageal adenocarcinoma ajcc v8;clinical stage iib esophageal adenocarcinoma ajcc v8;exactmatch
clinical stage iia esophageal adenocarcinoma ajcc v8;clinical stage iia esophageal adenocarcinoma ajcc v8;exactmatch
clinical stage ii esophageal adenocarcinoma ajcc v8;clinical stage ii esophageal adenocarcinoma ajcc v8;exactmatch
clinical stage i esophageal adenocarcinoma ajcc v8;clinical stage i esophageal adenocarcinoma ajcc v8;exactmatch
clinical stage 0 esophageal adenocarcinoma ajcc v8;clinical stage 0 esophageal adenocarcinoma ajcc v8;exactmatch
esophageal adenocarcinoma by ajcc v8 clinical stage;esophageal adenocarcinoma by ajcc v8 clinical stage;exactmatch
esophageal adenocarcinoma by ajcc v8 stage;esophageal adenocarcinoma by ajcc v8 stage;exactmatch
esophageal cancer by ajcc v8 stage;esophageal cancer by ajcc v8 stage;exactmatch
lower alveolar ridge squamous cell carcinoma;lower alveolar ridge squamous cell carcinoma;exactmatch
class 2 uveal melanoma;class 2 uveal melanoma;exactmatch
locally advanced rectal carcinoma;locally advanced rectal carcinoma;exactmatch
von hippel-lindau syndrome;cerebroretinal angiomatosis;exactmatch
hyperplasia;hyperplasia;exactmatch
hypercalcemia;hypercalcemia;exactmatch
hydrocephalus;hydrocephalus;exactmatch
hydatidiform mole;hydatid mole;exactmatch
hiv infection;hiv infection;exactmatch
langerhans cell histiocytosis;histiocytosis x;exactmatch
histiocytosis;histiocytic infiltrate;exactmatch
genetic disorder;genetic condition;exactmatch
portal hypertension;portal hypertension;exactmatch
hepatomegaly;hepatomegaly;exactmatch
hepatocellular carcinoma;carcinoma, hepatocellular, malignant;exactmatch
hepatitis c infection;hcv infection;exactmatch
hepatitis b infection;hepatitis b;exactmatch
hepatitis;hepatitis;exactmatch
hemoptysis;coughing up blood;exactmatch
hemoglobinopathy;hemoglobinopathies / iron metabolism;exactmatch
hypertension;htn;exactmatch
hyperthyroidism;hyperthyroidism;exactmatch
angiosarcoma;angiosarcoma;exactmatch
inflammatory bowel disease;autoimmune bowel disorder;exactmatch
actinic keratosis;actinic (solar) keratosis;exactmatch
keratoacanthoma;cutaneous keratoacanthoma;exactmatch
jaundice;jaundice;exactmatch
iris neoplasm;iris neoplasm;exactmatch
intestinal neoplasm;intestinal neoplasm;exactmatch
pancreatic insulin-producing neuroendocrine tumor;beta cell tumor;exactmatch
infratentorial neoplasm;brain neoplasms, infratentorial;exactmatch
inflammation;inflammation;exactmatch
hypoglycemia;hypoglycemia;exactmatch
epidermal inclusion cyst;epidermal cyst;exactmatch
impotence;erectile dysfunction;exactmatch
alpha heavy chain disease;alpha heavy chain disease;exactmatch
immunodeficiency syndrome;immunodeficiency;exactmatch
ileal neoplasm;ileal neoplasm;exactmatch
hypothalamic neoplasm;hypothalamic neoplasm;exactmatch
hypopharyngeal neoplasm;hypopharyngeal neoplasm;exactmatch
hematuria;hematuria;exactmatch
hemangiopericytoma;hemangiopericytoma;exactmatch
rheumatoid arthritis;ra;exactmatch
digestive system neoplasm;digestive neoplasm;exactmatch
glioma;glial neoplasm;exactmatch
glioblastoma;cns, glioblastoma (gbm);exactmatch
gingival neoplasm;gingival neoplasm;exactmatch
castleman disease;aflh;exactmatch
giant cell tumor;giant cell tumor;exactmatch
male reproductive system neoplasm;male reproductive system neoplasm;exactmatch
female reproductive system neoplasm;female reproductive system neoplasm;exactmatch
gastrin-producing neuroendocrine tumor;g cell tumor;exactmatch
jugulotympanic paraganglioma;glomus jugulare neoplasm;exactmatch
ganglioneuroma;ganglioneuroma, benign;exactmatch
gallbladder neoplasm;gallbladder neoplasm;exactmatch
pathologic fracture;pathologic fracture;exactmatch
fracture;bone fracture;exactmatch
fistula;fistula;exactmatch
fibrosis;fibrosis;exactmatch
fibrosarcoma;fibrosarcoma, malignant;exactmatch
glomus tumor;glomus neoplasm;exactmatch
pancreatic glucagon-producing neuroendocrine tumor;alpha cell tumor;exactmatch
cavernous hemangioma;cavernoma;exactmatch
head and neck neoplasm;head and neck neoplasm;exactmatch
hemangioma;angioma;exactmatch
hemangioendothelioma;angioendothelioma;exactmatch
heavy chain disease;hcd;exactmatch
heart neoplasm;cardiac neoplasm;exactmatch
congestive heart failure;chf;exactmatch
heart disorder;heart disease;exactmatch
hearing disorder;hearing disorder;exactmatch
cowden syndrome;cowden disease;exactmatch
granuloma;granuloma;exactmatch
hamartoma;hamartoma;exactmatch
hairy nevus;hair nevus;exactmatch
gynecomastia;gynecomastia;exactmatch
ovarian gynandroblastoma;gynandroblastoma;exactmatch
granulosa cell tumor;granulosa cell neoplasm;exactmatch
biological agent;biologic;exactmatch
foreign body granuloma;foreign body granuloma;exactmatch
kidney disorder;kidney disease;exactmatch
kidney neoplasm;kidney neoplasm;exactmatch
krukenberg tumor;krukenberg neoplasm;exactmatch
alveolar cell;alveolar cell;exactmatch
anterior cranial fossa;anterior cranial fossa;exactmatch
follicular lymphoma;follicle center lymphoma;exactmatch
lymphoma;lymphoma, malignant;exactmatch
anal transitional zone;anal transitional zone;exactmatch
lymphedema;lymphedema;exactmatch
anal region;anal region;exactmatch
anal gland;anal gland;exactmatch
alpha cell;alpha cell;exactmatch
non-hodgkin lymphoma;nhl;exactmatch
adrenal gland tissue;adrenal gland tissue;exactmatch
lymphangiosarcoma;lymphangiosarcoma, malignant;exactmatch
activated lymphocyte;activated lymphocyte;exactmatch
acinar salivary gland system;acinar salivary gland system;exactmatch
acidophilic cell;acidophilic cell;exactmatch
accessory nerve;accessory nerve;exactmatch
lymphangioleiomyoma;lymphangioleiomyoma;exactmatch
mixed cell lymphoma;mixed cell lymphoma;exactmatch
lymphoplasmacytic lymphoma;immunocytoma, lymphoplasmacytic type;exactmatch
laryngeal neoplasm;laryngeal neoplasm;exactmatch
atrioventricular node;a-v node;exactmatch
basophilic cell;basophilic cell;exactmatch
base of the brain;base of brain;exactmatch
maxillary sinus neoplasm;maxillary sinus neoplasm;exactmatch
diffuse cutaneous mastocytosis;diffuse cutaneous mastocytosis;exactmatch
axon;axon;exactmatch
axial skeleton;axial skeleton;exactmatch
benign mastocytoma;benign mastocytoma;exactmatch
malignant retinal neoplasm;malignant neoplasm of retina;exactmatch
apex of the lung;apex of lung;exactmatch
carcinoid syndrome;carcinoid syndrome;exactmatch
arm;arm;exactmatch
malabsorption syndrome;malabsorption;exactmatch
aponeurosis;aponeurosis;exactmatch
apocrine sweat gland;apocrine sweat gland;exactmatch
apex of the tongue;apex of tongue;exactmatch
maffucci syndrome;chondrodysplasia with hemangioma;exactmatch
acquired progressive lymphangioma;acquired progressive lymphangioma;exactmatch
ovarian stromal luteoma;luteoma, benign;exactmatch
lung neoplasm;lung neoplasm;exactmatch
childhood acute lymphoblastic leukemia;acute lymphoblastic leukemia (all);exactmatch
chronic phase chronic myelogenous leukemia, bcr-abl1 positive;chronic phase cml;exactmatch
chronic myelogenous leukemia, bcr-abl1 positive;bcr-abl positive chronic myelogenous leukemia;exactmatch
accelerated phase chronic myelogenous leukemia, bcr-abl1 positive;accelerated phase cml;exactmatch
myeloid leukemia;leukemia, granulocytic, malignant;exactmatch
acute myeloid leukemia;aml;exactmatch
acute megakaryoblastic leukemia;amkl;exactmatch
mast cell leukemia;mast cell leukemia;exactmatch
acute lymphoblastic leukemia;all;exactmatch
lung disorder;disorder of lung;exactmatch
calla positive lymphoblastic leukemia;calla positive lymphoblastic leukemia;exactmatch
acute basophilic leukemia;acute basophilic leukemia;exactmatch
chronic lymphocytic leukemia;b cell cll;exactmatch
b-cell leukemia;b-cell leukemia;exactmatch
leukemia;blood (leukemia);exactmatch
leiomyosarcoma;leiomyosarcoma, malignant;exactmatch
leiomyoma;fibroid;exactmatch
philadelphia-negative myelogenous leukemia;philadelphia-negative myelogenous leukemia;exactmatch
philadelphia-positive myelogenous leukemia;ph1-positive granulocytic leukemia;exactmatch
chronic myelomonocytic leukemia;cmml;exactmatch
chronic neutrophilic leukemia;chronic neutrophilic leukemia;exactmatch
breast lump;breast lump;exactmatch
liver and intrahepatic bile duct disorder;hepatic disorder;exactmatch
liposarcoma;liposarcoma, malignant;exactmatch
lipomatosis;launois-bensaude syndrome;exactmatch
lipoma;lipoma, benign;exactmatch
lip neoplasm;lip neoplasm;exactmatch
linitis plastica;linitis plastica;exactmatch
leydig cell tumor;interstitial cell neoplasm;exactmatch
oral leukoplakia;leukokeratosis of oral mucosa;exactmatch
leukoplakia;keratotic plaque;exactmatch
adult t-cell leukemia/lymphoma;atll;exactmatch
t acute lymphoblastic leukemia;acute t cell leukemia;exactmatch
acute promyelocytic leukemia with pml-rara;"aml with t(15;17)(q22;q12)";exactmatch
prolymphocytic leukemia;pll;exactmatch
plasma cell leukemia;leukemia plasmacytic;exactmatch
fibromatosis;fibromatosis;exactmatch
fibroma;fibroma, benign;exactmatch
breast fibrocystic change;breast fibrocystic change;exactmatch
chordoma;chordoma, malignant;exactmatch
colon polyp;colon polyp;exactmatch
colon neoplasm;colon neoplasm;exactmatch
ulcerative colitis;colitis ulcerative;exactmatch
cirrhosis;cirrhosis;exactmatch
cytogenetic abnormality;aberrant chromosome;exactmatch
choroid neoplasm;choroid neoplasm;exactmatch
choriocarcinoma;choriocarcinoma, malignant;exactmatch
chondrosarcoma;chondrosarcoma, malignant;exactmatch
colorectal neoplasm;colorectal neoplasm;exactmatch
chondroblastoma;chondroblastoma;exactmatch
bile duct adenoma;adenoma of bile duct;exactmatch
cervical neoplasm;cervical neoplasm;exactmatch
cervical polyp;adenomatous polyp of cervix;exactmatch
cerebrovascular disorder;cerebrovascular disease;exactmatch
intraventricular brain neoplasm;brain neoplasms, intraventricular;exactmatch
cerebellar neoplasm;cerebellar neoplasm;exactmatch
colorectal carcinoma;crc;exactmatch
epithelial mesenchymal transition tumor of the mouse mammary gland;epithelial mesenchymal transition tumor of the mouse mammary gland;exactmatch
dermatitis;dermatitis;exactmatch
adenoid cystic carcinoma;adenocystic carcinoma;exactmatch
cytopenia;cytopenia;exactmatch
cyst;cyst;exactmatch
phyllodes tumor;csp;exactmatch
papillary cystadenoma;cystadenoma, papillary, benign;exactmatch
mucinous cystadenoma;adenoma, mucinous, benign;exactmatch
cystadenoma;cystadenoma, benign;exactmatch
cystadenocarcinoma;cystadenocarcinoma, malignant;exactmatch
cushing syndrome;cortisol excess;exactmatch
complication;complication;exactmatch
crohn disease;crohn disease;exactmatch
craniopharyngioma;craniopharyngioma, benign;exactmatch
cranial nerve neoplasm;cranial nerve neoplasm;exactmatch
well differentiated invasive adenocarcinoma of the mouse prostate gland;well differentiated invasive adenocarcinoma of the mouse prostate gland;exactmatch
seizure;convulsion;exactmatch
conjunctival neoplasm;conjunctiva neoplasm;exactmatch
condyloma;condyloma;exactmatch
central nervous system disorder;central nervous system disease;exactmatch
carotid body paraganglioma;carotid body chemodectoma;exactmatch
cardiovascular disorder;cardiovascular disease;exactmatch
benign skin neoplasm;benign cutaneous neoplasm;exactmatch
skin squamous cell carcinoma in situ;intraepidermal squamous cell carcinoma;exactmatch
coagulation disorder;coagulation defect;exactmatch
bladder neoplasm;bladder neoplasm;exactmatch
bladder disorder;bladder disease;exactmatch
biliary system disorder;biliary disease;exactmatch
bile duct neoplasm;bile duct neoplasm;exactmatch
benign prostatic hyperplasia;bph;exactmatch
benign ovarian neoplasm;benign neoplasm of ovary;exactmatch
transitional cell carcinoma;carcinoma, urothelial, malignant;exactmatch
benign colon neoplasm;benign colon neoplasm;exactmatch
psychiatric disorder;mental disorder;exactmatch
nevoid basal cell carcinoma syndrome;basal cell nevus syndrome;exactmatch
barrett esophagus;be;exactmatch
bacterial infection;bacterial disease;exactmatch
autoimmune disease;autoimmune disease;exactmatch
ataxia telangiectasia syndrome;ataxia telangiectasia;exactmatch
brain neoplasm;brain neoplasm;exactmatch
non-neoplastic breast disorder;non-neoplastic breast disease;exactmatch
breast neoplasm;breast neoplasm;exactmatch
bronchitis;bronchial infection;exactmatch
squamous cell carcinoma;carcinoma, squamous cell, malignant;exactmatch
scirrhous adenocarcinoma;adenocarcinoma with productive fibrosis;exactmatch
papillary carcinoma;papillary carcinoma;exactmatch
lung non-small cell carcinoma;lung non-small cell carcinoma;exactmatch
breast ductal carcinoma in situ;breast ductal carcinoma in situ;exactmatch
minimally invasive lung adenocarcinoma;bac;exactmatch
skin basosquamous cell carcinoma;basosquamous tumor, malignant;exactmatch
skin basal cell carcinoma;bcc;exactmatch
malignant skin neoplasm;malignant neoplasm of skin;exactmatch
prostate adenocarcinoma;adenocarcinoma of prostate;exactmatch
female breast carcinoma;breast carcinoma, female;exactmatch
carcinoma in situ;carcinoma, in situ, malignant;exactmatch
carcinoma;carcinoma, malignant;exactmatch
carcinoid tumor;carcinoid;exactmatch
burkitt lymphoma;burkitt lymphoma;exactmatch
dysphagia;difficulty swallowing;exactmatch
diabetes mellitus;dm;exactmatch
fever;fever;exactmatch
enchondroma;central chondroma;exactmatch
basal transcription factor gene;basal transcription factor gene;exactmatch
endocrine system disorder;disorder of endocrine system;exactmatch
muscle contraction;contractile;exactmatch
myosin-11;myh11;exactmatch
enchondromatosis;dyschondroplasia;exactmatch
ww domain-containing transcription regulator protein 1;taz;exactmatch
intermediate filament gene;intermediate filament gene;exactmatch
mouse ovarian histiocytic sarcoma;mouse ovarian histiocytic sarcoma;exactmatch
yolk sac tumor;carcinoma, yolk sac;exactmatch
mouse ovarian hemangiosarcoma;mouse ovarian hemangiosarcoma;exactmatch
mouse malignant ovarian sertoli cell tumor;mouse malignant ovarian sertoli cell tumor;exactmatch
mouse malignant ovarian granulosa cell tumor;mouse malignant ovarian granulosa cell tumor;exactmatch
mouse malignant ovarian thecoma;mouse malignant ovarian thecoma;exactmatch
mouse choriocarcinoma;mouse choriocarcinoma;exactmatch
mouse yolk sac carcinoma;mouse yolk sac carcinoma;exactmatch
tumor embolism;tumor embolism;exactmatch
endocrine neoplasm;endocrine neoplasm;exactmatch
endometrial neoplasm;endometrial neoplasm;exactmatch
translational regulation;translation alteration;exactmatch
seizure disorder;epilepsy;exactmatch
fatigue;fatigue;exactmatch
fallopian tube neoplasm;fallopian tube neoplasm;exactmatch
eyelid neoplasm;eyelid neoplasm;exactmatch
eye neoplasm;eye neoplasm;exactmatch
exostosis;exostosis;exactmatch
esophageal neoplasm;esophageal neoplasm;exactmatch
esophageal disorder;esophageal disorder;exactmatch
epidural spinal canal neoplasm;epidural neoplasm;exactmatch
endometrial hyperplasia;endometrial hyperplasia;exactmatch
ependymoma;cns, ependymoma;exactmatch
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;ec 2.7.1.153;exactmatch
platelet-derived growth factor receptor beta;beta platelet-derived growth factor receptor;exactmatch
platelet-derived growth factor receptor alpha;alpha platelet-derived growth factor receptor;exactmatch
eosinophilic granuloma;chronic unifocal langerhans cell histiocytosis;exactmatch
eosinophilia;eosinophilia;exactmatch
endometriosis;endometriosis;exactmatch
mouse ovarian embryonal carcinoma;mouse ovarian embryonal carcinoma;exactmatch
mouse ovarian cystadenocarcinoma;mouse ovarian cystadenocarcinoma;exactmatch
mouse ovarian tubulostromal adenocarcinoma;mouse ovarian tubulostromal adenocarcinoma;exactmatch
enzyme inhibitor gene;enzyme inhibitor gene;exactmatch
dyspnea;dyspnea;exactmatch
dyspareunia;dyspareunia;exactmatch
dysgerminoma;dysgerminoma, malignant;exactmatch
myh11 gene;myh11;exactmatch
col1a2 gene;col1a2;exactmatch
duodenal neoplasm;duodenal neoplasm;exactmatch
col1a1 gene;col1a1;exactmatch
proteinase inhibitor gene;proteinase inhibitor gene;exactmatch
mouse ovarian hemangioma;mouse ovarian hemangioma;exactmatch
down syndrome;down syndrome;exactmatch
disseminated intravascular coagulation;consumptive coagulopathy;exactmatch
disease or disorder;diagnosis;exactmatch
digestive system disorder;digestive disease;exactmatch
inhibition of cancer cell growth;inhibition of cancer cell growth;exactmatch
diarrhea;diarrhea;exactmatch
translational activation;protein synthesis induction;exactmatch
dysuria;dysuria;exactmatch
ear neoplasm;ear neoplasm;exactmatch
eczema;atopic dermatitis;exactmatch
edema;edema;exactmatch
mouse benign sex cord stromal mixed tumor;mouse benign sex cord stromal mixed tumor;exactmatch
mouse benign sertoli cell tumor;mouse benign sertoli cell tumor;exactmatch
mouse benign granulosa cell tumor;mouse benign granulosa cell tumor;exactmatch
mouse benign thecoma;mouse benign thecoma;exactmatch
mouse benign ovarian teratoma;mouse benign ovarian teratoma;exactmatch
mouse benign luteoma;mouse benign luteoma;exactmatch
mouse ovarian cystadenoma;mouse ovarian cystadenoma;exactmatch
mouse ovarian tubulostromal adenoma;mouse ovarian tubulostromal adenoma;exactmatch
mouse malignant ovarian neoplasm;mouse malignant ovarian neoplasm;exactmatch
mouse benign ovarian neoplasm;mouse benign ovarian neoplasm;exactmatch
mouse ovarian neoplasm;mouse ovarian neoplasm;exactmatch
effusion;effusion;exactmatch
mouse ovarian disorder;mouse ovarian disorder;exactmatch
translation initiation;translation initiation;exactmatch
translation process;genetic translation;exactmatch
beta cell;beta cell;exactmatch
mediastinal cyst;cyst of mediastinum;exactmatch
bladder mucosa;bladder mucosa;exactmatch
neural retina;neural retina;exactmatch
peripheral nervous system neoplasm;cns-excluded nervous sys. cancer;exactmatch
omentum;omentum;exactmatch
olfactory sulcus;olfactory sulcus;exactmatch
olfactory mucosa;mucosa, nasal;exactmatch
pericardial effusion;fluid, pericardial;exactmatch
nonmembranous cytoplasmic organelle;nonmembranous cytoplasmic organelle;exactmatch
penile neoplasm;neoplasm of penis;exactmatch
neck muscle;neck muscle;exactmatch
organ of special sense;organ of special sense;exactmatch
nasolacrimal duct;duct, nasolacrimal;exactmatch
penile fibromatosis;penile fibromatosis;exactmatch
nail;nail;exactmatch
myofibroblast;myofibroblast;exactmatch
myoepithelial cell;basket cell;exactmatch
mucous salivary gland;gland, salivary, mucous;exactmatch
parotid gland neoplasm;neoplasm of parotid;exactmatch
peritoneal neoplasm;peritoneal neoplasm;exactmatch
peutz-jeghers syndrome;jeghers-peutz syndrome;exactmatch
pluripotent bone marrow stem cell;pluripotent bone marrow stem cell;exactmatch
pineal region neoplasm;neoplasm of pineal area;exactmatch
pineocyte;pinealocyte;exactmatch
pleural neoplasm;neoplasm of pleura;exactmatch
phalanx;phalanges;exactmatch
pleural effusion;pleural_effusion;exactmatch
perineum;perineum;exactmatch
pituitary gland neoplasm;neoplasm of pituitary;exactmatch
pituitary gland adenoma;adenoma, anterior lobe pituitary gland, benign;exactmatch
parathyroid gland tissue;human parathyroid;exactmatch
ovarian cortex;ovarian cortex;exactmatch
skin discoloration;skin discoloration;exactmatch
c-cell;c cell;exactmatch
adrenal gland pheochromocytoma;adrenal gland chromaffin paraganglioma;exactmatch
pharyngeal neoplasm;neoplasm of pharynx;exactmatch
ovarian tissue;human ovarian tissue;exactmatch
ovarian medulla;ovarian medulla;exactmatch
ovarian follicle;follicle;exactmatch
parathyroid gland neoplasm;neoplasm of parathyroid;exactmatch
minor salivary gland;minor salivary gland;exactmatch
middle cranial fossa;middle cranial fossa;exactmatch
lower gastrointestinal tract;gastrointestinal tract, lower;exactmatch
lymphatic vessel;lymphatic vessel;exactmatch
lymph node tissue;lymph node tissue;exactmatch
pain;pain;exactmatch
lymph node cortex;lymph node cortex;exactmatch
lymph node by anatomic site;lymph node station;exactmatch
lung tissue;lung parenchyma;exactmatch
extramammary paget disease;cutaneous paget's disease;exactmatch
nipple paget disease;nipple paget disease;exactmatch
paraneoplastic syndrome;paraneoplastic syndrome;exactmatch
long bone;long bone;exactmatch
ovarian cyst;cyst of ovary;exactmatch
liver ligament;liver ligament;exactmatch
lh cell;lh cell;exactmatch
osteoporosis;osteoporosis;exactmatch
leptomeninges;cns-leptom;exactmatch
osteoid osteoma;osteoid osteoma;exactmatch
lymphoid follicle;lymphoid follicle;exactmatch
male breast;male breast;exactmatch
pancreatic neoplasm;neoplasm of pancreas;exactmatch
male urethra;male urethra;exactmatch
mesothelium;mesothelium;exactmatch
mesothelial cell;mesothelial cell;exactmatch
mesentery;mesentery;exactmatch
meningothelial cell;arachnoidal cell;exactmatch
meningeal layer of the dura mater;meningeal layer of the dura mater;exactmatch
extra-adrenal paraganglioma;extra-adrenal paraganglioma;exactmatch
membranous cytoplasmic organelle;membrane-limited cytoplasmic organelle;exactmatch
paraganglioma;neoplasm of paraganglion;exactmatch
membrane of the brain or spinal cord;membrane of the brain or spinal cord;exactmatch
papilledema;papilledema;exactmatch
mature t-lymphocyte;mature t-cell;exactmatch
pancreatitis;inflammatory pancreatic disease;exactmatch
mature b-lymphocyte;mature b-cell;exactmatch
marginal zone of the lymph node;marginal zone of lymph node;exactmatch
mantle zone;mantle zone;exactmatch
plantar region;plantar;exactmatch
polycythemia vera;polycythemia rubra vera;exactmatch
left hypochondriac region;left hypochondriac region;exactmatch
rhabdomyoma;rhabdomyoma, benign;exactmatch
stratified columnar epithelium;stratified columnar epithelium;exactmatch
sternocleidomastoid muscle;sternocleidomastoid muscle;exactmatch
salivary gland neoplasm;neoplasm of salivary gland;exactmatch
splenic pulp;splenic pulp;exactmatch
supernumerary circular chromosome;ring chromosome;exactmatch
rhabdomyosarcoma;rhabdomyosarcoma, malignant;exactmatch
spermatogenic cell;spermatogenic cell;exactmatch
somatotroph cell;gh cell;exactmatch
sebaceous gland neoplasm;sebaceous gland neoplasm;exactmatch
small intestinal wall tissue;small intestinal wall tissue;exactmatch
retroperitoneal neoplasm;retroperitoneal neoplasm;exactmatch
small intestinal mucosa;small intestinal mucosa;exactmatch
small intestinal glandular cell;small intestinal glandular cell;exactmatch
skin tissue;human skin;exactmatch
skin squamous cell;skin squamous cell;exactmatch
skin of the face;skin of the face;exactmatch
stratified epithelium;stratified epithelium;exactmatch
stratum reticulare;stratum reticulare;exactmatch
posterior cranial fossa;posterior cranial fossa;exactmatch
sweat gland;sudoriferous gland;exactmatch
thalamencephalon;inter brain;exactmatch
testicular tissue;human testicular tissue;exactmatch
terminal ductal lobular unit cell;terminal ductal lobular unit cell;exactmatch
skull neoplasm;neoplasm of skull;exactmatch
skin tag;acrochordon;exactmatch
skin nodule;cutaneous nodule;exactmatch
skin neoplasm;neoplasm of skin;exactmatch
skin disorder;cutaneous disorder;exactmatch
striated muscle cell;striated muscle cell;exactmatch
supporting cell of the nervous system;supporting cell of the nervous system;exactmatch
digestive system signs and symptoms;digestive system signs and symptoms;exactmatch
finding;finding;exactmatch
superficial intracranial venous system;superficial intracranial venous system;exactmatch
sezary syndrome;ctcl / sezary syndrome;exactmatch
subcutis;subcutis;exactmatch
stroma of the ovarian cortex;stroma of the ovarian cortex;exactmatch
solitary reticulohistiocytoma;reticulohistiocytic granuloma;exactmatch
sinus;sinus;exactmatch
simple epithelium;simple epithelium;exactmatch
lactotroph adenoma;lactotrope adenoma;exactmatch
refractile media;dioptric media;exactmatch
pseudomyxoma peritonei;gelatinous ascites;exactmatch
pruritus;itch;exactmatch
pyriform sinus;piriform recess;exactmatch
prostate neoplasm;neoplasm of prostate;exactmatch
pulmonary lobule;pulmonary lobule;exactmatch
pulmonary acinus;pulmonary acinus;exactmatch
pseudostratified epithelium;pseudostratified epithelium;exactmatch
simple cuboidal epithelium;simple cuboidal epithelium;exactmatch
prostatic tissue;prostatic parenchyma;exactmatch
precancerous condition;precancerous condition;exactmatch
primordial germ cell;primordial germ cell;exactmatch
polyp;polyp;exactmatch
familial adenomatous polyposis;apc - adenomatous polyposis coli;exactmatch
fibroepithelial polyp;fibropapilloma, benign;exactmatch
posterior mediastinum;mediastinum, posterior;exactmatch
psoriasis;psoriasis;exactmatch
renal tissue;renal tissue;exactmatch
renal vein;renal vein;exactmatch
rete testis;rete testis;exactmatch
simple columnar epithelium;simple columnar epithelium;exactmatch
respiratory system neoplasm;respiratory system neoplasm;exactmatch
sheath of schwann;neurilemma;exactmatch
serous salivary gland;gland, salivary, serous;exactmatch
sensory-somatic nervous system;sensory-somatic nervous system;exactmatch
second portion of the duodenum;descending portion of duodenum;exactmatch
sebaceous gland;gland, sebaceous;exactmatch
rectal polyp;polyp of rectum;exactmatch
salivary gland tissue;salivary gland tissue;exactmatch
sacral region;sacrum;exactmatch
rectal neoplasm;neoplasm of rectum;exactmatch
right lumbar region;right lumbar region;exactmatch
right inguinal region;right inguinal region;exactmatch
retinal pigment epithelium;retinal pigmented epithelial layer;exactmatch
sexual dysfunction;sexual dysfunction;exactmatch
left lumbar region;left lumbar region;exactmatch
osteoma;osteoma, benign;exactmatch
bladder tissue;bladder tissue;exactmatch
diaphragma sellae;diaphragma sellae;exactmatch
acute myeloid leukemia without maturation;aml without maturation;exactmatch
dura mater;dura;exactmatch
duct salivary gland system;duct salivary gland system;exactmatch
myelofibrosis;myelofibrosis;exactmatch
myelodysplastic syndrome;dysmyelopoietic syndrome;exactmatch
distal convoluted tubule;distal convoluted tubule;exactmatch
mycosis fungoides;ctcl/ mycosis fungoides;exactmatch
musculoskeletal pain;musculoskeletal pain;exactmatch
acute myeloid leukemia with maturation;aml with maturation;exactmatch
deep intracranial venous system;deep intracranial venous system;exactmatch
plasma cell myeloma;kahler disease;exactmatch
cuboidal epithelium;cuboidal epithelium;exactmatch
mucocele of the appendix;appendiceal mucocele;exactmatch
oral disorder;oral disease;exactmatch
cowper gland;bulbourethral gland;exactmatch
corticotroph cell;acth cell;exactmatch
eccrine sweat gland;eccrine sweat gland;exactmatch
electron-transport chain of the respiratory enzymes;electron transport chain of the respiratory enzymes;exactmatch
extrahepatic bile duct;extrahepatic bile duct;exactmatch
myositis ossificans;myositis ossificans;exactmatch
myxosarcoma;myxosarcoma, malignant;exactmatch
exocrine pancreas;exocrine pancreas;exactmatch
esophageal tissue;esophageal tissue;exactmatch
esophageal squamous cell;esophageal squamous cell;exactmatch
angiomyxoma;angiomyxoma;exactmatch
esophageal mucosa;esophageal mucosa;exactmatch
epithelial cell junction;epithelial cell junction;exactmatch
epiphysis of the bone;epiphysis;exactmatch
endocrine cell;endocrine cell;exactmatch
epigastric region;epigastric region;exactmatch
benign granular cell tumor;benign granular cell myoblastoma;exactmatch
endometrial stroma;endometrial stroma;exactmatch
endometrial glandular cell;endometrial glandular cell;exactmatch
endometrial cavity;endometrial cavity;exactmatch
endocrine testis;endocrine testis;exactmatch
endocrine sex organ;endocrine sex organ;exactmatch
monosomy;monosomy;exactmatch
corneoscleral coat;corneoscleral coat;exactmatch
squamous metaplasia;squamous metaplasia;exactmatch
bone of the extremity;bone of extremity;exactmatch
multiple endocrine neoplasia type 1;mea type 1;exactmatch
melanoma;melanoma, malignant;exactmatch
bronchus-associated lymphoid tissue;balt;exactmatch
bronchial tree;bronchial tree;exactmatch
bronchial epithelium;bronchial epithelium;exactmatch
meigs syndrome;meigs syndrome;exactmatch
bone surface;bone surface;exactmatch
body part;body part;exactmatch
conjunctival epithelium;conjunctival epithelium;exactmatch
medulloblastoma;cns, medulloblastoma;exactmatch
body of the nail;body of the nail;exactmatch
blood vessel tissue;blood vessel tissue;exactmatch
blood capillary;blood capillary;exactmatch
bladder urothelium;bladder transitional cell epithelium;exactmatch
bladder urothelial cell;bladder transitional cell;exactmatch
mediastinal neoplasm;mediastinal neoplasm;exactmatch
canal of hering;canal of hering;exactmatch
multiple endocrine neoplasia type 2a;mea type 2a;exactmatch
cardia gland;cardia gland;exactmatch
cartilaginous tissue;cartilage;exactmatch
metaplasia;metaplasia;exactmatch
common carotid artery;common carotid artery;exactmatch
metabolic disorder;metabolic disease;exactmatch
collecting tube;collecting tube;exactmatch
mesothelioma;mesothelioma;exactmatch
mesenchymoma;mesenchymoma;exactmatch
chondroblast;chondroblast;exactmatch
meningioma;meningioma;exactmatch
cervical lymph node;cervical lymph node;exactmatch
ceruminous gland;ceruminous gland;exactmatch
cerebral sulcus;cerebral sulcus;exactmatch
meningeal neoplasm;meningeal neoplasm;exactmatch
cementoblast;cementoblast;exactmatch
cell of the epidermis;cell of the epidermis;exactmatch
multiple endocrine neoplasia type 2b;men 2b;exactmatch
nasopharyngeal neoplasm;nasopharyngeal neoplasm;exactmatch
eye appendage;eye appendage;exactmatch
osteochondroma;osteochondroma, benign;exactmatch
night sweats;night sweating;exactmatch
odontogenic neoplasm;odontogenic neoplasm;exactmatch
obstruction;obstruction;exactmatch
obesity;obesity;exactmatch
interlobular bile duct;interlobular bile duct;exactmatch
intercalated duct;intercalated duct;exactmatch
inguinal lymph node;inguinal lymph node;exactmatch
nodule;nodule;exactmatch
immature b-lymphocyte;immature b-lymphocyte;exactmatch
interstitial cell;interstitial cell;exactmatch
vestibular schwannoma;acoustic neurilemmoma;exactmatch
neuroma;neuroma;exactmatch
hyaline cartilage;hyaline cartilage;exactmatch
epencephalon;epencephalon;exactmatch
hilar area of the kidney;hilar area of kidney;exactmatch
neurofibromatosis type 2;acoustic neurofibromatosis;exactmatch
hepatic tissue;hepatic parenchyma;exactmatch
odontoma;fibro-odontoma;exactmatch
interstitial cell of cajal;interstitial cell of cajal;exactmatch
nausea;nausea;exactmatch
lacrimal sac;lacrimal sac;exactmatch
osteoblastoma;giant osteoid osteoma;exactmatch
large intestinal wall tissue;large intestinal wall tissue;exactmatch
large intestinal mucosa;large intestinal mucosa;exactmatch
large intestinal glandular cell;large intestinal glandular cell;exactmatch
bone paget disease;bone paget disease;exactmatch
lactotroph cell;lactotrope cell;exactmatch
oropharyngeal neoplasm;neoplasm of oropharynx;exactmatch
lacrimal apparatus;lacrimal apparatus;exactmatch
interstitial segment of the fallopian tube;interstitial segment of the fallopian tube;exactmatch
orbit neoplasm;neoplasm of orbit;exactmatch
opportunistic infection;oi;exactmatch
islet cell;islet cell;exactmatch
irregular bone;irregular bone;exactmatch
oligodendroglioma;oligodendroglioma;exactmatch
intracranial venous system;intracranial venous system;exactmatch
intracellular membrane;intracellular membrane;exactmatch
hepatic lobule;hepatic lobule;exactmatch
hepatic duct;hepatic duct;exactmatch
neurofibromatosis type 1;nf1;exactmatch
neoplasm;neoplasia;exactmatch
fundic gland;fundic gland;exactmatch
fsh cell;fsh cell;exactmatch
embryonal neoplasm;embryonal neoplasm;exactmatch
frontal sulcus;frontal sulcus;exactmatch
neoplasm by site;neoplasm by site;exactmatch
foramen of monroe;foramen of monroe;exactmatch
foot;foot;exactmatch
flat bone;flat bone;exactmatch
hematopoietic and lymphoid cell;hematopoietic and lymphoid cell;exactmatch
metastatic neoplasm;metastasis;exactmatch
finger;finger;exactmatch
cytoskeleton filament;cytoskeletal filament;exactmatch
neck neoplasm;neck neoplasm;exactmatch
female urethra;female urethra;exactmatch
nausea and vomiting;nausea and vomiting;exactmatch
falciform ligament;falciform ligament;exactmatch
radiation-related neoplasm;radiation induced neoplasm;exactmatch
ganglion cell layer;ganglion cell layer;exactmatch
gastric glandular cell;gastric glandular cell;exactmatch
gastric mucosa;gastric mucosa;exactmatch
neurofibroma;neurofibroma, benign;exactmatch
head and neck muscle;head and neck muscle;exactmatch
hand;hand;exactmatch
hair follicle infundibulum;hair follicle infundibulum;exactmatch
hair;hair;exactmatch
neuroblastoma;neuroblastoma, malignant;exactmatch
gonadotroph cell;gonadotrope cell;exactmatch
schwannoma;benign neurilemmoma;exactmatch
nervous system neoplasm;neoplasm of nervous system;exactmatch
gingiva;gingiva;exactmatch
genito-urinary region;genito-urinary region;exactmatch
wilms tumor;nephroblastoma;exactmatch
gastroesophageal junction;gastroesophageal junction;exactmatch
gastric tissue;gastric tissue;exactmatch
hereditary neoplastic syndrome;familial neoplastic syndrome;exactmatch
ascites;ascites;exactmatch
arthritis;arthritis;exactmatch
premalignant hematologic condition;premalignant hematologic condition;exactmatch
skin cystic basal cell carcinoma;cystic basal cell carcinoma;exactmatch
classic type atypical fibroxanthoma;classic type atypical fibroxanthoma;exactmatch
skin basaloid carcinoma;basaloid skin squamous cell carcinoma;exactmatch
skin pseudovascular squamous cell carcinoma;pseudovascular skin squamous cell carcinoma;exactmatch
skin micronodular basal cell carcinoma;basal cell carcinoma, micronodular;exactmatch
skin infundibulocystic basal cell carcinoma;infundibulocystic basal cell carcinoma;exactmatch
skin infiltrating basal cell carcinoma;infiltrating basal cell carcinoma;exactmatch
skin follicular basal cell carcinoma;follicular basal cell carcinoma;exactmatch
skin clear cell basal cell carcinoma;clear cell basal cell carcinoma;exactmatch
fibrosarcomatous dermatofibrosarcoma protuberans;fibrosarcomatous dermatofibrosarcoma protuberans;exactmatch
skin adenoid basal cell carcinoma;adenoid basal cell carcinoma;exactmatch
digital papillary adenocarcinoma;aggressive digital papillary adenocarcinoma;exactmatch
primary cutaneous mucinous carcinoma;adnexal mucinous adenocarcinoma;exactmatch
pre-malignant skin epithelial lesion;pre-malignant skin epithelial lesion;exactmatch
conventional lipoma;classic type lipoma;exactmatch
malignant skin vascular neoplasm;malignant cutaneous vascular neoplasm;exactmatch
tubular apocrine adenoma;tubular apocrine adenoma;exactmatch
spindle cell type atypical fibroxanthoma;spindle cell type atypical fibroxanthoma;exactmatch
melanoacanthoma;melanoacanthoma;exactmatch
desmoplastic trichoepithelioma;desmoplastic trichoepithelioma;exactmatch
non-neoplastic endocrine disorder;non-neoplastic endocrine disorder;exactmatch
connective and soft tissue disorder;connective and soft tissue disease;exactmatch
non-neoplastic soft tissue disorder;non-neoplastic soft tissue disorder;exactmatch
non-neoplastic bone disorder;non-neoplastic bone disorder;exactmatch
head and neck disorder;head and neck disorder;exactmatch
non-neoplastic gonadal disorder;non-neoplastic gonadal disorder;exactmatch
non-neoplastic adrenal gland disorder;non-neoplastic adrenal gland disorder;exactmatch
non-neoplastic thyroid gland disorder;non-neoplastic thyroid gland disorder;exactmatch
endocrine syndrome;endocrine syndrome;exactmatch
non-neoplastic digestive system disorder;non-neoplastic digestive system disorder;exactmatch
non-neoplastic pleural disorder;non-neoplastic pleural disease;exactmatch
non-neoplastic lung disorder;non-neoplastic lung disorder;exactmatch
non-neoplastic skin disorder;non-neoplastic cutaneous disorder;exactmatch
dermatosis;dermatosis;exactmatch
genital human papillomavirus infection;genital human papilloma virus infection;exactmatch
multiple lobular capillary hemangiomas;multiple lobular capillary hemangiomas;exactmatch
disorder by site;disease by site;exactmatch
follicular myxoma;follicular myxoma;exactmatch
classic type trichoepithelioma;classic type trichoepithelioma;exactmatch
arteriovenous malformation/hemangioma;avm/h;exactmatch
conventional alveolar rhabdomyosarcoma;conventional alveolar rhabdomyosarcoma;exactmatch
lipomatous hemangiopericytoma;lipomatous hemangiopericytoma;exactmatch
infantile hemangiopericytoma;infantile hemangiopericytoma;exactmatch
glomus tumor of uncertain malignant potential;glomus tumor of uncertain malignant potential;exactmatch
glomangiomatosis;glomangiomatosis;exactmatch
inflammatory leiomyosarcoma;inflammatory leiomyosarcoma;exactmatch
granular cell leiomyosarcoma;granular cell leiomyosarcoma;exactmatch
solid alveolar rhabdomyosarcoma;solid alveolar rhabdomyosarcoma;exactmatch
"t(11;14)(q13;q32)";"t(11;14)(q13;q32)";exactmatch
conventional extraskeletal myxoid chondrosarcoma;conventional extraskeletal myxoid chondrosarcoma;exactmatch
atypical spindle cell/pleomorphic lipomatous tumor;atypical spindle cell lipoma;exactmatch
mediastinal lipomatosis;mediastinal lipomatosis;exactmatch
steroid lipomatosis;steroid lipomatosis;exactmatch
pelvic lipomatosis;pelvic lipomatosis;exactmatch
liver angiomyolipoma;hepatic angiomyolipoma;exactmatch
lipoblastoma;embryonic lipoma;exactmatch
secondary chondrosarcoma;secondary chondrosarcoma;exactmatch
lymphadenopathic kaposi sarcoma;lymphadenopathic kaposi sarcoma;exactmatch
extraskeletal myxoid chondrosarcoma;emc;exactmatch
desmoplastic trichilemmoma;desmoplastic trichilemmoma;exactmatch
radiation-related angiosarcoma;radiation-induced angiosarcoma;exactmatch
classic type trichilemmoma;classic type trichilemmoma;exactmatch
benign hair follicle neoplasm;benign follicular neoplasm;exactmatch
large cell acanthoma;large cell acanthoma;exactmatch
acantholytic acanthoma;acantholytic acanthoma;exactmatch
epidermolytic acanthoma;epidermolytic acanthoma;exactmatch
desmoplastic fibroblastoma;collagenous fibroma;exactmatch
adult xanthogranuloma;adult xanthogranuloma;exactmatch
angiosarcoma associated with lymphedema;angiosarcoma associated with lymphedema;exactmatch
angiomatosis;angiomatosis;exactmatch
retiform hemangioendothelioma;hobnail hemangioendothelioma;exactmatch
kaposiform hemangioendothelioma;khe;exactmatch
skin lymphangioma;cutaneous lymphangioma;exactmatch
intra-abdominal lymphangioma;intra-abdominal lymphangioma;exactmatch
hemangioma of peripheral nerve;hemangioma of peripheral nerve;exactmatch
hobnail hemangioma;hobnail hemangioma;exactmatch
glomeruloid hemangioma;glomeruloid hemangioma;exactmatch
peripheral nervous system disorder;disorder of peripheral nervous system;exactmatch
infectious disorder by site;infectious disorder by site;exactmatch
non-neoplastic central nervous system disorder;non-neoplastic central nervous system disease;exactmatch
retroperitoneal disorder;retroperitoneal disease;exactmatch
human papillomavirus-related cervical squamous cell carcinoma;hpv-related cervical squamous cell carcinoma;exactmatch
human papillomavirus-related cervical carcinoma;hpv-related cervical carcinoma;exactmatch
human papillomavirus-related carcinoma;hpv-related carcinoma;exactmatch
virus-related malignant neoplasm;virus related cancer;exactmatch
non-neoplastic cardiovascular disorder;non-neoplastic cardiovascular disease;exactmatch
respiratory and thoracic disorder;respiratory and thoracic disease;exactmatch
non-neoplastic retroperitoneal disorder;non-neoplastic retroperitoneal disease;exactmatch
non-neoplastic peritoneal disorder;non-neoplastic peritoneal disease;exactmatch
human papillomavirus-related verrucous carcinoma;hpv-related verrucous carcinoma;exactmatch
non-neoplastic peritoneal and retroperitoneal disorder;non-neoplastic peritoneal and retroperitoneal disease;exactmatch
peritoneal and retroperitoneal disorder;peritoneal and retroperitoneal disease;exactmatch
non-neoplastic head and neck disorder;non-neoplastic head and neck disease;exactmatch
non-neoplastic neck disorder;non-neoplastic neck disease;exactmatch
non-neoplastic laryngeal disorder;non-neoplastic laryngeal disease;exactmatch
skull disorder;skull disease;exactmatch
non-neoplastic ear disorder;non-neoplastic ear disease;exactmatch
human papillomavirus-related endocervical adenocarcinoma;hpv-related endocervical adenocarcinoma;exactmatch
human papillomavirus-related vulvar squamous cell carcinoma;hpv-related vulvar squamous cell carcinoma;exactmatch
non-neoplastic peripheral nervous system disorder;non-neoplastic peripheral nervous system disease;exactmatch
ebv-related malignant neoplasm;ebv related malignancy;exactmatch
ebv-related post-transplant lymphoproliferative disorder;ebv-related ptld;exactmatch
ebv-related clonal post-transplant lymphoproliferative disorder;ebv related clonal ptld;exactmatch
ebv-related burkitt lymphoma;ebv related burkitt's lymphoma;exactmatch
ebv-related non-hodgkin lymphoma;ebv related non-hodgkin's lymphoma;exactmatch
ebv-related hodgkin lymphoma;ebv related hodgkin's lymphoma;exactmatch
ebv-related lymphoma;ebv related lymphoma;exactmatch
ebv-related carcinoma;ebv related carcinoma;exactmatch
hepatitis c virus-related hepatocellular carcinoma;hepatitis c virus related hepatocellular carcinoma;exactmatch
human papillomavirus-related esophageal squamous cell carcinoma;hpv-related esophageal squamous cell carcinoma;exactmatch
hepatitis b virus-related hepatocellular carcinoma;hepatitis b virus related hepatocellular carcinoma;exactmatch
hepatitis virus-related hepatocellular carcinoma;hepatitis virus related hepatocellular carcinoma;exactmatch
htlv-1-related malignant neoplasm;htlv-1 related malignancy;exactmatch
human papillomavirus-related adenocarcinoma;hpv-related adenocarcinoma;exactmatch
human papillomavirus-related squamous cell carcinoma;hpv-related squamous cell carcinoma;exactmatch
human papillomavirus-related squamous cell carcinoma of the penis;hpv-related penile squamous cell carcinoma;exactmatch
human papillomavirus-related anal squamous cell carcinoma;hpv-related anal squamous cell carcinoma;exactmatch
non-neoplastic oral cavity disorder;non-neoplastic oral cavity disorder;exactmatch
non-neoplastic oral disorder;non-neoplastic oral disease;exactmatch
neck disorder;neck disease;exactmatch
non-neoplastic eye disorder;non-neoplastic eye disease;exactmatch
penile non-neoplastic disorder;penile non-neoplastic disorder;exactmatch
testicular non-neoplastic disorder;testicular non-neoplastic disease;exactmatch
non-neoplastic reproductive system disorder;non-neoplastic reproductive system disease;exactmatch
female non-neoplastic reproductive system disorder;female non-neoplastic reproductive system disease;exactmatch
male non-neoplastic reproductive system disorder;male non-neoplastic reproductive system disease;exactmatch
non-neoplastic retinal disorder;non-neoplastic retinal disorder;exactmatch
conjunctival disorder;conjunctival disease;exactmatch
non-neoplastic bladder disorder;non-neoplastic bladder disorder;exactmatch
sinonasal disorder;nasal cavity and paranasal sinus disorder;exactmatch
non-neoplastic kidney disorder;non-neoplastic kidney disorder;exactmatch
non-neoplastic urinary system disorder;non-neoplastic urinary system disorder;exactmatch
oculomotor nerve disorder;oculomotor nerve disorder;exactmatch
facial nerve disorder;facial nerve disorder;exactmatch
abducens nerve disorder;abducens nerve disease;exactmatch
vagus nerve disorder;vagus nerve disorder;exactmatch
non-neoplastic nervous system disorder;non-neoplastic nervous system disorder;exactmatch
placental non-neoplastic disorder;non-neoplastic placenta disorder;exactmatch
vulvar non-neoplastic disorder;vulvar non-neoplastic disease;exactmatch
vaginal non-neoplastic disorder;vaginal non-neoplastic disease;exactmatch
cervical non-neoplastic disorder;cervical non-neoplastic disease;exactmatch
conductive hearing loss;conductive deafness;exactmatch
head and neck precancerous condition;head and neck precancerous condition;exactmatch
oral cavity disorder;oral cavity disease;exactmatch
transplant-related kaposi sarcoma;transplant-related kaposi sarcoma;exactmatch
transplant-related hematologic malignancy;transplant-related hematologic malignancy;exactmatch
transplant-related renal cell carcinoma;transplant-related renal cell cancer;exactmatch
transplant-related lung carcinoma;transplant-related lung cancer;exactmatch
transplant-related skin squamous cell carcinoma;tcssc;exactmatch
transplant-related hepatocellular carcinoma;transplant-related hepatocellular cancer;exactmatch
transplant-related bladder urothelial carcinoma;transplant-related bladder transitional cell carcinoma;exactmatch
transplant-related carcinoma;transplant-related carcinoma;exactmatch
transplant-related malignant neoplasm;transplant-related cancer;exactmatch
vulvar disorder;vulvar disease;exactmatch
uterine non-neoplastic disorder;uterine non-neoplastic disease;exactmatch
ovarian non-neoplastic disorder;ovarian non-neoplastic disease;exactmatch
mesenchymal extraskeletal chondrosarcoma;extraskeletal mesenchymal chondrosarcoma;exactmatch
classic rhabdomyoma;classic rhabdomyoma;exactmatch
nasopharyngeal angiofibroma;nasopharyngeal angiofibroma;exactmatch
adult anaplastic large cell lymphoma;adult anaplastic large cell lymphoma;exactmatch
childhood mesenchymal chondrosarcoma;childhood mesenchymal chondrosarcoma;exactmatch
adult desmoplastic small round cell tumor;adult desmoplastic small round cell tumor;exactmatch
childhood desmoplastic small round cell tumor;childhood desmoplastic small round cell tumor;exactmatch
childhood clear cell sarcoma of soft parts;childhood clear cell sarcoma of soft parts;exactmatch
adult clear cell sarcoma of soft parts;adult clear cell sarcoma of soft parts;exactmatch
adult pleomorphic rhabdomyosarcoma;adult pleomorphic rhabdomyosarcoma;exactmatch
childhood liver and intrahepatic bile duct neoplasm;childhood hepatic neoplasm;exactmatch
adult systemic anaplastic large cell lymphoma;adult systemic anaplastic large cell lymphoma;exactmatch
childhood extraskeletal osteosarcoma;childhood extraosseous osteosarcoma;exactmatch
adult primary cutaneous anaplastic large cell lymphoma;adult primary cutaneous anaplastic large cell lymphoma;exactmatch
childhood yolk sac tumor;childhood endodermal sinus neoplasm;exactmatch
adult ganglioglioma;adult ganglioglioma;exactmatch
childhood ganglioglioma;childhood ganglioglioma;exactmatch
philadelphia chromosome negative bcr-abl1 negative chronic myelogenous leukemia;philadelphia chromosome negative bcr-abl1 negative chronic myelogenous leukemia;exactmatch
unresectable malignant neoplasm;unresectable malignant neoplasm;exactmatch
recurrent hematologic malignancy;recurrent hematologic cancer;exactmatch
adult mesenchymal chondrosarcoma;adult mesenchymal chondrosarcoma;exactmatch
childhood myxoid chondrosarcoma;childhood myxoid chondrosarcoma;exactmatch
adult spinal cord ependymoma;adult spinal cord ependymoma;exactmatch
carcinoma arising in nasal papillomatosis;carcinoma arising in nasal papillomatosis;exactmatch
follicular ameloblastoma;follicular ameloblastoma;exactmatch
extraosseous/peripheral ameloblastoma;ameloblastoma, extraosseous/peripheral type;exactmatch
vaginal melanoma;melanoma of vagina;exactmatch
parathyroid gland oncocytic adenoma;parathyroid gland oncocytic adenoma;exactmatch
pituitary gland basophil carcinoma;basophil adenocarcinoma;exactmatch
metastatic ovarian small cell carcinoma, hypercalcemic type;metastatic ovarian small cell carcinoma, hypercalcemic type;exactmatch
ovarian small cell carcinoma;ovarian small cell cancer;exactmatch
scirrhous hepatocellular carcinoma;hepatocellular carcinoma, scirrhous;exactmatch
adult myxoid chondrosarcoma;adult myxoid chondrosarcoma;exactmatch
pericardial carcinomatosis;carcinomatosis of the pericardium;exactmatch
pleural carcinomatosis;carcinomatosis of the pleura;exactmatch
meningeal carcinomatosis;carcinomatosis of the meninges;exactmatch
peritoneal carcinomatosis;abdominal carcinomatosis;exactmatch
metastatic carcinoma in the adrenal cortex;metastatic carcinoma in the adrenal cortex;exactmatch
thyroid gland adenocarcinoma;thyroid adenocarcinoma;exactmatch
mucin-producing adenocarcinoma;mucin-producing adenocarcinoma;exactmatch
refractory hematologic malignancy;refractory hematologic cancer;exactmatch
leukemia (antiquated);leukemia (antiquated);exactmatch
recurrent peripheral primitive neuroectodermal tumor of bone;recurrent neuroepithelioma of bone;exactmatch
stage iv aids-related anal canal cancer ajcc v6 and v7;stage iv aids-related anal canal cancer;exactmatch
extraskeletal ewing sarcoma/peripheral primitive neuroectodermal tumor;extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor;exactmatch
metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor;metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor;exactmatch
ewing sarcoma/peripheral primitive neuroectodermal tumor;efts;exactmatch
l1 acute lymphoblastic leukemia;fab ll;exactmatch
borderline ovarian endometrioid cystadenofibroma;borderline malignancy ovarian endometrioid cystadenofibroma;exactmatch
ovarian endometrioid cystadenofibroma;ovarian endometrioid cystadenofibroma;exactmatch
ovarian endometrioid adenofibroma;endometrioid adenoma, nos;exactmatch
stage iii aids-related anal canal cancer ajcc v6 and v7;stage iii aids-related anal canal cancer;exactmatch
localized peripheral primitive neuroectodermal tumor of bone;localized neuroepithelioma of bone;exactmatch
stage ii aids-related anal canal cancer ajcc v6 and v7;stage ii aids-related anal canal cancer;exactmatch
stage i aids-related anal canal cancer ajcc v6 and v7;stage i aids-related anal canal cancer;exactmatch
stage 0 aids-related anal canal cancer ajcc v6 and v7;stage 0 aids-related anal canal cancer;exactmatch
l2 acute lymphoblastic leukemia;acute lymphoblastic leukemia, l2 type, nos;exactmatch
secondary myelodysplastic syndrome;secondary mds;exactmatch
localized adrenal gland pheochromocytoma;localized adrenal gland pheochromocytoma;exactmatch
adult l1 acute lymphoblastic leukemia;adult l1 acute lymphoblastic leukemia;exactmatch
localized primitive neuroectodermal tumor;localized primitive neuroectodermal tumor;exactmatch
recurrent primitive neuroectodermal tumor;recurrent primitive neuroectodermal tumor;exactmatch
positive lymph node;positive;exactmatch
peritoneal and retroperitoneal hemorrhage;peritoneal and retroperitoneal hemorrhage;exactmatch
peripheral t-cell lymphoma, large cell;peripheral t-cell lymphoma, large cell;exactmatch
immune system and related disorders;immune system and related disorders;exactmatch
myeloproliferative neoplasm, unclassifiable;cmpd, u;exactmatch
histiocytic sarcoma;histiocytic sarcoma;exactmatch
unresectable hepatocellular carcinoma;non-resectable hepatocellular carcinoma;exactmatch
postauricular lymphadenitis;postauricular lymphadenitis;exactmatch
stage ii centroblastic follicular lymphoma;stage ii centroblastic follicular lymphoma;exactmatch
stage i centroblastic follicular lymphoma;stage i centroblastic follicular lymphoma;exactmatch
resectable cholangiocarcinoma;resectable cholangiocarcinoma;exactmatch
recurrent cholangiocarcinoma;recurrent cholangiocarcinoma;exactmatch
unresectable cholangiocarcinoma;non-resectable cholangiocarcinoma;exactmatch
resectable duodenal carcinoma;resectable duodenal carcinoma;exactmatch
periampullary adenocarcinoma;periampullary adenocarcinoma;exactmatch
ann arbor stage i b-cell non-hodgkin lymphoma;ann arbor stage i b-cell non-hodgkin lymphoma;exactmatch
anaplastic (malignant) intracranial meningioma;anaplastic (malignant) intracranial meningioma;exactmatch
granular cell ameloblastoma;granular cell ameloblastoma;exactmatch
adult central nervous system mature teratoma;adult central nervous system mature teratoma;exactmatch
gingival angiofibroma;gingival angiofibroma;exactmatch
small intestinal gastrin-producing neuroendocrine tumor;small intestinal g cell net;exactmatch
colorectal adenoma with moderate dysplasia;colorectal adenoma with moderate dysplasia;exactmatch
colorectal tubular adenoma;colorectal tubular adenoma;exactmatch
small intestinal vip-producing neuroendocrine tumor;small intestinal vip-producing net;exactmatch
pancreatic vip-producing neuroendocrine tumor;pancreatic vip producing net;exactmatch
small intestinal somatostatin-producing neuroendocrine tumor;small intestinal somatostatin producing tumor;exactmatch
small intestinal l-cell glucagon-like peptide-producing neuroendocrine tumor;small intestinal l-cell glucagon-like peptide-producing net;exactmatch
small intestinal enterochromaffin cell serotonin-producing neuroendocrine tumor;small intestinal ec-cell serotonin-producing net;exactmatch
small intestinal small cell neuroendocrine carcinoma;small intestinal small cell carcinoma;exactmatch
colorectal intraepithelial neoplasia;colorectal dysplasia;exactmatch
l-cell glucagon-like peptide-producing neuroendocrine tumor;l-cell glucagon-like peptide-producing net;exactmatch
colon l-cell glucagon-like peptide-producing neuroendocrine tumor;colon l-cell glucagon-like peptide-producing net;exactmatch
colon enterochromaffin cell serotonin-producing neuroendocrine tumor;colon enterochromaffin cell serotonin-producing neuroendocrine tumor;exactmatch
appendix l-cell glucagon-like peptide-producing neuroendocrine tumor;appendiceal l-cell glucagon-like peptide-producing net;exactmatch
gastric gastrin-producing neuroendocrine tumor;gastric gastrin producing tumor;exactmatch
gastric enterochromaffin cell serotonin-producing neuroendocrine tumor;gastric ec cell serotonin-producing net;exactmatch
small intestinal mantle cell lymphoma;mantle cell lymphoma of small intestine;exactmatch
colorectal adenoma with mild dysplasia;colorectal adenoma with mild dysplasia;exactmatch
colorectal low grade intraepithelial neoplasia;colorectal low grade intraepithelial neoplasia;exactmatch
adult central nervous system immature teratoma;adult central nervous system immature teratoma;exactmatch
disseminated malignant neoplasm;disseminated malignant neoplasm;exactmatch
benign osteoclastic giant cell-rich tumor of bone;benign osteoclastic giant cell-rich tumor of bone;exactmatch
bone schwannoma;benign bone neurilemmoma;exactmatch
bone lipoma;bone lipoma;exactmatch
superficial bladder carcinoma;superficial bladder cancer;exactmatch
distal-type epithelioid sarcoma;conventional epithelioid sarcoma;exactmatch
proximal-type epithelioid sarcoma;central epithelioid sarcoma;exactmatch
peripheral primitive neuroectodermal tumor of soft tissues;peripheral neuroectodermal tumor of soft tissues;exactmatch
disseminated carcinoma;disseminated carcinoma;exactmatch
colorectal high grade intraepithelial neoplasia;colorectal high grade intraepithelial neoplasia;exactmatch
paraproteinemia;paraproteinemia;exactmatch
stage 0 lung cancer ajcc v6 and v7;bronchial carcinoma in situ;exactmatch
pancreatic acth-producing neuroendocrine tumor;ectopic acth-producing pancreatic neuroendocrine tumor;exactmatch
colon burkitt lymphoma;colon burkitt lymphoma;exactmatch
small intestinal high grade intraepithelial neoplasia;small intestinal high grade intraepithelial neoplasia;exactmatch
small intestinal low grade intraepithelial neoplasia;small intestinal low grade intraepithelial neoplasia;exactmatch
small intestinal intraepithelial neoplasia;small intestinal dysplasia;exactmatch
gastric mantle cell lymphoma;gastric mantle cell lymphoma;exactmatch
gastric sarcoma;gastric sarcoma;exactmatch
benign gastric soft tissue neoplasm;benign gastric soft tissue neoplasm;exactmatch
small intestinal atypical burkitt/burkitt-like lymphoma;primary small intestinal atypical burkitt's/burkitt's-like lymphoma;exactmatch
ampulla of vater squamous cell carcinoma;ampulla of vater squamous cell carcinoma;exactmatch
ampulla of vater mucinous adenocarcinoma;ampulla of vater mucinous adenocarcinoma;exactmatch
ampulla of vater intestinal-type adenocarcinoma;ampulla of vater intestinal-type adenocarcinoma;exactmatch
ampulla of vater clear cell adenocarcinoma;ampulla of vater clear cell adenocarcinoma;exactmatch
adenoma of the colon with intramucosal adenocarcinoma;adenoma of colon with intramucosal adenocarcinoma;exactmatch
ampulla of vater tubulovillous adenoma;ampulla of vater tubulovillous adenoma;exactmatch
colon mantle cell lymphoma;colon mantle cell lymphoma;exactmatch
small intestinal burkitt lymphoma;primary small intestinal burkitt's lymphoma;exactmatch
high grade gastric intraepithelial neoplasia;high grade gastric intraepithelial neoplasia;exactmatch
metastatic carcinoma in the lung;metastatic carcinoma in the lung;exactmatch
duodenal somatostatin-producing neuroendocrine tumor;duodenal somatostatin producing tumor;exactmatch
childhood central nervous system germinoma;central nervous system germinoma;exactmatch
childhood central nervous system immature teratoma;childhood central nervous system immature teratoma;exactmatch
childhood central nervous system mature teratoma;childhood central nervous system mature teratoma;exactmatch
childhood central nervous system mixed germ cell tumor;central nervous system mixed germ cell tumor;exactmatch
adult central nervous system mixed germ cell tumor;adult central nervous system mixed germ cell tumor;exactmatch
ampulla of vater adenosquamous carcinoma;ampulla of vater adenosquamous carcinoma;exactmatch
ampulla of vater undifferentiated carcinoma;ampulla of vater undifferentiated carcinoma;exactmatch
esophageal verrucous carcinoma;esophageal verrucous cancer;exactmatch
esophageal adenosquamous carcinoma;esophageal adenosquamous cancer;exactmatch
low grade gastric intraepithelial neoplasia;gastric mild intraepithelial neoplasia (dysplasia);exactmatch
intermediate risk gastric gastrointestinal stromal tumor;intermediate risk gastric gist;exactmatch
intermediate risk small intestinal gastrointestinal stromal tumor;intermediate risk small intestinal gist;exactmatch
intermediate risk esophageal gastrointestinal stromal tumor;intermediate risk esophageal gist;exactmatch
high risk esophageal gastrointestinal stromal tumor;high risk esophageal gist;exactmatch
low risk esophageal gastrointestinal stromal tumor;low risk esophageal gist;exactmatch
esophageal gastrointestinal stromal tumor;esophageal gist;exactmatch
high grade esophageal glandular intraepithelial neoplasia;esophageal high-grade glandular intraepithelial neoplasia;exactmatch
low grade esophageal glandular intraepithelial neoplasia;esophageal low grade glandular intraepithelial neoplasia;exactmatch
low grade esophageal squamous intraepithelial neoplasia;esophageal low grade squamous intraepithelial neoplasia;exactmatch
high grade esophageal squamous intraepithelial neoplasia;esophageal high-grade squamous intraepithelial neoplasia;exactmatch
esophageal high grade intraepithelial neoplasia;esophageal high grade intraepithelial neoplasia;exactmatch
esophageal glandular intraepithelial neoplasia;esophageal glandular dysplasia;exactmatch
esophageal squamous intraepithelial neoplasia;esophageal squamous dysplasia;exactmatch
esophageal undifferentiated carcinoma;esophageal undifferentiated carcinoma;exactmatch
hhv8-related malignant neoplasm;hhv-8 related malignancy;exactmatch
virus-related carcinoma;virus related carcinoma;exactmatch
virus-related lymphoma;virus related lymphoma;exactmatch
stage ic;stage ic;exactmatch
myocardial infarction;heart attack;exactmatch
general qualifier;general modifier;exactmatch
disease qualifier;disease qualifier;exactmatch
toxicity;tox;exactmatch
stage ia2;stage ia2;exactmatch
stage ia1;stage ia1;exactmatch
stage iiic;stage iiic;exactmatch
stage ivb;stage ivb;exactmatch
stage ib1;stage ib1;exactmatch
stage iva;stage iva;exactmatch
stage iiib;stage iiib;exactmatch
stage iiia;stage iiia;exactmatch
stage ib;stage ib;exactmatch
stage ia;stage ia;exactmatch
stage v;stage 5;exactmatch
stage ivs;stage ivs;exactmatch
stage 0;stage 0;exactmatch
stage ib2;stage ib2;exactmatch
grade 1;g1;exactmatch
postsurgical stage i;postsurgical stage i;exactmatch
pretext stage 4;pretext stage 4;exactmatch
pretext stage 3;pretext stage 3;exactmatch
pretext stage 2;pretext stage 2;exactmatch
pretext stage 1;pretext stage 1;exactmatch
postsurgical stage iv;postsurgical stage iv;exactmatch
postsurgical stage iii;postsurgical stage iii;exactmatch
postsurgical stage ii;postsurgical stage ii;exactmatch
hepatoblastoma stage;hepatoblastoma stage;exactmatch
stage ii;stage 2;exactmatch
limited stage;early stage;exactmatch
extensive stage;extensive stage;exactmatch
stage d;stage d;exactmatch
stage c;stage c;exactmatch
stage b;stage b;exactmatch
stage a;stage a;exactmatch
stage ivc;stage ivc;exactmatch
stage iv;stage 4;exactmatch
stage iii;stage 3;exactmatch
stage iic;stage iic;exactmatch
aflatoxins-related hepatocellular carcinoma;aflatoxins-related hepatocellular cancer;exactmatch
ionizing radiation-related malignant neoplasm;ionizing radiation-related malignant neoplasm;exactmatch
alcohol-related laryngeal carcinoma;alcohol-related laryngeal carcinoma;exactmatch
alcohol-related esophageal squamous cell carcinoma;alcohol-related esophageal carcinoma;exactmatch
alcohol-related carcinoma;alcohol-related carcinoma;exactmatch
asbestos-related malignant mesothelioma;asbestos-related malignant mesothelioma;exactmatch
asbestos-related lung carcinoma;asbestos-related lung cancer;exactmatch
alcohol-related hepatocellular carcinoma;alcohol-related hepatocellular cancer;exactmatch
solar radiation-related skin squamous cell carcinoma;solar radiation-related skin squamous cell carcinoma;exactmatch
stage iib;stage iib;exactmatch
solar radiation-related cutaneous melanoma;solar radiation-related cutaneous (skin) melanoma;exactmatch
old burn scar-related cutaneous melanoma;old burn scar-related cutaneous (skin) melanoma;exactmatch
old burn scar-related skin squamous cell carcinoma;old burn scar-related skin squamous cell carcinoma;exactmatch
poorly differentiated prostate adenocarcinoma;poorly differentiated prostate adenocarcinoma;exactmatch
immunodeficiency-related burkitt lymphoma;immunodeficiency associated burkitt lymphoma;exactmatch
sporadic burkitt lymphoma;sporadic burkitt lymphoma;exactmatch
alkylating agent-related acute myeloid leukemia and myelodysplastic syndrome;alkylating agent related acute myeloid leukemia and myelodysplastic syndrome;exactmatch
benzene-related acute myeloid leukemia;benzene-related acute myeloid leukemia;exactmatch
neoplasm by cause;neoplasm by cause;exactmatch
occupational neoplasm;occupational neoplasm;exactmatch
immunodeficiency-related neoplasm;immunodeficiency-related neoplasm;exactmatch
stage iia;stage iia;exactmatch
stage i;stage 1;exactmatch
stage 0is;stage 0is;exactmatch
stage 0a;stage 0a;exactmatch
radiation toxicity;radiation toxicity;exactmatch
drug toxicity;drug toxicity;exactmatch
senile sebaceous hyperplasia;senile sebaceous hyperplasia;exactmatch
lymphoma by lukes-collins classification (antiquated);lymphoma by lukes-collins classification (antiquated);exactmatch
metaplastic carcinoma;metaplastic carcinoma;exactmatch
breast sclerosing papilloma;breast sclerosing papilloma;exactmatch
breast intraductal proliferative lesion;breast intraductal proliferative lesion;exactmatch
breast usual ductal hyperplasia;breast hyperplasia without atypia;exactmatch
gastrointestinal autonomic nerve tumor;gant;exactmatch
breast lobular neoplasia;breast ln;exactmatch
thymic papillary adenocarcinoma;papillary carcinoma of thymus;exactmatch
disease grade qualifier;disease grade qualifier;exactmatch
grade 2;g2;exactmatch
chronic lymphocytic leukemia/small lymphocytic lymphoma;b-cell lymphocytic leukemia/small lymphocytic lymphoma;exactmatch
gata1 gene;gata binding protein 1 gene;exactmatch
kinase;kinase;exactmatch
il3 gene;il3;exactmatch
cell maturation;cell maturation;exactmatch
adrenal gland neoplasm;adrenal gland neoplasm;exactmatch
transcription elongation;transcription elongation;exactmatch
hla-a gene;hla-a;exactmatch
adrenal cortex neoplasm;adrenal cortex neoplasm;exactmatch
runx1t1 gene;runx1t1;exactmatch
transcription process;transcription process;exactmatch
pituitary gland chromophobe adenoma;chromophobe adenoma;exactmatch
g2 to m transition process;g2 to m transition process;exactmatch
pituitary gland basophil adenoma;basophilic adenoma;exactmatch
adenoma;adenoma, benign;exactmatch
warthin tumor;adenolymphoma;exactmatch
transport protein gene;transport protein gene;exactmatch
papillary adenocarcinoma;adenocarcinoma, papillary, malignant;exactmatch
adrenal rest tumor;adrenal rest neoplasm;exactmatch
mouse pulmonary disorder;mouse pulmonary disorder;exactmatch
grade 3;g3;exactmatch
cell cycle progression;cell cycle progression;exactmatch
ovarian sertoli-leydig cell tumor;androblastoma;exactmatch
neoplasm of the diffuse neuroendocrine system;apudoma;exactmatch
anal neoplasm;anal neoplasm;exactmatch
anorexia;anorexia;exactmatch
angiokeratoma;angiokeratoma;exactmatch
aneuploidy;aneuploid;exactmatch
anemia;anemia;exactmatch
amyloidosis;amyloid;exactmatch
primary myelofibrosis;amm;exactmatch
stat5b gene;stat5b;exactmatch
alzheimer's disease;alzheimer disease;exactmatch
rela gene;rela;exactmatch
zbtb16 gene;zbtb16;exactmatch
granulocytopenia;granulocytopenia;exactmatch
epithelial proliferative lesions of the mouse pulmonary system;epithelial proliferative lesions of the mouse pulmonary system;exactmatch
pulmonary proliferative lesions of the mouse;pulmonary proliferative lesions of the mouse;exactmatch
adenocarcinoma;adenocarcinoma, malignant;exactmatch
fusion gene;fusion gene;exactmatch
acquired immunodeficiency syndrome;aids;exactmatch
paresthesia;paresthesia;exactmatch
squamous cell carcinoma in situ of the nipple;intraepidermal squamous carcinoma of nipple;exactmatch
viscera;viscera;exactmatch
stage is;stage 1s;exactmatch
birt-hogg-dube syndrome;birt-hogg-dube;exactmatch
oncolysis;oncolysis;exactmatch
telangiectasia;telangiectasia;exactmatch
syndrome;syndrome;exactmatch
embryo;embryo;exactmatch
biochemical process;biochemical process;exactmatch
disease stage qualifier;disease stage qualifier;exactmatch
disease clinical qualifier;disease clinical qualifier;exactmatch
disease morphology qualifier;disease morphology qualifier;exactmatch
intermediate grade;intermediate grade;exactmatch
grade 4;g4;exactmatch
grade 3b;grade 3b;exactmatch
grade 3a;grade 3a;exactmatch
advanced adult hepatocellular carcinoma;advanced adult hepatocellular carcinoma;exactmatch
metastatic breast carcinoma in the skin;breast carcinoma metastatic in the skin;exactmatch
high-risk cancer;high-risk cancer;exactmatch
endocervical carcinoma;carcinoma of endocervix;exactmatch
tyrosine-protein kinase jak2;ec 2.7.1.112;exactmatch
congenital abnormality;birth defect;exactmatch
cell movement;cell movement;exactmatch
philadelphia chromosome;ph;exactmatch
pericentric inversion;pericentric inversion;exactmatch
paracentric inversion;paracentric inversion;exactmatch
nipple carcinoma;nipple cancer;exactmatch
cysteine peptidase gene;cysteine peptidase gene;exactmatch
pancreatic delta cell neuroendocrine tumor;pancreatic delta cell net;exactmatch
b-cell differentiation;b cell differentiation;exactmatch
hot nodule;hot nodule;exactmatch
cold nodule;cold nodule;exactmatch
chiasma;chiasma;exactmatch
stage iv testicular non-seminomatous germ cell tumor;stage iv testicular non-seminomatous germ cell tumor;exactmatch
non-functioning pancreatic delta cell neuroendocrine tumor;non-functional pancreatic delta cell net;exactmatch
therapy-related myeloid neoplasm;acute myeloid leukaemias and myelodysplastic syndromes, therapy-related;exactmatch
mature b-cell neoplasm;mature b-cell lymphocytic neoplasm;exactmatch
aids-related carcinoma;aids related carcinoma;exactmatch
helicobacter pylori-related gastric adenocarcinoma;helicobacter pylori-related gastric adenocarcinoma;exactmatch
cigarette smoking-related carcinoma;cigarette smoking-related carcinoma;exactmatch
old burn scar-related neoplasm;old burn scar-related neoplasm;exactmatch
immunodeficiency-related malignant neoplasm;immunodeficiency-related malignant neoplasm;exactmatch
opisthorchis viverrini-related cholangiocarcinoma;liver fluke-related cholangiocarcinoma;exactmatch
schistosoma hematobium-related bladder squamous cell carcinoma;schistosoma hematobium-related bladder squamous cell carcinoma;exactmatch
parasite-related carcinoma;parasite-related carcinoma;exactmatch
parasite-related malignant neoplasm;parasite-related cancer;exactmatch
helicobacter pylori-related carcinoma;helicobacter pylori-related carcinoma;exactmatch
asbestos-related malignant neoplasm;asbestos-related cancer;exactmatch
helicobacter pylori-associated gastric mucosa-associated lymphoid tissue lymphoma;helicobacter pylori-associated gastric malt;exactmatch
helicobacter pylori-related non-hodgkin lymphoma;helicobacter pylori-related non-hodgkin lymphoma;exactmatch
helicobacter pylori-related malignant neoplasm;helicobacter pylori-related malignancy;exactmatch
bacterium-related malignant neoplasm;bacterium-related cancer;exactmatch
"t(16;16)(p13.1;q22)";"t(16;16)(p13.1;q22)";exactmatch
"t(15;17)(q24;q21)";"t(15;17)(q22;q12)";exactmatch
microgranular acute promyelocytic leukemia;hypogranular acute promyelocytic leukemia;exactmatch
tobacco chewing-related carcinoma;tobacco chewing-related carcinoma;exactmatch
aromatic dyes-related malignant neoplasm;aromatic dyes-related cancer;exactmatch
pre-pre-b acute lymphoblastic leukemia;pre-pre-b acute lymphoblastic leukemia;exactmatch
female reproductive system precancerous condition;female reproductive system precancerous condition;exactmatch
common acute lymphoblastic leukemia;common all;exactmatch
polycythemia (excluding polycythemia vera);polycythemia (excluding polycythemia vera);exactmatch
mixed cell type gastrointestinal stromal tumor;mixed cell type gist;exactmatch
spindle cell type gastrointestinal stromal tumor;spindle cell type gist;exactmatch
non-invasive verrucous carcinoma of the penis;non-invasive penile verrucous carcinoma;exactmatch
penile carcinoma in situ;bowen disease of the penis;exactmatch
endometrial intraepithelial neoplasia;ein;exactmatch
stage iii testicular non-seminomatous germ cell tumor ajcc v6 and v7;stage iii testicular non-seminomatous germ cell tumor;exactmatch
solar radiation-related malignant neoplasm;solar radiation-related cancer;exactmatch
stage ii testicular non-seminomatous germ cell tumor ajcc v6 and v7;stage ii testicular non-seminomatous germ cell tumor;exactmatch
stage i testicular non-seminomatous germ cell tumor ajcc v6 and v7;stage i testicular non-seminomatous germ cell tumor;exactmatch
metastatic penile carcinoma;metastatic carcinoma of penis;exactmatch
myxoid liposarcoma;mlps;exactmatch
myelodysplastic/myeloproliferative neoplasm, unclassifiable;mds/mpd, u;exactmatch
lymphohistiocytoid mesothelioma;lymphohistiocytoid mesothelioma;exactmatch
giant hemangioma;giant hemangioma;exactmatch
typical acute promyelocytic leukemia;hypergranular acute promyelocytic leukemia;exactmatch
topoisomerase ii inhibitor-related acute myeloid leukemia;topoisomerase ii inhibitor related acute myeloid leukemia;exactmatch
alkylating agent-related acute myeloid leukemia;alkylating agent related acute myeloid leukemia;exactmatch
"t(11;18)(q21;q21)";api2-mlt translocation;exactmatch
digestive system neuroendocrine neoplasm;digestive system neuroendocrine neoplasm;exactmatch
pancreatic neuroendocrine tumor;islet cell tumor;exactmatch
skin radiation-related angiosarcoma;cutaneous radiation-induced angiosarcoma;exactmatch
human papillomavirus-related malignant neoplasm;hpv-related malignancy;exactmatch
extragastrointestinal gastrointestinal stromal tumor;egist;exactmatch
"t(1;19)(q23;p13.3)";"t(1;19) (q23;p13.3); pbx/e2a";exactmatch
clonal ccnd1 gene rearrangement;bcl-1 rearrangement;exactmatch
loss of chromosome 5q;5q deletion;exactmatch
acute myeloid leukemia not otherwise specified;aml not otherwise specified;exactmatch
"t(2;5)(p23;q35)";"t(2;5)";exactmatch
pulmonary sulcus neoplasm;pulmonary sulcus neoplasm;exactmatch
psammoma body formation;psammoma body formation;exactmatch
virus-related sarcoma;virus-related sarcoma;exactmatch
"t(2;8)(p11;q24)";"t(2;8)";exactmatch
previously treated myelodysplastic syndrome;previously treated myelodysplastic syndrome;exactmatch
secondary myelofibrosis;secondary myelofibrosis;exactmatch
therapy-related myelodysplastic syndrome;therapy related myelodysplastic syndrome;exactmatch
vulvar lichen sclerosus;vulvar lichen sclerosus;exactmatch
myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia;mds-rs-mld;exactmatch
thyroid gland well-differentiated tumor of uncertain malignant potential;atypical follicular adenoma;exactmatch
"t(2;18)(p12;q21)";"t(2;18)(p12;q21)";exactmatch
"t(1;14)(p22;q32)";"t(1;14)(p22;q32)";exactmatch
"t(9;14)(p13;q32)";pax5-igh translocation;exactmatch
non-small cell adenocarcinoma;non-small cell adenocarcinoma;exactmatch
stage iib cutaneous melanoma ajcc v6 and v7;stage iib cutaneous (skin) melanoma;exactmatch
high risk colorectal gastrointestinal stromal tumor;high risk colorectal gastrointestinal stromal tumor;exactmatch
intermediate risk colorectal gastrointestinal stromal tumor;intermediate risk colorectal gastrointestinal stromal tumor;exactmatch
low risk colorectal gastrointestinal stromal tumor;low risk colorectal gastrointestinal stromal tumor;exactmatch
very low risk colorectal gastrointestinal stromal tumor;very low risk colorectal gastrointestinal stromal tumor;exactmatch
colorectal gastrointestinal stromal tumor;colorectal (colon or rectal) gastrointestinal stromal tumor (gist);exactmatch
very low risk small intestinal gastrointestinal stromal tumor;very low risk small intestinal gastrointestinal stromal tumor;exactmatch
very low risk gastric gastrointestinal stromal tumor;very low risk gastric gastrointestinal stromal tumor;exactmatch
very low risk esophageal gastrointestinal stromal tumor;very low risk esophageal gastrointestinal stromal tumor;exactmatch
very low risk gastrointestinal stromal tumor;vlr gist;exactmatch
childhood kidney wilms tumor;childhood kidney nephroblastoma;exactmatch
pre-b acute lymphoblastic leukemia;pre-b all;exactmatch
mycosis fungoides (working formulation);mycosis fungoides (working formulation);exactmatch
mature t-cell and nk-cell neoplasm;mature t-cell neoplasm;exactmatch
bladder non-invasive papillary urothelial carcinoma, low grade;bladder non-invasive papillary urothelial carcinoma, low grade;exactmatch
infiltrating bladder urothelial carcinoma;infiltrating bladder urothelial carcinoma;exactmatch
bladder papillary urothelial neoplasm of low malignant potential;bladder punlmp;exactmatch
papillary urothelial neoplasm;papillary transitional cell neoplasm of the urinary tract;exactmatch
bladder urothelial dysplasia;bladder low grade intraurothelial neoplasia;exactmatch
transitional cell intraepithelial neoplasia;transitional cell intraepithelial neoplasia;exactmatch
bladder urothelial proliferation of uncertain malignant potential;bladder urothelial proliferation of uncertain malignant potential;exactmatch
bladder non-invasive papillary urothelial carcinoma, high grade;bladder non-invasive papillary urothelial carcinoma, high grade;exactmatch
congenital combined immunodeficiency;congenital combined immunodeficiency;exactmatch
type 2 papillary renal cell carcinoma;type 2 papillary renal cell cancer;exactmatch
parasitic infection;parasitic disease;exactmatch
aids-related plasmablastic lymphoma;aids-related plasmablastic lymphoma;exactmatch
aids-related diffuse large b-cell lymphoma arising in hhv8-positive multicentric castleman disease;aids-related diffuse large b-cell lymphoma arising in hhv8-positive multicentric castleman disease;exactmatch
aids-related burkitt lymphoma with plasmacytoid differentiation;aids-related burkitt lymphoma with plasmacytoid differentiation;exactmatch
diffuse large b-cell lymphoma arising in hhv8-positive multicentric castleman disease;diffuse large b-cell lymphoma arising in hhv8-positive multicentric castleman disease;exactmatch
multicentric castleman disease;multicentric angiofollicular lymphoid hyperplasia;exactmatch
castleman disease, plasma cell type;angiofollicular lymphoid hyperplasia, plasma cell type;exactmatch
type 1 papillary renal cell carcinoma;type 1 papillary renal cell cancer;exactmatch
classic variant of chromophobe renal cell carcinoma;classic variant of chromophobe renal cell carcinoma;exactmatch
metastatic kidney carcinoma;metastatic kidney carcinoma;exactmatch
localized ewing sarcoma/peripheral primitive neuroectodermal tumor;localized ewing sarcoma/peripheral primitive neuroectodermal tumor;exactmatch
t-cell and nk-cell neoplasm;t-cell neoplasm;exactmatch
b-cell neoplasm;b-cell lymphocytic neoplasm;exactmatch
moderately differentiated prostate adenocarcinoma;moderately differentiated prostate adenocarcinoma;exactmatch
well differentiated prostate adenocarcinoma;well differentiated prostate adenocarcinoma;exactmatch
retroperitoneal leiomyosarcoma;retroperitoneal leiomyosarcoma;exactmatch
localized peripheral primitive neuroectodermal tumor;localized peripheral primitive neuroectodermal tumor;exactmatch
localized askin tumor;localized askin tumor;exactmatch
recurrent askin tumor;recurrent askin tumor;exactmatch
eosinophilic variant of chromophobe renal cell carcinoma;eosinophilic variant of chromophobe renal cell carcinoma;exactmatch
recurrent peripheral primitive neuroectodermal tumor;recurrent peripheral primitive neuroectodermal tumor;exactmatch
recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor;recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor;exactmatch
t-cell proliferation of uncertain malignant potential;t-cell proliferation of uncertain malignant potential;exactmatch
sarcomatoid renal cell carcinoma;rcc w/ sarcomatoid features;exactmatch
unclassified renal cell carcinoma;unclassified renal cell cancer;exactmatch
renal cell carcinoma associated with xp11.2 translocations/tfe3 gene fusions;renal cell cancer associated with xp11.2 translocations/tfe3 gene fusions;exactmatch
sporadic papillary renal cell carcinoma;sporadic papillary renal cell carcinoma;exactmatch
castleman disease, hyaline-vascular type;angiofollicular lymphoid hyperplasia, hyaline-vascular type;exactmatch
human papillomavirus infection;hpv;exactmatch
endometrial endometrioid adenocarcinoma with spindled epithelial cells;endometrial endometrioid adenocarcinoma with spindled epithelial cells;exactmatch
penile paget disease;paget disease of the penis;exactmatch
reticulosarcoma;reticulosarcoma;exactmatch
malignant lymphoma, large cell type;malignant lymphoma, large cell type;exactmatch
diffuse malignant lymphoma;diffuse malignant lymphoma;exactmatch
malignant lymphoma, convoluted;malignant lymphoma, convoluted;exactmatch
mature t-all;cortical t all;exactmatch
metastatic urethral carcinoma;metastatic carcinoma of urethra;exactmatch
metastatic ureter carcinoma;metastatic carcinoma of ureter;exactmatch
pigmented nevus;pigmented nevus;exactmatch
oxyphilic endometrial endometrioid adenocarcinoma;oxyphilic endometrial endometrioid adenocarcinoma;exactmatch
malignant endometrial neoplasm;malignant endometrial neoplasm;exactmatch
bile duct carcinoma;bile duct cancer;exactmatch
bile duct adenocarcinoma;adenocarcinoma;exactmatch
malignant non-hodgkin lymphoma, cleaved cell;malignant non-hodgkin lymphoma, cleaved cell;exactmatch
hodgkin's lymphoma (antiquated);hodgkin's lymphoma (antiquated);exactmatch
hodgkin's disease, nodular sclerosis, lymphocyte depletion;hodgkin disease, nodular sclerosis, lymphocyte depletion;exactmatch
nodular sclerosis classic hodgkin lymphoma, syncytial variant;hodgkin disease, nodular sclerosis, syncytial variant;exactmatch
mucin-producing carcinoma;mucin-producing carcinoma;exactmatch
aids-related lymphoma by working formulation;aids-related lymphoma by working formulation;exactmatch
malignant lymphoma by cell type (working formulation);malignant lymphoma by cell type (working formulation);exactmatch
stage iiic breast cancer ajcc v6;stage iiic breast cancer;exactmatch
endometrial endometrioid adenocarcinoma, ciliated variant;ciliated uterine corpus endometrioid adenocarcinoma;exactmatch
endometrial endometrioid adenocarcinoma with small nonvillous papillae;endometrial endometrioid adenocarcinoma with small nonvillous papillae;exactmatch
villoglandular endometrial endometrioid adenocarcinoma;endometrioid adenocarcinoma, villoglandular;exactmatch
endometrial endometrioid adenocarcinoma with an undifferentiated carcinomatous component;endometrial endometrioid adenocarcinoma with an undifferentiated carcinomatous component;exactmatch
endometrial endometrioid adenocarcinoma with a poorly differentiated carcinomatous component;endometrial endometrioid adenocarcinoma with a poorly differentiated carcinomatous component;exactmatch
endometrial endometrioid adenocarcinoma with clear cell change;endometrial endometrioid adenocarcinoma with clear cell change;exactmatch
endometrial endometrioid adenocarcinoma with metaplastic changes;endometrial endometrioid adenocarcinoma with metaplastic changes;exactmatch
endometrial endometrioid adenocarcinoma with small glands, tubules or cords;endometrial endometrioid adenocarcinoma with small glands, tubules or cords;exactmatch
endometrial endometrioid adenocarcinoma with papillae;endometrial endometrioid adenocarcinoma with papillae;exactmatch
endometrial endometrioid adenocarcinoma, secretory variant;endometrial endometrioid adenocarcinoma, secretory variant;exactmatch
endometrial serous adenocarcinoma;endometrial serous adenocarcinoma;exactmatch
grade 3 invasive breast carcinoma;grade 3 infiltrating breast carcinoma;exactmatch
grade 2 invasive breast carcinoma;grade 2 infiltrating breast carcinoma;exactmatch
grade 1 invasive breast carcinoma;favorable infiltrating breast carcinoma;exactmatch
invasive breast carcinoma by histologic grade;infiltrating breast carcinoma by histologic grade;exactmatch
soft tissue neoplasm;neoplasm of soft tissue;exactmatch
thymic epithelial cell;tec;exactmatch
thymus medulla;thymus medulla;exactmatch
metastatic malignant neoplasm;metastatic cancer;exactmatch
t-cell prolymphocytic leukemia, cerebriform cell variant;t-cell prolymphocytic leukemia, cerebriform cell variant;exactmatch
t-cell prolymphocytic leukemia, small cell variant;t-cell prolymphocytic leukemia, small cell variant;exactmatch
benign spinal cord neoplasm;benign neoplasm of spinal cord;exactmatch
hodgkin-like adult t-cell leukemia/lymphoma;hodgkin's-like adult t-cell lymphoma/leukemia;exactmatch
lymphomatous adult t-cell leukemia/lymphoma;lymphomatous adult t-cell leukemia/lymphoma;exactmatch
acute adult t-cell leukemia/lymphoma;acute adult t-cell leukemia/lymphoma;exactmatch
metastatic benign neoplasm;metastatic benign neoplasm;exactmatch
oral cavity leukoplakia;leukoplakia of mouth;exactmatch
small lymphocytic lymphoma with plasmacytoid differentiation;small lymphocytic lymphoma with plasmacytoid differentiation;exactmatch
non-hereditary clear cell renal cell carcinoma;non-hereditary clear cell renal cell carcinoma;exactmatch
hereditary clear cell renal cell carcinoma;hereditary clear cell renal cell cancer;exactmatch
benign nasolacrimal duct neoplasm;benign lacrimal duct neoplasm;exactmatch
lymphatic spread;lymphatic spread;exactmatch
secondary neoplasm;neoplasm, secondary;exactmatch
bone marrow basophilia;bone marrow basophilia;exactmatch
ineffective hematopoiesis;ineffective hematopoiesis;exactmatch
chronic lymphocytic leukemia with plasmacytoid differentiation;chronic lymphocytic leukemia with plasmacytoid differentiation;exactmatch
polyclonal polymorphic post-transplant lymphoproliferative disorder;polyclonal polymorphic post-transplant lymphoproliferative disorder;exactmatch
auer rods present;auer rods present;exactmatch
endocrine system finding;endocrine system;exactmatch
finding by cause;finding by cause;exactmatch
chemical exposure;chemical exposure;exactmatch
benign adrenal gland neoplasm;benign adrenal gland neoplasm;exactmatch
hematopoietic system finding;hematopoietic system;exactmatch
connective and soft tissue finding;connective and soft tissue finding;exactmatch
congenital or acquired anatomic abnormality;anatomic abnormality;exactmatch
urinary system finding;urinary system;exactmatch
reproductive system finding;reproductive system;exactmatch
monoclonal polymorphic post-transplant lymphoproliferative disorder;monoclonal polymorphic post-transplant lymphoproliferative disorder;exactmatch
eye and ear finding;eye and ear finding;exactmatch
head and neck finding;head and neck finding;exactmatch
integumentary system finding;dermatological;exactmatch
nervous system finding;nervous system;exactmatch
benign thyroid gland neoplasm;benign neoplasm of thyroid;exactmatch
digestive system finding;digestive system finding;exactmatch
finding by site or system;finding by site or system;exactmatch
benzene exposure;benzene exposure;exactmatch
benign choroid neoplasm;benign choroid neoplasm;exactmatch
thyroid gland follicle;thyroid gland follicle;exactmatch
benign conjunctival neoplasm;benign conjunctiva neoplasm;exactmatch
myeloblasts under 1 percent of peripheral blood white cells;myeloblasts less than 1 percent of peripheral blood white cells;exactmatch
ring sideroblasts 15 percent or more of erythroid precursors;ring sideroblasts 15 percent or more of erythroid precursors;exactmatch
hemoglobin f increased;hemoglobin f increased;exactmatch
myeloblasts under 20 percent of peripheral blood white cells;myeloblasts less than 20 percent of peripheral blood white cells;exactmatch
myeloblasts 5-19 percent of peripheral blood white cells;myeloblasts 5-19 percent of peripheral blood white cells;exactmatch
myeloblasts under 5 percent of peripheral blood white cells;myeloblasts less than 5 percent of peripheral blood white cells;exactmatch
blasts under 20 percent of peripheral blood white cells;blasts less than 20 percent of peripheral blood white cells;exactmatch
myeloblasts under 10 percent of bone marrow nucleated cells;myeloblasts less than 10 percent of bone marrow nucleated cells;exactmatch
benign corneal neoplasm;benign cornea neoplasm;exactmatch
leukoerythroblastic reaction;leukoerythroblastic reaction;exactmatch
myeloblasts under 20 percent of bone marrow nucleated cells;myeloblasts less than 20 percent of bone marrow nucleated cells;exactmatch
immature granulocytes in peripheral blood increased;immature granulocytes in peripheral blood increased;exactmatch
blasts 20 percent or more of bone marrow nucleated cells;blasts 20 percent or more of bone marrow nucleated cells;exactmatch
blasts 20 percent or more of peripheral blood white cells;blasts 20 percent or more of peripheral blood white cells;exactmatch
bone marrow fibrosis;bone marrow fibrosis;exactmatch
myeloblasts 10-19 percent of peripheral blood white cells;myeloblasts 10-19 percent of peripheral blood white cells;exactmatch
myeloblasts 5-19 percent of bone marrow nucleated cells;myeloblasts 5-19 percent of bone marrow nucleated cells;exactmatch
myeloblasts 5-9 percent of bone marrow nucleated cells;myeloblasts 5-9 percent of bone marrow nucleated cells;exactmatch
atypical lymphocytes present in peripheral blood;atypical lymphocytes present in peripheral blood;exactmatch
monoblasts 80 percent or more of bone marrow monocytic cells;monoblasts 80 percent or more of bone marrow monocytic cells;exactmatch
atypical lymphocytes present in bone marrow;atypical lymphocytes present in bone marrow;exactmatch
normal bone marrow test result;normal bone marrow test result;exactmatch
megakaryoblasts 50 percent or more of bone marrow nucleated cells;megakaryoblasts 50 percent or more of bone marrow nucleated cells;exactmatch
erythroid precursors 80 percent or more of bone marrow nucleated cells;erythroid precursors 80 percent or more of bone marrow nucleated cells;exactmatch
myeloblasts 20 percent or more of bone marrow non-erythroid cells;myeloblasts 20 percent or more of bone marrow non-erythroid cells;exactmatch
erythroid precursors 50 percent or more of bone marrow nucleated cells;erythroid precursors 50 percent or more of bone marrow nucleated cells;exactmatch
neoplastic promonocytes in bone marrow markedly increased;neoplastic promonocytes in bone marrow markedly increased;exactmatch
monoblasts 20 percent or more of bone marrow nucleated cells;monoblasts 20 percent or more of bone marrow nucleated cells;exactmatch
myeloblasts 20 percent or more of bone marrow nucleated cells;myeloblasts 20 percent or more of bone marrow nucleated cells;exactmatch
benign retinal neoplasm;benign neoplasm of retina;exactmatch
neoplastic monocytes and precursors 20 percent or more of bone marrow cells;neoplastic monocytes and precursors 20 percent or more of bone marrow cells;exactmatch
promyelocytes, myelocytes, and mature neutrophils 10 percent or more of bone marrow cells;promyelocytes, myelocytes, and mature neutrophils 10 percent or more of bone marrow cells;exactmatch
bone marrow dysplasia present in 10 percent or more of the cells of two or more myeloid cell lines;bone marrow dysplasia present in 10 percent or more of the cells of two or more myeloid cell lines;exactmatch
bone marrow dysplasia present in 50 percent or more of the cells of two cell lines;bone marrow dysplasia present in 50 percent or more of the cells of two cell lines;exactmatch
bone marrow dysplasia present;bone marrow dysplasia present;exactmatch
bone marrow eosinophilia;bone marrow eosinophilia;exactmatch
laboratory test result;lab_result;exactmatch
neoplastic growth or spread;neoplastic growth or spread;exactmatch
other finding;other finding;exactmatch
"t(14;19)(q32;q13.1)";"t(14;19)(q32;q13.1)";exactmatch
"t(11;17)(q13;q21)";"t(11;17)(q13;q21)";exactmatch
"t(11;17)(q23;q21)";"t(11;17)(q23;q21)";exactmatch
"t(5;17)(q35;q21)";"t(5;17)(q35;q21)";exactmatch
"t(x;14)(q28;11)";"t(x;14)(q28;11)";exactmatch
benign lymph node neoplasm;benign lymph node neoplasm;exactmatch
"t(1;7)(p33;q35)";"t(1;7)(p33;q35)";exactmatch
"t(5;14)(q31.1;q32.3)";"t(5;14)(q31.1;q32.3)";exactmatch
"t(14;14)(q11;q32)";"t(14;14)(q11;q32)";exactmatch
"t(9;11)(q21;q23)";"t(9;11)(q21;q23)";exactmatch
"t(3;14)(q27;q32)";"t(3;14)(q27;q32)";exactmatch
"t(7;10)(q34;q24)";"t(7;10)(q34;q24)";exactmatch
"t(10;14)(q24;q11)";"t(10;14)(q24;q11)";exactmatch
"t(11;14)(p13;q11)";"t(11;14)(p13;q11)";exactmatch
"t(11;14)(p15;q11)";"t(11;14)(p15;q11)";exactmatch
intra-abdominal hemangioma;hemangioma of intra-abdominal structure;exactmatch
"t(7;9)(q34;q34.3)";"t(7;9)(q34;q34.3)";exactmatch
"t(4;11)(q21;q23)";"t(4;11)(q21;q23)";exactmatch
"t(21;22)(q22;q12)";"t(21;22)(q22;q12)";exactmatch
regional lymph node involvement;nodal_involvement;exactmatch
"t(1;13)(p36;q14)";"t(1;13)(p36;q14)";exactmatch
monosomy 13;monosomy 13;exactmatch
"t(5;12)(q33;q13-15)";"t(5;12)(q33;q13-15)";exactmatch
"t(2;12)(q35-37;q13-15)";"t(2;12)(q35-37;q13-15)";exactmatch
"t(2;12)(p22-24;q13-15)";"t(2;12)(p22-24;q13-15)";exactmatch
stage 0 colon cancer ajcc v6 and v7;carcinoma in situ of colon;exactmatch
"t(1;12)(p32-34;q13-15)";"t(1;12)(p32-34;q13-15)";exactmatch
"t(3;12)(q27-28;q13-15)";"t(3;12)(q27-28;q13-15)";exactmatch
"t(11;22)(p13;q12)";"t(11;22)(p13;q12)";exactmatch
"t(7;22)(p22;q12)";"t(7;22)(p22;q12)";exactmatch
"t(12;22)(q13;q12)";"t(12;22)(q13;q12)";exactmatch
"inv(16)(p13.1;q22)";"inv(16)(p13.1;q22)";exactmatch
"t(11;19)(q23.3;p13.3)";"t(11;19)(q23.3;p13.3)";exactmatch
"t(11;19)(q23;p13.1)";"t(11;19)(q23;p13.1)";exactmatch
"t(9;11)(p21.3;q23.3)";"t(9;11)(p21.3;q23.3)";exactmatch
stage 0 esophageal cancer ajcc v6;carcinoma in situ of esophagus ajcc v6;exactmatch
"t(17;22)(q21;q12)";"t(17;22)(q21;q12)";exactmatch
"t(1;14)(p32;q11)";"t(1;14)(p32;q11)";exactmatch
fusion protein expression;fusion protein expression;exactmatch
protein deregulation;protein deregulation;exactmatch
lung carcinoma metastatic in the bone;lung carcinoma metastatic in the bone;exactmatch
"b acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1";acute lymphoblastic leukemia, philadelphia chromosome positive;exactmatch
secondary carcinoma;secondary carcinoma;exactmatch
benign pineal region neoplasm;benign neoplasm of pineal parenchyma;exactmatch
colon carcinoma metastatic in the liver;colon carcinoma metastatic in the liver;exactmatch
prostate carcinoma metastatic in the bone;prostate carcinoma metastatic in the bone;exactmatch
prostate carcinoma metastatic in the lung;prostate carcinoma metastatic in the lung;exactmatch
lung carcinoma metastatic in the liver;lung carcinoma metastatic in the liver;exactmatch
lung carcinoma metastatic in the brain;lung carcinoma metastatic in the brain;exactmatch
oncogene deregulation;gene deregulation;exactmatch
breast carcinoma metastatic in the bone;breast carcinoma metastatic in the bone;exactmatch
breast carcinoma metastatic in the liver;breast carcinoma metastatic in the liver;exactmatch
breast carcinoma metastatic in the brain;breast carcinoma metastatic in the brain;exactmatch
breast carcinoma metastatic in the lung;breast carcinoma metastatic in the lung;exactmatch
benign parathyroid gland neoplasm;benign neoplasm of parathyroid;exactmatch
lesion by stage;lesion by stage;exactmatch
lesion by grade;lesion by grade;exactmatch
chromosomal loss;chromosomal loss;exactmatch
"t(12;16)(q13;p11)";"t(12;16)(q13;p11)";exactmatch
microsatellite instability;msi;exactmatch
"t(8;14)(q24;q32)";"t(8;14)(q24;q32)";exactmatch
tumor-suppressor pathway deregulation;tumor-suppressor pathway deregulation;exactmatch
signal transduction pathway deregulation;signal transduction pathway deregulation;exactmatch
molecular pathway deregulation;molecular pathway deregulation;exactmatch
retinal hemangioma;retina angioma;exactmatch
cell cycle deregulation;cell cycle deregulation;exactmatch
messenger rna overexpression;messenger rna overexpression;exactmatch
deregulation of protein and messenger rna expression;deregulation of protein and messenger rna expression;exactmatch
tumor-suppressor gene inactivation;tumor-suppressor gene inactivation;exactmatch
clonal gene rearrangement;clonal gene rearrangement;exactmatch
polysomy;polysomy;exactmatch
intracranial hemangioma;angioma of intracranial structure;exactmatch
tp53 gene inactivation;inactivating tp53 gene mutation;exactmatch
rb1 gene inactivation;inactivating rb gene mutation;exactmatch
gene abnormality;gene abnormality;exactmatch
"t(8;22)(q24;q11)";"t(8;22)(q24;q11)";exactmatch
myeloblasts 10-19 percent of bone marrow nucleated cells;myeloblasts 10-19 percent of bone marrow nucleated cells;exactmatch
benign lacrimal gland neoplasm;benign lacrimal gland neoplasm;exactmatch
myeloblasts under 5 percent of bone marrow nucleated cells;myeloblasts less than 5 percent of bone marrow nucleated cells;exactmatch
chronic myelomonocytic leukemia-1;cmml-1;exactmatch
hilar cholangiocarcinoma;hilar cc;exactmatch
malignant reproductive system neoplasm;malignant reproductive system neoplasm;exactmatch
sinus histiocytosis with massive lymphadenopathy;rosai-dorfman disease;exactmatch
metastatic peripheral primitive neuroectodermal tumor of bone;metastatic peripheral neuroepithelioma of bone;exactmatch
abdominal and gastrointestinal infection;abdominal and gastrointestinal infection;exactmatch
benign cervical neoplasm;benign cervical neoplasm;exactmatch
chronic myelomonocytic leukemia-2;cmml-2;exactmatch
chronic myelomonocytic leukemia with eosinophilia;cmml with eosinophilia;exactmatch
benign uterine corpus neoplasm;benign corpus uteri neoplasm;exactmatch
spermatic cord lipoma;lipoma of spermatic cord;exactmatch
"acute myeloid leukemia with t(11;17)(q13;q21)";"apl with t(11;17)(q13;q21); numa1-rara";exactmatch
"acute myeloid leukemia with t(5;17)(q35;q21)";"aml with t(5;17)(q35;q21)";exactmatch
"acute myeloid leukemia with t(11;17)(q23;q21)";"apl with t(11;17)(q23;q21); plzf-rara";exactmatch
acute myeloid leukemia with a variant rara translocation;aml with a variant rara translocation;exactmatch
biphasic pulmonary blastoma;biphasic pulmonary blastoma;exactmatch
epithelial predominant pulmonary blastoma;epithelial predominant pulmonary blastoma;exactmatch
subungual glomus tumor;subungual glomus tumor;exactmatch
diffuse large b-cell lymphoma germinal center b-cell type;dlbcl germinal center b-cell type;exactmatch
adult botryoid-type embryonal rhabdomyosarcoma;adult botryoid sarcoma;exactmatch
benign uterine neoplasm;benign neoplasm of uterus;exactmatch
cervical carcinosarcoma;cervical carcinosarcoma;exactmatch
early invasive cervical adenocarcinoma;cervical microinvasive adenocarcinoma;exactmatch
cervical mucinous adenocarcinoma;cervical mucinous adenocarcinoma;exactmatch
early invasive cervical squamous cell carcinoma;early invasive cervical squamous cell carcinoma;exactmatch
testicular dermoid cyst;testicular dermoid cyst;exactmatch
reinke crystals formation;reinke crystals formation;exactmatch
breast intraductal papillary neoplasm;breast intraductal papillary neoplasm;exactmatch
breast atypical papilloma;atypical breast papilloma;exactmatch
diffuse large b-cell lymphoma activated b-cell type;abc dlbcl;exactmatch
breast peripheral papilloma;breast peripheral papilloma;exactmatch
breast central papilloma;breast central papilloma;exactmatch
breast flat ductal epithelial atypia;breast flat ductal epithelial atypia;exactmatch
invasive breast papillary carcinoma;infiltrating papillary breast carcinoma;exactmatch
invasive breast micropapillary carcinoma;infiltrating micropapillary breast carcinoma;exactmatch
breast intraductal  neoplasm;breast intraductal  neoplasm;exactmatch
metastatic carcinoma in the bone;metastatic carcinoma in the bone;exactmatch
well differentiated malignant neoplasm;well differentiated malignant neoplasm;exactmatch
undifferentiated malignant neoplasm;undifferentiated malignant neoplasm;exactmatch
poorly differentiated malignant neoplasm;poorly differentiated malignant neoplasm;exactmatch
starry sky pattern;starry sky pattern;exactmatch
osteolytic neoplasm;osteolytic neoplasm;exactmatch
benign pleural neoplasm;benign neoplasm of pleura;exactmatch
necrotic neoplasm;necrotic neoplasm;exactmatch
microinvasive malignant neoplasm;microinvasive malignant neoplasm;exactmatch
non-invasive lesion;non-invasive lesion;exactmatch
diffuse cellular infiltrate;diffuse cellular infiltrate;exactmatch
anaplastic malignant neoplasm;anaplastic malignant neoplasm;exactmatch
call exner bodies present;call exner bodies present;exactmatch
benign cardiac neoplasm;benign cardiac neoplasm;exactmatch
verocay bodies present;verocay bodies present;exactmatch
dutcher body;dutcher body;exactmatch
benign tracheal neoplasm;benign neoplasm of trachea;exactmatch
ground glass nuclear inclusion;ground glass nuclear inclusion;exactmatch
nuclear inclusion;nuclear inclusion;exactmatch
russell body;russell body;exactmatch
bead-like arrangement of elastic fibers;bead-like arrangement of elastic fibers;exactmatch
papillary neoplasm;papillary neoplasm;exactmatch
premalignant neoplasm;premalignant;exactmatch
tubular neoplasm;tubular neoplasm;exactmatch
villous neoplasm;villous neoplasm;exactmatch
moderately differentiated malignant neoplasm;moderately differentiated malignant neoplasm;exactmatch
low grade malignant neoplasm;low grade malignant neoplasm;exactmatch
intermediate grade malignant neoplasm;intermediate grade malignant neoplasm;exactmatch
high grade malignant neoplasm;high grade malignant neoplasm;exactmatch
grade 4 malignant neoplasm;grade 4 malignant neoplasm;exactmatch
grade 3b malignant neoplasm;grade 3b malignant neoplasm;exactmatch
grade 3a malignant neoplasm;grade 3a malignant neoplasm;exactmatch
grade 3 malignant neoplasm;grade 3 malignant neoplasm;exactmatch
malignant neoplasm by grade;malignant neoplasm by grade;exactmatch
grade 2 malignant neoplasm;grade 2 malignant neoplasm;exactmatch
benign mediastinal neoplasm;benign mediastinal neoplasm;exactmatch
grade 1 malignant neoplasm;grade 1 malignant neoplasm;exactmatch
localized neoplasm;localized neoplasm;exactmatch
non-encapsulated neoplasm;non-encapsulated neoplasm;exactmatch
encapsulated neoplasm;encapsulated neoplasm;exactmatch
childhood botryoid-type embryonal rhabdomyosarcoma of the vulva;childhood botryoid-type embryonal rhabdomyosarcoma of the vulva;exactmatch
benign vaginal neoplasm;benign neoplasm of vagina;exactmatch
myeloblasts under 2 percent of peripheral blood white cells;myeloblasts less than 2 percent of bone marrow nucleated cells;exactmatch
benign ureter neoplasm;benign neoplasm of ureter;exactmatch
micropapillary pattern;micropapillary pattern;exactmatch
multifocal lesion;multifocal;exactmatch
benign bladder neoplasm;benign bladder neoplasm;exactmatch
fibrotic stroma formation;fibrotic stroma formation;exactmatch
single-file linear pattern;single-file linear pattern;exactmatch
bilateral mass;bilateral mass;exactmatch
sweating;sweating;exactmatch
resectable mass;resectable mass;exactmatch
firm mass;firm mass;exactmatch
unresectable mass;unresectable mass;exactmatch
metastatic/recurrent disease;metastatic/recurrent disease;exactmatch
localized disease;local;exactmatch
newly diagnosed disease;newly diagnosed disease;exactmatch
benign renal pelvis neoplasm;benign kidney pelvis neoplasm;exactmatch
progressive clinical course;progressive clinical course;exactmatch
chronic clinical course;chronic clinical course;exactmatch
solid growth pattern;solid growth pattern;exactmatch
necrotic change;necrosis;exactmatch
brca1-associated hereditary breast and ovarian cancer syndrome;brca1 syndrome;exactmatch
benign orbit neoplasm;benign neoplasm of orbit;exactmatch
digestive system adenoma;digestive system adenoma;exactmatch
small intestinal hamartoma;polyp of the small bowel;exactmatch
astler-coller b1 colorectal carcinoma;astler-coller b1 colorectal carcinoma;exactmatch
astler-coller b1 rectal carcinoma;astler-coller b1 rectal carcinoma;exactmatch
astler-coller a colon carcinoma;astler-coller a colon carcinoma;exactmatch
astler-coller b2 colorectal carcinoma;astler-coller b2 colorectal carcinoma;exactmatch
astler-coller b2 rectal carcinoma;astler-coller b2 rectal carcinoma;exactmatch
astler-coller c1 colon carcinoma;astler-coller c1 colon carcinoma;exactmatch
steatosis;fatty change;exactmatch
astler-coller c2 colon carcinoma;astler-coller c2 colon carcinoma;exactmatch
mesenchymal differentiation;mesenchymal differentiation;exactmatch
benign urethral neoplasm;benign neoplasm of urethra;exactmatch
fetal -epithelial differentiation;fetal -epithelial differentiation;exactmatch
multinodular mass;multinodular mass;exactmatch
thorotrast exposure;thorotrast contrast exposure;exactmatch
globular hyaline body;globular hyaline body;exactmatch
acute clinical course;acute clinical course;exactmatch
favorable clinical outcome;favorable clinical outcome;exactmatch
accelerated phase of disease;accelerated phase;exactmatch
superficial lesion;superficial lesion;exactmatch
benign testicular neoplasm;benign neoplasm of testis;exactmatch
in situ lesion;in situ lesion;exactmatch
invasive lesion;invasive;exactmatch
borderline lesion;borderline lesion;exactmatch
malignant cellular infiltrate;malignant cellular infiltrate;exactmatch
anaplastic lesion;anaplasia;exactmatch
benign vulvar neoplasm;benign neoplasm of vulva;exactmatch
encapsulated mass;encapsulated;exactmatch
chronic phase of disease;chronic phase of disease;exactmatch
hereditary female breast carcinoma;familial female breast carcinoma;exactmatch
hereditary male breast carcinoma;familial male breast carcinoma;exactmatch
indolent clinical course;indolent clinical course;exactmatch
aggressive clinical course;aggressive clinical course;exactmatch
rapidly enlarging mass;rapidly enlarging mass;exactmatch
hereditary ovarian carcinoma;familial ovarian carcinoma;exactmatch
brca2-associated hereditary breast and ovarian cancer syndrome;brca2 syndrome;exactmatch
villous pattern;villous pattern;exactmatch
benign cellular infiltrate;benign cellular infiltrate;exactmatch
necrotic lesion;necrotic lesion;exactmatch
microinvasive lesion;microinvasive;exactmatch
extensive stage lesion;extensive stage lesion;exactmatch
benign scrotal neoplasm;benign neoplasm of scrotum;exactmatch
intermediate grade lesion;intermediate grade lesion;exactmatch
grade 4 lesion;grade 4 lesion;exactmatch
benign epididymal neoplasm;benign epididymal neoplasm;exactmatch
undifferentiated lesion;undifferentiated lesion;exactmatch
well differentiated lesion;well differentiated lesion;exactmatch
poorly differentiated lesion;poorly differentiated lesion;exactmatch
moderately differentiated lesion;moderately differentiated lesion;exactmatch
low grade lesion;low grade lesion;exactmatch
benign prostate neoplasm;benign neoplasm of prostate;exactmatch
high grade lesion;high grade lesion;exactmatch
comedo necrosis;comedo change;exactmatch
non-seminomatous lesion;non-seminomatous lesion;exactmatch
non-malignant cellular infiltrate;non-malignant cellular infiltrate;exactmatch
monosomy 16;monosomy 16;exactmatch
giant rod chromosome;giant rod chromosome;exactmatch
chromosome 1 abnormality;aberrant chromosome 1;exactmatch
"t(16;21)(p11;q22)";"t(16;21)(p11.2;q22.2)";exactmatch
monosomy x;monosomy x;exactmatch
vaginal leukoplakia;leukoplakia of vagina;exactmatch
monosomy 11;monosomy 11;exactmatch
monosomy 8;monosomy 8;exactmatch
monosomy 6;monosomy 6;exactmatch
trisomy 18;trisomy 18;exactmatch
uterine polyp;polyp of uterus;exactmatch
"t(10;11)(p11;q23)";"t(10;11)(p11;q23)";exactmatch
loss of chromosome 19;loss of chromosome 19;exactmatch
"t(6;11)(q27;q23)";"t(6;11)(q27;q23)";exactmatch
"t(7;11)(p15;p15)";"t(7;11)(p15;p15)";exactmatch
"t(3;21)(q26;q22)";"t(3;21)(q26.2;q22)";exactmatch
i(19);i(19);exactmatch
del(9p21p22);del(9)(p21p22);exactmatch
"t(7;9)(q34;q32)";"t(7;9)(q34;q32)";exactmatch
"inv(14)(q11;q32.1)";"inv(14)(q11;q32.1)";exactmatch
loss of chromosome 17;loss of chromosome 17;exactmatch
gain of chromosome 6p;gain of chromosome 6p;exactmatch
polysomy 10;polysomy 10;exactmatch
cyclin d1 messenger rna overexpression;ccnd1 gene overexpression;exactmatch
cdh1 gene inactivation;cdh1 gene inactivation;exactmatch
ccnd1 gene amplification;bcl-1 gene amplification;exactmatch
fgfr1 gene amplification;bfgfr gene amplification;exactmatch
egfr gene amplification;amplified;exactmatch
loss of chromosome 11q atm gene locus;loss of chromosome 11q atm gene locus;exactmatch
loss of chromosome 3p fhit gene locus;loss of chromosome 3p fhit gene locus;exactmatch
loss of e-cadherin expression;loss of e-cadherin expression;exactmatch
myc gene amplification;mrtl gene amplification;exactmatch
gain of chromosome 17q22-q24;gain of chromosome 17q22-q24;exactmatch
c-erbb2 messenger rna overexpression;erbb2 messenger rna overexpression;exactmatch
vaginal polyp;polyp, vaginal, benign;exactmatch
erbb2 protein overexpression;erbb2 protein overexpression;exactmatch
erbb2 gene amplification;erbb2 amplification;exactmatch
gain of chromosome 19q;gain of chromosome 19q;exactmatch
loss of chromosome 9p;loss of chromosome 9p;exactmatch
gain of chromosome 20q13;gain of chromosome 20q13;exactmatch
tetrasomy;tetrasomy;exactmatch
tetrasomy 12;tetrasomy 12;exactmatch
loss of chromosome y;loss of chromosome y;exactmatch
secondary hypertension;secondary hypertension;exactmatch
del(11p13-pter);del(11p13-pter);exactmatch
del(10q24-qter);del(10q24-qter);exactmatch
del(9p22-pter);del(9p22-pter);exactmatch
del(6q22-qter);del(6q22-qter);exactmatch
del(5q13-31);del(5q13-31);exactmatch
loss of chromosome 4;loss of chromosome 4;exactmatch
del(1p13-22);del(1p13-22);exactmatch
del(1p36);1p36 deletion;exactmatch
loss of chromosome 18;loss of chromosome 18;exactmatch
rearrangement of 6q25;rearrangement of 6q25;exactmatch
rearrangement of 6q13;rearrangement of 6q13;exactmatch
rearrangement of 8q21;rearrangement of 8q21;exactmatch
del(8q24.1);del(8q24.1);exactmatch
i(8)(q10);i(8)(q10);exactmatch
"t(1;3)(p36;q23-25)";"t(1;3)(p36;q23-25)";exactmatch
rearrangement of 12q13;rearrangement of 12q13;exactmatch
del(11q25);del(11q25);exactmatch
del(13q21-qter);del(13q21-qter);exactmatch
loss of chromosome 18p;loss of chromosome 18p;exactmatch
del(22q13);del(22q13);exactmatch
loss of chromosome 1;loss of chromosome 1;exactmatch
gain of chromosome 6q;gain of chromosome 6q;exactmatch
loss of chromosome 16p;loss of chromosome 16p;exactmatch
del(6q21q25);del(6)(q21q25);exactmatch
increased nfkappab pathway activation;increased nfkappab pathway activation;exactmatch
gain of chromosome 9q34;gain of chromosome 9q34;exactmatch
"t(x;2)(q11-12;p23)";"t(x;2)(q11-12;p23)";exactmatch
"t(2;17)(p23;q23)";"t(2;17)(p23;q23)";exactmatch
rearrangement of 17p11-13;rearrangement of 17p11-13;exactmatch
loss of chromosome 3;loss of chromosome 3;exactmatch
loss of chromosome 10;loss of chromosome 10;exactmatch
loss of chromosome 9;loss of chromosome 9;exactmatch
loss of chromosome 6q;loss of chromosome 6q;exactmatch
gain of chromosome 12q15-qter;gain of chromosome 12q15-qter;exactmatch
gain of chromosome 7p13-pter;gain of chromosome 7p13-pter;exactmatch
polysomy 3;polysomy 3;exactmatch
polysomy 17;polysomy 17;exactmatch
del(11p15);del(11p15);exactmatch
touton giant cell;touton giant cell;exactmatch
rhabdomyoblast;rhabdomyoblast;exactmatch
neoplastic centrocyte;neoplastic centrocyte;exactmatch
spider cell;spider cell;exactmatch
reproductive system neoplasm;neoplasm of reproductive system;exactmatch
physaliphorous cell;physalipherous cell;exactmatch
anaplastic cell;anaplastic cell;exactmatch
sea-blue histiocyte;sea-blue histiocyte;exactmatch
tear-drop red blood cell;dacrocyte;exactmatch
neoplastic keratinocyte;neoplastic keratinocyte;exactmatch
abnormal lymphocyte;abnormal lymphocyte;exactmatch
neutrophil with pseudo pelger-huet nucleus;neutrophil with pseudo pelger-huet nucleus;exactmatch
giant platelet;giant platelet;exactmatch
sezary cell;cerebriform lymphocyte;exactmatch
calcification;calcification;exactmatch
segmented neutrophil;segmented neutrophil;exactmatch
sideroblast;sideroblast;exactmatch
abnormal epithelial cell;abnormal epithelial cell;exactmatch
large keratinocyte;large keratinocyte;exactmatch
gain of chromosome xq;gain of chromosome xq;exactmatch
neoplastic glandular cell;neoplastic glandular cell;exactmatch
abnormal myoepithelial cell;abnormal myoepithelial cell;exactmatch
metastatic rectal squamous cell carcinoma;metastatic rectal squamous cell carcinoma;exactmatch
neoplastic transitional cell;neoplastic transitional cell;exactmatch
abnormal transitional cell;abnormal transitional cell;exactmatch
abnormal keratinocyte;abnormal keratinocyte;exactmatch
neoplastic glandular cell with clear cytoplasm;neoplastic glandular cell with clear cytoplasm;exactmatch
abnormal glandular cell;abnormal glandular cell;exactmatch
neoplastic neuroendocrine cell;neoplastic neuroendocrine cell;exactmatch
neoplastic epithelial cell;neoplastic epithelial cell;exactmatch
neoplastic squamous cell;neoplastic squamous cell;exactmatch
alteration in respiration;alteration in respiration;exactmatch
neoplastic basaloid cell;neoplastic basaloid cell;exactmatch
neoplastic hobnail cell;neoplastic hobnail cell;exactmatch
neoplastic clear cell;neoplastic clear cell;exactmatch
neoplastic epithelial clear cell;neoplastic epithelial clear cell;exactmatch
paget cell;paget cell;exactmatch
bcr-abl1 fusion protein expression;bcr-abl;exactmatch
p190 fusion protein expression;p190 bcr-abl1 fusion protein expression;exactmatch
p230 fusion protein expression;p230 bcr-abl1 fusion protein expression;exactmatch
fos gene amplification;fos gene amplification;exactmatch
vhl gene inactivation;vhl gene inactivation;exactmatch
nf2 gene inactivation;inactivating acn gene mutation;exactmatch
nf1 gene inactivation;inactivating nf1 gene mutation;exactmatch
wt1 gene inactivation;wt-1 tumor-suppressor gene inactivation;exactmatch
apc gene inactivation;apc gene inactivation;exactmatch
mdm2 gene amplification;actfs gene amplification;exactmatch
hras gene amplification;hras gene amplification;exactmatch
nmyc gene amplification;mycn gene amplification;exactmatch
p210 fusion protein expression;p210 bcr-abl1 fusion protein expression;exactmatch
gain of chromosome 10;gain of chromosome 10;exactmatch
gain of chromosome 16;gain of chromosome 16;exactmatch
loss of chromosome 4q;loss of chromosome 4q;exactmatch
kras gene amplification;kras gene activation;exactmatch
transforming growth factor-beta overexpression;transforming growth factor-beta overexpression;exactmatch
growth factor overexpression;growth factor overexpression;exactmatch
ctnnb1 gene mutation;beta catenin gene mutation;exactmatch
brca1 gene inactivation;brca1 gene inactivation;exactmatch
brca2 gene inactivation;brca2 gene inactivation;exactmatch
men1 gene inactivation;mea i gene inactivation;exactmatch
ptch gene inactivation;ptch gene inactivation;exactmatch
atic-alk fusion protein expression;atic-alk fusion protein expression;exactmatch
tfg-alk fusion protein expression;tfg-alk fusion protein expression;exactmatch
tpm3-alk fusion protein expression;tpm3-alk fusion protein expression;exactmatch
npm-alk fusion protein expression;npm-alk fusion protein expression;exactmatch
fhit gene inactivation;fhit gene inactivation;exactmatch
inactivating pms2 gene mutation;inactivating pms2 gene mutation;exactmatch
pms1 gene inactivation;pms1 gene inactivation;exactmatch
inactivating msh6 gene mutation;inactivating msh6 gene mutation;exactmatch
mismatch repair gene inactivation;mismatch repair gene inactivation;exactmatch
inactivating mlh1 gene mutation;inactivating mlh1 gene mutation;exactmatch
inactivating msh2 gene mutation;inactivating msh2 gene mutation;exactmatch
tsc2 gene inactivation;inactivating tsc2 gene mutation;exactmatch
lkb1 gene inactivation;lkb1 gene inactivation;exactmatch
smad4 gene inactivation;dpc4 tumor-suppressor gene inactivation;exactmatch
pten gene inactivation;inactivating mmac1 gene mutation;exactmatch
rearrangement of 1p11-q11;rearrangement of 1p11-q11;exactmatch
gain of chromosome 20;gain of chromosome 20;exactmatch
"t(12;15)(p13;q25)";"t(12;15)(p13;q25)";exactmatch
gain of chromosome 2p;gain of chromosome 2p;exactmatch
clonal immunoglobulin light chain gene rearrangement;clonal immunoglobulin light chain gene rearrangement;exactmatch
clonal immunoglobulin heavy chain gene rearrangement;clonal igh gene rearrangement;exactmatch
clonal immunoglobulin gene rearrangement;clonal immunoglobulin gene rearrangement;exactmatch
clonal bcl2 gene rearrangement;clonal bcl-2 gene rearrangement;exactmatch
gain of chromosome 12q;12q gain;exactmatch
gain of chromosome 9p;gain of chromosome 9p;exactmatch
stage 0is bladder urothelial carcinoma ajcc v6 and v7;bladder flat cis;exactmatch
chromosomal gain;chromosomal gain;exactmatch
clonal t-cell receptor beta chain gene rearrangement;clonal t-cell receptor beta chain gene rearrangement;exactmatch
"inv(2)(p23;q35)";"inv(2)(p23;q35)";exactmatch
"t(2;3)(p23;q21)";"t(2;3)(p23;q21)";exactmatch
"t(1;2)(q25;p23)";"t(1;2)(q25;p23)";exactmatch
trisomy 5;trisomy 5;exactmatch
i(7q);isochromosome 7q;exactmatch
apoptotic pathway deregulation;apoptotic pathway deregulation;exactmatch
stage 0 penile cancer ajcc v6;stage 0 carcinoma of penis ajcc v6;exactmatch
clonal t-cell receptor gene rearrangement;clonal t-cell receptor gene rearrangement;exactmatch
clonal t-cell receptor gamma chain gene rearrangement;clonal t-cell receptor gamma chain gene rearrangement;exactmatch
monosomy 21;monosomy 21;exactmatch
gain of chromosome 3;gain of chromosome 3;exactmatch
gain of chromosome 18;gain of chromosome 18;exactmatch
gain of chromosome 17;chromosome 17 amplification;exactmatch
gain of chromosome 15;gain of chromosome 15;exactmatch
gain of chromosome 12;gain of chromosome 12;exactmatch
gain of chromosome 9;+9;exactmatch
monosomy 22;monosomy 22;exactmatch
neoplasm of uncertain malignant potential;borderline neoplasm;exactmatch
gain of chromosome 22;gain of chromosome 22;exactmatch
clonal bcl6 gene rearrangement;clonal bcl-6 gene rearrangement;exactmatch
gain of chromosome 19;gain of chromosome 19;exactmatch
gain of chromosome 8;+8;exactmatch
gain of chromosome 7;chromosome 7 gain;exactmatch
gain of chromosome 7q;gain of chromosome 7q;exactmatch
clonal immunoglobulin lambda light chain gene rearrangement;clonal immunoglobulin lambda light chain gene rearrangement;exactmatch
clonal immunoglobulin kappa light chain gene rearrangement;clonal immunoglobulin kappa light chain gene rearrangement;exactmatch
clonal antigen receptor gene rearrangement;clonal antigen receptor gene rearrangement;exactmatch
del(12p13);del(12)(p13);exactmatch
trisomy 8q;trisomy 8q;exactmatch
"t(8;8)(p11-12;q12)";"t(8;8)(p11-12;q12)";exactmatch
trisomy 8;trisomy 8;exactmatch
"t(6;8)(q27;p11)";"t(6;8)(q27;p11)";exactmatch
"t(8;9)(p11;q32-34)";"t(8;9)(p11;q32-34)";exactmatch
"t(8;13)(p11;q11)";"t(8;13)(p11;q11)";exactmatch
stage 0 skin cancer;carcinoma in situ of skin;exactmatch
"t(5;12)(q33;p13)";"t(5;12)(q33;p13)";exactmatch
inv(22);inv(22);exactmatch
trisomy 20;trisomy 20;exactmatch
"t(9;15)(q22;q21)";"t(9;15)(q22;q21)";exactmatch
inv(14);inv(14);exactmatch
"t(9;17)(q22;q11)";"t(9;17)(q22;q11)";exactmatch
"t(x;17)(p11.2;q25)";"t(x;17)(p11.2;q25)";exactmatch
molecular genetic variation;anomaly;exactmatch
"t(x;18)(p11;q11)";"t(x;18)(p11.2;q11.2)";exactmatch
tracheal carcinoma in situ;carcinoma in situ of trachea;exactmatch
"t(2;13)(q35;q14)";"t(2;13)(q35;q14)";exactmatch
"t(1;2)(p11;q35-36)";"t(1;2)(p11;q35-36)";exactmatch
loss of chromosome 20q;loss of chromosome 20q;exactmatch
"t(3;3)(q21.3;q26.2)";"t(3;3)(q21.3;q26.2)";exactmatch
"inv(3)(q21.3;q26.2)";"inv(3)(q21.3;q26.2)";exactmatch
loss of chromosome 7q;7q deletion;exactmatch
trisomy 3;trisomy 3;exactmatch
del(17p13);-17p13;exactmatch
del(6q21);del(6)(q21);exactmatch
del(11q22q23);11q22-23 deletion;exactmatch
del(13q14);del(13)(q14);exactmatch
trisomy 12;trisomy 12;exactmatch
grade iii prostatic intraepithelial neoplasia;adenocarcinoma in situ of prostate;exactmatch
"t(1;22)(p13.3;q13.1)";"t(1;22)(p13.3;q13.1)";exactmatch
"t(8;16)(p11;p13)";"t(8;16)(p11;p13)";exactmatch
"t(3;5)(q25;q34)";"t(3;5)(q25;q34)";exactmatch
"ins(3;3)";"ins(3;3)";exactmatch
monosomy 7;monosomy 7;exactmatch
loss of chromosome 12p;12p del;exactmatch
stage 0 breast cancer ajcc v6 and v7;breast cancer stage 0;exactmatch
"t(5;12)(q31;p12)";"t(5;12)(q31;p12)";exactmatch
monosomy 10;monosomy 10;exactmatch
del(6q25);del(6)(q25);exactmatch
gain of chromosome 1;gain of chromosome 1;exactmatch
gain of chromosome 21;gain of chromosome 21;exactmatch
loss of chromosome 13;-13 del(13q);exactmatch
loss of chromosome 8;chromosome 8 deletion;exactmatch
del(7q21-32);del(7)(q21-32);exactmatch
del(11q23);11q23 deletion;exactmatch
"t(6;9)(p23;q34.1)";"t(6;9)(p22.3;q34.1)";exactmatch
trisomy 4;trisomy 4;exactmatch
trisomy 13;trisomy 13;exactmatch
loss of chromosome 5;-5;exactmatch
del(6q23);del(6)(q23);exactmatch
gain of chromosome 11;gain of chromosome 11;exactmatch
loss of chromosome 7;-7;exactmatch
monosomy 5;monosomy 5;exactmatch
gain of chromosome 13;gain of chromosome 13;exactmatch
partial trisomy 1q;partial trisomy 1q;exactmatch
"t(17;22)(q22;q13)";"t(17;22)(q22;q13)";exactmatch
"t(7;14)(q35;q32.1)";"t(7;14)(q35;q32.1)";exactmatch
loss of chromosome x;loss of chromosome x;exactmatch
gain of chromosome x;additional x chromosome;exactmatch
del(14q21);del(14)(q21);exactmatch
gain of chromosome 7p;gain of chromosome 7p;exactmatch
del(13q32-qter);del(13q32-qter);exactmatch
del(13q12-13);del(13q12-13);exactmatch
del(8p21-pter);del(8p21-pter);exactmatch
del(3p21-23);del(3)(p21-23);exactmatch
gain of chromosome 1q21-31;gain of chromosome 1q21-31;exactmatch
gain of chromosome 1p31;gain of chromosome 1p31;exactmatch
gain of chromosome 7q32;gain of chromosome 7q32;exactmatch
loss of chromosome 11;-11;exactmatch
rearrangement of 8q11-13;rearrangement of 8q11-13;exactmatch
loss of chromosome 2q;loss of chromosome 2q;exactmatch
loss of chromosome 2p;loss of chromosome 2p;exactmatch
rearrangement of 1p11-13;rearrangement of 1p11-13;exactmatch
gain of chromosome 5q;gain of chromosome 5q;exactmatch
rearrangement of 11q13-21;rearrangement of 11q13-21;exactmatch
loss of chromosome 16;loss of chromosome 16;exactmatch
chromosomal rearrangement;chromosomal rearrangement;exactmatch
"t(7;19)(q34;q13)";"t(7;19)(q34;q13)";exactmatch
"t(v;11q23.3)";11q23.3 translocation;exactmatch
loss of chromosome 10q;loss of chromosome 10q;exactmatch
gain of chromosome 15q;gain of chromosome 15q;exactmatch
gain of chromosome 8q;8q gain;exactmatch
gain of chromosome 3q;gain of chromosome 3q;exactmatch
gain of chromosome 5;gain of chromosome 5;exactmatch
ccnd1 protein overexpression;b-cell lymphoma 1 protein overexpression;exactmatch
gain of chromosome 17q;gain of chromosome 17q;exactmatch
gain of chromosome 9q;gain of chromosome 9q;exactmatch
gain of chromosome 1q;1q amplification;exactmatch
gain of chromosome 20q;gain of chromosome 20q;exactmatch
loss of chromosome 16q;16q loss;exactmatch
unbalanced translocation of chromosome 1;unbalanced translocation of chromosome 1;exactmatch
i(17q);isochromosome 17q;exactmatch
trisomy 7;trisomy 7;exactmatch
trisomy 6;trisomy 6;exactmatch
ring chromosome 1;ring chromosome 1;exactmatch
"der(15;21)(q10;q10)";"der(15;21)(q10;q10)";exactmatch
del(19p12);del(19)(p12);exactmatch
gain of chromosome 5p;gain of chromosome 5p;exactmatch
loss of chromosome 14;loss of chromosome 14;exactmatch
loss of chromosome 22;loss of chromosome 22;exactmatch
high-frequency microsatellite instability;high;exactmatch
del(5q22);del(5q22);exactmatch
loss of chromosome 10p;loss of chromosome 10p;exactmatch
monosomy 17;monosomy 17;exactmatch
loss of chromosome 22q;loss of chromosome 22q;exactmatch
loss of chromosome 11p;loss of chromosome 11p;exactmatch
loss of chromosome 6;loss of chromosome 6;exactmatch
loss of chromosome 8p;loss of chromosome 8p;exactmatch
loss of chromosome 3p;3p deletion;exactmatch
loss of chromosome 1p;1p deletion;exactmatch
loss of chromosome 6p;loss of chromosome 6p;exactmatch
loss of chromosome 17p;17p deletion;exactmatch
loss of chromosome 12q;loss of chromosome 12q;exactmatch
loss of chromosome 13q;13q deletion;exactmatch
loss of chromosome 18q;loss of chromosome 18q;exactmatch
trisomy 2;trisomy 2;exactmatch
nodular neoplasm;nodular neoplasm;exactmatch
benign laryngeal neoplasm;benign laryngeal neoplasm;exactmatch
edematous stroma formation;edematous stroma formation;exactmatch
lobular capillary hemangioma;granulation tissue-type hemangioma;exactmatch
chronic leukemia;chronic leukemia;exactmatch
mucous polyp of cervix;mucous polyp of cervix;exactmatch
metastatic carcinoma;carcinoma, metastatic, nos;exactmatch
metrorrhagia;intermenstrual bleeding;exactmatch
menstrual disorder;menstrual disorder;exactmatch
mass;mass;exactmatch
primary malignant liver neoplasm;primary malignant liver neoplasm;exactmatch
lymphocytosis;lymphocyte count increased;exactmatch
nephrotic syndrome;nephrosis;exactmatch
lower back pain;lower back pain;exactmatch
chronic monocytic leukemia;chronic monocytic leukemia;exactmatch
leg pain;leg pain;exactmatch
li-fraumeni syndrome;li-fraumeni;exactmatch
klinefelter syndrome;47,xxy syndrome;exactmatch
cystic kidney disease;cystic kidney disease;exactmatch
granular cell tumor;abrikossoff tumor;exactmatch
breast adenosis;adenosis of breast;exactmatch
noonan syndrome;noonan syndrome;exactmatch
pure red cell aplasia;prca;exactmatch
postmenopausal hemorrhage;postmenopausal hemorrhage;exactmatch
lobular capillary hemangioma of skin and subcutaneous tissue;lobular capillary hemangioma of skin and subcutaneous tissue;exactmatch
hypercalcemia of malignancy;hypercalcemia of malignancy;exactmatch
colon villous adenoma;colon villous adenoma;exactmatch
ectopic pregnancy;ectopic pregnancy;exactmatch
toxemia of pregnancy;toxemia of pregnancy;exactmatch
pregnancy complication;complication related to pregnancy;exactmatch
lung papillary adenoma;adenoma, bronchial, benign;exactmatch
lung squamous cell carcinoma;epidermoid cell carcinoma of lung;exactmatch
epithelioid cell type gastrointestinal stromal tumor;epithelioid cell type gist;exactmatch
cecum carcinoma;carcinoma of cecum;exactmatch
lip carcinoma;carcinoma of lip;exactmatch
parakeratosis;parakeratosis;exactmatch
benign penile neoplasm;benign neoplasm of penis;exactmatch
pancytopenia;pancytopenia;exactmatch
wdha syndrome;islet cell wdha syndrome;exactmatch
therapy-related neoplasm;therapy related neoplasm;exactmatch
iris disorder;iris disorder;exactmatch
choroid plexus neoplasm;choroid plexus neoplasm;exactmatch
severe combined immunodeficiency;scid;exactmatch
high grade lymphoma;high grade lymphoma;exactmatch
immunoblastic lymphoma;immunoblastic lymphoma;exactmatch
fibrous dysplasia;fibrous dysplasia;exactmatch
grade 3 follicular lymphoma;follicular large cell lymphoma;exactmatch
erythroid hyperplasia;erythroid hyperplasia;exactmatch
intermediate grade lymphoma;intermediate grade lymphoma;exactmatch
endomyocardial fibrosis;endomyocardial fibrosis;exactmatch
endocervical polyp;endocervical polyp;exactmatch
empyema;empyema;exactmatch
hypersplenism;hypersplenism;exactmatch
b-cell non-hodgkin lymphoma;b-cell non hodgkin's lymphoma;exactmatch
vulvar dystrophy;vulvar dystrophy;exactmatch
inclusion body fibromatosis;digital fibrous tumor of reye;exactmatch
skin pigmentation disorder;pigmentation disorders;exactmatch
disturbance of skin sensation;disturbance of skin sensation;exactmatch
fluid discharge;discharge;exactmatch
zollinger ellison syndrome;zollinger ellison syndrome;exactmatch
polyostotic fibrous dysplasia;polyostotic fibrous dysplasia;exactmatch
flank pain;flank pain;exactmatch
low grade lymphoma;low grade lymphoma;exactmatch
diffuse mixed cell lymphoma;diffuse mixed cell lymphoma;exactmatch
aids-related lymphoma;aids lymphoma;exactmatch
hypergammaglobulinemia;hypergammaglobulinemia;exactmatch
inguinal hernia;inguinal hernia;exactmatch
diaphragmatic hernia;diaphragmatic hernia;exactmatch
hernia;hernia;exactmatch
mature t-cell and nk-cell non-hodgkin lymphoma;mature t- and nk-cell lymphomas;exactmatch
primary cutaneous t-cell non-hodgkin lymphoma;ctcl;exactmatch
heart block by ecg finding;conduction block;exactmatch
headache;headache;exactmatch
t-cell non-hodgkin lymphoma;non-hodgkin's t-cell lymphoma;exactmatch
hair disorder;hair disorder;exactmatch
gout;gout;exactmatch
grade 1 follicular lymphoma;follicular lymphoma grade 1;exactmatch
adult diffuse small cleaved cell lymphoma;adult diffuse poorly differentiated cell lymphoma;exactmatch
gallbladder disorder;gall bladder disease;exactmatch
pulmonary hamartoma;hamartoma of lung;exactmatch
reticuloendothelial hyperplasia;reticuloendothelial hyperplasia;exactmatch
conn syndrome;conn syndrome;exactmatch
malignant posterior tongue neoplasm;malignant base of tongue neoplasm;exactmatch
poikilocytosis;poikilocytosis;exactmatch
anisocytosis;anisocytosis;exactmatch
acanthosis;acanthosis;exactmatch
malignant submandibular gland neoplasm;malignant neoplasm of submandibular gland;exactmatch
chondromatosis;chondromatosis;exactmatch
skin vascular disorder;skin vascular disorder;exactmatch
malignant parotid gland neoplasm;cancer of parotid;exactmatch
digestive system injury;digestive system injury;exactmatch
malignant sublingual gland neoplasm;malignant neoplasm of sublingual gland;exactmatch
balanitis xerotica obliterans;balanitis xerotica obliterans;exactmatch
postcoital bleeding;postcoital bleeding;exactmatch
mammary duct ectasia;comedomastitis;exactmatch
penile vascular disorder;penile vascular disorder;exactmatch
placental polyp;placenta polyp;exactmatch
myeloid sarcoma;chloroma;exactmatch
eyelid vascular disorder;eyelid vascular disorder;exactmatch
macrocephaly;macrocephaly;exactmatch
lower abdominal pain;lower abdominal pain;exactmatch
ovarian fibroma;fibroma of ovary;exactmatch
malignant neoplasm of the middle third of the esophagus;malignant middle third of esophagus neoplasm;exactmatch
malignant peritoneal neoplasm;cancer of peritoneum;exactmatch
lytic metastatic bone lesion;lytic metastatic bone lesion;exactmatch
bone marrow neoplasm;bone marrow neoplasm;exactmatch
malignant retroperitoneal neoplasm;malignant retroperitoneal neoplasm;exactmatch
malignant ampulla of vater neoplasm;malignant ampulla of vater neoplasm;exactmatch
malignant neoplasm of the lower third of the esophagus;malignant lower third of esophagus neoplasm;exactmatch
lymph node disorder;lymph node disorder;exactmatch
malignant neoplasm of the upper third of the esophagus;malignant neoplasm of proximal third of esophagus;exactmatch
malignant hard palate neoplasm;malignant hard palate neoplasm;exactmatch
malignant neoplasm of the thoracic esophagus;malignant neoplasm of thoracic esophagus;exactmatch
malignant pyriform fossa neoplasm;malignant neoplasm of pyriform fossa;exactmatch
malignant palate neoplasm;cancer of palate;exactmatch
mediastinal mass;mediastinal mass;exactmatch
low grade fever;low grade fever;exactmatch
malignant soft palate neoplasm;malignant neoplasm of soft palate;exactmatch
alpha fetoprotein increased;alpha fetoprotein increased;exactmatch
atypical chronic myeloid leukemia, bcr-abl1 negative;atypical cml;exactmatch
digestive system carcinoma in situ;digestive system carcinoma in situ;exactmatch
nodular sclerosis classic hodgkin lymphoma;classical hodgkin lymphoma, nodular sclerosis, nos;exactmatch
tobacco use disorder;tobacco use disorder;exactmatch
vascular disorder;unspecified vascular problem;exactmatch
uterine corpus degenerated leiomyoma;degenerated uterine fibroid;exactmatch
congenital genitourinary abnormality;congenital abnormality of the genitourinary system;exactmatch
cutaneous melanoma;cm;exactmatch
genital leukoplakia;genital leukoplakia;exactmatch
tracheal disorder;disorder of trachea;exactmatch
dental disorder;dental condition;exactmatch
immune system disorder;disorder of immune system;exactmatch
malignant neoplasm of lower jaw bone;malignant neoplasm of lower jaw bone;exactmatch
adrenal cortical hyperplasia;adrenal cortex hyperplasia;exactmatch
strabismus;squint;exactmatch
endometrial disorder;endometrial disorder;exactmatch
thyroid gland follicular adenoma;adenoma, follicular cell, benign;exactmatch
schistosomiasis;bilharzia;exactmatch
peripheral motor neuropathy;peripheral motor neuropathy;exactmatch
atrial myxoma;atrial myxoma;exactmatch
lung adenocarcinoma;adenocarcinoma;exactmatch
viral hepatitis;hepatitis viral;exactmatch
vision disorder;disorder of visual system;exactmatch
esophageal carcinoma;cancer of esophagus;exactmatch
malignant uvula neoplasm;malignant uvula neoplasm;exactmatch
mixed cellularity classic hodgkin lymphoma;hodgkin's disease mixed cellularity;exactmatch
pregnancy disorder;disorder of pregnancy;exactmatch
megakaryocytes increased in bone marrow;megakaryocytes increased in bone marrow;exactmatch
hypocellular bone marrow;bone marrow hypoplasia;exactmatch
neutrophilia;granulocytosis;exactmatch
nipple discharge;nipple discharge;exactmatch
neck mass;neck lump;exactmatch
aneurysmal bone cyst;abc;exactmatch
pulmonary mass;lung mass;exactmatch
adnexal mass;adnexal mass;exactmatch
monocytosis;monocytosis;exactmatch
appendicitis;acute appendicitis;exactmatch
chills;chill;exactmatch
normocytic anemia;normocytic anemia;exactmatch
cystic endometrial hyperplasia;cystic endometrial hyperplasia;exactmatch
juvenile xanthogranuloma;jxg;exactmatch
mallory bodies present;mallory bodies present;exactmatch
endocervical mucosa;endocervical mucosa;exactmatch
tenosynovial giant cell tumor;fibrous histiocytoma of tendon sheath;exactmatch
tenosynovial giant cell tumor, diffuse type;diffuse giant cell neoplasm of tendon sheath;exactmatch
fossa;fossa;exactmatch
lumbar region;lumbar region;exactmatch
hypochondriac region;hypochondriac region;exactmatch
synovial sarcoma;sarcoma, synovial, malignant;exactmatch
swelling;swelling;exactmatch
sweat gland neoplasm;neoplasm of sweat gland;exactmatch
kidney part;kidney part;exactmatch
neurogenic locus notch homolog protein 1;notch1;exactmatch
cell surface;cell surface;exactmatch
supratentorial neoplasm;brain neoplasms, supratentorial;exactmatch
spinal cord part;spinal cord part;exactmatch
peripheral nervous system part;peripheral nervous system part;exactmatch
central nervous system part;central nervous system part;exactmatch
superior vena cava syndrome;superior vena cava syndrome;exactmatch
anatomic surface;anatomic surface;exactmatch
mediastinum part;mediastinum part;exactmatch
mouse islet cell neoplasm;mouse islet cell neoplasm;exactmatch
mouse pancreatic ductal adenocarcinoma;mouse pancreatic ductal adenocarcinoma;exactmatch
mouse pancreatic intraepithelial neoplasia-3;mouse pancreatic intraepithelial neoplasia-3;exactmatch
mouse pancreatic intraepithelial neoplasia-2;mouse pancreatic intraepithelial neoplasia-2;exactmatch
mouse pancreatic intraepithelial neoplasia-1b;mouse pancreatic intraepithelial neoplasia-1b;exactmatch
mouse pancreatic intraepithelial neoplasia-1;mouse pancreatic intraepithelial neoplasia-1;exactmatch
mouse islet cell adenocarcinoma;mouse islet cell adenocarcinoma;exactmatch
mouse islet cell carcinoma;mouse islet cell carcinoma;exactmatch
mouse acinar cell adenocarcinoma;mouse acinar cell adenocarcinoma;exactmatch
malignant mouse pancreatic neoplasm;malignant mouse pancreatic neoplasm;exactmatch
teratoma;teratoma;exactmatch
testicular neoplasm;neoplasm of testis;exactmatch
mouse mixed acinar/islet cell adenoma;mouse mixed acinar/islet cell adenoma;exactmatch
mouse acinar cell adenoma;mouse acinar cell adenoma;exactmatch
benign mouse pancreatic neoplasm;benign mouse pancreatic neoplasm;exactmatch
mouse pancreatic acinar neoplasm;mouse pancreatic acinar neoplasm;exactmatch
mouse pancreatic neoplasm;mouse pancreatic neoplasm;exactmatch
mouse pancreatic disorder;mouse pancreatic disorder;exactmatch
thymic tissue;thymic tissue;exactmatch
ectoderm cell;ectoderm cell;exactmatch
endoderm cell;endoderm cell;exactmatch
spinal cord neoplasm;neoplasm of spinal cord;exactmatch
undersurface of the frontal lobe;undersurface of the frontal lobe;exactmatch
splenic neoplasm;splenic neoplasm;exactmatch
umbilical region;umbilical region;exactmatch
tunica vaginalis;tunica vaginalis;exactmatch
tunica intima;tunica intima;exactmatch
intraspinal neoplasm;intraspinal neoplasm;exactmatch
trunk;trunk;exactmatch
spinal cord compression;spinal cord compression;exactmatch
precursor b-lymphoblast;b-lymphoblast;exactmatch
tracheal epithelium;tracheal epithelium;exactmatch
odontogenic tissue;odontogenic tissue;exactmatch
tooth cell;tooth cell;exactmatch
somatostatin-producing neuroendocrine tumor;delta cell tumor;exactmatch
thyrotroph cell;thyrotrope cell;exactmatch
thyroid gland tissue;thyroid gland tissue;exactmatch
thyroid gland follicular cell;thyroid follicular cell;exactmatch
splenomegaly;splenomegaly;exactmatch
urothelial cell;urothelial cell;exactmatch
uterine gland;gland, endometrial;exactmatch
vascular smooth muscle tissue;vascular smooth muscle tissue;exactmatch
precursor t-lymphoblast;precursor t-lymphoblast;exactmatch
submandibular gland neoplasm;neoplasm of submandibular gland;exactmatch
glandular cell;glandular cell;exactmatch
endometrial stromal cell;endometrial stromal cell;exactmatch
sublingual gland neoplasm;neoplasm of sublingual gland;exactmatch
endocervical columnar cell;endocervical columnar cell;exactmatch
other anatomic concept;other anatomic concept;exactmatch
mouse ovarian serous adenocarcinoma;mouse ovarian serous adenocarcinoma;exactmatch
cerebrovascular accident;cva;exactmatch
white matter;white matter tissue;exactmatch
gastric neoplasm;gastric neoplasm;exactmatch
vertebral canal;spinal canal;exactmatch
vermis;vermis;exactmatch
venous system;venous system;exactmatch
vascular system;vascular system;exactmatch
thecoma;thecoma;exactmatch
mouse islet cell adenoma;mouse islet cell adenoma;exactmatch
scar;scar;exactmatch
urticaria pigmentosa/maculopapular cutaneous mastocytosis;up/mpcm;exactmatch
vaginal neoplasm;neoplasm of vagina;exactmatch
congenital adrenal hyperplasia;adrenal hyperplasia;exactmatch
uveal neoplasm;neoplasm of uvea;exactmatch
uterine neoplasm;neoplasm of uterus;exactmatch
achondroplasia;achondroplasia;exactmatch
uterine corpus leiomyoma;body of uterus fibroid;exactmatch
abdominal mass;abdominal mass;exactmatch
urinary system neoplasm;neoplasm of urinary system;exactmatch
hemolytic anemia;hemolytic anemia;exactmatch
urinary system disorder;disorder of urinary system;exactmatch
urethra neoplasm;neoplasm of urethra;exactmatch
ureter neoplasm;neoplasm of ureter;exactmatch
ulcer;ulcer;exactmatch
tumor lysis syndrome;tumor lysis syndrome;exactmatch
tuberous sclerosis;bourneville's disease;exactmatch
other embryologic structure;other embryologic structure;exactmatch
amyotrophic lateral sclerosis;als;exactmatch
acquired hemolytic anemia;acquired hemolytic anemia;exactmatch
mouse somatostatinoma;mouse somatostatinoma;exactmatch
vulvar neoplasm;neoplasm of vulva;exactmatch
choroid disorder;choroid disease;exactmatch
synovial chondromatosis;henderson-jones syndrome;exactmatch
weight loss;weight decrease;exactmatch
carcinosarcoma;carcinosarcoma, malignant;exactmatch
head and neck squamous cell carcinoma;hnscc;exactmatch
burn;burn;exactmatch
bone marrow disorder;bone marrow disease;exactmatch
vomiting;emesis;exactmatch
autoimmune hemolytic anemia;autoimmune hemolytic anemia;exactmatch
benign neoplasm of lower jaw bone;benign neoplasm of lower jaw bone;exactmatch
beckwith-wiedemann syndrome;beckwith-wiedemann;exactmatch
basophilia;basophilia;exactmatch
peritoneal effusion;peritoneal_effusion;exactmatch
vocal cord polyp;polyp of vocal cord;exactmatch
viral infection;viral disease;exactmatch
macrocytic anemia;macrocytic anemia;exactmatch
tuberculosis;active tuberculosis;exactmatch
neuroectoderm;ectomesenchyme;exactmatch
neural crest;neural crest;exactmatch
reproductive system part;reproductive system part;exactmatch
splenic tissue;splenic tissue;exactmatch
gastrointestinal tract;alimentary canal;exactmatch
thrombocytopenia;platelet count decreased;exactmatch
skeletal system part;skeletal system part;exactmatch
polymerization;polymerization;exactmatch
cell part;cell component;exactmatch
essential thrombocythemia;et;exactmatch
autonomic nervous system part;autonomic nervous system part;exactmatch
trophoblastic tumor;trophoblastic neoplasm;exactmatch
thoracic neoplasm;neoplasm of thorax;exactmatch
embryonic urogenital system;embryonic urogenital system;exactmatch
trilaminar embryonic disc;trilaminar embryonic disc;exactmatch
gastrula;gastrula;exactmatch
mouse pancreatic intraepithelial neoplasia-1a;mouse pancreatic intraepithelial neoplasia-1a;exactmatch
extraembryonic structure;extraembryonic structure;exactmatch
mouse insulinoma;mouse insulinoma;exactmatch
thrombophlebitis;thrombophlebitis;exactmatch
thymoma;thymoma;exactmatch
thymus neoplasm;neoplasm of thymus;exactmatch
cloacal membrane;cloacal membrane;exactmatch
midgut;midgut;exactmatch
trisomy;trisomy;exactmatch
chromosomal translocation;chromosomal translocation;exactmatch
tracheal neoplasm;neoplasm of trachea;exactmatch
hindgut;hindgut;exactmatch
gonadal cord;gonadal cord;exactmatch
foregut;foregut;exactmatch
tonsillar neoplasm;neoplasm of tonsil;exactmatch
tongue neoplasm;neoplasm of tongue;exactmatch
embryonic nervous system;embryonic nervous system;exactmatch
embryonic disc;embryonic disc;exactmatch
thyroid gland nodule;nodule of thyroid;exactmatch
embryonic structure or system;embryologic structure or system;exactmatch
thyroid gland neoplasm;neoplasm of thyroid;exactmatch
cortical cord;cortical cord;exactmatch
hemorrhagic change;hemorrhagic change;exactmatch
true histiocytic lymphoma;true histiocytic lymphoma;exactmatch
desmoplastic stroma formation;desmoplastic stroma formation;exactmatch
herringbone growth pattern;herringbone growth pattern;exactmatch
pagetoid proliferation;pagetoid proliferation;exactmatch
nested pattern;nested pattern;exactmatch
lobulated growth pattern;lobular pattern;exactmatch
plexiform growth pattern;plexiform growth pattern;exactmatch
chronic myelogenous leukemia, bcr-abl1 positive in remission;cml in remission;exactmatch
whorling growth pattern;whorling growth pattern;exactmatch
storiform growth pattern;storiform growth pattern;exactmatch
morphologic architectural pattern;morphologic architectural pattern;exactmatch
radial growth phase;radial;exactmatch
polyclonal hypergammaglobulinemia;polyclonal hypergammaglobulinemia;exactmatch
blast cells increased in bone marrow;blast cells increased in bone marrow;exactmatch
blast cells present in peripheral blood;blast cells present in peripheral blood;exactmatch
blast cells present;blast cells present;exactmatch
acute myeloid leukemia in remission;aml in remission;exactmatch
anisochromasia;anisochromasia;exactmatch
abnormal hematology test result;abnormal hematology test result;exactmatch
junctional proliferation;junctional proliferation;exactmatch
vertical growth phase;vertical;exactmatch
insular pattern;insular pattern;exactmatch
monophasic pattern;monophasic pattern;exactmatch
gyriform trabecular pattern;gyriform trabecular pattern;exactmatch
trabecular pattern;trabecular pattern;exactmatch
pseudopapillary pattern;pseudopapillary pattern;exactmatch
papillary pattern;papillary pattern;exactmatch
antoni b pattern;antoni b pattern;exactmatch
benign lip neoplasm;benign lip neoplasm;exactmatch
antoni a pattern;antoni a pattern;exactmatch
biphasic pattern;biphasic pattern;exactmatch
nodular pattern;nodular pattern;exactmatch
angiodestructive pattern;angiodestructive pattern;exactmatch
angiocentric pattern;angiocentric pattern;exactmatch
nodular and diffuse pattern;nodular and diffuse pattern;exactmatch
diffuse pattern;diffuse architectural pattern;exactmatch
interfollicular pattern;interfollicular pattern;exactmatch
multinodular pattern;multinodular pattern;exactmatch
acute monocytic leukemia in remission;acute monocytic leukemia (in remission);exactmatch
childhood intracranial neoplasm;childhood intracranial neoplasm;exactmatch
bronchogenic carcinoma;bronchial carcinoma;exactmatch
endemic african kaposi sarcoma;endemic african kaposi sarcoma;exactmatch
columnar cell variant thyroid gland papillary carcinoma;columnar cell variant papillary carcinoma;exactmatch
salivary gland sialoblastoma;salivary gland sialoblastoma;exactmatch
salivary gland sialadenoma papilliferum;salivary gland sialadenoma papilliferum;exactmatch
salivary gland inverted ductal papilloma;salivary gland inverted ductal papilloma;exactmatch
salivary gland intraductal papilloma;salivary gland intraductal papilloma;exactmatch
salivary gland cystadenoma;salivary gland cystadenoma;exactmatch
parotid gland carcinosarcoma;parotid gland carcinosarcoma;exactmatch
salivary gland carcinosarcoma;carcinosarcoma of salivary gland;exactmatch
ann arbor stage iii lymphocyte-depleted classic hodgkin lymphoma;ann arbor stage iii lymphocyte-depleted classic hodgkin lymphoma;exactmatch
iatrogenic kaposi sarcoma;iatrogenic kaposi sarcoma;exactmatch
splenic disorder;spleen disorder;exactmatch
perivascular fibrosis;perivascular fibrosis;exactmatch
reticulin fibrosis of the bone marrow;reticulin fibrosis of the bone marrow;exactmatch
ann arbor stage iii mixed cellularity classic hodgkin lymphoma;ann arbor stage iii mixed cellularity classic hodgkin lymphoma;exactmatch
differentiated granulocytic sarcoma;differentiated granulocytic sarcoma;exactmatch
immature granulocytic sarcoma;immature granulocytic sarcoma;exactmatch
blastic granulocytic sarcoma;blastic granulocytic sarcoma;exactmatch
salivary gland ductal papilloma;salivary gland ductal papilloma;exactmatch
ann arbor stage iii hodgkin lymphoma;ann arbor stage iii hodgkin lymphoma;exactmatch
melanocytic dysplasia;melanocytic dysplasia;exactmatch
microaneurysm;charcot-bouchard aneurysm;exactmatch
ewing sarcoma/peripheral primitive neuroectodermal tumor of bone;ewing sarcoma/peripheral primitive neuroectodermal tumor of bone;exactmatch
conventional osteosarcoma;central osteosarcoma;exactmatch
chronic lymphocytic leukemia in remission;cll in remission;exactmatch
radiologic finding;radiologic finding;exactmatch
morphologic finding;morphologic finding;exactmatch
cartilaginous metaplasia;cartilaginous metaplasia;exactmatch
acute lymphoblastic leukemia in remission;all in remission;exactmatch
osseous metaplasia;bone metaplasia;exactmatch
grade 4 clear cell renal cell carcinoma;g4 nuclei bizarre and multilobated, 20 um or greater, nucleoli prominent, chromatin clumped;exactmatch
grade 3 clear cell renal cell carcinoma;"g3 nuclei very irregular, approximately 20 um; nucleoli large and prominent";exactmatch
grade 2 clear cell renal cell carcinoma;"g2 nuclei slightly irregular, approximately 15 um; nucleoli evident";exactmatch
grade 1 clear cell renal cell carcinoma;"g1 nuclei round, uniform, approximately 10 um; nucleoli inconspicuous or absent";exactmatch
head and neck carcinoma;carcinoma of head and neck;exactmatch
plasma cell leukemia in remission;leukemia plasmacytic (in remission);exactmatch
basal cell hyperplasia;basal cell hyperplasia;exactmatch
macrotrabecular pattern;macrotrabecular pattern;exactmatch
alveolar pattern;alveolar pattern;exactmatch
granulocytic sarcoma;granulocytic sarcoma;exactmatch
sinusoidal vascular channel formation;sinusoidal vascular channel formation;exactmatch
eosinophilic infiltrate;eosinophilic infiltrate;exactmatch
chronic inflammatory infiltrate;chronic inflammatory infiltrate;exactmatch
benign esophageal neoplasm;benign esophageal neoplasm;exactmatch
acute inflammatory infiltrate;acute inflammatory infiltrate;exactmatch
inflammatory infiltrate;inflammatory infiltrate;exactmatch
vascular channel formation;vascular channel formation;exactmatch
arborizing vascular channel formation;arborizing vascular channel formation;exactmatch
staghorn configuration;staghorn configuration;exactmatch
lymphocytic infiltrate;lymphocytic infiltrate;exactmatch
benign pharyngeal neoplasm;benign neoplasm of pharynx;exactmatch
thin-walled branching vascular pattern;thin-walled branching vascular pattern;exactmatch
intravascular thrombus formation;intravascular thrombus formation;exactmatch
dilated thin-walled vascular space formation;dilated thin-walled vascular space formation;exactmatch
cavernous lymphatic space formation;cavernous lymphatic space formation;exactmatch
vascular morphologic change;vascular morphologic change;exactmatch
atypical mitotic figures;atypical mitotic figures;exactmatch
polymorphonuclear cell infiltrate;neutrophilic infiltrate;exactmatch
lymphoplasmacytic infiltrate;lpi;exactmatch
organoid pattern;organoid pattern;exactmatch
ring sideroblasts present;ring sideroblasts present;exactmatch
chondromyxoid stroma formation;chondromyxoid stroma formation;exactmatch
fibromyxoid stroma formation;fibromyxoid stroma formation;exactmatch
hyalinized stroma formation;hyalinized stroma formation;exactmatch
benign small intestinal neoplasm;benign neoplasm of small intestine;exactmatch
mucoid stroma formation;mucoid stroma formation;exactmatch
myxoid stroma formation;myxoid stroma formation;exactmatch
stromal change;stromal change;exactmatch
pseudoangiomatoid space formation;pseudoangiomatoid space formation;exactmatch
hemophagocytosis;hemophagocytosis;exactmatch
dystrophic calcification;dystrophic calcification;exactmatch
red blood cells extravasation;red blood cells extravasation;exactmatch
hemosiderin deposition;hemosiderin deposition;exactmatch
benign gastric neoplasm;benign gastric neoplasm;exactmatch
nuclear atypia;nuclear atypia;exactmatch
metaplastic bone formation;metaplastic bone formation;exactmatch
emperipolesis;emperipolesis;exactmatch
low mitotic activity;low mitotic activity;exactmatch
high mitotic activity;high mitotic activity;exactmatch
benign hypopharyngeal neoplasm;benign hypopharyngeal neoplasm;exactmatch
glandular pattern;glandular pattern;exactmatch
tumor vascular invasion;tumor vascular invasion;exactmatch
epithelioid differentiation;epithelioid differentiation;exactmatch
rhabdomyosarcomatous differentiation;rhabdomyosarcomatous differentiation;exactmatch
distantly metastatic malignant neoplasm;distantly metastatic malignant neoplasm;exactmatch
honeycomb pattern;honeycomb pattern;exactmatch
endodermal sinus pattern;endodermal sinus pattern;exactmatch
benign floor of the mouth neoplasm;benign floor of mouth neoplasm;exactmatch
triphasic pattern;triphasic pattern;exactmatch
mitotic activity;mitosis (y/n);exactmatch
syncytial pattern;syncytial pattern;exactmatch
glomeruloid vessels present;glomeruloid vessels present;exactmatch
tubular pattern;tubular pattern;exactmatch
acinar pattern;acinar pattern;exactmatch
pseudoglandular pattern;pseudoglandular pattern;exactmatch
cribriform pattern;cribriform change;exactmatch
benign tongue neoplasm;benign neoplasm of tongue;exactmatch
benign tonsillar neoplasm;benign neoplasm of tonsil;exactmatch
rosette formation;rosette formation;exactmatch
flexner-wintersteiner rosette formation;flexner-wintersteiner rosette formation;exactmatch
homer wright rosette formation;homer wright rosette formation;exactmatch
comedo-like necrosis;comedo-like necrosis;exactmatch
tumor cell necrosis;tumor cell necrosis;exactmatch
fibrinoid necrosis;fibrinoid necrosis;exactmatch
absence of stromal invasion;absence of stromal invasion;exactmatch
stromal invasion;stromal invasion;exactmatch
hydropic villous change;hydropic villous change;exactmatch
keratin pearls formation;keratin pearls formation;exactmatch
benign nasopharyngeal neoplasm;benign nasopharyngeal neoplasm;exactmatch
enamel formation;enamel formation;exactmatch
dentin formation;dentin formation;exactmatch
cementum formation;cementum formation;exactmatch
multilayered rosette formation;multilayered rosette formation;exactmatch
pineocytomatous rosette formation;pineocytomatous rosette formation;exactmatch
ependymal rosette formation;ependymal rosette formation;exactmatch
pseudorosette formation;pseudorosette formation;exactmatch
monoblastic sarcoma;monoblastic sarcoma;exactmatch
hematopoietic and lymphoid system disorder;hematopoietic and lymphoid system disease;exactmatch
malignant splenic neoplasm;cancer of the spleen;exactmatch
malignant placental neoplasm;deciduoma, malignant;exactmatch
rare neoplastic syndrome;rare neoplastic syndrome;exactmatch
malignant uterine corpus neoplasm;malignant corpus uteri neoplasm;exactmatch
tall cell variant thyroid gland papillary carcinoma;tall cell variant papillary carcinoma;exactmatch
childhood botryoid-type embryonal rhabdomyosarcoma of the vagina;childhood botryoid-type embryonal rhabdomyosarcoma of the vagina;exactmatch
salivary gland sebaceous lymphadenoma;salivary gland sebaceous lymphadenoma;exactmatch
abnormal blood chemistry and hematology test result;abnormal blood chemistry and hematology test result;exactmatch
cardiovascular system finding;cardiovascular system;exactmatch
monoclonal gammopathy;monoclonal gammopathy;exactmatch
atypical lymphocytes present;atypical lymphocytes present;exactmatch
myocardial disorder;myocardial disorder;exactmatch
hyperkeratosis;hyperkeratosis;exactmatch
malignant exocervical neoplasm;malignant exocervical neoplasm;exactmatch
thrombocytosis;elevated platelet count;exactmatch
malignant endocervical neoplasm;malignant endocervical neoplasm;exactmatch
lymph node involvement;lymph node involvement;exactmatch
leukocytosis;elevated white blood cell count;exactmatch
neuroepithelial, perineurial, and schwann cell neoplasm;neural neoplasm;exactmatch
astler-coller b1 colon carcinoma;astler-coller b1 colon carcinoma;exactmatch
astler-coller b2 colon carcinoma;astler-coller b2 colon carcinoma;exactmatch
malignant orbit neoplasm;malignant neoplasm of orbit;exactmatch
tumor associated fever;tumor associated fever;exactmatch
malignant choroid neoplasm;malignant choroid neoplasm;exactmatch
carcinomatous ascites;carcinomatous ascites;exactmatch
malignant corneal neoplasm;malignant cornea neoplasm;exactmatch
unresectable malignant liver neoplasm;non-resectable hepatic malignant neoplasm;exactmatch
malignant conjunctival neoplasm;malignant conjunctiva neoplasm;exactmatch
malignant lacrimal gland neoplasm;malignant lacrimal gland neoplasm;exactmatch
malignant accessory urethral gland neoplasm;malignant accessory urethral gland neoplasm;exactmatch
malignant clitoral neoplasm;malignant clitoral neoplasm;exactmatch
malignant scrotal neoplasm;malignant neoplasm of scrotum;exactmatch
congenital adrenal gland disorder;congenital adrenal gland disorder;exactmatch
malignant spermatic cord neoplasm;malignant neoplasm of spermatic cord;exactmatch
erythrophagocytosis;erythrophagocytosis;exactmatch
malignant epididymal neoplasm;malignant epididymal neoplasm;exactmatch
childhood botryoid-type embryonal rhabdomyosarcoma;botryoid-type embryonal rhabdomyosarcoma;exactmatch
progressive disease;disease progression;exactmatch
nasal mass;mass of nose;exactmatch
malignant uterine neoplasm;cancer of uterus;exactmatch
gastrointestinal polyp;gi polyp;exactmatch
richter syndrome;richter syndrome;exactmatch
liver vascular disorder;hepatic vascular disorder;exactmatch
malignant glottis neoplasm;malignant glottis neoplasm;exactmatch
hemophagocytic syndrome;hemophagocytic syndrome;exactmatch
cauda equina syndrome;cauda equina syndrome;exactmatch
polycythaemia due to excess erythropoetin production;polycythaemia due to excess erythropoetin production;exactmatch
malignant sphenoid sinus neoplasm;malignant neoplasm of sphenoid sinus;exactmatch
malignant neoplasm of multiple primary sites;malignant neoplasm of multiple primary sites;exactmatch
malignant frontal sinus neoplasm;malignant frontal sinus neoplasm;exactmatch
endobronchial mass;endobronchial mass;exactmatch
axillary lipoma;axillary lipoma;exactmatch
local tumor spread;local tumor spread;exactmatch
intrahepatic cholangiocarcinoma;cholangiocarcinoma, intrahepatic, malignant;exactmatch
mixed tumor of the parotid gland;mixed tumor of parotid gland;exactmatch
malignant ethmoid sinus neoplasm;malignant ethmoid sinus neoplasm;exactmatch
adrenal hyperplasia;adrenal gland hyperplasia;exactmatch
malignant maxillary sinus neoplasm;malignant maxillary sinus neoplasm;exactmatch
malignant supraglottis neoplasm;malignant neoplasm of supraglottis;exactmatch
abnormal urine test result;abnormal urine test result;exactmatch
malignant subglottis neoplasm;malignant neoplasm of subglottis;exactmatch
crystal formation;crystal deposition;exactmatch
lung kaposi sarcoma;kaposi's sarcoma of lung;exactmatch
abnormal bone marrow test result;abnormal bone marrow test result;exactmatch
throat carcinoma;throat cancer;exactmatch
vascular proliferation;vascular proliferation;exactmatch
digestive system infection;digestive system infection;exactmatch
malignant bone marrow neoplasm;malignant bone marrow neoplasm;exactmatch
skin kaposi sarcoma;cutaneous (skin) kaposi sarcoma;exactmatch
lymph node neoplasm;lymph node neoplasm;exactmatch
malignant mediastinal neoplasm;cancer of mediastinum;exactmatch
bone injury;bone injury;exactmatch
malignant cardiac neoplasm;cardiac neoplasm, malignant;exactmatch
nucleated red blood cells present;nucleated red blood cells present;exactmatch
behavioral disorder;behavior-related disorder;exactmatch
malignant pleural neoplasm;cancer of pleura;exactmatch
clinical course of disease;clinical course;exactmatch
malignant nasolacrimal duct neoplasm;malignant lacrimal duct neoplasm;exactmatch
recurrent malignant salivary gland neoplasm;recurrent malignant neoplasm of salivary gland;exactmatch
hematopoietic and lymphoid system neoplasm;hematopoietic and lymphoid system neoplasm;exactmatch
malignant endocrine neoplasm;endocrine neoplasm, malignant;exactmatch
malignant thoracic neoplasm;malignant neoplasm of thorax;exactmatch
metastasizing pleomorphic adenoma of the salivary gland;metastasizing mixed tumor of salivary gland;exactmatch
stage 0 lung large cell carcinoma ajcc v6 and v7;stage 0 large cell carcinoma of lung;exactmatch
stage iiib lung small cell carcinoma without pleural effusion ajcc v7;stage iiib lung small cell carcinoma without pleural effusion ajcc v7;exactmatch
stage iiib lung small cell carcinoma with pleural effusion ajcc v7;stage iiib lung small cell carcinoma with pleural effusion ajcc v7;exactmatch
non-neoplastic respiratory system disorder;non-neoplastic respiratory system disorder;exactmatch
benign axillary neoplasm;benign axillary neoplasm;exactmatch
axillary neoplasm;axillary neoplasm;exactmatch
histiocytoma;histiocytoma;exactmatch
metastatic malignant neoplasm in the axilla;axillary metastases;exactmatch
axillary disorder;axillary disease;exactmatch
chest wall disorder;chest wall disease;exactmatch
sternal disorder;sternal disorder;exactmatch
non-neoplastic thoracic disorder;non-neoplastic thoracic disease;exactmatch
thoracic disorder;thoracic disease;exactmatch
non-neoplastic heart disorder;non-neoplastic heart disorder;exactmatch
arthropathy;arthropathy;exactmatch
normal laboratory test result;normal lab test result;exactmatch
localized malignant gallbladder neoplasm;localized malignant gallbladder neoplasm;exactmatch
ciliary body mixed cell melanoma;ciliary body mixed cell melanoma;exactmatch
malignant lymph node neoplasm;lymph node cancer;exactmatch
ann arbor stage iii nodular sclerosis classic hodgkin lymphoma;ann arbor stage iii nodular sclerosis classic hodgkin lymphoma;exactmatch
metastatic malignant neoplasm in the bone;bone metastases;exactmatch
pagetoid reticulosis;pagetoid reticulosis;exactmatch
metastatic malignant neoplasm in the pleura;metastases to pleura;exactmatch
hypercellular bone marrow;hypercellular bone marrow;exactmatch
non-neoplastic hair disorder;non-neoplastic hair disorder;exactmatch
choroid mixed cell melanoma;choroid mixed cell melanoma;exactmatch
metastatic malignant neoplasm in the lung;lung metastases;exactmatch
mixed cell uveal melanoma;mixed cell uveal melanoma;exactmatch
epithelioid cell uveal melanoma;epithelioid cell uveal melanoma;exactmatch
metastatic malignant neoplasm in the mediastinum;metastases to mediastinum;exactmatch
non-neoplastic dental disorder;non-neoplastic dental disorder;exactmatch
gastrointestinal stromal tumor of the gastrointestinal tract;digestive stromal neoplasm;exactmatch
ciliary body disorder;ciliary body disease;exactmatch
non-neoplastic bile duct disorder;non-neoplastic bile duct disorder;exactmatch
non-neoplastic vascular disorder;non-neoplastic vascular disorder;exactmatch
malignant carotid body paraganglioma;chemodectoma, malignant;exactmatch
salivary gland sebaceous adenoma;salivary gland sebaceous adenoma;exactmatch
eye lymphoma;eye lymphoma;exactmatch
epiglottic carcinoma;epiglottic cancer;exactmatch
stage ivc major salivary gland cancer ajcc v7;stage ivc major salivary gland cancer;exactmatch
stage ivb major salivary gland cancer ajcc v7;stage ivb major salivary gland cancer;exactmatch
stage iva major salivary gland cancer ajcc v7;stage iva major salivary gland cancer;exactmatch
posterior pharyngeal wall squamous cell carcinoma;posterior pharyngeal wall squamous cell carcinoma;exactmatch
posterior pharyngeal wall carcinoma;posterior pharyngeal wall carcinoma;exactmatch
mixed tumor of the salivary gland;mixed tumor of salivary gland;exactmatch
malignant cerebellar neoplasm;cancer of cerebellum;exactmatch
salivary gland adenosquamous carcinoma;salivary gland adenosquamous carcinoma;exactmatch
ocular adnexal mucosa-associated lymphoid tissue lymphoma;ocular adnexal malt lymphoma;exactmatch
breast mucosa-associated lymphoid tissue lymphoma;breast extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue;exactmatch
parotid gland mucosa-associated lymphoid tissue lymphoma;parotid gland malt lymphoma;exactmatch
immunodeficiency-related disorder;immunodeficiency-related disorder;exactmatch
positive laboratory test result;positive laboratory test result;exactmatch
negative test result;negative test result;exactmatch
malignant brain neoplasm;brain cancer;exactmatch
benign uvula neoplasm;benign uvula neoplasm;exactmatch
malignant brain stem neoplasm;malignant brain stem neoplasm;exactmatch
salivary gland myoepithelial carcinoma;salivary gland myoepithelial carcinoma;exactmatch
salivary gland epithelial-myoepithelial carcinoma;salivary gland epithelial myoepithelial carcinoma;exactmatch
salivary gland lymphoepithelial carcinoma;lymphoepithelial salivary gland carcinoma;exactmatch
salivary gland large cell carcinoma;large cell salivary gland carcinoma;exactmatch
hearing loss;hearing loss;exactmatch
malignant pineal region neoplasm;malignant neoplasm of pineal gland;exactmatch
congenital cardiovascular abnormality;congenital abnormality of the circulatory system;exactmatch
grade i neuroendocrine carcinoma;grade i neuroendocrine carcinoma;exactmatch
grade iii neuroendocrine carcinoma;grade iii neuroendocrine carcinoma;exactmatch
grade ii neuroendocrine carcinoma;grade ii neuroendocrine carcinoma;exactmatch
nasopharyngeal disorder;nasopharyngeal disorder;exactmatch
malignant spinal cord neoplasm;malignant neoplasm of spinal cord;exactmatch
thymic undifferentiated carcinoma;thymic undifferentiated carcinoma;exactmatch
testicular teratoma with somatic-type malignancy;testicular teratoma with non-germ cell malignancy;exactmatch
malignant cranial nerve neoplasm;cranial nerve neoplasm, malignant;exactmatch
salivary gland small cell neuroendocrine carcinoma;salivary gland small cell neuroendocrine carcinoma;exactmatch
salivary gland polymorphous adenocarcinoma;polymorphous adenocarcinoma, classic;exactmatch
high grade anal canal intraepithelial neoplasia;asin-h;exactmatch
injury;injury;exactmatch
poroma;eccrine poroma;exactmatch
refractory ureter urothelial carcinoma;refractory ureter urothelial carcinoma;exactmatch
thrombopoiesis;thrombocytopoiesis;exactmatch
biosynthetic process;anabolism;exactmatch
refractory sezary syndrome;refractory sezary syndrome;exactmatch
recurrent sezary syndrome;recurrent sezary syndrome;exactmatch
refractory giant cell glioblastoma;refractory giant cell glioblastoma;exactmatch
refractory renal pelvis urothelial carcinoma;refractory renal pelvis urothelial carcinoma;exactmatch
refractory urethral urothelial carcinoma;refractory urethral urothelial carcinoma;exactmatch
locally advanced lymphoma;locally advanced lymphoma;exactmatch
refractory male reproductive system carcinoma;refractory male reproductive system carcinoma;exactmatch
myxoid pleomorphic liposarcoma;myxoid pleomorphic liposarcoma;exactmatch
atypical lipomatous tumor/well differentiated liposarcoma of deep soft tissue;alt/wdlps of deep soft tissue;exactmatch
superficial atypical lipomatous tumor/well differentiated liposarcoma;superficial alt/wdlps;exactmatch
lipoma-like atypical lipomatous tumor/well differentiated liposarcoma;lipoma-like alt/wdlps;exactmatch
pax/foxo1 fusion gene;pax family/foxo1 fusion gene;exactmatch
acute lymphoblastic leukemia, susceptibility to, 3;all 3;exactmatch
melanoma-astrocytoma syndrome;melanoma neural system tumor syndrome;exactmatch
subcellular process;cell process;exactmatch
refractory penile carcinoma;refractory penile carcinoma;exactmatch
advanced intrahepatic cholangiocarcinoma;advanced intrahepatic cholangiocarcinoma;exactmatch
ewsr1-smad3positive fibroblastic tumor;ewsr1-smad3-rearranged fibroblastic tumor;exactmatch
superficial cd34-positive fibroblastic tumor;scd34ft;exactmatch
angiofibroma of soft tissue;angiofibroma of soft tissue;exactmatch
"t(5;8)(p15;q13)";"t(5;8)(p15;q13)";exactmatch
del(9p21);del(9p21);exactmatch
del(11p15.5);del(11p15.5);exactmatch
organogenesis;organogenesis;exactmatch
ligand binding protein;binding protein;exactmatch
ewsr1/smad3 fusion gene;ews rna-binding protein 1-mothers against decapentaplegic homolog 3 fusion gene;exactmatch
refractory rectal squamous cell carcinoma;refractory rectal squamous cell carcinoma;exactmatch
fn1/egf fusion gene;fn1-egf fusion gene;exactmatch
cdh11/usp6 fusion gene;cdh11-tre17 fusion gene;exactmatch
col1a1/usp6 fusion gene;col1a1-usp6 fusion gene;exactmatch
unresectable lung carcinoid tumor;unresectable lung carcinoid tumor;exactmatch
advanced lung carcinoid tumor;advanced lung carcinoid tumor;exactmatch
metastatic lung carcinoid tumor;metastatic lung carcinoid tumor;exactmatch
metastatic nasopharyngeal nonkeratinizing carcinoma;metastatic nasopharyngeal nonkeratinizing carcinoma;exactmatch
refractory esophageal adenocarcinoma;refractory esophageal adenocarcinoma;exactmatch
unresectable glioblastoma;unresectable glioblastoma;exactmatch
senescence;senescence;exactmatch
tp53-associated li-fraumeni syndrome;li-fraumeni syndrome, tp53-associated;exactmatch
advanced malignant small intestinal neoplasm;advanced malignant small intestinal neoplasm;exactmatch
metastatic malignant small intestinal neoplasm;metastatic malignant small intestinal neoplasm;exactmatch
germline mutation;germline mutation;exactmatch
growth factor receptor;growth factor receptor;exactmatch
antigen presentation;antigen presentation;exactmatch
cdh1-associated breast carcinoma syndrome;cdh1-associated breast cancer syndrome;exactmatch
receptor tyrosine kinase;ec 2.7.10.1;exactmatch
female breast carcinoma in situ;female breast carcinoma in situ;exactmatch
refractory breast implant-associated anaplastic large cell lymphoma;refractory breast implant-associated anaplastic large cell lymphoma;exactmatch
invasive female breast carcinoma;invasive female breast carcinoma;exactmatch
localized sarcoma;localized sarcoma;exactmatch
locally recurrent disease;locally recurrent disease;exactmatch
localized prostate carcinoma;localized prostate carcinoma;exactmatch
vulvar angiosarcoma;vulvar angiosarcoma;exactmatch
unresectable nasal cavity squamous cell carcinoma;unresectable nasal cavity squamous cell carcinoma;exactmatch
unresectable sinonasal squamous cell carcinoma;unresectable sinonasal squamous cell carcinoma;exactmatch
recurrent breast implant-associated anaplastic large cell lymphoma;recurrent breast implant-associated anaplastic large cell lymphoma;exactmatch
locally recurrent head and neck squamous cell carcinoma;locally recurrent head and neck squamous cell carcinoma;exactmatch
unresectable glioma;unresectable glioma;exactmatch
locally advanced lung small cell carcinoma;locally advanced lung small cell carcinoma;exactmatch
advanced distal bile duct adenocarcinoma;advanced distal bile duct adenocarcinoma;exactmatch
psammocarcinoma;psammocarcinoma;exactmatch
adenomatous polyposis coli protein;apc;exactmatch
advanced malignant thoracic neoplasm;advanced malignant thoracic neoplasm;exactmatch
metastatic malignant thoracic neoplasm;metastatic malignant thoracic neoplasm;exactmatch
advanced malignant genitourinary system neoplasm;advanced malignant genitourinary system neoplasm;exactmatch
refractory lung non-squamous non-small cell carcinoma;refractory lung non-squamous non-small cell carcinoma;exactmatch
palb2-associated malignant neoplasm;palb2-associated malignant neoplasm;exactmatch
rectal large cell neuroendocrine carcinoma;rectal large cell neuroendocrine carcinoma;exactmatch
locally advanced unresectable primary central chondrosarcoma;locally advanced unresectable primary central chondrosarcoma;exactmatch
advanced lung adenocarcinoma;advanced lung adenocarcinoma;exactmatch
locally advanced lung neuroendocrine neoplasm;locally advanced lung neuroendocrine neoplasm;exactmatch
recurrent lung neuroendocrine neoplasm;recurrent lung neuroendocrine neoplasm;exactmatch
non-functioning lung carcinoid tumor;non-functioning lung carcinoid tumor;exactmatch
functioning lung carcinoid tumor;functioning lung carcinoid tumor;exactmatch
canine sebaceous gland epithelioma;canine sebaceous gland epithelioma;exactmatch
plaque-like dermatofibrosarcoma protuberans;plaque-like dermatofibrosarcoma protuberans;exactmatch
plaque-like lesion;plaque-like lesion;exactmatch
somatic-type malignancy;somatic_malignancy_type;exactmatch
enzyme inhibitor protein;enzyme inhibitor protein;exactmatch
immunoregulation;immunomodulation;exactmatch
gene mutation;dna alteration;exactmatch
chemical carcinogenesis;carcinogenesis, chemical;exactmatch
cell proliferation;cell proliferation;exactmatch
cell growth regulation;cell growth regulation;exactmatch
carcinogenesis;cancer induction;exactmatch
structural protein;structural protein;exactmatch
blast cell proliferation;blast cell proliferation;exactmatch
protein degradation process;protein degradation;exactmatch
somatic mutation;somatic mutation;exactmatch
tyrosine-protein phosphatase non-receptor type 11;ec 3.1.3.48;exactmatch
cdkn2a gene;cdkn2a;exactmatch
ccnd1 gene;ccnd1;exactmatch
t-cell receptor gene;t-cell receptor gene;exactmatch
loss of heterozygosity;loh;exactmatch
megakaryocyte differentiation;megakaryocyte differentiation;exactmatch
myogenesis;myogenesis;exactmatch
proteolysis;protein cleavage;exactmatch
epithelioid myxofibrosarcoma;epithelioid myxofibrosarcoma;exactmatch
intracellular transport;intracellular transport;exactmatch
regression;regressing;exactmatch
molecular interaction process;binding;exactmatch
stable disease;sd;exactmatch
hepatocyte growth factor receptor;c-met;exactmatch
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase pten;ec 3.1.3.16;exactmatch
tert gene;tert;exactmatch
b-cell lymphoma protein 3;b-cell cll/lymphoma 3;exactmatch
homologous recombination;homologous recombination;exactmatch
receptor;receptor;exactmatch
erg gene;erg;exactmatch
tumor initiation;tumor initiation;exactmatch
leukemogenesis;leukemogenesis;exactmatch
rna transport;rna transport;exactmatch
tumorigenesis;oncogenesis;exactmatch
brca2 gene;brca2;exactmatch
receptor mediated endocytosis;rme;exactmatch
histologic grade;grade;exactmatch
lmo2 gene;lim domain only 2 (rhombotin-like 1) gene;exactmatch
brca1 gene;brca1;exactmatch
erbb2 gene;erbb2;exactmatch
gene variant positive;gene mutant positive;exactmatch
sigmoid colon carcinoma;sigmoid colon carcinoma;exactmatch
yap1/tfe3 fusion gene;yap1-tfe3 fusion gene;exactmatch
actb/fosb fusion gene;actb-fosb fusion gene;exactmatch
serpine1/fosb fusion gene;serpine1-fosb fusion gene;exactmatch
cell cycle protein;cell cycle protein;exactmatch
egfr gene;egfr;exactmatch
epithelioid hemangioendothelioma with yap1-tfe3 gene fusion;epithelioid hemangioendothelioma with yap1-tfe3 gene fusion;exactmatch
bcl2 gene;b-cell cll/lymphoma 2 gene;exactmatch
epithelioid hemangioendothelioma with wwtr1-camta1 gene fusion;epithelioid hemangioendothelioma with wwtr1-camta1 gene fusion;exactmatch
"t(7;19)(q22;q13)";"t(7;19)(q22;q13)";exactmatch
bladder flat urothelial carcinoma;bladder flat urothelial carcinoma;exactmatch
disease progression;disease progression;exactmatch
blasts less than 50 percent of bone marrow nucleated cells;blasts less than 50 percent of bone marrow nucleated cells;exactmatch
ahrr/ncoa2 fusion gene;ahrr-ncoa2 fusion gene;exactmatch
ahrr gene;ahrr;exactmatch
expression positive;expressed;exactmatch
elevated expression;elevated expression;exactmatch
decreased expression;decreased expression;exactmatch
maturation;development;exactmatch
immune system process;immune function;exactmatch
carbohydrate metabolic process;carbohydrate metabolic process;exactmatch
angiogenic process;angiogenesis;exactmatch
immune response process;immune response;exactmatch
breast cancer type 2 susceptibility protein;brca1/brca2-containing complex, subunit 2;exactmatch
cell respiration;cell respiration;exactmatch
biological process;biological function;exactmatch
breast cancer type 1 susceptibility protein;brca1;exactmatch
merlin;merlin;exactmatch
cyclin-dependent kinase inhibitor 2a;cdk4 inhibitor;exactmatch
metastatic medulloblastoma;metastatic medulloblastoma;exactmatch
recurrent malignant genitourinary system neoplasm;recurrent malignant genitourinary system neoplasm;exactmatch
advanced salivary gland carcinoma;advanced salivary gland carcinoma;exactmatch
refractory salivary gland carcinoma;refractory salivary gland carcinoma;exactmatch
refractory malignant salivary gland neoplasm;refractory malignant salivary gland neoplasm;exactmatch
invasive male breast carcinoma;invasive male breast carcinoma;exactmatch
male breast carcinoma in situ;male breast carcinoma in situ;exactmatch
synovial chondrosarcoma;synovial chondrosarcoma;exactmatch
unresectable anal canal squamous cell carcinoma;unresectable anal canal squamous cell carcinoma;exactmatch
recurrent acral lentiginous melanoma;recurrent acral lentiginous melanoma;exactmatch
unresectable vaginal carcinoma;unresectable vaginal carcinoma;exactmatch
conjunctival diffuse large b-cell lymphoma;conjunctival diffuse large b-cell lymphoma;exactmatch
conjunctival non-hodgkin lymphoma;conjunctival non-hodgkin lymphoma;exactmatch
conjunctival mucosa-associated lymphoid tissue lymphoma;conjunctival mucosa-associated lymphoid tissue lymphoma;exactmatch
conjunctival follicular lymphoma;conjunctival follicular lymphoma;exactmatch
smad4 gene mutation;dpc4 gene mutation;exactmatch
metastatic anal canal squamous cell carcinoma;metastatic anal canal squamous cell carcinoma;exactmatch
refractory extrahepatic bile duct carcinoma;refractory extrahepatic bile duct carcinoma;exactmatch
locally recurrent anal canal squamous cell carcinoma;locally recurrent anal canal squamous cell carcinoma;exactmatch
advanced rectal adenocarcinoma;advanced rectal adenocarcinoma;exactmatch
recurrent anal canal squamous cell carcinoma;recurrent anal canal squamous cell carcinoma;exactmatch
lacrimal system carcinoma;lacrimal apparatus carcinoma;exactmatch
lacrimal drainage system melanoma;lacrimal drainage system melanoma;exactmatch
lacrimal drainage system lymphoepithelial carcinoma;lacrimal drainage system lymphoepithelial carcinoma;exactmatch
lacrimal drainage system adenoid cystic carcinoma;adenoid cystic carcinoma of the lacrimal drainage system;exactmatch
refractory ampulla of vater carcinoma;refractory ampulla of vater carcinoma;exactmatch
refractory distal bile duct adenocarcinoma;refractory distal bile duct adenocarcinoma;exactmatch
conjunctival myxoma;conjunctival myxoma;exactmatch
lacrimal gland mucosa-associated lymphoid tissue lymphoma;lacrimal gland mucosa-associated lymphoid tissue lymphoma;exactmatch
locally advanced transitional cell carcinoma;locally advanced transitional cell carcinoma;exactmatch
advanced nasopharyngeal carcinoma;advanced nasopharyngeal carcinoma;exactmatch
lacrimal gland follicular lymphoma;lacrimal gland follicular lymphoma;exactmatch
lacrimal drainage system diffuse large b-cell lymphoma;lacrimal drainage system diffuse large b-cell lymphoma;exactmatch
lacrimal gland diffuse large b-cell lymphoma;lacrimal gland diffuse large b-cell lymphoma;exactmatch
lacrimal system diffuse large b-cell lymphoma;lacrimal system diffuse large b-cell lymphoma;exactmatch
lacrimal drainage system mucosa-associated lymphoid tissue lymphoma;lacrimal drainage system mucosa-associated lymphoid tissue lymphoma;exactmatch
lacrimal system mucosa-associated lymphoid tissue lymphoma;lacrimal system mucosa-associated lymphoid tissue lymphoma;exactmatch
primary uveal non-hodgkin lymphoma;primary uveal lymphoma;exactmatch
lacrimal drainage system non-hodgkin lymphoma;lacrimal drainage system lymphoma;exactmatch
lacrimal gland non-hodgkin lymphoma;lacrimal gland lymphoma;exactmatch
lacrimal system non-hodgkin lymphoma;lacrimal system lymphoma;exactmatch
secondary choroidal non-hodgkin lymphoma;secondary choroidal lymphoma;exactmatch
primary iris non-hodgkin lymphoma;primary iris lymphoma;exactmatch
primary ciliary body non-hodgkin lymphoma;primary ciliary body lymphoma;exactmatch
primary choroidal non-hodgkin lymphoma;choroidal reactive lymphoid hyperplasia;exactmatch
lacrimal drainage system mucoepidermoid carcinoma;lacrimal drainage system mucoepidermoid carcinoma;exactmatch
lacrimal drainage system carcinoma;carcinoma of the lacrimal drainage system;exactmatch
lacrimal drainage system adenocarcinoma;adenocarcinoma of the lacrimal drainage system;exactmatch
metastatic malignant neoplasm in the regional lymph nodes;metastatic malignant neoplasm in the regional lymph nodes;exactmatch
lacrimal gland oncocytoma;lacrimal gland oncocytoma;exactmatch
nasolacrimal duct neoplasm;lacrimal duct neoplasm;exactmatch
locally advanced triple-negative breast carcinoma;locally advanced triple-negative breast carcinoma;exactmatch
advanced triple-negative breast carcinoma;advanced triple-negative breast carcinoma;exactmatch
visual pathway medulloepithelioma;medulloepithelioma of the optic disc and optic nerve;exactmatch
visual pathway melanocytoma;optic disc and optic nerve melanocytoma;exactmatch
eye melanocytoma;eye melanocytoma;exactmatch
malignant visual pathway neoplasm;malignant neoplasms of the optic disc and optic nerve;exactmatch
lacrimal drainage system non-keratinizing squamous cell carcinoma;lacrimal drainage system non-keratinizing squamous cell carcinoma;exactmatch
metastatic malignant neoplasm in the visual pathway;metastatic malignant neoplasm in the visual pathway;exactmatch
locally advanced lung adenocarcinoma;locally advanced lung adenocarcinoma;exactmatch
locally advanced lung adenosquamous carcinoma;locally advanced lung adenosquamous carcinoma;exactmatch
refractory transformed marginal zone lymphoma to diffuse large b-cell lymphoma;refractory transformed marginal zone lymphoma to diffuse large b-cell lymphoma;exactmatch
recurrent transformed marginal zone lymphoma to diffuse large b-cell lymphoma;recurrent transformed marginal zone lymphoma to diffuse large b-cell lymphoma;exactmatch
incidental gallbladder carcinoma;igbc;exactmatch
catenin beta-1;beta catenin;exactmatch
lacrimal gland oncocytic adenocarcinoma;lacrimal gland oncocytic adenocarcinoma;exactmatch
lacrimal gland myoepithelioma;lacrimal gland myoepithelioma;exactmatch
lacrimal gland myoepithelial carcinoma;lacrimal gland myoepithelial carcinoma;exactmatch
lacrimal gland carcinosarcoma;lacrimal gland carcinosarcoma;exactmatch
lacrimal drainage system inverted papilloma;inverted papilloma of the lacrimal drainage system;exactmatch
lacrimal drainage system exophytic papilloma;exophytic papilloma of the lacrimal drainage system;exactmatch
metastatic malignant neoplasm in the lacrimal drainage system;metastatic malignant neoplasm in the lacrimal drainage system;exactmatch
metastatic malignant neoplasm in the lacrimal gland;metastatic malignant neoplasm in the lacrimal gland;exactmatch
metastatic malignant neoplasm in the lacrimal system;metastatic malignant neoplasm in the lacrimal apparatus;exactmatch
malignant lacrimal drainage system neoplasm;malignant lacrimal drainage system neoplasm;exactmatch
benign lacrimal drainage system neoplasm;benign lacrimal drainage system neoplasm;exactmatch
lacrimal drainage system neoplasm;lacrimal drainage system neoplasm;exactmatch
lacrimal drainage system;lacrimal drainage system;exactmatch
malignant lacrimal system neoplasm;malignant lacrimal apparatus neoplasm;exactmatch
benign lacrimal system neoplasm;benign lacrimal apparatus neoplasm;exactmatch
unresectable malignant gastric neoplasm;unresectable malignant gastric neoplasm;exactmatch
lacrimal gland warthin tumor;lacrimal gland warthin tumor;exactmatch
lacrimal gland acinic cell carcinoma;lacrimal gland acinic cell carcinoma;exactmatch
lacrimal gland epithelialmyoepithelial carcinoma;lacrimal gland epithelialmyoepithelial carcinoma;exactmatch
conjunctival stromal tumor;conjunctival stromal tumor;exactmatch
solitary fibrous tumor/hemangiopericytoma of the optic nerve sheath;solitary fibrous tumor/hemangiopericytoma of the optic nerve sheath;exactmatch
recurrent low grade astrocytoma;recurrent low grade astrocytic tumor;exactmatch
recurrent epithelioid mesothelioma;recurrent epithelioid mesothelioma;exactmatch
breast ductal carcinoma in situ, comedo type;breast ductal carcinoma in situ, comedo type;exactmatch
foxo1 gene rearrangement;fkh1 gene rearrangement;exactmatch
marked distention of terminal duct lobular units present;marked distention of terminal duct lobular units present;exactmatch
malignant cells with uniform nuclei present;malignant cells with uniform nuclei present;exactmatch
breast florid lobular carcinoma in situ;breast florid lobular carcinoma in situ;exactmatch
breast classic lobular carcinoma in situ;breast classic lcis;exactmatch
unresectable abdominal neuroendocrine neoplasm;unresectable abdominal neuroendocrine neoplasm;exactmatch
advanced epithelioid mesothelioma;advanced epithelioid mesothelioma;exactmatch
encapsulated breast papillary carcinoma with invasion;encapsulated breast papillary carcinoma with invasion;exactmatch
locally advanced pleural malignant mesothelioma;locally advanced pleural malignant mesothelioma;exactmatch
locally advanced malignant mesothelioma;locally advanced malignant mesothelioma;exactmatch
metastatic malignant neoplasm in the supraclavicular lymph nodes;metastatic malignant neoplasm in the supraclavicular lymph nodes;exactmatch
tumor mass of the extremity;tumor mass of the extremity;exactmatch
cyclin-dependent kinase inhibitor 1c;beckwith-wiedemann syndrome protein;exactmatch
rac-alpha serine/threonine kinase;akt1;exactmatch
locally invasive lesion;locally invasive lesion;exactmatch
encapsulated breast papillary carcinoma;breast intracystic papillary carcinoma;exactmatch
breast solid papillary carcinoma in situ;breast solid papillary carcinoma in situ;exactmatch
conjunctival hemangioma;conjunctival hemangioma;exactmatch
breast nodular fasciitis;breast nodular fasciitis;exactmatch
breast neurofibroma;breast neurofibroma;exactmatch
breast schwannoma;breast schwannoma;exactmatch
experimental organism malignant pituicytoma;experimental organism malignant pituicytoma;exactmatch
experimental organism amphophilic vacuolar adenoma;adenoma, amphophilic vacuolar;exactmatch
experimental organism amphophilic vacuolar carcinoma;carcinoma, amphophilic vacuolar;exactmatch
experimental organism benign mesovarial leiomyoma;experimental organism benign mesovarial leiomyoma;exactmatch
breast angiolipoma;breast angiolipoma;exactmatch
primary breast angiosarcoma;primary angiosarcoma of the breast;exactmatch
invasive breast solid papillary carcinoma;breast solid papillary carcinoma with invasion;exactmatch
devil facial tumor disease 2;dft2;exactmatch
devil facial tumor disease 1;dft1;exactmatch
tumor progression;progression;exactmatch
breast cellular fibroadenoma;breast cellular fibroadenoma;exactmatch
ocular surface squamous neoplasia;conjunctival squamous neoplasia;exactmatch
unresectable biliary tract carcinoma;unresectable biliary tract carcinoma;exactmatch
intraductal cellular proliferation;intraductal cellular proliferation;exactmatch
refractory desmoid fibromatosis;refractory desmoid fibromatosis;exactmatch
apc gene;apc;exactmatch
locally advanced adenoid cystic carcinoma;locally advanced adenoid cystic carcinoma;exactmatch
locally advanced thyroid gland hurthle cell carcinoma;locally advanced thyroid gland hurthle cell carcinoma;exactmatch
metastatic primary malignant brain neoplasm;metastatic primary malignant brain neoplasm;exactmatch
advanced primary malignant brain neoplasm;advanced primary malignant brain neoplasm;exactmatch
advanced malignant digestive system neoplasm;advanced malignant digestive system neoplasm;exactmatch
transcriptional activation;gene activation;exactmatch
malignant hypothalamic neoplasm;malignant hypothalamic neoplasm;exactmatch
unresectable small intestinal adenocarcinoma;unresectable small intestinal adenocarcinoma;exactmatch
locally advanced small intestinal adenocarcinoma;locally advanced small intestinal adenocarcinoma;exactmatch
locally advanced distal bile duct carcinoma;locally advanced distal bile duct carcinoma;exactmatch
refractory adenoid cystic carcinoma;refractory adenoid cystic carcinoma;exactmatch
resectable leiomyosarcoma;resectable leiomyosarcoma;exactmatch
metastatic distal bile duct carcinoma;metastatic distal bile duct carcinoma;exactmatch
conjunctival sarcoma;conjunctival sarcoma;exactmatch
conjunctival rhabdomyosarcoma;conjunctival rhabdomyosarcoma;exactmatch
conjunctival leiomyosarcoma;conjunctival leiomyosarcoma;exactmatch
conjunctival angiosarcoma;conjunctival angiosarcoma;exactmatch
conjunctival lymphangioma;conjunctival lymphangioma;exactmatch
apoptosis;apoptosis;exactmatch
breast neuroendocrine carcinoma;breast neuroendocrine carcinoma;exactmatch
breast carcinoma with neuroendocrine differentiation;breast adenocarcinoma with neuroendocrine differentiation;exactmatch
recurrent breast adenocarcinoma;recurrent breast adenocarcinoma;exactmatch
locally invasive desmoid-type fibromatosis;locally invasive desmoid-type fibromatosis;exactmatch
locally advanced osteosarcoma;locally advanced osteosarcoma;exactmatch
refractory malignant glomus tumor;refractory malignant glomus tumor;exactmatch
locally advanced malignant glomus tumor;locally advanced malignant glomus tumor;exactmatch
metastatic malignant glomus tumor;metastatic malignant glomus tumor;exactmatch
unresectable malignant glomus tumor;unresectable malignant glomus tumor;exactmatch
breast neuroendocrine tumor g2;breast neuroendocrine tumor g2;exactmatch
breast neuroendocrine tumor;breast neuroendocrine tumor;exactmatch
breast tall cell carcinoma with reversed polarity;breast tall cell carcinoma with reversed polarity;exactmatch
tall columnar adenocarcinoma cell with reversed polarity;tall columnar adenocarcinoma cell with reversed polarity;exactmatch
breast polymorphous adenocarcinoma;breast pma;exactmatch
metastatic endometrial mixed cell adenocarcinoma;metastatic endometrial mixed cell adenocarcinoma;exactmatch
recurrent endometrial adenosquamous carcinoma;recurrent endometrial adenosquamous carcinoma;exactmatch
metastatic endometrial adenosquamous carcinoma;metastatic endometrial adenosquamous carcinoma;exactmatch
metastatic endometrial clear cell adenocarcinoma;metastatic endometrial clear cell adenocarcinoma;exactmatch
cdh1 gene;cdh1;exactmatch
cdk4 gene;cdk4;exactmatch
ext1 gene;ext1;exactmatch
tumor cell invasion;invasion;exactmatch
nuclear receptor coactivator gene;nuclear receptor coactivator gene;exactmatch
serine/threonine phosphorylation;serine/threonine phosphorylation;exactmatch
transcription coactivator gene;transcription coactivator gene;exactmatch
mediator complex component gene;mediator complex component gene;exactmatch
mismatch repair;dna mismatch repair;exactmatch
biochemical pathway;biochemical pathway;exactmatch
melanogenesis;melanogenesis;exactmatch
dephosphorylation;dephosphorylation;exactmatch
transcription repressor/corepressor gene;transcription corepressor gene;exactmatch
hmga2 gene;hmga2;exactmatch
hmga1 gene;hmga1;exactmatch
hmga family gene;hmga family gene;exactmatch
hmg family gene;hmg family gene;exactmatch
tfiid subunit gene;tfiid subunit gene;exactmatch
tbp-associated factor gene;tbp-associated factor gene;exactmatch
cell maintenance;cell growth and maintenance;exactmatch
ncoa2 gene;ncoa2;exactmatch
nuclear receptor gene;nuclear receptor gene;exactmatch
adenosine triphosphate;adenosine triphosphate;exactmatch
microfilament gene;microfilament gene;exactmatch
nup98 gene;nup98;exactmatch
nucleoporin gene;nucleoporin gene;exactmatch
cytoskeletal modeling;cytoskeletal modeling;exactmatch
bap1 gene;bap1;exactmatch
metastasis suppression;metastasis suppression;exactmatch
cell proliferation regulatory process;cell proliferation regulation;exactmatch
regulation of cell shape;regulation of cell shape;exactmatch
cytoskeletal gene;cytoskeletal gene;exactmatch
transcription coregulator gene;transcription coactivator/corepressor gene;exactmatch
structural protein gene;structural gene;exactmatch
fgfr4 gene;fgfr4;exactmatch
tumor cell mobility;tumor cell mobility;exactmatch
lipid binding;lipid binding;exactmatch
rna binding;rna binding;exactmatch
protein phosphatase gene;protein phosphatase gene;exactmatch
receptor tyrosine kinase gene;receptor tyrosine kinase gene;exactmatch
cellular process;cell function;exactmatch
apoptosis regulation gene;apoptosis regulation gene;exactmatch
helicase;helicase;exactmatch
protein, organized by location;protein, organized by location;exactmatch
ligand binding;ligand binding;exactmatch
skeletal development;skeletal development;exactmatch
phosphoprotein phosphatase;phosphoprotein phosphatase;exactmatch
protein family;protein family;exactmatch
receptor gene;receptor gene;exactmatch
cdkn1b gene;cdkn1b;exactmatch
diagnostic or prognostic factor;diagnostic or prognostic factor;exactmatch
protein, organized by structure;protein, organized by structure;exactmatch
transcription factor gene;proto-oncogene, transcription factor;exactmatch
protein, organized by function;protein, organized by function;exactmatch
sensory process;sensory process;exactmatch
organismal process;organism-level process;exactmatch
cancer progression;cancer disease progression;exactmatch
biophysical process;biophysical process;exactmatch
pattern formation;pattern formation;exactmatch
myeloproliferation;myeloproliferation;exactmatch
regulation of proteolysis;proteolytic regulation;exactmatch
transcription initiation;initiation;exactmatch
peptide metabolism;peptide metabolism;exactmatch
subcellular protein targeting;intracellular protein transport;exactmatch
bcl-2 gene family;bcl-2 gene family;exactmatch
birc3 gene;birc3;exactmatch
m phase process;m phase;exactmatch
apoptosis inhibitor gene;apoptosis inhibitor gene;exactmatch
telomere maintenance gene;telomere maintenance gene;exactmatch
base excision repair;ber;exactmatch
regulatory gene;regulatory gene;exactmatch
cell-matrix adhesion process;cell attachment;exactmatch
property or attribute;property or attribute;exactmatch
protein complex subunit;protein complex subunit;exactmatch
conceptual entity;conceptual entity;exactmatch
rna interference;post-transcriptional gene silencing;exactmatch
telomere maintenance;telomere maintenance;exactmatch
inflammatory response;inflammation process;exactmatch
positive regulation of apoptosis;apoptosis induction;exactmatch
stimulation of cell proliferation;mitogenesis;exactmatch
adipogenesis;adipogenesis;exactmatch
limb development;limb development;exactmatch
enzyme gene;enzyme gene;exactmatch
bmpr1a gene;bmpr1a;exactmatch
bone morphogenetic protein receptor gene;bone morphogenetic protein receptor gene;exactmatch
receptor serine/threonine kinase gene;receptor serine/threonine kinase gene;exactmatch
growth factor gene;growth factor gene;exactmatch
ezh2 gene;ezh2;exactmatch
ligand binding protein gene;ligand binding protein gene;exactmatch
lyase gene;lyase gene;exactmatch
metallopeptidase gene;metallopeptidase gene;exactmatch
dna mismatch repair protein msh2;dna mismatch repair protein msh2;exactmatch
translation process gene;translation process gene;exactmatch
pik3ca gene;pik3ca;exactmatch
calcium binding;calcium binding;exactmatch
intermediary metabolic process;intermediary metabolic process;exactmatch
tumor-associated process;tumor process;exactmatch
tumor expansion;tumor expansion;exactmatch
npm1 gene;npm1;exactmatch
dna mismatch repair protein mlh1;coca2;exactmatch
3'-5' exonuclease;3'-5' exonuclease;exactmatch
cell cycle gene;cell cycle gene;exactmatch
mouse lymphoma;mouse lymphoma;exactmatch
mouse squamous cell carcinoma;mouse squamous cell carcinoma;exactmatch
mouse carcinoid tumor;mouse carcinoid tumor;exactmatch
mouse malignant mixed mesodermal tumor;carcinosarcoma of the mouse;exactmatch
mouse mixed mesodermal tumor;mouse mixed mesodermal tumor;exactmatch
mouse giant cell neoplasm;mouse giant cell neoplasm;exactmatch
mouse leukemia;mouse leukemia;exactmatch
mouse sarcoma;mouse sarcoma;exactmatch
mouse lobular neoplasm;mouse lobular neoplasm;exactmatch
cytokine gene;cytokine gene;exactmatch
mouse neuroglia neoplasm;mouse neuroglia neoplasm;exactmatch
microanatomic structure;microanatomic structure;exactmatch
g protein-coupled receptor signaling;g protein coupled receptor signaling;exactmatch
calcium signaling;calcium ion signaling;exactmatch
neuronal transmission;nerve impulse transmission;exactmatch
rara gene;rara;exactmatch
deubiquitination;deubiquitinating;exactmatch
protein or riboprotein complex;protein or riboprotein complex;exactmatch
reproductive process;reproductive process;exactmatch
aging-related process;aging process;exactmatch
protein dephosphorylation;dephosphorylation;exactmatch
dna replication proofreading;dna proofreading;exactmatch
coagulation process;blood coagulation;exactmatch
cell death signaling process;cell death signaling;exactmatch
intracellular signaling process;cell communication process;exactmatch
protein methylation;methylation;exactmatch
glycosylation;glycosylation;exactmatch
suppression of cancer cell invasion;suppression of cancer cell invasion;exactmatch
cd44 gene;cd44;exactmatch
dna repair protein;dna repair protein;exactmatch
cell adhesion molecule gene;cell adhesion molecule gene;exactmatch
ctnnb1 gene;ctnnb1;exactmatch
tumor suppressor protein;tumor suppressor protein;exactmatch
gtp binding;gtp binding;exactmatch
iap family gene;iap family gene;exactmatch
g protein-coupled receptor gene;g protein coupled receptor gene;exactmatch
signaling pathway gene;proto-oncogene, signaling factor;exactmatch
gene expression process;gene expression process;exactmatch
gene regulation process;gene expression alteration;exactmatch
protein turnover;protein degradation;exactmatch
cell stress process;cell stress process;exactmatch
developmental process;developmental process;exactmatch
myelopoiesis;myelopoiesis;exactmatch
histogenic process;histiogenic process;exactmatch
multicellular process;multicellular process;exactmatch
cell division process;cell division;exactmatch
cell growth process;cell growth process;exactmatch
cell viability process;cell viability process;exactmatch
replication-associated process;replication process;exactmatch
transport process;molecular transport;exactmatch
nociception;nociception;exactmatch
neurologic process;neurologic process;exactmatch
dna sequence rearrangement;dna sequence rearrangement;exactmatch
dna sequence alteration process;dna sequence alteration;exactmatch
cellular stress response;cellular stress response;exactmatch
cellular stress;cellular stress;exactmatch
transmembrane transport;membrane transport;exactmatch
stress response signaling;stress response signaling;exactmatch
ext2 gene;ext2;exactmatch
transcription coactivator;transcription activator;exactmatch
fibroblast growth factor gene family;fgf;exactmatch
ntrk1 gene;ntrk1;exactmatch
ras superfamily protein;ras superfamily protein;exactmatch
myc family gene;myc family gene;exactmatch
fgf4 gene;fgf4;exactmatch
gli family gene;gli family gene;exactmatch
transcription repressor/corepressor;repressor;exactmatch
fhit gene;fhit;exactmatch
runx1 gene;aml1;exactmatch
etv6/runx1 fusion gene;aml1/tel fusion gene;exactmatch
signaling protein;signaling pathway protein;exactmatch
erbb receptor family protein;egf receptor family;exactmatch
tyrosine phosphorylation;tyrosine phosphorylation;exactmatch
protein phosphorylation process;phosphorylation;exactmatch
cyclin-dependent kinase inhibitor protein;cdk inhibitor protein;exactmatch
mlh1 gene;mlh1;exactmatch
ccdc6/ret fusion gene;ccdc6-ret fusion gene;exactmatch
pttg1 gene;pttg1;exactmatch
negative regulation of cell cycle;cell cycle arrest;exactmatch
kit gene;kit;exactmatch
cell cycle checkpoint;cell cycle checkpoint;exactmatch
carcinogenesis, radiation;carcinogenesis, radiation;exactmatch
physical carcinogenesis;carcinogenesis, physical;exactmatch
carcinogenesis mechanism;carcinogenesis mechanism;exactmatch
biological carcinogenesis;biological carcinogenesis;exactmatch
cancer biology;biology of cancer;exactmatch
metabolic pathway;metabolic pathway;exactmatch
protein patched homolog 1;ptc;exactmatch
securin;eap1;exactmatch
dna binding;dna binding;exactmatch
cyclin-dependent kinase inhibitor gene;cdk inhibitor gene;exactmatch
pms2 gene;pms2;exactmatch
pms1 gene;mlh2;exactmatch
kmt2a gene;kmt2a;exactmatch
cbfb gene;cbfb;exactmatch
atm gene;atm;exactmatch
msh2 gene;msh2;exactmatch
protein-protein interaction;protein-protein interaction;exactmatch
regulatory protein;regulatory protein;exactmatch
vhl gene;vhl;exactmatch
etv6 gene;ets variant 6 gene;exactmatch
dna maintenance;dna maintenance;exactmatch
x-ray cross complementing group;x-ray cross complementing family gene;exactmatch
pdgfb gene;pdgfb;exactmatch
small g protein;small g protein;exactmatch
pathogenesis;pathogenesis;exactmatch
wt1 gene;wt1;exactmatch
tsc2 gene;tsc2;exactmatch
bcr gene;bcr;exactmatch
tsc1 gene;tsc1;exactmatch
smad4 gene;smad family member 4 gene;exactmatch
ret gene;ret;exactmatch
pten gene;pten;exactmatch
ptch1 gene;ptch1;exactmatch
men1 gene;men1;exactmatch
stk11 gene;lkb1;exactmatch
fli1 gene;fli1;exactmatch
ewsr1 gene;ews rna-binding protein 1 gene;exactmatch
met gene;met;exactmatch
ets family gene;ets family gene;exactmatch
g protein gene;g protein gene;exactmatch
irf4 gene;irf4;exactmatch
fosl1 gene;fos-like antigen 1 gene;exactmatch
fgf6 gene;fgf6;exactmatch
mybl1 gene;myb proto-oncogene like 1 gene;exactmatch
mycn gene;mycn;exactmatch
smarcb1 gene;smarcb1;exactmatch
mecom gene;evi1;exactmatch
cdkn1c gene;cdkn1c;exactmatch
braf gene;b-raf proto-oncogene, serine/threonine kinase gene;exactmatch
bcl3 gene;b-cell cll/lymphoma 3 gene;exactmatch
akt2 gene;akt serine/threonine kinase 2 gene;exactmatch
akt1 gene;akt1;exactmatch
mdm2 gene;mdm2;exactmatch
disease marker;disease marker;exactmatch
experimental tumor;experimental tumor;exactmatch
host defense mechanism;host defense;exactmatch
heparan sulfate biosynthesis;heparan sulfate biosynthesis;exactmatch
leukocyte trafficking;leukocyte trafficking;exactmatch
tumor oxygenation;tumor oxygenation;exactmatch
cancer gene;cancer gene;exactmatch
metabolic process;metabolic;exactmatch
recombination repair;homologous recombination repair;exactmatch
fos gene;fos;exactmatch
document;document;exactmatch
environmental and occupational exposure;environmental and occupational exposure;exactmatch
malignant conversion;malignant conversion;exactmatch
cell cycle regulation process;cell cycle control;exactmatch
mammary tumorigenesis;mammary tumorigenesis;exactmatch
hepatocarcinogenesis;hepatocarcinogenesis;exactmatch
metal ion binding;metal ion binding;exactmatch
g1/s transition checkpoint;g1-s restriction point;exactmatch
nucleocytoplasmic transport;nucleocytoplasmic shuttling;exactmatch
docking;docking;exactmatch
protein metabolism process;protein metabolism;exactmatch
cell ontogeny;cell ontogeny;exactmatch
double strand break repair;double strand break repair;exactmatch
mrna expression;expressed;exactmatch
mediator complex;mediator;exactmatch
atp hydrolysis;atp hydrolysis;exactmatch
negative regulation of apoptosis;apoptosis inhibition;exactmatch
fibroblast growth factor receptor family gene;fgf receptor family gene;exactmatch
fgfr1 gene;fgfr1;exactmatch
post-translational regulation;post-translational regulation;exactmatch
biochemical reaction;biochemical reaction;exactmatch
swi/snf-related gene;swi/snf-related gene;exactmatch
negative regulation of g1 phase;g1 arrest;exactmatch
brca1 gene mutation;brca1 gene mutation;exactmatch
chromatin remodeling;chromatin remodeling;exactmatch
regulatory pathway;regulatory pathway;exactmatch
clonal evolution;clonal evolution;exactmatch
dna repair gene;dna repair gene;exactmatch
angiogenic switch;angiogenic switch;exactmatch
cell-cell adhesion process;cell-cell adhesion process;exactmatch
brca2 gene mutation;brca2 gene mutation;exactmatch
lipid metabolic process;lipid metabolic process;exactmatch
nucleotide metabolic process;metabolism, purines/pyrimidines/nucleotides/nucleic acids;exactmatch
cancer cell growth regulation;cancer cell growth regulation;exactmatch
skin carcinogenesis;skin carcinogenesis;exactmatch
pharmacologic substance;agent;exactmatch
drug, food, chemical or biomedical material;drug, food, chemical or biomedical material;exactmatch
transcriptional regulation;transcription regulation;exactmatch
thymic t-cell selection;thymic t-cell selection;exactmatch
t-cell receptor activation;t-cell receptor activation;exactmatch
t-cell differentiation;t-cell development;exactmatch
t-cell activation;t-cell activation;exactmatch
rna-protein interaction;rna-protein interaction;exactmatch
cancer cell growth;cancer cell growth;exactmatch
rna synthesis;rna synthesis;exactmatch
receptor signaling;receptor signaling;exactmatch
physiology-regulatory factor;physiology-regulatory factor;exactmatch
protein kinase protein phosphorylation;protein kinase protein phosphorylation;exactmatch
protein expression;expressed;exactmatch
protein-carbohydrate interaction;protein-carbohydrate interaction;exactmatch
post-transcriptional regulation;post-transcriptional control;exactmatch
tumor promotion;tumor promotion;exactmatch
drug or chemical by structure;drug or chemical by structure;exactmatch
environment-to-cell communication;environment to cell communication and signaling;exactmatch
in vitro model;in vitro model;exactmatch
b-lymphoma development;b-lymphoma development;exactmatch
b cell proliferation;b cell proliferation;exactmatch
neural development;neural development;exactmatch
tumor angiogenesis;tumor angiogenesis;exactmatch
ubiquitination;protein ubiquitination;exactmatch
metabolic control;metabolic control;exactmatch
rna processing;rna metabolism: processing and transport;exactmatch
t-cell differentiation in the thymus;t-cell differentiation in the thymus;exactmatch
deletion mutation;deletion;exactmatch
signaling molecule;signaling molecule;exactmatch
b-cell activation;b-cell activation;exactmatch
msh6 gene;msh6;exactmatch
occupation or discipline;occupation or discipline;exactmatch
macromolecular sequence alteration process;macromolecular sequence alteration process;exactmatch
metastasis;metastasis;exactmatch
serine/threonine-protein kinase b-raf;94 kda b-raf protein;exactmatch
rous sarcoma;rous sarcoma;exactmatch
mouse small cell undifferentiated carcinoma;mouse small cell undifferentiated carcinoma;exactmatch
refractory grade 2 follicular lymphoma;refractory grade 2 follicular lymphoma;exactmatch
advanced follicular lymphoma;advanced follicular lymphoma;exactmatch
locally advanced esophageal squamous cell carcinoma;locally advanced esophageal squamous cell carcinoma;exactmatch
herpesvirus infection;herpesvirus infection;exactmatch
recurrent grade 3b follicular lymphoma;recurrent grade 3b follicular lymphoma;exactmatch
refractory grade 3b follicular lymphoma;refractory grade 3b follicular lymphoma;exactmatch
refractory grade 3a follicular lymphoma;refractory grade 3a follicular lymphoma;exactmatch
refractory grade 3 follicular lymphoma;refractory grade 3 follicular lymphoma;exactmatch
refractory grade 1 follicular lymphoma;refractory grade 1 follicular lymphoma;exactmatch
advanced transformed non-hodgkin lymphoma;advanced transformed non-hodgkin lymphoma;exactmatch
recurrent plasma cell neoplasm;recurrent plasma cell neoplasm;exactmatch
refractory chronic lymphocytic leukemia/small lymphocytic lymphoma;refractory chronic lymphocytic leukemia/small lymphocytic lymphoma;exactmatch
refractory myeloid neoplasm;refractory myeloid neoplasm;exactmatch
refractory malignant lymphoid neoplasm;refractory malignant lymphoid neoplasm;exactmatch
advanced renal pelvis urothelial carcinoma;advanced renal pelvis urothelial carcinoma;exactmatch
locally advanced renal pelvis carcinoma;locally advanced renal pelvis carcinoma;exactmatch
advanced renal pelvis and ureter urothelial carcinoma;advanced renal pelvis and ureter urothelial carcinoma;exactmatch
advanced marginal zone lymphoma;advanced marginal zone lymphoma;exactmatch
advanced basal cell carcinoma;advanced basal cell carcinoma;exactmatch
metastatic distal esophagus adenocarcinoma;metastatic distal esophagus adenocarcinoma;exactmatch
advanced kidney medullary carcinoma;advanced kidney medullary carcinoma;exactmatch
refractory acute leukemia of ambiguous lineage;refractory acute leukemia of ambiguous lineage;exactmatch
recurrent acute leukemia of ambiguous lineage;recurrent acute leukemia of ambiguous lineage;exactmatch
epithelioid malignant peripheral nerve sheath tumor of the skin;cutaneous epithelioid malignant peripheral nerve sheath tumor;exactmatch
malignant peripheral nerve sheath tumor of the skin;cutaneous malignant peripheral nerve sheath tumor;exactmatch
refractory kidney carcinoma;refractory kidney carcinoma;exactmatch
recurrent kidney carcinoma;recurrent kidney carcinoma;exactmatch
cutaneous perineurioma;cutaneous perineurioma;exactmatch
locally advanced kidney carcinoma;locally advanced kidney carcinoma;exactmatch
apc promoter 1b variant;apc gene promoter 1b variant;exactmatch
advanced kidney carcinoma;advanced kidney carcinoma;exactmatch
wound repair;wound healing;exactmatch
advanced uterine corpus cancer;advanced uterine corpus cancer;exactmatch
advanced primary cutaneous t-cell non-hodgkin lymphoma;advanced primary cutaneous t-cell non-hodgkin lymphoma;exactmatch
advanced hodgkin lymphoma;advanced hodgkin lymphoma;exactmatch
advanced non-hodgkin lymphoma;advanced non-hodgkin lymphoma;exactmatch
germline apc promoter 1b variant;apc promoter 1b germline variant;exactmatch
metastatic intrahepatic cholangiocarcinoma;metastatic intrahepatic cholangiocarcinoma;exactmatch
unresectable distal esophagus adenocarcinoma;unresectable distal esophagus adenocarcinoma;exactmatch
g protein;g protein;exactmatch
unresectable prostate carcinoma;unresectable prostate carcinoma;exactmatch
transformation;cell transformation;exactmatch
transferase;ec 2;exactmatch
advanced transitional cell carcinoma;advanced transitional cell carcinoma;exactmatch
transcription;gene transcription;exactmatch
rearrangement of 12p13.2;12p13.2 rearrangement;exactmatch
rearrangement of 11p15;11p15 rearrangement;exactmatch
unresectable lung non-small cell squamous carcinoma;unresectable lung non-small cell squamous carcinoma;exactmatch
unresectable endometrial carcinoma;unresectable endometrial carcinoma;exactmatch
acute myeloid leukemia arising from previous myelodysplastic/myeloproliferative neoplasm;acute myeloid leukemia arising from previous myelodysplastic/myeloproliferative neoplasm;exactmatch
spermatogenesis;spermatogenesis;exactmatch
refractory lung non-small cell squamous carcinoma;refractory lung non-small cell squamous carcinoma;exactmatch
unresectable esophageal squamous cell carcinoma;unresectable esophageal squamous cell carcinoma;exactmatch
advanced esophageal squamous cell carcinoma;advanced esophageal squamous cell carcinoma;exactmatch
refractory esophageal squamous cell carcinoma;refractory esophageal squamous cell carcinoma;exactmatch
refractory squamous cell carcinoma;refractory squamous cell carcinoma;exactmatch
refractory esophageal carcinoma;refractory esophageal carcinoma;exactmatch
acute myeloid leukemia arising from previous myeloproliferative neoplasm;acute myeloid leukemia arising from previous myeloproliferative neoplasm;exactmatch
recurrent myeloid neoplasm;recurrent myeloid neoplasm;exactmatch
unresectable uveal melanoma;unresectable uveal melanoma;exactmatch
locally advanced sarcomatoid renal cell carcinoma;locally advanced sarcomatoid renal cell carcinoma;exactmatch
unresectable pancreatic ductal adenocarcinoma;unresectable pancreatic ductal adenocarcinoma;exactmatch
metastatic distal bile duct adenocarcinoma;metastatic distal bile duct adenocarcinoma;exactmatch
unresectable distal bile duct adenocarcinoma;unresectable distal bile duct adenocarcinoma;exactmatch
unresectable ovarian undifferentiated carcinoma;unresectable ovarian undifferentiated carcinoma;exactmatch
metastatic ovarian undifferentiated carcinoma;metastatic ovarian undifferentiated carcinoma;exactmatch
locally advanced esophageal adenocarcinoma;locally advanced esophageal adenocarcinoma;exactmatch
locally advanced unclassified renal cell carcinoma;locally advanced unclassified renal cell carcinoma;exactmatch
locally advanced papillary renal cell carcinoma;locally advanced papillary renal cell carcinoma;exactmatch
recurrent malignant lymphoid neoplasm;recurrent malignant lymphoid neoplasm;exactmatch
partially involuting congenital hemangioma;pich;exactmatch
non-involuting congenital hemangioma;nich;exactmatch
rapidly involuting congenital hemangioma;rich;exactmatch
sinusoidal hemangioma;sinusoidal hemangioma;exactmatch
cutaneous epithelioid angiomatous nodule;cutaneous epithelioid angiomatous nodule;exactmatch
tumor marker;tumor marker;exactmatch
progesterone receptor expressing malignant neoplasm;progesterone receptor expressing malignant neoplasm;exactmatch
skin myxofibrosarcoma;dermal myxofibrosarcoma;exactmatch
skin ewing sarcoma;cutaneous ewing sarcoma;exactmatch
cellular granularity present;cellular granularity present;exactmatch
liver neuroendocrine tumor g1;hepatic neuroendocrine tumor g1;exactmatch
gallbladder neuroendocrine tumor g3;gallbladder neuroendocrine tumor g3;exactmatch
gallbladder adenoma, intestinal-type;gallbladder adenoma, intestinal-type;exactmatch
gallbladder pyloric gland adenoma;gallbladder pyloric gland adenoma;exactmatch
liver small cell neuroendocrine carcinoma;hepatic small cell carcinoma;exactmatch
liver large cell neuroendocrine carcinoma;hepatic large cell neuroendocrine carcinoma;exactmatch
liver neuroendocrine tumor g3;hepatic neuroendocrine tumor g3;exactmatch
liver neuroendocrine tumor g2;hepatic neuroendocrine tumor g2;exactmatch
liver mixed adenoneuroendocrine carcinoma;liver manec;exactmatch
low grade pancreatic intraepithelial neoplasia;low grade panin;exactmatch
small progressed hepatocellular carcinoma;small progressed hepatocellular carcinoma;exactmatch
focus of carcinoma cells measuring equal to or less than 2 cm present;focus of carcinoma cells measuring equal to or less than 2 cm present;exactmatch
small hepatocellular carcinoma;small hcc;exactmatch
neutrophil-rich hepatocellular carcinoma;neutrophil-rich hepatocellular carcinoma;exactmatch
chromophobe hepatocellular carcinoma;chromophobe hepatocellular carcinoma;exactmatch
abrupt nuclear anaplasia;abrupt nuclear anaplasia;exactmatch
macrotrabecular massive hepatocellular carcinoma;mtm-hcc;exactmatch
extrahepatic bile duct neuroendocrine tumor g3;extrahepatic bile duct neuroendocrine tumor g3;exactmatch
low grade biliary intraepithelial neoplasia;low grade bilin;exactmatch
primitive non-neural granular cell tumor;dermal non-neural granular cell tumor;exactmatch
ebv-positive inflammatory follicular dendritic cell sarcoma;ebv-positive inflammatory follicular dendritic cell sarcoma;exactmatch
gallbladder soft tissue neoplasm;gallbladder soft tissue neoplasm;exactmatch
hepatobiliary soft tissue neoplasm;hepatobiliary soft tissue neoplasm;exactmatch
esophageal soft tissue neoplasm;esophageal soft tissue neoplasm;exactmatch
digestive system soft tissue neoplasm;digestive system soft tissue neoplasm;exactmatch
digestive system inflammatory myofibroblastic tumor;digestive system inflammatory myofibroblastic tumor;exactmatch
digestive system diffuse large b-cell lymphoma;digestive system diffuse large b-cell lymphoma;exactmatch
digestive system sarcoma;digestive system sarcoma;exactmatch
conventional follicular dendritic cell sarcoma;conventional follicular dendritic cell sarcoma;exactmatch
unresectable neuroendocrine carcinoma;unresectable neuroendocrine carcinoma;exactmatch
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue involving the digestive system;extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue involving the digestive system;exactmatch
pancreatic neuroendocrine tumor g3;pancreatic neuroendocrine tumor g3;exactmatch
pancreatic invasive micropapillary adenocarcinoma;pancreatic impc;exactmatch
pancreatic undifferentiated carcinoma with rhabdoid cells;pancreatic undifferentiated carcinoma with rhabdoid cells;exactmatch
pancreatic poorly cohesive adenocarcinoma;pancreatic poorly cohesive adenocarcinoma;exactmatch
unresectable large cell neuroendocrine carcinoma;unresectable large cell neuroendocrine carcinoma;exactmatch
unresectable digestive system mixed adenoneuroendocrine carcinoma;unresectable digestive system mixed adenoneuroendocrine carcinoma;exactmatch
steatohepatitic hepatocellular carcinoma;sh-hcc;exactmatch
beta-catenin-activated inflammatory hepatocellular adenoma;beta-catenin-activated inflammatory hepatocellular adenoma;exactmatch
high grade anal intraepithelial neoplasia;high grade anal intraepithelial neoplasia;exactmatch
recurrent salivary gland squamous cell carcinoma;recurrent salivary gland squamous cell carcinoma;exactmatch
gastric neuroendocrine tumor g3;gastric neuroendocrine tumor g3;exactmatch
esophageal neuroendocrine tumor g3;esophageal neuroendocrine tumor g3;exactmatch
digestive system neuroendocrine tumor g3;digestive system neuroendocrine tumor g3;exactmatch
gastroblastoma;gastroblastoma;exactmatch
columnar cells with differentiation to chief cells and parietal cells present;columnar cells with differentiation to chief cells and parietal cells present;exactmatch
oxyntic gland adenoma;oga;exactmatch
unresectable salivary gland squamous cell carcinoma;unresectable salivary gland squamous cell carcinoma;exactmatch
metastatic salivary gland squamous cell carcinoma;metastatic salivary gland squamous cell carcinoma;exactmatch
rectal neuroendocrine tumor g3;rectal neuroendocrine tumor g3;exactmatch
unresectable paranasal sinus squamous cell carcinoma;unresectable paranasal sinus squamous cell carcinoma;exactmatch
unresectable nasopharyngeal squamous cell carcinoma;unresectable nasopharyngeal squamous cell carcinoma;exactmatch
unresectable hypopharyngeal squamous cell carcinoma;unresectable hypopharyngeal squamous cell carcinoma;exactmatch
unresectable laryngeal squamous cell carcinoma;unresectable laryngeal squamous cell carcinoma;exactmatch
unresectable oral cavity squamous cell carcinoma;unresectable oral cavity squamous cell carcinoma;exactmatch
invasive focus of carcinoma cells measuring 1 mm or less present;invasive focus of carcinoma cells measuring 1 mm or less present;exactmatch
bap1 tumor predisposition syndrome;bap1 tumor predisposition syndrome;exactmatch
small intestinal neuroendocrine tumor g3;small intestinal neuroendocrine tumor g3;exactmatch
high grade appendix mucinous neoplasm;hamn;exactmatch
appendix neuroendocrine tumor g3;appendix neuroendocrine tumor g3;exactmatch
ileal neuroendocrine tumor g3;ileal neuroendocrine tumor g3;exactmatch
colon neuroendocrine tumor g3;colon neuroendocrine tumor g3;exactmatch
colorectal neuroendocrine tumor g3;colorectal neuroendocrine tumor g3;exactmatch
inflammatory bowel disease-associated colorectal adenocarcinoma;inflammatory bowel disease-associated colorectal adenocarcinoma;exactmatch
phosphatidylinositol-4,5-bisphosphate 3-kinase;1-phosphatidylinositol 3-kinase;exactmatch
colorectal adenoma-like adenocarcinoma;colorectal adenoma-like adenocarcinoma;exactmatch
colorectal poorly cohesive adenocarcinoma;colorectal poorly cohesive adenocarcinoma;exactmatch
malat1/gli1 fusion gene;malat1-gli1 fusion gene;exactmatch
rectal conventional adenoma;rectal conventional adenoma;exactmatch
colon conventional adenoma;colon conventional adenoma;exactmatch
colorectal conventional adenoma;colorectal conventional adenoma;exactmatch
ampulla of vater neuroendocrine tumor g3;ampulla of vater neuroendocrine tumor g3;exactmatch
duodenal neuroendocrine tumor g3;duodenal neuroendocrine tumor g3;exactmatch
intestinal neuroendocrine tumor g3;intestinal neuroendocrine tumor g3;exactmatch
midgut neuroendocrine tumor g3;midgut neuroendocrine tumor g3;exactmatch
jejunal neuroendocrine tumor g3;jejunal neuroendocrine tumor g3;exactmatch
unresectable colorectal adenocarcinoma;unresectable colorectal adenocarcinoma;exactmatch
metastatic unclassified renal cell carcinoma;metastatic unclassified renal cell carcinoma;exactmatch
advanced unclassified renal cell carcinoma;advanced unclassified renal cell carcinoma;exactmatch
advanced ovarian carcinosarcoma;advanced ovarian carcinosarcoma;exactmatch
metastatic ovarian clear cell adenocarcinoma;metastatic ovarian clear cell adenocarcinoma;exactmatch
metastatic malignant neoplasm in the urinary system;metastatic malignant neoplasm in the urinary system;exactmatch
advanced ovarian endometrioid adenocarcinoma;advanced ovarian endometrioid adenocarcinoma;exactmatch
malignant optic nerve neoplasm;malignant optic nerve neoplasm;exactmatch
malignant fundus neoplasm;malignant fundus neoplasm;exactmatch
metastatic ovarian endometrioid adenocarcinoma;metastatic ovarian endometrioid adenocarcinoma;exactmatch
advanced ovarian serous adenocarcinoma;advanced ovarian serous adenocarcinoma;exactmatch
metastatic ovarian carcinosarcoma;metastatic ovarian carcinosarcoma;exactmatch
locally advanced chondrosarcoma;locally advanced chondrosarcoma;exactmatch
metastatic uterine corpus carcinosarcoma;metastatic uterine corpus carcinosarcoma;exactmatch
advanced malignant mixed mesodermal (mullerian) tumor;advanced malignant mixed mesodermal (mullerian) tumor;exactmatch
metastatic malignant mixed mesodermal (mullerian) tumor;metastatic malignant mixed mesodermal (mullerian) tumor;exactmatch
advanced carcinosarcoma;advanced carcinosarcoma;exactmatch
metastatic carcinosarcoma;metastatic carcinosarcoma;exactmatch
actb/gli1 fusion gene;actb-gli fusion gene;exactmatch
malignant jejunal neoplasm;malignant jejunal neoplasm;exactmatch
advanced ovarian clear cell adenocarcinoma;advanced ovarian clear cell adenocarcinoma;exactmatch
recurrent mucosal melanoma;recurrent mucosal melanoma;exactmatch
unresectable primary peritoneal adenocarcinoma;unresectable primary peritoneal adenocarcinoma;exactmatch
locally advanced thyroid gland carcinoma;locally advanced thyroid gland carcinoma;exactmatch
metastatic primary peritoneal adenocarcinoma;metastatic primary peritoneal adenocarcinoma;exactmatch
refractory fallopian tube adenocarcinoma;refractory fallopian tube adenocarcinoma;exactmatch
unresectable fallopian tube adenocarcinoma;unresectable fallopian tube adenocarcinoma;exactmatch
unresectable fallopian tube carcinoma;unresectable fallopian tube carcinoma;exactmatch
refractory ovarian adenocarcinoma;refractory ovarian adenocarcinoma;exactmatch
advanced malignant germ cell tumor;advanced malignant germ cell tumor;exactmatch
advanced primary malignant central nervous system neoplasm;advanced primary malignant central nervous system neoplasm;exactmatch
resectable malignant female reproductive system neoplasm;resectable malignant female reproductive system neoplasm;exactmatch
platinum-resistant malignant germ cell tumor;platinum-resistant malignant germ cell tumor;exactmatch
resectable adenocarcinoma of unknown primary;resectable adenocarcinoma of unknown primary;exactmatch
resectable carcinoma of unknown primary;resectable carcinoma of unknown primary;exactmatch
advanced carcinoma of unknown primary;advanced carcinoma of unknown primary;exactmatch
advanced adenocarcinoma of unknown primary;advanced adenocarcinoma of unknown primary;exactmatch
advanced platinum-resistant malignant germ cell tumor;advanced platinum-resistant malignant germ cell tumor;exactmatch
metastatic platinum-resistant malignant germ cell tumor;metastatic platinum-resistant malignant germ cell tumor;exactmatch
resectable platinum-resistant malignant germ cell tumor;resectable platinum-resistant malignant germ cell tumor;exactmatch
refractory myeloproliferative neoplasm;refractory myeloproliferative neoplasm;exactmatch
locally advanced colon carcinoma;locally advanced colon carcinoma;exactmatch
"t(7;12)(p21-22;q13-15)";"t(7;12)(p21-22;q13-15)";exactmatch
locally advanced vaginal carcinoma;locally advanced vaginal carcinoma;exactmatch
advanced endometrioid adenocarcinoma;advanced endometrioid adenocarcinoma;exactmatch
metastatic endometrial endometrioid adenocarcinoma;metastatic endometrial endometrioid adenocarcinoma;exactmatch
advanced endometrial adenocarcinoma;advanced endometrial adenocarcinoma;exactmatch
metastatic endometrial serous adenocarcinoma;metastatic endometrial serous adenocarcinoma;exactmatch
advanced penile carcinoma;advanced penile carcinoma;exactmatch
locally advanced penile carcinoma;locally advanced penile carcinoma;exactmatch
advanced vaginal carcinoma;advanced vaginal carcinoma;exactmatch
advanced vulvar carcinoma;advanced vulvar carcinoma;exactmatch
plaque-like cd34-positive dermal fibroma;medallion-like dermal dendrocyte hamartoma;exactmatch
locally advanced vulvar carcinoma;locally advanced vulvar carcinoma;exactmatch
advanced pharyngeal carcinoma;advanced pharyngeal carcinoma;exactmatch
advanced oropharyngeal carcinoma;advanced oropharyngeal carcinoma;exactmatch
locally advanced oropharyngeal carcinoma;locally advanced oropharyngeal carcinoma;exactmatch
advanced rectal squamous cell carcinoma;advanced rectal squamous cell carcinoma;exactmatch
malignant lymphoma, large cell, cleaved and non-cleaved;malignant lymphoma, large cell, cleaved and non-cleaved;exactmatch
locally advanced rectal squamous cell carcinoma;locally advanced rectal squamous cell carcinoma;exactmatch
advanced endometrial serous adenocarcinoma;advanced endometrial serous adenocarcinoma;exactmatch
advanced endometrial endometrioid adenocarcinoma;advanced endometrial endometrioid adenocarcinoma;exactmatch
metastatic malignant skin neoplasm;metastatic malignant skin neoplasm;exactmatch
advanced malignant skin neoplasm;advanced malignant skin neoplasm;exactmatch
dermatomyofibroma;dermatomyofibroma;exactmatch
reproduction;reproduction;exactmatch
rel gene;rel;exactmatch
unresectable thyroid gland anaplastic carcinoma;unresectable thyroid gland anaplastic carcinoma;exactmatch
refractory thyroid gland anaplastic carcinoma;refractory thyroid gland anaplastic carcinoma;exactmatch
metastatic thyroid gland anaplastic carcinoma;metastatic thyroid gland anaplastic carcinoma;exactmatch
recurrent extracranial malignant solid neoplasm;recurrent extracranial malignant solid neoplasm;exactmatch
regeneration;regeneration;exactmatch
unresectable rhabdoid tumor;unresectable rhabdoid tumor;exactmatch
metastatic rhabdoid tumor;metastatic rhabdoid tumor;exactmatch
metastatic desmoplastic small round cell tumor;metastatic desmoplastic small round cell tumor;exactmatch
unresectable desmoplastic small round cell tumor;unresectable desmoplastic small round cell tumor;exactmatch
dna recombination process;dna recombination;exactmatch
refractory malignant mastocytosis;refractory malignant mastocytosis;exactmatch
primary brain neoplasm;primary brain neoplasm;exactmatch
unresectable primary peritoneal carcinoma;unresectable primary peritoneal carcinoma;exactmatch
refractory primary peritoneal adenocarcinoma;refractory primary peritoneal adenocarcinoma;exactmatch
advanced sarcomatoid renal cell carcinoma;advanced sarcomatoid renal cell carcinoma;exactmatch
recurrent ocular melanoma;recurrent ocular melanoma;exactmatch
advanced myxofibrosarcoma;advanced myxofibrosarcoma;exactmatch
indolent t-cell non-hodgkin lymphoma;indolent t-cell non-hodgkin lymphoma;exactmatch
indolent b-cell non-hodgkin lymphoma;indolent b-cell non-hodgkin lymphoma;exactmatch
locally advanced liver carcinoma;locally advanced liver carcinoma;exactmatch
locally advanced non-cutaneous melanoma;locally advanced non-cutaneous melanoma;exactmatch
locally advanced ocular melanoma;locally advanced ocular melanoma;exactmatch
metastatic ocular melanoma;metastatic ocular melanoma;exactmatch
recurrent lung non-small cell squamous carcinoma;recurrent lung non-small cell squamous carcinoma;exactmatch
signaling pathway;signal transduction pathway;exactmatch
locally advanced cutaneous melanoma;locally advanced cutaneous melanoma;exactmatch
locally advanced malignant skin neoplasm;locally advanced malignant skin neoplasm;exactmatch
locally advanced oral cavity carcinoma;locally advanced oral cavity carcinoma;exactmatch
locally advanced hypopharyngeal carcinoma;locally advanced hypopharyngeal carcinoma;exactmatch
oligometastatic prostate carcinoma;oligometastatic prostate carcinoma;exactmatch
advanced diffuse large b-cell lymphoma;advanced diffuse large b-cell lymphoma;exactmatch
refractory extrarenal rhabdoid tumor of the ovary;refractory extrarenal rhabdoid tumor of the ovary;exactmatch
locally advanced fibrosarcoma;locally advanced fibrosarcoma;exactmatch
unresectable bile duct carcinoma;unresectable bile duct carcinoma;exactmatch
colon large cell neuroendocrine carcinoma;colon large cell neuroendocrine carcinoma;exactmatch
endogenous cushing syndrome;endogenous cushing syndrome;exactmatch
metastatic chromophobe renal cell carcinoma;metastatic chromophobe renal cell carcinoma;exactmatch
advanced chromophobe renal cell carcinoma;advanced chromophobe renal cell carcinoma;exactmatch
aggressive variant prostate carcinoma;avpca;exactmatch
refractory cutaneous squamous cell carcinoma of the head and neck;refractory cutaneous squamous cell carcinoma of the head and neck;exactmatch
advanced cutaneous squamous cell carcinoma of the head and neck;advanced cutaneous squamous cell carcinoma of the head and neck;exactmatch
metastatic cutaneous squamous cell carcinoma of the head and neck;metastatic cutaneous squamous cell carcinoma of the head and neck;exactmatch
advanced cutaneous melanoma;advanced cutaneous melanoma;exactmatch
locally advanced synovial sarcoma;locally advanced synovial sarcoma;exactmatch
metastatic ampulla of vater carcinoma;metastatic ampulla of vater carcinoma;exactmatch
refractory primary myelofibrosis;refractory primary myelofibrosis;exactmatch
refractory myelodysplastic/myeloproliferative neoplasm;refractory myelodysplastic/myeloproliferative neoplasm;exactmatch
advanced biliary tract carcinoma;advanced biliary tract carcinoma;exactmatch
advanced pancreatobiliary carcinoma;advanced pancreatobiliary carcinoma;exactmatch
signal transduction;cell communication and signaling;exactmatch
advanced ampulla of vater carcinoma;advanced ampulla of vater carcinoma;exactmatch
locally advanced ampulla of vater carcinoma;locally advanced ampulla of vater carcinoma;exactmatch
recurrent extrarenal rhabdoid tumor of the ovary;recurrent extrarenal rhabdoid tumor of the ovary;exactmatch
extrarenal rhabdoid tumor of the ovary;extrarenal rhabdoid tumor of the ovary;exactmatch
refractory extraskeletal myxoid chondrosarcoma;refractory extraskeletal myxoid chondrosarcoma;exactmatch
metastatic fallopian tube serous adenocarcinoma;metastatic fallopian tube serous adenocarcinoma;exactmatch
visceral angiosarcoma;visceral angiosarcoma;exactmatch
human papillomavirus-related mucosal head and neck squamous cell carcinoma;hpv-associated mucosal head and neck squamous cell carcinoma;exactmatch
refractory primary peritoneal serous adenocarcinoma;refractory primary peritoneal serous adenocarcinoma;exactmatch
unresectable primary peritoneal serous adenocarcinoma;unresectable primary peritoneal serous adenocarcinoma;exactmatch
metastatic primary peritoneal serous adenocarcinoma;metastatic primary peritoneal serous adenocarcinoma;exactmatch
refractory fallopian tube serous adenocarcinoma;refractory fallopian tube serous adenocarcinoma;exactmatch
unresectable fallopian tube serous adenocarcinoma;unresectable fallopian tube serous adenocarcinoma;exactmatch
refractory ovarian serous adenocarcinoma;refractory ovarian serous adenocarcinoma;exactmatch
ann arbor stage iix (bulky) non-hodgkin lymphoma;ann arbor stage iix (bulky) non-hodgkin lymphoma;exactmatch
recurrent triple-negative breast carcinoma;recurrent triple-negative breast carcinoma;exactmatch
supratentorial gliosarcoma;supratentorial gliosarcoma;exactmatch
recurrent prostate adenocarcinoma;recurrent prostate adenocarcinoma;exactmatch
ribonuclease;ribonuclease;exactmatch
locally advanced glioblastoma;locally advanced glioblastoma;exactmatch
metastatic glioblastoma;metastatic glioblastoma;exactmatch
advanced glioblastoma;advanced glioblastoma;exactmatch
tongue adenoid cystic carcinoma;tongue adenoid cystic carcinoma;exactmatch
thymic neuroendocrine carcinoma;thymic neuroendocrine carcinoma;exactmatch
ovarian neuroendocrine carcinoma;ovarian neuroendocrine carcinoma;exactmatch
endometrial neuroendocrine carcinoma;endometrial neuroendocrine carcinoma;exactmatch
ann arbor stage iix (bulky) diffuse large b-cell lymphoma;ann arbor stage iix (bulky) diffuse large b-cell lymphoma;exactmatch
non-neoplastic endocrine pancreas disorder;non-neoplastic endocrine pancreas disorder;exactmatch
cutaneous lymphoma;cutaneous lymphoma;exactmatch
metastatic primary central chondrosarcoma;metastatic primary central chondrosarcoma;exactmatch
unresectable primary central chondrosarcoma;unresectable primary central chondrosarcoma;exactmatch
recurrent hairy cell leukemia variant;recurrent hairy cell leukemia variant;exactmatch
refractory hairy cell leukemia variant;refractory hairy cell leukemia variant;exactmatch
rna splicing;rna splicing;exactmatch
central nervous system involvement in recurrent b acute lymphoblastic leukemia;central nervous system involvement in recurrent b acute lymphoblastic leukemia;exactmatch
chromosome 13q abnormality;13q aberration;exactmatch
chromosome 12 abnormality;chromosome 12 aberration;exactmatch
chromosome 17p abnormality;17p aberration;exactmatch
ntrk gene rearrangement;ntrk family gene rearrangement;exactmatch
mediastinal non-hodgkin lymphoma;mediastinal non-hodgkin lymphoma;exactmatch
parietal lobe anaplastic astrocytoma;parietal lobe anaplastic astrocytoma;exactmatch
liver and intrahepatic bile duct soft tissue neoplasm;liver and intrahepatic bile duct soft tissue neoplasm;exactmatch
intestinal soft tissue neoplasm;intestinal soft tissue neoplasm;exactmatch
digestive system solitary fibrous tumor;digestive system solitary fibrous tumor;exactmatch
ccnd1 gene translocation;bcl-1 gene translocation;exactmatch
maxillofacial osteoid osteoma;maxillofacial osteoid osteoma;exactmatch
maxillofacial chondromyxoid fibroma;maxillofacial chondromyxoid fibroma;exactmatch
maxillofacial chondroblastoma;maxillofacial chondroblastoma;exactmatch
maxillofacial osteoma;maxillofacial osteoma;exactmatch
maxillofacial chondroma;maxillofacial chondroma;exactmatch
benign maxillofacial neoplasm;benign maxillofacial neoplasm;exactmatch
ccnd1 gene rearrangement;bcl-1 gene rearrangement;exactmatch
p21 ras protein;transforming protein p21;exactmatch
maxillofacial desmoplastic fibroma;maxillofacial desmoplastic fibroma;exactmatch
cellular tumor antigen p53;antigen ny-co-13;exactmatch
bilateral thalamic glioma;bilateral thalamic glioma;exactmatch
maxillofacial neoplasm;maxillofacial neoplasm;exactmatch
maxillofacial osteosarcoma;maxillofacial osteosarcoma;exactmatch
maxillofacial mesenchymal chondrosarcoma;maxillofacial mesenchymal chondrosarcoma;exactmatch
maxillofacial chondrosarcoma;maxillofacial chondrosarcoma;exactmatch
maxillofacial sarcoma;maxillofacial sarcoma;exactmatch
maxillofacial osteoblastoma;maxillofacial osteoblastoma;exactmatch
ctrp disease finding;ctrp disease finding;exactmatch
unresectable salivary gland carcinoma;unresectable salivary gland carcinoma;exactmatch
benign inner ear neoplasm;benign inner ear neoplasm;exactmatch
advanced cervical adenosquamous carcinoma;advanced cervical adenosquamous carcinoma;exactmatch
advanced cervical squamous cell carcinoma, not otherwise specified;advanced cervical squamous cell carcinoma, not otherwise specified;exactmatch
unresectable cervical adenocarcinoma;unresectable cervical adenocarcinoma;exactmatch
unresectable cervical adenosquamous carcinoma;unresectable cervical adenosquamous carcinoma;exactmatch
malignant inner ear neoplasm;malignant inner ear neoplasm;exactmatch
unresectable cervical squamous cell carcinoma, not otherwise specified;unresectable cervical squamous cell carcinoma, not otherwise specified;exactmatch
unresectable cervical carcinoma;unresectable cervical carcinoma;exactmatch
aggressive papillary tumor;aggressive papillary tumor;exactmatch
recurrent metastatic malignant neoplasm in the leptomeninges;recurrent metastatic malignant neoplasm in the leptomeninges;exactmatch
advanced differentiated thyroid gland carcinoma;advanced differentiated thyroid gland carcinoma;exactmatch
metastatic differentiated thyroid gland carcinoma;metastatic differentiated thyroid gland carcinoma;exactmatch
s phase process;s phase;exactmatch
retinoblastoma-associated protein;p105-rb;exactmatch
benign head and neck neoplasm;benign head and neck neoplasm;exactmatch
focal cemento-osseous dysplasia;focal cod;exactmatch
cemento-osseous dysplasia;cod;exactmatch
maxillofacial bone;maxillofacial bone;exactmatch
gtpase nras;gtpase nras;exactmatch
gtpase kras;gtpase kras;exactmatch
salivary gland hodgkin lymphoma;primary salivary gland hodgkin lymphoma;exactmatch
odontogenic carcinoma;odontogenic carcinoma;exactmatch
parotid gland diffuse large b-cell lymphoma;parotid gland diffuse large b-cell lymphoma;exactmatch
salivary gland diffuse large b-cell lymphoma;primary salivary gland diffuse large b-cell lymphoma;exactmatch
parotid gland follicular lymphoma;parotid gland follicular lymphoma;exactmatch
salivary gland follicular lymphoma;primary salivary gland follicular lymphoma;exactmatch
advanced pharyngeal squamous cell carcinoma;advanced pharyngeal squamous cell carcinoma;exactmatch
salivary gland mucosa-associated lymphoid tissue lymphoma;salivary gland malt lymphoma;exactmatch
salivary gland non-hodgkin lymphoma;primary salivary gland non-hodgkin lymphoma;exactmatch
ossifying fibroma;ossifying fibroma;exactmatch
salivary gland lymphoma;primary salivary gland lymphoma;exactmatch
recurrent pharyngeal squamous cell carcinoma;recurrent pharyngeal squamous cell carcinoma;exactmatch
parotid gland nodular fasciitis;parotid gland nodular fasciitis;exactmatch
salivary gland nodular fasciitis;salivary gland nodular fasciitis;exactmatch
metastatic pharyngeal squamous cell carcinoma;metastatic pharyngeal squamous cell carcinoma;exactmatch
parotid gland sialolipoma;parotid gland sialolipoma;exactmatch
refractory acute biphenotypic leukemia;refractory acute biphenotypic leukemia;exactmatch
sclerosing odontogenic carcinoma;soc;exactmatch
odontogenic carcinosarcoma;ameloblastic carcinosarcoma;exactmatch
odontogenic sarcoma;odontogenic sarcoma;exactmatch
ameloblastic fibrodentinosarcoma;ameloblastic fibrodentinosarcoma;exactmatch
primordial odontogenic tumor;primordial odontogenic tumor;exactmatch
recurrent ectomesenchymoma;recurrent ectomesenchymoma;exactmatch
locally advanced intrahepatic cholangiocarcinoma;locally advanced intrahepatic cholangiocarcinoma;exactmatch
pancreatic squamous cell carcinoma;pancreatic squamous cell carcinoma;exactmatch
primary bone diffuse large b-cell lymphoma;primary bone diffuse large b-cell lymphoma;exactmatch
lung alveolar soft part sarcoma;lung alveolar soft part sarcoma;exactmatch
retroperitoneal undifferentiated pleomorphic sarcoma;retroperitoneal undifferentiated pleomorphic sarcoma;exactmatch
tongue adenosquamous carcinoma;tongue adenosquamous carcinoma;exactmatch
non-neoplastic appendix disorder;non-neoplastic appendix disorder;exactmatch
appendix disorder;appendix disorder;exactmatch
tonsillar disorder;tonsillar disorder;exactmatch
non-neoplastic gingival disorder;non-neoplastic gingival disorder;exactmatch
gingival disorder;gingival disorder;exactmatch
tongue disorder;tongue disorder;exactmatch
ameloblastic fibroodontosarcoma;ameloblastic fibroodontosarcoma;exactmatch
primary middle ear meningioma;primary middle ear meningioma;exactmatch
locally advanced endometrial adenocarcinoma;locally advanced endometrial adenocarcinoma;exactmatch
salivary gland lipoma;salivary gland lipoma;exactmatch
uveal melanocytoma;uveal melanocytoma;exactmatch
unresectable lung adenocarcinoma;unresectable lung adenocarcinoma;exactmatch
fos family gene;fos family gene;exactmatch
refractory vaginal carcinoma;refractory vaginal carcinoma;exactmatch
refractory vulvar carcinoma;refractory vulvar carcinoma;exactmatch
metastatic malignant neoplasm in the uvea;metastatic malignant neoplasm in the uvea;exactmatch
iris mixed cell melanoma;iris mixed cell melanoma;exactmatch
locally advanced cervical squamous cell carcinoma, not otherwise specified;locally advanced cervical squamous cell carcinoma;exactmatch
uveal nevus;uveal nevus;exactmatch
refractory acute myelomonocytic leukemia;refractory acute myelomonocytic leukemia;exactmatch
choroid nevus;choroid nevus;exactmatch
ciliary body nevus;ciliary body nevus;exactmatch
iris epithelioid cell melanoma;iris epithelioid cell melanoma;exactmatch
eif1ax gene mutation;eif1a gene mutation;exactmatch
metastatic malignant neoplasm in the conjunctiva;metastatic malignant neoplasm in the conjunctiva;exactmatch
conjunctival spitz nevus;conjunctival spitz nevus;exactmatch
refractory acute myeloid leukemia not otherwise specified;refractory acute myeloid leukemia not otherwise specified;exactmatch
refractory acute monoblastic and monocytic leukemia;refractory acute monoblastic and monocytic leukemia;exactmatch
retinal astrocytoma;acquired retinal astrocytoma;exactmatch
locally advanced endometrial endometrioid adenocarcinoma;locally advanced endometrial endometrioid adenocarcinoma;exactmatch
unresectable kidney medullary carcinoma;unresectable kidney medullary carcinoma;exactmatch
metastatic thyroid gland hurthle cell carcinoma;metastatic thyroid gland hurthle cell carcinoma;exactmatch
recurrent thyroid gland hurthle cell carcinoma;recurrent thyroid gland hurthle cell carcinoma;exactmatch
unresectable thyroid gland hurthle cell carcinoma;unresectable thyroid gland hurthle cell carcinoma;exactmatch
unresectable thyroid gland follicular carcinoma;unresectable thyroid gland follicular carcinoma;exactmatch
unresectable thyroid gland papillary carcinoma;unresectable thyroid gland papillary carcinoma;exactmatch
unresectable poorly differentiated thyroid gland carcinoma;unresectable poorly differentiated thyroid gland carcinoma;exactmatch
advanced rhabdoid tumor;advanced rhabdoid tumor;exactmatch
resectable pancreatic adenosquamous carcinoma;resectable pancreatic adenosquamous carcinoma;exactmatch
retinal hamartoma;retinal hamartoma;exactmatch
unresectable kidney carcinoma;unresectable kidney carcinoma;exactmatch
ciliary body adenocarcinoma;ciliary body adenocarcinoma;exactmatch
ciliary body adenoma;ciliary body adenoma;exactmatch
experimental model;experimental model;exactmatch
retinal pigment epithelium adenocarcinoma;adenocarcinoma of the retinal pigment epithelium;exactmatch
adenoma of the retinal pigment epithelium;adenoma of the retinal pigment epithelium;exactmatch
combined hamartoma of the retina and retinal pigment epithelium;combined hamartoma of the retina and retinal pigment epithelium;exactmatch
"t(9;22)(q22;q12)";"t(9;22)(q22;q12)";exactmatch
"t(12;22)(q13.3;q12)";"t(12;22)(q13.3;q12)";exactmatch
"t(12;22)(q13.12;q12)";"t(12;22)(q13.12;q12)";exactmatch
rna helicase;ec 3.6.4.13;exactmatch
nf1 gene;nf1;exactmatch
recurrent supratentorial glioblastoma;recurrent supratentorial glioblastoma;exactmatch
metastatic vulvar squamous cell carcinoma;metastatic vulvar squamous cell carcinoma;exactmatch
recurrent vulvar squamous cell carcinoma;recurrent vulvar squamous cell carcinoma;exactmatch
unresectable vulvar squamous cell carcinoma;unresectable vulvar squamous cell carcinoma;exactmatch
unresectable vulvar carcinoma;unresectable vulvar carcinoma;exactmatch
xrcc family gene mutation;x-ray cross complementing family gene mutation;exactmatch
acute myeloid leukemia with mll rearrangement;acute myeloid leukemia with 11q23 abnormalities;exactmatch
fus gene rearrangement;fus gene rearrangement;exactmatch
locally advanced rectal adenocarcinoma;locally advanced rectal adenocarcinoma;exactmatch
neurofibromin;nf1;exactmatch
refractory al amyloidosis;refractory al amyloidosis;exactmatch
recurrent al amyloidosis;recurrent al amyloidosis;exactmatch
recurrent poorly differentiated thyroid gland carcinoma;recurrent poorly differentiated thyroid gland carcinoma;exactmatch
metastatic poorly differentiated thyroid gland carcinoma;metastatic poorly differentiated thyroid gland carcinoma;exactmatch
locally advanced endometrioid adenocarcinoma;locally advanced endometrioid adenocarcinoma;exactmatch
refractory intrahepatic cholangiocarcinoma;refractory intrahepatic cholangiocarcinoma;exactmatch
nf2 gene;nf2;exactmatch
conjunctival oncocytoma;conjunctival oncocytoma;exactmatch
conjunctival keratoacanthoma;conjunctival keratoacanthoma;exactmatch
atypical ewing sarcoma;atypical ewing sarcoma;exactmatch
ipsilateral nodule;ipsilateral_nodules;exactmatch
conjunctival blue nevus;conjunctival blue nevus;exactmatch
chronic inflammation;chronic inflammation;exactmatch
inflamed juvenile conjunctival nevus;ijcn;exactmatch
locally advanced adrenal cortex carcinoma;locally advanced adrenal cortex carcinoma;exactmatch
protein tyrosine phosphatase;ppt-phosphatase;exactmatch
conjunctival subepithelial nevus;conjunctival stromal nevus;exactmatch
stromal proliferation of nevus cells present;stromal proliferation of nevus cells present;exactmatch
conjunctival compound nevus;conjunctival compound nevus;exactmatch
conjunctival junctional nevus;conjunctival junctional nevus;exactmatch
conjunctival sebaceous carcinoma;conjunctival sebaceous carcinoma;exactmatch
conjunctival carcinoma;conjunctival carcinoma;exactmatch
conjunctival adenosquamous carcinoma;conjunctival adenosquamous carcinoma;exactmatch
conjunctival spindle cell carcinoma;conjunctival spindle cell carcinoma;exactmatch
sialolipoma;sialolipoma;exactmatch
salivary gland hemangioma;salivary gland hemangioma;exactmatch
inflammatory fibroid polyp;inflammatory fibroid polyp;exactmatch
sinonasal ameloblastoma;sinonasal ameloblastoma;exactmatch
sinonasal ewing sarcoma/peripheral primitive neuroectodermal tumor;sinonasal ewing sarcoma/peripheral primitive neuroectodermal tumor;exactmatch
sinonasal olfactory neuroblastoma;sinonasal olfactory neuroblastoma;exactmatch
nasal cavity extranodal nk/t-cell lymphoma;nasal cavity extranodal nk/t-cell lymphoma;exactmatch
sinonasal extranodal nk/t-cell lymphoma;sinonasal extranodal nk/t-cell lymphoma;exactmatch
sinonasal non-hodgkin lymphoma;sinonasal non-hodgkin lymphoma;exactmatch
sinonasal lymphoma;sinonasal lymphoma;exactmatch
sinonasal plasmacytoma;sinonasal plasmacytoma;exactmatch
peritoneal implant;peritoneal implant;exactmatch
vaginal discharge;vaginal discharge;exactmatch
primary sinonasal meningioma;primary sinonasal meningioma;exactmatch
unresectable esophageal adenocarcinoma;unresectable esophageal adenocarcinoma;exactmatch
unresectable anal squamous cell carcinoma;unresectable anal squamous cell carcinoma;exactmatch
metastatic intracranial malignant neoplasm;metastatic intracranial malignant neoplasm;exactmatch
recurrent intracranial neoplasm;recurrent intracranial neoplasm;exactmatch
sinonasal neurofibroma;sinonasal neurofibroma;exactmatch
sinonasal schwannoma;sinonasal schwannoma;exactmatch
malignant sinonasal soft tissue neoplasm;malignant sinonasal soft tissue neoplasm;exactmatch
serine/threonine protein kinase;ec 2.7.11;exactmatch
nasopharyngeal lymphoma;nasopharyngeal lymphoma;exactmatch
refractory uveal melanoma;refractory uveal melanoma;exactmatch
pharyngeal non-hodgkin lymphoma;pharyngeal non-hodgkin lymphoma;exactmatch
pharyngeal lymphoma;pharyngeal lymphoma;exactmatch
nasopharyngeal pituitary gland adenoma;nasopharyngeal pituitary gland adenoma;exactmatch
ectopic pituitary gland adenoma;ectopic pituitary gland adenoma;exactmatch
nasopharyngeal adenoid cystic carcinoma;nasopharyngeal adenoid cystic carcinoma;exactmatch
advanced anal canal squamous cell carcinoma;advanced anal canal squamous cell carcinoma;exactmatch
advanced thyroid gland anaplastic carcinoma;advanced thyroid gland anaplastic carcinoma;exactmatch
refractory anal canal squamous cell carcinoma;refractory anal canal squamous cell carcinoma;exactmatch
mast/stem cell growth factor receptor kit;antigen cd117;exactmatch
advanced chordoma;advanced chordoma;exactmatch
refractory microsatellite stable colorectal carcinoma;refractory microsatellite stable colorectal carcinoma;exactmatch
refractory lung squamous cell carcinoma;refractory lung squamous cell carcinoma;exactmatch
advanced lung squamous cell carcinoma;advanced lung squamous cell carcinoma;exactmatch
refractory ocular melanoma;refractory ocular melanoma;exactmatch
refractory non-cutaneous melanoma;refractory non-cutaneous melanoma;exactmatch
microsatellite stable colorectal carcinoma;microsatellite stable colorectal carcinoma;exactmatch
sinonasal hemangioma;sinonasal hemangioma;exactmatch
sinonasal leiomyoma;sinonasal leiomyoma;exactmatch
benign sinonasal soft tissue neoplasm;benign sinonasal soft tissue neoplasm;exactmatch
gastric adenocarcinoma and proximal polyposis of the stomach;gapps;exactmatch
sinonasal nut carcinoma;nasal cavity and paranasal sinus nut carcinoma;exactmatch
head and neck nut carcinoma;head and neck nut carcinoma;exactmatch
sinonasal lymphoepithelial carcinoma;sinonasal lymphoepithelial carcinoma;exactmatch
sinonasal spindle cell squamous cell carcinoma;nasal cavity and paranasal sinus spindle cell (sarcomatoid) squamous cell carcinoma;exactmatch
sinonasal human papillomavirus-related carcinoma with adenoid cystic-like features;sinonasal hpv-related carcinoma with adenoid cystic-like features;exactmatch
sinonasal keratinizing squamous cell carcinoma;nasal cavity and paranasal sinus keratinizing squamous cell carcinoma;exactmatch
refractory indolent non-hodgkin lymphoma;refractory indolent non-hodgkin lymphoma;exactmatch
gastrointestinal clear cell sarcoma/malignant gastrointestinal neuroectodermal tumor;ccs/ gnet;exactmatch
sinonasal epithelioid hemangioendothelioma;sinonasal epithelioid hemangioendothelioma;exactmatch
fibroblast growth factor receptor family;fgf receptor;exactmatch
digestive system kaposi sarcoma;digestive system kaposi sarcoma;exactmatch
refractory meningioma;refractory meningioma;exactmatch
digestive system rhabdomyosarcoma;digestive system rhabdomyosarcoma;exactmatch
digestive system leiomyosarcoma;digestive system leiomyosarcoma;exactmatch
digestive system lipoma;digestive system lipoma;exactmatch
digestive system leiomyoma;digestive system leiomyoma;exactmatch
sinonasal neuroendocrine carcinoma;nasal cavity and paranasal sinus neuroendocrine carcinoma;exactmatch
sinonasal large cell neuroendocrine carcinoma;nasal cavity and paranasal sinus large cell neuroendocrine carcinoma;exactmatch
sinonasal teratocarcinosarcoma;nasal cavity and paranasal sinus teratocarcinosarcoma;exactmatch
benign sinonasal neoplasm;benign nasal cavity and paranasal sinus neoplasm;exactmatch
sinonasal solitary fibrous tumor;sinonasal solitary fibrous tumor;exactmatch
sinonasal glomangiopericytoma;sinonasal glomangiopericytoma;exactmatch
sinonasal desmoid fibromatosis;sinonasal desmoid fibromatosis;exactmatch
intermediate sinonasal soft tissue neoplasm;intermediate sinonasal soft tissue neoplasm;exactmatch
sinonasal synovial sarcoma;sinonasal synovial sarcoma;exactmatch
sinonasal malignant peripheral nerve sheath tumor;sinonasal malignant peripheral nerve sheath tumor;exactmatch
sinonasal angiosarcoma;sinonasal angiosarcoma;exactmatch
sinonasal rhabdomyosarcoma;sinonasal rhabdomyosarcoma;exactmatch
sinonasal leiomyosarcoma;sinonasal leiomyosarcoma;exactmatch
sinonasal undifferentiated pleomorphic sarcoma;sinonasal undifferentiated pleomorphic sarcoma;exactmatch
sinonasal fibrosarcoma;sinonasal fibrosarcoma;exactmatch
sinonasal sarcoma;sinonasal sarcoma;exactmatch
sinonasal soft tissue neoplasm;sinonasal soft tissue neoplasm;exactmatch
sinonasal pleomorphic adenoma;sinonasal pleomorphic adenoma;exactmatch
malignant sinonasal neoplasm;malignant nasal cavity and paranasal sinus neoplasm;exactmatch
pharyngeal hodgkin lymphoma;pharyngeal hodgkin lymphoma;exactmatch
nasopharyngeal non-hodgkin lymphoma;nasopharyngeal non-hodgkin lymphoma;exactmatch
salivary gland lymphadenoma;salivary gland lymphadenoma;exactmatch
neck carcinoma of unknown primary;neck cup;exactmatch
paratesticular sarcomatoid mesothelioma;paratesticular sarcomatoid mesothelioma;exactmatch
paratesticular epithelioid mesothelioma;paratesticular epithelioid mesothelioma;exactmatch
rb1 gene;rb;exactmatch
tp53 gene;p53;exactmatch
head and neck heterotopia-associated carcinoma;head and neck accessory tissue-associated carcinoma;exactmatch
head and neck merkel cell carcinoma;head and neck lymph nodes merkel cell carcinoma;exactmatch
extracutaneous merkel cell carcinoma;extracutaneous merkel cell carcinoma;exactmatch
head and neck follicular dendritic cell sarcoma;head and neck follicular dendritic cell sarcoma;exactmatch
unresectable paratesticular malignant mesothelioma;unresectable paratesticular malignant mesothelioma;exactmatch
oropharyngeal non-hodgkin lymphoma;oropharyngeal non-hodgkin lymphoma;exactmatch
oropharyngeal hodgkin lymphoma;oropharyngeal hodgkin lymphoma;exactmatch
oropharyngeal lymphoma;oropharyngeal lymphoma;exactmatch
oropharyngeal polymorphous adenocarcinoma;oropharyngeal polymorphous adenocarcinoma;exactmatch
oropharyngeal pleomorphic adenoma;oropharyngeal pleomorphic adenoma;exactmatch
refractory primitive neuroectodermal tumor;refractory primitive neuroectodermal tumor;exactmatch
g1 phase process;g1;exactmatch
paratesticular biphasic mesothelioma;paratesticular biphasic mesothelioma;exactmatch
unresectable paratesticular epithelioid mesothelioma;unresectable paratesticular epithelioid mesothelioma;exactmatch
nasopharyngeal hodgkin lymphoma;nasopharyngeal hodgkin lymphoma;exactmatch
tumor suppressor gene;anti-oncogene;exactmatch
salivary gland poorly differentiated neuroendocrine carcinoma;salivary gland poorly differentiated neuroendocrine carcinoma;exactmatch
salivary gland large cell neuroendocrine carcinoma;salivary gland large cell neuroendocrine carcinoma;exactmatch
salivary gland poorly differentiated carcinoma;salivary gland poorly differentiated carcinoma;exactmatch
salivary gland sebaceous carcinoma;salivary gland sebaceous adenocarcinoma;exactmatch
recurrent hereditary thyroid gland medullary carcinoma;recurrent hereditary thyroid gland medullary carcinoma;exactmatch
unresectable hereditary thyroid gland medullary carcinoma;unresectable hereditary thyroid gland medullary carcinoma;exactmatch
horse transitional cell carcinoma;horse transitional cell carcinoma;exactmatch
unresectable pleural biphasic mesothelioma;unresectable pleural biphasic mesothelioma;exactmatch
unresectable paratesticular sarcomatoid mesothelioma;unresectable paratesticular sarcomatoid mesothelioma;exactmatch
unresectable pleural sarcomatoid mesothelioma;unresectable pleural sarcomatoid mesothelioma;exactmatch
unresectable pleural epithelioid mesothelioma;unresectable pleural epithelioid mesothelioma;exactmatch
unresectable peritoneal biphasic mesothelioma;unresectable peritoneal biphasic mesothelioma;exactmatch
unresectable peritoneal sarcomatoid mesothelioma;unresectable peritoneal sarcomatoid mesothelioma;exactmatch
unresectable peritoneal epithelioid mesothelioma;unresectable peritoneal epithelioid mesothelioma;exactmatch
unresectable peritoneal malignant mesothelioma;unresectable peritoneal malignant mesothelioma;exactmatch
unresectable paratesticular biphasic mesothelioma;unresectable paratesticular biphasic mesothelioma;exactmatch
recurrent ganglioneuroblastoma;recurrent ganglioneuroblastoma;exactmatch
refractory ganglioneuroblastoma;refractory ganglioneuroblastoma;exactmatch
refractory acute undifferentiated leukemia;refractory acute undifferentiated leukemia;exactmatch
laryngeal large cell neuroendocrine carcinoma;laryngeal large cell neuroendocrine carcinoma;exactmatch
laryngeal chondroma;laryngeal chondroma;exactmatch
laryngeal granular cell tumor;laryngeal granular cell tumor;exactmatch
tongue liposarcoma;tongue liposarcoma;exactmatch
laryngeal inflammatory myofibroblastic tumor;laryngeal inflammatory myofibroblastic tumor;exactmatch
malignant laryngeal soft tissue neoplasm;malignant laryngeal soft tissue neoplasm;exactmatch
benign laryngeal soft tissue neoplasm;benign laryngeal soft tissue neoplasm;exactmatch
laryngeal soft tissue neoplasm;laryngeal soft tissue neoplasm;exactmatch
laryngeal poorly differentiated neuroendocrine carcinoma;laryngeal neuroendocrine carcinoma, grade iii;exactmatch
advanced gastrointestinal stromal tumor;advanced gist;exactmatch
laryngeal moderately differentiated neuroendocrine carcinoma;laryngeal atypical carcinoid tumor;exactmatch
laryngeal well differentiated neuroendocrine carcinoma;laryngeal carcinoid tumor;exactmatch
laryngeal neuroendocrine carcinoma;laryngeal neuroendocrine carcinoma;exactmatch
head and neck poorly differentiated neuroendocrine carcinoma;head and neck neuroendocrine carcinoma, grade iii;exactmatch
head and neck moderately differentiated neuroendocrine carcinoma;head and neck atypical carcinoid tumor;exactmatch
head and neck well differentiated neuroendocrine carcinoma;head and neck carcinoid tumor;exactmatch
neuroendocrine carcinoma, excluding head and neck;neuroendocrine carcinoma, excluding head and neck;exactmatch
laryngeal chondrosarcoma;laryngeal chondrosarcoma;exactmatch
laryngeal soft tissue sarcoma;laryngeal soft tissue sarcoma;exactmatch
recurrent mature t-cell and nk-cell neoplasm;recurrent mature t-cell and nk-cell neoplasm;exactmatch
refractory mature t-cell and nk-cell neoplasm;refractory mature t-cell and nk-cell neoplasm;exactmatch
oral cavity myeloid sarcoma;oral cavity myeloid sarcoma;exactmatch
head and neck melanocytic neoplasm;head and neck melanocytic neoplasm;exactmatch
oral mucosa langerhans cell histiocytosis;oral cavity langerhans cell histiocytosis;exactmatch
head and neck langerhans cell histiocytosis;head and neck langerhans cell histiocytosis;exactmatch
head and neck histiocytic and dendritic cell neoplasm;head and neck histiocytic and dendritic cell neoplasm;exactmatch
oral cavity soft tissue sarcoma;oral cavity soft tissue sarcoma;exactmatch
benign oral cavity soft tissue neoplasm;benign oral cavity soft tissue neoplasm;exactmatch
oral cavity soft tissue neoplasm;oral cavity soft tissue neoplasm;exactmatch
oral cavity low grade myofibroblastic sarcoma;oral cavity low grade myofibroblastic sarcoma;exactmatch
oral cavity kaposi sarcoma;oral cavity kaposi sarcoma;exactmatch
oral squamous cell papilloma;oral squamous cell papilloma;exactmatch
oral verruca vulgaris;oral verruca vulgaris;exactmatch
abl1 gene;abl;exactmatch
oropharyngeal human papillomavirus-negative squamous cell carcinoma;oropharyngeal hpv negative squamous cell carcinoma;exactmatch
laryngeal pleomorphic adenoma;laryngeal pleomorphic adenoma;exactmatch
mouse undifferentiated carcinoma;mouse undifferentiated carcinoma;exactmatch
recurrent malignant mastocytosis;recurrent malignant mastocytosis;exactmatch
mouse large cell undifferentiated carcinoma;mouse large cell undifferentiated carcinoma;exactmatch
mouse thyroid diffuse large b-cell lymphoma;mouse thyroid diffuse large b-cell lymphoma;exactmatch
mouse chondrocyte neoplasm;mouse chondrocyte neoplasm;exactmatch
mouse musculoskeletal system;mouse musculoskeletal system;exactmatch
mouse reproductive system;mouse reproductive body system;exactmatch
mouse thyroid angiosarcoma;mouse thyroid angiosarcoma;exactmatch
mouse thyroid sarcoma;mouse thyroid sarcoma;exactmatch
mouse thyroid plasmacytoma;mouse thyroid plasmacytoma;exactmatch
mouse thyroid immunoblastic lymphoma;mouse thyroid immunoblastic lymphoma;exactmatch
mouse thyroid non-hodgkin's lymphoma;mouse thyroid non-hodgkin's lymphoma;exactmatch
mouse gastric neoplasm;mouse gastric neoplasm;exactmatch
mouse thyroid hodgkin's lymphoma;mouse thyroid hodgkin's lymphoma;exactmatch
mouse thyroid lymphoma;mouse thyroid lymphoma;exactmatch
mouse papillary and follicular adenocarcinoma;mouse papillary and follicular adenocarcinoma;exactmatch
mouse follicular variant papillary carcinoma;mouse follicular variant papillary carcinoma;exactmatch
mouse papillary thyroid carcinoma;mouse papillary thyroid carcinoma;exactmatch
mouse hurthle cell carcinoma of the thyroid;mouse hurthle cell carcinoma of the thyroid;exactmatch
mouse trabecular follicular adenocarcinoma;mouse trabecular follicular adenocarcinoma;exactmatch
mouse chondrogenic neoplasm;mouse chondrogenic neoplasm;exactmatch
benign mouse gastric neoplasm;benign mouse gastric neoplasm;exactmatch
well-differentiated mouse thyroid carcinoma;well-differentiated mouse thyroid carcinoma;exactmatch
mouse gastric mesenchymal neoplasm;mouse gastric mesenchymal neoplasm;exactmatch
malignant mouse gastric fibrous histocytoma;malignant mouse gastric fibrous histocytoma;exactmatch
mouse gastric xanthoma;mouse gastric xanthoma;exactmatch
mouse gastric liposarcoma;mouse gastric liposarcoma;exactmatch
mouse gastric inflammatory myofibroblastic neoplasm;mouse gastric inflammatory myofibroblastic neoplasm;exactmatch
mouse gastric hemangioma;mouse gastric hemangioma;exactmatch
malignant mouse gastric gastrointestinal stromal tumor;malignant mouse gastric gastrointestinal stromal tumor;exactmatch
mouse gastric gastrointestinal stromal tumor;mouse gastric gastrointestinal stromal tumor;exactmatch
immature mouse gastric teratoma;immature mouse gastric teratoma;exactmatch
benign mouse gastric gastrointestinal stromal neoplasm;benign mouse gastric gastrointestinal stromal neoplasm;exactmatch
malignant mouse gastric germ cell neoplasm;malignant mouse gastric germ cell neoplasm;exactmatch
mouse gastric germ cell neoplasm;mouse gastric germ cell neoplasm;exactmatch
mouse gastric lipoma;mouse gastric lipoma;exactmatch
mouse gastric epithelioid leiomyoma;mouse gastric epithelioid leiomyoma;exactmatch
mouse gastric leiomyoma;mouse gastric leiomyoma;exactmatch
mouse gastric hamartoma;mouse gastric hamartoma;exactmatch
benign mouse gastric granular cell tumor;benign mouse gastric granular cell tumor;exactmatch
mouse follicular thyroid carcinoma;mouse follicular thyroid carcinoma;exactmatch
recurrent mouse thyroid carcinoma;recurrent mouse thyroid carcinoma;exactmatch
lymphoma of the mouse nose and paranasal sinuses;lymphoma of the mouse nose and paranasal sinuses;exactmatch
malignant mouse smooth muscle neoplasm;malignant mouse smooth muscle neoplasm;exactmatch
mouse gallbladder small cell gallbladder;mouse gallbladder small cell gallbladder;exactmatch
mouse gallbladder squamous cell gallbladder;mouse gallbladder squamous cell gallbladder;exactmatch
mouse gallbladder adenocarcinoma;mouse gallbladder adenocarcinoma;exactmatch
mouse gallbladder carcinoma;mouse gallbladder carcinoma;exactmatch
malignant mouse gallbladder neoplasm;malignant mouse gallbladder neoplasm;exactmatch
mouse gallbladder neoplasm;mouse gallbladder neoplasm;exactmatch
malignant mouse skeletal muscle neoplasm;malignant mouse skeletal muscle neoplasm;exactmatch
malignant mouse muscle neoplasm;malignant mouse muscle neoplasm;exactmatch
mouse gallbladder lymphoma;mouse gallbladder lymphoma;exactmatch
mouse myomatous neoplasm;mouse myomatous neoplasm;exactmatch
mouse soft tissue neoplasm;mouse soft tissue neoplasm;exactmatch
malignant mouse lipomatous neoplasm;malignant mouse lipomatous neoplasm;exactmatch
mouse lipomatous neoplasm;mouse lipomatous neoplasm;exactmatch
mouse connective and soft tissue neoplasms;mouse connective and soft tissue neoplasms;exactmatch
mouse placental choriocarcinoma;mouse placental choriocarcinoma;exactmatch
metastasis to the mouse placenta;metastasis to the mouse placenta;exactmatch
mouse gallbladder carcinosarcoma;mouse gallbladder carcinosarcoma;exactmatch
mouse gallbladder mucosa associated lymphoid tissue lymphoma;mouse gallbladder mucosa associated lymphoid tissue lymphoma;exactmatch
poorly differentiated mouse thyroid carcinoma;poorly differentiated mouse thyroid carcinoma;exactmatch
malignant mouse thyroid neoplasm;malignant mouse thyroid neoplasm;exactmatch
mouse medullary thyroid carcinoma with amyloid stroma;mouse medullary thyroid carcinoma with amyloid stroma;exactmatch
mouse medullary thyroid carcinoma;mouse c cell carcinoma;exactmatch
mouse anaplastic small cell thyroid carcinoma;mouse anaplastic small cell thyroid carcinoma;exactmatch
mouse anaplastic giant cell thyroid carcinoma;mouse anaplastic giant cell thyroid carcinoma;exactmatch
mouse anaplastic thyroid carcinoma;mouse anaplastic thyroid carcinoma;exactmatch
mouse thyroid carcinoma;mouse thyroid carcinoma;exactmatch
metastasis to the mouse thyroid;metastasis to the mouse thyroid;exactmatch
mouse thyroid neoplasm;mouse thyroid neoplasm;exactmatch
mouse gallbladder melanoma;mouse gallbladder melanoma;exactmatch
metastatic neoplasm to the mouse gallbladder;metastatic neoplasm to the mouse gallbladder;exactmatch
rhabdomyosarcoma of the mouse gallbladder;rhabdomyosarcoma of the mouse gallbladder;exactmatch
mouse gallbladder malignant fibrous histiocytoma;mouse gallbladder malignant fibrous histiocytoma;exactmatch
mouse gallbladder leiomyosarcoma;mouse gallbladder leiomyosarcoma;exactmatch
mouse gallbladder kaposi's sarcoma;mouse gallbladder kaposi's sarcoma;exactmatch
mouse gallbladder angiosarcoma;mouse gallbladder angiosarcoma;exactmatch
mouse gallbladder sarcoma;mouse gallbladder sarcoma;exactmatch
mouse gastric neuroendocrine neoplasm;mouse gastric neuroendocrine neoplasm;exactmatch
mouse gastric carcinoid neoplasm;mouse gastric carcinoid neoplasm;exactmatch
mouse gastric small cell carcinoma;mouse gastric small cell carcinoma;exactmatch
wwtr1 gene;ww domain containing transcription regulator 1 gene;exactmatch
genitalia;genitalia;exactmatch
appetite;appetite;exactmatch
14q32.33;14q32.33;exactmatch
usp8 gene;usp8;exactmatch
usp6 gene;usp6;exactmatch
tfe3 gene;tfe3;exactmatch
tcf3 gene;e2a;exactmatch
pparg gene;pparg;exactmatch
hairy cell;hairy cell;exactmatch
pml gene;pml;exactmatch
pdgfrb gene;pdgfrb;exactmatch
pdgfra gene;pdgfra;exactmatch
pax7 gene;pax7;exactmatch
pax5 gene;pax5;exactmatch
pax3 gene;pax3;exactmatch
nup214 gene;nup214;exactmatch
record;record;exactmatch
paraaortic region;paraaortic;exactmatch
mouse gastric teratoma;mouse gastric teratoma;exactmatch
secondary acute myeloid leukemia;secondary_aml;exactmatch
immunoprotein gene;immunoprotein gene;exactmatch
nras gene;nras;exactmatch
kras gene;k-ras gene;exactmatch
ras family gene;ras family gene;exactmatch
metastatic malignant testicular germ cell tumor;metastatic malignant testicular germ cell tumor;exactmatch
musculoskeletal system part;musculoskeletal system part;exactmatch
cervical neck region;cervical neck region;exactmatch
digestive system part;digestive system part;exactmatch
description;descr;exactmatch
cardiovascular system part;cardiovascular system part;exactmatch
nevus cell;nevocyte;exactmatch
leukemic cell;leukemic cell;exactmatch
condition;condition;exactmatch
body cavity;body cavity;exactmatch
anal margin;anal verge;exactmatch
chest;chest;exactmatch
numa1 gene;numa1;exactmatch
ntrk3 gene;ntrk3;exactmatch
notch1 gene;notch1;exactmatch
mouse gastric fundus carcinoma;mouse gastric fundus carcinoma;exactmatch
primary mouse gastric non-hodgkin's lymphoma;primary mouse gastric non-hodgkin's lymphoma;exactmatch
mouse gastric hodgkin's lymphoma;mouse gastric hodgkin's lymphoma;exactmatch
mouse gastric lymphoma;mouse gastric lymphoma;exactmatch
recurrent mouse gastric cancer;recurrent mouse gastric cancer;exactmatch
mouse gastric squamous cell carcinoma;mouse gastric squamous cell carcinoma;exactmatch
mouse gastric pylorus carcinoma;mouse gastric pylorus carcinoma;exactmatch
mouse gastric kaposi's sarcoma;mouse gastric kaposi's sarcoma;exactmatch
mouse gastric cardia carcinoma;mouse gastric cardia carcinoma;exactmatch
mme gene;cd10;exactmatch
mouse gastric body carcinoma;mouse gastric body carcinoma;exactmatch
mouse gastric adenosquamous carcinoma;mouse gastric adenosquamous carcinoma;exactmatch
mouse gastric adenocarcinoma;mouse gastric adenocarcinoma;exactmatch
carcinoma in situ of the mouse antrum;carcinoma in situ of the mouse antrum;exactmatch
mouse gastric carcinoma;mouse gastric carcinoma;exactmatch
malignant mouse gastric neoplasm;malignant mouse gastric neoplasm;exactmatch
mature mouse gastric teratoma;mature mouse gastric teratoma;exactmatch
secondary mouse gastric non-hodgkin's lymphoma;secondary mouse gastric non-hodgkin's lymphoma;exactmatch
malignant mouse gastric cardio-esophageal junction neoplasm;malignant mouse gastric cardio-esophageal junction neoplasm;exactmatch
mouse barrett's adenocarcinoma;mouse barrett's adenocarcinoma;exactmatch
malignant mouse gastric granular cell tumor;malignant mouse gastric granular cell tumor;exactmatch
afdn gene;af6;exactmatch
mllt3 gene;af9;exactmatch
aff1 gene;af4;exactmatch
mllt1 gene;enl;exactmatch
jak2 gene;jak2;exactmatch
gli1 gene;gli family zinc finger 1 gene;exactmatch
foxo1 gene;foxo1;exactmatch
flt3 gene;flt3;exactmatch
fgfr3 gene;fgfr3;exactmatch
etv4 gene;e1af;exactmatch
etv1 gene;ets variant gene 1 gene;exactmatch
dek gene;dek;exactmatch
bcl6 gene;b-cell cll/lymphoma 6 gene;exactmatch
mouse gastric carcinosarcoma;mouse gastric carcinosarcoma;exactmatch
mixed malignant mouse gastric neoplasm;mixed malignant mouse gastric neoplasm;exactmatch
malignant mouse placental neoplasm;malignant mouse placental neoplasm;exactmatch
recurrent mouse uterine sarcoma;recurrent mouse uterine sarcoma;exactmatch
mouse endometrial stromal sarcoma;mouse endometrial stromal sarcoma;exactmatch
plasma cell neoplasms of the mouse salivary glands;plasma cell neoplasms of the mouse salivary glands;exactmatch
mouse neoplasms by histopathology;mouse neoplasms by histopathology;exactmatch
mouse metastatic neoplasms;mouse metastatic neoplasms;exactmatch
mouse precancerous conditions;mouse precancerous conditions;exactmatch
mouse noncancerous conditions;mouse noncancerous conditions;exactmatch
mouse neoplasms;mouse neoplasms;exactmatch
mouse cancer-related conditions;mouse cancer-related conditions;exactmatch
plasmacytoma of the mouse salivary glands;plasmacytoma of the mouse salivary glands;exactmatch
lymphoma of the mouse salivary glands;lymphoma of the mouse salivary glands;exactmatch
mouse neoplasms by cell type;mouse neoplasms by cell type;exactmatch
lymphoproliferative neoplasms of the mouse salivary glands;lymphoproliferative neoplasms of the mouse salivary glands;exactmatch
hematopoietic neoplasms of the mouse salivary glands;hematopoietic neoplasms of the mouse salivary glands;exactmatch
metastatic carcinoma of the mouse salivary glands;metastatic carcinoma of the mouse salivary glands;exactmatch
adenocarcinoma of the mouse salivary glands;adenocarcinoma of the mouse salivary glands;exactmatch
squamous cell carcinoma of the mouse salivary glands;squamous cell carcinoma of the mouse salivary glands;exactmatch
papillary adenocarcinoma of the mouse salivary glands;papillary adenocarcinoma of the mouse salivary glands;exactmatch
adenoid cystic carcinoma of the mouse salivary glands;adenoid cystic carcinoma of the mouse salivary glands;exactmatch
mouse neoplasms by location;mouse neoplasms by location;exactmatch
mouse neoplasms by morphology;mouse neoplasms by morphology;exactmatch
mouse benign epithelial neoplasm;mouse benign epithelial neoplasm;exactmatch
mouse myeloid cell neoplasm;mouse myeloid cell neoplasm;exactmatch
mouse squamous cell neoplasm;mouse squamous cell neoplasm;exactmatch
mouse adenocarcinoma;mouse adenocarcinoma;exactmatch
mouse carcinoma;mouse carcinoma;exactmatch
mouse adenoma;mouse adenoma;exactmatch
mouse transitional cell neoplasm;mouse transitional cell neoplasm;exactmatch
mouse plasma cell dyscrasia;mouse plasma cell dyscrasia;exactmatch
mouse neural cell neoplasm;mouse neural cell neoplasm;exactmatch
mouse monocyte neoplasm;mouse monocyte neoplasm;exactmatch
mouse acinar cell neoplasm;mouse acinar cell neoplasm;exactmatch
mouse mesenchymal neoplasm;mouse mesenchymal neoplasm;exactmatch
mouse melanocyte neoplasm;mouse melanocyte neoplasm;exactmatch
mouse lymph cell neoplasm;mouse lymph cell neoplasm;exactmatch
mouse granulosa cell tumor;mouse granulosa cell tumor;exactmatch
mouse germ cell neoplasm;mouse germ cell neoplasm;exactmatch
mouse epithelial cell neoplasms;mouse epithelial cell neoplasms;exactmatch
mouse ductal cell neoplasm;mouse ductal cell neoplasm;exactmatch
acinic cell carcinoma of the mouse salivary glands;acinic cell carcinoma of the mouse salivary glands;exactmatch
carcinoma of the mouse salivary glands;carcinoma of the mouse salivary glands;exactmatch
high grade mucoepidermoid tumor of the mouse salivary glands;high grade mucoepidermoid tumor of the mouse salivary glands;exactmatch
papilloma of the mouse larynx;papilloma of the mouse larynx;exactmatch
cartilage/bone neoplasms of the mouse larynx;cartilage/bone neoplasms of the mouse larynx;exactmatch
acinic cell carcinoma of the mouse larynx;acinic cell carcinoma of the mouse larynx;exactmatch
mucoepidermoid carcinoma of the mouse larynx;mucoepidermoid carcinoma of the mouse larynx;exactmatch
adenoid cystic carcinoma of the mouse larynx;adenoid cystic carcinoma of the mouse larynx;exactmatch
squamous cell carcinoma in-situ of the mouse larynx;squamous cell carcinoma in-situ of the mouse larynx;exactmatch
squamous cell carcinoma of the mouse larynx;squamous cell carcinoma of the mouse larynx;exactmatch
carcinoma of the mouse larynx;carcinoma of the mouse larynx;exactmatch
epithelial neoplasms of the mouse larynx;epithelial neoplasms of the mouse larynx;exactmatch
low grade mucoepidermoid tumor of the mouse salivary glands;low grade mucoepidermoid tumor of the mouse salivary glands;exactmatch
mouse laryngeal neoplasms;mouse laryngeal neoplasms;exactmatch
embryonal rhabdomyosarcoma of the mouse nose and paranasal sinuses;embryonal rhabdomyosarcoma of the mouse nose and paranasal sinuses;exactmatch
skeletal muscle neoplasms of the mouse nose and paranasal sinuses;skeletal muscle neoplasms of the mouse nose and paranasal sinuses;exactmatch
leiomyosarcoma of the mouse nose and paranasal sinuses;leiomyosarcoma of the mouse nose and paranasal sinuses;exactmatch
smooth muscle neoplasms of the mouse nose and paranasal sinuses;smooth muscle neoplasms of the mouse nose and paranasal sinuses;exactmatch
plasmacytoma of the mouse nose and paranasal sinuses;plasmacytoma of the mouse nose and paranasal sinuses;exactmatch
plasma cell neoplasms of the mouse nose and paranasal sinuses;plasma cell neoplasms of the mouse nose and paranasal sinuses;exactmatch
chondrosarcoma of the mouse larynx;chondrosarcoma of the mouse larynx;exactmatch
osteosarcoma of the mouse larynx;osteosarcoma of the mouse larynx;exactmatch
histiocytic neoplasms of the mouse larynx;histiocytic neoplasms of the mouse larynx;exactmatch
malignant fibrous histiocytoma of the mouse larynx;malignant fibrous histiocytoma of the mouse larynx;exactmatch
mucoepidermoid tumor of the mouse salivary glands;mucoepidermoid tumor of the mouse salivary glands;exactmatch
myoepithelioma of the mouse salivary glands;myoepithelioma of the mouse salivary glands;exactmatch
sebaceous lymphadenoma of the mouse salivary glands;sebaceous lymphadenoma of the mouse salivary glands;exactmatch
clear cell adenoma of the mouse salivary glands;clear cell adenoma of the mouse salivary glands;exactmatch
basal cell adenoma of the mouse salivary glands;basal cell adenoma of the mouse salivary glands;exactmatch
warthin's tumor of the mouse salivary glands;warthin's tumor of the mouse salivary glands;exactmatch
oxyphilic adenoma of the mouse salivary glands;oxyphilic adenoma of the mouse salivary glands;exactmatch
monomorphic adenoma of the mouse salivary glands;monomorphic adenoma of the mouse salivary glands;exactmatch
carcinoma in pleomorphic adenoma of the mouse salivary glands;carcinoma in pleomorphic adenoma of the mouse salivary glands;exactmatch
pleomorphic adenoma of the mouse salivary glands;pleomorphic adenoma of the mouse salivary glands;exactmatch
adenoma of the mouse salivary glands;adenoma of the mouse salivary glands;exactmatch
epithelial neoplasms of the mouse salivary glands;epithelial neoplasms of the mouse salivary glands;exactmatch
mouse salivary gland neoplasms;mouse salivary gland neoplasms;exactmatch
carcinoid tumor of the mouse larynx;carcinoid tumor of the mouse larynx;exactmatch
neuroendocrine neoplasms of the mouse larynx;neuroendocrine neoplasms of the mouse larynx;exactmatch
mouse adenosquamous carcinoma;mouse adenosquamous carcinoma;exactmatch
mouse papilloma;mouse papilloma;exactmatch
mouse uterine sarcoma;mouse uterine sarcoma;exactmatch
mouse exocervical carcinoma;mouse exocervical carcinoma;exactmatch
metastatic carcinoma to the mouse uterine cervix;metastatic carcinoma to the mouse uterine cervix;exactmatch
metastasis to the mouse cervix;metastasis to the mouse cervix;exactmatch
malignant mouse exocervical neoplasm;malignant mouse exocervical neoplasm;exactmatch
malignant mouse endocervical neoplasm;malignant mouse endocervical neoplasm;exactmatch
undifferentiated mouse cervical carcinoma;undifferentiated mouse cervical carcinoma;exactmatch
mouse recurrent cervical carcinoma;mouse recurrent cervical carcinoma;exactmatch
mouse infiltrating cervical carcinoma;mouse infiltrating cervical carcinoma;exactmatch
mouse endocervical carcinoma;mouse endocervical carcinoma;exactmatch
mouse endometrial carcinoma;mouse endometrial carcinoma;exactmatch
mouse cervical squamous cell carcinoma;mouse cervical squamous cell carcinoma;exactmatch
mouse cervical small cell carcinoma;mouse cervical small cell carcinoma;exactmatch
mouse cervical adenosquamous cell carcinoma;mouse cervical adenosquamous cell carcinoma;exactmatch
mouse cervical adenoid cystic carcinoma;mouse cervical adenoid cystic carcinoma;exactmatch
mouse uterine cervix endometrioid adenocarcinoma;mouse uterine cervix endometrioid adenocarcinoma;exactmatch
mouse uterine cervix clear cell adenocarcinoma;mouse uterine cervix clear cell adenocarcinoma;exactmatch
mouse mesonephric adenocarcinoma;mouse mesonephric adenocarcinoma;exactmatch
malignant mouse uterine corpus neoplasm;malignant mouse uterine corpus neoplasm;exactmatch
mouse endometrial adenocarcinoma;mouse endometrial adenocarcinoma;exactmatch
mouse angiosarcoma;mouse angiosarcoma;exactmatch
recurrent malignant mouse endometrial neoplasm;recurrent malignant mouse endometrial neoplasm;exactmatch
mouse uterine gestational choriocarcinoma;mouse uterine gestational choriocarcinoma;exactmatch
mouse uterine choriocarcinoma;mouse uterine choriocarcinoma;exactmatch
mouse uterine mullerian adenosarcoma;mouse uterine mullerian adenosarcoma;exactmatch
mouse uterine malignant mixed mesodermal (mullerian) tumor;mouse uterine malignant mixed mesodermal (mullerian) tumor;exactmatch
malignant mouse uterine corpus mixed neoplasm;malignant mouse uterine corpus mixed neoplasm;exactmatch
undifferentiated mouse endometrial carcinoma;undifferentiated mouse endometrial carcinoma;exactmatch
recurrent mouse endometrial carcinoma;recurrent mouse endometrial carcinoma;exactmatch
mouse endometrial squamous cell carcinoma;mouse endometrial squamous cell carcinoma;exactmatch
mouse endometrial adenocarcinoma with squamous metaplasia;mouse endometrial adenocarcinoma with squamous metaplasia;exactmatch
mouse endometrial adenosquamous carcinoma;mouse endometrial adenosquamous carcinoma;exactmatch
mouse endometrial mixed carcinoma;mouse endometrial mixed carcinoma;exactmatch
papillary serous carcinoma of the mouse endometrium;papillary serous carcinoma of the mouse endometrium;exactmatch
serous carcinoma of the mouse endometrium;serous carcinoma of the mouse endometrium;exactmatch
mouse endometrial mucinous adenocarcinoma;mouse endometrial mucinous adenocarcinoma;exactmatch
mouse endometrial endometrioid adenocarcinoma;mouse endometrial endometrioid adenocarcinoma;exactmatch
mouse endometrial clear cell adenocarcinoma;mouse endometrial clear cell adenocarcinoma;exactmatch
mouse cervical adenocarcinoma in situ;mouse cervical adenocarcinoma in situ;exactmatch
mouse cervical adenocarcinoma;mouse cervical adenocarcinoma;exactmatch
mouse cervical carcinoma;mouse cervical carcinoma;exactmatch
mouse genitourinary neoplasms;mouse genitourinary neoplasms;exactmatch
mouse pituitary gland neoplasms;mouse pituitary gland neoplasms;exactmatch
mouse adrenal gland neoplasms;mouse adrenal gland neoplasms;exactmatch
mouse integumentary system neoplasms;mouse integumentary system neoplasms;exactmatch
mouse digestive system neoplasms;mouse digestive system neoplasms;exactmatch
mouse female reproductive system neoplasms;mouse female reproductive system neoplasms;exactmatch
mouse male reproductive system neoplasms;mouse male reproductive system neoplasms;exactmatch
mouse reproductive system neoplasms;mouse reproductive system neoplasms;exactmatch
mouse gastrointestinal system neoplasms;mouse gastrointestinal system neoplasms;exactmatch
malignant mouse cervical neoplasm;malignant mouse cervical neoplasm;exactmatch
mouse synovial sarcoma;mouse synovial sarcoma;exactmatch
mouse rhabdomyosarcoma;mouse rhabdomyosarcoma;exactmatch
mouse osteosarcoma;mouse osteosarcoma;exactmatch
mouse leiomyosarcoma;mouse leiomyosarcoma;exactmatch
mouse kaposi's sarcoma;mouse kaposi's sarcoma;exactmatch
mouse chondrosarcoma;mouse chondrosarcoma;exactmatch
mouse fibrosarcoma;mouse fibrosarcoma;exactmatch
tumors of the mouse pulmonary system;neoplasms of the mouse pulmonary system;exactmatch
mouse special sense organ neoplasms;mouse special sense organ neoplasms;exactmatch
mouse biliary tract;biliary tract (mmhcc);exactmatch
mouse pancreas;mouse pancreas;exactmatch
malignant mouse uterine neoplasms;malignant mouse uterine neoplasms;exactmatch
undifferentiated mouse fallopian tube carcinoma;undifferentiated mouse fallopian tube carcinoma;exactmatch
mouse fallopian tube squamous cell carcinoma;mouse fallopian tube squamous cell carcinoma;exactmatch
mouse fallopian tube gestational choriocarcinoma;mouse fallopian tube gestational choriocarcinoma;exactmatch
fallopian tube papillary serous adenocarcinoma of mouse;fallopian tube papillary serous adenocarcinoma of mouse;exactmatch
mouse fallopian tube serous adenocarcinoma;mouse fallopian tube serous adenocarcinoma;exactmatch
mouse fallopian tube papillary adenocarcinoma;mouse fallopian tube papillary adenocarcinoma;exactmatch
mouse fallopian tube mucinous adenocarcinoma;mouse fallopian tube mucinous adenocarcinoma;exactmatch
mouse fallopian tube endometrioid adenocarcinoma;mouse fallopian tube endometrioid adenocarcinoma;exactmatch
mouse fallopian tube clear cell adenocarcinoma;mouse fallopian tube clear cell adenocarcinoma;exactmatch
mouse fallopian tube adenocarcinoma;mouse fallopian tube adenocarcinoma;exactmatch
mouse fallopian tube carcinoma;mouse fallopian tube carcinoma;exactmatch
malignant mouse fallopian tube neoplasm;malignant mouse fallopian tube neoplasm;exactmatch
benign mouse fallopian tube neoplasm;benign mouse fallopian tube neoplasm;exactmatch
mouse fallopian tube neoplasm;mouse fallopian tube neoplasm;exactmatch
immunoglobulin family gene;immunoglobulin family gene;exactmatch
immunoglobulin-like c2-type domain;ig-like c2-type;exactmatch
eukaryota;eukaryota;exactmatch
hypoglossal nerve disorder;disorder of xii nerve;exactmatch
external ear disorder;external ear disorder;exactmatch
chronic lymphadenitis;chronic lymphadenitis;exactmatch
thymus disorder;thymus disorder;exactmatch
hodgkin's paragranuloma involving spleen;hodgkin's paragranuloma involving spleen;exactmatch
lymphosarcoma involving spleen;lymphosarcoma involving spleen;exactmatch
reticulosarcoma involving spleen;reticulosarcoma involving spleen;exactmatch
hodgkin's paragranuloma;hodgkin paragranuloma, nos;exactmatch
accessory nerve disorder;accessory nerve disorder;exactmatch
sarcomatoid carcinoma;carcinoma, spindle cell, malignant;exactmatch
trigeminal nerve disorder;trigeminal nerve disorder;exactmatch
polyneuropathy;polyneuropathy;exactmatch
vaginal hemorrhage;vaginal hemorrhage;exactmatch
cervical lymphadenitis;cervical lymphadenitis;exactmatch
hypogammaglobulinemia;agammaglobulinemia;exactmatch
liver failure;hepatic failure;exactmatch
lymphosarcoma;lymphosarcoma;exactmatch
acute lymphadenitis;acute lymphadenitis;exactmatch
spindle cell sarcoma;spindle cell sarcoma;exactmatch
malignant spindle cell neoplasm;malignant spindle cell neoplasm;exactmatch
soft tissue disorder;soft tissue disease;exactmatch
verruca vulgaris;common wart;exactmatch
spindle cell squamous cell carcinoma;epidermoid spindle cell carcinoma;exactmatch
juvenile pilocytic astrocytoma;juvenile pilocytic astrocytoma;exactmatch
endocrine pancreas disorder;endocrine pancreas disease;exactmatch
middle ear disorder;middle ear disorder;exactmatch
rectal hemorrhage;rectal hemorrhage;exactmatch
eosinophilic endomyocardial disease;eosinophilic endomyocardial disease;exactmatch
hypereosinophilic syndrome;hyper eosinophilic syndrome;exactmatch
spitz nevus;benign juvenile melanoma;exactmatch
alk tyrosine kinase receptor;alk;exactmatch
pancreatic neuroendocrine neoplasm;pancreatic endocrine neoplasm;exactmatch
female reproductive system disorder;female reproductive system disease;exactmatch
male reproductive system disorder;disorder of male reproductive system;exactmatch
acquired hemangioma;acquired hemangioma;exactmatch
submandibular lymphadenitis;submandibular lymphadenitis;exactmatch
chronic cystitis;chronic cystitis;exactmatch
verruca plantaris;plantar wart;exactmatch
vasculitis;vasculitis;exactmatch
vaginal disorder;vaginal disease;exactmatch
parathyroid gland disorder;parathyroid gland disease;exactmatch
pleural disorder;pleural disease;exactmatch
placenta disorder;placenta disease;exactmatch
pituitary gland disorder;pituitary gland disease;exactmatch
pharyngeal disorder;pharyngeal disorder;exactmatch
peritonitis;peritonitis;exactmatch
peritoneal disorder;peritoneal disease;exactmatch
penile disorder;penile disease;exactmatch
paranasal sinus disorder;paranasal sinus disease;exactmatch
uveal disorder;uveal disease;exactmatch
pancreatic disorder;pancreatic disorder;exactmatch
ovarian disorder;ovarian disease;exactmatch
osteomalacia;osteomalacia;exactmatch
osteogenesis imperfecta;osteogenesis imperfecta;exactmatch
nutritional disorder;nutritional disorder;exactmatch
nervous system disorder;disorder of nervous system;exactmatch
mycobacterial infection;mycobacterial infection;exactmatch
polycythemia;polycythemia;exactmatch
prostate disorder;prostate disease;exactmatch
respiratory system disorder;disorder of respiratory system;exactmatch
infectious lung disorder;infectious lung disease;exactmatch
uterine disorder;uterine disease;exactmatch
urinary frequency;urinary frequency;exactmatch
urethra disorder;urethra disease;exactmatch
erythema;erythema;exactmatch
turner syndrome;45,x gonadal dysgenesis;exactmatch
pulmonary tuberculosis;lung tb;exactmatch
thyroiditis;thyroiditis;exactmatch
thyroid gland disorder;thyroid gland disease;exactmatch
thymic cyst;thymic cyst;exactmatch
thrombosis;thrombosis;exactmatch
testicular disorder;testicular disease;exactmatch
stomach disorder;stomach disorder;exactmatch
sjogren syndrome;sjogren syndrome;exactmatch
salivary gland disorder;salivary gland disease;exactmatch
retinal disorder;retinal disease;exactmatch
degenerative disorder;degenerative disease;exactmatch
small cell carcinoma, fusiform cell type;small cell cancer, fusiform cell type;exactmatch
menorrhagia;menorrhagia;exactmatch
high risk gastrointestinal stromal tumor;hr gist;exactmatch
uterine corpus adenomatoid tumor;uterine corpus adenomatoid tumor;exactmatch
non-hodgkin's lymphoma, lymphoblastic (wf);non-hodgkin's lymphoma, lymphoblastic (wf);exactmatch
cranial nodular fasciitis;cranial nodular fasciitis;exactmatch
stage ivb vulvar cancer ajcc v6 and v7;stage ivb carcinoma of vulva;exactmatch
uterine corpus choriocarcinoma;gestational uterine corpus choriocarcinoma;exactmatch
high risk small intestinal gastrointestinal stromal tumor;high risk small intestinal gist;exactmatch
low risk small intestinal gastrointestinal stromal tumor;low risk small intestinal gist;exactmatch
low risk gastrointestinal stromal tumor;lr gist;exactmatch
metanephric adenoma;embryonal adenoma;exactmatch
adult yolk sac tumor;adult endodermal sinus neoplasm;exactmatch
high risk gastric gastrointestinal stromal tumor;high risk gastric gist;exactmatch
low risk gastric gastrointestinal stromal tumor;low risk gastric gist;exactmatch
low grade anal canal intraepithelial neoplasia;asin-l;exactmatch
familial adenomatous polyposis associated medulloblastoma;fap associated medulloblastoma;exactmatch
tobacco-related carcinoma;tobacco-related carcinoma;exactmatch
gastric non-hodgkin lymphoma;gastric non-hodgkin lymphoma;exactmatch
enterochromaffin-like cell neuroendocrine tumor g1;ecl cell net g1;exactmatch
papillary eccrine carcinoma;papillary eccrine carcinoma;exactmatch
stage 0 squamous cell carcinoma;carcinoma, squamous cell, in situ, malignant;exactmatch
malignant lymphoma, large cell, cleaved;malignant lymphoma, large cell, cleaved;exactmatch
hodgkin's disease, nodular sclerosis, lymphocyte predominance;hodgkin's disease, nodular sclerosis, lymphocyte predominance;exactmatch
mouse spindle cell neoplasm;mouse spindle cell neoplasm;exactmatch
glandular cell intraepithelial neoplasia;glandular cell intraepithelial neoplasia;exactmatch
intermediate risk gastrointestinal stromal tumor;ir gist;exactmatch
lymphoma by stage;lymphoma by stage;exactmatch
lymphoma/leukemia by kiel classification (antiquated);lymphoma/leukemia by kiel classification (antiquated);exactmatch
malignant lymphoma, non-cleaved, diffuse;malignant lymphoma, non-cleaved, diffuse;exactmatch
familial atypical mole melanoma syndrome;famm syndrome;exactmatch
eccrine carcinoma;carcinoma, eccrine gland, malignant;exactmatch
spindle cell neoplasm;spindle cell neoplasm;exactmatch
myelodysplastic/myeloproliferative neoplasm;mds-mpd;exactmatch
pre t-all;pre t-all;exactmatch
dendritic cell tumor, not otherwise specified;dendritic cell sarcoma, nos;exactmatch
malignant lymphoma, non-cleaved cell type;malignant lymphoma, non-cleaved cell type;exactmatch
cellular angiofibroma;cellular angiofibroma;exactmatch
giant cell angiofibroma;giant cell angiofibroma;exactmatch
nipple duct carcinoma;nipple duct carcinoma;exactmatch
transplant-related disorder;transplant-related disorder;exactmatch
environment-related neoplasm;environment-related neoplasm;exactmatch
proliferating trichilemmal tumor;pilar cyst;exactmatch
t-cell immunodeficiency;t-cell immunodeficiency;exactmatch
peritoneal hemorrhage;hemoperitoneum;exactmatch
suppurative lymphadenitis;suppurative lymphadenitis;exactmatch
hematopoietic and lymphoid cell neoplasm;hemolymphoreticular tumor, malignant;exactmatch
trichoblastoma;brooke tumor;exactmatch
early gastric cancer;egc;exactmatch
benign skin vascular neoplasm;benign cutaneous vascular neoplasm;exactmatch
endemic burkitt lymphoma;african burkitt lymphoma;exactmatch
infection-related neoplasm;infection-related neoplasm;exactmatch
helicobacter pylori-associated gastritis;helicobacter gastritis;exactmatch
nasal cavity disorder;nasal cavity disease;exactmatch
malignant lymphoma, histiocytic, diffuse;malignant lymphoma, histiocytic, diffuse;exactmatch
hodgkin's disease, nodular sclerosis, mixed cellularity;hodgkin's disease, nodular sclerosis, mixed cellularity;exactmatch
liver embryonal sarcoma;embryonal sarcoma;exactmatch
nonpigmented nevus;nonpigmented nevus;exactmatch
cylindroma;cylindroma;exactmatch
ureter disorder;ureter disease;exactmatch
sebaceous hyperplasia;sebaceous hyperplasia;exactmatch
respiratory distress;respiratory distress;exactmatch
inner ear disorder;inner ear disorder;exactmatch
infection-related malignant neoplasm;infection related cancer;exactmatch
"t(11;22)(q24;q12)";"t(11;22) (q24;q12)";exactmatch
"t(14;18)(q32;q21)";"t(14;18)(q32;q21)";exactmatch
glossopharyngeal nerve disorder;glossopharyngeal nerve disorder;exactmatch
olfactory nerve disorder;disorder of 1st nerve;exactmatch
radiation-related malignant neoplasm;radiation-induced cancer;exactmatch
vestibulocochlear nerve disorder;acoustic nerve disorder;exactmatch
rheumatologic disorder;collagen disease;exactmatch
infiltrating bladder urothelial carcinoma, micropapillary variant;infiltrating bladder urothelial carcinoma, micropapillary variant;exactmatch
gastric leiomyosarcoma;gastric leiomyosarcoma;exactmatch
hashimoto thyroiditis;autoimmune thyroiditis;exactmatch
disseminated adenocarcinoma;disseminated adenocarcinoma;exactmatch
adult spinal cord glioblastoma;adult spinal cord glioblastoma;exactmatch
skin sclerosing/morphoeic basal cell carcinoma;basal cell carcinoma sclerosing type;exactmatch
secondary polycythemia;secondary polycythemia;exactmatch
mesenteric lymphadenitis;mesenteric lymphadenitis;exactmatch
mediastinal disorder;mediastinal disease;exactmatch
hydrolase gene;hydrolase family gene;exactmatch
extracellular matrix protein gene;ecm protein gene;exactmatch
tumor suppression;tumor suppression;exactmatch
membrane protein gene;membrane protein gene;exactmatch
viral carcinogenesis;viral carcinogenesis;exactmatch
biological carcinogenesis, non-viral;biological carcinogenesis, non-viral;exactmatch
antibacterial response;anti-bacterial response;exactmatch
peptidase gene;peptidase gene;exactmatch
collagen gene;collagen gene;exactmatch
adaptor signaling protein gene;adapter protein gene;exactmatch
helicase gene;helicase gene;exactmatch
ion channel protein gene;ion channel protein gene;exactmatch
signal transducer and activator of transcription family gene;stat family gene;exactmatch
homeostatic process;homeostasis;exactmatch
interleukin gene;interleukin gene;exactmatch
cytokine signaling;cytokine signal transduction;exactmatch
non-receptor protein tyrosine phosphatase gene;cytosolic protein tyrosine phosphatase gene;exactmatch
non-receptor tyrosine kinase gene;non-receptor tyrosine kinase gene;exactmatch
retinoic acid binding;retinoic acid binding;exactmatch
protein tyrosine phosphatase gene;ptp family gene;exactmatch
hematologic and lymphocytic disorder;blood disease;exactmatch
glycosyltransferase gene;glycosyltransferase gene;exactmatch
immune cell activation process;immune cell activation;exactmatch
adaptor signaling protein;adapter protein;exactmatch
receptor-type tyrosine-protein kinase flt3;cd135 antigen;exactmatch
transcription regulatory protein;transcription regulation protein;exactmatch
heterotrimeric g protein subunit gene;heterotrimeric g protein subunit gene;exactmatch
cellular migration process;cell migration;exactmatch
nervous system development;nervous system development;exactmatch
cell fate control;cell fate control;exactmatch
phosphatase family gene;phosphatase family gene;exactmatch
growth factor receptor gene;growth factor receptor gene;exactmatch
fibroblast growth factor receptor 3;cd333 antigen;exactmatch
heparin binding;heparin binding;exactmatch
ptb domain;pid;exactmatch
phagocytosis;phagocytosis;exactmatch
methyltransferase gene;methyltransferase gene;exactmatch
phosphoinositol kinase family gene;phosphatidylinositol kinase family gene;exactmatch
endoribonuclease dicer;dicer1;exactmatch
rnase iii family protein;rnase iii family protein;exactmatch
endoribonuclease;endoribonuclease;exactmatch
mouse bladder papilloma;mouse bladder papilloma;exactmatch
mouse bladder adenocarcinoma;mouse bladder adenocarcinoma;exactmatch
mouse bladder carcinoma;mouse bladder carcinoma;exactmatch
mouse bladder sarcoma;mouse bladder sarcoma;exactmatch
mouse bladder lymphoma;mouse bladder lymphoma;exactmatch
metastatic neoplasm to the mouse urinary bladder;metastatic neoplasm to the mouse urinary bladder;exactmatch
malignant mouse bladder paraganglioma;malignant mouse bladder paraganglioma;exactmatch
malignant mouse bladder neoplasm;malignant mouse bladder neoplasm;exactmatch
mouse bladder leiomyoma;mouse bladder leiomyoma;exactmatch
double-stranded rna binding domain;double-stranded rna binding domain;exactmatch
benign mouse bladder paraganglioma;benign mouse bladder paraganglioma;exactmatch
benign mouse bladder neoplasm;benign mouse bladder neoplasm;exactmatch
mouse bladder inflammatory myofibroblastic neoplasm;mouse bladder inflammatory myofibroblastic neoplasm;exactmatch
mouse bladder paraganglioma;mouse bladder paraganglioma;exactmatch
mouse bladder neoplasm;mouse bladder neoplasm;exactmatch
mouse urinary tract neoplasm;mouse urinary tract neoplasm;exactmatch
gtpase gene;gtpase gene;exactmatch
mouse bladder squamous cell carcinoma;mouse bladder squamous cell carcinoma;exactmatch
mouse bladder transitional cell carcinoma;mouse bladder transitional cell carcinoma;exactmatch
cyclin-dependent kinase gene;cdk encoding gene;exactmatch
cyclin gene;cyclin family gene;exactmatch
dicer1 gene;dicer1;exactmatch
endoribonuclease gene;endoribonuclease gene;exactmatch
ribonuclease gene;ribonuclease gene;exactmatch
esterase gene;esterase gene;exactmatch
polymerase gene;polymerase gene;exactmatch
oxidoreductase gene;oxidoreductase gene;exactmatch
mitochondrial membrane;mitochondrial membrane;exactmatch
dual-specificity phosphoprotein phosphatase;dual specificity phosphoprotein phosphatase;exactmatch
serine/threonine protein kinase gene;stk;exactmatch
kinase family gene;kinase family gene;exactmatch
phosphotransferase gene;phosphotransferase gene;exactmatch
transferase gene;transferase gene;exactmatch
transmembrane protein gene;transmembrane protein gene;exactmatch
g1 to s transition process;g1 to s transition process;exactmatch
fibroblast growth factor receptor 4;cd334 antigen;exactmatch
anticoagulant agent;anticoagulant agent;exactmatch
non-neoplastic hematologic and lymphocytic disorder;non-malignant hematologic and lymphocytic disorder;exactmatch
lymphadenitis;adenitis;exactmatch
corneal disorder;corneal disease;exactmatch
dyspepsia;dyspepsia;exactmatch
diverticulum;diverticulum;exactmatch
vip-producing neuroendocrine tumor;vip producing neoplasm;exactmatch
type 2 diabetes mellitus;adult onset diabetes;exactmatch
dermatomyositis;dermatomyositis;exactmatch
cystitis;bladder infection;exactmatch
cranial nerve disorder;cranial nerve disease;exactmatch
connective tissue disorder;connective tissue disease;exactmatch
embolism;embolism;exactmatch
infectious disorder;clinical infection;exactmatch
colitis;colitis;exactmatch
cholangitis;biliary tract infection;exactmatch
celiac disease;celiac disease;exactmatch
mucinous adenocarcinoma;adenocarcinoma, mucinous, malignant;exactmatch
breast disorder;breast disease;exactmatch
balanitis;balanitis;exactmatch
ear disorder;ear disease;exactmatch
enteritis;enteritis;exactmatch
non-neoplastic connective and soft tissue disorder;non-neoplastic connective and soft tissue disease;exactmatch
intestinal disorder;intestinal disorder;exactmatch
lip disorder;lip disease;exactmatch
lichen sclerosus et atrophicus;lichen sclerosus et atrophicus;exactmatch
leukopenia;leukocytopenia;exactmatch
radiation-related leukemia;radiation-induced leukemia;exactmatch
acute eosinophilic leukemia;acute eosinophilic leukemia;exactmatch
laryngeal disorder;laryngeal disease;exactmatch
lacrimal system disorder;disorder of lacrimal system;exactmatch
antigen;antigen;exactmatch
epistaxis;epistaxis;exactmatch
hemorrhage;bleeding;exactmatch
gonadal disorder;disorder of gonads;exactmatch
gastroesophageal reflux disease;gerd;exactmatch
gastritis;gastritis;exactmatch
fallopian tube disorder;fallopian tube disease;exactmatch
eyelid disorder;eyelid disorder;exactmatch
eye disorder;eye disease;exactmatch
ataxia;ataxia;exactmatch
anal disorder;anal disorder;exactmatch
aneurysm;aneurysm;exactmatch
mouse female reproductive system disorder;mouse female reproductive system disorder;exactmatch
mouse nervous system disorder;mouse nervous system disorder;exactmatch
mouse skin disorder;mouse skin disorder;exactmatch
mouse mammary gland disorder;mouse mammary gland disorder;exactmatch
mouse hematologic disorder;mouse hematologic disorder;exactmatch
mouse head and neck disorder;mouse head and neck disorder;exactmatch
mouse prostate disorder;mouse prostate disorder;exactmatch
mouse male reproductive system disorder;mouse male reproductive system disorder;exactmatch
mouse reproductive system disorder;mouse reproductive system disorder;exactmatch
adrenal gland disorder;adrenal gland disease;exactmatch
mouse urinary tract disorder;mouse urinary tract disorder;exactmatch
mouse endocrine gland system disorder;mouse endocrine gland system disorder;exactmatch
mouse digestive system disorder;mouse digestive system disorder;exactmatch
mouse connective and soft tissue disorder;mouse connective and soft tissue disorder;exactmatch
mouse cardiovascular system disorder;mouse cardiovascular disorder;exactmatch
mouse disorder by site;mouse disorder by site;exactmatch
ptpn11 gene;ptpn11;exactmatch
mouse respiratory system disorder;mouse respiratory system disorder;exactmatch
mouse skeletal system disorder;mouse skeletal system disorder;exactmatch
t-cell receptor beta locus;t-cell receptor beta gene;exactmatch
t-cell receptor gamma locus;t-cell rearranging gene, gamma;exactmatch
acanthosis nigricans;acanthosis nigricans;exactmatch
radiation-induced disorder;radiation-induced abnormalities;exactmatch
abnormal laboratory test result;abnormal lab test result;exactmatch
abdominal pain;abdominal pain;exactmatch
fosb gene;fosb;exactmatch
gene product;gene product;exactmatch
zap70 gene;zap70;exactmatch
xenobiotic metabolism;xenobiotic metabolism;exactmatch
mesonephric duct;mesonephric duct;exactmatch
mesonephros;mesonephros;exactmatch
intraductal hyperplasia;ductal hyperplasia;exactmatch
immunoglobulin kappa locus;igk;exactmatch
22q11.1-q11.2;22q11.1-q11.2;exactmatch
immunoglobulin lambda locus;igl;exactmatch
immunoglobulin heavy locus;igh;exactmatch
angiocentric immunoproliferative lesion of the mouse nose and paranasal sinuses;angiocentric immunoproliferative lesion of the mouse nose and paranasal sinuses;exactmatch
malignant non-hodgkin's lymphoma, diffuse, lymphocytic, poorly differentiated;malignant non-hodgkin's lymphoma, diffuse, lymphocytic, poorly differentiated;exactmatch
lymphoproliferative neoplasms of the mouse nose and paranasal sinuses;lymphoproliferative neoplasms of the mouse nose and paranasal sinuses;exactmatch
mouse myeloproliferation;mouse myeloproliferation;exactmatch
small b cell lymphoma of the mouse hematologic system;small b cell lymphoma of the mouse hematologic system;exactmatch
mature b cell neoplasms of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;exactmatch
mouse precursor b cell lymphoblastic lymphoma and leukemia;mouse precursor b cell lymphoblastic lymphoma and leukemia;exactmatch
precursor b cell neoplasm of the mouse hematologic system;precursor b cell neoplasm of the mouse hematologic system;exactmatch
b cell neoplasms of the mouse hematologic system;b cell neoplasms of the mouse hematologic system;exactmatch
lymphoid neoplasms and related disorders of the mouse hematologic system;lymphoid neoplasms and related disorders of the mouse hematologic system;exactmatch
mouse myeloproliferative disease;mouse myeloproliferative disease;exactmatch
mouse myeloid proliferation;mouse myeloid proliferation;exactmatch
follicular b cell lymphoma of the mouse hematologic system;follicular b cell lymphoma of the mouse hematologic system;exactmatch
cytopenia with increased blasts of mouse;cytopenia with increased blasts of mouse;exactmatch
mouse myelodysplastic syndrome;mouse myelodysplastic syndrome;exactmatch
myeloid dysplasia of mouse;myeloid dysplasia of mouse;exactmatch
mouse bi-phenotypic leukemia;mouse bi-phenotypic leukemia;exactmatch
mouse megakaryocytic leukemia;mouse megakaryocytic leukemia;exactmatch
mouse erythroid leukemia;mouse erythroid leukemia;exactmatch
mouse monocytic leukemia;mouse monocytic leukemia;exactmatch
splenic marginal zone lymphoma of the mouse hematologic system;splenic marginal zone lymphoma of the mouse hematologic system;exactmatch
diffuse large b cell lymphoma of the mouse hematologic system;diffuse large b cell lymphoma of the mouse hematologic system;exactmatch
mouse tumors of neuroepithelial tissue;mouse tumors of neuroepithelial tissue;exactmatch
b-nk cell lymphoma of the mouse hematologic system;b-nk cell lymphoma of the mouse hematologic system;exactmatch
mouse t-nk cell lymphoma;mouse t-nk cell lymphoma;exactmatch
small t cell lymphoma of the mouse hematologic system;small t cell lymphoma of the mouse hematologic system;exactmatch
mature t cell lineage lymphoma of the mouse hematologic system;mature t cell lineage lymphoma of the mouse hematologic system;exactmatch
large cell anaplastic lymphoma of the mouse hematologic system;large cell anaplastic lymphoma of the mouse hematologic system;exactmatch
mouse precursor t cell lymphoblastic lymphoma/leukemia;mouse precursor t cell lymphoblastic lymphoma/leukemia;exactmatch
precursor t cell neoplasm of the mouse hematologic system;precursor t cell neoplasm of the mouse hematologic system;exactmatch
t cell neoplasms of the mouse hematologic system;t cell neoplasms of the mouse hematologic system;exactmatch
anaplastic plasmacytoma of the mouse hematologic system;anaplastic plasmacytoma of the mouse hematologic system;exactmatch
centroblastic diffuse large b cell lymphoma of the mouse hematologic system;centroblastic diffuse large b cell lymphoma of the mouse hematologic system;exactmatch
extraosseus plasmacytoma of the mouse hematologic system;extraosseus plasmacytoma of the mouse hematologic system;exactmatch
plasmacytoma of the mouse hematologic system;plasmacytoma of the mouse hematologic system;exactmatch
plasma cell neoplasm of the mouse hematologic system;plasma cell neoplasm of the mouse hematologic system;exactmatch
classic burkitt lymphoma of the mouse hematologic system;classic burkitt lymphoma of the mouse hematologic system;exactmatch
primary mediastinal thymic diffuse large b cell lymphoma of the mouse hematologic system;primary mediastinal thymic diffuse large b cell lymphoma of the mouse hematologic system;exactmatch
histiocyte-associated diffuse large b cell lymphoma of the mouse hematologic system;histiocyte-associated diffuse large b cell lymphoma of the mouse hematologic system;exactmatch
immunoblastic diffuse large b cell lymphoma of the mouse hematologic system;immunoblastic diffuse large b cell lymphoma of the mouse hematologic system;exactmatch
mouse myelomonocytic leukemia;mouse myelomonocytic leukemia;exactmatch
mouse mpd-like myeloid leukemia;mouse mpd-like myeloid leukemia;exactmatch
mouse myeloid leukemia with maturation;mouse myeloid leukemia with maturation;exactmatch
malignant peripheral nerve sheath tumor of the mouse skin;malignant peripheral nerve sheath tumor of the mouse skin;exactmatch
b-cell lymphomas of the mouse skin;b-cell lymphomas of the mouse skin;exactmatch
mouse cutaneous lymphomas;mouse cutaneous lymphomas;exactmatch
mouse cutaneous tumors of hematopoietic origin;mouse cutaneous tumors of hematopoietic origin;exactmatch
unclassified malignant spindle cell neoplasm of the mouse skin;unclassified malignant spindle cell neoplasm of the mouse skin;exactmatch
liposarcoma of the mouse skin;liposarcoma of the mouse skin;exactmatch
rhabdomyosarcoma of the mouse skin;rhabdomyosarcoma of the mouse skin;exactmatch
leiomyosarcoma of the mouse skin;leiomyosarcoma of the mouse skin;exactmatch
lymphangiosarcoma of the mouse skin;lymphangiosarcoma of the mouse skin;exactmatch
mouse myeloid leukemia without maturation;mouse myeloid leukemia without maturation;exactmatch
hemangiosarcoma of the mouse skin;hemangiosarcoma of the mouse skin;exactmatch
sarcomas of the mouse skin and subcutis;sarcomas of the mouse skin and subcutis;exactmatch
granular cell tumor of the mouse skin;granular cell tumor of the mouse skin;exactmatch
neurofibroma of the mouse skin;neurofibroma of the mouse skin;exactmatch
schwannoma of the mouse skin;schwannoma of the mouse skin;exactmatch
hibernoma of the mouse skin;hibernoma of the mouse skin;exactmatch
lipoma of the mouse skin;lipoma of the mouse skin;exactmatch
t-cell lymphomas of the mouse skin;t-cell lymphomas of the mouse skin;exactmatch
other lymphomas of the mouse skin;other lymphomas of the mouse skin;exactmatch
plasma cell neoplasms of the mouse skin;plasma cell neoplasms of the mouse skin;exactmatch
benign plasma cell proliferations of the mouse skin;benign plasma cell proliferations of the mouse skin;exactmatch
mouse myeloid leukemia;mouse myeloid leukemia;exactmatch
mouse non-lymphoid leukemia;mouse non-lymphoid leukemia;exactmatch
mouse mast cell hematopoietic sarcoma;mouse mast cell hematopoietic sarcoma;exactmatch
mouse histiocytic sarcoma;mouse histiocytic sarcoma;exactmatch
mouse granulocytic sarcoma;mouse granulocytic sarcoma;exactmatch
mouse non-lymphoid hematopoietic sarcoma;mouse non-lymphoid hematopoietic sarcoma;exactmatch
non-lymphoid hematopoietic neoplasm of mouse;non-lymphoid hematopoietic neoplasm of mouse;exactmatch
mouse hematologic neoplasms and related disorders;mouse hematologic neoplasms and related disorders;exactmatch
other cutaneous neoplasms of hematopoietic origin of mouse;other cutaneous neoplasms of hematopoietic origin of mouse;exactmatch
mastocytoma of the mouse skin;mastocytoma of the mouse skin;exactmatch
mast cell neoplasms of the mouse skin;mast cell neoplasms of the mouse skin;exactmatch
malignant histiocytic neoplasms of the mouse skin;malignant histiocytic neoplasms of the mouse skin;exactmatch
benign histiocytic neoplasms of the mouse skin;benign histiocytic neoplasms of the mouse skin;exactmatch
histiocytic neoplasms of the mouse skin;histiocytic neoplasms of the mouse skin;exactmatch
malignant plasmacytoma of the mouse skin;malignant plasmacytoma of the mouse skin;exactmatch
mouse nervous system neoplasms;mouse nervous system neoplasms;exactmatch
mouse astrocytic tumours;mouse astrocytic tumours;exactmatch
fibroma of the mouse skin;fibroma of the mouse skin;exactmatch
mouse pineal parenchymal tumour of intermediate differentiation;mouse pineal parenchymal tumour of intermediate differentiation;exactmatch
mouse medullomyoblastoma;mouse medullomyoblastoma;exactmatch
mouse large cell medulloblastoma;mouse large cell medulloblastoma;exactmatch
mouse desmoplastic medulloblastoma;mouse desmoplastic medulloblastoma;exactmatch
mouse medulloblastoma;mouse medulloblastoma;exactmatch
mouse ependymoblastoma;mouse ependymoblastoma;exactmatch
mouse medulloepithelioma;mouse medulloepithelioma;exactmatch
mouse embryonal tumours;mouse embryonal tumours;exactmatch
mouse pineoblastoma;mouse pineoblastoma;exactmatch
mouse supratentorial primitive neuroectodermal tumour;mouse supratentorial primitive neuroectodermal tumour;exactmatch
mouse pineocytoma;mouse pineocytoma;exactmatch
mouse pineal parenchymal tumours;mouse pineal parenchymal tumours;exactmatch
neuroblastomas of the mouse adrenal gland and sympathetic nervous system;neuroblastomas of the mouse adrenal gland and sympathetic nervous system;exactmatch
mouse olfactory neuroepithelioma;mouse olfactory neuroepithelioma;exactmatch
mouse olfactory neuroblastoma;mouse olfactory neuroblastoma;exactmatch
mouse neuroblastic tumours;mouse neuroblastic tumours;exactmatch
paraganglioma of the mouse filum terminale;paraganglioma of the mouse filum terminale;exactmatch
mouse melanotic medulloblastoma;mouse melanotic medulloblastoma;exactmatch
mouse neuroblastoma;mouse neuroblastoma;exactmatch
mouse diffuse astrocytoma;mouse diffuse astrocytoma;exactmatch
mouse perineurioma;mouse perineurioma;exactmatch
mouse melanotic psammomatous mpnst;mouse melanotic psammomatous mpnst;exactmatch
mouse melanotic mpnst;mouse melanotic mpnst;exactmatch
mouse mpnst with divergent mesenchymal and / or epithelial differentiation;mouse mpnst with divergent mesenchymal and / or epithelial differentiation;exactmatch
mouse epithelioid mpnst;mouse epithelioid mpnst;exactmatch
malignant mouse peripheral nerve sheath tumor;malignant mouse peripheral nerve sheath tumor;exactmatch
mouse soft tissue perineurioma;mouse soft tissue perineurioma;exactmatch
mouse intraneural perineurioma;mouse intraneural perineurioma;exactmatch
mouse plexiform neurofibroma;mouse plexiform neurofibroma;exactmatch
mouse ganglioneuroblastoma;mouse ganglioneuroblastoma;exactmatch
mouse neurofibroma;mouse neurofibroma;exactmatch
mouse melanotic neurilemmoma / neurinoma;mouse melanotic neurilemmoma / neurinoma;exactmatch
mouse plexiform neurilemmoma / neurinoma;mouse plexiform neurilemmoma / neurinoma;exactmatch
mouse cellular neurilemmoma / neurinoma;mouse cellular neurilemmoma / neurinoma;exactmatch
mouse schwannoma;mouse schwannoma;exactmatch
tumors of the mouse peripheral nerves;tumors of the mouse peripheral nerves;exactmatch
atypical mouse tertoid/thaboid tumour;atypical mouse tertoid/thaboid tumour;exactmatch
mouse cerebellar liponeurocytoma;mouse cerebellar liponeurocytoma;exactmatch
mouse central neurocytoma;mouse central neurocytoma;exactmatch
mouse anaplastic ganglioglioma;mouse anaplastic ganglioglioma;exactmatch
mouse pleomorphic xanthoastrocytoma;mouse pleomorphic xanthoastrocytoma;exactmatch
mouse anaplastic oligoastrocytoma;mouse anaplastic oligoastrocytoma;exactmatch
mouse oligoastrocytoma;mouse oligoastrocytoma;exactmatch
mixed mouse gliomas;mixed mouse gliomas;exactmatch
mouse anaplastic oligodendroglioma;mouse anaplastic oligodendroglioma;exactmatch
mouse oligodendroglioma;mouse oligodendroglioma;exactmatch
mouse oligodendroglial tumours;mouse oligodendroglial tumours;exactmatch
mouse subependymal giant cell astrocytoma;mouse subependymal giant cell astrocytoma;exactmatch
mouse pilocytic astrocytoma;mouse pilocytic astrocytoma;exactmatch
mouse ganglioglioma;mouse ganglioglioma;exactmatch
mouse gliosarcoma;mouse gliosarcoma;exactmatch
mouse giant cell glioblastoma;mouse giant cell glioblastoma;exactmatch
mouse glioblastoma;mouse glioblastoma;exactmatch
mouse anaplastic astrocytoma;mouse anaplastic astrocytoma;exactmatch
mouse gemistocytic astrocytoma;mouse gemistocytic astrocytoma;exactmatch
mouse protoplasmic astrocytoma;mouse protoplasmic astrocytoma;exactmatch
mouse fibrillary astrocytoma;mouse fibrillary astrocytoma;exactmatch
mouse ependymal tumours;mouse ependymal tumours;exactmatch
mouse ependymoma;mouse ependymoma;exactmatch
mouse cellular ependymoma;mouse cellular ependymoma;exactmatch
mouse papillary ependymoma;mouse papillary ependymoma;exactmatch
mouse dysembryoplastic neuroepithelial tumour;mouse dysembryoplastic neuroepithelial tumour;exactmatch
mouse desmoplastic infantile astrocytoma / ganglioglioma;mouse desmoplastic infantile astrocytoma / ganglioglioma;exactmatch
dysplastic lhermitte-duclos gangliocytoma of mouse cerebellum;dysplastic lhermitte-duclos gangliocytoma of mouse cerebellum;exactmatch
mouse gangliocytoma;mouse gangliocytoma;exactmatch
mouse neuronal and mixed neuronal-glial tumours;mouse neuronal and mixed neuronal-glial tumours;exactmatch
mouse chordoid glioma of the 3rd ventricle;mouse chordoid glioma of the 3rd ventricle;exactmatch
mouse gliomatosis cerebri;mouse gliomatosis cerebri;exactmatch
mouse astroblastoma;mouse astroblastoma;exactmatch
mouse glial tumours of uncertain origin;mouse glial tumours of uncertain origin;exactmatch
mouse choroid plexus tumours;mouse choroid plexus tumours;exactmatch
mouse subependymoma;mouse subependymoma;exactmatch
mouse myxopapillary ependymoma;mouse myxopapillary ependymoma;exactmatch
mouse anaplastic ependymoma;mouse anaplastic ependymoma;exactmatch
mouse tanycytic ependymoma;mouse tanycytic ependymoma;exactmatch
mouse clear cell ependymoma;mouse clear cell ependymoma;exactmatch
hemangioma of the mouse skin;hemangioma of the mouse skin;exactmatch
benign mesenchymal neoplasms of the mouse skin;benign mesenchymal neoplasms of the mouse skin;exactmatch
tumors of the mouse meningothelial cells;tumors of the mouse meningothelial cells;exactmatch
papillary mammary carcinoma of mouse;papillary mammary carcinoma of mouse;exactmatch
adenosquamous metaplastic carcinoma of the mouse mammary gland;adenosquamous metaplastic carcinoma of the mouse mammary gland;exactmatch
metaplastic carcinoma of the mouse mammary gland;metaplastic carcinoma of the mouse mammary gland;exactmatch
monomorphic myoepithelial spindle cell carcinoma of the mouse mammary gland;monomorphic myoepithelial spindle cell carcinoma of the mouse mammary gland;exactmatch
myoepithelial and mixed glandular myoepithelial carcinoma of the mouse mammary gland;myoepithelial and mixed glandular myoepithelial carcinoma of the mouse mammary gland;exactmatch
myoepithelial carcinoma of the mouse mammary gland;myoepithelial carcinoma of the mouse mammary gland;exactmatch
other mammary carcinoma of mouse;other mammary carcinoma of mouse;exactmatch
solid mammary carcinoma of mouse;solid mammary carcinoma of mouse;exactmatch
cribriform mammary carcinoma of mouse;cribriform mammary carcinoma of mouse;exactmatch
osseous metaplastic carcinoma of the mouse mammary gland;osseous metaplastic carcinoma of the mouse mammary gland;exactmatch
glandular mammary carcinoma of mouse;glandular mammary carcinoma of mouse;exactmatch
acinar mammary carcinoma of mouse;acinar mammary carcinoma of mouse;exactmatch
luminal carcinoma of the mouse mammary gland;luminal carcinoma of the mouse mammary gland;exactmatch
carcinoma of the mouse mammary gland: histologic patterns;carcinoma of the mouse mammary gland: histologic patterns;exactmatch
malignant neoplasms of the mouse mammary gland;malignant neoplasms of the mouse mammary gland;exactmatch
carcinoma in situ of the mouse mammary gland;carcinoma in situ of the mouse mammary gland;exactmatch
high grade mouse min;high grade min;exactmatch
squamous metaplastic carcinoma of the mouse mammary gland;squamous metaplastic carcinoma of the mouse mammary gland;exactmatch
spindle cell metaplastic carcinoma of the mouse mammary gland;spindle cell metaplastic carcinoma of the mouse mammary gland;exactmatch
invasive carcinoma of the mouse prostate gland;ic of the mouse prostate gland;exactmatch
low grade mouse prostatic intraepithelial neoplasia;low grade mouse prostatic intraepithelial neoplasia;exactmatch
microinvasive neuroendocrine carcinoma of the mouse prostate gland;microinvasive ne carcinoma of the mouse prostate gland;exactmatch
undifferentiated microinvasive carcinoma of the mouse prostate gland;undifferentiated microinvasive carcinoma of the mouse prostate gland;exactmatch
microinvasive adenocarcinoma of the mouse prostate gland;microinvasive adenocarcinoma of the mouse prostate gland;exactmatch
microinvasive carcinoma of the mouse prostate gland;microinvasive carcinoma of the mouse prostate gland;exactmatch
carcinoma of the mouse prostate gland;carcinoma of the mouse prostate gland;exactmatch
malignant neoplasms of the mouse prostate gland;malignant neoplasms of the mouse prostate gland;exactmatch
high grade mouse prostatic intraepithelial neoplasia;high grade mouse prostatic intraepithelial neoplasia;exactmatch
prostatic intraepithelial neoplasia of the mouse prostate gland;prostatic intraepithelial neoplasia of the mouse prostate gland;exactmatch
other metaplastic carcinomas of the mouse mammary gland;other metaplastic carcinomas of the mouse mammary gland;exactmatch
combined epithelial / stromal atypical hyperplasia of the mouse prostate gland;combined epithelial / stromal atypical hyperplasia of the mouse prostate gland;exactmatch
stromal atypical hyperplasia of the mouse prostate gland;stromal atypical hyperplasia of the mouse prostate gland;exactmatch
epithelial atypical hyperplasia of the mouse prostate gland;epithelial atypical hyperplasia of the mouse prostate gland;exactmatch
atypical hyperplasia of the mouse prostate gland;atypical hyperplasia of the mouse prostate gland;exactmatch
high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;exactmatch
neoplasms of the mouse prostate gland;neoplasms of the mouse prostate gland;exactmatch
other cancer of the mouse mammary gland nos;other cancer of the mouse mammary gland nos;exactmatch
mixed mouse min nos;mixed min nos;exactmatch
solid mouse min nos;solid min nos;exactmatch
cystic mouse min nos;cystic min nos;exactmatch
mouse leiomyoma;mouse leiomyoma;exactmatch
mouse b cell neoplasms;mouse b cell neoplasms;exactmatch
mouse plasma cell neoplasm;mouse plasma cell neoplasm;exactmatch
mouse basal cell neoplasm;mouse basal cell neoplasm;exactmatch
mouse luminal carcinoma;mouse luminal carcinoma;exactmatch
mouse mixed neoplasm;mouse mixed neoplasm;exactmatch
mouse myoepithelioma;mouse myoepithelioma;exactmatch
mouse lipoma;mouse lipoma;exactmatch
mouse angioma;mouse angioma;exactmatch
simple mouse min nos;simple min nos;exactmatch
mouse mesothelioma;mouse mesothelioma;exactmatch
mouse hemangiopericytoma;mouse hemangiopericytoma;exactmatch
mouse intraepithelial neoplasia;mouse intraepithelial neoplasia;exactmatch
mouse malignant mesenchymal neoplasm;mouse malignant mesenchymal neoplasm;exactmatch
mouse benign mesenchymal neoplasm;mouse benign mesenchymal neoplasm;exactmatch
hematopoietic neoplasms of the mouse nose and paranasal sinuses;hematopoietic neoplasms of the mouse nose and paranasal sinuses;exactmatch
mouse liposarcoma;mouse liposarcoma;exactmatch
mouse t cell neoplasms;mouse t cell neoplasms;exactmatch
mouse plasmacytoma;mouse plasmacytoma;exactmatch
mouse mast cell neoplasm;mouse mast cell neoplasm;exactmatch
mouse granular cell neoplasm;mouse granular cell neoplasm;exactmatch
mouse min nos;min nos;exactmatch
ductal mouse min;ductal min;exactmatch
lobuloalveolar mouse min;lobuloalveolar min;exactmatch
low grade mouse min;low grade min;exactmatch
intraepithelial neoplasia of the mouse mammary gland;intraepithelial neoplasia of the mouse mammary gland;exactmatch
adenomyoepithelioma of the mouse mammary gland;adenomyoepithelioma of the mouse mammary gland;exactmatch
adenoma of the mouse mammary gland;adenoma of the mouse mammary gland;exactmatch
papilloma of the mouse mammary gland;papilloma of the mouse mammary gland;exactmatch
fibroadenoma of the mouse mammary gland;fibroadenoma of the mouse mammary gland;exactmatch
benign neoplasms of the mouse mammary gland;benign neoplasms of the mouse mammary gland;exactmatch
neoplasms of the mouse mammary gland;neoplasms of the mouse mammary gland;exactmatch
murine experimental organism diagnosis;murine experimental organism diagnosis;exactmatch
mouse clear cell neoplasm;mouse clear cell neoplasm;exactmatch
mouse stromal neoplasm;mouse stromal neoplasm;exactmatch
mouse hibernoma;mouse hibernoma;exactmatch
microinvasive small cell carcinoma of the mouse prostate gland;microinvasive small cell carcinoma of the mouse prostate gland;exactmatch
invasive adenocarcinoma of the mouse prostate gland;invasive adenocarcinoma of the mouse prostate gland;exactmatch
other adnexal neoplasms of the mouse skin;other adnexal neoplasms of the mouse skin;exactmatch
squamous neoplasms of the mouse skin;squamous neoplasms of the mouse skin;exactmatch
moderately-differentiated squamous cell carcinoma of the mouse skin;moderately-differentiated squamous cell carcinoma of the mouse skin;exactmatch
well-differentiated squamous cell carcinoma of the mouse skin;well-differentiated squamous cell carcinoma of the mouse skin;exactmatch
squamous cell carcinoma of the mouse skin;squamous cell carcinoma of the mouse skin;exactmatch
squamous cell carcinoma in situ of the mouse skin;squamous cell carcinoma in situ of the mouse skin;exactmatch
benign basal cell tumor of the mouse skin;benign basal cell tumor of the mouse skin;exactmatch
papilloma of the mouse skin;papilloma of the mouse skin;exactmatch
benign squamous neoplasms of the mouse skin;benign squamous neoplasms of the mouse skin;exactmatch
other mouse melanoma;other mouse melanoma;exactmatch
spindle-cell squamous cell carcinoma of the mouse skin;spindle-cell squamous cell carcinoma of the mouse skin;exactmatch
mouse amelanotic spindle and epithelioid melanoma;mouse amelanotic spindle and epithelioid melanoma;exactmatch
mouse spindle and epithelioid melanoma;mouse spindle and epithelioid melanoma;exactmatch
mouse amelanotic spindle-cell melanoma;mouse amelanotic spindle-cell melanoma;exactmatch
mouse spindle-cell melanoma;mouse spindle-cell melanoma;exactmatch
mouse amelanotic epithelioid melanoma;mouse amelanotic epithelioid melanoma;exactmatch
mouse epithelioid melanoma;mouse epithelioid melanoma;exactmatch
mouse melanoma;mouse melanoma;exactmatch
poorly-differentiated squamous cell carcinoma of the mouse skin;poorly-differentiated squamous cell carcinoma of the mouse skin;exactmatch
malignant basal cell tumor of the mouse skin;malignant basal cell tumor of the mouse skin;exactmatch
moderately differentiated invasive adenocarcinoma of the mouse prostate gland;moderately differentiated invasive adenocarcinoma of the mouse prostate gland;exactmatch
superficial basal cell carcinoma type of basaloid follicular neoplasm of the mouse skin;superficial basal cell carcinoma type of basaloid follicular neoplasm of the mouse skin;exactmatch
mixed tumors of the mouse skin;mixed tumors of the mouse skin;exactmatch
apocrine neoplasms of the mouse skin;apocrine neoplasms of the mouse skin;exactmatch
mouse eccrine neoplasms;mouse eccrine neoplasms;exactmatch
sebaceous carcinoma of the mouse skin;sebaceous carcinoma of the mouse skin;exactmatch
sebaceous adenoma of the mouse skin;sebaceous adenoma of the mouse skin;exactmatch
sebaceous neoplasms and hyperplasias of the mouse skin;sebaceous neoplasms and hyperplasias of the mouse skin;exactmatch
other variants of basaloid follicular neoplasm of the mouse skin;other variants of basaloid follicular neoplasm of the mouse skin;exactmatch
spiradenoma type of basaloid follicular neoplasm of the mouse skin;spiradenoma type of basaloid follicular neoplasm of the mouse skin;exactmatch
adnexal neoplasms of the mouse skin;adnexal neoplasms of the mouse skin;exactmatch
cylindroma type of basaloid follicular neoplasm of the mouse skin;cylindroma type of basaloid follicular neoplasm of the mouse skin;exactmatch
trichofolliculoma type of basaloid follicular neoplasm of the mouse skin;trichofolliculoma type of basaloid follicular neoplasm of the mouse skin;exactmatch
trichoepithelioma type of basaloid follicular neoplasm of the mouse skin;trichoepithelioma type of basaloid follicular neoplasm of the mouse skin;exactmatch
trichoblastoma type of basaloid follicular neoplasm of the mouse skin;trichoblastoma type of basaloid follicular neoplasm of the mouse skin;exactmatch
pilomatrixoma type of basaloid follicular neoplasm of the mouse skin;pilomatrixoma type of basaloid follicular neoplasm of the mouse skin;exactmatch
basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;exactmatch
follicular neoplasms of the mouse skin;follicular neoplasms of the mouse skin;exactmatch
mouse malignant melanocytic neoplasms;mouse malignant melanocytic neoplasms;exactmatch
mouse melanocytic neoplasms of uncertain malignant potential;mouse melanocytic neoplasms of uncertain malignant potential;exactmatch
mouse melanocytoma;mouse melanocytoma;exactmatch
leiomyosarcoma of the mouse prostate gland;leiomyosarcoma of the mouse prostate gland;exactmatch
papilloma of the mouse pulmonary system;papilloma of the mouse pulmonary system;exactmatch
benign tumors of the mouse pulmonary system;benign tumors of the mouse pulmonary system;exactmatch
carcinosarcoma of the mouse prostate gland;carcinosarcoma of the mouse prostate gland;exactmatch
sarcoma nos of the mouse prostate gland;sarcoma nos of the mouse prostate gland;exactmatch
osteosarcoma of the mouse prostate gland;osteosarcoma of the mouse prostate gland;exactmatch
chondrosarcoma of the mouse prostate gland;chondrosarcoma of the mouse prostate gland;exactmatch
rhabdomyosarcoma of the mouse prostate gland;rhabdomyosarcoma of the mouse prostate gland;exactmatch
sarcoma of the mouse prostate gland;sarcoma of the mouse prostate gland;exactmatch
mouse benign melanocytic neoplasms;mouse benign melanocytic neoplasms;exactmatch
adenosquamous cell carcinoma of the mouse prostate gland;adenosquamous cell carcinoma of the mouse prostate gland;exactmatch
squamous cell carcinoma of the mouse prostate gland;squamous cell carcinoma of the mouse prostate gland;exactmatch
spindle cell / sarcomatoid carcinoma of the mouse prostate gland;spindle cell / sarcomatoid carcinoma of the mouse prostate gland;exactmatch
invasive small cell carcinoma of the mouse prostate gland;invasive small cell carcinoma of the mouse prostate gland;exactmatch
invasive neuroendocrine carcinoma of the mouse prostate gland;invasive neuroendocrine carcinoma of the mouse prostate gland;exactmatch
undifferentiated invasive carcinoma of the mouse prostate gland;undifferentiated invasive carcinoma of the mouse prostate gland;exactmatch
poorly differentiated invasive adenocarcinoma of the mouse prostate gland;poorly differentiated invasive adenocarcinoma of the mouse prostate gland;exactmatch
adenoma of the mouse pulmonary system;adenoma of the mouse pulmonary system;exactmatch
papillary adenoma of the mouse pulmonary system;papillary adenoma of the mouse pulmonary system;exactmatch
solid adenoma of the mouse pulmonary system;solid adenoma of the mouse pulmonary system;exactmatch
adenoma of the mouse pulmonary system with mixed subtypes;adenoma of the mouse pulmonary system with mixed subtypes;exactmatch
mouse melanocytic neoplasms and proliferations;mouse melanocytic neoplasms and proliferations;exactmatch
neoplasms of the mouse skin;neoplasms and proliferations of the mouse skin;exactmatch
carcinoma, other, of the mouse pulmonary system;carcinoma, other, of the mouse pulmonary system;exactmatch
neuroendocrine carcinoma of the mouse pulmonary system;neuroendocrine carcinoma of the mouse pulmonary system;exactmatch
adenosquamous carcinoma of the mouse pulmonary system;adenosquamous carcinoma of the mouse pulmonary system;exactmatch
adenocarcinoma nos of the mouse pulmonary system;adenocarcinoma nos of the mouse pulmonary system;exactmatch
adenocarcinoma with mixed subtypes of the mouse pulmonary system;adenocarcinoma with mixed subtypes of the mouse pulmonary system;exactmatch
solid adenocarcinoma of the mouse pulmonary system;solid adenocarcinoma of the mouse pulmonary system;exactmatch
acinar adenocarcinoma of the mouse pulmonary system;acinar adenocarcinoma of the mouse pulmonary system;exactmatch
papillary adenocarcinoma of the mouse pulmonary system;papillary adenocarcinoma of the mouse pulmonary system;exactmatch
adenocarcinoma of the mouse pulmonary system;adenocarcinoma of the mouse pulmonary system;exactmatch
squamous cell carcinoma of the mouse pulmonary system;squamous cell carcinoma of the mouse pulmonary system;exactmatch
malignant tumors of the mouse pulmonary system;malignant tumors of the mouse pulmonary system;exactmatch
squamous dysplasia of the mouse pulmonary system;squamous dysplasia of the mouse pulmonary system;exactmatch
preinvasive lesions of the mouse pulmonary system;preinvasive lesions of the mouse pulmonary system;exactmatch
tumors of the mouse meninges;tumors of the mouse meninges;exactmatch
mouse fibroma;mouse fibroma;exactmatch
mouse meningioma;mouse meningioma;exactmatch
hemangiopericytoma of the mouse blood vessel, malignant;hemangiopericytoma of the mouse blood vessel, malignant;exactmatch
osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;exactmatch
osteosarcoma of the mouse skeletal system, nos;osteosarcoma of the mouse skeletal system, nos;exactmatch
osteoma of the mouse skeletal system, nos;osteoma of the mouse skeletal system, nos;exactmatch
mouse skeletal system neoplasms;mouse skeletal system neoplasms;exactmatch
hemangioblastoma of the mouse blood vessel;hemangioblastoma of the mouse blood vessel;exactmatch
acquired tufted hemangioma of the mouse blood vessel;acquired tufted hemangioma of the mouse blood vessel;exactmatch
angiofibroma of the mouse blood vessel, nos;angiofibroma of the mouse blood vessel, nos;exactmatch
hemangiopericytoma of the mouse blood vessel, nos;hemangiopericytoma of the mouse blood vessel, nos;exactmatch
fibroblastic osteosarcoma of the mouse skeletal system;fibroblastic osteosarcoma of the mouse skeletal system;exactmatch
hemangiopericytoma of the mouse blood vessel, benign;hemangiopericytoma of the mouse blood vessel, benign;exactmatch
verrucous keratotic hemangioma of the mouse blood vessel;verrucous keratotic hemangioma of the mouse blood vessel;exactmatch
angiokeratoma of the mouse blood vessel;angiokeratoma of the mouse blood vessel;exactmatch
kaposi sarcoma of the mouse blood vessel;kaposi sarcoma of the mouse blood vessel;exactmatch
spindle cell hemangioendothelioma of the mouse blood vessel;spindle cell hemangioendothelioma of the mouse blood vessel;exactmatch
endovascular papillary angioendothelioma of the mouse blood vessel;endovascular papillary angioendothelioma of the mouse blood vessel;exactmatch
kupffer cell sarcoma of the mouse blood vessel;kupffer cell sarcoma of the mouse blood vessel;exactmatch
chondroblastic osteosarcoma of the mouse skeletal system;chondroblastic osteosarcoma of the mouse skeletal system;exactmatch
telangiectatic osteosarcoma of the mouse skeletal system;telangiectatic osteosarcoma of the mouse skeletal system;exactmatch
chondroblastoma of the mouse skeletal system, nos;chondroblastoma of the mouse skeletal system, nos;exactmatch
osteoblastoma of the mouse skeletal system, nos;osteoblastoma of the mouse skeletal system, nos;exactmatch
juxtacortical chondroma of the mouse skeletal system;juxtacortical chondroma of the mouse skeletal system;exactmatch
chondrosarcoma of the mouse skeletal system, nos;chondrosarcoma of the mouse skeletal system, nos;exactmatch
chondromatosis of the mouse skeletal system, nos;chondromatosis of the mouse skeletal system, nos;exactmatch
chondroma of the mouse skeletal system, nos;chondroma of the mouse skeletal system, nos;exactmatch
osteochondromatosis of the mouse skeletal system, nos;osteochondromatosis of the mouse skeletal system, nos;exactmatch
osteochondroma of the mouse skeletal system;osteochondroma of the mouse skeletal system;exactmatch
aggressive osteoblastoma of the mouse skeletal system;aggressive osteoblastoma of the mouse skeletal system;exactmatch
intracortical osteosarcoma of the mouse skeletal system;intracortical osteosarcoma of the mouse skeletal system;exactmatch
osteosarcoma in paget disease of the mouse skeletal system;osteosarcoma in paget disease of the mouse skeletal system;exactmatch
high grade surface osteosarcoma of the mouse skeletal system;high grade surface osteosarcoma of the mouse skeletal system;exactmatch
periosteal osteosarcoma of the mouse skeletal system;periosteal osteosarcoma of the mouse skeletal system;exactmatch
parosteal osteosarcoma of the mouse skeletal system;parosteal osteosarcoma of the mouse skeletal system;exactmatch
osteoid osteoma of the mouse skeletal system, nos;osteoid osteoma of the mouse skeletal system, nos;exactmatch
intraosseous well differentiated osteosarcoma of the mouse skeletal system;intraosseous well differentiated osteosarcoma of the mouse skeletal system;exactmatch
central osteosarcoma of the mouse skeletal system;central osteosarcoma of the mouse skeletal system;exactmatch
small cell osteosarcoma of the mouse skeletal system;small cell osteosarcoma of the mouse skeletal system;exactmatch
intramuscular hemangioma of the mouse blood vessel;intramuscular hemangioma of the mouse blood vessel;exactmatch
capillary hemangioma of the mouse blood vessel;capillary hemangioma of the mouse blood vessel;exactmatch
hemangioendothelioma of the mouse blood vessel, malignant;hemangioendothelioma of the mouse blood vessel, malignant;exactmatch
mouse adipose tissue;adipose tissue (mmhcc);exactmatch
mouse primary cardiac tumors;mouse primary cardiac tumors;exactmatch
mouse bladder;bladder (mmhcc);exactmatch
mouse urinary system;mouse renal/urologic body system;exactmatch
mouse nasal cavity;mouse nasal cavity;exactmatch
mouse nose;mouse nose;exactmatch
mouse special sensory organ;mouse organ of special sense;exactmatch
mouse periosteum;mouse periosteum;exactmatch
mouse connective tissue;connective tissue (mmhcc);exactmatch
hemangioendothelioma of the mouse blood vessel, nos;hemangioendothelioma of the mouse blood vessel, nos;exactmatch
mouse muscle;mouse muscle;exactmatch
mouse cartilage;cartilage (mmhcc);exactmatch
mouse soft tissue;mouse soft tissue;exactmatch
mouse skeletal system;mouse skeletal system;exactmatch
mouse uterus;mouse uterus;exactmatch
mouse placenta;mouse placenta;exactmatch
mouse oviduct;mouse oviduct;exactmatch
mouse cardiac sarcoma;mouse cardiac sarcoma;exactmatch
mouse cardiac angiosarcoma;mouse cardiac angiosarcoma;exactmatch
mouse cardiac rhabdomyosarcoma;mouse cardiac rhabdomyosarcoma;exactmatch
mouse cardiac mesothelioma;mouse cardiac mesothelioma;exactmatch
hemangioendothelioma of the mouse blood vessel, benign;hemangioendothelioma of the mouse blood vessel, benign;exactmatch
hemangioma of the mouse blood vessel, nos;hemangioma of the mouse blood vessel, nos;exactmatch
epithelioid hemangioma of the mouse blood vessel;epithelioid hemangioma of the mouse blood vessel;exactmatch
epithelioid hemangioma of the mouse blood vessel, malignant;epithelioid hemangioma of the mouse blood vessel, malignant;exactmatch
epithelioid hemangioma of the mouse blood vessel, nos;epithelioid hemangioma of the mouse blood vessel, nos;exactmatch
racemose hemangioma of the mouse blood vessel;racemose hemangioma of the mouse blood vessel;exactmatch
venous hemangioma of the mouse blood vessel;venous hemangioma of the mouse blood vessel;exactmatch
cavernous hemangioma of the mouse blood vessel;cavernous hemangioma of the mouse blood vessel;exactmatch
hemangiosarcoma of the mouse blood vessel;hemangiosarcoma of the mouse blood vessel;exactmatch
hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;exactmatch
mouse primary tumors of the blood vessel;mouse primary tumors of the blood vessel;exactmatch
mouse cardiovascular system neoplasms;mouse cardiovascular system neoplasms;exactmatch
mouse cardiac kaposi's sarcoma;mouse cardiac kaposi's sarcoma;exactmatch
mouse cardiac malignant fibrous histiocytoma;mouse cardiac malignant fibrous histiocytoma;exactmatch
mouse cardiac fibrosarcoma;mouse cardiac fibrosarcoma;exactmatch
juxtacortical chondrosarcoma of the mouse skeletal system;juxtacortical chondrosarcoma of the mouse skeletal system;exactmatch
chondroblastoma of the mouse skeletal system, malignant;chondroblastoma of the mouse skeletal system, malignant;exactmatch
mouse female reproductive system;female reproductive system (mmhcc);exactmatch
non-keratinizing carcinoma of the mouse pharynx;non-keratinizing carcinoma of the mouse pharynx;exactmatch
embryonal rhabdomyosarcoma of the mouse pharynx;embryonal rhabdomyosarcoma of the mouse pharynx;exactmatch
skeletal muscle neoplasms of the mouse pharynx;skeletal muscle neoplasms of the mouse pharynx;exactmatch
undifferentiated carcinoma of the mouse pharynx with lymphoid stroma;undifferentiated carcinoma of the mouse pharynx with lymphoid stroma;exactmatch
undifferentiated carcinoma of the mouse pharynx without lymphoid stroma;undifferentiated carcinoma of the mouse pharynx without lymphoid stroma;exactmatch
undifferentiated carcinoma of the mouse pharynx;undifferentiated carcinoma of the mouse pharynx;exactmatch
non-keratinizing carcinoma of the mouse pharynx with lymphoid stroma;non-keratinizing carcinoma of the mouse pharynx with lymphoid stroma;exactmatch
non-keratinizing carcinoma of the mouse pharynx without lymphoid stroma;non-keratinizing carcinoma of the mouse pharynx without lymphoid stroma;exactmatch
squamous cell carcinoma of the mouse pharynx;squamous cell carcinoma of the mouse pharynx;exactmatch
synovial sarcoma of the mouse pharynx;synovial sarcoma of the mouse pharynx;exactmatch
epithelial neoplasms of the mouse pharynx;epithelial neoplasms of the mouse pharynx;exactmatch
mouse pharyngeal neoplasms;mouse pharyngeal neoplasms;exactmatch
plasmacytoma of the mouse oral cavity;plasmacytoma of the mouse oral cavity;exactmatch
plasma cell neoplasms of the mouse oral cavity;plasma cell neoplasms of the mouse oral cavity;exactmatch
lymphoma of the mouse oral cavity;lymphoma of the mouse oral cavity;exactmatch
lymphoproliferative neoplasms of the mouse oral cavity;lymphoproliferative neoplasms of the mouse oral cavity;exactmatch
hematopoietic neoplasms of the mouse oral cavity;hematopoietic neoplasms of the mouse oral cavity;exactmatch
synovial neoplasms of the mouse pharynx;synovial neoplasms of the mouse pharynx;exactmatch
vascular-fibrous neoplasms of the mouse pharynx;vascular-fibrous neoplasms of the mouse pharynx;exactmatch
myxoid chondrosarcoma of the mouse skeletal system;myxoid chondrosarcoma of the mouse skeletal system;exactmatch
squamous cell carcinoma of the mouse nose and paranasal sinuses;squamous cell carcinoma of the mouse nose and paranasal sinuses;exactmatch
melanocytic neoplasms of the mouse nose and paranasal sinuses;melanocytic neoplasms of the mouse nose and paranasal sinuses;exactmatch
mouse meningothelial meningioma;mouse meningothelial meningioma;exactmatch
olfactory neuroblastoma of the mouse nose and paranasal sinuses;olfactory neuroblastoma of the mouse nose and paranasal sinuses;exactmatch
neural neoplasms of the mouse nose and paranasal sinuses;neural neoplasms of the mouse nose and paranasal sinuses;exactmatch
adenocarcinoma of the mouse nose and paranasal sinuses;adenocarcinoma of the mouse nose and paranasal sinuses;exactmatch
melanoma of the mouse nose and paranasal sinuses;melanoma of the mouse nose and paranasal sinuses;exactmatch
verrucous carcinoma of the mouse nose and paranasal sinuses;verrucous carcinoma of the mouse nose and paranasal sinuses;exactmatch
papilloma of the mouse nose and paranasal sinuses;papilloma of the mouse nose and paranasal sinuses;exactmatch
angiofibroma of the mouse pharynx;angiofibroma of the mouse pharynx;exactmatch
epithelial neoplasms of the mouse nose and paranasal sinuses;epithelial neoplasms of the mouse nose and paranasal sinuses;exactmatch
mouse nose and paranasal sinuses neoplasms;mouse nose and paranasal sinuses neoplasms;exactmatch
plasmacytoma of the mouse pharynx;plasmacytoma of the mouse pharynx;exactmatch
plasma cell neoplasms of the mouse pharynx;plasma cell neoplasms of the mouse pharynx;exactmatch
lymphoma of the mouse pharynx;lymphoma of the mouse pharynx;exactmatch
lymphoproliferative neoplasms of the mouse pharynx;lymphoproliferative neoplasms of the mouse pharynx;exactmatch
hematopoietic neoplasms of the mouse pharynx;hematopoietic neoplasms of the mouse pharynx;exactmatch
melanoma of the mouse oral cavity;melanoma of the mouse oral cavity;exactmatch
melanocytic neoplasms of the mouse oral cavity;melanocytic neoplasms of the mouse oral cavity;exactmatch
synovial sarcoma of the mouse oral cavity;synovial sarcoma of the mouse oral cavity;exactmatch
mouse pituitary carcinoma, nos;mouse pituitary carcinoma, nos;exactmatch
mouse adrenal cortical adenoma, glomerulosa cell;mouse adrenal cortical adenoma, glomerulosa cell;exactmatch
mouse adrenal cortical adenoma, clear cell;mouse adrenal cortical adenoma, clear cell;exactmatch
mouse adrenal cortical adenoma, pigmented;mouse adrenal cortical adenoma, pigmented;exactmatch
mouse adrenal cortical adenoma;mouse adrenal cortical adenoma;exactmatch
mouse adrenal cortical adenoma, compact cell;mouse adrenal cortical adenoma, compact cell;exactmatch
mouse adrenal cortical carcinoma;mouse adrenal cortex carcinoma;exactmatch
mouse adrenal cortical adenoma, nos;mouse adrenal cortical adenoma, nos;exactmatch
mouse pituitary adenoma, nos;mouse pituitary adenoma, nos;exactmatch
synovial neoplasms of the mouse oral cavity;synovial neoplasms of the mouse oral cavity;exactmatch
mouse endocrine gland system neoplasms;mouse endocrine gland system neoplasms;exactmatch
giant cell tumor of bone of the mouse skeletal system, malignant;giant cell tumor of bone of the mouse skeletal system, malignant;exactmatch
giant cell tumor of bone of the mouse skeletal system, nos;giant cell tumor of bone of the mouse skeletal system, nos;exactmatch
dedifferentiated chondrosarcoma of the mouse skeletal system;dedifferentiated chondrosarcoma of the mouse skeletal system;exactmatch
clear cell chondrosarcoma of the mouse skeletal system;clear cell chondrosarcoma of the mouse skeletal system;exactmatch
chondromyxoid fibroma of the mouse skeletal system;chondromyxoid fibroma of the mouse skeletal system;exactmatch
mesenchymal chondrosarcoma of the mouse skeletal system;mesenchymal chondrosarcoma of the mouse skeletal system;exactmatch
mouse adrenal cortical adenoma, mixed cell;mouse adrenal cortical adenoma, mixed cell;exactmatch
t cell neoplasms of undetermined character of the mouse hematologic system;t cell neoplasms of undetermined character of the mouse hematologic system;exactmatch
burkitt-like lymphoma of the mouse hematologic system;burkitt-like lymphoma of the mouse hematologic system;exactmatch
morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;exactmatch
neurofibroma of the mouse oral cavity;neurofibroma of the mouse oral cavity;exactmatch
neurilemoma of the mouse oral cavity;neurilemoma of the mouse oral cavity;exactmatch
neural neoplasms of the mouse oral cavity;neural neoplasms of the mouse oral cavity;exactmatch
leiomyosarcoma of the mouse oral cavity;leiomyosarcoma of the mouse oral cavity;exactmatch
leiomyoma of the mouse oral cavity;leiomyoma of the mouse oral cavity;exactmatch
smooth muscle neoplasms of the mouse oral cavity;smooth muscle neoplasms of the mouse oral cavity;exactmatch
adenosquamous cell carcinoma of the mouse oral cavity;adenosquamous cell carcinoma of the mouse oral cavity;exactmatch
verrucous carcinoma of the mouse oral cavity;verrucous carcinoma of the mouse oral cavity;exactmatch
squamous cell carcinoma in-situ of the mouse oral cavity;squamous cell carcinoma in-situ of the mouse oral cavity;exactmatch
squamous cell carcinoma of the mouse oral cavity;squamous cell carcinoma of the mouse oral cavity;exactmatch
carcinoma of the mouse oral cavity;carcinoma of the mouse oral cavity;exactmatch
epithelial neoplasms of the mouse oral cavity;epithelial neoplasms of the mouse oral cavity;exactmatch
mouse oral cavity neoplasms;mouse oral cavity neoplasms;exactmatch
mouse head and neck neoplasms;mouse head and neck neoplasms;exactmatch
subtypes of diffuse large b cell lymphoma of the mouse hematologic system;subtypes of diffuse large b cell lymphoma of the mouse hematologic system;exactmatch
mouse ovary;mouse ovary;exactmatch
carcinoma of the mouse nose and paranasal sinuses;carcinoma of the mouse nose and paranasal sinuses;exactmatch
mouse thyroid gland;mouse thyroid;exactmatch
germinoma of the mouse nervous system;germinoma of the mouse nervous system;exactmatch
teratoma of the mouse nervous system with malignant transformation;teratoma of the mouse nervous system with malignant transformation;exactmatch
immature teratoma of the mouse nervous system;immature teratoma of the mouse nervous system;exactmatch
mature teratoma of the mouse nervous system;mature teratoma of the mouse nervous system;exactmatch
teratoma of the mouse nervous system;teratoma of the mouse nervous system;exactmatch
choriocarcinoma of the mouse nervous system;choriocarcinoma of the mouse nervous system;exactmatch
yolk sac tumour of the mouse nervous system;yolk sac tumour of the mouse nervous system;exactmatch
embryonal carcinoma of the mouse nervous system;embryonal carcinoma of the mouse nervous system;exactmatch
germ cell tumors of the mouse nervous system;germ cell tumors of the mouse nervous system;exactmatch
tumors of the mouse sellar region;tumors of the mouse sellar region;exactmatch
granulocytic sarcoma of the mouse nervous system;granulocytic sarcoma of the mouse nervous system;exactmatch
plasmacytoma of the mouse nervous system;plasmacytoma of the mouse nervous system;exactmatch
malignant lymphomas of the mouse nervous system;malignant lymphomas of the mouse nervous system;exactmatch
lymphomas and haemopoietic neoplasms of the mouse nervous system;lymphomas and haemopoietic neoplasms of the mouse nervous system;exactmatch
mouse hemangioblastoma;mouse hemangioblastoma;exactmatch
mouse nervous system tumors of uncertain histogenesis;mouse nervous system tumors of uncertain histogenesis;exactmatch
mouse fibrous / fibroblastic meningioma;mouse fibrous / fibroblastic meningioma;exactmatch
mixed germ cell tumours of the mouse nervous system;mixed germ cell tumours of the mouse nervous system;exactmatch
mouse craniopharyngioma;mouse craniopharyngioma;exactmatch
malignant melanoma of the mouse nervous system;malignant melanoma of the mouse nervous system;exactmatch
adenoma of the mouse intestinal tract;adenoma of the mouse intestinal tract;exactmatch
high grade sessile villous dysplasia of the mouse intestinal tract;high grade sessile villous dysplasia of the mouse intestinal tract;exactmatch
low grade sessile villous dysplasia of the mouse intestinal tract;low grade sessile villous dysplasia of the mouse intestinal tract;exactmatch
sessile villous adenoma of the mouse intestinal tract;sessile villous adenoma of the mouse intestinal tract;exactmatch
high grade sessile tubular dysplasia of the mouse intestinal tract;high grade sessile tubular dysplasia of the mouse intestinal tract;exactmatch
low grade sessile tubular dysplasia of the mouse intestinal tract;low grade sessile tubular dysplasia of the mouse intestinal tract;exactmatch
sessile tubular adenoma of the mouse intestinal tract;sessile tubular adenoma of the mouse intestinal tract;exactmatch
sessile adenoma of the mouse intestinal tract;sessile adenoma of the mouse intestinal tract;exactmatch
benign neoplasms of the mouse intestinal tract;benign neoplasms of the mouse intestinal tract;exactmatch
mouse adamantinomatous craniopharyngioma;mouse adamantinomatous craniopharyngioma;exactmatch
gastrointestinal intraepithelial neoplasia of mouse;gastro-intestinal intraepithelial neoplasia;exactmatch
neoplasms of the mouse intestinal tract;neoplasms of the mouse intestinal tract;exactmatch
acute enteritis of the mouse intestinal tract;acute enteritis of the mouse intestinal tract;exactmatch
inflammatory diseases of the mouse intestinal tract;inflammatory diseases of the mouse intestinal tract;exactmatch
metastatic tumours of the mouse nervous system;metastatic tumours of the mouse nervous system;exactmatch
granular cell tumor of the mouse sellar region;granular cell tumor of the mouse sellar region;exactmatch
mouse papillary craniopharyngioma;mouse papillary craniopharyngioma;exactmatch
mouse meningeal melanomatosis;mouse meningeal melanomatosis;exactmatch
melanocytoma of the mouse nervous system;melanocytoma of the mouse nervous system;exactmatch
low grade sessile tubulovillous dysplasia of the mouse intestinal tract;low grade sessile tubulovillous dysplasia of the mouse intestinal tract;exactmatch
mouse chordoid meningioma;mouse chordoid meningioma;exactmatch
angiolipoma of the mouse nervous system;angiolipoma of the mouse nervous system;exactmatch
lipoma of the mouse nervous system;lipoma of the mouse nervous system;exactmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;exactmatch
mouse anaplastic meningioma;mouse anaplastic meningioma;exactmatch
mouse rhabdoid meningioma;mouse rhabdoid meningioma;exactmatch
mouse papillary meningioma;mouse papillary meningioma;exactmatch
atypical mouse meningioma;atypical mouse meningioma;exactmatch
mouse clear cell meningioma;mouse clear cell meningioma;exactmatch
intracranial liposarcoma of the mouse nervous system;intracranial liposarcoma of the mouse nervous system;exactmatch
mouse transitional mixed meningioma;mouse transitional mixed meningioma;exactmatch
mouse lymphoplasmacyte-rich meningioma;mouse lymphoplasmacyte-rich meningioma;exactmatch
mouse secretory meningioma;mouse secretory meningioma;exactmatch
mouse microcystic meningioma;mouse microcystic meningioma;exactmatch
mouse angiomatous meningioma;mouse angiomatous meningioma;exactmatch
mouse psammomatous meningioma;mouse psammomatous meningioma;exactmatch
mouse pituitary gland;mouse hypophysis;exactmatch
hibernoma of the mouse nervous system;hibernoma of the mouse nervous system;exactmatch
solitary fibrous tumour of the mouse nervous system;solitary fibrous tumour of the mouse nervous system;exactmatch
diffuse melanocytosis of the mouse nervous system;diffuse melanocytosis of the mouse nervous system;exactmatch
osteosarcoma of the mouse nervous system;osteosarcoma of the mouse nervous system;exactmatch
primary melanocytic lesions of the mouse nervous system;primary melanocytic lesions of the mouse nervous system;exactmatch
kaposi sarcoma of the mouse nervous system;kaposi sarcoma of the mouse nervous system;exactmatch
angiosarcoma of the mouse nervous system;angiosarcoma of the mouse nervous system;exactmatch
hemangiopericytoma of the mouse nervous system;haemangiopericytoma of the mouse nervous system;exactmatch
epithelioid haemangioendothelioma of the mouse nervous system;epithelioid haemangioendothelioma of the mouse nervous system;exactmatch
hemangioma of the mouse nervous system;haemangioma of the mouse nervous system;exactmatch
osteochondroma of the mouse nervous system;osteochondroma of the mouse nervous system;exactmatch
osteoma of the mouse nervous system;osteoma of the mouse nervous system;exactmatch
fibrosarcoma of the mouse nervous system;fibrosarcoma of the mouse nervous system;exactmatch
chondrosarcoma of the mouse nervous system;chondrosarcoma of the mouse nervous system;exactmatch
chondroma of the mouse nervous system;chondroma of the mouse nervous system;exactmatch
rhabdomyosarcoma of the mouse nervous system;rhabdomyosarcoma of the mouse nervous system;exactmatch
rhabdomyoma of the mouse nervous system;rhabdomyoma of the mouse nervous system;exactmatch
leiomyosarcoma of the mouse nervous system;leiomyosarcoma of the mouse nervous system;exactmatch
leiomyoma of the mouse nervous system;leiomyoma of the mouse nervous system;exactmatch
malignant fibrous histiocytoma of the mouse nervous system;malignant fibrous histiocytoma of the mouse nervous system;exactmatch
sessile tubulovillous adenoma of the mouse intestinal tract;sessile tubulovillous adenoma of the mouse intestinal tract;exactmatch
mouse metaplastic meningioma;mouse metaplastic meningioma;exactmatch
high grade sessile tubulovillous dysplasia of the mouse intestinal tract;high grade sessile tubulovillous dysplasia of the mouse intestinal tract;exactmatch
mouse gastrointestinal tract;gastrointestinal tract (mmhcc);exactmatch
mouse melanocyte;mouse melanocyte;exactmatch
mouse skin;mouse integument;exactmatch
mouse integument system;integument system (mmhcc);exactmatch
mouse intestine;intestine (mmhcc);exactmatch
mouse gallbladder;gallbladder;exactmatch
mouse liver;liver (mmhcc);exactmatch
mouse stomach;mouse stomach;exactmatch
mouse pharynx;mouse pharynx;exactmatch
mouse prostate gland;mouse prostate;exactmatch
mouse salivary gland;mouse salivary gland;exactmatch
mouse oral cavity;mouse buccal cavity;exactmatch
mouse digestive system;digestive system (mmhcc);exactmatch
mouse blood vessel;blood vessel (mmhcc);exactmatch
mouse heart;heart (mmhcc);exactmatch
mouse cardiovascular system;cardiovascular system (mmhcc);exactmatch
experimental organism anatomical concept;experimental organism anatomical concept;exactmatch
mouse hair follicle;mouse hair follicle;exactmatch
mouse skin gland;mouse skin gland;exactmatch
mouse sebaceous gland;mouse sebaceous gland;exactmatch
mouse mammary gland;mammary gland (mmhcc);exactmatch
mouse endocrine gland system;endocrine gland system (mmhcc);exactmatch
mouse peripheral nervous system;mouse peripheral nervous system;exactmatch
mouse neuroblast;mouse neuroblast;exactmatch
mouse oligodendroglial cell;mouse oligodendrocyte;exactmatch
mouse adrenal gland;adrenal gland (mmhcc);exactmatch
mouse ependyma;cns - brain - ependyma (mmhcc);exactmatch
mouse choroid plexus;cns - brain - choroid plexus (mmhcc);exactmatch
mouse astrocyte;mouse astrocyte;exactmatch
mouse brain;cns - brain (mmhcc);exactmatch
mouse central nervous system;cns (mmhcc);exactmatch
mouse nervous system;mouse nervous system;exactmatch
mouse larynx;larynx (mmhcc);exactmatch
mouse respiratory system;mouse pulmonary body system;exactmatch
mouse bone marrow;bone marrow (mmhcc);exactmatch
mouse lymphohematopoietic system;lymphohematopoietic system (mmhcc);exactmatch
experimental organism diagnosis;experimental organism diagnosis;exactmatch
mouse meninges;cns - brain - meninges (mmhcc);exactmatch
mouse male reproductive system;male reproductive system (mmhcc);exactmatch
high grade flat tubulovillous dysplasia of the mouse intestinal tract;high grade flat tubulovillous dysplasia of the mouse intestinal tract;exactmatch
high grade pedunculated tubulovillous dysplasia of the mouse intestinal tract;high grade pedunculated tubulovillous dysplasia of the mouse intestinal tract;exactmatch
low grade pedunculated tubulovillous dysplasia of the mouse intestinal tract;low grade pedunculated tubulovillous dysplasia of the mouse intestinal tract;exactmatch
pedunculated tubulovillous adenoma of the mouse intestinal tract;pedunculated tubulovillous adenoma of the mouse intestinal tract;exactmatch
high grade pedunculated tubular dysplasia of the mouse intestinal tract;high grade pedunculated tubular dysplasia of the mouse intestinal tract;exactmatch
low grade pedunculated tubular dysplasia of the mouse intestinal tract;low grade pedunculated tubular dysplasia of the mouse intestinal tract;exactmatch
pedunculated tubular adenoma of the mouse intestinal tract;pedunculated tubular adenoma of the mouse intestinal tract;exactmatch
pedunculated adenoma of the mouse intestinal tract;pedunculated adenoma of the mouse intestinal tract;exactmatch
low grade flat tubulovillous dysplasia of the mouse intestinal tract;low grade flat tubulovillous dysplasia of the mouse intestinal tract;exactmatch
leiomyoma of the mouse intestinal tract;leiomyoma of the mouse intestinal tract;exactmatch
flat tubulovillous adenoma of the mouse intestinal tract;flat tubulovillous adenoma of the mouse intestinal tract;exactmatch
high grade flat villous dysplasia of the mouse intestinal tract;high grade flat villous dysplasia of the mouse intestinal tract;exactmatch
low grade flat villous dysplasia of the mouse intestinal tract;low grade flat villous dysplasia of the mouse intestinal tract;exactmatch
high grade flat tubular dysplasia of the mouse intestinal tract;high grade flat tubular dysplasia of the mouse intestinal tract;exactmatch
low grade flat tubular dysplasia of the mouse intestinal tract;low grade flat tubular dysplasia of the mouse intestinal tract;exactmatch
mouse anatomy concepts;mouse anatomy;exactmatch
flat tubular adenoma of the mouse intestinal tract;flat tubular adenoma of the mouse intestinal tract;exactmatch
fibroma of the mouse intestinal tract;fibroma of the mouse intestinal tract;exactmatch
flat villous adenoma of the mouse intestinal tract;flat villous adenoma of the mouse intestinal tract;exactmatch
lipoma of the mouse intestinal tract;lipoma of the mouse intestinal tract;exactmatch
villous adenocarcinoma of the mouse intestinal tract;villous adenocarcinoma of the mouse intestinal tract;exactmatch
flat adenoma of the mouse intestinal tract;flat adenoma of the mouse intestinal tract;exactmatch
hemangiosarcoma of the mouse intestinal tract;hemangiosarcoma of the mouse intestinal tract;exactmatch
lymphoma of the mouse intestinal tract;lymphoma of the mouse intestinal tract;exactmatch
leiomyosarcoma of the mouse intestinal tract;leiomyosarcoma of the mouse intestinal tract;exactmatch
neuroendocrine cell carcinoma of the mouse intestinal tract;neuroendocrine cell carcinoma of the mouse intestinal tract;exactmatch
fibrosarcoma of the mouse intestinal tract;fibrosarcoma of the mouse intestinal tract;exactmatch
signet ring cell adenocarcinoma of the mouse intestinal tract;signet ring cell adenocarcinoma of the mouse intestinal tract;exactmatch
squamous cell carcinoma of the mouse intestinal tract;squamous cell carcinoma of the mouse intestinal tract;exactmatch
mucinous adenocarcinoma of the mouse intestinal tract;mucinous adenocarcinoma of the mouse intestinal tract;exactmatch
liposarcoma of the mouse intestinal tract;liposarcoma of the mouse intestinal tract;exactmatch
tubular adenocarcinoma of the mouse intestinal tract;tubular adenocarcinoma of the mouse intestinal tract;exactmatch
adenocarcinoma of the mouse intestinal tract;adenocarcinoma of the mouse intestinal tract;exactmatch
malignant neoplasms of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;exactmatch
neuroendocrine adenoma of the mouse intestinal tract;neuroendocrine adenoma of the mouse intestinal tract;exactmatch
hemangioma of the mouse intestinal tract;hemangioma of the mouse intestinal tract;exactmatch
mouse thyroid sarcoma;mouse thyroid angiosarcoma;narrowmatch
mouse connective and soft tissue neoplasms;mouse chondrogenic neoplasm;narrowmatch
mouse chondrogenic neoplasm;mouse chondrocyte neoplasm;narrowmatch
mouse mesenchymal neoplasm;mouse chondrocyte neoplasm;narrowmatch
mouse anatomy concepts;mouse musculoskeletal system;narrowmatch
mouse anatomy concepts;mouse reproductive system;narrowmatch
mouse thyroid lymphoma;mouse thyroid hodgkin's lymphoma;narrowmatch
malignant mouse thyroid neoplasm;mouse thyroid sarcoma;narrowmatch
malignant mouse thyroid neoplasm;mouse thyroid plasmacytoma;narrowmatch
mouse thyroid diffuse large b-cell lymphoma;mouse thyroid immunoblastic lymphoma;narrowmatch
mouse thyroid non-hodgkin's lymphoma;mouse thyroid diffuse large b-cell lymphoma;narrowmatch
mouse thyroid lymphoma;mouse thyroid non-hodgkin's lymphoma;narrowmatch
mouse gastric neoplasm;benign mouse gastric neoplasm;narrowmatch
malignant mouse thyroid neoplasm;mouse thyroid lymphoma;narrowmatch
well-differentiated mouse thyroid carcinoma;mouse papillary and follicular adenocarcinoma;narrowmatch
mouse gastrointestinal system neoplasms;mouse gastric neoplasm;narrowmatch
mouse gastric leiomyoma;mouse gastric epithelioid leiomyoma;narrowmatch
benign mouse gastric neoplasm;benign mouse gastric gastrointestinal stromal neoplasm;narrowmatch
malignant mouse gastric germ cell neoplasm;immature mouse gastric teratoma;narrowmatch
mouse gastric mesenchymal neoplasm;mouse gastric hemangioma;narrowmatch
malignant mouse gastric neoplasm;malignant mouse gastric gastrointestinal stromal tumor;narrowmatch
mouse gastric gastrointestinal stromal tumor;malignant mouse gastric gastrointestinal stromal tumor;narrowmatch
well-differentiated mouse thyroid carcinoma;mouse papillary thyroid carcinoma;narrowmatch
mouse gastric mesenchymal neoplasm;mouse gastric gastrointestinal stromal tumor;narrowmatch
mouse gastric neoplasm;mouse gastric mesenchymal neoplasm;narrowmatch
mouse gastric teratoma;immature mouse gastric teratoma;narrowmatch
malignant mouse gastric neoplasm;malignant mouse gastric germ cell neoplasm;narrowmatch
mouse gastric gastrointestinal stromal tumor;benign mouse gastric gastrointestinal stromal neoplasm;narrowmatch
mouse gastric germ cell neoplasm;malignant mouse gastric germ cell neoplasm;narrowmatch
mouse gastric neoplasm;mouse gastric germ cell neoplasm;narrowmatch
benign mouse gastric neoplasm;mouse gastric lipoma;narrowmatch
mouse gastric mesenchymal neoplasm;mouse gastric leiomyoma;narrowmatch
benign mouse gastric neoplasm;mouse gastric leiomyoma;narrowmatch
benign mouse gastric neoplasm;mouse gastric hamartoma;narrowmatch
benign mouse gastric neoplasm;benign mouse gastric granular cell tumor;narrowmatch
mouse papillary thyroid carcinoma;mouse follicular variant papillary carcinoma;narrowmatch
mouse gallbladder sarcoma;rhabdomyosarcoma of the mouse gallbladder;narrowmatch
well-differentiated mouse thyroid carcinoma;mouse hurthle cell carcinoma of the thyroid;narrowmatch
malignant mouse gallbladder neoplasm;mouse gallbladder carcinoma;narrowmatch
malignant mouse gallbladder neoplasm;mouse gallbladder melanoma;narrowmatch
mouse gallbladder lymphoma;mouse gallbladder mucosa associated lymphoid tissue lymphoma;narrowmatch
malignant mouse gallbladder neoplasm;mouse gallbladder lymphoma;narrowmatch
malignant mouse gallbladder neoplasm;mouse gallbladder carcinosarcoma;narrowmatch
mouse gallbladder carcinoma;mouse gallbladder small cell gallbladder;narrowmatch
mouse gallbladder carcinoma;mouse gallbladder squamous cell gallbladder;narrowmatch
mouse gallbladder carcinoma;mouse gallbladder adenocarcinoma;narrowmatch
mouse gallbladder neoplasm;malignant mouse gallbladder neoplasm;narrowmatch
mouse follicular thyroid carcinoma;mouse trabecular follicular adenocarcinoma;narrowmatch
mouse digestive system neoplasms;mouse gallbladder neoplasm;narrowmatch
malignant mouse muscle neoplasm;malignant mouse skeletal muscle neoplasm;narrowmatch
malignant mouse muscle neoplasm;malignant mouse smooth muscle neoplasm;narrowmatch
mouse myomatous neoplasm;malignant mouse muscle neoplasm;narrowmatch
mouse soft tissue neoplasm;mouse myomatous neoplasm;narrowmatch
mouse connective and soft tissue neoplasms;mouse soft tissue neoplasm;narrowmatch
mouse mesenchymal neoplasm;mouse soft tissue neoplasm;narrowmatch
malignant mouse gallbladder neoplasm;mouse gallbladder sarcoma;narrowmatch
mouse gallbladder sarcoma;mouse gallbladder angiosarcoma;narrowmatch
mouse gallbladder sarcoma;mouse gallbladder kaposi's sarcoma;narrowmatch
mouse gallbladder sarcoma;mouse gallbladder leiomyosarcoma;narrowmatch
well-differentiated mouse thyroid carcinoma;mouse follicular thyroid carcinoma;narrowmatch
mouse thyroid carcinoma;well-differentiated mouse thyroid carcinoma;narrowmatch
mouse thyroid carcinoma;recurrent mouse thyroid carcinoma;narrowmatch
mouse thyroid carcinoma;poorly differentiated mouse thyroid carcinoma;narrowmatch
mouse medullary thyroid carcinoma;mouse medullary thyroid carcinoma with amyloid stroma;narrowmatch
mouse thyroid carcinoma;mouse medullary thyroid carcinoma;narrowmatch
mouse anaplastic thyroid carcinoma;mouse anaplastic small cell thyroid carcinoma;narrowmatch
mouse anaplastic thyroid carcinoma;mouse anaplastic giant cell thyroid carcinoma;narrowmatch
mouse thyroid carcinoma;mouse anaplastic thyroid carcinoma;narrowmatch
malignant mouse thyroid neoplasm;mouse thyroid carcinoma;narrowmatch
malignant mouse thyroid neoplasm;metastasis to the mouse thyroid;narrowmatch
mouse thyroid neoplasm;malignant mouse thyroid neoplasm;narrowmatch
mouse endocrine gland system neoplasms;mouse thyroid neoplasm;narrowmatch
malignant mouse gallbladder neoplasm;metastatic neoplasm to the mouse gallbladder;narrowmatch
mouse gallbladder sarcoma;mouse gallbladder malignant fibrous histiocytoma;narrowmatch
mouse gastric mesenchymal neoplasm;mouse gastric inflammatory myofibroblastic neoplasm;narrowmatch
growth factor receptor gene;flt3 gene;narrowmatch
mouse gastric mesenchymal neoplasm;mouse gastric liposarcoma;narrowmatch
transcription factor gene;pax3 gene;narrowmatch
transcription coactivator gene;wwtr1 gene;narrowmatch
nuclear receptor gene;pparg gene;narrowmatch
transcription factor gene;pml gene;narrowmatch
receptor tyrosine kinase gene;pdgfrb gene;narrowmatch
receptor tyrosine kinase gene;pdgfra gene;narrowmatch
transcription factor gene;pax7 gene;narrowmatch
transcription factor gene;pax5 gene;narrowmatch
nucleoporin gene;nup214 gene;narrowmatch
non-receptor tyrosine kinase gene;jak2 gene;narrowmatch
regulatory gene;numa1 gene;narrowmatch
receptor tyrosine kinase gene;ntrk3 gene;narrowmatch
receptor gene;notch1 gene;narrowmatch
metallopeptidase gene;mme gene;narrowmatch
cytoskeletal gene;afdn gene;narrowmatch
transcription factor gene;mllt3 gene;narrowmatch
transcription factor gene;aff1 gene;narrowmatch
transcription factor gene;tcf3 gene;narrowmatch
transcription factor gene;tfe3 gene;narrowmatch
cysteine peptidase gene;usp6 gene;narrowmatch
cysteine peptidase gene;usp8 gene;narrowmatch
neoplastic melanocyte;nevus cell;narrowmatch
neoplastic hematopoietic and lymphoid cell;leukemic cell;narrowmatch
malignant cell;leukemic cell;narrowmatch
general qualifier;condition;narrowmatch
anatomic structure, system, or substance;body cavity;narrowmatch
body region;anal margin;narrowmatch
body region;chest;narrowmatch
document;description;narrowmatch
body region;paraaortic region;narrowmatch
leukemic lymphocyte;hairy cell;narrowmatch
neoplastic b-lymphocyte;hairy cell;narrowmatch
conceptual entity;record;narrowmatch
reproductive system part;genitalia;narrowmatch
organismal process;appetite;narrowmatch
chromosome band;14q32.33;narrowmatch
transcription factor gene;mllt1 gene;narrowmatch
gli family gene;gli1 gene;narrowmatch
mouse gastric mesenchymal neoplasm;mouse gastric xanthoma;narrowmatch
malignant mouse gastric neoplasm;mouse gastric carcinoma;narrowmatch
mouse gastric carcinoma;mouse gastric kaposi's sarcoma;narrowmatch
mouse gastric carcinoma;mouse gastric fundus carcinoma;narrowmatch
mouse gastric carcinoma;mouse gastric cardia carcinoma;narrowmatch
mouse gastric carcinoma;mouse gastric body carcinoma;narrowmatch
mouse gastric carcinoma;mouse gastric adenosquamous carcinoma;narrowmatch
mouse gastric carcinoma;mouse gastric adenocarcinoma;narrowmatch
mouse gastric carcinoma;carcinoma in situ of the mouse antrum;narrowmatch
mouse gastric neoplasm;malignant mouse gastric neoplasm;narrowmatch
transcription factor gene;foxo1 gene;narrowmatch
mouse gastric teratoma;mature mouse gastric teratoma;narrowmatch
mouse gastric neoplasm;mouse gastric teratoma;narrowmatch
mouse gastric carcinoma;mouse gastric small cell carcinoma;narrowmatch
mouse gastric neuroendocrine neoplasm;mouse gastric small cell carcinoma;narrowmatch
mouse gastric neuroendocrine neoplasm;mouse gastric carcinoid neoplasm;narrowmatch
mouse gastric neoplasm;mouse gastric neuroendocrine neoplasm;narrowmatch
mouse gastric mesenchymal neoplasm;malignant mouse gastric fibrous histocytoma;narrowmatch
mouse gastric carcinoma;mouse gastric pylorus carcinoma;narrowmatch
mouse gastric carcinoma;mouse gastric squamous cell carcinoma;narrowmatch
mouse gastric carcinoma;recurrent mouse gastric cancer;narrowmatch
malignant mouse gastric neoplasm;mouse gastric lymphoma;narrowmatch
body part;cardiovascular system part;narrowmatch
receptor tyrosine kinase gene;flt3 gene;narrowmatch
fibroblast growth factor receptor family gene;fgfr3 gene;narrowmatch
ets family gene;etv4 gene;narrowmatch
ets family gene;etv1 gene;narrowmatch
regulatory gene;dek gene;narrowmatch
transcription regulation gene;bcl6 gene;narrowmatch
mixed malignant mouse gastric neoplasm;mouse gastric carcinosarcoma;narrowmatch
malignant mouse gastric neoplasm;mixed malignant mouse gastric neoplasm;narrowmatch
malignant mouse gastric neoplasm;malignant mouse gastric granular cell tumor;narrowmatch
malignant mouse gastric cardio-esophageal junction neoplasm;mouse barrett's adenocarcinoma;narrowmatch
malignant mouse gastric neoplasm;malignant mouse gastric cardio-esophageal junction neoplasm;narrowmatch
mouse gastric lymphoma;secondary mouse gastric non-hodgkin's lymphoma;narrowmatch
mouse gastric lymphoma;primary mouse gastric non-hodgkin's lymphoma;narrowmatch
mouse gastric lymphoma;mouse gastric hodgkin's lymphoma;narrowmatch
mouse lipomatous neoplasm;malignant mouse lipomatous neoplasm;narrowmatch
mouse neoplasms by location;mouse integumentary system neoplasms;narrowmatch
mouse connective and soft tissue neoplasms;mouse lipomatous neoplasm;narrowmatch
mouse neoplasms by cell type;mouse transitional cell neoplasm;narrowmatch
mouse carcinoma;mouse adenosquamous carcinoma;narrowmatch
mouse epithelial cell neoplasms;mouse squamous cell neoplasm;narrowmatch
mouse carcinoma;mouse adenocarcinoma;narrowmatch
mouse epithelial cell neoplasms;mouse carcinoma;narrowmatch
mouse neoplasms by morphology;mouse carcinoma;narrowmatch
mouse benign epithelial neoplasm;mouse adenoma;narrowmatch
mouse neoplasms by morphology;mouse adenoma;narrowmatch
mouse plasma cell neoplasm;mouse plasma cell dyscrasia;narrowmatch
mouse neoplasms by cell type;mouse epithelial cell neoplasms;narrowmatch
mouse neoplasms by cell type;mouse neural cell neoplasm;narrowmatch
mouse neoplasms by cell type;mouse myeloid cell neoplasm;narrowmatch
mouse neoplasms by cell type;mouse monocyte neoplasm;narrowmatch
mouse neoplasms by cell type;mouse mesenchymal neoplasm;narrowmatch
mouse epithelial cell neoplasms;mouse melanocyte neoplasm;narrowmatch
mouse neoplasms by cell type;mouse lymph cell neoplasm;narrowmatch
mouse neoplasms by cell type;mouse granulosa cell tumor;narrowmatch
mouse squamous cell neoplasm;mouse adenosquamous carcinoma;narrowmatch
mouse epithelial cell neoplasms;mouse benign epithelial neoplasm;narrowmatch
mouse benign epithelial neoplasm;mouse papilloma;narrowmatch
mouse sarcoma;mouse angiosarcoma;narrowmatch
mouse male reproductive system disorder;mouse male reproductive system neoplasms;narrowmatch
mouse reproductive system neoplasms;mouse male reproductive system neoplasms;narrowmatch
mouse reproductive system disorder;mouse reproductive system neoplasms;narrowmatch
mouse genitourinary neoplasms;mouse reproductive system neoplasms;narrowmatch
mouse neoplasms by location;mouse genitourinary neoplasms;narrowmatch
mouse digestive system neoplasms;mouse gastrointestinal system neoplasms;narrowmatch
mouse sarcoma;mouse synovial sarcoma;narrowmatch
malignant mouse skeletal muscle neoplasm;mouse rhabdomyosarcoma;narrowmatch
mouse sarcoma;mouse rhabdomyosarcoma;narrowmatch
mouse sarcoma;mouse osteosarcoma;narrowmatch
mouse sarcoma;mouse leiomyosarcoma;narrowmatch
mouse sarcoma;mouse kaposi's sarcoma;narrowmatch
mouse chondrocyte neoplasm;mouse chondrosarcoma;narrowmatch
mouse sarcoma;mouse chondrosarcoma;narrowmatch
mouse sarcoma;mouse fibrosarcoma;narrowmatch
mouse neoplasms by cell type;mouse germ cell neoplasm;narrowmatch
mouse neoplasms by cell type;mouse ductal cell neoplasm;narrowmatch
mouse female reproductive system disorder;mouse female reproductive system neoplasms;narrowmatch
monomorphic adenoma of the mouse salivary glands;sebaceous lymphadenoma of the mouse salivary glands;narrowmatch
carcinoma of the mouse salivary glands;adenoid cystic carcinoma of the mouse salivary glands;narrowmatch
carcinoma of the mouse salivary glands;acinic cell carcinoma of the mouse salivary glands;narrowmatch
epithelial neoplasms of the mouse salivary glands;carcinoma of the mouse salivary glands;narrowmatch
mucoepidermoid tumor of the mouse salivary glands;high grade mucoepidermoid tumor of the mouse salivary glands;narrowmatch
mucoepidermoid tumor of the mouse salivary glands;low grade mucoepidermoid tumor of the mouse salivary glands;narrowmatch
adenoma of the mouse salivary glands;mucoepidermoid tumor of the mouse salivary glands;narrowmatch
adenoma of the mouse salivary glands;myoepithelioma of the mouse salivary glands;narrowmatch
monomorphic adenoma of the mouse salivary glands;clear cell adenoma of the mouse salivary glands;narrowmatch
mouse epithelial cell neoplasms;mouse acinar cell neoplasm;narrowmatch
monomorphic adenoma of the mouse salivary glands;basal cell adenoma of the mouse salivary glands;narrowmatch
spinal region;cervical neck region;narrowmatch
monomorphic adenoma of the mouse salivary glands;warthin's tumor of the mouse salivary glands;narrowmatch
monomorphic adenoma of the mouse salivary glands;oxyphilic adenoma of the mouse salivary glands;narrowmatch
adenoma of the mouse salivary glands;monomorphic adenoma of the mouse salivary glands;narrowmatch
pleomorphic adenoma of the mouse salivary glands;carcinoma in pleomorphic adenoma of the mouse salivary glands;narrowmatch
adenoma of the mouse salivary glands;pleomorphic adenoma of the mouse salivary glands;narrowmatch
carcinoma of the mouse salivary glands;papillary adenocarcinoma of the mouse salivary glands;narrowmatch
carcinoma of the mouse salivary glands;squamous cell carcinoma of the mouse salivary glands;narrowmatch
carcinoma of the mouse salivary glands;adenocarcinoma of the mouse salivary glands;narrowmatch
carcinoma of the mouse salivary glands;metastatic carcinoma of the mouse salivary glands;narrowmatch
mouse neoplasms by histopathology;mouse neoplasms by morphology;narrowmatch
mouse neoplasms by histopathology;mouse neoplasms by cell type;narrowmatch
mouse neoplasms;mouse neoplasms by location;narrowmatch
mouse neoplasms;mouse neoplasms by histopathology;narrowmatch
mouse neoplasms;mouse metastatic neoplasms;narrowmatch
mouse cancer-related conditions;mouse precancerous conditions;narrowmatch
mouse cancer-related conditions;mouse noncancerous conditions;narrowmatch
murine experimental organism diagnosis;mouse neoplasms;narrowmatch
murine experimental organism diagnosis;mouse cancer-related conditions;narrowmatch
plasma cell neoplasms of the mouse salivary glands;plasmacytoma of the mouse salivary glands;narrowmatch
mouse salivary gland neoplasms;plasma cell neoplasms of the mouse salivary glands;narrowmatch
lymphoproliferative neoplasms of the mouse salivary glands;lymphoma of the mouse salivary glands;narrowmatch
mouse lymphoma;lymphoma of the mouse salivary glands;narrowmatch
mouse salivary gland neoplasms;lymphoproliferative neoplasms of the mouse salivary glands;narrowmatch
mouse salivary gland neoplasms;hematopoietic neoplasms of the mouse salivary glands;narrowmatch
mouse reproductive system neoplasms;mouse female reproductive system neoplasms;narrowmatch
mouse neoplasms by location;mouse digestive system neoplasms;narrowmatch
mouse mesenchymal neoplasm;mouse lipomatous neoplasm;narrowmatch
mouse endometrial carcinoma;mouse endometrial adenocarcinoma;narrowmatch
mouse endometrial carcinoma;mouse endometrial mixed carcinoma;narrowmatch
serous carcinoma of the mouse endometrium;papillary serous carcinoma of the mouse endometrium;narrowmatch
mouse endometrial adenocarcinoma;serous carcinoma of the mouse endometrium;narrowmatch
mouse endometrial adenocarcinoma;mouse endometrial mucinous adenocarcinoma;narrowmatch
mouse endometrial adenocarcinoma;mouse endometrial endometrioid adenocarcinoma;narrowmatch
mouse endometrial adenocarcinoma;mouse endometrial clear cell adenocarcinoma;narrowmatch
mouse endometrial adenocarcinoma;mouse endometrial adenocarcinoma with squamous metaplasia;narrowmatch
malignant mouse uterine corpus neoplasm;mouse endometrial carcinoma;narrowmatch
malignant mouse exocervical neoplasm;mouse exocervical carcinoma;narrowmatch
malignant mouse uterine neoplasms;malignant mouse uterine corpus neoplasm;narrowmatch
metastasis to the mouse cervix;metastatic carcinoma to the mouse uterine cervix;narrowmatch
malignant mouse cervical neoplasm;metastasis to the mouse cervix;narrowmatch
malignant mouse cervical neoplasm;malignant mouse exocervical neoplasm;narrowmatch
malignant mouse cervical neoplasm;malignant mouse endocervical neoplasm;narrowmatch
mouse cervical carcinoma;undifferentiated mouse cervical carcinoma;narrowmatch
mouse cervical carcinoma;mouse recurrent cervical carcinoma;narrowmatch
malignant mouse uterine corpus mixed neoplasm;mouse endometrial mixed carcinoma;narrowmatch
mouse endometrial mixed carcinoma;mouse endometrial adenosquamous carcinoma;narrowmatch
mouse endometrial carcinoma;mouse endometrial squamous cell carcinoma;narrowmatch
mouse endometrial carcinoma;recurrent malignant mouse endometrial neoplasm;narrowmatch
mouse connective and soft tissue disorder;mouse connective and soft tissue neoplasms;narrowmatch
mouse neoplasms by location;mouse connective and soft tissue neoplasms;narrowmatch
malignant mouse placental neoplasm;mouse placental choriocarcinoma;narrowmatch
malignant mouse placental neoplasm;metastasis to the mouse placenta;narrowmatch
mouse female reproductive system neoplasms;malignant mouse placental neoplasm;narrowmatch
mouse endometrial stromal sarcoma;recurrent mouse uterine sarcoma;narrowmatch
mouse uterine sarcoma;mouse endometrial stromal sarcoma;narrowmatch
malignant mouse uterine corpus neoplasm;mouse uterine sarcoma;narrowmatch
mouse uterine choriocarcinoma;mouse uterine gestational choriocarcinoma;narrowmatch
malignant mouse uterine corpus neoplasm;mouse uterine choriocarcinoma;narrowmatch
malignant mouse uterine corpus mixed neoplasm;mouse uterine mullerian adenosarcoma;narrowmatch
malignant mouse uterine corpus mixed neoplasm;mouse uterine malignant mixed mesodermal (mullerian) tumor;narrowmatch
malignant mouse uterine corpus neoplasm;malignant mouse uterine corpus mixed neoplasm;narrowmatch
mouse endometrial carcinoma;undifferentiated mouse endometrial carcinoma;narrowmatch
recurrent malignant mouse endometrial neoplasm;recurrent mouse endometrial carcinoma;narrowmatch
mouse cervical carcinoma;mouse infiltrating cervical carcinoma;narrowmatch
mouse cervical carcinoma;mouse exocervical carcinoma;narrowmatch
mouse digestive system disorder;mouse digestive system neoplasms;narrowmatch
mouse fallopian tube neoplasm;benign mouse fallopian tube neoplasm;narrowmatch
mouse fallopian tube adenocarcinoma;mouse fallopian tube papillary adenocarcinoma;narrowmatch
mouse fallopian tube adenocarcinoma;mouse fallopian tube mucinous adenocarcinoma;narrowmatch
mouse fallopian tube adenocarcinoma;mouse fallopian tube endometrioid adenocarcinoma;narrowmatch
mouse fallopian tube adenocarcinoma;mouse fallopian tube clear cell adenocarcinoma;narrowmatch
mouse fallopian tube carcinoma;mouse fallopian tube adenocarcinoma;narrowmatch
malignant mouse fallopian tube neoplasm;mouse fallopian tube carcinoma;narrowmatch
mouse fallopian tube neoplasm;malignant mouse fallopian tube neoplasm;narrowmatch
mouse female reproductive system neoplasms;mouse fallopian tube neoplasm;narrowmatch
malignant mouse endocervical neoplasm;mouse endocervical carcinoma;narrowmatch
mouse digestive system;mouse pancreas;narrowmatch
mouse digestive system;mouse biliary tract;narrowmatch
mouse neoplasms by location;mouse special sense organ neoplasms;narrowmatch
epithelial proliferative lesions of the mouse pulmonary system;tumors of the mouse pulmonary system;narrowmatch
mouse neoplasms by location;tumors of the mouse pulmonary system;narrowmatch
mouse endocrine gland system neoplasms;mouse pituitary gland neoplasms;narrowmatch
mouse endocrine gland system neoplasms;mouse adrenal gland neoplasms;narrowmatch
mouse fallopian tube adenocarcinoma;mouse fallopian tube serous adenocarcinoma;narrowmatch
mouse fallopian tube papillary adenocarcinoma;fallopian tube papillary serous adenocarcinoma of mouse;narrowmatch
mouse fallopian tube serous adenocarcinoma;fallopian tube papillary serous adenocarcinoma of mouse;narrowmatch
mouse fallopian tube carcinoma;mouse fallopian tube gestational choriocarcinoma;narrowmatch
mouse cervical carcinoma;mouse endocervical carcinoma;narrowmatch
mouse cervical carcinoma;mouse cervical squamous cell carcinoma;narrowmatch
mouse cervical carcinoma;mouse cervical small cell carcinoma;narrowmatch
mouse cervical carcinoma;mouse cervical adenosquamous cell carcinoma;narrowmatch
mouse cervical carcinoma;mouse cervical adenoid cystic carcinoma;narrowmatch
mouse cervical adenocarcinoma;mouse uterine cervix endometrioid adenocarcinoma;narrowmatch
mouse cervical adenocarcinoma;mouse uterine cervix clear cell adenocarcinoma;narrowmatch
mouse cervical adenocarcinoma;mouse mesonephric adenocarcinoma;narrowmatch
mouse cervical adenocarcinoma;mouse cervical adenocarcinoma in situ;narrowmatch
mouse cervical carcinoma;mouse cervical adenocarcinoma;narrowmatch
malignant mouse cervical neoplasm;mouse cervical carcinoma;narrowmatch
malignant mouse uterine neoplasms;malignant mouse cervical neoplasm;narrowmatch
mouse female reproductive system neoplasms;malignant mouse uterine neoplasms;narrowmatch
mouse fallopian tube carcinoma;undifferentiated mouse fallopian tube carcinoma;narrowmatch
mouse fallopian tube carcinoma;mouse fallopian tube squamous cell carcinoma;narrowmatch
body part;digestive system part;narrowmatch
eye disorder;lacrimal system disorder;narrowmatch
body part;musculoskeletal system part;narrowmatch
urinary system finding;urinary frequency;narrowmatch
non-neoplastic liver and intrahepatic bile duct disorder;liver failure;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);lymphosarcoma;narrowmatch
vascular disorder;vasculitis;narrowmatch
female reproductive system disorder;vaginal disorder;narrowmatch
eye disorder;uveal disorder;narrowmatch
female reproductive system disorder;uterine disorder;narrowmatch
genitourinary signs and symptoms;urinary frequency;narrowmatch
urinary system disorder;urethra disorder;narrowmatch
non-neoplastic endocrine disorder;thyroiditis;narrowmatch
skin discoloration;erythema;narrowmatch
gonadal dysgenesis;turner syndrome;narrowmatch
rare non-neoplastic disorder;turner syndrome;narrowmatch
non-neoplastic endocrine disorder;turner syndrome;narrowmatch
endocrine syndrome;turner syndrome;narrowmatch
tuberculosis;pulmonary tuberculosis;narrowmatch
infectious lung disorder;pulmonary tuberculosis;narrowmatch
deficiency of humoral immunity;hypogammaglobulinemia;narrowmatch
female reproductive system finding;vaginal hemorrhage;narrowmatch
reproductive system hemorrhage;vaginal hemorrhage;narrowmatch
neuropathy;polyneuropathy;narrowmatch
lower gastrointestinal hemorrhage;rectal hemorrhage;narrowmatch
non-neoplastic heart disorder;eosinophilic endomyocardial disease;narrowmatch
connective and soft tissue disorder;soft tissue disorder;narrowmatch
reproductive system disorder;female reproductive system disorder;narrowmatch
reproductive system disorder;male reproductive system disorder;narrowmatch
cystitis;chronic cystitis;narrowmatch
ear disorder;external ear disorder;narrowmatch
thoracic disorder;thymus disorder;narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's paragranuloma involving spleen;narrowmatch
lymphosarcoma;lymphosarcoma involving spleen;narrowmatch
reticulosarcoma;reticulosarcoma involving spleen;narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's paragranuloma;narrowmatch
cranial nerve disorder;hypoglossal nerve disorder;narrowmatch
cranial nerve disorder;accessory nerve disorder;narrowmatch
cranial nerve disorder;trigeminal nerve disorder;narrowmatch
non-neoplastic thyroid gland disorder;thyroiditis;narrowmatch
neck disorder;thyroid gland disorder;narrowmatch
pancreatic disorder;endocrine pancreas disorder;narrowmatch
non-neoplastic bone disorder;osteogenesis imperfecta;narrowmatch
male reproductive system disorder;penile disorder;narrowmatch
neck disorder;parathyroid gland disorder;narrowmatch
sinonasal disorder;paranasal sinus disorder;narrowmatch
digestive system disorder;pancreatic disorder;narrowmatch
female reproductive system disorder;ovarian disorder;narrowmatch
metabolic bone disorder;osteomalacia;narrowmatch
col1a1 associated connective tissue disorder;osteogenesis imperfecta;narrowmatch
metabolic disorder;nutritional disorder;narrowmatch
mediastinal cyst;thymic cyst;narrowmatch
disorder by site;nervous system disorder;narrowmatch
bacterial infection;mycobacterial infection;narrowmatch
menstrual disorder;menorrhagia;narrowmatch
thoracic disorder;mediastinal disorder;narrowmatch
oral disorder;lip disorder;narrowmatch
dermatitis;lichen sclerosus et atrophicus;narrowmatch
cytopenia;leukopenia;narrowmatch
peritoneal and retroperitoneal disorder;peritoneal disorder;narrowmatch
non-neoplastic peritoneal disorder;peritonitis;narrowmatch
otolaryngologic disorder;pharyngeal disorder;narrowmatch
neck disorder;pharyngeal disorder;narrowmatch
non-neoplastic vascular disorder;thrombosis;narrowmatch
male reproductive system disorder;testicular disorder;narrowmatch
digestive system disorder;stomach disorder;narrowmatch
autoimmune disease;sjogren syndrome;narrowmatch
syndrome;sjogren syndrome;narrowmatch
head and neck disorder;salivary gland disorder;narrowmatch
eye disorder;retinal disorder;narrowmatch
infectious disorder by site;infectious lung disorder;narrowmatch
non-neoplastic lung disorder;infectious lung disorder;narrowmatch
respiratory and thoracic disorder;respiratory system disorder;narrowmatch
male reproductive system disorder;prostate disorder;narrowmatch
hematologic and lymphocytic disorder;polycythemia;narrowmatch
thoracic disorder;pleural disorder;narrowmatch
pregnancy disorder;placenta disorder;narrowmatch
head and neck disorder;pituitary gland disorder;narrowmatch
ear disorder;middle ear disorder;narrowmatch
endocrine system disorder;endocrine pancreas disorder;narrowmatch
g protein gene;ras family gene;narrowmatch
l1 acute lymphoblastic leukemia;adult l1 acute lymphoblastic leukemia;narrowmatch
disorder by site;immune system and related disorders;narrowmatch
malignant lymphoma centroblastic, follicular;stage ii centroblastic follicular lymphoma;narrowmatch
malignant lymphoma centroblastic, follicular;stage i centroblastic follicular lymphoma;narrowmatch
hemorrhage;peritoneal and retroperitoneal hemorrhage;narrowmatch
positive laboratory test result;positive lymph node;narrowmatch
leukemia (antiquated);l1 acute lymphoblastic leukemia;narrowmatch
leukemia (antiquated);l2 acute lymphoblastic leukemia;narrowmatch
malignant lymphoma, large cell type;malignant lymphoma, large cell, cleaved and non-cleaved;narrowmatch
leukemia (antiquated);pre t-all;narrowmatch
connective and soft tissue neoplasm (antiquated);intermediate risk gastrointestinal stromal tumor;narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's disease, nodular sclerosis, lymphocyte predominance;narrowmatch
lymphoma;lymphoma by stage;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);lymphoma/leukemia by kiel classification (antiquated);narrowmatch
diffuse malignant lymphoma;malignant lymphoma, non-cleaved, diffuse;narrowmatch
malignant lymphoma, non-cleaved cell type;malignant lymphoma, non-cleaved, diffuse;narrowmatch
malignant non-hodgkin lymphoma, cleaved cell;malignant lymphoma, large cell, cleaved;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);peripheral t-cell lymphoma, large cell;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);leukemia (antiquated);narrowmatch
leukemia (antiquated);philadelphia chromosome negative bcr-abl1 negative chronic myelogenous leukemia;narrowmatch
pituitary gland neoplasm (antiquated);pituitary gland basophil carcinoma;narrowmatch
disease or disorder;disorder by site;narrowmatch
non-neoplastic disorder by site;non-neoplastic digestive system disorder;narrowmatch
digestive system disorder;non-neoplastic digestive system disorder;narrowmatch
epithelial neoplasm (antiquated);classic type trichoepithelioma;narrowmatch
mouse salivary gland neoplasms;epithelial neoplasms of the mouse salivary glands;narrowmatch
benign hemangiopericytoma;lipomatous hemangiopericytoma;narrowmatch
benign hemangiopericytoma;infantile hemangiopericytoma;narrowmatch
ccnd1 gene translocation;"t(11;14)(q13;q32)";narrowmatch
connective and soft tissue neoplasm (antiquated);mesenchymal extraskeletal chondrosarcoma;narrowmatch
abnormal blood chemistry and hematology test result;paraproteinemia;narrowmatch
intermediate risk gastrointestinal stromal tumor;intermediate risk gastric gastrointestinal stromal tumor;narrowmatch
intermediate risk gastrointestinal stromal tumor;intermediate risk small intestinal gastrointestinal stromal tumor;narrowmatch
intermediate risk gastrointestinal stromal tumor;intermediate risk esophageal gastrointestinal stromal tumor;narrowmatch
high risk gastrointestinal stromal tumor;high risk esophageal gastrointestinal stromal tumor;narrowmatch
low risk gastrointestinal stromal tumor;low risk esophageal gastrointestinal stromal tumor;narrowmatch
neoplasm by special category;spindle cell neoplasm;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);dendritic cell tumor, not otherwise specified;narrowmatch
non-neoplastic disorder by special category;degenerative disorder;narrowmatch
peritoneal and retroperitoneal hemorrhage;peritoneal hemorrhage;narrowmatch
polycythemia (excluding polycythemia vera);secondary polycythemia;narrowmatch
ear disorder;inner ear disorder;narrowmatch
ventilation or perfusion signs and symptoms;respiratory distress;narrowmatch
hyperplasia;sebaceous hyperplasia;narrowmatch
urinary system disorder;ureter disorder;narrowmatch
immunodeficiency syndrome;t-cell immunodeficiency;narrowmatch
intra-abdominal hemorrhage;peritoneal hemorrhage;narrowmatch
ebv-related burkitt lymphoma;endemic burkitt lymphoma;narrowmatch
diffuse malignant lymphoma;malignant non-hodgkin's lymphoma, diffuse, lymphocytic, poorly differentiated;narrowmatch
gastritis;helicobacter pylori-associated gastritis;narrowmatch
sinonasal disorder;nasal cavity disorder;narrowmatch
malignant lymphoma, large cell type;malignant lymphoma, histiocytic, diffuse;narrowmatch
diffuse malignant lymphoma;malignant lymphoma, histiocytic, diffuse;narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's disease, nodular sclerosis, mixed cellularity;narrowmatch
grade iii neuroendocrine carcinoma;small cell carcinoma, fusiform cell type;narrowmatch
spindle cell neoplasm;malignant spindle cell neoplasm;narrowmatch
autoimmune disease;hashimoto thyroiditis;narrowmatch
lymphocytic thyroiditis;hashimoto thyroiditis;narrowmatch
immune system disorder;rheumatologic disorder;narrowmatch
cranial nerve disorder;vestibulocochlear nerve disorder;narrowmatch
malignant lymphoma by cell type (working formulation);malignant lymphoma, non-cleaved cell type;narrowmatch
lymphoma by working formulation (antiquated);non-hodgkin's lymphoma, lymphoblastic (wf);narrowmatch
high risk gastrointestinal stromal tumor;high risk small intestinal gastrointestinal stromal tumor;narrowmatch
low risk gastrointestinal stromal tumor;low risk small intestinal gastrointestinal stromal tumor;narrowmatch
connective and soft tissue neoplasm (antiquated);high risk gastrointestinal stromal tumor;narrowmatch
connective and soft tissue neoplasm (antiquated);low risk gastrointestinal stromal tumor;narrowmatch
high risk gastrointestinal stromal tumor;high risk gastric gastrointestinal stromal tumor;narrowmatch
low risk gastrointestinal stromal tumor;low risk gastric gastrointestinal stromal tumor;narrowmatch
epithelial neoplasm (antiquated);nipple duct carcinoma;narrowmatch
immunodeficiency-related disorder;transplant-related disorder;narrowmatch
neoplasm by cause;environment-related neoplasm;narrowmatch
11q translocation;"t(11;22)(q24;q12)";narrowmatch
ewsr1 gene translocation;"t(11;22)(q24;q12)";narrowmatch
chromosomal translocation;"t(14;18)(q32;q21)";narrowmatch
cranial nerve disorder;glossopharyngeal nerve disorder;narrowmatch
leukemia (antiquated);acute eosinophilic leukemia;narrowmatch
neck disorder;laryngeal disorder;narrowmatch
otolaryngologic disorder;laryngeal disorder;narrowmatch
ribonuclease;endoribonuclease;narrowmatch
transcription coactivator gene;signal transducer and activator of transcription family gene;narrowmatch
metabolic process;homeostatic process;narrowmatch
cytokine gene;interleukin gene;narrowmatch
environment-to-cell communication;cytokine signaling;narrowmatch
protein tyrosine phosphatase gene;non-receptor protein tyrosine phosphatase gene;narrowmatch
kinase family gene;non-receptor tyrosine kinase gene;narrowmatch
protein family;rnase iii family protein;narrowmatch
rna recognition motif;double-stranded rna binding domain;narrowmatch
kinase family gene;serine/threonine protein kinase gene;narrowmatch
endoribonuclease gene;dicer1 gene;narrowmatch
ribonuclease gene;endoribonuclease gene;narrowmatch
esterase gene;ribonuclease gene;narrowmatch
hydrolase gene;esterase gene;narrowmatch
transferase gene;polymerase gene;narrowmatch
enzyme gene;oxidoreductase gene;narrowmatch
intracellular membrane;mitochondrial membrane;narrowmatch
transmembrane protein gene;ion channel protein gene;narrowmatch
transport protein gene;ion channel protein gene;narrowmatch
signaling pathway gene;adaptor signaling protein gene;narrowmatch
structural protein gene;extracellular matrix protein gene;narrowmatch
protein binding domain;ptb domain;narrowmatch
cell defense process;phagocytosis;narrowmatch
transferase gene;methyltransferase gene;narrowmatch
kinase family gene;phosphoinositol kinase family gene;narrowmatch
esterase gene;phosphatase family gene;narrowmatch
protein phosphatase gene;protein tyrosine phosphatase gene;narrowmatch
hydrolase gene;helicase gene;narrowmatch
ligand binding;retinoic acid binding;narrowmatch
cancer cell growth regulation;tumor suppression;narrowmatch
gene;membrane protein gene;narrowmatch
biological carcinogenesis;viral carcinogenesis;narrowmatch
biological carcinogenesis;biological carcinogenesis, non-viral;narrowmatch
antimicrobial effect;antibacterial response;narrowmatch
hydrolase gene;peptidase gene;narrowmatch
extracellular matrix protein gene;collagen gene;narrowmatch
phosphoprotein phosphatase;dual-specificity phosphoprotein phosphatase;narrowmatch
phosphotransferase gene;kinase family gene;narrowmatch
digestive system disorder;intestinal disorder;narrowmatch
mouse genitourinary neoplasms;mouse urinary tract neoplasm;narrowmatch
benign mouse bladder neoplasm;mouse bladder leiomyoma;narrowmatch
benign mouse bladder neoplasm;benign mouse bladder paraganglioma;narrowmatch
mouse bladder neoplasm;benign mouse bladder neoplasm;narrowmatch
mouse bladder neoplasm;mouse bladder inflammatory myofibroblastic neoplasm;narrowmatch
mouse bladder neoplasm;mouse bladder paraganglioma;narrowmatch
mouse urinary tract neoplasm;mouse bladder neoplasm;narrowmatch
mouse urinary tract disorder;mouse urinary tract neoplasm;narrowmatch
hydrolase gene;gtpase gene;narrowmatch
transferase gene;phosphotransferase gene;narrowmatch
enzyme gene;hydrolase gene;narrowmatch
organism;eukaryota;narrowmatch
immunoglobulin domain;immunoglobulin-like c2-type domain;narrowmatch
gene;immunoglobulin family gene;narrowmatch
gene;immunoprotein gene;narrowmatch
ras family gene;nras gene;narrowmatch
ras family gene;kras gene;narrowmatch
benign mouse bladder neoplasm;mouse bladder papilloma;narrowmatch
mouse bladder neoplasm;malignant mouse bladder neoplasm;narrowmatch
malignant mouse bladder neoplasm;malignant mouse bladder paraganglioma;narrowmatch
mouse metastatic neoplasms;metastatic neoplasm to the mouse urinary bladder;narrowmatch
enzyme gene;transferase gene;narrowmatch
membrane protein gene;transmembrane protein gene;narrowmatch
interphase process;g1 to s transition process;narrowmatch
cell cycle gene;cyclin gene;narrowmatch
serine/threonine protein kinase gene;cyclin-dependent kinase gene;narrowmatch
cell cycle gene;cyclin-dependent kinase gene;narrowmatch
mouse bladder carcinoma;mouse bladder transitional cell carcinoma;narrowmatch
mouse bladder carcinoma;mouse bladder squamous cell carcinoma;narrowmatch
mouse bladder carcinoma;mouse bladder adenocarcinoma;narrowmatch
malignant mouse bladder neoplasm;mouse bladder carcinoma;narrowmatch
mouse carcinoma;mouse bladder carcinoma;narrowmatch
malignant mouse bladder neoplasm;mouse bladder sarcoma;narrowmatch
mouse sarcoma;mouse bladder sarcoma;narrowmatch
malignant mouse bladder neoplasm;mouse bladder lymphoma;narrowmatch
malignant mouse bladder neoplasm;metastatic neoplasm to the mouse urinary bladder;narrowmatch
protein-carbohydrate interaction;heparin binding;narrowmatch
receptor gene;growth factor receptor gene;narrowmatch
cellular process;cell fate control;narrowmatch
disorder by site;breast disorder;narrowmatch
nervous system disorder;cranial nerve disorder;narrowmatch
eye disorder;corneal disorder;narrowmatch
connective and soft tissue disorder;connective tissue disorder;narrowmatch
inflammatory disorder;infectious disorder;narrowmatch
non-neoplastic intestinal disorder;colitis;narrowmatch
non-neoplastic bile duct disorder;cholangitis;narrowmatch
malabsorption syndrome;celiac disease;narrowmatch
penile non-neoplastic disorder;balanitis;narrowmatch
transferase gene;glycosyltransferase gene;narrowmatch
movement disorder;ataxia;narrowmatch
digestive system disorder;anal disorder;narrowmatch
cardiovascular system finding;aneurysm;narrowmatch
retroperitoneal disorder;adrenal gland disorder;narrowmatch
dermatitis;acanthosis nigricans;narrowmatch
disease or disorder;radiation-induced disorder;narrowmatch
laboratory test result;abnormal laboratory test result;narrowmatch
non-neoplastic bladder disorder;cystitis;narrowmatch
myopathy;dermatomyositis;narrowmatch
rheumatologic disorder;dermatomyositis;narrowmatch
autoimmune disease;dermatomyositis;narrowmatch
biological agent;antigen;narrowmatch
finding by cause;hemorrhage;narrowmatch
reproductive system disorder;gonadal disorder;narrowmatch
non-neoplastic esophageal disorder;gastroesophageal reflux disease;narrowmatch
non-neoplastic stomach disorder;gastritis;narrowmatch
female reproductive system disorder;fallopian tube disorder;narrowmatch
eye disorder;eyelid disorder;narrowmatch
disorder by site;eye disorder;narrowmatch
hemorrhage;epistaxis;narrowmatch
non-neoplastic intestinal disorder;enteritis;narrowmatch
non-neoplastic vascular disorder;embolism;narrowmatch
otolaryngologic disorder;ear disorder;narrowmatch
digestive system signs and symptoms;dyspepsia;narrowmatch
congenital or acquired anatomic abnormality;diverticulum;narrowmatch
diabetes mellitus;type 2 diabetes mellitus;narrowmatch
pain;abdominal pain;narrowmatch
fos family gene;fosb gene;narrowmatch
non-receptor tyrosine kinase gene;zap70 gene;narrowmatch
mouse disorder by site;mouse digestive system disorder;narrowmatch
mouse disorder by site;mouse cardiovascular system disorder;narrowmatch
murine experimental organism diagnosis;mouse disorder by site;narrowmatch
non-receptor protein tyrosine phosphatase gene;ptpn11 gene;narrowmatch
non-neoplastic disorder by site;non-neoplastic connective and soft tissue disorder;narrowmatch
connective and soft tissue disorder;non-neoplastic connective and soft tissue disorder;narrowmatch
non-neoplastic disorder by site;non-neoplastic hematologic and lymphocytic disorder;narrowmatch
hematologic and lymphocytic disorder;non-neoplastic hematologic and lymphocytic disorder;narrowmatch
hematopoietic and lymphoid system disorder;hematologic and lymphocytic disorder;narrowmatch
agent affecting blood or body fluid;anticoagulant agent;narrowmatch
immune system process;immune cell activation process;narrowmatch
signaling protein;adaptor signaling protein;narrowmatch
regulatory protein;transcription regulatory protein;narrowmatch
signaling pathway gene;heterotrimeric g protein subunit gene;narrowmatch
cell movement;cellular migration process;narrowmatch
organogenesis;nervous system development;narrowmatch
mouse disorder by site;mouse connective and soft tissue disorder;narrowmatch
mouse disorder by site;mouse endocrine gland system disorder;narrowmatch
detoxification;xenobiotic metabolism;narrowmatch
mouse disorder by site;mouse urinary tract disorder;narrowmatch
other embryologic structure;mesonephric duct;narrowmatch
other embryologic structure;mesonephros;narrowmatch
hyperplasia;intraductal hyperplasia;narrowmatch
chromosome band;22q11.1-q11.2;narrowmatch
mouse disorder by site;mouse skeletal system disorder;narrowmatch
mouse disorder by site;mouse respiratory system disorder;narrowmatch
mouse disorder by site;mouse nervous system disorder;narrowmatch
mouse disorder by site;mouse skin disorder;narrowmatch
mouse disorder by site;mouse mammary gland disorder;narrowmatch
mouse disorder by site;mouse hematologic disorder;narrowmatch
mouse disorder by site;mouse head and neck disorder;narrowmatch
mouse male reproductive system disorder;mouse prostate disorder;narrowmatch
mouse reproductive system disorder;mouse male reproductive system disorder;narrowmatch
mouse reproductive system disorder;mouse female reproductive system disorder;narrowmatch
mouse disorder by site;mouse reproductive system disorder;narrowmatch
epithelial neoplasms of the mouse salivary glands;adenoma of the mouse salivary glands;narrowmatch
benign neoplasms of the mouse intestinal tract;lipoma of the mouse intestinal tract;narrowmatch
mouse digestive system neoplasms;mouse salivary gland neoplasms;narrowmatch
mouse meningioma;mouse rhabdoid meningioma;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;intracranial liposarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;hibernoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;angiolipoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;lipoma of the mouse nervous system;narrowmatch
mouse lipoma;lipoma of the mouse nervous system;narrowmatch
tumors of the mouse meninges;mesenchymal non-meningothelial tumours of the mouse nervous system;narrowmatch
mouse meningioma;mouse anaplastic meningioma;narrowmatch
mouse meningioma;mouse papillary meningioma;narrowmatch
mouse meningioma;mouse psammomatous meningioma;narrowmatch
mouse meningioma;atypical mouse meningioma;narrowmatch
mouse meningioma;mouse chordoid meningioma;narrowmatch
mouse meningioma;mouse clear cell meningioma;narrowmatch
mouse meningioma;mouse metaplastic meningioma;narrowmatch
mouse meningioma;mouse lymphoplasmacyte-rich meningioma;narrowmatch
mouse meningioma;mouse secretory meningioma;narrowmatch
mouse meningioma;mouse microcystic meningioma;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;solitary fibrous tumour of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;fibrosarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;malignant fibrous histiocytoma of the mouse nervous system;narrowmatch
mouse leiomyoma;leiomyoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;hemangiopericytoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;epithelioid haemangioendothelioma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;hemangioma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;osteochondroma of the mouse nervous system;narrowmatch
mouse osteosarcoma;osteosarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;osteosarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;osteoma of the mouse nervous system;narrowmatch
mouse chondrosarcoma;chondrosarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;chondrosarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;chondroma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;rhabdomyosarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;rhabdomyoma of the mouse nervous system;narrowmatch
mouse leiomyosarcoma;leiomyosarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;leiomyosarcoma of the mouse nervous system;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;leiomyoma of the mouse nervous system;narrowmatch
mouse meningioma;mouse angiomatous meningioma;narrowmatch
mouse meningioma;mouse transitional mixed meningioma;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;angiosarcoma of the mouse nervous system;narrowmatch
mouse embryonal tumours;mouse supratentorial primitive neuroectodermal tumour;narrowmatch
atypical mouse tertoid/thaboid tumour;mouse cellular neurilemmoma / neurinoma;narrowmatch
tumors of the mouse peripheral nerves;mouse schwannoma;narrowmatch
mouse neuroglia neoplasm;mouse schwannoma;narrowmatch
mouse nervous system neoplasms;tumors of the mouse peripheral nerves;narrowmatch
mouse embryonal tumours;atypical mouse tertoid/thaboid tumour;narrowmatch
mouse supratentorial primitive neuroectodermal tumour;mouse ganglioneuroblastoma;narrowmatch
mouse supratentorial primitive neuroectodermal tumour;mouse neuroblastoma;narrowmatch
mouse medulloblastoma;mouse melanotic medulloblastoma;narrowmatch
mouse meningioma;mouse fibrous / fibroblastic meningioma;narrowmatch
mouse medulloblastoma;mouse medullomyoblastoma;narrowmatch
mouse medulloblastoma;mouse large cell medulloblastoma;narrowmatch
mouse medulloblastoma;mouse desmoplastic medulloblastoma;narrowmatch
mouse embryonal tumours;mouse medulloblastoma;narrowmatch
mouse embryonal tumours;mouse ependymoblastoma;narrowmatch
mouse embryonal tumours;mouse medulloepithelioma;narrowmatch
mouse tumors of neuroepithelial tissue;mouse embryonal tumours;narrowmatch
atypical mouse tertoid/thaboid tumour;mouse plexiform neurilemmoma / neurinoma;narrowmatch
atypical mouse tertoid/thaboid tumour;mouse melanotic neurilemmoma / neurinoma;narrowmatch
tumors of the mouse peripheral nerves;mouse neurofibroma;narrowmatch
mouse neural cell neoplasm;mouse neurofibroma;narrowmatch
mouse meningioma;mouse meningothelial meningioma;narrowmatch
tumors of the mouse meningothelial cells;mouse meningioma;narrowmatch
tumors of the mouse meninges;tumors of the mouse meningothelial cells;narrowmatch
mouse nervous system neoplasms;tumors of the mouse meninges;narrowmatch
malignant mouse peripheral nerve sheath tumor;mouse melanotic psammomatous mpnst;narrowmatch
malignant mouse peripheral nerve sheath tumor;mouse melanotic mpnst;narrowmatch
malignant mouse peripheral nerve sheath tumor;mouse mpnst with divergent mesenchymal and / or epithelial differentiation;narrowmatch
malignant mouse peripheral nerve sheath tumor;mouse epithelioid mpnst;narrowmatch
mouse neural cell neoplasm;malignant mouse peripheral nerve sheath tumor;narrowmatch
tumors of the mouse peripheral nerves;malignant mouse peripheral nerve sheath tumor;narrowmatch
mouse perineurioma;mouse soft tissue perineurioma;narrowmatch
mouse perineurioma;mouse intraneural perineurioma;narrowmatch
tumors of the mouse peripheral nerves;mouse perineurioma;narrowmatch
mouse neuroglia neoplasm;mouse perineurioma;narrowmatch
mouse neurofibroma;mouse plexiform neurofibroma;narrowmatch
mouse sarcoma;angiosarcoma of the mouse nervous system;narrowmatch
mouse sarcoma;kaposi sarcoma of the mouse nervous system;narrowmatch
mouse pineal parenchymal tumours;mouse pineoblastoma;narrowmatch
sessile villous adenoma of the mouse intestinal tract;low grade sessile villous dysplasia of the mouse intestinal tract;narrowmatch
flat tubular adenoma of the mouse intestinal tract;low grade flat tubular dysplasia of the mouse intestinal tract;narrowmatch
flat adenoma of the mouse intestinal tract;flat tubular adenoma of the mouse intestinal tract;narrowmatch
adenoma of the mouse intestinal tract;flat adenoma of the mouse intestinal tract;narrowmatch
sessile tubulovillous adenoma of the mouse intestinal tract;high grade sessile tubulovillous dysplasia of the mouse intestinal tract;narrowmatch
sessile tubulovillous adenoma of the mouse intestinal tract;low grade sessile tubulovillous dysplasia of the mouse intestinal tract;narrowmatch
sessile adenoma of the mouse intestinal tract;sessile tubulovillous adenoma of the mouse intestinal tract;narrowmatch
sessile villous adenoma of the mouse intestinal tract;high grade sessile villous dysplasia of the mouse intestinal tract;narrowmatch
sessile adenoma of the mouse intestinal tract;sessile villous adenoma of the mouse intestinal tract;narrowmatch
mouse intraepithelial neoplasia;gastrointestinal intraepithelial neoplasia of mouse;narrowmatch
sessile tubular adenoma of the mouse intestinal tract;high grade sessile tubular dysplasia of the mouse intestinal tract;narrowmatch
sessile tubular adenoma of the mouse intestinal tract;low grade sessile tubular dysplasia of the mouse intestinal tract;narrowmatch
sessile adenoma of the mouse intestinal tract;sessile tubular adenoma of the mouse intestinal tract;narrowmatch
adenoma of the mouse intestinal tract;sessile adenoma of the mouse intestinal tract;narrowmatch
mouse adenoma;adenoma of the mouse intestinal tract;narrowmatch
benign neoplasms of the mouse intestinal tract;adenoma of the mouse intestinal tract;narrowmatch
neoplasms of the mouse intestinal tract;benign neoplasms of the mouse intestinal tract;narrowmatch
flat tubular adenoma of the mouse intestinal tract;high grade flat tubular dysplasia of the mouse intestinal tract;narrowmatch
flat adenoma of the mouse intestinal tract;flat villous adenoma of the mouse intestinal tract;narrowmatch
flat villous adenoma of the mouse intestinal tract;low grade flat villous dysplasia of the mouse intestinal tract;narrowmatch
flat villous adenoma of the mouse intestinal tract;high grade flat villous dysplasia of the mouse intestinal tract;narrowmatch
mouse lipoma;lipoma of the mouse intestinal tract;narrowmatch
benign neoplasms of the mouse intestinal tract;leiomyoma of the mouse intestinal tract;narrowmatch
mouse leiomyoma;leiomyoma of the mouse intestinal tract;narrowmatch
benign neoplasms of the mouse intestinal tract;fibroma of the mouse intestinal tract;narrowmatch
mouse fibroma;fibroma of the mouse intestinal tract;narrowmatch
pedunculated tubulovillous adenoma of the mouse intestinal tract;high grade pedunculated tubulovillous dysplasia of the mouse intestinal tract;narrowmatch
pedunculated tubulovillous adenoma of the mouse intestinal tract;low grade pedunculated tubulovillous dysplasia of the mouse intestinal tract;narrowmatch
pedunculated adenoma of the mouse intestinal tract;pedunculated tubulovillous adenoma of the mouse intestinal tract;narrowmatch
pedunculated tubular adenoma of the mouse intestinal tract;high grade pedunculated tubular dysplasia of the mouse intestinal tract;narrowmatch
pedunculated tubular adenoma of the mouse intestinal tract;low grade pedunculated tubular dysplasia of the mouse intestinal tract;narrowmatch
pedunculated adenoma of the mouse intestinal tract;pedunculated tubular adenoma of the mouse intestinal tract;narrowmatch
adenoma of the mouse intestinal tract;pedunculated adenoma of the mouse intestinal tract;narrowmatch
flat tubulovillous adenoma of the mouse intestinal tract;high grade flat tubulovillous dysplasia of the mouse intestinal tract;narrowmatch
flat tubulovillous adenoma of the mouse intestinal tract;low grade flat tubulovillous dysplasia of the mouse intestinal tract;narrowmatch
flat adenoma of the mouse intestinal tract;flat tubulovillous adenoma of the mouse intestinal tract;narrowmatch
neoplasms of the mouse intestinal tract;gastrointestinal intraepithelial neoplasia of mouse;narrowmatch
mouse gastrointestinal system neoplasms;neoplasms of the mouse intestinal tract;narrowmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;kaposi sarcoma of the mouse nervous system;narrowmatch
mouse nervous system neoplasms;lymphomas and haemopoietic neoplasms of the mouse nervous system;narrowmatch
mouse nervous system neoplasms;germ cell tumors of the mouse nervous system;narrowmatch
lymphomas and haemopoietic neoplasms of the mouse nervous system;granulocytic sarcoma of the mouse nervous system;narrowmatch
mouse sarcoma;granulocytic sarcoma of the mouse nervous system;narrowmatch
lymphomas and haemopoietic neoplasms of the mouse nervous system;plasmacytoma of the mouse nervous system;narrowmatch
lymphomas and haemopoietic neoplasms of the mouse nervous system;malignant lymphomas of the mouse nervous system;narrowmatch
mouse lymphoma;malignant lymphomas of the mouse nervous system;narrowmatch
mouse lymph cell neoplasm;lymphomas and haemopoietic neoplasms of the mouse nervous system;narrowmatch
mouse nervous system tumors of uncertain histogenesis;mouse hemangioblastoma;narrowmatch
inflammatory diseases of the mouse intestinal tract;acute enteritis of the mouse intestinal tract;narrowmatch
tumors of the mouse meninges;mouse nervous system tumors of uncertain histogenesis;narrowmatch
primary melanocytic lesions of the mouse nervous system;mouse meningeal melanomatosis;narrowmatch
primary melanocytic lesions of the mouse nervous system;malignant melanoma of the mouse nervous system;narrowmatch
primary melanocytic lesions of the mouse nervous system;melanocytoma of the mouse nervous system;narrowmatch
primary melanocytic lesions of the mouse nervous system;diffuse melanocytosis of the mouse nervous system;narrowmatch
mouse melanocyte neoplasm;primary melanocytic lesions of the mouse nervous system;narrowmatch
tumors of the mouse meninges;primary melanocytic lesions of the mouse nervous system;narrowmatch
mouse germ cell neoplasm;germ cell tumors of the mouse nervous system;narrowmatch
germ cell tumors of the mouse nervous system;germinoma of the mouse nervous system;narrowmatch
germ cell tumors of the mouse nervous system;embryonal carcinoma of the mouse nervous system;narrowmatch
mouse carcinoma;embryonal carcinoma of the mouse nervous system;narrowmatch
mouse digestive system disorder;inflammatory diseases of the mouse intestinal tract;narrowmatch
mouse noncancerous conditions;inflammatory diseases of the mouse intestinal tract;narrowmatch
mouse metastatic neoplasms;metastatic tumours of the mouse nervous system;narrowmatch
tumors of the mouse sellar region;granular cell tumor of the mouse sellar region;narrowmatch
mouse craniopharyngioma;mouse papillary craniopharyngioma;narrowmatch
mouse craniopharyngioma;mouse adamantinomatous craniopharyngioma;narrowmatch
tumors of the mouse sellar region;mouse craniopharyngioma;narrowmatch
mouse nervous system neoplasms;tumors of the mouse sellar region;narrowmatch
germ cell tumors of the mouse nervous system;mixed germ cell tumours of the mouse nervous system;narrowmatch
teratoma of the mouse nervous system;teratoma of the mouse nervous system with malignant transformation;narrowmatch
teratoma of the mouse nervous system;immature teratoma of the mouse nervous system;narrowmatch
teratoma of the mouse nervous system;mature teratoma of the mouse nervous system;narrowmatch
germ cell tumors of the mouse nervous system;teratoma of the mouse nervous system;narrowmatch
germ cell tumors of the mouse nervous system;choriocarcinoma of the mouse nervous system;narrowmatch
germ cell tumors of the mouse nervous system;yolk sac tumour of the mouse nervous system;narrowmatch
mouse pineal parenchymal tumours;mouse pineal parenchymal tumour of intermediate differentiation;narrowmatch
mouse pineal parenchymal tumours;mouse pineocytoma;narrowmatch
mouse head and neck neoplasms;mouse salivary gland neoplasms;narrowmatch
mouse leukemia;mouse non-lymphoid leukemia;narrowmatch
mouse myeloid leukemia;mouse myelomonocytic leukemia;narrowmatch
mouse myeloid leukemia;mouse mpd-like myeloid leukemia;narrowmatch
mouse myeloid leukemia;mouse myeloid leukemia with maturation;narrowmatch
mouse myeloid leukemia;mouse myeloid leukemia without maturation;narrowmatch
mouse myeloid cell neoplasm;mouse myeloid leukemia;narrowmatch
mouse non-lymphoid leukemia;mouse myeloid leukemia;narrowmatch
non-lymphoid hematopoietic neoplasm of mouse;mouse non-lymphoid leukemia;narrowmatch
mouse non-lymphoid hematopoietic sarcoma;mouse mast cell hematopoietic sarcoma;narrowmatch
mast cell neoplasms of the mouse skin;mastocytoma of the mouse skin;narrowmatch
mouse non-lymphoid hematopoietic sarcoma;mouse histiocytic sarcoma;narrowmatch
mouse non-lymphoid hematopoietic sarcoma;mouse granulocytic sarcoma;narrowmatch
non-lymphoid hematopoietic neoplasm of mouse;mouse non-lymphoid hematopoietic sarcoma;narrowmatch
mouse sarcoma;mouse non-lymphoid hematopoietic sarcoma;narrowmatch
mouse hematologic neoplasms and related disorders;non-lymphoid hematopoietic neoplasm of mouse;narrowmatch
mouse hematologic disorder;mouse hematologic neoplasms and related disorders;narrowmatch
mouse neoplasms by location;mouse hematologic neoplasms and related disorders;narrowmatch
mouse myeloid leukemia;mouse monocytic leukemia;narrowmatch
mouse monocyte neoplasm;mouse monocytic leukemia;narrowmatch
mouse non-lymphoid leukemia;mouse erythroid leukemia;narrowmatch
mouse non-lymphoid leukemia;mouse megakaryocytic leukemia;narrowmatch
b cell neoplasms of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;narrowmatch
precursor b cell neoplasm of the mouse hematologic system;mouse precursor b cell lymphoblastic lymphoma and leukemia;narrowmatch
b cell neoplasms of the mouse hematologic system;precursor b cell neoplasm of the mouse hematologic system;narrowmatch
lymphoid neoplasms and related disorders of the mouse hematologic system;b cell neoplasms of the mouse hematologic system;narrowmatch
mouse b cell neoplasms;b cell neoplasms of the mouse hematologic system;narrowmatch
mouse hematologic neoplasms and related disorders;lymphoid neoplasms and related disorders of the mouse hematologic system;narrowmatch
mouse myeloid proliferation;mouse myeloproliferative disease;narrowmatch
mouse myeloid proliferation;mouse myeloproliferation;narrowmatch
mouse myeloid cell neoplasm;mouse myeloid proliferation;narrowmatch
non-lymphoid hematopoietic neoplasm of mouse;mouse myeloid proliferation;narrowmatch
myeloid dysplasia of mouse;cytopenia with increased blasts of mouse;narrowmatch
myeloid dysplasia of mouse;mouse myelodysplastic syndrome;narrowmatch
mouse hematologic disorder;myeloid dysplasia of mouse;narrowmatch
mouse precancerous conditions;myeloid dysplasia of mouse;narrowmatch
mouse non-lymphoid leukemia;mouse bi-phenotypic leukemia;narrowmatch
mouse cutaneous tumors of hematopoietic origin;other cutaneous neoplasms of hematopoietic origin of mouse;narrowmatch
mouse cutaneous tumors of hematopoietic origin;mast cell neoplasms of the mouse skin;narrowmatch
mature b cell neoplasms of the mouse hematologic system;splenic marginal zone lymphoma of the mouse hematologic system;narrowmatch
sarcomas of the mouse skin and subcutis;malignant peripheral nerve sheath tumor of the mouse skin;narrowmatch
sarcomas of the mouse skin and subcutis;liposarcoma of the mouse skin;narrowmatch
mouse liposarcoma;liposarcoma of the mouse skin;narrowmatch
mouse rhabdomyosarcoma;rhabdomyosarcoma of the mouse skin;narrowmatch
sarcomas of the mouse skin and subcutis;rhabdomyosarcoma of the mouse skin;narrowmatch
mouse leiomyosarcoma;leiomyosarcoma of the mouse skin;narrowmatch
sarcomas of the mouse skin and subcutis;leiomyosarcoma of the mouse skin;narrowmatch
mouse neural cell neoplasm;malignant peripheral nerve sheath tumor of the mouse skin;narrowmatch
mouse angiosarcoma;lymphangiosarcoma of the mouse skin;narrowmatch
mouse mast cell neoplasm;mast cell neoplasms of the mouse skin;narrowmatch
sarcomas of the mouse skin and subcutis;lymphangiosarcoma of the mouse skin;narrowmatch
mouse angiosarcoma;hemangiosarcoma of the mouse skin;narrowmatch
sarcomas of the mouse skin and subcutis;hemangiosarcoma of the mouse skin;narrowmatch
non-neoplastic skin disorder;dermatosis;narrowmatch
neoplasms of the mouse skin;sarcomas of the mouse skin and subcutis;narrowmatch
mouse sarcoma;sarcomas of the mouse skin and subcutis;narrowmatch
benign mesenchymal neoplasms of the mouse skin;granular cell tumor of the mouse skin;narrowmatch
mouse spindle cell neoplasm;unclassified malignant spindle cell neoplasm of the mouse skin;narrowmatch
sarcomas of the mouse skin and subcutis;unclassified malignant spindle cell neoplasm of the mouse skin;narrowmatch
neoplasms of the mouse skin;mouse cutaneous tumors of hematopoietic origin;narrowmatch
mouse lymphoma;mouse cutaneous lymphomas;narrowmatch
histiocytic neoplasms of the mouse skin;malignant histiocytic neoplasms of the mouse skin;narrowmatch
histiocytic neoplasms of the mouse skin;benign histiocytic neoplasms of the mouse skin;narrowmatch
mouse cutaneous tumors of hematopoietic origin;histiocytic neoplasms of the mouse skin;narrowmatch
plasma cell neoplasms of the mouse skin;malignant plasmacytoma of the mouse skin;narrowmatch
mouse plasmacytoma;malignant plasmacytoma of the mouse skin;narrowmatch
mouse skin disorder;benign plasma cell proliferations of the mouse skin;narrowmatch
mouse cancer-related conditions;benign plasma cell proliferations of the mouse skin;narrowmatch
mouse cutaneous tumors of hematopoietic origin;plasma cell neoplasms of the mouse skin;narrowmatch
mouse plasma cell neoplasm;plasma cell neoplasms of the mouse skin;narrowmatch
mouse cutaneous lymphomas;other lymphomas of the mouse skin;narrowmatch
mouse cutaneous lymphomas;t-cell lymphomas of the mouse skin;narrowmatch
mouse t cell neoplasms;t-cell lymphomas of the mouse skin;narrowmatch
mouse cutaneous lymphomas;b-cell lymphomas of the mouse skin;narrowmatch
mouse b cell neoplasms;b-cell lymphomas of the mouse skin;narrowmatch
mouse cutaneous tumors of hematopoietic origin;mouse cutaneous lymphomas;narrowmatch
mature b cell neoplasms of the mouse hematologic system;small b cell lymphoma of the mouse hematologic system;narrowmatch
mature b cell neoplasms of the mouse hematologic system;follicular b cell lymphoma of the mouse hematologic system;narrowmatch
mouse tumors of neuroepithelial tissue;mouse pineal parenchymal tumours;narrowmatch
mouse ependymoma;mouse tanycytic ependymoma;narrowmatch
mouse glial tumours of uncertain origin;mouse astroblastoma;narrowmatch
mouse tumors of neuroepithelial tissue;mouse glial tumours of uncertain origin;narrowmatch
mouse neuroglia neoplasm;mouse glial tumours of uncertain origin;narrowmatch
mouse tumors of neuroepithelial tissue;mouse choroid plexus tumours;narrowmatch
mouse ependymal tumours;mouse subependymoma;narrowmatch
mouse ependymal tumours;mouse myxopapillary ependymoma;narrowmatch
mouse ependymal tumours;mouse anaplastic ependymoma;narrowmatch
mouse ependymoma;mouse clear cell ependymoma;narrowmatch
mouse oligodendroglial tumours;mouse anaplastic oligodendroglioma;narrowmatch
mouse ependymoma;mouse papillary ependymoma;narrowmatch
mouse ependymoma;mouse cellular ependymoma;narrowmatch
mouse ependymal tumours;mouse ependymoma;narrowmatch
mouse tumors of neuroepithelial tissue;mouse ependymal tumours;narrowmatch
mixed mouse gliomas;mouse anaplastic oligoastrocytoma;narrowmatch
mixed mouse gliomas;mouse oligoastrocytoma;narrowmatch
mouse tumors of neuroepithelial tissue;mixed mouse gliomas;narrowmatch
mouse glial tumours of uncertain origin;mouse gliomatosis cerebri;narrowmatch
mouse glial tumours of uncertain origin;mouse chordoid glioma of the 3rd ventricle;narrowmatch
mouse neuroglia neoplasm;mouse neuronal and mixed neuronal-glial tumours;narrowmatch
mouse tumors of neuroepithelial tissue;mouse neuronal and mixed neuronal-glial tumours;narrowmatch
mouse neuroblastic tumours;neuroblastomas of the mouse adrenal gland and sympathetic nervous system;narrowmatch
mouse neuroblastic tumours;mouse olfactory neuroepithelioma;narrowmatch
mouse neuroblastic tumours;mouse olfactory neuroblastoma;narrowmatch
mouse tumors of neuroepithelial tissue;mouse neuroblastic tumours;narrowmatch
mouse neuroglia neoplasm;mouse neuroblastic tumours;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;paraganglioma of the mouse filum terminale;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;mouse cerebellar liponeurocytoma;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;mouse central neurocytoma;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;mouse anaplastic ganglioglioma;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;mouse ganglioglioma;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;mouse dysembryoplastic neuroepithelial tumour;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;mouse desmoplastic infantile astrocytoma / ganglioglioma;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;dysplastic lhermitte-duclos gangliocytoma of mouse cerebellum;narrowmatch
mouse neuronal and mixed neuronal-glial tumours;mouse gangliocytoma;narrowmatch
mouse neural cell neoplasm;mouse neuronal and mixed neuronal-glial tumours;narrowmatch
mouse neuroglia neoplasm;mixed mouse gliomas;narrowmatch
mouse oligodendroglial tumours;mouse oligodendroglioma;narrowmatch
mature b cell neoplasms of the mouse hematologic system;diffuse large b cell lymphoma of the mouse hematologic system;narrowmatch
plasma cell neoplasm of the mouse hematologic system;anaplastic plasmacytoma of the mouse hematologic system;narrowmatch
t cell neoplasms of the mouse hematologic system;mature t cell lineage lymphoma of the mouse hematologic system;narrowmatch
t cell neoplasms of undetermined character of the mouse hematologic system;large cell anaplastic lymphoma of the mouse hematologic system;narrowmatch
precursor t cell neoplasm of the mouse hematologic system;mouse precursor t cell lymphoblastic lymphoma/leukemia;narrowmatch
t cell neoplasms of the mouse hematologic system;precursor t cell neoplasm of the mouse hematologic system;narrowmatch
lymphoid neoplasms and related disorders of the mouse hematologic system;t cell neoplasms of the mouse hematologic system;narrowmatch
mouse t cell neoplasms;t cell neoplasms of the mouse hematologic system;narrowmatch
mature b cell neoplasms of the mouse hematologic system;b-nk cell lymphoma of the mouse hematologic system;narrowmatch
plasma cell neoplasm of the mouse hematologic system;extraosseus plasmacytoma of the mouse hematologic system;narrowmatch
mouse tumors of neuroepithelial tissue;mouse oligodendroglial tumours;narrowmatch
plasma cell neoplasm of the mouse hematologic system;plasmacytoma of the mouse hematologic system;narrowmatch
mature b cell neoplasms of the mouse hematologic system;plasma cell neoplasm of the mouse hematologic system;narrowmatch
mature b cell neoplasms of the mouse hematologic system;classic burkitt lymphoma of the mouse hematologic system;narrowmatch
subtypes of diffuse large b cell lymphoma of the mouse hematologic system;primary mediastinal thymic diffuse large b cell lymphoma of the mouse hematologic system;narrowmatch
morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;histiocyte-associated diffuse large b cell lymphoma of the mouse hematologic system;narrowmatch
morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;immunoblastic diffuse large b cell lymphoma of the mouse hematologic system;narrowmatch
morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;centroblastic diffuse large b cell lymphoma of the mouse hematologic system;narrowmatch
mature t cell lineage lymphoma of the mouse hematologic system;small t cell lymphoma of the mouse hematologic system;narrowmatch
mature t cell lineage lymphoma of the mouse hematologic system;mouse t-nk cell lymphoma;narrowmatch
mouse neoplasms by location;mouse nervous system neoplasms;narrowmatch
mouse nervous system disorder;mouse nervous system neoplasms;narrowmatch
mouse neuroglia neoplasm;mouse oligodendroglial tumours;narrowmatch
mouse astrocytic tumours;mouse subependymal giant cell astrocytoma;narrowmatch
mouse astrocytic tumours;mouse pleomorphic xanthoastrocytoma;narrowmatch
mouse astrocytic tumours;mouse pilocytic astrocytoma;narrowmatch
mouse glioblastoma;mouse gliosarcoma;narrowmatch
mouse glioblastoma;mouse giant cell glioblastoma;narrowmatch
mouse astrocytic tumours;mouse glioblastoma;narrowmatch
mouse astrocytic tumours;mouse anaplastic astrocytoma;narrowmatch
mouse diffuse astrocytoma;mouse gemistocytic astrocytoma;narrowmatch
mouse diffuse astrocytoma;mouse protoplasmic astrocytoma;narrowmatch
mouse diffuse astrocytoma;mouse fibrillary astrocytoma;narrowmatch
mouse astrocytic tumours;mouse diffuse astrocytoma;narrowmatch
mouse tumors of neuroepithelial tissue;mouse astrocytic tumours;narrowmatch
mouse neuroglia neoplasm;mouse astrocytic tumours;narrowmatch
mouse nervous system neoplasms;mouse tumors of neuroepithelial tissue;narrowmatch
mouse angioma;hemangioma of the mouse intestinal tract;narrowmatch
benign neoplasms of the mouse intestinal tract;hemangioma of the mouse intestinal tract;narrowmatch
adenoma of the mouse intestinal tract;neuroendocrine adenoma of the mouse intestinal tract;narrowmatch
mouse head and neck disorder;mouse head and neck neoplasms;narrowmatch
squamous cell carcinoma of the mouse oral cavity;verrucous carcinoma of the mouse oral cavity;narrowmatch
squamous cell carcinoma of the mouse oral cavity;squamous cell carcinoma in-situ of the mouse oral cavity;narrowmatch
carcinoma of the mouse oral cavity;squamous cell carcinoma of the mouse oral cavity;narrowmatch
epithelial neoplasms of the mouse oral cavity;carcinoma of the mouse oral cavity;narrowmatch
mouse oral cavity neoplasms;epithelial neoplasms of the mouse oral cavity;narrowmatch
mouse digestive system neoplasms;mouse oral cavity neoplasms;narrowmatch
mouse head and neck neoplasms;mouse oral cavity neoplasms;narrowmatch
mouse neoplasms by location;mouse head and neck neoplasms;narrowmatch
mouse adrenal gland neoplasms;mouse adrenal cortical adenoma;narrowmatch
diffuse large b cell lymphoma of the mouse hematologic system;subtypes of diffuse large b cell lymphoma of the mouse hematologic system;narrowmatch
diffuse large b cell lymphoma of the mouse hematologic system;morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;narrowmatch
mature b cell neoplasms of the mouse hematologic system;burkitt-like lymphoma of the mouse hematologic system;narrowmatch
t cell neoplasms of the mouse hematologic system;t cell neoplasms of undetermined character of the mouse hematologic system;narrowmatch
mouse adrenal cortical adenoma;mouse adrenal cortical adenoma, mixed cell;narrowmatch
mouse adrenal cortical adenoma;mouse adrenal cortical adenoma, glomerulosa cell;narrowmatch
mouse adrenal cortical adenoma;mouse adrenal cortical adenoma, clear cell;narrowmatch
carcinoma of the mouse oral cavity;adenosquamous cell carcinoma of the mouse oral cavity;narrowmatch
mouse adenosquamous carcinoma;adenosquamous cell carcinoma of the mouse oral cavity;narrowmatch
mouse oral cavity neoplasms;smooth muscle neoplasms of the mouse oral cavity;narrowmatch
mouse leiomyoma;leiomyoma of the mouse oral cavity;narrowmatch
mouse lymphoma;lymphoma of the mouse oral cavity;narrowmatch
hematopoietic neoplasms of the mouse oral cavity;lymphoproliferative neoplasms of the mouse oral cavity;narrowmatch
mouse oral cavity neoplasms;hematopoietic neoplasms of the mouse oral cavity;narrowmatch
melanocytic neoplasms of the mouse oral cavity;melanoma of the mouse oral cavity;narrowmatch
mouse oral cavity neoplasms;melanocytic neoplasms of the mouse oral cavity;narrowmatch
mouse synovial sarcoma;synovial sarcoma of the mouse oral cavity;narrowmatch
synovial neoplasms of the mouse oral cavity;synovial sarcoma of the mouse oral cavity;narrowmatch
mouse oral cavity neoplasms;synovial neoplasms of the mouse oral cavity;narrowmatch
neural neoplasms of the mouse oral cavity;neurofibroma of the mouse oral cavity;narrowmatch
mouse neurofibroma;neurofibroma of the mouse oral cavity;narrowmatch
neural neoplasms of the mouse oral cavity;neurilemoma of the mouse oral cavity;narrowmatch
mouse oral cavity neoplasms;neural neoplasms of the mouse oral cavity;narrowmatch
mouse leiomyosarcoma;leiomyosarcoma of the mouse oral cavity;narrowmatch
smooth muscle neoplasms of the mouse oral cavity;leiomyosarcoma of the mouse oral cavity;narrowmatch
smooth muscle neoplasms of the mouse oral cavity;leiomyoma of the mouse oral cavity;narrowmatch
mouse adrenal cortical adenoma;mouse adrenal cortical adenoma, pigmented;narrowmatch
mouse adenoma;mouse adrenal cortical adenoma;narrowmatch
hematopoietic neoplasms of the mouse oral cavity;plasma cell neoplasms of the mouse oral cavity;narrowmatch
mouse skeletal system neoplasms;chondroblastoma of the mouse skeletal system, nos;narrowmatch
mouse chondrosarcoma;mesenchymal chondrosarcoma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;mesenchymal chondrosarcoma of the mouse skeletal system;narrowmatch
mouse chondrosarcoma;myxoid chondrosarcoma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;myxoid chondrosarcoma of the mouse skeletal system;narrowmatch
mouse chondrocyte neoplasm;chondroblastoma of the mouse skeletal system, malignant;narrowmatch
mouse skeletal system neoplasms;chondroblastoma of the mouse skeletal system, malignant;narrowmatch
mouse chondrocyte neoplasm;chondroblastoma of the mouse skeletal system, nos;narrowmatch
mouse chondrosarcoma;juxtacortical chondrosarcoma of the mouse skeletal system;narrowmatch
mouse adrenal cortical adenoma;mouse adrenal cortical adenoma, compact cell;narrowmatch
mouse skeletal system neoplasms;juxtacortical chondrosarcoma of the mouse skeletal system;narrowmatch
mouse chondrocyte neoplasm;juxtacortical chondroma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;juxtacortical chondroma of the mouse skeletal system;narrowmatch
mouse chondrosarcoma;chondrosarcoma of the mouse skeletal system, nos;narrowmatch
mouse skeletal system neoplasms;chondrosarcoma of the mouse skeletal system, nos;narrowmatch
mouse chondrocyte neoplasm;chondromatosis of the mouse skeletal system, nos;narrowmatch
mouse skeletal system neoplasms;chondromatosis of the mouse skeletal system, nos;narrowmatch
mouse fibroma;chondromyxoid fibroma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;chondromyxoid fibroma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;clear cell chondrosarcoma of the mouse skeletal system;narrowmatch
mouse chondrosarcoma;clear cell chondrosarcoma of the mouse skeletal system;narrowmatch
mouse adrenal gland neoplasms;mouse adrenal cortical carcinoma;narrowmatch
mouse carcinoma;mouse adrenal cortical carcinoma;narrowmatch
mouse adrenal cortical adenoma;mouse adrenal cortical adenoma, nos;narrowmatch
mouse pituitary gland neoplasms;mouse pituitary carcinoma, nos;narrowmatch
mouse carcinoma;mouse pituitary carcinoma, nos;narrowmatch
mouse pituitary gland neoplasms;mouse pituitary adenoma, nos;narrowmatch
mouse adenoma;mouse pituitary adenoma, nos;narrowmatch
mouse endocrine gland system disorder;mouse endocrine gland system neoplasms;narrowmatch
mouse neoplasms by location;mouse endocrine gland system neoplasms;narrowmatch
mouse skeletal system neoplasms;giant cell tumor of bone of the mouse skeletal system, malignant;narrowmatch
mouse giant cell neoplasm;giant cell tumor of bone of the mouse skeletal system, malignant;narrowmatch
mouse skeletal system neoplasms;giant cell tumor of bone of the mouse skeletal system, nos;narrowmatch
mouse giant cell neoplasm;giant cell tumor of bone of the mouse skeletal system, nos;narrowmatch
mouse chondrosarcoma;dedifferentiated chondrosarcoma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;dedifferentiated chondrosarcoma of the mouse skeletal system;narrowmatch
lymphoproliferative neoplasms of the mouse oral cavity;lymphoma of the mouse oral cavity;narrowmatch
plasma cell neoplasms of the mouse oral cavity;plasmacytoma of the mouse oral cavity;narrowmatch
neoplasms of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;narrowmatch
smooth muscle neoplasms of the mouse nose and paranasal sinuses;leiomyosarcoma of the mouse nose and paranasal sinuses;narrowmatch
epithelial neoplasms of the mouse larynx;carcinoma of the mouse larynx;narrowmatch
epithelial neoplasms of the mouse larynx;papilloma of the mouse larynx;narrowmatch
mouse laryngeal neoplasms;epithelial neoplasms of the mouse larynx;narrowmatch
mouse head and neck neoplasms;mouse laryngeal neoplasms;narrowmatch
skeletal muscle neoplasms of the mouse nose and paranasal sinuses;embryonal rhabdomyosarcoma of the mouse nose and paranasal sinuses;narrowmatch
mouse nose and paranasal sinuses neoplasms;skeletal muscle neoplasms of the mouse nose and paranasal sinuses;narrowmatch
mouse leiomyosarcoma;leiomyosarcoma of the mouse nose and paranasal sinuses;narrowmatch
mouse nose and paranasal sinuses neoplasms;smooth muscle neoplasms of the mouse nose and paranasal sinuses;narrowmatch
mouse nose and paranasal sinuses neoplasms;melanocytic neoplasms of the mouse nose and paranasal sinuses;narrowmatch
plasma cell neoplasms of the mouse nose and paranasal sinuses;plasmacytoma of the mouse nose and paranasal sinuses;narrowmatch
hematopoietic neoplasms of the mouse nose and paranasal sinuses;plasma cell neoplasms of the mouse nose and paranasal sinuses;narrowmatch
lymphoma of the mouse nose and paranasal sinuses;angiocentric immunoproliferative lesion of the mouse nose and paranasal sinuses;narrowmatch
lymphoproliferative neoplasms of the mouse nose and paranasal sinuses;lymphoma of the mouse nose and paranasal sinuses;narrowmatch
mouse lymphoma;lymphoma of the mouse nose and paranasal sinuses;narrowmatch
hematopoietic neoplasms of the mouse nose and paranasal sinuses;lymphoproliferative neoplasms of the mouse nose and paranasal sinuses;narrowmatch
mouse nose and paranasal sinuses neoplasms;hematopoietic neoplasms of the mouse nose and paranasal sinuses;narrowmatch
mouse carcinoma;carcinoma of the mouse larynx;narrowmatch
mouse squamous cell carcinoma;squamous cell carcinoma of the mouse larynx;narrowmatch
carcinoma of the mouse larynx;squamous cell carcinoma of the mouse larynx;narrowmatch
squamous cell carcinoma of the mouse larynx;squamous cell carcinoma in-situ of the mouse larynx;narrowmatch
neuroendocrine neoplasms of the mouse larynx;carcinoid tumor of the mouse larynx;narrowmatch
mouse carcinoid tumor;carcinoid tumor of the mouse larynx;narrowmatch
mouse laryngeal neoplasms;neuroendocrine neoplasms of the mouse larynx;narrowmatch
histiocytic neoplasms of the mouse larynx;malignant fibrous histiocytoma of the mouse larynx;narrowmatch
mouse malignant mesenchymal neoplasm;malignant fibrous histiocytoma of the mouse larynx;narrowmatch
mouse laryngeal neoplasms;histiocytic neoplasms of the mouse larynx;narrowmatch
mouse osteosarcoma;osteosarcoma of the mouse larynx;narrowmatch
cartilage/bone neoplasms of the mouse larynx;osteosarcoma of the mouse larynx;narrowmatch
mouse chondrosarcoma;chondrosarcoma of the mouse larynx;narrowmatch
cartilage/bone neoplasms of the mouse larynx;chondrosarcoma of the mouse larynx;narrowmatch
mouse laryngeal neoplasms;cartilage/bone neoplasms of the mouse larynx;narrowmatch
mouse acinar cell neoplasm;acinic cell carcinoma of the mouse larynx;narrowmatch
carcinoma of the mouse larynx;acinic cell carcinoma of the mouse larynx;narrowmatch
carcinoma of the mouse larynx;mucoepidermoid carcinoma of the mouse larynx;narrowmatch
carcinoma of the mouse larynx;adenoid cystic carcinoma of the mouse larynx;narrowmatch
melanocytic neoplasms of the mouse nose and paranasal sinuses;melanoma of the mouse nose and paranasal sinuses;narrowmatch
neural neoplasms of the mouse nose and paranasal sinuses;olfactory neuroblastoma of the mouse nose and paranasal sinuses;narrowmatch
mouse head and neck neoplasms;mouse pharyngeal neoplasms;narrowmatch
epithelial neoplasms of the mouse pharynx;undifferentiated carcinoma of the mouse pharynx;narrowmatch
synovial neoplasms of the mouse pharynx;synovial sarcoma of the mouse pharynx;narrowmatch
mouse pharyngeal neoplasms;synovial neoplasms of the mouse pharynx;narrowmatch
mouse rhabdomyosarcoma;embryonal rhabdomyosarcoma of the mouse pharynx;narrowmatch
skeletal muscle neoplasms of the mouse pharynx;embryonal rhabdomyosarcoma of the mouse pharynx;narrowmatch
mouse pharyngeal neoplasms;skeletal muscle neoplasms of the mouse pharynx;narrowmatch
undifferentiated carcinoma of the mouse pharynx;undifferentiated carcinoma of the mouse pharynx with lymphoid stroma;narrowmatch
undifferentiated carcinoma of the mouse pharynx;undifferentiated carcinoma of the mouse pharynx without lymphoid stroma;narrowmatch
mouse undifferentiated carcinoma;undifferentiated carcinoma of the mouse pharynx;narrowmatch
mouse neuroblastic tumours;olfactory neuroblastoma of the mouse nose and paranasal sinuses;narrowmatch
non-keratinizing carcinoma of the mouse pharynx;non-keratinizing carcinoma of the mouse pharynx with lymphoid stroma;narrowmatch
non-keratinizing carcinoma of the mouse pharynx;non-keratinizing carcinoma of the mouse pharynx without lymphoid stroma;narrowmatch
epithelial neoplasms of the mouse pharynx;non-keratinizing carcinoma of the mouse pharynx;narrowmatch
epithelial neoplasms of the mouse pharynx;squamous cell carcinoma of the mouse pharynx;narrowmatch
mouse squamous cell carcinoma;squamous cell carcinoma of the mouse pharynx;narrowmatch
mouse pharyngeal neoplasms;epithelial neoplasms of the mouse pharynx;narrowmatch
mouse digestive system neoplasms;mouse pharyngeal neoplasms;narrowmatch
mouse pharyngeal neoplasms;vascular-fibrous neoplasms of the mouse pharynx;narrowmatch
vascular-fibrous neoplasms of the mouse pharynx;angiofibroma of the mouse pharynx;narrowmatch
mouse pharyngeal neoplasms;hematopoietic neoplasms of the mouse pharynx;narrowmatch
hematopoietic neoplasms of the mouse pharynx;lymphoproliferative neoplasms of the mouse pharynx;narrowmatch
mouse nose and paranasal sinuses neoplasms;neural neoplasms of the mouse nose and paranasal sinuses;narrowmatch
carcinoma of the mouse nose and paranasal sinuses;adenocarcinoma of the mouse nose and paranasal sinuses;narrowmatch
squamous cell carcinoma of the mouse nose and paranasal sinuses;verrucous carcinoma of the mouse nose and paranasal sinuses;narrowmatch
carcinoma of the mouse nose and paranasal sinuses;squamous cell carcinoma of the mouse nose and paranasal sinuses;narrowmatch
epithelial neoplasms of the mouse nose and paranasal sinuses;carcinoma of the mouse nose and paranasal sinuses;narrowmatch
epithelial neoplasms of the mouse nose and paranasal sinuses;papilloma of the mouse nose and paranasal sinuses;narrowmatch
mouse nose and paranasal sinuses neoplasms;epithelial neoplasms of the mouse nose and paranasal sinuses;narrowmatch
mouse special sense organ neoplasms;mouse nose and paranasal sinuses neoplasms;narrowmatch
mouse head and neck neoplasms;mouse nose and paranasal sinuses neoplasms;narrowmatch
plasma cell neoplasms of the mouse pharynx;plasmacytoma of the mouse pharynx;narrowmatch
lymphoma of the mouse pharynx;plasmacytoma of the mouse pharynx;narrowmatch
b cell neoplasms of the mouse hematologic system;plasmacytoma of the mouse pharynx;narrowmatch
hematopoietic neoplasms of the mouse pharynx;plasma cell neoplasms of the mouse pharynx;narrowmatch
lymphoproliferative neoplasms of the mouse pharynx;lymphoma of the mouse pharynx;narrowmatch
mouse lymphoma;lymphoma of the mouse pharynx;narrowmatch
mouse chondrocyte neoplasm;chondroma of the mouse skeletal system, nos;narrowmatch
mouse skeletal system neoplasms;chondroma of the mouse skeletal system, nos;narrowmatch
mouse chondrocyte neoplasm;osteochondromatosis of the mouse skeletal system, nos;narrowmatch
mouse respiratory system;mouse larynx;narrowmatch
mouse brain;mouse meninges;narrowmatch
mouse brain;mouse ependyma;narrowmatch
mouse brain;mouse choroid plexus;narrowmatch
mouse brain;mouse astrocyte;narrowmatch
mouse central nervous system;mouse brain;narrowmatch
mouse nervous system;mouse central nervous system;narrowmatch
mouse anatomy concepts;mouse nervous system;narrowmatch
mouse anatomy concepts;mouse respiratory system;narrowmatch
mouse anatomy concepts;mouse integument system;narrowmatch
mouse lymphohematopoietic system;mouse bone marrow;narrowmatch
mouse anatomy concepts;mouse lymphohematopoietic system;narrowmatch
mouse integument system;mouse mammary gland;narrowmatch
mouse skin gland;mouse sebaceous gland;narrowmatch
mouse skin;mouse skin gland;narrowmatch
mouse skin;mouse hair follicle;narrowmatch
mouse skin;mouse melanocyte;narrowmatch
mouse brain;mouse oligodendroglial cell;narrowmatch
mouse nervous system;mouse neuroblast;narrowmatch
mouse nervous system;mouse peripheral nervous system;narrowmatch
mouse anatomy concepts;mouse endocrine gland system;narrowmatch
mouse soft tissue;mouse periosteum;narrowmatch
mouse soft tissue;mouse adipose tissue;narrowmatch
mouse soft tissue;mouse connective tissue;narrowmatch
mouse soft tissue;mouse muscle;narrowmatch
mouse soft tissue;mouse cartilage;narrowmatch
mouse musculoskeletal system;mouse soft tissue;narrowmatch
mouse musculoskeletal system;mouse skeletal system;narrowmatch
mouse female reproductive system;mouse uterus;narrowmatch
mouse female reproductive system;mouse placenta;narrowmatch
mouse female reproductive system;mouse oviduct;narrowmatch
mouse female reproductive system;mouse ovary;narrowmatch
mouse reproductive system;mouse female reproductive system;narrowmatch
mouse endocrine gland system;mouse thyroid gland;narrowmatch
mouse endocrine gland system;mouse pituitary gland;narrowmatch
mouse endocrine gland system;mouse adrenal gland;narrowmatch
mouse integument system;mouse skin;narrowmatch
mouse gastrointestinal tract;mouse intestine;narrowmatch
mouse skeletal system neoplasms;osteochondromatosis of the mouse skeletal system, nos;narrowmatch
mouse malignant mesenchymal neoplasm;fibrosarcoma of the mouse intestinal tract;narrowmatch
malignant neoplasms of the mouse intestinal tract;lymphoma of the mouse intestinal tract;narrowmatch
mouse lymphoma;lymphoma of the mouse intestinal tract;narrowmatch
mouse leiomyosarcoma;leiomyosarcoma of the mouse intestinal tract;narrowmatch
malignant neoplasms of the mouse intestinal tract;leiomyosarcoma of the mouse intestinal tract;narrowmatch
mouse malignant mesenchymal neoplasm;leiomyosarcoma of the mouse intestinal tract;narrowmatch
mouse fibrosarcoma;fibrosarcoma of the mouse intestinal tract;narrowmatch
malignant neoplasms of the mouse intestinal tract;fibrosarcoma of the mouse intestinal tract;narrowmatch
malignant neoplasms of the mouse intestinal tract;squamous cell carcinoma of the mouse intestinal tract;narrowmatch
mouse biliary tract;mouse gallbladder;narrowmatch
mouse squamous cell carcinoma;squamous cell carcinoma of the mouse intestinal tract;narrowmatch
adenocarcinoma of the mouse intestinal tract;signet ring cell adenocarcinoma of the mouse intestinal tract;narrowmatch
adenocarcinoma of the mouse intestinal tract;villous adenocarcinoma of the mouse intestinal tract;narrowmatch
adenocarcinoma of the mouse intestinal tract;mucinous adenocarcinoma of the mouse intestinal tract;narrowmatch
adenocarcinoma of the mouse intestinal tract;tubular adenocarcinoma of the mouse intestinal tract;narrowmatch
mouse adenocarcinoma;adenocarcinoma of the mouse intestinal tract;narrowmatch
malignant neoplasms of the mouse intestinal tract;adenocarcinoma of the mouse intestinal tract;narrowmatch
mouse malignant mesenchymal neoplasm;hemangiosarcoma of the mouse intestinal tract;narrowmatch
malignant neoplasms of the mouse intestinal tract;hemangiosarcoma of the mouse intestinal tract;narrowmatch
mouse angiosarcoma;hemangiosarcoma of the mouse intestinal tract;narrowmatch
mouse liposarcoma;liposarcoma of the mouse intestinal tract;narrowmatch
mouse digestive system;mouse liver;narrowmatch
mouse gastrointestinal tract;mouse stomach;narrowmatch
mouse digestive system;mouse gastrointestinal tract;narrowmatch
mouse digestive system;mouse pharynx;narrowmatch
mouse digestive system;mouse salivary gland;narrowmatch
mouse digestive system;mouse oral cavity;narrowmatch
mouse anatomy concepts;mouse digestive system;narrowmatch
mouse cardiovascular system;mouse blood vessel;narrowmatch
mouse cardiovascular system;mouse heart;narrowmatch
mouse anatomy concepts;mouse cardiovascular system;narrowmatch
mouse male reproductive system;mouse prostate gland;narrowmatch
mouse reproductive system;mouse male reproductive system;narrowmatch
experimental organism anatomical concept;mouse anatomy concepts;narrowmatch
malignant neoplasms of the mouse intestinal tract;neuroendocrine cell carcinoma of the mouse intestinal tract;narrowmatch
malignant neoplasms of the mouse intestinal tract;liposarcoma of the mouse intestinal tract;narrowmatch
mouse anatomy concepts;mouse special sensory organ;narrowmatch
mouse special sensory organ;mouse nose;narrowmatch
mouse nose;mouse nasal cavity;narrowmatch
mouse hemangiopericytoma;hemangiopericytoma of the mouse blood vessel, malignant;narrowmatch
mouse skeletal system neoplasms;osteoma of the mouse skeletal system, nos;narrowmatch
mouse skeletal system disorder;mouse skeletal system neoplasms;narrowmatch
mouse neoplasms by location;mouse skeletal system neoplasms;narrowmatch
hemangioma of the mouse blood vessel;hemangioblastoma of the mouse blood vessel;narrowmatch
hemangioma of the mouse blood vessel;acquired tufted hemangioma of the mouse blood vessel;narrowmatch
mouse primary tumors of the blood vessel;angiofibroma of the mouse blood vessel, nos;narrowmatch
hemangioma of the mouse blood vessel;hemangiopericytoma of the mouse blood vessel, malignant;narrowmatch
hemangioma of the mouse blood vessel;hemangiopericytoma of the mouse blood vessel, nos;narrowmatch
mouse anatomy concepts;mouse urinary system;narrowmatch
mouse hemangiopericytoma;hemangiopericytoma of the mouse blood vessel, nos;narrowmatch
hemangioma of the mouse blood vessel;hemangiopericytoma of the mouse blood vessel, benign;narrowmatch
mouse hemangiopericytoma;hemangiopericytoma of the mouse blood vessel, benign;narrowmatch
hemangioma of the mouse blood vessel;verrucous keratotic hemangioma of the mouse blood vessel;narrowmatch
mouse primary tumors of the blood vessel;angiokeratoma of the mouse blood vessel;narrowmatch
mouse kaposi's sarcoma;kaposi sarcoma of the mouse blood vessel;narrowmatch
mouse primary tumors of the blood vessel;kaposi sarcoma of the mouse blood vessel;narrowmatch
osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system, nos;narrowmatch
mouse skeletal system neoplasms;osteosarcoma of the mouse skeletal system;narrowmatch
mouse osteosarcoma;osteosarcoma of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;chondroblastic osteosarcoma of the mouse skeletal system;narrowmatch
mouse chondrocyte neoplasm;osteochondroma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;osteochondroma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;aggressive osteoblastoma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;osteoblastoma of the mouse skeletal system, nos;narrowmatch
osteosarcoma of the mouse skeletal system;intracortical osteosarcoma of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;high grade surface osteosarcoma of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;periosteal osteosarcoma of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;parosteal osteosarcoma of the mouse skeletal system;narrowmatch
mouse skeletal system neoplasms;osteoid osteoma of the mouse skeletal system, nos;narrowmatch
osteosarcoma of the mouse skeletal system;intraosseous well differentiated osteosarcoma of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;central osteosarcoma of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;small cell osteosarcoma of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;osteosarcoma in paget disease of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;telangiectatic osteosarcoma of the mouse skeletal system;narrowmatch
osteosarcoma of the mouse skeletal system;fibroblastic osteosarcoma of the mouse skeletal system;narrowmatch
hemangioma of the mouse blood vessel;spindle cell hemangioendothelioma of the mouse blood vessel;narrowmatch
mouse primary tumors of the blood vessel;endovascular papillary angioendothelioma of the mouse blood vessel;narrowmatch
mouse angiosarcoma;kupffer cell sarcoma of the mouse blood vessel;narrowmatch
mouse neoplasms by location;mouse cardiovascular system neoplasms;narrowmatch
mouse cardiac sarcoma;mouse cardiac kaposi's sarcoma;narrowmatch
mouse primary cardiac tumors;mouse cardiac malignant fibrous histiocytoma;narrowmatch
mouse malignant mesenchymal neoplasm;mouse cardiac malignant fibrous histiocytoma;narrowmatch
mouse fibrosarcoma;mouse cardiac fibrosarcoma;narrowmatch
mouse cardiac sarcoma;mouse cardiac fibrosarcoma;narrowmatch
mouse primary cardiac tumors;mouse cardiac mesothelioma;narrowmatch
mouse mesothelioma;mouse cardiac mesothelioma;narrowmatch
mouse rhabdomyosarcoma;mouse cardiac rhabdomyosarcoma;narrowmatch
mouse cardiac sarcoma;mouse cardiac rhabdomyosarcoma;narrowmatch
mouse angiosarcoma;mouse cardiac angiosarcoma;narrowmatch
mouse cardiac sarcoma;mouse cardiac angiosarcoma;narrowmatch
mouse primary cardiac tumors;mouse cardiac sarcoma;narrowmatch
mouse sarcoma;mouse cardiac sarcoma;narrowmatch
mouse cardiovascular system neoplasms;mouse primary cardiac tumors;narrowmatch
mouse urinary system;mouse bladder;narrowmatch
mouse kaposi's sarcoma;mouse cardiac kaposi's sarcoma;narrowmatch
mouse cardiovascular system disorder;mouse cardiovascular system neoplasms;narrowmatch
mouse primary tumors of the blood vessel;kupffer cell sarcoma of the mouse blood vessel;narrowmatch
mouse cardiovascular system neoplasms;mouse primary tumors of the blood vessel;narrowmatch
hemangioma of the mouse blood vessel;intramuscular hemangioma of the mouse blood vessel;narrowmatch
hemangioma of the mouse blood vessel;capillary hemangioma of the mouse blood vessel;narrowmatch
hemangioma of the mouse blood vessel;hemangioendothelioma of the mouse blood vessel, malignant;narrowmatch
hemangioma of the mouse blood vessel;hemangioendothelioma of the mouse blood vessel, nos;narrowmatch
hemangioma of the mouse blood vessel;hemangioendothelioma of the mouse blood vessel, benign;narrowmatch
hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel, nos;narrowmatch
hemangioma of the mouse blood vessel;epithelioid hemangioma of the mouse blood vessel;narrowmatch
epithelioid hemangioma of the mouse blood vessel;epithelioid hemangioma of the mouse blood vessel, malignant;narrowmatch
epithelioid hemangioma of the mouse blood vessel;epithelioid hemangioma of the mouse blood vessel, nos;narrowmatch
hemangioma of the mouse blood vessel;racemose hemangioma of the mouse blood vessel;narrowmatch
hemangioma of the mouse blood vessel;venous hemangioma of the mouse blood vessel;narrowmatch
hemangioma of the mouse blood vessel;cavernous hemangioma of the mouse blood vessel;narrowmatch
hemangioma of the mouse blood vessel;hemangiosarcoma of the mouse blood vessel;narrowmatch
mouse primary tumors of the blood vessel;hemangioma of the mouse blood vessel;narrowmatch
mouse angioma;hemangioma of the mouse blood vessel;narrowmatch
anogenital human papillomavirus infection;genital human papillomavirus infection;narrowmatch
cancer-related condition;paraneoplastic syndrome;narrowmatch
skin disorder;non-neoplastic skin disorder;narrowmatch
other embryologic structure;hindgut;narrowmatch
mycobacterial infection;tuberculosis;narrowmatch
neuroepithelial tissue;neuroectoderm;narrowmatch
ectoderm;neuroectoderm;narrowmatch
other embryologic structure;neural crest;narrowmatch
other embryologic structure;midgut;narrowmatch
aneuploidy;trisomy;narrowmatch
chromosomal rearrangement;chromosomal translocation;narrowmatch
other embryologic structure;gonadal cord;narrowmatch
tissue;splenic tissue;narrowmatch
other embryologic structure;foregut;narrowmatch
other embryologic structure;embryonic nervous system;narrowmatch
other embryologic structure;embryonic disc;narrowmatch
anatomic structure, system, or substance;embryonic structure or system;narrowmatch
other embryologic structure;cortical cord;narrowmatch
other embryologic structure;cloacal membrane;narrowmatch
non-neoplastic vascular disorder;thrombophlebitis;narrowmatch
embryonic structure or system;other embryologic structure;narrowmatch
neoplastic syndrome;tumor lysis syndrome;narrowmatch
cancer-related condition;tumor lysis syndrome;narrowmatch
injury;ulcer;narrowmatch
nausea and vomiting;vomiting;narrowmatch
abnormal hematology test result;basophilia;narrowmatch
effusion;peritoneal effusion;narrowmatch
polyp;vocal cord polyp;narrowmatch
non-neoplastic laryngeal disorder;vocal cord polyp;narrowmatch
infectious disorder;viral infection;narrowmatch
anemia;macrocytic anemia;narrowmatch
immune hemolytic anemia;autoimmune hemolytic anemia;narrowmatch
hemolytic anemia;acquired hemolytic anemia;narrowmatch
normocytic anemia;hemolytic anemia;narrowmatch
central nervous system degenerative disorder;amyotrophic lateral sclerosis;narrowmatch
congenital adrenal gland disorder;congenital adrenal hyperplasia;narrowmatch
non-neoplastic bone disorder;achondroplasia;narrowmatch
mass;abdominal mass;narrowmatch
genitourinary system disorder;urinary system disorder;narrowmatch
spleen part;splenic tissue;narrowmatch
digestive system part;gastrointestinal tract;narrowmatch
injury;burn;narrowmatch
mouse pancreatic neoplasm;mouse pancreatic acinar neoplasm;narrowmatch
malignant mouse pancreatic neoplasm;mouse islet cell carcinoma;narrowmatch
malignant mouse pancreatic neoplasm;mouse acinar cell adenocarcinoma;narrowmatch
malignant mouse pancreatic neoplasm;mouse pancreatic ductal adenocarcinoma;narrowmatch
mouse pancreatic neoplasm;malignant mouse pancreatic neoplasm;narrowmatch
benign mouse pancreatic neoplasm;mouse mixed acinar/islet cell adenoma;narrowmatch
benign mouse pancreatic neoplasm;mouse acinar cell adenoma;narrowmatch
mouse pancreatic neoplasm;benign mouse pancreatic neoplasm;narrowmatch
mouse pancreatic disorder;mouse pancreatic neoplasm;narrowmatch
cytopenia;thrombocytopenia;narrowmatch
mouse digestive system neoplasms;mouse pancreatic neoplasm;narrowmatch
mouse digestive system disorder;mouse pancreatic disorder;narrowmatch
body part;mediastinum part;narrowmatch
urinary system part;kidney part;narrowmatch
body part;anatomic surface;narrowmatch
body part;fossa;narrowmatch
spinal region;lumbar region;narrowmatch
mouse islet cell carcinoma;mouse islet cell adenocarcinoma;narrowmatch
mouse pancreatic neoplasm;mouse pancreatic intraepithelial neoplasia-1;narrowmatch
mouse pancreatic intraepithelial neoplasia-1;mouse pancreatic intraepithelial neoplasia-1b;narrowmatch
mouse pancreatic neoplasm;mouse pancreatic intraepithelial neoplasia-2;narrowmatch
musculoskeletal system part;skeletal system part;narrowmatch
biochemical reaction;polymerization;narrowmatch
body part;cell part;narrowmatch
body part;reproductive system part;narrowmatch
peripheral nervous system part;autonomic nervous system part;narrowmatch
other embryologic structure;embryonic urogenital system;narrowmatch
embryonic disc;trilaminar embryonic disc;narrowmatch
embryo;gastrula;narrowmatch
mouse pancreatic intraepithelial neoplasia-1;mouse pancreatic intraepithelial neoplasia-1a;narrowmatch
embryonic structure or system;extraembryonic structure;narrowmatch
mouse islet cell neoplasm;mouse insulinoma;narrowmatch
mouse islet cell neoplasm;mouse somatostatinoma;narrowmatch
mouse islet cell neoplasm;mouse islet cell adenoma;narrowmatch
mouse pancreatic neoplasm;mouse islet cell neoplasm;narrowmatch
mouse pancreatic neoplasm;mouse pancreatic intraepithelial neoplasia-3;narrowmatch
hematopoietic and lymphoid system disorder;bone marrow disorder;narrowmatch
weight change;weight loss;narrowmatch
sign;swelling;narrowmatch
syndrome;noonan syndrome;narrowmatch
complication;pregnancy complication;narrowmatch
reproductive system hemorrhage;postmenopausal hemorrhage;narrowmatch
female reproductive system finding;postmenopausal hemorrhage;narrowmatch
morphologic finding;parakeratosis;narrowmatch
cytopenia;pancytopenia;narrowmatch
neoplastic syndrome;wdha syndrome;narrowmatch
endocrine syndrome;wdha syndrome;narrowmatch
syndrome;nephrotic syndrome;narrowmatch
back pain;lower back pain;narrowmatch
non-neoplastic kidney disorder;nephrotic syndrome;narrowmatch
non-neoplastic breast disorder;breast adenosis;narrowmatch
cervical non-neoplastic disorder;mucous polyp of cervix;narrowmatch
reproductive system hemorrhage;metrorrhagia;narrowmatch
female reproductive system finding;metrorrhagia;narrowmatch
ovarian non-neoplastic disorder;menstrual disorder;narrowmatch
finding;mass;narrowmatch
pregnancy finding;pregnancy complication;narrowmatch
hypertension-associated pregnancy disorder;toxemia of pregnancy;narrowmatch
pregnancy disorder;ectopic pregnancy;narrowmatch
hypercalcemia;hypercalcemia of malignancy;narrowmatch
hepatitis;viral hepatitis;narrowmatch
cardiovascular disorder;vascular disorder;narrowmatch
congenital systemic disorder;congenital genitourinary abnormality;narrowmatch
leukoplakia;genital leukoplakia;narrowmatch
respiratory system disorder;tracheal disorder;narrowmatch
oral cavity disorder;dental disorder;narrowmatch
behavioral disorder;tobacco use disorder;narrowmatch
immune system and related disorders;immune system disorder;narrowmatch
adrenal hyperplasia;adrenal cortical hyperplasia;narrowmatch
non-neoplastic vision disorder;strabismus;narrowmatch
uterine disorder;endometrial disorder;narrowmatch
parasitic infection;schistosomiasis;narrowmatch
peripheral neuropathy;peripheral motor neuropathy;narrowmatch
hyperplasia;reticuloendothelial hyperplasia;narrowmatch
non-neoplastic hematologic and lymphocytic disorder;pure red cell aplasia;narrowmatch
abnormal hematology test result;lymphocytosis;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);chronic monocytic leukemia;narrowmatch
uveal disorder;choroid disorder;narrowmatch
vulvar non-neoplastic disorder;vulvar dystrophy;narrowmatch
fibrous dysplasia;polyostotic fibrous dysplasia;narrowmatch
bone tumor of undefined neoplastic nature;fibrous dysplasia;narrowmatch
abnormal bone marrow test result;erythroid hyperplasia;narrowmatch
lymphoma by working formulation (antiquated);intermediate grade lymphoma;narrowmatch
non-neoplastic heart disorder;endomyocardial fibrosis;narrowmatch
lymphoma by working formulation (antiquated);high grade lymphoma;narrowmatch
bacterial infection;empyema;narrowmatch
non-neoplastic skin disorder;skin pigmentation disorder;narrowmatch
pain in extremity;leg pain;narrowmatch
sensory manifestations;disturbance of skin sensation;narrowmatch
body substance discharge;fluid discharge;narrowmatch
neoplastic syndrome;zollinger ellison syndrome;narrowmatch
endocrine syndrome;zollinger ellison syndrome;narrowmatch
endometrial hyperplasia;cystic endometrial hyperplasia;narrowmatch
endocrine syndrome;conn syndrome;narrowmatch
fibrosis;scar;narrowmatch
pain;flank pain;narrowmatch
lymphoma by working formulation (antiquated);low grade lymphoma;narrowmatch
mixed cell lymphoma;diffuse mixed cell lymphoma;narrowmatch
biliary system disorder;gallbladder disorder;narrowmatch
endocrine syndrome;klinefelter syndrome;narrowmatch
non-neoplastic kidney disorder;cystic kidney disease;narrowmatch
uveal disorder;iris disorder;narrowmatch
congenital combined immunodeficiency;severe combined immunodeficiency;narrowmatch
splenic disorder;hypersplenism;narrowmatch
abnormal blood chemistry and hematology test result;hypergammaglobulinemia;narrowmatch
hernia;inguinal hernia;narrowmatch
hernia;diaphragmatic hernia;narrowmatch
congenital or acquired anatomic abnormality;hernia;narrowmatch
arrhythmia by ecg finding;heart block by ecg finding;narrowmatch
neurological signs and symptoms;headache;narrowmatch
skin disorder;hair disorder;narrowmatch
metabolic disorder;gout;narrowmatch
arthritis;gout;narrowmatch
malignant non-hodgkin lymphoma, cleaved cell;adult diffuse small cleaved cell lymphoma;narrowmatch
body region;hypochondriac region;narrowmatch
mucosa;endocervical mucosa;narrowmatch
meninges;meningeal layer of the dura mater;narrowmatch
integumentary system signs and symptoms;pruritus;narrowmatch
epithelium;retinal pigment epithelium;narrowmatch
sexual dysfunction and infertility;sexual dysfunction;narrowmatch
male reproductive system part;rete testis;narrowmatch
vein;renal vein;narrowmatch
tissue;renal tissue;narrowmatch
dermatitis;psoriasis;narrowmatch
eye part;refractile media;narrowmatch
sinus;pyriform sinus;narrowmatch
polyp;fibroepithelial polyp;narrowmatch
lung tissue;pulmonary lobule;narrowmatch
respiratory system part;pulmonary acinus;narrowmatch
epithelium;pseudostratified epithelium;narrowmatch
tissue;prostatic tissue;narrowmatch
cancer-related condition;precancerous condition;narrowmatch
embryonic cell;primordial germ cell;narrowmatch
germ cell;primordial germ cell;narrowmatch
retina layer;retinal pigment epithelium;narrowmatch
inguinal region;right inguinal region;narrowmatch
lumbar region;right lumbar region;narrowmatch
spinal region;sacral region;narrowmatch
skin;skin of the face;narrowmatch
non-neoplastic soft tissue disorder;solitary reticulohistiocytoma;narrowmatch
body part;sinus;narrowmatch
epithelium;simple epithelium;narrowmatch
simple epithelium;simple cuboidal epithelium;narrowmatch
cuboidal epithelium;simple cuboidal epithelium;narrowmatch
simple epithelium;simple columnar epithelium;narrowmatch
columnar epithelium;simple columnar epithelium;narrowmatch
nerve sheath;sheath of schwann;narrowmatch
salivary gland;serous salivary gland;narrowmatch
peripheral nervous system part;sensory-somatic nervous system;narrowmatch
digestive system part;second portion of the duodenum;narrowmatch
exocrine gland;sebaceous gland;narrowmatch
colorectal polyp;rectal polyp;narrowmatch
tissue;salivary gland tissue;narrowmatch
disease or disorder;polyp;narrowmatch
mediastinum part;posterior mediastinum;narrowmatch
cell of the epidermis;skin squamous cell;narrowmatch
fibroblast;myofibroblast;narrowmatch
effusion;pericardial effusion;narrowmatch
cytoplasmic organelle;nonmembranous cytoplasmic organelle;narrowmatch
retina layer;neural retina;narrowmatch
head and neck muscle;neck muscle;narrowmatch
head and neck part;nasolacrimal duct;narrowmatch
duct;nasolacrimal duct;narrowmatch
integumentary system part;nail;narrowmatch
epithelial cell;myoepithelial cell;narrowmatch
fossa;posterior cranial fossa;narrowmatch
salivary gland;mucous salivary gland;narrowmatch
salivary gland;minor salivary gland;narrowmatch
fossa;middle cranial fossa;narrowmatch
syndrome;paraneoplastic syndrome;narrowmatch
tissue;mesothelium;narrowmatch
cell;mesothelial cell;narrowmatch
body part;mesentery;narrowmatch
mucosa;olfactory mucosa;narrowmatch
frontal sulcus;olfactory sulcus;narrowmatch
body part;omentum;narrowmatch
organ;organ of special sense;narrowmatch
bone marrow stem cell;pluripotent bone marrow stem cell;narrowmatch
pluripotent stem cell;pluripotent bone marrow stem cell;narrowmatch
body region;plantar region;narrowmatch
neuroepithelial cell;pineocyte;narrowmatch
bone;phalanx;narrowmatch
effusion;pleural effusion;narrowmatch
body region;perineum;narrowmatch
tissue;parathyroid gland tissue;narrowmatch
integumentary system signs and symptoms;skin discoloration;narrowmatch
integumentary system finding;skin discoloration;narrowmatch
neuroendocrine cell;c-cell;narrowmatch
endocrine reproductive tissue;ovarian tissue;narrowmatch
ovarian tissue;ovarian medulla;narrowmatch
female reproductive system part;ovarian follicle;narrowmatch
ovarian tissue;ovarian cortex;narrowmatch
squamous cell;skin squamous cell;narrowmatch
soft tissue;skin tissue;narrowmatch
cell structure;cell surface;narrowmatch
transitional cell;urothelial cell;narrowmatch
skeletal system part;vertebral canal;narrowmatch
brain part;vermis;narrowmatch
cardiovascular system part;venous system;narrowmatch
cardiovascular system part;vascular system;narrowmatch
blood vessel tissue;vascular smooth muscle tissue;narrowmatch
smooth muscle tissue;vascular smooth muscle tissue;narrowmatch
female reproductive system part;uterine gland;narrowmatch
sign or symptom;splenomegaly;narrowmatch
cell;tooth cell;narrowmatch
brain part;undersurface of the frontal lobe;narrowmatch
body region;umbilical region;narrowmatch
male reproductive system part;tunica vaginalis;narrowmatch
blood vessel tissue;tunica intima;narrowmatch
body region;trunk;narrowmatch
cancer-related condition;spinal cord compression;narrowmatch
pseudostratified columnar ciliated epithelium;tracheal epithelium;narrowmatch
nerve tissue;white matter;narrowmatch
cerebrovascular disorder;cerebrovascular accident;narrowmatch
mouse malignant ovarian neoplasm;mouse ovarian serous adenocarcinoma;narrowmatch
anatomic structure, system, or substance;other anatomic concept;narrowmatch
central nervous system part;spinal cord part;narrowmatch
nervous system part;peripheral nervous system part;narrowmatch
nervous system part;central nervous system part;narrowmatch
cancer-related condition;superior vena cava syndrome;narrowmatch
syndrome;superior vena cava syndrome;narrowmatch
tissue;thymic tissue;narrowmatch
embryonic cell;ectoderm cell;narrowmatch
embryonic cell;endoderm cell;narrowmatch
immature b-lymphocyte;precursor b-lymphoblast;narrowmatch
lymphoblast;precursor b-lymphoblast;narrowmatch
immature t-lymphocyte;precursor t-lymphoblast;narrowmatch
lymphoblast;precursor t-lymphoblast;narrowmatch
epithelial cell;glandular cell;narrowmatch
endometrioid stromal cell;endometrial stromal cell;narrowmatch
columnar cell;endocervical columnar cell;narrowmatch
connective and soft tissue;odontogenic tissue;narrowmatch
acidophilic cell;thyrotroph cell;narrowmatch
skin part;skin tissue;narrowmatch
neck muscle;sternocleidomastoid muscle;narrowmatch
skin tissue;subcutis;narrowmatch
female reproductive system part;stroma of the ovarian cortex;narrowmatch
muscle cell;striated muscle cell;narrowmatch
skin part;stratum reticulare;narrowmatch
epithelium;stratified epithelium;narrowmatch
stratified epithelium;stratified columnar epithelium;narrowmatch
columnar epithelium;stratified columnar epithelium;narrowmatch
splenic tissue;splenic pulp;narrowmatch
tissue;thyroid gland tissue;narrowmatch
cytogenetic abnormality;supernumerary circular chromosome;narrowmatch
germ cell;spermatogenic cell;narrowmatch
acidophilic cell;somatotroph cell;narrowmatch
intestinal wall tissue;small intestinal wall tissue;narrowmatch
intestinal mucosa;small intestinal mucosa;narrowmatch
small intestinal wall tissue;small intestinal mucosa;narrowmatch
enterocyte;small intestinal glandular cell;narrowmatch
intracranial venous system;superficial intracranial venous system;narrowmatch
disease, disorder or finding;finding;narrowmatch
sign or symptom;digestive system signs and symptoms;narrowmatch
digestive system finding;digestive system signs and symptoms;narrowmatch
glandular cell;thyroid gland follicular cell;narrowmatch
endocrine cell;thyroid gland follicular cell;narrowmatch
thyroid gland epithelial tissue;thyroid gland follicle;narrowmatch
glandular epithelial tissue;thyroid gland follicle;narrowmatch
thymic tissue;thymus medulla;narrowmatch
epithelial cell;thymic epithelial cell;narrowmatch
brain part;thalamencephalon;narrowmatch
endocrine reproductive tissue;testicular tissue;narrowmatch
glandular cell;terminal ductal lobular unit cell;narrowmatch
fibroepithelial polyp;skin tag;narrowmatch
non-neoplastic skin disorder;skin tag;narrowmatch
integumentary system signs and symptoms;skin nodule;narrowmatch
exocrine gland;sweat gland;narrowmatch
disorder by site;skin disorder;narrowmatch
neuron, neuroepithelial cell, and supporting cell of the nervous system;supporting cell of the nervous system;narrowmatch
viral infection;viral hepatitis;narrowmatch
hepatic infection;viral hepatitis;narrowmatch
disorder by site;vision disorder;narrowmatch
mitotic activity;high mitotic activity;narrowmatch
vascular morphologic change;intravascular thrombus formation;narrowmatch
dilated vascular space formation;dilated thin-walled vascular space formation;narrowmatch
cavernous vascular space formation;cavernous lymphatic space formation;narrowmatch
dilated thin-walled vascular space formation;cavernous lymphatic space formation;narrowmatch
morphologic finding;vascular morphologic change;narrowmatch
morphologic finding;atypical mitotic figures;narrowmatch
mitotic activity;low mitotic activity;narrowmatch
morphologic finding;mitotic activity;narrowmatch
morphologic finding;dentin formation;narrowmatch
tumor cell necrosis;comedo-like necrosis;narrowmatch
necrotic change;tumor cell necrosis;narrowmatch
necrotic change;fibrinoid necrosis;narrowmatch
absence of invasion;absence of stromal invasion;narrowmatch
morphologic finding;stromal invasion;narrowmatch
hydropic change;hydropic villous change;narrowmatch
prominent keratin formation;keratin pearls formation;narrowmatch
vascular morphologic change;thin-walled branching vascular pattern;narrowmatch
thin-walled branching vascular pattern;staghorn configuration;narrowmatch
vascular channel formation;sinusoidal vascular channel formation;narrowmatch
vascular channel formation;arborizing vascular channel formation;narrowmatch
calcification;dystrophic calcification;narrowmatch
morphologic finding;red blood cells extravasation;narrowmatch
deposit;hemosiderin deposition;narrowmatch
atypia;nuclear atypia;narrowmatch
morphologic finding;metaplastic bone formation;narrowmatch
morphologic finding;emperipolesis;narrowmatch
morphologic finding;hemophagocytosis;narrowmatch
cellular infiltrate;lymphoplasmacytic infiltrate;narrowmatch
cellular infiltrate;lymphocytic infiltrate;narrowmatch
acute inflammatory infiltrate;polymorphonuclear cell infiltrate;narrowmatch
acute inflammatory infiltrate;eosinophilic infiltrate;narrowmatch
inflammatory infiltrate;chronic inflammatory infiltrate;narrowmatch
inflammatory infiltrate;acute inflammatory infiltrate;narrowmatch
cellular infiltrate;inflammatory infiltrate;narrowmatch
vascular morphologic change;vascular channel formation;narrowmatch
morphologic finding;enamel formation;narrowmatch
morphologic finding;cementum formation;narrowmatch
abnormal bone marrow test result;ring sideroblasts present;narrowmatch
morphologic architectural pattern;papillary pattern;narrowmatch
morphologic architectural pattern;organoid pattern;narrowmatch
morphologic architectural pattern;alveolar pattern;narrowmatch
morphologic architectural pattern;insular pattern;narrowmatch
trabecular pattern;macrotrabecular pattern;narrowmatch
trabecular pattern;gyriform trabecular pattern;narrowmatch
morphologic architectural pattern;trabecular pattern;narrowmatch
morphologic architectural pattern;pseudopapillary pattern;narrowmatch
morphologic architectural pattern;antoni b pattern;narrowmatch
rosette formation;multilayered rosette formation;narrowmatch
morphologic architectural pattern;antoni a pattern;narrowmatch
morphologic architectural pattern;monophasic pattern;narrowmatch
morphologic architectural pattern;biphasic pattern;narrowmatch
morphologic architectural pattern;angiodestructive pattern;narrowmatch
morphologic architectural pattern;angiocentric pattern;narrowmatch
morphologic architectural pattern;nodular and diffuse pattern;narrowmatch
morphologic architectural pattern;diffuse pattern;narrowmatch
morphologic architectural pattern;cribriform pattern;narrowmatch
morphologic architectural pattern;pseudoglandular pattern;narrowmatch
morphologic architectural pattern;acinar pattern;narrowmatch
morphologic architectural pattern;tubular pattern;narrowmatch
rosette formation;pineocytomatous rosette formation;narrowmatch
rosette formation;ependymal rosette formation;narrowmatch
rosette formation;pseudorosette formation;narrowmatch
rosette formation;homer wright rosette formation;narrowmatch
rosette formation;flexner-wintersteiner rosette formation;narrowmatch
morphologic finding;rosette formation;narrowmatch
morphologic finding;tumor vascular invasion;narrowmatch
tissue differentiation;epithelioid differentiation;narrowmatch
mesenchymal differentiation;rhabdomyosarcomatous differentiation;narrowmatch
morphologic architectural pattern;honeycomb pattern;narrowmatch
morphologic architectural pattern;endodermal sinus pattern;narrowmatch
morphologic architectural pattern;glandular pattern;narrowmatch
morphologic architectural pattern;triphasic pattern;narrowmatch
morphologic architectural pattern;syncytial pattern;narrowmatch
vascular morphologic change;glomeruloid vessels present;narrowmatch
morphologic finding;pseudoangiomatoid space formation;narrowmatch
abnormal tissue present;stromal change;narrowmatch
anemia;normocytic anemia;narrowmatch
premalignant lesion;borderline lesion;narrowmatch
cellular infiltrate;non-malignant cellular infiltrate;narrowmatch
invasive lesion;microinvasive lesion;narrowmatch
lesion by morphology;necrotic lesion;narrowmatch
cellular infiltrate;benign cellular infiltrate;narrowmatch
morphologic architectural pattern;villous pattern;narrowmatch
non-invasive lesion;in situ lesion;narrowmatch
lesion by morphology;invasive lesion;narrowmatch
cellular infiltrate;malignant cellular infiltrate;narrowmatch
epithelial neoplasm (antiquated);biphasic pulmonary blastoma;narrowmatch
lesion by morphology;anaplastic lesion;narrowmatch
lesion;superficial lesion;narrowmatch
mass;encapsulated mass;narrowmatch
clinical course of disease;indolent clinical course;narrowmatch
clinical course of disease;aggressive clinical course;narrowmatch
mass;rapidly enlarging mass;narrowmatch
crystal formation;reinke crystals formation;narrowmatch
lesion by morphology;non-seminomatous lesion;narrowmatch
necrotic change;comedo necrosis;narrowmatch
lesion by grade;high grade lesion;narrowmatch
lesion by grade;low grade lesion;narrowmatch
clinical course of disease;newly diagnosed disease;narrowmatch
clinical course of disease;progressive clinical course;narrowmatch
mouse neurofibroma;neurofibroma of the mouse skin;narrowmatch
clinical course of disease;chronic clinical course;narrowmatch
clinical course of disease;acute clinical course;narrowmatch
clinical course of disease;favorable clinical outcome;narrowmatch
clinical course of disease;accelerated phase of disease;narrowmatch
clinical course of disease;chronic phase of disease;narrowmatch
lesion by stage;extensive stage lesion;narrowmatch
lesion by grade;intermediate grade lesion;narrowmatch
lesion by grade;grade 4 lesion;narrowmatch
lesion by morphology;undifferentiated lesion;narrowmatch
lesion by morphology;well differentiated lesion;narrowmatch
lesion by morphology;poorly differentiated lesion;narrowmatch
lesion by morphology;moderately differentiated lesion;narrowmatch
infectious disorder by site;abdominal and gastrointestinal infection;narrowmatch
epithelial neoplasm (antiquated);epithelial predominant pulmonary blastoma;narrowmatch
stromal change;myxoid stroma formation;narrowmatch
morphologic finding;bead-like arrangement of elastic fibers;narrowmatch
morphologic finding;starry sky pattern;narrowmatch
morphologic finding;call exner bodies present;narrowmatch
morphologic finding;verocay bodies present;narrowmatch
nuclear inclusion;dutcher body;narrowmatch
nuclear inclusion;ground glass nuclear inclusion;narrowmatch
morphologic finding;nuclear inclusion;narrowmatch
morphologic finding;russell body;narrowmatch
neoplasm by special category;nodular neoplasm;narrowmatch
malignant neoplasm;well differentiated malignant neoplasm;narrowmatch
stromal change;edematous stroma formation;narrowmatch
stromal change;desmoplastic stroma formation;narrowmatch
stromal change;chondromyxoid stroma formation;narrowmatch
stromal change;fibromyxoid stroma formation;narrowmatch
stromal change;hyalinized stroma formation;narrowmatch
stromal change;mucoid stroma formation;narrowmatch
myxoid changes present;myxoid stroma formation;narrowmatch
cellular infiltrate;diffuse cellular infiltrate;narrowmatch
lesion by morphology;non-invasive lesion;narrowmatch
neoplasm by special category;premalignant neoplasm;narrowmatch
neoplasm by special category;tubular neoplasm;narrowmatch
malignant neoplasm;undifferentiated malignant neoplasm;narrowmatch
malignant neoplasm;poorly differentiated malignant neoplasm;narrowmatch
malignant neoplasm;moderately differentiated malignant neoplasm;narrowmatch
malignant neoplasm by grade;low grade malignant neoplasm;narrowmatch
malignant neoplasm by grade;intermediate grade malignant neoplasm;narrowmatch
malignant neoplasm by grade;high grade malignant neoplasm;narrowmatch
malignant neoplasm by grade;grade 4 malignant neoplasm;narrowmatch
grade 3 malignant neoplasm;grade 3b malignant neoplasm;narrowmatch
grade 3 malignant neoplasm;grade 3a malignant neoplasm;narrowmatch
malignant neoplasm by grade;grade 3 malignant neoplasm;narrowmatch
malignant neoplasm;malignant neoplasm by grade;narrowmatch
malignant neoplasm by grade;grade 2 malignant neoplasm;narrowmatch
malignant neoplasm by grade;grade 1 malignant neoplasm;narrowmatch
neoplasm by special category;non-encapsulated neoplasm;narrowmatch
neoplasm by special category;villous neoplasm;narrowmatch
morphologic architectural pattern;interfollicular pattern;narrowmatch
nodular pattern;multinodular pattern;narrowmatch
acute myeloid leukemia in remission;acute monocytic leukemia in remission;narrowmatch
disease or disorder;behavioral disorder;narrowmatch
pulmonary mass;endobronchial mass;narrowmatch
abnormal hematology test result;abnormal bone marrow test result;narrowmatch
vascular morphologic change;vascular proliferation;narrowmatch
abdominal and gastrointestinal infection;digestive system infection;narrowmatch
non-neoplastic digestive system disorder;digestive system infection;narrowmatch
musculoskeletal injury;bone injury;narrowmatch
abnormal cells present;nucleated red blood cells present;narrowmatch
finding;clinical course of disease;narrowmatch
neoplastic growth or spread;local tumor spread;narrowmatch
deposit;crystal formation;narrowmatch
abnormal laboratory test result;abnormal urine test result;narrowmatch
vascular disorder;liver vascular disorder;narrowmatch
liver and intrahepatic bile duct disorder;liver vascular disorder;narrowmatch
syndrome;cauda equina syndrome;narrowmatch
non-neoplastic peripheral nervous system disorder;cauda equina syndrome;narrowmatch
secondary polycythemia;polycythaemia due to excess erythropoetin production;narrowmatch
digestive system disorder;gastrointestinal polyp;narrowmatch
polyp;gastrointestinal polyp;narrowmatch
mass;nasal mass;narrowmatch
abnormal hematology test result;leukocytosis;narrowmatch
non-neoplastic endocrine disorder;congenital adrenal gland disorder;narrowmatch
hemophagocytosis;erythrophagocytosis;narrowmatch
clinical course of disease;progressive disease;narrowmatch
colon cancer by astler-coller stage;astler-coller b1 colon carcinoma;narrowmatch
astler-coller b1 colorectal carcinoma;astler-coller b1 colon carcinoma;narrowmatch
abnormal hematology test result;atypical lymphocytes present;narrowmatch
neoplastic syndrome;rare neoplastic syndrome;narrowmatch
rare disorder;rare neoplastic syndrome;narrowmatch
abnormal laboratory test result;abnormal blood chemistry and hematology test result;narrowmatch
finding by site or system;cardiovascular system finding;narrowmatch
paraproteinemia;monoclonal gammopathy;narrowmatch
non-neoplastic heart disorder;myocardial disorder;narrowmatch
morphologic finding;hyperkeratosis;narrowmatch
abnormal hematology test result;thrombocytosis;narrowmatch
extramedullary involvement;lymph node involvement;narrowmatch
malignant neoplasm;malignant neoplasm of multiple primary sites;narrowmatch
hyperplasia;adrenal hyperplasia;narrowmatch
morphologic architectural pattern;nodular pattern;narrowmatch
abnormal bone marrow test result;hypocellular bone marrow;narrowmatch
non-neoplastic breast disorder;mammary duct ectasia;narrowmatch
vascular disorder;penile vascular disorder;narrowmatch
penile disorder;penile vascular disorder;narrowmatch
vascular disorder;eyelid vascular disorder;narrowmatch
eyelid disorder;eyelid vascular disorder;narrowmatch
female reproductive system disorder;pregnancy disorder;narrowmatch
abnormal bone marrow test result;megakaryocytes increased in bone marrow;narrowmatch
abnormal hematology test result;neutrophilia;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);true histiocytic lymphoma;narrowmatch
fluid discharge;nipple discharge;narrowmatch
mass;neck mass;narrowmatch
mass;pulmonary mass;narrowmatch
mass;adnexal mass;narrowmatch
abnormal hematology test result;monocytosis;narrowmatch
non-neoplastic appendix disorder;appendicitis;narrowmatch
body temperature associated symptom;chills;narrowmatch
reproductive system hemorrhage;postcoital bleeding;narrowmatch
balanitis;balanitis xerotica obliterans;narrowmatch
digestive system finding;digestive system injury;narrowmatch
injury;digestive system injury;narrowmatch
morphologic finding;mallory bodies present;narrowmatch
morphologic finding;hemorrhagic change;narrowmatch
lytic bone lesion;lytic metastatic bone lesion;narrowmatch
mass;mediastinal mass;narrowmatch
fever;low grade fever;narrowmatch
elevated test result;alpha fetoprotein increased;narrowmatch
abnormal blood chemistry and hematology test result;alpha fetoprotein increased;narrowmatch
afp level finding;alpha fetoprotein increased;narrowmatch
abdominal pain;lower abdominal pain;narrowmatch
congenital or acquired anatomic abnormality;macrocephaly;narrowmatch
abnormal hematology test result;poikilocytosis;narrowmatch
abnormal hematology test result;anisocytosis;narrowmatch
morphologic finding;acanthosis;narrowmatch
vascular disorder;skin vascular disorder;narrowmatch
skin disorder;skin vascular disorder;narrowmatch
non-neoplastic adrenal gland disorder;congenital adrenal gland disorder;narrowmatch
malignant ascites;carcinomatous ascites;narrowmatch
fever;tumor associated fever;narrowmatch
microscopic finding;morphologic finding;narrowmatch
acute leukemia in remission;acute myeloid leukemia in remission;narrowmatch
abnormal hematology test result;anisochromasia;narrowmatch
hematopoietic system finding;abnormal hematology test result;narrowmatch
abnormal blood chemistry and hematology test result;abnormal hematology test result;narrowmatch
lymphoid leukemia in remission;chronic lymphocytic leukemia in remission;narrowmatch
chronic leukemia in remission;chronic lymphocytic leukemia in remission;narrowmatch
clinical test result;radiologic finding;narrowmatch
mesenchymal metaplasia;cartilaginous metaplasia;narrowmatch
astler-coller b2 colorectal carcinoma;astler-coller b2 colon carcinoma;narrowmatch
lymphoid leukemia in remission;acute lymphoblastic leukemia in remission;narrowmatch
acute leukemia in remission;acute lymphoblastic leukemia in remission;narrowmatch
mesenchymal metaplasia;osseous metaplasia;narrowmatch
lymphoid leukemia in remission;plasma cell leukemia in remission;narrowmatch
hyperplasia;basal cell hyperplasia;narrowmatch
aneurysm;microaneurysm;narrowmatch
dysplasia;melanocytic dysplasia;narrowmatch
myeloid leukemia in remission;acute myeloid leukemia in remission;narrowmatch
abnormal hematology test result;blast cells present;narrowmatch
blast cells present;blast cells present in peripheral blood;narrowmatch
abnormal bone marrow test result;blast cells increased in bone marrow;narrowmatch
growth phase;vertical growth phase;narrowmatch
growth phase;radial growth phase;narrowmatch
morphologic architectural pattern;junctional proliferation;narrowmatch
morphologic architectural pattern;pagetoid proliferation;narrowmatch
morphologic architectural pattern;nested pattern;narrowmatch
morphologic architectural pattern;lobulated growth pattern;narrowmatch
morphologic architectural pattern;plexiform growth pattern;narrowmatch
myeloid leukemia in remission;chronic myelogenous leukemia, bcr-abl1 positive in remission;narrowmatch
chronic leukemia in remission;chronic myelogenous leukemia, bcr-abl1 positive in remission;narrowmatch
morphologic architectural pattern;whorling growth pattern;narrowmatch
morphologic architectural pattern;storiform growth pattern;narrowmatch
morphologic architectural pattern;herringbone growth pattern;narrowmatch
morphologic finding;morphologic architectural pattern;narrowmatch
hypergammaglobulinemia;polyclonal hypergammaglobulinemia;narrowmatch
blast cells present;blast cells increased in bone marrow;narrowmatch
hematopoietic and lymphoid system disorder;splenic disorder;narrowmatch
fibrosis;perivascular fibrosis;narrowmatch
bone marrow fibrosis;reticulin fibrosis of the bone marrow;narrowmatch
respiratory and thoracic disorder;thoracic disorder;narrowmatch
heart disorder;non-neoplastic heart disorder;narrowmatch
non-neoplastic cardiovascular disorder;non-neoplastic heart disorder;narrowmatch
vascular disorder;non-neoplastic vascular disorder;narrowmatch
non-neoplastic cardiovascular disorder;non-neoplastic vascular disorder;narrowmatch
hearing impairment;hearing loss;narrowmatch
congenital systemic disorder;congenital cardiovascular abnormality;narrowmatch
non-neoplastic cardiovascular disorder;congenital cardiovascular abnormality;narrowmatch
epithelial neoplasm (antiquated);grade i neuroendocrine carcinoma;narrowmatch
epithelial neoplasm (antiquated);grade iii neuroendocrine carcinoma;narrowmatch
epithelial neoplasm (antiquated);grade ii neuroendocrine carcinoma;narrowmatch
pharyngeal disorder;nasopharyngeal disorder;narrowmatch
immune system and related disorders;immunodeficiency-related disorder;narrowmatch
laboratory test result;positive laboratory test result;narrowmatch
clinical test result;negative test result;narrowmatch
colon cancer by astler-coller stage;astler-coller b2 colon carcinoma;narrowmatch
non-neoplastic thoracic disorder;non-neoplastic heart disorder;narrowmatch
thoracic disorder;non-neoplastic thoracic disorder;narrowmatch
disorder by site;hematopoietic and lymphoid system disorder;narrowmatch
non-neoplastic disorder by site;non-neoplastic thoracic disorder;narrowmatch
abnormal bone marrow test result;hypercellular bone marrow;narrowmatch
hair disorder;non-neoplastic hair disorder;narrowmatch
non-neoplastic skin disorder;non-neoplastic hair disorder;narrowmatch
dental disorder;non-neoplastic dental disorder;narrowmatch
non-neoplastic oral cavity disorder;non-neoplastic dental disorder;narrowmatch
uveal disorder;ciliary body disorder;narrowmatch
non-neoplastic hepatobiliary disorder;non-neoplastic bile duct disorder;narrowmatch
bile duct disorder;non-neoplastic bile duct disorder;narrowmatch
laboratory test result;normal laboratory test result;narrowmatch
non-neoplastic connective and soft tissue disorder;arthropathy;narrowmatch
non-neoplastic disorder by site;non-neoplastic respiratory system disorder;narrowmatch
respiratory system disorder;non-neoplastic respiratory system disorder;narrowmatch
thoracic disorder;axillary disorder;narrowmatch
thoracic disorder;chest wall disorder;narrowmatch
chest wall disorder;sternal disorder;narrowmatch
cell;meningothelial cell;narrowmatch
cytoplasmic organelle;membranous cytoplasmic organelle;narrowmatch
non-neoplastic disorder by site;non-neoplastic skin disorder;narrowmatch
hepatoblastoma stage;pretext stage 1;narrowmatch
disease grade qualifier;grade 3;narrowmatch
disease grade qualifier;grade 2;narrowmatch
disease grade qualifier;grade 1;narrowmatch
disease morphology qualifier;disease grade qualifier;narrowmatch
hepatoblastoma stage;pretext stage 4;narrowmatch
hepatoblastoma stage;pretext stage 3;narrowmatch
hepatoblastoma stage;pretext stage 2;narrowmatch
hepatoblastoma stage;postsurgical stage iv;narrowmatch
disease stage qualifier;stage b;narrowmatch
hepatoblastoma stage;postsurgical stage iii;narrowmatch
hepatoblastoma stage;postsurgical stage ii;narrowmatch
hepatoblastoma stage;postsurgical stage i;narrowmatch
disease stage qualifier;hepatoblastoma stage;narrowmatch
disease stage qualifier;limited stage;narrowmatch
disease stage qualifier;extensive stage;narrowmatch
disease stage qualifier;stage d;narrowmatch
grade 3;grade 3a;narrowmatch
grade 3;grade 3b;narrowmatch
disease grade qualifier;grade 4;narrowmatch
histologic grade;intermediate grade;narrowmatch
nodule;hot nodule;narrowmatch
nodule;cold nodule;narrowmatch
other anatomic concept;chiasma;narrowmatch
germ cell tumor (antiquated);stage iv testicular non-seminomatous germ cell tumor;narrowmatch
disease clinical qualifier;high-risk cancer;narrowmatch
other anatomic concept;viscera;narrowmatch
disease stage qualifier;stage is;narrowmatch
general qualifier;oncolysis;narrowmatch
vascular ectasia;telangiectasia;narrowmatch
disease or disorder;syndrome;narrowmatch
disturbance of skin sensation;paresthesia;narrowmatch
embryonic structure;embryo;narrowmatch
disease qualifier;disease stage qualifier;narrowmatch
disease qualifier;disease clinical qualifier;narrowmatch
disease qualifier;disease morphology qualifier;narrowmatch
disease stage qualifier;stage c;narrowmatch
disease stage qualifier;stage a;narrowmatch
peptidase gene;cysteine peptidase gene;narrowmatch
stage 0;stage 0is;narrowmatch
stage iv;stage ivs;narrowmatch
disease stage qualifier;stage iv;narrowmatch
disease stage qualifier;stage iii;narrowmatch
stage ii;stage iic;narrowmatch
stage ii;stage iib;narrowmatch
stage ii;stage iia;narrowmatch
disease stage qualifier;stage i;narrowmatch
stage 0;stage 0a;narrowmatch
stage iv;stage ivc;narrowmatch
toxicity;radiation toxicity;narrowmatch
toxicity;drug toxicity;narrowmatch
sebaceous hyperplasia;senile sebaceous hyperplasia;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);lymphoma by lukes-collins classification (antiquated);narrowmatch
neoplasm by cause;occupational neoplasm;narrowmatch
neoplasm by special category;neoplasm by cause;narrowmatch
immunodeficiency syndrome;congenital combined immunodeficiency;narrowmatch
disease stage qualifier;stage v;narrowmatch
stage i;stage ia;narrowmatch
stage i;stage ib;narrowmatch
stage iii;stage iiia;narrowmatch
disease stage qualifier;stage ii;narrowmatch
stage ib cervix;stage ib2;narrowmatch
stage ib cervix;stage ib1;narrowmatch
disease stage qualifier;stage 0;narrowmatch
myocardial disorder;myocardial infarction;narrowmatch
qualifier;general qualifier;narrowmatch
qualifier;disease qualifier;narrowmatch
injury;toxicity;narrowmatch
stage ia;stage ia2;narrowmatch
stage ia;stage ia1;narrowmatch
stage iii;stage iiic;narrowmatch
stage i;stage ic;narrowmatch
stage iv;stage ivb;narrowmatch
stage iv;stage iva;narrowmatch
stage iii;stage iiib;narrowmatch
cell differentiation process;b-cell differentiation;narrowmatch
chromosomal inversion;paracentric inversion;narrowmatch
infectious disorder;parasitic infection;narrowmatch
non-neoplastic disorder by site;non-neoplastic breast disorder;narrowmatch
cervical disorder;cervical polyp;narrowmatch
uterine polyp;cervical polyp;narrowmatch
non-neoplastic brain disorder;cerebrovascular disorder;narrowmatch
non-neoplastic vascular disorder;cerebrovascular disorder;narrowmatch
nervous system disorder;central nervous system disorder;narrowmatch
disorder by site;cardiovascular disorder;narrowmatch
non-neoplastic lung disorder;bronchitis;narrowmatch
breast disorder;non-neoplastic breast disorder;narrowmatch
autoimmune disease;rheumatoid arthritis;narrowmatch
non-neoplastic hematologic and lymphocytic disorder;coagulation disorder;narrowmatch
urinary system disorder;bladder disorder;narrowmatch
hepatobiliary disorder;biliary system disorder;narrowmatch
hyperplasia;benign prostatic hyperplasia;narrowmatch
disease or disorder;psychiatric disorder;narrowmatch
infectious disorder;bacterial infection;narrowmatch
immune system disorder;autoimmune disease;narrowmatch
molecular abnormality;cytogenetic abnormality;narrowmatch
non-neoplastic liver and intrahepatic bile duct disorder;cirrhosis;narrowmatch
inflammatory bowel disease;ulcerative colitis;narrowmatch
colorectal polyp;colon polyp;narrowmatch
gene regulation process;translational regulation;narrowmatch
glucose metabolism disorder;diabetes mellitus;narrowmatch
non-neoplastic endocrine pancreas disorder;diabetes mellitus;narrowmatch
dermatosis;dermatitis;narrowmatch
digestive system signs and symptoms;dysphagia;narrowmatch
ctrp disease finding;dysphagia;narrowmatch
abnormal hematology test result;cytopenia;narrowmatch
lesion;cyst;narrowmatch
endocrine syndrome;cushing syndrome;narrowmatch
inflammatory bowel disease;crohn disease;narrowmatch
enteritis;crohn disease;narrowmatch
invasive adenocarcinoma of the mouse prostate gland;well differentiated invasive adenocarcinoma of the mouse prostate gland;narrowmatch
neurological signs and symptoms;seizure;narrowmatch
finding by cause;complication;narrowmatch
malignant neoplasms of the mouse mammary gland;epithelial mesenchymal transition tumor of the mouse mammary gland;narrowmatch
peritoneal disorder;ascites;narrowmatch
arthritis;rheumatoid arthritis;narrowmatch
chromosomal inversion;pericentric inversion;narrowmatch
pituitary gland neoplasm (antiquated);pituitary gland basophil adenoma;narrowmatch
transcription process;transcription elongation;narrowmatch
immunoprotein gene;hla-a gene;narrowmatch
mhc class i gene;hla-a gene;narrowmatch
transcription factor gene;gata1 gene;narrowmatch
transcription factor gene;runx1t1 gene;narrowmatch
pituitary gland neoplasm (antiquated);pituitary gland chromophobe adenoma;narrowmatch
interphase process;g2 to m transition process;narrowmatch
epithelial neoplasm;adenoma;narrowmatch
rheumatologic disorder;rheumatoid arthritis;narrowmatch
ligand binding protein gene;transport protein gene;narrowmatch
gene;fusion gene;narrowmatch
t-cell immunodeficiency;acquired immunodeficiency syndrome;narrowmatch
subcellular process;biochemical process;narrowmatch
congenital or acquired anatomic abnormality;congenital abnormality;narrowmatch
cell movement process;cell movement;narrowmatch
chromosomal translocation;philadelphia chromosome;narrowmatch
cell growth process;cell maturation;narrowmatch
interleukin gene;il3 gene;narrowmatch
protein family;kinase;narrowmatch
gene expression process;transcription process;narrowmatch
arthropathy;arthritis;narrowmatch
vascular malformation;arteriovenous malformation/hemangioma;narrowmatch
eating disorder;anorexia;narrowmatch
vascular ectasia;angiokeratoma;narrowmatch
numerical chromosomal abnormality;aneuploidy;narrowmatch
non-neoplastic hematologic and lymphocytic disorder;anemia;narrowmatch
cell cycle process;cell cycle progression;narrowmatch
signal transducer and activator of transcription family gene;stat5b gene;narrowmatch
dementia;alzheimer's disease;narrowmatch
transcription factor gene;rela gene;narrowmatch
transcription repressor/corepressor gene;zbtb16 gene;narrowmatch
leukopenia;granulocytopenia;narrowmatch
pulmonary proliferative lesions of the mouse;epithelial proliferative lesions of the mouse pulmonary system;narrowmatch
mouse pulmonary disorder;pulmonary proliferative lesions of the mouse;narrowmatch
mouse respiratory system disorder;mouse pulmonary disorder;narrowmatch
genetic disorder;congenital combined immunodeficiency;narrowmatch
viral infection;human papillomavirus infection;narrowmatch
central nervous system part;membrane of the brain or spinal cord;narrowmatch
non-neoplastic genitourinary system disorder;non-neoplastic reproductive system disorder;narrowmatch
female non-neoplastic reproductive system disorder;placental non-neoplastic disorder;narrowmatch
placenta disorder;placental non-neoplastic disorder;narrowmatch
male non-neoplastic reproductive system disorder;penile non-neoplastic disorder;narrowmatch
penile disorder;penile non-neoplastic disorder;narrowmatch
male non-neoplastic reproductive system disorder;testicular non-neoplastic disorder;narrowmatch
testicular disorder;testicular non-neoplastic disorder;narrowmatch
reproductive system disorder;non-neoplastic reproductive system disorder;narrowmatch
non-neoplastic reproductive system disorder;female non-neoplastic reproductive system disorder;narrowmatch
bladder disorder;non-neoplastic bladder disorder;narrowmatch
female reproductive system disorder;female non-neoplastic reproductive system disorder;narrowmatch
non-neoplastic reproductive system disorder;male non-neoplastic reproductive system disorder;narrowmatch
male reproductive system disorder;male non-neoplastic reproductive system disorder;narrowmatch
non-neoplastic eye disorder;non-neoplastic retinal disorder;narrowmatch
retinal disorder;non-neoplastic retinal disorder;narrowmatch
eye disorder;conjunctival disorder;narrowmatch
non-neoplastic disorder by site;non-neoplastic eye disorder;narrowmatch
female non-neoplastic reproductive system disorder;vulvar non-neoplastic disorder;narrowmatch
vulvar disorder;vulvar non-neoplastic disorder;narrowmatch
vaginal disorder;vaginal non-neoplastic disorder;narrowmatch
female non-neoplastic reproductive system disorder;vaginal non-neoplastic disorder;narrowmatch
oral disorder;non-neoplastic oral disorder;narrowmatch
non-neoplastic head and neck disorder;non-neoplastic oral disorder;narrowmatch
head and neck disorder;neck disorder;narrowmatch
otolaryngologic disorder;sinonasal disorder;narrowmatch
hearing loss;conductive hearing loss;narrowmatch
precancerous condition by site;head and neck precancerous condition;narrowmatch
head and neck disorder;head and neck precancerous condition;narrowmatch
oral disorder;oral cavity disorder;narrowmatch
female reproductive system disorder;vulvar disorder;narrowmatch
female non-neoplastic reproductive system disorder;uterine non-neoplastic disorder;narrowmatch
uterine disorder;uterine non-neoplastic disorder;narrowmatch
female non-neoplastic reproductive system disorder;ovarian non-neoplastic disorder;narrowmatch
ovarian disorder;ovarian non-neoplastic disorder;narrowmatch
cervical disorder;cervical non-neoplastic disorder;narrowmatch
uterine non-neoplastic disorder;cervical non-neoplastic disorder;narrowmatch
eye disorder;non-neoplastic eye disorder;narrowmatch
non-neoplastic urinary system disorder;non-neoplastic bladder disorder;narrowmatch
non-neoplastic oral disorder;non-neoplastic oral cavity disorder;narrowmatch
non-neoplastic disorder by site;non-neoplastic endocrine disorder;narrowmatch
disorder by site;head and neck disorder;narrowmatch
gonadal disorder;non-neoplastic gonadal disorder;narrowmatch
congenital reproductive system abnormality;non-neoplastic gonadal disorder;narrowmatch
non-neoplastic retroperitoneal disorder;non-neoplastic adrenal gland disorder;narrowmatch
adrenal gland disorder;non-neoplastic adrenal gland disorder;narrowmatch
non-neoplastic neck disorder;non-neoplastic thyroid gland disorder;narrowmatch
thyroid gland disorder;non-neoplastic thyroid gland disorder;narrowmatch
endocrine system disorder;non-neoplastic endocrine disorder;narrowmatch
kidney disorder;non-neoplastic kidney disorder;narrowmatch
endocrine system disorder;endocrine syndrome;narrowmatch
syndrome;endocrine syndrome;narrowmatch
non-neoplastic thoracic disorder;non-neoplastic pleural disorder;narrowmatch
pleural disorder;non-neoplastic pleural disorder;narrowmatch
non-neoplastic respiratory system disorder;non-neoplastic lung disorder;narrowmatch
non-neoplastic thoracic disorder;non-neoplastic lung disorder;narrowmatch
lung disorder;non-neoplastic lung disorder;narrowmatch
non-neoplastic musculoskeletal disorder;non-neoplastic bone disorder;narrowmatch
connective tissue disorder;non-neoplastic bone disorder;narrowmatch
non-neoplastic connective and soft tissue disorder;non-neoplastic soft tissue disorder;narrowmatch
soft tissue disorder;non-neoplastic soft tissue disorder;narrowmatch
non-neoplastic urinary system disorder;non-neoplastic kidney disorder;narrowmatch
urinary system disorder;non-neoplastic urinary system disorder;narrowmatch
non-neoplastic genitourinary system disorder;non-neoplastic urinary system disorder;narrowmatch
cranial nerve disorder;facial nerve disorder;narrowmatch
cranial nerve disorder;abducens nerve disorder;narrowmatch
cranial nerve disorder;vagus nerve disorder;narrowmatch
non-neoplastic disorder by site;non-neoplastic nervous system disorder;narrowmatch
nervous system disorder;non-neoplastic nervous system disorder;narrowmatch
non-neoplastic nervous system disorder;non-neoplastic peripheral nervous system disorder;narrowmatch
peripheral nervous system disorder;non-neoplastic peripheral nervous system disorder;narrowmatch
central nervous system disorder;non-neoplastic central nervous system disorder;narrowmatch
non-neoplastic nervous system disorder;non-neoplastic central nervous system disorder;narrowmatch
infectious disorder;infectious disorder by site;narrowmatch
nervous system disorder;peripheral nervous system disorder;narrowmatch
disorder by site;connective and soft tissue disorder;narrowmatch
oral cavity disorder;non-neoplastic oral cavity disorder;narrowmatch
ear disorder;non-neoplastic ear disorder;narrowmatch
endometrial endometrioid adenocarcinoma with papillae;endometrial endometrioid adenocarcinoma with small nonvillous papillae;narrowmatch
chromosome 1 abnormality;"t(1;14)(p22;q32)";narrowmatch
epithelial neoplasm (antiquated);non-invasive verrucous carcinoma of the penis;narrowmatch
precancerous condition by site;female reproductive system precancerous condition;narrowmatch
female reproductive system disorder;female reproductive system precancerous condition;narrowmatch
occupational malignant neoplasm;aromatic dyes-related malignant neoplasm;narrowmatch
chromosomal translocation;"t(16;16)(p13.1;q22)";narrowmatch
rara gene translocation;"t(15;17)(q24;q21)";narrowmatch
chromosomal translocation;"t(2;18)(p12;q21)";narrowmatch
chromosomal translocation;"t(1;14)(p22;q32)";narrowmatch
connective and soft tissue neoplasm (antiquated);very low risk gastrointestinal stromal tumor;narrowmatch
chromosomal translocation;"t(9;14)(p13;q32)";narrowmatch
high risk gastrointestinal stromal tumor;high risk colorectal gastrointestinal stromal tumor;narrowmatch
intermediate risk gastrointestinal stromal tumor;intermediate risk colorectal gastrointestinal stromal tumor;narrowmatch
low risk gastrointestinal stromal tumor;low risk colorectal gastrointestinal stromal tumor;narrowmatch
very low risk gastrointestinal stromal tumor;very low risk colorectal gastrointestinal stromal tumor;narrowmatch
very low risk gastrointestinal stromal tumor;very low risk small intestinal gastrointestinal stromal tumor;narrowmatch
very low risk gastrointestinal stromal tumor;very low risk gastric gastrointestinal stromal tumor;narrowmatch
polycythemia;polycythemia (excluding polycythemia vera);narrowmatch
leukemia (antiquated);common acute lymphoblastic leukemia;narrowmatch
leukemia (antiquated);pre-b acute lymphoblastic leukemia;narrowmatch
leukemia (antiquated);pre-pre-b acute lymphoblastic leukemia;narrowmatch
epithelial neoplasm (antiquated);endometrial endometrioid adenocarcinoma with metaplastic changes;narrowmatch
epithelial neoplasm (antiquated);endometrial endometrioid adenocarcinoma with small glands, tubules or cords;narrowmatch
epithelial neoplasm (antiquated);endometrial endometrioid adenocarcinoma with papillae;narrowmatch
invasive breast carcinoma;invasive breast carcinoma by histologic grade;narrowmatch
lymphoma by working formulation (antiquated);malignant lymphoma by cell type (working formulation);narrowmatch
lymphoma by working formulation (antiquated);aids-related lymphoma by working formulation;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);reticulosarcoma;narrowmatch
malignant lymphoma by cell type (working formulation);malignant lymphoma, large cell type;narrowmatch
lymphoma by working formulation (antiquated);diffuse malignant lymphoma;narrowmatch
malignant lymphoma by cell type (working formulation);malignant lymphoma, convoluted;narrowmatch
leukemia (antiquated);mature t-all;narrowmatch
malignant lymphoma by cell type (working formulation);malignant non-hodgkin lymphoma, cleaved cell;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);hodgkin's lymphoma (antiquated);narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's disease, nodular sclerosis, lymphocyte depletion;narrowmatch
lymphoma by working formulation (antiquated);mycosis fungoides (working formulation);narrowmatch
very low risk gastrointestinal stromal tumor;very low risk esophageal gastrointestinal stromal tumor;narrowmatch
cutaneous precancerous condition;vulvar lichen sclerosus;narrowmatch
non-neoplastic head and neck disorder;non-neoplastic ear disorder;narrowmatch
peritoneal and retroperitoneal disorder;non-neoplastic peritoneal and retroperitoneal disorder;narrowmatch
disorder by site;respiratory and thoracic disorder;narrowmatch
retroperitoneal disorder;non-neoplastic retroperitoneal disorder;narrowmatch
non-neoplastic peritoneal and retroperitoneal disorder;non-neoplastic retroperitoneal disorder;narrowmatch
peritoneal and retroperitoneal disorder;retroperitoneal disorder;narrowmatch
non-neoplastic peritoneal and retroperitoneal disorder;non-neoplastic peritoneal disorder;narrowmatch
peritoneal disorder;non-neoplastic peritoneal disorder;narrowmatch
non-neoplastic disorder by site;non-neoplastic peritoneal and retroperitoneal disorder;narrowmatch
disorder by site;peritoneal and retroperitoneal disorder;narrowmatch
vulvar dystrophy;vulvar lichen sclerosus;narrowmatch
non-neoplastic disorder by site;non-neoplastic head and neck disorder;narrowmatch
head and neck disorder;non-neoplastic head and neck disorder;narrowmatch
non-neoplastic head and neck disorder;non-neoplastic neck disorder;narrowmatch
neck disorder;non-neoplastic neck disorder;narrowmatch
non-neoplastic neck disorder;non-neoplastic laryngeal disorder;narrowmatch
laryngeal disorder;non-neoplastic laryngeal disorder;narrowmatch
head and neck disorder;skull disorder;narrowmatch
cardiovascular disorder;non-neoplastic cardiovascular disorder;narrowmatch
non-neoplastic disorder by site;non-neoplastic cardiovascular disorder;narrowmatch
myelofibrosis;secondary myelofibrosis;narrowmatch
cancer-related condition;secondary myelofibrosis;narrowmatch
female reproductive system precancerous condition;vulvar lichen sclerosus;narrowmatch
lichen sclerosus et atrophicus;vulvar lichen sclerosus;narrowmatch
chromosome 1 abnormality;"t(1;19)(q23;p13.3)";narrowmatch
chromosomal translocation;"t(1;19)(q23;p13.3)";narrowmatch
clonal gene rearrangement;clonal ccnd1 gene rearrangement;narrowmatch
ccnd1 gene rearrangement;clonal ccnd1 gene rearrangement;narrowmatch
11q translocation;"t(11;18)(q21;q21)";narrowmatch
chromosomal loss;loss of chromosome 5q;narrowmatch
chromosome 5 abnormality;loss of chromosome 5q;narrowmatch
rearrangement of 2p23;"t(2;5)(p23;q35)";narrowmatch
chromosomal translocation;"t(2;5)(p23;q35)";narrowmatch
chromosome 5 rearrangement;"t(2;5)(p23;q35)";narrowmatch
calcification;psammoma body formation;narrowmatch
chromosomal translocation;"t(2;8)(p11;q24)";narrowmatch
myeloid neoplasm finding;previously treated myelodysplastic syndrome;narrowmatch
translation process;translational regulation;narrowmatch
translational regulation;translational activation;narrowmatch
disturbance in bowel function;diarrhea;narrowmatch
skeletal system part;epiphysis of the bone;narrowmatch
bile duct;extrahepatic bile duct;narrowmatch
exocrine gland;exocrine pancreas;narrowmatch
tissue;esophageal tissue;narrowmatch
squamous cell;esophageal squamous cell;narrowmatch
esophageal tissue;esophageal mucosa;narrowmatch
mucosa;esophageal mucosa;narrowmatch
cell junction;epithelial cell junction;narrowmatch
body region;epigastric region;narrowmatch
cell part;electron-transport chain of the respiratory enzymes;narrowmatch
female reproductive system part;endometrial stroma;narrowmatch
glandular cell;endometrial glandular cell;narrowmatch
body cavity;endometrial cavity;narrowmatch
female reproductive system part;endometrial cavity;narrowmatch
endocrine sex organ;endocrine testis;narrowmatch
endocrine gland;endocrine sex organ;narrowmatch
secretory cell;endocrine cell;narrowmatch
head and neck part;eye appendage;narrowmatch
nausea and vomiting;nausea;narrowmatch
liver ligament;falciform ligament;narrowmatch
digestive system signs and symptoms;nausea and vomiting;narrowmatch
mucosa;gastric mucosa;narrowmatch
glandular cell;gastric glandular cell;narrowmatch
retina layer;ganglion cell layer;narrowmatch
exocrine gland;fundic gland;narrowmatch
gonadotroph cell;fsh cell;narrowmatch
cerebral sulcus;frontal sulcus;narrowmatch
neoplasm;neoplasm by site;narrowmatch
brain part;foramen of monroe;narrowmatch
lower extremity part;foot;narrowmatch
disease or disorder;neoplasm;narrowmatch
bone;flat bone;narrowmatch
digit;finger;narrowmatch
upper extremity part;finger;narrowmatch
cell part;cytoskeleton filament;narrowmatch
urethra;female urethra;narrowmatch
epithelial cell;endocrine cell;narrowmatch
sweat gland;eccrine sweat gland;narrowmatch
genetic disorder;hereditary neoplastic syndrome;narrowmatch
cell;cell of the epidermis;narrowmatch
connective and soft tissue neoplasm (antiquated);mesenchymoma;narrowmatch
cartilage cell;chondroblast;narrowmatch
head and neck lymph node;cervical lymph node;narrowmatch
apocrine sweat gland;ceruminous gland;narrowmatch
brain part;cerebral sulcus;narrowmatch
tooth cell;cementoblast;narrowmatch
osteoblast;cementoblast;narrowmatch
connective tissue;cartilaginous tissue;narrowmatch
membrane of the brain or spinal cord;dura mater;narrowmatch
exocrine gland;cardia gland;narrowmatch
digestive system part;canal of hering;narrowmatch
mucosa-associated lymphoid tissue;bronchus-associated lymphoid tissue;narrowmatch
organ;bronchial tree;narrowmatch
pseudostratified columnar ciliated epithelium;bronchial epithelium;narrowmatch
cancer-related condition;meigs syndrome;narrowmatch
neoplastic syndrome;meigs syndrome;narrowmatch
renal tubule;collecting tube;narrowmatch
non-neoplastic disorder by special category;metabolic disorder;narrowmatch
carotid artery;common carotid artery;narrowmatch
morphologic finding;metaplasia;narrowmatch
salivary gland tissue;duct salivary gland system;narrowmatch
bone marrow disorder;myelofibrosis;narrowmatch
convoluted tubule;distal convoluted tubule;narrowmatch
central nervous system part;diaphragma sellae;narrowmatch
pain;musculoskeletal pain;narrowmatch
intracranial venous system;deep intracranial venous system;narrowmatch
glandular epithelium;cuboidal epithelium;narrowmatch
digestive system finding;mucocele of the appendix;narrowmatch
otolaryngologic disorder;oral disorder;narrowmatch
urethral gland;cowper gland;narrowmatch
basophilic cell;corticotroph cell;narrowmatch
aneuploidy;monosomy;narrowmatch
eye part;corneoscleral coat;narrowmatch
epithelial metaplasia;squamous metaplasia;narrowmatch
stratified columnar epithelium;conjunctival epithelium;narrowmatch
gastric tissue;gastric mucosa;narrowmatch
neoplastic syndrome;hereditary neoplastic syndrome;narrowmatch
cancer cell growth regulation;inhibition of cancer cell growth;narrowmatch
gonadotroph cell;lh cell;narrowmatch
lymph node;lymph node by anatomic site;narrowmatch
tissue;lung tissue;narrowmatch
digestive system part;lower gastrointestinal tract;narrowmatch
bone;long bone;narrowmatch
cyst;ovarian cyst;narrowmatch
female reproductive system finding;ovarian cyst;narrowmatch
ligament;liver ligament;narrowmatch
metabolic bone disorder;osteoporosis;narrowmatch
acidophilic cell;lactotroph cell;narrowmatch
meninges;leptomeninges;narrowmatch
lumbar region;left lumbar region;narrowmatch
hypochondriac region;left hypochondriac region;narrowmatch
intestinal wall tissue;large intestinal wall tissue;narrowmatch
intestinal mucosa;large intestinal mucosa;narrowmatch
large intestinal wall tissue;large intestinal mucosa;narrowmatch
enterocyte;large intestinal glandular cell;narrowmatch
lymphoid tissue;lymph node cortex;narrowmatch
lymph node tissue;lymph node cortex;narrowmatch
symptom;pain;narrowmatch
tissue;lymph node tissue;narrowmatch
membrane;membrane of the brain or spinal cord;narrowmatch
edema;papilledema;narrowmatch
mature lymphocyte;mature t-lymphocyte;narrowmatch
peripheral (post-thymic) t-lymphocyte;mature t-lymphocyte;narrowmatch
non-neoplastic pancreatic disorder;pancreatitis;narrowmatch
mature lymphocyte;mature b-lymphocyte;narrowmatch
b-lymphocyte;mature b-lymphocyte;narrowmatch
marginal zone;marginal zone of the lymph node;narrowmatch
lymph node tissue;marginal zone of the lymph node;narrowmatch
lymphoid tissue;mantle zone;narrowmatch
urethra;male urethra;narrowmatch
breast;male breast;narrowmatch
lymphoid tissue;lymphoid follicle;narrowmatch
cardiovascular system part;lymphatic vessel;narrowmatch
lymph node part;lymph node tissue;narrowmatch
metabolic bone disorder;bone paget disease;narrowmatch
head and neck part;lacrimal sac;narrowmatch
tissue;gastric tissue;narrowmatch
cell;hematopoietic and lymphoid cell;narrowmatch
non-neoplastic peripheral nervous system disorder;neuroma;narrowmatch
cartilaginous tissue;hyaline cartilage;narrowmatch
brain part;epencephalon;narrowmatch
kidney part;hilar area of the kidney;narrowmatch
hepatobiliary tissue;hepatic tissue;narrowmatch
hepatic tissue;hepatic lobule;narrowmatch
bile duct;hepatic duct;narrowmatch
muscle;head and neck muscle;narrowmatch
eye appendage;lacrimal apparatus;narrowmatch
upper extremity part;hand;narrowmatch
hair part;hair follicle infundibulum;narrowmatch
integumentary system part;hair;narrowmatch
adenohypophysial cell;gonadotroph cell;narrowmatch
tissue;gingiva;narrowmatch
body region;genito-urinary region;narrowmatch
digestive system part;gastroesophageal junction;narrowmatch
b-lymphocyte;immature b-lymphocyte;narrowmatch
immature lymphocyte;immature b-lymphocyte;narrowmatch
sweating;night sweats;narrowmatch
congenital or acquired anatomic abnormality;nodule;narrowmatch
infectious disorder;opportunistic infection;narrowmatch
endocrine cell of the digestive system;islet cell;narrowmatch
bone;irregular bone;narrowmatch
venous system;intracranial venous system;narrowmatch
cellular membrane;intracellular membrane;narrowmatch
female reproductive system part;interstitial segment of the fallopian tube;narrowmatch
stromal cell;interstitial cell of cajal;narrowmatch
connective and soft tissue cell;interstitial cell;narrowmatch
non-neoplastic dental disorder;odontoma;narrowmatch
hamartoma;odontoma;narrowmatch
finding by cause;obstruction;narrowmatch
sign;obesity;narrowmatch
intrahepatic bile duct;interlobular bile duct;narrowmatch
duct;intercalated duct;narrowmatch
lymph node by anatomic site;inguinal lymph node;narrowmatch
anatomic surface;bone surface;narrowmatch
bone;bone of the extremity;narrowmatch
anatomic structure, system, or substance;body part;narrowmatch
musculoskeletal process;muscle contraction;narrowmatch
non-neoplastic brain disorder;seizure disorder;narrowmatch
abnormal hematology test result;eosinophilia;narrowmatch
female non-neoplastic reproductive system disorder;endometriosis;narrowmatch
glandular hyperplasia;endometrial hyperplasia;narrowmatch
endometrial disorder;endometrial hyperplasia;narrowmatch
transcription factor gene;basal transcription factor gene;narrowmatch
disorder by site;endocrine system disorder;narrowmatch
cytoskeletal gene;intermediate filament gene;narrowmatch
mouse malignant ovarian neoplasm;mouse ovarian embryonal carcinoma;narrowmatch
mouse malignant ovarian neoplasm;mouse ovarian histiocytic sarcoma;narrowmatch
mouse malignant ovarian neoplasm;mouse ovarian hemangiosarcoma;narrowmatch
mouse malignant ovarian neoplasm;mouse malignant ovarian sertoli cell tumor;narrowmatch
mouse malignant ovarian neoplasm;mouse malignant ovarian granulosa cell tumor;narrowmatch
mouse malignant ovarian neoplasm;mouse malignant ovarian thecoma;narrowmatch
mouse malignant ovarian neoplasm;mouse choriocarcinoma;narrowmatch
mouse malignant ovarian neoplasm;mouse yolk sac carcinoma;narrowmatch
digestive system disorder;esophageal disorder;narrowmatch
non-neoplastic bone disorder;exostosis;narrowmatch
mental and behavioral signs and symptoms;fatigue;narrowmatch
sign;fever;narrowmatch
heart failure;congestive heart failure;narrowmatch
thoracic disorder;heart disorder;narrowmatch
cardiovascular disorder;heart disorder;narrowmatch
non-neoplastic ear disorder;hearing disorder;narrowmatch
non-neoplastic disorder by special category;hamartoma;narrowmatch
pilosebaceous hamartoma;hairy nevus;narrowmatch
non-neoplastic breast disorder;gynecomastia;narrowmatch
pharmacologic substance;biological agent;narrowmatch
granuloma;foreign body granuloma;narrowmatch
lesion;granuloma;narrowmatch
fracture;pathologic fracture;narrowmatch
bone injury;fracture;narrowmatch
congenital or acquired anatomic abnormality;fistula;narrowmatch
morphologic finding;fibrosis;narrowmatch
non-neoplastic breast disorder;breast fibrocystic change;narrowmatch
pathologic process;tumor embolism;narrowmatch
mouse malignant ovarian neoplasm;mouse ovarian cystadenocarcinoma;narrowmatch
integumentary system part;body of the nail;narrowmatch
collagen gene;col1a2 gene;narrowmatch
dermatitis;eczema;narrowmatch
genitourinary signs and symptoms;dysuria;narrowmatch
urinary system finding;dysuria;narrowmatch
alteration in respiration;dyspnea;narrowmatch
genitourinary signs and symptoms;dyspareunia;narrowmatch
reproductive system finding;dyspareunia;narrowmatch
cytoskeletal gene;myh11 gene;narrowmatch
collagen gene;col1a1 gene;narrowmatch
tubulostromal adenocarcinoma;mouse ovarian tubulostromal adenocarcinoma;narrowmatch
gene;enzyme inhibitor gene;narrowmatch
enzyme inhibitor gene;proteinase inhibitor gene;narrowmatch
genetic disorder;down syndrome;narrowmatch
syndrome;down syndrome;narrowmatch
coagulation disorder;disseminated intravascular coagulation;narrowmatch
disease, disorder or finding;disease or disorder;narrowmatch
disorder by site;digestive system disorder;narrowmatch
swelling;edema;narrowmatch
protein expression;translation process;narrowmatch
translation process;translation initiation;narrowmatch
mouse female reproductive system disorder;mouse ovarian disorder;narrowmatch
mouse malignant ovarian neoplasm;mouse ovarian tubulostromal adenocarcinoma;narrowmatch
mouse benign ovarian neoplasm;mouse ovarian hemangioma;narrowmatch
mouse benign ovarian neoplasm;mouse benign sex cord stromal mixed tumor;narrowmatch
mouse benign ovarian neoplasm;mouse benign sertoli cell tumor;narrowmatch
mouse benign ovarian neoplasm;mouse benign granulosa cell tumor;narrowmatch
mouse benign ovarian neoplasm;mouse benign thecoma;narrowmatch
mouse benign ovarian neoplasm;mouse benign ovarian teratoma;narrowmatch
mouse benign ovarian neoplasm;mouse benign luteoma;narrowmatch
mouse benign ovarian neoplasm;mouse ovarian cystadenoma;narrowmatch
tubulostromal adenoma;mouse ovarian tubulostromal adenoma;narrowmatch
mouse benign ovarian neoplasm;mouse ovarian tubulostromal adenoma;narrowmatch
mouse ovarian neoplasm;mouse malignant ovarian neoplasm;narrowmatch
mouse ovarian neoplasm;mouse benign ovarian neoplasm;narrowmatch
mouse ovarian disorder;mouse ovarian neoplasm;narrowmatch
fluid and electrolyte manifestation;effusion;narrowmatch
hemangiopericytic neoplasm;hemangiopericytoma;narrowmatch
abnormal urine test result;hematuria;narrowmatch
genitourinary signs and symptoms;hematuria;narrowmatch
non-neoplastic vascular disorder;lymphedema;narrowmatch
musculoskeletal system part;aponeurosis;narrowmatch
sweat gland;apocrine sweat gland;narrowmatch
organ of special sense part;apex of the tongue;narrowmatch
respiratory system part;apex of the lung;narrowmatch
intermediate grade lymphoma;mixed cell lymphoma;narrowmatch
fossa;anterior cranial fossa;narrowmatch
digestive system part;anal transitional zone;narrowmatch
body region;anal region;narrowmatch
congenital hematological disorder;hemoglobinopathy;narrowmatch
exocrine gland;anal gland;narrowmatch
epithelial cell;alveolar cell;narrowmatch
islet cell;alpha cell;narrowmatch
tissue;adrenal gland tissue;narrowmatch
lymphocyte;activated lymphocyte;narrowmatch
salivary gland tissue;acinar salivary gland system;narrowmatch
adenohypophysial cell;acidophilic cell;narrowmatch
syndrome;malabsorption syndrome;narrowmatch
non-neoplastic intestinal disorder;malabsorption syndrome;narrowmatch
upper extremity part;arm;narrowmatch
ectopic hormone secretion syndrome associated with neoplasia;carcinoid syndrome;narrowmatch
soft tissue;blood vessel tissue;narrowmatch
capillary;blood capillary;narrowmatch
blood vessel;blood capillary;narrowmatch
urothelium;bladder urothelium;narrowmatch
urothelial cell;bladder urothelial cell;narrowmatch
tissue;bladder tissue;narrowmatch
bladder tissue;bladder mucosa;narrowmatch
mucosa;bladder mucosa;narrowmatch
cyst;mediastinal cyst;narrowmatch
islet cell;beta cell;narrowmatch
adenohypophysial cell;basophilic cell;narrowmatch
brain part;base of the brain;narrowmatch
nervous system part;axon;narrowmatch
skeletal system part;axial skeleton;narrowmatch
heart part;atrioventricular node;narrowmatch
cranial nerve;accessory nerve;narrowmatch
thoracic disorder;lung disorder;narrowmatch
respiratory system disorder;lung disorder;narrowmatch
syndrome;immunodeficiency syndrome;narrowmatch
non-neoplastic thyroid gland disorder;hyperthyroidism;narrowmatch
non-neoplastic endocrine disorder;hyperthyroidism;narrowmatch
hypertension;portal hypertension;narrowmatch
blood pressure finding;hypertension;narrowmatch
non-neoplastic disorder by special category;hyperplasia;narrowmatch
abnormal blood chemistry and hematology test result;hypercalcemia;narrowmatch
non-neoplastic brain disorder;hydrocephalus;narrowmatch
viral infection;hiv infection;narrowmatch
morphologic finding;histiocytosis;narrowmatch
disease or disorder;genetic disorder;narrowmatch
digestive system signs and symptoms;hepatomegaly;narrowmatch
chronic viral hepatitis;hepatitis c infection;narrowmatch
chronic viral hepatitis;hepatitis b infection;narrowmatch
non-neoplastic liver and intrahepatic bile duct disorder;hepatitis;narrowmatch
respiratory system signs and symptoms;hemoptysis;narrowmatch
abnormal blood chemistry and hematology test result;hypoglycemia;narrowmatch
immune system disorder;immunodeficiency syndrome;narrowmatch
mass;breast lump;narrowmatch
male reproductive system finding;impotence;narrowmatch
hepatobiliary disorder;liver and intrahepatic bile duct disorder;narrowmatch
cancer-related condition;linitis plastica;narrowmatch
oral cavity and lip precancerous condition;oral leukoplakia;narrowmatch
leukoplakia;oral leukoplakia;narrowmatch
precancerous condition;leukoplakia;narrowmatch
leukemia (antiquated);calla positive lymphoblastic leukemia;narrowmatch
leukemia (antiquated);b-cell leukemia;narrowmatch
urinary system disorder;kidney disorder;narrowmatch
digestive system signs and symptoms;jaundice;narrowmatch
inflammatory disorder;inflammatory bowel disease;narrowmatch
intestinal precancerous condition;inflammatory bowel disease;narrowmatch
non-neoplastic intestinal disorder;inflammatory bowel disease;narrowmatch
finding by cause;inflammation;narrowmatch
skin cyst;epidermal inclusion cyst;narrowmatch
sexual dysfunction;impotence;narrowmatch
mouse granular cell neoplasm;granular cell tumor of the mouse skin;narrowmatch
stage iva;stage iva1;narrowmatch
benign mesenchymal neoplasms of the mouse skin;neurofibroma of the mouse skin;narrowmatch
reproductive system part;female reproductive system part;narrowmatch
renal tissue;nephron;narrowmatch
testicular tissue;seminiferous tubule;narrowmatch
musculoskeletal system part;ligament;narrowmatch
aponeurosis;tendon;narrowmatch
skeletal system part;joint;narrowmatch
organ of special sense part;ear part;narrowmatch
body part;nervous system part;narrowmatch
reproductive system part;male reproductive system part;narrowmatch
hereditary neoplastic syndrome;constitutional mismatch repair deficiency syndrome;narrowmatch
body part;respiratory system part;narrowmatch
body part;urinary system part;narrowmatch
body part;immune system part;narrowmatch
central nervous system part;brain part;narrowmatch
body part;endocrine system part;narrowmatch
male reproductive system finding;castration resistance;narrowmatch
cardiovascular system part;heart part;narrowmatch
hematopoietic and lymphoid tissue;lymphoid tissue;narrowmatch
striated muscle tissue;skeletal muscle tissue;narrowmatch
hematopoietic and lymphoid tissue;hematopoietic tissue;narrowmatch
nerve tissue and nerve sheaths;nerve tissue;narrowmatch
peripheral nervous system part;neural pathway;narrowmatch
ependyma and remnants of the central canal of the spinal cord;ependyma;narrowmatch
glandular cell;acinar cell;narrowmatch
secretory cell;acinar cell;narrowmatch
connective tissue;bone tissue;narrowmatch
head and neck part;dentition;narrowmatch
musculoskeletal system part;face;narrowmatch
body region;neck;narrowmatch
ganglion;sensory ganglion;narrowmatch
connective and soft tissue cell;synovial cell;narrowmatch
musculoskeletal system part;muscle;narrowmatch
cell;secretory cell;narrowmatch
embryonic structure;embryonic cell;narrowmatch
cell;embryonic cell;narrowmatch
endothelium;vascular endothelium;narrowmatch
integumentary system part;skin part;narrowmatch
body part;breast part;narrowmatch
urethra part;prostatic urethra;narrowmatch
gene mutation;biallelic mutation;narrowmatch
neuroectodermal cell;neuroblast;narrowmatch
respiratory system part;alveolus;narrowmatch
murine experimental organism diagnosis;mouse teratocarcinoma;narrowmatch
rat neoplasms by location;rat ovarian adenocarcinoma;narrowmatch
fusion gene;pcm1/jak2 fusion gene;narrowmatch
chromosomal translocation;"t(8;9)(p22;p24.1)";narrowmatch
gene mutation;monoallelic mutation;narrowmatch
bone of the extremity;bone of the lower extremity;narrowmatch
experimental organism neoplasm;experimental organism benign plasma cell tumor;narrowmatch
head and neck part;wall of the pharynx;narrowmatch
rearrangement detected;translocations involving tyrosine kinases or cytokine receptors present;narrowmatch
stem cell;pluripotent stem cell;narrowmatch
spinal cord part;cervicomedullary junction;narrowmatch
organ;breast;narrowmatch
gene variant;gata2 gene mutation;narrowmatch
rearrangement detected;xp11.2 translocations/tfe3 gene fusions present;narrowmatch
lymphoid tissue;splenic white pulp;narrowmatch
splenic pulp;splenic white pulp;narrowmatch
cyclin-dependent kinase inhibitor protein;cdkn2a gene product;narrowmatch
cranial nerve;vestibulocochlear nerve;narrowmatch
organ of special sense part;eye part;narrowmatch
anatomic structure, system, or substance;organ;narrowmatch
immature lymphocyte;lymphoblast;narrowmatch
hematopoietic blast cell;lymphoblast;narrowmatch
digestive system part;ampulla of vater;narrowmatch
membrane;pericardium;narrowmatch
bone marrow dysplasia present;multilineage dysplasia present;narrowmatch
laboratory test result;limited early t-cell differentiation;narrowmatch
heart part;endocardium;narrowmatch
glial cell;ependymal cell;narrowmatch
striated muscle cell;cardiomyocyte;narrowmatch
muscle cell;smooth muscle cell;narrowmatch
salivary gland;major salivary gland;narrowmatch
skeletal system part;vertebral column;narrowmatch
gene rearrangement abnormality;crlf2 gene rearrangement;narrowmatch
respiratory system part;alveolar wall;narrowmatch
duct;prostatic duct;narrowmatch
epithelium;gut epithelium;narrowmatch
cell part;chromatin;narrowmatch
human chromosome;chromosome 1;narrowmatch
chromosome;human chromosome;narrowmatch
rearrangement of 3q;bcl6 gene rearrangement;narrowmatch
gene rearrangement abnormality;bcl6 gene rearrangement;narrowmatch
dna structure;chromosome;narrowmatch
gene rearrangement abnormality;bcl2 gene rearrangement;narrowmatch
gene rearrangement abnormality;myc gene rearrangement;narrowmatch
cell structure;nucleus;narrowmatch
gene variant;pold1 gene mutation;narrowmatch
cytogenetic abnormality;11q aberration;narrowmatch
childhood acute lymphoblastic leukemia in remission;childhood t acute lymphoblastic leukemia in remission;narrowmatch
protein structure;amino acid sequence;narrowmatch
bone tissue;periosteum;narrowmatch
glandular epithelium;columnar epithelium;narrowmatch
pseudostratified columnar epithelium;pseudostratified columnar ciliated epithelium;narrowmatch
stratified epithelium;stratified squamous epithelium;narrowmatch
human chromosome;chromosome 10;narrowmatch
human chromosome;chromosome 11;narrowmatch
human chromosome;chromosome 12;narrowmatch
human chromosome;chromosome 13;narrowmatch
human chromosome;chromosome 3;narrowmatch
human chromosome;chromosome 22;narrowmatch
human chromosome;chromosome 21;narrowmatch
human chromosome;chromosome 20;narrowmatch
human chromosome;chromosome 2;narrowmatch
human chromosome;chromosome 19;narrowmatch
human chromosome;chromosome 18;narrowmatch
human chromosome;chromosome 17;narrowmatch
chromosomal translocation;"t(11;12)(p15;p13)";narrowmatch
rearrangement of 11p15;"t(11;12)(p15;p13)";narrowmatch
chromosome 12 abnormality;"t(11;12)(p15;p13)";narrowmatch
human chromosome;chromosome 16;narrowmatch
mll gene translocation;"t(10;11)(p12;q23)";narrowmatch
human chromosome;chromosome 15;narrowmatch
human chromosome;chromosome 14;narrowmatch
squamous epithelium;stratified squamous epithelium;narrowmatch
dna repair gene mutation;pold1 gene mutation;narrowmatch
epithelium;prostatic epithelium;narrowmatch
gene product sequence variation;msh2 protein variant;narrowmatch
rearrangement of 11p15;"t(5;11)(q35;p15)";narrowmatch
chromosome 5 rearrangement;"t(5;11)(q35;p15)";narrowmatch
negative test result;human papillomavirus negative;narrowmatch
expression negative;rb1 negative;narrowmatch
bovine neoplasm;bovine leukemia;narrowmatch
gene product sequence variation;brca2 protein variant;narrowmatch
gene product sequence variation;brca1 protein variant;narrowmatch
genetic finding;microsatellite stable;narrowmatch
gene variant;pole gene mutation;narrowmatch
translation process gene;eif1ax gene;narrowmatch
chromosome band;7p15-p14;narrowmatch
mature b-lymphocyte;memory b-lymphocyte;narrowmatch
lymphocyte;immature lymphocyte;narrowmatch
gene variant;tert gene mutation;narrowmatch
telomere maintenance gene mutation;tert gene mutation;narrowmatch
musculoskeletal system part;fascia;narrowmatch
chromosomal translocation;"t(5;11)(q35;p15)";narrowmatch
rearrangement of 11p15;"t(11;15)(p15;q35)";narrowmatch
chromosomal translocation;"t(11;15)(p15;q35)";narrowmatch
bipolar neuron;olfactory receptor cell;narrowmatch
dna repair gene mutation;pole gene mutation;narrowmatch
expression negative;cdkn2a negative;narrowmatch
gene amplification abnormality;cdk4 gene amplification;narrowmatch
gene abnormality;dna repair gene mutation;narrowmatch
deleterious mutation;deleterious palb2 gene mutation;narrowmatch
palb2 gene mutation;deleterious palb2 gene mutation;narrowmatch
membrane;mucosa;narrowmatch
heart part;epicardium;narrowmatch
non-neoplastic hematologic and lymphocytic disorder;platelet disorder;narrowmatch
nervous system finding;ventricular involvement only;narrowmatch
glandular cell;columnar cell;narrowmatch
glandular cell;cuboidal cell;narrowmatch
neuron;ganglion cell;narrowmatch
neuron;bipolar neuron;narrowmatch
neuroectodermal cell;olfactory receptor cell;narrowmatch
tissue;connective and soft tissue;narrowmatch
fgfr gene amplification;fgfr3 gene amplification;narrowmatch
membrane;peritoneum;narrowmatch
brain ventricle;fourth ventricle;narrowmatch
abnormal lymphocyte;reactive lymphocyte;narrowmatch
spinal nerve plexus;lumbar plexus;narrowmatch
organ system;reproductive system;narrowmatch
body cavity;pleural cavity;narrowmatch
brain ventricle;lateral ventricle;narrowmatch
spinal cord part;conus medullaris;narrowmatch
aneuploidy;hypoploidy;narrowmatch
brain ventricle;third ventricle;narrowmatch
vulvar disorder;vulvar squamous intraepithelial lesion;narrowmatch
canine neoplasm;canine sarcoma;narrowmatch
blood vessel;venule;narrowmatch
gene product sequence variation;myd88 protein variant;narrowmatch
gene variant;myd88 gene mutation;narrowmatch
vein;vena cava;narrowmatch
abnormal tissue present;mammary gland type features present;narrowmatch
vein;superior vena cava;narrowmatch
epithelium;squamous epithelium;narrowmatch
epithelial cell;squamous cell;narrowmatch
breast;female breast;narrowmatch
vertebra;sacral vertebra;narrowmatch
brca1 gene mutation;deleterious brca1 gene mutation;narrowmatch
deleterious homologous recombination pathway gene mutation;deleterious brca1 gene mutation;narrowmatch
deleterious brca gene mutation;deleterious brca1 gene mutation;narrowmatch
gene variant;bap1 gene mutation;narrowmatch
monoclonal gammopathy;igm monoclonal gammopathy;narrowmatch
lesion by morphology;submucosal lesion;narrowmatch
other anatomic concept;venous sinus;narrowmatch
lesion;unclassifiable lesion;narrowmatch
cardiac atrium;left atrium;narrowmatch
cardiac atrium;right atrium;narrowmatch
epithelium;alveolar epithelium;narrowmatch
epithelial cell;transitional cell;narrowmatch
connective and soft tissue cell;endothelial cell;narrowmatch
chromosomal translocation;ewsr1 gene translocation;narrowmatch
ewsr1 gene rearrangement;ewsr1 gene translocation;narrowmatch
vein;inferior vena cava;narrowmatch
blood vessel;vein;narrowmatch
brca2 gene mutation;deleterious brca2 gene mutation;narrowmatch
skeletal system part;skull;narrowmatch
bone of the lower extremity;tibia;narrowmatch
body region;thorax;narrowmatch
vertebra;thoracic vertebra;narrowmatch
autonomic nervous system part;sympathetic nervous system;narrowmatch
flat bone;sternum;narrowmatch
nerve;spinal nerve;narrowmatch
nerve root;spinal nerve root;narrowmatch
musculoskeletal system part;skeletal system;narrowmatch
canine neoplasm;canine transitional cell carcinoma;narrowmatch
organ;seminal vesicle;narrowmatch
skin;scrotum;narrowmatch
experimental organism neoplasm;experimental organism benign endometrial adenoma;narrowmatch
organ system;respiratory system;narrowmatch
vein;pulmonary vein;narrowmatch
artery;pulmonary artery;narrowmatch
endocrine system part;posterior lobe of the pituitary gland;narrowmatch
long bone;tibia;narrowmatch
anatomic structure, system, or substance;tissue;narrowmatch
organ;tonsil;narrowmatch
cranial nerve;trigeminal nerve;narrowmatch
canine neoplasm;canine histiocytic sarcoma;narrowmatch
murine experimental organism diagnosis;mouse testicular teratoma;narrowmatch
canine neoplasm;canine prostate carcinoma;narrowmatch
canine neoplasm;canine leukemia;narrowmatch
cranial nerve;vagus nerve;narrowmatch
eye part;uvea;narrowmatch
figo stage iiia;figo stage iiia2;narrowmatch
figo stage iiia1;figo stage iiia1(ii);narrowmatch
figo stage iiia1;figo stage iiia1(i);narrowmatch
figo stage iiia;figo stage iiia1;narrowmatch
figo stage ic;figo stage ic3;narrowmatch
figo stage ic;figo stage ic2;narrowmatch
organ system;genitourinary system;narrowmatch
figo stage ic;figo stage ic1;narrowmatch
cranial nerve;trochlear nerve;narrowmatch
deleterious brca gene mutation;deleterious brca2 gene mutation;narrowmatch
gene variant;cdkn2a gene mutation;narrowmatch
receptor tyrosine kinase gene rearrangement;alk gene rearrangement;narrowmatch
genetic finding;1p/19q codeletion status unknown;narrowmatch
kinase;janus kinase family;narrowmatch
epithelium;mammary epithelium;narrowmatch
mammary gland tissue;mammary epithelium;narrowmatch
mucosa-associated lymphoid tissue;gut-associated lymphoid tissue;narrowmatch
fusion gene;c11orf95/rela fusion gene;narrowmatch
fusion protein expression;c11orf95-rela fusion protein expression;narrowmatch
bone;vertebra;narrowmatch
gene product sequence variation;h3 protein variant;narrowmatch
oxidoreductase gene;idh gene family;narrowmatch
h3 protein variant;h3 k27m mutation;narrowmatch
canine neoplasm;canine rhabdomyosarcoma;narrowmatch
canine neoplasm;canine hepatocellular carcinoma;narrowmatch
canine neoplasm;canine glioma;narrowmatch
peripheral nervous system part;nerve plexus;narrowmatch
genetic finding;idh gene family mutation status unknown;narrowmatch
stratified epithelium;corneal epithelium;narrowmatch
gene abnormality;core binding factor complex mutation;narrowmatch
protein family;mismatch repair protein;narrowmatch
post-translational modification;histone modification;narrowmatch
morphologic architectural pattern;multinodular and vacuolated pattern;narrowmatch
organ system;exocrine system;narrowmatch
abnormal immunology test result;nuclear expression of stat6 protein;narrowmatch
gene variant;prkar1a gene mutation;narrowmatch
abnormal immunology test result;loss of brg1 protein expression;narrowmatch
embryonic structure;embryonic tissue;narrowmatch
tissue;embryonic tissue;narrowmatch
rearrangement detected;c19mc amplification;narrowmatch
genetic finding;c19mc amplification;narrowmatch
organ;duct;narrowmatch
human papillomavirus positive;human papillomavirus-16 positive;narrowmatch
positive laboratory test result;epstein-barr virus positive;narrowmatch
medulloblastoma;medulloblastoma, not otherwise specified;narrowmatch
medulloblastoma;medulloblastoma, genetically defined;narrowmatch
cytogenetic abnormality;chromosome 17 abnormality;narrowmatch
signaling pathway status;wnt pathway activated;narrowmatch
gene abnormality;idh gene family mutation;narrowmatch
receptor status;tnfrsf8 positive;narrowmatch
mismatch repair gene mutation;msh2 gene mutation;narrowmatch
genetic finding;philadelphia chromosome negative;narrowmatch
gene variant;flt3 gene mutation;narrowmatch
receptor tyrosine kinase gene mutation;flt3 gene mutation;narrowmatch
gene product sequence variation;fgfr3 protein variant;narrowmatch
ras family gene mutation;activating ras mutation;narrowmatch
central nervous system part;falx cerebri;narrowmatch
kidney part;renal pelvis;narrowmatch
rearrangement negative;philadelphia chromosome negative;narrowmatch
transitional epithelium;urothelium;narrowmatch
expression positive;tnfrsf8 positive;narrowmatch
positive laboratory test result;human papillomavirus positive;narrowmatch
expression negative;bcr/abl1 fusion negative;narrowmatch
rearrangement negative;bcr/abl1 fusion negative;narrowmatch
gene variant;stk11 gene mutation;narrowmatch
gene variant;pms1 gene mutation;narrowmatch
mismatch repair gene mutation;pms1 gene mutation;narrowmatch
gene variant;msh2 gene mutation;narrowmatch
spinal cord part;cervical spinal cord;narrowmatch
gene product sequence variation;flt3 protein variant;narrowmatch
spinal cord part;thoracic spinal cord;narrowmatch
conjunctiva;bulbar conjunctiva;narrowmatch
expression positive;ncam1 positive;narrowmatch
abnormal cell;neoplastic cell;narrowmatch
anatomic structure, system, or substance;organ system;narrowmatch
hematopoietic and lymphoid cell;hematopoietic blast cell;narrowmatch
neoplastic cell;malignant cell;narrowmatch
dysplastic megakaryocyte;micromegakaryocyte;narrowmatch
leukemic lymphocyte;neoplastic lymphoblast;narrowmatch
neoplastic blast;neoplastic lymphoblast;narrowmatch
lymphoid tissue;mucosa-associated lymphoid tissue;narrowmatch
hematopoietic and lymphatic system part;hematopoietic system;narrowmatch
canine neoplasm;canine mastocytoma;narrowmatch
organ system;integumentary system;narrowmatch
body cavity;thoracic cavity;narrowmatch
rare non-neoplastic disorder;thrombocytopenia 2;narrowmatch
lymph node by anatomic site;supraclavicular lymph node;narrowmatch
feline experimental organism diagnosis;feline lymphoma;narrowmatch
rat neoplasms by location;rat pituitary gland neoplasm;narrowmatch
human chromosome;chromosome 4;narrowmatch
ligand binding domain;rna recognition motif;narrowmatch
membranous cytoplasmic organelle;plasma membrane;narrowmatch
cellular membrane;plasma membrane;narrowmatch
gene feature;regulatory element;narrowmatch
rearrangement of 21q;"t(12;21)(p13.2;q22.1)";narrowmatch
chromosomal translocation;"t(12;21)(p13.2;q22.1)";narrowmatch
rearrangement of 12p13.2;"t(12;21)(p13.2;q22.1)";narrowmatch
etv6 gene rearrangement;"t(12;21)(p13.2;q22.1)";narrowmatch
body fluid or substance;male genital system fluid or secretion;narrowmatch
experimental organism neoplasm by organism;gerbil experimental organism diagnosis;narrowmatch
experimental organism neoplasm by organism;devil facial tumor disease;narrowmatch
fish experimental organism diagnosis;rainbow trout mesothelioma;narrowmatch
morphologic finding;intercellular bridges present;narrowmatch
protein domain;ligand binding domain;narrowmatch
blasts more than 5 percent of bone marrow nucleated cells;blasts 10 percent or more of bone marrow nucleated cells;narrowmatch
gene abnormality;notch family gene mutation;narrowmatch
gene variant;smarcb1 gene mutation;narrowmatch
anchoring junction;zonula adherens;narrowmatch
stage iii;stage iiid;narrowmatch
blasts 5 percent or less of bone marrow nucleated cells;blasts under 5 percent of bone marrow nucleated cells;narrowmatch
gene variant;dicer1 gene mutation;narrowmatch
prostate carcinoma by gene expression profile;basal-like prostate carcinoma;narrowmatch
prostate carcinoma by gene expression profile;luminal b prostate carcinoma;narrowmatch
prostate carcinoma by gene expression profile;luminal a prostate carcinoma;narrowmatch
prostate carcinoma;prostate carcinoma by gene expression profile;narrowmatch
nuclear structure;nucleosome core particle;narrowmatch
protein domain;immunoglobulin domain;narrowmatch
blasts 30 percent or less of bone marrow nucleated cells;blasts under 30 percent of bone marrow nucleated cells;narrowmatch
blasts more than 5 percent of peripheral blood white cells;blasts 10 percent or more of peripheral blood white cells;narrowmatch
gene abnormality;pi3k/mtor pathway mutation;narrowmatch
experimental organism diagnosis;experimental organism non-neoplastic disorder;narrowmatch
morphologic finding;tumor margin configuration;narrowmatch
blasts under 30 percent of bone marrow nucleated cells;blasts under 25 percent of bone marrow nucleated cells;narrowmatch
blasts under 10 percent of bone marrow nucleated cells;blasts 5 percent or less of bone marrow nucleated cells;narrowmatch
myeloblasts 5 percent or more of bone marrow nucleated cells;myeloblasts 10 percent or more of bone marrow nucleated cells;narrowmatch
blasts 10 percent or more of bone marrow nucleated cells;myeloblasts 10 percent or more of bone marrow nucleated cells;narrowmatch
experimental organism neoplasm by organism;fish experimental organism diagnosis;narrowmatch
stage ia;stage ia3;narrowmatch
neoplastic plasma cells 10 percent or more of bone marrow nucleated cells;neoplastic plasma cells more than 20 percent of bone marrow nucleated cells;narrowmatch
hamster neoplasm;hamster pituitary carcinoma;narrowmatch
experimental organism neoplasm by organism;seal lymphosarcoma;narrowmatch
experimental organism neoplasm by organism;rattlesnake fibroma;narrowmatch
rabbit neoplasm;rabbit papilloma;narrowmatch
lymphomas and haemopoietic neoplasms of the mouse nervous system;mouse thymic lymphoma;narrowmatch
mouse neoplasms by cell type;mouse histiocytic and dendritic cell neoplasm;narrowmatch
equine experimental organism diagnosis;horse sarcoid;narrowmatch
hamster neoplasm;hamster small intestinal neoplasm;narrowmatch
hamster neoplasm;hamster fibrosarcoma;narrowmatch
gene abnormality;raf family gene mutation;narrowmatch
hamster neoplasm;hamster lung carcinoma;narrowmatch
hamster neoplasm;hamster adrenal carcinoma;narrowmatch
leporine experimental organism diagnosis;rabbit neoplasm;narrowmatch
experimental organism neoplasm by organism;hamster neoplasm;narrowmatch
experimental organism neoplasm by organism;tamarin colon adenocarcinoma;narrowmatch
experimental organism neoplasm by organism;seal lymphoma;narrowmatch
fish experimental organism diagnosis;poeciliopsis lucida hepatocellular carcinoma;narrowmatch
experimental organism neoplasm by organism;turtle neoplasm;narrowmatch
fish experimental organism diagnosis;walleye dermal sarcoma;narrowmatch
experimental organism neoplasm by organism;budgerigar testicular carcinoma;narrowmatch
chicken neoplasm;chicken lymphoma;narrowmatch
gene abnormality;jak family gene mutation;narrowmatch
receptor tyrosine kinase gene mutation;pdgfr family gene mutation;narrowmatch
blasts 2 percent or more of bone marrow nucleated cells;blasts 5 percent or more of bone marrow nucleated cells;narrowmatch
gene product sequence variation;met protein variant;narrowmatch
feline experimental organism diagnosis;feline large granular lymphocyte lymphoma;narrowmatch
hamster neoplasm;hamster mammary carcinoma;narrowmatch
rat erythroid leukemia;rat erythroleukemia;narrowmatch
mouse erythroid leukemia;mouse erythroleukemia;narrowmatch
chromosome arm;7p;narrowmatch
chromosome arm;22q;narrowmatch
chromosome arm;2p;narrowmatch
chromosome arm;14q;narrowmatch
feline experimental organism diagnosis;feline reticulum cell sarcoma;narrowmatch
fish experimental organism diagnosis;fish melanoma;narrowmatch
galline experimental organism diagnosis;chicken neoplasm;narrowmatch
neoplastic plasma cells under 50 percent of bone marrow nucleated cells;neoplastic plasma cells 30 percent or less of bone marrow nucleated cells;narrowmatch
immunophenotypic finding;neoplastic cells with double expression of myc and bcl2 proteins present;narrowmatch
human chromosome;chromosome 5;narrowmatch
disease stage qualifier;binet stage;narrowmatch
deleterious mutation;deleterious homologous recombination pathway gene mutation;narrowmatch
homologous recombination repair gene mutation;deleterious homologous recombination pathway gene mutation;narrowmatch
gene abnormality;receptor tyrosine kinase gene mutation;narrowmatch
cytogenetic abnormality;chromosome 13 abnormality;narrowmatch
deleterious mutation;deleterious brca gene mutation;narrowmatch
dna repair gene mutation;deleterious brca gene mutation;narrowmatch
disease stage qualifier;st. jude stage;narrowmatch
disease stage qualifier;rai stage;narrowmatch
ajcc v8 stage;differentiated thyroid gland carcinoma under 55 years ajcc v8 stage;narrowmatch
disease stage qualifier;stage iie;narrowmatch
disease stage qualifier;stage ie;narrowmatch
disease stage qualifier;lugano stage;narrowmatch
disease stage qualifier;ann arbor stage;narrowmatch
disease stage qualifier;ensat stage;narrowmatch
protein binding domain;ankyrin repeat;narrowmatch
ajcc v8 stage;differentiated thyroid gland carcinoma 55 years and older ajcc v8 stage;narrowmatch
gene abnormality;ccaat enhancer binding protein gene mutation;narrowmatch
blasts less than 50 percent of bone marrow nucleated cells;blasts 30 percent or less of bone marrow nucleated cells;narrowmatch
blasts 2 percent or more of peripheral blood white cells;blasts 5 percent or more of peripheral blood white cells;narrowmatch
negative test result;epstein-barr virus negative;narrowmatch
anatomy qualifier;myoepithelial;narrowmatch
disease morphology qualifier;mucinous;narrowmatch
histologic grade;moderately differentiated;narrowmatch
histologic grade;low grade;narrowmatch
disease morphology qualifier;invasive;narrowmatch
histologic grade;high grade;narrowmatch
disease morphology qualifier;anaplastic;narrowmatch
disease morphology qualifier;malignant;narrowmatch
chromosome 12 abnormality;ddit3 gene rearrangement;narrowmatch
gene rearrangement abnormality;ddit3 gene rearrangement;narrowmatch
disease stage qualifier;riss stage;narrowmatch
experimental organism neoplasm by organism;porcine leukemia;narrowmatch
cell part;cell structure;narrowmatch
stage iva;stage iva2;narrowmatch
microanatomic structure;macromolecular structure;narrowmatch
ajcc v7 stage;differentiated thyroid gland carcinoma 45 years and older ajcc v7 stage;narrowmatch
ajcc v7 stage;differentiated thyroid gland carcinoma under 45 years ajcc v7 stage;narrowmatch
laboratory test result;psa level finding;narrowmatch
abnormal cells present;superficial monoclonal gastrointestinal tract t-cell infiltrate present;narrowmatch
blast cells increased in bone marrow;blasts 50 percent or less of bone marrow nucleated cells;narrowmatch
fusion gene;cic/dux4 fusion gene;narrowmatch
malignant neoplasm of multiple primary sites;malignant neoplasm of lung - multiple primary sites;narrowmatch
disease stage qualifier;breast cancer prognostic stage;narrowmatch
disease stage qualifier;breast cancer anatomic stage;narrowmatch
protein domain;egf-like domain;narrowmatch
lesion;acral lesion;narrowmatch
chromosomal rearrangement;rearrangement of 6p25.3;narrowmatch
amino acid sequence;nuclear localization signal;narrowmatch
lesion;breast implant-related lesion;narrowmatch
immunophenotypic finding;neoplastic cells with tfh cell phenotype present;narrowmatch
disease stage qualifier;international staging system stage;narrowmatch
disease stage qualifier;durie/salmon stage;narrowmatch
high risk myelodysplastic syndrome;refractory high risk myelodysplastic syndrome;narrowmatch
high risk myelodysplastic syndrome;recurrent high risk myelodysplastic syndrome;narrowmatch
myeloid neoplasm finding;high risk myelodysplastic syndrome;narrowmatch
expression positive;cd8 positive;narrowmatch
activating raf mutation;activating braf mutation;narrowmatch
braf gene mutation;activating braf mutation;narrowmatch
activating ras mutation;activating hras mutation;narrowmatch
ligand binding domain;gtp binding domain;narrowmatch
ligand binding domain;dag/pe-binding domain;narrowmatch
substrate interaction domain;tyrosine kinase domain;narrowmatch
ligand binding domain;substrate interaction domain;narrowmatch
cell structure;cellular membrane;narrowmatch
progressive central nervous system neoplasm;progressive disease in neuroblastoma;narrowmatch
protein domain;walker-a motif;narrowmatch
protein binding domain;brct domain;narrowmatch
disease stage qualifier;whitmore-jewett stage;narrowmatch
chromosome band;2p12;narrowmatch
stage iiia;stage iiia2;narrowmatch
stage iiia;stage iiia1;narrowmatch
epithelial cell junction;anchoring junction;narrowmatch
cell part;cell junction;narrowmatch
hras gene mutation;activating hras mutation;narrowmatch
mouse salivary gland neoplasms;mouse submandibular gland neoplasm;narrowmatch
mouse adrenal gland neoplasms;mouse adrenal gland pheochromocytoma;narrowmatch
experimental organism neoplasm by organism;marmoset lymphoma;narrowmatch
lymphoid tissue;germinal center;narrowmatch
gene variant;ptch1 gene mutation;narrowmatch
hedgehog pathway mutation;ptch1 gene mutation;narrowmatch
chromosome structure;chromosome arm;narrowmatch
gene rearrangement abnormality;irf4 gene rearrangement;narrowmatch
gene product sequence variation;alk protein variant;narrowmatch
cancer tnm finding category;postneoadjuvant therapy pathologic tnm finding;narrowmatch
protein binding domain;sh2 domain;narrowmatch
tissue;ocular tissue;narrowmatch
hamster neoplasm;hamster melanoma;narrowmatch
mitochondrial membrane;inner mitochondrial membrane;narrowmatch
endoplasmic reticulum;rough endoplasmic reticulum;narrowmatch
organ;gland;narrowmatch
stratified epithelium;transitional epithelium;narrowmatch
hair part;hair follicle;narrowmatch
chromosomal rearrangement;gene rearrangement abnormality;narrowmatch
gene abnormality;gene rearrangement abnormality;narrowmatch
chromosomal translocation;11q translocation;narrowmatch
rearrangement of 11q;11q translocation;narrowmatch
dna repair gene mutation;homologous recombination repair gene mutation;narrowmatch
gene variant;rb1 gene mutation;narrowmatch
rabbit neoplasm;rabbit uterine carcinoma;narrowmatch
chromosome arm;7q;narrowmatch
protein structure;protein domain;narrowmatch
nuclear structure;chromosome structure;narrowmatch
rabbit neoplasm;rabbit cutaneous lymphoma;narrowmatch
rabbit neoplasm;rabbit fibroma;narrowmatch
rabbit neoplasm;rabbit oral cavity squamous cell carcinoma;narrowmatch
rabbit neoplasm;rabbit plasmacytoma;narrowmatch
primary amyloidosis;recurrent primary amyloidosis;narrowmatch
recurrent plasma cell neoplasm;recurrent primary amyloidosis;narrowmatch
recurrent primary malignant neoplasm;recurrent primary amyloidosis;narrowmatch
transferase gene;ubiquitin-transferase gene;narrowmatch
dna repair gene mutation;mismatch repair gene mutation;narrowmatch
gene variant;sf3b1 gene mutation;narrowmatch
gene rearrangement abnormality;tfe3 gene rearrangement;narrowmatch
hamster neoplasm;hamster pancreatic ductal adenocarcinoma;narrowmatch
macromolecular structure;protein structure;narrowmatch
mouse thyroid neoplasm;hemangioendothelioma of the mouse thyroid gland;narrowmatch
disease stage qualifier;ajcc v8 stage;narrowmatch
embryonic structure or system;embryonic structure;narrowmatch
canine neoplasm;canine soft tissue sarcoma;narrowmatch
canine neoplasm;canine thyroid adenocarcinoma;narrowmatch
feline experimental organism diagnosis;feline mammary carcinoma;narrowmatch
nonmembranous cytoplasmic organelle;cytoskeleton;narrowmatch
cell structure;cytoplasm;narrowmatch
human chromosome;chromosome 9;narrowmatch
loss of heterozygosity;chromosome arm 9p loss of heterozygosity;narrowmatch
chromosome structure;telomere;narrowmatch
loss of heterozygosity;chromosome arm 3p loss of heterozygosity;narrowmatch
human chromosome;chromosome 8;narrowmatch
human chromosome;chromosome 7;narrowmatch
gene abnormality;ras family gene mutation;narrowmatch
cdkn2a-p16 status;cdkn2a-p16 negative;narrowmatch
cdkn2a negative;cdkn2a-p16 negative;narrowmatch
human chromosome;chromosome 6;narrowmatch
membranous cytoplasmic organelle;endoplasmic reticulum;narrowmatch
anatomic structure, system, or substance;body fluid or substance;narrowmatch
cytoskeleton filament;microtubule;narrowmatch
membranous cytoplasmic organelle;mitochondrion;narrowmatch
zinc-binding, dna-binding motif;c2h2 zinc finger;narrowmatch
genetic finding;unmethylated mgmt gene promoter;narrowmatch
human chromosome;chromosome y;narrowmatch
human chromosome;chromosome x;narrowmatch
feline experimental organism diagnosis;feline osteosarcoma;narrowmatch
feline experimental organism diagnosis;feline oral squamous cell carcinoma;narrowmatch
canine neoplasm;canine oral squamous cell carcinoma;narrowmatch
cell structure;subcellular structure;narrowmatch
male genital system fluid or secretion;semen;narrowmatch
nonmembranous cytoplasmic organelle;ribosome;narrowmatch
extraembryonic structure;placenta;narrowmatch
chromosomal translocation;"t(9;22)(q34.1;q11.2)";narrowmatch
cell part;cytoplasmic organelle;narrowmatch
cell part;nucleosome;narrowmatch
intracellular membrane;nuclear membrane;narrowmatch
chromosomal translocation;"t(8;21)(q22;q22)";narrowmatch
rearrangement of 21q;"t(8;21)(q22;q22)";narrowmatch
macromolecular structure;dna structure;narrowmatch
gerbil experimental organism diagnosis;gerbil fibrosarcoma;narrowmatch
mouse neoplasms;mouse rectum carcinoma;narrowmatch
equine experimental organism diagnosis;horse lymphoma;narrowmatch
hamster neoplasm;hamster lymphosarcoma;narrowmatch
hamster neoplasm;hamster lymphoma;narrowmatch
hamster neoplasm;hamster kidney tumor;narrowmatch
experimental organism neoplasm by organism;gibbon lymphosarcoma;narrowmatch
gerbil experimental organism diagnosis;gerbil melanoma;narrowmatch
experimental organism neoplasm by organism;frog pronephric kidney tumor;narrowmatch
protein domain;transmembrane domain;narrowmatch
feline experimental organism diagnosis;feline erythroleukemia;narrowmatch
experimental organism neoplasm by organism;duck neoplasm;narrowmatch
bovine neoplasm;bovine rectal myxoma;narrowmatch
bovine neoplasm;bovine lymphosarcoma;narrowmatch
experimental organism neoplasm by organism;baboon lymphoma;narrowmatch
experimental organism diagnosis;experimental organism neoplasm;narrowmatch
fish melanoma;xiphophorus melanoma;narrowmatch
mouse neoplasms;mouse reticulum cell sarcoma;narrowmatch
experimental organism neoplasm by organism;ovine sinus tumor;narrowmatch
experimental organism neoplasm by organism;rhesus monkey lymphoma;narrowmatch
experimental organism neoplasm by organism;rhesus monkey mammary tumor;narrowmatch
hamster neoplasm;hamster chondrosarcoma;narrowmatch
canine neoplasm;canine acanthomatous epulis;narrowmatch
experimental organism neoplasm by organism;bat skin tumor;narrowmatch
experimental organism neoplasm by organism;suncus murinus mammary tumor;narrowmatch
experimental organism neoplasm by organism;quail fibrosarcoma;narrowmatch
fish experimental organism diagnosis;pike sarcoma;narrowmatch
mouse endocrine gland system neoplasms;mouse leydig cell tumor;narrowmatch
hamster neoplasm;hamster insulinoma;narrowmatch
chicken neoplasm;chicken monocytic leukemia;narrowmatch
canine neoplasm;canine pancreatic carcinoma;narrowmatch
experimental organism neoplasm by organism;budgerigar fibrosarcoma;narrowmatch
rat histopathology diagnoses for proliferative changes;rat neoplasms;narrowmatch
chromosome band;7q34;narrowmatch
experimental organism neoplasm by organism;porcine lymphoma;narrowmatch
experimental organism neoplasm by organism;zebra finch neoplasm;narrowmatch
experimental organism neoplasm by organism;xenopus neoplasm;narrowmatch
fish experimental organism diagnosis;rainbow trout hepatoma;narrowmatch
fish melanoma;medaka melanoma;narrowmatch
experimental organism neoplasm by organism;galline experimental organism diagnosis;narrowmatch
experimental organism neoplasm by organism;leporine experimental organism diagnosis;narrowmatch
ligand binding domain;metal binding site;narrowmatch
experimental organism neoplasm by organism;feline experimental organism diagnosis;narrowmatch
experimental organism neoplasm by organism;bovine neoplasm;narrowmatch
experimental organism neoplasm by organism;canine neoplasm;narrowmatch
raf family gene mutation;activating raf mutation;narrowmatch
gene variant;apc gene mutation;narrowmatch
subcellular structure;nuclear structure;narrowmatch
chromosome structure;gene feature;narrowmatch
qualifier;anatomy qualifier;narrowmatch
chromosome structure;chromosome band;narrowmatch
metal binding site;zinc-binding, dna-binding motif;narrowmatch
dna binding domain;zinc-binding, dna-binding motif;narrowmatch
ligand binding domain;protein binding domain;narrowmatch
ligand binding domain;dna binding domain;narrowmatch
experimental organism neoplasm;experimental organism neoplasm by organism;narrowmatch
experimental organism neoplasm by organism;equine experimental organism diagnosis;narrowmatch
fish experimental organism diagnosis;medaka hepatoma;narrowmatch
chicken neoplasm;chicken bursal lymphoma;narrowmatch
mouse neoplasms;mouse basal cell carcinoma;narrowmatch
equine experimental organism diagnosis;horse melanoma;narrowmatch
hamster neoplasm;hamster uterine leiomyosarcoma;narrowmatch
hamster neoplasm;hamster ductus deferens leiomyosarcoma;narrowmatch
hamster neoplasm;hamster cholangiocarcinoma;narrowmatch
hamster neoplasm;hamster buccal pouch carcinoma;narrowmatch
experimental organism neoplasm by organism;guinea pig leukemia;narrowmatch
experimental organism neoplasm by organism;guinea pig colon adenocarcinoma;narrowmatch
fish experimental organism diagnosis;goldfish erythrophoroma;narrowmatch
gerbil experimental organism diagnosis;gerbil fibroma;narrowmatch
feline experimental organism diagnosis;feline fibrosarcoma;narrowmatch
hematopoietic stem cell;bone marrow stem cell;narrowmatch
feline experimental organism diagnosis;feline bronchioloalveolar lung carcinoma;narrowmatch
chicken neoplasm;chicken hepatoma;narrowmatch
chicken neoplasm;chicken fibrosarcoma;narrowmatch
endocrine system part;anterior lobe of the pituitary gland;narrowmatch
peripheral nervous system part;peripheral nerve;narrowmatch
histologic grade;poorly differentiated;narrowmatch
fusion protein expression;ewsr1-creb1 fusion protein expression;narrowmatch
acute lymphoblastic leukemia by gene expression profile;ddit4l acute lymphoblastic leukemia;narrowmatch
acute lymphoblastic leukemia;acute lymphoblastic leukemia by gene expression profile;narrowmatch
central nervous system vascular malformation;meningioangiomatosis;narrowmatch
abnormal immunology test result;loss of ini 1 protein expression;narrowmatch
fusion gene;hey1/ncoa2 fusion gene;narrowmatch
connective tissue disorder;bone tumor of undefined neoplastic nature;narrowmatch
laboratory test result;no identifiable line of differentiation;narrowmatch
head and neck finding;nasal glial heterotopia;narrowmatch
gene variant;pten gene mutation;narrowmatch
fusion gene;wwtr1/camta1 fusion gene;narrowmatch
fusion protein expression;wwtr1-camta1 fusion protein expression;narrowmatch
mixture of morphologic patterns;mixture of embryonal and alveolar features present;narrowmatch
connective and soft tissue neoplasm (antiquated);non-cutaneous leiomyosarcoma;narrowmatch
rat endocrine system neoplasms;rat adrenal gland pheochromocytoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat neuroblastoma;narrowmatch
rat endocrine system neoplasms;rat insulinoma;narrowmatch
acute lymphoblastic leukemia by gene expression profile;acute lymphoblastic leukemia by rose cluster;narrowmatch
acute lymphoblastic leukemia by rose cluster;rose cluster 1;narrowmatch
acute lymphoblastic leukemia by rose cluster;rose cluster 2;narrowmatch
acute lymphoblastic leukemia by rose cluster;rose cluster 3;narrowmatch
leukemia finding;high risk acute leukemia;narrowmatch
radiologic finding;pulmonary nodule;narrowmatch
major salivary gland;sublingual salivary gland;narrowmatch
major salivary gland;submandibular gland;narrowmatch
head and neck part;uvula;narrowmatch
head and neck part;soft palate;narrowmatch
head and neck part;hard palate;narrowmatch
head and neck part;palate;narrowmatch
organ of special sense part;base of the tongue;narrowmatch
head and neck part;lip;narrowmatch
acute lymphoblastic leukemia by rose cluster;rose cluster 8;narrowmatch
acute lymphoblastic leukemia by rose cluster;rose cluster 7;narrowmatch
acute lymphoblastic leukemia by rose cluster;rose cluster 6;narrowmatch
acute lymphoblastic leukemia by rose cluster;rose cluster 5;narrowmatch
acute lymphoblastic leukemia by rose cluster;rose cluster 4;narrowmatch
fus gene translocation;"t(11;16)(p11;p11)";narrowmatch
fusion gene;myh9/usp6 fusion gene;narrowmatch
body region;cervical esophagus;narrowmatch
head and neck disorder;otolaryngologic disorder;narrowmatch
experimental organism neoplasm;experimental organism benign ganglioglioma;narrowmatch
experimental organism neoplasm;experimental organism malignant astrocytoma;narrowmatch
eye finding;exophthalmos;narrowmatch
sign or symptom;exophthalmos;narrowmatch
in-transit metastasis;cutaneous melanoma in-transit metastasis;narrowmatch
metastasis;satellite tumor;narrowmatch
protein family;catenin family protein;narrowmatch
gene variant;vhl gene mutation;narrowmatch
11q translocation;"t(11;16)(q13;p13)";narrowmatch
gene variant;tsc2 gene mutation;narrowmatch
gene variant;tsc1 gene mutation;narrowmatch
gene variant;pms2 gene mutation;narrowmatch
mismatch repair gene mutation;pms2 gene mutation;narrowmatch
gene variant;tp53 gene mutation;narrowmatch
gene variant;msh6 gene mutation;narrowmatch
mismatch repair gene mutation;msh6 gene mutation;narrowmatch
experimental organism neoplasm;experimental organism malignant oligodendroglioma;narrowmatch
chromosomal inversion;inv(16);narrowmatch
hemorrhage;digestive system hemorrhage;narrowmatch
digestive system signs and symptoms;digestive system hemorrhage;narrowmatch
fusion protein expression;c11orf95-mkl2 fusion protein expression;narrowmatch
canine neoplasm;canine melanoma;narrowmatch
metastasis;direct extension;narrowmatch
endocrine system finding;virilization;narrowmatch
chromosomal translocation;"t(10;19)(q26;q13)";narrowmatch
cic gene rearrangement;"t(10;19)(q26;q13)";narrowmatch
chromosomal translocation;"t(4;19)(q35;q13)";narrowmatch
cic gene rearrangement;"t(4;19)(q35;q13)";narrowmatch
fusion protein expression;cic-dux4l fusion protein expression;narrowmatch
fusion protein expression;cic-dux4 fusion protein expression;narrowmatch
hereditary colorectal cancer syndrome;hereditary nonpolyposis colorectal cancer syndrome;narrowmatch
canine neoplasm;canine osteosarcoma;narrowmatch
adenocarcinoma of the mouse intestinal tract;mouse colon adenocarcinoma;narrowmatch
neuropathy;peripheral neuropathy;narrowmatch
peripheral nervous system disorder;peripheral neuropathy;narrowmatch
head and neck part;hypopharynx;narrowmatch
body region;thoracic esophagus;narrowmatch
mismatch repair gene mutation;mlh1 gene mutation;narrowmatch
smooth muscle tissue;myometrium;narrowmatch
urinary system part;dome of the bladder;narrowmatch
organ;spermatic cord;narrowmatch
organ;epididymis;narrowmatch
testicular non-neoplastic disorder;undescended testes;narrowmatch
female reproductive system part;appendage of the uterus;narrowmatch
uterine ligament;broad ligament;narrowmatch
female reproductive system part;corpus uteri;narrowmatch
mucosa;endometrium;narrowmatch
ear part;external ear;narrowmatch
female reproductive system part;cervix uteri;narrowmatch
female reproductive system part;ectocervix;narrowmatch
female reproductive system part;endocervix;narrowmatch
female reproductive system part;clitoris;narrowmatch
labium;labium minus;narrowmatch
labium;labium majus;narrowmatch
breast part;nipple;narrowmatch
bladder wall;lateral wall of the bladder;narrowmatch
morphologic finding;invasive focus of carcinoma cells measuring more than 5 mm present;narrowmatch
urinary system part;ureteric orifice;narrowmatch
exocrine gland;urethral gland;narrowmatch
brain part;temporal lobe;narrowmatch
brain part;frontal lobe;narrowmatch
brain part;cerebral hemisphere;narrowmatch
meninges;spinal meninges;narrowmatch
meninges;cerebral meninges;narrowmatch
membrane of the brain or spinal cord;meninges;narrowmatch
body cavity;orbit;narrowmatch
head and neck part;lacrimal gland;narrowmatch
exocrine gland;lacrimal gland;narrowmatch
eye part;ciliary body;narrowmatch
membrane;choroid;narrowmatch
eye part;retina;narrowmatch
eye part;cornea;narrowmatch
eye appendage;conjunctiva;narrowmatch
mucosa;conjunctiva;narrowmatch
body region;retroperitoneum;narrowmatch
jaw bone;mandible;narrowmatch
body region;abdominal esophagus;narrowmatch
digestive system part;pylorus;narrowmatch
rearrangement of 11q;mll gene rearrangement;narrowmatch
11q23 abnormality;mll gene rearrangement;narrowmatch
gene rearrangement abnormality;mll gene rearrangement;narrowmatch
infantile lesion;neonatal lesion;narrowmatch
childhood lesion;infantile lesion;narrowmatch
hematopoietic system finding;bone marrow and extramedullary involvement;narrowmatch
bone marrow and extramedullary involvement;extramedullary involvement;narrowmatch
digestive system part;antrum pylori;narrowmatch
irregular bone;mandible;narrowmatch
digestive system part;body of stomach;narrowmatch
digestive system part;fundus of the stomach;narrowmatch
digestive system part;gastric cardia;narrowmatch
fusion gene;dnajb1/prkaca fusion gene;narrowmatch
body region;lower third of the esophagus;narrowmatch
body region;middle third of the esophagus;narrowmatch
body region;upper third of the esophagus;narrowmatch
digestive system part;duodenum;narrowmatch
diverticulum;meckel diverticulum;narrowmatch
digestive system finding;meckel diverticulum;narrowmatch
digestive system part;ascending colon;narrowmatch
fusion gene;nab2/stat6 fusion gene;narrowmatch
head and neck part;subglottis;narrowmatch
head and neck part;supraglottis;narrowmatch
canine neoplasm;canine hemangiosarcoma;narrowmatch
paranasal sinus;sphenoid sinus;narrowmatch
paranasal sinus;frontal sinus;narrowmatch
paranasal sinus;ethmoid sinus;narrowmatch
paranasal sinus;maxillary sinus;narrowmatch
ear part;middle ear;narrowmatch
duct;pancreatic duct;narrowmatch
gene rearrangement abnormality;nup98 gene rearrangement;narrowmatch
chromosomal translocation;"t(7;12)(q36;p13)";narrowmatch
etv6 gene rearrangement;"t(7;12)(q36;p13)";narrowmatch
chromosome 7 rearrangement;"t(7;12)(q36;p13)";narrowmatch
digestive system part;descending colon;narrowmatch
gene variant;mlh1 gene mutation;narrowmatch
gene variant;idh2 gene mutation;narrowmatch
nerve;peripheral nerve;narrowmatch
polymerase gene;pold1 gene;narrowmatch
malignant neoplasms of the mouse intestinal tract;metastatic carcinoma of the mouse intestinal tract;narrowmatch
benign neoplasms of the mouse intestinal tract;serrated lesion of the mouse intestinal tract;narrowmatch
adenocarcinoma of the mouse intestinal tract;intramucosal carcinoma of the mouse intestinal tract;narrowmatch
gene product sequence variation;pdgfra protein variant;narrowmatch
protein tyrosine phosphatase;non-receptor type protein tyrosine phosphatase;narrowmatch
aneuploidy;hyperploidy;narrowmatch
polymerase gene;pole gene;narrowmatch
sign or symptom;absence of signs or symptoms;narrowmatch
intermediate filament gene;krt5 gene;narrowmatch
intermediate filament gene;krt17 gene;narrowmatch
decreased expression;claudin-low;narrowmatch
genetic finding;claudin-low;narrowmatch
gene product sequence variation;jak2 protein variant;narrowmatch
braf protein variant;braf np_004324.2:p.v600x;narrowmatch
fusion gene;cbfa2t3/glis2 fusion gene;narrowmatch
fusion gene;mnx1/etv6 fusion gene;narrowmatch
connective and soft tissue finding;musculoskeletal finding;narrowmatch
connective and soft tissue injury;musculoskeletal injury;narrowmatch
uveal melanoma;uveal melanoma by gene expression profile;narrowmatch
aneuploidy;minimal aneuploidy;narrowmatch
transport protein gene;atp1a1 gene;narrowmatch
translocase gene;atp1a1 gene;narrowmatch
morphologic finding;paneth cell-like change;narrowmatch
duct;branch duct;narrowmatch
fusion gene;tmprss2/ets family fusion gene;narrowmatch
endogenous cushing syndrome;cushing disease;narrowmatch
experimental organism neoplasm;experimental organism benign seminoma;narrowmatch
non-neoplastic vascular disorder;vascular malformation;narrowmatch
congenital cardiovascular abnormality;vascular malformation;narrowmatch
protein or riboprotein complex;succinate dehydrogenase;narrowmatch
chromosomal inversion;inv(3);narrowmatch
glioblastoma;glioblastoma by gene expression profile;narrowmatch
experimental organism neoplasm;experimental organism basal cell carcinoma;narrowmatch
experimental organism neoplasm;experimental organism basal cell adenoma;narrowmatch
electrocardiographic finding;arrhythmia by ecg finding;narrowmatch
fusion gene;nup98/kdm5a fusion gene;narrowmatch
erbb receptor family protein;egfr gene product;narrowmatch
transport protein gene;atp2b3 gene;narrowmatch
fusion gene;nono/tfe3 fusion gene;narrowmatch
adaptor signaling protein gene;ywhae gene;narrowmatch
transcription repressor/corepressor gene;bcor gene;narrowmatch
fusion gene;tpm4/alk fusion gene;narrowmatch
fusion gene;tpm3/alk fusion gene;narrowmatch
fusion gene;tfg/alk fusion gene;narrowmatch
fusion gene;npm1/rara long fusion gene;narrowmatch
fusion gene;npm1/rara short fusion gene;narrowmatch
fusion gene;msn/alk fusion gene;narrowmatch
mature t-lymphocyte;effector t-lymphocyte;narrowmatch
fusion gene;mll/ell fusion gene;narrowmatch
fusion gene;fus/creb3l1 fusion gene;narrowmatch
fusion gene;has2/plag1 fusion gene;narrowmatch
fusion gene;col1a2/plag1 fusion gene;narrowmatch
fusion gene;cbfb/myh11 fusion gene;narrowmatch
clinical course of disease;metastatic/recurrent disease;narrowmatch
fusion gene;bcr/jak2 fusion gene;narrowmatch
non-neoplastic muscle disorder;myopathy;narrowmatch
expression positive;hormone receptor positive;narrowmatch
receptor status;hormone receptor positive;narrowmatch
transcription regulation gene;camta1 gene;narrowmatch
non-neoplastic hematologic and lymphocytic disorder;congenital hematological disorder;narrowmatch
microfilament gene;actb gene;narrowmatch
experimental organism neoplasm;experimental organism malignant hibernoma;narrowmatch
experimental organism neoplasm;experimental organism malignant hepatocholangiocellular carcinoma;narrowmatch
experimental organism neoplasm;experimental organism benign bone osteofibroma;narrowmatch
experimental organism neoplasm;experimental organism benign basalioma;narrowmatch
necrotic change;ischemic necrosis;narrowmatch
laboratory test result;genetic finding;narrowmatch
congenital genitourinary abnormality;congenital reproductive system abnormality;narrowmatch
non-neoplastic reproductive system disorder;congenital reproductive system abnormality;narrowmatch
blood vessel;great blood vessel;narrowmatch
neoplasm by special category;miscellaneous neoplasm;narrowmatch
hyperplasia;lymphoid hyperplasia;narrowmatch
gene variant;palb2 gene mutation;narrowmatch
fanconi anemia complementation group gene mutation;palb2 gene mutation;narrowmatch
translocase gene;atp2b3 gene;narrowmatch
ion channel protein gene;cacna1d gene;narrowmatch
idh gene family mutation;idh2 gene mutation;narrowmatch
untreated childhood glioblastoma;untreated childhood gliosarcoma;narrowmatch
untreated childhood low grade astrocytic tumor;untreated childhood subependymal giant cell astrocytoma;narrowmatch
untreated childhood diffuse astrocytoma;untreated childhood protoplasmic astrocytoma;narrowmatch
untreated central nervous system neoplasm;untreated childhood pleomorphic xanthoastrocytoma;narrowmatch
untreated central nervous system neoplasm;untreated childhood pilomyxoid astrocytoma;narrowmatch
untreated childhood low grade astrocytic tumor;untreated childhood pilocytic astrocytoma;narrowmatch
untreated central nervous system neoplasm;untreated childhood oligodendroglioma;narrowmatch
untreated central nervous system neoplasm;untreated childhood oligoastrocytoma;narrowmatch
untreated central nervous system neoplasm;untreated childhood gliomatosis cerebri;narrowmatch
untreated childhood high grade astrocytic tumor;untreated childhood anaplastic astrocytoma;narrowmatch
untreated childhood high grade astrocytic tumor;untreated childhood glioblastoma;narrowmatch
untreated childhood glioblastoma;untreated childhood giant cell glioblastoma;narrowmatch
untreated childhood diffuse astrocytoma;untreated childhood gemistocytic astrocytoma;narrowmatch
untreated childhood diffuse astrocytoma;untreated childhood fibrillary astrocytoma;narrowmatch
untreated childhood low grade astrocytic tumor;untreated childhood diffuse astrocytoma;narrowmatch
untreated central nervous system neoplasm;untreated childhood cerebral astrocytoma;narrowmatch
untreated central nervous system neoplasm;untreated childhood anaplastic oligodendroglioma;narrowmatch
untreated central nervous system neoplasm;untreated childhood supratentorial primitive neuroectodermal tumor;narrowmatch
experimental organism neoplasm;experimental organism malignant neuromyoblastoma;narrowmatch
experimental organism neoplasm;experimental organism benign acinar-islet cell tumor;narrowmatch
non-neoplastic central nervous system disorder;movement disorder;narrowmatch
gene variant;nf1 gene mutation;narrowmatch
gene variant;men1 gene mutation;narrowmatch
receptor tyrosine kinase gene amplification;fgfr gene amplification;narrowmatch
gene amplification abnormality;fgf gene amplification;narrowmatch
non-neoplastic soft tissue disorder;non-neoplastic muscle disorder;narrowmatch
non-neoplastic musculoskeletal disorder;non-neoplastic muscle disorder;narrowmatch
experimental organism neoplasm;experimental organism benign keratoacanthoma;narrowmatch
organ;tracheobronchial tree;narrowmatch
reproductive system finding;female reproductive system finding;narrowmatch
reproductive system finding;male reproductive system finding;narrowmatch
progressive neoplastic disease;extranodal involvement;narrowmatch
idh2 protein variant;idh2 np_002159.2:p.r172x;narrowmatch
gene product sequence variation;idh2 protein variant;narrowmatch
neoplasm by special category;liquid tumor;narrowmatch
cystic hygroma;congenital cystic hygroma;narrowmatch
untreated central nervous system neoplasm;untreated childhood anaplastic oligoastrocytoma;narrowmatch
progressive clinical course;slowly progressive clinical course;narrowmatch
experimental organism neoplasm;experimental organism islet cell adenoma neoplasm;narrowmatch
neoplastic plasma cell;circulating plasma cell;narrowmatch
l2 acute lymphoblastic leukemia;adult l2 acute lymphoblastic leukemia;narrowmatch
adult non-t non-b acute lymphoblastic leukemia;non-t non-b calla negative adult acute lymphoblastic leukemia;narrowmatch
childhood non-t non-b acute lymphoblastic leukemia;non-t non-b calla negative childhood acute lymphoblastic leukemia;narrowmatch
leukemia (antiquated);childhood non-t non-b acute lymphoblastic leukemia;narrowmatch
leukemia (antiquated);adult non-t non-b acute lymphoblastic leukemia;narrowmatch
l2 acute lymphoblastic leukemia;childhood l2 acute lymphoblastic leukemia;narrowmatch
l1 acute lymphoblastic leukemia;childhood l1 acute lymphoblastic leukemia;narrowmatch
experimental organism neoplasm;experimental organism benign nephroblastoma neoplasm;narrowmatch
urethra part;distal urethra;narrowmatch
experimental organism neoplasm;experimental organism benign thymoma neoplasm;narrowmatch
experimental organism neoplasm;experimental organism benign teratoma neoplasm;narrowmatch
experimental organism neoplasm;experimental organism benign stromal tumor neoplasm;narrowmatch
experimental organism neoplasm;experimental organism lymphosarcoma neoplasm;narrowmatch
experimental organism neoplasm;experimental organism mixed lymphoma neoplasm;narrowmatch
experimental organism neoplasm;experimental organism histiocytic lymphoma neoplasm;narrowmatch
experimental organism neoplasm;experimental organism acidophil carcinoma;narrowmatch
tdt positive acute lymphoblastic leukemia;adult tdt positive acute lymphoblastic leukemia;narrowmatch
tdt positive acute lymphoblastic leukemia;childhood tdt positive acute lymphoblastic leukemia;narrowmatch
tdt negative acute lymphoblastic leukemia;adult tdt negative acute lymphoblastic leukemia;narrowmatch
tdt negative acute lymphoblastic leukemia;childhood tdt negative acute lymphoblastic leukemia;narrowmatch
urethra part;proximal urethra;narrowmatch
newly diagnosed disease;newly diagnosed childhood ependymoma;narrowmatch
untreated central nervous system neoplasm;untreated childhood pineoblastoma;narrowmatch
disease stage qualifier;bclc stage;narrowmatch
nervous system finding;untreated central nervous system neoplasm;narrowmatch
untreated central nervous system neoplasm;untreated childhood high grade astrocytic tumor;narrowmatch
untreated central nervous system neoplasm;untreated childhood low grade astrocytic tumor;narrowmatch
malignant cellular infiltrate;leukemic infiltration of brain;narrowmatch
body region;jaw region;narrowmatch
lytic metastatic bone lesion;osteolytic lesions of multiple myeloma;narrowmatch
non-neoplastic urinary system disorder;urolithiasis;narrowmatch
non-neoplastic kidney disorder;nephrolithiasis;narrowmatch
urolithiasis;nephrolithiasis;narrowmatch
pre-b acute lymphoblastic leukemia;adult pre-b acute lymphoblastic leukemia;narrowmatch
connective and soft tissue neoplasm (antiquated);mixed osteosarcoma;narrowmatch
brain part;parietal lobe;narrowmatch
brain part;occipital lobe;narrowmatch
brain part;brain ventricle;narrowmatch
supporting cell of the nervous system;glial cell;narrowmatch
neuron, neuroepithelial cell, and supporting cell of the nervous system;neuron;narrowmatch
dendritic cell;follicular dendritic cell;narrowmatch
cell;antigen presenting cell;narrowmatch
perineural cell;schwann cell;narrowmatch
connective and soft tissue cell;schwann cell;narrowmatch
glial cell;oligodendrocyte;narrowmatch
neuroepithelial cell;glial cell;narrowmatch
connective and soft tissue cell;muscle cell;narrowmatch
spermatogenic cell;spermatozoon;narrowmatch
endocrine-stromal cell;leydig cell;narrowmatch
experimental organism neoplasm;experimental organism malignant renal mesenchymal tumor;narrowmatch
experimental organism neoplasm;experimental organism malignant neuroendocrine cell tumor;narrowmatch
experimental organism neoplasm;experimental organism benign neuroendocrine cell tumor;narrowmatch
experimental organism neoplasm;experimental organism benign mixed mullerian tumor;narrowmatch
experimental organism neoplasm;experimental organism benign mixed sertoli-leydig cell tumor;narrowmatch
epithelial tissue;islet of langerhans;narrowmatch
axon;myelinated nerve fiber;narrowmatch
neuron;sensory neuron;narrowmatch
abnormal tissue present;dilated cystic spaces present;narrowmatch
sensory neuron;photoreceptor cell;narrowmatch
blood vessel;aorta;narrowmatch
endocrine gland;adrenal gland;narrowmatch
cranial nerve;abducens nerve;narrowmatch
body cavity;abdomen;narrowmatch
cell;stem cell;narrowmatch
neoplastic large lymphocyte;reed-sternberg cell;narrowmatch
antigen presenting cell;phagocytic cell;narrowmatch
connective and soft tissue cell;pericyte;narrowmatch
neural crest-derived cell;apud cell;narrowmatch
signaling protein;gnas gene product;narrowmatch
regulatory gene;c11orf95 gene;narrowmatch
ganglion cell;retinal ganglion cell;narrowmatch
stromal change;prominent stromal reaction;narrowmatch
non-neoplastic peritoneal disorder;peritoneal gliomatosis;narrowmatch
retinal ganglion cell;photoreceptor cell;narrowmatch
abnormal cell;giant cell;narrowmatch
cell;zygote;narrowmatch
blood vessel;arteriole;narrowmatch
laboratory test result;pathology result;narrowmatch
connective and soft tissue cell;theca cell;narrowmatch
connective and soft tissue cell;stromal cell;narrowmatch
bone cell;osteoblast;narrowmatch
histiocytic and dendritic cell;histiocyte;narrowmatch
macrophage;histiocyte;narrowmatch
connective and soft tissue cell;histiocyte;narrowmatch
abnormal macrophage;foam cell;narrowmatch
phagocytic cell;macrophage;narrowmatch
germ cell;oocyte;narrowmatch
cartilage cell;chondrocyte;narrowmatch
connective and soft tissue cell;adipocyte;narrowmatch
cell;connective and soft tissue cell;narrowmatch
neural crest-derived cell;chromaffin cell;narrowmatch
myeloid cell;megakaryocyte;narrowmatch
bone marrow stem cell;bone marrow myeloid stem cell;narrowmatch
hematopoietic and lymphoid cell;hematopoietic stem cell;narrowmatch
endocrine-stromal cell;theca cell;narrowmatch
neuroendocrine cell;endocrine cell of the digestive system;narrowmatch
disease stage qualifier;figo stage;narrowmatch
endocrine cell of the digestive system;delta cell;narrowmatch
cell;germ cell;narrowmatch
endocrine-stromal cell;sertoli cell;narrowmatch
gastric glandular cell;parietal cell;narrowmatch
cell of the epidermis;melanocyte;narrowmatch
skin squamous cell;keratinocyte;narrowmatch
glandular cell;hepatocyte;narrowmatch
endocrine-stromal cell;granulosa cell;narrowmatch
glandular cell;enterocyte;narrowmatch
cell of the epidermis;langerhans cell;narrowmatch
dendritic cell;langerhans cell;narrowmatch
histiocytic and dendritic cell;dendritic cell;narrowmatch
antigen presenting cell;dendritic cell;narrowmatch
tooth cell;ameloblast;narrowmatch
epithelial cell;ameloblast;narrowmatch
cell;epithelial cell;narrowmatch
limb;upper extremity;narrowmatch
peripheral nervous system part;autonomic nervous system;narrowmatch
lymph node by anatomic site;head and neck lymph node;narrowmatch
cranial nerve;hypoglossal nerve;narrowmatch
vertebra;lumbar vertebra;narrowmatch
limb;lower extremity;narrowmatch
renal tissue;renal medulla;narrowmatch
renal tissue;renal cortex;narrowmatch
eye part;iris;narrowmatch
organ;intestine;narrowmatch
organ system;immune system;narrowmatch
heart part;cardiac ventricle;narrowmatch
peripheral nervous system part;ganglion;narrowmatch
heart part;cardiac atrium;narrowmatch
organ;heart;narrowmatch
body region;inguinal region;narrowmatch
organ;gonad;narrowmatch
head and neck part;glottis;narrowmatch
cranial nerve;glossopharyngeal nerve;narrowmatch
reproductive system;male reproductive system;narrowmatch
organ;lymph node;narrowmatch
hematopoietic and lymphatic system part;lymphatic system;narrowmatch
hematopoietic and lymphoid cell;mast cell;narrowmatch
body region;mediastinum;narrowmatch
body cavity;pelvis;narrowmatch
endocrine gland;parathyroid gland;narrowmatch
autonomic nervous system part;parasympathetic nervous system;narrowmatch
head and neck part;paranasal sinus;narrowmatch
sinus;paranasal sinus;narrowmatch
head and neck part;oropharynx;narrowmatch
cranial nerve;optic nerve;narrowmatch
eye part;optic disc;narrowmatch
cranial nerve;olfactory nerve;narrowmatch
cranial nerve;oculomotor nerve;narrowmatch
flat bone;occipital bone;narrowmatch
organ of special sense;nose;narrowmatch
organ system;nervous system;narrowmatch
organ system;musculoskeletal system;narrowmatch
tissue;membrane;narrowmatch
immunophenotypic finding;growth hormone and prolactin-producing neoplastic cells present;narrowmatch
congenital adrenal hyperplasia;macronodular adrenal hyperplasia;narrowmatch
body region;axilla;narrowmatch
spinal nerve plexus;brachial plexus;narrowmatch
venous sinus;cavernous sinus;narrowmatch
spinal nerve root;cauda equina;narrowmatch
cutaneous precancerous condition;epidermodysplasia verruciformis;narrowmatch
artery;carotid artery;narrowmatch
organ system;cardiovascular system;narrowmatch
cardiovascular system part;capillary;narrowmatch
respiratory system part;bronchus;narrowmatch
gene product sequence variation;kit protein variant;narrowmatch
cranial nerve;facial nerve;narrowmatch
secondary myelofibrosis;myelofibrosis transformation in essential thrombocythemia;narrowmatch
anatomic structure, system, or substance;body region;narrowmatch
cardiovascular system part;blood vessel;narrowmatch
organ;biliary tract;narrowmatch
abnormal tissue present;dedifferentiated malignant infiltrate;narrowmatch
bile duct;intrahepatic bile duct;narrowmatch
exocrine gland;bartholin gland;narrowmatch
vertebra;cervical vertebra;narrowmatch
brain part;choroid plexus;narrowmatch
spinal region;coccyx;narrowmatch
irregular bone;coccyx;narrowmatch
eye appendage;eyelid;narrowmatch
gland;exocrine gland;narrowmatch
epithelial tissue;epithelium;narrowmatch
head and neck part;epiglottis;narrowmatch
skin tissue;epidermis;narrowmatch
germinal layer;endoderm;narrowmatch
fusion gene;ywhae/fam22 fusion gene;narrowmatch
fusion protein expression;ywhae-fam22 fusion protein expression;narrowmatch
organ system;endocrine system;narrowmatch
chromosomal translocation;"t(10;17)(q22;p13)";narrowmatch
gland;endocrine gland;narrowmatch
germinal layer;ectoderm;narrowmatch
skin tissue;dermis;narrowmatch
nerve;cranial nerve;narrowmatch
extrahepatic bile duct;common bile duct;narrowmatch
stem cell;hematopoietic stem cell;narrowmatch
hematopoietic and lymphoid cell;myeloid cell;narrowmatch
cd8-positive t-lymphocyte;cytotoxic t-lymphocyte;narrowmatch
gonad;testis;narrowmatch
body region;head;narrowmatch
body region;head and neck;narrowmatch
organ;urethra;narrowmatch
organ;ureter;narrowmatch
organ;kidney;narrowmatch
organ;bladder;narrowmatch
organ system;urinary system;narrowmatch
exocrine gland;prostate gland;narrowmatch
reproductive system;female reproductive system;narrowmatch
organ;penis;narrowmatch
organ;vulva;narrowmatch
organ;vagina;narrowmatch
organ;uterus;narrowmatch
gonad;ovary;narrowmatch
appendage of the uterus;ovary;narrowmatch
organ;fallopian tube;narrowmatch
head and neck part;larynx;narrowmatch
body cavity;oral cavity;narrowmatch
organ of special sense;tongue;narrowmatch
head and neck part;nasopharynx;narrowmatch
body fluid or substance;blood;narrowmatch
organ;thymus gland;narrowmatch
organ;spleen;narrowmatch
organ;bone marrow;narrowmatch
body region;limb;narrowmatch
organ;trachea;narrowmatch
serous salivary gland;parotid gland;narrowmatch
major salivary gland;parotid gland;narrowmatch
exocrine gland;salivary gland;narrowmatch
experimental organism neoplasm by organism;woodchuck hepatocellular carcinoma;narrowmatch
rat neoplasms by morphology;rat malignant meningioma;narrowmatch
head and neck part;pharynx;narrowmatch
canine neoplasm;canine mammary carcinoma;narrowmatch
head and neck part;nasal cavity;narrowmatch
body cavity;nasal cavity;narrowmatch
appendage of the uterus;fallopian tube;narrowmatch
organ of special sense;eye;narrowmatch
effector t-lymphocyte;cytotoxic t-lymphocyte;narrowmatch
connective and soft tissue;connective tissue;narrowmatch
digestive system part;cecum;narrowmatch
digestive system part;appendix;narrowmatch
digestive system part;large intestine;narrowmatch
organ system;digestive system;narrowmatch
organ;gallbladder;narrowmatch
duct;bile duct;narrowmatch
digestive system part;anal canal;narrowmatch
skeletal system part;cartilage;narrowmatch
endocrine gland;thyroid gland;narrowmatch
blood vessel;artery;narrowmatch
striated muscle tissue;myocardium;narrowmatch
tissue;mammary gland tissue;narrowmatch
breast part;mammary gland;narrowmatch
exocrine gland;mammary gland;narrowmatch
skeletal system part;bone;narrowmatch
psa level finding;psa progression;narrowmatch
digestive system part;colon;narrowmatch
digestive system part;sigmoid colon;narrowmatch
digestive system part;transverse colon;narrowmatch
digestive system part;small intestine;narrowmatch
endocrine gland;pituitary gland;narrowmatch
endocrine gland;pineal gland;narrowmatch
neuroendocrine tissue;adrenal medulla;narrowmatch
adrenal gland tissue;adrenal medulla;narrowmatch
glandular epithelial tissue;adrenal cortex;narrowmatch
adrenal gland tissue;adrenal cortex;narrowmatch
organ of special sense;ear;narrowmatch
organ;pancreas;narrowmatch
organ;liver;narrowmatch
organ;stomach;narrowmatch
digestive system part;rectum;narrowmatch
organ;esophagus;narrowmatch
digestive system part;jejunum;narrowmatch
digestive system part;ileum;narrowmatch
abnormal cells present;malignant germinomatous cells present;narrowmatch
soft tissue;muscle tissue;narrowmatch
muscle tissue;striated muscle tissue;narrowmatch
muscle tissue;smooth muscle tissue;narrowmatch
skeletal system part;clivus;narrowmatch
oral mucosa;buccal mucosa;narrowmatch
mucosa;tympanic membrane;narrowmatch
ear part;inner ear;narrowmatch
ear part;external acoustic meatus;narrowmatch
skeletal system part;sella turcica;narrowmatch
skeletal system part;jugular foramen;narrowmatch
skeletal system part;foramen magnum;narrowmatch
skeletal system part;base of the skull;narrowmatch
nervous system part;central nervous system;narrowmatch
gain of chromosome 21;intrachromosomal amplification of chromosome 21;narrowmatch
abnormal cell;signet ring cell;narrowmatch
mature b-lymphocyte;plasma cell;narrowmatch
endocrine cell;neuroendocrine cell;narrowmatch
connective and soft tissue cell;fibroblast;narrowmatch
soft tissue;endothelium;narrowmatch
mouse carcinoma;mouse kidney carcinoma;narrowmatch
head and neck part;tooth;narrowmatch
microanatomic structure;cell;narrowmatch
brain part;infratentorial brain;narrowmatch
brain part;pons varolii;narrowmatch
mature t-lymphocyte;cd8-positive t-lymphocyte;narrowmatch
mouse plasma cell neoplasm;mouse plasma cell myeloma;narrowmatch
rat neoplasms by morphology;rat plasma cell myeloma;narrowmatch
rat neoplasms by morphology;rat malignant peripheral nerve sheath tumor;narrowmatch
mature t-lymphocyte;cd4-positive t-lymphocyte;narrowmatch
peripheral (post-thymic) t-lymphocyte and natural killer cell;natural killer cell;narrowmatch
hematopoietic and lymphoid cell;lymphocyte;narrowmatch
dysplastic erythroid precursor;megaloblast;narrowmatch
abnormal hematopoietic and lymphoid cell;abnormal red blood cell;narrowmatch
peripheral blood cell;erythrocyte;narrowmatch
peripheral blood cell;platelet;narrowmatch
hematopoietic and lymphoid cell;peripheral blood cell;narrowmatch
sagittal sinus;superior sagittal sinus;narrowmatch
venous sinus;sagittal sinus;narrowmatch
brain nucleus;supratentorial brain;narrowmatch
glandular epithelium;terminal ductal lobular unit;narrowmatch
mammary gland tissue;terminal ductal lobular unit;narrowmatch
glial cell;astrocyte;narrowmatch
experimental organism neoplasm;experimental organism glandular polyp;narrowmatch
experimental organism neoplasm;experimental organism malignant mesovarial leiomyoma;narrowmatch
experimental organism neoplasm;experimental organism benign epithelial stromal tumor;narrowmatch
experimental organism neoplasm;experimental organism malignant neuroepithelial carcinoma;narrowmatch
experimental organism neoplasm;experimental organism benign adenomyoepithelioma;narrowmatch
brain part;thalamus;narrowmatch
brain part;hypothalamus;narrowmatch
brain part;diencephalon;narrowmatch
general qualifier;discoloration;narrowmatch
cerebral white matter;corpus callosum;narrowmatch
brain part;cerebellum;narrowmatch
brain part;cerebral cortex;narrowmatch
brain part;medulla oblongata;narrowmatch
brain part;brain stem;narrowmatch
central nervous system part;brain;narrowmatch
organ;brain;narrowmatch
experimental organism neoplasm;experimental organism mesenchymal proliferative lesion;narrowmatch
experimental organism neoplasm;experimental organism malignant sarcoma arising from fibroadenoma;narrowmatch
t-lymphocyte and natural killer cell;t-lymphocyte;narrowmatch
experimental organism neoplasm;experimental organism benign mixed sex cord stromal tumor;narrowmatch
cell of the epidermis;skin basal cell;narrowmatch
epithelial cell;skin basal cell;narrowmatch
lymphocyte;b-lymphocyte;narrowmatch
membrane;synovial membrane;narrowmatch
soft tissue;synovial membrane;narrowmatch
soft tissue;adipose tissue;narrowmatch
connective and soft tissue;soft tissue;narrowmatch
organ;skin;narrowmatch
membrane;pleura;narrowmatch
organ;lung;narrowmatch
nervous system part;nerve;narrowmatch
nervous system part;peripheral nervous system;narrowmatch
central nervous system part;spinal cord;narrowmatch
organ;spinal cord;narrowmatch
experimental organism neoplasm;experimental organism malignant mixed sex cord stromal tumor;narrowmatch
disease morphology qualifier;papillary;narrowmatch
disease morphology qualifier;tubular;narrowmatch
benign mesenchymal neoplasms of the mouse skin;schwannoma of the mouse skin;narrowmatch
circulatory process;leukocyte trafficking;narrowmatch
gene;cancer gene;narrowmatch
biochemical process;metabolic process;narrowmatch
double strand break repair;recombination repair;narrowmatch
fos family gene;fos gene;narrowmatch
intellectual property;document;narrowmatch
record;document;narrowmatch
finding by cause;environmental and occupational exposure;narrowmatch
transformation;malignant conversion;narrowmatch
intermediary metabolic process;nucleotide metabolic process;narrowmatch
tumorigenesis;mammary tumorigenesis;narrowmatch
carcinogenesis;hepatocarcinogenesis;narrowmatch
chelating activity;metal ion binding;narrowmatch
cell cycle checkpoint;g1/s transition checkpoint;narrowmatch
intracellular transport;nucleocytoplasmic transport;narrowmatch
ligand binding;docking;narrowmatch
intermediary metabolic process;protein metabolism process;narrowmatch
tumor-associated process;tumor oxygenation;narrowmatch
cellular process;cell ontogeny;narrowmatch
cell cycle process;cell cycle regulation process;narrowmatch
dna repair;double strand break repair;narrowmatch
transcription regulation gene;swi/snf-related gene;narrowmatch
protein or riboprotein complex;mediator complex;narrowmatch
g1 phase process;negative regulation of g1 phase;narrowmatch
chromatin structural process;chromatin remodeling;narrowmatch
biochemical pathway;regulatory pathway;narrowmatch
disease progression;clonal evolution;narrowmatch
gene;dna repair gene;narrowmatch
tumor-associated process;angiogenic switch;narrowmatch
cell adhesion process;cell-cell adhesion process;narrowmatch
gene variant;brca2 gene mutation;narrowmatch
xrcc family gene mutation;brca2 gene mutation;narrowmatch
fanconi anemia complementation group gene mutation;brca2 gene mutation;narrowmatch
gene variant;brca1 gene mutation;narrowmatch
fanconi anemia complementation group gene mutation;brca1 gene mutation;narrowmatch
homologous recombination repair gene mutation;brca1 gene mutation;narrowmatch
intermediary metabolic process;lipid metabolic process;narrowmatch
pathologic process;cancer cell growth regulation;narrowmatch
protein metabolism process;post-translational regulation;narrowmatch
lymphocyte activation process;t-cell activation;narrowmatch
drug, food, chemical or biomedical material;drug or chemical by structure;narrowmatch
tumorigenesis;tumor promotion;narrowmatch
drug, food, chemical or biomedical material;pharmacologic substance;narrowmatch
gene regulation process;transcriptional regulation;narrowmatch
t-cell differentiation in the thymus;thymic t-cell selection;narrowmatch
intercellular communication process;t-cell receptor activation;narrowmatch
cell differentiation process;t-cell differentiation;narrowmatch
carcinogenesis;skin carcinogenesis;narrowmatch
cancer progression;cancer cell growth;narrowmatch
rna binding;rna-protein interaction;narrowmatch
gene expression process;rna synthesis;narrowmatch
environment-to-cell communication;receptor signaling;narrowmatch
drug, food, chemical or biomedical material;physiology-regulatory factor;narrowmatch
protein phosphorylation process;protein kinase protein phosphorylation;narrowmatch
gene expression process;protein expression;narrowmatch
molecular interaction process;protein-carbohydrate interaction;narrowmatch
multicellular process;environment-to-cell communication;narrowmatch
experimental model;in vitro model;narrowmatch
cancer progression;metastasis;narrowmatch
biochemical process;macromolecular sequence alteration process;narrowmatch
tumorigenesis;cancer cell growth;narrowmatch
tumorigenesis;b-lymphoma development;narrowmatch
cell proliferation;b cell proliferation;narrowmatch
organogenesis;neural development;narrowmatch
neovascularization;tumor angiogenesis;narrowmatch
post-translational modification;ubiquitination;narrowmatch
metabolic process;metabolic control;narrowmatch
post-transcriptional regulation;rna processing;narrowmatch
t-cell differentiation;t-cell differentiation in the thymus;narrowmatch
mutation abnormality;deletion mutation;narrowmatch
gene rearrangement abnormality;deletion mutation;narrowmatch
physiology-regulatory factor;signaling molecule;narrowmatch
lymphocyte activation process;b-cell activation;narrowmatch
dna repair gene;msh6 gene;narrowmatch
conceptual entity;occupation or discipline;narrowmatch
subcellular process;biochemical reaction;narrowmatch
fibroblast growth factor receptor family gene;fgfr1 gene;narrowmatch
rna synthesis;mrna expression;narrowmatch
hmga family gene;hmga2 gene;narrowmatch
protein phosphorylation process;serine/threonine phosphorylation;narrowmatch
transcription coregulator gene;transcription coactivator gene;narrowmatch
transcription coactivator gene;mediator complex component gene;narrowmatch
dna repair;mismatch repair;narrowmatch
biosynthetic process;melanogenesis;narrowmatch
tumor expansion;tumor cell invasion;narrowmatch
biochemical reaction;dephosphorylation;narrowmatch
hmga family gene;hmga1 gene;narrowmatch
transcription regulation gene;transcription factor gene;narrowmatch
hmg family gene;hmga family gene;narrowmatch
transcription regulation gene;hmg family gene;narrowmatch
basal transcription factor gene;tfiid subunit gene;narrowmatch
tfiid subunit gene;tbp-associated factor gene;narrowmatch
cell viability process;cell maintenance;narrowmatch
biological process;cellular process;narrowmatch
gene;apoptosis regulation gene;narrowmatch
transcription coactivator gene;nuclear receptor coactivator gene;narrowmatch
nuclear receptor coactivator gene;ncoa2 gene;narrowmatch
transcription coregulator gene;transcription repressor/corepressor gene;narrowmatch
receptor gene;nuclear receptor gene;narrowmatch
cell migration inhibition process;metastasis suppression;narrowmatch
cell proliferation;cell proliferation regulatory process;narrowmatch
cellular process;regulation of cell shape;narrowmatch
cytoskeletal gene;microfilament gene;narrowmatch
structural protein gene;cytoskeletal gene;narrowmatch
gene;structural protein gene;narrowmatch
fibroblast growth factor receptor family gene;fgfr4 gene;narrowmatch
tumor expansion;tumor cell mobility;narrowmatch
molecular interaction process;lipid binding;narrowmatch
nucleic acid binding;rna binding;narrowmatch
phosphatase family gene;protein phosphatase gene;narrowmatch
kinase family gene;receptor tyrosine kinase gene;narrowmatch
receptor gene;receptor tyrosine kinase gene;narrowmatch
transcription regulation gene;transcription coregulator gene;narrowmatch
transcription factor gene;nuclear receptor gene;narrowmatch
hydrolase;helicase;narrowmatch
apoptosis regulation gene;bcl-2 gene family;narrowmatch
receptor tyrosine kinase gene;fibroblast growth factor receptor family gene;narrowmatch
tumor progression;cancer progression;narrowmatch
ligand binding protein gene;receptor gene;narrowmatch
cyclin-dependent kinase inhibitor gene;cdkn1b gene;narrowmatch
protein;protein, organized by location;narrowmatch
protein;protein, organized by structure;narrowmatch
protein;protein, organized by function;narrowmatch
neurologic process;sensory process;narrowmatch
biological process;organismal process;narrowmatch
subcellular process;biophysical process;narrowmatch
iap family gene;birc3 gene;narrowmatch
morphogenesis;pattern formation;narrowmatch
cell proliferation;myeloproliferation;narrowmatch
organogenesis;limb development;narrowmatch
signal transduction;stress response signaling;narrowmatch
biosynthetic process;heparan sulfate biosynthesis;narrowmatch
intermediary metabolic process;atp hydrolysis;narrowmatch
negative regulation of cell death;negative regulation of apoptosis;narrowmatch
protein;protein family;narrowmatch
phosphatase;phosphoprotein phosphatase;narrowmatch
organogenesis;skeletal development;narrowmatch
molecular interaction process;ligand binding;narrowmatch
cell cycle process;m phase process;narrowmatch
apoptosis regulation gene;apoptosis inhibitor gene;narrowmatch
gene;telomere maintenance gene;narrowmatch
excision repair;base excision repair;narrowmatch
gene;regulatory gene;narrowmatch
cell adhesion process;cell-matrix adhesion process;narrowmatch
protein;protein complex subunit;narrowmatch
post-transcriptional regulation;rna interference;narrowmatch
dna maintenance;telomere maintenance;narrowmatch
host defense mechanism;inflammatory response;narrowmatch
positive regulation of cell death;positive regulation of apoptosis;narrowmatch
intracellular transport;subcellular protein targeting;narrowmatch
protein metabolism process;peptide metabolism;narrowmatch
transcription process;transcription initiation;narrowmatch
post-translational regulation;regulation of proteolysis;narrowmatch
gene regulation process;post-transcriptional regulation;narrowmatch
multicellular process;host defense mechanism;narrowmatch
fusion gene;cdh11/usp6 fusion gene;narrowmatch
cellular process;cell proliferation;narrowmatch
hydrolysis;proteolysis;narrowmatch
post-translational regulation;protein degradation process;narrowmatch
histogenic process;myogenesis;narrowmatch
immune system process;immunoregulation;narrowmatch
mutation abnormality;gene mutation;narrowmatch
gene abnormality;gene mutation;narrowmatch
carcinogenesis mechanism;chemical carcinogenesis;narrowmatch
cell growth process;cell growth regulation;narrowmatch
mutation abnormality;loss of heterozygosity;narrowmatch
tumorigenesis;carcinogenesis;narrowmatch
protein, organized by function;structural protein;narrowmatch
regulatory protein;enzyme inhibitor protein;narrowmatch
cell proliferation;blast cell proliferation;narrowmatch
mutation abnormality;somatic mutation;narrowmatch
cyclin-dependent kinase inhibitor gene;cdkn2a gene;narrowmatch
cyclin gene;ccnd1 gene;narrowmatch
post-translational modification;proteolysis;narrowmatch
ligand binding protein;receptor;narrowmatch
endocytotic process;receptor mediated endocytosis;narrowmatch
fa complementation group gene;brca2 gene;narrowmatch
glycosyltransferase gene;ext1 gene;narrowmatch
cyclin-dependent kinase gene;cdk4 gene;narrowmatch
cell adhesion molecule gene;cdh1 gene;narrowmatch
clinical course of disease;regression;narrowmatch
biophysical process;molecular interaction process;narrowmatch
clinical course of disease;stable disease;narrowmatch
telomere maintenance gene;tert gene;narrowmatch
transport process;intracellular transport;narrowmatch
dna recombination process;homologous recombination;narrowmatch
ets family gene;erg gene;narrowmatch
tumorigenesis;tumor initiation;narrowmatch
tumorigenesis;leukemogenesis;narrowmatch
transport process;rna transport;narrowmatch
pathogenesis;tumorigenesis;narrowmatch
x-ray cross complementing group;brca2 gene;narrowmatch
immunoprotein gene;t-cell receptor gene;narrowmatch
myeloid cell differentiation;megakaryocyte differentiation;narrowmatch
serine/threonine protein kinase gene;stk11 gene;narrowmatch
transcription factor gene;ahrr gene;narrowmatch
receptor tyrosine kinase gene;egfr gene;narrowmatch
receptor tyrosine kinase gene;erbb2 gene;narrowmatch
chromosomal translocation;"t(7;19)(q22;q13)";narrowmatch
chromosome 7 rearrangement;"t(7;19)(q22;q13)";narrowmatch
pathologic process;disease progression;narrowmatch
blasts 50 percent or less of bone marrow nucleated cells;blasts less than 50 percent of bone marrow nucleated cells;narrowmatch
fusion gene;ahrr/ncoa2 fusion gene;narrowmatch
lesion;plaque-like lesion;narrowmatch
disease grade qualifier;histologic grade;narrowmatch
chromosomal translocation;"t(5;8)(p15;q13)";narrowmatch
chromosome 5 rearrangement;"t(5;8)(p15;q13)";narrowmatch
chromosomal deletion;del(9p21);narrowmatch
chromosomal deletion;del(11p15.5);narrowmatch
developmental process;organogenesis;narrowmatch
protein, organized by function;ligand binding protein;narrowmatch
fusion gene;ewsr1/smad3 fusion gene;narrowmatch
regulatory protein;cell cycle protein;narrowmatch
fusion gene;serpine1/fosb fusion gene;narrowmatch
fusion gene;actb/fosb fusion gene;narrowmatch
fusion gene;yap1/tfe3 fusion gene;narrowmatch
transcription factor gene;lmo2 gene;narrowmatch
fa complementation group gene;brca1 gene;narrowmatch
homologous recombination repair gene;brca1 gene;narrowmatch
bcl-2 gene family;bcl2 gene;narrowmatch
host defense mechanism;immune system process;narrowmatch
intermediary metabolic process;carbohydrate metabolic process;narrowmatch
histogenic process;angiogenic process;narrowmatch
immune system process;immune response process;narrowmatch
energy metabolism process;cell respiration;narrowmatch
reproductive process;maturation;narrowmatch
abnormal laboratory test result;decreased expression;narrowmatch
elevated test result;elevated expression;narrowmatch
positive laboratory test result;expression positive;narrowmatch
positive laboratory test result;gene variant positive;narrowmatch
genetic finding;gene variant positive;narrowmatch
glycosyltransferase gene;ext2 gene;narrowmatch
transcription factor gene;men1 gene;narrowmatch
cell cycle process;negative regulation of cell cycle;narrowmatch
transcription regulatory protein;transcription coactivator;narrowmatch
growth factor gene;fibroblast growth factor gene family;narrowmatch
receptor tyrosine kinase gene;ntrk1 gene;narrowmatch
small g protein;ras superfamily protein;narrowmatch
transcription factor gene;myc family gene;narrowmatch
fibroblast growth factor gene family;fgf4 gene;narrowmatch
transcription factor gene;gli family gene;narrowmatch
transcription regulatory protein;transcription repressor/corepressor;narrowmatch
hydrolase gene;fhit gene;narrowmatch
molecular interaction process;protein-protein interaction;narrowmatch
protein, organized by function;signaling protein;narrowmatch
receptor tyrosine kinase;erbb receptor family protein;narrowmatch
protein phosphorylation process;tyrosine phosphorylation;narrowmatch
post-translational modification;protein phosphorylation process;narrowmatch
phosphorylation process;protein phosphorylation process;narrowmatch
cell cycle protein;cyclin-dependent kinase inhibitor protein;narrowmatch
dna repair gene;mlh1 gene;narrowmatch
fusion gene;ccdc6/ret fusion gene;narrowmatch
transcription factor gene;runx1 gene;narrowmatch
cell cycle gene;pttg1 gene;narrowmatch
serine/threonine protein kinase gene;atm gene;narrowmatch
in vitro model;experimental tumor;narrowmatch
cell cycle process;cell cycle checkpoint;narrowmatch
physical carcinogenesis;carcinogenesis, radiation;narrowmatch
carcinogenesis mechanism;physical carcinogenesis;narrowmatch
cancer biology;carcinogenesis mechanism;narrowmatch
carcinogenesis mechanism;biological carcinogenesis;narrowmatch
biology;cancer biology;narrowmatch
biochemical pathway;metabolic pathway;narrowmatch
receptor tyrosine kinase gene;kit gene;narrowmatch
nucleic acid binding;dna binding;narrowmatch
cell cycle gene;cyclin-dependent kinase inhibitor gene;narrowmatch
dna repair gene;pms2 gene;narrowmatch
dna repair gene;pms1 gene;narrowmatch
methyltransferase gene;kmt2a gene;narrowmatch
transcription factor gene;cbfb gene;narrowmatch
dna repair gene;msh2 gene;narrowmatch
protein, organized by function;regulatory protein;narrowmatch
receptor gene;ptch1 gene;narrowmatch
g protein;small g protein;narrowmatch
receptor tyrosine kinase gene;met gene;narrowmatch
ligand binding protein gene;ewsr1 gene;narrowmatch
ets family gene;fli1 gene;narrowmatch
ets family gene;etv6 gene;narrowmatch
dna maintenance process;dna maintenance;narrowmatch
dna repair gene;x-ray cross complementing group;narrowmatch
growth factor gene;pdgfb gene;narrowmatch
pathologic process;pathogenesis;narrowmatch
serine/threonine protein kinase gene;bcr gene;narrowmatch
transcription factor gene;wt1 gene;narrowmatch
regulatory gene;vhl gene;narrowmatch
signaling pathway gene;tsc2 gene;narrowmatch
ligand binding protein gene;tsc1 gene;narrowmatch
signaling pathway gene;smad4 gene;narrowmatch
receptor tyrosine kinase gene;ret gene;narrowmatch
signaling pathway gene;pten gene;narrowmatch
growth factor receptor gene;met gene;narrowmatch
transcription factor gene;ets family gene;narrowmatch
biomarker;disease marker;narrowmatch
ubiquitin-transferase gene;mdm2 gene;narrowmatch
signaling pathway gene;bcr gene;narrowmatch
signaling pathway gene;g protein gene;narrowmatch
transcription coactivator gene;irf4 gene;narrowmatch
fos family gene;fosl1 gene;narrowmatch
fibroblast growth factor gene family;fgf6 gene;narrowmatch
transcription factor gene;mybl1 gene;narrowmatch
myc family gene;mycn gene;narrowmatch
swi/snf-related gene;smarcb1 gene;narrowmatch
transcription regulation gene;mecom gene;narrowmatch
methyltransferase gene;mecom gene;narrowmatch
cyclin-dependent kinase inhibitor gene;cdkn1c gene;narrowmatch
serine/threonine protein kinase gene;braf gene;narrowmatch
transcription regulation gene;bcl3 gene;narrowmatch
serine/threonine protein kinase gene;akt2 gene;narrowmatch
serine/threonine protein kinase gene;akt1 gene;narrowmatch
cysteine peptidase gene;bap1 gene;narrowmatch
cytoskeletal process;cytoskeletal modeling;narrowmatch
transport protein gene;nucleoporin gene;narrowmatch
mouse adenosquamous carcinoma;adenosquamous cell carcinoma of the mouse prostate gland;narrowmatch
mouse rhabdomyosarcoma;rhabdomyosarcoma of the mouse prostate gland;narrowmatch
sarcoma of the mouse prostate gland;rhabdomyosarcoma of the mouse prostate gland;narrowmatch
mouse leiomyosarcoma;leiomyosarcoma of the mouse prostate gland;narrowmatch
sarcoma of the mouse prostate gland;leiomyosarcoma of the mouse prostate gland;narrowmatch
malignant neoplasms of the mouse prostate gland;sarcoma of the mouse prostate gland;narrowmatch
mouse malignant mesenchymal neoplasm;sarcoma of the mouse prostate gland;narrowmatch
mouse sarcoma;sarcoma of the mouse prostate gland;narrowmatch
invasive carcinoma of the mouse prostate gland;adenosquamous cell carcinoma of the mouse prostate gland;narrowmatch
mouse undifferentiated carcinoma;undifferentiated invasive carcinoma of the mouse prostate gland;narrowmatch
invasive carcinoma of the mouse prostate gland;squamous cell carcinoma of the mouse prostate gland;narrowmatch
mouse squamous cell carcinoma;squamous cell carcinoma of the mouse prostate gland;narrowmatch
invasive carcinoma of the mouse prostate gland;spindle cell / sarcomatoid carcinoma of the mouse prostate gland;narrowmatch
mouse spindle cell neoplasm;spindle cell / sarcomatoid carcinoma of the mouse prostate gland;narrowmatch
invasive neuroendocrine carcinoma of the mouse prostate gland;invasive small cell carcinoma of the mouse prostate gland;narrowmatch
mouse small cell undifferentiated carcinoma;invasive small cell carcinoma of the mouse prostate gland;narrowmatch
invasive carcinoma of the mouse prostate gland;invasive neuroendocrine carcinoma of the mouse prostate gland;narrowmatch
sarcoma of the mouse prostate gland;chondrosarcoma of the mouse prostate gland;narrowmatch
mouse chondrosarcoma;chondrosarcoma of the mouse prostate gland;narrowmatch
sarcoma of the mouse prostate gland;osteosarcoma of the mouse prostate gland;narrowmatch
mouse osteosarcoma;osteosarcoma of the mouse prostate gland;narrowmatch
tumors of the mouse pulmonary system;malignant tumors of the mouse pulmonary system;narrowmatch
preinvasive lesions of the mouse pulmonary system;squamous dysplasia of the mouse pulmonary system;narrowmatch
epithelial proliferative lesions of the mouse pulmonary system;preinvasive lesions of the mouse pulmonary system;narrowmatch
mouse cancer-related conditions;preinvasive lesions of the mouse pulmonary system;narrowmatch
adenoma of the mouse pulmonary system;adenoma of the mouse pulmonary system with mixed subtypes;narrowmatch
adenoma of the mouse pulmonary system;solid adenoma of the mouse pulmonary system;narrowmatch
adenoma of the mouse pulmonary system;papillary adenoma of the mouse pulmonary system;narrowmatch
mouse adenoma;adenoma of the mouse pulmonary system;narrowmatch
benign tumors of the mouse pulmonary system;adenoma of the mouse pulmonary system;narrowmatch
mouse papilloma;papilloma of the mouse pulmonary system;narrowmatch
benign tumors of the mouse pulmonary system;papilloma of the mouse pulmonary system;narrowmatch
tumors of the mouse pulmonary system;benign tumors of the mouse pulmonary system;narrowmatch
malignant neoplasms of the mouse prostate gland;carcinosarcoma of the mouse prostate gland;narrowmatch
mouse malignant mixed mesodermal tumor;carcinosarcoma of the mouse prostate gland;narrowmatch
sarcoma of the mouse prostate gland;sarcoma nos of the mouse prostate gland;narrowmatch
invasive carcinoma of the mouse prostate gland;undifferentiated invasive carcinoma of the mouse prostate gland;narrowmatch
invasive adenocarcinoma of the mouse prostate gland;poorly differentiated invasive adenocarcinoma of the mouse prostate gland;narrowmatch
malignant tumors of the mouse pulmonary system;squamous cell carcinoma of the mouse pulmonary system;narrowmatch
malignant neoplasms of the mouse mammary gland;other cancer of the mouse mammary gland nos;narrowmatch
atypical hyperplasia of the mouse prostate gland;stromal atypical hyperplasia of the mouse prostate gland;narrowmatch
atypical hyperplasia of the mouse prostate gland;epithelial atypical hyperplasia of the mouse prostate gland;narrowmatch
high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;atypical hyperplasia of the mouse prostate gland;narrowmatch
mouse precancerous conditions;high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;narrowmatch
neoplasms of the mouse prostate gland;high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;narrowmatch
mouse prostate disorder;neoplasms of the mouse prostate gland;narrowmatch
mouse male reproductive system neoplasms;neoplasms of the mouse prostate gland;narrowmatch
metaplastic carcinoma of the mouse mammary gland;other metaplastic carcinomas of the mouse mammary gland;narrowmatch
invasive adenocarcinoma of the mouse prostate gland;moderately differentiated invasive adenocarcinoma of the mouse prostate gland;narrowmatch
metaplastic carcinoma of the mouse mammary gland;spindle cell metaplastic carcinoma of the mouse mammary gland;narrowmatch
mouse spindle cell neoplasm;spindle cell metaplastic carcinoma of the mouse mammary gland;narrowmatch
metaplastic carcinoma of the mouse mammary gland;osseous metaplastic carcinoma of the mouse mammary gland;narrowmatch
metaplastic carcinoma of the mouse mammary gland;squamous metaplastic carcinoma of the mouse mammary gland;narrowmatch
mouse squamous cell carcinoma;squamous metaplastic carcinoma of the mouse mammary gland;narrowmatch
mouse adenosquamous carcinoma;adenosquamous metaplastic carcinoma of the mouse mammary gland;narrowmatch
metaplastic carcinoma of the mouse mammary gland;adenosquamous metaplastic carcinoma of the mouse mammary gland;narrowmatch
atypical hyperplasia of the mouse prostate gland;combined epithelial / stromal atypical hyperplasia of the mouse prostate gland;narrowmatch
mouse intraepithelial neoplasia;prostatic intraepithelial neoplasia of the mouse prostate gland;narrowmatch
high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;prostatic intraepithelial neoplasia of the mouse prostate gland;narrowmatch
prostatic intraepithelial neoplasia of the mouse prostate gland;low grade mouse prostatic intraepithelial neoplasia;narrowmatch
mouse adenocarcinoma;invasive adenocarcinoma of the mouse prostate gland;narrowmatch
invasive carcinoma of the mouse prostate gland;invasive adenocarcinoma of the mouse prostate gland;narrowmatch
carcinoma of the mouse prostate gland;invasive carcinoma of the mouse prostate gland;narrowmatch
microinvasive neuroendocrine carcinoma of the mouse prostate gland;microinvasive small cell carcinoma of the mouse prostate gland;narrowmatch
mouse small cell undifferentiated carcinoma;microinvasive small cell carcinoma of the mouse prostate gland;narrowmatch
microinvasive carcinoma of the mouse prostate gland;microinvasive neuroendocrine carcinoma of the mouse prostate gland;narrowmatch
microinvasive carcinoma of the mouse prostate gland;undifferentiated microinvasive carcinoma of the mouse prostate gland;narrowmatch
mouse undifferentiated carcinoma;undifferentiated microinvasive carcinoma of the mouse prostate gland;narrowmatch
mouse adenocarcinoma;microinvasive adenocarcinoma of the mouse prostate gland;narrowmatch
microinvasive carcinoma of the mouse prostate gland;microinvasive adenocarcinoma of the mouse prostate gland;narrowmatch
carcinoma of the mouse prostate gland;microinvasive carcinoma of the mouse prostate gland;narrowmatch
mouse carcinoma;carcinoma of the mouse prostate gland;narrowmatch
malignant neoplasms of the mouse prostate gland;carcinoma of the mouse prostate gland;narrowmatch
neoplasms of the mouse prostate gland;malignant neoplasms of the mouse prostate gland;narrowmatch
prostatic intraepithelial neoplasia of the mouse prostate gland;high grade mouse prostatic intraepithelial neoplasia;narrowmatch
mouse squamous cell carcinoma;squamous cell carcinoma of the mouse pulmonary system;narrowmatch
malignant tumors of the mouse pulmonary system;adenocarcinoma of the mouse pulmonary system;narrowmatch
nucleoporin gene;nup98 gene;narrowmatch
basaloid follicular neoplasm of the mouse skin;trichoblastoma type of basaloid follicular neoplasm of the mouse skin;narrowmatch
adnexal neoplasms of the mouse skin;sebaceous neoplasms and hyperplasias of the mouse skin;narrowmatch
basaloid follicular neoplasm of the mouse skin;other variants of basaloid follicular neoplasm of the mouse skin;narrowmatch
basaloid follicular neoplasm of the mouse skin;superficial basal cell carcinoma type of basaloid follicular neoplasm of the mouse skin;narrowmatch
basaloid follicular neoplasm of the mouse skin;spiradenoma type of basaloid follicular neoplasm of the mouse skin;narrowmatch
basaloid follicular neoplasm of the mouse skin;cylindroma type of basaloid follicular neoplasm of the mouse skin;narrowmatch
basaloid follicular neoplasm of the mouse skin;trichofolliculoma type of basaloid follicular neoplasm of the mouse skin;narrowmatch
basaloid follicular neoplasm of the mouse skin;trichoepithelioma type of basaloid follicular neoplasm of the mouse skin;narrowmatch
basaloid follicular neoplasm of the mouse skin;pilomatrixoma type of basaloid follicular neoplasm of the mouse skin;narrowmatch
squamous cell carcinoma of the mouse skin;well-differentiated squamous cell carcinoma of the mouse skin;narrowmatch
follicular neoplasms of the mouse skin;basaloid follicular neoplasm of the mouse skin;narrowmatch
adnexal neoplasms of the mouse skin;follicular neoplasms of the mouse skin;narrowmatch
neoplasms of the mouse skin;adnexal neoplasms of the mouse skin;narrowmatch
squamous neoplasms of the mouse skin;malignant basal cell tumor of the mouse skin;narrowmatch
poorly-differentiated squamous cell carcinoma of the mouse skin;spindle-cell squamous cell carcinoma of the mouse skin;narrowmatch
mouse spindle cell neoplasm;spindle-cell squamous cell carcinoma of the mouse skin;narrowmatch
squamous cell carcinoma of the mouse skin;poorly-differentiated squamous cell carcinoma of the mouse skin;narrowmatch
sebaceous neoplasms and hyperplasias of the mouse skin;sebaceous adenoma of the mouse skin;narrowmatch
mouse adenoma;sebaceous adenoma of the mouse skin;narrowmatch
sebaceous neoplasms and hyperplasias of the mouse skin;sebaceous carcinoma of the mouse skin;narrowmatch
mouse carcinoma;sebaceous carcinoma of the mouse skin;narrowmatch
mouse neuroglia neoplasm;schwannoma of the mouse skin;narrowmatch
benign mesenchymal neoplasms of the mouse skin;hibernoma of the mouse skin;narrowmatch
mouse hibernoma;hibernoma of the mouse skin;narrowmatch
benign mesenchymal neoplasms of the mouse skin;lipoma of the mouse skin;narrowmatch
mouse lipoma;lipoma of the mouse skin;narrowmatch
hemangioma of the mouse blood vessel;hemangioma of the mouse skin;narrowmatch
benign mesenchymal neoplasms of the mouse skin;hemangioma of the mouse skin;narrowmatch
benign mesenchymal neoplasms of the mouse skin;fibroma of the mouse skin;narrowmatch
mouse fibroma;fibroma of the mouse skin;narrowmatch
neoplasms of the mouse skin;benign mesenchymal neoplasms of the mouse skin;narrowmatch
adnexal neoplasms of the mouse skin;other adnexal neoplasms of the mouse skin;narrowmatch
adnexal neoplasms of the mouse skin;mixed tumors of the mouse skin;narrowmatch
mouse mixed neoplasm;mixed tumors of the mouse skin;narrowmatch
adnexal neoplasms of the mouse skin;apocrine neoplasms of the mouse skin;narrowmatch
adnexal neoplasms of the mouse skin;mouse eccrine neoplasms;narrowmatch
squamous cell carcinoma of the mouse skin;moderately-differentiated squamous cell carcinoma of the mouse skin;narrowmatch
squamous neoplasms of the mouse skin;squamous cell carcinoma of the mouse skin;narrowmatch
mouse adenocarcinoma;adenocarcinoma of the mouse pulmonary system;narrowmatch
malignant tumors of the mouse pulmonary system;neuroendocrine carcinoma of the mouse pulmonary system;narrowmatch
mouse melanocytic neoplasms and proliferations;mouse benign melanocytic neoplasms;narrowmatch
mouse melanocyte neoplasm;mouse melanocytic neoplasms and proliferations;narrowmatch
neoplasms of the mouse skin;mouse melanocytic neoplasms and proliferations;narrowmatch
mouse skin disorder;neoplasms of the mouse skin;narrowmatch
mouse integumentary system neoplasms;neoplasms of the mouse skin;narrowmatch
mouse carcinoma;carcinoma, other, of the mouse pulmonary system;narrowmatch
malignant tumors of the mouse pulmonary system;carcinoma, other, of the mouse pulmonary system;narrowmatch
mouse adenosquamous carcinoma;adenosquamous carcinoma of the mouse pulmonary system;narrowmatch
mouse squamous cell carcinoma;squamous cell carcinoma of the mouse skin;narrowmatch
malignant tumors of the mouse pulmonary system;adenosquamous carcinoma of the mouse pulmonary system;narrowmatch
adenocarcinoma of the mouse pulmonary system;adenocarcinoma nos of the mouse pulmonary system;narrowmatch
adenocarcinoma of the mouse pulmonary system;adenocarcinoma with mixed subtypes of the mouse pulmonary system;narrowmatch
adenocarcinoma of the mouse pulmonary system;solid adenocarcinoma of the mouse pulmonary system;narrowmatch
mouse acinar cell neoplasm;acinar adenocarcinoma of the mouse pulmonary system;narrowmatch
adenocarcinoma of the mouse pulmonary system;acinar adenocarcinoma of the mouse pulmonary system;narrowmatch
adenocarcinoma of the mouse pulmonary system;papillary adenocarcinoma of the mouse pulmonary system;narrowmatch
mouse benign melanocytic neoplasms;mouse melanocytoma;narrowmatch
mouse melanocytic neoplasms and proliferations;mouse melanocytic neoplasms of uncertain malignant potential;narrowmatch
mouse melanocytic neoplasms and proliferations;mouse malignant melanocytic neoplasms;narrowmatch
mouse malignant melanocytic neoplasms;mouse melanoma;narrowmatch
squamous neoplasms of the mouse skin;squamous cell carcinoma in situ of the mouse skin;narrowmatch
squamous neoplasms of the mouse skin;benign basal cell tumor of the mouse skin;narrowmatch
mouse basal cell neoplasm;benign basal cell tumor of the mouse skin;narrowmatch
benign squamous neoplasms of the mouse skin;papilloma of the mouse skin;narrowmatch
squamous neoplasms of the mouse skin;benign squamous neoplasms of the mouse skin;narrowmatch
mouse squamous cell neoplasm;squamous neoplasms of the mouse skin;narrowmatch
neoplasms of the mouse skin;squamous neoplasms of the mouse skin;narrowmatch
mouse melanoma;other mouse melanoma;narrowmatch
mouse spindle and epithelioid melanoma;mouse amelanotic spindle and epithelioid melanoma;narrowmatch
mouse melanoma;mouse spindle and epithelioid melanoma;narrowmatch
mouse spindle-cell melanoma;mouse amelanotic spindle-cell melanoma;narrowmatch
mouse melanoma;mouse spindle-cell melanoma;narrowmatch
mouse spindle cell neoplasm;mouse spindle-cell melanoma;narrowmatch
mouse epithelioid melanoma;mouse amelanotic epithelioid melanoma;narrowmatch
mouse melanoma;mouse epithelioid melanoma;narrowmatch
carcinoma of the mouse mammary gland: histologic patterns;metaplastic carcinoma of the mouse mammary gland;narrowmatch
myoepithelial carcinoma of the mouse mammary gland;monomorphic myoepithelial spindle cell carcinoma of the mouse mammary gland;narrowmatch
mouse spindle cell neoplasm;monomorphic myoepithelial spindle cell carcinoma of the mouse mammary gland;narrowmatch
pathologic process;tumor-associated process;narrowmatch
enzyme gene;lyase gene;narrowmatch
gene;enzyme gene;narrowmatch
peptidase gene;metallopeptidase gene;narrowmatch
gene;translation process gene;narrowmatch
phosphoinositol kinase family gene;pik3ca gene;narrowmatch
metal ion binding;calcium binding;narrowmatch
metabolic process;intermediary metabolic process;narrowmatch
tumor progression;tumor expansion;narrowmatch
biological process;multicellular process;narrowmatch
structural protein gene;npm1 gene;narrowmatch
gene product;protein or riboprotein complex;narrowmatch
organismal process;reproductive process;narrowmatch
organismal process;aging-related process;narrowmatch
protein, organized by function;dna repair protein;narrowmatch
multicellular process;developmental process;narrowmatch
hematopoietic process;myelopoiesis;narrowmatch
gene;ligand binding protein gene;narrowmatch
regulatory gene;ezh2 gene;narrowmatch
gene;growth factor gene;narrowmatch
receptor gene;receptor serine/threonine kinase gene;narrowmatch
mouse neoplasms by morphology;mouse sarcoma;narrowmatch
mouse neoplasms by morphology;mouse lymphoma;narrowmatch
mouse neoplasms by morphology;mouse lobular neoplasm;narrowmatch
mouse neoplasms by cell type;mouse neuroglia neoplasm;narrowmatch
anatomic structure, system, or substance;microanatomic structure;narrowmatch
receptor signaling;g protein-coupled receptor signaling;narrowmatch
intracellular signaling process;calcium signaling;narrowmatch
intercellular communication process;neuronal transmission;narrowmatch
nuclear receptor gene;rara gene;narrowmatch
post-translational modification;deubiquitination;narrowmatch
gene;cytokine gene;narrowmatch
exonuclease;3'-5' exonuclease;narrowmatch
bone morphogenetic protein receptor gene;bmpr1a gene;narrowmatch
receptor serine/threonine kinase gene;bone morphogenetic protein receptor gene;narrowmatch
serine/threonine protein kinase gene;receptor serine/threonine kinase gene;narrowmatch
developmental process;histogenic process;narrowmatch
cellular process;cell division process;narrowmatch
myoepithelial carcinoma of the mouse mammary gland;myoepithelial and mixed glandular myoepithelial carcinoma of the mouse mammary gland;narrowmatch
protein, organized by function;tumor suppressor protein;narrowmatch
biochemical reaction;glycosylation;narrowmatch
inhibition of cancer cell growth;suppression of cancer cell invasion;narrowmatch
dephosphorylation;protein dephosphorylation;narrowmatch
post-translational modification;protein dephosphorylation;narrowmatch
cell adhesion molecule gene;cd44 gene;narrowmatch
ligand binding protein gene;cell adhesion molecule gene;narrowmatch
signaling pathway gene;ctnnb1 gene;narrowmatch
molecular interaction process;gtp binding;narrowmatch
cellular process;cell growth process;narrowmatch
apoptosis inhibitor gene;iap family gene;narrowmatch
receptor gene;g protein-coupled receptor gene;narrowmatch
gene;signaling pathway gene;narrowmatch
gene;cell cycle gene;narrowmatch
biosynthetic process;adipogenesis;narrowmatch
nucleotide;adenosine triphosphate;narrowmatch
cell proliferation;stimulation of cell proliferation;narrowmatch
methylation;protein methylation;narrowmatch
post-translational modification;protein methylation;narrowmatch
biochemical process;intracellular signaling process;narrowmatch
stress response signaling;cell death signaling process;narrowmatch
cellular process;cell viability process;narrowmatch
dna maintenance process;replication-associated process;narrowmatch
biochemical process;transport process;narrowmatch
sensory process;nociception;narrowmatch
organismal process;neurologic process;narrowmatch
dna sequence alteration process;dna sequence rearrangement;narrowmatch
macromolecular sequence alteration process;dna sequence alteration process;narrowmatch
cell stress process;cellular stress response;narrowmatch
cell stress process;cellular stress;narrowmatch
pathologic process;cell stress process;narrowmatch
degradation;protein turnover;narrowmatch
gene expression process;gene regulation process;narrowmatch
biochemical process;gene expression process;narrowmatch
replication-associated process;dna replication proofreading;narrowmatch
host defense mechanism;coagulation process;narrowmatch
mouse mesenchymal neoplasm;mouse sarcoma;narrowmatch
mouse neoplasms by morphology;mouse leukemia;narrowmatch
mouse neoplasms by cell type;mouse giant cell neoplasm;narrowmatch
mouse adenoma;adenoma of the mouse mammary gland;narrowmatch
low grade mouse min;ductal mouse min;narrowmatch
low grade mouse min;lobuloalveolar mouse min;narrowmatch
intraepithelial neoplasia of the mouse mammary gland;low grade mouse min;narrowmatch
neoplasms of the mouse mammary gland;intraepithelial neoplasia of the mouse mammary gland;narrowmatch
mouse intraepithelial neoplasia;intraepithelial neoplasia of the mouse mammary gland;narrowmatch
benign neoplasms of the mouse mammary gland;adenomyoepithelioma of the mouse mammary gland;narrowmatch
mouse myoepithelioma;adenomyoepithelioma of the mouse mammary gland;narrowmatch
benign neoplasms of the mouse mammary gland;adenoma of the mouse mammary gland;narrowmatch
mouse mixed neoplasm;mouse mixed mesodermal tumor;narrowmatch
mouse papilloma;papilloma of the mouse mammary gland;narrowmatch
benign neoplasms of the mouse mammary gland;papilloma of the mouse mammary gland;narrowmatch
mouse adenoma;fibroadenoma of the mouse mammary gland;narrowmatch
benign neoplasms of the mouse mammary gland;fibroadenoma of the mouse mammary gland;narrowmatch
neoplasms of the mouse mammary gland;benign neoplasms of the mouse mammary gland;narrowmatch
mouse mammary gland disorder;neoplasms of the mouse mammary gland;narrowmatch
mouse integumentary system neoplasms;neoplasms of the mouse mammary gland;narrowmatch
intraepithelial neoplasia of the mouse mammary gland;mouse min nos;narrowmatch
mouse min nos;simple mouse min nos;narrowmatch
mouse min nos;cystic mouse min nos;narrowmatch
mouse min nos;solid mouse min nos;narrowmatch
carcinoma of the mouse mammary gland: histologic patterns;myoepithelial carcinoma of the mouse mammary gland;narrowmatch
mouse myoepithelioma;myoepithelial carcinoma of the mouse mammary gland;narrowmatch
luminal carcinoma of the mouse mammary gland;other mammary carcinoma of mouse;narrowmatch
luminal carcinoma of the mouse mammary gland;solid mammary carcinoma of mouse;narrowmatch
luminal carcinoma of the mouse mammary gland;papillary mammary carcinoma of mouse;narrowmatch
luminal carcinoma of the mouse mammary gland;cribriform mammary carcinoma of mouse;narrowmatch
luminal carcinoma of the mouse mammary gland;glandular mammary carcinoma of mouse;narrowmatch
luminal carcinoma of the mouse mammary gland;acinar mammary carcinoma of mouse;narrowmatch
carcinoma of the mouse mammary gland: histologic patterns;luminal carcinoma of the mouse mammary gland;narrowmatch
mouse luminal carcinoma;luminal carcinoma of the mouse mammary gland;narrowmatch
malignant neoplasms of the mouse mammary gland;carcinoma of the mouse mammary gland: histologic patterns;narrowmatch
neoplasms of the mouse mammary gland;malignant neoplasms of the mouse mammary gland;narrowmatch
intraepithelial neoplasia of the mouse mammary gland;carcinoma in situ of the mouse mammary gland;narrowmatch
intraepithelial neoplasia of the mouse mammary gland;high grade mouse min;narrowmatch
mouse min nos;mixed mouse min nos;narrowmatch
experimental organism neoplasm by organism;murine experimental organism diagnosis;narrowmatch
mouse neoplasms by cell type;mouse clear cell neoplasm;narrowmatch
mouse neoplasms by morphology;mouse stromal neoplasm;narrowmatch
mouse benign mesenchymal neoplasm;mouse angioma;narrowmatch
mouse malignant mesenchymal neoplasm;mouse mesothelioma;narrowmatch
mouse malignant mesenchymal neoplasm;mouse hemangiopericytoma;narrowmatch
mouse mesenchymal neoplasm;mouse malignant mesenchymal neoplasm;narrowmatch
mouse mesenchymal neoplasm;mouse benign mesenchymal neoplasm;narrowmatch
malignant mouse lipomatous neoplasm;mouse liposarcoma;narrowmatch
mouse sarcoma;mouse liposarcoma;narrowmatch
mouse neoplasms by morphology;mouse intraepithelial neoplasia;narrowmatch
mouse neoplasms by cell type;mouse spindle cell neoplasm;narrowmatch
mouse undifferentiated carcinoma;mouse large cell undifferentiated carcinoma;narrowmatch
mouse undifferentiated carcinoma;mouse small cell undifferentiated carcinoma;narrowmatch
mouse carcinoma;mouse undifferentiated carcinoma;narrowmatch
mouse squamous cell neoplasm;mouse squamous cell carcinoma;narrowmatch
mouse carcinoma;mouse squamous cell carcinoma;narrowmatch
mouse epithelial cell neoplasms;mouse carcinoid tumor;narrowmatch
mouse mixed mesodermal tumor;mouse malignant mixed mesodermal tumor;narrowmatch
mouse epithelial cell neoplasms;mouse mesothelioma;narrowmatch
mouse benign mesenchymal neoplasm;mouse leiomyoma;narrowmatch
mouse benign mesenchymal neoplasm;mouse hibernoma;narrowmatch
mouse benign mesenchymal neoplasm;mouse fibroma;narrowmatch
mouse neural cell neoplasm;mouse granular cell neoplasm;narrowmatch
mouse neoplasms by cell type;mouse mast cell neoplasm;narrowmatch
mouse plasma cell dyscrasia;mouse plasmacytoma;narrowmatch
mouse b cell neoplasms;mouse plasmacytoma;narrowmatch
mouse lymph cell neoplasm;mouse t cell neoplasms;narrowmatch
mouse lymphoma;mouse t cell neoplasms;narrowmatch
mouse lymph cell neoplasm;mouse b cell neoplasms;narrowmatch
mouse lymphoma;mouse b cell neoplasms;narrowmatch
mouse neoplasms by cell type;mouse plasma cell neoplasm;narrowmatch
mouse epithelial cell neoplasms;mouse basal cell neoplasm;narrowmatch
mouse adenocarcinoma;mouse luminal carcinoma;narrowmatch
mouse neoplasms by morphology;mouse mixed neoplasm;narrowmatch
mouse mixed neoplasm;mouse myoepithelioma;narrowmatch
mouse benign mesenchymal neoplasm;mouse lipoma;narrowmatch
mouse neoplasms by morphology;mouse fibroma;narrowmatch
fusion gene;fn1/egf fusion gene;narrowmatch
fusion gene;col1a1/usp6 fusion gene;narrowmatch
disease morphology qualifier;villous;narrowmatch
cystic change;variably-sized cysts filled with clear, serous, or gelatinous fluid;narrowmatch
loss of heterozygosity;chromosome 11 loss of heterozygosity;narrowmatch
loss of heterozygosity;chromosome 10 loss of heterozygosity;narrowmatch
loss of heterozygosity;chromosome 8 loss of heterozygosity;narrowmatch
loss of heterozygosity;chromosome 6 loss of heterozygosity;narrowmatch
loss of heterozygosity;chromosome arm 5q loss of heterozygosity;narrowmatch
chromosome 1 abnormality;chromosome arm 1p loss of heterozygosity;narrowmatch
loss of heterozygosity;chromosome arm 1p loss of heterozygosity;narrowmatch
somatic mutation;short somatic mutation;narrowmatch
gene variant;sdhaf2 gene mutation;narrowmatch
positive laboratory test result;hif1a overexpression positive;narrowmatch
elevated expression;hif1a overexpression positive;narrowmatch
pi3k/mtor pathway mutation;pi3k gene mutation;narrowmatch
gene abnormality;cdk gene mutation;narrowmatch
high risk non-muscle invasive bladder urothelial carcinoma;recurrent high risk non-muscle invasive bladder urothelial carcinoma;narrowmatch
urinary system finding;high risk non-muscle invasive bladder urothelial carcinoma;narrowmatch
feline experimental organism diagnosis;feline histiocytic sarcoma;narrowmatch
loss of heterozygosity;chromosome 15 loss of heterozygosity;narrowmatch
loss of heterozygosity;chromosome 18 loss of heterozygosity;narrowmatch
loss of heterozygosity;chromosome 22 loss of heterozygosity;narrowmatch
blast cells increased in bone marrow;blasts 0.01 percent or more of bone marrow nucleated cells;narrowmatch
lymphoma finding;lymphoma in remission;narrowmatch
disease response;platinum sensitivity;narrowmatch
enzyme gene;translocase gene;narrowmatch
morphologic finding;marked thickening of the bladder urothelium present;narrowmatch
gene variant positive;nf1 mutation positive malignant peripheral nerve sheath tumor;narrowmatch
biomarker positive malignant neoplasm;nf1 mutation positive malignant peripheral nerve sheath tumor;narrowmatch
skin disorder;subcutaneous disorder;narrowmatch
tsc2 gene inactivation;tsc2 monoallelic inactivation;narrowmatch
loss of heterozygosity;tsc2 monoallelic inactivation;narrowmatch
monoallelic mutation;tsc2 monoallelic inactivation;narrowmatch
mesenchymal metaplasia;smooth muscle metaplasia;narrowmatch
morphologic finding;intra or intercytoplasmic lumina present;narrowmatch
abnormal cells present;malignant epithelial cells with cytoplasmic vacuoles or flocculent cytoplasmic inclusions containing wispy eosinophilic material present;narrowmatch
morphologic architectural pattern;microcystic growth pattern;narrowmatch
morphologic architectural pattern;reticular growth pattern;narrowmatch
castration resistance;resistance to second-generation androgen receptor axis-targeted agents;narrowmatch
resectable mass;borderline resectable mass;narrowmatch
lymphoma in remission;hodgkin lymphoma in remission;narrowmatch
feline experimental organism diagnosis;feline melanoma;narrowmatch
experimental organism neoplasm;experimental organism ductal cell adenoma;narrowmatch
experimental organism neoplasm;experimental organism ductal cell adenocarcinoma;narrowmatch
experimental organism neoplasm;experimental organism intramural schwannoma;narrowmatch
experimental organism neoplasm;experimental organism endocardial schwannoma;narrowmatch
immunophenotypic finding;loss of immunohistochemical expression of succinate dehydrogenase (sdh) b;narrowmatch
sdhb negative;loss of immunohistochemical expression of succinate dehydrogenase (sdh) b;narrowmatch
malignant cellular infiltrate;malignant primitive cellular infiltrate;narrowmatch
chromosomal translocation;rara gene translocation;narrowmatch
blasts 0.01 percent or more of bone marrow nucleated cells;blasts 0.1 percent or more of bone marrow nucleated cells;narrowmatch
chromosome 17 abnormality;rara gene translocation;narrowmatch
myeloid neoplasm finding;high risk chronic myelomonocytic leukemia;narrowmatch
high risk acute leukemia;high risk acute myeloid leukemia;narrowmatch
fusion gene;creb3l2/pparg fusion gene;narrowmatch
gene amplification abnormality;receptor tyrosine kinase gene amplification;narrowmatch
gene rearrangement abnormality;receptor tyrosine kinase gene rearrangement;narrowmatch
blast cells present;myeloblasts present;narrowmatch
experimental organism neoplasm;experimental organism brunner's gland carcinoma;narrowmatch
experimental organism neoplasm;experimental organism benign thecoma;narrowmatch
experimental organism neoplasm;experimental organism malignant thecoma;narrowmatch
disorder by site;genitourinary system disorder;narrowmatch
laboratory test result;afp level finding;narrowmatch
eye part;vitreoretinal area;narrowmatch
gene variant;prkaca gene mutation;narrowmatch
gene variant;cacna1d gene mutation;narrowmatch
gene variant;atp2b3 gene mutation;narrowmatch
gene variant;atp1a1 gene mutation;narrowmatch
gene variant;kcnj5 gene mutation;narrowmatch
condition;medical condition;narrowmatch
malignant basaloid cell;malignant basal cell;narrowmatch
expression negative;sdhb negative;narrowmatch
acute myeloid leukemia in remission;acute monoblastic and monocytic leukemia in remission;narrowmatch
acute myeloid leukemia in remission;acute myeloid leukemia with multilineage dysplasia in remission;narrowmatch
other anatomic concept;peritoneum and retroperitoneum;narrowmatch
non-neoplastic disorder by site;non-neoplastic genitourinary system disorder;narrowmatch
genitourinary system disorder;non-neoplastic genitourinary system disorder;narrowmatch
lymphoma in remission;non-hodgkin lymphoma in remission;narrowmatch
cellular infiltrate;scattered neuroendocrine cells by immunohistochemistry present;narrowmatch
chromosome 12 abnormality;etv6 gene rearrangement;narrowmatch
progressive neoplastic disease;progressive thyroid carcinoma;narrowmatch
figo stage iia;figo stage iia2;narrowmatch
figo stage iia;figo stage iia1;narrowmatch
figo stage ib;figo stage ib3;narrowmatch
expression positive;cd15 positive;narrowmatch
expression positive;cd14 positive;narrowmatch
expression positive;eno2 positive;narrowmatch
expression negative;hla-dr negative;narrowmatch
elevated test result;increased fibroblast growth factor pathway activation;narrowmatch
head and neck part;nasal vestibule;narrowmatch
elevated test result;elevated ldh;narrowmatch
abnormal blood chemistry and hematology test result;elevated ldh;narrowmatch
receptor status;her2/neu status;narrowmatch
receptor status;estrogen receptor status;narrowmatch
receptor status;progesterone receptor status;narrowmatch
metastatic/recurrent disease;oligometastatic disease;narrowmatch
morphologic finding;morphologic features resembling salivary gland adenocarcinoma;narrowmatch
genetic finding;hypermutated sample;narrowmatch
esterase;exonuclease;narrowmatch
myeloid neoplasm finding;intermediate risk acute myeloid leukemia;narrowmatch
leukemia finding;intermediate risk acute myeloid leukemia;narrowmatch
laboratory test result;cdkn2a-p16 status;narrowmatch
immunophenotypic finding;asph-positive neoplastic cells present;narrowmatch
asph positive;asph-positive neoplastic cells present;narrowmatch
intermediate risk acute myeloid leukemia;normal karyotype intermediate risk acute myeloid leukemia;narrowmatch
leukemia finding;non-m3 acute myeloid leukemia;narrowmatch
myeloid neoplasm finding;non-m3 acute myeloid leukemia;narrowmatch
aging-related process;aging;narrowmatch
protein family;atpase;narrowmatch
vascular morphologic change;intravascular myofibroblastic proliferation;narrowmatch
ligand binding protein;actin-binding protein;narrowmatch
blasts 0.1 percent or more of bone marrow nucleated cells;blasts 1 percent or more of bone marrow nucleated cells;narrowmatch
body region;paratesticular region;narrowmatch
canine neoplasm;canine transmissible venereal tumor;narrowmatch
intermediate risk acute myeloid leukemia;refractory intermediate risk acute myeloid leukemia;narrowmatch
high risk acute myeloid leukemia;refractory high risk acute myeloid leukemia;narrowmatch
canine neoplasm;canine thyroid gland medullary carcinoma;narrowmatch
morphologic architectural pattern;tubuloglandular pattern;narrowmatch
11q aberration;11q23 abnormality;narrowmatch
location description;primary site of disease;narrowmatch
respiratory system finding;lung parenchyma tumor location;narrowmatch
dna repair gene;fa complementation group gene;narrowmatch
dna repair gene mutation;fanconi anemia complementation group gene mutation;narrowmatch
morphologic architectural pattern;labyrinthine growth pattern;narrowmatch
abnormal tissue present;proliferation of squamous nests with little stromal reaction;narrowmatch
negative test result;rearrangement negative;narrowmatch
positive laboratory test result;rearrangement detected;narrowmatch
braf gene mutation;braf exon 15 mutation;narrowmatch
gene variant;plcb4 gene mutation;narrowmatch
cytogenetic abnormality;3q abnormality;narrowmatch
canine neoplasm;canine nephroblastoma;narrowmatch
canine neoplasm;canine langerhans cell histiocytosis;narrowmatch
canine neoplasm;canine granular cell tumor;narrowmatch
canine neoplasm;canine gastrointestinal stromal tumor;narrowmatch
gene variant;foxl2 gene mutation;narrowmatch
deposit;dense eosinophilic basement membrane deposit;narrowmatch
lung parenchyma tumor location;peripheral lung parenchyma tumor;narrowmatch
lung parenchyma tumor location;central lung parenchyma tumor;narrowmatch
interstitial cell;renomedullary interstitial cell;narrowmatch
abnormal cells present;small, stellate, or spindled cells present;narrowmatch
esterase gene;plcb4 gene;narrowmatch
nervous system finding;high risk meningioma;narrowmatch
urinary system part;urethra part;narrowmatch
gene variant;cysltr2 gene mutation;narrowmatch
urinary system finding;bladder diverticulum;narrowmatch
diverticulum;bladder diverticulum;narrowmatch
cytogenetic abnormality;chromosome 7 abnormality;narrowmatch
cytogenetic abnormality;chromosome 5 abnormality;narrowmatch
morphologic architectural pattern;growth phase;narrowmatch
non-hodgkin lymphoma in remission;diffuse large b-cell lymphoma in partial remission;narrowmatch
non-hodgkin lymphoma in remission;diffuse large b-cell lymphoma in complete remission;narrowmatch
urinary system finding;kidney tumor, middle section;narrowmatch
urinary system finding;kidney tumor, lower pole;narrowmatch
urinary system finding;kidney tumor, upper pole;narrowmatch
acute leukemia in remission;acute bilineal leukemia in remission;narrowmatch
blasts 1 percent or more of peripheral blood white cells;blasts 2 percent or more of peripheral blood white cells;narrowmatch
gene rearrangement abnormality;etv6 gene rearrangement;narrowmatch
biological process;subcellular process;narrowmatch
expression positive;cd34 positive;narrowmatch
gene fusion abnormality;bcl6 gene fusion;narrowmatch
round cell liposarcoma;metastatic round cell liposarcoma;narrowmatch
round cell liposarcoma;refractory round cell liposarcoma;narrowmatch
structural protein gene;histone gene;narrowmatch
kit gene mutation;somatic kit gene mutation;narrowmatch
somatic mutation;somatic kit gene mutation;narrowmatch
gene abnormality;hedgehog pathway mutation;narrowmatch
endocrine system finding;hormone resistance;narrowmatch
chromogranin positive;chromogranin-positive neoplastic cells present;narrowmatch
disease response;platinum resistance;narrowmatch
experimental organism neoplasm by organism;sheep lung adenocarcinoma;narrowmatch
progressive medulloblastoma;progressive medulloblastoma, shh-activated;narrowmatch
progressive neoplastic disease;progressive central nervous system neoplasm;narrowmatch
nervous system finding;progressive central nervous system neoplasm;narrowmatch
progressive central nervous system neoplasm;progressive ependymoma;narrowmatch
progressive central nervous system neoplasm;progressive medulloblastoma;narrowmatch
notch family gene mutation;notch2 gene mutation;narrowmatch
gene variant;notch2 gene mutation;narrowmatch
gene variant;cd79b gene mutation;narrowmatch
diffuse large b-cell lymphoma, not otherwise specified;diffuse large b-cell lymphoma, not otherwise specified molecular subtypes;narrowmatch
blasts under 10 percent of peripheral blood white cells;blasts 5 percent or less of peripheral blood white cells;narrowmatch
protein tyrosine kinase;alk gene product;narrowmatch
immunophenotypic finding;hmb45-positive cells present;narrowmatch
pmel positive;hmb45-positive cells present;narrowmatch
abnormal cells present;small aggregates of tumor cells present;narrowmatch
abnormal finding;fibrinous material present;narrowmatch
regulatory gene;samd9 gene;narrowmatch
positive laboratory test result;biomarker positive malignant neoplasm;narrowmatch
myeloid neoplasm finding;high grade myeloid neoplasm;narrowmatch
male reproductive system finding;castration-naive;narrowmatch
soft tissue sarcoma, excluding rhabdomyosarcoma;refractory soft tissue sarcoma, excluding rhabdomyosarcoma;narrowmatch
soft tissue sarcoma, excluding rhabdomyosarcoma;recurrent soft tissue sarcoma, excluding rhabdomyosarcoma;narrowmatch
musculoskeletal finding;soft tissue sarcoma, excluding rhabdomyosarcoma;narrowmatch
protein deregulation;pdgfr protein overexpression;narrowmatch
receptor tyrosine kinase gene amplification;pdgfr gene amplification;narrowmatch
immunophenotypic finding;chromogranin-positive neoplastic cells present;narrowmatch
expression positive;chromogranin positive;narrowmatch
gene variant;cdh1 gene mutation;narrowmatch
fusion gene;c11orf95/mkl2 fusion gene;narrowmatch
clinical course of disease;inoperable disease;narrowmatch
abnormal cells present;peribronchial proliferation of neoplastic cells present;narrowmatch
animal;vertebrata;narrowmatch
mammalia;primate;narrowmatch
experimental organism neoplasm;experimental organism benign mesoblastic nephroma;narrowmatch
vertebrata;mammalia;narrowmatch
hominidae;human;narrowmatch
transcription coactivator gene;mrtfb gene;narrowmatch
canine neoplasm;canine mammary adenoma;narrowmatch
akt1 gene mutation;activating akt1 gene mutation;narrowmatch
blasts 5 percent or more of bone marrow nucleated cells;blasts more than 5 percent of bone marrow nucleated cells;narrowmatch
eukaryota;animal;narrowmatch
histologic grade;undifferentiated;narrowmatch
disease morphology qualifier;diffuse;narrowmatch
disease morphology qualifier;benign;narrowmatch
histologic grade;well differentiated;narrowmatch
g protein-coupled receptor gene;cysltr2 gene;narrowmatch
disease stage qualifier;masaoka-koga stage;narrowmatch
blasts under 20 percent of peripheral blood white cells;blasts under 15 percent of peripheral blood white cells;narrowmatch
blasts under 20 percent of bone marrow nucleated cells;blasts under 15 percent of bone marrow nucleated cells;narrowmatch
blast cells present in peripheral blood;blasts 1 percent or more of peripheral blood white cells;narrowmatch
gene product sequence variation;gnas protein variant;narrowmatch
gene product sequence variation;cdkn2a protein variant;narrowmatch
gene product sequence variation;tp53 protein variant;narrowmatch
disease stage qualifier;mediastinal malignant germ cell tumor stage;narrowmatch
gene variant;wt1 gene mutation;narrowmatch
human papillomavirus negative;human papillomavirus-16 negative;narrowmatch
receptor tyrosine kinase gene mutation;fgfr gene mutation;narrowmatch
blast cells present in peripheral blood;blasts 30 percent or less of peripheral blood white cells;narrowmatch
immature myeloid cells increased in bone marrow;myeloblasts 5 percent or more of bone marrow nucleated cells;narrowmatch
blasts 5 percent or more of bone marrow nucleated cells;myeloblasts 5 percent or more of bone marrow nucleated cells;narrowmatch
blasts 5 percent or more of peripheral blood white cells;blasts more than 5 percent of peripheral blood white cells;narrowmatch
chromosome 13q abnormality;rb1 gene deletion;narrowmatch
gene deletion;rb1 gene deletion;narrowmatch
blasts 30 percent or less of peripheral blood white cells;blasts under 30 percent of peripheral blood white cells;narrowmatch
blasts 10 percent or more of peripheral blood white cells;blasts more than 10 percent of peripheral blood white cells;narrowmatch
cdk gene mutation;cdk4 gene mutation;narrowmatch
invasive lesion;questionable invasive lesion;narrowmatch
multihormonal immunoreactivity present;multihormonal immunoreactivity present in a single cell type;narrowmatch
estrogen receptor status;estrogen receptor positive;narrowmatch
hormone receptor positive;estrogen receptor positive;narrowmatch
morphologic finding;cytoplasmic alteration;narrowmatch
experimental organism neoplasm;experimental organism adenocarcinoma arising in fibroadenoma;narrowmatch
tumor mass;more than two separate tumor masses present in the same organ;narrowmatch
tumor mass;two separate tumor masses present in the same organ;narrowmatch
multihormonal immunoreactivity present;multihormonal immunoreactivity present in two or more cell types;narrowmatch
chromosomal translocation;mit family translocation;narrowmatch
dysplasia;squamous dysplasia;narrowmatch
protein deregulation;tfeb protein overexpression;narrowmatch
gene variant;usp8 gene mutation;narrowmatch
morphologic finding;crooke hyaline change;narrowmatch
neoplastic corticotroph cell;neoplastic corticotroph cell with scarce secretory granules;narrowmatch
neoplastic corticotroph cell;neoplastic corticotroph cell with abundant secretory granules;narrowmatch
histone gene;histone h3 gene;narrowmatch
myeloblasts under 10 percent of bone marrow nucleated cells;myeloblasts 5 percent or less of bone marrow nucleated cells;narrowmatch
estrogen receptor status;estrogen receptor negative;narrowmatch
expression negative;estrogen receptor negative;narrowmatch
hormone receptor positive;progesterone receptor positive;narrowmatch
progesterone receptor status;progesterone receptor positive;narrowmatch
morphologic finding;cytoplasmic accumulation of black pigment;narrowmatch
discoloration;black discoloration;narrowmatch
syndrome;intestinal polyposis syndrome;narrowmatch
lymphoplasmacytic infiltrate;bone marrow lymphoplasmacytic infiltrate;narrowmatch
low grade lesion;low grade neuroendocrine lesion;narrowmatch
poorly differentiated lesion;poorly differentiated neuroendocrine lesion;narrowmatch
intermediate grade lesion;intermediate grade neuroendocrine lesion;narrowmatch
well differentiated lesion;well differentiated neuroendocrine lesion;narrowmatch
tumor mass;aerodigestive invasive malignancy;narrowmatch
sellar region;intrasellar region;narrowmatch
body region;sellar region;narrowmatch
stromal change;primitive mesenchymal stroma formation;narrowmatch
chromosomal gain;gain of chromosome 14q;narrowmatch
expression negative;progesterone receptor negative;narrowmatch
progesterone receptor status;progesterone receptor negative;narrowmatch
blasts 5 percent or less of bone marrow nucleated cells;myeloblasts 5 percent or less of bone marrow nucleated cells;narrowmatch
blasts under 30 percent of peripheral blood white cells;blasts 20 percent or less of peripheral blood white cells;narrowmatch
gene variant;cdk4 gene mutation;narrowmatch
steatosis;hepatic steatosis;narrowmatch
regulatory gene;ankrd26 gene;narrowmatch
gene abnormality;telomere maintenance gene mutation;narrowmatch
helicase gene;ddx41 gene;narrowmatch
gene variant;ankrd26 gene mutation;narrowmatch
gene variant;ddx41 gene mutation;narrowmatch
gene variant;med12 gene mutation;narrowmatch
flt3 gene mutation;activating flt3 gene mutation;narrowmatch
morphologic finding;muscle invasion;narrowmatch
expression positive;cd1a positive;narrowmatch
abnormal cells present;bone marrow lymphoplasmacytic infiltration of less than 10%;narrowmatch
igm monoclonal gammopathy;serum igm monoclonal gammopathy of less than 30g/l;narrowmatch
chromosomal rearrangement;chromosome 7 rearrangement;narrowmatch
chromosome 7 abnormality;chromosome 7 rearrangement;narrowmatch
chromosomal rearrangement;chromosome 5 rearrangement;narrowmatch
chromosome 5 abnormality;chromosome 5 rearrangement;narrowmatch
gene variant;cdkn1b gene mutation;narrowmatch
blasts of mixed phenotype present;blasts expressing b-lymphoid, t-lymphoid, and myeloid markers present;narrowmatch
blasts of mixed phenotype present;blasts expressing b-lymphoid and t-lymphoid markers present;narrowmatch
expression positive;cd4 positive;narrowmatch
receptor tyrosine kinase gene rearrangement;fgfr gene rearrangement;narrowmatch
genetic finding;mgmt gene promoter methylation;narrowmatch
chromosomal translocation;xp11.2 translocation;narrowmatch
gene rearrangement abnormality;t-cell receptor gene rearrangement;narrowmatch
expression positive;pmel positive;narrowmatch
neoplastic plasma cells present in bone marrow;neoplastic plasma cells under 50 percent of bone marrow nucleated cells;narrowmatch
metastatic soft tissue sarcoma, excluding liposarcoma;locally advanced soft tissue sarcoma, excluding liposarcoma;narrowmatch
soft tissue sarcoma, excluding liposarcoma;metastatic soft tissue sarcoma, excluding liposarcoma;narrowmatch
musculoskeletal finding;soft tissue sarcoma, excluding liposarcoma;narrowmatch
male reproductive system finding;castration-sensitive;narrowmatch
mit family translocation;tfeb gene translocation;narrowmatch
mit family translocation;tfe3 gene translocation;narrowmatch
xp11.2 translocation;tfe3 gene translocation;narrowmatch
tfe3 gene rearrangement;tfe3 gene translocation;narrowmatch
gene rearrangement abnormality;nutm1 gene rearrangement;narrowmatch
dna repair gene;homologous recombination repair gene;narrowmatch
body region;lateral pharyngeal space;narrowmatch
body region;retropharyngeal space;narrowmatch
neoplasm by special category;non-malignant neoplasm;narrowmatch
chromosome 12 abnormality;rearrangement of 12p13.2;narrowmatch
viral infection;herpesvirus infection;narrowmatch
reactive vascular proliferation;cutaneous epithelioid angiomatous nodule;narrowmatch
disease marker;tumor marker;narrowmatch
tumor initiation;transformation;narrowmatch
enzyme;transferase;narrowmatch
transcription process;transcription;narrowmatch
chromosomal rearrangement;rearrangement of 12p13.2;narrowmatch
chromosomal rearrangement;rearrangement of 11p15;narrowmatch
chromosome 13 abnormality;chromosome 13q abnormality;narrowmatch
gametogenesis;spermatogenesis;narrowmatch
cushing syndrome;endogenous cushing syndrome;narrowmatch
cellular process;signal transduction;narrowmatch
biochemical pathway;signaling pathway;narrowmatch
non-neoplastic pancreatic disorder;non-neoplastic endocrine pancreas disorder;narrowmatch
endocrine pancreas disorder;non-neoplastic endocrine pancreas disorder;narrowmatch
rna processing;rna splicing;narrowmatch
apc gene mutation;apc promoter 1b variant;narrowmatch
chromosome 5 abnormality;apc promoter 1b variant;narrowmatch
apc promoter 1b variant;germline apc promoter 1b variant;narrowmatch
germline mutation;germline apc promoter 1b variant;narrowmatch
cell cycle gene;tp53 gene;narrowmatch
interphase process;g1 phase process;narrowmatch
verruca vulgaris;oral verruca vulgaris;narrowmatch
non-receptor tyrosine kinase gene;abl1 gene;narrowmatch
protein kinase;serine/threonine protein kinase;narrowmatch
female reproductive system finding;vaginal discharge;narrowmatch
receptor tyrosine kinase;fibroblast growth factor receptor family;narrowmatch
morphologic finding;focus of carcinoma cells measuring equal to or less than 2 cm present;narrowmatch
morphologic finding;abrupt nuclear anaplasia;narrowmatch
kinase;phosphatidylinositol-4,5-bisphosphate 3-kinase;narrowmatch
fusion gene;malat1/gli1 fusion gene;narrowmatch
morphologic finding;columnar cells with differentiation to chief cells and parietal cells present;narrowmatch
morphologic finding;invasive focus of carcinoma cells measuring 1 mm or less present;narrowmatch
morphologic finding;cellular granularity present;narrowmatch
regeneration;wound repair;narrowmatch
leukemia finding;central nervous system involvement in recurrent b acute lymphoblastic leukemia;narrowmatch
cytogenetic abnormality;chromosome 12 abnormality;narrowmatch
cell cycle gene;rb1 gene;narrowmatch
esterase;phosphatase;narrowmatch
gene product;protein;narrowmatch
protein kinase;protein tyrosine kinase;narrowmatch
post-translational regulation;post-translational modification;narrowmatch
phosphotransferase;protein kinase;narrowmatch
transferase;phosphotransferase;narrowmatch
biochemical reaction;phosphorylation process;narrowmatch
protein, organized by structure;phosphoprotein;narrowmatch
biological process;pathologic process;narrowmatch
chromosome 17 abnormality;chromosome 17p abnormality;narrowmatch
enzyme;oxidoreductase;narrowmatch
biochemical reaction;oxidation/reduction;narrowmatch
reproductive system finding;left-sided breast carcinoma;narrowmatch
gene product sequence variation;mutyh protein variant;narrowmatch
gene product sequence variation;med12 protein variant;narrowmatch
gene product sequence variation;sdhd protein variant;narrowmatch
gene product sequence variation;sdhb protein variant;narrowmatch
gene variant;prkd2 gene mutation;narrowmatch
ras family gene;hras gene;narrowmatch
receptor;cell surface receptor;narrowmatch
chromosome 17 abnormality;usp6 gene rearrangement;narrowmatch
receptor tyrosine kinase gene rearrangement;ntrk gene rearrangement;narrowmatch
esterase;ribonuclease;narrowmatch
fusion gene;actb/gli1 fusion gene;narrowmatch
chromosomal translocation;"t(7;12)(p21-22;q13-15)";narrowmatch
chromosome 12 abnormality;"t(7;12)(p21-22;q13-15)";narrowmatch
chromosome 7 rearrangement;"t(7;12)(p21-22;q13-15)";narrowmatch
reproductive process;reproduction;narrowmatch
transcription factor gene;rel gene;narrowmatch
multicellular process;regeneration;narrowmatch
dna sequence rearrangement;dna recombination process;narrowmatch
alveolar ridge;lower alveolar ridge;narrowmatch
alveolar ridge;upper alveolar ridge;narrowmatch
protein deregulation;fosl1 protein overexpression;narrowmatch
11q translocation;11q12 translocation;narrowmatch
gene rearrangement abnormality;usp6 gene rearrangement;narrowmatch
transcription factor gene;rb1 gene;narrowmatch
cancer gene;tumor suppressor gene;narrowmatch
expression positive;asph positive;narrowmatch
ctrp disease finding;tumor mass of the extremity;narrowmatch
disease progression;tumor progression;narrowmatch
morphologic finding;intraductal cellular proliferation;narrowmatch
chromosome 13q abnormality;foxo1 gene rearrangement;narrowmatch
gene rearrangement abnormality;foxo1 gene rearrangement;narrowmatch
dilated terminal duct lobular units present;marked distention of terminal duct lobular units present;narrowmatch
abnormal cells present;malignant cells with uniform nuclei present;narrowmatch
tumor mass;tumor mass of the extremity;narrowmatch
invasive lesion;locally invasive lesion;narrowmatch
signaling protein;g protein;narrowmatch
signaling pathway gene;apc gene;narrowmatch
tall columnar adenocarcinoma cell;tall columnar adenocarcinoma cell with reversed polarity;narrowmatch
cell death process;apoptosis;narrowmatch
transcriptional regulation;transcriptional activation;narrowmatch
gene variant;smad4 gene mutation;narrowmatch
head and neck part;lacrimal drainage system;narrowmatch
aging-related process;senescence;narrowmatch
tumor-associated process;tumor progression;narrowmatch
devil facial tumor disease;devil facial tumor disease 1;narrowmatch
devil facial tumor disease;devil facial tumor disease 2;narrowmatch
experimental organism neoplasm;experimental organism benign mesovarial leiomyoma;narrowmatch
myelopoiesis;thrombopoiesis;narrowmatch
metabolic process;biosynthetic process;narrowmatch
fusion gene;pax/foxo1 fusion gene;narrowmatch
hereditary neoplastic syndrome;acute lymphoblastic leukemia, susceptibility to, 3;narrowmatch
hereditary neoplastic syndrome;melanoma-astrocytoma syndrome;narrowmatch
canine neoplasm;canine sebaceous gland epithelioma;narrowmatch
mutation abnormality;germline mutation;narrowmatch
receptor;growth factor receptor;narrowmatch
immune response process;antigen presentation;narrowmatch
receptor;receptor tyrosine kinase;narrowmatch
protein tyrosine kinase;receptor tyrosine kinase;narrowmatch
recurrent disease;locally recurrent disease;narrowmatch
experimental organism neoplasm;experimental organism malignant pituicytoma;narrowmatch
experimental organism neoplasm;experimental organism amphophilic vacuolar adenoma;narrowmatch
experimental organism neoplasm;experimental organism amphophilic vacuolar carcinoma;narrowmatch
experimental organism neoplasm;rous sarcoma;narrowmatch
biological model;experimental model;narrowmatch
equine experimental organism diagnosis;horse transitional cell carcinoma;narrowmatch
bone;maxillofacial bone;narrowmatch
cemento-osseous dysplasia;focal cemento-osseous dysplasia;narrowmatch
non-neoplastic dental disorder;cemento-osseous dysplasia;narrowmatch
other finding;ctrp disease finding;narrowmatch
rearrangement of 11q;ccnd1 gene rearrangement;narrowmatch
ccnd1 gene rearrangement;ccnd1 gene translocation;narrowmatch
11q translocation;ccnd1 gene translocation;narrowmatch
ras superfamily protein;p21 ras protein;narrowmatch
non-neoplastic digestive system disorder;non-neoplastic appendix disorder;narrowmatch
retinal hamartoma;combined hamartoma of the retina and retinal pigment epithelium;narrowmatch
appendix disorder;non-neoplastic appendix disorder;narrowmatch
digestive system disorder;appendix disorder;narrowmatch
oral cavity disorder;tonsillar disorder;narrowmatch
non-neoplastic oral cavity disorder;non-neoplastic gingival disorder;narrowmatch
gingival disorder;non-neoplastic gingival disorder;narrowmatch
oral cavity disorder;gingival disorder;narrowmatch
oral cavity disorder;tongue disorder;narrowmatch
interphase process;s phase process;narrowmatch
helicase;rna helicase;narrowmatch
dna repair gene mutation;xrcc family gene mutation;narrowmatch
signaling pathway gene;nf1 gene;narrowmatch
hamartoma;retinal hamartoma;narrowmatch
non-neoplastic retinal disorder;retinal hamartoma;narrowmatch
transcription factor gene;fos family gene;narrowmatch
gene variant;eif1ax gene mutation;narrowmatch
ewsr1 gene translocation;"t(9;22)(q22;q12)";narrowmatch
ddit3 gene rearrangement;"t(12;22)(q13.3;q12)";narrowmatch
ewsr1 gene translocation;"t(12;22)(q13.3;q12)";narrowmatch
chromosome 12 abnormality;"t(12;22)(q13.12;q12)";narrowmatch
ewsr1 gene translocation;"t(12;22)(q13.12;q12)";narrowmatch
gene rearrangement abnormality;fus gene rearrangement;narrowmatch
neoplastic nodule;ipsilateral nodule;narrowmatch
inflammation;chronic inflammation;narrowmatch
phosphoprotein phosphatase;protein tyrosine phosphatase;narrowmatch
stromal change;stromal proliferation of nevus cells present;narrowmatch
signaling pathway gene;nf2 gene;narrowmatch
gene product sequence variation;rb1 protein variant;narrowmatch
gene product sequence variation;ptpn11 protein variant;narrowmatch
gene product sequence variation;ptch1 protein variant;narrowmatch
protein, organized by function;enzyme;narrowmatch
digestive system part;proximal stomach;narrowmatch
bone marrow failure;bone marrow failure syndrome;narrowmatch
syndrome;bone marrow failure syndrome;narrowmatch
hydrolase;esterase;narrowmatch
myelopoiesis;erythropoiesis;narrowmatch
gene product sequence variation;pten protein variant;narrowmatch
neoantigen-positive;patient-specific neoantigen-positive;narrowmatch
neoantigen-positive;shared neoantigen-positive;narrowmatch
very high risk myelodysplastic syndrome;recurrent very high risk myelodysplastic syndrome;narrowmatch
positive laboratory test result;neoantigen-positive;narrowmatch
mixture of morphologic patterns;mixture of melanocytic neoplastic components present;narrowmatch
head and neck part;sinonasal tract and oral cavity;narrowmatch
melanin pigment present;melanin-pigmented epithelioid cells present;narrowmatch
hereditary neoplastic syndrome;hereditary colorectal cancer syndrome;narrowmatch
intermediary metabolic process;energy metabolism process;narrowmatch
transmembrane transport;endocytotic process;narrowmatch
integumentary system finding;skin with high degree of cumulative sun damage;narrowmatch
dna repair;excision repair;narrowmatch
integumentary system part;nail matrix;narrowmatch
gene rearrangement abnormality;ewsr1 gene rearrangement;narrowmatch
transcription factor gene;homeobox gene;narrowmatch
gene expression process;gene expression;narrowmatch
deletion mutation;gene deletion;narrowmatch
reproductive process;gametogenesis;narrowmatch
reproductive process;fertilization;narrowmatch
head and neck finding;second primary squamous cell carcinoma of the head and neck;narrowmatch
gene product sequence variation;fgfr4 protein variant;narrowmatch
lymphoma finding;diffuse large b-cell lymphoma with associated monoclonal small b-cell population in bone marrow;narrowmatch
receptor status;hormone receptor negative;narrowmatch
expression negative;hormone receptor negative;narrowmatch
mixed neoplastic epithelial cell population;mixed malignant epithelial cell population;narrowmatch
reactive vascular proliferation;atypical vascular lesion;narrowmatch
non-neoplastic skin disorder;atypical vascular lesion;narrowmatch
fusion gene;cic/dux4l fusion gene;narrowmatch
gene rearrangement abnormality;cic gene rearrangement;narrowmatch
very high risk myelodysplastic syndrome;refractory very high risk myelodysplastic syndrome;narrowmatch
myeloid neoplasm finding;very high risk myelodysplastic syndrome;narrowmatch
pathologic process;neovascularization;narrowmatch
cell growth process;cell growth;narrowmatch
abdominal mass;abdominal neoplasm, excluding pancreas neoplasm;narrowmatch
gene product sequence variation;apc protein variant;narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's sarcoma;narrowmatch
cell viability process;cell survival;narrowmatch
dysplasia;dysplasia negative;narrowmatch
negative test result;dysplasia negative;narrowmatch
cell movement;cell motility;narrowmatch
cellular process;cell differentiation process;narrowmatch
aerodigestive invasive malignancy;upper aerodigestive invasive malignancy;narrowmatch
cell division process;cell cycle process;narrowmatch
multicellular process;intercellular communication process;narrowmatch
cellular process;cell aging;narrowmatch
biological sciences;biology;narrowmatch
occupation or discipline;biological sciences;narrowmatch
diagnostic or prognostic factor;biomarker;narrowmatch
experimental malignant melanoma;b16 malignant melanoma;narrowmatch
tumor mass;abdominal neoplasm, excluding pancreas neoplasm;narrowmatch
chromosomal translocation;brd4 gene translocation;narrowmatch
gene rearrangement abnormality;pax3 gene rearrangement;narrowmatch
mixture of morphologic patterns;neuroendocrine and non-neuroendocrine neoplastic components present;narrowmatch
chromosomal translocation;nutm1 gene translocation;narrowmatch
nutm1 gene rearrangement;nutm1 gene translocation;narrowmatch
negative test result;expression negative;narrowmatch
transcriptional regulation;transcriptional repression;narrowmatch
body region;trunk and extremities;narrowmatch
ligand binding protein;dna binding protein;narrowmatch
replication-associated process;dna replication;narrowmatch
dna maintenance;dna repair;narrowmatch
structural protein;cytoskeletal protein;narrowmatch
m phase process;cytokinesis;narrowmatch
reproductive process;conception;narrowmatch
experimental malignant melanoma;cloudman s91 malignant melanoma;narrowmatch
gene product sequence variation;dicer1 protein variant;narrowmatch
gene product sequence variation;ctnnb1 protein variant;narrowmatch
gene product sequence variation;cdc73 protein variant;narrowmatch
major histocompatibility complex gene;mhc class i gene;narrowmatch
digestive system finding;non-recurrent esophageal carcinoma;narrowmatch
respiratory system finding;non-recurrent lung carcinoma;narrowmatch
mouse squamous cell carcinoma;squamous cell carcinoma of the mouse tongue;narrowmatch
bone marrow dysplasia present;bone marrow dysplasia present in less than 10 percent of myeloid cells;narrowmatch
myeloblasts 1 percent or less of peripheral blood white cells;myeloblasts 1 percent of peripheral blood white cells;narrowmatch
conceptual entity;model;narrowmatch
m phase process;mitosis;narrowmatch
cytoskeletal protein;microtubule associated protein;narrowmatch
abnormal cells present;pigmented dendritic melanocytes present;narrowmatch
fibrosis;liver fibrosis;narrowmatch
chromosomal translocation;fus gene translocation;narrowmatch
musculoskeletal disorder;non-neoplastic musculoskeletal disorder;narrowmatch
fus gene rearrangement;fus gene translocation;narrowmatch
alkylation process;methylation;narrowmatch
m phase process;metaphase process;narrowmatch
metabolic process;detoxification;narrowmatch
protein, organized by location;membrane protein;narrowmatch
mouse neoplasms;experimental malignant melanoma;narrowmatch
gene;major histocompatibility complex gene;narrowmatch
myeloblasts under 2 percent of peripheral blood white cells;myeloblasts 1 percent or less of peripheral blood white cells;narrowmatch
myeloid neoplasm finding;high risk chronic myelogenous leukemia, bcr-abl1 positive;narrowmatch
leukemia finding;high risk chronic myelogenous leukemia, bcr-abl1 positive;narrowmatch
myeloid neoplasm finding;very high risk chronic myelogenous leukemia, bcr-abl1 positive;narrowmatch
cytogenetic abnormality;abnormal karyotype;narrowmatch
myc family gene;myc gene;narrowmatch
developmental process;morphogenesis;narrowmatch
fusion gene;gata2/mecom fusion gene;narrowmatch
gene variant;samd9l gene mutation;narrowmatch
gene variant;samd9 gene mutation;narrowmatch
regulatory gene;samd9l gene;narrowmatch
round cell liposarcoma;unresectable round cell liposarcoma;narrowmatch
metastatic round cell liposarcoma;advanced round cell liposarcoma;narrowmatch
spinal region;thoracic region;narrowmatch
body region;spinal region;narrowmatch
high risk acute leukemia;high risk acute lymphoblastic leukemia;narrowmatch
urinary system finding;very high risk prostate carcinoma;narrowmatch
urinary system finding;high risk prostate carcinoma;narrowmatch
leukemia finding;very high risk chronic myelogenous leukemia, bcr-abl1 positive;narrowmatch
cell cycle process;interphase process;narrowmatch
membrane protein;transmembrane protein;narrowmatch
plasma cell neoplasm finding;high risk plasma cell myeloma;narrowmatch
decreased expression;neoplastic cells with cd38 dim-to-negative expression present;narrowmatch
decreased expression;neoplastic cells with cd45 dim-to-negative expression present;narrowmatch
cd56-positive neoplastic cells present;neoplastic cells with bright cd56 expression present;narrowmatch
gene product sequence variation;notch1 protein variant;narrowmatch
gene product sequence variation;nf1 protein variant;narrowmatch
biochemical reaction;hydrolysis;narrowmatch
enzyme;hydrolase;narrowmatch
structural protein;histone;narrowmatch
histone;histone h3;narrowmatch
histogenic process;hematopoietic process;narrowmatch
experimental malignant melanoma;harding-passey malignant melanoma;narrowmatch
hydrolase;gtpase;narrowmatch
organismal process;embryogenesis;narrowmatch
developmental process;tissue growth;narrowmatch
digestive system part;pancreatobiliary system;narrowmatch
non-neoplastic connective and soft tissue disorder;non-neoplastic musculoskeletal disorder;narrowmatch
immunophenotypic finding;neoplastic cells with cd45 dim-to-negative expression present;narrowmatch
immunophenotypic finding;neoplastic cells with cd38 dim-to-negative expression present;narrowmatch
hematopoietic system finding;lymphoma finding;narrowmatch
hla-dr negative;hla-dr-negative neoplastic cells present;narrowmatch
hematopoietic system finding;leukemia finding;narrowmatch
hematopoietic system finding;myeloid neoplasm finding;narrowmatch
hematopoietic system finding;plasma cell neoplasm finding;narrowmatch
high risk chronic myelomonocytic leukemia;refractory high risk chronic myelomonocytic leukemia;narrowmatch
high risk chronic myelomonocytic leukemia;recurrent high risk chronic myelomonocytic leukemia;narrowmatch
urinary system finding;recurrent non-muscle invasive bladder urothelial carcinoma (nmibc) with a prior history of low or intermediate risk nmibc;narrowmatch
blasts 1 percent or more of bone marrow nucleated cells;blasts 2 percent or more of bone marrow nucleated cells;narrowmatch
11q translocation;mll gene translocation;narrowmatch
mll gene rearrangement;mll gene translocation;narrowmatch
gene product sequence variation;sf3b1 protein variant;narrowmatch
immunity;humoral immunity;narrowmatch
immunity;cell-mediated immunity;narrowmatch
immune system process;immunity;narrowmatch
dna repair gene mutation;inactivating brca gene mutation;narrowmatch
immunophenotypic finding;hla-dr-negative neoplastic cells present;narrowmatch
clinical course of disease;localized disease;narrowmatch
neoplastic stromal cell;neoplastic mononuclear stromal cell;narrowmatch
mass;unresectable mass;narrowmatch
proliferative change of the rat urinary system;rat urinary system neoplasms;narrowmatch
immunophenotypic finding;vip-positive neoplastic cells present;narrowmatch
immunophenotypic finding;somatostatin-positive neoplastic cells present;narrowmatch
immunophenotypic finding;gastrin-positive neoplastic cells present;narrowmatch
body region;periampullary region;narrowmatch
digestive system obstruction;biliary obstruction;narrowmatch
rat neoplasms;rat neoplasms by morphology;narrowmatch
rat nervous system and sensory organs neoplasms;rat special sensory organ neoplasms;narrowmatch
proliferative change of the rat soft tissue and musculoskeletal system;rat soft tissue and musculoskeletal system neoplasms;narrowmatch
proliferative change of the rat nervous system and sensory organs;rat nervous system and sensory organs neoplasms;narrowmatch
proliferative change of the rat respiratory system;rat respiratory system neoplasms;narrowmatch
rat genital system neoplasms;rat male genital system neoplasms;narrowmatch
proliferative change of the rat integumentary system;rat integumentary system neoplasms;narrowmatch
proliferative change of the rat hematopoietic and mononuclear phagocytic system;rat hematopoietic and mononuclear phagocytic system neoplasms;narrowmatch
proliferative change of the rat genital system;rat genital system neoplasms;narrowmatch
rat genital system neoplasms;rat female genital system neoplasms;narrowmatch
proliferative change of the rat endocrine system;rat endocrine system neoplasms;narrowmatch
immunophenotypic finding;glucagon-like peptide positive neoplastic cells present;narrowmatch
eno2 positive;neuron-specific enolase positive neoplastic cells present;narrowmatch
immunophenotypic finding;neuron-specific enolase positive neoplastic cells present;narrowmatch
neoplastic growth or spread;submucosal tumor growth;narrowmatch
morphologic finding;metaplasia of malignant cells present;narrowmatch
rat reproductive system part;rat male reproductive system part;narrowmatch
rat reproductive system part;rat female reproductive system part;narrowmatch
rat anatomy concepts;rat urinary system part;narrowmatch
rat anatomy concepts;rat special sensory organ part;narrowmatch
rat anatomy concepts;rat respiratory system part;narrowmatch
rat anatomy concepts;rat reproductive system part;narrowmatch
rat anatomy concepts;rat nervous system part;narrowmatch
rat anatomy concepts;rat musculoskeletal system part;narrowmatch
rat anatomy concepts;rat lymphohematopoietic system part;narrowmatch
rat anatomy concepts;rat integument system part;narrowmatch
rat anatomy concepts;rat endocrine system part;narrowmatch
rat anatomy concepts;rat digestive system part;narrowmatch
rat anatomy concepts;rat cardiovascular system part;narrowmatch
absence of muscle invasion;absence of invasion of the muscularis externa;narrowmatch
proliferative change of the rat digestive system;rat digestive system neoplasms;narrowmatch
proliferative change of the rat cardiovascular system;rat cardiovascular system neoplasms;narrowmatch
metaplasia of malignant cells present;spindle cell metaplasia of malignant cells present;narrowmatch
rat nervous system part;rat spinal meninx;narrowmatch
rat respiratory system part;rat trachea;narrowmatch
rat digestive system part;rat tooth;narrowmatch
rat digestive system part;rat tongue;narrowmatch
rat endocrine system part;rat thyroid gland;narrowmatch
rat lymphohematopoietic system part;rat thymus;narrowmatch
rat male reproductive system part;rat testis;narrowmatch
rat digestive system part;rat sublingual gland;narrowmatch
rat nervous system part;rat spinal cord;narrowmatch
rat neoplasms;rat neoplasms by location;narrowmatch
rat musculoskeletal system part;rat soft tissue;narrowmatch
rat integument system part;rat skin/subcutaneous tissue;narrowmatch
rat musculoskeletal system part;rat skeletal system;narrowmatch
rat musculoskeletal system part;rat skeletal muscle;narrowmatch
rat male reproductive system part;rat seminal vesicle;narrowmatch
rat digestive system part;rat salivary gland;narrowmatch
rat urinary system part;rat renal pelvis;narrowmatch
rat urinary system part;rat ureter;narrowmatch
rat urinary system part;rat urethra;narrowmatch
rat urinary system part;rat urinary bladder;narrowmatch
rat female reproductive system part;rat uterine cervix;narrowmatch
ultrastructural finding;enterochromaffin type granules present;narrowmatch
ultrastructural finding;enterochromaffin-like type granules present;narrowmatch
immunophenotypic finding;serotonin-positive neoplastic cells present;narrowmatch
immunophenotypic finding;argentaffin positive neoplastic cells present;narrowmatch
chromogranin-positive neoplastic cells present;chromogranin-a positive neoplastic cells present;narrowmatch
signaling pathway gene;malt1 gene;narrowmatch
cell cycle gene;rassf1 gene;narrowmatch
malignant epithelial large cell with vesicular nucleus and distinct nucleolus;malignant epithelial cell with vesicular nucleus, distinct nucleolus, and abundant pink cytoplasm;narrowmatch
lesion by morphology;intramucosal lesion;narrowmatch
disturbance in bowel function;tenesmus;narrowmatch
lesion;childhood lesion;narrowmatch
lesion;adulthood lesion;narrowmatch
rat integument system part;rat zymbal gland;narrowmatch
rat female reproductive system part;rat vagina;narrowmatch
rat female reproductive system part;rat uterus;narrowmatch
metaplasia of malignant cells present;squamous metaplasia of malignant cells present;narrowmatch
metaplasia of malignant cells present;mesenchymal metaplasia of malignant cells present;narrowmatch
rat male reproductive system part;rat preputial gland;narrowmatch
tobacco toxicity;cigarette smoking toxicity;narrowmatch
morphologic architectural pattern;hemorrhagic pattern;narrowmatch
morphologic architectural pattern;sclerotic pattern;narrowmatch
epithelial component present;entrapped respiratory epithelium present;narrowmatch
malignant round germ cell;malignant round germ cell with glycogen-rich cytoplasm and round nucleus;narrowmatch
cancer stage (antiquated);stage i retinoblastoma;narrowmatch
dna repair gene;mutyh gene;narrowmatch
tobacco toxicity;tobacco chewing toxicity;narrowmatch
toxicity;tobacco toxicity;narrowmatch
neoplastic epithelial polygonal cell;neoplastic epithelial large polygonal cell;narrowmatch
toxicity;alcohol toxicity;narrowmatch
adenocarcinoma cell;basophilic adenocarcinoma cell;narrowmatch
abnormal tissue present;prominent elastic tissue cores present;narrowmatch
epithelial component present;multifocal epithelial proliferations less than 1mm in diameter present;narrowmatch
neoplastic epithelial polygonal cell;malignant epithelial medium-sized polygonal cell;narrowmatch
malignant epithelial cell;malignant epithelial medium-sized polygonal cell;narrowmatch
neoplastic epithelial large polygonal cell;malignant epithelial large polygonal cell;narrowmatch
stage i retinoblastoma;stage ia retinoblastoma;narrowmatch
stage i retinoblastoma;stage ib retinoblastoma;narrowmatch
cancer stage (antiquated);stage ii retinoblastoma;narrowmatch
stage ii retinoblastoma;stage iia retinoblastoma;narrowmatch
rat proliferative change by location;proliferative change of the rat respiratory system;narrowmatch
rat proliferative change by location;proliferative change of the rat nervous system and sensory organs;narrowmatch
rat proliferative change by location;proliferative change of the rat integumentary system;narrowmatch
rat proliferative change by location;proliferative change of the rat hematopoietic and mononuclear phagocytic system;narrowmatch
rat proliferative change by location;proliferative change of the rat genital system;narrowmatch
rat proliferative change by location;proliferative change of the rat endocrine system;narrowmatch
rat proliferative change by location;proliferative change of the rat digestive system;narrowmatch
rat proliferative change by location;proliferative change of the rat cardiovascular system;narrowmatch
rat histopathology diagnoses for proliferative changes;rat proliferative change by location;narrowmatch
adenocarcinoma cell with eosinophilic cytoplasm;large adenocarcinoma cell with eosinophilic cytoplasm;narrowmatch
malignant cell with eosinophilic cytoplasm;large adenocarcinoma cell with eosinophilic cytoplasm;narrowmatch
stage ii retinoblastoma;stage iib retinoblastoma;narrowmatch
glandular pattern;non-specific glandular pattern;narrowmatch
absence of invasion;absence of muscle invasion;narrowmatch
urinary system part;kidney and ureter;narrowmatch
malignant epithelial large cell;malignant epithelial large polygonal cell;narrowmatch
neoplastic epithelial small oval cell;malignant epithelial small oval cell;narrowmatch
mesenchymal metaplasia of malignant cells present;cartilaginous metaplasia of malignant cells present;narrowmatch
abnormal tissue present;proliferation of small ducts present;narrowmatch
necrotic change;single cell necrosis;narrowmatch
abnormal tissue present;ectopic thyroid tissue present;narrowmatch
morphologic finding;squamoid corpuscle;narrowmatch
syndrome;lipase hypersecretion syndrome;narrowmatch
morphologic finding;melanin pigment present;narrowmatch
malignant small round cell;malignant small round cell with scant amount of dark granular cytoplasm;narrowmatch
abnormal epithelial cell;small cuboidal cell resembling fetal hepatocyte;narrowmatch
common bile duct;distal common bile duct;narrowmatch
malignant epithelial oval cell;malignant epithelial small oval cell;narrowmatch
abnormal tissue present;cysts containing proteinaceous fluid present;narrowmatch
digestive system fistula;anorectal fistula;narrowmatch
mucosa;anal mucosa;narrowmatch
neoplastic cutaneous basal cell;malignant cutaneous basal cell;narrowmatch
malignant basal cell;malignant cutaneous basal cell;narrowmatch
abnormal tissue present;fibrovascular stalks present;narrowmatch
mesenchymal metaplasia of malignant cells present;osseous metaplasia of malignant cells present;narrowmatch
ultrastructural finding;cytoplasmic membrane-bound granules present;narrowmatch
glandular pattern;microglandular pattern;narrowmatch
malignant mesothelial cell;malignant spindle mesothelial cell;narrowmatch
malignant spindle cell;malignant spindle mesothelial cell;narrowmatch
neoplastic epithelial oval cell;neoplastic epithelial small oval cell;narrowmatch
neoplastic epithelial small polygonal cell;malignant epithelial small polygonal cell;narrowmatch
malignant epithelial small cell;malignant epithelial small polygonal cell;narrowmatch
neoplastic epithelial polygonal cell;neoplastic epithelial small polygonal cell;narrowmatch
neoplastic epithelial oval cell;malignant epithelial oval cell;narrowmatch
malignant epithelial cell;malignant epithelial oval cell;narrowmatch
neoplastic epithelial cell;neoplastic epithelial oval cell;narrowmatch
autoimmune nervous system disorder;myasthenia gravis;narrowmatch
invasive lesion;widely invasive lesion;narrowmatch
invasive lesion;minimally invasive lesion;narrowmatch
neoplastic mesothelial cell;cuboidal neoplastic mesothelial cell;narrowmatch
neoplastic mesothelial cell;flattened neoplastic mesothelial cell;narrowmatch
morphologic finding;absence of invasion or limited invasion present;narrowmatch
mesenchymal component present;dense collagenized tissue present;narrowmatch
tissue differentiation;histiocytoid differentiation;narrowmatch
rat male reproductive system part;rat prostate;narrowmatch
rat soft tissue;rat pleura;narrowmatch
abnormal tissue present;mucinous fibroplasia;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat malignant mesothelioma;narrowmatch
rat digestive system neoplasms;rat malignant odontogenic tumor;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant neuromyoblastoma;narrowmatch
rat neoplasms by morphology;rat malignant neuroendocrine cell tumor;narrowmatch
rat neoplasms by morphology;rat malignant mixed tumor;narrowmatch
rat male genital system neoplasms;rat malignant mixed sertoli-leydig cell tumor;narrowmatch
rat female genital system neoplasms;rat malignant mixed muellerian tumor;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant mixed glioma;narrowmatch
rat urinary system neoplasms;rat malignant mesenchymoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat malignant hemangiopericytoma;narrowmatch
rat integumentary system neoplasms;rat malignant melanoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant melanoma;narrowmatch
rat endocrine system neoplasms;rat malignant medullary tumor;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat malignant mast cell tumor;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat malignant lymphoma;narrowmatch
rat special sensory organ neoplasms;rat malignant intraocular schwannoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat malignant intraocular schwannoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant oligodendroglioma;narrowmatch
rat endocrine system neoplasms;rat malignant pinealoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant reticulosis;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat malignant schwannoma;narrowmatch
rat neuroblastoma;rat olfactory neuroblastoma;narrowmatch
rat benign odontogenic tumor;rat odontoma;narrowmatch
rat benign odontogenic tumor;rat odontogenic fibroma;narrowmatch
rat special sensory organ neoplasms;rat ocular dermoid;narrowmatch
rat respiratory system neoplasms;rat non-keratinizing epithelioma;narrowmatch
rat hyperplasia;rat neuroendocrine cell hyperplasia;narrowmatch
rat urinary system neoplasms;rat nephroblastoma;narrowmatch
rat endocrine system neoplasms;rat myelolipoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat meningeal sarcoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat medulloblastoma;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat malignant thymoma;narrowmatch
rat female genital system neoplasms;rat malignant thecoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat malignant teratoma;narrowmatch
rat genital system neoplasms;rat malignant sertoli cell tumor;narrowmatch
rat male genital system neoplasms;rat malignant seminoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat malignant hibernoma;narrowmatch
rat genital system neoplasms;rat malignant granulosa cell tumor;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat osteoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat hemangiosarcoma;narrowmatch
rat endocrine system neoplasms;rat islet cell adenoma;narrowmatch
rat histopathology diagnoses for proliferative changes;rat hyperplasia;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat histiocytic sarcoma;narrowmatch
rat hepatic neoplasm;rat hepatocholangiocellular carcinoma;narrowmatch
rat hepatic neoplasm;rat hepatocholangiocellular adenoma;narrowmatch
rat hepatic neoplasm;rat hepatocellular carcinoma;narrowmatch
rat hepatic neoplasm;rat hepatocellular adenoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat hemangioma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat malignant fibrous histiocytoma;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat granulocytic leukemia;narrowmatch
rat female genital system neoplasms;rat glandular polyp;narrowmatch
rat carcinoma;rat follicular cell carcinoma;narrowmatch
rat adenoma;rat follicular cell adenoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat fibrosarcoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat fibroma;narrowmatch
rat integumentary system neoplasms;rat fibroadenoma;narrowmatch
rat endocrine system neoplasms;rat islet cell carcinoma;narrowmatch
rat respiratory system neoplasms;rat keratinizing cystic epithelioma;narrowmatch
rat neoplasms by morphology;rat keratoacanthoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat leiomyoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant ependymoma;narrowmatch
rat cardiovascular system neoplasms;rat malignant endocardial schwannoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant craniopharyngioma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat malignant chordoma;narrowmatch
rat cardiovascular system neoplasms;rat malignant atriocaval mesothelioma;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant astrocytoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat lymphangioma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat liposarcoma;narrowmatch
neoplastic large cell with abundant cytoplasm;adenocarcinoma cell with abundant cytoplasm;narrowmatch
adenocarcinoma cell;adenocarcinoma cell with abundant cytoplasm;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat lipoma;narrowmatch
rat male genital system neoplasms;rat leydig cell carcinoma;narrowmatch
rat male genital system neoplasms;rat leydig cell adenoma;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat leukemia;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat leiomyosarcoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat osteochondroma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat osteosarcoma;narrowmatch
rat endocrine system part;rat pituitary gland;narrowmatch
rat digestive system part;rat esophagus;narrowmatch
rat musculoskeletal system part;rat joint;narrowmatch
rat lymphohematopoietic system part;rat hematopoietic tissue;narrowmatch
rat cardiovascular system part;rat heart;narrowmatch
rat digestive system part;rat glandular stomach;narrowmatch
rat digestive system part;rat forestomach;narrowmatch
rat special sensory organ part;rat eyelid;narrowmatch
rat special sensory organ part;rat eyeball;narrowmatch
rat male reproductive system part;rat epididymis;narrowmatch
rat respiratory system part;rat bronchiole;narrowmatch
rat special sensory organ part;rat external ear;narrowmatch
rat nervous system part;rat cranial nerve;narrowmatch
rat special sensory organ part;rat conjunctiva;narrowmatch
rat male reproductive system part;rat coagulating gland;narrowmatch
rat female reproductive system part;rat clitoral gland;narrowmatch
rat nervous system part;rat cerebral meninx;narrowmatch
rat nervous system part;rat cerebellum;narrowmatch
rat urinary system part;rat kidney;narrowmatch
rat respiratory system part;rat larynx;narrowmatch
rat digestive system part;rat liver;narrowmatch
rat respiratory system part;rat lung;narrowmatch
rat endocrine system part;rat pineal gland;narrowmatch
rat soft tissue;rat peritoneum;narrowmatch
rat soft tissue;rat pericardium;narrowmatch
rat digestive system part;rat parotid gland;narrowmatch
rat endocrine system part;rat parathyroid gland;narrowmatch
rat respiratory system part;rat paranasal sinus;narrowmatch
rat digestive system part;rat pancreas;narrowmatch
rat female reproductive system part;rat oviduct;narrowmatch
rat female reproductive system part;rat ovary;narrowmatch
rat cavity;rat oral cavity;narrowmatch
rat respiratory system part;rat nasopharynx;narrowmatch
rat respiratory system part;rat nasal cavity;narrowmatch
rat lymphohematopoietic system part;rat mononuclear phagocytic tissue;narrowmatch
rat digestive system part;rat mandibular gland;narrowmatch
rat integument system part;rat mammary gland;narrowmatch
rat respiratory system part;rat bronchus;narrowmatch
rat nervous system part;rat brain;narrowmatch
rat neoplasms by morphology;rat papilloma;narrowmatch
rat male genital system neoplasms;rat rete testis adenoma;narrowmatch
rat carcinoma;rat squamous cell carcinoma;narrowmatch
rat carcinoma;rat sebaceous cell carcinoma;narrowmatch
rat adenoma;rat sebaceous cell adenoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat sarcoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat rhabdomyosarcoma;narrowmatch
rat special sensory organ neoplasms;rat retinoblastoma;narrowmatch
rat male genital system neoplasms;rat rete testis carcinoma;narrowmatch
rat urinary system neoplasms;liposarcoma of the rat kidney;narrowmatch
rat endocrine system part;rat adrenal gland;narrowmatch
rat urinary system neoplasms;lipoma of the rat kidney;narrowmatch
rat endocrine system neoplasms;rat pituicytoma;narrowmatch
rat endocrine system neoplasms;rat pars intermedia adenoma;narrowmatch
rat adenoma;rat pars intermedia adenoma;narrowmatch
rat carcinoma;rat pars distalis carcinoma;narrowmatch
rat endocrine system neoplasms;rat pars distalis adenoma;narrowmatch
rat adenoma;rat pars distalis adenoma;narrowmatch
epithelial component present;large neoplastic glands with branching and papillary infolding present;narrowmatch
rat digestive system neoplasms;rat squamous cell papilloma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat synovial sarcoma;narrowmatch
rat carcinoma;rat transitional cell carcinoma;narrowmatch
experimental organism anatomical concept;rat anatomy concepts;narrowmatch
neoplastic neuroendocrine cell;neoplastic neuroendocrine small cell;narrowmatch
morphologic finding;polarization of nuclei towards the glandular lumen;narrowmatch
morphologic finding;intraluminal masses of mucin present;narrowmatch
adenocarcinoma cell;tall columnar adenocarcinoma cell;narrowmatch
rat female genital system neoplasms;rat yolk sac carcinoma;narrowmatch
rat special sensory organ neoplasms;rat uveal leiomyoma;narrowmatch
rat neoplasms;rat unclassifiable malignant tumor;narrowmatch
rat neoplasms;rat unclassifiable benign tumor;narrowmatch
adenocarcinoma cell with abundant cytoplasm;adenocarcinoma cell with foamy cytoplasm;narrowmatch
tubulostromal adenoma;rat tubulostromal adenoma;narrowmatch
rat adenoma;rat tubulostromal adenoma;narrowmatch
tubulostromal adenocarcinoma;rat tubulostromal adenocarcinoma;narrowmatch
rat adenocarcinoma;rat tubulostromal adenocarcinoma;narrowmatch
rat urinary system neoplasms;rat transitional cell papilloma;narrowmatch
stage ii retinoblastoma;stage iic retinoblastoma;narrowmatch
rat proliferative change by location;proliferative change of the rat soft tissue and musculoskeletal system;narrowmatch
rat proliferative change by location;proliferative change of the rat urinary system;narrowmatch
follicular differentiation;tricholemmal differentiation;narrowmatch
skeletal system part;upper clivus;narrowmatch
skeletal system part;posterior foramen magnum;narrowmatch
toxicity;aflatoxins toxicity;narrowmatch
peripheral nervous system part;anterior visual pathway;narrowmatch
skeletal system part;anterior foramen magnum;narrowmatch
non-neoplastic endocrine disorder;hypopituitarism;narrowmatch
hyperkeratosis;epidermolytic ichthyosis;narrowmatch
abnormal cells present;shadow cells present;narrowmatch
malignant epithelial cell;malignant apocrine cell;narrowmatch
morphologic architectural pattern;fenestrated pattern;narrowmatch
adnexal differentiation;follicular differentiation;narrowmatch
follicular differentiation;trichoblastic differentiation;narrowmatch
cancer stage (antiquated);stage iib nasopharyngeal keratinizing squamous cell carcinoma;narrowmatch
cancer stage (antiquated);stage iia nasopharyngeal keratinizing squamous cell carcinoma;narrowmatch
morphologic architectural pattern;compartmentalized pattern;narrowmatch
epithelial component present;anastomosing cells connected to the basal layer of the epidermis present;narrowmatch
sensory ganglion;trigeminal ganglion;narrowmatch
skeletal system part;petrous apex;narrowmatch
body region;petroclival region;narrowmatch
body region;periocular region;narrowmatch
rat salivary gland neoplasm;adenoma of the rat parotid gland;narrowmatch
rat salivary gland neoplasm;adenoma of the rat mandibular gland;narrowmatch
rat salivary gland neoplasm;adenocarcinoma of the rat sublingual gland;narrowmatch
rat salivary gland neoplasm;adenocarcinoma of the rat salivary gland;narrowmatch
rat salivary gland neoplasm;adenocarcinoma of the rat parotid gland;narrowmatch
rat salivary gland neoplasm;adenocarcinoma of the rat mandibular gland;narrowmatch
rat malignant odontogenic tumor;rat acanthomatous ameloblastoma;narrowmatch
rat odontoma;rat compound odontoma;narrowmatch
rat odontoma;rat complex odontoma;narrowmatch
rat anatomy concepts;rat cavity;narrowmatch
candidate tumor suppressor gene;flcn gene;narrowmatch
pigment;melanin;narrowmatch
lymphocytic infiltrate;perivascular lymphocytic infiltrate;narrowmatch
body region;sphenocavernous region;narrowmatch
body region;sphenoorbital region;narrowmatch
neoplastic apocrine cell;malignant apocrine cell;narrowmatch
neoplastic eccrine cell;malignant eccrine cell;narrowmatch
rat salivary gland neoplasm;adenoma of the rat sublingual gland;narrowmatch
large melanoma cell;giant melanoma cell;narrowmatch
melanoma cell;signet ring melanoma cell;narrowmatch
signet ring cell;signet ring melanoma cell;narrowmatch
melanoma cell;small melanoma cell;narrowmatch
melanoma cell;large melanoma cell;narrowmatch
integumentary system signs and symptoms;actinic damage;narrowmatch
injury;actinic damage;narrowmatch
skin tissue;dermo-epidermal junction;narrowmatch
large melanoma cell;melanoma cell with large nucleus and abundant pale cytoplasm;narrowmatch
malignant epithelial cell;malignant eccrine cell;narrowmatch
morphologic architectural pattern;fenestrating pattern;narrowmatch
carcinomatous component present;arborising network of cords of basaloid cells present;narrowmatch
stromal change;fibrovascular stroma formation;narrowmatch
adnexal differentiation;matrical differentiation;narrowmatch
abnormal tissue present;slit-like stromal retraction present;narrowmatch
epithelial component present;proliferation of basaloid cells parallel to the long axis of the epidermis present;narrowmatch
morphologic architectural pattern;micronodular pattern;narrowmatch
large melanoma cell;balloon melanoma cell;narrowmatch
radiation toxicity;ionizing radiation toxicity;narrowmatch
skin;flexural skin;narrowmatch
lesion;lesion with diameter of 4 mm or more;narrowmatch
malignant eccrine cell;eccrine adenocarcinoma cell;narrowmatch
adenocarcinoma cell;eccrine adenocarcinoma cell;narrowmatch
neoplastic glandular cell;neoplastic eccrine cell;narrowmatch
neoplastic glandular cell;neoplastic apocrine cell;narrowmatch
adnexal differentiation;apocrine differentiation;narrowmatch
glandular differentiation;apocrine differentiation;narrowmatch
outer root sheath;pilar sheath;narrowmatch
hair part;outer root sheath;narrowmatch
epithelium;germinative follicular epithelium;narrowmatch
body part;chest wall;narrowmatch
abnormal tissue present;nests of nevus cells resembling nerve bundles present;narrowmatch
morphologic architectural pattern;wedge-shaped growth pattern;narrowmatch
cutaneous involvement;epidermal involvement;narrowmatch
abnormal tissue present;area of depigmentation at the periphery of the dermal melanocytic infiltrate present;narrowmatch
abnormal tissue present;melanocytes near the tips and sides of elongated rete ridges present;narrowmatch
rat salivary gland neoplasm;adenoma of the rat salivary gland;narrowmatch
rat salivary gland neoplasm;benign mixed tumor of the rat mandibular gland;narrowmatch
urethral gland;skene gland;narrowmatch
rat digestive system neoplasms;rat hepatic neoplasm;narrowmatch
rat endocrine system neoplasms;adenocarcinoma of the rat parathyroid gland;narrowmatch
gestational trophoblastic tumor by figo stage;figo stage i gestational trophoblastic tumor;narrowmatch
rat digestive system neoplasms;acinar cell adenocarcinoma of the rat pancreas;narrowmatch
rat digestive system neoplasms;ductal cell adenocarcinoma of the rat pancreas;narrowmatch
rat digestive system neoplasms;acinar cell adenoma of the rat pancreas;narrowmatch
rat digestive system neoplasms;ductal cell adenoma of the rat pancreas;narrowmatch
neoplasm by obsolete classification;gestational trophoblastic tumor by figo stage;narrowmatch
rat intestinal neoplasm;squamous cell papilloma of the rat forestomach;narrowmatch
rat intestinal neoplasm;benign neuroendocrine cell tumor of the rat glandular stomach;narrowmatch
rat intestinal neoplasm;squamous cell papilloma of the rat esophagus;narrowmatch
rat intestinal neoplasm;squamous cell carcinoma of the rat forestomach;narrowmatch
rat intestinal neoplasm;squamous cell carcinoma of the rat esophagus;narrowmatch
rat intestinal neoplasm;signet ring cell adenocarcinoma of the rat glandular stomach;narrowmatch
rat neuroendocrine cell hyperplasia;neuroendocrine cell hyperplasia of the rat glandular stomach;narrowmatch
rat intestinal neoplasm;malignant neuroendocrine cell tumor of the rat glandular stomach;narrowmatch
squamous cell carcinoma of the rat esophagus;exophytic squamous cell carcinoma of the rat esophagus;narrowmatch
rat endocrine system neoplasms;adenoma of the rat parathyroid gland;narrowmatch
rat endocrine system neoplasms;rat c-cell ganglioneuroma;narrowmatch
rat endocrine system neoplasms;benign medullary tumor of the rat adrenal gland;narrowmatch
rat endocrine system neoplasms;malignant medullary tumor of the rat adrenal gland;narrowmatch
rat female genital system neoplasms;benign mixed muellerian tumor of the rat uterus;narrowmatch
rat female genital system neoplasms;benign mixed muellerian tumor of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;benign granulosa cell tumor of the rat ovary;narrowmatch
rat female genital system neoplasms;adenosquamous carcinoma of the rat uterus;narrowmatch
rat female genital system neoplasms;adenosquamous carcinoma of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;adenoma of the rat uterus;narrowmatch
rat female genital system neoplasms;adenoma of the rat oviduct;narrowmatch
rat female genital system neoplasms;adenoma of the rat clitoral gland;narrowmatch
rat female genital system neoplasms;adenocarcinoma of the rat uterus;narrowmatch
rat female genital system neoplasms;adenocarcinoma of the rat oviduct;narrowmatch
gestational trophoblastic tumor by figo stage;figo stage ii gestational trophoblastic tumor;narrowmatch
rat female genital system neoplasms;adenocarcinoma of the rat clitoral gland;narrowmatch
figo stage i gestational trophoblastic tumor;figo stage ic gestational trophoblastic tumor;narrowmatch
figo stage i gestational trophoblastic tumor;figo stage ib gestational trophoblastic tumor;narrowmatch
figo stage i gestational trophoblastic tumor;figo stage ia gestational trophoblastic tumor;narrowmatch
squamous cell carcinoma of the rat esophagus;endophytic squamous cell carcinoma of the rat esophagus;narrowmatch
rat intestinal neoplasm;benign basal cell tumor of the rat forestomach;narrowmatch
rat salivary gland neoplasm;benign mixed tumor of the rat parotid gland;narrowmatch
rat salivary gland neoplasm;squamous cell carcinoma of the rat salivary gland;narrowmatch
rat digestive system neoplasms;rat intestinal neoplasm;narrowmatch
rat digestive system neoplasms;rat salivary gland neoplasm;narrowmatch
rat salivary gland neoplasm;squamous cell metaplasia of the rat sublingual gland;narrowmatch
rat salivary gland neoplasm;squamous cell metaplasia of the rat salivary gland;narrowmatch
rat salivary gland neoplasm;squamous cell metaplasia of the rat parotid gland;narrowmatch
rat salivary gland neoplasm;squamous cell metaplasia of the rat mandibular gland;narrowmatch
rat salivary gland neoplasm;squamous cell carcinoma of the rat sublingual gland;narrowmatch
rat salivary gland neoplasm;squamous cell carcinoma of the rat parotid gland;narrowmatch
rat intestinal neoplasm;basal cell carcinoma of the rat forestomach;narrowmatch
rat salivary gland neoplasm;squamous cell carcinoma of the rat mandibular gland;narrowmatch
rat salivary gland neoplasm;malignant mixed tumor of the rat sublingual gland;narrowmatch
rat salivary gland neoplasm;malignant mixed tumor of the rat salivary gland;narrowmatch
rat salivary gland neoplasm;malignant mixed tumor of the rat parotid gland;narrowmatch
rat salivary gland neoplasm;malignant mixed tumor of the rat mandibular gland;narrowmatch
rat salivary gland neoplasm;benign mixed tumor of the rat sublingual gland;narrowmatch
rat salivary gland neoplasm;benign mixed tumor of the rat salivary gland;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat cecum;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat colon;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat duodenum;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat glandular stomach;narrowmatch
rat intestinal neoplasm;basal cell carcinoma of the rat esophagus;narrowmatch
rat intestinal neoplasm;adenoma of the rat small intestine;narrowmatch
rat intestinal neoplasm;adenoma of the rat rectum;narrowmatch
rat intestinal neoplasm;adenoma of the rat large intestine;narrowmatch
rat intestinal neoplasm;adenoma of the rat jejunum;narrowmatch
rat intestinal neoplasm;adenoma of the rat ileum;narrowmatch
rat intestinal neoplasm;adenoma of the rat glandular stomach;narrowmatch
rat intestinal neoplasm;adenoma of the rat duodenum;narrowmatch
rat intestinal neoplasm;adenoma of the rat colon;narrowmatch
rat intestinal neoplasm;adenoma of the rat cecum;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat small intestine;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat rectum;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat large intestine;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat jejunum;narrowmatch
rat intestinal neoplasm;adenocarcinoma of the rat ileum;narrowmatch
abnormal tissue present;infundibular-like structures present;narrowmatch
morphologic finding;prominent keratin formation;narrowmatch
epithelial differentiation;adnexal differentiation;narrowmatch
neoplastic sertoli cell;neoplastic large polygonal sertoli cell;narrowmatch
neoplastic sex cord-stromal cell;neoplastic leutein cell;narrowmatch
peritonitis;sclerosing peritonitis;narrowmatch
neoplastic sex cord-stromal cell;neoplastic small sex cord-stromal cell;narrowmatch
neoplastic sex cord-stromal cell;lipid-rich neoplastic spindle cell;narrowmatch
neoplastic spindle cell;lipid-rich neoplastic spindle cell;narrowmatch
non-neoplastic gonadal disorder;gonadal dysgenesis;narrowmatch
neoplastic sertoli cell;neoplastic sertoli cell with clear cytoplasm;narrowmatch
neoplastic sex cord-stromal cell;malignant sex cord-stromal cell;narrowmatch
morphologic architectural pattern;polyvesicular vitelline pattern;narrowmatch
malignant cell;malignant sex cord-stromal cell;narrowmatch
abnormal tissue present;embryoid bodies present;narrowmatch
abnormal tissue present;seminomatous component present;narrowmatch
abnormal tissue present;one germ layer present;narrowmatch
morphologic finding;inconspicuous syncytiotrophoblastic cell component;narrowmatch
malignant trophoblastic cell;malignant intermediate type trophoblastic cell;narrowmatch
neoplastic intermediate type trophoblastic cell;malignant intermediate type trophoblastic cell;narrowmatch
morphologic architectural pattern;pseudolobular pattern;narrowmatch
menstrual disorder;amenorrhea;narrowmatch
reproductive system finding;hirsutism;narrowmatch
stromal change;sarcomatoid stroma formation;narrowmatch
reproductive system hemorrhage;first trimester bleeding;narrowmatch
female reproductive system finding;first trimester bleeding;narrowmatch
abnormal tissue present;tissues derived from two or three embryonic layers present;narrowmatch
abnormal tissue present;single type of tissue derived from one embryonic layer present;narrowmatch
hyperthyroidism;thyrotoxicosis;narrowmatch
abnormal tissue present;aberrant thyroid tissue present;narrowmatch
abnormal tissue present;malignant component present;narrowmatch
mass;fetiform mass;narrowmatch
abnormal tissue present;annular tubules present;narrowmatch
lesion;small lesion;narrowmatch
neoplastic sex cord-stromal cell;neoplastic sex cord-stromal cell resembling steroid hormone-secreting cell;narrowmatch
female reproductive system part;ovarian hilus;narrowmatch
retiform structures present;retiform structures comprise more than 10% and less than 90% of the tumor;narrowmatch
retiform structures present;retiform structures comprise 90% or more of the tumor;narrowmatch
abnormal tissue present;retiform structures present;narrowmatch
environmental and occupational exposure;radiation exposure;narrowmatch
mass;testicular mass;narrowmatch
neoplasm by obsolete classification;germ cell tumor (antiquated);narrowmatch
neoplastic small epithelial cell with scant amount of cytoplasm;small adenocarcinoma cell with scant amount of cytoplasm;narrowmatch
blastemal cell;nephrogenic blastemal cell;narrowmatch
immunodeficiency syndrome;x-linked lymphoproliferative syndrome;narrowmatch
cancer stage (antiquated);stage iv retinoblastoma;narrowmatch
stage iii retinoblastoma;stage iiib retinoblastoma;narrowmatch
epithelial cell;renal tubular epithelial cell;narrowmatch
neoplastic epithelial cell with eosinophilic cytoplasm;adenocarcinoma cell with eosinophilic cytoplasm;narrowmatch
adenocarcinoma cell;adenocarcinoma cell with eosinophilic cytoplasm;narrowmatch
adenocarcinoma cell;small adenocarcinoma cell with scant amount of cytoplasm;narrowmatch
malignant germ cell;malignant round germ cell;narrowmatch
vascular morphologic change;delicate vascular network formation;narrowmatch
stage iii retinoblastoma;stage iiia retinoblastoma;narrowmatch
cancer stage (antiquated);stage iii retinoblastoma;narrowmatch
urethra part;posterior portion of the urethra;narrowmatch
urethra part;anterior portion of the urethra;narrowmatch
urethra part;bulbomembranous urethra;narrowmatch
urethra part;penile portion of the urethra;narrowmatch
embryonic cell;blastemal cell;narrowmatch
morphologic architectural pattern;blastemal pattern;narrowmatch
blastemal pattern;diffuse blastemal pattern;narrowmatch
blastemal pattern;nodular blastemal pattern;narrowmatch
malignant germ cell;malignant small germ cell;narrowmatch
malignant germ cell;malignant giant germ cell;narrowmatch
giant neoplastic germ cell;malignant giant germ cell;narrowmatch
testicular mass;painless testicular mass;narrowmatch
painless mass;painless testicular mass;narrowmatch
tissue damage;tissue breakdown;narrowmatch
ligament;uterine ligament;narrowmatch
elevated test result;high plasma renin activity;narrowmatch
abnormal blood chemistry and hematology test result;high plasma renin activity;narrowmatch
neoplastic epithelial cell;neoplastic small epithelial cell with scant amount of cytoplasm;narrowmatch
neoplastic epithelial cell;neoplastic epithelial cell with eosinophilic cytoplasm;narrowmatch
abnormal tissue present;tubular structures present;narrowmatch
neoplastic blastemal cell;malignant blastemal cell;narrowmatch
malignant cell;malignant blastemal cell;narrowmatch
blastemal pattern;serpentine blastemal pattern;narrowmatch
hydropic villous change;generalized hydropic villous change;narrowmatch
hydropic villous change;localized hydropic villous change;narrowmatch
epithelium;ovarian surface epithelium;narrowmatch
abnormal tissue present;beaded anastomosing cords present;narrowmatch
glandular differentiation;eccrine differentiation;narrowmatch
neoplastic apocrine cell;neoplastic apocrine cell with eosinophilic granular cytoplasm;narrowmatch
neoplastic glandular cell with eosinophilic granular cytoplasm;neoplastic apocrine cell with eosinophilic granular cytoplasm;narrowmatch
neoplastic apocrine cell with eosinophilic granular cytoplasm;apocrine carcinoma cell with eosinophilic granular cytoplasm;narrowmatch
apocrine carcinoma cell;apocrine carcinoma cell with eosinophilic granular cytoplasm;narrowmatch
adenocarcinoma cell with eosinophilic granular cytoplasm;apocrine carcinoma cell with eosinophilic granular cytoplasm;narrowmatch
stromal change;paucicellular stroma present;narrowmatch
morphologic architectural pattern;canalicular pattern;narrowmatch
ovarian tissue;ovarian surface epithelium;narrowmatch
neoplastic glandular cell;neoplastic columnar epithelial cell;narrowmatch
mutation abnormality;point mutation;narrowmatch
neoplastic cuboidal cell;malignant cuboidal epithelial cell;narrowmatch
malignant epithelial cell;malignant cuboidal epithelial cell;narrowmatch
adenocarcinoma cell;small to medium size adenocarcinoma cell with oval nucleus;narrowmatch
morphologic architectural pattern;lobular pattern;narrowmatch
epithelial cell;terminal duct cell;narrowmatch
adnexal differentiation;eccrine differentiation;narrowmatch
abnormal tissue present;extensive secretory changes present;narrowmatch
lesion by morphology;intraductal lesion;narrowmatch
morphologic architectural pattern;pericanalicular growth pattern;narrowmatch
neoplasm by obsolete classification;connective and soft tissue neoplasm (antiquated);narrowmatch
mixed neoplastic epithelial cell population;mixed neoplastic glandular and squamous cell population;narrowmatch
neoplasm by obsolete classification;epithelial neoplasm (antiquated);narrowmatch
hyperplastic tissue present;hyperplastic epithelial tissue present;narrowmatch
epithelial component present;hyperplastic epithelial tissue present;narrowmatch
abnormal tissue present;hyperplastic tissue present;narrowmatch
dilated terminal duct lobular units present;dilated terminal duct lobular units with acini lined by more than two layers of columnar epithelial cells present;narrowmatch
dilated terminal duct lobular units present;dilated terminal duct lobular units with acini lined by one or two layers of columnar epithelial cells present;narrowmatch
epithelial component present;dilated terminal duct lobular units present;narrowmatch
abnormal tissue present;spaces lined by one to three layers of monotonous atypical cells present;narrowmatch
malignant epithelial cell;malignant basaloid cell;narrowmatch
neoplastic basaloid cell;malignant basaloid cell;narrowmatch
lesion;juvenile lesion;narrowmatch
body region;subareolar region;narrowmatch
mass;large mass;narrowmatch
dentin formation;dysplastic dentin formation;narrowmatch
abnormal tissue present;tumor droplets present;narrowmatch
abnormal tissue present;rosette-like configurations present;narrowmatch
epithelial tissue;mesonephric remnants;narrowmatch
carcinomatous component present;malignant glandular epithelium resembling the endocervical epithelium present;narrowmatch
morphologic architectural pattern;complex glandular pattern;narrowmatch
adenocarcinoma cell;ciliated adenocarcinoma cell;narrowmatch
female reproductive system part;rete ovarii;narrowmatch
biophysical process;degradation;narrowmatch
stromal change;myomatous stroma formation;narrowmatch
mixed cellular population;mixed neoplastic epithelial cell population;narrowmatch
neoplastic hobnail cell;malignant hobnail cell;narrowmatch
epithelial component present;neoplastic glandular epithelium resembling the normal endometrium present;narrowmatch
neoplastic glandular epithelium resembling the normal endometrium present;atypical glandular epithelium resembling the normal endometrium present;narrowmatch
atypical glandular epithelium resembling the normal endometrium present;malignant glandular epithelium resembling the normal endometrium present;narrowmatch
carcinomatous component present;malignant glandular epithelium resembling the normal endometrium present;narrowmatch
nodule;mural nodule;narrowmatch
epithelial component present;gastrointestinal type epithelium present;narrowmatch
epithelial component present;endocervical type epithelium present;narrowmatch
epithelial neoplasm (antiquated);infiltrating ureter urothelial carcinoma with mixed differentiation;narrowmatch
malignant hyperchromatic epithelial cell;malignant hyperchromatic small epithelial cell;narrowmatch
abnormal tissue present;duct-like structures present;narrowmatch
abnormal tissue present;endometrial type glands and stroma present;narrowmatch
neoplastic cell;neoplastic ghost cell;narrowmatch
lesion;extraosseous lesion;narrowmatch
lesion;intraosseous lesion;narrowmatch
neoplastic epithelial cell;neoplastic epithelial cell with granular cytoplasm;narrowmatch
abnormal tissue present;anastomosing strands of tumor cells present;narrowmatch
epithelial component present;islands of odontogenic epithelium present;narrowmatch
mucosa;ciliated respiratory mucosa;narrowmatch
abnormal tissue present;tissue of mullerian origin present;narrowmatch
stromal change;fibromuscular stroma formation;narrowmatch
squamous cell;basal cell of the squamous epithelium;narrowmatch
skin basal cell;basal cell of the squamous epithelium;narrowmatch
abnormal tissue present;prominent squamous eddies present;narrowmatch
genitalia;female genitalia;narrowmatch
organic chemical;lipid;narrowmatch
mass;vaginal mass;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat erythroid leukemia;narrowmatch
rat female genital system neoplasms;rat endometrial stromal sarcoma;narrowmatch
rat female genital system neoplasms;benign sertoli cell tumor of the rat ovary;narrowmatch
female reproductive system part;labium;narrowmatch
skin;skin of the extremity;narrowmatch
melanoma cell;dendritic melanoma cell;narrowmatch
low grade b-cell non-hodgkin's lymphoma;primary low grade b-cell dural lymphoma;narrowmatch
skin;head skin;narrowmatch
skeletal system part;metaphysis;narrowmatch
childhood acute lymphoblastic leukemia in remission;childhood acute lymphoblastic leukemia in complete remission;narrowmatch
childhood acute lymphoblastic leukemia in remission;childhood acute lymphoblastic leukemia in partial remission;narrowmatch
epithelial neoplasm (antiquated);benign ovarian partly luteinized thecoma;narrowmatch
immunophenotypic finding;cd34-positive neoplastic cells present;narrowmatch
lesion by morphology;non-proliferating breast lesion;narrowmatch
hereditary connective tissue disorder;hereditary multiple exostoses;narrowmatch
hereditary neoplastic syndrome;hereditary multiple exostoses;narrowmatch
exostosis;hereditary multiple exostoses;narrowmatch
gene variant;fh gene mutation;narrowmatch
gene variant;flcn gene mutation;narrowmatch
malignant connective and soft tissue cell;malignant spindle-shaped to round cell;narrowmatch
papular lesion;red papular lesion;narrowmatch
hyperplasia;epidermal hyperplasia;narrowmatch
regression;spontaneous regression;narrowmatch
lesion;acquired lesion;narrowmatch
lesion;rarely metastasizing lesion;narrowmatch
lesion;locally aggressive lesion;narrowmatch
malignant endothelial cell;malignant oval endothelial cell;narrowmatch
malignant endothelial cell;malignant spindle endothelial cell;narrowmatch
spindle endothelial cell;malignant spindle endothelial cell;narrowmatch
malignant endothelial cell;malignant epithelioid endothelial cell;narrowmatch
epithelioid endothelial cell;malignant epithelioid endothelial cell;narrowmatch
blood vessel tissue;blood vessel endothelium;narrowmatch
vascular endothelium;blood vessel endothelium;narrowmatch
morphologic finding;collagen bundles formation;narrowmatch
neoplastic endothelial cell;neoplastic plump endothelial cell;narrowmatch
neoplastic hobnail cell;neoplastic plump endothelial cell;narrowmatch
integumentary system signs and symptoms;skin red dot;narrowmatch
lesion;skin red dot;narrowmatch
lesion;congenital lesion;narrowmatch
neoplastic spindle-shaped to round cell;malignant spindle-shaped to round cell;narrowmatch
cd34 positive;cd34-positive neoplastic cells present;narrowmatch
mesenchymal differentiation;cartilaginous differentiation;narrowmatch
non-neoplastic heart disorder;heart failure;narrowmatch
urinary system finding;urinary retention;narrowmatch
injury;tissue damage;narrowmatch
alterations in hearing;tinnitus;narrowmatch
hematopoietic system finding;lymphadenopathy;narrowmatch
head and neck finding;sore throat;narrowmatch
sign;regurgitation;narrowmatch
obstruction;nasal obstruction;narrowmatch
hearing disorder;hearing impairment;narrowmatch
pericyte;myopericyte;narrowmatch
non-neoplastic hair disorder;alopecia;narrowmatch
abnormal finding;cancer other;narrowmatch
respiratory system finding;airway obstruction;narrowmatch
obstruction;airway obstruction;narrowmatch
tissue breakdown;erosion;narrowmatch
cardiovascular system finding;fluid and electrolyte manifestation;narrowmatch
sign;body substance discharge;narrowmatch
vaginal discharge;abnormal vaginal discharge;narrowmatch
visual manifestations;visual disturbance;narrowmatch
integumentary system finding;skin erosion;narrowmatch
erosion;skin erosion;narrowmatch
perivascular arrangement of tumor cells;concentric perivascular arrangement of tumor cells;narrowmatch
nuclear atypia;marked nuclear atypia present;narrowmatch
lesion with diameter greater than 10 mm;lesion with diameter greater than 2 cm;narrowmatch
lesion;deep lesion;narrowmatch
vascular channel formation;capillary sized vascular channel formation;narrowmatch
vascular channel formation;vascular channel formation with muscular walls;narrowmatch
dilated vascular space formation;huge vascular channel formation;narrowmatch
vascular channel formation;dilated vascular space formation;narrowmatch
cellular process;cell defense process;narrowmatch
cell death process;regulation of cell death process;narrowmatch
clinical course of disease;disease response;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);stage iv splenic marginal zone lymphoma;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);stage iii splenic marginal zone lymphoma;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);stage ii splenic marginal zone lymphoma;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);stage i splenic marginal zone lymphoma;narrowmatch
mesenchymal differentiation;osseous differentiation;narrowmatch
sign or symptom;sign;narrowmatch
sensory manifestations;visual manifestations;narrowmatch
malignant cell with eosinophilic cytoplasm;malignant polygonal cell with eosinophilic cytoplasm;narrowmatch
carbohydrate metabolism disorder;glucose metabolism disorder;narrowmatch
non-neoplastic endocrine disorder;glucose metabolism disorder;narrowmatch
malignant hemangiopericytoma;malignant cardiac hemangiopericytoma;narrowmatch
neoplastic cell with eosinophilic cytoplasm;malignant cell with eosinophilic cytoplasm;narrowmatch
malignant cell;malignant cell with eosinophilic cytoplasm;narrowmatch
morphologic architectural pattern;spindle cell pattern;narrowmatch
morphologic architectural pattern;cord-like pattern;narrowmatch
neoplastic polygonal cell with eosinophilic cytoplasm;malignant polygonal cell with eosinophilic cytoplasm;narrowmatch
pathology result;tissue differentiation uncertain;narrowmatch
giant cell;wreath-like multinucleated giant cell;narrowmatch
abnormal tissue present;epithelioid component present;narrowmatch
neoplastic spindle cell;malignant spindle cell;narrowmatch
morphologic architectural pattern;pseudoalveolar pattern;narrowmatch
morphologic architectural pattern;pseudogranulomatous pattern;narrowmatch
abnormal tissue present;spindle cell component present;narrowmatch
abnormal tissue present;lipomatous component present;narrowmatch
ultrastructural finding;intermediate filaments present;narrowmatch
malignant cell with eosinophilic cytoplasm;malignant cell with large nucleus and abundant eosinophilic cytoplasm;narrowmatch
cytoplasmic alteration;intracytoplasmic eosinophilic inclusion;narrowmatch
neoplastic growth or spread;arterial embolic tumor spread;narrowmatch
malignant osteoblast;malignant spindle-shaped osteoblast;narrowmatch
malignant osteoblast;malignant small osteoblast;narrowmatch
malignant small cell;malignant small osteoblast;narrowmatch
morphologic finding;large spaces filled with blood present;narrowmatch
abnormal tissue present;new bone formation;narrowmatch
hemangiopericytoma;retroperitoneal hemangiopericytoma;narrowmatch
lesion with diameter of 5 cm or less;lesion with diameter of 2 cm or less;narrowmatch
abnormal tissue present;osteoid formation;narrowmatch
abnormal tissue present;nidus formation;narrowmatch
abnormal tissue present;smooth muscle component present;narrowmatch
vascular morphologic change;thick-walled vessels present;narrowmatch
neoplastic epithelioid cell;neoplastic perivascular epithelioid cell;narrowmatch
chromosomal gain;gain of chromosome 12q13-14;narrowmatch
chromosome 12 abnormality;gain of chromosome 12q13-14;narrowmatch
vascular morphologic change;intraluminal tumor growth;narrowmatch
abnormal tissue present;epithelial component present;narrowmatch
breast carcinoma by gene expression profile;normal breast-like subtype of breast carcinoma;narrowmatch
calcification;chicken wire calcification;narrowmatch
stromal change;high grade non cartilaginous sarcomatous stroma present;narrowmatch
esophageal disorder;non-neoplastic esophageal disorder;narrowmatch
non-neoplastic digestive system disorder;non-neoplastic esophageal disorder;narrowmatch
malignant chondrocyte;malignant chondrocyte with clear cytoplasm;narrowmatch
hyaline cartilage differentiation;well differentiated hyaline cartilage present;narrowmatch
neoplastic small round cell;malignant small round cell;narrowmatch
malignant small cell;malignant small round cell;narrowmatch
stromal change;low grade cartilaginous component present;narrowmatch
malignant connective and soft tissue cell;malignant chondrocyte;narrowmatch
breast carcinoma by gene expression profile;luminal b breast carcinoma;narrowmatch
atypical chondrocyte;malignant chondrocyte;narrowmatch
cartilaginous differentiation;hyaline cartilage differentiation;narrowmatch
neoplastic chondrocyte;neoplastic spindle-shaped chondrocyte;narrowmatch
neoplastic connective and soft tissue spindle cell;neoplastic spindle-shaped chondrocyte;narrowmatch
neoplastic chondrocyte;neoplastic stellate chondrocyte;narrowmatch
neoplastic stellate cell;neoplastic stellate chondrocyte;narrowmatch
bone tissue;medullary bone;narrowmatch
intestinal disorder;non-neoplastic intestinal disorder;narrowmatch
non-neoplastic digestive system disorder;non-neoplastic intestinal disorder;narrowmatch
stomach disorder;non-neoplastic stomach disorder;narrowmatch
non-neoplastic digestive system disorder;non-neoplastic stomach disorder;narrowmatch
breast carcinoma by gene expression profile;luminal a breast carcinoma;narrowmatch
breast adenocarcinoma;breast carcinoma by gene expression profile;narrowmatch
non-neoplastic hepatobiliary disorder;non-neoplastic liver and intrahepatic bile duct disorder;narrowmatch
liver and intrahepatic bile duct disorder;non-neoplastic liver and intrahepatic bile duct disorder;narrowmatch
non-neoplastic disorder;non-neoplastic disorder by special category;narrowmatch
non-neoplastic disorder by special category;rare non-neoplastic disorder;narrowmatch
rare disorder;rare non-neoplastic disorder;narrowmatch
non-neoplastic disorder by site;non-neoplastic vision disorder;narrowmatch
vision disorder;non-neoplastic vision disorder;narrowmatch
non-neoplastic disorder;non-neoplastic disorder by site;narrowmatch
disease or disorder;non-neoplastic disorder;narrowmatch
orbit hemangiopericytoma;benign orbit hemangiopericytoma;narrowmatch
benign hemangiopericytoma;benign orbit hemangiopericytoma;narrowmatch
non-neoplastic digestive system disorder;non-neoplastic pancreatic disorder;narrowmatch
pancreatic disorder;non-neoplastic pancreatic disorder;narrowmatch
sign or symptom;ventilation or perfusion signs and symptoms;narrowmatch
stromal change;thin bands of collagen present;narrowmatch
rat female genital system neoplasms;rat endometrial stromal polyp;narrowmatch
neoplastic connective and soft tissue spindle cell;neoplastic spindle-shaped fibrohistiocytic cell;narrowmatch
melanin pigment present;melanin-pigmented dendritic cells present;narrowmatch
morphologic finding;wide vessel-like spaces formation;narrowmatch
xanthomatous cell;xanthomatous fibrohistiocytic cell;narrowmatch
neoplastic fibrohistiocytic cell;xanthomatous fibrohistiocytic cell;narrowmatch
neoplastic connective and soft tissue epithelioid cell;neoplastic epithelioid fibrohistiocytic cell;narrowmatch
neoplastic fibrohistiocytic cell;neoplastic epithelioid fibrohistiocytic cell;narrowmatch
neoplastic fibrohistiocytic cell;neoplastic spindle-shaped fibrohistiocytic cell;narrowmatch
malignant fibrohistiocytic cell;malignant large hyperchromatic fibrohistiocytic cell;narrowmatch
malignant spindle cell;malignant mesenchymal spindle cell;narrowmatch
malignant spindle cell;malignant spindle-shaped fibrohistiocytic cell;narrowmatch
neoplastic spindle-shaped fibrohistiocytic cell;malignant spindle-shaped fibrohistiocytic cell;narrowmatch
malignant fibrohistiocytic cell;malignant spindle-shaped fibrohistiocytic cell;narrowmatch
abnormal cell;xanthomatous cell;narrowmatch
malignant fibrohistiocytic cell;malignant ovoid to spindle-shaped fibrohistiocytic cell;narrowmatch
morphologic finding;cellular pleomorphism;narrowmatch
malignant connective and soft tissue cell;malignant fibrohistiocytic cell;narrowmatch
tissue differentiation;myofibroblastic differentiation;narrowmatch
sarcomatous component present;fibrosarcomatous component present;narrowmatch
mesenchymal differentiation;fibroblastoma-like differentiation;narrowmatch
connective and soft tissue neoplasm (antiquated);conventional dermatofibrosarcoma protuberans;narrowmatch
malignant spindle cell;malignant spindle-shaped smooth muscle cell;narrowmatch
malignant smooth muscle cell;malignant spindle-shaped smooth muscle cell;narrowmatch
neoplastic spindle-shaped smooth muscle cell;malignant spindle-shaped smooth muscle cell;narrowmatch
abnormal cells present;intersecting sharply marginated clusters of spindle cells present;narrowmatch
malignant connective and soft tissue cell;malignant smooth muscle cell;narrowmatch
neoplastic smooth muscle cell;malignant smooth muscle cell;narrowmatch
mesenchymal metaplasia;lipomatous metaplasia;narrowmatch
morphologic architectural pattern;alternative fascicle (bundle) pattern;narrowmatch
morphologic finding;hydropic change;narrowmatch
neoplastic connective and soft tissue epithelioid cell;neoplastic epithelioid smooth muscle cell;narrowmatch
neoplastic smooth muscle cell;neoplastic epithelioid smooth muscle cell;narrowmatch
muscle;dartoic muscle;narrowmatch
dilated vascular space formation;cavernous vascular space formation;narrowmatch
vascular channel formation;slit-like vascular channel formation;narrowmatch
vascular channel formation;venous type vascular channel formation;narrowmatch
neoplastic fibrohistiocytic cell;malignant fibrohistiocytic cell;narrowmatch
malignant stromal cell;malignant mesenchymal spindle cell;narrowmatch
malignant smooth muscle cell;malignant epithelioid smooth muscle cell;narrowmatch
primitive round to oval cell;primitive mesenchymal round to oval cell;narrowmatch
leukemia in remission;myeloid leukemia in remission;narrowmatch
myeloid neoplasm finding;myeloid leukemia in remission;narrowmatch
leukemia in remission;chronic leukemia in remission;narrowmatch
leukemia in remission;acute leukemia in remission;narrowmatch
leukemia finding;leukemia in remission;narrowmatch
urinary system part;bladder wall;narrowmatch
arborizing vascular channel formation;delicate arborizing vascular channel formation;narrowmatch
primitive mesenchymal cell;primitive mesenchymal round to oval cell;narrowmatch
neoplastic connective and soft tissue spindle cell;malignant mesenchymal spindle cell;narrowmatch
stromal change;non lipogenic sarcomatous stroma present;narrowmatch
morphologic architectural pattern;floret-like pattern;narrowmatch
neoplastic lipocyte;neoplastic spindle-shaped adipocyte;narrowmatch
neoplastic connective and soft tissue spindle cell;neoplastic spindle-shaped adipocyte;narrowmatch
intravascular thrombus formation;intravascular fibrin thrombus formation;narrowmatch
mass;painful mass;narrowmatch
mass;painless mass;narrowmatch
leukemia in remission;lymphoid leukemia in remission;narrowmatch
intracytoplasmic eosinophilic inclusion;intracytoplasmic eosinophilic spherical inclusion;narrowmatch
stromal change;numerous stromal mast cells present;narrowmatch
morphologic finding;nuclear palisading;narrowmatch
neoplastic mononuclear stromal cell;neoplastic elongated mononuclear stromal cell;narrowmatch
neoplastic mononuclear stromal cell;neoplastic ovoid mononuclear stromal cell;narrowmatch
effusion;joint effusion;narrowmatch
malignant connective and soft tissue cell;malignant histiocyte-like cell;narrowmatch
neoplastic histiocyte-like cell;malignant histiocyte-like cell;narrowmatch
thin-walled branching vascular pattern;curvilinear thin-walled vascular pattern;narrowmatch
malignant fibroblast;vacuolated malignant fibroblast;narrowmatch
malignant fibroblast;malignant epithelioid fibroblast;narrowmatch
malignant connective and soft tissue cell;malignant fibroblast;narrowmatch
neoplastic fibroblast;malignant fibroblast;narrowmatch
morphologic finding;inclusion-like nucleoli;narrowmatch
malignant spindle cell;malignant spindle-shaped fibroblast;narrowmatch
malignant fibroblast;malignant spindle-shaped fibroblast;narrowmatch
neoplastic spindle-shaped fibroblast;malignant spindle-shaped fibroblast;narrowmatch
lymph node;regional lymph node;narrowmatch
neoplastic epithelioid smooth muscle cell;malignant epithelioid smooth muscle cell;narrowmatch
malignant smooth muscle cell;malignant smooth muscle cell with granular cytoplasmic change;narrowmatch
neurological signs and symptoms;sensory manifestations;narrowmatch
tissue;intestinal wall tissue;narrowmatch
non-neoplastic central nervous system disorder;central nervous system vascular malformation;narrowmatch
vascular malformation;central nervous system vascular malformation;narrowmatch
nerve plexus;spinal nerve plexus;narrowmatch
stratified squamous epithelium;oral cavity epithelium;narrowmatch
vaginal polyp;vaginal fibroepithelial polyp;narrowmatch
fibroepithelial polyp;vaginal fibroepithelial polyp;narrowmatch
renal tubule;convoluted tubule;narrowmatch
brain white matter;cerebral white matter;narrowmatch
epithelium;vaginal epithelium;narrowmatch
brain part;brain nucleus;narrowmatch
white matter;brain white matter;narrowmatch
brain part;brain white matter;narrowmatch
ocular tissue;retina layer;narrowmatch
pseudostratified epithelium;pseudostratified columnar epithelium;narrowmatch
columnar epithelium;pseudostratified columnar epithelium;narrowmatch
vaginal epithelium;vaginal squamous epithelium;narrowmatch
congenital nervous system disorder;central nervous system vascular malformation;narrowmatch
lymphoid tissue;marginal zone;narrowmatch
marginal zone;splenic marginal zone;narrowmatch
immunodeficiency-related disorder;aids-related disorder;narrowmatch
neurological signs and symptoms;motor manifestations;narrowmatch
sensory manifestations;alterations in hearing;narrowmatch
sign or symptom;integumentary system signs and symptoms;narrowmatch
sign or symptom;genitourinary signs and symptoms;narrowmatch
digestive system signs and symptoms;disturbance in bowel function;narrowmatch
high grade b-cell non-hodgkin's lymphoma;high grade burkitt-like lymphoma;narrowmatch
high grade burkitt-like lymphoma;recurrent high grade burkitt-like lymphoma;narrowmatch
high grade burkitt-like lymphoma;refractory high grade burkitt-like lymphoma;narrowmatch
high grade burkitt-like lymphoma;stage i high grade burkitt-like lymphoma;narrowmatch
high grade burkitt-like lymphoma;stage ii high grade burkitt-like lymphoma;narrowmatch
high grade burkitt-like lymphoma;stage iii high grade burkitt-like lymphoma;narrowmatch
high grade burkitt-like lymphoma;stage iv high grade burkitt-like lymphoma;narrowmatch
germ cell tumor (antiquated);stage i extragonadal seminoma;narrowmatch
malignant neoplasm;occupational malignant neoplasm;narrowmatch
occupational neoplasm;occupational malignant neoplasm;narrowmatch
stratified squamous epithelium;vaginal squamous epithelium;narrowmatch
urethral gland;gland of littre;narrowmatch
neoplastic striated muscle cell;neoplastic skeletal muscle cell;narrowmatch
primitive striated muscle cell;primitive skeletal muscle cell;narrowmatch
stratified squamous epithelium;cervix squamous epithelium;narrowmatch
epithelium;cervix epithelium;narrowmatch
abnormal tissue present;fibrovascular septa present;narrowmatch
primitive skeletal muscle cell;primitive malignant skeletal muscle cell;narrowmatch
malignant rhabdomyoblast;primitive malignant skeletal muscle cell;narrowmatch
primitive malignant skeletal muscle cell;primitive malignant skeletal spindle cell;narrowmatch
primitive skeletal spindle cell;primitive malignant skeletal spindle cell;narrowmatch
morphologic architectural pattern;cambium layer;narrowmatch
stratified squamous epithelium;tongue epithelium;narrowmatch
malignant skeletal muscle cell;malignant rhabdomyoblast;narrowmatch
rhabdomyoblast;malignant rhabdomyoblast;narrowmatch
neoplastic skeletal muscle cell;malignant skeletal muscle cell;narrowmatch
malignant connective and soft tissue cell;malignant skeletal muscle cell;narrowmatch
primitive skeletal muscle cell;primitive skeletal spindle cell;narrowmatch
rhabdomyoblast;neoplastic striated muscle cell with eosinophilic granular cytoplasm;narrowmatch
rhabdomyoblast;neoplastic large striated muscle cell with clear cytoplasm;narrowmatch
cervix epithelium;cervix squamous epithelium;narrowmatch
gut epithelium;esophageal epithelium;narrowmatch
esophageal mucosa;esophageal epithelium;narrowmatch
stratified squamous epithelium;esophageal squamous epithelium;narrowmatch
respiratory system part;hilar area of the lung;narrowmatch
simple cuboidal epithelium;renal tubule epithelium;narrowmatch
kidney part;renal tubule;narrowmatch
ovarian cyst;benign ovarian cyst;narrowmatch
epithelium;oropharynx epithelium;narrowmatch
epithelium;nasopharynx epithelium;narrowmatch
epithelium;nasal cavity epithelium;narrowmatch
vascular endothelium;lymphatic vessel endothelium;narrowmatch
epithelium;laryngeal epithelium;narrowmatch
mucosa;laryngeal mucosa;narrowmatch
mucosa;intestinal mucosa;narrowmatch
oral cavity epithelium;gingival epithelium;narrowmatch
tumor suppressor gene;candidate tumor suppressor gene;narrowmatch
simple columnar epithelium;gallbladder epithelium;narrowmatch
esophageal epithelium;esophageal squamous epithelium;narrowmatch
spindle cell component present;spindle cell osteo-fibrous component present;narrowmatch
morphologic architectural pattern;zonal pattern;narrowmatch
abnormal tissue present;fibrous septa present;narrowmatch
cancer stage (antiquated);stage iii extrahepatic bile duct cancer;narrowmatch
epithelial neoplasm (antiquated);stage 0 oral cavity verrucous carcinoma;narrowmatch
stage iv oral cavity verrucous carcinoma;stage ivc oral cavity verrucous carcinoma;narrowmatch
stage iv oral cavity verrucous carcinoma;stage ivb oral cavity verrucous carcinoma;narrowmatch
stage iv oral cavity verrucous carcinoma;stage iva oral cavity verrucous carcinoma;narrowmatch
stage iv extrahepatic bile duct cancer;stage ivb extrahepatic bile duct cancer;narrowmatch
stage iv extrahepatic bile duct cancer;stage iva extrahepatic bile duct cancer;narrowmatch
cancer stage (antiquated);stage iv extrahepatic bile duct cancer;narrowmatch
cancer stage (antiquated);stage ii extrahepatic bile duct cancer;narrowmatch
epithelial neoplasm (antiquated);pancreatic mucinous cystadenocarcinoma;narrowmatch
cancer stage (antiquated);stage i extrahepatic bile duct cancer;narrowmatch
non-neoplastic liver and intrahepatic bile duct disorder;liver mesenchymal hamartoma;narrowmatch
mesenchymal hamartoma;liver mesenchymal hamartoma;narrowmatch
cancer stage (antiquated);stage iva pancreatic cancer;narrowmatch
epithelial neoplasm (antiquated);solid pseudopapillary carcinoma of the pancreas;narrowmatch
epithelial neoplasm (antiquated);pancreatic intraductal papillary-mucinous carcinoma;narrowmatch
epithelial neoplasm (antiquated);pancreatic intraductal papillary-mucinous neoplasm with intermediate grade dysplasia;narrowmatch
astler-coller b3 colorectal carcinoma;astler-coller b3 colon carcinoma;narrowmatch
colon cancer by astler-coller stage;astler-coller b3 colon carcinoma;narrowmatch
astler-coller b3 colorectal carcinoma;astler-coller b3 rectal carcinoma;narrowmatch
rectal cancer by astler-coller stage;astler-coller b3 rectal carcinoma;narrowmatch
cancer stage (antiquated);stage iib nasopharyngeal carcinoma;narrowmatch
cancer stage (antiquated);stage iia nasopharyngeal carcinoma;narrowmatch
colorectal cancer by astler-coller stage;astler-coller c1 colorectal carcinoma;narrowmatch
colorectal cancer by astler-coller stage;astler-coller c2 colorectal carcinoma;narrowmatch
colorectal cancer by astler-coller stage;astler-coller c3 colorectal carcinoma;narrowmatch
colorectal cancer by astler-coller stage;astler-coller b3 colorectal carcinoma;narrowmatch
colorectal cancer by astler-coller stage;astler-coller a colorectal carcinoma;narrowmatch
rectal cancer by astler-coller stage;astler-coller a rectal carcinoma;narrowmatch
astler-coller a colorectal carcinoma;astler-coller a rectal carcinoma;narrowmatch
rectal cancer by astler-coller stage;astler-coller c2 rectal carcinoma;narrowmatch
astler-coller c2 colorectal carcinoma;astler-coller c2 rectal carcinoma;narrowmatch
rectal cancer by astler-coller stage;astler-coller c1 rectal carcinoma;narrowmatch
astler-coller c1 colorectal carcinoma;astler-coller c1 rectal carcinoma;narrowmatch
rectal cancer by astler-coller stage;astler-coller c3 rectal carcinoma;narrowmatch
astler-coller c3 colorectal carcinoma;astler-coller c3 rectal carcinoma;narrowmatch
epithelial neoplasm (antiquated);pancreatic mucinous cystadenoma;narrowmatch
cancer stage (antiquated);stage iva esophageal cancer;narrowmatch
malignant transitional cell;malignant spindle transitional cell;narrowmatch
adenocarcinoma cell with abundant cytoplasm;adenocarcinoma cell with abundant pale cytoplasm;narrowmatch
non-neoplastic skin disorder;skin appendage hamartoma;narrowmatch
hamartoma;central nervous system hamartoma;narrowmatch
non-neoplastic central nervous system disorder;central nervous system hamartoma;narrowmatch
morphologic architectural pattern;intracanalicular growth pattern;narrowmatch
malignant component present;sarcomatous component present;narrowmatch
mesenchymal component present;sarcomatous component present;narrowmatch
fibrotic stroma formation;fibrotic stroma with finger-like projections present;narrowmatch
neoplastic large cell with abundant pale cytoplasm;adenocarcinoma cell with abundant pale cytoplasm;narrowmatch
cancer stage (antiquated);stage ivb esophageal cancer;narrowmatch
abnormal tissue present;intracytoplasmic and extracytoplasmic eosinophilic material present;narrowmatch
adnexal differentiation;sebaceous differentiation;narrowmatch
abnormal cells present;malignant epithelial cells with abundant clear cytoplasm containing glycogen present;narrowmatch
epithelial differentiation;acinar cell differentiation;narrowmatch
abnormal cells present;malignant epithelial cells with abundant cytoplasmic neutral lipids present;narrowmatch
metaplasia;mesenchymal metaplasia;narrowmatch
metaplasia;spindle cell metaplasia;narrowmatch
hamartoma;skin appendage hamartoma;narrowmatch
skin appendage hamartoma;eccrine sweat gland hamartoma;narrowmatch
skin appendage hamartoma;pilosebaceous hamartoma;narrowmatch
neoplastic syndrome;pancoast syndrome;narrowmatch
colorectal sporadic serrated polyp;colorectal hyperplastic polyp;narrowmatch
hyperplastic polyp;colorectal hyperplastic polyp;narrowmatch
colorectal hamartoma;colorectal juvenile polyp;narrowmatch
juvenile polyp;colorectal juvenile polyp;narrowmatch
gastrointestinal polyp;colorectal polyp;narrowmatch
intestinal disorder;colorectal polyp;narrowmatch
adult acute lymphoblastic leukemia in remission;adult acute lymphoblastic leukemia in partial remission;narrowmatch
adult acute lymphoblastic leukemia in remission;adult acute lymphoblastic leukemia in complete remission;narrowmatch
tubular structures present;tubular structures of glycogen-rich non-ciliated cells present;narrowmatch
epithelial differentiation;type ii cell differentiation;narrowmatch
epithelial differentiation;club cell differentiation;narrowmatch
morphologic architectural pattern;lepidic growth pattern;narrowmatch
pulmonary nodule;solitary pulmonary nodule;narrowmatch
morphologic finding;nuclear molding;narrowmatch
chemical exposure;asbestos exposure;narrowmatch
epithelial neoplasm (antiquated);laryngeal carcinoid tumor;narrowmatch
malignant epithelial spindle cell;malignant spindle transitional cell;narrowmatch
new bone formation;blue bone formation;narrowmatch
rat male genital system neoplasms;rat benign sertoli cell tumor;narrowmatch
rat neoplasms by morphology;rat carcinoma;narrowmatch
rat respiratory system neoplasms;rat bronchiolo-alveolar carcinoma;narrowmatch
rat respiratory system neoplasms;rat bronchiolo-alveolar adenoma;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat benign thymoma;narrowmatch
rat female genital system neoplasms;rat benign thecoma;narrowmatch
morphologic finding;prostatic crystalloids present;narrowmatch
rat neoplasms by morphology;rat benign teratoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat benign schwannoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat benign mesothelioma;narrowmatch
rat endocrine system neoplasms;rat benign pinealoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat benign oligodendroglioma;narrowmatch
rat digestive system neoplasms;rat benign odontogenic tumor;narrowmatch
rat digestive system neoplasms;rat benign neuroendocrine cell tumor;narrowmatch
rat neoplasms by morphology;rat benign mixed tumor;narrowmatch
rat female genital system neoplasms;rat benign mixed sex cord stromal tumor;narrowmatch
rat female genital system neoplasms;rat benign mixed muellerian tumor;narrowmatch
rat carcinoma;rat carcinoma, nos;narrowmatch
rat endocrine system neoplasms;rat c-cell adenoma;narrowmatch
rat endocrine system neoplasms;rat c-cell carcinoma;narrowmatch
morphologic finding;absence of basal cell layer;narrowmatch
rat female genital system neoplasms;rat embryonal carcinoma;narrowmatch
abnormal tissue present;glomerulations;narrowmatch
rat adenoma;rat ductal cell adenoma;narrowmatch
rat adenocarcinoma;rat ductal cell adenocarcinoma;narrowmatch
rat adenoma;rat cystadenoma;narrowmatch
rat adenocarcinoma;rat cystadenocarcinoma;narrowmatch
rat endocrine system neoplasms;rat cortical carcinoma;narrowmatch
rat endocrine system neoplasms;rat cortical adenoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat choroid plexus papilloma;narrowmatch
rat nervous system and sensory organs neoplasms;rat choroid plexus carcinoma;narrowmatch
rat carcinoma;rat choriocarcinoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat chondrosarcoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat chondroma;narrowmatch
rat hepatic neoplasm;rat cholangioma;narrowmatch
rat hepatic neoplasm;rat cholangiocarcinoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat benign mixed glioma;narrowmatch
rat nervous system and sensory organs neoplasms;rat benign meningioma;narrowmatch
mitotic activity;two to 10 mitoses per 10hpf;narrowmatch
rat histopathology diagnoses for proliferative changes;tissue autolysed diagnosis not possible;narrowmatch
rat integumentary system neoplasms;rat adenocarcinoma arising in fibroadenoma;narrowmatch
rat carcinoma;rat adenocarcinoma;narrowmatch
rat endocrine system neoplasms;rat acinar islet cell adenoma;narrowmatch
rat adenoma;rat acinar islet cell adenoma;narrowmatch
rat adenoma;rat acinar cell adenoma;narrowmatch
rat digestive system neoplasms;rat acinar cell adenocarcinoma;narrowmatch
rat adenocarcinoma;rat acinar cell adenocarcinoma;narrowmatch
neoplastic acinar cell;secretory adenocarcinoma cell;narrowmatch
rat endocrine system neoplasms;rat benign medullary tumor;narrowmatch
adenocarcinoma cell;secretory adenocarcinoma cell;narrowmatch
elevated test result;serum prostate specific antigen increased;narrowmatch
abnormal blood chemistry and hematology test result;serum prostate specific antigen increased;narrowmatch
psa progression;serum prostate specific antigen increased;narrowmatch
murine experimental organism diagnosis;rat histopathology diagnoses for proliferative changes;narrowmatch
high mitotic activity;more than 10 mitoses per 10hpf;narrowmatch
mitotic activity;less than 2 mitoses per 10hpf;narrowmatch
rat neoplasms by morphology;rat adenoma;narrowmatch
rat carcinoma;rat adenosquamous carcinoma;narrowmatch
rat odontoma;rat ameloblastic odontoma;narrowmatch
rat benign odontogenic tumor;rat ameloblastoma;narrowmatch
rat female genital system neoplasms;rat benign luteoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat benign hibernoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat benign hemangiopericytoma;narrowmatch
rat integumentary system neoplasms;rat benign hair follicle tumor;narrowmatch
rat genital system neoplasms;rat benign granulosa cell tumor;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat benign granular cell tumor;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat benign fibrous histiocytoma;narrowmatch
rat nervous system and sensory organs neoplasms;rat benign ependymoma;narrowmatch
rat cardiovascular system neoplasms;rat benign endocardial schwannoma;narrowmatch
rat endocrine system neoplasms;rat benign craniopharyngioma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat benign chordoma;narrowmatch
rat neoplasms by morphology;rat benign basal cell tumor;narrowmatch
rat cardiovascular system neoplasms;rat benign atriocaval mesothelioma;narrowmatch
rat nervous system and sensory organs neoplasms;rat benign astrocytoma;narrowmatch
rat carcinoma;rat basal cell carcinoma;narrowmatch
cardiovascular system finding;blood pressure finding;narrowmatch
syndrome;neoplastic syndrome;narrowmatch
tumor-associated process;tumor replacement;narrowmatch
abnormal cell;abnormal germ cell;narrowmatch
tissue differentiation;endodermal differentiation;narrowmatch
tissue differentiation;ectodermal differentiation;narrowmatch
neoplastic germ cell;malignant germ cell;narrowmatch
malignant cell;malignant germ cell;narrowmatch
tissue differentiation;"undifferentiated ""fetal-type"" tissues present";narrowmatch
tissue differentiation;"fully differentiated ""adult-type"" tissues present";narrowmatch
embryonic tissue;germinal layer;narrowmatch
syndrome;parinaud syndrome;narrowmatch
lesion;hereditary lesion;narrowmatch
epithelium;rathke pouch epithelium;narrowmatch
deposit;cholesterol deposit;narrowmatch
keratin present;nodules of compact keratin present;narrowmatch
clinical course of disease;aggravated disease;narrowmatch
neoplastic mononuclear stromal cell;neoplastic vacuolated stromal cell;narrowmatch
neoplastic melanocyte;polyhedral melanocyte;narrowmatch
neoplastic melanocyte;fusiform melanocyte;narrowmatch
tissue differentiation;mesodermal differentiation;narrowmatch
malignant component present;sarcomatous or carcinomatous component present;narrowmatch
neoplastic cytotrophoblastic cell;malignant cytotrophoblastic cell;narrowmatch
malignant trophoblastic cell;malignant cytotrophoblastic cell;narrowmatch
abnormal tissue present;osseous component present;narrowmatch
abnormal tissue present;cartilaginous component present;narrowmatch
abnormal tissue present;mesenchymal component present;narrowmatch
melanoma cell;medium size melanoma cell;narrowmatch
lesion with diameter greater than 10 mm;lesion with diameter greater than 15 mm;narrowmatch
spindle melanoma cell;spindle b melanoma cell;narrowmatch
spindle melanoma cell;spindle a melanoma cell;narrowmatch
mixture of morphologic patterns;mixture of germ cell neoplastic components present;narrowmatch
neoplastic large germ cell;malignant large germ cell with abundant cytoplasm;narrowmatch
malignant primitive germ cell;malignant large germ cell with abundant cytoplasm;narrowmatch
morphologic finding;schiller-duval body;narrowmatch
morphologic architectural pattern;sinusoidal growth pattern;narrowmatch
cytoplasmic alteration;cytoplasmic hyaline globules present;narrowmatch
malignant trophoblastic cell;malignant syncytiotrophoblastic giant cell;narrowmatch
neoplastic syncytiotrophoblastic cell;malignant syncytiotrophoblastic giant cell;narrowmatch
neoplastic melanocyte;nevoid polygonal cell;narrowmatch
brain part;cerebellopontine angle;narrowmatch
tall columnar adenocarcinoma cell;mucinous tall columnar adenocarcinoma cell;narrowmatch
morphologic finding;infiltrating tumor margins present;narrowmatch
lesion with diameter greater than 2 cm;lesion with diameter greater than 10 cm;narrowmatch
lesion;lesion with diameter of 5 cm or less;narrowmatch
neoplastic mononuclear stromal cell;neoplastic epithelioid stromal cell;narrowmatch
neoplastic elongated mononuclear stromal cell;neoplastic spindle stromal cell;narrowmatch
anticoagulant agent;heparan sulfate;narrowmatch
stromal cell;endometrioid stromal cell;narrowmatch
vascular proliferation;plexiform vasculature present;narrowmatch
tumor margin configuration;pushing tumor margin;narrowmatch
medical condition;preexisting condition;narrowmatch
cytoplasmic alteration;cytoplasmic eosinophilic globules present;narrowmatch
malignant cell;malignant stellate cell;narrowmatch
neoplastic neuroepithelial cell;malignant neuroectodermal cell;narrowmatch
malignant cell;malignant neuroectodermal cell;narrowmatch
malignant cell;primitive round to oval cell;narrowmatch
tissue differentiation;neuroectodermal differentiation;narrowmatch
lesion;non-hereditary lesion;narrowmatch
mitotic activity;five or less mitoses per 50hpf;narrowmatch
mitotic activity;more than 5 mitoses per 50hpf;narrowmatch
morphologic finding;distortion of the hair follicle;narrowmatch
skin nodule;dermal nodule;narrowmatch
abnormal tissue present;striated muscle component present;narrowmatch
morphologic finding;melanin-forming neuroepithelial cells present;narrowmatch
malignant neuroectodermal cell;malignant neuroectodermal small cell;narrowmatch
neoplastic small neuroepithelial cell;malignant neuroectodermal small cell;narrowmatch
malignant neuroectodermal cell;malignant neuroectodermal large cell;narrowmatch
malignant neuroectodermal cell;malignant neuroectodermal round cell;narrowmatch
morphologic finding;nodular, reticulin-free zones present;narrowmatch
malignant neuroectodermal cell;malignant neuroectodermal cell with hyperchromatic nucleus and scanty cytoplasm;narrowmatch
morphologic finding;pseudostratified tumor cells present;narrowmatch
pseudostratified tumor cells present;pseudostratified neuroepithelial tumor cells present;narrowmatch
metastatic lesion;drop metastasis;narrowmatch
nervous system part;nerve root;narrowmatch
morphologic finding;apple green dichromism present in polarized congo-red stained sections;narrowmatch
deposit;amorphous, eosinophilic, and acellular deposit;narrowmatch
fibrotic stroma formation;elastin fibers present;narrowmatch
epithelial component present;carcinomatous component present;narrowmatch
malignant component present;carcinomatous component present;narrowmatch
head and neck part;floor of mouth;narrowmatch
morphologic finding;cellular stratification;narrowmatch
morphologic finding;single malignant cells present;narrowmatch
urinary system part;renal pelvis and ureter;narrowmatch
necrotic change;intraluminal necrosis;narrowmatch
adenocarcinoma cell;round adenocarcinoma cell;narrowmatch
cervix epithelium;cervix glandular epithelium;narrowmatch
glandular epithelium;cervix glandular epithelium;narrowmatch
tumor-suppressor gene inactivation;rassf1a gene inactivation;narrowmatch
malignant epithelial large cell;malignant epithelial large cell with vesicular nucleus and distinct nucleolus;narrowmatch
body region;rectosigmoid region;narrowmatch
gene;transcription regulation gene;narrowmatch
neoplasm by obsolete classification;odontoameloblastoma;narrowmatch
odontogenic cyst;odontogenic keratocyst;narrowmatch
odontogenic tissue;odontogenic epithelium;narrowmatch
epithelium;odontogenic epithelium;narrowmatch
head and neck part;sinonasal tract;narrowmatch
respiratory system signs and symptoms;rhinorrhea;narrowmatch
malignant transitional cell;malignant transitional cell with large nucleus and small nucleolus;narrowmatch
malignant transitional cell;malignant transitional cell with eccentrically placed large nucleus and small nucleolus;narrowmatch
urothelium;renal pelvis urothelium;narrowmatch
urothelial cell;renal pelvis urothelial cell;narrowmatch
adenocarcinoma cell with intracytoplasmic mucin;mucinous tall columnar adenocarcinoma cell;narrowmatch
adenocarcinoma cell with abundant cytoplasm;round adenocarcinoma cell with abundant cytoplasm and vesicular nucleus;narrowmatch
round adenocarcinoma cell;round adenocarcinoma cell with abundant cytoplasm and vesicular nucleus;narrowmatch
malignant component present;prominent in situ component present;narrowmatch
prominent in situ component present;prominent intraductal component present;narrowmatch
abnormal cells present;melanoma cells present;narrowmatch
primary site of disease;primary site unspecified;narrowmatch
lesion;synchronous lesion;narrowmatch
malignant epithelial cell;malignant epithelial cell with ground glass cytoplasm;narrowmatch
upper gastrointestinal hemorrhage;gastric hemorrhage;narrowmatch
morphologic finding;preserved nuclear polarity;narrowmatch
malignant transitional cell;lipoblast-like malignant transitional cell;narrowmatch
malignant transitional cell;malignant transitional cell with clear cytoplasm;narrowmatch
immunophenotypic finding;human chorionic gonadotropin-positive neoplastic cells present;narrowmatch
abnormal tissue present;heterologous elements present;narrowmatch
epithelium;paranasal sinus epithelium;narrowmatch
head and neck part;throat;narrowmatch
lesion;dome-shaped lesion;narrowmatch
mucin-producing neoplastic epithelial cell;mucin-producing malignant epithelial cell;narrowmatch
fusion protein expression;crtc1-maml2 fusion protein expression;narrowmatch
11q translocation;"t(11;19)(q21;p13)";narrowmatch
keratin present;horny masses of keratin present;narrowmatch
stromal change;early stromal invasion present;narrowmatch
epithelium;urachal epithelium;narrowmatch
nuclear palisading;peripheral nuclear palisading;narrowmatch
malignant hyperchromatic epithelial cell;malignant hyperchromatic squamous cell;narrowmatch
malignant small squamous cell;malignant hyperchromatic squamous cell;narrowmatch
malignant epithelial small cell;malignant small squamous cell;narrowmatch
malignant squamous cell;malignant small squamous cell;narrowmatch
morphologic finding;endophytic tumor growth;narrowmatch
gingiva;upper gingiva;narrowmatch
gingiva;lower gingiva;narrowmatch
lesion;exophytic papillary lesion;narrowmatch
body region;colorectal region;narrowmatch
malignant epithelial cell;mucin-producing malignant epithelial cell;narrowmatch
oral cavity cyst;odontogenic cyst;narrowmatch
morphologic finding;acantholysis;narrowmatch
body region;postcricoid region;narrowmatch
morphologic finding;windblown appearance of atypical keratinocytes;narrowmatch
abnormal tissue present;angiosarcoma-like areas present;narrowmatch
skin erosion;skin ulcer;narrowmatch
ulcer;skin ulcer;narrowmatch
radiation toxicity;solar radiation toxicity;narrowmatch
malignant epithelial cell;malignant hyperchromatic epithelial cell;narrowmatch
radiologic finding;no evidence of radiologic finding;narrowmatch
negative test result;no evidence of radiologic finding;narrowmatch
columnar cell;bronchial epithelial cell;narrowmatch
morphologic architectural pattern;mixture of morphologic patterns;narrowmatch
malignant squamous cell;malignant large squamous cell;narrowmatch
head and neck part;lip and oral cavity;narrowmatch
head and neck part;retromolar trigone;narrowmatch
wall of the pharynx;posterior wall of the pharynx;narrowmatch
head and neck part;postcricoid region;narrowmatch
figo stage ii gestational trophoblastic tumor;figo stage iia gestational trophoblastic tumor;narrowmatch
rat female genital system neoplasms;benign thecoma of the rat ovary;narrowmatch
mass;resectable mass;narrowmatch
regulatory pathway;foxa transcription factor signaling pathway;narrowmatch
regulatory pathway;hypoxia and oxygen homeostasis regulation of hif-1-alpha pathway;narrowmatch
hedgehog family-mediated signaling pathway;hedgehog signaling events mediated by gli family proteins;narrowmatch
glucocorticoid receptor signaling pathway;glucocorticoid receptor regulatory network;narrowmatch
signaling pathway;glucocorticoid receptor signaling pathway;narrowmatch
regulatory pathway;foxo transcription factor family signaling pathway;narrowmatch
regulatory pathway;foxm1 transcription factor signaling pathway;narrowmatch
foxa transcription factor signaling pathway;foxa2 and foxa3 transcription factor signaling pathway;narrowmatch
signaling pathway;fgf signaling pathway;narrowmatch
ephrin a signaling pathway;ephrin a2 forward signaling pathway;narrowmatch
immune response regulation pathway;fc-epsilon receptor i signaling pathway pid;narrowmatch
signaling pathway;fas signaling pathway pid;narrowmatch
signaling pathway;erbb2/erbb3 signaling pathway;narrowmatch
epidermal growth factor receptor pathway;epidermal growth factor receptor downstream signaling pathway;narrowmatch
signaling pathway;epidermal growth factor receptor family pathway;narrowmatch
signaling pathway;erythropoietin signaling pathway;narrowmatch
ephrin b signaling pathway;ephrin b reverse signaling pathway;narrowmatch
hypoxia and oxygen homeostasis regulation of hif-1-alpha pathway;hif-1-alpha transcription factor pathway;narrowmatch
signaling pathway;interferon-gamma signaling pathway;narrowmatch
signaling pathway;igf1 pathway;narrowmatch
signaling pathway;il1-mediated signaling pathway;narrowmatch
cell differentiation or development pathway;nephrin signaling pathway in the kidney podocyte;narrowmatch
signaling pathway;nectin adhesion pathway;narrowmatch
signaling pathway;n-cadherin signaling pathway;narrowmatch
signaling pathway;mtor signaling pathway pid;narrowmatch
signaling pathway;lysophosphatidic acid receptor signaling pathway;narrowmatch
epidermal growth factor receptor pathway;internalization pathway for epidermal growth factor receptor;narrowmatch
regulatory pathway;integrin angiogenesis pathway;narrowmatch
insulin pathway;insulin-mediated glucose transport pathway;narrowmatch
signaling pathway;insulin pathway;narrowmatch
signaling pathway;il6-mediated signaling pathway;narrowmatch
signaling pathway;il4-mediated signaling pathway;narrowmatch
il2-mediated signaling pathway;il2/stat5 signaling pathway;narrowmatch
il2-mediated signaling pathway;il2/pi3k signaling pathway;narrowmatch
signaling pathway;il2-mediated signaling pathway;narrowmatch
signaling pathway;il23-mediated signaling pathway;narrowmatch
ephrin b signaling pathway;ephrin b forward signaling pathway;narrowmatch
signaling pathway;ephrin b signaling pathway;narrowmatch
androgen-mediated signaling pathway;nongenotropic androgen signaling pathway;narrowmatch
regulatory pathway;atf-2 transcription factor signaling pathway;narrowmatch
immune response regulation pathway;t-cell receptor signaling pathway in naive cd4+ t cells;narrowmatch
signaling pathway;t-cell receptor signaling pathway in naive cd4+ t cells;narrowmatch
immune response regulation pathway;bcr immune response signaling pathway;narrowmatch
aurora kinase signaling pathway;aurora a signaling pathway;narrowmatch
cell cycle regulation pathway;aurora kinase signaling pathway;narrowmatch
signaling pathway;aurora kinase signaling pathway;narrowmatch
signaling pathway;atypical nf-kappab signaling pathway;narrowmatch
signaling pathway;arf6 pathway;narrowmatch
signaling pathway;ephrin a signaling pathway;narrowmatch
signaling pathway;angiopoietin-1 receptor signaling pathway;narrowmatch
signaling pathway;androgen-mediated signaling pathway;narrowmatch
cell motility pathway;alpham/beta2 integrin signaling pathway;narrowmatch
cell motility pathway;alpha6/beta1 and alpha6/beta4 integrin signaling pathway;narrowmatch
signaling pathway;hedgehog family-mediated signaling pathway;narrowmatch
signaling pathway;wnt signaling pathway kegg;narrowmatch
cancer pathway;endometrial cancer pathway;narrowmatch
signaling pathway;t-cell receptor signaling pathway in naive cd8+ t cells;narrowmatch
immune response regulation pathway;t-cell receptor signaling pathway in naive cd8+ t cells;narrowmatch
signaling pathway;wnt signaling pathway pid;narrowmatch
wnt signaling pathway pid;canonical wnt signaling pathway;narrowmatch
endothelin pathway;egfr-dependent endothelin signaling pathway;narrowmatch
signaling pathway;endothelin pathway;narrowmatch
signaling pathway;epidermal growth factor receptor pathway;narrowmatch
e-cadherin signaling pathway;adherens junction formation pathway;narrowmatch
e-cadherin signaling pathway;e-cadherin signaling pathway in keratinocytes;narrowmatch
signaling pathway;e-cadherin signaling pathway;narrowmatch
cell cycle regulation pathway;e2f transcription factor pathway;narrowmatch
p53 pathway for transcriptional regulation;p53 effector pathway;narrowmatch
regulatory pathway;p53 pathway for transcriptional regulation;narrowmatch
signaling pathway;cxcr4-mediated signaling pathway;narrowmatch
signaling pathway;cxcr3-mediated signaling pathway;narrowmatch
androgen-mediated signaling pathway;coregulation pathway for androgen receptor activity;narrowmatch
signaling pathway;class i pi3k signaling pathway;narrowmatch
signaling pathway;ceramide signaling pathway pid;narrowmatch
signaling pathway;cd40/cd40l signaling pathway;narrowmatch
signaling pathway;neurotrophic factor-mediated ntrk1 signaling pathway;narrowmatch
integrin angiogenesis pathway;osteopontin-mediated signaling pathway;narrowmatch
cancer pathway;acute myeloid leukemia pathway;narrowmatch
non-neoplastic esophageal disorder;esophagitis;narrowmatch
transcription regulation gene;arid1a gene;narrowmatch
lesion;endobronchial lesion;narrowmatch
foreign body granuloma;silicon granuloma;narrowmatch
pregnancy disorder;hypertension-associated pregnancy disorder;narrowmatch
sign;weight change;narrowmatch
clinical course of disease;systemic disease;narrowmatch
malignant neoplasm;non-hematologic malignancy;narrowmatch
body region;extraperitoneal space;narrowmatch
biochemical pathway;drug pathway;narrowmatch
psychiatric disorder;cognitive disorder;narrowmatch
rat carcinoma;rat pars intermedia carcinoma;narrowmatch
rat adenoma;rat sertoliform tubular adenoma;narrowmatch
creb family gene;atf1 gene;narrowmatch
stage ii adult diffuse mixed cell lymphoma;stage ii non-contiguous adult diffuse mixed cell lymphoma;narrowmatch
stage ii adult diffuse small cleaved cell lymphoma;stage ii non-contiguous adult diffuse small cleaved cell lymphoma;narrowmatch
regulatory gene;fus gene;narrowmatch
transcription regulation gene;ddit3 gene;narrowmatch
malignant hemangiopericytoma;recurrent malignant hemangiopericytoma;narrowmatch
morphologic finding;islands of neuropil-like matrix present;narrowmatch
glial differentiation;ependymal differentiation;narrowmatch
cancer stage (antiquated);stage iva bladder cancer;narrowmatch
cancer stage (antiquated);stage iib bladder cancer;narrowmatch
cancer stage (antiquated);stage iia bladder cancer;narrowmatch
description;location description;narrowmatch
metastasis;in-transit metastasis;narrowmatch
disease stage qualifier;advanced stage;narrowmatch
psa progression;psa failure;narrowmatch
non-neoplastic disorder by special category;inflammatory disorder;narrowmatch
mutation abnormality;deleterious mutation;narrowmatch
soft tissue;paratesticular soft tissue;narrowmatch
female reproductive system finding;pregnancy finding;narrowmatch
regulatory gene;nutm1 gene;narrowmatch
cell cycle gene;brd4 gene;narrowmatch
cancer gene;malat1 gene;narrowmatch
rna synthesis;microrna synthesis;narrowmatch
regulatory pathway;homeostasis regulation pathway;narrowmatch
infectious disease pathway;amoebiasis pathway;narrowmatch
signaling pathway;p38 mapk signaling pathway pid;narrowmatch
signaling pathway;reelin signaling pathway pid;narrowmatch
sphingosine 1-phosphate signaling pathway;sphingosine 1-phosphate receptor 2 signaling pathway;narrowmatch
signaling pathway;sphingosine 1-phosphate signaling pathway;narrowmatch
signaling pathway;retinoic acid receptor family-mediated signaling pathway;narrowmatch
regulatory pathway;telomerase regulation pathway;narrowmatch
cell cycle regulation pathway;regulation of retinoblastoma protein pathway;narrowmatch
regulation of cytoplasmic and nuclear smad2/3 signaling pathway;regulation of nuclear smad2/3 signaling pathway;narrowmatch
regulatory pathway;regulation of cytoplasmic and nuclear smad2/3 signaling pathway;narrowmatch
t-cell receptor signaling pathway in naive cd4+ t cells;ras signaling in the cd4+ tcr pathway;narrowmatch
infectious disease pathway;malaria pathway;narrowmatch
signaling pathway;syndecan-mediated signaling pathway;narrowmatch
wnt signaling pathway pid;presenilin action in notch and wnt signaling pathways;narrowmatch
acute eosinophilic leukemia;childhood acute eosinophilic leukemia;narrowmatch
signaling pathway;plasma membrane estrogen receptor signaling pathway;narrowmatch
signaling pathway;pdgfr-beta signaling pathway;narrowmatch
signaling pathway;pdgfr-alpha signaling pathway;narrowmatch
apoptosis regulation pathway;nerve growth factor receptor signaling pathway;narrowmatch
sphingosine 1-phosphate signaling pathway;sphingosine 1-phosphate receptor 3 signaling pathway;narrowmatch
signaling pathway;hepatocyte growth factor receptor signaling pathway pid;narrowmatch
signaling pathway;ptpn1 signaling pathway;narrowmatch
signaling pathway;mast/stem cell growth factor receptor signaling pathway;narrowmatch
infectious disease pathway;bacterial invasion of epithelial cell pathway;narrowmatch
acquired hemolytic anemia;immune hemolytic anemia;narrowmatch
regulatory pathway;transport pathway;narrowmatch
digestive system obstruction;bowel obstruction;narrowmatch
signaling pathway;vegfr3 lymphatic signaling pathway;narrowmatch
vegfr1 and vegfr2 signaling;vegfr1 signaling pathway;narrowmatch
neurotrophic factor-mediated ntrk1 signaling pathway;ntrk1/mapk signaling pathway;narrowmatch
neurotrophic factor-mediated ntrk1 signaling pathway;ntrk1/pi3k/plc-gamma signaling pathway;narrowmatch
signaling pathway;thromboxane a2 receptor family signaling pathway;narrowmatch
syndecan-mediated signaling pathway;syndecan-3-mediated signaling pathway;narrowmatch
syndecan-mediated signaling pathway;syndecan-2-mediated signaling pathway;narrowmatch
e-cadherin signaling pathway;adherens junction stabilization pathway;narrowmatch
p38 mapk signaling pathway pid;p38-alpha and p38-beta signaling pathway;narrowmatch
signaling pathway;proto-oncogene tyrosine-protein kinase receptor ret signaling pathway;narrowmatch
signaling pathway;vegfr1 and vegfr2 signaling;narrowmatch
infectious disease pathway;epithelial cell signaling pathway in helicobacter pylori infection;narrowmatch
infectious disease pathway;chagas disease pathway;narrowmatch
primary neoplasm;primary malignant neoplasm;narrowmatch
lymphocyte predominant type hodgkin's disease;recurrent hodgkin's disease lymphocyte predominance type;narrowmatch
germ cell tumor (antiquated);stage ii extragonadal non-seminomatous germ cell tumor;narrowmatch
germ cell tumor (antiquated);stage i extragonadal non-seminomatous germ cell tumor;narrowmatch
germ cell tumor (antiquated);stage iii extragonadal mixed germ cell tumor;narrowmatch
germ cell tumor (antiquated);stage i extragonadal mixed germ cell tumor;narrowmatch
lymphocyte predominant type hodgkin's disease;stage iv hodgkin's disease lymphocyte predominance type;narrowmatch
lymphocyte predominant type hodgkin's disease;stage iii hodgkin's disease lymphocyte predominance type;narrowmatch
lymphocyte predominant type hodgkin's disease;refractory hodgkin's disease lymphocyte predominance type;narrowmatch
ligand binding protein gene;gpc3 gene;narrowmatch
chronic leukemia in remission;chronic myelomonocytic leukemia in remission;narrowmatch
epithelial neoplasm (antiquated);cancer stage (antiquated);narrowmatch
epithelial neoplasm (antiquated);mucin-rich endometrial endometrioid adenocarcinoma;narrowmatch
malignant hemangiopericytoma;primary malignant hemangiopericytoma;narrowmatch
malignant hemangiopericytoma;metastatic malignant hemangiopericytoma;narrowmatch
digestive system signs and symptoms;steatorrhea;narrowmatch
cancer stage (antiquated);stage iv gastric cancer with metastasis;narrowmatch
acute erythroid leukemia in remission;pure erythroid leukemia in remission;narrowmatch
germ cell tumor (antiquated);stage iii extragonadal non-seminomatous germ cell tumor;narrowmatch
germ cell tumor (antiquated);stage iv extragonadal non-seminomatous germ cell tumor;narrowmatch
germ cell tumor (antiquated);stage ii extragonadal seminoma;narrowmatch
germ cell tumor (antiquated);stage iii extragonadal seminoma;narrowmatch
malignant lymphoma, large cell, cleaved;malignant lymphoma follicular, large cleaved cell type;narrowmatch
malignant lymphoma, non-cleaved cell type;malignant lymphoma follicular, large noncleaved cell type;narrowmatch
lymphoma/leukemia by kiel classification (antiquated);malignant lymphoma centroblastic, follicular;narrowmatch
head and neck part;alveolar ridge;narrowmatch
heterotrimeric g protein subunit gene;gna11 gene;narrowmatch
gene variant;gna11 gene mutation;narrowmatch
gene variant;gnaq gene mutation;narrowmatch
precancerous condition by site;cutaneous precancerous condition;narrowmatch
skin disorder;cutaneous precancerous condition;narrowmatch
cancer stage (antiquated);stage iv gastric cancer without metastasis;narrowmatch
psychiatric disorder;eating disorder;narrowmatch
nutritional disorder;eating disorder;narrowmatch
pediatric disorder;developmental disorder;narrowmatch
disease or disorder;pediatric disorder;narrowmatch
germ cell tumor (antiquated);stage iv extragonadal seminoma;narrowmatch
myeloid leukemia in remission;chronic myelomonocytic leukemia in remission;narrowmatch
acute myeloid leukemia in remission;myeloid sarcoma in remission;narrowmatch
adaptor signaling protein;myeloid differentiation primary response protein myd88;narrowmatch
experimental organism non-neoplastic disorder;marek disease;narrowmatch
oxidoreductase;isocitrate dehydrogenase [nadp], mitochondrial;narrowmatch
nervous system neoplasm (antiquated);neurofibromatosis 1 and 2 (nf1 and nf2);narrowmatch
idh gene family;idh2 gene;narrowmatch
fa complementation group gene;palb2 gene;narrowmatch
rare non-neoplastic disorder;nelson syndrome;narrowmatch
syndrome;nelson syndrome;narrowmatch
rare neoplastic syndrome;muir-torre syndrome;narrowmatch
stage ii adult diffuse large cell lymphoma;stage ii non-contiguous adult diffuse large cell lymphoma;narrowmatch
germ cell tumor (antiquated);stage ii extragonadal mixed germ cell tumor;narrowmatch
stage ii adult diffuse large cell lymphoma;stage ii contiguous adult diffuse large cell lymphoma;narrowmatch
stage ii adult diffuse mixed cell lymphoma;stage ii contiguous adult diffuse mixed cell lymphoma;narrowmatch
stage ii adult diffuse small cleaved cell lymphoma;stage ii contiguous adult diffuse small cleaved cell lymphoma;narrowmatch
rare neoplastic syndrome;denys-drash syndrome;narrowmatch
rare non-neoplastic disorder;aniridia;narrowmatch
rare non-neoplastic disorder;acromegaly;narrowmatch
syndrome;acromegaly;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);chronic lymphoblastic lymphoma;narrowmatch
rare non-neoplastic disorder;proteus syndrome;narrowmatch
histiocytosis;sinus histiocytosis;narrowmatch
positive lymph node;positive axillary lymph node;narrowmatch
neoplasm by obsolete classification;retro-orbital neoplasm;narrowmatch
angiokeratoma;vulvar angiokeratoma;narrowmatch
hodgkin's lymphoma (antiquated);lymphocyte predominant type hodgkin's disease;narrowmatch
acute myeloid leukemia in remission;acute myelomonocytic leukemia in remission;narrowmatch
protein family;fanconi anemia complementation group protein;narrowmatch
cancer stage (antiquated);stage iic soft tissue sarcoma;narrowmatch
cancer stage (antiquated);stage ivb pancreatic cancer;narrowmatch
stage iic soft tissue sarcoma;stage iic adult soft tissue sarcoma;narrowmatch
acute erythroid leukemia in remission;erythroleukemia in remission;narrowmatch
respiratory system finding;respiratory system signs and symptoms;narrowmatch
sign or symptom;respiratory system signs and symptoms;narrowmatch
rare non-neoplastic disorder;47,xyy syndrome;narrowmatch
syndrome;47,xyy syndrome;narrowmatch
progressive disease;progressive neoplastic disease;narrowmatch
neoplasm by special category;primary neoplasm;narrowmatch
adaptor signaling protein gene;myd88 gene;narrowmatch
sarcoma;sarcoma by fnclcc grade;narrowmatch
signaling pathway;vegf signaling pathway;narrowmatch
regulatory pathway;tight junction assembly pathway;narrowmatch
signaling pathway;adipocytokine signaling pathway;narrowmatch
homeostasis regulation pathway;long-term potentiation pathway;narrowmatch
signaling pathway;gonadotropin-releasing hormone signaling pathway;narrowmatch
cancer pathway;glioblastoma multiforme pathway;narrowmatch
regulatory pathway;gap junction assembly pathway;narrowmatch
cancer pathway;melanoma pathway;narrowmatch
immune response regulation pathway;fc epsilon receptor i signaling pathway kegg;narrowmatch
infectious disease pathway;pathogenic escherichia coli infection pathway;narrowmatch
signaling pathway;calcium-mediated signaling pathway;narrowmatch
metabolic pathway;endocytosis pathway;narrowmatch
dna repair pathway;mismatch repair pathway;narrowmatch
signaling pathway;cytokine-cytokine receptor signaling pathway;narrowmatch
metabolic pathway;melanogenesis pathway;narrowmatch
cancer pathway;colorectal cancer pathway;narrowmatch
cancer pathway;chronic myeloid leukemia pathway;narrowmatch
homeostasis regulation pathway;long-term depression pathway;narrowmatch
immune response regulation pathway;chemokine signaling pathway;narrowmatch
signaling pathway;insulin/insulin receptor signaling pathway;narrowmatch
disease pathway;type ii diabetes mellitus pathway;narrowmatch
infectious disease pathway;leishmaniasis infection pathway;narrowmatch
homeostasis regulation pathway;vascular smooth muscle contraction pathway;narrowmatch
signaling pathway;notch signaling pathway;narrowmatch
signaling pathway;jak-stat signaling pathway;narrowmatch
cancer pathway;prostate cancer pathway;narrowmatch
signaling pathway;hedgehog signaling pathway;narrowmatch
signaling pathway;erbb family signaling pathway;narrowmatch
cancer pathway;basal cell carcinoma pathway;narrowmatch
signaling pathway;toll-like receptor signaling pathway;narrowmatch
homeostasis regulation pathway;aldosterone-regulated sodium reabsorption pathway;narrowmatch
cancer pathway;small cell lung cancer pathway;narrowmatch
cancer pathway;renal cell carcinoma pathway;narrowmatch
transport pathway;fc gamma receptor-mediated phagocytosis pathway;narrowmatch
immune response regulation pathway;fc gamma receptor-mediated phagocytosis pathway;narrowmatch
cancer pathway;papillary thyroid carcinoma pathway;narrowmatch
cell differentiation or development pathway;progesterone-mediated oocyte maturation pathway;narrowmatch
signaling pathway;adherens junction assembly pathway;narrowmatch
immune response regulation pathway;hematopoietic cell lineage pathway;narrowmatch
sarcoma by fnclcc grade;fnclcc sarcoma grade 1;narrowmatch
adult non-hodgkin's lymphoma grade;intermediate grade adult non-hodgkin's lymphoma;narrowmatch
acute leukemia in remission;childhood acute leukemia in remission;narrowmatch
childhood myeloid leukemia in remission;childhood acute myeloid leukemia in remission;narrowmatch
childhood acute leukemia in remission;childhood acute myeloid leukemia in remission;narrowmatch
acute myeloid leukemia in remission;childhood acute myeloid leukemia in remission;narrowmatch
acute leukemia in remission;adult acute leukemia in remission;narrowmatch
adult non-hodgkin's lymphoma grade;high grade adult non-hodgkin's lymphoma;narrowmatch
high grade lymphoma;high grade adult non-hodgkin's lymphoma;narrowmatch
intermediate grade lymphoma;intermediate grade adult non-hodgkin's lymphoma;narrowmatch
cancer pathway;bladder cancer pathway;narrowmatch
adult non-hodgkin's lymphoma grade;low grade adult non-hodgkin's lymphoma;narrowmatch
low grade lymphoma;low grade adult non-hodgkin's lymphoma;narrowmatch
childhood large cell lymphoma;childhood diffuse large cell lymphoma;narrowmatch
disease stage qualifier;ajcc v7 stage;narrowmatch
disease stage qualifier;ajcc v6 stage;narrowmatch
sarcoma by fnclcc grade;fnclcc sarcoma grade 3;narrowmatch
sarcoma by fnclcc grade;fnclcc sarcoma grade 2;narrowmatch
childhood non-t non-b acute lymphoblastic leukemia;non-t non-b calla positive childhood acute lymphoblastic leukemia;narrowmatch
calla positive lymphoblastic leukemia;non-t non-b calla positive childhood acute lymphoblastic leukemia;narrowmatch
signaling pathway;mtor signaling pathway kegg;narrowmatch
cell differentiation or development pathway;dorso-ventral axis formation pathway;narrowmatch
dna repair pathway;base excision repair pathway;narrowmatch
immune response regulation pathway;b cell receptor signaling pathway;narrowmatch
cell differentiation or development pathway;axon guidance pathway;narrowmatch
disease pathway;arrhythmogenic right ventricular cardiomyopathy pathway;narrowmatch
mrna biosynthesis pathway;spliceosome pathway;narrowmatch
immune response regulation pathway;t cell receptor signaling pathway kegg;narrowmatch
cancer pathway;pancreatic cancer pathway;narrowmatch
cancer pathway;non-small cell lung cancer pathway;narrowmatch
cell differentiation or development pathway;neurotrophin signaling pathway;narrowmatch
immune response regulation pathway;natural killer cell-mediated cytotoxicity pathway;narrowmatch
calla positive lymphoblastic leukemia;non-t non-b calla positive adult acute lymphoblastic leukemia;narrowmatch
adult non-t non-b acute lymphoblastic leukemia;non-t non-b calla positive adult acute lymphoblastic leukemia;narrowmatch
immune response regulation pathway;leukocyte transendothelial migration pathway;narrowmatch
disease pathway;cancer pathway;narrowmatch
cell motility pathway;actin cytoskeleton regulation pathway;narrowmatch
cancer stage (antiquated);stage ivb bladder cancer;narrowmatch
myeloid leukemia in remission;childhood myeloid leukemia in remission;narrowmatch
sarcoma;sarcoma by nci grade;narrowmatch
gene product sequence variation;akt1 protein variant;narrowmatch
gene product sequence variation;egfr protein variant;narrowmatch
braf exon 15 mutation;braf nm_004333.4:c.1799t>a;narrowmatch
braf exon 15 mutation;braf nm_004333.4:c.1799_1800deltginsaa;narrowmatch
braf np_004324.2:p.v600x;braf np_004324.2:p.v600e;narrowmatch
gene product sequence variation;braf protein variant;narrowmatch
gene variant;akt1 gene mutation;narrowmatch
akt family gene mutation;akt1 gene mutation;narrowmatch
regulatory gene;sf3b1 gene;narrowmatch
transcription regulation gene;cic gene;narrowmatch
mass;tumor mass;narrowmatch
mediator complex component gene;med12 gene;narrowmatch
immunoprotein gene;ighg1 gene;narrowmatch
glycosyltransferase gene;has2 gene;narrowmatch
epithelial neoplasm (antiquated);breast solid neuroendocrine carcinoma;narrowmatch
molecular sequence variation;gene product sequence variation;narrowmatch
molecular genetic variation;gene variant;narrowmatch
receptor tyrosine kinase gene mutation;egfr gene mutation;narrowmatch
gene variant;egfr gene mutation;narrowmatch
gene product sequence variation;kras protein variant;narrowmatch
gene product sequence variation;nras protein variant;narrowmatch
fusion gene;dek/nup214 fusion gene;narrowmatch
fusion gene;col1a1/pdgfb fusion gene;narrowmatch
fusion gene;pml/rara fusion gene;narrowmatch
pediatric disorder;neonatal disorder;narrowmatch
injury;connective and soft tissue injury;narrowmatch
connective and soft tissue finding;connective and soft tissue injury;narrowmatch
congenital genitourinary abnormality;congenital urinary system abnormality;narrowmatch
non-neoplastic urinary system disorder;congenital urinary system abnormality;narrowmatch
experimental organism neoplasm;zymbal's gland carcinoma;narrowmatch
experimental organism neoplasm;zymbal's gland adenoma;narrowmatch
experimental organism neoplasm;undetermined sertoli cell tumor;narrowmatch
experimental organism neoplasm;experimental organism pituitary gland adenoma;narrowmatch
experimental organism neoplasm;experimental organism benign melanocytoma;narrowmatch
experimental organism neoplasm;benign histiocytoma;narrowmatch
gene product sequence variation;pik3ca protein variant;narrowmatch
molecular abnormality;molecular sequence variation;narrowmatch
transcription regulation gene;patz1 gene;narrowmatch
fusion gene;ewsr1/fli1 fusion gene;narrowmatch
homeobox gene;dux4 gene;narrowmatch
cytoskeletal gene;msn gene;narrowmatch
regulatory gene;lpp gene;narrowmatch
oxidoreductase gene;kdm5a gene;narrowmatch
homeobox gene;mnx1 gene;narrowmatch
transcription factor gene;gata2 gene;narrowmatch
transcription regulation gene;ell gene;narrowmatch
ets family gene;fev gene;narrowmatch
regulatory gene;fip1l1 gene;narrowmatch
cytoskeletal gene;tpm4 gene;narrowmatch
receptor gene;crlf2 gene;narrowmatch
immunoprotein gene;cd79b gene;narrowmatch
structural protein gene;cltc gene;narrowmatch
transferase gene;atic gene;narrowmatch
hydrolase gene;atic gene;narrowmatch
regulatory gene;rnf213 gene;narrowmatch
sign or symptom;hepatosplenomegaly;narrowmatch
cytoskeletal gene;myh9 gene;narrowmatch
transcription factor gene;mlf1 gene;narrowmatch
kinase family gene;map2k4 gene;narrowmatch
receptor gene;notch2 gene;narrowmatch
cytoskeletal gene;tpm3 gene;narrowmatch
signaling pathway gene;tfg gene;narrowmatch
transcription factor gene;tcf12 gene;narrowmatch
transcription factor gene;hnf1a gene;narrowmatch
regulatory gene;ssx4 gene;narrowmatch
regulatory gene;ssx2 gene;narrowmatch
regulatory gene;ssx1 gene;narrowmatch
transcription regulation gene;ss18 gene;narrowmatch
regulatory gene;sh3gl1 gene;narrowmatch
regulatory gene;sdhd gene;narrowmatch
regulatory gene;sdhc gene;narrowmatch
oxidoreductase gene;sdhb gene;narrowmatch
regulatory gene;sdhaf2 gene;narrowmatch
regulatory gene;prkar1a gene;narrowmatch
transcription factor gene;phox2b gene;narrowmatch
fusion gene;ewsr1/ddit3 fusion gene;narrowmatch
eye and ear finding;eye finding;narrowmatch
malignant hemangiopericytoma;well differentiated malignant hemangiopericytoma;narrowmatch
fusion gene;taf15/nr4a3 fusion gene;narrowmatch
fusion gene;rbm15/mkl1 fusion gene;narrowmatch
fusion gene;sfpq/tfe3 fusion gene;narrowmatch
fusion gene;tfe3/aspscr1 fusion gene;narrowmatch
fusion gene;stat5b/rara fusion gene;narrowmatch
fusion gene;tfg/nr4a3 fusion gene;narrowmatch
fusion gene;mllt10/clp1 fusion gene;narrowmatch
fusion gene;mll/sh3gl1 fusion gene;narrowmatch
fusion gene;nup98/nsd1 fusion gene;narrowmatch
fusion gene;ss18/ssx2 fusion gene;narrowmatch
fusion gene;hmga2/lpp long fusion gene;narrowmatch
fusion gene;hmga2/lpp short fusion gene;narrowmatch
fusion gene;etv6/jak2 fusion gene;narrowmatch
fusion gene;etv6/ntrk3 fusion gene;narrowmatch
fusion gene;etv6/pdgfrb fusion gene;narrowmatch
fusion gene;tcf12/nr4a3 fusion gene;narrowmatch
fusion gene;pcm1/ret fusion gene;narrowmatch
fusion gene;aspscr1/tfe3 fusion gene;narrowmatch
fusion gene;jazf1/suz12 fusion gene;narrowmatch
pax/foxo1 fusion gene;pax3/foxo1 fusion gene;narrowmatch
fusion gene;nsd1/nup98 fusion gene;narrowmatch
finding;sign or symptom;narrowmatch
fusion gene;cltc/alk fusion gene;narrowmatch
fusion gene;rnf213/alk fusion gene;narrowmatch
fusion gene;ctnnb1/plag1 fusion gene;narrowmatch
fusion gene;golga5/ret fusion gene;narrowmatch
fusion gene;trim33/ret fusion gene;narrowmatch
fusion gene;trim24/ret fusion gene;narrowmatch
fusion gene;ncoa4/ret fusion gene;narrowmatch
fusion gene;prkar1a/ret fusion gene;narrowmatch
fusion gene;brd4/nutm1 fusion gene;narrowmatch
fusion gene;malat1/tfeb fusion gene;narrowmatch
fusion gene;fip1l1/pdgfra fusion gene;narrowmatch
fusion gene;crtc1/maml2 fusion gene;narrowmatch
fusion gene;eml4/alk fusion gene;narrowmatch
fusion gene;erc1/ret fusion gene;narrowmatch
fusion gene;ss18/ssx4 fusion gene;narrowmatch
fusion gene;ss18/ssx1 fusion gene;narrowmatch
fusion gene;ewsr1/erg fusion gene;narrowmatch
fusion gene;fus/atf1 fusion gene;narrowmatch
bcr/abl1 fusion gene;bcr/abl1 fusion gene p190;narrowmatch
fusion gene;runx1/mecom fusion gene;narrowmatch
fusion gene;runx1/runx1t1 fusion gene;narrowmatch
fusion gene;tcf3/pbx1 fusion gene;narrowmatch
fusion gene;fus/creb3l2 fusion gene;narrowmatch
fusion gene;fus/erg fusion gene;narrowmatch
fusion gene;fus/ddit3 fusion gene;narrowmatch
fusion gene;ewsr1/etv4 fusion gene;narrowmatch
fusion gene;tfe3/prcc fusion gene;narrowmatch
fusion gene;ewsr1/etv1 fusion gene;narrowmatch
fusion gene;ewsr1/nr4a3 fusion gene;narrowmatch
fusion gene;ewsr1/creb1 fusion gene;narrowmatch
fusion gene;ewsr1/patz1 fusion gene;narrowmatch
fusion gene;ewsr1/fev fusion gene;narrowmatch
fusion gene;ewsr1/atf1 fusion gene;narrowmatch
fusion gene;ewsr1/wt1 fusion gene;narrowmatch
bcr/abl1 fusion gene;bcr/abl1 fusion gene p210;narrowmatch
bcr/abl1 fusion gene;bcr/abl1 fusion gene p230;narrowmatch
fusion gene;bcr/fgfr1 fusion gene;narrowmatch
fusion gene;bcr/pdgfra fusion gene;narrowmatch
bilateral breast carcinoma;contralateral breast carcinoma;narrowmatch
fusion gene;tpm3/ntrk1 fusion gene;narrowmatch
autoimmune disease;autoimmune nervous system disorder;narrowmatch
non-neoplastic nervous system disorder;autoimmune nervous system disorder;narrowmatch
fusion gene;prcc/tfe3 fusion gene;narrowmatch
fusion gene;zbtb16/rara fusion gene;narrowmatch
fusion gene;pax8/pparg fusion gene;narrowmatch
pax/foxo1 fusion gene;pax7/foxo1 fusion gene;narrowmatch
fusion gene;npm1/alk fusion gene;narrowmatch
fusion gene;numa1/rara fusion gene;narrowmatch
fusion gene;mll/mllt4 fusion gene;narrowmatch
fusion gene;mll/mllt10 fusion gene;narrowmatch
fusion gene;mll/mllt3 fusion gene;narrowmatch
fusion gene;mll/mllt1 fusion gene;narrowmatch
fusion gene;mll/aff1 fusion gene;narrowmatch
conceptual entity;intellectual property;narrowmatch
transcription regulation gene;asxl1 gene;narrowmatch
transcription factor gene;pbx1 gene;narrowmatch
hemoglobinopathy;hemoglobin trait;narrowmatch
non-neoplastic stomach disorder;gastric non-neoplastic polyp;narrowmatch
gastric polyp;gastric non-neoplastic polyp;narrowmatch
digestive system dysplasia;gastric dysplasia;narrowmatch
malignant cellular infiltrate;poorly cohesive malignant cellular infiltrate;narrowmatch
primary malignant neoplasm;second primary malignant neoplasm;narrowmatch
female reproductive system finding;vaginal bleeding;narrowmatch
non-neoplastic pancreatic disorder;acinar cystic transformation of the pancreas;narrowmatch
papillary pattern;thin-branching papillae present;narrowmatch
lyase gene;fh gene;narrowmatch
papillary pattern;tall papillae present;narrowmatch
abnormal cells present;cellular changes resembling foveolar epithelium cells;narrowmatch
creb family gene;creb3l2 gene;narrowmatch
creb family gene;creb3l1 gene;narrowmatch
transcription coactivator gene;maml2 gene;narrowmatch
transcription coactivator gene;crtc1 gene;narrowmatch
ear part;internal auditory canal;narrowmatch
glandular differentiation;gastric-type epithelial differentiation;narrowmatch
glandular differentiation;foveolar-type epithelium present;narrowmatch
ion channel protein gene;kcnj5 gene;narrowmatch
abnormal cells present;pancreatobiliary-type malignant cells present;narrowmatch
figo stage ia;figo stage ia2;narrowmatch
figo stage ia;figo stage ia1;narrowmatch
figo stage i;figo stage ia;narrowmatch
figo stage;figo stage i;narrowmatch
stage ii cervix;stage iia cervix;narrowmatch
stage iia;stage iia cervix;narrowmatch
stage ii;stage ii cervix;narrowmatch
stage ib;stage ib cervix;narrowmatch
non-infectious cystitis;cystitis cystica and glandularis;narrowmatch
chronic cystitis;cystitis cystica and glandularis;narrowmatch
colorectal neuroendocrine neoplasm;colorectal neuroendocrine tumor;narrowmatch
intestinal neuroendocrine tumor;colorectal neuroendocrine tumor;narrowmatch
nuclear receptor gene;nr4a3 gene;narrowmatch
tbp-associated factor gene;taf15 gene;narrowmatch
neoplastic syndrome;di guglielmo syndrome;narrowmatch
dysplasia;digestive system dysplasia;narrowmatch
serine/threonine protein kinase gene;prkd2 gene;narrowmatch
gene variant;asxl1 gene mutation;narrowmatch
round cell liposarcoma;round cell liposarcoma nci grade 3;narrowmatch
malignant hemangiopericytoma;conventional malignant hemangiopericytoma;narrowmatch
sarcoma;sarcoma by ajcc grade;narrowmatch
connective and soft tissue neoplasm (antiquated);inflammatory malignant fibrous histiocytoma nci grade 3;narrowmatch
connective and soft tissue neoplasm (antiquated);inflammatory malignant fibrous histiocytoma nci grade 2;narrowmatch
connective and soft tissue neoplasm (antiquated);storiform-pleomorphic malignant fibrous histiocytoma nci grade 3;narrowmatch
connective and soft tissue neoplasm (antiquated);storiform-pleomorphic malignant fibrous histiocytoma nci grade 2;narrowmatch
connective and soft tissue neoplasm (antiquated);fibrosarcoma nci grade 2;narrowmatch
round cell liposarcoma;round cell liposarcoma nci grade 2;narrowmatch
stage iiic;stage iiic2;narrowmatch
chondrosarcoma nci grade 2;myxoid chondrosarcoma nci grade 2;narrowmatch
connective and soft tissue neoplasm (antiquated);myxoid chondrosarcoma nci grade 1;narrowmatch
connective and soft tissue neoplasm (antiquated);chondrosarcoma nci grade 1;narrowmatch
connective and soft tissue neoplasm (antiquated);chondrosarcoma nci grade 2;narrowmatch
connective and soft tissue neoplasm (antiquated);chondrosarcoma nci grade 3;narrowmatch
hemangiopericytic neoplasm;malignant hemangiopericytoma nci grade 3;narrowmatch
hemangiopericytic neoplasm;malignant hemangiopericytoma nci grade 2;narrowmatch
laboratory test result;receptor status;narrowmatch
pleural effusion;malignant pleural effusion;narrowmatch
granuloma;granuloma by site;narrowmatch
chronic kidney disease;chronic kidney disease, stage 5;narrowmatch
stage iiic;stage iiic1;narrowmatch
stage iia cervix;stage iia2;narrowmatch
stage iia cervix;stage iia1;narrowmatch
chromosomal rearrangement;chromosomal deletion;narrowmatch
hereditary neoplastic syndrome;familial isolated hyperparathyroidism;narrowmatch
hereditary neoplastic syndrome;inherited bone marrow failure syndrome;narrowmatch
bone marrow failure syndrome;inherited bone marrow failure syndrome;narrowmatch
morphologic finding;atypia;narrowmatch
lesion;multicentric lesion;narrowmatch
transcription factor gene;tfeb gene;narrowmatch
disease grade qualifier;grade 2/3;narrowmatch
fusion gene;bcr/abl1 fusion gene;narrowmatch
neoplastic eosinophilic cell oncocyte;neoplastic eosinophilic spindle cell;narrowmatch
neoplastic epithelial spindle cell;neoplastic eosinophilic spindle cell;narrowmatch
morphologic finding;deposit;narrowmatch
figo stage i;figo stage ib;narrowmatch
figo stage ib;figo stage ib1;narrowmatch
figo stage ib;figo stage ib2;narrowmatch
pdgfr gene amplification;pdgfra gene amplification;narrowmatch
connective tissue disorder;hereditary connective tissue disorder;narrowmatch
metabolic disorder;metabolic bone disorder;narrowmatch
non-neoplastic bone disorder;metabolic bone disorder;narrowmatch
abnormal cells present;basal cells with pale cytoplasm present;narrowmatch
epithelial neoplasm (antiquated);gallbladder mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia;narrowmatch
epithelial neoplasm (antiquated);gallbladder intracholecystic papillary (tubular) neoplasm with intermediate grade intraepithelial neoplasia;narrowmatch
oncogene deregulation;pdgfra gene amplification;narrowmatch
gene abnormality;akt family gene mutation;narrowmatch
figo stage i;figo stage ic;narrowmatch
hepatobiliary disorder;non-neoplastic hepatobiliary disorder;narrowmatch
non-neoplastic digestive system disorder;non-neoplastic hepatobiliary disorder;narrowmatch
epithelial neoplasm (antiquated);bile duct mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia;narrowmatch
myeloid cell differentiation;thrombocyte differentiation;narrowmatch
myeloid cell differentiation;erythrocyte differentiation;narrowmatch
hematopoietic process;myeloid cell differentiation;narrowmatch
myelopoiesis;megakaryopoiesis;narrowmatch
lymphoid hyperplasia;benign lymphoid hyperplasia;narrowmatch
metabolic disorder;carbohydrate metabolism disorder;narrowmatch
metabolic disorder;lipodystrophy;narrowmatch
crystal formation;calcium oxalate crystal deposition;narrowmatch
gene variant;etv6 gene mutation;narrowmatch
gene variant;ezh2 gene mutation;narrowmatch
transcription regulation gene;mrtfa gene;narrowmatch
ligand binding protein gene;rbm15 gene;narrowmatch
non-neoplastic vision disorder;low vision;narrowmatch
congenital systemic disorder;congenital nervous system disorder;narrowmatch
non-neoplastic nervous system disorder;congenital nervous system disorder;narrowmatch
brain disorder;non-neoplastic brain disorder;narrowmatch
non-neoplastic central nervous system disorder;non-neoplastic brain disorder;narrowmatch
congenital abnormality;congenital systemic disorder;narrowmatch
germline mutation;unmutated immunoglobulin heavy chain variable region gene;narrowmatch
abnormal karyotype;complex karyotype;narrowmatch
central nervous system disorder;spinal cord disorder;narrowmatch
non-neoplastic vision disorder;blindness;narrowmatch
epithelial metaplasia;nephrogenic metaplasia;narrowmatch
epithelial neoplasm (antiquated);bile duct intraductal papillary neoplasm with intermediate grade intraepithelial neoplasia;narrowmatch
intrahepatic bile duct;intrahepatic large bile duct;narrowmatch
gene variant;hnf1a gene mutation;narrowmatch
abnormal tissue present;small cell component present;narrowmatch
gene variant;pik3ca gene mutation;narrowmatch
pi3k gene mutation;pik3ca gene mutation;narrowmatch
cytoplasmic alteration;intracytoplasmic lipofuscin present;narrowmatch
figo stage iv;figo stage ivb;narrowmatch
figo stage iv;figo stage iva;narrowmatch
figo stage;figo stage iv;narrowmatch
figo stage iiic;figo stage iiic2;narrowmatch
figo stage iiic;figo stage iiic1;narrowmatch
figo stage iii;figo stage iiic;narrowmatch
figo stage iii;figo stage iiib;narrowmatch
figo stage iii;figo stage iiia;narrowmatch
figo stage;figo stage iii;narrowmatch
figo stage ii;figo stage iib;narrowmatch
figo stage ii;figo stage iia;narrowmatch
figo stage;figo stage ii;narrowmatch
morphologic finding;perinuclear halo present;narrowmatch
metaplasia;epithelial metaplasia;narrowmatch
biliary system disorder;bile duct disorder;narrowmatch
central nervous system disorder;brain disorder;narrowmatch
gene variant;bmpr1a gene mutation;narrowmatch
gene variant;mutyh gene mutation;narrowmatch
dna repair gene mutation;mutyh gene mutation;narrowmatch
colorectal hamartoma;colorectal cowden-associated polyp;narrowmatch
hamartomatous polyp;gastrointestinal hamartoma;narrowmatch
gastrointestinal polyp;gastrointestinal hamartoma;narrowmatch
gastrointestinal hamartoma;colorectal hamartoma;narrowmatch
colorectal polyp;colorectal hamartoma;narrowmatch
non-neoplastic intestinal disorder;colorectal hamartoma;narrowmatch
colorectal polyp;colorectal sporadic serrated polyp;narrowmatch
abnormal tissue present;villous projections of the neoplastic epithelium present;narrowmatch
neuroma;appendix neuroma;narrowmatch
non-neoplastic appendix disorder;appendix neuroma;narrowmatch
epithelial neoplasm (antiquated);high grade appendix mucinous adenocarcinoma;narrowmatch
dysplasia;generalized dysplasia;narrowmatch
malignant neoplasm;primary malignant neoplasm;narrowmatch
transcription factor gene;mllt10 gene;narrowmatch
rat female genital system neoplasms;choriocarcinoma of the rat ovary;narrowmatch
rat digestive system neoplasms;squamous cell carcinoma of the rat tongue;narrowmatch
neoplasm by special category;neoplasm, uncertain whether benign or malignant;narrowmatch
clear cell neoplasm;clear cell malignant neoplasm;narrowmatch
epithelial neoplasm (antiquated);malignant tumor, small cell type;narrowmatch
malignant neoplasm;malignant neoplasm, uncertain whether primary or metastatic;narrowmatch
connective and soft tissue neoplasm (antiquated);fibroblastic liposarcoma;narrowmatch
multifocal osteosarcoma;asynchronous multifocal osteosarcoma;narrowmatch
rat female genital system neoplasms;teratoma of the rat ovary;narrowmatch
rat digestive system neoplasms;squamous cell papilloma of the rat tongue;narrowmatch
rat integumentary system neoplasms;squamous cell papilloma of the rat skin;narrowmatch
rat urinary system neoplasms;transitional cell papilloma of the rat urinary bladder;narrowmatch
rat urinary system neoplasms;transitional cell papilloma of the rat urethra;narrowmatch
rat urinary system neoplasms;transitional cell papilloma of the rat ureter;narrowmatch
rat urinary system neoplasms;transitional cell papilloma of the rat renal pelvis;narrowmatch
rat urinary system neoplasms;transitional cell carcinoma of the rat urinary bladder;narrowmatch
rat urinary system neoplasms;transitional cell carcinoma of the rat urethra;narrowmatch
rat urinary system neoplasms;transitional cell carcinoma of the rat ureter;narrowmatch
epithelial neoplasm (antiquated);glassy cell carcinoma;narrowmatch
epithelial neoplasm (antiquated);giant cell and spindle cell carcinoma;narrowmatch
epithelial neoplasm (antiquated);polygonal cell carcinoma;narrowmatch
respiratory system finding;tumorlet;narrowmatch
physiology-regulatory factor;mitogen;narrowmatch
benign hemangiopericytoma;benign mediastinal hemangiopericytoma;narrowmatch
connective and soft tissue neoplasm (antiquated);extraskeletal osteoma;narrowmatch
neuroma;multiple mucosal neuromas;narrowmatch
connective and soft tissue neoplasm (antiquated);fibrous synovial sarcoma;narrowmatch
morphologic finding;minimal invasion present;narrowmatch
lung adenocarcinoma, mixed subtype;lung adenocarcinoma with mixed bronchioloalveolar and invasive components;narrowmatch
epithelial neoplasm (antiquated);carcinoid tumor of uncertain malignant potential;narrowmatch
epithelial neoplasm (antiquated);carcinoma simplex;narrowmatch
enteroglucagonoma;malignant enteroglucagonoma;narrowmatch
epithelial neoplasm (antiquated);islet cell adenoma;narrowmatch
squamous cell carcinoma;squamous cell carcinoma, clear cell type;narrowmatch
keratinizing squamous cell carcinoma;squamous cell carcinoma with horn formation;narrowmatch
squamous cell carcinoma;squamous cell carcinoma in situ with questionable stromal invasion;narrowmatch
morphologic finding;keratin present;narrowmatch
rat urinary system neoplasms;transitional cell carcinoma of the rat renal pelvis;narrowmatch
rat integumentary system neoplasms;squamous cell carcinoma of the rat skin;narrowmatch
epithelial neoplasm (antiquated);medullary carcinoma, not otherwise specified;narrowmatch
rat respiratory system neoplasms;papilloma of the rat bronchus;narrowmatch
rat respiratory system neoplasms;squamous cell carcinoma of the rat bronchiole;narrowmatch
rat integumentary system neoplasms;sebaceous cell carcinoma of the rat skin;narrowmatch
rat integumentary system neoplasms;sebaceous cell adenoma of the rat skin;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat myxolipomatous lipoma;narrowmatch
rat soft tissue and musculoskeletal system neoplasms;rat angiolipomatous lipoma;narrowmatch
rat respiratory system neoplasms;papilloma of the rat trachea;narrowmatch
rat respiratory system neoplasms;papilloma of the rat larynx;narrowmatch
rat respiratory system neoplasms;papilloma of the rat bronchiole;narrowmatch
rat urinary system neoplasms;squamous cell papilloma of the rat urinary bladder;narrowmatch
rat respiratory system neoplasms;olfactory neuroblastoma of the rat nasal cavity;narrowmatch
rat respiratory system neoplasms;non-keratinizing epithelioma of the rat lung;narrowmatch
rat integumentary system neoplasms;melanotic malignant melanoma of the rat skin;narrowmatch
rat integumentary system neoplasms;malignant melanoma of the rat skin;narrowmatch
rat respiratory system neoplasms;malignant neuroendocrine cell tumor of the rat trachea;narrowmatch
rat respiratory system neoplasms;malignant mesothelioma of the rat pleura;narrowmatch
rat respiratory system neoplasms;malignant mesothelioma of the rat peritoneum;narrowmatch
rat respiratory system neoplasms;squamous cell carcinoma of the rat bronchus;narrowmatch
rat respiratory system neoplasms;squamous cell carcinoma of the rat larynx;narrowmatch
rat respiratory system neoplasms;squamous cell carcinoma of the rat lung;narrowmatch
rat respiratory system neoplasms;squamous cell carcinoma of the rat nasal cavity;narrowmatch
rat urinary system neoplasms;squamous cell papilloma of the rat urethra;narrowmatch
rat respiratory system neoplasms;squamous cell papilloma of the rat trachea;narrowmatch
rat respiratory system neoplasms;squamous cell papilloma of the rat paranasal sinus;narrowmatch
rat respiratory system neoplasms;squamous cell papilloma of the rat nasopharynx;narrowmatch
rat respiratory system neoplasms;squamous cell papilloma of the rat nasal cavity;narrowmatch
rat respiratory system neoplasms;squamous cell papilloma of the rat larynx;narrowmatch
rat respiratory system neoplasms;squamous cell papilloma of the rat bronchus;narrowmatch
rat respiratory system neoplasms;squamous cell papilloma of the rat bronchiole;narrowmatch
rat urinary system neoplasms;squamous cell carcinoma of the rat urinary bladder;narrowmatch
rat urinary system neoplasms;squamous cell carcinoma of the rat urethra;narrowmatch
rat urinary system neoplasms;squamous cell carcinoma of the rat ureter;narrowmatch
rat respiratory system neoplasms;squamous cell carcinoma of the rat trachea;narrowmatch
rat urinary system neoplasms;squamous cell carcinoma of the rat renal pelvis;narrowmatch
rat respiratory system neoplasms;squamous cell carcinoma of the rat paranasal sinus;narrowmatch
rat respiratory system neoplasms;squamous cell carcinoma of the rat nasopharynx;narrowmatch
malignant hemangiopericytoma;malignant mediastinal hemangiopericytoma;narrowmatch
epithelial neoplasm (antiquated);benign thymoma;narrowmatch
rat urinary system neoplasms;malignant mesenchymal tumor of the rat kidney;narrowmatch
chromosomal rearrangement;chromosomal inversion;narrowmatch
hodgkin lymphoma;hodgkin lymphoma by clinical course;narrowmatch
neoplastic trophoblastic cell;malignant trophoblastic cell;narrowmatch
malignant cell;malignant trophoblastic cell;narrowmatch
cytogenetic abnormality;double minutes;narrowmatch
cytogenetic abnormality;homogeneously staining region;narrowmatch
cytogenetic abnormality;derivative chromosome;narrowmatch
chromosomal rearrangement;chromosomal insertion;narrowmatch
cytogenetic abnormality;numerical chromosomal abnormality;narrowmatch
activating flt3 gene mutation;flt3 internal tandem duplication;narrowmatch
chromosomal translocation;unbalanced translocation;narrowmatch
chromosomal translocation;balanced chromosomal translocation;narrowmatch
intermediate grade lymphoma;intermediate grade b-cell non-hodgkin's lymphoma;narrowmatch
high grade lymphoma;high grade b-cell non-hodgkin's lymphoma;narrowmatch
low grade lymphoma;low grade b-cell non-hodgkin's lymphoma;narrowmatch
neoplasm by special category;cystic neoplasm;narrowmatch
pituitary gland neoplasm (antiquated);pituitary gland acidophil adenoma;narrowmatch
leukemia (antiquated);tdt positive acute lymphoblastic leukemia;narrowmatch
physiology-regulatory factor;neurotransmitter;narrowmatch
her2/neu status;her2/neu negative;narrowmatch
expression negative;her2/neu negative;narrowmatch
adult diffuse small cleaved cell lymphoma;recurrent adult diffuse small cleaved cell lymphoma;narrowmatch
meningioma;meningioma by site;narrowmatch
malignant intracranial neoplasm;malignant intracranial neoplasm by morphology;narrowmatch
kidney hemangiopericytoma;benign kidney hemangiopericytoma;narrowmatch
benign hemangiopericytoma;benign kidney hemangiopericytoma;narrowmatch
postoperative spindle cell nodule;postoperative spindle cell nodule of the bladder;narrowmatch
non-neoplastic bladder disorder;postoperative spindle cell nodule of the bladder;narrowmatch
non-neoplastic soft tissue disorder;postoperative spindle cell nodule;narrowmatch
skeletal system part;thoracic spine;narrowmatch
skeletal system part;lumbar spine;narrowmatch
skeletal system part;cervical spine;narrowmatch
morphologic finding;sclerosis;narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's granuloma;narrowmatch
epithelial neoplasm (antiquated);pancreatic mucinous-cystic neoplasm with intermediate grade dysplasia;narrowmatch
abnormal tissue present;oligodendroglial component present;narrowmatch
leukemia (antiquated);tdt negative acute lymphoblastic leukemia;narrowmatch
islet cell adenoma;pancreatic delta cell adenoma;narrowmatch
ovarian sex cord-stromal tumor;ovarian stromal tumor with minor sex cord elements;narrowmatch
nervous system neoplasm (antiquated);polar spongioblastoma;narrowmatch
neoplasm by obsolete classification;nervous system neoplasm (antiquated);narrowmatch
nervous system neoplasm (antiquated);hemangioblastic meningioma;narrowmatch
neoplasm by obsolete classification;spontaneously regressed retinoblastoma;narrowmatch
nervous system neoplasm (antiquated);spongioneuroblastoma;narrowmatch
nervous system neoplasm (antiquated);medulloepithelioma not otherwise specified;narrowmatch
nervous system neoplasm (antiquated);cerebellar sarcoma;narrowmatch
nervous system neoplasm (antiquated);oligodendroblastoma;narrowmatch
connective and soft tissue neoplasm (antiquated);benign hemangioendothelioma;narrowmatch
islet cell adenoma;pancreatic g-cell adenoma;narrowmatch
germ cell tumor (antiquated);malignant trophoblastic teratoma;narrowmatch
connective and soft tissue neoplasm (antiquated);benign stromal tumor;narrowmatch
connective and soft tissue neoplasm (antiquated);angiomyosarcoma;narrowmatch
connective and soft tissue neoplasm (antiquated);periosteal fibrosarcoma;narrowmatch
connective and soft tissue neoplasm (antiquated);giant cell sarcoma;narrowmatch
neoplasm by obsolete classification;clear cell neoplasm;narrowmatch
neoplasm by obsolete classification;granulosa cell-theca cell tumor;narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's disease, lymphocyte depletion, diffuse fibrosis;narrowmatch
hodgkin's lymphoma (antiquated);hodgkin's disease, lymphocyte depletion, reticular;narrowmatch
urinary tract precancerous condition;diffuse hyperplastic perilobar nephroblastomatosis;narrowmatch
capillary;carotid body;narrowmatch
islet cell adenoma;pancreatic beta cell adenoma;narrowmatch
islet cell adenoma;pancreatic alpha cell adenoma;narrowmatch
epithelial neoplasm (antiquated);pancreatic polypeptide tumor;narrowmatch
stage iva esophageal cancer;stage iva esophageal squamous cell carcinoma;narrowmatch
stage ivb esophageal cancer;stage ivb esophageal squamous cell carcinoma;narrowmatch
stage ivb esophageal cancer;stage ivb esophageal adenocarcinoma;narrowmatch
stage iva esophageal cancer;stage iva esophageal adenocarcinoma;narrowmatch
phakomatosis;neurofibromatosis;narrowmatch
abnormal urine test result;phosphaturia;narrowmatch
paraneoplastic syndrome;oncogenic osteomalacia;narrowmatch
osteomalacia;oncogenic osteomalacia;narrowmatch
neoplastic osteoblast;epithelioid osteoblast;narrowmatch
epithelial neoplasm (antiquated);enteroglucagonoma;narrowmatch
skin basal cell carcinoma;skin metatypical carcinoma;narrowmatch
keratin pearls formation;keratin horn pearls formation;narrowmatch
rat respiratory system neoplasms;malignant mesothelioma of the rat pericardium;narrowmatch
rat integumentary system neoplasms;keratoacanthoma of the rat skin;narrowmatch
transcription factor gene;tbxt gene;narrowmatch
rat male genital system neoplasms;adenocarcinoma of the rat seminal vesicle;narrowmatch
rat nervous system and sensory organs neoplasms;adenoma of the rat lacrimal gland;narrowmatch
figo stage iii gestational trophoblastic tumor;figo stage iiib gestational trophoblastic tumor;narrowmatch
rat nervous system and sensory organs neoplasms;adenoma of the rat intraorbital lacrimal gland;narrowmatch
rat nervous system and sensory organs neoplasms;adenoma of the rat harderian gland;narrowmatch
rat nervous system and sensory organs neoplasms;adenoma of the rat extraorbital lacrimal gland;narrowmatch
rat male genital system neoplasms;adenoma of the rat coagulating gland;narrowmatch
rat integumentary system neoplasms;adenolipoma of the rat mammary gland;narrowmatch
rat male genital system neoplasms;adenocarcinoma of the rat prostate;narrowmatch
rat integumentary system neoplasms;adenocarcinoma arising in fibroadenoma of the rat mammary gland;narrowmatch
rat male genital system neoplasms;adenocarcinoma of the rat preputial gland;narrowmatch
rat integumentary system neoplasms;adenocarcinoma of the rat mammary gland;narrowmatch
rat nervous system and sensory organs neoplasms;adenocarcinoma of the rat lacrimal gland;narrowmatch
figo stage iii gestational trophoblastic tumor;figo stage iiia gestational trophoblastic tumor;narrowmatch
rat nervous system and sensory organs neoplasms;adenocarcinoma of the rat intraorbital lacrimal gland;narrowmatch
rat nervous system and sensory organs neoplasms;adenocarcinoma of the rat harderian gland;narrowmatch
rat nervous system and sensory organs neoplasms;adenocarcinoma of the rat extraorbital lacrimal gland;narrowmatch
rat integumentary system neoplasms;adenoma of the rat mammary gland;narrowmatch
rat male genital system neoplasms;adenoma of the rat preputial gland;narrowmatch
rat male genital system neoplasms;adenoma of the rat prostate;narrowmatch
rat male genital system neoplasms;adenoma of the rat seminal vesicle;narrowmatch
rat integumentary system neoplasms;carcinosarcoma of the rat mammary gland;narrowmatch
rat male genital system neoplasms;carcinoma of the rat rete testis;narrowmatch
rat nervous system and sensory organs neoplasms;carcinoma of the rat choroid plexus;narrowmatch
rat nervous system and sensory organs neoplasms;benign oligodendroglioma of the rat spinal cord;narrowmatch
rat integumentary system neoplasms;benign mixed tumor of the rat mammary gland;narrowmatch
rat nervous system and sensory organs neoplasms;benign mixed glioma of the rat spinal cord;narrowmatch
rat nervous system and sensory organs neoplasms;benign meningioma of the rat spinal meninx;narrowmatch
rat nervous system and sensory organs neoplasms;benign meningioma of the rat cerebral meninx;narrowmatch
rat male genital system neoplasms;benign granulosa cell tumor of the rat testis;narrowmatch
rat nervous system and sensory organs neoplasms;benign ependymoma of the rat spinal cord;narrowmatch
figo stage iii gestational trophoblastic tumor;figo stage iiic gestational trophoblastic tumor;narrowmatch
rat nervous system and sensory organs neoplasms;benign ependymoma of the rat brain;narrowmatch
rat nervous system and sensory organs neoplasms;benign astrocytoma of the rat spinal cord;narrowmatch
rat nervous system and sensory organs neoplasms;benign astrocytoma of the rat brain;narrowmatch
rat male genital system neoplasms;basal cell carcinoma of the rat preputial gland;narrowmatch
rat male genital system neoplasms;adenocarcinoma of the rat coagulating gland;narrowmatch
rat female genital system neoplasms;yolk sac carcinoma of the rat uterus;narrowmatch
rat integumentary system neoplasms;fibroadenoma of the rat mammary gland;narrowmatch
rat female genital system neoplasms;endometrial stromal polyp of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;malignant mixed muellerian tumor of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;malignant granulosa cell tumor of the rat ovary;narrowmatch
rat female genital system neoplasms;keratoacanthoma of the rat vagina;narrowmatch
rat female genital system neoplasms;keratoacanthoma of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;endometrial stromal sarcoma of the rat uterus;narrowmatch
rat female genital system neoplasms;endometrial stromal sarcoma of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;endometrial stromal polyp of the rat uterus;narrowmatch
figo stage ii gestational trophoblastic tumor;figo stage iib gestational trophoblastic tumor;narrowmatch
rat female genital system neoplasms;yolk sac carcinoma of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;decidual reaction of the rat uterus;narrowmatch
rat female genital system neoplasms;decidual reaction of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;cystadenoma of the rat ovary;narrowmatch
rat female genital system neoplasms;cystadenocarcinoma of the rat ovary;narrowmatch
rat female genital system neoplasms;choriocarcinoma of the rat uterus;narrowmatch
rat female genital system neoplasms;choriocarcinoma of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;choriocarcinoma of the rat oviduct;narrowmatch
rat female genital system neoplasms;malignant mixed muellerian tumor of the rat uterus;narrowmatch
rat female genital system neoplasms;malignant sertoli cell tumor of the rat ovary;narrowmatch
figo stage ii gestational trophoblastic tumor;figo stage iic gestational trophoblastic tumor;narrowmatch
rat female genital system neoplasms;malignant thecoma of the rat ovary;narrowmatch
rat female genital system neoplasms;yolk sac carcinoma of the rat oviduct;narrowmatch
rat female genital system neoplasms;yolk sac carcinoma of the rat ovary;narrowmatch
tubulostromal adenoma;tubulostromal adenoma of the rat ovary;narrowmatch
rat female genital system neoplasms;tubulostromal adenoma of the rat ovary;narrowmatch
gestational trophoblastic tumor by figo stage;figo stage iii gestational trophoblastic tumor;narrowmatch
tubulostromal adenocarcinoma;tubulostromal adenocarcinoma of the rat ovary;narrowmatch
rat female genital system neoplasms;tubulostromal adenocarcinoma of the rat ovary;narrowmatch
rat female genital system neoplasms;squamous cell papilloma of the rat vagina;narrowmatch
rat female genital system neoplasms;squamous cell papilloma of the rat uterus;narrowmatch
rat female genital system neoplasms;squamous cell papilloma of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;squamous cell papilloma of the rat clitoral gland;narrowmatch
rat female genital system neoplasms;squamous cell carcinoma of the rat vagina;narrowmatch
rat female genital system neoplasms;squamous cell carcinoma of the rat uterus;narrowmatch
rat female genital system neoplasms;squamous cell carcinoma of the rat uterine cervix;narrowmatch
rat female genital system neoplasms;squamous cell carcinoma of the rat clitoral gland;narrowmatch
gestational trophoblastic tumor by figo stage;figo stage iv gestational trophoblastic tumor;narrowmatch
rat nervous system and sensory organs neoplasms;keratoacanthoma of the rat external ear;narrowmatch
rat respiratory system neoplasms;keratinizing cystic epithelioma of the rat lung;narrowmatch
rat male genital system neoplasms;squamous cell papilloma of the rat preputial gland;narrowmatch
rat respiratory system neoplasms;adenocarcinoma of the rat trachea;narrowmatch
rat respiratory system neoplasms;adenocarcinoma of the rat paranasal sinus;narrowmatch
rat respiratory system neoplasms;adenocarcinoma of the rat nasopharynx;narrowmatch
rat respiratory system neoplasms;adenocarcinoma of the rat nasal cavity;narrowmatch
rat respiratory system neoplasms;adenocarcinoma of the rat larynx;narrowmatch
rat respiratory system neoplasms;adenocarcinoma of the rat bronchus;narrowmatch
rat respiratory system neoplasms;adenocarcinoma of the rat bronchiole;narrowmatch
rat nervous system and sensory organs neoplasms;squamous cell papilloma of the rat eyelid;narrowmatch
rat integumentary system neoplasms;sebaceous cell adenoma of the rat zymbal gland;narrowmatch
rat nervous system and sensory organs neoplasms;squamous cell papilloma of the rat external ear;narrowmatch
rat nervous system and sensory organs neoplasms;squamous cell papilloma of the rat conjunctiva;narrowmatch
rat integumentary system neoplasms;squamous cell carcinoma of the rat zymbal gland;narrowmatch
rat male genital system neoplasms;squamous cell carcinoma of the rat preputial gland;narrowmatch
rat nervous system and sensory organs neoplasms;squamous cell carcinoma of the rat eyelid;narrowmatch
rat nervous system and sensory organs neoplasms;squamous cell carcinoma of the rat external ear;narrowmatch
rat nervous system and sensory organs neoplasms;squamous cell carcinoma of the rat conjunctiva;narrowmatch
rat urinary system neoplasms;adenocarcinoma of the rat urinary bladder;narrowmatch
rat urinary system neoplasms;adenoma of the rat kidney;narrowmatch
rat respiratory system neoplasms;adenoma of the rat nasal cavity;narrowmatch
rat respiratory system neoplasms;adenoma of the rat nasopharynx;narrowmatch
rat respiratory system neoplasms;epithelioid mesothelioma of the rat pericardium;narrowmatch
rat respiratory system neoplasms;carcinoma of the rat lung;narrowmatch
rat urinary system neoplasms;carcinoma of the rat kidney;narrowmatch
rat integumentary system neoplasms;benign basosquamous tumor of the rat skin;narrowmatch
rat integumentary system neoplasms;benign basal cell tumor of the rat skin;narrowmatch
rat respiratory system neoplasms;benign mesothelioma of the rat pleura;narrowmatch
rat respiratory system neoplasms;benign mesothelioma of the rat peritoneum;narrowmatch
rat respiratory system neoplasms;benign mesothelioma of the rat pericardium;narrowmatch
rat integumentary system neoplasms;basal cell carcinoma of the rat skin;narrowmatch
rat integumentary system neoplasms;amelanotic malignant melanoma of the rat skin;narrowmatch
rat respiratory system neoplasms;adenosquamous carcinoma of the rat paranasal sinus;narrowmatch
rat respiratory system neoplasms;adenosquamous carcinoma of the rat nasopharynx;narrowmatch
rat respiratory system neoplasms;adenosquamous carcinoma of the rat nasal cavity;narrowmatch
rat respiratory system neoplasms;adenosquamous carcinoma of the rat lung;narrowmatch
rat respiratory system neoplasms;adenoma of the rat paranasal sinus;narrowmatch
rat integumentary system neoplasms;sebaceous cell carcinoma of the rat zymbal gland;narrowmatch
rat integumentary system neoplasms;rat tricholemmoma type benign follicle hair tumor;narrowmatch
rat nervous system and sensory organs neoplasms;malignant astrocytoma of the rat brain;narrowmatch
rat nervous system and sensory organs neoplasms;malignant mixed glioma of the rat spinal cord;narrowmatch
rat nervous system and sensory organs neoplasms;malignant reticulosis of the rat spinal cord;narrowmatch
rat nervous system and sensory organs neoplasms;malignant reticulosis of the rat brain;narrowmatch
rat nervous system and sensory organs neoplasms;malignant oligodendroglioma of the rat spinal cord;narrowmatch
rat nervous system and sensory organs neoplasms;malignant oligodendroglioma of the rat brain;narrowmatch
rat nervous system and sensory organs neoplasms;malignant neuromyoblastoma of the rat cranial nerve;narrowmatch
rat nervous system and sensory organs neoplasms;malignant neuromyoblastoma of the rat brain;narrowmatch
rat integumentary system neoplasms;malignant mixed tumor of the rat mammary gland;narrowmatch
figo stage iv gestational trophoblastic tumor;figo stage iva gestational trophoblastic tumor;narrowmatch
rat integumentary system neoplasms;rat trichofolliculoma type benign follicle hair tumor;narrowmatch
rat nervous system and sensory organs neoplasms;malignant melanoma of the rat spinal meninx;narrowmatch
rat nervous system and sensory organs neoplasms;malignant melanoma of the rat cerebral meninx;narrowmatch
rat nervous system and sensory organs neoplasms;malignant intraocular schwannoma of the rat eyeball;narrowmatch
rat nervous system and sensory organs neoplasms;malignant glioma of the rat spinal cord;narrowmatch
rat nervous system and sensory organs neoplasms;malignant ependymoma of the rat spinal cord;narrowmatch
rat nervous system and sensory organs neoplasms;malignant ependymoma of the rat brain;narrowmatch
rat nervous system and sensory organs neoplasms;malignant astrocytoma of the rat spinal cord;narrowmatch
rat male genital system neoplasms;malignant sertoli cell tumor of the rat testis;narrowmatch
rat special sensory organ neoplasms;malignant uveal melanoma of the rat eyeball;narrowmatch
figo stage iv gestational trophoblastic tumor;figo stage ivb gestational trophoblastic tumor;narrowmatch
rat nervous system and sensory organs neoplasms;meningeal sarcoma of the rat cerebral meninx;narrowmatch
rat integumentary system neoplasms;rat trichoepithelioma type benign follicle hair tumor;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat pleomorphic lymphoma;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat plasmacytic lymphoma;narrowmatch
rat integumentary system neoplasms;rat pilomatricoma type benign follicle hair tumor;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat neutrophilic leukemia;narrowmatch
figo stage iv gestational trophoblastic tumor;figo stage ivc gestational trophoblastic tumor;narrowmatch
rat nervous system and sensory organs neoplasms;rat malignant glioma;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat lymphocytic lymphoma;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat lymphoblastic lymphoma;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat large granular lymphocyte leukemia;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat eosinophilic leukemia;narrowmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;rat basophilic leukemia;narrowmatch
rat nervous system and sensory organs neoplasms;papilloma of the rat choroid plexus;narrowmatch
rat nervous system and sensory organs neoplasms;ocular dermoid of the rat eyeball;narrowmatch
rat nervous system and sensory organs neoplasms;meningeal sarcoma of the rat spinal meninx;narrowmatch
nucleic acids, nucleosides, and nucleotides;nucleic acids;narrowmatch
neoplasm;neoplasm by special category;narrowmatch
leukemia (antiquated);t-cell chronic lymphocytic leukemia;narrowmatch
high grade adult non-hodgkin's lymphoma;stage iv high grade adult non-hodgkin's lymphoma;narrowmatch
immunophenotypic finding;cytokeratin-positive neoplastic cells present;narrowmatch
lymphoma by working formulation (antiquated);adult non-hodgkin's lymphoma grade;narrowmatch
high grade adult non-hodgkin's lymphoma;recurrent high grade adult non-hodgkin's lymphoma;narrowmatch
adult diffuse large cell lymphoma;recurrent adult diffuse large cell lymphoma;narrowmatch
adult diffuse mixed cell lymphoma;recurrent adult diffuse mixed cell lymphoma;narrowmatch
intermediate grade adult non-hodgkin's lymphoma;recurrent intermediate grade adult non-hodgkin's lymphoma;narrowmatch
low grade adult non-hodgkin's lymphoma;recurrent low grade adult non-hodgkin's lymphoma;narrowmatch
adult diffuse large cell lymphoma;stage iv adult diffuse large cell lymphoma;narrowmatch
abnormal laboratory test result;elevated test result;narrowmatch
adult diffuse mixed cell lymphoma;stage iv adult diffuse mixed cell lymphoma;narrowmatch
adult diffuse small cleaved cell lymphoma;stage iv adult diffuse small cleaved cell lymphoma;narrowmatch
intermediate grade adult non-hodgkin's lymphoma;stage iv intermediate grade adult non-hodgkin's lymphoma;narrowmatch
low grade adult non-hodgkin's lymphoma;stage iv low grade adult non-hodgkin's lymphoma;narrowmatch
high grade adult non-hodgkin's lymphoma;stage iii high grade adult non-hodgkin's lymphoma;narrowmatch
adult diffuse large cell lymphoma;stage iii adult diffuse large cell lymphoma;narrowmatch
adult diffuse mixed cell lymphoma;stage iii adult diffuse mixed cell lymphoma;narrowmatch
pi3k/mtor pathway mutation;alk gene mutation;narrowmatch
receptor tyrosine kinase gene mutation;alk gene mutation;narrowmatch
gene variant;alk gene mutation;narrowmatch
fusion protein expression;alk fusion protein expression;narrowmatch
rearrangement of 21q;erg gene rearrangement;narrowmatch
gene rearrangement abnormality;erg gene rearrangement;narrowmatch
fusion protein expression;tmprss2-erg fusion protein expression;narrowmatch
gene variant;gata1 gene mutation;narrowmatch
signaling pathway status;sonic hedgehog/patch pathway activated;narrowmatch
laboratory test result;signaling pathway status;narrowmatch
blasts of mixed phenotype present;blasts expressing cd56 and immature t-cell markers present;narrowmatch
blasts of mixed phenotype present;blasts expressing t-lymphoid and myeloid markers present;narrowmatch
blasts of mixed phenotype present;blasts expressing b-lymphoid and myeloid markers present;narrowmatch
blast cells present;blasts of mixed phenotype present;narrowmatch
epithelial neoplasm (antiquated);stage iv oral cavity verrucous carcinoma;narrowmatch
epithelial neoplasm (antiquated);stage iii oral cavity verrucous carcinoma;narrowmatch
epithelial neoplasm (antiquated);stage ii oral cavity verrucous carcinoma;narrowmatch
epithelial neoplasm (antiquated);stage i oral cavity verrucous carcinoma;narrowmatch
granuloma by site;nasal cavity and paranasal sinus lethal midline granuloma;narrowmatch
adult diffuse small cleaved cell lymphoma;stage iii adult diffuse small cleaved cell lymphoma;narrowmatch
intermediate grade adult non-hodgkin's lymphoma;stage iii intermediate grade adult non-hodgkin's lymphoma;narrowmatch
clinical test result;abnormal finding;narrowmatch
experimental organism neoplasm;cystic keratinizing epithelioma;narrowmatch
lymphoma by working formulation (antiquated);adult non-hodgkin's lymphoma stage;narrowmatch
model;biological model;narrowmatch
nodule;neoplastic nodule;narrowmatch
experimental organism neoplasm;tubulostromal adenocarcinoma;narrowmatch
ito cell tumor;malignant ito cell tumor;narrowmatch
ito cell tumor;benign ito cell tumor;narrowmatch
experimental organism neoplasm;ito cell tumor;narrowmatch
tissue;choristoma;narrowmatch
low grade adult non-hodgkin's lymphoma;stage iii low grade adult non-hodgkin's lymphoma;narrowmatch
hypoploidy;hypodiploidy;narrowmatch
hyperploidy;hyperdiploidy;narrowmatch
genetic finding;recurrent genetic abnormalities present;narrowmatch
syndrome;poems syndrome;narrowmatch
mature b-lymphocyte;ebv-transformed mature b-lymphocyte;narrowmatch
gene variant positive;braf v600e mutation present;narrowmatch
binet stage;binet stage c;narrowmatch
low grade adult non-hodgkin's lymphoma;stage i low grade adult non-hodgkin's lymphoma;narrowmatch
bone marrow disorder;bone marrow failure;narrowmatch
intermediate grade adult non-hodgkin's lymphoma;stage i intermediate grade adult non-hodgkin's lymphoma;narrowmatch
adult diffuse small cleaved cell lymphoma;stage i adult diffuse small cleaved cell lymphoma;narrowmatch
high grade adult non-hodgkin's lymphoma;stage ii high grade adult non-hodgkin's lymphoma;narrowmatch
adult diffuse large cell lymphoma;stage ii adult diffuse large cell lymphoma;narrowmatch
adult diffuse mixed cell lymphoma;stage ii adult diffuse mixed cell lymphoma;narrowmatch
adult diffuse small cleaved cell lymphoma;stage ii adult diffuse small cleaved cell lymphoma;narrowmatch
nucleic acids;ribonucleic acid;narrowmatch
therapy-related toxicity;immunosuppression-related post-transplant toxicity;narrowmatch
drug toxicity;immunosuppression-related post-transplant toxicity;narrowmatch
intermediate grade adult non-hodgkin's lymphoma;stage ii intermediate grade adult non-hodgkin's lymphoma;narrowmatch
ovarian monodermal teratoma;ovarian monodermal and highly specialized teratoma;narrowmatch
malignant mesenchymoma;childhood malignant mesenchymoma;narrowmatch
malignant hemangiopericytoma;malignant childhood hemangiopericytoma;narrowmatch
low grade adult non-hodgkin's lymphoma;stage ii low grade adult non-hodgkin's lymphoma;narrowmatch
high grade adult non-hodgkin's lymphoma;stage i high grade adult non-hodgkin's lymphoma;narrowmatch
adult diffuse large cell lymphoma;stage i adult diffuse large cell lymphoma;narrowmatch
adult diffuse mixed cell lymphoma;stage i adult diffuse mixed cell lymphoma;narrowmatch
gene variant;npm1 gene mutation;narrowmatch
bone marrow dysplasia present;unilineage dysplasia present;narrowmatch
polyp;neoplastic polyp;narrowmatch
dysplasia;mild dysplasia;narrowmatch
cemento-osseous dysplasia;florid cemento-osseous dysplasia;narrowmatch
polyp;hamartomatous polyp;narrowmatch
hamartoma;hamartomatous polyp;narrowmatch
non-neoplastic nevus;connective tissue nevus;narrowmatch
hamartoma;connective tissue nevus;narrowmatch
dysplasia;severe dysplasia;narrowmatch
dysplasia;moderate dysplasia;narrowmatch
epithelial metaplasia;intestinal metaplasia;narrowmatch
cytologic atypia;glandular cell atypia;narrowmatch
epithelial metaplasia;apocrine metaplasia;narrowmatch
epithelial metaplasia;glandular metaplasia;narrowmatch
atypical hyperplasia;atypical glandular hyperplasia;narrowmatch
glandular hyperplasia;atypical glandular hyperplasia;narrowmatch
cytologic atypia;koilocytotic atypia;narrowmatch
pathology result;microscopic finding;narrowmatch
subcapsular adrenal tumor;malignant subcapsular adrenal tumor;narrowmatch
squamous metaplasia;squamous metaplasia of bladder;narrowmatch
oncogene deregulation;tbxt gene duplication;narrowmatch
gene amplification abnormality;tbxt gene duplication;narrowmatch
fgfr gene mutation;fgfr4 gene mutation;narrowmatch
developmental disorder;mental retardation;narrowmatch
soft tissue;joint capsule;narrowmatch
metastatic lesion;distant intracranial metastasis;narrowmatch
experimental organism neoplasm;yolk sac adenoma;narrowmatch
hereditary neoplastic syndrome;phakomatosis;narrowmatch
calcification;microcalcification;narrowmatch
fgfr gene rearrangement;fgfr1 gene rearrangement;narrowmatch
receptor tyrosine kinase gene rearrangement;pdgfrb gene rearrangement;narrowmatch
chromosome 5 rearrangement;pdgfrb gene rearrangement;narrowmatch
receptor tyrosine kinase gene rearrangement;pdgfra gene rearrangement;narrowmatch
benign mesenchymoma;renal benign mesenchymoma;narrowmatch
gene variant;jak2 gene mutation;narrowmatch
jak family gene mutation;jak2 gene mutation;narrowmatch
mouth mucous membrane leukoplakia;leukoplakia of buccal mucosa;narrowmatch
gene variant;fgfr4 gene mutation;narrowmatch
subcapsular adrenal tumor;benign subcapsular adrenal tumor;narrowmatch
cytologic atypia;squamous cell atypia;narrowmatch
gene variant;ptpn11 gene mutation;narrowmatch
aids-related lymphoma by working formulation;aids-related diffuse mixed cell lymphoma;narrowmatch
hepatitis;chronic hepatitis;narrowmatch
experimental organism neoplasm;subcapsular adrenal tumor;narrowmatch
mammary duct ectasia;focal mammary duct ectasia;narrowmatch
aids-related lymphoma by working formulation;aids-related diffuse small cleaved cell lymphoma;narrowmatch
diffuse malignant lymphoma;aids-related diffuse small cleaved cell lymphoma;narrowmatch
malignant non-hodgkin lymphoma, cleaved cell;aids-related diffuse small cleaved cell lymphoma;narrowmatch
diffuse mixed cell lymphoma;aids-related diffuse mixed cell lymphoma;narrowmatch
diffuse malignant lymphoma;aids-related diffuse mixed cell lymphoma;narrowmatch
cytologic atypia;severe cytologic atypia;narrowmatch
organogenesis;odontogenesis;narrowmatch
morphologic finding;hyperchromasia;narrowmatch
chronic inflammation;mild chronic inflammation;narrowmatch
bone marrow and extramedullary involvement;bone marrow involvement;narrowmatch
genitourinary signs and symptoms;sexual dysfunction and infertility;narrowmatch
reproductive system finding;sexual dysfunction and infertility;narrowmatch
disease or disorder;cancer-related condition;narrowmatch
viral hepatitis;chronic viral hepatitis;narrowmatch
chronic hepatitis;chronic viral hepatitis;narrowmatch
morphologic finding;architectural distortion;narrowmatch
hepatic steatosis;macrovesicular steatosis;narrowmatch
precancerous atypia;severe cytologic atypia;narrowmatch
cytologic atypia;moderate cytologic atypia;narrowmatch
cytologic atypia;mild cytologic atypia;narrowmatch
atypia;cytologic atypia;narrowmatch
abnormal cells present;malignant cells with nuclei of various sizes and shapes present;narrowmatch
polyp;fibrous polyp;narrowmatch
malignant lymphoma, large cell type;childhood large cell lymphoma;narrowmatch
childhood large cell lymphoma;recurrent childhood large cell lymphoma;narrowmatch
childhood large cell lymphoma;stage iv childhood large cell lymphoma;narrowmatch
childhood large cell lymphoma;stage iii childhood large cell lymphoma;narrowmatch
childhood large cell lymphoma;stage ii childhood large cell lymphoma;narrowmatch
childhood large cell lymphoma;stage i childhood large cell lymphoma;narrowmatch
morphologic finding;hypocellular tissue;narrowmatch
hyperplasia;glandular hyperplasia;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);small lymphocytic lymphoma variant;narrowmatch
binet stage;binet stage b;narrowmatch
binet stage;binet stage a;narrowmatch
viral infection;merkel cell polyomavirus infection;narrowmatch
nephrogenic adenoma;bladder nephrogenic adenoma;narrowmatch
oral disorder;oral cavity and lip precancerous condition;narrowmatch
head and neck precancerous condition;oral cavity and lip precancerous condition;narrowmatch
digestive system precancerous condition;gastric precancerous condition;narrowmatch
stomach disorder;gastric precancerous condition;narrowmatch
digestive system precancerous condition;esophageal precancerous condition;narrowmatch
esophageal disorder;esophageal precancerous condition;narrowmatch
precancerous condition;precancerous condition by site;narrowmatch
non-neoplastic bladder disorder;bladder nephrogenic adenoma;narrowmatch
epithelial neoplasm (antiquated);thyroid gland papillary and follicular carcinoma;narrowmatch
non-neoplastic urinary system disorder;nephrogenic adenoma;narrowmatch
digestive system precancerous condition;pancreatic precancerous condition;narrowmatch
pancreatic exocrine neoplasm;pancreatic precancerous condition;narrowmatch
head and neck precancerous condition;laryngeal precancerous condition;narrowmatch
laryngeal disorder;laryngeal precancerous condition;narrowmatch
digestive system precancerous condition;anal precancerous condition;narrowmatch
anal disorder;anal precancerous condition;narrowmatch
lung disorder;pulmonary precancerous condition;narrowmatch
precancerous condition by site;pulmonary precancerous condition;narrowmatch
connective and soft tissue neoplasm (antiquated);granular cell odontogenic fibroma;narrowmatch
connective and soft tissue neoplasm (antiquated);hybrid odontogenic fibroma;narrowmatch
intestinal disorder;intestinal precancerous condition;narrowmatch
digestive system precancerous condition;hepatobiliary precancerous condition;narrowmatch
hepatobiliary disorder;hepatobiliary precancerous condition;narrowmatch
epithelial neoplasm (antiquated);breast intracystic papillary carcinoma;narrowmatch
methyltransferase gene;nsd1 gene;narrowmatch
hereditary neoplastic syndrome;dysplastic nevus syndrome;narrowmatch
non-neoplastic nevus;nevus of ota;narrowmatch
transcription factor gene;foxl2 gene;narrowmatch
hereditary connective tissue disorder;col1a1 associated connective tissue disorder;narrowmatch
malignant esophageal neoplasm;malignant esophageal neoplasm by topographic region;narrowmatch
malignant esophageal neoplasm;malignant esophageal neoplasm by anatomic region;narrowmatch
polyp;paranasal sinus polyp;narrowmatch
paranasal sinus disorder;paranasal sinus polyp;narrowmatch
industrial aid;pigment;narrowmatch
acute myeloid leukemia in remission;acute erythroid leukemia in remission;narrowmatch
immunophenotypic finding;ebv-positive neoplastic cells present;narrowmatch
epithelial neoplasm (antiquated);focal intraductal papillomatosis;narrowmatch
non-neoplastic kidney disorder;chronic kidney disease;narrowmatch
transcription regulation gene;prcc gene;narrowmatch
nervous system neoplasm (antiquated);central nervous system neuroepithelial neoplasm of uncertain origin;narrowmatch
germ cell tumor (antiquated);pineal region dysgerminoma;narrowmatch
non-neoplastic soft tissue disorder;subepidermal nodular fibrosis;narrowmatch
transcription factor gene;plag1 gene;narrowmatch
transcription regulation gene;nono gene;narrowmatch
transcription regulation gene;sfpq gene;narrowmatch
non-neoplastic, non-molar trophoblastic disorder;exaggerated placental site;narrowmatch
regulatory gene;aspscr1 gene;narrowmatch
epithelial neoplasm (antiquated);diffuse intraductal papillomatosis;narrowmatch
nucleic acids, nucleosides, and nucleotides;nucleotide;narrowmatch
colorectal cancer by astler-coller stage;rectal cancer by astler-coller stage;narrowmatch
colorectal cancer by astler-coller stage;colon cancer by astler-coller stage;narrowmatch
cancer stage (antiquated);colorectal cancer by astler-coller stage;narrowmatch
organic chemical;nucleic acids, nucleosides, and nucleotides;narrowmatch
connective and soft tissue neoplasm (antiquated);hemangiopericytic neoplasm;narrowmatch
neoplasm by special category;neoplastic polyp;narrowmatch
drug or chemical by structure;organic chemical;narrowmatch
lymphoma;lymphoma by site;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);lymphoma by working formulation (antiquated);narrowmatch
malignant lymphoma, non-cleaved cell type;non-burkitt's lymphoma;narrowmatch
methyltransferase gene;suz12 gene;narrowmatch
transcription regulation gene;jazf1 gene;narrowmatch
neoplasm by obsolete classification;hematopoietic and lymphoid neoplasm (antiquated);narrowmatch
epithelial neoplasm (antiquated);borderline ovarian serous surface papillary tumor;narrowmatch
ovarian monodermal teratoma;ovarian dermoid cyst with secondary tumor;narrowmatch
epithelial neoplasm (antiquated);borderline ovarian serous papillary cystic tumor;narrowmatch
epithelial neoplasm (antiquated);mixed mucinous and non-mucinous bronchioloalveolar carcinoma;narrowmatch
non-hodgkin lymphoma by clinical course;non-hodgkin lymphoma with variable clinical course;narrowmatch
non-hodgkin lymphoma;non-hodgkin lymphoma by clinical course;narrowmatch
aids-related lymphoma by working formulation;aids-related diffuse large cell lymphoma;narrowmatch
malignant lymphoma, large cell type;aids-related diffuse large cell lymphoma;narrowmatch
diffuse malignant lymphoma;aids-related diffuse large cell lymphoma;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);t-zone variant peripheral t-cell lymphoma;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);malignant histiocytosis;narrowmatch
neoplasm by special category;infrequent neoplasm;narrowmatch
digestive system precancerous condition;intestinal precancerous condition;narrowmatch
digestive system disorder;digestive system precancerous condition;narrowmatch
precancerous condition by site;digestive system precancerous condition;narrowmatch
chromosomal loss;1p/19q codeletion;narrowmatch
childhood acute leukemia in remission;childhood acute lymphoblastic leukemia in remission;narrowmatch
acute lymphoblastic leukemia in remission;childhood acute lymphoblastic leukemia in remission;narrowmatch
adult acute leukemia in remission;adult acute lymphoblastic leukemia in remission;narrowmatch
acute lymphoblastic leukemia in remission;adult acute lymphoblastic leukemia in remission;narrowmatch
adult acute leukemia in remission;adult acute myeloid leukemia in remission;narrowmatch
acute myeloid leukemia in remission;adult acute myeloid leukemia in remission;narrowmatch
chromosome 1 abnormality;1p/19q codeletion;narrowmatch
chromosomal rearrangement;rearrangement of 21q;narrowmatch
atypia;precancerous atypia;narrowmatch
chromosomal rearrangement;rearrangement of 11q;narrowmatch
11q aberration;rearrangement of 11q;narrowmatch
chromosomal rearrangement;rearrangement of 3q;narrowmatch
3q abnormality;rearrangement of 3q;narrowmatch
epithelial neoplasm (antiquated);thyroid gland undifferentiated small cell carcinoma;narrowmatch
malignant lymphoma, large cell type;adult diffuse large cell lymphoma;narrowmatch
diffuse malignant lymphoma;adult diffuse large cell lymphoma;narrowmatch
symptom;body temperature associated symptom;narrowmatch
malignant hemangiopericytoma;malignant adult hemangiopericytoma;narrowmatch
obstruction;digestive system obstruction;narrowmatch
digestive system finding;digestive system obstruction;narrowmatch
experimental organism neoplasm;tubulostromal adenoma;narrowmatch
epithelial neoplasm (antiquated);granular renal cell carcinoma;narrowmatch
tmprss2/ets family fusion gene;tmprss2/erg fusion gene;narrowmatch
virilization;abnormal virilization;narrowmatch
primate;hominidae;narrowmatch
endocrine system finding;precocious puberty;narrowmatch
reproductive system finding;precocious puberty;narrowmatch
cranial nerve disorder;optic nerve disorder;narrowmatch
eye finding;ophthalmoplegia;narrowmatch
acute eosinophilic leukemia;adult acute eosinophilic leukemia;narrowmatch
reproductive system finding;reproductive system hemorrhage;narrowmatch
hemorrhage;reproductive system hemorrhage;narrowmatch
perforation;digestive system perforation;narrowmatch
digestive system injury;digestive system perforation;narrowmatch
malignant mesenchymoma;adult malignant mesenchymoma;narrowmatch
respiratory system signs and symptoms;wheezing;narrowmatch
diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma;narrowmatch
gastrointestinal hemorrhage;upper gastrointestinal hemorrhage;narrowmatch
pharmacologic substance;agent affecting blood or body fluid;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);stage iv cutaneous t-cell non-hodgkin lymphoma;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);stage iii cutaneous t-cell non-hodgkin lymphoma;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);stage ii cutaneous t-cell non-hodgkin lymphoma;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);stage i cutaneous t-cell non-hodgkin lymphoma;narrowmatch
body cavity;cranial cavity;narrowmatch
mucosa;oral mucosa;narrowmatch
genetic disorder;dna repair disorder;narrowmatch
peutz-jeghers polyp;peutz-jeghers polyp of the small intestine;narrowmatch
small intestinal hamartoma;peutz-jeghers polyp of the small intestine;narrowmatch
skin angiokeratoma;angiokeratoma of fordyce;narrowmatch
leukoplakia;mucous membrane leukoplakia;narrowmatch
mucous membrane leukoplakia;mouth mucous membrane leukoplakia;narrowmatch
oral cavity leukoplakia;mouth mucous membrane leukoplakia;narrowmatch
integumentary system signs and symptoms;peau d'orange;narrowmatch
finding;clinical test result;narrowmatch
cystitis;non-infectious cystitis;narrowmatch
motor manifestations;gait disturbance;narrowmatch
non-neoplastic intestinal disorder;small intestinal infection;narrowmatch
digestive system infection;gastric infection;narrowmatch
digestive system infection;small intestinal infection;narrowmatch
bowel obstruction;small intestinal obstruction;narrowmatch
infectious disorder by site;pleural infection;narrowmatch
non-neoplastic pleural disorder;pleural infection;narrowmatch
pain;pain in extremity;narrowmatch
gastrointestinal hemorrhage;lower gastrointestinal hemorrhage;narrowmatch
sexual dysfunction;decreased libido;narrowmatch
cranial nerve disorder;trochlear nerve disorder;narrowmatch
hemorrhage;intra-abdominal hemorrhage;narrowmatch
non-neoplastic liver and intrahepatic bile duct disorder;hepatic infection;narrowmatch
digestive system infection;hepatic infection;narrowmatch
elevated test result;hemoglobin increased;narrowmatch
abnormal blood chemistry and hematology test result;hemoglobin increased;narrowmatch
fistula;digestive system fistula;narrowmatch
non-neoplastic stomach disorder;gastric infection;narrowmatch
neoplastic lipocyte;neoplastic mature adipocyte;narrowmatch
cancer tnm finding category;clinical tnm finding;narrowmatch
neoplastic lipocyte;neoplastic lipoblast;narrowmatch
neoplastic endocrine cell;neoplastic endocrine clear cell;narrowmatch
neoplastic muscle cell;neoplastic smooth muscle cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic muscle cell;narrowmatch
neoplastic epithelial spindle cell;neoplastic neuroendocrine spindle cell;narrowmatch
neoplastic neuroendocrine cell;neoplastic neuroendocrine spindle cell;narrowmatch
neoplastic epithelial polygonal cell;neoplastic neuroendocrine polygonal cell;narrowmatch
neoplastic neuroendocrine cell;neoplastic neuroendocrine polygonal cell;narrowmatch
neoplastic adrenal cortical cell;neoplastic adrenal cortical compact cell;narrowmatch
neoplastic epithelial clear cell;neoplastic endocrine clear cell;narrowmatch
neoplastic adenohypophysial cell;neoplastic somatotroph cell;narrowmatch
neoplastic endocrine cell;malignant endocrine cell;narrowmatch
malignant epithelial cell;malignant endocrine cell;narrowmatch
neoplastic adrenal cortical cell;neoplastic glomerulosa cell;narrowmatch
neoplastic epithelial cell;neoplastic endocrine cell;narrowmatch
neoplastic adenohypophysial cell;neoplastic endocrine null cell;narrowmatch
neoplastic adenohypophysial cell;neoplastic thyrotroph cell;narrowmatch
neoplastic adenohypophysial cell;neoplastic gonadotroph cell;narrowmatch
neoplastic glandular cell;neoplastic oncocyte;narrowmatch
neoplastic large cell with abundant cytoplasm;neoplastic oncocyte;narrowmatch
neoplastic oncocyte;malignant oncocyte;narrowmatch
adenocarcinoma cell with abundant cytoplasm;malignant oncocyte;narrowmatch
neoplastic spindle cell;neoplastic connective and soft tissue spindle cell;narrowmatch
malignant rhabdomyoblast;bizarre cell with evidence of skeletal muscle differentiation;narrowmatch
neoplastic connective and soft tissue spindle cell;spindle cell myoblast;narrowmatch
rhabdomyoblast;spindle cell myoblast;narrowmatch
malignant rhabdomyoblast;round cell with primitive myoblastic differentiation;narrowmatch
neoplastic round cell;round cell with primitive myoblastic differentiation;narrowmatch
round striated muscle cell;round cell with primitive myoblastic differentiation;narrowmatch
rhabdomyoblast;round striated muscle cell;narrowmatch
rhabdomyoblast;primitive striated muscle cell;narrowmatch
neoplastic skeletal muscle cell;strap-like skeletal muscle cell;narrowmatch
neoplastic muscle cell;neoplastic striated muscle cell;narrowmatch
neoplastic connective and soft tissue spindle cell;neoplastic spindle-shaped smooth muscle cell;narrowmatch
neoplastic smooth muscle cell;neoplastic spindle-shaped smooth muscle cell;narrowmatch
malignant small cell;malignant small undifferentiated cell;narrowmatch
neoplastic glandular cell;neoplastic acinar cell;narrowmatch
neoplastic adenohypophysial cell;neoplastic corticotroph cell;narrowmatch
neoplastic adenohypophysial cell;neoplastic lactotroph cell;narrowmatch
neoplastic connective and soft tissue spindle cell;neoplastic spindle-shaped fibroblast;narrowmatch
malignant cell;malignant langerhans cell;narrowmatch
neoplastic sex cord-stromal cell;neoplastic leydig cell;narrowmatch
neoplastic sex cord-stromal cell;neoplastic sertoli cell;narrowmatch
neoplastic sex cord-stromal cell;neoplastic granulosa cell;narrowmatch
neoplastic dendritic cell;neoplastic follicular dendritic cell;narrowmatch
neoplastic dendritic cell;neoplastic interdigitating dendritic cell;narrowmatch
neoplastic epithelial cell;mucin-producing neoplastic epithelial cell;narrowmatch
neoplastic langerhans cell;malignant langerhans cell;narrowmatch
neoplastic dendritic cell;neoplastic langerhans cell;narrowmatch
abnormal epithelial cell;atypical epithelial cell;narrowmatch
neoplastic histiocytic and dendritic cell;neoplastic histiocyte;narrowmatch
abnormal connective and soft tissue cell;neoplastic connective and soft tissue cell;narrowmatch
neoplastic cell;neoplastic connective and soft tissue cell;narrowmatch
neoplastic polygonal cell with abundant granular cytoplasm;malignant polygonal cell with abundant granular cytoplasm;narrowmatch
malignant cell;malignant polygonal cell with abundant granular cytoplasm;narrowmatch
neoplastic cell with eosinophilic cytoplasm;neoplastic glandular cell with eosinophilic granular cytoplasm;narrowmatch
neoplastic glandular cell;neoplastic glandular cell with eosinophilic granular cytoplasm;narrowmatch
malignant germ cell;malignant primitive germ cell;narrowmatch
neoplastic cell;neoplastic sex cord-stromal cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic stellate cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic osteoblast;narrowmatch
neoplastic round cell;primitive mesenchymal round cell;narrowmatch
primitive mesenchymal cell;primitive mesenchymal round cell;narrowmatch
malignant apocrine cell;apocrine carcinoma cell;narrowmatch
adenocarcinoma cell;apocrine carcinoma cell;narrowmatch
malignant connective and soft tissue cell;primitive mesenchymal cell;narrowmatch
neoplastic trophoblastic cell;neoplastic syncytiotrophoblastic cell;narrowmatch
abnormal syncytiotrophoblastic cell;neoplastic syncytiotrophoblastic cell;narrowmatch
neoplastic large cell;neoplastic large germ cell;narrowmatch
neoplastic germ cell;neoplastic large germ cell;narrowmatch
abnormal germ cell;neoplastic germ cell;narrowmatch
neoplastic cell;neoplastic germ cell;narrowmatch
neoplastic sex cord-stromal cell;signet ring stromal cell;narrowmatch
signet ring cell;signet ring stromal cell;narrowmatch
malignant connective and soft tissue cell;malignant osteoblast;narrowmatch
neoplastic osteoblast;malignant osteoblast;narrowmatch
neoplastic connective and soft tissue cell;neoplastic connective and soft tissue spindle cell;narrowmatch
neoplastic fibroblast;neoplastic spindle-shaped fibroblast;narrowmatch
neoplastic glandular cell with eosinophilic granular cytoplasm;adenocarcinoma cell with eosinophilic granular cytoplasm;narrowmatch
neoplastic small b-lymphocyte;neoplastic small cleaved follicle center cell;narrowmatch
neoplastic immunoblast;neoplastic b-immunoblast;narrowmatch
neoplastic large lymphocyte;neoplastic immunoblast;narrowmatch
neoplastic large cell;neoplastic large lymphocyte;narrowmatch
neoplastic lymphocyte;neoplastic large lymphocyte;narrowmatch
neoplastic medium-sized b-lymphocyte with basophilic cytoplasm;neoplastic medium-sized b-lymphocyte with eccentric basophilic cytoplasm;narrowmatch
neoplastic lymphocyte;neoplastic medium-sized lymphocyte;narrowmatch
neoplastic b-lymphocyte;neoplastic monocytoid b-lymphocyte;narrowmatch
neoplastic centrocyte;neoplastic small cleaved follicle center cell;narrowmatch
neoplastic t-lymphocyte and neoplastic natural killer cell;neoplastic natural killer cell;narrowmatch
neoplastic b-lymphocyte;centrocyte-like cell;narrowmatch
neoplastic b-lymphocyte;lymphoplasmacytoid cell;narrowmatch
neoplastic small b-lymphocyte;neoplastic small lymphocyte with clumped chromatin;narrowmatch
neoplastic lymphocyte;neoplastic small lymphocyte;narrowmatch
neoplastic t-lymphocyte;pleomorphic t-lymphocyte;narrowmatch
pleomorphic lymphocyte;pleomorphic t-lymphocyte;narrowmatch
pleomorphic cell;pleomorphic lymphocyte;narrowmatch
neoplastic large b-lymphocyte;neoplastic b-immunoblast;narrowmatch
neoplastic b-immunoblast;plasmablastic immunoblast;narrowmatch
neoplastic immunoblast;neoplastic t-immunoblast;narrowmatch
neoplastic large t-lymphocyte;neoplastic t-immunoblast;narrowmatch
abnormal large granular lymphocyte;neoplastic t-cell large granular lymphocyte;narrowmatch
neoplastic large t-lymphocyte;neoplastic t-cell large granular lymphocyte;narrowmatch
neoplastic large lymphocyte;anaplastic large lymphocyte;narrowmatch
anaplastic cell;anaplastic large lymphocyte;narrowmatch
anaplastic t-lymphocyte;anaplastic large t-lymphocyte;narrowmatch
anaplastic large lymphocyte;anaplastic large t-lymphocyte;narrowmatch
neoplastic large t-lymphocyte;anaplastic large t-lymphocyte;narrowmatch
neoplastic t-lymphocyte;neoplastic large t-lymphocyte;narrowmatch
neoplastic large lymphocyte;neoplastic large t-lymphocyte;narrowmatch
anaplastic large lymphocyte;anaplastic large b-lymphocyte;narrowmatch
neoplastic large b-lymphocyte;anaplastic large b-lymphocyte;narrowmatch
neoplastic follicle center b-cell;neoplastic centroblast;narrowmatch
neoplastic large b-lymphocyte;neoplastic centroblast;narrowmatch
neoplastic b-lymphocyte;neoplastic large b-lymphocyte;narrowmatch
neoplastic large lymphocyte;neoplastic large b-lymphocyte;narrowmatch
neoplastic lymphocyte;pleomorphic lymphocyte;narrowmatch
neoplastic lymphocyte;neoplastic medium-sized to large lymphocyte;narrowmatch
neoplastic spindle-shaped fibroblast;neoplastic spindle-shaped myofibroblast;narrowmatch
neoplastic polygonal cell;polygonal brown fat cell;narrowmatch
neoplastic lipoblast;multivacuolated lipoblast;narrowmatch
neoplastic lipoblast;monovacuolated lipoblast;narrowmatch
neoplastic connective and soft tissue cell;multilobated lipoblast-like cell;narrowmatch
polygonal brown fat cell;pale brown fat cell;narrowmatch
polygonal brown fat cell;eosinophilic brown fat cell;narrowmatch
polygonal brown fat cell;multivacuolated brown fat cell;narrowmatch
neoplastic lipocyte;polygonal brown fat cell;narrowmatch
malignant connective and soft tissue cell;malignant glomus cell;narrowmatch
neoplastic b-lymphocyte;neoplastic small to medium-sized b-lymphocyte with pale cytoplasm;narrowmatch
glomus cell;malignant glomus cell;narrowmatch
neoplastic connective and soft tissue cell;glomus cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic myoid cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic fusiform cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic fibrohistiocytic cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic histiocyte-like cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic fibroblast-like cell;narrowmatch
pleomorphic connective and soft tissue cell;pleomorphic lipoblast;narrowmatch
malignant lipocyte;pleomorphic lipoblast;narrowmatch
neoplastic lipoblast;pleomorphic lipoblast;narrowmatch
malignant lipocyte;signet ring lipoblast;narrowmatch
neoplastic small to medium-sized lymphocyte;neoplastic small to medium-sized b-lymphocyte with pale cytoplasm;narrowmatch
neoplastic lymphocyte;neoplastic small to medium-sized lymphocyte;narrowmatch
neoplastic hematopoietic and lymphoid cell;neoplastic lymphocyte;narrowmatch
abnormal lymphocyte;neoplastic lymphocyte;narrowmatch
malignant cell;neoplastic lymphocyte;narrowmatch
abnormal cell;abnormal hematopoietic and lymphoid cell;narrowmatch
neoplastic cartilage cell;neoplastic chondroblast;narrowmatch
neoplastic chondrocyte;atypical chondrocyte;narrowmatch
neoplastic cartilage cell;neoplastic chondrocyte;narrowmatch
neoplastic connective and soft tissue cell;chondrocyte-like cell;narrowmatch
neoplastic connective and soft tissue cell;ganglion-like cell;narrowmatch
neoplastic stromal cell;hyperchromatic stromal cell;narrowmatch
atypical adipocyte;hyperchromatic adipocyte;narrowmatch
neoplastic lipocyte;atypical adipocyte;narrowmatch
neoplastic lipoblast;signet ring lipoblast;narrowmatch
adenocarcinoma cell with eosinophilic cytoplasm;adenocarcinoma cell with eosinophilic granular cytoplasm;narrowmatch
neoplastic lobular epithelial cell;lobular carcinoma cell;narrowmatch
neoplastic connective and soft tissue cell;physaliphorous cell;narrowmatch
neoplastic basaloid cell;neoplastic non-cutaneous basaloid cell;narrowmatch
giant cell;giant epithelial cell;narrowmatch
malignant epithelial cell;malignant epithelial clear cell;narrowmatch
neoplastic epithelial clear cell;malignant epithelial clear cell;narrowmatch
malignant basaloid cell;malignant non-cutaneous basaloid cell;narrowmatch
neoplastic non-cutaneous basaloid cell;malignant non-cutaneous basaloid cell;narrowmatch
adenocarcinoma cell;malignant non-cutaneous basaloid cell;narrowmatch
neoplastic glandular cell;neoplastic non-cutaneous basaloid cell;narrowmatch
neoplastic basaloid cell;neoplastic cutaneous basal cell;narrowmatch
malignant epithelial spindle cell;malignant spindle squamous cell;narrowmatch
malignant epithelial cell;malignant myoepithelial cell;narrowmatch
neoplastic myoepithelial cell;malignant myoepithelial cell;narrowmatch
dysplastic epithelial cell;malignant epithelial cell;narrowmatch
malignant cell;malignant epithelial cell;narrowmatch
malignant epithelial cell;malignant transitional cell;narrowmatch
neoplastic transitional cell;malignant transitional cell;narrowmatch
adenocarcinoma cell with intracytoplasmic mucin;signet ring adenocarcinoma cell;narrowmatch
abnormal epithelial cell;giant epithelial cell;narrowmatch
neoplastic squamous cell;dysplastic squamous cell;narrowmatch
non-keratinizing malignant squamous cell;non-keratinizing malignant small squamous cell;narrowmatch
malignant small squamous cell;non-keratinizing malignant small squamous cell;narrowmatch
abnormal trophoblastic cell;neoplastic trophoblastic cell;narrowmatch
neoplastic cell;neoplastic trophoblastic cell;narrowmatch
abnormal trophoblastic cell;abnormal intermediate type trophoblastic cell;narrowmatch
abnormal trophoblastic cell;abnormal cytotrophoblastic cell;narrowmatch
abnormal trophoblastic cell;abnormal syncytiotrophoblastic cell;narrowmatch
abnormal cell;abnormal trophoblastic cell;narrowmatch
adenocarcinoma cell;poorly differentiated adenocarcinoma cell;narrowmatch
malignant small cell;malignant epithelial small cell;narrowmatch
malignant epithelial cell;malignant epithelial small cell;narrowmatch
dysplastic epithelial cell;dysplastic glandular cell;narrowmatch
neoplastic glandular cell;dysplastic glandular cell;narrowmatch
malignant large squamous cell;non-keratinizing malignant large squamous cell;narrowmatch
non-keratinizing malignant squamous cell;non-keratinizing malignant large squamous cell;narrowmatch
malignant squamous cell;non-keratinizing malignant squamous cell;narrowmatch
malignant squamous cell;keratinizing malignant squamous cell;narrowmatch
signet ring cell;signet ring adenocarcinoma cell;narrowmatch
malignant squamous cell;malignant spindle squamous cell;narrowmatch
giant cell;warthin-finkeldey polykaryocyte;narrowmatch
adenocarcinoma cell;paget cell;narrowmatch
abnormal squamous cell;neoplastic squamous cell;narrowmatch
ventilation or perfusion signs and symptoms;alteration in respiration;narrowmatch
neoplastic epithelial cell;neoplastic basaloid cell;narrowmatch
neoplastic cell;neoplastic hobnail cell;narrowmatch
neoplastic cell;neoplastic clear cell;narrowmatch
neoplastic clear cell;neoplastic epithelial clear cell;narrowmatch
neoplastic epithelial cell;neoplastic epithelial clear cell;narrowmatch
abnormal epithelial cell;neoplastic epithelial cell;narrowmatch
malignant large squamous cell;multinucleated malignant squamous cell;narrowmatch
neoplastic cell;neoplastic epithelial cell;narrowmatch
neoplastic keratinocyte;large keratinocyte;narrowmatch
abnormal keratinocyte;neoplastic keratinocyte;narrowmatch
neoplastic squamous cell;neoplastic keratinocyte;narrowmatch
abnormal cell;abnormal epithelial cell;narrowmatch
neoplastic striated muscle cell;rhabdomyoblast;narrowmatch
neoplastic follicle center b-cell;neoplastic centrocyte;narrowmatch
dysplastic epithelial cell;neoplastic squamous cell;narrowmatch
neoplastic endocrine cell;neoplastic neuroendocrine cell;narrowmatch
neoplastic epithelial cell;neoplastic glandular cell;narrowmatch
abnormal glandular cell;neoplastic glandular cell;narrowmatch
malignant epithelial giant cell;multinucleated malignant squamous cell;narrowmatch
dysplastic glandular cell;adenocarcinoma cell;narrowmatch
malignant epithelial cell;adenocarcinoma cell;narrowmatch
abnormal epithelial cell;abnormal squamous cell;narrowmatch
dysplastic squamous cell;malignant squamous cell;narrowmatch
malignant epithelial cell;malignant squamous cell;narrowmatch
abnormal myoepithelial cell;neoplastic myoepithelial cell;narrowmatch
neoplastic epithelial cell;neoplastic myoepithelial cell;narrowmatch
abnormal epithelial cell;abnormal myoepithelial cell;narrowmatch
abnormal transitional cell;neoplastic transitional cell;narrowmatch
neoplastic epithelial cell;neoplastic transitional cell;narrowmatch
abnormal epithelial cell;abnormal transitional cell;narrowmatch
abnormal squamous cell;abnormal keratinocyte;narrowmatch
neoplastic glandular cell;neoplastic glandular cell with clear cytoplasm;narrowmatch
abnormal epithelial cell;abnormal glandular cell;narrowmatch
neoplastic epithelial cell;dysplastic epithelial cell;narrowmatch
abnormal lymphocyte;warthin-finkeldey polykaryocyte;narrowmatch
adenocarcinoma cell;lobular carcinoma cell;narrowmatch
neoplastic polygonal cell;neoplastic polygonal cell with abundant granular cytoplasm;narrowmatch
mucin-producing malignant epithelial cell;mucin-producing adenocarcinoma cell;narrowmatch
adenocarcinoma cell;mucin-producing adenocarcinoma cell;narrowmatch
neoplastic neuroendocrine polygonal cell;malignant neuroendocrine polygonal cell;narrowmatch
malignant neuroendocrine large cell;malignant neuroendocrine polygonal cell;narrowmatch
malignant epithelial spindle cell;malignant neuroendocrine spindle cell;narrowmatch
neoplastic neuroendocrine spindle cell;malignant neuroendocrine spindle cell;narrowmatch
malignant neuroendocrine cell;malignant neuroendocrine spindle cell;narrowmatch
neoplastic large cell with abundant cytoplasm;neoplastic polygonal cell;narrowmatch
abnormal cell;abnormal connective and soft tissue cell;narrowmatch
large adenocarcinoma cell with eosinophilic cytoplasm;polygonal adenocarcinoma cell with eosinophilic cytoplasm;narrowmatch
adenocarcinoma cell with abundant cytoplasm;polygonal adenocarcinoma cell with eosinophilic cytoplasm;narrowmatch
malignant polygonal cell with eosinophilic cytoplasm;polygonal adenocarcinoma cell with eosinophilic cytoplasm;narrowmatch
neoplastic spindle cell;neoplastic epithelial spindle cell;narrowmatch
neoplastic epithelial cell;neoplastic epithelial spindle cell;narrowmatch
malignant epithelial large cell;anaplastic carcinoma cell;narrowmatch
anaplastic cell;anaplastic carcinoma cell;narrowmatch
adenocarcinoma cell;giant adenocarcinoma cell;narrowmatch
malignant epithelial giant cell;giant adenocarcinoma cell;narrowmatch
adenocarcinoma cell;ductal carcinoma cell;narrowmatch
neoplastic ductal epithelial cell;ductal carcinoma cell;narrowmatch
neoplastic glandular cell;neoplastic lobular epithelial cell;narrowmatch
neoplastic glandular cell;neoplastic ductal epithelial cell;narrowmatch
malignant spindle cell;spindle melanoma cell;narrowmatch
melanoma cell;spindle melanoma cell;narrowmatch
neoplastic melanocyte;melanoma cell;narrowmatch
malignant cell;melanoma cell;narrowmatch
melanoma cell;epithelioid melanoma cell;narrowmatch
neoplastic melanocyte;epithelioid melanocyte;narrowmatch
neoplastic melanocyte;spindle melanocyte;narrowmatch
neoplastic spindle cell;spindle melanocyte;narrowmatch
neoplastic melanocyte;atypical melanocyte;narrowmatch
nevus cell;balloon nevus cell;narrowmatch
neoplastic cell;neoplastic melanocyte;narrowmatch
malignant small cell;malignant small hyperchromatic cell;narrowmatch
malignant cell;malignant small cell;narrowmatch
abnormal macrophage;hemosiderin-laden macrophage;narrowmatch
neoplastic astrocyte;giant astrocyte;narrowmatch
malignant squamous cell;malignant clear squamous cell;narrowmatch
malignant neuroendocrine cell;malignant neuroendocrine small cell;narrowmatch
giant epithelial cell;malignant epithelial giant cell;narrowmatch
neoplastic cell;neoplastic spindle cell;narrowmatch
neoplastic large cell;malignant epithelial large cell;narrowmatch
malignant epithelial cell;malignant epithelial large cell;narrowmatch
malignant neuroendocrine cell;malignant neuroendocrine large cell;narrowmatch
malignant epithelial large cell;malignant neuroendocrine large cell;narrowmatch
neoplastic neuroendocrine small cell;malignant neuroendocrine small cell;narrowmatch
malignant epithelial small cell;malignant neuroendocrine small cell;narrowmatch
neoplastic multinucleated giant cell;giant astrocyte;narrowmatch
neoplastic large cell;neoplastic multinucleated giant cell;narrowmatch
giant cell;neoplastic multinucleated giant cell;narrowmatch
giant cell;large osteoclastic giant cell;narrowmatch
malignant epithelial clear cell;adenocarcinoma clear cell;narrowmatch
adenocarcinoma cell;adenocarcinoma clear cell;narrowmatch
neoplastic glandular cell with clear cytoplasm;adenocarcinoma clear cell;narrowmatch
malignant epithelial clear cell;malignant clear squamous cell;narrowmatch
neoplastic multinucleated giant cell;malignant epithelial giant cell;narrowmatch
malignant epithelial large cell;malignant epithelial giant cell;narrowmatch
neoplastic neuroendocrine cell;malignant neuroendocrine cell;narrowmatch
malignant endocrine cell;malignant neuroendocrine cell;narrowmatch
adenocarcinoma cell;granular adenocarcinoma cell;narrowmatch
malignant endocrine cell;malignant thyroid gland follicular cell;narrowmatch
neoplastic thyroid gland follicular cell;malignant thyroid gland follicular cell;narrowmatch
adenocarcinoma cell;malignant thyroid gland follicular cell;narrowmatch
neoplastic endocrine cell;neoplastic thyroid gland follicular cell;narrowmatch
neoplastic glandular cell;neoplastic thyroid gland follicular cell;narrowmatch
abnormal macrophage;tingible body macrophage;narrowmatch
abnormal macrophage;lipid-laden macrophage;narrowmatch
abnormal connective and soft tissue cell;abnormal macrophage;narrowmatch
neoplastic mesothelial cell;malignant mesothelial cell;narrowmatch
malignant cell;malignant mesothelial cell;narrowmatch
abnormal cell;abnormal mesothelial cell;narrowmatch
malignant rhabdomyoblast;giant cell with myoblastic differentiation;narrowmatch
neoplastic multinucleated giant cell;giant cell with myoblastic differentiation;narrowmatch
giant cell;osteoclast-like giant cell;narrowmatch
leukemic lymphocyte;neoplastic t-cell large granular lymphocyte;narrowmatch
neoplastic centrocyte;neoplastic large cleaved follicle center cell;narrowmatch
neoplastic large b-lymphocyte;neoplastic large cleaved follicle center cell;narrowmatch
fusion protein expression;tcf12-nr4a3 fusion protein expression;narrowmatch
fusion protein expression;etv6-ntrk3 fusion protein expression;narrowmatch
fusion protein expression;has2-plag1 fusion protein expression;narrowmatch
fusion protein expression;col1a2-plag1 fusion protein expression;narrowmatch
fusion protein expression;pax7-foxo1 fusion protein expression;narrowmatch
fusion protein expression;pax3-foxo1 fusion protein expression;narrowmatch
fusion protein expression;fus-ddit3 fusion protein expression;narrowmatch
fusion protein expression;ewsr1-wt1 fusion protein expression;narrowmatch
fusion protein expression;taf15-nr4a3 fusion protein expression;narrowmatch
fusion protein expression;ewsr1-fli1 fusion protein expression;narrowmatch
fusion protein expression;ewsr1-nr4a3 fusion protein expression;narrowmatch
fusion protein expression;ewsr1-atf1 fusion protein expression;narrowmatch
fusion protein expression;ewsr1-etv4 fusion protein expression;narrowmatch
fusion protein expression;ewsr1-etv1 fusion protein expression;narrowmatch
fusion protein expression;ewsr1-erg fusion protein expression;narrowmatch
fusion protein expression;kmt2a-af4 fusion protein expression;narrowmatch
fusion protein expression;etv6-runx1 fusion protein expression;narrowmatch
fusion protein expression;fus-atf1 fusion protein expression;narrowmatch
ss18-ssx fusion protein expression;ss18-ssx1 fusion protein expression;narrowmatch
ss18-ssx fusion protein expression;ss18-ssx2 fusion protein expression;narrowmatch
ss18-ssx fusion protein expression;ss18-ssx4 fusion protein expression;narrowmatch
trisomy;trisomy 16;narrowmatch
trisomy;trisomy 17;narrowmatch
chromosome 17 abnormality;trisomy 17;narrowmatch
epithelial neoplasm (antiquated);pulmonary adenomatosis;narrowmatch
chromosomal loss;loss of chromosome 11q;narrowmatch
11q aberration;loss of chromosome 11q;narrowmatch
cardiovascular system finding;cardiovascular system signs and symptoms;narrowmatch
sign or symptom;cardiovascular system signs and symptoms;narrowmatch
fusion protein expression;hmga2-lpp fusion protein expression;narrowmatch
fusion protein expression;ewsr1-patz1 fusion protein expression;narrowmatch
chromosome 1 abnormality;"t(1;22)(p36.1;q12)";narrowmatch
chromosomal translocation;"t(1;22)(p36.1;q12)";narrowmatch
fusion protein expression;ewsr1-fev fusion protein expression;narrowmatch
chromosomal translocation;"t(2;22)(q33;q12)";narrowmatch
fusion protein expression;aspl-tfe3 fusion protein expression;narrowmatch
fusion protein expression;tcf3-pbx1 fusion protein expression;narrowmatch
fusion protein expression;pml-rara fusion protein expression;narrowmatch
tetrasomy;tetrasomy 7;narrowmatch
leukemic lymphocyte;neoplastic prolymphocyte;narrowmatch
chromosomal deletion;del(6q25-27);narrowmatch
chromosomal gain;gain of chromosome 12q13;narrowmatch
chromosome 12 abnormality;gain of chromosome 12q13;narrowmatch
neoplastic t-lymphocyte;neoplastic t-prolymphocyte;narrowmatch
neoplastic prolymphocyte;neoplastic t-prolymphocyte;narrowmatch
neoplastic b-lymphocyte;neoplastic b-prolymphocyte;narrowmatch
neoplastic prolymphocyte;neoplastic b-prolymphocyte;narrowmatch
neoplastic myeloid blast;neoplastic monoblast;narrowmatch
fusion protein expression;numa1-rara fusion protein expression;narrowmatch
neoplastic myeloblast;medium-sized neoplastic myeloblast with coarse cytoplasmic basophilic granules;narrowmatch
neoplastic myeloblast;neoplastic myeloblast without azurophilic granules;narrowmatch
neoplastic myeloblast;neoplastic myeloblast with azurophilic granules;narrowmatch
neoplastic myeloblast with basophilic cytoplasm;neoplastic medium-sized myeloblast with basophilic agranular cytoplasm;narrowmatch
neoplastic myeloblast with basophilic cytoplasm;neoplastic myeloblast with abundant basophilic cytoplasm;narrowmatch
neutrophil with abnormal cytoplasmic granulation;neutrophil with pseudo chediak-higashi granules;narrowmatch
neutrophil with abnormal cytoplasmic granulation;neutrophil with cytoplasmic hypogranularity;narrowmatch
chromosome 17 abnormality;del(17q25);narrowmatch
chromosomal deletion;del(17q25);narrowmatch
chromosomal translocation;"t(9;22)(q22-31;q12)";narrowmatch
trisomy;trisomy 11;narrowmatch
fusion protein expression;npm1-rara fusion protein expression;narrowmatch
fusion protein expression;zbtb16-rara fusion protein expression;narrowmatch
aids-related disorder;oral cavity hairy leukoplakia;narrowmatch
oral cavity leukoplakia;oral cavity hairy leukoplakia;narrowmatch
fusion protein expression;cbfb-myh11 fusion protein expression;narrowmatch
fusion protein expression;aml1-eto fusion protein expression;narrowmatch
fusion protein expression;fip1l1-pdgfralpha fusion protein expression;narrowmatch
alk fusion protein expression;cltc-alk fusion protein expression;narrowmatch
11q12 translocation;"t(6;11)(p21;q12)";narrowmatch
tfeb gene translocation;"t(6;11)(p21;q12)";narrowmatch
chromosomal rearrangement;rearrangement of 2p23;narrowmatch
messenger rna overexpression;zap70 messenger rna overexpression;narrowmatch
chromosomal translocation;"t(16;17)(q22;p13)";narrowmatch
chromosome 17 abnormality;"t(16;17)(q22;p13)";narrowmatch
metastasis;intravascular metastasis;narrowmatch
chromosome 7 abnormality;tetrasomy 7;narrowmatch
tfe3 gene translocation;"t(x;1)(p11.2;q21)";narrowmatch
reed-sternberg cell;hodgkin cell;narrowmatch
heterotrimeric g protein subunit gene;gnas gene;narrowmatch
immature t-lymphocyte;immature peripheral gamma/delta cell of cytotoxic type;narrowmatch
immature lymphocyte;immature t-lymphocyte;narrowmatch
t-lymphocyte;immature t-lymphocyte;narrowmatch
cytotoxic t-lymphocyte;mature cytotoxic t-lymphocyte;narrowmatch
mature t-lymphocyte;peripheral epidermotropic t-lymphocyte;narrowmatch
marginal zone b-lymphocyte;marginal zone b-lymphocyte of nodal type;narrowmatch
symptom;malaise;narrowmatch
heterotrimeric g protein subunit gene;gnaq gene;narrowmatch
messenger rna overexpression;bcl2 gene mrna overexpression;narrowmatch
gastrointestinal hamartoma;juvenile polyp;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);pseudolymphoma;narrowmatch
finding;lesion;narrowmatch
receptor tyrosine kinase gene;alk gene;narrowmatch
chromosomal translocation;bcl2 gene translocation;narrowmatch
bcl2 gene rearrangement;bcl2 gene translocation;narrowmatch
messenger rna overexpression;cd44 messenger rna overexpression;narrowmatch
peripheral (post-thymic) t-lymphocyte;immature peripheral gamma/delta cell of cytotoxic type;narrowmatch
immature t-lymphocyte;immature peripheral alpha/beta cell of cytotoxic type;narrowmatch
peripheral (post-thymic) t-lymphocyte;immature peripheral alpha/beta cell of cytotoxic type;narrowmatch
clinical course of disease;unfavorable clinical outcome;narrowmatch
mature b-lymphocyte;postgerminal center b-lymphocyte;narrowmatch
gait disturbance;ataxic gait;narrowmatch
postgerminal center b-lymphocyte;postgerminal center memory b-lymphocyte;narrowmatch
memory b-lymphocyte;postgerminal center memory b-lymphocyte;narrowmatch
mature b-lymphocyte;naive pregerminal center b-lymphocyte;narrowmatch
dendritic cell;interdigitating dendritic cell;narrowmatch
mature b-lymphocyte;germinal center b-lymphocyte;narrowmatch
marginal zone b-lymphocyte;postgerminal center marginal zone b-lymphocyte;narrowmatch
postgerminal center b-lymphocyte;postgerminal center marginal zone b-lymphocyte;narrowmatch
mature b-lymphocyte;activated b-lymphocyte;narrowmatch
activated lymphocyte;activated b-lymphocyte;narrowmatch
mature b-lymphocyte;peripheral b-lymphocyte of inner mantle zone;narrowmatch
mature t-lymphocyte;intraepithelial t-lymphocyte;narrowmatch
mature b-lymphocyte;peripheral b-lymphocyte;narrowmatch
mature b-lymphocyte;thymic b-lymphocyte;narrowmatch
messenger rna overexpression;irf4/mum1 messenger rna overexpression;narrowmatch
messenger rna overexpression;cyclin d2 messenger rna overexpression;narrowmatch
chromosome 1 abnormality;"t(x;1)(p11.2;q21)";narrowmatch
chromosomal translocation;"t(9;12)(q34;p13)";narrowmatch
chromosomal gain;gain of chromosome 14;narrowmatch
abdominal mass;intestinal mass;narrowmatch
chromosomal translocation;"t(9;22)(p24;q11)";narrowmatch
fusion protein expression;bcr-jak2 fusion protein expression;narrowmatch
chromosomal translocation;"t(9;12)(p24;p13)";narrowmatch
etv6 gene rearrangement;"t(9;12)(p24;p13)";narrowmatch
fusion protein expression;tel-jak2 fusion protein expression;narrowmatch
chromosome 12 abnormality;"t(9;12)(q34;p13)";narrowmatch
messenger rna overexpression;pkcbeta1 messenger rna overexpression;narrowmatch
fusion protein expression;tel-abl fusion protein expression;narrowmatch
fusion protein expression;bcr-pdgfralpha fusion protein expression;narrowmatch
chromosomal translocation;"t(4;22)(q12;q11)";narrowmatch
fusion protein expression;bcr-fgfr1 fusion protein expression;narrowmatch
chromosomal translocation;"t(8;22)(p11;q11)";narrowmatch
chromosome 1 abnormality;"t(x;1)(p11.2;p34)";narrowmatch
tfe3 gene translocation;"t(x;1)(p11.2;p34)";narrowmatch
disturbance in bowel function;constipation;narrowmatch
respiratory system signs and symptoms;cough;narrowmatch
neurological signs and symptoms;dizziness;narrowmatch
abnormal blood chemistry and hematology test result;hypocalcemia;narrowmatch
messenger rna overexpression;lmo2 messenger rna overexpression;narrowmatch
messenger rna overexpression;a-myb messenger rna overexpression;narrowmatch
messenger rna overexpression;bcl-6 messenger rna overexpression;narrowmatch
messenger rna overexpression;cd10 messenger rna overexpression;narrowmatch
precancerous condition by site;male reproductive system precancerous condition;narrowmatch
male reproductive system neoplasm;male reproductive system precancerous condition;narrowmatch
malignant neoplasm;metachronous malignant neoplasm;narrowmatch
clinical course of disease;recurrent disease;narrowmatch
ascites;malignant ascites;narrowmatch
colitis;typhlitis;narrowmatch
motor manifestations;tremor;narrowmatch
non-neoplastic pleural disorder;pneumothorax;narrowmatch
cardiovascular system signs and symptoms;palpitation;narrowmatch
abnormal blood chemistry and hematology test result;hypophosphatemia;narrowmatch
abnormal blood chemistry and hematology test result;hypokalemia;narrowmatch
dysplastic neutrophil;neutrophil with abnormal cytoplasmic granulation;narrowmatch
dysplastic neutrophil;hypolobated neutrophil;narrowmatch
pleomorphic epithelial cell;pleomorphic adenocarcinoma cell;narrowmatch
neoplastic lymphoblast;neoplastic b-lymphoblast;narrowmatch
neoplastic myeloid cell;neoplastic promonocyte;narrowmatch
neoplastic promyelocyte;hypogranular promyelocyte;narrowmatch
neoplastic promyelocyte;hypergranular promyelocyte;narrowmatch
neoplastic granulocyte;neoplastic promyelocyte;narrowmatch
neoplastic t-lymphocyte;neoplastic t-lymphoblast;narrowmatch
neoplastic lymphoblast;neoplastic t-lymphoblast;narrowmatch
neoplastic b-lymphocyte;neoplastic b-lymphoblast;narrowmatch
neoplastic myeloid blast;neoplastic megakaryoblast;narrowmatch
neoplastic hematopoietic and lymphoid cell;neoplastic mast cell;narrowmatch
neoplastic myeloid cell;neoplastic myeloid blast;narrowmatch
neoplastic blast;neoplastic myeloid blast;narrowmatch
neoplastic myeloblast;neoplastic myeloblast with basophilic cytoplasm;narrowmatch
neoplastic granulocyte;neoplastic myeloblast;narrowmatch
neoplastic myeloid blast;neoplastic myeloblast;narrowmatch
leukemic cell;neoplastic blast;narrowmatch
neoplastic mast cell;immature malignant mast cell;narrowmatch
neoplastic granulocyte;neoplastic neutrophilic precursor;narrowmatch
neoplastic b-lymphocyte;neoplastic plasma cell;narrowmatch
neoplastic plasma cell;pseudo-gaucher cell;narrowmatch
neoplastic plasma cell;mott cell;narrowmatch
malignant thyroid gland follicular cell;malignant thyroid gland oncocyte;narrowmatch
neoplastic oncocyte;neoplastic thyroid gland oncocyte;narrowmatch
neoplastic thyroid gland follicular cell;neoplastic thyroid gland oncocyte;narrowmatch
neoplastic endothelial cell;epithelioid endothelial cell;narrowmatch
neoplastic endothelial cell;spindle endothelial cell;narrowmatch
neoplastic endothelial cell;vacuolated endothelial cell;narrowmatch
abnormal endothelial cell;neoplastic endothelial cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic endothelial cell;narrowmatch
abnormal connective and soft tissue cell;abnormal endothelial cell;narrowmatch
malignant epithelial cell;undifferentiated carcinoma cell;narrowmatch
neoplastic spindle cell;hyperchromatic spindle cell;narrowmatch
neoplastic plasma cell;pleomorphic plasma cell;narrowmatch
neoplastic plasma cell;plasmablast;narrowmatch
neoplastic plasma cell;anaplastic plasma cell;narrowmatch
neoplastic plasma cell;flame cell;narrowmatch
malignant cell;immature malignant mast cell;narrowmatch
abnormal hematopoietic and lymphoid cell;neoplastic hematopoietic and lymphoid cell;narrowmatch
adenocarcinoma cell;pleomorphic adenocarcinoma cell;narrowmatch
abnormal hematopoietic and lymphoid cell;abnormal eosinophil;narrowmatch
neoplastic myeloid cell;neoplastic monocyte;narrowmatch
abnormal monocyte;neoplastic monocyte;narrowmatch
abnormal myeloid cell;abnormal monocyte;narrowmatch
abnormal platelet;large atypical platelet;narrowmatch
abnormal hematopoietic and lymphoid cell;abnormal platelet;narrowmatch
neoplastic polygonal cell;neoplastic epithelial polygonal cell;narrowmatch
neoplastic epithelial cell;neoplastic epithelial polygonal cell;narrowmatch
abnormal neutrophil;dysplastic neutrophil;narrowmatch
neoplastic cell;neoplastic hematopoietic and lymphoid cell;narrowmatch
abnormal neutrophil;toxic neutrophil;narrowmatch
abnormal hematopoietic and lymphoid cell;abnormal neutrophil;narrowmatch
reed-sternberg cell;popcorn cell;narrowmatch
neoplastic large lymphocyte;hodgkin-like cell;narrowmatch
reed-sternberg cell;mummified cell;narrowmatch
neoplastic large lymphocyte;reed-sternberg-like cell;narrowmatch
reed-sternberg cell;lacunar reed-sternberg cell;narrowmatch
abnormal hematopoietic and lymphoid cell;abnormal myeloid cell;narrowmatch
abnormal myeloid cell;abnormal megakaryocyte;narrowmatch
abnormal megakaryocyte;large megakaryocyte;narrowmatch
abnormal megakaryocyte;giant megakaryocyte;narrowmatch
neoplastic erythroblast;neoplastic large erythroblast;narrowmatch
sideroblast;ring sideroblast;narrowmatch
abnormal erythroid precursor;abnormal erythroblast;narrowmatch
abnormal erythroblast;dysplastic erythroblast;narrowmatch
dysplastic erythroid precursor;dysplastic erythroblast;narrowmatch
dysplastic erythroid precursor;large multinucleated erythroid cell;narrowmatch
abnormal erythroid precursor;dysplastic erythroid precursor;narrowmatch
abnormal myeloid cell;abnormal erythroid precursor;narrowmatch
neoplastic granulocyte;faggot cell;narrowmatch
abnormal granulocyte;dysplastic granulocyte;narrowmatch
abnormal myeloid cell;abnormal granulocyte;narrowmatch
dysplastic megakaryocyte;hyperchromatic megakaryocyte;narrowmatch
hypolobated megakaryocyte;monolobed megakaryocyte;narrowmatch
dysplastic megakaryocyte;hypolobated megakaryocyte;narrowmatch
abnormal megakaryocyte;dysplastic megakaryocyte;narrowmatch
malignant oncocyte;malignant thyroid gland oncocyte;narrowmatch
neoplastic thyroid gland oncocyte;malignant thyroid gland oncocyte;narrowmatch
neoplastic cell;neoplastic round cell;narrowmatch
neoplastic glial cell;neoplastic oligodendrocyte-like cell;narrowmatch
neoplastic perineural cell;neoplastic perineurial cell;narrowmatch
neoplastic mononuclear stromal cell;malignant stromal cell;narrowmatch
malignant connective and soft tissue cell;malignant stromal cell;narrowmatch
neoplastic perineural cell;neoplastic perineurial-like cell;narrowmatch
neoplastic perineural cell;neoplastic schwann cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic stromal cell;narrowmatch
neoplastic cell;rhabdoid cell;narrowmatch
neoplastic neuroepithelial cell;neoplastic ganglion cell;narrowmatch
neoplastic round cell;neoplastic small round cell;narrowmatch
neoplastic neuroepithelial cell;neoplastic neuroblast;narrowmatch
neoplastic glial cell;neoplastic elongated glial cell;narrowmatch
neoplastic glial cell;neoplastic ependymal cell;narrowmatch
neoplastic trophoblastic cell;neoplastic intermediate type trophoblastic cell;narrowmatch
abnormal intermediate type trophoblastic cell;neoplastic intermediate type trophoblastic cell;narrowmatch
neoplastic glial cell;neoplastic oligodendrocyte;narrowmatch
neoplastic trophoblastic cell;neoplastic cytotrophoblastic cell;narrowmatch
neoplastic cell;neoplastic meningothelial cell;narrowmatch
neoplastic meningothelial cell;spindle-shaped meningothelial cell;narrowmatch
neoplastic meningothelial cell;meningothelial cell with elongated processes;narrowmatch
neoplastic meningothelial cell;eosinophilic meningothelial cell;narrowmatch
pleomorphic cell;pleomorphic epithelial cell;narrowmatch
malignant epithelial cell;pleomorphic epithelial cell;narrowmatch
neoplastic large b-lymphocyte;multilobated neoplastic b-lymphocyte;narrowmatch
large adenocarcinoma cell with eosinophilic cytoplasm;malignant eosinophilic cell oncocyte;narrowmatch
neoplastic eosinophilic cell oncocyte;malignant eosinophilic cell oncocyte;narrowmatch
malignant oncocyte;malignant eosinophilic cell oncocyte;narrowmatch
neoplastic cell with eosinophilic cytoplasm;neoplastic eosinophilic cell oncocyte;narrowmatch
neoplastic oncocyte;neoplastic eosinophilic cell oncocyte;narrowmatch
abnormal lymphocyte;atypical lymphocyte;narrowmatch
neoplastic cell with eosinophilic cytoplasm;neoplastic polygonal cell with eosinophilic cytoplasm;narrowmatch
neoplastic polygonal cell;neoplastic polygonal cell with eosinophilic cytoplasm;narrowmatch
neoplastic large cell with abundant cytoplasm;neoplastic large cell with abundant pale cytoplasm;narrowmatch
neoplastic cell;neoplastic large cell;narrowmatch
neoplastic meningothelial cell;small meningothelial cell;narrowmatch
neoplastic meningothelial cell;meningothelial cell with clear cytoplasm;narrowmatch
abnormal cytotrophoblastic cell;neoplastic cytotrophoblastic cell;narrowmatch
xanthomatous cell;xanthomatous astrocyte;narrowmatch
neoplastic astrocyte;xanthomatous astrocyte;narrowmatch
neoplastic serous epithelial cell;serous adenocarcinoma cell;narrowmatch
neoplastic glandular cell;neoplastic serous epithelial cell;narrowmatch
pleomorphic cell;pleomorphic connective and soft tissue cell;narrowmatch
neoplastic connective and soft tissue cell;pleomorphic connective and soft tissue cell;narrowmatch
neoplastic cell;pleomorphic cell;narrowmatch
odontoma;compound odontoma;narrowmatch
malignant spindle cell;malignant epithelial spindle cell;narrowmatch
neoplastic epithelial spindle cell;malignant epithelial spindle cell;narrowmatch
malignant epithelial cell;malignant epithelial spindle cell;narrowmatch
malignant epithelial spindle cell;adenocarcinoma spindle cell;narrowmatch
adenocarcinoma cell;adenocarcinoma spindle cell;narrowmatch
neoplastic large cell;neoplastic large cell with abundant cytoplasm;narrowmatch
neoplastic large cell with abundant cytoplasm;neoplastic large cell with abundant eosinophilic cytoplasm;narrowmatch
neoplastic cell with eosinophilic cytoplasm;neoplastic large cell with abundant eosinophilic cytoplasm;narrowmatch
neoplastic cell;neoplastic cell with eosinophilic cytoplasm;narrowmatch
neoplastic cell;neoplastic epithelioid cell;narrowmatch
adenocarcinoma cell;serous adenocarcinoma cell;narrowmatch
neoplastic glandular cell;neoplastic epithelial cell with intracytoplasmic mucin;narrowmatch
neoplastic astrocyte;neoplastic piloid astrocyte;narrowmatch
adenocarcinoma cell;adenocarcinoma cell with intracytoplasmic mucin;narrowmatch
neoplastic astrocyte;poorly differentiated neoplastic astrocyte;narrowmatch
neoplastic astrocyte;anaplastic astrocyte;narrowmatch
neoplastic astrocyte;neoplastic astrocyte with few flaccid processes;narrowmatch
neoplastic large germ cell;giant neoplastic germ cell;narrowmatch
neoplastic multinucleated giant cell;giant neoplastic germ cell;narrowmatch
neoplastic astrocyte;gemistocytic neoplastic astrocyte;narrowmatch
neoplastic astrocyte;fibrillary neoplastic astrocyte;narrowmatch
neoplastic glial cell;neoplastic astrocyte;narrowmatch
neoplastic neuroepithelial cell;neoplastic glial cell;narrowmatch
neoplastic neuroepithelial cell and neoplastic perineural cell;neoplastic neuroepithelial cell;narrowmatch
neoplastic stromal cell;neoplastic multinucleated stromal cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic spindle-shaped to round cell;narrowmatch
neoplastic cell;neoplastic blastemal cell;narrowmatch
neoplastic epithelioid cell;atypical epithelioid cell;narrowmatch
neoplastic epithelial cell with intracytoplasmic mucin;adenocarcinoma cell with intracytoplasmic mucin;narrowmatch
rhabdomyoblast;spider cell;narrowmatch
neoplastic large cell;anaplastic cell;narrowmatch
malignant connective and soft tissue cell;malignant lipocyte;narrowmatch
chromosomal translocation;"t(x;18)(p11;q11)";narrowmatch
trisomy;trisomy 8;narrowmatch
chromosomal translocation;"t(9;15)(q22;q21)";narrowmatch
chromosomal translocation;"t(9;17)(q22;q11)";narrowmatch
chromosome 17 abnormality;"t(9;17)(q22;q11)";narrowmatch
tfe3 gene translocation;"t(x;17)(p11.2;q25)";narrowmatch
chromosome 17 abnormality;"t(x;17)(p11.2;q25)";narrowmatch
molecular sequence variation;molecular genetic variation;narrowmatch
chromosomal translocation;"t(2;13)(q35;q14)";narrowmatch
monosomy;monosomy 13;narrowmatch
foxo1 gene rearrangement;"t(2;13)(q35;q14)";narrowmatch
chromosome 1 abnormality;"t(1;2)(p11;q35-36)";narrowmatch
chromosomal translocation;"t(1;2)(p11;q35-36)";narrowmatch
chromosomal translocation;"t(12;15)(p13;q25)";narrowmatch
chromosome 12 abnormality;"t(12;15)(p13;q25)";narrowmatch
cytogenetic abnormality;chromosome 1 abnormality;narrowmatch
cytogenetic abnormality;giant rod chromosome;narrowmatch
trisomy;trisomy 20;narrowmatch
chromosomal inversion;inv(22);narrowmatch
chromosome 5 rearrangement;"t(5;12)(q33;p13)";narrowmatch
chromosome 12 abnormality;"t(5;12)(q33;p13)";narrowmatch
chromosome 12 abnormality;"t(5;12)(q31;p12)";narrowmatch
chromosome 5 rearrangement;"t(5;12)(q31;p12)";narrowmatch
chromosomal loss;loss of chromosome 7q;narrowmatch
chromosome 7 abnormality;loss of chromosome 7q;narrowmatch
rearrangement of 3q;"inv(3)(q21.3;q26.2)";narrowmatch
paracentric inversion;"inv(3)(q21.3;q26.2)";narrowmatch
inv(3);"inv(3)(q21.3;q26.2)";narrowmatch
rearrangement of 3q;"t(3;3)(q21.3;q26.2)";narrowmatch
chromosomal translocation;"t(3;3)(q21.3;q26.2)";narrowmatch
chromosomal loss;loss of chromosome 20q;narrowmatch
chromosomal translocation;"t(6;8)(q27;p11)";narrowmatch
chromosomal translocation;"t(8;9)(p11;q32-34)";narrowmatch
chromosomal translocation;"t(8;13)(p11;q11)";narrowmatch
chromosome 13q abnormality;"t(8;13)(p11;q11)";narrowmatch
chromosomal translocation;"t(5;12)(q33;p13)";narrowmatch
monosomy;monosomy 16;narrowmatch
chromosome 13 abnormality;monosomy 13;narrowmatch
chromosome 12 abnormality;loss of chromosome 12p;narrowmatch
chromosome 7 rearrangement;"t(7;22)(p22;q12)";narrowmatch
inv(16);"inv(16)(p13.1;q22)";narrowmatch
mll gene translocation;"t(11;19)(q23.3;p13.3)";narrowmatch
mll gene translocation;"t(11;19)(q23;p13.1)";narrowmatch
mll gene translocation;"t(9;11)(p21.3;q23.3)";narrowmatch
chromosome 17 abnormality;"t(17;22)(q21;q12)";narrowmatch
ewsr1 gene translocation;"t(17;22)(q21;q12)";narrowmatch
chromosomal translocation;"t(7;22)(p22;q12)";narrowmatch
erg gene rearrangement;"t(21;22)(q22;q12)";narrowmatch
chromosomal translocation;"t(5;12)(q33;q13-15)";narrowmatch
ewsr1 gene translocation;"t(21;22)(q22;q12)";narrowmatch
mll gene translocation;"t(9;11)(q21;q23)";narrowmatch
mll gene translocation;"t(4;11)(q21;q23)";narrowmatch
rara gene translocation;"t(11;17)(q13;q21)";narrowmatch
11q translocation;"t(11;17)(q13;q21)";narrowmatch
11q23 abnormality;"t(11;17)(q23;q21)";narrowmatch
rara gene translocation;"t(11;17)(q23;q21)";narrowmatch
pericentric inversion;"inv(16)(p13.1;q22)";narrowmatch
ewsr1 gene translocation;"t(12;22)(q13;q12)";narrowmatch
rearrangement of 12q13;"t(12;22)(q13;q12)";narrowmatch
ewsr1 gene translocation;"t(11;22)(p13;q12)";narrowmatch
chromosome 12 abnormality;"t(5;12)(q33;q13-15)";narrowmatch
chromosome 5 rearrangement;"t(5;12)(q33;q13-15)";narrowmatch
chromosomal translocation;"t(2;12)(q35-37;q13-15)";narrowmatch
chromosome 12 abnormality;"t(2;12)(q35-37;q13-15)";narrowmatch
chromosomal translocation;"t(2;12)(p22-24;q13-15)";narrowmatch
chromosome 12 abnormality;"t(2;12)(p22-24;q13-15)";narrowmatch
chromosome 1 abnormality;"t(1;12)(p32-34;q13-15)";narrowmatch
chromosomal translocation;"t(1;12)(p32-34;q13-15)";narrowmatch
chromosome 12 abnormality;"t(1;12)(p32-34;q13-15)";narrowmatch
rearrangement of 3q;"t(3;12)(q27-28;q13-15)";narrowmatch
chromosomal translocation;"t(3;12)(q27-28;q13-15)";narrowmatch
chromosome 12 abnormality;"t(3;12)(q27-28;q13-15)";narrowmatch
chromosome 1 abnormality;"t(1;13)(p36;q14)";narrowmatch
chromosomal translocation;"t(1;13)(p36;q14)";narrowmatch
foxo1 gene rearrangement;"t(1;13)(p36;q14)";narrowmatch
chromosomal translocation;"t(5;12)(q31;p12)";narrowmatch
chromosomal loss;loss of chromosome 12p;narrowmatch
rara gene translocation;"t(5;17)(q35;q21)";narrowmatch
t-cell receptor gene rearrangement;clonal t-cell receptor gene rearrangement;narrowmatch
clonal gene rearrangement;clonal bcl6 gene rearrangement;narrowmatch
bcl6 gene rearrangement;clonal bcl6 gene rearrangement;narrowmatch
clonal t-cell receptor gene rearrangement;clonal t-cell receptor gamma chain gene rearrangement;narrowmatch
chromosome 7 rearrangement;clonal t-cell receptor gamma chain gene rearrangement;narrowmatch
clonal t-cell receptor gene rearrangement;clonal t-cell receptor beta chain gene rearrangement;narrowmatch
chromosome 7 rearrangement;clonal t-cell receptor beta chain gene rearrangement;narrowmatch
clonal antigen receptor gene rearrangement;clonal t-cell receptor gene rearrangement;narrowmatch
clonal immunoglobulin gene rearrangement;clonal immunoglobulin light chain gene rearrangement;narrowmatch
numerical chromosomal abnormality;chromosomal gain;narrowmatch
clonal immunoglobulin gene rearrangement;clonal immunoglobulin heavy chain gene rearrangement;narrowmatch
clonal antigen receptor gene rearrangement;clonal immunoglobulin gene rearrangement;narrowmatch
clonal gene rearrangement;clonal bcl2 gene rearrangement;narrowmatch
bcl2 gene rearrangement;clonal bcl2 gene rearrangement;narrowmatch
chromosomal gain;gain of chromosome 12q;narrowmatch
chromosome 12 abnormality;gain of chromosome 12q;narrowmatch
chromosomal gain;gain of chromosome 9p;narrowmatch
clonal gene rearrangement;clonal antigen receptor gene rearrangement;narrowmatch
clonal immunoglobulin light chain gene rearrangement;clonal immunoglobulin kappa light chain gene rearrangement;narrowmatch
clonal immunoglobulin light chain gene rearrangement;clonal immunoglobulin lambda light chain gene rearrangement;narrowmatch
chromosome 7 abnormality;gain of chromosome 7q;narrowmatch
chromosomal gain;gain of chromosome 18;narrowmatch
chromosomal gain;gain of chromosome 17;narrowmatch
chromosome 17 abnormality;gain of chromosome 17;narrowmatch
chromosomal gain;gain of chromosome 15;narrowmatch
chromosomal gain;gain of chromosome 12;narrowmatch
chromosome 12 abnormality;gain of chromosome 12;narrowmatch
chromosomal gain;gain of chromosome 9;narrowmatch
monosomy;monosomy 22;narrowmatch
chromosomal gain;gain of chromosome 3;narrowmatch
chromosomal gain;gain of chromosome 22;narrowmatch
chromosomal gain;gain of chromosome 19;narrowmatch
chromosomal gain;gain of chromosome 8;narrowmatch
chromosomal gain;gain of chromosome 7;narrowmatch
chromosome 7 abnormality;gain of chromosome 7;narrowmatch
chromosomal gain;gain of chromosome 7q;narrowmatch
chromosomal gain;gain of chromosome 2p;narrowmatch
rearrangement of 2p23;"inv(2)(p23;q35)";narrowmatch
chromosome 7 abnormality;monosomy 7;narrowmatch
chromosome 12 abnormality;trisomy 12;narrowmatch
chromosomal deletion;del(6q21);narrowmatch
chromosomal deletion;del(11q22q23);narrowmatch
rearrangement of 11q;del(11q22q23);narrowmatch
11q23 abnormality;del(11q22q23);narrowmatch
chromosomal deletion;del(13q14);narrowmatch
chromosome 13q abnormality;del(13q14);narrowmatch
trisomy;trisomy 12;narrowmatch
chromosome 1 abnormality;"t(1;22)(p13.3;q13.1)";narrowmatch
paracentric inversion;"inv(2)(p23;q35)";narrowmatch
chromosomal translocation;"t(1;22)(p13.3;q13.1)";narrowmatch
chromosomal translocation;"t(8;16)(p11;p13)";narrowmatch
rearrangement of 3q;"t(3;5)(q25;q34)";narrowmatch
chromosomal translocation;"t(3;5)(q25;q34)";narrowmatch
chromosome 5 rearrangement;"t(3;5)(q25;q34)";narrowmatch
chromosomal insertion;"ins(3;3)";narrowmatch
monosomy;monosomy 7;narrowmatch
chromosome 17p abnormality;del(17p13);narrowmatch
chromosomal deletion;del(17p13);narrowmatch
trisomy;trisomy 3;narrowmatch
chromosomal inversion;inv(14);narrowmatch
rearrangement of 3q;"t(2;3)(p23;q21)";narrowmatch
rearrangement of 2p23;"t(2;3)(p23;q21)";narrowmatch
chromosomal translocation;"t(2;3)(p23;q21)";narrowmatch
rearrangement of 2p23;"t(1;2)(q25;p23)";narrowmatch
chromosome 1 abnormality;"t(1;2)(q25;p23)";narrowmatch
chromosomal translocation;"t(1;2)(q25;p23)";narrowmatch
trisomy;trisomy 5;narrowmatch
chromosome 5 abnormality;trisomy 5;narrowmatch
isochromosome;i(7q);narrowmatch
chromosome 7 abnormality;i(7q);narrowmatch
molecular pathway deregulation;apoptotic pathway deregulation;narrowmatch
chromosomal deletion;del(12p13);narrowmatch
chromosome 12 abnormality;del(12p13);narrowmatch
trisomy;trisomy 8q;narrowmatch
chromosomal translocation;"t(8;8)(p11-12;q12)";narrowmatch
11q translocation;"t(11;17)(q23;q21)";narrowmatch
chromosome 5 rearrangement;"t(5;17)(q35;q21)";narrowmatch
abnormal macrophage;sea-blue histiocyte;narrowmatch
myeloblasts under 20 percent of peripheral blood white cells;myeloblasts 5-19 percent of peripheral blood white cells;narrowmatch
myeloblasts under 20 percent of bone marrow nucleated cells;myeloblasts 5-19 percent of bone marrow nucleated cells;narrowmatch
myeloblasts 1 percent or less of peripheral blood white cells;myeloblasts under 1 percent of peripheral blood white cells;narrowmatch
ring sideroblasts present;ring sideroblasts 15 percent or more of erythroid precursors;narrowmatch
hemoglobin increased;hemoglobin f increased;narrowmatch
blasts under 20 percent of peripheral blood white cells;myeloblasts under 20 percent of peripheral blood white cells;narrowmatch
myeloblasts present;myeloblasts under 20 percent of peripheral blood white cells;narrowmatch
blasts 5-19 percent of peripheral blood white cells;myeloblasts 5-19 percent of peripheral blood white cells;narrowmatch
myeloblasts under 10 percent of peripheral blood white cells;myeloblasts under 5 percent of peripheral blood white cells;narrowmatch
blasts more than 10 percent of peripheral blood white cells;blasts 20 percent or more of peripheral blood white cells;narrowmatch
blasts 20 percent or less of peripheral blood white cells;blasts under 20 percent of peripheral blood white cells;narrowmatch
blasts under 10 percent of bone marrow nucleated cells;myeloblasts under 10 percent of bone marrow nucleated cells;narrowmatch
myeloblasts under 20 percent of bone marrow nucleated cells;myeloblasts under 10 percent of bone marrow nucleated cells;narrowmatch
abnormal hematology test result;leukoerythroblastic reaction;narrowmatch
immature myeloid cells increased in bone marrow;myeloblasts under 20 percent of bone marrow nucleated cells;narrowmatch
blasts under 20 percent of bone marrow nucleated cells;myeloblasts under 20 percent of bone marrow nucleated cells;narrowmatch
blast cells present in peripheral blood;immature granulocytes in peripheral blood increased;narrowmatch
myeloblasts 5-19 percent of bone marrow nucleated cells;myeloblasts 5-9 percent of bone marrow nucleated cells;narrowmatch
myeloblasts 10 percent or more of bone marrow nucleated cells;myeloblasts 20 percent or more of bone marrow nucleated cells;narrowmatch
blasts 20 percent or more of bone marrow nucleated cells;myeloblasts 20 percent or more of bone marrow nucleated cells;narrowmatch
eosinophilia;bone marrow eosinophilia;narrowmatch
megakaryocytes increased in bone marrow;megakaryoblasts 50 percent or more of bone marrow nucleated cells;narrowmatch
erythroid precursors 50 percent or more of bone marrow nucleated cells;erythroid precursors 80 percent or more of bone marrow nucleated cells;narrowmatch
myeloblasts 20 percent or more of bone marrow nucleated cells;myeloblasts 20 percent or more of bone marrow non-erythroid cells;narrowmatch
immature myeloid cells increased in bone marrow;erythroid precursors 50 percent or more of bone marrow nucleated cells;narrowmatch
cells of monocytic lineage 80 percent or more of bone marrow leukemic cells;neoplastic promonocytes in bone marrow markedly increased;narrowmatch
cells of monocytic lineage 80 percent or more of bone marrow leukemic cells;monoblasts 80 percent or more of bone marrow monocytic cells;narrowmatch
monoblasts 20 percent or more of bone marrow nucleated cells;monoblasts 80 percent or more of bone marrow monocytic cells;narrowmatch
immature myeloid cells increased in bone marrow;monoblasts 20 percent or more of bone marrow nucleated cells;narrowmatch
blasts 20 percent or more of bone marrow nucleated cells;monoblasts 20 percent or more of bone marrow nucleated cells;narrowmatch
immature myeloid cells increased in bone marrow;neoplastic monocytes and precursors 20 percent or more of bone marrow cells;narrowmatch
normal bone marrow test result;promyelocytes, myelocytes, and mature neutrophils 10 percent or more of bone marrow cells;narrowmatch
bone marrow dysplasia present;bone marrow dysplasia present in 10 percent or more of the cells of two or more myeloid cell lines;narrowmatch
bone marrow dysplasia present;bone marrow dysplasia present in 50 percent or more of the cells of two cell lines;narrowmatch
abnormal bone marrow test result;bone marrow dysplasia present;narrowmatch
abnormal bone marrow test result;bone marrow eosinophilia;narrowmatch
blasts 10 percent or more of bone marrow nucleated cells;blasts 20 percent or more of bone marrow nucleated cells;narrowmatch
fibrosis;bone marrow fibrosis;narrowmatch
normal laboratory test result;normal bone marrow test result;narrowmatch
morphologic finding;necrotic change;narrowmatch
astler-coller c2 colorectal carcinoma;astler-coller c2 colon carcinoma;narrowmatch
tissue differentiation;mesenchymal differentiation;narrowmatch
epithelial differentiation;fetal -epithelial differentiation;narrowmatch
mass;multinodular mass;narrowmatch
chemical exposure;thorotrast exposure;narrowmatch
morphologic finding;globular hyaline body;narrowmatch
morphologic finding;steatosis;narrowmatch
mass;firm mass;narrowmatch
myeloblasts 5-19 percent of peripheral blood white cells;myeloblasts 10-19 percent of peripheral blood white cells;narrowmatch
morphologic architectural pattern;solid growth pattern;narrowmatch
papillary pattern;micropapillary pattern;narrowmatch
lesion by focality;multifocal lesion;narrowmatch
stromal change;fibrotic stroma formation;narrowmatch
morphologic architectural pattern;single-file linear pattern;narrowmatch
mass;bilateral mass;narrowmatch
sign;sweating;narrowmatch
colon cancer by astler-coller stage;astler-coller c2 colon carcinoma;narrowmatch
astler-coller c1 colorectal carcinoma;astler-coller c1 colon carcinoma;narrowmatch
colon cancer by astler-coller stage;astler-coller c1 colon carcinoma;narrowmatch
astler-coller b2 colorectal carcinoma;astler-coller b2 rectal carcinoma;narrowmatch
blasts 10-19 percent of bone marrow nucleated cells;myeloblasts 10-19 percent of bone marrow nucleated cells;narrowmatch
myeloblasts 5-19 percent of bone marrow nucleated cells;myeloblasts 10-19 percent of bone marrow nucleated cells;narrowmatch
myeloblasts 10 percent or more of bone marrow nucleated cells;myeloblasts 10-19 percent of bone marrow nucleated cells;narrowmatch
myeloblasts 5 percent or less of bone marrow nucleated cells;myeloblasts under 5 percent of bone marrow nucleated cells;narrowmatch
blasts under 5 percent of bone marrow nucleated cells;myeloblasts under 5 percent of bone marrow nucleated cells;narrowmatch
myeloblasts under 5 percent of peripheral blood white cells;myeloblasts under 2 percent of peripheral blood white cells;narrowmatch
gastrointestinal hamartoma;small intestinal hamartoma;narrowmatch
non-neoplastic intestinal disorder;small intestinal hamartoma;narrowmatch
colorectal cancer by astler-coller stage;astler-coller b1 colorectal carcinoma;narrowmatch
rectal cancer by astler-coller stage;astler-coller b1 rectal carcinoma;narrowmatch
astler-coller b1 colorectal carcinoma;astler-coller b1 rectal carcinoma;narrowmatch
colon cancer by astler-coller stage;astler-coller a colon carcinoma;narrowmatch
astler-coller a colorectal carcinoma;astler-coller a colon carcinoma;narrowmatch
colorectal cancer by astler-coller stage;astler-coller b2 colorectal carcinoma;narrowmatch
rectal cancer by astler-coller stage;astler-coller b2 rectal carcinoma;narrowmatch
immature myeloid cells increased in bone marrow;megakaryoblasts 50 percent or more of bone marrow nucleated cells;narrowmatch
abnormal bone marrow test result;atypical lymphocytes present in bone marrow;narrowmatch
chromosomal translocation;"t(x;14)(q28;11)";narrowmatch
molecular pathway deregulation;cell cycle deregulation;narrowmatch
protein deregulation;fusion protein expression;narrowmatch
deregulation of protein and messenger rna expression;protein deregulation;narrowmatch
gene abnormality;oncogene deregulation;narrowmatch
molecular pathway deregulation;tumor-suppressor pathway deregulation;narrowmatch
molecular pathway deregulation;signal transduction pathway deregulation;narrowmatch
molecular abnormality;molecular pathway deregulation;narrowmatch
connective and soft tissue neoplasm (antiquated);retinal hemangioma;narrowmatch
deregulation of protein and messenger rna expression;messenger rna overexpression;narrowmatch
molecular genetic variation;gene abnormality;narrowmatch
gene abnormality;deregulation of protein and messenger rna expression;narrowmatch
gene abnormality;tumor-suppressor gene inactivation;narrowmatch
gene rearrangement abnormality;clonal gene rearrangement;narrowmatch
numerical chromosomal abnormality;polysomy;narrowmatch
tumor-suppressor gene inactivation;tp53 gene inactivation;narrowmatch
tp53 gene mutation;tp53 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;rb1 gene inactivation;narrowmatch
chromosomal translocation;"t(1;14)(p32;q11)";narrowmatch
chromosome 1 abnormality;"t(1;14)(p32;q11)";narrowmatch
chromosome 7 rearrangement;"t(7;9)(q34;q34.3)";narrowmatch
chromosomal translocation;"t(7;9)(q34;q34.3)";narrowmatch
chromosome 1 abnormality;"t(1;7)(p33;q35)";narrowmatch
chromosomal translocation;"t(1;7)(p33;q35)";narrowmatch
chromosome 7 rearrangement;"t(1;7)(p33;q35)";narrowmatch
chromosomal translocation;"t(5;14)(q31.1;q32.3)";narrowmatch
chromosome 5 rearrangement;"t(5;14)(q31.1;q32.3)";narrowmatch
chromosomal translocation;"t(14;19)(q32;q13.1)";narrowmatch
chromosomal translocation;"t(14;14)(q11;q32)";narrowmatch
rearrangement of 3q;"t(3;14)(q27;q32)";narrowmatch
chromosomal translocation;"t(3;14)(q27;q32)";narrowmatch
chromosomal translocation;"t(7;10)(q34;q24)";narrowmatch
chromosome 7 rearrangement;"t(7;10)(q34;q24)";narrowmatch
chromosomal translocation;"t(10;14)(q24;q11)";narrowmatch
chromosomal translocation;"t(11;14)(p13;q11)";narrowmatch
chromosomal translocation;"t(11;14)(p15;q11)";narrowmatch
rearrangement of 11p15;"t(11;14)(p15;q11)";narrowmatch
rb1 gene mutation;rb1 gene inactivation;narrowmatch
chromosomal translocation;"t(8;22)(q24;q11)";narrowmatch
atypical lymphocytes present;atypical lymphocytes present in bone marrow;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);polyclonal polymorphic post-transplant lymphoproliferative disorder;narrowmatch
head and neck finding;eye and ear finding;narrowmatch
finding by site or system;head and neck finding;narrowmatch
finding by site or system;integumentary system finding;narrowmatch
finding by site or system;nervous system finding;narrowmatch
finding by site or system;digestive system finding;narrowmatch
finding;finding by site or system;narrowmatch
hematopoietic and lymphoid neoplasm (antiquated);monoclonal polymorphic post-transplant lymphoproliferative disorder;narrowmatch
oral leukoplakia;oral cavity leukoplakia;narrowmatch
chromosomal translocation;"t(8;14)(q24;q32)";narrowmatch
neoplastic growth or spread;lymphatic spread;narrowmatch
abnormal bone marrow test result;bone marrow basophilia;narrowmatch
basophilia;bone marrow basophilia;narrowmatch
abnormal hematology test result;ineffective hematopoiesis;narrowmatch
chemical exposure;benzene exposure;narrowmatch
morphologic finding;auer rods present;narrowmatch
atypical lymphocytes present;atypical lymphocytes present in peripheral blood;narrowmatch
finding by site or system;reproductive system finding;narrowmatch
finding by site or system;endocrine system finding;narrowmatch
finding by site or system;urinary system finding;narrowmatch
non-neoplastic disorder by special category;congenital or acquired anatomic abnormality;narrowmatch
genomic instability;microsatellite instability;narrowmatch
rearrangement of 12q13;"t(12;16)(q13;p11)";narrowmatch
fus gene translocation;"t(12;16)(q13;p11)";narrowmatch
numerical chromosomal abnormality;chromosomal loss;narrowmatch
lesion;lesion by stage;narrowmatch
lesion;lesion by grade;narrowmatch
morphologic finding;lesion by grade;narrowmatch
lymph node involvement;regional lymph node involvement;narrowmatch
finding;other finding;narrowmatch
clinical course of disease;neoplastic growth or spread;narrowmatch
clinical test result;laboratory test result;narrowmatch
finding;finding by cause;narrowmatch
environmental and occupational exposure;chemical exposure;narrowmatch
finding by site or system;hematopoietic system finding;narrowmatch
finding by site or system;connective and soft tissue finding;narrowmatch
monosomy;monosomy 10;narrowmatch
monosomy;monosomy 21;narrowmatch
chromosomal deletion;del(6q25);narrowmatch
chromosomal gain;gain of chromosome 17q22-q24;narrowmatch
vaginal non-neoplastic disorder;vaginal polyp;narrowmatch
protein deregulation;erbb2 protein overexpression;narrowmatch
oncogene deregulation;erbb2 gene amplification;narrowmatch
receptor tyrosine kinase gene amplification;erbb2 gene amplification;narrowmatch
chromosomal gain;gain of chromosome 19q;narrowmatch
chromosomal loss;loss of chromosome 9p;narrowmatch
chromosomal gain;gain of chromosome 20q13;narrowmatch
chromosome 17 abnormality;gain of chromosome 17q22-q24;narrowmatch
monosomy;monosomy 6;narrowmatch
chromosomal gain;gain of chromosome 6p;narrowmatch
chromosomal loss;loss of chromosome 19;narrowmatch
chromosomal loss;loss of chromosome 17;narrowmatch
chromosome 17 abnormality;loss of chromosome 17;narrowmatch
monosomy;monosomy x;narrowmatch
genital leukoplakia;vaginal leukoplakia;narrowmatch
monosomy;monosomy 11;narrowmatch
polyp;vaginal polyp;narrowmatch
messenger rna overexpression;c-erbb2 messenger rna overexpression;narrowmatch
oncogene deregulation;myc gene amplification;narrowmatch
gene amplification abnormality;myc gene amplification;narrowmatch
polysomy;polysomy 10;narrowmatch
polysomy;polysomy 3;narrowmatch
tumor-suppressor gene inactivation;cdh1 gene inactivation;narrowmatch
cdh1 gene mutation;cdh1 gene inactivation;narrowmatch
gene amplification abnormality;ccnd1 gene amplification;narrowmatch
oncogene deregulation;ccnd1 gene amplification;narrowmatch
oncogene deregulation;fgfr1 gene amplification;narrowmatch
fgfr gene amplification;fgfr1 gene amplification;narrowmatch
oncogene deregulation;egfr gene amplification;narrowmatch
receptor tyrosine kinase gene amplification;egfr gene amplification;narrowmatch
chromosomal deletion;loss of chromosome 11q atm gene locus;narrowmatch
rearrangement of 11q;loss of chromosome 11q atm gene locus;narrowmatch
chromosomal deletion;loss of chromosome 3p fhit gene locus;narrowmatch
protein deregulation;loss of e-cadherin expression;narrowmatch
messenger rna overexpression;cyclin d1 messenger rna overexpression;narrowmatch
monosomy;monosomy 8;narrowmatch
trisomy;trisomy 18;narrowmatch
polysomy;polysomy 17;narrowmatch
chromosomal deletion;del(6q21q25);narrowmatch
chromosome 12 abnormality;tetrasomy 12;narrowmatch
chromosomal loss;loss of chromosome y;narrowmatch
chromosomal loss;loss of chromosome 18;narrowmatch
chromosome 1 abnormality;loss of chromosome 1;narrowmatch
chromosomal loss;loss of chromosome 1;narrowmatch
chromosomal gain;gain of chromosome 6q;narrowmatch
chromosomal loss;loss of chromosome 16p;narrowmatch
signaling pathway status;increased nfkappab pathway activation;narrowmatch
polyp;uterine polyp;narrowmatch
chromosomal gain;gain of chromosome 9q34;narrowmatch
rearrangement of 2p23;"t(x;2)(q11-12;p23)";narrowmatch
chromosomal translocation;"t(x;2)(q11-12;p23)";narrowmatch
rearrangement of 2p23;"t(2;17)(p23;q23)";narrowmatch
chromosomal translocation;"t(2;17)(p23;q23)";narrowmatch
chromosome 17 abnormality;"t(2;17)(p23;q23)";narrowmatch
chromosomal rearrangement;rearrangement of 17p11-13;narrowmatch
tetrasomy;tetrasomy 12;narrowmatch
polysomy;tetrasomy;narrowmatch
paracentric inversion;"inv(14)(q11;q32.1)";narrowmatch
inv(14);"inv(14)(q11;q32.1)";narrowmatch
uterine disorder;uterine polyp;narrowmatch
erg gene rearrangement;"t(16;21)(p11;q22)";narrowmatch
fus gene translocation;"t(16;21)(p11;q22)";narrowmatch
mll gene translocation;"t(10;11)(p11;q23)";narrowmatch
mll gene translocation;"t(6;11)(q27;q23)";narrowmatch
chromosomal translocation;"t(7;11)(p15;p15)";narrowmatch
rearrangement of 11p15;"t(7;11)(p15;p15)";narrowmatch
chromosome 7 rearrangement;"t(7;11)(p15;p15)";narrowmatch
rearrangement of 21q;"t(3;21)(q26;q22)";narrowmatch
rearrangement of 3q;"t(3;21)(q26;q22)";narrowmatch
chromosomal translocation;"t(3;21)(q26;q22)";narrowmatch
isochromosome;i(19);narrowmatch
chromosomal deletion;del(9p21p22);narrowmatch
chromosomal translocation;"t(7;9)(q34;q32)";narrowmatch
chromosome 7 rearrangement;"t(7;9)(q34;q32)";narrowmatch
chromosome 17 abnormality;polysomy 17;narrowmatch
chromosomal gain;gain of chromosome xq;narrowmatch
chromosomal deletion;del(14q21);narrowmatch
mismatch repair gene mutation;mismatch repair gene inactivation;narrowmatch
tumor-suppressor gene inactivation;fhit gene inactivation;narrowmatch
mismatch repair gene inactivation;inactivating pms2 gene mutation;narrowmatch
pms2 gene mutation;inactivating pms2 gene mutation;narrowmatch
mismatch repair gene inactivation;pms1 gene inactivation;narrowmatch
pms1 gene mutation;pms1 gene inactivation;narrowmatch
mismatch repair gene inactivation;inactivating msh6 gene mutation;narrowmatch
msh6 gene mutation;inactivating msh6 gene mutation;narrowmatch
mismatch repair gene inactivation;inactivating mlh1 gene mutation;narrowmatch
smad4 gene mutation;smad4 gene inactivation;narrowmatch
mlh1 gene mutation;inactivating mlh1 gene mutation;narrowmatch
mismatch repair gene inactivation;inactivating msh2 gene mutation;narrowmatch
msh2 gene mutation;inactivating msh2 gene mutation;narrowmatch
tumor-suppressor gene inactivation;tsc2 gene inactivation;narrowmatch
tsc2 gene mutation;tsc2 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;lkb1 gene inactivation;narrowmatch
stk11 gene mutation;lkb1 gene inactivation;narrowmatch
alk fusion protein expression;npm-alk fusion protein expression;narrowmatch
alk fusion protein expression;tpm3-alk fusion protein expression;narrowmatch
alk fusion protein expression;tfg-alk fusion protein expression;narrowmatch
finding by cause;injury;narrowmatch
giant cell;touton giant cell;narrowmatch
abnormal red blood cell;tear-drop red blood cell;narrowmatch
abnormal hematopoietic and lymphoid cell;abnormal lymphocyte;narrowmatch
dysplastic neutrophil;neutrophil with pseudo pelger-huet nucleus;narrowmatch
abnormal platelet;giant platelet;narrowmatch
leukemic lymphocyte;sezary cell;narrowmatch
cerebriform lymphocyte;sezary cell;narrowmatch
deposit;calcification;narrowmatch
abnormal neutrophil;segmented neutrophil;narrowmatch
abnormal erythroblast;sideroblast;narrowmatch
fusion protein expression;bcr-abl1 fusion protein expression;narrowmatch
bcr-abl1 fusion protein expression;p190 fusion protein expression;narrowmatch
bcr-abl1 fusion protein expression;p230 fusion protein expression;narrowmatch
bcr-abl1 fusion protein expression;p210 fusion protein expression;narrowmatch
alk fusion protein expression;atic-alk fusion protein expression;narrowmatch
tumor-suppressor gene inactivation;smad4 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;pten gene inactivation;narrowmatch
gene variant;ctnnb1 gene mutation;narrowmatch
gene amplification abnormality;nmyc gene amplification;narrowmatch
apc gene mutation;apc gene inactivation;narrowmatch
gene amplification abnormality;mdm2 gene amplification;narrowmatch
oncogene deregulation;mdm2 gene amplification;narrowmatch
gene amplification abnormality;hras gene amplification;narrowmatch
oncogene deregulation;hras gene amplification;narrowmatch
gene amplification abnormality;fos gene amplification;narrowmatch
oncogene deregulation;fos gene amplification;narrowmatch
oncogene deregulation;nmyc gene amplification;narrowmatch
pten gene mutation;pten gene inactivation;narrowmatch
chromosomal gain;gain of chromosome 10;narrowmatch
chromosomal gain;gain of chromosome 16;narrowmatch
chromosomal loss;loss of chromosome 4q;narrowmatch
gene amplification abnormality;kras gene amplification;narrowmatch
oncogene deregulation;kras gene amplification;narrowmatch
growth factor overexpression;transforming growth factor-beta overexpression;narrowmatch
elevated expression;growth factor overexpression;narrowmatch
tumor-suppressor gene inactivation;apc gene inactivation;narrowmatch
wt1 gene mutation;wt1 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;wt1 gene inactivation;narrowmatch
nf1 gene mutation;nf1 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;ptch gene inactivation;narrowmatch
ptch1 gene mutation;ptch gene inactivation;narrowmatch
tumor-suppressor gene inactivation;men1 gene inactivation;narrowmatch
men1 gene mutation;men1 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;brca2 gene inactivation;narrowmatch
brca2 gene mutation;brca2 gene inactivation;narrowmatch
inactivating brca gene mutation;brca2 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;brca1 gene inactivation;narrowmatch
brca1 gene mutation;brca1 gene inactivation;narrowmatch
inactivating brca gene mutation;brca1 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;vhl gene inactivation;narrowmatch
vhl gene mutation;vhl gene inactivation;narrowmatch
nf2 gene mutation;nf2 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;nf2 gene inactivation;narrowmatch
tumor-suppressor gene inactivation;nf1 gene inactivation;narrowmatch
chromosome 17p abnormality;rearrangement of 17p11-13;narrowmatch
chromosomal loss;loss of chromosome 3;narrowmatch
chromosomal loss;loss of chromosome 10;narrowmatch
chromosomal loss;loss of chromosome 10p;narrowmatch
chromosomal translocation;"t(7;19)(q34;q13)";narrowmatch
chromosome 7 rearrangement;"t(7;19)(q34;q13)";narrowmatch
mll gene translocation;"t(v;11q23.3)";narrowmatch
chromosomal loss;loss of chromosome 10q;narrowmatch
chromosomal loss;loss of chromosome 16q;narrowmatch
chromosomal deletion;del(5q22);narrowmatch
chromosome 5 rearrangement;del(5q22);narrowmatch
monosomy;monosomy 17;narrowmatch
chromosomal loss;loss of chromosome 6p;narrowmatch
chromosome 17 abnormality;monosomy 17;narrowmatch
chromosomal loss;loss of chromosome 22q;narrowmatch
chromosomal loss;loss of chromosome 11p;narrowmatch
chromosomal loss;loss of chromosome 6;narrowmatch
chromosomal loss;loss of chromosome 8p;narrowmatch
chromosomal loss;loss of chromosome 3p;narrowmatch
chromosome 1 abnormality;loss of chromosome 1p;narrowmatch
chromosome 7 rearrangement;"t(7;14)(q35;q32.1)";narrowmatch
chromosomal translocation;"t(7;14)(q35;q32.1)";narrowmatch
chromosome 17 abnormality;"t(17;22)(q22;q13)";narrowmatch
chromosomal translocation;"t(17;22)(q22;q13)";narrowmatch
trisomy;trisomy 4;narrowmatch
trisomy;trisomy 13;narrowmatch
chromosome 13 abnormality;trisomy 13;narrowmatch
chromosomal gain;gain of chromosome 21;narrowmatch
chromosomal loss;loss of chromosome 5;narrowmatch
chromosome 5 abnormality;loss of chromosome 5;narrowmatch
chromosomal gain;gain of chromosome 11;narrowmatch
chromosomal loss;loss of chromosome 7;narrowmatch
chromosome 7 abnormality;loss of chromosome 7;narrowmatch
monosomy;monosomy 5;narrowmatch
chromosome 5 abnormality;monosomy 5;narrowmatch
chromosomal gain;gain of chromosome 13;narrowmatch
chromosome 13 abnormality;gain of chromosome 13;narrowmatch
chromosome 1 abnormality;partial trisomy 1q;narrowmatch
trisomy;partial trisomy 1q;narrowmatch
chromosomal loss;loss of chromosome 1p;narrowmatch
chromosomal loss;loss of chromosome 17p;narrowmatch
chromosomal loss;loss of chromosome 9;narrowmatch
isochromosome;i(17q);narrowmatch
chromosomal gain;gain of chromosome 9q;narrowmatch
chromosomal gain;gain of chromosome 1q;narrowmatch
chromosome 1 abnormality;gain of chromosome 1q;narrowmatch
chromosomal gain;gain of chromosome 15q;narrowmatch
chromosomal gain;gain of chromosome 20q;narrowmatch
unbalanced translocation;unbalanced translocation of chromosome 1;narrowmatch
chromosome 1 abnormality;unbalanced translocation of chromosome 1;narrowmatch
chromosome 17 abnormality;i(17q);narrowmatch
chromosome 17p abnormality;loss of chromosome 17p;narrowmatch
trisomy;trisomy 7;narrowmatch
chromosome 7 abnormality;trisomy 7;narrowmatch
trisomy;trisomy 6;narrowmatch
chromosome 1 abnormality;ring chromosome 1;narrowmatch
supernumerary circular chromosome;ring chromosome 1;narrowmatch
derivative chromosome;"der(15;21)(q10;q10)";narrowmatch
chromosomal deletion;del(19p12);narrowmatch
chromosome 17 abnormality;gain of chromosome 17q;narrowmatch
chromosomal gain;gain of chromosome 17q;narrowmatch
protein deregulation;ccnd1 protein overexpression;narrowmatch
chromosome 5 abnormality;gain of chromosome 5;narrowmatch
chromosomal loss;loss of chromosome 12q;narrowmatch
chromosome 12 abnormality;loss of chromosome 12q;narrowmatch
chromosomal loss;loss of chromosome 13q;narrowmatch
chromosome 13q abnormality;loss of chromosome 13q;narrowmatch
chromosomal loss;loss of chromosome 18q;narrowmatch
trisomy;trisomy 2;narrowmatch
microsatellite instability;high-frequency microsatellite instability;narrowmatch
chromosomal loss;loss of chromosome 22;narrowmatch
chromosomal loss;loss of chromosome 14;narrowmatch
chromosomal gain;gain of chromosome 5p;narrowmatch
chromosome 5 abnormality;gain of chromosome 5p;narrowmatch
chromosomal gain;gain of chromosome 8q;narrowmatch
chromosomal gain;gain of chromosome 3q;narrowmatch
3q abnormality;gain of chromosome 3q;narrowmatch
chromosomal gain;gain of chromosome 5;narrowmatch
chromosomal translocation;"t(6;9)(p23;q34.1)";narrowmatch
11q23 abnormality;del(11q23);narrowmatch
rearrangement of 11q;del(11q23);narrowmatch
chromosomal deletion;del(8q24.1);narrowmatch
chromosome 1 abnormality;del(1p13-22);narrowmatch
hypertension;secondary hypertension;narrowmatch
chromosomal deletion;del(1p36);narrowmatch
chromosome 1 abnormality;del(1p36);narrowmatch
chromosomal rearrangement;rearrangement of 6q25;narrowmatch
chromosomal rearrangement;rearrangement of 6q13;narrowmatch
chromosomal rearrangement;rearrangement of 8q21;narrowmatch
isochromosome;i(8)(q10);narrowmatch
chromosomal deletion;del(11q23);narrowmatch
rearrangement of 3q;"t(1;3)(p36;q23-25)";narrowmatch
chromosome 1 abnormality;"t(1;3)(p36;q23-25)";narrowmatch
chromosomal translocation;"t(1;3)(p36;q23-25)";narrowmatch
chromosomal rearrangement;rearrangement of 12q13;narrowmatch
chromosome 12 abnormality;rearrangement of 12q13;narrowmatch
chromosomal rearrangement;rearrangement of 1p11-q11;narrowmatch
chromosome 1 abnormality;rearrangement of 1p11-q11;narrowmatch
chromosomal deletion;del(1p13-22);narrowmatch
chromosomal loss;loss of chromosome 4;narrowmatch
chromosome 5 rearrangement;del(5q13-31);narrowmatch
chromosomal deletion;del(5q13-31);narrowmatch
chromosomal loss;loss of chromosome 6q;narrowmatch
chromosomal gain;gain of chromosome 12q15-qter;narrowmatch
chromosome 12 abnormality;gain of chromosome 12q15-qter;narrowmatch
chromosomal gain;gain of chromosome 7p13-pter;narrowmatch
chromosome 7 abnormality;gain of chromosome 7p13-pter;narrowmatch
chromosomal deletion;del(22q13);narrowmatch
chromosomal loss;loss of chromosome 18p;narrowmatch
chromosomal deletion;del(13q21-qter);narrowmatch
chromosome 13q abnormality;del(13q21-qter);narrowmatch
chromosomal deletion;del(11q25);narrowmatch
rearrangement of 11q;del(11q25);narrowmatch
chromosomal deletion;del(11p13-pter);narrowmatch
chromosomal deletion;del(10q24-qter);narrowmatch
chromosomal deletion;del(9p22-pter);narrowmatch
chromosomal deletion;del(6q22-qter);narrowmatch
chromosomal deletion;del(11p15);narrowmatch
rearrangement of 11p15;del(11p15);narrowmatch
chromosomal gain;gain of chromosome 20;narrowmatch
chromosomal loss;loss of chromosome 2p;narrowmatch
chromosome 1 abnormality;rearrangement of 1p11-13;narrowmatch
chromosomal gain;gain of chromosome 5q;narrowmatch
chromosome 5 abnormality;gain of chromosome 5q;narrowmatch
rearrangement of 11q;rearrangement of 11q13-21;narrowmatch
chromosomal loss;loss of chromosome 16;narrowmatch
cytogenetic abnormality;chromosomal rearrangement;narrowmatch
chromosomal rearrangement;rearrangement of 8q11-13;narrowmatch
chromosomal gain;gain of chromosome x;narrowmatch
chromosomal deletion;del(6q23);narrowmatch
chromosomal loss;loss of chromosome x;narrowmatch
chromosomal loss;loss of chromosome 13;narrowmatch
chromosome 13 abnormality;loss of chromosome 13;narrowmatch
chromosomal loss;loss of chromosome 8;narrowmatch
chromosomal deletion;del(7q21-32);narrowmatch
chromosome 7 rearrangement;del(7q21-32);narrowmatch
chromosomal rearrangement;rearrangement of 1p11-13;narrowmatch
chromosomal loss;loss of chromosome 2q;narrowmatch
chromosomal gain;gain of chromosome 1;narrowmatch
chromosomal loss;loss of chromosome 11;narrowmatch
chromosome 1 abnormality;gain of chromosome 1;narrowmatch
chromosomal deletion;del(13q32-qter);narrowmatch
chromosome 13q abnormality;del(13q32-qter);narrowmatch
chromosomal deletion;del(13q12-13);narrowmatch
chromosome 13q abnormality;del(13q12-13);narrowmatch
chromosomal deletion;del(8p21-pter);narrowmatch
chromosomal deletion;del(3p21-23);narrowmatch
chromosomal gain;gain of chromosome 1q21-31;narrowmatch
chromosome 1 abnormality;gain of chromosome 1q21-31;narrowmatch
chromosomal gain;gain of chromosome 1p31;narrowmatch
chromosome 1 abnormality;gain of chromosome 1p31;narrowmatch
chromosomal gain;gain of chromosome 7q32;narrowmatch
chromosome 7 abnormality;gain of chromosome 7q32;narrowmatch
chromosomal gain;gain of chromosome 7p;narrowmatch
chromosome 7 abnormality;gain of chromosome 7p;narrowmatch
postgerminal center b-lymphocyte;postgerminal center b-lymphocyte of unknown differentiation stage;narrowmatch
marginal zone b-lymphocyte;postgerminal center b-lymphocyte of unknown differentiation stage;narrowmatch
signal transduction pathway deregulation;jak-stat pathway deregulation;narrowmatch
abnormal granulocyte;neoplastic granulocyte;narrowmatch
neoplastic histiocyte;large malignant histiocyte;narrowmatch
neoplastic hematopoietic and lymphoid cell;neoplastic histiocytic and dendritic cell;narrowmatch
hematopoietic and lymphoid cell;histiocytic and dendritic cell;narrowmatch
histiocyte;mature tissue histiocyte;narrowmatch
neoplastic granulocyte;neoplastic eosinophilic precursor;narrowmatch
morphologic finding;mature neutrophils present;narrowmatch
neoplastic myeloid cell;neoplastic granulocyte;narrowmatch
progressive clinical course;rapidly progressive clinical course;narrowmatch
hemangiopericytoma;malignant hemangiopericytoma;narrowmatch
bone marrow myeloid stem cell;bone marrow stem cell committed to the basophil lineage;narrowmatch
trisomy;trisomy 21;narrowmatch
bone marrow myeloid stem cell;bone marrow stem cell committed to the megakaryocytic lineage;narrowmatch
bone marrow myeloid stem cell;bone marrow myeloid stem cell with some degree of commitment to the erythroid lineage;narrowmatch
neoplastic erythroblast;neoplastic medium to large size erythroblast;narrowmatch
neoplastic myeloid blast;neoplastic erythroblast;narrowmatch
abnormal erythroblast;neoplastic erythroblast;narrowmatch
large malignant histiocyte;large multinucleated malignant histiocyte;narrowmatch
localized disease;unifocal disease;narrowmatch
clinical course of disease;multifocal unisystem disease;narrowmatch
lesion;bone lesion;narrowmatch
abnormal blood chemistry and hematology test result;serum total tryptase levels increased;narrowmatch
neoplastic mast cell;leukemic mast cell;narrowmatch
leukemic cell;leukemic mast cell;narrowmatch
morphologic finding;paracortical involvement with residual follicles present;narrowmatch
neoplastic histiocytic and dendritic cell;neoplastic dendritic cell;narrowmatch
immunophenotypic finding;cd35-positive neoplastic cells present;narrowmatch
immunophenotypic finding;cd21-positive neoplastic cells present;narrowmatch
hmb45-positive cells present;hmb-45-positive neoplastic cells present;narrowmatch
immunophenotypic finding;cd1a-positive neoplastic cells present;narrowmatch
cd1a positive;cd1a-positive neoplastic cells present;narrowmatch
ultrastructural finding;birbeck granules present;narrowmatch
microscopic finding;ultrastructural finding;narrowmatch
monoclonal cellular population present;monoclonal langerhans cells present;narrowmatch
non-neoplastic endocrine disorder;diabetes insipidus;narrowmatch
bone lesion;multiple destructive bone lesions;narrowmatch
odontoma;complex odontoma;narrowmatch
myeloblasts 20 percent or more of bone marrow nucleated cells;myeloblasts 90 percent or more of bone marrow non-erythroid cells;narrowmatch
lesion;macular lesion;narrowmatch
hamartoma;chondroid hamartoma;narrowmatch
therapy-related toxicity;chemotherapeutic agent toxicity;narrowmatch
drug toxicity;chemotherapeutic agent toxicity;narrowmatch
neoplastic ganglion cell;neoplastic retinal ganglion cell;narrowmatch
sellar region;suprasellar region;narrowmatch
clinical course of disease;extraocular dissemination of disease;narrowmatch
tumor-suppressor pathway deregulation;rb-e2f pathway deregulation;narrowmatch
morphologic architectural pattern;serrated glandular architecture;narrowmatch
morphologic architectural pattern;sheet-like growth pattern;narrowmatch
fusion protein expression;dek-nup214 fusion protein expression;narrowmatch
deposit;pseudo-psammoma body formation;narrowmatch
tissue differentiation;epithelial differentiation;narrowmatch
mass;ossified mass;narrowmatch
connective and soft tissue neoplasm (antiquated);round cell liposarcoma;narrowmatch
congenital melanocytic nevus;giant congenital nevus;narrowmatch
pigmented nevus;giant congenital nevus;narrowmatch
cutaneous precancerous condition;precancerous melanosis;narrowmatch
toxicity;therapy-related toxicity;narrowmatch
lesion by morphology;premalignant lesion;narrowmatch
mesenchymoma;benign mesenchymoma;narrowmatch
mesenchymoma;malignant mesenchymoma;narrowmatch
hemangiopericytoma;benign hemangiopericytoma;narrowmatch
germ cell tumor (antiquated);intermediate immature teratoma;narrowmatch
blasts of mixed phenotype present;dual population of bone marrow blasts present;narrowmatch
blast cells increased in bone marrow;dual population of bone marrow blasts present;narrowmatch
neoplastic blast;neoplastic blast coexpressing myeloid and lymphoid lineage antigens;narrowmatch
neoplastic blast;undifferentiated neoplastic blast;narrowmatch
bone marrow myeloid stem cell;bone marrow stem cell with some commitment to monocytic differentiation;narrowmatch
blast cells increased in bone marrow;immature myeloid cells increased in bone marrow;narrowmatch
myeloblasts present;immature myeloid cells increased in bone marrow;narrowmatch
granulocytes increased in bone marrow;neoplastic promyelocytes in bone marrow markedly increased;narrowmatch
bone marrow myeloid stem cell;granulocyte-monocyte progenitor cell;narrowmatch
morphologic finding;abnormal eosinophilic granules present;narrowmatch
granulocytes increased in bone marrow;neoplastic granulocytes and precursors 20 percent or more of bone marrow cells;narrowmatch
immature myeloid cells increased in bone marrow;cells of monocytic lineage 80 percent or more of bone marrow leukemic cells;narrowmatch
bone marrow myeloid stem cell;bone marrow stem cell with potential to differentiate to granulocytic lineage;narrowmatch
elevated test result;serum total tryptase levels increased;narrowmatch
integumentary system signs and symptoms;macular lesion;narrowmatch
lesion;rare lesion;narrowmatch
tissue;hepatobiliary tissue;narrowmatch
extrahepatic bile duct;hilar portion of the hepatic duct;narrowmatch
morphologic architectural pattern;lamellar pattern;narrowmatch
bile duct epithelium;extrahepatic bile duct epithelium;narrowmatch
bile duct epithelium;intrahepatic bile duct epithelium;narrowmatch
bile duct tissue;bile duct epithelium;narrowmatch
glandular epithelium;bile duct epithelium;narrowmatch
hepatobiliary tissue;bile duct tissue;narrowmatch
digestive system part;hepatobiliary system;narrowmatch
gene amplification abnormality;pituitary tumor transforming gene overexpression;narrowmatch
epithelial neoplasm (antiquated);gallbladder tubulopapillary adenoma;narrowmatch
epithelial neoplasm (antiquated);gallbladder papillary adenoma;narrowmatch
epithelial neoplasm (antiquated);gallbladder tubular adenoma;narrowmatch
gene variant;myc gene mutation;narrowmatch
cell structure;protoplasm;narrowmatch
epithelial differentiation;neuroendocrine differentiation;narrowmatch
epithelial differentiation;glandular differentiation;narrowmatch
hepatic duct;hilar portion of the hepatic duct;narrowmatch
paranasal sinus polyp;frontal sinus polyp;narrowmatch
gastric non-neoplastic polyp;gastric hamartomatous polyp;narrowmatch
gastrointestinal hamartoma;gastric hamartomatous polyp;narrowmatch
bacterial infection;chlamydophila psittaci infection;narrowmatch
benign skin melanocytic nevus;cockade nevus;narrowmatch
skin hemangiopericytoma;malignant skin hemangiopericytoma;narrowmatch
malignant hemangiopericytoma;malignant skin hemangiopericytoma;narrowmatch
hemangiopericytoma;skin hemangiopericytoma;narrowmatch
angiokeratoma;skin angiokeratoma;narrowmatch
xanthoma;cutaneous verruciform xanthoma;narrowmatch
non-neoplastic skin disorder;cutaneous verruciform xanthoma;narrowmatch
hereditary neoplastic syndrome;multiple self healing epithelioma of ferguson-smith;narrowmatch
chromosomal translocation;"t(3;14)(p14.1;q32)";narrowmatch
cancer stage (antiquated);stage 0 extrahepatic bile duct cancer;narrowmatch
reactive vascular proliferation;intravascular papillary endothelial hyperplasia;narrowmatch
morphologic finding;bile pigment present;narrowmatch
morphologic finding;neutral epithelial mucin present;narrowmatch
non-neoplastic kidney disorder;renal failure;narrowmatch
transcription regulation gene;cdc73 gene;narrowmatch
oncogene deregulation;pituitary tumor transforming gene overexpression;narrowmatch
lesion;peau chagrine lesion;narrowmatch
bacterial infection;campylobacter jejuni infection;narrowmatch
chromosomal translocation;"t(3;8)(p12;q21)";narrowmatch
neoplastic epithelioid cell;neoplastic connective and soft tissue epithelioid cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic connective and soft tissue epithelioid cell;narrowmatch
fusion protein expression;ss18-ssx fusion protein expression;narrowmatch
monosomy;monosomy 3;narrowmatch
fusion protein expression;col1a1-pdgfbeta fusion protein expression;narrowmatch
small intestinal infection;campylobacter jejuni infection;narrowmatch
gene variant;ret gene mutation;narrowmatch
oncogene deregulation;c-met gene amplification;narrowmatch
receptor tyrosine kinase gene mutation;ret gene mutation;narrowmatch
gene variant;cdkn1c gene mutation;narrowmatch
monoclonal cellular population present;monoclonal myeloid or lymphoid cells present;narrowmatch
unifocal disease;unifocal disease at presentation;narrowmatch
abnormal hematology test result;mast cells 10 percent or more of peripheral blood white cells;narrowmatch
abnormal bone marrow test result;mast cells 20 percent or more of bone marrow nucleated cells;narrowmatch
integumentary system signs and symptoms;peau chagrine lesion;narrowmatch
rearrangement of 8q21;"t(3;8)(p12;q21)";narrowmatch
chromosomal gain;gain of chromosome 10p;narrowmatch
epithelial neoplasm (antiquated);trichoepithelial carcinoma;narrowmatch
epithelial neoplasm (antiquated);trichofollicular carcinoma;narrowmatch
receptor tyrosine kinase gene amplification;c-met gene amplification;narrowmatch
stem cell;epithelial stem cell;narrowmatch
stem cell;multipotent stem cell;narrowmatch
lymphoma/leukemia by kiel classification (antiquated);diffuse centroblastic-centrocytic lymphoma;narrowmatch
gene variant;cdc73 gene mutation;narrowmatch
glandular cell;apocrine cell;narrowmatch
epithelial cell;eccrine cell;narrowmatch
glandular epithelial tissue;glandular epithelium;narrowmatch
epithelium;glandular epithelium;narrowmatch
digestive system part;anus;narrowmatch
epithelial neoplasm (antiquated);syringoacanthoma;narrowmatch
neoplastic sebocyte;malignant sebocyte;narrowmatch
adenocarcinoma cell;malignant sebocyte;narrowmatch
neoplastic epithelial cell;neoplastic sebocyte;narrowmatch
glandular cell;sebocyte;narrowmatch
morphologic finding;tissue differentiation;narrowmatch
neoplastic ganglion cell;neoplastic maturing ganglion cell;narrowmatch
signal transduction pathway deregulation;ras-raf pathway deregulation;narrowmatch
neoplastic epithelioid cell;malignant epithelioid cell;narrowmatch
ependyma and remnants of the central canal of the spinal cord;subependymal tissue;narrowmatch
neural pathway;visual pathway;narrowmatch
lesion;secondary lesion;narrowmatch
nerve tissue, neuroepithelial tissue, and nerve sheaths;nerve tissue and nerve sheaths;narrowmatch
perineural cell;perineurial cell;narrowmatch
nerve tissue and nerve sheaths;nerve sheath;narrowmatch
soft tissue;nerve sheath;narrowmatch
malignant cell;malignant epithelioid cell;narrowmatch
lesion;nodular lesion;narrowmatch
malignant connective and soft tissue cell;malignant perineural cell;narrowmatch
neoplastic perineural cell;malignant perineural cell;narrowmatch
necrotic change;geographic necrosis;narrowmatch
mass;pseudoencapsulated mass;narrowmatch
thick-walled vessels present;thick-walled hyalinized vessels present;narrowmatch
hyalinized vessels present;thick-walled hyalinized vessels present;narrowmatch
morphologic finding;absence of malignant features;narrowmatch
musculoskeletal system part;epidural spinal canal space;narrowmatch
musculoskeletal system part;intradural extramedullary spinal canal space;narrowmatch
neoplastic ependymal cell;neoplastic subependymal glial cell;narrowmatch
ependymal cell;subependymal cell;narrowmatch
morphologic finding;intracellular accumulation of lipids;narrowmatch
morphologic finding;dense intercellular reticulin network present;narrowmatch
nodular lesion;multinodular lesion;narrowmatch
morphologic finding;rosenthal fibers present;narrowmatch
cystic change;macrocystic change;narrowmatch
morphologic finding;eosinophilic granular bodies present;narrowmatch
vascular morphologic change;hyalinized vessels present;narrowmatch
morphologic finding;low cellularity present;narrowmatch
neoplastic astrocyte;neoplastic protoplasmic astrocyte;narrowmatch
mass;slow growing mass;narrowmatch
lesion;well-circumscribed lesion;narrowmatch
cystic change;microcystic change;narrowmatch
vascular proliferation;microvascular proliferation;narrowmatch
morphologic finding;cystic change;narrowmatch
morphologic architectural pattern;infiltrative growth pattern;narrowmatch
morphologic finding;increased cellularity present;narrowmatch
protein deregulation;loss of merlin expression;narrowmatch
pituitary gland neoplasm (antiquated);pituitary gland acidophil carcinoma;narrowmatch
gene variant;nras gene mutation;narrowmatch
myeloblasts under 20 percent of peripheral blood white cells;myeloblasts under 10 percent of peripheral blood white cells;narrowmatch
blasts under 20 percent of bone marrow nucleated cells;blasts 10-19 percent of bone marrow nucleated cells;narrowmatch
blasts under 20 percent of peripheral blood white cells;blasts 5-19 percent of peripheral blood white cells;narrowmatch
blasts 5 percent or less of peripheral blood white cells;blasts under 5 percent of peripheral blood white cells;narrowmatch
blasts under 15 percent of bone marrow nucleated cells;blasts under 10 percent of bone marrow nucleated cells;narrowmatch
blasts under 25 percent of bone marrow nucleated cells;blasts under 20 percent of bone marrow nucleated cells;narrowmatch
fusion protein expression;etv6-pdgfrb fusion protein expression;narrowmatch
ras family gene mutation;nras gene mutation;narrowmatch
cystic lesion;unicystic lesion;narrowmatch
oncogene deregulation;fgf6 gene amplification;narrowmatch
fgf gene amplification;fgf6 gene amplification;narrowmatch
oncogene deregulation;fgf4 gene amplification;narrowmatch
fgf gene amplification;fgf4 gene amplification;narrowmatch
chromosomal deletion;del(3p25);narrowmatch
chromosomal loss;loss of chromosome 12;narrowmatch
chromosome 12 abnormality;loss of chromosome 12;narrowmatch
blasts under 10 percent of peripheral blood white cells;myeloblasts under 10 percent of peripheral blood white cells;narrowmatch
abnormal blood chemistry and hematology test result;elevated serum lysozyme;narrowmatch
elevated test result;elevated serum lysozyme;narrowmatch
dysplasia negative;absence of bone marrow dysplasia;narrowmatch
cystic lesion;multilocular lesion;narrowmatch
lesion;cystic lesion;narrowmatch
morphologic finding;vater-pacini corpuscles-like structures present;narrowmatch
supporting cell of the nervous system;perineural cell;narrowmatch
morphologic finding;melanosomes present;narrowmatch
morphologic finding;pseudo-onion bulbs formation;narrowmatch
neoplastic ganglion cell;neoplastic perineural cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic perineural cell;narrowmatch
neuron, neuroepithelial cell, and supporting cell of the nervous system;neuroepithelial cell;narrowmatch
nerve tissue, neuroepithelial tissue, and nerve sheaths;neuroepithelial tissue;narrowmatch
neoplastic cell;neoplastic neuroepithelial cell and neoplastic perineural cell;narrowmatch
nerve sheath;perineural tissue;narrowmatch
tissue;nerve tissue, neuroepithelial tissue, and nerve sheaths;narrowmatch
cell;neuron, neuroepithelial cell, and supporting cell of the nervous system;narrowmatch
normal bone marrow test result;absence of bone marrow dysplasia;narrowmatch
neoplastic astrocyte;neoplastic large ganglioid astrocyte;narrowmatch
morphologic architectural pattern;perivascular pseudopalisading;narrowmatch
neoplastic neuroepithelial cell;neoplastic round neuroepithelial cell;narrowmatch
differentiating neuroblasts present;differentiating neuroblasts under 5 percent of the tumor cells;narrowmatch
abnormal tissue present;ganglioneuroma component present;narrowmatch
abnormal tissue present;ganglioneuroblastoma component present;narrowmatch
morphologic finding;hemorrhagic neuroblastic nodules present;narrowmatch
schwannian stroma more than 50 percent of the tumor volume;schwannian stroma predominant component of the tumor volume;narrowmatch
prominent schwannian stroma present;schwannian stroma more than 50 percent of the tumor volume;narrowmatch
abnormal cells present;differentiating neuroblasts present;narrowmatch
differentiating neuroblasts present;differentiating neuroblasts more than 5 percent of the tumor cells;narrowmatch
morphologic finding;neuropil present;narrowmatch
neoplastic small neuroepithelial cell;neoplastic small mature neuroepithelial cell;narrowmatch
neuroepithelial cell;neuroectodermal cell;narrowmatch
ectoderm cell;neuroectodermal cell;narrowmatch
stromal change;prominent schwannian stroma present;narrowmatch
epithelial neoplasm (antiquated);complex epithelial neoplasm;narrowmatch
clinical course of disease;regional disease;narrowmatch
abnormal cells present;clusters and cords of gfap positive epithelioid tumor cells present;narrowmatch
morphologic architectural pattern;perivascular arrangement of tumor cells;narrowmatch
abnormal tissue present;mature schwannian stroma present;narrowmatch
morphologic finding;ganglion cells present;narrowmatch
abnormal cells present;scattered collections of differentiating neuroblasts present;narrowmatch
morphologic finding;abnormal tissue present;narrowmatch
mesenchymal differentiation;lipomatous differentiation;narrowmatch
stromal change;pale eosinophilic stroma formation;narrowmatch
dysplasia;cortical dysplasia;narrowmatch
morphologic finding;aggregates of poorly differentiated neuroepithelial cells present;narrowmatch
strabismus;downward ocular deviation;narrowmatch
neoplastic ganglion cell;dysplastic ganglion cell;narrowmatch
neoplastic ganglion cell;neoplastic mature ganglion cell;narrowmatch
tissue differentiation;neuronal differentiation;narrowmatch
neoplastic epithelial cell;neoplastic cuboidal cell;narrowmatch
mass;cauliflower-like mass;narrowmatch
epithelium;choroid plexus epithelium;narrowmatch
lesion;lesion by morphology;narrowmatch
morphologic finding;lesion by morphology;narrowmatch
morphologic finding;cellular infiltrate;narrowmatch
morphologic finding;abnormal cells present;narrowmatch
pineocytomatous rosette formation;large pineocytomatous rosette formation;narrowmatch
neoplastic small neuroepithelial cell;neoplastic small immature neuroepithelial cell;narrowmatch
tissue differentiation;glial differentiation;narrowmatch
eicosanoid modulation;eicosanoid activity induction;narrowmatch
neoplastic cell;neoplastic mesothelial cell;narrowmatch
epithelial neoplasm (antiquated);mixed cell adenocarcinoma;narrowmatch
epithelial neoplasm (antiquated);water-clear cell adenocarcinoma;narrowmatch
metabolic process;resistance process;narrowmatch
nucleotide metabolic process;nucleotide biosynthesis process;narrowmatch
biochemical process;dna maintenance process;narrowmatch
eicosanoid activity induction;leukotriene activity induction;narrowmatch
cellular process;cell movement process;narrowmatch
neoplastic neuroepithelial cell;neoplastic small neuroepithelial cell;narrowmatch
cellular process;cell death process;narrowmatch
cellular process;cell adhesion process;narrowmatch
organismal process;circulatory process;narrowmatch
pituitary gland neoplasm (antiquated);pituitary gland mixed acidophil-basophil carcinoma;narrowmatch
organismal process;musculoskeletal process;narrowmatch
pituitary gland neoplasm (antiquated);pituitary gland mixed acidophil-basophil adenoma;narrowmatch
stromal change;collagenous stroma formation;narrowmatch
abnormal mesothelial cell;neoplastic mesothelial cell;narrowmatch
secretory cell;endocrine-stromal cell;narrowmatch
tissue;endocrine reproductive tissue;narrowmatch
cellular infiltrate;mixed cellular population;narrowmatch
neuroepithelial tissue;pineal parenchyma;narrowmatch
abnormal tissue present;nests of tumor cell nuclei in a fibrillary matrix;narrowmatch
pain;back pain;narrowmatch
necrotic change;pseudopalisading necrosis;narrowmatch
epithelial neoplasm (antiquated);papillary eccrine adenoma;narrowmatch
abnormal cells present;fascicles of spindly tumor cells present;narrowmatch
perinuclear halo present;clear perinuclear halo present;narrowmatch
pseudorosette formation;perivascular pseudorosette formation;narrowmatch
protein or riboprotein complex;protein kinase b;narrowmatch
ependyma and remnants of the central canal of the spinal cord;remnants of the central canal of the spinal cord;narrowmatch
neuroepithelial tissue;ependyma and remnants of the central canal of the spinal cord;narrowmatch
membrane of the brain or spinal cord;ependyma and remnants of the central canal of the spinal cord;narrowmatch
gene deletion;cdkn2a gene deletion;narrowmatch
necrotic change;extensive necrosis;narrowmatch
pathology result;precise histogenesis unknown;narrowmatch
benign skin melanocytic nevus;nevus spilus;narrowmatch
bacterial infection;borrelia burgdorferi infection;narrowmatch
rosette formation;collagen rosette formation;narrowmatch
neoplastic thyroid gland follicular cell;neoplastic thyroid gland follicular signet ring cell;narrowmatch
central nervous system degenerative disorder;dementia;narrowmatch
nested pattern;nesting (zellballen) growth pattern;narrowmatch
malignant connective and soft tissue cell;malignant endothelial cell;narrowmatch
neoplastic endothelial cell;malignant endothelial cell;narrowmatch
neoplastic thyroid gland follicular cell;neoplastic thyroid gland follicular cell with large and hyperchromatic nucleus;narrowmatch
neoplastic endocrine clear cell;neoplastic thyroid gland follicular clear cell;narrowmatch
neoplastic thyroid gland follicular cell;neoplastic thyroid gland follicular clear cell;narrowmatch
signet ring cell;neoplastic thyroid gland follicular signet ring cell;narrowmatch
follicular structures present;microfollicular structures present;narrowmatch
pseudostratified tumor cells present;pseudostratified columnar tumor cells present;narrowmatch
morphologic finding;nuclear grooves;narrowmatch
morphologic finding;nuclear clearing;narrowmatch
nuclear inclusion;nuclear pseudoinclusion;narrowmatch
lesion;diffuse lesion;narrowmatch
neoplastic thyroid gland follicular clear cell;malignant thyroid gland follicular clear cell;narrowmatch
malignant thyroid gland follicular cell;malignant thyroid gland follicular clear cell;narrowmatch
cognitive disorder;dementia;narrowmatch
immunodeficiency syndrome;deficiency of humoral immunity;narrowmatch
degenerative disorder;central nervous system degenerative disorder;narrowmatch
non-neoplastic central nervous system disorder;central nervous system degenerative disorder;narrowmatch
adenocarcinoma cell;malignant parathyroid gland cell;narrowmatch
neoplastic endocrine cell;neoplastic parathyroid gland cell;narrowmatch
neoplastic glandular cell;neoplastic parathyroid gland cell;narrowmatch
morphologic finding;perineural invasion;narrowmatch
endocrine system disorder;hyperparathyroidism;narrowmatch
parathyroid gland disorder;hyperparathyroidism;narrowmatch
glandular epithelial tissue;parathyroid gland epithelial tissue;narrowmatch
parathyroid gland tissue;parathyroid gland epithelial tissue;narrowmatch
glandular cell;parathyroid gland parenchymal cell;narrowmatch
endocrine cell;parathyroid gland parenchymal cell;narrowmatch
finding;cancer tnm finding;narrowmatch
human papillomavirus infection;anogenital human papillomavirus infection;narrowmatch
molecular genetic variation;genomic instability;narrowmatch
lesion with diameter of 10 mm or less;lesion less than 10 mm in diameter;narrowmatch
clinical course of disease;residual disease;narrowmatch
adenocarcinoma clear cell;malignant thyroid gland follicular clear cell;narrowmatch
follicular structures present;macrofollicular structures present;narrowmatch
neoplastic parathyroid gland cell;malignant parathyroid gland cell;narrowmatch
connective tissue nevus;eruptive collagenoma;narrowmatch
neoplasm;neoplasm by morphology;narrowmatch
eccrine sweat gland hamartoma;porokeratotic eccrine ostial and dermal duct nevus;narrowmatch
high grade lymphoma;high grade t-cell lymphoma;narrowmatch
low grade lymphoma;low grade t-cell lymphoma;narrowmatch
gastrointestinal hamartoma;peutz-jeghers polyp;narrowmatch
nervous system disorder;neuropathy;narrowmatch
leukoplakia of vocal cords;interarytenoid leukoplakia;narrowmatch
connective tissue nevus;sclerotic fibroma;narrowmatch
morphologic finding;follicular structures present;narrowmatch
pilosebaceous hamartoma;moniliform hamartoma;narrowmatch
eccrine sweat gland hamartoma;eccrine angiomatous hamartoma;narrowmatch
oral leukoplakia;proliferative verrucous leukoplakia;narrowmatch
oral leukoplakia;speckled oral leukoplakia;narrowmatch
oral leukoplakia;ulcerated oral leukoplakia;narrowmatch
gingival polyp;gingival fibroepithelial polyp;narrowmatch
fibroepithelial polyp;gingival fibroepithelial polyp;narrowmatch
connective and soft tissue neoplasm (antiquated);coccygeal body neoplasm;narrowmatch
pilosebaceous hamartoma;basal cell nevus with comedones;narrowmatch
cyst;oral cavity cyst;narrowmatch
vulvar squamous intraepithelial lesion;vulvar low grade squamous intraepithelial lesion;narrowmatch
epithelial differentiation;follicular cell differentiation;narrowmatch
osteoclast-like giant cell;non-neoplastic osteoclast-like giant cell;narrowmatch
motor manifestations;vocal cord paralysis;narrowmatch
sign;hoarseness;narrowmatch
mucin-producing malignant epithelial cell;malignant goblet-like mucous cell;narrowmatch
mucin-producing malignant epithelial cell;malignant cuboidal mucous cell;narrowmatch
epithelial tissue;thyroid gland epithelial tissue;narrowmatch
thyroid gland tissue;thyroid gland epithelial tissue;narrowmatch
malignant epithelial cell;malignant squamoid cell;narrowmatch
immunophenotypic finding;calcitonin positive neoplastic cells present;narrowmatch
immunophenotypic finding;thyroglobulin-positive neoplastic cells present;narrowmatch
malignant neuroendocrine small cell;malignant neuroendocrine small round cell;narrowmatch
elevated test result;serum calcitonin level increased;narrowmatch
abnormal blood chemistry and hematology test result;serum calcitonin level increased;narrowmatch
neoplastic neuroendocrine cell;neoplastic c-cell;narrowmatch
malignant endocrine cell;malignant parathyroid gland cell;narrowmatch
neoplastic parathyroid gland cell;neoplastic parathyroid gland chief cell;narrowmatch
collagen rosette formation;prominent collagen rosette formation;narrowmatch
digestive system hemorrhage;gastrointestinal hemorrhage;narrowmatch
lesion by focality;unifocal lesion;narrowmatch
lesion;lesion by focality;narrowmatch
morphologic architectural pattern;focal pattern;narrowmatch
nodule;satellite nodule;narrowmatch
morphologic finding;ganglion cell-like elements present;narrowmatch
neoplastic connective and soft tissue cell;neoplastic schwann-like cell;narrowmatch
neoplastic neuroendocrine cell;neoplastic epithelioid neuroendocrine cell;narrowmatch
heart part;base of the heart;narrowmatch
digestive system dysplasia;colon dysplasia;narrowmatch
painless mass;slow growing painless mass;narrowmatch
slow growing mass;slow growing painless mass;narrowmatch
neoplastic chromaffin cell;malignant chromaffin cell;narrowmatch
malignant neuroendocrine cell;malignant chromaffin cell;narrowmatch
neoplastic neuroendocrine cell;neoplastic chromaffin cell;narrowmatch
clinical course of disease;no evidence of metastatic disease;narrowmatch
mild dysplasia;mild colon dysplasia;narrowmatch
neoplastic parathyroid gland clear cell;neoplastic parathyroid gland water-clear cell;narrowmatch
neoplastic connective and soft tissue cell;neoplastic fibroblast;narrowmatch
neoplastic connective and soft tissue cell;neoplastic lipocyte;narrowmatch
striated muscle cell;skeletal muscle cell;narrowmatch
atypical adipocyte;malignant lipocyte;narrowmatch
abnormal tissue present;cartilage-like elements present;narrowmatch
spinal region;lumbosacral region;narrowmatch
skeletal system part;jaw bone;narrowmatch
neoplastic connective and soft tissue cell;malignant connective and soft tissue cell;narrowmatch
malignant cell;malignant connective and soft tissue cell;narrowmatch
connective and soft tissue cell;bone cell;narrowmatch
sign or symptom;symptom;narrowmatch
genitourinary system disorder;reproductive system disorder;narrowmatch
cancer tnm finding category;pathologic tnm finding;narrowmatch
disease or disorder;rare disorder;narrowmatch
cancer tnm finding;cancer tnm finding category;narrowmatch
neoplastic connective and soft tissue cell;neoplastic cartilage cell;narrowmatch
connective and soft tissue cell;cartilage cell;narrowmatch
connective and soft tissue;remnants of the notochord;narrowmatch
colon dysplasia;mild colon dysplasia;narrowmatch
neoplastic adrenal cortical cell;neoplastic adrenal cortical oncocyte;narrowmatch
malignant parathyroid gland cell;malignant parathyroid gland chief cell;narrowmatch
neoplastic parathyroid gland oncocyte;malignant parathyroid gland oncocyte;narrowmatch
sdh complex gene mutation;sdhb gene mutation;narrowmatch
gene abnormality;sdh complex gene mutation;narrowmatch
fibrotic stroma formation;broad fibrous bands formation;narrowmatch
hyperparathyroidism;primary hyperparathyroidism;narrowmatch
neoplastic parathyroid gland cell;neoplastic parathyroid gland clear cell;narrowmatch
neoplastic endocrine clear cell;neoplastic parathyroid gland clear cell;narrowmatch
neoplastic glandular cell with clear cytoplasm;neoplastic parathyroid gland clear cell;narrowmatch
malignant parathyroid gland cell;malignant parathyroid gland oncocyte;narrowmatch
neoplastic oncocyte;neoplastic adrenal cortical oncocyte;narrowmatch
malignant oncocyte;malignant parathyroid gland oncocyte;narrowmatch
neoplastic parathyroid gland cell;neoplastic parathyroid gland oncocyte;narrowmatch
neoplastic oncocyte;neoplastic parathyroid gland oncocyte;narrowmatch
neoplastic parathyroid gland clear cell;malignant parathyroid gland clear cell;narrowmatch
malignant parathyroid gland cell;malignant parathyroid gland clear cell;narrowmatch
adenocarcinoma clear cell;malignant parathyroid gland clear cell;narrowmatch
neoplastic parathyroid gland chief cell;malignant parathyroid gland chief cell;narrowmatch
gene variant;sdhb gene mutation;narrowmatch
sdh complex gene mutation;sdhc gene mutation;narrowmatch
gene variant;sdhc gene mutation;narrowmatch
sdh complex gene mutation;sdhd gene mutation;narrowmatch
neuroectodermal cell;neural crest-derived cell;narrowmatch
neuroendocrine cell;neural crest-derived cell;narrowmatch
epithelial tissue;neuroendocrine tissue;narrowmatch
neoplastic adrenal cortical cell;malignant adrenal cortical cell;narrowmatch
malignant endocrine cell;malignant adrenal cortical cell;narrowmatch
adenocarcinoma cell;malignant adrenal cortical cell;narrowmatch
neoplastic adrenal cortical cell;neoplastic adrenal cortical clear cell;narrowmatch
neoplastic endocrine clear cell;neoplastic adrenal cortical clear cell;narrowmatch
neoplastic endocrine cell;neoplastic adrenal cortical cell;narrowmatch
neoplastic glandular cell;neoplastic adrenal cortical cell;narrowmatch
glandular cell;adrenal cortical cell;narrowmatch
endocrine cell;adrenal cortical cell;narrowmatch
intracytoplasmic lipofuscin present;abundant intracytoplasmic lipofuscin present;narrowmatch
primary site of disease;primary site unknown;narrowmatch
gene variant;sdhd gene mutation;narrowmatch
laryngeal precancerous condition;laryngeal keratosis;narrowmatch
leukoplakia;laryngeal keratosis;narrowmatch
hamartoma;organoid nevus;narrowmatch
fusion protein expression;tfg-nr4a3 fusion protein expression;narrowmatch
epithelial neoplasm (antiquated);lung adenocarcinoma, mixed subtype;narrowmatch
vascular malformation;vascular ectasia;narrowmatch
non-neoplastic vascular disorder;reactive vascular proliferation;narrowmatch
fusion protein expression;ewsr1-ddit3 fusion protein expression;narrowmatch
hemangiopericytoma;orbit hemangiopericytoma;narrowmatch
rearrangement of 3q;"t(3;9)(q11-12;q22)";narrowmatch
chromosomal translocation;"t(3;9)(q11-12;q22)";narrowmatch
fusion protein expression;fus-erg fusion protein expression;narrowmatch
orbit hemangiopericytoma;malignant orbit hemangiopericytoma;narrowmatch
alk fusion protein expression;myh9-alk fusion protein expression;narrowmatch
alk fusion protein expression;alo17-alk fusion protein expression;narrowmatch
alk fusion protein expression;tpm4-alk fusion protein expression;narrowmatch
rearrangement of 2p23;"t(2;22)(p23;q11)";narrowmatch
chromosomal translocation;"t(2;22)(p23;q11)";narrowmatch
rearrangement of 2p23;"t(2;17)(p23;q35)";narrowmatch
chromosomal translocation;"t(2;17)(p23;q35)";narrowmatch
epithelial neoplasm (antiquated);lung signet ring cell carcinoma;narrowmatch
epithelial neoplasm (antiquated);lung clear cell adenocarcinoma;narrowmatch
3q abnormality;gain of chromosome 3q24-qter;narrowmatch
chromosomal gain;gain of chromosome 3q24-qter;narrowmatch
ebv-transformed mature b-lymphocyte;ebv-transformed late germinal center/post-germinal center b-lymphocyte;narrowmatch
mass;pleural mass;narrowmatch
pleural infection;pyothorax;narrowmatch
empyema;pyothorax;narrowmatch
drug, food, chemical or biomedical material;industrial aid;narrowmatch
gene variant;nf2 gene mutation;narrowmatch
tumor-suppressor gene inactivation;gpc3 gene inactivation;narrowmatch
morphologic finding;absence of invasion;narrowmatch
hyperplasia;adenomatous hyperplasia of the ciliary body;narrowmatch
gene abnormality;gene fusion abnormality;narrowmatch
gene amplification abnormality;gene duplication abnormality;narrowmatch
gene abnormality;gene amplification abnormality;narrowmatch
molecular genetic variation;mutation abnormality;narrowmatch
epithelial neoplasm (antiquated);intermediate grade lung neuroendocrine neoplasm;narrowmatch
epithelial neoplasm (antiquated);low grade lung neuroendocrine neoplasm;narrowmatch
chromosome 17 abnormality;"t(2;17)(p23;q35)";narrowmatch
malignant hemangiopericytoma;malignant orbit hemangiopericytoma;narrowmatch
nervous system finding;central nervous system cyst;narrowmatch
finding by site or system;respiratory system finding;narrowmatch
neoplastic small to medium-sized lymphocyte;neoplastic small to medium-sized b-lymphocyte resembling a centrocyte;narrowmatch
immunophenotypic finding;cd56-positive neoplastic cells present;narrowmatch
ncam1 positive;cd56-positive neoplastic cells present;narrowmatch
immunophenotypic finding;cd4-positive neoplastic cells present;narrowmatch
cd4 positive;cd4-positive neoplastic cells present;narrowmatch
hemangiopericytoma;kidney hemangiopericytoma;narrowmatch
myeloid cell;precursor of plasmacytoid dendritic cell;narrowmatch
neoplasm by special category;neoplasm by obsolete classification;narrowmatch
rearrangement of 2p23;"t(2;19)(p23;p13)";narrowmatch
diffuse large b-cell lymphoma, not otherwise specified;diffuse large b-cell lymphoma, not otherwise specified by gene expression profile;narrowmatch
gene abnormality;pdcd1lg2 gene overexpression;narrowmatch
collagen rosette formation;poor collagen rosette formation;narrowmatch
fusion protein expression;fus-creb3l1 fusion protein expression;narrowmatch
fusion protein expression;fus-creb3l2 fusion protein expression;narrowmatch
chromosomal translocation;"t(7;16)(q33;p11)";narrowmatch
chromosome 7 rearrangement;"t(7;16)(q33;p11)";narrowmatch
neoplastic b-lymphocyte;neoplastic small to medium-sized b-lymphocyte resembling a centrocyte;narrowmatch
neoplastic b-lymphocyte;neoplastic follicle center b-cell;narrowmatch
abnormal cells present;confluent sheets of neoplastic b-lymphocytes present;narrowmatch
cutaneous involvement;dermal involvement;narrowmatch
chromosomal translocation;"t(2;19)(p23;p13)";narrowmatch
immunoprotein gene;pdcd1lg2 gene;narrowmatch
gene variant;notch1 gene mutation;narrowmatch
notch family gene mutation;notch1 gene mutation;narrowmatch
fusion protein expression;v-mll fusion protein expression;narrowmatch
immunophenotypic finding;cd15-positive neoplastic cells present;narrowmatch
cd15 positive;cd15-positive neoplastic cells present;narrowmatch
thymic cyst;multilocular thymic cyst;narrowmatch
gamma/delta t-lymphocyte;activated mature gamma/delta t-lymphocyte with a cytotoxic phenotype;narrowmatch
morphologic finding;rimming of adipose tissue cells present;narrowmatch
neoplastic t-lymphocyte;neoplastic immunoblast-like t-lymphocyte;narrowmatch
integumentary system signs and symptoms;papulovesicular lesion;narrowmatch
lesion;papulovesicular lesion;narrowmatch
immunophenotypic finding;cd8-positive neoplastic cells present;narrowmatch
cd8 positive;cd8-positive neoplastic cells present;narrowmatch
thymic epithelial cell;thymic medullary epithelial cell;narrowmatch
chromosomal translocation;"t(15;22)(p11;q11)";narrowmatch
thymic epithelial cell;thymic epithelial cell capable of differentiating towards both cortical and medullary cell type;narrowmatch
intermediate filaments present;concentric aggregates of intermediate filaments present;narrowmatch
lesion with diameter of 4 mm or more;lesion with diameter greater than 10 mm;narrowmatch
lesion with diameter of 2 cm or less;lesion with diameter of 10 mm or less;narrowmatch
neoplastic endocrine cell;neoplastic adenohypophysial cell;narrowmatch
neoplastic glandular cell;neoplastic adenohypophysial cell;narrowmatch
immunophenotypic finding;multihormonal immunoreactivity present;narrowmatch
ultrastructural finding;giant mitochondria present;narrowmatch
negative test result;no evidence of hormonal immunoreactivity present;narrowmatch
ultrastructural finding;well developed rough endoplasmic reticulum present;narrowmatch
thymic epithelial cell;thymic epithelial cell capable of differentiating towards cortical cell type;narrowmatch
ultrastructural finding;misplaced exocytosis present;narrowmatch
neoplastic lactotroph cell;neoplastic lactotroph cell with small secretory granules;narrowmatch
neoplastic lactotroph cell;neoplastic lactotroph cell with large secretory granules;narrowmatch
malignant adenohypophysial cell;malignant lactotroph cell;narrowmatch
neoplastic lactotroph cell;malignant lactotroph cell;narrowmatch
malignant adenohypophysial cell;malignant thyrotroph cell;narrowmatch
neoplastic thyrotroph cell;malignant thyrotroph cell;narrowmatch
adenocarcinoma cell;malignant adenohypophysial cell;narrowmatch
malignant endocrine cell;malignant adenohypophysial cell;narrowmatch
neoplastic adenohypophysial cell;malignant adenohypophysial cell;narrowmatch
mass;fungating mass;narrowmatch
cyst;central nervous system cyst;narrowmatch
atypical glandular hyperplasia;atypical endometrial hyperplasia;narrowmatch
endometrial hyperplasia;atypical endometrial hyperplasia;narrowmatch
female reproductive system precancerous condition;atypical endometrial hyperplasia;narrowmatch
coccygeal body neoplasm;malignant coccygeal body neoplasm;narrowmatch
morphologic finding;capsular invasion;narrowmatch
malignant neoplasm;nonestrogen-dependent malignant neoplasm;narrowmatch
clinical course of disease;presymptomatic cancer;narrowmatch
gene rearrangement abnormality;pparg gene rearrangement;narrowmatch
chromosome 1 abnormality;ntrk1 gene rearrangement;narrowmatch
ntrk gene rearrangement;ntrk1 gene rearrangement;narrowmatch
receptor tyrosine kinase gene rearrangement;ret/ptc rearrangement;narrowmatch
endocrine system finding;presence of a hormonal syndrome;narrowmatch
endocrine system finding;absence of a hormonal syndrome;narrowmatch
lesion with diameter of 10 mm or less;lesion less than 5 mm in diameter;narrowmatch
malignant adenohypophysial cell;malignant corticotroph cell;narrowmatch
neoplastic corticotroph cell;malignant corticotroph cell;narrowmatch
malignant adenohypophysial cell;malignant somatotroph cell;narrowmatch
11q aberration;gain of chromosome 11q13;narrowmatch
chromosomal gain;gain of chromosome 13q;narrowmatch
chromosome 13q abnormality;gain of chromosome 13q;narrowmatch
non-neoplastic heart disorder;hamartoma of mature cardiac myocytes;narrowmatch
hamartoma;hamartoma of mature cardiac myocytes;narrowmatch
primordial germ cell;pluripotent primordial germ cell;narrowmatch
primordial germ cell;totipotent primordial germ cell;narrowmatch
epithelial stem cell;thymic epithelial stem cell;narrowmatch
thymic epithelial cell;thymic epithelial stem cell;narrowmatch
fusion protein expression;brd4-nut fusion protein expression;narrowmatch
nutm1 gene translocation;"t(15;19)(q13;p13.1)";narrowmatch
brd4 gene translocation;"t(15;19)(q13;p13.1)";narrowmatch
epithelial tissue;glandular epithelial tissue;narrowmatch
tissue;epithelial tissue;narrowmatch
epithelial tissue;thymic epithelial tissue;narrowmatch
thymic tissue;thymic epithelial tissue;narrowmatch
chromosomal gain;gain of chromosome 22q;narrowmatch
chromosomal gain;gain of chromosome 11q13;narrowmatch
neoplastic somatotroph cell;malignant somatotroph cell;narrowmatch
chromosomal gain;gain of chromosome 4;narrowmatch
neoplastic somatotroph cell;neoplastic somatotroph cell with scarce secretory granules;narrowmatch
neoplastic somatotroph cell;neoplastic somatotroph cell with abundant secretory granules;narrowmatch
gene variant;hras gene mutation;narrowmatch
ras family gene mutation;hras gene mutation;narrowmatch
chromosomal gain;gain of chromosome 4q;narrowmatch
gene variant;gnas gene mutation;narrowmatch
epithelial neoplasm (antiquated);pituitary gland neoplasm (antiquated);narrowmatch
glandular cell;adenohypophysial cell;narrowmatch
endocrine cell;adenohypophysial cell;narrowmatch
glial cell;pituicyte;narrowmatch
brain part;pituitary stalk;narrowmatch
skeletal system part;tuberculum sellae;narrowmatch
chromosomal deletion;del(18q21);narrowmatch
chromosomal loss;loss of chromosome 3q;narrowmatch
3q abnormality;loss of chromosome 3q;narrowmatch
gene amplification abnormality;akt2 gene amplification;narrowmatch
oncogene deregulation;akt2 gene amplification;narrowmatch
tumor-suppressor gene inactivation;map2k4 gene inactivation;narrowmatch
signaling pathway;erbb2 signaling pathway;narrowmatch
apoptosis regulation pathway;igf1r antiapoptosis pathway;narrowmatch
signaling pathway;igf-1 signaling pathway;narrowmatch
disease pathway;skeletal muscle hypertrophy pathway;narrowmatch
signaling pathway;ifn gamma signaling pathway;narrowmatch
regulatory pathway;hswi-snf pathway;narrowmatch
apoptosis regulation pathway;hiv-i nef in apoptosis pathway;narrowmatch
cell differentiation or development pathway;segmentation clock pathway;narrowmatch
cell differentiation or development pathway;skeletal myogenesis pathway;narrowmatch
cell cycle regulation pathway;g1/s checkpoint pathway;narrowmatch
infectious disease pathway;human cytomegalovirus infection pathway;narrowmatch
signaling pathway;beta-catenin accumulation pathway;narrowmatch
drug pathway;inhibition of cellular proliferation by gleevec pathway;narrowmatch
signaling pathway;growth hormone signaling pathway;narrowmatch
drug pathway;corticosteroid cardioprotection pathway;narrowmatch
gastrointestinal polyp;gallbladder polyp;narrowmatch
gallbladder disorder;gallbladder polyp;narrowmatch
signaling pathway;il12 signaling pathway;narrowmatch
signaling pathway;il22 signaling pathway;narrowmatch
immune response regulation pathway;il2rb pathway;narrowmatch
signaling pathway;il3 signaling pathway;narrowmatch
immune response regulation pathway;no2-dependent il12 pathway;narrowmatch
signaling pathway;nitric oxide pathway;narrowmatch
signaling pathway;nerve growth factor pathway;narrowmatch
disease pathway;nfat pathway;narrowmatch
regulatory pathway;nfat pathway;narrowmatch
signaling pathway;mtor signaling pathway biocarta;narrowmatch
signaling pathway;hepatocyte growth factor receptor signaling pathway biocarta;narrowmatch
cell motility pathway;calpain-2 cell motility pathway;narrowmatch
signaling pathway;mapkinase signaling pathway;narrowmatch
homeostasis regulation pathway;longevity pathway;narrowmatch
cell differentiation or development pathway;keratinocyte differentiation pathway;narrowmatch
signaling pathway;insulin signaling pathway;narrowmatch
signaling pathway;il7 signaling pathway;narrowmatch
signaling pathway;il6 signaling pathway;narrowmatch
signaling pathway;il4 signaling pathway;narrowmatch
cell cycle regulation pathway;g2/m checkpoint pathway;narrowmatch
immune response regulation pathway;fc epsilon receptor i signaling pathway biocarta;narrowmatch
cell cycle regulation pathway;p27 regulation pathway;narrowmatch
regulatory pathway;estrogen receptor regulation by carm1 pathway;narrowmatch
regulatory pathway;ctcf pathway;narrowmatch
signaling pathway;creb activation signaling pathway;narrowmatch
apoptosis regulation pathway;apoptosis dna damage pathway;narrowmatch
cell cycle regulation pathway;cyclin regulation of cell cycle pathway;narrowmatch
signaling pathway;cell to cell adhesion signaling pathway;narrowmatch
cell motility pathway;cell migration pathway;narrowmatch
regulatory pathway;egf receptor downregulation by cbl pathway;narrowmatch
disease pathway;cardiac hypertrophy pathway;narrowmatch
degradation pathway;cyclin e degradation pathway;narrowmatch
cell cycle regulation pathway;btg cell cycle regulation pathway;narrowmatch
signaling pathway;bioactive peptide signaling pathway;narrowmatch
immune response regulation pathway;b-cell survival pathway;narrowmatch
dna repair pathway;bard1 pathway;narrowmatch
regulatory pathway;bad regulation pathway;narrowmatch
disease pathway;cancer susceptibility pathway;narrowmatch
dna repair pathway;atm signaling pathway;narrowmatch
signaling pathway;t-cell activation co-stimulatory signaling pathway;narrowmatch
immune response regulation pathway;t-cell activation co-stimulatory signaling pathway;narrowmatch
degradation pathway;dicer pathway;narrowmatch
cell motility pathway;extracellular matrix binding pathway;narrowmatch
apoptosis regulation pathway;fas signaling pathway biocarta;narrowmatch
signaling pathway;fas signaling pathway biocarta;narrowmatch
energy metabolism pathway;electron transport pathway;narrowmatch
cell differentiation or development pathway;erythrocyte differentiation pathway;narrowmatch
signaling pathway;erk1/erk2 mapk signaling pathway;narrowmatch
cell differentiation or development pathway;neuronal survival pathway;narrowmatch
protein cycling pathway;erbb3 receptor recycling pathway;narrowmatch
signaling pathway;epo signaling pathway;narrowmatch
apoptosis regulation pathway;erythropoietin neuroprotection pathway;narrowmatch
regulatory pathway;eif4 regulation pathway;narrowmatch
regulatory pathway;map kinase inactivation of smrt corepressor pathway;narrowmatch
signaling pathway;egf signaling pathway;narrowmatch
cell cycle regulation pathway;efp cell cycle pathway;narrowmatch
transport pathway;vesicle transport pathway;narrowmatch
signaling pathway;phospholipid signaling pathway;narrowmatch
signaling pathway;notch proteolysis and signaling pathway;narrowmatch
disease pathway;hypoxia pathway;narrowmatch
abnormal blood chemistry and hematology test result;serum soluble fas ligand level increased;narrowmatch
paranasal sinus polyp;sphenoid sinus polyp;narrowmatch
oral leukoplakia;leukoplakia of lip;narrowmatch
polyp;gingival polyp;narrowmatch
non-neoplastic gingival disorder;gingival polyp;narrowmatch
pilosebaceous hamartoma;nevus comedonicus;narrowmatch
non-neoplastic nevus;mongolian spot;narrowmatch
non-neoplastic skin disorder;non-neoplastic nevus;narrowmatch
laryngeal keratosis;leukoplakia of vocal cords;narrowmatch
paranasal sinus polyp;ethmoid sinus polyp;narrowmatch
viral infection;htlv-1 infection;narrowmatch
paranasal sinus polyp;maxillary sinus polyp;narrowmatch
neoplastic hematopoietic and lymphoid cell;cd4+/cd56+ neoplastic medium-sized cell;narrowmatch
t-lymphocyte and natural killer cell;precursor natural killer cell;narrowmatch
immature lymphocyte;precursor natural killer cell;narrowmatch
parasitic infection;opisthorchis viverrini infection;narrowmatch
schistosomiasis;schistosoma hematobium infection;narrowmatch
gastric infection;helicobacter pylori infection;narrowmatch
oral cavity hairy leukoplakia;hairy leukoplakia of tongue;narrowmatch
leukoplakia of tongue;hairy leukoplakia of tongue;narrowmatch
leukoplakia;esophageal leukoplakia;narrowmatch
stomach disorder;gastric polyp;narrowmatch
apoptotic pathway deregulation;fas apoptosis pathway deregulation;narrowmatch
mature t-lymphocyte;t-lymphocyte with a post-thymic immunophenotype;narrowmatch
neoplastic t-prolymphocyte;neoplastic cerebriform t-prolymphocyte;narrowmatch
neoplastic small t-lymphocyte;neoplastic small t-prolymphocyte;narrowmatch
neoplastic t-prolymphocyte;neoplastic small t-prolymphocyte;narrowmatch
integumentary system finding;cutaneous involvement;narrowmatch
gastrointestinal polyp;anal polyp;narrowmatch
anal disorder;anal polyp;narrowmatch
cytoplasmic alteration;cytoplasmic protrusions present;narrowmatch
t-lymphocyte and natural killer cell;peripheral (post-thymic) t-lymphocyte and natural killer cell;narrowmatch
lymphocyte;t-lymphocyte and natural killer cell;narrowmatch
neoplastic lymphocyte;neoplastic t-lymphocyte and neoplastic natural killer cell;narrowmatch
morphologic finding;coarse azurophilic granules present;narrowmatch
intestinal metaplasia;intestinal metaplasia of gastric mucosa;narrowmatch
gastrointestinal polyp;gastric polyp;narrowmatch
bacterial infection;helicobacter pylori infection;narrowmatch
herpesvirus infection;hhv8 infection;narrowmatch
signaling pathway;p53 signaling pathway biocarta;narrowmatch
regulatory pathway;phosphoinositide pathway;narrowmatch
signaling pathway;rb checkpoint signaling pathway;narrowmatch
signaling pathway;ras signaling pathway;narrowmatch
cell cycle regulation pathway;g1 to s transition pathway;narrowmatch
homeostasis regulation pathway;ion channels in vascular endothelium pathway;narrowmatch
signaling pathway;rac1 cell motility signaling pathway;narrowmatch
cell cycle regulation pathway;pten-dependent cell cycle arrest and apoptosis pathway;narrowmatch
apoptosis regulation pathway;pten-dependent cell cycle arrest and apoptosis pathway;narrowmatch
cell cycle regulation pathway;ptc1 regulation of cell cycle pathway;narrowmatch
signaling pathway;thrombin/protease-activated receptor signaling pathway;narrowmatch
signaling pathway;notch and wnt signaling pathway;narrowmatch
regulatory pathway;ppar-alpha gene regulation pathway;narrowmatch
cell cycle regulation pathway;cell cycle progression pathway;narrowmatch
signaling pathway;phospholipase c signaling pathway;narrowmatch
regulatory pathway;pitx2 transcription regulation pathway;narrowmatch
signaling pathway;pdgf signaling pathway;narrowmatch
cell cycle regulation pathway;p53 signaling pathway biocarta;narrowmatch
cell cycle regulation pathway;rb checkpoint signaling pathway;narrowmatch
immune response regulation pathway;dsrna induction pathway;narrowmatch
signaling pathway;sonic hedgehog pathway;narrowmatch
degradation pathway;e2f1 degradation pathway;narrowmatch
signaling pathway;wnt signaling pathway biocarta;narrowmatch
skin angiokeratoma;angiokeratoma of mibelli;narrowmatch
regulatory pathway;angiogenesis pathway;narrowmatch
signaling pathway;trka receptor signaling pathway;narrowmatch
signaling pathway;tpo signaling pathway;narrowmatch
signaling pathway;tnfr1 signaling pathway;narrowmatch
signaling pathway;interferon signaling modulation pathway;narrowmatch
signaling pathway;tgf beta signaling pathway biocarta;narrowmatch
homeostasis regulation pathway;mucosal healing pathway;narrowmatch
regulatory pathway;tert regulation pathway;narrowmatch
regulatory pathway;terc regulation pathway;narrowmatch
genetic information processing pathway;telomere pathway;narrowmatch
immune response regulation pathway;t cell receptor signaling pathway biocarta;narrowmatch
signaling pathway;t cell receptor signaling pathway biocarta;narrowmatch
signaling pathway;sprouty regulation of tyrosine kinase signaling pathway;narrowmatch
signaling pathway;atm signaling pathway;narrowmatch
signaling pathway;angiotensin ii signaling pathway;narrowmatch
metabolic pathway;ribosomal biogenesis pathway;narrowmatch
elevated expression;interleukin-13 overexpression;narrowmatch
fusion protein expression;api2-mlt fusion protein expression;narrowmatch
clonal gene rearrangement;clonal bcl3 gene rearrangement;narrowmatch
abnormal immunology test result;colony-stimulating factor overexpression;narrowmatch
elevated expression;colony-stimulating factor overexpression;narrowmatch
abnormal immunology test result;lymphotoxin-alpha overexpression;narrowmatch
elevated expression;lymphotoxin-alpha overexpression;narrowmatch
abnormal immunology test result;interleukin-13 overexpression;narrowmatch
abnormal immunology test result;interleukin-10 overexpression;narrowmatch
elevated expression;interleukin-5 overexpression;narrowmatch
elevated expression;interleukin-10 overexpression;narrowmatch
abnormal immunology test result;interleukin-9 overexpression;narrowmatch
elevated expression;interleukin-9 overexpression;narrowmatch
abnormal immunology test result;interleukin-7 overexpression;narrowmatch
elevated expression;interleukin-7 overexpression;narrowmatch
abnormal immunology test result;interleukin-6 overexpression;narrowmatch
elevated expression;interleukin-6 overexpression;narrowmatch
integumentary system part;hair part;narrowmatch
immune system part;lymph node part;narrowmatch
lymphoid tissue;interfollicular area of the lymph node;narrowmatch
lymph node tissue;interfollicular area of the lymph node;narrowmatch
paracentric inversion;inv(22q12);narrowmatch
immune system part;tonsil part;narrowmatch
body part;extremity part;narrowmatch
extremity part;lower extremity part;narrowmatch
extremity part;upper extremity part;narrowmatch
body part;organ of special sense part;narrowmatch
body part;integumentary system part;narrowmatch
body part;head and neck part;narrowmatch
sign or symptom;mental and behavioral signs and symptoms;narrowmatch
creb family gene;creb1 gene;narrowmatch
transcription factor gene;creb family gene;narrowmatch
tonsil part;tonsillar tissue;narrowmatch
tissue;tonsillar tissue;narrowmatch
immune system part;spleen part;narrowmatch
symptom;constitutional symptom;narrowmatch
abnormal immunology test result;interleukin-5 overexpression;narrowmatch
abnormal immunology test result;interleukin-2 overexpression;narrowmatch
cell differentiation or development pathway;alk pathway;narrowmatch
sign or symptom;neurological signs and symptoms;narrowmatch
oral leukoplakia;aneuploid dysplastic oral leukoplakia;narrowmatch
fusion protein expression;stat5b-rara fusion protein expression;narrowmatch
rara gene translocation;"t(17;17)(q21;q21)";narrowmatch
fusion protein expression;rbm15-mkl1 fusion protein expression;narrowmatch
gene variant;cebpa gene mutation;narrowmatch
ccaat enhancer binding protein gene mutation;cebpa gene mutation;narrowmatch
nervous system finding;neurological signs and symptoms;narrowmatch
gene variant;runx1 gene mutation;narrowmatch
elevated expression;interleukin-2 overexpression;narrowmatch
core binding factor complex mutation;runx1 gene mutation;narrowmatch
sexual dysfunction and infertility;infertility;narrowmatch
chromosomal deletion;del(4)(q12);narrowmatch
alk fusion protein expression;msn-alk fusion protein expression;narrowmatch
signal transduction pathway deregulation;pi3k-akt pathway deregulation;narrowmatch
signal transduction pathway deregulation;myc pathway deregulation;narrowmatch
molecular pathway deregulation;jun pathway deregulation;narrowmatch
chromosome 7 rearrangement;"del(7)(q11;q36)";narrowmatch
chromosomal deletion;"del(7)(q11;q36)";narrowmatch
chromosomal deletion;del(20)(q11);narrowmatch
fusion protein expression;kmt2a-af10 fusion protein expression;narrowmatch
abnormal laboratory test result;abnormal immunology test result;narrowmatch
lymphocyte;mature lymphocyte;narrowmatch
mature b-lymphocyte;mature b-lymphocyte at the germinal center stage of differentiation;narrowmatch
peripheral (post-thymic) t-lymphocyte and natural killer cell;peripheral (post-thymic) t-lymphocyte;narrowmatch
t-lymphocyte;peripheral (post-thymic) t-lymphocyte;narrowmatch
reed-sternberg cell;pleomorphic reed-sternberg cell;narrowmatch
serine/threonine protein kinase gene;prkaca gene;narrowmatch
morphologic finding;progressive transformation of germinal centers;narrowmatch
point mutation;c-kit somatic point mutation;narrowmatch
short somatic mutation;c-kit somatic point mutation;narrowmatch
somatic kit gene mutation;c-kit somatic point mutation;narrowmatch
fusion protein expression;kmt2a-een fusion protein expression;narrowmatch
fusion protein expression;kmt2a-ell fusion protein expression;narrowmatch
fusion protein expression;kmt2a-enl fusion protein expression;narrowmatch
fusion protein expression;mllt3-kmt2a fusion protein expression;narrowmatch
inv(22);inv(22q12);narrowmatch
delta cell;delta cell of the pancreas;narrowmatch
islet cell;delta cell of the pancreas;narrowmatch
thyroiditis;lymphocytic thyroiditis;narrowmatch
cell cycle regulation pathway;cell cycle pathway;narrowmatch
apoptosis regulation pathway;apoptosis pathway;narrowmatch
neurodegenerative disorders pathway;amyotrophic lateral sclerosis pathway;narrowmatch
neurodegenerative disorders pathway;alzheimer's disease pathway kegg;narrowmatch
mouse hepatic system neoplasm;malignant neoplasms of mouse liver;narrowmatch
mouse hepatic system neoplasm;benign neoplasms of mouse liver;narrowmatch
epithelial differentiation;squamous differentiation;narrowmatch
tissue differentiation;squamoid differentiation;narrowmatch
neoplastic lymphocyte;neoplastic b-lymphocyte;narrowmatch
structural protein;scaffolding protein;narrowmatch
herpesvirus infection;ebv infection;narrowmatch
malignant neoplasms of mouse liver;hepatocellular carcinoma of the mouse;narrowmatch
benign neoplasms of mouse liver;hepatocellular adenoma of the mouse;narrowmatch
mouse digestive system disorder;mouse liver disorder;narrowmatch
mouse liver disorder;non-neoplastic proliferation of the mouse liver;narrowmatch
mouse cancer-related conditions;non-neoplastic proliferation of the mouse liver;narrowmatch
carbohydrate metabolism pathway;citrate cycle (tca cycle) pathway;narrowmatch
oral cavity leukoplakia;leukoplakia of gingiva;narrowmatch
neurodegenerative disorders pathway;huntington's disease pathway;narrowmatch
carbohydrate metabolism pathway;inositol phosphate metabolism pathway;narrowmatch
signaling pathway;akt signaling pathway;narrowmatch
cell differentiation or development pathway;agrin pathway;narrowmatch
apoptosis regulation pathway;regulation of apoptosis pathway;narrowmatch
cytogenetic abnormality;isochromosome;narrowmatch
residual disease;minimal residual disease;narrowmatch
oral cavity leukoplakia;leukoplakia of tongue;narrowmatch
neurodegenerative disorders pathway;prion disease pathway;narrowmatch
signaling pathway;phosphatidylinositol signaling system pathway;narrowmatch
neurodegenerative disorders pathway;parkinson's disease pathway kegg;narrowmatch
energy metabolism pathway;oxidative phosphorylation pathway;narrowmatch
integumentary system finding;skin cyst;narrowmatch
cyst;skin cyst;narrowmatch
genetic information processing pathway;mrna biosynthesis pathway;narrowmatch
signaling pathway;mapk signaling pathway;narrowmatch
cell motility pathway;focal adhesion pathway;narrowmatch
benign neoplasms of mouse liver;mouse ito cell tumor, benign;narrowmatch
malignant neoplasms of mouse liver;mouse hepatocholangiocellular adenocarcinoma;narrowmatch
benign neoplasms of mouse liver;mouse hepatocholangiocellular adenoma;narrowmatch
neoplastic large b-lymphocyte;neoplastic large b-lymphocyte with pale cytoplasm;narrowmatch
neoplastic large b-lymphocyte;neoplastic immunoblast-like b-lymphocyte;narrowmatch
protein deregulation;alk kinase overexpression;narrowmatch
clinical course of disease;bulky disease;narrowmatch
bone marrow and extramedullary involvement;bone marrow and blood involvement;narrowmatch
defective heavy chain present;defective mu heavy chain present;narrowmatch
abnormal cells present;vacuolated plasma cells in the bone marrow;narrowmatch
negative test result;negative bone marrow and peripheral blood;narrowmatch
atypical lymphocytes present in peripheral blood;prolymphocytes exceed 55 percent of lymphoid cells in the peripheral blood;narrowmatch
morphologic finding;fried-egg appearance of the bone marrow;narrowmatch
abnormal hematology test result;tartrate resistant acid phosphatase positive cells present;narrowmatch
pain;bone pain;narrowmatch
bone marrow and blood involvement;extensive bone marrow and blood involvement;narrowmatch
atypical lymphocytes present in bone marrow;lymphoblasts 25 percent or less of bone marrow nucleated cells;narrowmatch
blasts under 30 percent of bone marrow nucleated cells;lymphoblasts 25 percent or less of bone marrow nucleated cells;narrowmatch
neoplastic t-lymphocyte and neoplastic natural killer cell;neoplastic t-lymphocyte;narrowmatch
peripheral b-lymphocyte;transformed peripheral b-lymphocyte;narrowmatch
body cavity;pericardial cavity;narrowmatch
benign neoplasms of mouse liver;mouse cholangioma;narrowmatch
pain;chest pain;narrowmatch
malignant neoplasms of mouse liver;mouse cholangiocarcinoma;narrowmatch
mouse liver disorder;mouse hepatic system neoplasm;narrowmatch
mouse digestive system neoplasms;mouse hepatic system neoplasm;narrowmatch
defective heavy chain present;defective alpha heavy chain present;narrowmatch
morphologic finding;villous atrophy;narrowmatch
lesion by morphology;lymphoepithelial lesion;narrowmatch
mature b-lymphocyte;marginal zone b-lymphocyte;narrowmatch
neoplastic b-lymphocyte;villous lymphocyte;narrowmatch
morphologic finding;nuclear pleomorphism;narrowmatch
neoplastic b-lymphocyte;neoplastic small b-lymphocyte;narrowmatch
neoplastic small lymphocyte;neoplastic small b-lymphocyte;narrowmatch
abnormal laboratory test result;hyperviscosity;narrowmatch
clinical course of disease;widespread disease;narrowmatch
cellular infiltrate;polymorphic cellular infiltrate;narrowmatch
cellular infiltrate;monomorphic cellular infiltrate;narrowmatch
mature t-lymphocyte;gamma/delta t-lymphocyte;narrowmatch
elevated test result;serum soluble fas ligand level increased;narrowmatch
chemical exposure;drug exposure;narrowmatch
tumor-suppressor gene inactivation;cdk4 gene inactivation;narrowmatch
clinical course of disease;transformed phase of disease;narrowmatch
lesion;exophytic polypoid lesion;narrowmatch
lesion;intraocular lesion;narrowmatch
lesion;primary lesion;narrowmatch
lesion;metastatic lesion;narrowmatch
morphologic finding;morphologic overlap;narrowmatch
lesion;composite lesion;narrowmatch
cdk4 gene mutation;cdk4 gene inactivation;narrowmatch
biochemical reaction;alkylation process;narrowmatch
molecular interaction process;receptor binding;narrowmatch
molecular interaction process;nucleic acid binding;narrowmatch
receptor binding;leukotriene receptor binding;narrowmatch
transport process;ion transport process;narrowmatch
cellular process;ion transport process;narrowmatch
receptor binding;cytokine receptor binding;narrowmatch
molecular interaction process;chelating activity;narrowmatch
neoplastic lymphocyte;transformed neoplastic lymphocyte;narrowmatch
oncogene deregulation;rel gene amplification;narrowmatch
gene amplification abnormality;rel gene amplification;narrowmatch
biochemical process;enzyme activity alteration;narrowmatch
biochemical process;chromatin structural process;narrowmatch
injury;perforation;narrowmatch
cellular process;cytoskeletal process;narrowmatch
cellular process;cell membrane process;narrowmatch
intercellular communication process;intercellular communication induction;narrowmatch
cellular migration process;cell migration inhibition process;narrowmatch
regulation of cell death process;negative regulation of cell death;narrowmatch
regulation of cell death process;positive regulation of cell death;narrowmatch
non-neoplastic soft tissue disorder;xanthoma;narrowmatch
ovarian cyst;ovarian endometriotic cyst;narrowmatch
protein degradation process;protein degradation inhibition;narrowmatch
neoplastic syndrome;ectopic hormone secretion syndrome associated with neoplasia;narrowmatch
endocrine syndrome;ectopic hormone secretion syndrome associated with neoplasia;narrowmatch
lipid metabolic process;eicosanoid modulation;narrowmatch
enzyme activity alteration;enzyme inhibition;narrowmatch
molecular interaction process;antigen binding;narrowmatch
odontogenic cyst;calcifying odontogenic cyst;narrowmatch
transport process;glucose transport induction;narrowmatch
chromosome 7 rearrangement;"t(7;17)(p15;q21)";narrowmatch
connective and soft tissue neoplasm (antiquated);endometrioid stromal sarcoma of the cervix;narrowmatch
dysplasia;cervical glandular dysplasia;narrowmatch
extremity part;digit;narrowmatch
brain part;forebrain;narrowmatch
placental non-neoplastic disorder;non-neoplastic, non-molar trophoblastic disorder;narrowmatch
fusion protein expression;jazf1-suz12 fusion protein expression;narrowmatch
chromosomal translocation;"t(7;17)(p15;q21)";narrowmatch
chromosome 17 abnormality;"t(7;17)(p15;q21)";narrowmatch
tumor-suppressor gene inactivation;tsc1 gene inactivation;narrowmatch
lower abdominal pain;pelvic pain;narrowmatch
epithelial neoplasm (antiquated);ovarian endometrioid adenocarcinofibroma;narrowmatch
ovarian dermoid cyst with secondary pituitary-type tumor;ovarian dermoid cyst with prolactin secreting adenoma;narrowmatch
ovarian dermoid cyst with secondary pituitary-type tumor;ovarian dermoid cyst with corticotropin secreting adenoma;narrowmatch
ovarian dermoid cyst with secondary tumor;ovarian dermoid cyst with secondary pituitary-type tumor;narrowmatch
ovarian leydig cell tumor;ovarian leydig cell tumor, not otherwise specified;narrowmatch
ovarian sex cord-stromal tumor;ovarian sex cord-stromal tumor of mixed or unclassified cell types;narrowmatch
uterine disorder;cervical disorder;narrowmatch
connective and soft tissue neoplasm (antiquated);endometrioid stromal sarcoma of the vagina;narrowmatch
congenital reproductive system abnormality;hypospadias;narrowmatch
penile non-neoplastic disorder;hypospadias;narrowmatch
tsc1 gene mutation;tsc1 gene inactivation;narrowmatch
calcification;cerebral calcification;narrowmatch
skin patch;cafe au lait spot;narrowmatch
gene variant;atm gene mutation;narrowmatch
syndrome;potter syndrome;narrowmatch
gene variant;braf gene mutation;narrowmatch
raf family gene mutation;braf gene mutation;narrowmatch
hamartoma;mesenchymal hamartoma;narrowmatch
mesenchymal hamartoma;cartilaginous hamartoma;narrowmatch
transport pathway;protein cycling pathway;narrowmatch
myoepithelial cell;salivary gland myoepithelial cell;narrowmatch
hemangiopericytoma;breast hemangiopericytoma;narrowmatch
hyperploidy;hypertriploidy;narrowmatch
hypoploidy;hypotriploidy;narrowmatch
congenital urinary system abnormality;hypospadias;narrowmatch
granuloma;lipogranuloma;narrowmatch
signal transduction;signal transduction induction;narrowmatch
tumor vascular invasion;angioinvasion;narrowmatch
leukemic lymphocyte;leukemic natural killer cell;narrowmatch
organ system;hematopoietic and lymphatic system;narrowmatch
epithelial neoplasm (antiquated);intraepidermal epithelioma of jadassohn;narrowmatch
fusion protein expression;evi1-aml1 fusion protein expression;narrowmatch
neoplastic lymphocyte;leukemic lymphocyte;narrowmatch
leukemic cell;leukemic lymphocyte;narrowmatch
leukemic lymphocyte;leukemic plasma cell;narrowmatch
circulating plasma cell;leukemic plasma cell;narrowmatch
neoplastic natural killer cell;leukemic natural killer cell;narrowmatch
multipotent stem cell;multipotent bone marrow stem cell;narrowmatch
leukemic lymphocyte;leukemic medium-sized b-lymphocyte with basophilic cytoplasm;narrowmatch
neoplastic medium-sized b-lymphocyte with basophilic cytoplasm;leukemic medium-sized b-lymphocyte with basophilic cytoplasm;narrowmatch
leukemic lymphocyte;leukemic small lymphocyte with clumped chromatin;narrowmatch
neoplastic small lymphocyte with clumped chromatin;leukemic small lymphocyte with clumped chromatin;narrowmatch
abnormal myeloid cell;neoplastic myeloid cell;narrowmatch
leukemic cell;neoplastic myeloid cell;narrowmatch
bone marrow myeloid stem cell;bone marrow stem cell at the earliest stage of myeloid differentiation;narrowmatch
body part;hematopoietic and lymphatic system part;narrowmatch
tissue;hematopoietic and lymphoid tissue;narrowmatch
blasts under 10 percent of peripheral blood white cells;immature granulocytes in peripheral blood under 10 percent;narrowmatch
monoclonal cellular population present;monoclonal eosinophils present;narrowmatch
gene variant;kras gene mutation;narrowmatch
ras family gene mutation;kras gene mutation;narrowmatch
cardiovascular system finding;electrocardiographic finding;narrowmatch
epithelial neoplasm (antiquated);superficial spreading adenocarcinoma;narrowmatch
epithelial neoplasm (antiquated);pancreatic non-invasive mucinous cystadenocarcinoma;narrowmatch
immature myeloid cells increased in bone marrow;granulocytes increased in bone marrow;narrowmatch
blasts under 15 percent of peripheral blood white cells;blasts under 10 percent of peripheral blood white cells;narrowmatch
bone marrow fibrosis;marked bone marrow fibrosis;narrowmatch
reticulin fibrosis of the bone marrow;minimal reticulin fibrosis of the bone marrow;narrowmatch
morphologic finding;osteosclerosis;narrowmatch
morphologic finding;extramedullary hematopoiesis;narrowmatch
elevated test result;increased red cell mass;narrowmatch
abnormal blood chemistry and hematology test result;increased red cell mass;narrowmatch
crystal formation;charcot-leyden crystals formation;narrowmatch
positive laboratory test result;monoclonal cellular population present;narrowmatch
bone marrow myeloid stem cell;bone marrow stem cell with predominant neutrophil differentiation;narrowmatch
bone marrow stem cell;multipotent bone marrow stem cell;narrowmatch
gastrointestinal polyp;hyperplastic polyp;narrowmatch
immunophenotypic finding;s-100-positive neoplastic cells present;narrowmatch
morphologic finding;germinal centers with prominent hyalinized vessels present;narrowmatch
morphologic finding;reactive germinal centers present;narrowmatch
abnormal macrophage;atypical histiocyte;narrowmatch
pathology result;immunophenotypic finding;narrowmatch
immunophenotypic finding;cd14-positive neoplastic cells present;narrowmatch
cd14 positive;cd14-positive neoplastic cells present;narrowmatch
immunophenotypic finding;cd68-positive neoplastic cells present;narrowmatch
sinus histiocytosis;massive sinusoidal histiocytic infiltrate;narrowmatch
mass;solitary mass;narrowmatch
cellular infiltrate;plasmacytic infiltrate;narrowmatch
grade iii neuroendocrine carcinoma;small cell intermediate cell carcinoma;narrowmatch
lymphadenopathy;cervical lymphadenopathy;narrowmatch
abnormal lymphocyte;abnormal large granular lymphocyte;narrowmatch
morphologic finding;dysplasia;narrowmatch
host defense mechanism;antimicrobial effect;narrowmatch
immune cell activation process;lymphocyte activation process;narrowmatch
abnormal cells present;sheets of interfollicular plasma cells present;narrowmatch
property or attribute;qualifier;narrowmatch
epithelial neoplasm (antiquated);verrucous papilloma;narrowmatch
radiologic finding;osteosclerotic lesion;narrowmatch
immunoglobulin deposition;immunoglobulin heavy chain deposition;narrowmatch
immunoglobulin deposition;immunoglobulin light chain deposition;narrowmatch
deposit;immunoglobulin deposition;narrowmatch
lytic metastatic bone lesion;solitary lytic metastatic bone lesion;narrowmatch
bone lesion;lytic bone lesion;narrowmatch
radiologic finding;lytic bone lesion;narrowmatch
lesion;localized lesion;narrowmatch
neoplastic plasma cells 30 percent or less of bone marrow nucleated cells;neoplastic plasma cells under 20 percent of bone marrow nucleated cells;narrowmatch
plasma cell;bone marrow-homing plasma cell;narrowmatch
neoplastic plasma cells present in bone marrow;neoplastic plasma cells 10 percent or more of bone marrow nucleated cells;narrowmatch
paraproteinemia;monoclonal paraproteinemia present in lower than myeloma levels;narrowmatch
neoplastic plasma cells more than 20 percent of bone marrow nucleated cells;neoplastic plasma cells more than 30 percent of bone marrow nucleated cells;narrowmatch
neoplastic plasma cells 10 percent or more of bone marrow nucleated cells;neoplastic plasma cells between 10 and 30 percent of bone marrow nucleated cells;narrowmatch
neoplastic plasma cells under 20 percent of bone marrow nucleated cells;neoplastic plasma cells under 10 percent of bone marrow nucleated cells;narrowmatch
abnormal bone marrow test result;neoplastic plasma cells present in bone marrow;narrowmatch
chromosomal gain;gain of chromosome 12p;narrowmatch
chromosome 12 abnormality;gain of chromosome 12p;narrowmatch
isochromosome;i(12p);narrowmatch
neoplastic t-lymphocyte;neoplastic t-lymphocyte with clear cytoplasm;narrowmatch
neoplastic t-lymphocyte;signet ring-like neoplastic t-lymphocyte;narrowmatch
anaplastic t-lymphocyte;flower-like t-lymphocyte;narrowmatch
neoplastic small to medium-sized t-lymphocyte;neoplastic small to medium-sized t-lymphocyte with irregular nucleus;narrowmatch
anaplastic t-lymphocyte;doughnut cell;narrowmatch
anaplastic t-lymphocyte;hallmark cell;narrowmatch
neoplastic t-lymphocyte;anaplastic t-lymphocyte;narrowmatch
anaplastic cell;anaplastic t-lymphocyte;narrowmatch
morphologic finding;proliferation of follicular dendritic cells present;narrowmatch
lymphocytic infiltrate;epidermotropic lymphocytic infiltrate;narrowmatch
microvascular proliferation;proliferation of high endothelial venules present;narrowmatch
proteinase inhibitor gene;serpine1 gene;narrowmatch
non-neoplastic skin disorder;erythroderma;narrowmatch
morphologic finding;mucinous degeneration;narrowmatch
tumor-suppressor gene inactivation;cdkn2a gene inactivation;narrowmatch
cdkn2a gene mutation;cdkn2a gene inactivation;narrowmatch
morphologic finding;single cell exocytosis;narrowmatch
activated lymphocyte;activated skin-homing t-lymphocyte;narrowmatch
mature t-lymphocyte;activated skin-homing t-lymphocyte;narrowmatch
mature cytotoxic t-lymphocyte;activated mature cytotoxic t-lymphocyte;narrowmatch
localized lesion;localized skin lesion;narrowmatch
biochemical pathway;cell motility pathway;narrowmatch
metabolic pathway;degradation pathway;narrowmatch
biochemical pathway;disease pathway;narrowmatch
regulatory pathway;cell cycle regulation pathway;narrowmatch
urinary system finding;kidney cyst;narrowmatch
cyst;kidney cyst;narrowmatch
regulatory pathway;apoptosis regulation pathway;narrowmatch
regulatory pathway;immune response regulation pathway;narrowmatch
clinical course of disease;extranodal disease;narrowmatch
mesenchymal differentiation;sarcomatoid features;narrowmatch
regression;complete regression;narrowmatch
regression;partial regression;narrowmatch
integumentary system signs and symptoms;papular lesion;narrowmatch
lesion;papular lesion;narrowmatch
cutaneous involvement;multicentric cutaneous involvement;narrowmatch
morphologic finding;pautrier microabscess present;narrowmatch
clinical course of disease;extracutaneous dissemination of disease;narrowmatch
chromosome 12 abnormality;i(12p);narrowmatch
neoplastic t-lymphocyte;neoplastic medium-sized t-lymphocyte;narrowmatch
neoplastic small lymphocyte;neoplastic small t-lymphocyte;narrowmatch
morphologic finding;pautrier-like microabscess present;narrowmatch
morphologic finding;osteoclastic activity present;narrowmatch
neoplastic medium-sized to large t-lymphocyte;pleomorphic medium-sized to large t-lymphocyte;narrowmatch
pleomorphic t-lymphocyte;pleomorphic medium-sized to large t-lymphocyte;narrowmatch
neoplastic small t-lymphocyte;pleomorphic small t-lymphocyte;narrowmatch
pleomorphic t-lymphocyte;pleomorphic small t-lymphocyte;narrowmatch
neoplastic medium-sized lymphocyte;neoplastic medium-sized t-lymphocyte;narrowmatch
integumentary system signs and symptoms;skin plaque;narrowmatch
pleomorphic t-lymphocyte;polylobated t-lymphocyte;narrowmatch
transcription factor gene;cebpa gene;narrowmatch
serine/threonine protein kinase gene;prkcb gene;narrowmatch
cyclin gene;ccnd2 gene;narrowmatch
integumentary system signs and symptoms;skin rash;narrowmatch
extramedullary involvement;peripheral blood involvement;narrowmatch
digestive system disorder;hepatobiliary disorder;narrowmatch
neoplastic t-lymphocyte;neoplastic small t-lymphocyte;narrowmatch
neoplastic small to medium-sized lymphocyte;neoplastic small to medium-sized t-lymphocyte;narrowmatch
neoplastic t-lymphocyte;neoplastic small to medium-sized t-lymphocyte;narrowmatch
ischemic necrosis;coagulative necrosis;narrowmatch
integumentary system signs and symptoms;skin patch;narrowmatch
lesion;skin patch;narrowmatch
integumentary system signs and symptoms;scaly skin eruption;narrowmatch
neoplastic t-lymphocyte;cerebriform lymphocyte;narrowmatch
lymphadenopathy;dermatopathic lymphadenopathy;narrowmatch
nodule;subcutaneous nodule;narrowmatch
integumentary system finding;subcutaneous involvement;narrowmatch
morphologic finding;karyorrhexis;narrowmatch
morphologic finding;sinusoidal infiltration;narrowmatch
neoplastic t-lymphocyte;neoplastic medium-sized to large t-lymphocyte;narrowmatch
neoplastic medium-sized to large lymphocyte;neoplastic medium-sized to large t-lymphocyte;narrowmatch
intraepithelial t-lymphocyte;intraepithelial t-lymphocyte of the intestine;narrowmatch
intestinal mass;intestinal ulcerated mass;narrowmatch
digestive system perforation;intestinal perforation;narrowmatch
natural killer cell;activated natural killer cell;narrowmatch
biochemical pathway;cell differentiation or development pathway;narrowmatch
biochemical pathway;dna repair pathway;narrowmatch
neoplastic t-lymphocyte;cerebriform-like lymphocyte;narrowmatch
chromosomal loss;loss of chromosome 21;narrowmatch
epithelial neoplasm (antiquated);type 1 renal papillary adenoma;narrowmatch
mass;asymptomatic mass;narrowmatch
fusion protein expression;nono-tfe3 fusion protein expression;narrowmatch
fusion protein expression;psf-tfe3 fusion protein expression;narrowmatch
fusion protein expression;prcc-tfe3 fusion protein expression;narrowmatch
pericentric inversion;"inv(x)(p11;q12)";narrowmatch
hemoglobin trait;sickle cell trait;narrowmatch
chromosomal loss;loss of chromosome 2;narrowmatch
abnormal cells present;confluent sheets of anaplastic t-lymphocytes present;narrowmatch
chromosomal loss;loss of chromosome 14q;narrowmatch
rearrangement of 3q;"t(3;12)(q13;q24)";narrowmatch
chromosomal translocation;"t(3;12)(q13;q24)";narrowmatch
chromosome 12 abnormality;"t(3;12)(q13;q24)";narrowmatch
rearrangement of 6q25;"t(3;6)(p13;q25)";narrowmatch
chromosomal translocation;"t(3;6)(p13;q25)";narrowmatch
chromosomal translocation;"t(3;8)(p14;q24)";narrowmatch
epithelial neoplasm (antiquated);type 2 renal papillary adenoma;narrowmatch
11q translocation;"t(5;11)(q35;q13)";narrowmatch
chromosome 5 rearrangement;"t(5;11)(q35;q13)";narrowmatch
smarcb1 gene mutation;smarcb1 gene inactivation;narrowmatch
chromosomal gain;gain of chromosome y;narrowmatch
thrombocytopenia;thrombocytopenia due to immune destruction;narrowmatch
chromosomal gain;gain of chromosome 18q;narrowmatch
hyperplasia;parathyroid hyperplasia;narrowmatch
gene variant;fgfr3 gene mutation;narrowmatch
fgfr gene mutation;fgfr3 gene mutation;narrowmatch
chromosomal loss;loss of chromosome 9q;narrowmatch
urinary tract precancerous condition;urethral glandular metaplasia;narrowmatch
cystitis cystica and glandularis;cystitis glandularis;narrowmatch
dysplasia;urothelial dysplasia;narrowmatch
urinary tract precancerous condition;intestinal metaplasia of bladder urachal epithelium;narrowmatch
urinary tract precancerous condition;intestinal metaplasia of bladder urothelium;narrowmatch
bladder disorder;intestinal metaplasia of bladder urothelium;narrowmatch
precancerous condition by site;urinary tract precancerous condition;narrowmatch
tumor-suppressor gene inactivation;smarcb1 gene inactivation;narrowmatch
gene variant;met gene mutation;narrowmatch
receptor tyrosine kinase gene mutation;met gene mutation;narrowmatch
neoplastic growth or spread;multiple tumor masses;narrowmatch
metabolic pathway;carbohydrate metabolism pathway;narrowmatch
finding by site or system;immune system finding;narrowmatch
abnormal blood chemistry and hematology test result;defective heavy chain present;narrowmatch
morphologic finding;abundance of small lymphocytes;narrowmatch
reed-sternberg cell;classical reed-sternberg cell;narrowmatch
pdgfr protein overexpression;pdgfralpha protein overexpression;narrowmatch
gene variant;pdgfra gene mutation;narrowmatch
pdgfr family gene mutation;pdgfra gene mutation;narrowmatch
gene variant;mdm2 gene mutation;narrowmatch
protein deregulation;egfr protein overexpression;narrowmatch
immunophenotypic finding;cd30-positive neoplastic cells present;narrowmatch
tnfrsf8 positive;cd30-positive neoplastic cells present;narrowmatch
gene variant;kit gene mutation;narrowmatch
receptor tyrosine kinase gene mutation;kit gene mutation;narrowmatch
protein deregulation;c-kit tyrosine kinase protein overexpression;narrowmatch
integumentary system finding;solitary skin tumor;narrowmatch
immune system finding;immunodeficiency;narrowmatch
metabolic pathway;energy metabolism pathway;narrowmatch
clinical course of disease;bilateral disease;narrowmatch
biochemical pathway;genetic information processing pathway;narrowmatch
polyp;vulvar polyp;narrowmatch
vulvar non-neoplastic disorder;vulvar polyp;narrowmatch
clinical course of disease;non-contiguous disease;narrowmatch
clinical course of disease;contiguous disease;narrowmatch
clinical course of disease;below the diaphragm disease;narrowmatch
clinical course of disease;above the diaphragm disease;narrowmatch
genital leukoplakia;cervical leukoplakia;narrowmatch
clinical course of disease;refractory disease;narrowmatch
atypia;cervical atypia;narrowmatch
neoplastic b-lymphocyte;lymphoblast-like neoplastic b-lymphocyte;narrowmatch
abnormal tissue present;myxoid changes present;narrowmatch
morphologic architectural pattern;fascicular pattern;narrowmatch
negative test result;negative peripheral blood;narrowmatch
disease pathway;infectious disease pathway;narrowmatch
disease pathway;neurodegenerative disorders pathway;narrowmatch
fusion gene;atic/alk fusion gene;narrowmatch
pseudoangiomatoid space formation;morphologic finding;broadmatch
birc3/malt1 fusion gene;fusion gene;broadmatch
mouse thyroid immunoblastic lymphoma;mouse thyroid diffuse large b-cell lymphoma;broadmatch
mouse chondrocyte neoplasm;mouse chondrogenic neoplasm;broadmatch
mouse chondrocyte neoplasm;mouse mesenchymal neoplasm;broadmatch
mouse musculoskeletal system;mouse anatomy concepts;broadmatch
mouse reproductive system;mouse anatomy concepts;broadmatch
mouse thyroid angiosarcoma;mouse thyroid sarcoma;broadmatch
mouse thyroid sarcoma;malignant mouse thyroid neoplasm;broadmatch
mouse thyroid plasmacytoma;malignant mouse thyroid neoplasm;broadmatch
mouse thyroid diffuse large b-cell lymphoma;mouse thyroid non-hodgkin's lymphoma;broadmatch
mouse follicular thyroid carcinoma;well-differentiated mouse thyroid carcinoma;broadmatch
mouse thyroid non-hodgkin's lymphoma;mouse thyroid lymphoma;broadmatch
mouse thyroid hodgkin's lymphoma;mouse thyroid lymphoma;broadmatch
mouse thyroid lymphoma;malignant mouse thyroid neoplasm;broadmatch
mouse papillary and follicular adenocarcinoma;well-differentiated mouse thyroid carcinoma;broadmatch
mouse follicular variant papillary carcinoma;mouse papillary thyroid carcinoma;broadmatch
mouse papillary thyroid carcinoma;well-differentiated mouse thyroid carcinoma;broadmatch
mouse hurthle cell carcinoma of the thyroid;well-differentiated mouse thyroid carcinoma;broadmatch
mouse chondrogenic neoplasm;mouse connective and soft tissue neoplasms;broadmatch
mouse gastric neoplasm;mouse gastrointestinal system neoplasms;broadmatch
benign mouse gastric neoplasm;mouse gastric neoplasm;broadmatch
benign mouse gastric gastrointestinal stromal neoplasm;benign mouse gastric neoplasm;broadmatch
malignant mouse gastric gastrointestinal stromal tumor;mouse gastric gastrointestinal stromal tumor;broadmatch
mouse gastric gastrointestinal stromal tumor;mouse gastric mesenchymal neoplasm;broadmatch
mouse gastric mesenchymal neoplasm;mouse gastric neoplasm;broadmatch
immature mouse gastric teratoma;mouse gastric teratoma;broadmatch
immature mouse gastric teratoma;malignant mouse gastric germ cell neoplasm;broadmatch
malignant mouse gastric germ cell neoplasm;malignant mouse gastric neoplasm;broadmatch
malignant mouse gastric germ cell neoplasm;mouse gastric germ cell neoplasm;broadmatch
mouse gastric germ cell neoplasm;mouse gastric neoplasm;broadmatch
mouse gastric lipoma;benign mouse gastric neoplasm;broadmatch
mouse gastric epithelioid leiomyoma;mouse gastric leiomyoma;broadmatch
mouse gastric leiomyoma;mouse gastric mesenchymal neoplasm;broadmatch
mouse gastric leiomyoma;benign mouse gastric neoplasm;broadmatch
mouse gastric hamartoma;benign mouse gastric neoplasm;broadmatch
benign mouse gastric granular cell tumor;benign mouse gastric neoplasm;broadmatch
benign mouse gastric gastrointestinal stromal neoplasm;mouse gastric gastrointestinal stromal tumor;broadmatch
mouse trabecular follicular adenocarcinoma;mouse follicular thyroid carcinoma;broadmatch
well-differentiated mouse thyroid carcinoma;mouse thyroid carcinoma;broadmatch
mouse gastric hemangioma;mouse gastric mesenchymal neoplasm;broadmatch
mouse gallbladder neoplasm;mouse digestive system neoplasms;broadmatch
mouse gallbladder lymphoma;malignant mouse gallbladder neoplasm;broadmatch
mouse gallbladder carcinosarcoma;malignant mouse gallbladder neoplasm;broadmatch
mouse gallbladder small cell gallbladder;mouse gallbladder carcinoma;broadmatch
mouse gallbladder squamous cell gallbladder;mouse gallbladder carcinoma;broadmatch
mouse gallbladder adenocarcinoma;mouse gallbladder carcinoma;broadmatch
mouse gallbladder carcinoma;malignant mouse gallbladder neoplasm;broadmatch
malignant mouse gallbladder neoplasm;mouse gallbladder neoplasm;broadmatch
malignant mouse skeletal muscle neoplasm;malignant mouse muscle neoplasm;broadmatch
recurrent mouse thyroid carcinoma;mouse thyroid carcinoma;broadmatch
malignant mouse smooth muscle neoplasm;malignant mouse muscle neoplasm;broadmatch
malignant mouse muscle neoplasm;mouse myomatous neoplasm;broadmatch
mouse myomatous neoplasm;mouse soft tissue neoplasm;broadmatch
mouse soft tissue neoplasm;mouse connective and soft tissue neoplasms;broadmatch
mouse soft tissue neoplasm;mouse mesenchymal neoplasm;broadmatch
malignant mouse lipomatous neoplasm;mouse lipomatous neoplasm;broadmatch
mouse lipomatous neoplasm;mouse connective and soft tissue neoplasms;broadmatch
mouse gallbladder mucosa associated lymphoid tissue lymphoma;mouse gallbladder lymphoma;broadmatch
mouse gallbladder melanoma;malignant mouse gallbladder neoplasm;broadmatch
mouse gallbladder sarcoma;malignant mouse gallbladder neoplasm;broadmatch
mouse gallbladder angiosarcoma;mouse gallbladder sarcoma;broadmatch
poorly differentiated mouse thyroid carcinoma;mouse thyroid carcinoma;broadmatch
mouse medullary thyroid carcinoma with amyloid stroma;mouse medullary thyroid carcinoma;broadmatch
mouse medullary thyroid carcinoma;mouse thyroid carcinoma;broadmatch
mouse anaplastic small cell thyroid carcinoma;mouse anaplastic thyroid carcinoma;broadmatch
mouse anaplastic giant cell thyroid carcinoma;mouse anaplastic thyroid carcinoma;broadmatch
mouse anaplastic thyroid carcinoma;mouse thyroid carcinoma;broadmatch
mouse thyroid carcinoma;malignant mouse thyroid neoplasm;broadmatch
metastasis to the mouse thyroid;malignant mouse thyroid neoplasm;broadmatch
malignant mouse thyroid neoplasm;mouse thyroid neoplasm;broadmatch
mouse thyroid neoplasm;mouse endocrine gland system neoplasms;broadmatch
metastatic neoplasm to the mouse gallbladder;malignant mouse gallbladder neoplasm;broadmatch
rhabdomyosarcoma of the mouse gallbladder;mouse gallbladder sarcoma;broadmatch
mouse gallbladder malignant fibrous histiocytoma;mouse gallbladder sarcoma;broadmatch
mouse gallbladder leiomyosarcoma;mouse gallbladder sarcoma;broadmatch
mouse gallbladder kaposi's sarcoma;mouse gallbladder sarcoma;broadmatch
malignant mouse gastric gastrointestinal stromal tumor;malignant mouse gastric neoplasm;broadmatch
mouse gastric inflammatory myofibroblastic neoplasm;mouse gastric mesenchymal neoplasm;broadmatch
mouse connective and soft tissue neoplasms;mouse connective and soft tissue disorder;broadmatch
nup214 gene;nucleoporin gene;broadmatch
pparg gene;nuclear receptor gene;broadmatch
pml gene;transcription factor gene;broadmatch
pdgfrb gene;receptor tyrosine kinase gene;broadmatch
pdgfra gene;receptor tyrosine kinase gene;broadmatch
pax7 gene;transcription factor gene;broadmatch
pax5 gene;transcription factor gene;broadmatch
pax3 gene;transcription factor gene;broadmatch
numa1 gene;regulatory gene;broadmatch
gli1 gene;gli family gene;broadmatch
ntrk3 gene;receptor tyrosine kinase gene;broadmatch
notch1 gene;receptor gene;broadmatch
mme gene;metallopeptidase gene;broadmatch
afdn gene;cytoskeletal gene;broadmatch
mllt3 gene;transcription factor gene;broadmatch
aff1 gene;transcription factor gene;broadmatch
mllt1 gene;transcription factor gene;broadmatch
wwtr1 gene;transcription coactivator gene;broadmatch
tcf3 gene;transcription factor gene;broadmatch
tfe3 gene;transcription factor gene;broadmatch
usp6 gene;cysteine peptidase gene;broadmatch
leukemic cell;neoplastic hematopoietic and lymphoid cell;broadmatch
leukemic cell;malignant cell;broadmatch
condition;general qualifier;broadmatch
body cavity;anatomic structure, system, or substance;broadmatch
anal margin;body region;broadmatch
chest;body region;broadmatch
description;document;broadmatch
paraaortic region;body region;broadmatch
hairy cell;leukemic lymphocyte;broadmatch
hairy cell;neoplastic b-lymphocyte;broadmatch
record;conceptual entity;broadmatch
genitalia;reproductive system part;broadmatch
appetite;organismal process;broadmatch
14q32.33;chromosome band;broadmatch
usp8 gene;cysteine peptidase gene;broadmatch
jak2 gene;non-receptor tyrosine kinase gene;broadmatch
foxo1 gene;transcription factor gene;broadmatch
mouse gastric liposarcoma;mouse gastric mesenchymal neoplasm;broadmatch
malignant mouse gastric neoplasm;mouse gastric neoplasm;broadmatch
mouse gastric fundus carcinoma;mouse gastric carcinoma;broadmatch
mouse gastric cardia carcinoma;mouse gastric carcinoma;broadmatch
mouse gastric body carcinoma;mouse gastric carcinoma;broadmatch
mouse gastric adenosquamous carcinoma;mouse gastric carcinoma;broadmatch
mouse gastric adenocarcinoma;mouse gastric carcinoma;broadmatch
carcinoma in situ of the mouse antrum;mouse gastric carcinoma;broadmatch
mouse gastric carcinoma;malignant mouse gastric neoplasm;broadmatch
mature mouse gastric teratoma;mouse gastric teratoma;broadmatch
flt3 gene;growth factor receptor gene;broadmatch
mouse gastric teratoma;mouse gastric neoplasm;broadmatch
mouse gastric small cell carcinoma;mouse gastric carcinoma;broadmatch
mouse gastric small cell carcinoma;mouse gastric neuroendocrine neoplasm;broadmatch
mouse gastric carcinoid neoplasm;mouse gastric neuroendocrine neoplasm;broadmatch
mouse gastric neuroendocrine neoplasm;mouse gastric neoplasm;broadmatch
malignant mouse gastric fibrous histocytoma;mouse gastric mesenchymal neoplasm;broadmatch
mouse gastric xanthoma;mouse gastric mesenchymal neoplasm;broadmatch
mouse gastric kaposi's sarcoma;mouse gastric carcinoma;broadmatch
mouse gastric pylorus carcinoma;mouse gastric carcinoma;broadmatch
mouse gastric squamous cell carcinoma;mouse gastric carcinoma;broadmatch
recurrent mouse gastric cancer;mouse gastric carcinoma;broadmatch
flt3 gene;receptor tyrosine kinase gene;broadmatch
fgfr3 gene;fibroblast growth factor receptor family gene;broadmatch
etv4 gene;ets family gene;broadmatch
etv1 gene;ets family gene;broadmatch
dek gene;regulatory gene;broadmatch
bcl6 gene;transcription regulation gene;broadmatch
mouse gastric carcinosarcoma;mixed malignant mouse gastric neoplasm;broadmatch
mixed malignant mouse gastric neoplasm;malignant mouse gastric neoplasm;broadmatch
malignant mouse gastric granular cell tumor;malignant mouse gastric neoplasm;broadmatch
mouse barrett's adenocarcinoma;malignant mouse gastric cardio-esophageal junction neoplasm;broadmatch
malignant mouse gastric cardio-esophageal junction neoplasm;malignant mouse gastric neoplasm;broadmatch
secondary mouse gastric non-hodgkin's lymphoma;mouse gastric lymphoma;broadmatch
primary mouse gastric non-hodgkin's lymphoma;mouse gastric lymphoma;broadmatch
mouse gastric hodgkin's lymphoma;mouse gastric lymphoma;broadmatch
mouse gastric lymphoma;malignant mouse gastric neoplasm;broadmatch
mouse lipomatous neoplasm;mouse mesenchymal neoplasm;broadmatch
mouse connective and soft tissue neoplasms;mouse neoplasms by location;broadmatch
carcinoid tumor of the mouse larynx;neuroendocrine neoplasms of the mouse larynx;broadmatch
mouse neural cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse adenocarcinoma;mouse carcinoma;broadmatch
mouse carcinoma;mouse epithelial cell neoplasms;broadmatch
mouse carcinoma;mouse neoplasms by morphology;broadmatch
mouse adenoma;mouse benign epithelial neoplasm;broadmatch
mouse adenoma;mouse neoplasms by morphology;broadmatch
mouse transitional cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse plasma cell dyscrasia;mouse plasma cell neoplasm;broadmatch
mouse myeloid cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse acinar cell neoplasm;mouse epithelial cell neoplasms;broadmatch
mouse monocyte neoplasm;mouse neoplasms by cell type;broadmatch
mouse mesenchymal neoplasm;mouse neoplasms by cell type;broadmatch
mouse melanocyte neoplasm;mouse epithelial cell neoplasms;broadmatch
mouse lymph cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse granulosa cell tumor;mouse neoplasms by cell type;broadmatch
mouse germ cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse epithelial cell neoplasms;mouse neoplasms by cell type;broadmatch
mouse squamous cell neoplasm;mouse epithelial cell neoplasms;broadmatch
mouse adenosquamous carcinoma;mouse carcinoma;broadmatch
mouse adenosquamous carcinoma;mouse squamous cell neoplasm;broadmatch
mouse benign epithelial neoplasm;mouse epithelial cell neoplasms;broadmatch
mouse reproductive system neoplasms;mouse reproductive system disorder;broadmatch
mouse reproductive system neoplasms;mouse genitourinary neoplasms;broadmatch
mouse genitourinary neoplasms;mouse neoplasms by location;broadmatch
mouse gastrointestinal system neoplasms;mouse digestive system neoplasms;broadmatch
mouse synovial sarcoma;mouse sarcoma;broadmatch
mouse rhabdomyosarcoma;malignant mouse skeletal muscle neoplasm;broadmatch
mouse rhabdomyosarcoma;mouse sarcoma;broadmatch
mouse osteosarcoma;mouse sarcoma;broadmatch
mouse leiomyosarcoma;mouse sarcoma;broadmatch
mouse kaposi's sarcoma;mouse sarcoma;broadmatch
mouse chondrosarcoma;mouse chondrocyte neoplasm;broadmatch
mouse chondrosarcoma;mouse sarcoma;broadmatch
mouse fibrosarcoma;mouse sarcoma;broadmatch
mouse angiosarcoma;mouse sarcoma;broadmatch
mouse papilloma;mouse benign epithelial neoplasm;broadmatch
mouse ductal cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse neoplasms by morphology;mouse neoplasms by histopathology;broadmatch
mouse male reproductive system neoplasms;mouse male reproductive system disorder;broadmatch
basal cell adenoma of the mouse salivary glands;monomorphic adenoma of the mouse salivary glands;broadmatch
carcinoma of the mouse salivary glands;epithelial neoplasms of the mouse salivary glands;broadmatch
high grade mucoepidermoid tumor of the mouse salivary glands;mucoepidermoid tumor of the mouse salivary glands;broadmatch
low grade mucoepidermoid tumor of the mouse salivary glands;mucoepidermoid tumor of the mouse salivary glands;broadmatch
mucoepidermoid tumor of the mouse salivary glands;adenoma of the mouse salivary glands;broadmatch
myoepithelioma of the mouse salivary glands;adenoma of the mouse salivary glands;broadmatch
sebaceous lymphadenoma of the mouse salivary glands;monomorphic adenoma of the mouse salivary glands;broadmatch
clear cell adenoma of the mouse salivary glands;monomorphic adenoma of the mouse salivary glands;broadmatch
warthin's tumor of the mouse salivary glands;monomorphic adenoma of the mouse salivary glands;broadmatch
mouse neoplasms by cell type;mouse neoplasms by histopathology;broadmatch
oxyphilic adenoma of the mouse salivary glands;monomorphic adenoma of the mouse salivary glands;broadmatch
monomorphic adenoma of the mouse salivary glands;adenoma of the mouse salivary glands;broadmatch
carcinoma in pleomorphic adenoma of the mouse salivary glands;pleomorphic adenoma of the mouse salivary glands;broadmatch
pleomorphic adenoma of the mouse salivary glands;adenoma of the mouse salivary glands;broadmatch
adenoma of the mouse salivary glands;epithelial neoplasms of the mouse salivary glands;broadmatch
epithelial neoplasms of the mouse salivary glands;mouse salivary gland neoplasms;broadmatch
mouse salivary gland neoplasms;mouse digestive system neoplasms;broadmatch
acinic cell carcinoma of the mouse salivary glands;carcinoma of the mouse salivary glands;broadmatch
adenoid cystic carcinoma of the mouse salivary glands;carcinoma of the mouse salivary glands;broadmatch
papillary adenocarcinoma of the mouse salivary glands;carcinoma of the mouse salivary glands;broadmatch
squamous cell carcinoma of the mouse salivary glands;carcinoma of the mouse salivary glands;broadmatch
mouse neoplasms by location;mouse neoplasms;broadmatch
mouse neoplasms by histopathology;mouse neoplasms;broadmatch
mouse metastatic neoplasms;mouse neoplasms;broadmatch
mouse precancerous conditions;mouse cancer-related conditions;broadmatch
mouse noncancerous conditions;mouse cancer-related conditions;broadmatch
mouse neoplasms;murine experimental organism diagnosis;broadmatch
mouse cancer-related conditions;murine experimental organism diagnosis;broadmatch
plasmacytoma of the mouse salivary glands;plasma cell neoplasms of the mouse salivary glands;broadmatch
plasma cell neoplasms of the mouse salivary glands;mouse salivary gland neoplasms;broadmatch
lymphoma of the mouse salivary glands;lymphoproliferative neoplasms of the mouse salivary glands;broadmatch
lymphoma of the mouse salivary glands;mouse lymphoma;broadmatch
lymphoproliferative neoplasms of the mouse salivary glands;mouse salivary gland neoplasms;broadmatch
hematopoietic neoplasms of the mouse salivary glands;mouse salivary gland neoplasms;broadmatch
metastatic carcinoma of the mouse salivary glands;carcinoma of the mouse salivary glands;broadmatch
adenocarcinoma of the mouse salivary glands;carcinoma of the mouse salivary glands;broadmatch
mouse male reproductive system neoplasms;mouse reproductive system neoplasms;broadmatch
mouse female reproductive system neoplasms;mouse reproductive system neoplasms;broadmatch
mouse placental choriocarcinoma;malignant mouse placental neoplasm;broadmatch
metastatic carcinoma to the mouse uterine cervix;metastasis to the mouse cervix;broadmatch
mouse endometrial mucinous adenocarcinoma;mouse endometrial adenocarcinoma;broadmatch
mouse endometrial endometrioid adenocarcinoma;mouse endometrial adenocarcinoma;broadmatch
mouse endometrial clear cell adenocarcinoma;mouse endometrial adenocarcinoma;broadmatch
mouse endometrial adenocarcinoma with squamous metaplasia;mouse endometrial adenocarcinoma;broadmatch
mouse endometrial adenocarcinoma;mouse endometrial carcinoma;broadmatch
mouse endometrial carcinoma;malignant mouse uterine corpus neoplasm;broadmatch
malignant mouse uterine corpus neoplasm;malignant mouse uterine neoplasms;broadmatch
metastasis to the mouse cervix;malignant mouse cervical neoplasm;broadmatch
mouse endocervical carcinoma;mouse cervical carcinoma;broadmatch
malignant mouse exocervical neoplasm;malignant mouse cervical neoplasm;broadmatch
malignant mouse endocervical neoplasm;malignant mouse cervical neoplasm;broadmatch
undifferentiated mouse cervical carcinoma;mouse cervical carcinoma;broadmatch
mouse recurrent cervical carcinoma;mouse cervical carcinoma;broadmatch
mouse infiltrating cervical carcinoma;mouse cervical carcinoma;broadmatch
mouse exocervical carcinoma;malignant mouse exocervical neoplasm;broadmatch
mouse exocervical carcinoma;mouse cervical carcinoma;broadmatch
serous carcinoma of the mouse endometrium;mouse endometrial adenocarcinoma;broadmatch
papillary serous carcinoma of the mouse endometrium;serous carcinoma of the mouse endometrium;broadmatch
mouse endometrial mixed carcinoma;mouse endometrial carcinoma;broadmatch
mouse endometrial mixed carcinoma;malignant mouse uterine corpus mixed neoplasm;broadmatch
metastasis to the mouse placenta;malignant mouse placental neoplasm;broadmatch
malignant mouse placental neoplasm;mouse female reproductive system neoplasms;broadmatch
recurrent mouse uterine sarcoma;mouse endometrial stromal sarcoma;broadmatch
mouse endometrial stromal sarcoma;mouse uterine sarcoma;broadmatch
mouse uterine sarcoma;malignant mouse uterine corpus neoplasm;broadmatch
mouse uterine gestational choriocarcinoma;mouse uterine choriocarcinoma;broadmatch
mouse uterine choriocarcinoma;malignant mouse uterine corpus neoplasm;broadmatch
mouse uterine mullerian adenosarcoma;malignant mouse uterine corpus mixed neoplasm;broadmatch
mouse uterine malignant mixed mesodermal (mullerian) tumor;malignant mouse uterine corpus mixed neoplasm;broadmatch
malignant mouse uterine corpus mixed neoplasm;malignant mouse uterine corpus neoplasm;broadmatch
undifferentiated mouse endometrial carcinoma;mouse endometrial carcinoma;broadmatch
recurrent mouse endometrial carcinoma;recurrent malignant mouse endometrial neoplasm;broadmatch
recurrent malignant mouse endometrial neoplasm;mouse endometrial carcinoma;broadmatch
mouse endometrial squamous cell carcinoma;mouse endometrial carcinoma;broadmatch
mouse endometrial adenosquamous carcinoma;mouse endometrial mixed carcinoma;broadmatch
mouse endocervical carcinoma;malignant mouse endocervical neoplasm;broadmatch
mouse cervical squamous cell carcinoma;mouse cervical carcinoma;broadmatch
mouse female reproductive system neoplasms;mouse female reproductive system disorder;broadmatch
mouse biliary tract;mouse digestive system;broadmatch
mouse fallopian tube clear cell adenocarcinoma;mouse fallopian tube adenocarcinoma;broadmatch
mouse fallopian tube adenocarcinoma;mouse fallopian tube carcinoma;broadmatch
mouse fallopian tube carcinoma;malignant mouse fallopian tube neoplasm;broadmatch
malignant mouse fallopian tube neoplasm;mouse fallopian tube neoplasm;broadmatch
benign mouse fallopian tube neoplasm;mouse fallopian tube neoplasm;broadmatch
mouse fallopian tube neoplasm;mouse female reproductive system neoplasms;broadmatch
mouse pancreas;mouse digestive system;broadmatch
mouse special sense organ neoplasms;mouse neoplasms by location;broadmatch
mouse cervical small cell carcinoma;mouse cervical carcinoma;broadmatch
tumors of the mouse pulmonary system;epithelial proliferative lesions of the mouse pulmonary system;broadmatch
tumors of the mouse pulmonary system;mouse neoplasms by location;broadmatch
mouse pituitary gland neoplasms;mouse endocrine gland system neoplasms;broadmatch
mouse adrenal gland neoplasms;mouse endocrine gland system neoplasms;broadmatch
mouse integumentary system neoplasms;mouse neoplasms by location;broadmatch
mouse digestive system neoplasms;mouse digestive system disorder;broadmatch
mouse digestive system neoplasms;mouse neoplasms by location;broadmatch
mouse fallopian tube endometrioid adenocarcinoma;mouse fallopian tube adenocarcinoma;broadmatch
mouse fallopian tube mucinous adenocarcinoma;mouse fallopian tube adenocarcinoma;broadmatch
mouse fallopian tube papillary adenocarcinoma;mouse fallopian tube adenocarcinoma;broadmatch
mouse fallopian tube serous adenocarcinoma;mouse fallopian tube adenocarcinoma;broadmatch
mouse cervical adenosquamous cell carcinoma;mouse cervical carcinoma;broadmatch
mouse cervical adenoid cystic carcinoma;mouse cervical carcinoma;broadmatch
mouse uterine cervix endometrioid adenocarcinoma;mouse cervical adenocarcinoma;broadmatch
mouse uterine cervix clear cell adenocarcinoma;mouse cervical adenocarcinoma;broadmatch
mouse mesonephric adenocarcinoma;mouse cervical adenocarcinoma;broadmatch
mouse cervical adenocarcinoma in situ;mouse cervical adenocarcinoma;broadmatch
mouse cervical adenocarcinoma;mouse cervical carcinoma;broadmatch
mouse cervical carcinoma;malignant mouse cervical neoplasm;broadmatch
malignant mouse cervical neoplasm;malignant mouse uterine neoplasms;broadmatch
malignant mouse uterine neoplasms;mouse female reproductive system neoplasms;broadmatch
undifferentiated mouse fallopian tube carcinoma;mouse fallopian tube carcinoma;broadmatch
mouse fallopian tube squamous cell carcinoma;mouse fallopian tube carcinoma;broadmatch
mouse fallopian tube gestational choriocarcinoma;mouse fallopian tube carcinoma;broadmatch
fallopian tube papillary serous adenocarcinoma of mouse;mouse fallopian tube serous adenocarcinoma;broadmatch
fallopian tube papillary serous adenocarcinoma of mouse;mouse fallopian tube papillary adenocarcinoma;broadmatch
nevus cell;neoplastic melanocyte;broadmatch
cardiovascular system part;body part;broadmatch
digestive system part;body part;broadmatch
turner syndrome;gonadal dysgenesis;broadmatch
vaginal disorder;female reproductive system disorder;broadmatch
uveal disorder;eye disorder;broadmatch
uterine disorder;female reproductive system disorder;broadmatch
urinary frequency;genitourinary signs and symptoms;broadmatch
urinary frequency;urinary system finding;broadmatch
urethra disorder;urinary system disorder;broadmatch
erythema;skin discoloration;broadmatch
turner syndrome;rare non-neoplastic disorder;broadmatch
thrombosis;non-neoplastic vascular disorder;broadmatch
turner syndrome;non-neoplastic endocrine disorder;broadmatch
turner syndrome;endocrine syndrome;broadmatch
pulmonary tuberculosis;tuberculosis;broadmatch
pulmonary tuberculosis;infectious lung disorder;broadmatch
thyroiditis;non-neoplastic thyroid gland disorder;broadmatch
thyroiditis;non-neoplastic endocrine disorder;broadmatch
thyroid gland disorder;neck disorder;broadmatch
vasculitis;vascular disorder;broadmatch
lymphosarcoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
liver failure;non-neoplastic liver and intrahepatic bile duct disorder;broadmatch
hypogammaglobulinemia;deficiency of humoral immunity;broadmatch
female reproductive system disorder;reproductive system disorder;broadmatch
male reproductive system disorder;reproductive system disorder;broadmatch
chronic cystitis;cystitis;broadmatch
external ear disorder;ear disorder;broadmatch
thymus disorder;thoracic disorder;broadmatch
hodgkin's paragranuloma involving spleen;hodgkin's lymphoma (antiquated);broadmatch
lymphosarcoma involving spleen;lymphosarcoma;broadmatch
reticulosarcoma involving spleen;reticulosarcoma;broadmatch
hodgkin's paragranuloma;hodgkin's lymphoma (antiquated);broadmatch
hypoglossal nerve disorder;cranial nerve disorder;broadmatch
accessory nerve disorder;cranial nerve disorder;broadmatch
trigeminal nerve disorder;cranial nerve disorder;broadmatch
polyneuropathy;neuropathy;broadmatch
vaginal hemorrhage;reproductive system hemorrhage;broadmatch
vaginal hemorrhage;female reproductive system finding;broadmatch
thymic cyst;mediastinal cyst;broadmatch
testicular disorder;male reproductive system disorder;broadmatch
eosinophilic endomyocardial disease;non-neoplastic heart disorder;broadmatch
mycobacterial infection;bacterial infection;broadmatch
pancreatic disorder;digestive system disorder;broadmatch
ovarian disorder;female reproductive system disorder;broadmatch
osteomalacia;metabolic bone disorder;broadmatch
osteogenesis imperfecta;col1a1 associated connective tissue disorder;broadmatch
osteogenesis imperfecta;non-neoplastic bone disorder;broadmatch
nutritional disorder;metabolic disorder;broadmatch
nervous system disorder;disorder by site;broadmatch
menorrhagia;menstrual disorder;broadmatch
stomach disorder;digestive system disorder;broadmatch
mediastinal disorder;thoracic disorder;broadmatch
lip disorder;oral disorder;broadmatch
lichen sclerosus et atrophicus;dermatitis;broadmatch
leukopenia;cytopenia;broadmatch
acute eosinophilic leukemia;leukemia (antiquated);broadmatch
laryngeal disorder;neck disorder;broadmatch
laryngeal disorder;otolaryngologic disorder;broadmatch
paranasal sinus disorder;sinonasal disorder;broadmatch
parathyroid gland disorder;neck disorder;broadmatch
penile disorder;male reproductive system disorder;broadmatch
peritoneal disorder;peritoneal and retroperitoneal disorder;broadmatch
sjogren syndrome;autoimmune disease;broadmatch
sjogren syndrome;syndrome;broadmatch
salivary gland disorder;head and neck disorder;broadmatch
retinal disorder;eye disorder;broadmatch
infectious lung disorder;infectious disorder by site;broadmatch
infectious lung disorder;non-neoplastic lung disorder;broadmatch
respiratory system disorder;respiratory and thoracic disorder;broadmatch
prostate disorder;male reproductive system disorder;broadmatch
polycythemia;hematologic and lymphocytic disorder;broadmatch
pleural disorder;thoracic disorder;broadmatch
placenta disorder;pregnancy disorder;broadmatch
pituitary gland disorder;head and neck disorder;broadmatch
pharyngeal disorder;neck disorder;broadmatch
pharyngeal disorder;otolaryngologic disorder;broadmatch
peritonitis;non-neoplastic peritoneal disorder;broadmatch
soft tissue disorder;connective and soft tissue disorder;broadmatch
rectal hemorrhage;lower gastrointestinal hemorrhage;broadmatch
cervical neck region;spinal region;broadmatch
hodgkin's disease, nodular sclerosis, lymphocyte predominance;hodgkin's lymphoma (antiquated);broadmatch
peritoneal and retroperitoneal hemorrhage;hemorrhage;broadmatch
positive lymph node;positive laboratory test result;broadmatch
l1 acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
l2 acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
adult l1 acute lymphoblastic leukemia;l1 acute lymphoblastic leukemia;broadmatch
malignant lymphoma, large cell, cleaved and non-cleaved;malignant lymphoma, large cell type;broadmatch
intermediate risk gastrointestinal stromal tumor;connective and soft tissue neoplasm (antiquated);broadmatch
lymphoma by stage;lymphoma;broadmatch
malignant lymphoma, non-cleaved cell type;malignant lymphoma by cell type (working formulation);broadmatch
lymphoma/leukemia by kiel classification (antiquated);hematopoietic and lymphoid neoplasm (antiquated);broadmatch
malignant lymphoma, non-cleaved, diffuse;diffuse malignant lymphoma;broadmatch
malignant lymphoma, non-cleaved, diffuse;malignant lymphoma, non-cleaved cell type;broadmatch
malignant lymphoma, large cell, cleaved;malignant non-hodgkin lymphoma, cleaved cell;broadmatch
spindle cell neoplasm;neoplasm by special category;broadmatch
pre t-all;leukemia (antiquated);broadmatch
dendritic cell tumor, not otherwise specified;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
stage i centroblastic follicular lymphoma;malignant lymphoma centroblastic, follicular;broadmatch
stage ii centroblastic follicular lymphoma;malignant lymphoma centroblastic, follicular;broadmatch
immune system and related disorders;disorder by site;broadmatch
peripheral t-cell lymphoma, large cell;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
non-neoplastic digestive system disorder;digestive system disorder;broadmatch
classic type trichoepithelioma;epithelial neoplasm (antiquated);broadmatch
lipomatous hemangiopericytoma;benign hemangiopericytoma;broadmatch
infantile hemangiopericytoma;benign hemangiopericytoma;broadmatch
"t(11;14)(q13;q32)";ccnd1 gene translocation;broadmatch
mesenchymal extraskeletal chondrosarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
paraproteinemia;abnormal blood chemistry and hematology test result;broadmatch
intermediate risk gastric gastrointestinal stromal tumor;intermediate risk gastrointestinal stromal tumor;broadmatch
intermediate risk small intestinal gastrointestinal stromal tumor;intermediate risk gastrointestinal stromal tumor;broadmatch
intermediate risk esophageal gastrointestinal stromal tumor;intermediate risk gastrointestinal stromal tumor;broadmatch
high risk esophageal gastrointestinal stromal tumor;high risk gastrointestinal stromal tumor;broadmatch
low risk esophageal gastrointestinal stromal tumor;low risk gastrointestinal stromal tumor;broadmatch
pituitary gland basophil carcinoma;pituitary gland neoplasm (antiquated);broadmatch
philadelphia chromosome negative bcr-abl1 negative chronic myelogenous leukemia;leukemia (antiquated);broadmatch
leukemia (antiquated);hematopoietic and lymphoid neoplasm (antiquated);broadmatch
malignant non-hodgkin's lymphoma, diffuse, lymphocytic, poorly differentiated;diffuse malignant lymphoma;broadmatch
non-hodgkin's lymphoma, lymphoblastic (wf);lymphoma by working formulation (antiquated);broadmatch
middle ear disorder;ear disorder;broadmatch
nasal cavity disorder;sinonasal disorder;broadmatch
sebaceous hyperplasia;hyperplasia;broadmatch
ureter disorder;urinary system disorder;broadmatch
t-cell immunodeficiency;immunodeficiency syndrome;broadmatch
peritoneal hemorrhage;intra-abdominal hemorrhage;broadmatch
peritoneal hemorrhage;peritoneal and retroperitoneal hemorrhage;broadmatch
endemic burkitt lymphoma;ebv-related burkitt lymphoma;broadmatch
helicobacter pylori-associated gastritis;gastritis;broadmatch
malignant lymphoma, histiocytic, diffuse;malignant lymphoma, large cell type;broadmatch
high risk small intestinal gastrointestinal stromal tumor;high risk gastrointestinal stromal tumor;broadmatch
malignant lymphoma, histiocytic, diffuse;diffuse malignant lymphoma;broadmatch
hodgkin's disease, nodular sclerosis, mixed cellularity;hodgkin's lymphoma (antiquated);broadmatch
small cell carcinoma, fusiform cell type;grade iii neuroendocrine carcinoma;broadmatch
malignant spindle cell neoplasm;spindle cell neoplasm;broadmatch
degenerative disorder;non-neoplastic disorder by special category;broadmatch
endocrine pancreas disorder;endocrine system disorder;broadmatch
endocrine pancreas disorder;pancreatic disorder;broadmatch
respiratory distress;ventilation or perfusion signs and symptoms;broadmatch
inner ear disorder;ear disorder;broadmatch
secondary polycythemia;polycythemia (excluding polycythemia vera);broadmatch
hashimoto thyroiditis;autoimmune disease;broadmatch
low risk small intestinal gastrointestinal stromal tumor;low risk gastrointestinal stromal tumor;broadmatch
high risk gastrointestinal stromal tumor;connective and soft tissue neoplasm (antiquated);broadmatch
low risk gastrointestinal stromal tumor;connective and soft tissue neoplasm (antiquated);broadmatch
high risk gastric gastrointestinal stromal tumor;high risk gastrointestinal stromal tumor;broadmatch
low risk gastric gastrointestinal stromal tumor;low risk gastrointestinal stromal tumor;broadmatch
nipple duct carcinoma;epithelial neoplasm (antiquated);broadmatch
transplant-related disorder;immunodeficiency-related disorder;broadmatch
environment-related neoplasm;neoplasm by cause;broadmatch
"t(11;22)(q24;q12)";11q translocation;broadmatch
"t(11;22)(q24;q12)";ewsr1 gene translocation;broadmatch
"t(14;18)(q32;q21)";chromosomal translocation;broadmatch
glossopharyngeal nerve disorder;cranial nerve disorder;broadmatch
vestibulocochlear nerve disorder;cranial nerve disorder;broadmatch
rheumatologic disorder;immune system disorder;broadmatch
hashimoto thyroiditis;lymphocytic thyroiditis;broadmatch
lacrimal system disorder;eye disorder;broadmatch
intestinal disorder;digestive system disorder;broadmatch
antigen;biological agent;broadmatch
dicer1 gene;endoribonuclease gene;broadmatch
interleukin gene;cytokine gene;broadmatch
cytokine signaling;environment-to-cell communication;broadmatch
non-receptor protein tyrosine phosphatase gene;protein tyrosine phosphatase gene;broadmatch
non-receptor tyrosine kinase gene;kinase family gene;broadmatch
rnase iii family protein;protein family;broadmatch
endoribonuclease;ribonuclease;broadmatch
double-stranded rna binding domain;rna recognition motif;broadmatch
endoribonuclease gene;ribonuclease gene;broadmatch
phosphotransferase gene;transferase gene;broadmatch
ribonuclease gene;esterase gene;broadmatch
esterase gene;hydrolase gene;broadmatch
polymerase gene;transferase gene;broadmatch
oxidoreductase gene;enzyme gene;broadmatch
mitochondrial membrane;intracellular membrane;broadmatch
dual-specificity phosphoprotein phosphatase;phosphoprotein phosphatase;broadmatch
serine/threonine protein kinase gene;kinase family gene;broadmatch
homeostatic process;metabolic process;broadmatch
signal transducer and activator of transcription family gene;transcription coactivator gene;broadmatch
ion channel protein gene;transmembrane protein gene;broadmatch
ion channel protein gene;transport protein gene;broadmatch
methyltransferase gene;transferase gene;broadmatch
phosphoinositol kinase family gene;kinase family gene;broadmatch
phosphatase family gene;esterase gene;broadmatch
protein tyrosine phosphatase gene;protein phosphatase gene;broadmatch
helicase gene;hydrolase gene;broadmatch
retinoic acid binding;ligand binding;broadmatch
tumor suppression;cancer cell growth regulation;broadmatch
membrane protein gene;gene;broadmatch
viral carcinogenesis;biological carcinogenesis;broadmatch
biological carcinogenesis, non-viral;biological carcinogenesis;broadmatch
antibacterial response;antimicrobial effect;broadmatch
peptidase gene;hydrolase gene;broadmatch
collagen gene;extracellular matrix protein gene;broadmatch
extracellular matrix protein gene;structural protein gene;broadmatch
adaptor signaling protein gene;signaling pathway gene;broadmatch
kinase family gene;phosphotransferase gene;broadmatch
transferase gene;enzyme gene;broadmatch
hemorrhage;finding by cause;broadmatch
hydrolase gene;enzyme gene;broadmatch
benign mouse bladder neoplasm;mouse bladder neoplasm;broadmatch
mouse bladder inflammatory myofibroblastic neoplasm;mouse bladder neoplasm;broadmatch
mouse bladder paraganglioma;mouse bladder neoplasm;broadmatch
mouse bladder neoplasm;mouse urinary tract neoplasm;broadmatch
mouse urinary tract neoplasm;mouse urinary tract disorder;broadmatch
mouse urinary tract neoplasm;mouse genitourinary neoplasms;broadmatch
gtpase gene;hydrolase gene;broadmatch
eukaryota;organism;broadmatch
transmembrane protein gene;membrane protein gene;broadmatch
immunoglobulin-like c2-type domain;immunoglobulin domain;broadmatch
immunoglobulin family gene;gene;broadmatch
immunoprotein gene;gene;broadmatch
nras gene;ras family gene;broadmatch
kras gene;ras family gene;broadmatch
ras family gene;g protein gene;broadmatch
musculoskeletal system part;body part;broadmatch
benign mouse bladder paraganglioma;benign mouse bladder neoplasm;broadmatch
mouse bladder leiomyoma;benign mouse bladder neoplasm;broadmatch
mouse bladder papilloma;benign mouse bladder neoplasm;broadmatch
malignant mouse bladder neoplasm;mouse bladder neoplasm;broadmatch
g1 to s transition process;interphase process;broadmatch
cyclin gene;cell cycle gene;broadmatch
cyclin-dependent kinase gene;serine/threonine protein kinase gene;broadmatch
cyclin-dependent kinase gene;cell cycle gene;broadmatch
mouse bladder transitional cell carcinoma;mouse bladder carcinoma;broadmatch
mouse bladder squamous cell carcinoma;mouse bladder carcinoma;broadmatch
mouse bladder adenocarcinoma;mouse bladder carcinoma;broadmatch
mouse bladder carcinoma;malignant mouse bladder neoplasm;broadmatch
mouse bladder carcinoma;mouse carcinoma;broadmatch
mouse bladder sarcoma;malignant mouse bladder neoplasm;broadmatch
mouse bladder sarcoma;mouse sarcoma;broadmatch
mouse bladder lymphoma;malignant mouse bladder neoplasm;broadmatch
metastatic neoplasm to the mouse urinary bladder;malignant mouse bladder neoplasm;broadmatch
metastatic neoplasm to the mouse urinary bladder;mouse metastatic neoplasms;broadmatch
malignant mouse bladder paraganglioma;malignant mouse bladder neoplasm;broadmatch
phagocytosis;cell defense process;broadmatch
ptb domain;protein binding domain;broadmatch
heparin binding;protein-carbohydrate interaction;broadmatch
ataxia;movement disorder;broadmatch
connective tissue disorder;connective and soft tissue disorder;broadmatch
infectious disorder;inflammatory disorder;broadmatch
colitis;non-neoplastic intestinal disorder;broadmatch
cholangitis;non-neoplastic bile duct disorder;broadmatch
celiac disease;malabsorption syndrome;broadmatch
breast disorder;disorder by site;broadmatch
balanitis;penile non-neoplastic disorder;broadmatch
anal disorder;digestive system disorder;broadmatch
growth factor receptor gene;receptor gene;broadmatch
aneurysm;cardiovascular system finding;broadmatch
adrenal gland disorder;retroperitoneal disorder;broadmatch
acanthosis nigricans;dermatitis;broadmatch
radiation-induced disorder;disease or disorder;broadmatch
abnormal laboratory test result;laboratory test result;broadmatch
abdominal pain;pain;broadmatch
fosb gene;fos family gene;broadmatch
corneal disorder;eye disorder;broadmatch
cranial nerve disorder;nervous system disorder;broadmatch
cystitis;non-neoplastic bladder disorder;broadmatch
dermatomyositis;myopathy;broadmatch
gonadal disorder;reproductive system disorder;broadmatch
gastroesophageal reflux disease;non-neoplastic esophageal disorder;broadmatch
gastritis;non-neoplastic stomach disorder;broadmatch
fallopian tube disorder;female reproductive system disorder;broadmatch
eyelid disorder;eye disorder;broadmatch
eye disorder;disorder by site;broadmatch
epistaxis;hemorrhage;broadmatch
enteritis;non-neoplastic intestinal disorder;broadmatch
embolism;non-neoplastic vascular disorder;broadmatch
ear disorder;otolaryngologic disorder;broadmatch
dyspepsia;digestive system signs and symptoms;broadmatch
diverticulum;congenital or acquired anatomic abnormality;broadmatch
type 2 diabetes mellitus;diabetes mellitus;broadmatch
dermatomyositis;autoimmune disease;broadmatch
dermatomyositis;rheumatologic disorder;broadmatch
zap70 gene;non-receptor tyrosine kinase gene;broadmatch
xenobiotic metabolism;detoxification;broadmatch
mesonephric duct;other embryologic structure;broadmatch
mouse cardiovascular system disorder;mouse disorder by site;broadmatch
ptpn11 gene;non-receptor protein tyrosine phosphatase gene;broadmatch
non-neoplastic connective and soft tissue disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic connective and soft tissue disorder;connective and soft tissue disorder;broadmatch
non-neoplastic hematologic and lymphocytic disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic hematologic and lymphocytic disorder;hematologic and lymphocytic disorder;broadmatch
hematologic and lymphocytic disorder;hematopoietic and lymphoid system disorder;broadmatch
anticoagulant agent;agent affecting blood or body fluid;broadmatch
immune cell activation process;immune system process;broadmatch
adaptor signaling protein;signaling protein;broadmatch
transcription regulatory protein;regulatory protein;broadmatch
heterotrimeric g protein subunit gene;signaling pathway gene;broadmatch
cellular migration process;cell movement;broadmatch
nervous system development;organogenesis;broadmatch
glycosyltransferase gene;transferase gene;broadmatch
cell fate control;cellular process;broadmatch
mouse disorder by site;murine experimental organism diagnosis;broadmatch
mouse connective and soft tissue disorder;mouse disorder by site;broadmatch
mesonephros;other embryologic structure;broadmatch
mouse digestive system disorder;mouse disorder by site;broadmatch
intraductal hyperplasia;hyperplasia;broadmatch
22q11.1-q11.2;chromosome band;broadmatch
mouse skeletal system disorder;mouse disorder by site;broadmatch
mouse respiratory system disorder;mouse disorder by site;broadmatch
mouse nervous system disorder;mouse disorder by site;broadmatch
mouse skin disorder;mouse disorder by site;broadmatch
mouse mammary gland disorder;mouse disorder by site;broadmatch
mouse hematologic disorder;mouse disorder by site;broadmatch
mouse head and neck disorder;mouse disorder by site;broadmatch
mouse prostate disorder;mouse male reproductive system disorder;broadmatch
mouse male reproductive system disorder;mouse reproductive system disorder;broadmatch
mouse female reproductive system disorder;mouse reproductive system disorder;broadmatch
mouse reproductive system disorder;mouse disorder by site;broadmatch
mouse urinary tract disorder;mouse disorder by site;broadmatch
mouse endocrine gland system disorder;mouse disorder by site;broadmatch
mouse salivary gland neoplasms;mouse head and neck neoplasms;broadmatch
carcinoid tumor of the mouse larynx;mouse carcinoid tumor;broadmatch
disorder by site;disease or disorder;broadmatch
atypical mouse meningioma;mouse meningioma;broadmatch
angiolipoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
lipoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
lipoma of the mouse nervous system;mouse lipoma;broadmatch
mesenchymal non-meningothelial tumours of the mouse nervous system;tumors of the mouse meninges;broadmatch
mouse anaplastic meningioma;mouse meningioma;broadmatch
mouse rhabdoid meningioma;mouse meningioma;broadmatch
mouse papillary meningioma;mouse meningioma;broadmatch
mouse chordoid meningioma;mouse meningioma;broadmatch
mouse fibrous / fibroblastic meningioma;mouse meningioma;broadmatch
mouse clear cell meningioma;mouse meningioma;broadmatch
mouse metaplastic meningioma;mouse meningioma;broadmatch
mouse lymphoplasmacyte-rich meningioma;mouse meningioma;broadmatch
mouse secretory meningioma;mouse meningioma;broadmatch
mouse microcystic meningioma;mouse meningioma;broadmatch
mouse angiomatous meningioma;mouse meningioma;broadmatch
mouse psammomatous meningioma;mouse meningioma;broadmatch
hibernoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
intracranial liposarcoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
solitary fibrous tumour of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
fibrosarcoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
hemangioma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
osteochondroma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
osteosarcoma of the mouse nervous system;mouse osteosarcoma;broadmatch
osteosarcoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
osteoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
chondrosarcoma of the mouse nervous system;mouse chondrosarcoma;broadmatch
chondrosarcoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
chondroma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
rhabdomyosarcoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
rhabdomyoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
leiomyosarcoma of the mouse nervous system;mouse leiomyosarcoma;broadmatch
leiomyosarcoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
leiomyoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
leiomyoma of the mouse nervous system;mouse leiomyoma;broadmatch
malignant fibrous histiocytoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
mouse transitional mixed meningioma;mouse meningioma;broadmatch
mouse meningothelial meningioma;mouse meningioma;broadmatch
hemangiopericytoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
mouse medullomyoblastoma;mouse medulloblastoma;broadmatch
mouse schwannoma;mouse neuroglia neoplasm;broadmatch
tumors of the mouse peripheral nerves;mouse nervous system neoplasms;broadmatch
atypical mouse tertoid/thaboid tumour;mouse embryonal tumours;broadmatch
mouse ganglioneuroblastoma;mouse supratentorial primitive neuroectodermal tumour;broadmatch
mouse neuroblastoma;mouse supratentorial primitive neuroectodermal tumour;broadmatch
mouse supratentorial primitive neuroectodermal tumour;mouse embryonal tumours;broadmatch
mouse melanotic medulloblastoma;mouse medulloblastoma;broadmatch
mouse large cell medulloblastoma;mouse medulloblastoma;broadmatch
mouse meningioma;tumors of the mouse meningothelial cells;broadmatch
mouse desmoplastic medulloblastoma;mouse medulloblastoma;broadmatch
mouse medulloblastoma;mouse embryonal tumours;broadmatch
mouse ependymoblastoma;mouse embryonal tumours;broadmatch
mouse medulloepithelioma;mouse embryonal tumours;broadmatch
mouse embryonal tumours;mouse tumors of neuroepithelial tissue;broadmatch
mouse pineal parenchymal tumour of intermediate differentiation;mouse pineal parenchymal tumours;broadmatch
mouse pineoblastoma;mouse pineal parenchymal tumours;broadmatch
mouse schwannoma;tumors of the mouse peripheral nerves;broadmatch
mouse cellular neurilemmoma / neurinoma;atypical mouse tertoid/thaboid tumour;broadmatch
mouse plexiform neurilemmoma / neurinoma;atypical mouse tertoid/thaboid tumour;broadmatch
mouse melanotic neurilemmoma / neurinoma;atypical mouse tertoid/thaboid tumour;broadmatch
tumors of the mouse meningothelial cells;tumors of the mouse meninges;broadmatch
tumors of the mouse meninges;mouse nervous system neoplasms;broadmatch
mouse melanotic psammomatous mpnst;malignant mouse peripheral nerve sheath tumor;broadmatch
mouse melanotic mpnst;malignant mouse peripheral nerve sheath tumor;broadmatch
mouse mpnst with divergent mesenchymal and / or epithelial differentiation;malignant mouse peripheral nerve sheath tumor;broadmatch
mouse epithelioid mpnst;malignant mouse peripheral nerve sheath tumor;broadmatch
malignant mouse peripheral nerve sheath tumor;mouse neural cell neoplasm;broadmatch
malignant mouse peripheral nerve sheath tumor;tumors of the mouse peripheral nerves;broadmatch
mouse soft tissue perineurioma;mouse perineurioma;broadmatch
mouse intraneural perineurioma;mouse perineurioma;broadmatch
mouse perineurioma;tumors of the mouse peripheral nerves;broadmatch
mouse perineurioma;mouse neuroglia neoplasm;broadmatch
mouse plexiform neurofibroma;mouse neurofibroma;broadmatch
mouse neurofibroma;mouse neural cell neoplasm;broadmatch
mouse neurofibroma;tumors of the mouse peripheral nerves;broadmatch
epithelioid haemangioendothelioma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
angiosarcoma of the mouse nervous system;mouse sarcoma;broadmatch
mouse pineal parenchymal tumours;mouse tumors of neuroepithelial tissue;broadmatch
high grade sessile tubular dysplasia of the mouse intestinal tract;sessile tubular adenoma of the mouse intestinal tract;broadmatch
flat adenoma of the mouse intestinal tract;adenoma of the mouse intestinal tract;broadmatch
high grade sessile tubulovillous dysplasia of the mouse intestinal tract;sessile tubulovillous adenoma of the mouse intestinal tract;broadmatch
low grade sessile tubulovillous dysplasia of the mouse intestinal tract;sessile tubulovillous adenoma of the mouse intestinal tract;broadmatch
sessile tubulovillous adenoma of the mouse intestinal tract;sessile adenoma of the mouse intestinal tract;broadmatch
high grade sessile villous dysplasia of the mouse intestinal tract;sessile villous adenoma of the mouse intestinal tract;broadmatch
low grade sessile villous dysplasia of the mouse intestinal tract;sessile villous adenoma of the mouse intestinal tract;broadmatch
sessile villous adenoma of the mouse intestinal tract;sessile adenoma of the mouse intestinal tract;broadmatch
low grade sessile tubular dysplasia of the mouse intestinal tract;sessile tubular adenoma of the mouse intestinal tract;broadmatch
acute enteritis of the mouse intestinal tract;inflammatory diseases of the mouse intestinal tract;broadmatch
sessile tubular adenoma of the mouse intestinal tract;sessile adenoma of the mouse intestinal tract;broadmatch
sessile adenoma of the mouse intestinal tract;adenoma of the mouse intestinal tract;broadmatch
adenoma of the mouse intestinal tract;mouse adenoma;broadmatch
adenoma of the mouse intestinal tract;benign neoplasms of the mouse intestinal tract;broadmatch
benign neoplasms of the mouse intestinal tract;neoplasms of the mouse intestinal tract;broadmatch
gastrointestinal intraepithelial neoplasia of mouse;neoplasms of the mouse intestinal tract;broadmatch
gastrointestinal intraepithelial neoplasia of mouse;mouse intraepithelial neoplasia;broadmatch
flat tubular adenoma of the mouse intestinal tract;flat adenoma of the mouse intestinal tract;broadmatch
low grade flat tubular dysplasia of the mouse intestinal tract;flat tubular adenoma of the mouse intestinal tract;broadmatch
high grade flat tubular dysplasia of the mouse intestinal tract;flat tubular adenoma of the mouse intestinal tract;broadmatch
flat villous adenoma of the mouse intestinal tract;flat adenoma of the mouse intestinal tract;broadmatch
leiomyoma of the mouse intestinal tract;mouse leiomyoma;broadmatch
fibroma of the mouse intestinal tract;benign neoplasms of the mouse intestinal tract;broadmatch
fibroma of the mouse intestinal tract;mouse fibroma;broadmatch
high grade pedunculated tubulovillous dysplasia of the mouse intestinal tract;pedunculated tubulovillous adenoma of the mouse intestinal tract;broadmatch
low grade pedunculated tubulovillous dysplasia of the mouse intestinal tract;pedunculated tubulovillous adenoma of the mouse intestinal tract;broadmatch
pedunculated tubulovillous adenoma of the mouse intestinal tract;pedunculated adenoma of the mouse intestinal tract;broadmatch
high grade pedunculated tubular dysplasia of the mouse intestinal tract;pedunculated tubular adenoma of the mouse intestinal tract;broadmatch
low grade pedunculated tubular dysplasia of the mouse intestinal tract;pedunculated tubular adenoma of the mouse intestinal tract;broadmatch
pedunculated tubular adenoma of the mouse intestinal tract;pedunculated adenoma of the mouse intestinal tract;broadmatch
pedunculated adenoma of the mouse intestinal tract;adenoma of the mouse intestinal tract;broadmatch
high grade flat tubulovillous dysplasia of the mouse intestinal tract;flat tubulovillous adenoma of the mouse intestinal tract;broadmatch
low grade flat tubulovillous dysplasia of the mouse intestinal tract;flat tubulovillous adenoma of the mouse intestinal tract;broadmatch
flat tubulovillous adenoma of the mouse intestinal tract;flat adenoma of the mouse intestinal tract;broadmatch
high grade flat villous dysplasia of the mouse intestinal tract;flat villous adenoma of the mouse intestinal tract;broadmatch
low grade flat villous dysplasia of the mouse intestinal tract;flat villous adenoma of the mouse intestinal tract;broadmatch
neoplasms of the mouse intestinal tract;mouse gastrointestinal system neoplasms;broadmatch
inflammatory diseases of the mouse intestinal tract;mouse digestive system disorder;broadmatch
angiosarcoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
mouse nervous system tumors of uncertain histogenesis;tumors of the mouse meninges;broadmatch
granulocytic sarcoma of the mouse nervous system;mouse sarcoma;broadmatch
plasmacytoma of the mouse nervous system;lymphomas and haemopoietic neoplasms of the mouse nervous system;broadmatch
malignant lymphomas of the mouse nervous system;lymphomas and haemopoietic neoplasms of the mouse nervous system;broadmatch
malignant lymphomas of the mouse nervous system;mouse lymphoma;broadmatch
lymphomas and haemopoietic neoplasms of the mouse nervous system;mouse lymph cell neoplasm;broadmatch
lymphomas and haemopoietic neoplasms of the mouse nervous system;mouse nervous system neoplasms;broadmatch
mouse hemangioblastoma;mouse nervous system tumors of uncertain histogenesis;broadmatch
mouse meningeal melanomatosis;primary melanocytic lesions of the mouse nervous system;broadmatch
inflammatory diseases of the mouse intestinal tract;mouse noncancerous conditions;broadmatch
malignant melanoma of the mouse nervous system;primary melanocytic lesions of the mouse nervous system;broadmatch
melanocytoma of the mouse nervous system;primary melanocytic lesions of the mouse nervous system;broadmatch
diffuse melanocytosis of the mouse nervous system;primary melanocytic lesions of the mouse nervous system;broadmatch
primary melanocytic lesions of the mouse nervous system;mouse melanocyte neoplasm;broadmatch
primary melanocytic lesions of the mouse nervous system;tumors of the mouse meninges;broadmatch
kaposi sarcoma of the mouse nervous system;mesenchymal non-meningothelial tumours of the mouse nervous system;broadmatch
kaposi sarcoma of the mouse nervous system;mouse sarcoma;broadmatch
granulocytic sarcoma of the mouse nervous system;lymphomas and haemopoietic neoplasms of the mouse nervous system;broadmatch
germ cell tumors of the mouse nervous system;mouse nervous system neoplasms;broadmatch
germ cell tumors of the mouse nervous system;mouse germ cell neoplasm;broadmatch
germinoma of the mouse nervous system;germ cell tumors of the mouse nervous system;broadmatch
metastatic tumours of the mouse nervous system;mouse metastatic neoplasms;broadmatch
granular cell tumor of the mouse sellar region;tumors of the mouse sellar region;broadmatch
mouse papillary craniopharyngioma;mouse craniopharyngioma;broadmatch
mouse adamantinomatous craniopharyngioma;mouse craniopharyngioma;broadmatch
mouse craniopharyngioma;tumors of the mouse sellar region;broadmatch
tumors of the mouse sellar region;mouse nervous system neoplasms;broadmatch
mixed germ cell tumours of the mouse nervous system;germ cell tumors of the mouse nervous system;broadmatch
teratoma of the mouse nervous system with malignant transformation;teratoma of the mouse nervous system;broadmatch
immature teratoma of the mouse nervous system;teratoma of the mouse nervous system;broadmatch
mature teratoma of the mouse nervous system;teratoma of the mouse nervous system;broadmatch
teratoma of the mouse nervous system;germ cell tumors of the mouse nervous system;broadmatch
choriocarcinoma of the mouse nervous system;germ cell tumors of the mouse nervous system;broadmatch
yolk sac tumour of the mouse nervous system;germ cell tumors of the mouse nervous system;broadmatch
embryonal carcinoma of the mouse nervous system;mouse carcinoma;broadmatch
embryonal carcinoma of the mouse nervous system;germ cell tumors of the mouse nervous system;broadmatch
mouse pineocytoma;mouse pineal parenchymal tumours;broadmatch
neuroblastomas of the mouse adrenal gland and sympathetic nervous system;mouse neuroblastic tumours;broadmatch
neuroendocrine neoplasms of the mouse larynx;mouse laryngeal neoplasms;broadmatch
mouse histiocytic sarcoma;mouse non-lymphoid hematopoietic sarcoma;broadmatch
mouse myeloid leukemia with maturation;mouse myeloid leukemia;broadmatch
mouse myeloid leukemia without maturation;mouse myeloid leukemia;broadmatch
mouse myeloid leukemia;mouse myeloid cell neoplasm;broadmatch
mouse myeloid leukemia;mouse non-lymphoid leukemia;broadmatch
mouse non-lymphoid leukemia;non-lymphoid hematopoietic neoplasm of mouse;broadmatch
mouse non-lymphoid leukemia;mouse leukemia;broadmatch
mouse mast cell hematopoietic sarcoma;mouse non-lymphoid hematopoietic sarcoma;broadmatch
mouse granulocytic sarcoma;mouse non-lymphoid hematopoietic sarcoma;broadmatch
mast cell neoplasms of the mouse skin;mouse mast cell neoplasm;broadmatch
mouse non-lymphoid hematopoietic sarcoma;non-lymphoid hematopoietic neoplasm of mouse;broadmatch
mouse non-lymphoid hematopoietic sarcoma;mouse sarcoma;broadmatch
non-lymphoid hematopoietic neoplasm of mouse;mouse hematologic neoplasms and related disorders;broadmatch
mouse hematologic neoplasms and related disorders;mouse hematologic disorder;broadmatch
mouse hematologic neoplasms and related disorders;mouse neoplasms by location;broadmatch
other cutaneous neoplasms of hematopoietic origin of mouse;mouse cutaneous tumors of hematopoietic origin;broadmatch
mastocytoma of the mouse skin;mast cell neoplasms of the mouse skin;broadmatch
mouse mpd-like myeloid leukemia;mouse myeloid leukemia;broadmatch
mouse myelomonocytic leukemia;mouse myeloid leukemia;broadmatch
mouse monocytic leukemia;mouse myeloid leukemia;broadmatch
mouse monocytic leukemia;mouse monocyte neoplasm;broadmatch
precursor b cell neoplasm of the mouse hematologic system;b cell neoplasms of the mouse hematologic system;broadmatch
b cell neoplasms of the mouse hematologic system;lymphoid neoplasms and related disorders of the mouse hematologic system;broadmatch
b cell neoplasms of the mouse hematologic system;mouse b cell neoplasms;broadmatch
lymphoid neoplasms and related disorders of the mouse hematologic system;mouse hematologic neoplasms and related disorders;broadmatch
mouse myeloproliferative disease;mouse myeloid proliferation;broadmatch
mouse myeloproliferation;mouse myeloid proliferation;broadmatch
mouse myeloid proliferation;mouse myeloid cell neoplasm;broadmatch
mouse myeloid proliferation;non-lymphoid hematopoietic neoplasm of mouse;broadmatch
cytopenia with increased blasts of mouse;myeloid dysplasia of mouse;broadmatch
mouse myelodysplastic syndrome;myeloid dysplasia of mouse;broadmatch
myeloid dysplasia of mouse;mouse hematologic disorder;broadmatch
myeloid dysplasia of mouse;mouse precancerous conditions;broadmatch
mouse bi-phenotypic leukemia;mouse non-lymphoid leukemia;broadmatch
mouse megakaryocytic leukemia;mouse non-lymphoid leukemia;broadmatch
mouse erythroid leukemia;mouse non-lymphoid leukemia;broadmatch
mast cell neoplasms of the mouse skin;mouse cutaneous tumors of hematopoietic origin;broadmatch
malignant histiocytic neoplasms of the mouse skin;histiocytic neoplasms of the mouse skin;broadmatch
mature b cell neoplasms of the mouse hematologic system;b cell neoplasms of the mouse hematologic system;broadmatch
lymphangiosarcoma of the mouse skin;sarcomas of the mouse skin and subcutis;broadmatch
rhabdomyosarcoma of the mouse skin;mouse rhabdomyosarcoma;broadmatch
rhabdomyosarcoma of the mouse skin;sarcomas of the mouse skin and subcutis;broadmatch
leiomyosarcoma of the mouse skin;mouse leiomyosarcoma;broadmatch
leiomyosarcoma of the mouse skin;sarcomas of the mouse skin and subcutis;broadmatch
malignant peripheral nerve sheath tumor of the mouse skin;mouse neural cell neoplasm;broadmatch
malignant peripheral nerve sheath tumor of the mouse skin;sarcomas of the mouse skin and subcutis;broadmatch
lymphangiosarcoma of the mouse skin;mouse angiosarcoma;broadmatch
hemangiosarcoma of the mouse skin;mouse angiosarcoma;broadmatch
benign histiocytic neoplasms of the mouse skin;histiocytic neoplasms of the mouse skin;broadmatch
hemangiosarcoma of the mouse skin;sarcomas of the mouse skin and subcutis;broadmatch
sarcomas of the mouse skin and subcutis;neoplasms of the mouse skin;broadmatch
sarcomas of the mouse skin and subcutis;mouse sarcoma;broadmatch
granular cell tumor of the mouse skin;benign mesenchymal neoplasms of the mouse skin;broadmatch
granular cell tumor of the mouse skin;mouse granular cell neoplasm;broadmatch
neurofibroma of the mouse skin;mouse neurofibroma;broadmatch
neurofibroma of the mouse skin;benign mesenchymal neoplasms of the mouse skin;broadmatch
liposarcoma of the mouse skin;mouse liposarcoma;broadmatch
liposarcoma of the mouse skin;sarcomas of the mouse skin and subcutis;broadmatch
unclassified malignant spindle cell neoplasm of the mouse skin;mouse spindle cell neoplasm;broadmatch
unclassified malignant spindle cell neoplasm of the mouse skin;sarcomas of the mouse skin and subcutis;broadmatch
histiocytic neoplasms of the mouse skin;mouse cutaneous tumors of hematopoietic origin;broadmatch
malignant plasmacytoma of the mouse skin;plasma cell neoplasms of the mouse skin;broadmatch
malignant plasmacytoma of the mouse skin;mouse plasmacytoma;broadmatch
benign plasma cell proliferations of the mouse skin;mouse skin disorder;broadmatch
benign plasma cell proliferations of the mouse skin;mouse cancer-related conditions;broadmatch
plasma cell neoplasms of the mouse skin;mouse cutaneous tumors of hematopoietic origin;broadmatch
plasma cell neoplasms of the mouse skin;mouse plasma cell neoplasm;broadmatch
other lymphomas of the mouse skin;mouse cutaneous lymphomas;broadmatch
t-cell lymphomas of the mouse skin;mouse cutaneous lymphomas;broadmatch
t-cell lymphomas of the mouse skin;mouse t cell neoplasms;broadmatch
b-cell lymphomas of the mouse skin;mouse cutaneous lymphomas;broadmatch
b-cell lymphomas of the mouse skin;mouse b cell neoplasms;broadmatch
mouse cutaneous lymphomas;mouse cutaneous tumors of hematopoietic origin;broadmatch
mouse cutaneous lymphomas;mouse lymphoma;broadmatch
mouse cutaneous tumors of hematopoietic origin;neoplasms of the mouse skin;broadmatch
mouse precursor b cell lymphoblastic lymphoma and leukemia;precursor b cell neoplasm of the mouse hematologic system;broadmatch
small b cell lymphoma of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;broadmatch
mouse olfactory neuroepithelioma;mouse neuroblastic tumours;broadmatch
mouse papillary ependymoma;mouse ependymoma;broadmatch
mouse glial tumours of uncertain origin;mouse neuroglia neoplasm;broadmatch
mouse choroid plexus tumours;mouse tumors of neuroepithelial tissue;broadmatch
mouse subependymoma;mouse ependymal tumours;broadmatch
mouse myxopapillary ependymoma;mouse ependymal tumours;broadmatch
mouse anaplastic ependymoma;mouse ependymal tumours;broadmatch
mouse tanycytic ependymoma;mouse ependymoma;broadmatch
mouse clear cell ependymoma;mouse ependymoma;broadmatch
mouse cellular ependymoma;mouse ependymoma;broadmatch
mouse oligodendroglial tumours;mouse tumors of neuroepithelial tissue;broadmatch
mouse ependymoma;mouse ependymal tumours;broadmatch
mouse ependymal tumours;mouse tumors of neuroepithelial tissue;broadmatch
mouse anaplastic oligoastrocytoma;mixed mouse gliomas;broadmatch
mouse oligoastrocytoma;mixed mouse gliomas;broadmatch
mixed mouse gliomas;mouse tumors of neuroepithelial tissue;broadmatch
mixed mouse gliomas;mouse neuroglia neoplasm;broadmatch
mouse anaplastic oligodendroglioma;mouse oligodendroglial tumours;broadmatch
mouse glial tumours of uncertain origin;mouse tumors of neuroepithelial tissue;broadmatch
mouse astroblastoma;mouse glial tumours of uncertain origin;broadmatch
mouse gliomatosis cerebri;mouse glial tumours of uncertain origin;broadmatch
mouse chordoid glioma of the 3rd ventricle;mouse glial tumours of uncertain origin;broadmatch
mouse olfactory neuroblastoma;mouse neuroblastic tumours;broadmatch
mouse neuroblastic tumours;mouse tumors of neuroepithelial tissue;broadmatch
mouse neuroblastic tumours;mouse neuroglia neoplasm;broadmatch
paraganglioma of the mouse filum terminale;mouse neuronal and mixed neuronal-glial tumours;broadmatch
mouse cerebellar liponeurocytoma;mouse neuronal and mixed neuronal-glial tumours;broadmatch
mouse central neurocytoma;mouse neuronal and mixed neuronal-glial tumours;broadmatch
mouse anaplastic ganglioglioma;mouse neuronal and mixed neuronal-glial tumours;broadmatch
mouse ganglioglioma;mouse neuronal and mixed neuronal-glial tumours;broadmatch
mouse dysembryoplastic neuroepithelial tumour;mouse neuronal and mixed neuronal-glial tumours;broadmatch
mouse desmoplastic infantile astrocytoma / ganglioglioma;mouse neuronal and mixed neuronal-glial tumours;broadmatch
dysplastic lhermitte-duclos gangliocytoma of mouse cerebellum;mouse neuronal and mixed neuronal-glial tumours;broadmatch
mouse gangliocytoma;mouse neuronal and mixed neuronal-glial tumours;broadmatch
mouse neuronal and mixed neuronal-glial tumours;mouse neural cell neoplasm;broadmatch
mouse neuronal and mixed neuronal-glial tumours;mouse tumors of neuroepithelial tissue;broadmatch
mouse neuronal and mixed neuronal-glial tumours;mouse neuroglia neoplasm;broadmatch
mouse oligodendroglioma;mouse oligodendroglial tumours;broadmatch
mouse oligodendroglial tumours;mouse neuroglia neoplasm;broadmatch
splenic marginal zone lymphoma of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;broadmatch
plasmacytoma of the mouse hematologic system;plasma cell neoplasm of the mouse hematologic system;broadmatch
mouse precursor t cell lymphoblastic lymphoma/leukemia;precursor t cell neoplasm of the mouse hematologic system;broadmatch
precursor t cell neoplasm of the mouse hematologic system;t cell neoplasms of the mouse hematologic system;broadmatch
t cell neoplasms of the mouse hematologic system;lymphoid neoplasms and related disorders of the mouse hematologic system;broadmatch
t cell neoplasms of the mouse hematologic system;mouse t cell neoplasms;broadmatch
b-nk cell lymphoma of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;broadmatch
anaplastic plasmacytoma of the mouse hematologic system;plasma cell neoplasm of the mouse hematologic system;broadmatch
extraosseus plasmacytoma of the mouse hematologic system;plasma cell neoplasm of the mouse hematologic system;broadmatch
plasma cell neoplasm of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;broadmatch
mouse subependymal giant cell astrocytoma;mouse astrocytic tumours;broadmatch
classic burkitt lymphoma of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;broadmatch
primary mediastinal thymic diffuse large b cell lymphoma of the mouse hematologic system;subtypes of diffuse large b cell lymphoma of the mouse hematologic system;broadmatch
histiocyte-associated diffuse large b cell lymphoma of the mouse hematologic system;morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;broadmatch
immunoblastic diffuse large b cell lymphoma of the mouse hematologic system;morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;broadmatch
centroblastic diffuse large b cell lymphoma of the mouse hematologic system;morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;broadmatch
diffuse large b cell lymphoma of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;broadmatch
follicular b cell lymphoma of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;broadmatch
large cell anaplastic lymphoma of the mouse hematologic system;t cell neoplasms of undetermined character of the mouse hematologic system;broadmatch
mature t cell lineage lymphoma of the mouse hematologic system;t cell neoplasms of the mouse hematologic system;broadmatch
small t cell lymphoma of the mouse hematologic system;mature t cell lineage lymphoma of the mouse hematologic system;broadmatch
mouse t-nk cell lymphoma;mature t cell lineage lymphoma of the mouse hematologic system;broadmatch
mouse pleomorphic xanthoastrocytoma;mouse astrocytic tumours;broadmatch
mouse pilocytic astrocytoma;mouse astrocytic tumours;broadmatch
mouse gliosarcoma;mouse glioblastoma;broadmatch
mouse giant cell glioblastoma;mouse glioblastoma;broadmatch
mouse glioblastoma;mouse astrocytic tumours;broadmatch
mouse anaplastic astrocytoma;mouse astrocytic tumours;broadmatch
mouse gemistocytic astrocytoma;mouse diffuse astrocytoma;broadmatch
mouse protoplasmic astrocytoma;mouse diffuse astrocytoma;broadmatch
mouse fibrillary astrocytoma;mouse diffuse astrocytoma;broadmatch
mouse diffuse astrocytoma;mouse astrocytic tumours;broadmatch
mouse astrocytic tumours;mouse tumors of neuroepithelial tissue;broadmatch
mouse astrocytic tumours;mouse neuroglia neoplasm;broadmatch
mouse tumors of neuroepithelial tissue;mouse nervous system neoplasms;broadmatch
mouse nervous system neoplasms;mouse nervous system disorder;broadmatch
mouse nervous system neoplasms;mouse neoplasms by location;broadmatch
leiomyoma of the mouse intestinal tract;benign neoplasms of the mouse intestinal tract;broadmatch
lipoma of the mouse intestinal tract;mouse lipoma;broadmatch
lipoma of the mouse intestinal tract;benign neoplasms of the mouse intestinal tract;broadmatch
morphologic variants of diffuse large b cell lymphoma of the mouse hematologic system;diffuse large b cell lymphoma of the mouse hematologic system;broadmatch
carcinoma of the mouse oral cavity;epithelial neoplasms of the mouse oral cavity;broadmatch
epithelial neoplasms of the mouse oral cavity;mouse oral cavity neoplasms;broadmatch
mouse oral cavity neoplasms;mouse digestive system neoplasms;broadmatch
mouse oral cavity neoplasms;mouse head and neck neoplasms;broadmatch
mouse head and neck neoplasms;mouse head and neck disorder;broadmatch
mouse head and neck neoplasms;mouse neoplasms by location;broadmatch
subtypes of diffuse large b cell lymphoma of the mouse hematologic system;diffuse large b cell lymphoma of the mouse hematologic system;broadmatch
burkitt-like lymphoma of the mouse hematologic system;mature b cell neoplasms of the mouse hematologic system;broadmatch
mouse adrenal cortical carcinoma;mouse adrenal gland neoplasms;broadmatch
t cell neoplasms of undetermined character of the mouse hematologic system;t cell neoplasms of the mouse hematologic system;broadmatch
mouse adrenal cortical adenoma, mixed cell;mouse adrenal cortical adenoma;broadmatch
mouse adrenal cortical adenoma, glomerulosa cell;mouse adrenal cortical adenoma;broadmatch
mouse adrenal cortical adenoma, clear cell;mouse adrenal cortical adenoma;broadmatch
mouse adrenal cortical adenoma, pigmented;mouse adrenal cortical adenoma;broadmatch
mouse adrenal cortical adenoma;mouse adrenal gland neoplasms;broadmatch
mouse adrenal cortical adenoma;mouse adenoma;broadmatch
squamous cell carcinoma of the mouse oral cavity;carcinoma of the mouse oral cavity;broadmatch
squamous cell carcinoma in-situ of the mouse oral cavity;squamous cell carcinoma of the mouse oral cavity;broadmatch
verrucous carcinoma of the mouse oral cavity;squamous cell carcinoma of the mouse oral cavity;broadmatch
adenosquamous cell carcinoma of the mouse oral cavity;carcinoma of the mouse oral cavity;broadmatch
melanoma of the mouse oral cavity;melanocytic neoplasms of the mouse oral cavity;broadmatch
melanocytic neoplasms of the mouse oral cavity;mouse oral cavity neoplasms;broadmatch
synovial sarcoma of the mouse oral cavity;mouse synovial sarcoma;broadmatch
synovial sarcoma of the mouse oral cavity;synovial neoplasms of the mouse oral cavity;broadmatch
synovial neoplasms of the mouse oral cavity;mouse oral cavity neoplasms;broadmatch
neurofibroma of the mouse oral cavity;neural neoplasms of the mouse oral cavity;broadmatch
neurofibroma of the mouse oral cavity;mouse neurofibroma;broadmatch
neurilemoma of the mouse oral cavity;neural neoplasms of the mouse oral cavity;broadmatch
neural neoplasms of the mouse oral cavity;mouse oral cavity neoplasms;broadmatch
leiomyosarcoma of the mouse oral cavity;mouse leiomyosarcoma;broadmatch
leiomyosarcoma of the mouse oral cavity;smooth muscle neoplasms of the mouse oral cavity;broadmatch
leiomyoma of the mouse oral cavity;smooth muscle neoplasms of the mouse oral cavity;broadmatch
leiomyoma of the mouse oral cavity;mouse leiomyoma;broadmatch
smooth muscle neoplasms of the mouse oral cavity;mouse oral cavity neoplasms;broadmatch
adenosquamous cell carcinoma of the mouse oral cavity;mouse adenosquamous carcinoma;broadmatch
mouse adrenal cortical adenoma, compact cell;mouse adrenal cortical adenoma;broadmatch
mouse adrenal cortical carcinoma;mouse carcinoma;broadmatch
lymphoproliferative neoplasms of the mouse oral cavity;hematopoietic neoplasms of the mouse oral cavity;broadmatch
juxtacortical chondroma of the mouse skeletal system;mouse chondrocyte neoplasm;broadmatch
myxoid chondrosarcoma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
chondroblastoma of the mouse skeletal system, malignant;mouse chondrocyte neoplasm;broadmatch
chondroblastoma of the mouse skeletal system, malignant;mouse skeletal system neoplasms;broadmatch
chondroblastoma of the mouse skeletal system, nos;mouse chondrocyte neoplasm;broadmatch
chondroblastoma of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
juxtacortical chondrosarcoma of the mouse skeletal system;mouse chondrosarcoma;broadmatch
juxtacortical chondrosarcoma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
juxtacortical chondroma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
mouse adrenal cortical adenoma, nos;mouse adrenal cortical adenoma;broadmatch
chondrosarcoma of the mouse skeletal system, nos;mouse chondrosarcoma;broadmatch
chondrosarcoma of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
chondromatosis of the mouse skeletal system, nos;mouse chondrocyte neoplasm;broadmatch
chondromatosis of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
chondroma of the mouse skeletal system, nos;mouse chondrocyte neoplasm;broadmatch
chondroma of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
osteochondromatosis of the mouse skeletal system, nos;mouse chondrocyte neoplasm;broadmatch
myxoid chondrosarcoma of the mouse skeletal system;mouse chondrosarcoma;broadmatch
mesenchymal chondrosarcoma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
mesenchymal chondrosarcoma of the mouse skeletal system;mouse chondrosarcoma;broadmatch
chondromyxoid fibroma of the mouse skeletal system;mouse fibroma;broadmatch
mouse pituitary carcinoma, nos;mouse pituitary gland neoplasms;broadmatch
mouse pituitary carcinoma, nos;mouse carcinoma;broadmatch
mouse pituitary adenoma, nos;mouse pituitary gland neoplasms;broadmatch
mouse pituitary adenoma, nos;mouse adenoma;broadmatch
mouse endocrine gland system neoplasms;mouse endocrine gland system disorder;broadmatch
mouse endocrine gland system neoplasms;mouse neoplasms by location;broadmatch
giant cell tumor of bone of the mouse skeletal system, malignant;mouse skeletal system neoplasms;broadmatch
giant cell tumor of bone of the mouse skeletal system, malignant;mouse giant cell neoplasm;broadmatch
giant cell tumor of bone of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
giant cell tumor of bone of the mouse skeletal system, nos;mouse giant cell neoplasm;broadmatch
dedifferentiated chondrosarcoma of the mouse skeletal system;mouse chondrosarcoma;broadmatch
dedifferentiated chondrosarcoma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
clear cell chondrosarcoma of the mouse skeletal system;mouse chondrosarcoma;broadmatch
clear cell chondrosarcoma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
chondromyxoid fibroma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
hematopoietic neoplasms of the mouse oral cavity;mouse oral cavity neoplasms;broadmatch
lymphoma of the mouse oral cavity;mouse lymphoma;broadmatch
hemangioma of the mouse intestinal tract;mouse angioma;broadmatch
plasma cell neoplasms of the mouse nose and paranasal sinuses;hematopoietic neoplasms of the mouse nose and paranasal sinuses;broadmatch
mouse laryngeal neoplasms;mouse head and neck neoplasms;broadmatch
embryonal rhabdomyosarcoma of the mouse nose and paranasal sinuses;skeletal muscle neoplasms of the mouse nose and paranasal sinuses;broadmatch
skeletal muscle neoplasms of the mouse nose and paranasal sinuses;mouse nose and paranasal sinuses neoplasms;broadmatch
leiomyosarcoma of the mouse nose and paranasal sinuses;mouse leiomyosarcoma;broadmatch
leiomyosarcoma of the mouse nose and paranasal sinuses;smooth muscle neoplasms of the mouse nose and paranasal sinuses;broadmatch
smooth muscle neoplasms of the mouse nose and paranasal sinuses;mouse nose and paranasal sinuses neoplasms;broadmatch
plasmacytoma of the mouse nose and paranasal sinuses;plasma cell neoplasms of the mouse nose and paranasal sinuses;broadmatch
angiocentric immunoproliferative lesion of the mouse nose and paranasal sinuses;lymphoma of the mouse nose and paranasal sinuses;broadmatch
neural neoplasms of the mouse nose and paranasal sinuses;mouse nose and paranasal sinuses neoplasms;broadmatch
lymphoma of the mouse nose and paranasal sinuses;lymphoproliferative neoplasms of the mouse nose and paranasal sinuses;broadmatch
lymphoma of the mouse nose and paranasal sinuses;mouse lymphoma;broadmatch
lymphoproliferative neoplasms of the mouse nose and paranasal sinuses;hematopoietic neoplasms of the mouse nose and paranasal sinuses;broadmatch
hematopoietic neoplasms of the mouse nose and paranasal sinuses;mouse nose and paranasal sinuses neoplasms;broadmatch
melanoma of the mouse nose and paranasal sinuses;melanocytic neoplasms of the mouse nose and paranasal sinuses;broadmatch
melanocytic neoplasms of the mouse nose and paranasal sinuses;mouse nose and paranasal sinuses neoplasms;broadmatch
olfactory neuroblastoma of the mouse nose and paranasal sinuses;neural neoplasms of the mouse nose and paranasal sinuses;broadmatch
epithelial neoplasms of the mouse larynx;mouse laryngeal neoplasms;broadmatch
papilloma of the mouse larynx;epithelial neoplasms of the mouse larynx;broadmatch
carcinoma of the mouse larynx;epithelial neoplasms of the mouse larynx;broadmatch
carcinoma of the mouse larynx;mouse carcinoma;broadmatch
malignant fibrous histiocytoma of the mouse larynx;histiocytic neoplasms of the mouse larynx;broadmatch
malignant fibrous histiocytoma of the mouse larynx;mouse malignant mesenchymal neoplasm;broadmatch
histiocytic neoplasms of the mouse larynx;mouse laryngeal neoplasms;broadmatch
osteosarcoma of the mouse larynx;mouse osteosarcoma;broadmatch
osteosarcoma of the mouse larynx;cartilage/bone neoplasms of the mouse larynx;broadmatch
chondrosarcoma of the mouse larynx;mouse chondrosarcoma;broadmatch
chondrosarcoma of the mouse larynx;cartilage/bone neoplasms of the mouse larynx;broadmatch
cartilage/bone neoplasms of the mouse larynx;mouse laryngeal neoplasms;broadmatch
acinic cell carcinoma of the mouse larynx;mouse acinar cell neoplasm;broadmatch
acinic cell carcinoma of the mouse larynx;carcinoma of the mouse larynx;broadmatch
mucoepidermoid carcinoma of the mouse larynx;carcinoma of the mouse larynx;broadmatch
adenoid cystic carcinoma of the mouse larynx;carcinoma of the mouse larynx;broadmatch
squamous cell carcinoma in-situ of the mouse larynx;squamous cell carcinoma of the mouse larynx;broadmatch
squamous cell carcinoma of the mouse larynx;carcinoma of the mouse larynx;broadmatch
squamous cell carcinoma of the mouse larynx;mouse squamous cell carcinoma;broadmatch
olfactory neuroblastoma of the mouse nose and paranasal sinuses;mouse neuroblastic tumours;broadmatch
adenocarcinoma of the mouse nose and paranasal sinuses;carcinoma of the mouse nose and paranasal sinuses;broadmatch
lymphoma of the mouse oral cavity;lymphoproliferative neoplasms of the mouse oral cavity;broadmatch
non-keratinizing carcinoma of the mouse pharynx without lymphoid stroma;non-keratinizing carcinoma of the mouse pharynx;broadmatch
embryonal rhabdomyosarcoma of the mouse pharynx;skeletal muscle neoplasms of the mouse pharynx;broadmatch
skeletal muscle neoplasms of the mouse pharynx;mouse pharyngeal neoplasms;broadmatch
undifferentiated carcinoma of the mouse pharynx with lymphoid stroma;undifferentiated carcinoma of the mouse pharynx;broadmatch
undifferentiated carcinoma of the mouse pharynx without lymphoid stroma;undifferentiated carcinoma of the mouse pharynx;broadmatch
undifferentiated carcinoma of the mouse pharynx;epithelial neoplasms of the mouse pharynx;broadmatch
undifferentiated carcinoma of the mouse pharynx;mouse undifferentiated carcinoma;broadmatch
non-keratinizing carcinoma of the mouse pharynx with lymphoid stroma;non-keratinizing carcinoma of the mouse pharynx;broadmatch
non-keratinizing carcinoma of the mouse pharynx;epithelial neoplasms of the mouse pharynx;broadmatch
verrucous carcinoma of the mouse nose and paranasal sinuses;squamous cell carcinoma of the mouse nose and paranasal sinuses;broadmatch
squamous cell carcinoma of the mouse pharynx;epithelial neoplasms of the mouse pharynx;broadmatch
squamous cell carcinoma of the mouse pharynx;mouse squamous cell carcinoma;broadmatch
epithelial neoplasms of the mouse pharynx;mouse pharyngeal neoplasms;broadmatch
mouse pharyngeal neoplasms;mouse digestive system neoplasms;broadmatch
mouse pharyngeal neoplasms;mouse head and neck neoplasms;broadmatch
plasmacytoma of the mouse oral cavity;plasma cell neoplasms of the mouse oral cavity;broadmatch
plasma cell neoplasms of the mouse oral cavity;hematopoietic neoplasms of the mouse oral cavity;broadmatch
embryonal rhabdomyosarcoma of the mouse pharynx;mouse rhabdomyosarcoma;broadmatch
synovial neoplasms of the mouse pharynx;mouse pharyngeal neoplasms;broadmatch
synovial sarcoma of the mouse pharynx;synovial neoplasms of the mouse pharynx;broadmatch
vascular-fibrous neoplasms of the mouse pharynx;mouse pharyngeal neoplasms;broadmatch
squamous cell carcinoma of the mouse nose and paranasal sinuses;carcinoma of the mouse nose and paranasal sinuses;broadmatch
carcinoma of the mouse nose and paranasal sinuses;epithelial neoplasms of the mouse nose and paranasal sinuses;broadmatch
papilloma of the mouse nose and paranasal sinuses;epithelial neoplasms of the mouse nose and paranasal sinuses;broadmatch
epithelial neoplasms of the mouse nose and paranasal sinuses;mouse nose and paranasal sinuses neoplasms;broadmatch
mouse nose and paranasal sinuses neoplasms;mouse special sense organ neoplasms;broadmatch
mouse nose and paranasal sinuses neoplasms;mouse head and neck neoplasms;broadmatch
plasmacytoma of the mouse pharynx;plasma cell neoplasms of the mouse pharynx;broadmatch
plasmacytoma of the mouse pharynx;lymphoma of the mouse pharynx;broadmatch
plasmacytoma of the mouse pharynx;b cell neoplasms of the mouse hematologic system;broadmatch
plasma cell neoplasms of the mouse pharynx;hematopoietic neoplasms of the mouse pharynx;broadmatch
lymphoma of the mouse pharynx;lymphoproliferative neoplasms of the mouse pharynx;broadmatch
lymphoma of the mouse pharynx;mouse lymphoma;broadmatch
lymphoproliferative neoplasms of the mouse pharynx;hematopoietic neoplasms of the mouse pharynx;broadmatch
hematopoietic neoplasms of the mouse pharynx;mouse pharyngeal neoplasms;broadmatch
angiofibroma of the mouse pharynx;vascular-fibrous neoplasms of the mouse pharynx;broadmatch
osteochondromatosis of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
osteochondroma of the mouse skeletal system;mouse chondrocyte neoplasm;broadmatch
osteochondroma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
mouse lymphohematopoietic system;mouse anatomy concepts;broadmatch
mouse astrocyte;mouse brain;broadmatch
mouse brain;mouse central nervous system;broadmatch
mouse central nervous system;mouse nervous system;broadmatch
mouse nervous system;mouse anatomy concepts;broadmatch
mouse larynx;mouse respiratory system;broadmatch
mouse respiratory system;mouse anatomy concepts;broadmatch
mouse bone marrow;mouse lymphohematopoietic system;broadmatch
mouse mammary gland;mouse integument system;broadmatch
mouse liver;mouse digestive system;broadmatch
mouse sebaceous gland;mouse skin gland;broadmatch
mouse skin gland;mouse skin;broadmatch
mouse hair follicle;mouse skin;broadmatch
mouse melanocyte;mouse skin;broadmatch
mouse skin;mouse integument system;broadmatch
mouse integument system;mouse anatomy concepts;broadmatch
mouse intestine;mouse gastrointestinal tract;broadmatch
mouse choroid plexus;mouse brain;broadmatch
mouse ependyma;mouse brain;broadmatch
mouse meninges;mouse brain;broadmatch
mouse oligodendroglial cell;mouse brain;broadmatch
mouse muscle;mouse soft tissue;broadmatch
mouse cartilage;mouse soft tissue;broadmatch
mouse soft tissue;mouse musculoskeletal system;broadmatch
mouse skeletal system;mouse musculoskeletal system;broadmatch
mouse uterus;mouse female reproductive system;broadmatch
mouse placenta;mouse female reproductive system;broadmatch
mouse oviduct;mouse female reproductive system;broadmatch
mouse ovary;mouse female reproductive system;broadmatch
mouse female reproductive system;mouse reproductive system;broadmatch
mouse thyroid gland;mouse endocrine gland system;broadmatch
mouse pituitary gland;mouse endocrine gland system;broadmatch
mouse adrenal gland;mouse endocrine gland system;broadmatch
mouse endocrine gland system;mouse anatomy concepts;broadmatch
mouse peripheral nervous system;mouse nervous system;broadmatch
mouse neuroblast;mouse nervous system;broadmatch
mouse gallbladder;mouse biliary tract;broadmatch
mouse stomach;mouse gastrointestinal tract;broadmatch
aggressive osteoblastoma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
signet ring cell adenocarcinoma of the mouse intestinal tract;adenocarcinoma of the mouse intestinal tract;broadmatch
leiomyosarcoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
leiomyosarcoma of the mouse intestinal tract;mouse malignant mesenchymal neoplasm;broadmatch
fibrosarcoma of the mouse intestinal tract;mouse fibrosarcoma;broadmatch
fibrosarcoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
fibrosarcoma of the mouse intestinal tract;mouse malignant mesenchymal neoplasm;broadmatch
squamous cell carcinoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
squamous cell carcinoma of the mouse intestinal tract;mouse squamous cell carcinoma;broadmatch
villous adenocarcinoma of the mouse intestinal tract;adenocarcinoma of the mouse intestinal tract;broadmatch
mouse gastrointestinal tract;mouse digestive system;broadmatch
mucinous adenocarcinoma of the mouse intestinal tract;adenocarcinoma of the mouse intestinal tract;broadmatch
tubular adenocarcinoma of the mouse intestinal tract;adenocarcinoma of the mouse intestinal tract;broadmatch
adenocarcinoma of the mouse intestinal tract;mouse adenocarcinoma;broadmatch
adenocarcinoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
malignant neoplasms of the mouse intestinal tract;neoplasms of the mouse intestinal tract;broadmatch
neuroendocrine adenoma of the mouse intestinal tract;adenoma of the mouse intestinal tract;broadmatch
hemangioma of the mouse intestinal tract;benign neoplasms of the mouse intestinal tract;broadmatch
leiomyosarcoma of the mouse intestinal tract;mouse leiomyosarcoma;broadmatch
lymphoma of the mouse intestinal tract;mouse lymphoma;broadmatch
lymphoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
hemangiosarcoma of the mouse intestinal tract;mouse malignant mesenchymal neoplasm;broadmatch
mouse pharynx;mouse digestive system;broadmatch
mouse salivary gland;mouse digestive system;broadmatch
mouse oral cavity;mouse digestive system;broadmatch
mouse digestive system;mouse anatomy concepts;broadmatch
mouse blood vessel;mouse cardiovascular system;broadmatch
mouse heart;mouse cardiovascular system;broadmatch
mouse cardiovascular system;mouse anatomy concepts;broadmatch
mouse prostate gland;mouse male reproductive system;broadmatch
mouse male reproductive system;mouse reproductive system;broadmatch
mouse anatomy concepts;experimental organism anatomical concept;broadmatch
neuroendocrine cell carcinoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
liposarcoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
liposarcoma of the mouse intestinal tract;mouse liposarcoma;broadmatch
hemangiosarcoma of the mouse intestinal tract;mouse angiosarcoma;broadmatch
hemangiosarcoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
mouse connective tissue;mouse soft tissue;broadmatch
mouse adipose tissue;mouse soft tissue;broadmatch
mouse periosteum;mouse soft tissue;broadmatch
hemangiopericytoma of the mouse blood vessel, benign;hemangioma of the mouse blood vessel;broadmatch
hemangioblastoma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
acquired tufted hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
angiofibroma of the mouse blood vessel, nos;mouse primary tumors of the blood vessel;broadmatch
hemangiopericytoma of the mouse blood vessel, malignant;hemangioma of the mouse blood vessel;broadmatch
hemangiopericytoma of the mouse blood vessel, malignant;mouse hemangiopericytoma;broadmatch
hemangiopericytoma of the mouse blood vessel, nos;hemangioma of the mouse blood vessel;broadmatch
hemangiopericytoma of the mouse blood vessel, nos;mouse hemangiopericytoma;broadmatch
hemangiopericytoma of the mouse blood vessel, benign;mouse hemangiopericytoma;broadmatch
mouse special sensory organ;mouse anatomy concepts;broadmatch
verrucous keratotic hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
angiokeratoma of the mouse blood vessel;mouse primary tumors of the blood vessel;broadmatch
kaposi sarcoma of the mouse blood vessel;mouse kaposi's sarcoma;broadmatch
kaposi sarcoma of the mouse blood vessel;mouse primary tumors of the blood vessel;broadmatch
spindle cell hemangioendothelioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
endovascular papillary angioendothelioma of the mouse blood vessel;mouse primary tumors of the blood vessel;broadmatch
kupffer cell sarcoma of the mouse blood vessel;mouse angiosarcoma;broadmatch
mouse skeletal system neoplasms;mouse neoplasms by location;broadmatch
mouse skeletal system neoplasms;mouse skeletal system disorder;broadmatch
osteoma of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
osteosarcoma of the mouse skeletal system, nos;osteosarcoma of the mouse skeletal system;broadmatch
osteoblastoma of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
intracortical osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
high grade surface osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
periosteal osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
parosteal osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
osteoid osteoma of the mouse skeletal system, nos;mouse skeletal system neoplasms;broadmatch
intraosseous well differentiated osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
central osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
small cell osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
osteosarcoma in paget disease of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
telangiectatic osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
fibroblastic osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
chondroblastic osteosarcoma of the mouse skeletal system;osteosarcoma of the mouse skeletal system;broadmatch
osteosarcoma of the mouse skeletal system;mouse osteosarcoma;broadmatch
osteosarcoma of the mouse skeletal system;mouse skeletal system neoplasms;broadmatch
kupffer cell sarcoma of the mouse blood vessel;mouse primary tumors of the blood vessel;broadmatch
intramuscular hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
capillary hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
mouse cardiac malignant fibrous histiocytoma;mouse primary cardiac tumors;broadmatch
mouse cardiac fibrosarcoma;mouse fibrosarcoma;broadmatch
mouse cardiac fibrosarcoma;mouse cardiac sarcoma;broadmatch
mouse cardiac mesothelioma;mouse primary cardiac tumors;broadmatch
mouse cardiac mesothelioma;mouse mesothelioma;broadmatch
mouse cardiac rhabdomyosarcoma;mouse rhabdomyosarcoma;broadmatch
mouse cardiac rhabdomyosarcoma;mouse cardiac sarcoma;broadmatch
mouse cardiac angiosarcoma;mouse angiosarcoma;broadmatch
mouse cardiac angiosarcoma;mouse cardiac sarcoma;broadmatch
mouse cardiac sarcoma;mouse primary cardiac tumors;broadmatch
mouse cardiac sarcoma;mouse sarcoma;broadmatch
mouse primary cardiac tumors;mouse cardiovascular system neoplasms;broadmatch
mouse bladder;mouse urinary system;broadmatch
mouse urinary system;mouse anatomy concepts;broadmatch
mouse nasal cavity;mouse nose;broadmatch
mouse nose;mouse special sensory organ;broadmatch
mouse cardiac malignant fibrous histiocytoma;mouse malignant mesenchymal neoplasm;broadmatch
mouse cardiac kaposi's sarcoma;mouse cardiac sarcoma;broadmatch
hemangioendothelioma of the mouse blood vessel, malignant;hemangioma of the mouse blood vessel;broadmatch
mouse cardiac kaposi's sarcoma;mouse kaposi's sarcoma;broadmatch
hemangioendothelioma of the mouse blood vessel, nos;hemangioma of the mouse blood vessel;broadmatch
hemangioendothelioma of the mouse blood vessel, benign;hemangioma of the mouse blood vessel;broadmatch
hemangioma of the mouse blood vessel, nos;hemangioma of the mouse blood vessel;broadmatch
epithelioid hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
epithelioid hemangioma of the mouse blood vessel, malignant;epithelioid hemangioma of the mouse blood vessel;broadmatch
epithelioid hemangioma of the mouse blood vessel, nos;epithelioid hemangioma of the mouse blood vessel;broadmatch
racemose hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
venous hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
cavernous hemangioma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
hemangiosarcoma of the mouse blood vessel;hemangioma of the mouse blood vessel;broadmatch
hemangioma of the mouse blood vessel;mouse primary tumors of the blood vessel;broadmatch
hemangioma of the mouse blood vessel;mouse angioma;broadmatch
mouse primary tumors of the blood vessel;mouse cardiovascular system neoplasms;broadmatch
mouse cardiovascular system neoplasms;mouse cardiovascular system disorder;broadmatch
mouse cardiovascular system neoplasms;mouse neoplasms by location;broadmatch
non-neoplastic digestive system disorder;non-neoplastic disorder by site;broadmatch
genital human papillomavirus infection;anogenital human papillomavirus infection;broadmatch
localized disease;clinical course of disease;broadmatch
embryonic nervous system;other embryologic structure;broadmatch
neural crest;other embryologic structure;broadmatch
midgut;other embryologic structure;broadmatch
trisomy;aneuploidy;broadmatch
chromosomal translocation;chromosomal rearrangement;broadmatch
hindgut;other embryologic structure;broadmatch
gonadal cord;other embryologic structure;broadmatch
foregut;other embryologic structure;broadmatch
embryonic disc;other embryologic structure;broadmatch
skeletal system part;musculoskeletal system part;broadmatch
embryonic structure or system;anatomic structure, system, or substance;broadmatch
cortical cord;other embryologic structure;broadmatch
cloacal membrane;other embryologic structure;broadmatch
thrombophlebitis;non-neoplastic vascular disorder;broadmatch
splenic tissue;spleen part;broadmatch
splenic tissue;tissue;broadmatch
gastrointestinal tract;digestive system part;broadmatch
neuroectoderm;ectoderm;broadmatch
neuroectoderm;neuroepithelial tissue;broadmatch
tuberculosis;mycobacterial infection;broadmatch
other embryologic structure;embryonic structure or system;broadmatch
vocal cord polyp;polyp;broadmatch
vocal cord polyp;non-neoplastic laryngeal disorder;broadmatch
viral infection;infectious disorder;broadmatch
macrocytic anemia;anemia;broadmatch
autoimmune hemolytic anemia;immune hemolytic anemia;broadmatch
acquired hemolytic anemia;hemolytic anemia;broadmatch
hemolytic anemia;normocytic anemia;broadmatch
amyotrophic lateral sclerosis;central nervous system degenerative disorder;broadmatch
congenital adrenal hyperplasia;congenital adrenal gland disorder;broadmatch
achondroplasia;non-neoplastic bone disorder;broadmatch
abdominal mass;mass;broadmatch
urinary system disorder;genitourinary system disorder;broadmatch
ulcer;injury;broadmatch
tumor lysis syndrome;cancer-related condition;broadmatch
tumor lysis syndrome;neoplastic syndrome;broadmatch
thrombocytopenia;cytopenia;broadmatch
polymerization;biochemical reaction;broadmatch
basophilia;abnormal hematology test result;broadmatch
mouse pancreatic disorder;mouse digestive system disorder;broadmatch
malignant mouse pancreatic neoplasm;mouse pancreatic neoplasm;broadmatch
mouse mixed acinar/islet cell adenoma;benign mouse pancreatic neoplasm;broadmatch
mouse acinar cell adenoma;benign mouse pancreatic neoplasm;broadmatch
benign mouse pancreatic neoplasm;mouse pancreatic neoplasm;broadmatch
mouse pancreatic acinar neoplasm;mouse pancreatic neoplasm;broadmatch
mouse pancreatic neoplasm;mouse pancreatic disorder;broadmatch
mouse pancreatic neoplasm;mouse digestive system neoplasms;broadmatch
mediastinum part;body part;broadmatch
cell part;body part;broadmatch
kidney part;urinary system part;broadmatch
anatomic surface;body part;broadmatch
fossa;body part;broadmatch
lumbar region;spinal region;broadmatch
hypochondriac region;body region;broadmatch
swelling;sign;broadmatch
endocervical mucosa;mucosa;broadmatch
mouse pancreatic ductal adenocarcinoma;malignant mouse pancreatic neoplasm;broadmatch
mouse acinar cell adenocarcinoma;malignant mouse pancreatic neoplasm;broadmatch
mouse islet cell carcinoma;malignant mouse pancreatic neoplasm;broadmatch
mouse islet cell adenocarcinoma;mouse islet cell carcinoma;broadmatch
reproductive system part;body part;broadmatch
autonomic nervous system part;peripheral nervous system part;broadmatch
embryonic urogenital system;other embryologic structure;broadmatch
trilaminar embryonic disc;embryonic disc;broadmatch
gastrula;embryo;broadmatch
mouse pancreatic intraepithelial neoplasia-1a;mouse pancreatic intraepithelial neoplasia-1;broadmatch
extraembryonic structure;embryonic structure or system;broadmatch
mouse insulinoma;mouse islet cell neoplasm;broadmatch
mouse somatostatinoma;mouse islet cell neoplasm;broadmatch
mouse islet cell adenoma;mouse islet cell neoplasm;broadmatch
mouse islet cell neoplasm;mouse pancreatic neoplasm;broadmatch
mouse pancreatic intraepithelial neoplasia-3;mouse pancreatic neoplasm;broadmatch
mouse pancreatic intraepithelial neoplasia-2;mouse pancreatic neoplasm;broadmatch
mouse pancreatic intraepithelial neoplasia-1b;mouse pancreatic intraepithelial neoplasia-1;broadmatch
mouse pancreatic intraepithelial neoplasia-1;mouse pancreatic neoplasm;broadmatch
peritoneal effusion;effusion;broadmatch
vomiting;nausea and vomiting;broadmatch
spinal cord part;central nervous system part;broadmatch
breast adenosis;non-neoplastic breast disorder;broadmatch
parakeratosis;morphologic finding;broadmatch
pancytopenia;cytopenia;broadmatch
wdha syndrome;neoplastic syndrome;broadmatch
wdha syndrome;endocrine syndrome;broadmatch
noonan syndrome;syndrome;broadmatch
nephrotic syndrome;syndrome;broadmatch
nephrotic syndrome;non-neoplastic kidney disorder;broadmatch
mucous polyp of cervix;cervical non-neoplastic disorder;broadmatch
klinefelter syndrome;endocrine syndrome;broadmatch
metrorrhagia;reproductive system hemorrhage;broadmatch
metrorrhagia;female reproductive system finding;broadmatch
menstrual disorder;ovarian non-neoplastic disorder;broadmatch
mass;finding;broadmatch
lymphocytosis;abnormal hematology test result;broadmatch
lower back pain;back pain;broadmatch
chronic monocytic leukemia;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
postmenopausal hemorrhage;female reproductive system finding;broadmatch
postmenopausal hemorrhage;reproductive system hemorrhage;broadmatch
pregnancy complication;complication;broadmatch
pregnancy complication;pregnancy finding;broadmatch
genital leukoplakia;leukoplakia;broadmatch
tracheal disorder;respiratory system disorder;broadmatch
dental disorder;oral cavity disorder;broadmatch
tobacco use disorder;behavioral disorder;broadmatch
immune system disorder;immune system and related disorders;broadmatch
adrenal cortical hyperplasia;adrenal hyperplasia;broadmatch
strabismus;non-neoplastic vision disorder;broadmatch
endometrial disorder;uterine disorder;broadmatch
schistosomiasis;parasitic infection;broadmatch
peripheral motor neuropathy;peripheral neuropathy;broadmatch
reticuloendothelial hyperplasia;hyperplasia;broadmatch
pure red cell aplasia;non-neoplastic hematologic and lymphocytic disorder;broadmatch
hypercalcemia of malignancy;hypercalcemia;broadmatch
ectopic pregnancy;pregnancy disorder;broadmatch
toxemia of pregnancy;hypertension-associated pregnancy disorder;broadmatch
leg pain;pain in extremity;broadmatch
cystic kidney disease;non-neoplastic kidney disorder;broadmatch
bone marrow disorder;hematopoietic and lymphoid system disorder;broadmatch
fluid discharge;body substance discharge;broadmatch
intermediate grade lymphoma;lymphoma by working formulation (antiquated);broadmatch
endomyocardial fibrosis;non-neoplastic heart disorder;broadmatch
high grade lymphoma;lymphoma by working formulation (antiquated);broadmatch
empyema;bacterial infection;broadmatch
vulvar dystrophy;vulvar non-neoplastic disorder;broadmatch
skin pigmentation disorder;non-neoplastic skin disorder;broadmatch
disturbance of skin sensation;sensory manifestations;broadmatch
zollinger ellison syndrome;neoplastic syndrome;broadmatch
iris disorder;uveal disorder;broadmatch
zollinger ellison syndrome;endocrine syndrome;broadmatch
cystic endometrial hyperplasia;endometrial hyperplasia;broadmatch
conn syndrome;endocrine syndrome;broadmatch
scar;fibrosis;broadmatch
choroid disorder;uveal disorder;broadmatch
weight loss;weight change;broadmatch
burn;injury;broadmatch
erythroid hyperplasia;abnormal bone marrow test result;broadmatch
fibrous dysplasia;bone tumor of undefined neoplastic nature;broadmatch
polyostotic fibrous dysplasia;fibrous dysplasia;broadmatch
flank pain;pain;broadmatch
severe combined immunodeficiency;congenital combined immunodeficiency;broadmatch
hypersplenism;splenic disorder;broadmatch
hypergammaglobulinemia;abnormal blood chemistry and hematology test result;broadmatch
inguinal hernia;hernia;broadmatch
diaphragmatic hernia;hernia;broadmatch
hernia;congenital or acquired anatomic abnormality;broadmatch
heart block by ecg finding;arrhythmia by ecg finding;broadmatch
headache;neurological signs and symptoms;broadmatch
hair disorder;skin disorder;broadmatch
gout;metabolic disorder;broadmatch
gout;arthritis;broadmatch
adult diffuse small cleaved cell lymphoma;malignant non-hodgkin lymphoma, cleaved cell;broadmatch
gallbladder disorder;biliary system disorder;broadmatch
diffuse mixed cell lymphoma;mixed cell lymphoma;broadmatch
low grade lymphoma;lymphoma by working formulation (antiquated);broadmatch
cell surface;cell structure;broadmatch
peripheral nervous system part;nervous system part;broadmatch
membrane of the brain or spinal cord;central nervous system part;broadmatch
pulmonary acinus;respiratory system part;broadmatch
renal vein;vein;broadmatch
renal tissue;tissue;broadmatch
psoriasis;dermatitis;broadmatch
refractile media;eye part;broadmatch
pruritus;integumentary system signs and symptoms;broadmatch
pyriform sinus;sinus;broadmatch
pulmonary lobule;lung tissue;broadmatch
pseudostratified epithelium;epithelium;broadmatch
pluripotent bone marrow stem cell;bone marrow stem cell;broadmatch
prostatic tissue;tissue;broadmatch
precancerous condition;cancer-related condition;broadmatch
primordial germ cell;embryonic cell;broadmatch
primordial germ cell;germ cell;broadmatch
polyp;disease or disorder;broadmatch
fibroepithelial polyp;polyp;broadmatch
posterior mediastinum;mediastinum part;broadmatch
rete testis;male reproductive system part;broadmatch
sexual dysfunction;sexual dysfunction and infertility;broadmatch
retinal pigment epithelium;epithelium;broadmatch
retinal pigment epithelium;retina layer;broadmatch
simple epithelium;epithelium;broadmatch
simple cuboidal epithelium;simple epithelium;broadmatch
simple cuboidal epithelium;cuboidal epithelium;broadmatch
simple columnar epithelium;simple epithelium;broadmatch
simple columnar epithelium;columnar epithelium;broadmatch
sheath of schwann;nerve sheath;broadmatch
serous salivary gland;salivary gland;broadmatch
sensory-somatic nervous system;peripheral nervous system part;broadmatch
second portion of the duodenum;digestive system part;broadmatch
sebaceous gland;exocrine gland;broadmatch
rectal polyp;colorectal polyp;broadmatch
salivary gland tissue;tissue;broadmatch
sacral region;spinal region;broadmatch
right lumbar region;lumbar region;broadmatch
right inguinal region;inguinal region;broadmatch
posterior cranial fossa;fossa;broadmatch
pluripotent bone marrow stem cell;pluripotent stem cell;broadmatch
solitary reticulohistiocytoma;non-neoplastic soft tissue disorder;broadmatch
minor salivary gland;salivary gland;broadmatch
neck muscle;head and neck muscle;broadmatch
nasolacrimal duct;head and neck part;broadmatch
nasolacrimal duct;duct;broadmatch
nail;integumentary system part;broadmatch
myofibroblast;fibroblast;broadmatch
myoepithelial cell;epithelial cell;broadmatch
mucous salivary gland;salivary gland;broadmatch
middle cranial fossa;fossa;broadmatch
plantar region;body region;broadmatch
paraneoplastic syndrome;cancer-related condition;broadmatch
paraneoplastic syndrome;syndrome;broadmatch
mesothelium;tissue;broadmatch
mesothelial cell;cell;broadmatch
mesentery;body part;broadmatch
meningothelial cell;cell;broadmatch
meningeal layer of the dura mater;meninges;broadmatch
neural retina;retina layer;broadmatch
nonmembranous cytoplasmic organelle;cytoplasmic organelle;broadmatch
pericardial effusion;effusion;broadmatch
olfactory mucosa;mucosa;broadmatch
pineocyte;neuroepithelial cell;broadmatch
phalanx;bone;broadmatch
pleural effusion;effusion;broadmatch
perineum;body region;broadmatch
parathyroid gland tissue;tissue;broadmatch
skin discoloration;integumentary system signs and symptoms;broadmatch
skin discoloration;integumentary system finding;broadmatch
c-cell;neuroendocrine cell;broadmatch
ovarian tissue;endocrine reproductive tissue;broadmatch
ovarian medulla;ovarian tissue;broadmatch
ovarian follicle;female reproductive system part;broadmatch
ovarian cortex;ovarian tissue;broadmatch
organ of special sense;organ;broadmatch
omentum;body part;broadmatch
olfactory sulcus;frontal sulcus;broadmatch
sinus;body part;broadmatch
skin of the face;skin;broadmatch
central nervous system part;nervous system part;broadmatch
umbilical region;body region;broadmatch
vascular system;cardiovascular system part;broadmatch
vascular smooth muscle tissue;blood vessel tissue;broadmatch
vascular smooth muscle tissue;smooth muscle tissue;broadmatch
uterine gland;female reproductive system part;broadmatch
urothelial cell;transitional cell;broadmatch
splenomegaly;sign or symptom;broadmatch
undersurface of the frontal lobe;brain part;broadmatch
tunica vaginalis;male reproductive system part;broadmatch
thyroid gland follicular cell;glandular cell;broadmatch
tunica intima;blood vessel tissue;broadmatch
trunk;body region;broadmatch
spinal cord compression;cancer-related condition;broadmatch
tracheal epithelium;pseudostratified columnar ciliated epithelium;broadmatch
odontogenic tissue;connective and soft tissue;broadmatch
tooth cell;cell;broadmatch
thyrotroph cell;acidophilic cell;broadmatch
venous system;cardiovascular system part;broadmatch
vermis;brain part;broadmatch
vertebral canal;skeletal system part;broadmatch
white matter;nerve tissue;broadmatch
superior vena cava syndrome;cancer-related condition;broadmatch
superior vena cava syndrome;syndrome;broadmatch
thymic tissue;tissue;broadmatch
ectoderm cell;embryonic cell;broadmatch
endoderm cell;embryonic cell;broadmatch
precursor b-lymphoblast;immature b-lymphocyte;broadmatch
precursor b-lymphoblast;lymphoblast;broadmatch
precursor t-lymphoblast;immature t-lymphocyte;broadmatch
precursor t-lymphoblast;lymphoblast;broadmatch
glandular cell;epithelial cell;broadmatch
endometrial stromal cell;endometrioid stromal cell;broadmatch
endocervical columnar cell;columnar cell;broadmatch
other anatomic concept;anatomic structure, system, or substance;broadmatch
mouse ovarian serous adenocarcinoma;mouse malignant ovarian neoplasm;broadmatch
cerebrovascular accident;cerebrovascular disorder;broadmatch
thyroid gland tissue;tissue;broadmatch
thyroid gland follicular cell;endocrine cell;broadmatch
skin squamous cell;squamous cell;broadmatch
spermatogenic cell;germ cell;broadmatch
stratum reticulare;skin part;broadmatch
stratified epithelium;epithelium;broadmatch
stratified columnar epithelium;stratified epithelium;broadmatch
stratified columnar epithelium;columnar epithelium;broadmatch
sternocleidomastoid muscle;neck muscle;broadmatch
splenic pulp;splenic tissue;broadmatch
supernumerary circular chromosome;cytogenetic abnormality;broadmatch
somatotroph cell;acidophilic cell;broadmatch
thyroid gland follicle;thyroid gland epithelial tissue;broadmatch
small intestinal wall tissue;intestinal wall tissue;broadmatch
small intestinal mucosa;intestinal mucosa;broadmatch
small intestinal mucosa;small intestinal wall tissue;broadmatch
small intestinal glandular cell;enterocyte;broadmatch
skin tissue;skin part;broadmatch
skin tissue;soft tissue;broadmatch
skin squamous cell;cell of the epidermis;broadmatch
striated muscle cell;muscle cell;broadmatch
stroma of the ovarian cortex;female reproductive system part;broadmatch
subcutis;skin tissue;broadmatch
superficial intracranial venous system;intracranial venous system;broadmatch
thyroid gland follicle;glandular epithelial tissue;broadmatch
thymus medulla;thymic tissue;broadmatch
thymic epithelial cell;epithelial cell;broadmatch
thalamencephalon;brain part;broadmatch
testicular tissue;endocrine reproductive tissue;broadmatch
terminal ductal lobular unit cell;glandular cell;broadmatch
skin tag;fibroepithelial polyp;broadmatch
skin tag;non-neoplastic skin disorder;broadmatch
skin nodule;integumentary system signs and symptoms;broadmatch
sweat gland;exocrine gland;broadmatch
skin disorder;disorder by site;broadmatch
supporting cell of the nervous system;neuron, neuroepithelial cell, and supporting cell of the nervous system;broadmatch
digestive system signs and symptoms;digestive system finding;broadmatch
digestive system signs and symptoms;sign or symptom;broadmatch
finding;disease, disorder or finding;broadmatch
congenital genitourinary abnormality;congenital systemic disorder;broadmatch
vascular disorder;cardiovascular disorder;broadmatch
viral hepatitis;hepatitis;broadmatch
tumor cell necrosis;necrotic change;broadmatch
cavernous lymphatic space formation;dilated thin-walled vascular space formation;broadmatch
vascular morphologic change;morphologic finding;broadmatch
atypical mitotic figures;morphologic finding;broadmatch
low mitotic activity;mitotic activity;broadmatch
high mitotic activity;mitotic activity;broadmatch
mitotic activity;morphologic finding;broadmatch
comedo-like necrosis;tumor cell necrosis;broadmatch
fibrinoid necrosis;necrotic change;broadmatch
pineocytomatous rosette formation;rosette formation;broadmatch
absence of stromal invasion;absence of invasion;broadmatch
stromal invasion;morphologic finding;broadmatch
hydropic villous change;hydropic change;broadmatch
keratin pearls formation;prominent keratin formation;broadmatch
enamel formation;morphologic finding;broadmatch
dentin formation;morphologic finding;broadmatch
cementum formation;morphologic finding;broadmatch
cavernous lymphatic space formation;cavernous vascular space formation;broadmatch
dilated thin-walled vascular space formation;dilated vascular space formation;broadmatch
intravascular thrombus formation;vascular morphologic change;broadmatch
thin-walled branching vascular pattern;vascular morphologic change;broadmatch
nuclear atypia;atypia;broadmatch
metaplastic bone formation;morphologic finding;broadmatch
emperipolesis;morphologic finding;broadmatch
hemophagocytosis;morphologic finding;broadmatch
lymphoplasmacytic infiltrate;cellular infiltrate;broadmatch
lymphocytic infiltrate;cellular infiltrate;broadmatch
polymorphonuclear cell infiltrate;acute inflammatory infiltrate;broadmatch
eosinophilic infiltrate;acute inflammatory infiltrate;broadmatch
chronic inflammatory infiltrate;inflammatory infiltrate;broadmatch
acute inflammatory infiltrate;inflammatory infiltrate;broadmatch
inflammatory infiltrate;cellular infiltrate;broadmatch
vascular channel formation;vascular morphologic change;broadmatch
arborizing vascular channel formation;vascular channel formation;broadmatch
sinusoidal vascular channel formation;vascular channel formation;broadmatch
staghorn configuration;thin-walled branching vascular pattern;broadmatch
multilayered rosette formation;rosette formation;broadmatch
ependymal rosette formation;rosette formation;broadmatch
red blood cells extravasation;morphologic finding;broadmatch
monophasic pattern;morphologic architectural pattern;broadmatch
macrotrabecular pattern;trabecular pattern;broadmatch
gyriform trabecular pattern;trabecular pattern;broadmatch
trabecular pattern;morphologic architectural pattern;broadmatch
pseudopapillary pattern;morphologic architectural pattern;broadmatch
papillary pattern;morphologic architectural pattern;broadmatch
antoni b pattern;morphologic architectural pattern;broadmatch
antoni a pattern;morphologic architectural pattern;broadmatch
biphasic pattern;morphologic architectural pattern;broadmatch
pseudorosette formation;rosette formation;broadmatch
angiodestructive pattern;morphologic architectural pattern;broadmatch
angiocentric pattern;morphologic architectural pattern;broadmatch
nodular and diffuse pattern;morphologic architectural pattern;broadmatch
diffuse pattern;morphologic architectural pattern;broadmatch
interfollicular pattern;morphologic architectural pattern;broadmatch
multinodular pattern;nodular pattern;broadmatch
acute monocytic leukemia in remission;acute myeloid leukemia in remission;broadmatch
insular pattern;morphologic architectural pattern;broadmatch
alveolar pattern;morphologic architectural pattern;broadmatch
organoid pattern;morphologic architectural pattern;broadmatch
cribriform pattern;morphologic architectural pattern;broadmatch
homer wright rosette formation;rosette formation;broadmatch
flexner-wintersteiner rosette formation;rosette formation;broadmatch
rosette formation;morphologic finding;broadmatch
tumor vascular invasion;morphologic finding;broadmatch
epithelioid differentiation;tissue differentiation;broadmatch
rhabdomyosarcomatous differentiation;mesenchymal differentiation;broadmatch
honeycomb pattern;morphologic architectural pattern;broadmatch
endodermal sinus pattern;morphologic architectural pattern;broadmatch
glandular pattern;morphologic architectural pattern;broadmatch
triphasic pattern;morphologic architectural pattern;broadmatch
syncytial pattern;morphologic architectural pattern;broadmatch
glomeruloid vessels present;vascular morphologic change;broadmatch
tubular pattern;morphologic architectural pattern;broadmatch
acinar pattern;morphologic architectural pattern;broadmatch
pseudoglandular pattern;morphologic architectural pattern;broadmatch
hemosiderin deposition;deposit;broadmatch
dystrophic calcification;calcification;broadmatch
viral hepatitis;viral infection;broadmatch
anaplastic lesion;lesion by morphology;broadmatch
necrotic lesion;lesion by morphology;broadmatch
benign cellular infiltrate;cellular infiltrate;broadmatch
villous pattern;morphologic architectural pattern;broadmatch
in situ lesion;non-invasive lesion;broadmatch
invasive lesion;lesion by morphology;broadmatch
borderline lesion;premalignant lesion;broadmatch
malignant cellular infiltrate;cellular infiltrate;broadmatch
superficial lesion;lesion;broadmatch
well differentiated malignant neoplasm;malignant neoplasm;broadmatch
encapsulated mass;mass;broadmatch
indolent clinical course;clinical course of disease;broadmatch
aggressive clinical course;clinical course of disease;broadmatch
rapidly enlarging mass;mass;broadmatch
reinke crystals formation;crystal formation;broadmatch
abdominal and gastrointestinal infection;infectious disorder by site;broadmatch
biphasic pulmonary blastoma;epithelial neoplasm (antiquated);broadmatch
microinvasive lesion;invasive lesion;broadmatch
non-malignant cellular infiltrate;cellular infiltrate;broadmatch
non-seminomatous lesion;lesion by morphology;broadmatch
comedo necrosis;necrotic change;broadmatch
progressive clinical course;clinical course of disease;broadmatch
chronic clinical course;clinical course of disease;broadmatch
acute clinical course;clinical course of disease;broadmatch
favorable clinical outcome;clinical course of disease;broadmatch
accelerated phase of disease;clinical course of disease;broadmatch
chronic phase of disease;clinical course of disease;broadmatch
extensive stage lesion;lesion by stage;broadmatch
intermediate grade lesion;lesion by grade;broadmatch
grade 4 lesion;lesion by grade;broadmatch
undifferentiated lesion;lesion by morphology;broadmatch
well differentiated lesion;lesion by morphology;broadmatch
poorly differentiated lesion;lesion by morphology;broadmatch
moderately differentiated lesion;lesion by morphology;broadmatch
low grade lesion;lesion by grade;broadmatch
high grade lesion;lesion by grade;broadmatch
epithelial predominant pulmonary blastoma;epithelial neoplasm (antiquated);broadmatch
undifferentiated malignant neoplasm;malignant neoplasm;broadmatch
ring sideroblasts present;abnormal bone marrow test result;broadmatch
edematous stroma formation;stromal change;broadmatch
verocay bodies present;morphologic finding;broadmatch
dutcher body;nuclear inclusion;broadmatch
ground glass nuclear inclusion;nuclear inclusion;broadmatch
nuclear inclusion;morphologic finding;broadmatch
russell body;morphologic finding;broadmatch
bead-like arrangement of elastic fibers;morphologic finding;broadmatch
nodular neoplasm;neoplasm by special category;broadmatch
desmoplastic stroma formation;stromal change;broadmatch
poorly differentiated malignant neoplasm;malignant neoplasm;broadmatch
chondromyxoid stroma formation;stromal change;broadmatch
fibromyxoid stroma formation;stromal change;broadmatch
hyalinized stroma formation;stromal change;broadmatch
mucoid stroma formation;stromal change;broadmatch
myxoid stroma formation;myxoid changes present;broadmatch
myxoid stroma formation;stromal change;broadmatch
stromal change;abnormal tissue present;broadmatch
call exner bodies present;morphologic finding;broadmatch
starry sky pattern;morphologic finding;broadmatch
diffuse cellular infiltrate;cellular infiltrate;broadmatch
non-invasive lesion;lesion by morphology;broadmatch
moderately differentiated malignant neoplasm;malignant neoplasm;broadmatch
low grade malignant neoplasm;malignant neoplasm by grade;broadmatch
intermediate grade malignant neoplasm;malignant neoplasm by grade;broadmatch
high grade malignant neoplasm;malignant neoplasm by grade;broadmatch
grade 4 malignant neoplasm;malignant neoplasm by grade;broadmatch
grade 3b malignant neoplasm;grade 3 malignant neoplasm;broadmatch
grade 3a malignant neoplasm;grade 3 malignant neoplasm;broadmatch
grade 3 malignant neoplasm;malignant neoplasm by grade;broadmatch
malignant neoplasm by grade;malignant neoplasm;broadmatch
grade 2 malignant neoplasm;malignant neoplasm by grade;broadmatch
grade 1 malignant neoplasm;malignant neoplasm by grade;broadmatch
non-encapsulated neoplasm;neoplasm by special category;broadmatch
villous neoplasm;neoplasm by special category;broadmatch
tubular neoplasm;neoplasm by special category;broadmatch
premalignant neoplasm;neoplasm by special category;broadmatch
nodular pattern;morphologic architectural pattern;broadmatch
vertical growth phase;growth phase;broadmatch
radial growth phase;growth phase;broadmatch
abnormal urine test result;abnormal laboratory test result;broadmatch
digestive system infection;abdominal and gastrointestinal infection;broadmatch
digestive system infection;non-neoplastic digestive system disorder;broadmatch
bone injury;musculoskeletal injury;broadmatch
nucleated red blood cells present;abnormal cells present;broadmatch
behavioral disorder;disease or disorder;broadmatch
clinical course of disease;finding;broadmatch
crystal formation;deposit;broadmatch
liver vascular disorder;vascular disorder;broadmatch
mallory bodies present;morphologic finding;broadmatch
liver vascular disorder;liver and intrahepatic bile duct disorder;broadmatch
cauda equina syndrome;syndrome;broadmatch
cauda equina syndrome;non-neoplastic peripheral nervous system disorder;broadmatch
polycythaemia due to excess erythropoetin production;secondary polycythemia;broadmatch
malignant neoplasm of multiple primary sites;malignant neoplasm;broadmatch
local tumor spread;neoplastic growth or spread;broadmatch
adrenal hyperplasia;hyperplasia;broadmatch
vascular proliferation;vascular morphologic change;broadmatch
abnormal bone marrow test result;abnormal hematology test result;broadmatch
endobronchial mass;pulmonary mass;broadmatch
gastrointestinal polyp;digestive system disorder;broadmatch
astler-coller b1 colon carcinoma;colon cancer by astler-coller stage;broadmatch
astler-coller b1 colon carcinoma;astler-coller b1 colorectal carcinoma;broadmatch
atypical lymphocytes present;abnormal hematology test result;broadmatch
rare neoplastic syndrome;neoplastic syndrome;broadmatch
rare neoplastic syndrome;rare disorder;broadmatch
abnormal blood chemistry and hematology test result;abnormal laboratory test result;broadmatch
cardiovascular system finding;finding by site or system;broadmatch
monoclonal gammopathy;paraproteinemia;broadmatch
myocardial disorder;non-neoplastic heart disorder;broadmatch
hyperkeratosis;morphologic finding;broadmatch
thrombocytosis;abnormal hematology test result;broadmatch
lymph node involvement;extramedullary involvement;broadmatch
leukocytosis;abnormal hematology test result;broadmatch
nasal mass;mass;broadmatch
gastrointestinal polyp;polyp;broadmatch
true histiocytic lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
hemorrhagic change;morphologic finding;broadmatch
junctional proliferation;morphologic architectural pattern;broadmatch
neck mass;mass;broadmatch
eyelid vascular disorder;vascular disorder;broadmatch
eyelid vascular disorder;eyelid disorder;broadmatch
pregnancy disorder;female reproductive system disorder;broadmatch
megakaryocytes increased in bone marrow;abnormal bone marrow test result;broadmatch
hypocellular bone marrow;abnormal bone marrow test result;broadmatch
neutrophilia;abnormal hematology test result;broadmatch
nipple discharge;fluid discharge;broadmatch
pulmonary mass;mass;broadmatch
lytic metastatic bone lesion;lytic bone lesion;broadmatch
adnexal mass;mass;broadmatch
monocytosis;abnormal hematology test result;broadmatch
appendicitis;non-neoplastic appendix disorder;broadmatch
chills;body temperature associated symptom;broadmatch
normocytic anemia;anemia;broadmatch
vision disorder;disorder by site;broadmatch
viral hepatitis;hepatic infection;broadmatch
penile vascular disorder;penile disorder;broadmatch
penile vascular disorder;vascular disorder;broadmatch
mammary duct ectasia;non-neoplastic breast disorder;broadmatch
postcoital bleeding;reproductive system hemorrhage;broadmatch
mediastinal mass;mass;broadmatch
low grade fever;fever;broadmatch
alpha fetoprotein increased;elevated test result;broadmatch
alpha fetoprotein increased;abnormal blood chemistry and hematology test result;broadmatch
alpha fetoprotein increased;afp level finding;broadmatch
lower abdominal pain;abdominal pain;broadmatch
macrocephaly;congenital or acquired anatomic abnormality;broadmatch
poikilocytosis;abnormal hematology test result;broadmatch
anisocytosis;abnormal hematology test result;broadmatch
acanthosis;morphologic finding;broadmatch
skin vascular disorder;vascular disorder;broadmatch
skin vascular disorder;skin disorder;broadmatch
digestive system injury;injury;broadmatch
digestive system injury;digestive system finding;broadmatch
balanitis xerotica obliterans;balanitis;broadmatch
progressive disease;clinical course of disease;broadmatch
erythrophagocytosis;hemophagocytosis;broadmatch
congenital adrenal gland disorder;non-neoplastic endocrine disorder;broadmatch
acute lymphoblastic leukemia in remission;acute leukemia in remission;broadmatch
abnormal hematology test result;abnormal blood chemistry and hematology test result;broadmatch
chronic lymphocytic leukemia in remission;lymphoid leukemia in remission;broadmatch
chronic lymphocytic leukemia in remission;chronic leukemia in remission;broadmatch
radiologic finding;clinical test result;broadmatch
morphologic finding;microscopic finding;broadmatch
cartilaginous metaplasia;mesenchymal metaplasia;broadmatch
acute lymphoblastic leukemia in remission;lymphoid leukemia in remission;broadmatch
osseous metaplasia;mesenchymal metaplasia;broadmatch
congenital adrenal gland disorder;non-neoplastic adrenal gland disorder;broadmatch
plasma cell leukemia in remission;lymphoid leukemia in remission;broadmatch
basal cell hyperplasia;hyperplasia;broadmatch
microaneurysm;aneurysm;broadmatch
melanocytic dysplasia;dysplasia;broadmatch
splenic disorder;hematopoietic and lymphoid system disorder;broadmatch
perivascular fibrosis;fibrosis;broadmatch
reticulin fibrosis of the bone marrow;bone marrow fibrosis;broadmatch
abnormal hematology test result;hematopoietic system finding;broadmatch
anisochromasia;abnormal hematology test result;broadmatch
acute myeloid leukemia in remission;acute leukemia in remission;broadmatch
acute myeloid leukemia in remission;myeloid leukemia in remission;broadmatch
pagetoid proliferation;morphologic architectural pattern;broadmatch
nested pattern;morphologic architectural pattern;broadmatch
lobulated growth pattern;morphologic architectural pattern;broadmatch
plexiform growth pattern;morphologic architectural pattern;broadmatch
chronic myelogenous leukemia, bcr-abl1 positive in remission;myeloid leukemia in remission;broadmatch
chronic myelogenous leukemia, bcr-abl1 positive in remission;chronic leukemia in remission;broadmatch
whorling growth pattern;morphologic architectural pattern;broadmatch
storiform growth pattern;morphologic architectural pattern;broadmatch
herringbone growth pattern;morphologic architectural pattern;broadmatch
morphologic architectural pattern;morphologic finding;broadmatch
polyclonal hypergammaglobulinemia;hypergammaglobulinemia;broadmatch
blast cells increased in bone marrow;blast cells present;broadmatch
blast cells increased in bone marrow;abnormal bone marrow test result;broadmatch
blast cells present in peripheral blood;blast cells present;broadmatch
blast cells present;abnormal hematology test result;broadmatch
hematopoietic and lymphoid system disorder;disorder by site;broadmatch
hypercellular bone marrow;abnormal bone marrow test result;broadmatch
non-neoplastic hair disorder;hair disorder;broadmatch
non-neoplastic heart disorder;non-neoplastic cardiovascular disorder;broadmatch
non-neoplastic vascular disorder;non-neoplastic cardiovascular disorder;broadmatch
hearing loss;hearing impairment;broadmatch
congenital cardiovascular abnormality;congenital systemic disorder;broadmatch
congenital cardiovascular abnormality;non-neoplastic cardiovascular disorder;broadmatch
grade i neuroendocrine carcinoma;epithelial neoplasm (antiquated);broadmatch
grade iii neuroendocrine carcinoma;epithelial neoplasm (antiquated);broadmatch
grade ii neuroendocrine carcinoma;epithelial neoplasm (antiquated);broadmatch
nasopharyngeal disorder;pharyngeal disorder;broadmatch
immunodeficiency-related disorder;immune system and related disorders;broadmatch
positive laboratory test result;laboratory test result;broadmatch
negative test result;clinical test result;broadmatch
astler-coller b2 colon carcinoma;colon cancer by astler-coller stage;broadmatch
astler-coller b2 colon carcinoma;astler-coller b2 colorectal carcinoma;broadmatch
tumor associated fever;fever;broadmatch
carcinomatous ascites;malignant ascites;broadmatch
non-neoplastic vascular disorder;vascular disorder;broadmatch
non-neoplastic heart disorder;heart disorder;broadmatch
non-neoplastic hair disorder;non-neoplastic skin disorder;broadmatch
non-neoplastic heart disorder;non-neoplastic thoracic disorder;broadmatch
non-neoplastic dental disorder;dental disorder;broadmatch
non-neoplastic dental disorder;non-neoplastic oral cavity disorder;broadmatch
ciliary body disorder;uveal disorder;broadmatch
non-neoplastic bile duct disorder;non-neoplastic hepatobiliary disorder;broadmatch
non-neoplastic bile duct disorder;bile duct disorder;broadmatch
normal laboratory test result;laboratory test result;broadmatch
arthropathy;non-neoplastic connective and soft tissue disorder;broadmatch
non-neoplastic respiratory system disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic respiratory system disorder;respiratory system disorder;broadmatch
axillary disorder;thoracic disorder;broadmatch
chest wall disorder;thoracic disorder;broadmatch
sternal disorder;chest wall disorder;broadmatch
non-neoplastic thoracic disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic thoracic disorder;thoracic disorder;broadmatch
thoracic disorder;respiratory and thoracic disorder;broadmatch
membranous cytoplasmic organelle;cytoplasmic organelle;broadmatch
membrane of the brain or spinal cord;membrane;broadmatch
dermatosis;non-neoplastic skin disorder;broadmatch
postsurgical stage iii;hepatoblastoma stage;broadmatch
grade 1;disease grade qualifier;broadmatch
disease grade qualifier;disease morphology qualifier;broadmatch
pretext stage 4;hepatoblastoma stage;broadmatch
pretext stage 3;hepatoblastoma stage;broadmatch
pretext stage 2;hepatoblastoma stage;broadmatch
pretext stage 1;hepatoblastoma stage;broadmatch
postsurgical stage iv;hepatoblastoma stage;broadmatch
postsurgical stage ii;hepatoblastoma stage;broadmatch
stage ivc;stage iv;broadmatch
postsurgical stage i;hepatoblastoma stage;broadmatch
hepatoblastoma stage;disease stage qualifier;broadmatch
limited stage;disease stage qualifier;broadmatch
extensive stage;disease stage qualifier;broadmatch
stage d;disease stage qualifier;broadmatch
stage c;disease stage qualifier;broadmatch
stage b;disease stage qualifier;broadmatch
grade 2;disease grade qualifier;broadmatch
grade 3;disease grade qualifier;broadmatch
grade 3a;grade 3;broadmatch
grade 3b;grade 3;broadmatch
chiasma;other anatomic concept;broadmatch
stage iv testicular non-seminomatous germ cell tumor;germ cell tumor (antiquated);broadmatch
high-risk cancer;disease clinical qualifier;broadmatch
viscera;other anatomic concept;broadmatch
stage is;disease stage qualifier;broadmatch
oncolysis;general qualifier;broadmatch
telangiectasia;vascular ectasia;broadmatch
syndrome;disease or disorder;broadmatch
paresthesia;disturbance of skin sensation;broadmatch
embryo;embryonic structure;broadmatch
disease stage qualifier;disease qualifier;broadmatch
disease clinical qualifier;disease qualifier;broadmatch
disease morphology qualifier;disease qualifier;broadmatch
intermediate grade;histologic grade;broadmatch
grade 4;disease grade qualifier;broadmatch
stage a;disease stage qualifier;broadmatch
stage ii;disease stage qualifier;broadmatch
hot nodule;nodule;broadmatch
radiation toxicity;toxicity;broadmatch
stage iii;disease stage qualifier;broadmatch
stage iic;stage ii;broadmatch
stage iib;stage ii;broadmatch
stage iia;stage ii;broadmatch
stage i;disease stage qualifier;broadmatch
stage 0is;stage 0;broadmatch
stage 0a;stage 0;broadmatch
drug toxicity;toxicity;broadmatch
stage ib2;stage ib cervix;broadmatch
senile sebaceous hyperplasia;sebaceous hyperplasia;broadmatch
lymphoma by lukes-collins classification (antiquated);hematopoietic and lymphoid neoplasm (antiquated);broadmatch
occupational neoplasm;neoplasm by cause;broadmatch
neoplasm by cause;neoplasm by special category;broadmatch
congenital combined immunodeficiency;immunodeficiency syndrome;broadmatch
congenital combined immunodeficiency;genetic disorder;broadmatch
parasitic infection;infectious disorder;broadmatch
stage iv;disease stage qualifier;broadmatch
stage ivs;stage iv;broadmatch
stage v;disease stage qualifier;broadmatch
stage ia;stage i;broadmatch
stage ib1;stage ib cervix;broadmatch
stage 0;disease stage qualifier;broadmatch
myocardial infarction;myocardial disorder;broadmatch
general qualifier;qualifier;broadmatch
disease qualifier;qualifier;broadmatch
toxicity;injury;broadmatch
stage ia2;stage ia;broadmatch
stage ia1;stage ia;broadmatch
stage iiic;stage iii;broadmatch
stage ic;stage i;broadmatch
stage ivb;stage iv;broadmatch
stage iva;stage iv;broadmatch
stage iiib;stage iii;broadmatch
stage iiia;stage iii;broadmatch
stage ib;stage i;broadmatch
cold nodule;nodule;broadmatch
b-cell differentiation;cell differentiation process;broadmatch
endometrial endometrioid adenocarcinoma with small nonvillous papillae;endometrial endometrioid adenocarcinoma with papillae;broadmatch
coagulation disorder;non-neoplastic hematologic and lymphocytic disorder;broadmatch
cerebrovascular disorder;non-neoplastic brain disorder;broadmatch
cerebrovascular disorder;non-neoplastic vascular disorder;broadmatch
central nervous system disorder;nervous system disorder;broadmatch
cardiovascular disorder;disorder by site;broadmatch
bronchitis;non-neoplastic lung disorder;broadmatch
non-neoplastic breast disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic breast disorder;breast disorder;broadmatch
bladder disorder;urinary system disorder;broadmatch
rheumatoid arthritis;rheumatologic disorder;broadmatch
biliary system disorder;hepatobiliary disorder;broadmatch
benign prostatic hyperplasia;hyperplasia;broadmatch
psychiatric disorder;disease or disorder;broadmatch
bacterial infection;infectious disorder;broadmatch
autoimmune disease;immune system disorder;broadmatch
ascites;peritoneal disorder;broadmatch
rheumatoid arthritis;autoimmune disease;broadmatch
cervical polyp;uterine polyp;broadmatch
cervical polyp;cervical disorder;broadmatch
cytogenetic abnormality;molecular abnormality;broadmatch
cirrhosis;non-neoplastic liver and intrahepatic bile duct disorder;broadmatch
diabetes mellitus;non-neoplastic endocrine pancreas disorder;broadmatch
dermatitis;dermatosis;broadmatch
dysphagia;digestive system signs and symptoms;broadmatch
dysphagia;ctrp disease finding;broadmatch
cytopenia;abnormal hematology test result;broadmatch
cyst;lesion;broadmatch
cushing syndrome;endocrine syndrome;broadmatch
crohn disease;inflammatory bowel disease;broadmatch
crohn disease;enteritis;broadmatch
well differentiated invasive adenocarcinoma of the mouse prostate gland;invasive adenocarcinoma of the mouse prostate gland;broadmatch
seizure;neurological signs and symptoms;broadmatch
complication;finding by cause;broadmatch
epithelial mesenchymal transition tumor of the mouse mammary gland;malignant neoplasms of the mouse mammary gland;broadmatch
colon polyp;colorectal polyp;broadmatch
ulcerative colitis;inflammatory bowel disease;broadmatch
rheumatoid arthritis;arthritis;broadmatch
arthritis;arthropathy;broadmatch
cysteine peptidase gene;peptidase gene;broadmatch
transport protein gene;ligand binding protein gene;broadmatch
hla-a gene;mhc class i gene;broadmatch
gata1 gene;transcription factor gene;broadmatch
runx1t1 gene;transcription factor gene;broadmatch
pituitary gland chromophobe adenoma;pituitary gland neoplasm (antiquated);broadmatch
g2 to m transition process;interphase process;broadmatch
pituitary gland basophil adenoma;pituitary gland neoplasm (antiquated);broadmatch
adenoma;epithelial neoplasm;broadmatch
fusion gene;gene;broadmatch
arteriovenous malformation/hemangioma;vascular malformation;broadmatch
acquired immunodeficiency syndrome;t-cell immunodeficiency;broadmatch
biochemical process;subcellular process;broadmatch
congenital abnormality;congenital or acquired anatomic abnormality;broadmatch
cell movement;cell movement process;broadmatch
philadelphia chromosome;chromosomal translocation;broadmatch
pericentric inversion;chromosomal inversion;broadmatch
paracentric inversion;chromosomal inversion;broadmatch
hla-a gene;immunoprotein gene;broadmatch
transcription elongation;transcription process;broadmatch
cell maturation;cell growth process;broadmatch
il3 gene;interleukin gene;broadmatch
anorexia;eating disorder;broadmatch
angiokeratoma;vascular ectasia;broadmatch
aneuploidy;numerical chromosomal abnormality;broadmatch
anemia;non-neoplastic hematologic and lymphocytic disorder;broadmatch
cell cycle progression;cell cycle process;broadmatch
stat5b gene;signal transducer and activator of transcription family gene;broadmatch
alzheimer's disease;dementia;broadmatch
rela gene;transcription factor gene;broadmatch
zbtb16 gene;transcription repressor/corepressor gene;broadmatch
granulocytopenia;leukopenia;broadmatch
epithelial proliferative lesions of the mouse pulmonary system;pulmonary proliferative lesions of the mouse;broadmatch
pulmonary proliferative lesions of the mouse;mouse pulmonary disorder;broadmatch
mouse pulmonary disorder;mouse respiratory system disorder;broadmatch
transcription process;gene expression process;broadmatch
kinase;protein family;broadmatch
human papillomavirus infection;viral infection;broadmatch
endometrial endometrioid adenocarcinoma with metaplastic changes;epithelial neoplasm (antiquated);broadmatch
papilledema;edema;broadmatch
female non-neoplastic reproductive system disorder;female reproductive system disorder;broadmatch
penile non-neoplastic disorder;male non-neoplastic reproductive system disorder;broadmatch
penile non-neoplastic disorder;penile disorder;broadmatch
testicular non-neoplastic disorder;male non-neoplastic reproductive system disorder;broadmatch
testicular non-neoplastic disorder;testicular disorder;broadmatch
non-neoplastic reproductive system disorder;reproductive system disorder;broadmatch
non-neoplastic reproductive system disorder;non-neoplastic genitourinary system disorder;broadmatch
female non-neoplastic reproductive system disorder;non-neoplastic reproductive system disorder;broadmatch
male non-neoplastic reproductive system disorder;non-neoplastic reproductive system disorder;broadmatch
non-neoplastic kidney disorder;kidney disorder;broadmatch
male non-neoplastic reproductive system disorder;male reproductive system disorder;broadmatch
non-neoplastic retinal disorder;non-neoplastic eye disorder;broadmatch
non-neoplastic retinal disorder;retinal disorder;broadmatch
conjunctival disorder;eye disorder;broadmatch
non-neoplastic eye disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic eye disorder;eye disorder;broadmatch
non-neoplastic bladder disorder;bladder disorder;broadmatch
placental non-neoplastic disorder;placenta disorder;broadmatch
placental non-neoplastic disorder;female non-neoplastic reproductive system disorder;broadmatch
vulvar non-neoplastic disorder;female non-neoplastic reproductive system disorder;broadmatch
vulvar non-neoplastic disorder;vulvar disorder;broadmatch
neck disorder;head and neck disorder;broadmatch
sinonasal disorder;otolaryngologic disorder;broadmatch
conductive hearing loss;hearing loss;broadmatch
head and neck precancerous condition;precancerous condition by site;broadmatch
head and neck precancerous condition;head and neck disorder;broadmatch
oral cavity disorder;oral disorder;broadmatch
vulvar disorder;female reproductive system disorder;broadmatch
uterine non-neoplastic disorder;female non-neoplastic reproductive system disorder;broadmatch
uterine non-neoplastic disorder;uterine disorder;broadmatch
ovarian non-neoplastic disorder;female non-neoplastic reproductive system disorder;broadmatch
ovarian non-neoplastic disorder;ovarian disorder;broadmatch
cervical non-neoplastic disorder;cervical disorder;broadmatch
cervical non-neoplastic disorder;uterine non-neoplastic disorder;broadmatch
vaginal non-neoplastic disorder;female non-neoplastic reproductive system disorder;broadmatch
vaginal non-neoplastic disorder;vaginal disorder;broadmatch
non-neoplastic bladder disorder;non-neoplastic urinary system disorder;broadmatch
non-neoplastic kidney disorder;non-neoplastic urinary system disorder;broadmatch
non-neoplastic oral disorder;oral disorder;broadmatch
endocrine syndrome;endocrine system disorder;broadmatch
non-neoplastic gonadal disorder;congenital reproductive system abnormality;broadmatch
non-neoplastic adrenal gland disorder;non-neoplastic retroperitoneal disorder;broadmatch
non-neoplastic adrenal gland disorder;adrenal gland disorder;broadmatch
non-neoplastic thyroid gland disorder;non-neoplastic neck disorder;broadmatch
non-neoplastic thyroid gland disorder;thyroid gland disorder;broadmatch
non-neoplastic endocrine disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic endocrine disorder;endocrine system disorder;broadmatch
endocrine syndrome;syndrome;broadmatch
non-neoplastic urinary system disorder;urinary system disorder;broadmatch
non-neoplastic pleural disorder;non-neoplastic thoracic disorder;broadmatch
non-neoplastic pleural disorder;pleural disorder;broadmatch
non-neoplastic lung disorder;non-neoplastic respiratory system disorder;broadmatch
non-neoplastic lung disorder;non-neoplastic thoracic disorder;broadmatch
non-neoplastic lung disorder;lung disorder;broadmatch
non-neoplastic skin disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic skin disorder;skin disorder;broadmatch
non-neoplastic gonadal disorder;gonadal disorder;broadmatch
head and neck disorder;disorder by site;broadmatch
non-neoplastic bone disorder;non-neoplastic musculoskeletal disorder;broadmatch
non-neoplastic bone disorder;connective tissue disorder;broadmatch
non-neoplastic urinary system disorder;non-neoplastic genitourinary system disorder;broadmatch
facial nerve disorder;cranial nerve disorder;broadmatch
abducens nerve disorder;cranial nerve disorder;broadmatch
vagus nerve disorder;cranial nerve disorder;broadmatch
non-neoplastic nervous system disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic nervous system disorder;nervous system disorder;broadmatch
non-neoplastic peripheral nervous system disorder;non-neoplastic nervous system disorder;broadmatch
non-neoplastic peripheral nervous system disorder;peripheral nervous system disorder;broadmatch
non-neoplastic central nervous system disorder;central nervous system disorder;broadmatch
non-neoplastic central nervous system disorder;non-neoplastic nervous system disorder;broadmatch
infectious disorder by site;infectious disorder;broadmatch
peripheral nervous system disorder;nervous system disorder;broadmatch
connective and soft tissue disorder;disorder by site;broadmatch
non-neoplastic soft tissue disorder;soft tissue disorder;broadmatch
non-neoplastic soft tissue disorder;non-neoplastic connective and soft tissue disorder;broadmatch
non-neoplastic oral disorder;non-neoplastic head and neck disorder;broadmatch
non-neoplastic oral cavity disorder;oral cavity disorder;broadmatch
endometrial endometrioid adenocarcinoma with small glands, tubules or cords;epithelial neoplasm (antiquated);broadmatch
"t(9;14)(p13;q32)";chromosomal translocation;broadmatch
female reproductive system precancerous condition;female reproductive system disorder;broadmatch
aromatic dyes-related malignant neoplasm;occupational malignant neoplasm;broadmatch
"t(16;16)(p13.1;q22)";chromosomal translocation;broadmatch
"t(15;17)(q24;q21)";rara gene translocation;broadmatch
"t(2;18)(p12;q21)";chromosomal translocation;broadmatch
"t(1;14)(p22;q32)";chromosome 1 abnormality;broadmatch
"t(1;14)(p22;q32)";chromosomal translocation;broadmatch
high risk colorectal gastrointestinal stromal tumor;high risk gastrointestinal stromal tumor;broadmatch
vulvar lichen sclerosus;vulvar dystrophy;broadmatch
intermediate risk colorectal gastrointestinal stromal tumor;intermediate risk gastrointestinal stromal tumor;broadmatch
low risk colorectal gastrointestinal stromal tumor;low risk gastrointestinal stromal tumor;broadmatch
very low risk colorectal gastrointestinal stromal tumor;very low risk gastrointestinal stromal tumor;broadmatch
very low risk small intestinal gastrointestinal stromal tumor;very low risk gastrointestinal stromal tumor;broadmatch
very low risk gastric gastrointestinal stromal tumor;very low risk gastrointestinal stromal tumor;broadmatch
very low risk esophageal gastrointestinal stromal tumor;very low risk gastrointestinal stromal tumor;broadmatch
very low risk gastrointestinal stromal tumor;connective and soft tissue neoplasm (antiquated);broadmatch
female reproductive system precancerous condition;precancerous condition by site;broadmatch
non-invasive verrucous carcinoma of the penis;epithelial neoplasm (antiquated);broadmatch
polycythemia (excluding polycythemia vera);polycythemia;broadmatch
common acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
endometrial endometrioid adenocarcinoma with papillae;epithelial neoplasm (antiquated);broadmatch
invasive breast carcinoma by histologic grade;invasive breast carcinoma;broadmatch
malignant lymphoma by cell type (working formulation);lymphoma by working formulation (antiquated);broadmatch
aids-related lymphoma by working formulation;lymphoma by working formulation (antiquated);broadmatch
reticulosarcoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
malignant lymphoma, large cell type;malignant lymphoma by cell type (working formulation);broadmatch
diffuse malignant lymphoma;lymphoma by working formulation (antiquated);broadmatch
malignant lymphoma, convoluted;malignant lymphoma by cell type (working formulation);broadmatch
mature t-all;leukemia (antiquated);broadmatch
malignant non-hodgkin lymphoma, cleaved cell;malignant lymphoma by cell type (working formulation);broadmatch
hodgkin's lymphoma (antiquated);hematopoietic and lymphoid neoplasm (antiquated);broadmatch
hodgkin's disease, nodular sclerosis, lymphocyte depletion;hodgkin's lymphoma (antiquated);broadmatch
mycosis fungoides (working formulation);lymphoma by working formulation (antiquated);broadmatch
pre-pre-b acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
pre-b acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
vulvar lichen sclerosus;cutaneous precancerous condition;broadmatch
vulvar lichen sclerosus;female reproductive system precancerous condition;broadmatch
non-neoplastic oral cavity disorder;non-neoplastic oral disorder;broadmatch
non-neoplastic head and neck disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic retroperitoneal disorder;non-neoplastic peritoneal and retroperitoneal disorder;broadmatch
retroperitoneal disorder;peritoneal and retroperitoneal disorder;broadmatch
non-neoplastic peritoneal disorder;non-neoplastic peritoneal and retroperitoneal disorder;broadmatch
non-neoplastic peritoneal disorder;peritoneal disorder;broadmatch
non-neoplastic peritoneal and retroperitoneal disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic peritoneal and retroperitoneal disorder;peritoneal and retroperitoneal disorder;broadmatch
peritoneal and retroperitoneal disorder;disorder by site;broadmatch
non-neoplastic head and neck disorder;head and neck disorder;broadmatch
vulvar lichen sclerosus;lichen sclerosus et atrophicus;broadmatch
non-neoplastic neck disorder;non-neoplastic head and neck disorder;broadmatch
non-neoplastic neck disorder;neck disorder;broadmatch
non-neoplastic laryngeal disorder;non-neoplastic neck disorder;broadmatch
non-neoplastic laryngeal disorder;laryngeal disorder;broadmatch
skull disorder;head and neck disorder;broadmatch
non-neoplastic ear disorder;non-neoplastic head and neck disorder;broadmatch
non-neoplastic ear disorder;ear disorder;broadmatch
non-neoplastic retroperitoneal disorder;retroperitoneal disorder;broadmatch
respiratory and thoracic disorder;disorder by site;broadmatch
non-neoplastic cardiovascular disorder;cardiovascular disorder;broadmatch
non-neoplastic cardiovascular disorder;non-neoplastic disorder by site;broadmatch
"t(1;19)(q23;p13.3)";chromosome 1 abnormality;broadmatch
"t(1;19)(q23;p13.3)";chromosomal translocation;broadmatch
clonal ccnd1 gene rearrangement;clonal gene rearrangement;broadmatch
clonal ccnd1 gene rearrangement;ccnd1 gene rearrangement;broadmatch
"t(11;18)(q21;q21)";11q translocation;broadmatch
loss of chromosome 5q;chromosomal loss;broadmatch
loss of chromosome 5q;chromosome 5 abnormality;broadmatch
"t(2;5)(p23;q35)";rearrangement of 2p23;broadmatch
"t(2;5)(p23;q35)";chromosomal translocation;broadmatch
"t(2;5)(p23;q35)";chromosome 5 rearrangement;broadmatch
psammoma body formation;calcification;broadmatch
"t(2;8)(p11;q24)";chromosomal translocation;broadmatch
previously treated myelodysplastic syndrome;myeloid neoplasm finding;broadmatch
secondary myelofibrosis;cancer-related condition;broadmatch
secondary myelofibrosis;myelofibrosis;broadmatch
diabetes mellitus;glucose metabolism disorder;broadmatch
translational regulation;gene regulation process;broadmatch
translational regulation;translation process;broadmatch
endometrial stroma;female reproductive system part;broadmatch
esophageal tissue;tissue;broadmatch
esophageal squamous cell;squamous cell;broadmatch
esophageal mucosa;esophageal tissue;broadmatch
esophageal mucosa;mucosa;broadmatch
epithelial cell junction;cell junction;broadmatch
epiphysis of the bone;skeletal system part;broadmatch
epigastric region;body region;broadmatch
endometrial glandular cell;glandular cell;broadmatch
dura mater;membrane of the brain or spinal cord;broadmatch
endometrial cavity;body cavity;broadmatch
endometrial cavity;female reproductive system part;broadmatch
endocrine testis;endocrine sex organ;broadmatch
endocrine sex organ;endocrine gland;broadmatch
endocrine cell;secretory cell;broadmatch
endocrine cell;epithelial cell;broadmatch
electron-transport chain of the respiratory enzymes;cell part;broadmatch
exocrine pancreas;exocrine gland;broadmatch
extrahepatic bile duct;bile duct;broadmatch
eye appendage;head and neck part;broadmatch
nausea;nausea and vomiting;broadmatch
ganglion cell layer;retina layer;broadmatch
fundic gland;exocrine gland;broadmatch
fsh cell;gonadotroph cell;broadmatch
frontal sulcus;cerebral sulcus;broadmatch
neoplasm by site;neoplasm;broadmatch
foramen of monroe;brain part;broadmatch
foot;lower extremity part;broadmatch
neoplasm;disease or disorder;broadmatch
flat bone;bone;broadmatch
finger;digit;broadmatch
finger;upper extremity part;broadmatch
cytoskeleton filament;cell part;broadmatch
female urethra;urethra;broadmatch
nausea and vomiting;digestive system signs and symptoms;broadmatch
falciform ligament;liver ligament;broadmatch
eccrine sweat gland;sweat gland;broadmatch
duct salivary gland system;salivary gland tissue;broadmatch
gastric mucosa;mucosa;broadmatch
cardia gland;exocrine gland;broadmatch
cervical lymph node;head and neck lymph node;broadmatch
ceruminous gland;apocrine sweat gland;broadmatch
cerebral sulcus;brain part;broadmatch
cementoblast;tooth cell;broadmatch
cementoblast;osteoblast;broadmatch
cell of the epidermis;cell;broadmatch
cartilaginous tissue;connective tissue;broadmatch
canal of hering;digestive system part;broadmatch
myelofibrosis;bone marrow disorder;broadmatch
bronchus-associated lymphoid tissue;mucosa-associated lymphoid tissue;broadmatch
bronchial tree;organ;broadmatch
bronchial epithelium;pseudostratified columnar ciliated epithelium;broadmatch
meigs syndrome;cancer-related condition;broadmatch
meigs syndrome;neoplastic syndrome;broadmatch
bone surface;anatomic surface;broadmatch
bone of the extremity;bone;broadmatch
chondroblast;cartilage cell;broadmatch
mesenchymoma;connective and soft tissue neoplasm (antiquated);broadmatch
collecting tube;renal tubule;broadmatch
metabolic disorder;non-neoplastic disorder by special category;broadmatch
distal convoluted tubule;convoluted tubule;broadmatch
diaphragma sellae;central nervous system part;broadmatch
musculoskeletal pain;pain;broadmatch
deep intracranial venous system;intracranial venous system;broadmatch
cuboidal epithelium;glandular epithelium;broadmatch
mucocele of the appendix;digestive system finding;broadmatch
oral disorder;otolaryngologic disorder;broadmatch
cowper gland;urethral gland;broadmatch
corticotroph cell;basophilic cell;broadmatch
monosomy;aneuploidy;broadmatch
corneoscleral coat;eye part;broadmatch
squamous metaplasia;epithelial metaplasia;broadmatch
conjunctival epithelium;stratified columnar epithelium;broadmatch
metaplasia;morphologic finding;broadmatch
common carotid artery;carotid artery;broadmatch
gastric glandular cell;glandular cell;broadmatch
gastric mucosa;gastric tissue;broadmatch
translational activation;translational regulation;broadmatch
leptomeninges;meninges;broadmatch
lower gastrointestinal tract;digestive system part;broadmatch
long bone;bone;broadmatch
ovarian cyst;cyst;broadmatch
ovarian cyst;female reproductive system finding;broadmatch
liver ligament;ligament;broadmatch
lh cell;gonadotroph cell;broadmatch
osteoporosis;metabolic bone disorder;broadmatch
left lumbar region;lumbar region;broadmatch
lacrimal apparatus;eye appendage;broadmatch
left hypochondriac region;hypochondriac region;broadmatch
large intestinal wall tissue;intestinal wall tissue;broadmatch
large intestinal mucosa;intestinal mucosa;broadmatch
large intestinal mucosa;large intestinal wall tissue;broadmatch
large intestinal glandular cell;enterocyte;broadmatch
bone paget disease;metabolic bone disorder;broadmatch
lactotroph cell;acidophilic cell;broadmatch
lung tissue;tissue;broadmatch
lymph node by anatomic site;lymph node;broadmatch
lymph node cortex;lymphoid tissue;broadmatch
lymph node cortex;lymph node tissue;broadmatch
mature t-lymphocyte;mature lymphocyte;broadmatch
mature t-lymphocyte;peripheral (post-thymic) t-lymphocyte;broadmatch
pancreatitis;non-neoplastic pancreatic disorder;broadmatch
mature b-lymphocyte;mature lymphocyte;broadmatch
mature b-lymphocyte;b-lymphocyte;broadmatch
marginal zone of the lymph node;marginal zone;broadmatch
marginal zone of the lymph node;lymph node tissue;broadmatch
mantle zone;lymphoid tissue;broadmatch
male urethra;urethra;broadmatch
male breast;breast;broadmatch
lymphoid follicle;lymphoid tissue;broadmatch
lymphatic vessel;cardiovascular system part;broadmatch
lymph node tissue;lymph node part;broadmatch
lymph node tissue;tissue;broadmatch
pain;symptom;broadmatch
lacrimal sac;head and neck part;broadmatch
opportunistic infection;infectious disorder;broadmatch
hereditary neoplastic syndrome;genetic disorder;broadmatch
hand;upper extremity part;broadmatch
epencephalon;brain part;broadmatch
hilar area of the kidney;kidney part;broadmatch
hepatic tissue;hepatobiliary tissue;broadmatch
hepatic lobule;hepatic tissue;broadmatch
hepatic duct;bile duct;broadmatch
hematopoietic and lymphoid cell;cell;broadmatch
head and neck muscle;muscle;broadmatch
hair follicle infundibulum;hair part;broadmatch
islet cell;endocrine cell of the digestive system;broadmatch
hair;integumentary system part;broadmatch
gonadotroph cell;adenohypophysial cell;broadmatch
gingiva;tissue;broadmatch
genito-urinary region;body region;broadmatch
gastroesophageal junction;digestive system part;broadmatch
gastric tissue;tissue;broadmatch
hereditary neoplastic syndrome;neoplastic syndrome;broadmatch
hyaline cartilage;cartilaginous tissue;broadmatch
neuroma;non-neoplastic peripheral nervous system disorder;broadmatch
immature b-lymphocyte;b-lymphocyte;broadmatch
immature b-lymphocyte;immature lymphocyte;broadmatch
irregular bone;bone;broadmatch
intracranial venous system;venous system;broadmatch
intracellular membrane;cellular membrane;broadmatch
interstitial segment of the fallopian tube;female reproductive system part;broadmatch
interstitial cell of cajal;stromal cell;broadmatch
interstitial cell;connective and soft tissue cell;broadmatch
odontoma;non-neoplastic dental disorder;broadmatch
odontoma;hamartoma;broadmatch
obstruction;finding by cause;broadmatch
obesity;sign;broadmatch
interlobular bile duct;intrahepatic bile duct;broadmatch
intercalated duct;duct;broadmatch
inguinal lymph node;lymph node by anatomic site;broadmatch
nodule;congenital or acquired anatomic abnormality;broadmatch
night sweats;sweating;broadmatch
body part;anatomic structure, system, or substance;broadmatch
body of the nail;integumentary system part;broadmatch
blood vessel tissue;soft tissue;broadmatch
mouse ovarian histiocytic sarcoma;mouse malignant ovarian neoplasm;broadmatch
endometriosis;female non-neoplastic reproductive system disorder;broadmatch
endometrial hyperplasia;glandular hyperplasia;broadmatch
endometrial hyperplasia;endometrial disorder;broadmatch
basal transcription factor gene;transcription factor gene;broadmatch
endocrine system disorder;disorder by site;broadmatch
muscle contraction;musculoskeletal process;broadmatch
intermediate filament gene;cytoskeletal gene;broadmatch
mouse ovarian hemangiosarcoma;mouse malignant ovarian neoplasm;broadmatch
mouse ovarian tubulostromal adenocarcinoma;tubulostromal adenocarcinoma;broadmatch
mouse malignant ovarian sertoli cell tumor;mouse malignant ovarian neoplasm;broadmatch
mouse malignant ovarian granulosa cell tumor;mouse malignant ovarian neoplasm;broadmatch
mouse malignant ovarian thecoma;mouse malignant ovarian neoplasm;broadmatch
mouse choriocarcinoma;mouse malignant ovarian neoplasm;broadmatch
mouse yolk sac carcinoma;mouse malignant ovarian neoplasm;broadmatch
tumor embolism;pathologic process;broadmatch
mouse ovarian embryonal carcinoma;mouse malignant ovarian neoplasm;broadmatch
eosinophilia;abnormal hematology test result;broadmatch
seizure disorder;non-neoplastic brain disorder;broadmatch
esophageal disorder;digestive system disorder;broadmatch
exostosis;non-neoplastic bone disorder;broadmatch
heart disorder;cardiovascular disorder;broadmatch
hearing disorder;non-neoplastic ear disorder;broadmatch
hamartoma;non-neoplastic disorder by special category;broadmatch
hairy nevus;pilosebaceous hamartoma;broadmatch
gynecomastia;non-neoplastic breast disorder;broadmatch
biological agent;pharmacologic substance;broadmatch
foreign body granuloma;granuloma;broadmatch
granuloma;lesion;broadmatch
pathologic fracture;fracture;broadmatch
fracture;bone injury;broadmatch
fistula;congenital or acquired anatomic abnormality;broadmatch
fibrosis;morphologic finding;broadmatch
breast fibrocystic change;non-neoplastic breast disorder;broadmatch
fever;sign;broadmatch
fatigue;mental and behavioral signs and symptoms;broadmatch
mouse ovarian cystadenocarcinoma;mouse malignant ovarian neoplasm;broadmatch
mouse ovarian tubulostromal adenocarcinoma;mouse malignant ovarian neoplasm;broadmatch
blood capillary;capillary;broadmatch
enzyme inhibitor gene;gene;broadmatch
dysuria;urinary system finding;broadmatch
dyspnea;alteration in respiration;broadmatch
dyspareunia;genitourinary signs and symptoms;broadmatch
dyspareunia;reproductive system finding;broadmatch
myh11 gene;cytoskeletal gene;broadmatch
col1a2 gene;collagen gene;broadmatch
col1a1 gene;collagen gene;broadmatch
proteinase inhibitor gene;enzyme inhibitor gene;broadmatch
mouse ovarian hemangioma;mouse benign ovarian neoplasm;broadmatch
down syndrome;genetic disorder;broadmatch
down syndrome;syndrome;broadmatch
disseminated intravascular coagulation;coagulation disorder;broadmatch
disease or disorder;disease, disorder or finding;broadmatch
digestive system disorder;disorder by site;broadmatch
inhibition of cancer cell growth;cancer cell growth regulation;broadmatch
diarrhea;disturbance in bowel function;broadmatch
dysuria;genitourinary signs and symptoms;broadmatch
eczema;dermatitis;broadmatch
edema;swelling;broadmatch
translation process;protein expression;broadmatch
mouse benign sex cord stromal mixed tumor;mouse benign ovarian neoplasm;broadmatch
mouse benign sertoli cell tumor;mouse benign ovarian neoplasm;broadmatch
mouse benign granulosa cell tumor;mouse benign ovarian neoplasm;broadmatch
mouse benign thecoma;mouse benign ovarian neoplasm;broadmatch
mouse benign ovarian teratoma;mouse benign ovarian neoplasm;broadmatch
mouse benign luteoma;mouse benign ovarian neoplasm;broadmatch
mouse ovarian cystadenoma;mouse benign ovarian neoplasm;broadmatch
mouse ovarian tubulostromal adenoma;tubulostromal adenoma;broadmatch
mouse ovarian tubulostromal adenoma;mouse benign ovarian neoplasm;broadmatch
mouse malignant ovarian neoplasm;mouse ovarian neoplasm;broadmatch
mouse benign ovarian neoplasm;mouse ovarian neoplasm;broadmatch
mouse ovarian neoplasm;mouse ovarian disorder;broadmatch
effusion;fluid and electrolyte manifestation;broadmatch
mouse ovarian disorder;mouse female reproductive system disorder;broadmatch
translation initiation;translation process;broadmatch
heart disorder;thoracic disorder;broadmatch
congestive heart failure;heart failure;broadmatch
hemangiopericytoma;hemangiopericytic neoplasm;broadmatch
anal gland;exocrine gland;broadmatch
apex of the tongue;organ of special sense part;broadmatch
apex of the lung;respiratory system part;broadmatch
mixed cell lymphoma;intermediate grade lymphoma;broadmatch
anterior cranial fossa;fossa;broadmatch
anal transitional zone;digestive system part;broadmatch
lymphedema;non-neoplastic vascular disorder;broadmatch
anal region;body region;broadmatch
alveolar cell;epithelial cell;broadmatch
hematuria;abnormal urine test result;broadmatch
alpha cell;islet cell;broadmatch
adrenal gland tissue;tissue;broadmatch
activated lymphocyte;lymphocyte;broadmatch
acinar salivary gland system;salivary gland tissue;broadmatch
acidophilic cell;adenohypophysial cell;broadmatch
accessory nerve;cranial nerve;broadmatch
lung disorder;thoracic disorder;broadmatch
apocrine sweat gland;sweat gland;broadmatch
aponeurosis;musculoskeletal system part;broadmatch
malabsorption syndrome;syndrome;broadmatch
malabsorption syndrome;non-neoplastic intestinal disorder;broadmatch
blood capillary;blood vessel;broadmatch
bladder urothelium;urothelium;broadmatch
bladder urothelial cell;urothelial cell;broadmatch
bladder tissue;tissue;broadmatch
bladder mucosa;bladder tissue;broadmatch
bladder mucosa;mucosa;broadmatch
mediastinal cyst;cyst;broadmatch
beta cell;islet cell;broadmatch
basophilic cell;adenohypophysial cell;broadmatch
base of the brain;brain part;broadmatch
axon;nervous system part;broadmatch
axial skeleton;skeletal system part;broadmatch
atrioventricular node;heart part;broadmatch
carcinoid syndrome;ectopic hormone secretion syndrome associated with neoplasia;broadmatch
arm;upper extremity part;broadmatch
lung disorder;respiratory system disorder;broadmatch
breast lump;mass;broadmatch
liver and intrahepatic bile duct disorder;hepatobiliary disorder;broadmatch
hyperthyroidism;non-neoplastic thyroid gland disorder;broadmatch
portal hypertension;hypertension;broadmatch
hypertension;blood pressure finding;broadmatch
hyperplasia;non-neoplastic disorder by special category;broadmatch
hypercalcemia;abnormal blood chemistry and hematology test result;broadmatch
hydrocephalus;non-neoplastic brain disorder;broadmatch
hiv infection;viral infection;broadmatch
histiocytosis;morphologic finding;broadmatch
genetic disorder;disease or disorder;broadmatch
hepatomegaly;digestive system signs and symptoms;broadmatch
hepatitis c infection;chronic viral hepatitis;broadmatch
hepatitis b infection;chronic viral hepatitis;broadmatch
hepatitis;non-neoplastic liver and intrahepatic bile duct disorder;broadmatch
hemoptysis;respiratory system signs and symptoms;broadmatch
hemoglobinopathy;congenital hematological disorder;broadmatch
hematuria;genitourinary signs and symptoms;broadmatch
hyperthyroidism;non-neoplastic endocrine disorder;broadmatch
hypoglycemia;abnormal blood chemistry and hematology test result;broadmatch
linitis plastica;cancer-related condition;broadmatch
immunodeficiency syndrome;syndrome;broadmatch
oral leukoplakia;oral cavity and lip precancerous condition;broadmatch
oral leukoplakia;leukoplakia;broadmatch
leukoplakia;precancerous condition;broadmatch
calla positive lymphoblastic leukemia;leukemia (antiquated);broadmatch
b-cell leukemia;leukemia (antiquated);broadmatch
kidney disorder;urinary system disorder;broadmatch
jaundice;digestive system signs and symptoms;broadmatch
inflammatory bowel disease;inflammatory disorder;broadmatch
inflammatory bowel disease;intestinal precancerous condition;broadmatch
inflammatory bowel disease;non-neoplastic intestinal disorder;broadmatch
inflammation;finding by cause;broadmatch
epidermal inclusion cyst;skin cyst;broadmatch
impotence;sexual dysfunction;broadmatch
impotence;male reproductive system finding;broadmatch
immunodeficiency syndrome;immune system disorder;broadmatch
schwannoma of the mouse skin;benign mesenchymal neoplasms of the mouse skin;broadmatch
schwannoma of the mouse skin;mouse neuroglia neoplasm;broadmatch
hibernoma of the mouse skin;benign mesenchymal neoplasms of the mouse skin;broadmatch
male reproductive system part;reproductive system part;broadmatch
seminiferous tubule;testicular tissue;broadmatch
ligament;musculoskeletal system part;broadmatch
tendon;aponeurosis;broadmatch
joint;skeletal system part;broadmatch
ear part;organ of special sense part;broadmatch
nervous system part;body part;broadmatch
female reproductive system part;reproductive system part;broadmatch
respiratory system part;body part;broadmatch
breast part;body part;broadmatch
urinary system part;body part;broadmatch
immune system part;body part;broadmatch
brain part;central nervous system part;broadmatch
endocrine system part;body part;broadmatch
castration resistance;male reproductive system finding;broadmatch
heart part;cardiovascular system part;broadmatch
skin part;integumentary system part;broadmatch
nephron;renal tissue;broadmatch
lymphoid tissue;hematopoietic and lymphoid tissue;broadmatch
skeletal muscle tissue;striated muscle tissue;broadmatch
hematopoietic tissue;hematopoietic and lymphoid tissue;broadmatch
ependyma;ependyma and remnants of the central canal of the spinal cord;broadmatch
acinar cell;glandular cell;broadmatch
acinar cell;secretory cell;broadmatch
bone tissue;connective tissue;broadmatch
dentition;head and neck part;broadmatch
face;musculoskeletal system part;broadmatch
neck;body region;broadmatch
sensory ganglion;ganglion;broadmatch
synovial cell;connective and soft tissue cell;broadmatch
muscle;musculoskeletal system part;broadmatch
secretory cell;cell;broadmatch
embryonic cell;embryonic structure;broadmatch
embryonic cell;cell;broadmatch
vascular endothelium;endothelium;broadmatch
nerve tissue;nerve tissue and nerve sheaths;broadmatch
constitutional mismatch repair deficiency syndrome;hereditary neoplastic syndrome;broadmatch
experimental organism benign plasma cell tumor;experimental organism neoplasm;broadmatch
alveolar wall;respiratory system part;broadmatch
bone of the lower extremity;bone of the extremity;broadmatch
alveolus;respiratory system part;broadmatch
mouse teratocarcinoma;murine experimental organism diagnosis;broadmatch
rat ovarian adenocarcinoma;rat neoplasms by location;broadmatch
pcm1/jak2 fusion gene;fusion gene;broadmatch
"t(8;9)(p22;p24.1)";chromosomal translocation;broadmatch
monoallelic mutation;gene mutation;broadmatch
biallelic mutation;gene mutation;broadmatch
wall of the pharynx;head and neck part;broadmatch
eye part;organ of special sense part;broadmatch
translocations involving tyrosine kinases or cytokine receptors present;rearrangement detected;broadmatch
pluripotent stem cell;stem cell;broadmatch
cervicomedullary junction;spinal cord part;broadmatch
breast;organ;broadmatch
gata2 gene mutation;gene variant;broadmatch
xp11.2 translocations/tfe3 gene fusions present;rearrangement detected;broadmatch
connective and soft tissue;tissue;broadmatch
neuroblast;neuroectodermal cell;broadmatch
splenic white pulp;lymphoid tissue;broadmatch
splenic white pulp;splenic pulp;broadmatch
cdkn2a gene product;cyclin-dependent kinase inhibitor protein;broadmatch
organ;anatomic structure, system, or substance;broadmatch
lymphoblast;immature lymphocyte;broadmatch
lymphoblast;hematopoietic blast cell;broadmatch
ampulla of vater;digestive system part;broadmatch
pericardium;membrane;broadmatch
multilineage dysplasia present;bone marrow dysplasia present;broadmatch
limited early t-cell differentiation;laboratory test result;broadmatch
endocardium;heart part;broadmatch
ependymal cell;glial cell;broadmatch
cardiomyocyte;striated muscle cell;broadmatch
smooth muscle cell;muscle cell;broadmatch
major salivary gland;salivary gland;broadmatch
vertebral column;skeletal system part;broadmatch
crlf2 gene rearrangement;gene rearrangement abnormality;broadmatch
vestibulocochlear nerve;cranial nerve;broadmatch
neural pathway;peripheral nervous system part;broadmatch
prostatic urethra;urethra part;broadmatch
fgfr3 gene amplification;fgfr gene amplification;broadmatch
nucleus;cell structure;broadmatch
human chromosome;chromosome;broadmatch
bcl6 gene rearrangement;rearrangement of 3q;broadmatch
bcl6 gene rearrangement;gene rearrangement abnormality;broadmatch
chromosome;dna structure;broadmatch
bcl2 gene rearrangement;gene rearrangement abnormality;broadmatch
myc gene rearrangement;gene rearrangement abnormality;broadmatch
chromatin;cell part;broadmatch
11q aberration;cytogenetic abnormality;broadmatch
pold1 gene mutation;dna repair gene mutation;broadmatch
childhood t acute lymphoblastic leukemia in remission;childhood acute lymphoblastic leukemia in remission;broadmatch
amino acid sequence;protein structure;broadmatch
periosteum;bone tissue;broadmatch
columnar epithelium;glandular epithelium;broadmatch
pseudostratified columnar ciliated epithelium;pseudostratified columnar epithelium;broadmatch
stratified squamous epithelium;stratified epithelium;broadmatch
stratified squamous epithelium;squamous epithelium;broadmatch
chromosome 1;human chromosome;broadmatch
chromosome 10;human chromosome;broadmatch
chromosome 11;human chromosome;broadmatch
chromosome 12;human chromosome;broadmatch
chromosome 22;human chromosome;broadmatch
chromosome 21;human chromosome;broadmatch
chromosome 20;human chromosome;broadmatch
chromosome 2;human chromosome;broadmatch
chromosome 19;human chromosome;broadmatch
chromosome 18;human chromosome;broadmatch
chromosome 17;human chromosome;broadmatch
"t(11;12)(p15;p13)";chromosomal translocation;broadmatch
"t(11;12)(p15;p13)";rearrangement of 11p15;broadmatch
"t(11;12)(p15;p13)";chromosome 12 abnormality;broadmatch
chromosome 16;human chromosome;broadmatch
"t(10;11)(p12;q23)";mll gene translocation;broadmatch
chromosome 15;human chromosome;broadmatch
chromosome 14;human chromosome;broadmatch
chromosome 13;human chromosome;broadmatch
pold1 gene mutation;gene variant;broadmatch
pole gene mutation;gene variant;broadmatch
prostatic duct;duct;broadmatch
microsatellite stable;genetic finding;broadmatch
"t(5;11)(q35;p15)";chromosome 5 rearrangement;broadmatch
human papillomavirus negative;negative test result;broadmatch
rb1 negative;expression negative;broadmatch
bovine leukemia;bovine neoplasm;broadmatch
brca2 protein variant;gene product sequence variation;broadmatch
brca1 protein variant;gene product sequence variation;broadmatch
msh2 protein variant;gene product sequence variation;broadmatch
eif1ax gene;translation process gene;broadmatch
pole gene mutation;dna repair gene mutation;broadmatch
7p15-p14;chromosome band;broadmatch
memory b-lymphocyte;mature b-lymphocyte;broadmatch
immature lymphocyte;lymphocyte;broadmatch
tert gene mutation;gene variant;broadmatch
tert gene mutation;telomere maintenance gene mutation;broadmatch
fascia;musculoskeletal system part;broadmatch
prostatic epithelium;epithelium;broadmatch
"t(5;11)(q35;p15)";rearrangement of 11p15;broadmatch
"t(5;11)(q35;p15)";chromosomal translocation;broadmatch
"t(11;15)(p15;q35)";rearrangement of 11p15;broadmatch
"t(11;15)(p15;q35)";chromosomal translocation;broadmatch
cdkn2a negative;expression negative;broadmatch
cdk4 gene amplification;gene amplification abnormality;broadmatch
dna repair gene mutation;gene abnormality;broadmatch
deleterious palb2 gene mutation;deleterious mutation;broadmatch
deleterious palb2 gene mutation;palb2 gene mutation;broadmatch
mucosa;membrane;broadmatch
epicardium;heart part;broadmatch
platelet disorder;non-neoplastic hematologic and lymphocytic disorder;broadmatch
ventricular involvement only;nervous system finding;broadmatch
columnar cell;glandular cell;broadmatch
cuboidal cell;glandular cell;broadmatch
ganglion cell;neuron;broadmatch
bipolar neuron;neuron;broadmatch
olfactory receptor cell;neuroectodermal cell;broadmatch
olfactory receptor cell;bipolar neuron;broadmatch
gut epithelium;epithelium;broadmatch
alk gene rearrangement;receptor tyrosine kinase gene rearrangement;broadmatch
peripheral nerve;peripheral nervous system part;broadmatch
third ventricle;brain ventricle;broadmatch
lumbar plexus;spinal nerve plexus;broadmatch
reproductive system;organ system;broadmatch
pleural cavity;body cavity;broadmatch
lateral ventricle;brain ventricle;broadmatch
conus medullaris;spinal cord part;broadmatch
hypoploidy;aneuploidy;broadmatch
fourth ventricle;brain ventricle;broadmatch
canine sarcoma;canine neoplasm;broadmatch
vein;blood vessel;broadmatch
venule;blood vessel;broadmatch
myd88 protein variant;gene product sequence variation;broadmatch
myd88 gene mutation;gene variant;broadmatch
vena cava;vein;broadmatch
mammary gland type features present;abnormal tissue present;broadmatch
superior vena cava;vein;broadmatch
inferior vena cava;vein;broadmatch
reactive lymphocyte;abnormal lymphocyte;broadmatch
squamous epithelium;epithelium;broadmatch
squamous cell;epithelial cell;broadmatch
female breast;breast;broadmatch
deleterious brca1 gene mutation;deleterious homologous recombination pathway gene mutation;broadmatch
deleterious brca1 gene mutation;deleterious brca gene mutation;broadmatch
bap1 gene mutation;gene variant;broadmatch
igm monoclonal gammopathy;monoclonal gammopathy;broadmatch
submucosal lesion;lesion by morphology;broadmatch
venous sinus;other anatomic concept;broadmatch
unclassifiable lesion;lesion;broadmatch
left atrium;cardiac atrium;broadmatch
right atrium;cardiac atrium;broadmatch
alveolar epithelium;epithelium;broadmatch
transitional cell;epithelial cell;broadmatch
endothelial cell;connective and soft tissue cell;broadmatch
ewsr1 gene translocation;chromosomal translocation;broadmatch
ewsr1 gene translocation;ewsr1 gene rearrangement;broadmatch
sacral vertebra;vertebra;broadmatch
vulvar squamous intraepithelial lesion;vulvar disorder;broadmatch
canine transitional cell carcinoma;canine neoplasm;broadmatch
deleterious brca2 gene mutation;deleterious brca gene mutation;broadmatch
skeletal system;musculoskeletal system part;broadmatch
thorax;body region;broadmatch
thoracic vertebra;vertebra;broadmatch
sympathetic nervous system;autonomic nervous system part;broadmatch
sternum;flat bone;broadmatch
spinal nerve;nerve;broadmatch
spinal nerve root;nerve root;broadmatch
skull;skeletal system part;broadmatch
seminal vesicle;organ;broadmatch
canine histiocytic sarcoma;canine neoplasm;broadmatch
scrotum;skin;broadmatch
experimental organism benign endometrial adenoma;experimental organism neoplasm;broadmatch
respiratory system;organ system;broadmatch
pulmonary vein;vein;broadmatch
pulmonary artery;artery;broadmatch
posterior lobe of the pituitary gland;endocrine system part;broadmatch
anterior lobe of the pituitary gland;endocrine system part;broadmatch
tibia;bone of the lower extremity;broadmatch
tibia;long bone;broadmatch
tissue;anatomic structure, system, or substance;broadmatch
tonsil;organ;broadmatch
mouse testicular teratoma;murine experimental organism diagnosis;broadmatch
canine prostate carcinoma;canine neoplasm;broadmatch
canine leukemia;canine neoplasm;broadmatch
vagus nerve;cranial nerve;broadmatch
uvea;eye part;broadmatch
figo stage iiia2;figo stage iiia;broadmatch
figo stage iiia1(ii);figo stage iiia1;broadmatch
figo stage iiia1(i);figo stage iiia1;broadmatch
figo stage iiia1;figo stage iiia;broadmatch
figo stage ic3;figo stage ic;broadmatch
figo stage ic2;figo stage ic;broadmatch
genitourinary system;organ system;broadmatch
figo stage ic1;figo stage ic;broadmatch
trochlear nerve;cranial nerve;broadmatch
trigeminal nerve;cranial nerve;broadmatch
deleterious brca1 gene mutation;brca1 gene mutation;broadmatch
deleterious brca2 gene mutation;brca2 gene mutation;broadmatch
exocrine system;organ system;broadmatch
h3 protein variant;gene product sequence variation;broadmatch
mammary epithelium;epithelium;broadmatch
mammary epithelium;mammary gland tissue;broadmatch
gut-associated lymphoid tissue;mucosa-associated lymphoid tissue;broadmatch
c11orf95/rela fusion gene;fusion gene;broadmatch
c11orf95-rela fusion protein expression;fusion protein expression;broadmatch
vertebra;bone;broadmatch
1p/19q codeletion status unknown;genetic finding;broadmatch
h3 k27m mutation;h3 protein variant;broadmatch
tnfrsf8 positive;receptor status;broadmatch
canine rhabdomyosarcoma;canine neoplasm;broadmatch
canine hepatocellular carcinoma;canine neoplasm;broadmatch
canine glioma;canine neoplasm;broadmatch
nerve plexus;peripheral nervous system part;broadmatch
idh gene family mutation status unknown;genetic finding;broadmatch
corneal epithelium;stratified epithelium;broadmatch
idh gene family mutation;gene abnormality;broadmatch
janus kinase family;kinase;broadmatch
core binding factor complex mutation;gene abnormality;broadmatch
mismatch repair protein;protein family;broadmatch
histone modification;post-translational modification;broadmatch
nuclear expression of stat6 protein;abnormal immunology test result;broadmatch
prkar1a gene mutation;gene variant;broadmatch
loss of brg1 protein expression;abnormal immunology test result;broadmatch
embryonic tissue;embryonic structure;broadmatch
embryonic tissue;tissue;broadmatch
c19mc amplification;rearrangement detected;broadmatch
c19mc amplification;genetic finding;broadmatch
duct;organ;broadmatch
human papillomavirus-16 positive;human papillomavirus positive;broadmatch
epstein-barr virus positive;positive laboratory test result;broadmatch
medulloblastoma, not otherwise specified;medulloblastoma;broadmatch
medulloblastoma, genetically defined;medulloblastoma;broadmatch
chromosome 17 abnormality;cytogenetic abnormality;broadmatch
wnt pathway activated;signaling pathway status;broadmatch
multinodular and vacuolated pattern;morphologic architectural pattern;broadmatch
idh gene family;oxidoreductase gene;broadmatch
tnfrsf8 positive;expression positive;broadmatch
cdkn2a gene mutation;gene variant;broadmatch
urothelium;transitional epithelium;broadmatch
flt3 gene mutation;receptor tyrosine kinase gene mutation;broadmatch
fgfr3 protein variant;gene product sequence variation;broadmatch
activating ras mutation;ras family gene mutation;broadmatch
falx cerebri;central nervous system part;broadmatch
renal pelvis;kidney part;broadmatch
philadelphia chromosome negative;rearrangement negative;broadmatch
philadelphia chromosome negative;genetic finding;broadmatch
human papillomavirus positive;positive laboratory test result;broadmatch
ncam1 positive;expression positive;broadmatch
bcr/abl1 fusion negative;expression negative;broadmatch
bcr/abl1 fusion negative;rearrangement negative;broadmatch
stk11 gene mutation;gene variant;broadmatch
pms1 gene mutation;gene variant;broadmatch
pms1 gene mutation;mismatch repair gene mutation;broadmatch
msh2 gene mutation;gene variant;broadmatch
msh2 gene mutation;mismatch repair gene mutation;broadmatch
flt3 gene mutation;gene variant;broadmatch
cervical spinal cord;spinal cord part;broadmatch
flt3 protein variant;gene product sequence variation;broadmatch
thoracic spinal cord;spinal cord part;broadmatch
neoplastic cell;abnormal cell;broadmatch
organ system;anatomic structure, system, or substance;broadmatch
hematopoietic blast cell;hematopoietic and lymphoid cell;broadmatch
malignant cell;neoplastic cell;broadmatch
micromegakaryocyte;dysplastic megakaryocyte;broadmatch
neoplastic lymphoblast;leukemic lymphocyte;broadmatch
neoplastic lymphoblast;neoplastic blast;broadmatch
mucosa-associated lymphoid tissue;lymphoid tissue;broadmatch
hematopoietic system;hematopoietic and lymphatic system part;broadmatch
canine mastocytoma;canine neoplasm;broadmatch
integumentary system;organ system;broadmatch
thoracic cavity;body cavity;broadmatch
thrombocytopenia 2;rare non-neoplastic disorder;broadmatch
supraclavicular lymph node;lymph node by anatomic site;broadmatch
bulbar conjunctiva;conjunctiva;broadmatch
chromosome 3;human chromosome;broadmatch
feline lymphoma;feline experimental organism diagnosis;broadmatch
rat pituitary gland neoplasm;rat neoplasms by location;broadmatch
male genital system fluid or secretion;body fluid or substance;broadmatch
plasma membrane;cellular membrane;broadmatch
regulatory element;gene feature;broadmatch
"t(12;21)(p13.2;q22.1)";rearrangement of 21q;broadmatch
"t(12;21)(p13.2;q22.1)";chromosomal translocation;broadmatch
"t(12;21)(p13.2;q22.1)";rearrangement of 12p13.2;broadmatch
"t(12;21)(p13.2;q22.1)";etv6 gene rearrangement;broadmatch
rna recognition motif;ligand binding domain;broadmatch
devil facial tumor disease;experimental organism neoplasm by organism;broadmatch
stage ia3;stage ia;broadmatch
rainbow trout mesothelioma;fish experimental organism diagnosis;broadmatch
intercellular bridges present;morphologic finding;broadmatch
ligand binding domain;protein domain;broadmatch
blasts 10 percent or more of bone marrow nucleated cells;blasts more than 5 percent of bone marrow nucleated cells;broadmatch
notch family gene mutation;gene abnormality;broadmatch
smarcb1 gene mutation;gene variant;broadmatch
fish experimental organism diagnosis;experimental organism neoplasm by organism;broadmatch
plasma membrane;membranous cytoplasmic organelle;broadmatch
zonula adherens;anchoring junction;broadmatch
stage iiid;stage iii;broadmatch
blasts under 5 percent of bone marrow nucleated cells;blasts 5 percent or less of bone marrow nucleated cells;broadmatch
luminal b prostate carcinoma;prostate carcinoma by gene expression profile;broadmatch
luminal a prostate carcinoma;prostate carcinoma by gene expression profile;broadmatch
prostate carcinoma by gene expression profile;prostate carcinoma;broadmatch
nucleosome core particle;nuclear structure;broadmatch
immunoglobulin domain;protein domain;broadmatch
blasts under 30 percent of bone marrow nucleated cells;blasts 30 percent or less of bone marrow nucleated cells;broadmatch
blasts 10 percent or more of peripheral blood white cells;blasts more than 5 percent of peripheral blood white cells;broadmatch
pi3k/mtor pathway mutation;gene abnormality;broadmatch
experimental organism non-neoplastic disorder;experimental organism diagnosis;broadmatch
tumor margin configuration;morphologic finding;broadmatch
blasts under 25 percent of bone marrow nucleated cells;blasts under 30 percent of bone marrow nucleated cells;broadmatch
blasts 5 percent or less of bone marrow nucleated cells;blasts under 10 percent of bone marrow nucleated cells;broadmatch
myeloblasts 10 percent or more of bone marrow nucleated cells;myeloblasts 5 percent or more of bone marrow nucleated cells;broadmatch
myeloblasts 10 percent or more of bone marrow nucleated cells;blasts 10 percent or more of bone marrow nucleated cells;broadmatch
dicer1 gene mutation;gene variant;broadmatch
gerbil experimental organism diagnosis;experimental organism neoplasm by organism;broadmatch
raf family gene mutation;gene abnormality;broadmatch
neoplastic plasma cells 30 percent or less of bone marrow nucleated cells;neoplastic plasma cells under 50 percent of bone marrow nucleated cells;broadmatch
hamster fibrosarcoma;hamster neoplasm;broadmatch
rattlesnake fibroma;experimental organism neoplasm by organism;broadmatch
rabbit papilloma;rabbit neoplasm;broadmatch
mouse thymic lymphoma;lymphomas and haemopoietic neoplasms of the mouse nervous system;broadmatch
mouse histiocytic and dendritic cell neoplasm;mouse neoplasms by cell type;broadmatch
horse sarcoid;equine experimental organism diagnosis;broadmatch
hamster small intestinal neoplasm;hamster neoplasm;broadmatch
hamster pituitary carcinoma;hamster neoplasm;broadmatch
hamster lung carcinoma;hamster neoplasm;broadmatch
jak family gene mutation;gene abnormality;broadmatch
hamster adrenal carcinoma;hamster neoplasm;broadmatch
rabbit neoplasm;leporine experimental organism diagnosis;broadmatch
hamster neoplasm;experimental organism neoplasm by organism;broadmatch
tamarin colon adenocarcinoma;experimental organism neoplasm by organism;broadmatch
seal lymphoma;experimental organism neoplasm by organism;broadmatch
poeciliopsis lucida hepatocellular carcinoma;fish experimental organism diagnosis;broadmatch
mouse submandibular gland neoplasm;mouse salivary gland neoplasms;broadmatch
seal lymphosarcoma;experimental organism neoplasm by organism;broadmatch
turtle neoplasm;experimental organism neoplasm by organism;broadmatch
walleye dermal sarcoma;fish experimental organism diagnosis;broadmatch
budgerigar testicular carcinoma;experimental organism neoplasm by organism;broadmatch
pdgfr family gene mutation;receptor tyrosine kinase gene mutation;broadmatch
blasts 5 percent or more of bone marrow nucleated cells;blasts 2 percent or more of bone marrow nucleated cells;broadmatch
met protein variant;gene product sequence variation;broadmatch
feline large granular lymphocyte lymphoma;feline experimental organism diagnosis;broadmatch
hamster mammary carcinoma;hamster neoplasm;broadmatch
rat erythroleukemia;rat erythroid leukemia;broadmatch
mouse erythroleukemia;mouse erythroid leukemia;broadmatch
7p;chromosome arm;broadmatch
22q;chromosome arm;broadmatch
2p;chromosome arm;broadmatch
14q;chromosome arm;broadmatch
feline reticulum cell sarcoma;feline experimental organism diagnosis;broadmatch
fish melanoma;fish experimental organism diagnosis;broadmatch
chicken neoplasm;galline experimental organism diagnosis;broadmatch
chicken lymphoma;chicken neoplasm;broadmatch
basal-like prostate carcinoma;prostate carcinoma by gene expression profile;broadmatch
neoplastic plasma cells more than 20 percent of bone marrow nucleated cells;neoplastic plasma cells 10 percent or more of bone marrow nucleated cells;broadmatch
chromosome 4;human chromosome;broadmatch
rai stage;disease stage qualifier;broadmatch
deleterious homologous recombination pathway gene mutation;homologous recombination repair gene mutation;broadmatch
receptor tyrosine kinase gene mutation;gene abnormality;broadmatch
chromosome 13 abnormality;cytogenetic abnormality;broadmatch
deleterious brca gene mutation;deleterious mutation;broadmatch
deleterious brca gene mutation;dna repair gene mutation;broadmatch
st. jude stage;disease stage qualifier;broadmatch
binet stage;disease stage qualifier;broadmatch
stage iie;disease stage qualifier;broadmatch
differentiated thyroid gland carcinoma under 45 years ajcc v7 stage;ajcc v7 stage;broadmatch
stage ie;disease stage qualifier;broadmatch
lugano stage;disease stage qualifier;broadmatch
ann arbor stage;disease stage qualifier;broadmatch
ensat stage;disease stage qualifier;broadmatch
ankyrin repeat;protein binding domain;broadmatch
differentiated thyroid gland carcinoma 55 years and older ajcc v8 stage;ajcc v8 stage;broadmatch
differentiated thyroid gland carcinoma 45 years and older ajcc v7 stage;ajcc v7 stage;broadmatch
deleterious homologous recombination pathway gene mutation;deleterious mutation;broadmatch
ccaat enhancer binding protein gene mutation;gene abnormality;broadmatch
blasts 30 percent or less of bone marrow nucleated cells;blasts less than 50 percent of bone marrow nucleated cells;broadmatch
blasts 5 percent or more of peripheral blood white cells;blasts 2 percent or more of peripheral blood white cells;broadmatch
moderately differentiated;histologic grade;broadmatch
low grade;histologic grade;broadmatch
invasive;disease morphology qualifier;broadmatch
high grade;histologic grade;broadmatch
anaplastic;disease morphology qualifier;broadmatch
malignant;disease morphology qualifier;broadmatch
ddit3 gene rearrangement;chromosome 12 abnormality;broadmatch
ddit3 gene rearrangement;gene rearrangement abnormality;broadmatch
riss stage;disease stage qualifier;broadmatch
porcine leukemia;experimental organism neoplasm by organism;broadmatch
cell structure;cell part;broadmatch
stage iva2;stage iva;broadmatch
stage iva1;stage iva;broadmatch
macromolecular structure;microanatomic structure;broadmatch
epstein-barr virus negative;negative test result;broadmatch
differentiated thyroid gland carcinoma under 55 years ajcc v8 stage;ajcc v8 stage;broadmatch
nuclear localization signal;amino acid sequence;broadmatch
neoplastic cells with double expression of myc and bcl2 proteins present;immunophenotypic finding;broadmatch
rearrangement of 6p25.3;chromosomal rearrangement;broadmatch
cic/dux4 fusion gene;fusion gene;broadmatch
malignant neoplasm of lung - multiple primary sites;malignant neoplasm of multiple primary sites;broadmatch
breast cancer prognostic stage;disease stage qualifier;broadmatch
breast cancer anatomic stage;disease stage qualifier;broadmatch
egf-like domain;protein domain;broadmatch
acral lesion;lesion;broadmatch
superficial monoclonal gastrointestinal tract t-cell infiltrate present;abnormal cells present;broadmatch
breast implant-related lesion;lesion;broadmatch
gtp binding domain;ligand binding domain;broadmatch
neoplastic cells with tfh cell phenotype present;immunophenotypic finding;broadmatch
international staging system stage;disease stage qualifier;broadmatch
durie/salmon stage;disease stage qualifier;broadmatch
refractory high risk myelodysplastic syndrome;high risk myelodysplastic syndrome;broadmatch
recurrent high risk myelodysplastic syndrome;high risk myelodysplastic syndrome;broadmatch
high risk myelodysplastic syndrome;myeloid neoplasm finding;broadmatch
psa level finding;laboratory test result;broadmatch
blasts 50 percent or less of bone marrow nucleated cells;blast cells increased in bone marrow;broadmatch
cd8 positive;expression positive;broadmatch
activating braf mutation;activating raf mutation;broadmatch
activating braf mutation;braf gene mutation;broadmatch
dag/pe-binding domain;ligand binding domain;broadmatch
tyrosine kinase domain;substrate interaction domain;broadmatch
substrate interaction domain;ligand binding domain;broadmatch
cellular membrane;cell structure;broadmatch
progressive disease in neuroblastoma;progressive central nervous system neoplasm;broadmatch
walker-a motif;protein domain;broadmatch
brct domain;protein binding domain;broadmatch
whitmore-jewett stage;disease stage qualifier;broadmatch
2p12;chromosome band;broadmatch
stage iiia2;stage iiia;broadmatch
stage iiia1;stage iiia;broadmatch
anchoring junction;epithelial cell junction;broadmatch
cell junction;cell part;broadmatch
activating hras mutation;hras gene mutation;broadmatch
activating hras mutation;activating ras mutation;broadmatch
mouse adrenal gland pheochromocytoma;mouse adrenal gland neoplasms;broadmatch
marmoset lymphoma;experimental organism neoplasm by organism;broadmatch
hemangioendothelioma of the mouse thyroid gland;mouse thyroid neoplasm;broadmatch
ocular tissue;tissue;broadmatch
ptch1 gene mutation;hedgehog pathway mutation;broadmatch
chromosome arm;chromosome structure;broadmatch
irf4 gene rearrangement;gene rearrangement abnormality;broadmatch
alk protein variant;gene product sequence variation;broadmatch
postneoadjuvant therapy pathologic tnm finding;cancer tnm finding category;broadmatch
sh2 domain;protein binding domain;broadmatch
germinal center;lymphoid tissue;broadmatch
inner mitochondrial membrane;mitochondrial membrane;broadmatch
protein structure;macromolecular structure;broadmatch
rough endoplasmic reticulum;endoplasmic reticulum;broadmatch
gland;organ;broadmatch
transitional epithelium;stratified epithelium;broadmatch
hair follicle;hair part;broadmatch
gene rearrangement abnormality;chromosomal rearrangement;broadmatch
gene rearrangement abnormality;gene abnormality;broadmatch
hamster pancreatic ductal adenocarcinoma;hamster neoplasm;broadmatch
ptch1 gene mutation;gene variant;broadmatch
11q translocation;chromosomal translocation;broadmatch
11q translocation;rearrangement of 11q;broadmatch
homologous recombination repair gene mutation;dna repair gene mutation;broadmatch
7q;chromosome arm;broadmatch
protein domain;protein structure;broadmatch
chromosome structure;nuclear structure;broadmatch
rabbit cutaneous lymphoma;rabbit neoplasm;broadmatch
rabbit fibroma;rabbit neoplasm;broadmatch
rabbit oral cavity squamous cell carcinoma;rabbit neoplasm;broadmatch
rabbit plasmacytoma;rabbit neoplasm;broadmatch
recurrent primary amyloidosis;primary amyloidosis;broadmatch
recurrent primary amyloidosis;recurrent plasma cell neoplasm;broadmatch
recurrent primary amyloidosis;recurrent primary malignant neoplasm;broadmatch
ubiquitin-transferase gene;transferase gene;broadmatch
mismatch repair gene mutation;dna repair gene mutation;broadmatch
sf3b1 gene mutation;gene variant;broadmatch
tfe3 gene rearrangement;gene rearrangement abnormality;broadmatch
rb1 gene mutation;gene variant;broadmatch
hamster melanoma;hamster neoplasm;broadmatch
telomere;chromosome structure;broadmatch
hamster chondrosarcoma;hamster neoplasm;broadmatch
chromosome arm 9p loss of heterozygosity;loss of heterozygosity;broadmatch
canine soft tissue sarcoma;canine neoplasm;broadmatch
canine thyroid adenocarcinoma;canine neoplasm;broadmatch
feline mammary carcinoma;feline experimental organism diagnosis;broadmatch
cytoskeleton;nonmembranous cytoplasmic organelle;broadmatch
cytoplasm;cell structure;broadmatch
chromosome 9;human chromosome;broadmatch
ajcc v8 stage;disease stage qualifier;broadmatch
chromosome arm 3p loss of heterozygosity;loss of heterozygosity;broadmatch
c2h2 zinc finger;zinc-binding, dna-binding motif;broadmatch
chromosome 8;human chromosome;broadmatch
chromosome 7;human chromosome;broadmatch
ras family gene mutation;gene abnormality;broadmatch
cdkn2a-p16 negative;cdkn2a-p16 status;broadmatch
cdkn2a-p16 negative;cdkn2a negative;broadmatch
chromosome 6;human chromosome;broadmatch
chromosome 5;human chromosome;broadmatch
embryonic structure;embryonic structure or system;broadmatch
endoplasmic reticulum;membranous cytoplasmic organelle;broadmatch
body fluid or substance;anatomic structure, system, or substance;broadmatch
microtubule;cytoskeleton filament;broadmatch
unmethylated mgmt gene promoter;genetic finding;broadmatch
chromosome y;human chromosome;broadmatch
chromosome x;human chromosome;broadmatch
feline osteosarcoma;feline experimental organism diagnosis;broadmatch
feline oral squamous cell carcinoma;feline experimental organism diagnosis;broadmatch
canine oral squamous cell carcinoma;canine neoplasm;broadmatch
subcellular structure;cell structure;broadmatch
semen;male genital system fluid or secretion;broadmatch
ribosome;nonmembranous cytoplasmic organelle;broadmatch
placenta;extraembryonic structure;broadmatch
"t(9;22)(q34.1;q11.2)";chromosomal translocation;broadmatch
cytoplasmic organelle;cell part;broadmatch
nucleosome;cell part;broadmatch
nuclear membrane;intracellular membrane;broadmatch
mitochondrion;membranous cytoplasmic organelle;broadmatch
rabbit uterine carcinoma;rabbit neoplasm;broadmatch
"t(8;21)(q22;q22)";chromosomal translocation;broadmatch
"t(8;21)(q22;q22)";rearrangement of 21q;broadmatch
frog pronephric kidney tumor;experimental organism neoplasm by organism;broadmatch
horse lymphoma;equine experimental organism diagnosis;broadmatch
hamster lymphosarcoma;hamster neoplasm;broadmatch
hamster lymphoma;hamster neoplasm;broadmatch
hamster kidney tumor;hamster neoplasm;broadmatch
gibbon lymphosarcoma;experimental organism neoplasm by organism;broadmatch
gerbil melanoma;gerbil experimental organism diagnosis;broadmatch
gerbil fibrosarcoma;gerbil experimental organism diagnosis;broadmatch
feline erythroleukemia;feline experimental organism diagnosis;broadmatch
dna structure;macromolecular structure;broadmatch
duck neoplasm;experimental organism neoplasm by organism;broadmatch
bovine rectal myxoma;bovine neoplasm;broadmatch
bovine lymphosarcoma;bovine neoplasm;broadmatch
baboon lymphoma;experimental organism neoplasm by organism;broadmatch
experimental organism neoplasm;experimental organism diagnosis;broadmatch
xiphophorus melanoma;fish melanoma;broadmatch
xenopus neoplasm;experimental organism neoplasm by organism;broadmatch
mouse rectum carcinoma;mouse neoplasms;broadmatch
mouse reticulum cell sarcoma;mouse neoplasms;broadmatch
ovine sinus tumor;experimental organism neoplasm by organism;broadmatch
rhesus monkey lymphoma;experimental organism neoplasm by organism;broadmatch
canine acanthomatous epulis;canine neoplasm;broadmatch
bat skin tumor;experimental organism neoplasm by organism;broadmatch
suncus murinus mammary tumor;experimental organism neoplasm by organism;broadmatch
quail fibrosarcoma;experimental organism neoplasm by organism;broadmatch
pike sarcoma;fish experimental organism diagnosis;broadmatch
mouse leydig cell tumor;mouse endocrine gland system neoplasms;broadmatch
hamster insulinoma;hamster neoplasm;broadmatch
chicken monocytic leukemia;chicken neoplasm;broadmatch
canine pancreatic carcinoma;canine neoplasm;broadmatch
budgerigar fibrosarcoma;experimental organism neoplasm by organism;broadmatch
rat neoplasms;rat histopathology diagnoses for proliferative changes;broadmatch
7q34;chromosome band;broadmatch
porcine lymphoma;experimental organism neoplasm by organism;broadmatch
zebra finch neoplasm;experimental organism neoplasm by organism;broadmatch
rhesus monkey mammary tumor;experimental organism neoplasm by organism;broadmatch
rainbow trout hepatoma;fish experimental organism diagnosis;broadmatch
medaka melanoma;fish melanoma;broadmatch
medaka hepatoma;fish experimental organism diagnosis;broadmatch
experimental organism neoplasm by organism;experimental organism neoplasm;broadmatch
metal binding site;ligand binding domain;broadmatch
feline experimental organism diagnosis;experimental organism neoplasm by organism;broadmatch
bovine neoplasm;experimental organism neoplasm by organism;broadmatch
canine neoplasm;experimental organism neoplasm by organism;broadmatch
activating raf mutation;raf family gene mutation;broadmatch
apc gene mutation;gene variant;broadmatch
nuclear structure;subcellular structure;broadmatch
gene feature;chromosome structure;broadmatch
anatomy qualifier;qualifier;broadmatch
chromosome band;chromosome structure;broadmatch
zinc-binding, dna-binding motif;metal binding site;broadmatch
zinc-binding, dna-binding motif;dna binding domain;broadmatch
protein binding domain;ligand binding domain;broadmatch
dna binding domain;ligand binding domain;broadmatch
transmembrane domain;protein domain;broadmatch
leporine experimental organism diagnosis;experimental organism neoplasm by organism;broadmatch
galline experimental organism diagnosis;experimental organism neoplasm by organism;broadmatch
mouse basal cell carcinoma;mouse neoplasms;broadmatch
equine experimental organism diagnosis;experimental organism neoplasm by organism;broadmatch
horse melanoma;equine experimental organism diagnosis;broadmatch
hamster uterine leiomyosarcoma;hamster neoplasm;broadmatch
hamster ductus deferens leiomyosarcoma;hamster neoplasm;broadmatch
hamster cholangiocarcinoma;hamster neoplasm;broadmatch
hamster buccal pouch carcinoma;hamster neoplasm;broadmatch
guinea pig leukemia;experimental organism neoplasm by organism;broadmatch
guinea pig colon adenocarcinoma;experimental organism neoplasm by organism;broadmatch
goldfish erythrophoroma;fish experimental organism diagnosis;broadmatch
gerbil fibroma;gerbil experimental organism diagnosis;broadmatch
feline fibrosarcoma;feline experimental organism diagnosis;broadmatch
bone marrow stem cell;hematopoietic stem cell;broadmatch
feline bronchioloalveolar lung carcinoma;feline experimental organism diagnosis;broadmatch
chicken hepatoma;chicken neoplasm;broadmatch
chicken fibrosarcoma;chicken neoplasm;broadmatch
chicken bursal lymphoma;chicken neoplasm;broadmatch
peritoneum;membrane;broadmatch
peripheral nerve;nerve;broadmatch
hibernoma of the mouse skin;mouse hibernoma;broadmatch
nasal glial heterotopia;head and neck finding;broadmatch
acute lymphoblastic leukemia by gene expression profile;acute lymphoblastic leukemia;broadmatch
meningioangiomatosis;central nervous system vascular malformation;broadmatch
loss of ini 1 protein expression;abnormal immunology test result;broadmatch
hey1/ncoa2 fusion gene;fusion gene;broadmatch
bone tumor of undefined neoplastic nature;connective tissue disorder;broadmatch
no identifiable line of differentiation;laboratory test result;broadmatch
ewsr1-creb1 fusion protein expression;fusion protein expression;broadmatch
wwtr1/camta1 fusion gene;fusion gene;broadmatch
myh9/usp6 fusion gene;fusion gene;broadmatch
wwtr1-camta1 fusion protein expression;fusion protein expression;broadmatch
mixture of embryonal and alveolar features present;mixture of morphologic patterns;broadmatch
non-cutaneous leiomyosarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
rat adrenal gland pheochromocytoma;rat endocrine system neoplasms;broadmatch
rat neuroblastoma;rat nervous system and sensory organs neoplasms;broadmatch
rat insulinoma;rat endocrine system neoplasms;broadmatch
"t(11;16)(p11;p11)";fus gene translocation;broadmatch
ddit4l acute lymphoblastic leukemia;acute lymphoblastic leukemia by gene expression profile;broadmatch
acute lymphoblastic leukemia by rose cluster;acute lymphoblastic leukemia by gene expression profile;broadmatch
rose cluster 1;acute lymphoblastic leukemia by rose cluster;broadmatch
rose cluster 2;acute lymphoblastic leukemia by rose cluster;broadmatch
pulmonary nodule;radiologic finding;broadmatch
sublingual salivary gland;major salivary gland;broadmatch
submandibular gland;major salivary gland;broadmatch
uvula;head and neck part;broadmatch
soft palate;head and neck part;broadmatch
hard palate;head and neck part;broadmatch
palate;head and neck part;broadmatch
base of the tongue;organ of special sense part;broadmatch
lip;head and neck part;broadmatch
rose cluster 8;acute lymphoblastic leukemia by rose cluster;broadmatch
rose cluster 7;acute lymphoblastic leukemia by rose cluster;broadmatch
rose cluster 6;acute lymphoblastic leukemia by rose cluster;broadmatch
rose cluster 5;acute lymphoblastic leukemia by rose cluster;broadmatch
rose cluster 4;acute lymphoblastic leukemia by rose cluster;broadmatch
rose cluster 3;acute lymphoblastic leukemia by rose cluster;broadmatch
pten gene mutation;gene variant;broadmatch
"t(11;16)(q13;p13)";11q translocation;broadmatch
hypopharynx;head and neck part;broadmatch
vhl gene mutation;gene variant;broadmatch
experimental organism malignant astrocytoma;experimental organism neoplasm;broadmatch
exophthalmos;eye finding;broadmatch
exophthalmos;sign or symptom;broadmatch
cutaneous melanoma in-transit metastasis;in-transit metastasis;broadmatch
satellite tumor;metastasis;broadmatch
catenin family protein;protein family;broadmatch
otolaryngologic disorder;head and neck disorder;broadmatch
tsc2 gene mutation;gene variant;broadmatch
c11orf95-mkl2 fusion protein expression;fusion protein expression;broadmatch
tsc1 gene mutation;gene variant;broadmatch
pms2 gene mutation;gene variant;broadmatch
pms2 gene mutation;mismatch repair gene mutation;broadmatch
tp53 gene mutation;gene variant;broadmatch
msh6 gene mutation;gene variant;broadmatch
msh6 gene mutation;mismatch repair gene mutation;broadmatch
mlh1 gene mutation;gene variant;broadmatch
experimental organism benign ganglioglioma;experimental organism neoplasm;broadmatch
experimental organism malignant oligodendroglioma;experimental organism neoplasm;broadmatch
inv(16);chromosomal inversion;broadmatch
digestive system hemorrhage;hemorrhage;broadmatch
canine melanoma;canine neoplasm;broadmatch
direct extension;metastasis;broadmatch
virilization;endocrine system finding;broadmatch
"t(10;19)(q26;q13)";chromosomal translocation;broadmatch
"t(10;19)(q26;q13)";cic gene rearrangement;broadmatch
"t(4;19)(q35;q13)";chromosomal translocation;broadmatch
"t(4;19)(q35;q13)";cic gene rearrangement;broadmatch
cic-dux4l fusion protein expression;fusion protein expression;broadmatch
cic-dux4 fusion protein expression;fusion protein expression;broadmatch
hereditary nonpolyposis colorectal cancer syndrome;hereditary colorectal cancer syndrome;broadmatch
canine osteosarcoma;canine neoplasm;broadmatch
mouse colon adenocarcinoma;adenocarcinoma of the mouse intestinal tract;broadmatch
peripheral neuropathy;neuropathy;broadmatch
peripheral neuropathy;peripheral nervous system disorder;broadmatch
digestive system hemorrhage;digestive system signs and symptoms;broadmatch
high risk acute leukemia;leukemia finding;broadmatch
cervical esophagus;body region;broadmatch
idh2 gene mutation;gene variant;broadmatch
endometrium;mucosa;broadmatch
spermatic cord;organ;broadmatch
epididymis;organ;broadmatch
undescended testes;testicular non-neoplastic disorder;broadmatch
appendage of the uterus;female reproductive system part;broadmatch
broad ligament;uterine ligament;broadmatch
corpus uteri;female reproductive system part;broadmatch
myometrium;smooth muscle tissue;broadmatch
cervix uteri;female reproductive system part;broadmatch
mandible;jaw bone;broadmatch
ectocervix;female reproductive system part;broadmatch
endocervix;female reproductive system part;broadmatch
clitoris;female reproductive system part;broadmatch
labium minus;labium;broadmatch
labium majus;labium;broadmatch
nipple;breast part;broadmatch
retroperitoneum;body region;broadmatch
dome of the bladder;urinary system part;broadmatch
lateral wall of the bladder;bladder wall;broadmatch
invasive focus of carcinoma cells measuring more than 5 mm present;morphologic finding;broadmatch
ureteric orifice;urinary system part;broadmatch
frontal lobe;brain part;broadmatch
cerebral hemisphere;brain part;broadmatch
spinal meninges;meninges;broadmatch
cerebral meninges;meninges;broadmatch
meninges;membrane of the brain or spinal cord;broadmatch
orbit;body cavity;broadmatch
lacrimal gland;head and neck part;broadmatch
lacrimal gland;exocrine gland;broadmatch
ciliary body;eye part;broadmatch
choroid;membrane;broadmatch
retina;eye part;broadmatch
cornea;eye part;broadmatch
conjunctiva;eye appendage;broadmatch
conjunctiva;mucosa;broadmatch
urethral gland;exocrine gland;broadmatch
external ear;ear part;broadmatch
mandible;irregular bone;broadmatch
thoracic esophagus;body region;broadmatch
antrum pylori;digestive system part;broadmatch
mll gene rearrangement;11q23 abnormality;broadmatch
mll gene rearrangement;gene rearrangement abnormality;broadmatch
neonatal lesion;infantile lesion;broadmatch
infantile lesion;childhood lesion;broadmatch
bone marrow and extramedullary involvement;hematopoietic system finding;broadmatch
extramedullary involvement;bone marrow and extramedullary involvement;broadmatch
pylorus;digestive system part;broadmatch
body of stomach;digestive system part;broadmatch
nab2/stat6 fusion gene;fusion gene;broadmatch
fundus of the stomach;digestive system part;broadmatch
gastric cardia;digestive system part;broadmatch
dnajb1/prkaca fusion gene;fusion gene;broadmatch
lower third of the esophagus;body region;broadmatch
middle third of the esophagus;body region;broadmatch
upper third of the esophagus;body region;broadmatch
abdominal esophagus;body region;broadmatch
mll gene rearrangement;rearrangement of 11q;broadmatch
duodenum;digestive system part;broadmatch
meckel diverticulum;diverticulum;broadmatch
meckel diverticulum;digestive system finding;broadmatch
subglottis;head and neck part;broadmatch
supraglottis;head and neck part;broadmatch
canine hemangiosarcoma;canine neoplasm;broadmatch
sphenoid sinus;paranasal sinus;broadmatch
frontal sinus;paranasal sinus;broadmatch
ethmoid sinus;paranasal sinus;broadmatch
maxillary sinus;paranasal sinus;broadmatch
middle ear;ear part;broadmatch
pancreatic duct;duct;broadmatch
nup98 gene rearrangement;gene rearrangement abnormality;broadmatch
"t(7;12)(q36;p13)";chromosomal translocation;broadmatch
"t(7;12)(q36;p13)";etv6 gene rearrangement;broadmatch
"t(7;12)(q36;p13)";chromosome 7 rearrangement;broadmatch
descending colon;digestive system part;broadmatch
ascending colon;digestive system part;broadmatch
mlh1 gene mutation;mismatch repair gene mutation;broadmatch
idh2 gene mutation;idh gene family mutation;broadmatch
pelvis;body cavity;broadmatch
absence of signs or symptoms;sign or symptom;broadmatch
serrated lesion of the mouse intestinal tract;benign neoplasms of the mouse intestinal tract;broadmatch
intramucosal carcinoma of the mouse intestinal tract;adenocarcinoma of the mouse intestinal tract;broadmatch
pdgfra protein variant;gene product sequence variation;broadmatch
non-receptor type protein tyrosine phosphatase;protein tyrosine phosphatase;broadmatch
hyperploidy;aneuploidy;broadmatch
pole gene;polymerase gene;broadmatch
pold1 gene;polymerase gene;broadmatch
krt17 gene;intermediate filament gene;broadmatch
egfr gene product;erbb receptor family protein;broadmatch
claudin-low;decreased expression;broadmatch
claudin-low;genetic finding;broadmatch
jak2 protein variant;gene product sequence variation;broadmatch
braf np_004324.2:p.v600x;braf protein variant;broadmatch
cbfa2t3/glis2 fusion gene;fusion gene;broadmatch
mnx1/etv6 fusion gene;fusion gene;broadmatch
nup98/kdm5a fusion gene;fusion gene;broadmatch
metastatic carcinoma of the mouse intestinal tract;malignant neoplasms of the mouse intestinal tract;broadmatch
musculoskeletal finding;connective and soft tissue finding;broadmatch
musculoskeletal injury;connective and soft tissue injury;broadmatch
uveal melanoma by gene expression profile;uveal melanoma;broadmatch
atp1a1 gene;translocase gene;broadmatch
paneth cell-like change;morphologic finding;broadmatch
branch duct;duct;broadmatch
tmprss2/ets family fusion gene;fusion gene;broadmatch
cushing disease;endogenous cushing syndrome;broadmatch
experimental organism benign seminoma;experimental organism neoplasm;broadmatch
vascular malformation;non-neoplastic vascular disorder;broadmatch
vascular malformation;congenital cardiovascular abnormality;broadmatch
succinate dehydrogenase;protein or riboprotein complex;broadmatch
inv(3);chromosomal inversion;broadmatch
glioblastoma by gene expression profile;glioblastoma;broadmatch
experimental organism basal cell carcinoma;experimental organism neoplasm;broadmatch
experimental organism basal cell adenoma;experimental organism neoplasm;broadmatch
arrhythmia by ecg finding;electrocardiographic finding;broadmatch
minimal aneuploidy;aneuploidy;broadmatch
krt5 gene;intermediate filament gene;broadmatch
effector t-lymphocyte;mature t-lymphocyte;broadmatch
atp2b3 gene;translocase gene;broadmatch
msn/alk fusion gene;fusion gene;broadmatch
bcor gene;transcription repressor/corepressor gene;broadmatch
tpm4/alk fusion gene;fusion gene;broadmatch
tpm3/alk fusion gene;fusion gene;broadmatch
tfg/alk fusion gene;fusion gene;broadmatch
npm1/rara long fusion gene;fusion gene;broadmatch
npm1/rara short fusion gene;fusion gene;broadmatch
nono/tfe3 fusion gene;fusion gene;broadmatch
mll/ell fusion gene;fusion gene;broadmatch
congenital hematological disorder;non-neoplastic hematologic and lymphocytic disorder;broadmatch
fus/creb3l1 fusion gene;fusion gene;broadmatch
has2/plag1 fusion gene;fusion gene;broadmatch
col1a2/plag1 fusion gene;fusion gene;broadmatch
cbfb/myh11 fusion gene;fusion gene;broadmatch
bcr/jak2 fusion gene;fusion gene;broadmatch
atic/alk fusion gene;fusion gene;broadmatch
sign or symptom;finding;broadmatch
ywhae gene;adaptor signaling protein gene;broadmatch
myopathy;non-neoplastic muscle disorder;broadmatch
hormone receptor positive;expression positive;broadmatch
hormone receptor positive;receptor status;broadmatch
actb gene;microfilament gene;broadmatch
experimental organism malignant hibernoma;experimental organism neoplasm;broadmatch
experimental organism malignant hepatocholangiocellular carcinoma;experimental organism neoplasm;broadmatch
experimental organism benign bone osteofibroma;experimental organism neoplasm;broadmatch
experimental organism benign basalioma;experimental organism neoplasm;broadmatch
ischemic necrosis;necrotic change;broadmatch
genetic finding;laboratory test result;broadmatch
congenital reproductive system abnormality;congenital genitourinary abnormality;broadmatch
congenital reproductive system abnormality;non-neoplastic reproductive system disorder;broadmatch
great blood vessel;blood vessel;broadmatch
miscellaneous neoplasm;neoplasm by special category;broadmatch
lymphoid hyperplasia;hyperplasia;broadmatch
palb2 gene mutation;gene variant;broadmatch
palb2 gene mutation;fanconi anemia complementation group gene mutation;broadmatch
camta1 gene;transcription regulation gene;broadmatch
atp1a1 gene;transport protein gene;broadmatch
atp2b3 gene;transport protein gene;broadmatch
nf1 gene mutation;gene variant;broadmatch
untreated childhood gliomatosis cerebri;untreated central nervous system neoplasm;broadmatch
untreated childhood protoplasmic astrocytoma;untreated childhood diffuse astrocytoma;broadmatch
untreated childhood pleomorphic xanthoastrocytoma;untreated central nervous system neoplasm;broadmatch
untreated childhood pilomyxoid astrocytoma;untreated central nervous system neoplasm;broadmatch
untreated childhood pilocytic astrocytoma;untreated childhood low grade astrocytic tumor;broadmatch
untreated childhood oligodendroglioma;untreated central nervous system neoplasm;broadmatch
untreated childhood oligoastrocytoma;untreated central nervous system neoplasm;broadmatch
untreated childhood gliosarcoma;untreated childhood glioblastoma;broadmatch
untreated childhood glioblastoma;untreated childhood high grade astrocytic tumor;broadmatch
slowly progressive clinical course;progressive clinical course;broadmatch
untreated childhood giant cell glioblastoma;untreated childhood glioblastoma;broadmatch
untreated childhood gemistocytic astrocytoma;untreated childhood diffuse astrocytoma;broadmatch
untreated childhood fibrillary astrocytoma;untreated childhood diffuse astrocytoma;broadmatch
untreated childhood diffuse astrocytoma;untreated childhood low grade astrocytic tumor;broadmatch
untreated childhood cerebral astrocytoma;untreated central nervous system neoplasm;broadmatch
untreated childhood anaplastic oligodendroglioma;untreated central nervous system neoplasm;broadmatch
untreated childhood anaplastic oligoastrocytoma;untreated central nervous system neoplasm;broadmatch
untreated childhood subependymal giant cell astrocytoma;untreated childhood low grade astrocytic tumor;broadmatch
untreated childhood supratentorial primitive neuroectodermal tumor;untreated central nervous system neoplasm;broadmatch
experimental organism malignant neuromyoblastoma;experimental organism neoplasm;broadmatch
experimental organism benign acinar-islet cell tumor;experimental organism neoplasm;broadmatch
men1 gene mutation;gene variant;broadmatch
fgfr gene amplification;receptor tyrosine kinase gene amplification;broadmatch
fgf gene amplification;gene amplification abnormality;broadmatch
non-neoplastic muscle disorder;non-neoplastic soft tissue disorder;broadmatch
non-neoplastic muscle disorder;non-neoplastic musculoskeletal disorder;broadmatch
experimental organism benign keratoacanthoma;experimental organism neoplasm;broadmatch
tracheobronchial tree;organ;broadmatch
female reproductive system finding;reproductive system finding;broadmatch
male reproductive system finding;reproductive system finding;broadmatch
extranodal involvement;progressive neoplastic disease;broadmatch
idh2 np_002159.2:p.r172x;idh2 protein variant;broadmatch
idh2 protein variant;gene product sequence variation;broadmatch
liquid tumor;neoplasm by special category;broadmatch
congenital cystic hygroma;cystic hygroma;broadmatch
movement disorder;non-neoplastic central nervous system disorder;broadmatch
untreated childhood anaplastic astrocytoma;untreated childhood high grade astrocytic tumor;broadmatch
distal urethra;urethra part;broadmatch
cacna1d gene;ion channel protein gene;broadmatch
experimental organism benign nephroblastoma neoplasm;experimental organism neoplasm;broadmatch
non-t non-b calla negative adult acute lymphoblastic leukemia;adult non-t non-b acute lymphoblastic leukemia;broadmatch
non-t non-b calla negative childhood acute lymphoblastic leukemia;childhood non-t non-b acute lymphoblastic leukemia;broadmatch
childhood non-t non-b acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
adult non-t non-b acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
childhood l2 acute lymphoblastic leukemia;l2 acute lymphoblastic leukemia;broadmatch
childhood l1 acute lymphoblastic leukemia;l1 acute lymphoblastic leukemia;broadmatch
circulating plasma cell;neoplastic plasma cell;broadmatch
experimental organism benign thymoma neoplasm;experimental organism neoplasm;broadmatch
proximal urethra;urethra part;broadmatch
experimental organism benign teratoma neoplasm;experimental organism neoplasm;broadmatch
experimental organism benign stromal tumor neoplasm;experimental organism neoplasm;broadmatch
experimental organism lymphosarcoma neoplasm;experimental organism neoplasm;broadmatch
experimental organism mixed lymphoma neoplasm;experimental organism neoplasm;broadmatch
experimental organism histiocytic lymphoma neoplasm;experimental organism neoplasm;broadmatch
experimental organism acidophil carcinoma;experimental organism neoplasm;broadmatch
experimental organism islet cell adenoma neoplasm;experimental organism neoplasm;broadmatch
adult l2 acute lymphoblastic leukemia;l2 acute lymphoblastic leukemia;broadmatch
adult tdt positive acute lymphoblastic leukemia;tdt positive acute lymphoblastic leukemia;broadmatch
childhood tdt positive acute lymphoblastic leukemia;tdt positive acute lymphoblastic leukemia;broadmatch
adult tdt negative acute lymphoblastic leukemia;tdt negative acute lymphoblastic leukemia;broadmatch
newly diagnosed childhood ependymoma;newly diagnosed disease;broadmatch
untreated childhood pineoblastoma;untreated central nervous system neoplasm;broadmatch
bclc stage;disease stage qualifier;broadmatch
untreated central nervous system neoplasm;nervous system finding;broadmatch
untreated childhood high grade astrocytic tumor;untreated central nervous system neoplasm;broadmatch
untreated childhood low grade astrocytic tumor;untreated central nervous system neoplasm;broadmatch
leukemic infiltration of brain;malignant cellular infiltrate;broadmatch
jaw region;body region;broadmatch
osteolytic lesions of multiple myeloma;lytic metastatic bone lesion;broadmatch
urolithiasis;non-neoplastic urinary system disorder;broadmatch
nephrolithiasis;non-neoplastic kidney disorder;broadmatch
nephrolithiasis;urolithiasis;broadmatch
adult pre-b acute lymphoblastic leukemia;pre-b acute lymphoblastic leukemia;broadmatch
mixed osteosarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
childhood tdt negative acute lymphoblastic leukemia;tdt negative acute lymphoblastic leukemia;broadmatch
temporal lobe;brain part;broadmatch
parietal lobe;brain part;broadmatch
occipital lobe;brain part;broadmatch
muscle cell;connective and soft tissue cell;broadmatch
follicular dendritic cell;dendritic cell;broadmatch
antigen presenting cell;cell;broadmatch
schwann cell;perineural cell;broadmatch
schwann cell;connective and soft tissue cell;broadmatch
oligodendrocyte;glial cell;broadmatch
glial cell;neuroepithelial cell;broadmatch
glial cell;supporting cell of the nervous system;broadmatch
leydig cell;endocrine-stromal cell;broadmatch
zygote;cell;broadmatch
experimental organism malignant renal mesenchymal tumor;experimental organism neoplasm;broadmatch
experimental organism malignant neuroendocrine cell tumor;experimental organism neoplasm;broadmatch
experimental organism benign neuroendocrine cell tumor;experimental organism neoplasm;broadmatch
experimental organism benign mixed mullerian tumor;experimental organism neoplasm;broadmatch
experimental organism benign mixed sertoli-leydig cell tumor;experimental organism neoplasm;broadmatch
islet of langerhans;epithelial tissue;broadmatch
giant cell;abnormal cell;broadmatch
neuron;neuron, neuroepithelial cell, and supporting cell of the nervous system;broadmatch
myelinated nerve fiber;axon;broadmatch
sensory neuron;neuron;broadmatch
dilated cystic spaces present;abnormal tissue present;broadmatch
adrenal gland;endocrine gland;broadmatch
abducens nerve;cranial nerve;broadmatch
abdomen;body cavity;broadmatch
stem cell;cell;broadmatch
reed-sternberg cell;neoplastic large lymphocyte;broadmatch
phagocytic cell;antigen presenting cell;broadmatch
pericyte;connective and soft tissue cell;broadmatch
apud cell;neural crest-derived cell;broadmatch
gnas gene product;signaling protein;broadmatch
c11orf95 gene;regulatory gene;broadmatch
retinal ganglion cell;ganglion cell;broadmatch
prominent stromal reaction;stromal change;broadmatch
peritoneal gliomatosis;non-neoplastic peritoneal disorder;broadmatch
photoreceptor cell;retinal ganglion cell;broadmatch
photoreceptor cell;sensory neuron;broadmatch
spermatozoon;spermatogenic cell;broadmatch
oocyte;germ cell;broadmatch
upper extremity;limb;broadmatch
macrophage;phagocytic cell;broadmatch
stromal cell;connective and soft tissue cell;broadmatch
osteoblast;bone cell;broadmatch
histiocyte;histiocytic and dendritic cell;broadmatch
histiocyte;macrophage;broadmatch
histiocyte;connective and soft tissue cell;broadmatch
foam cell;abnormal macrophage;broadmatch
pathology result;laboratory test result;broadmatch
chondrocyte;cartilage cell;broadmatch
germ cell;cell;broadmatch
adipocyte;connective and soft tissue cell;broadmatch
connective and soft tissue cell;cell;broadmatch
chromaffin cell;neural crest-derived cell;broadmatch
megakaryocyte;myeloid cell;broadmatch
bone marrow myeloid stem cell;bone marrow stem cell;broadmatch
hematopoietic stem cell;hematopoietic and lymphoid cell;broadmatch
hematopoietic stem cell;stem cell;broadmatch
theca cell;connective and soft tissue cell;broadmatch
theca cell;endocrine-stromal cell;broadmatch
endocrine cell of the digestive system;neuroendocrine cell;broadmatch
figo stage;disease stage qualifier;broadmatch
sertoli cell;endocrine-stromal cell;broadmatch
parietal cell;gastric glandular cell;broadmatch
melanocyte;cell of the epidermis;broadmatch
keratinocyte;skin squamous cell;broadmatch
hepatocyte;glandular cell;broadmatch
granulosa cell;endocrine-stromal cell;broadmatch
enterocyte;glandular cell;broadmatch
langerhans cell;cell of the epidermis;broadmatch
langerhans cell;dendritic cell;broadmatch
dendritic cell;histiocytic and dendritic cell;broadmatch
dendritic cell;antigen presenting cell;broadmatch
ameloblast;tooth cell;broadmatch
ameloblast;epithelial cell;broadmatch
epithelial cell;cell;broadmatch
delta cell;endocrine cell of the digestive system;broadmatch
aorta;blood vessel;broadmatch
arteriole;blood vessel;broadmatch
brain ventricle;brain part;broadmatch
cardiac ventricle;heart part;broadmatch
lower extremity;limb;broadmatch
renal medulla;renal tissue;broadmatch
renal cortex;renal tissue;broadmatch
iris;eye part;broadmatch
intestine;organ;broadmatch
immune system;organ system;broadmatch
hypoglossal nerve;cranial nerve;broadmatch
cardiac atrium;heart part;broadmatch
macronodular adrenal hyperplasia;congenital adrenal hyperplasia;broadmatch
heart;organ;broadmatch
inguinal region;body region;broadmatch
gonad;organ;broadmatch
glottis;head and neck part;broadmatch
glossopharyngeal nerve;cranial nerve;broadmatch
male reproductive system;reproductive system;broadmatch
growth hormone and prolactin-producing neoplastic cells present;immunophenotypic finding;broadmatch
lumbar vertebra;vertebra;broadmatch
lymph node;organ;broadmatch
lymphatic system;hematopoietic and lymphatic system part;broadmatch
mast cell;hematopoietic and lymphoid cell;broadmatch
parathyroid gland;endocrine gland;broadmatch
parasympathetic nervous system;autonomic nervous system part;broadmatch
paranasal sinus;head and neck part;broadmatch
paranasal sinus;sinus;broadmatch
oropharynx;head and neck part;broadmatch
optic nerve;cranial nerve;broadmatch
optic disc;eye part;broadmatch
olfactory nerve;cranial nerve;broadmatch
oculomotor nerve;cranial nerve;broadmatch
occipital bone;flat bone;broadmatch
nose;organ of special sense;broadmatch
nervous system;organ system;broadmatch
musculoskeletal system;organ system;broadmatch
membrane;tissue;broadmatch
mediastinum;body region;broadmatch
ganglion;peripheral nervous system part;broadmatch
facial nerve;cranial nerve;broadmatch
autonomic nervous system;peripheral nervous system part;broadmatch
kit protein variant;gene product sequence variation;broadmatch
cauda equina;spinal nerve root;broadmatch
epidermodysplasia verruciformis;cutaneous precancerous condition;broadmatch
carotid artery;artery;broadmatch
cardiovascular system;organ system;broadmatch
capillary;cardiovascular system part;broadmatch
bronchus;respiratory system part;broadmatch
brachial plexus;spinal nerve plexus;broadmatch
myelofibrosis transformation in essential thrombocythemia;secondary myelofibrosis;broadmatch
eyelid;eye appendage;broadmatch
body region;anatomic structure, system, or substance;broadmatch
blood vessel;cardiovascular system part;broadmatch
biliary tract;organ;broadmatch
dedifferentiated malignant infiltrate;abnormal tissue present;broadmatch
intrahepatic bile duct;bile duct;broadmatch
bartholin gland;exocrine gland;broadmatch
axilla;body region;broadmatch
cavernous sinus;venous sinus;broadmatch
cervical vertebra;vertebra;broadmatch
choroid plexus;brain part;broadmatch
coccyx;spinal region;broadmatch
exocrine gland;gland;broadmatch
epithelium;epithelial tissue;broadmatch
epiglottis;head and neck part;broadmatch
epidermis;skin tissue;broadmatch
endoderm;germinal layer;broadmatch
ywhae/fam22 fusion gene;fusion gene;broadmatch
ywhae-fam22 fusion protein expression;fusion protein expression;broadmatch
endocrine system;organ system;broadmatch
"t(10;17)(q22;p13)";chromosomal translocation;broadmatch
endocrine gland;gland;broadmatch
ectoderm;germinal layer;broadmatch
dermis;skin tissue;broadmatch
cranial nerve;nerve;broadmatch
common bile duct;extrahepatic bile duct;broadmatch
coccyx;irregular bone;broadmatch
myeloid cell;hematopoietic and lymphoid cell;broadmatch
cytotoxic t-lymphocyte;cd8-positive t-lymphocyte;broadmatch
cytotoxic t-lymphocyte;effector t-lymphocyte;broadmatch
prostate gland;exocrine gland;broadmatch
head and neck;body region;broadmatch
urethra;organ;broadmatch
ureter;organ;broadmatch
kidney;organ;broadmatch
bladder;organ;broadmatch
urinary system;organ system;broadmatch
testis;gonad;broadmatch
penis;organ;broadmatch
eye;organ of special sense;broadmatch
vulva;organ;broadmatch
vagina;organ;broadmatch
uterus;organ;broadmatch
ovary;gonad;broadmatch
ovary;appendage of the uterus;broadmatch
fallopian tube;organ;broadmatch
fallopian tube;appendage of the uterus;broadmatch
head;body region;broadmatch
larynx;head and neck part;broadmatch
oral cavity;body cavity;broadmatch
tongue;organ of special sense;broadmatch
thymus gland;organ;broadmatch
spleen;organ;broadmatch
bone marrow;organ;broadmatch
limb;body region;broadmatch
trachea;organ;broadmatch
parotid gland;serous salivary gland;broadmatch
parotid gland;major salivary gland;broadmatch
salivary gland;exocrine gland;broadmatch
woodchuck hepatocellular carcinoma;experimental organism neoplasm by organism;broadmatch
rat malignant meningioma;rat neoplasms by morphology;broadmatch
pharynx;head and neck part;broadmatch
canine mammary carcinoma;canine neoplasm;broadmatch
nasal cavity;head and neck part;broadmatch
nasal cavity;body cavity;broadmatch
nasopharynx;head and neck part;broadmatch
female reproductive system;reproductive system;broadmatch
thyroid gland;endocrine gland;broadmatch
cd8-positive t-lymphocyte;mature t-lymphocyte;broadmatch
cartilage;skeletal system part;broadmatch
appendix;digestive system part;broadmatch
large intestine;digestive system part;broadmatch
digestive system;organ system;broadmatch
gallbladder;organ;broadmatch
bile duct;duct;broadmatch
anal canal;digestive system part;broadmatch
connective tissue;connective and soft tissue;broadmatch
artery;blood vessel;broadmatch
pituitary gland;endocrine gland;broadmatch
myocardium;striated muscle tissue;broadmatch
mammary gland tissue;tissue;broadmatch
mammary gland;breast part;broadmatch
mammary gland;exocrine gland;broadmatch
bone;skeletal system part;broadmatch
psa progression;psa level finding;broadmatch
head and neck lymph node;lymph node by anatomic site;broadmatch
cecum;digestive system part;broadmatch
colon;digestive system part;broadmatch
sigmoid colon;digestive system part;broadmatch
transverse colon;digestive system part;broadmatch
pineal gland;endocrine gland;broadmatch
adrenal medulla;neuroendocrine tissue;broadmatch
adrenal medulla;adrenal gland tissue;broadmatch
adrenal cortex;glandular epithelial tissue;broadmatch
adrenal cortex;adrenal gland tissue;broadmatch
ear;organ of special sense;broadmatch
pancreas;organ;broadmatch
liver;organ;broadmatch
stomach;organ;broadmatch
rectum;digestive system part;broadmatch
esophagus;organ;broadmatch
jejunum;digestive system part;broadmatch
ileum;digestive system part;broadmatch
malignant germinomatous cells present;abnormal cells present;broadmatch
small intestine;digestive system part;broadmatch
blood;body fluid or substance;broadmatch
muscle tissue;soft tissue;broadmatch
striated muscle tissue;muscle tissue;broadmatch
base of the skull;skeletal system part;broadmatch
tympanic membrane;mucosa;broadmatch
inner ear;ear part;broadmatch
external acoustic meatus;ear part;broadmatch
sella turcica;skeletal system part;broadmatch
jugular foramen;skeletal system part;broadmatch
foramen magnum;skeletal system part;broadmatch
clivus;skeletal system part;broadmatch
intrachromosomal amplification of chromosome 21;gain of chromosome 21;broadmatch
smooth muscle tissue;muscle tissue;broadmatch
signet ring cell;abnormal cell;broadmatch
plasma cell;mature b-lymphocyte;broadmatch
neuroendocrine cell;endocrine cell;broadmatch
fibroblast;connective and soft tissue cell;broadmatch
endothelium;soft tissue;broadmatch
mouse kidney carcinoma;mouse carcinoma;broadmatch
terminal ductal lobular unit;glandular epithelium;broadmatch
buccal mucosa;oral mucosa;broadmatch
tooth;head and neck part;broadmatch
cell;microanatomic structure;broadmatch
infratentorial brain;brain part;broadmatch
mouse plasma cell myeloma;mouse plasma cell neoplasm;broadmatch
rat plasma cell myeloma;rat neoplasms by morphology;broadmatch
rat malignant peripheral nerve sheath tumor;rat neoplasms by morphology;broadmatch
cd4-positive t-lymphocyte;mature t-lymphocyte;broadmatch
natural killer cell;peripheral (post-thymic) t-lymphocyte and natural killer cell;broadmatch
lymphocyte;hematopoietic and lymphoid cell;broadmatch
megaloblast;dysplastic erythroid precursor;broadmatch
abnormal red blood cell;abnormal hematopoietic and lymphoid cell;broadmatch
erythrocyte;peripheral blood cell;broadmatch
platelet;peripheral blood cell;broadmatch
peripheral blood cell;hematopoietic and lymphoid cell;broadmatch
superior sagittal sinus;sagittal sinus;broadmatch
sagittal sinus;venous sinus;broadmatch
supratentorial brain;brain nucleus;broadmatch
pons varolii;brain part;broadmatch
terminal ductal lobular unit;mammary gland tissue;broadmatch
astrocyte;glial cell;broadmatch
t-lymphocyte;t-lymphocyte and natural killer cell;broadmatch
experimental organism mesenchymal proliferative lesion;experimental organism neoplasm;broadmatch
experimental organism benign epithelial stromal tumor;experimental organism neoplasm;broadmatch
experimental organism malignant neuroepithelial carcinoma;experimental organism neoplasm;broadmatch
experimental organism benign adenomyoepithelioma;experimental organism neoplasm;broadmatch
thalamus;brain part;broadmatch
hypothalamus;brain part;broadmatch
diencephalon;brain part;broadmatch
discoloration;general qualifier;broadmatch
corpus callosum;cerebral white matter;broadmatch
cerebellum;brain part;broadmatch
cerebral cortex;brain part;broadmatch
medulla oblongata;brain part;broadmatch
brain stem;brain part;broadmatch
brain;central nervous system part;broadmatch
brain;organ;broadmatch
central nervous system;nervous system part;broadmatch
experimental organism malignant mesovarial leiomyoma;experimental organism neoplasm;broadmatch
experimental organism glandular polyp;experimental organism neoplasm;broadmatch
skin basal cell;cell of the epidermis;broadmatch
experimental organism malignant sarcoma arising from fibroadenoma;experimental organism neoplasm;broadmatch
skin basal cell;epithelial cell;broadmatch
b-lymphocyte;lymphocyte;broadmatch
synovial membrane;membrane;broadmatch
synovial membrane;soft tissue;broadmatch
adipose tissue;soft tissue;broadmatch
soft tissue;connective and soft tissue;broadmatch
skin;organ;broadmatch
pleura;membrane;broadmatch
lung;organ;broadmatch
nerve;nervous system part;broadmatch
peripheral nervous system;nervous system part;broadmatch
spinal cord;central nervous system part;broadmatch
spinal cord;organ;broadmatch
experimental organism malignant mixed sex cord stromal tumor;experimental organism neoplasm;broadmatch
experimental organism benign mixed sex cord stromal tumor;experimental organism neoplasm;broadmatch
mucinous;disease morphology qualifier;broadmatch
myoepithelial;anatomy qualifier;broadmatch
papillary;disease morphology qualifier;broadmatch
hepatocarcinogenesis;carcinogenesis;broadmatch
fos gene;fos family gene;broadmatch
document;intellectual property;broadmatch
document;record;broadmatch
environmental and occupational exposure;finding by cause;broadmatch
leukocyte trafficking;circulatory process;broadmatch
malignant conversion;transformation;broadmatch
mammary tumorigenesis;tumorigenesis;broadmatch
metal ion binding;chelating activity;broadmatch
cancer cell growth;tumorigenesis;broadmatch
g1/s transition checkpoint;cell cycle checkpoint;broadmatch
nucleocytoplasmic transport;intracellular transport;broadmatch
docking;ligand binding;broadmatch
protein metabolism process;intermediary metabolic process;broadmatch
lipid metabolic process;intermediary metabolic process;broadmatch
nucleotide metabolic process;intermediary metabolic process;broadmatch
cancer cell growth regulation;pathologic process;broadmatch
recombination repair;double strand break repair;broadmatch
metabolic process;biochemical process;broadmatch
cancer gene;gene;broadmatch
tumor oxygenation;tumor-associated process;broadmatch
chromatin remodeling;chromatin structural process;broadmatch
regulatory pathway;biochemical pathway;broadmatch
clonal evolution;disease progression;broadmatch
dna repair gene;gene;broadmatch
angiogenic switch;tumor-associated process;broadmatch
cell-cell adhesion process;cell adhesion process;broadmatch
brca2 gene mutation;gene variant;broadmatch
brca2 gene mutation;xrcc family gene mutation;broadmatch
brca2 gene mutation;fanconi anemia complementation group gene mutation;broadmatch
brca1 gene mutation;gene variant;broadmatch
brca1 gene mutation;fanconi anemia complementation group gene mutation;broadmatch
brca1 gene mutation;homologous recombination repair gene mutation;broadmatch
double strand break repair;dna repair;broadmatch
cell cycle regulation process;cell cycle process;broadmatch
cell ontogeny;cellular process;broadmatch
cancer cell growth;cancer progression;broadmatch
b-lymphoma development;tumorigenesis;broadmatch
mediator complex;protein or riboprotein complex;broadmatch
rna synthesis;gene expression process;broadmatch
transcriptional regulation;gene regulation process;broadmatch
thymic t-cell selection;t-cell differentiation in the thymus;broadmatch
t-cell receptor activation;intercellular communication process;broadmatch
t-cell differentiation;cell differentiation process;broadmatch
t-cell activation;lymphocyte activation process;broadmatch
skin carcinogenesis;carcinogenesis;broadmatch
rna-protein interaction;rna binding;broadmatch
receptor signaling;environment-to-cell communication;broadmatch
b cell proliferation;cell proliferation;broadmatch
physiology-regulatory factor;drug, food, chemical or biomedical material;broadmatch
protein kinase protein phosphorylation;protein phosphorylation process;broadmatch
protein expression;gene expression process;broadmatch
protein-carbohydrate interaction;molecular interaction process;broadmatch
post-transcriptional regulation;gene regulation process;broadmatch
mrna expression;rna synthesis;broadmatch
host defense mechanism;multicellular process;broadmatch
pharmacologic substance;drug, food, chemical or biomedical material;broadmatch
tumor promotion;tumorigenesis;broadmatch
drug or chemical by structure;drug, food, chemical or biomedical material;broadmatch
environment-to-cell communication;multicellular process;broadmatch
neural development;organogenesis;broadmatch
tumor angiogenesis;neovascularization;broadmatch
ubiquitination;post-translational modification;broadmatch
metabolic control;metabolic process;broadmatch
rna processing;post-transcriptional regulation;broadmatch
t-cell differentiation in the thymus;t-cell differentiation;broadmatch
deletion mutation;mutation abnormality;broadmatch
deletion mutation;gene rearrangement abnormality;broadmatch
signaling molecule;physiology-regulatory factor;broadmatch
b-cell activation;lymphocyte activation process;broadmatch
msh6 gene;dna repair gene;broadmatch
occupation or discipline;conceptual entity;broadmatch
macromolecular sequence alteration process;biochemical process;broadmatch
metastasis;cancer progression;broadmatch
in vitro model;experimental model;broadmatch
negative regulation of g1 phase;g1 phase process;broadmatch
swi/snf-related gene;transcription regulation gene;broadmatch
experimental tumor;in vitro model;broadmatch
hmg family gene;transcription regulation gene;broadmatch
mismatch repair;dna repair;broadmatch
melanogenesis;biosynthetic process;broadmatch
tumor cell invasion;tumor expansion;broadmatch
dephosphorylation;biochemical reaction;broadmatch
hmga2 gene;hmga family gene;broadmatch
hmga1 gene;hmga family gene;broadmatch
hmga family gene;hmg family gene;broadmatch
tfiid subunit gene;basal transcription factor gene;broadmatch
m phase process;cell cycle process;broadmatch
tbp-associated factor gene;tfiid subunit gene;broadmatch
cell maintenance;cell viability process;broadmatch
cellular process;biological process;broadmatch
apoptosis regulation gene;gene;broadmatch
helicase;hydrolase;broadmatch
transcription factor gene;transcription regulation gene;broadmatch
bcl-2 gene family;apoptosis regulation gene;broadmatch
mediator complex component gene;transcription coactivator gene;broadmatch
transcription coactivator gene;transcription coregulator gene;broadmatch
serine/threonine phosphorylation;protein phosphorylation process;broadmatch
nuclear receptor coactivator gene;transcription coactivator gene;broadmatch
microfilament gene;cytoskeletal gene;broadmatch
cytoskeletal gene;structural protein gene;broadmatch
structural protein gene;gene;broadmatch
fgfr4 gene;fibroblast growth factor receptor family gene;broadmatch
tumor cell mobility;tumor expansion;broadmatch
lipid binding;molecular interaction process;broadmatch
rna binding;nucleic acid binding;broadmatch
protein phosphatase gene;phosphatase family gene;broadmatch
receptor tyrosine kinase gene;kinase family gene;broadmatch
receptor tyrosine kinase gene;receptor gene;broadmatch
transcription coregulator gene;transcription regulation gene;broadmatch
nuclear receptor gene;transcription factor gene;broadmatch
nuclear receptor gene;receptor gene;broadmatch
transcription repressor/corepressor gene;transcription coregulator gene;broadmatch
ncoa2 gene;nuclear receptor coactivator gene;broadmatch
birc3 gene;iap family gene;broadmatch
apoptosis inhibitor gene;apoptosis regulation gene;broadmatch
biochemical reaction;subcellular process;broadmatch
myeloproliferation;cell proliferation;broadmatch
protein, organized by structure;protein;broadmatch
protein, organized by function;protein;broadmatch
sensory process;neurologic process;broadmatch
organismal process;biological process;broadmatch
cancer progression;tumor progression;broadmatch
biophysical process;subcellular process;broadmatch
pattern formation;morphogenesis;broadmatch
limb development;organogenesis;broadmatch
telomere maintenance gene;gene;broadmatch
stress response signaling;signal transduction;broadmatch
heparan sulfate biosynthesis;biosynthetic process;broadmatch
atp hydrolysis;intermediary metabolic process;broadmatch
negative regulation of apoptosis;negative regulation of cell death;broadmatch
fibroblast growth factor receptor family gene;receptor tyrosine kinase gene;broadmatch
fgfr1 gene;fibroblast growth factor receptor family gene;broadmatch
post-translational regulation;protein metabolism process;broadmatch
protein, organized by location;protein;broadmatch
cdkn1b gene;cyclin-dependent kinase inhibitor gene;broadmatch
receptor gene;ligand binding protein gene;broadmatch
protein family;protein;broadmatch
base excision repair;excision repair;broadmatch
regulatory gene;gene;broadmatch
cell-matrix adhesion process;cell adhesion process;broadmatch
protein complex subunit;protein;broadmatch
rna interference;post-transcriptional regulation;broadmatch
telomere maintenance;dna maintenance;broadmatch
inflammatory response;host defense mechanism;broadmatch
positive regulation of apoptosis;positive regulation of cell death;broadmatch
subcellular protein targeting;intracellular transport;broadmatch
peptide metabolism;protein metabolism process;broadmatch
transcription initiation;transcription process;broadmatch
regulation of proteolysis;post-translational regulation;broadmatch
ligand binding;molecular interaction process;broadmatch
skeletal development;organogenesis;broadmatch
phosphoprotein phosphatase;phosphatase;broadmatch
negative regulation of cell cycle;cell cycle process;broadmatch
cell cycle checkpoint;cell cycle process;broadmatch
poorly differentiated;histologic grade;broadmatch
structural protein;protein, organized by function;broadmatch
immunoregulation;immune system process;broadmatch
gene mutation;mutation abnormality;broadmatch
gene mutation;gene abnormality;broadmatch
chemical carcinogenesis;carcinogenesis mechanism;broadmatch
cell proliferation;cellular process;broadmatch
cell growth regulation;cell growth process;broadmatch
carcinogenesis;tumorigenesis;broadmatch
enzyme inhibitor protein;regulatory protein;broadmatch
lmo2 gene;transcription factor gene;broadmatch
blast cell proliferation;cell proliferation;broadmatch
somatic mutation;mutation abnormality;broadmatch
cdkn2a gene;cyclin-dependent kinase inhibitor gene;broadmatch
ccnd1 gene;cyclin gene;broadmatch
t-cell receptor gene;immunoprotein gene;broadmatch
loss of heterozygosity;mutation abnormality;broadmatch
megakaryocyte differentiation;myeloid cell differentiation;broadmatch
myogenesis;histogenic process;broadmatch
protein degradation process;post-translational regulation;broadmatch
proteolysis;hydrolysis;broadmatch
proteolysis;post-translational modification;broadmatch
regression;clinical course of disease;broadmatch
molecular interaction process;biophysical process;broadmatch
stable disease;clinical course of disease;broadmatch
tert gene;telomere maintenance gene;broadmatch
intracellular transport;transport process;broadmatch
homologous recombination;dna recombination process;broadmatch
erg gene;ets family gene;broadmatch
tumor initiation;tumorigenesis;broadmatch
leukemogenesis;tumorigenesis;broadmatch
rna transport;transport process;broadmatch
tumorigenesis;pathogenesis;broadmatch
brca2 gene;x-ray cross complementing group;broadmatch
brca2 gene;fa complementation group gene;broadmatch
receptor mediated endocytosis;endocytotic process;broadmatch
receptor;ligand binding protein;broadmatch
histologic grade;disease grade qualifier;broadmatch
brca1 gene;fa complementation group gene;broadmatch
cdk4 gene;cyclin-dependent kinase gene;broadmatch
"t(5;8)(p15;q13)";chromosome 5 rearrangement;broadmatch
"t(7;19)(q22;q13)";chromosome 7 rearrangement;broadmatch
disease progression;pathologic process;broadmatch
blasts less than 50 percent of bone marrow nucleated cells;blasts 50 percent or less of bone marrow nucleated cells;broadmatch
ahrr/ncoa2 fusion gene;fusion gene;broadmatch
ahrr gene;transcription factor gene;broadmatch
plaque-like lesion;lesion;broadmatch
"t(5;8)(p15;q13)";chromosomal translocation;broadmatch
del(9p21);chromosomal deletion;broadmatch
brca1 gene;homologous recombination repair gene;broadmatch
del(11p15.5);chromosomal deletion;broadmatch
organogenesis;developmental process;broadmatch
ligand binding protein;protein, organized by function;broadmatch
ewsr1/smad3 fusion gene;fusion gene;broadmatch
fn1/egf fusion gene;fusion gene;broadmatch
cdh11/usp6 fusion gene;fusion gene;broadmatch
col1a1/usp6 fusion gene;fusion gene;broadmatch
"t(7;19)(q22;q13)";chromosomal translocation;broadmatch
erbb2 gene;receptor tyrosine kinase gene;broadmatch
egfr gene;receptor tyrosine kinase gene;broadmatch
cell cycle protein;regulatory protein;broadmatch
bcl2 gene;bcl-2 gene family;broadmatch
immune system process;host defense mechanism;broadmatch
carbohydrate metabolic process;intermediary metabolic process;broadmatch
angiogenic process;histogenic process;broadmatch
immune response process;immune system process;broadmatch
cell respiration;energy metabolism process;broadmatch
maturation;reproductive process;broadmatch
decreased expression;abnormal laboratory test result;broadmatch
elevated expression;elevated test result;broadmatch
expression positive;positive laboratory test result;broadmatch
gene variant positive;positive laboratory test result;broadmatch
gene variant positive;genetic finding;broadmatch
yap1/tfe3 fusion gene;fusion gene;broadmatch
actb/fosb fusion gene;fusion gene;broadmatch
serpine1/fosb fusion gene;fusion gene;broadmatch
cdh1 gene;cell adhesion molecule gene;broadmatch
ext1 gene;glycosyltransferase gene;broadmatch
carcinogenesis, radiation;physical carcinogenesis;broadmatch
erbb receptor family protein;receptor tyrosine kinase;broadmatch
myc family gene;transcription factor gene;broadmatch
fgf4 gene;fibroblast growth factor gene family;broadmatch
gli family gene;transcription factor gene;broadmatch
transcription repressor/corepressor;transcription regulatory protein;broadmatch
transcription coactivator;transcription regulatory protein;broadmatch
fhit gene;hydrolase gene;broadmatch
signaling protein;protein, organized by function;broadmatch
tyrosine phosphorylation;protein phosphorylation process;broadmatch
bcr gene;signaling pathway gene;broadmatch
protein phosphorylation process;post-translational modification;broadmatch
protein phosphorylation process;phosphorylation process;broadmatch
cyclin-dependent kinase inhibitor protein;cell cycle protein;broadmatch
mlh1 gene;dna repair gene;broadmatch
msh2 gene;dna repair gene;broadmatch
protein-protein interaction;molecular interaction process;broadmatch
regulatory protein;protein, organized by function;broadmatch
ras superfamily protein;small g protein;broadmatch
ntrk1 gene;receptor tyrosine kinase gene;broadmatch
fibroblast growth factor gene family;growth factor gene;broadmatch
ccdc6/ret fusion gene;fusion gene;broadmatch
physical carcinogenesis;carcinogenesis mechanism;broadmatch
carcinogenesis mechanism;cancer biology;broadmatch
biological carcinogenesis;carcinogenesis mechanism;broadmatch
cancer biology;biology;broadmatch
metabolic pathway;biochemical pathway;broadmatch
kit gene;receptor tyrosine kinase gene;broadmatch
dna binding;nucleic acid binding;broadmatch
cyclin-dependent kinase inhibitor gene;cell cycle gene;broadmatch
pms2 gene;dna repair gene;broadmatch
pms1 gene;dna repair gene;broadmatch
kmt2a gene;methyltransferase gene;broadmatch
cbfb gene;transcription factor gene;broadmatch
atm gene;serine/threonine protein kinase gene;broadmatch
pttg1 gene;cell cycle gene;broadmatch
runx1 gene;transcription factor gene;broadmatch
bcr gene;serine/threonine protein kinase gene;broadmatch
g protein gene;signaling pathway gene;broadmatch
ext2 gene;glycosyltransferase gene;broadmatch
vhl gene;regulatory gene;broadmatch
etv6 gene;ets family gene;broadmatch
dna maintenance;dna maintenance process;broadmatch
x-ray cross complementing group;dna repair gene;broadmatch
pdgfb gene;growth factor gene;broadmatch
small g protein;g protein;broadmatch
pathogenesis;pathologic process;broadmatch
wt1 gene;transcription factor gene;broadmatch
tsc2 gene;signaling pathway gene;broadmatch
irf4 gene;transcription coactivator gene;broadmatch
tsc1 gene;ligand binding protein gene;broadmatch
smad4 gene;signaling pathway gene;broadmatch
ret gene;receptor tyrosine kinase gene;broadmatch
pten gene;signaling pathway gene;broadmatch
ptch1 gene;receptor gene;broadmatch
men1 gene;transcription factor gene;broadmatch
stk11 gene;serine/threonine protein kinase gene;broadmatch
fli1 gene;ets family gene;broadmatch
ewsr1 gene;ligand binding protein gene;broadmatch
met gene;receptor tyrosine kinase gene;broadmatch
met gene;growth factor receptor gene;broadmatch
fosl1 gene;fos family gene;broadmatch
fgf6 gene;fibroblast growth factor gene family;broadmatch
mybl1 gene;transcription factor gene;broadmatch
mycn gene;myc family gene;broadmatch
smarcb1 gene;swi/snf-related gene;broadmatch
mecom gene;transcription regulation gene;broadmatch
mecom gene;methyltransferase gene;broadmatch
cdkn1c gene;cyclin-dependent kinase inhibitor gene;broadmatch
braf gene;serine/threonine protein kinase gene;broadmatch
bcl3 gene;transcription regulation gene;broadmatch
akt2 gene;serine/threonine protein kinase gene;broadmatch
akt1 gene;serine/threonine protein kinase gene;broadmatch
mdm2 gene;ubiquitin-transferase gene;broadmatch
disease marker;biomarker;broadmatch
ets family gene;transcription factor gene;broadmatch
regulation of cell shape;cellular process;broadmatch
cell proliferation regulatory process;cell proliferation;broadmatch
metastasis suppression;cell migration inhibition process;broadmatch
squamous cell carcinoma of the mouse prostate gland;mouse squamous cell carcinoma;broadmatch
leiomyosarcoma of the mouse prostate gland;sarcoma of the mouse prostate gland;broadmatch
sarcoma of the mouse prostate gland;malignant neoplasms of the mouse prostate gland;broadmatch
sarcoma of the mouse prostate gland;mouse malignant mesenchymal neoplasm;broadmatch
sarcoma of the mouse prostate gland;mouse sarcoma;broadmatch
adenosquamous cell carcinoma of the mouse prostate gland;mouse adenosquamous carcinoma;broadmatch
adenosquamous cell carcinoma of the mouse prostate gland;invasive carcinoma of the mouse prostate gland;broadmatch
squamous cell carcinoma of the mouse prostate gland;invasive carcinoma of the mouse prostate gland;broadmatch
spindle cell / sarcomatoid carcinoma of the mouse prostate gland;invasive carcinoma of the mouse prostate gland;broadmatch
invasive adenocarcinoma of the mouse prostate gland;mouse adenocarcinoma;broadmatch
spindle cell / sarcomatoid carcinoma of the mouse prostate gland;mouse spindle cell neoplasm;broadmatch
invasive small cell carcinoma of the mouse prostate gland;invasive neuroendocrine carcinoma of the mouse prostate gland;broadmatch
invasive small cell carcinoma of the mouse prostate gland;mouse small cell undifferentiated carcinoma;broadmatch
invasive neuroendocrine carcinoma of the mouse prostate gland;invasive carcinoma of the mouse prostate gland;broadmatch
undifferentiated invasive carcinoma of the mouse prostate gland;invasive carcinoma of the mouse prostate gland;broadmatch
undifferentiated invasive carcinoma of the mouse prostate gland;mouse undifferentiated carcinoma;broadmatch
poorly differentiated invasive adenocarcinoma of the mouse prostate gland;invasive adenocarcinoma of the mouse prostate gland;broadmatch
leiomyosarcoma of the mouse prostate gland;mouse leiomyosarcoma;broadmatch
rhabdomyosarcoma of the mouse prostate gland;sarcoma of the mouse prostate gland;broadmatch
rhabdomyosarcoma of the mouse prostate gland;mouse rhabdomyosarcoma;broadmatch
chondrosarcoma of the mouse prostate gland;sarcoma of the mouse prostate gland;broadmatch
preinvasive lesions of the mouse pulmonary system;mouse cancer-related conditions;broadmatch
adenoma of the mouse pulmonary system with mixed subtypes;adenoma of the mouse pulmonary system;broadmatch
solid adenoma of the mouse pulmonary system;adenoma of the mouse pulmonary system;broadmatch
papillary adenoma of the mouse pulmonary system;adenoma of the mouse pulmonary system;broadmatch
adenoma of the mouse pulmonary system;mouse adenoma;broadmatch
adenoma of the mouse pulmonary system;benign tumors of the mouse pulmonary system;broadmatch
papilloma of the mouse pulmonary system;mouse papilloma;broadmatch
papilloma of the mouse pulmonary system;benign tumors of the mouse pulmonary system;broadmatch
benign tumors of the mouse pulmonary system;tumors of the mouse pulmonary system;broadmatch
carcinosarcoma of the mouse prostate gland;malignant neoplasms of the mouse prostate gland;broadmatch
carcinosarcoma of the mouse prostate gland;mouse malignant mixed mesodermal tumor;broadmatch
sarcoma nos of the mouse prostate gland;sarcoma of the mouse prostate gland;broadmatch
osteosarcoma of the mouse prostate gland;mouse osteosarcoma;broadmatch
osteosarcoma of the mouse prostate gland;sarcoma of the mouse prostate gland;broadmatch
chondrosarcoma of the mouse prostate gland;mouse chondrosarcoma;broadmatch
moderately differentiated invasive adenocarcinoma of the mouse prostate gland;invasive adenocarcinoma of the mouse prostate gland;broadmatch
invasive adenocarcinoma of the mouse prostate gland;invasive carcinoma of the mouse prostate gland;broadmatch
squamous dysplasia of the mouse pulmonary system;preinvasive lesions of the mouse pulmonary system;broadmatch
spindle cell metaplastic carcinoma of the mouse mammary gland;mouse spindle cell neoplasm;broadmatch
high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;mouse precancerous conditions;broadmatch
high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;neoplasms of the mouse prostate gland;broadmatch
neoplasms of the mouse prostate gland;mouse prostate disorder;broadmatch
neoplasms of the mouse prostate gland;mouse male reproductive system neoplasms;broadmatch
other cancer of the mouse mammary gland nos;malignant neoplasms of the mouse mammary gland;broadmatch
other metaplastic carcinomas of the mouse mammary gland;metaplastic carcinoma of the mouse mammary gland;broadmatch
spindle cell metaplastic carcinoma of the mouse mammary gland;metaplastic carcinoma of the mouse mammary gland;broadmatch
osseous metaplastic carcinoma of the mouse mammary gland;metaplastic carcinoma of the mouse mammary gland;broadmatch
invasive carcinoma of the mouse prostate gland;carcinoma of the mouse prostate gland;broadmatch
squamous metaplastic carcinoma of the mouse mammary gland;metaplastic carcinoma of the mouse mammary gland;broadmatch
squamous metaplastic carcinoma of the mouse mammary gland;mouse squamous cell carcinoma;broadmatch
adenosquamous metaplastic carcinoma of the mouse mammary gland;mouse adenosquamous carcinoma;broadmatch
adenosquamous metaplastic carcinoma of the mouse mammary gland;metaplastic carcinoma of the mouse mammary gland;broadmatch
metaplastic carcinoma of the mouse mammary gland;carcinoma of the mouse mammary gland: histologic patterns;broadmatch
monomorphic myoepithelial spindle cell carcinoma of the mouse mammary gland;myoepithelial carcinoma of the mouse mammary gland;broadmatch
monomorphic myoepithelial spindle cell carcinoma of the mouse mammary gland;mouse spindle cell neoplasm;broadmatch
atypical hyperplasia of the mouse prostate gland;high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;broadmatch
epithelial atypical hyperplasia of the mouse prostate gland;atypical hyperplasia of the mouse prostate gland;broadmatch
stromal atypical hyperplasia of the mouse prostate gland;atypical hyperplasia of the mouse prostate gland;broadmatch
combined epithelial / stromal atypical hyperplasia of the mouse prostate gland;atypical hyperplasia of the mouse prostate gland;broadmatch
microinvasive small cell carcinoma of the mouse prostate gland;microinvasive neuroendocrine carcinoma of the mouse prostate gland;broadmatch
microinvasive small cell carcinoma of the mouse prostate gland;mouse small cell undifferentiated carcinoma;broadmatch
microinvasive neuroendocrine carcinoma of the mouse prostate gland;microinvasive carcinoma of the mouse prostate gland;broadmatch
undifferentiated microinvasive carcinoma of the mouse prostate gland;microinvasive carcinoma of the mouse prostate gland;broadmatch
undifferentiated microinvasive carcinoma of the mouse prostate gland;mouse undifferentiated carcinoma;broadmatch
microinvasive adenocarcinoma of the mouse prostate gland;mouse adenocarcinoma;broadmatch
microinvasive adenocarcinoma of the mouse prostate gland;microinvasive carcinoma of the mouse prostate gland;broadmatch
microinvasive carcinoma of the mouse prostate gland;carcinoma of the mouse prostate gland;broadmatch
carcinoma of the mouse prostate gland;mouse carcinoma;broadmatch
carcinoma of the mouse prostate gland;malignant neoplasms of the mouse prostate gland;broadmatch
malignant neoplasms of the mouse prostate gland;neoplasms of the mouse prostate gland;broadmatch
high grade mouse prostatic intraepithelial neoplasia;prostatic intraepithelial neoplasia of the mouse prostate gland;broadmatch
low grade mouse prostatic intraepithelial neoplasia;prostatic intraepithelial neoplasia of the mouse prostate gland;broadmatch
prostatic intraepithelial neoplasia of the mouse prostate gland;high risk proliferative disease of the mouse prostate gland of unknown or premalignant potential;broadmatch
prostatic intraepithelial neoplasia of the mouse prostate gland;mouse intraepithelial neoplasia;broadmatch
preinvasive lesions of the mouse pulmonary system;epithelial proliferative lesions of the mouse pulmonary system;broadmatch
malignant tumors of the mouse pulmonary system;tumors of the mouse pulmonary system;broadmatch
bap1 gene;cysteine peptidase gene;broadmatch
follicular neoplasms of the mouse skin;adnexal neoplasms of the mouse skin;broadmatch
spiradenoma type of basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;broadmatch
cylindroma type of basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;broadmatch
trichofolliculoma type of basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;broadmatch
trichoepithelioma type of basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;broadmatch
trichoblastoma type of basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;broadmatch
pilomatrixoma type of basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;broadmatch
basaloid follicular neoplasm of the mouse skin;follicular neoplasms of the mouse skin;broadmatch
adnexal neoplasms of the mouse skin;neoplasms of the mouse skin;broadmatch
squamous cell carcinoma in situ of the mouse skin;squamous neoplasms of the mouse skin;broadmatch
malignant basal cell tumor of the mouse skin;squamous neoplasms of the mouse skin;broadmatch
spindle-cell squamous cell carcinoma of the mouse skin;poorly-differentiated squamous cell carcinoma of the mouse skin;broadmatch
spindle-cell squamous cell carcinoma of the mouse skin;mouse spindle cell neoplasm;broadmatch
poorly-differentiated squamous cell carcinoma of the mouse skin;squamous cell carcinoma of the mouse skin;broadmatch
moderately-differentiated squamous cell carcinoma of the mouse skin;squamous cell carcinoma of the mouse skin;broadmatch
well-differentiated squamous cell carcinoma of the mouse skin;squamous cell carcinoma of the mouse skin;broadmatch
squamous cell carcinoma of the mouse skin;squamous neoplasms of the mouse skin;broadmatch
superficial basal cell carcinoma type of basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;broadmatch
other variants of basaloid follicular neoplasm of the mouse skin;basaloid follicular neoplasm of the mouse skin;broadmatch
sebaceous neoplasms and hyperplasias of the mouse skin;adnexal neoplasms of the mouse skin;broadmatch
sebaceous adenoma of the mouse skin;sebaceous neoplasms and hyperplasias of the mouse skin;broadmatch
lipoma of the mouse skin;benign mesenchymal neoplasms of the mouse skin;broadmatch
lipoma of the mouse skin;mouse lipoma;broadmatch
hemangioma of the mouse skin;hemangioma of the mouse blood vessel;broadmatch
hemangioma of the mouse skin;benign mesenchymal neoplasms of the mouse skin;broadmatch
fibroma of the mouse skin;benign mesenchymal neoplasms of the mouse skin;broadmatch
fibroma of the mouse skin;mouse fibroma;broadmatch
benign mesenchymal neoplasms of the mouse skin;neoplasms of the mouse skin;broadmatch
other adnexal neoplasms of the mouse skin;adnexal neoplasms of the mouse skin;broadmatch
mixed tumors of the mouse skin;adnexal neoplasms of the mouse skin;broadmatch
mixed tumors of the mouse skin;mouse mixed neoplasm;broadmatch
apocrine neoplasms of the mouse skin;adnexal neoplasms of the mouse skin;broadmatch
mouse eccrine neoplasms;adnexal neoplasms of the mouse skin;broadmatch
sebaceous carcinoma of the mouse skin;mouse carcinoma;broadmatch
sebaceous carcinoma of the mouse skin;sebaceous neoplasms and hyperplasias of the mouse skin;broadmatch
sebaceous adenoma of the mouse skin;mouse adenoma;broadmatch
squamous cell carcinoma of the mouse skin;mouse squamous cell carcinoma;broadmatch
benign basal cell tumor of the mouse skin;squamous neoplasms of the mouse skin;broadmatch
squamous cell carcinoma of the mouse pulmonary system;mouse squamous cell carcinoma;broadmatch
adenocarcinoma nos of the mouse pulmonary system;adenocarcinoma of the mouse pulmonary system;broadmatch
neoplasms of the mouse skin;mouse skin disorder;broadmatch
neoplasms of the mouse skin;mouse integumentary system neoplasms;broadmatch
carcinoma, other, of the mouse pulmonary system;mouse carcinoma;broadmatch
carcinoma, other, of the mouse pulmonary system;malignant tumors of the mouse pulmonary system;broadmatch
neuroendocrine carcinoma of the mouse pulmonary system;malignant tumors of the mouse pulmonary system;broadmatch
adenosquamous carcinoma of the mouse pulmonary system;mouse adenosquamous carcinoma;broadmatch
adenosquamous carcinoma of the mouse pulmonary system;malignant tumors of the mouse pulmonary system;broadmatch
adenocarcinoma with mixed subtypes of the mouse pulmonary system;adenocarcinoma of the mouse pulmonary system;broadmatch
benign basal cell tumor of the mouse skin;mouse basal cell neoplasm;broadmatch
solid adenocarcinoma of the mouse pulmonary system;adenocarcinoma of the mouse pulmonary system;broadmatch
acinar adenocarcinoma of the mouse pulmonary system;mouse acinar cell neoplasm;broadmatch
acinar adenocarcinoma of the mouse pulmonary system;adenocarcinoma of the mouse pulmonary system;broadmatch
papillary adenocarcinoma of the mouse pulmonary system;adenocarcinoma of the mouse pulmonary system;broadmatch
adenocarcinoma of the mouse pulmonary system;mouse adenocarcinoma;broadmatch
adenocarcinoma of the mouse pulmonary system;malignant tumors of the mouse pulmonary system;broadmatch
squamous cell carcinoma of the mouse pulmonary system;malignant tumors of the mouse pulmonary system;broadmatch
mouse melanocytic neoplasms and proliferations;neoplasms of the mouse skin;broadmatch
mouse melanocytic neoplasms and proliferations;mouse melanocyte neoplasm;broadmatch
mouse benign melanocytic neoplasms;mouse melanocytic neoplasms and proliferations;broadmatch
mouse melanocytoma;mouse benign melanocytic neoplasms;broadmatch
papilloma of the mouse skin;benign squamous neoplasms of the mouse skin;broadmatch
benign squamous neoplasms of the mouse skin;squamous neoplasms of the mouse skin;broadmatch
squamous neoplasms of the mouse skin;mouse squamous cell neoplasm;broadmatch
squamous neoplasms of the mouse skin;neoplasms of the mouse skin;broadmatch
other mouse melanoma;mouse melanoma;broadmatch
mouse amelanotic spindle and epithelioid melanoma;mouse spindle and epithelioid melanoma;broadmatch
mouse spindle and epithelioid melanoma;mouse melanoma;broadmatch
mouse amelanotic spindle-cell melanoma;mouse spindle-cell melanoma;broadmatch
mouse spindle-cell melanoma;mouse melanoma;broadmatch
mouse spindle-cell melanoma;mouse spindle cell neoplasm;broadmatch
mouse amelanotic epithelioid melanoma;mouse epithelioid melanoma;broadmatch
mouse epithelioid melanoma;mouse melanoma;broadmatch
mouse melanoma;mouse malignant melanocytic neoplasms;broadmatch
mouse malignant melanocytic neoplasms;mouse melanocytic neoplasms and proliferations;broadmatch
mouse melanocytic neoplasms of uncertain malignant potential;mouse melanocytic neoplasms and proliferations;broadmatch
myoepithelial and mixed glandular myoepithelial carcinoma of the mouse mammary gland;myoepithelial carcinoma of the mouse mammary gland;broadmatch
myoepithelial carcinoma of the mouse mammary gland;carcinoma of the mouse mammary gland: histologic patterns;broadmatch
myoepithelial carcinoma of the mouse mammary gland;mouse myoepithelioma;broadmatch
protein or riboprotein complex;gene product;broadmatch
translation process gene;gene;broadmatch
pik3ca gene;phosphoinositol kinase family gene;broadmatch
calcium binding;metal ion binding;broadmatch
intermediary metabolic process;metabolic process;broadmatch
tumor-associated process;pathologic process;broadmatch
tumor expansion;tumor progression;broadmatch
npm1 gene;structural protein gene;broadmatch
reproductive process;organismal process;broadmatch
cell viability process;cellular process;broadmatch
aging-related process;organismal process;broadmatch
dna repair protein;protein, organized by function;broadmatch
developmental process;multicellular process;broadmatch
myelopoiesis;hematopoietic process;broadmatch
histogenic process;developmental process;broadmatch
multicellular process;biological process;broadmatch
cell division process;cellular process;broadmatch
metallopeptidase gene;peptidase gene;broadmatch
enzyme gene;gene;broadmatch
lyase gene;enzyme gene;broadmatch
ligand binding protein gene;gene;broadmatch
mouse neuroglia neoplasm;mouse neoplasms by cell type;broadmatch
microanatomic structure;anatomic structure, system, or substance;broadmatch
g protein-coupled receptor signaling;receptor signaling;broadmatch
calcium signaling;intracellular signaling process;broadmatch
neuronal transmission;intercellular communication process;broadmatch
rara gene;nuclear receptor gene;broadmatch
deubiquitination;post-translational modification;broadmatch
cytokine gene;gene;broadmatch
3'-5' exonuclease;exonuclease;broadmatch
bmpr1a gene;bone morphogenetic protein receptor gene;broadmatch
bone morphogenetic protein receptor gene;receptor serine/threonine kinase gene;broadmatch
receptor serine/threonine kinase gene;serine/threonine protein kinase gene;broadmatch
receptor serine/threonine kinase gene;receptor gene;broadmatch
growth factor gene;gene;broadmatch
ezh2 gene;regulatory gene;broadmatch
cell growth process;cellular process;broadmatch
replication-associated process;dna maintenance process;broadmatch
other mammary carcinoma of mouse;luminal carcinoma of the mouse mammary gland;broadmatch
g protein-coupled receptor gene;receptor gene;broadmatch
protein dephosphorylation;post-translational modification;broadmatch
cd44 gene;cell adhesion molecule gene;broadmatch
cell adhesion molecule gene;ligand binding protein gene;broadmatch
ctnnb1 gene;signaling pathway gene;broadmatch
tumor suppressor protein;protein, organized by function;broadmatch
gtp binding;molecular interaction process;broadmatch
iap family gene;apoptosis inhibitor gene;broadmatch
signaling pathway gene;gene;broadmatch
transport process;biochemical process;broadmatch
cell cycle gene;gene;broadmatch
adipogenesis;biosynthetic process;broadmatch
adenosine triphosphate;nucleotide;broadmatch
stimulation of cell proliferation;cell proliferation;broadmatch
nup98 gene;nucleoporin gene;broadmatch
nucleoporin gene;transport protein gene;broadmatch
cytoskeletal modeling;cytoskeletal process;broadmatch
suppression of cancer cell invasion;inhibition of cancer cell growth;broadmatch
glycosylation;biochemical reaction;broadmatch
nociception;sensory process;broadmatch
neurologic process;organismal process;broadmatch
dna sequence rearrangement;dna sequence alteration process;broadmatch
dna sequence alteration process;macromolecular sequence alteration process;broadmatch
cellular stress response;cell stress process;broadmatch
cellular stress;cell stress process;broadmatch
cell stress process;pathologic process;broadmatch
protein turnover;degradation;broadmatch
gene regulation process;gene expression process;broadmatch
gene expression process;biochemical process;broadmatch
dna replication proofreading;replication-associated process;broadmatch
coagulation process;host defense mechanism;broadmatch
cell death signaling process;stress response signaling;broadmatch
intracellular signaling process;biochemical process;broadmatch
protein methylation;post-translational modification;broadmatch
mouse lobular neoplasm;mouse neoplasms by morphology;broadmatch
mouse lymphoma;mouse neoplasms by morphology;broadmatch
mouse sarcoma;mouse neoplasms by morphology;broadmatch
papilloma of the mouse mammary gland;benign neoplasms of the mouse mammary gland;broadmatch
intraepithelial neoplasia of the mouse mammary gland;neoplasms of the mouse mammary gland;broadmatch
intraepithelial neoplasia of the mouse mammary gland;mouse intraepithelial neoplasia;broadmatch
adenomyoepithelioma of the mouse mammary gland;benign neoplasms of the mouse mammary gland;broadmatch
adenomyoepithelioma of the mouse mammary gland;mouse myoepithelioma;broadmatch
adenoma of the mouse mammary gland;mouse adenoma;broadmatch
adenoma of the mouse mammary gland;benign neoplasms of the mouse mammary gland;broadmatch
papilloma of the mouse mammary gland;mouse papilloma;broadmatch
fibroadenoma of the mouse mammary gland;mouse adenoma;broadmatch
mouse sarcoma;mouse mesenchymal neoplasm;broadmatch
fibroadenoma of the mouse mammary gland;benign neoplasms of the mouse mammary gland;broadmatch
benign neoplasms of the mouse mammary gland;neoplasms of the mouse mammary gland;broadmatch
neoplasms of the mouse mammary gland;mouse mammary gland disorder;broadmatch
neoplasms of the mouse mammary gland;mouse integumentary system neoplasms;broadmatch
murine experimental organism diagnosis;experimental organism neoplasm by organism;broadmatch
mouse clear cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse stromal neoplasm;mouse neoplasms by morphology;broadmatch
low grade mouse min;intraepithelial neoplasia of the mouse mammary gland;broadmatch
lobuloalveolar mouse min;low grade mouse min;broadmatch
ductal mouse min;low grade mouse min;broadmatch
mouse min nos;intraepithelial neoplasia of the mouse mammary gland;broadmatch
solid mammary carcinoma of mouse;luminal carcinoma of the mouse mammary gland;broadmatch
papillary mammary carcinoma of mouse;luminal carcinoma of the mouse mammary gland;broadmatch
cribriform mammary carcinoma of mouse;luminal carcinoma of the mouse mammary gland;broadmatch
glandular mammary carcinoma of mouse;luminal carcinoma of the mouse mammary gland;broadmatch
acinar mammary carcinoma of mouse;luminal carcinoma of the mouse mammary gland;broadmatch
luminal carcinoma of the mouse mammary gland;carcinoma of the mouse mammary gland: histologic patterns;broadmatch
luminal carcinoma of the mouse mammary gland;mouse luminal carcinoma;broadmatch
carcinoma of the mouse mammary gland: histologic patterns;malignant neoplasms of the mouse mammary gland;broadmatch
malignant neoplasms of the mouse mammary gland;neoplasms of the mouse mammary gland;broadmatch
carcinoma in situ of the mouse mammary gland;intraepithelial neoplasia of the mouse mammary gland;broadmatch
high grade mouse min;intraepithelial neoplasia of the mouse mammary gland;broadmatch
mixed mouse min nos;mouse min nos;broadmatch
solid mouse min nos;mouse min nos;broadmatch
cystic mouse min nos;mouse min nos;broadmatch
simple mouse min nos;mouse min nos;broadmatch
mouse hibernoma;mouse benign mesenchymal neoplasm;broadmatch
mouse granular cell neoplasm;mouse neural cell neoplasm;broadmatch
mouse mast cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse hemangiopericytoma;mouse malignant mesenchymal neoplasm;broadmatch
mouse benign mesenchymal neoplasm;mouse mesenchymal neoplasm;broadmatch
mouse liposarcoma;malignant mouse lipomatous neoplasm;broadmatch
mouse liposarcoma;mouse sarcoma;broadmatch
mouse intraepithelial neoplasia;mouse neoplasms by morphology;broadmatch
mouse spindle cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse large cell undifferentiated carcinoma;mouse undifferentiated carcinoma;broadmatch
mouse small cell undifferentiated carcinoma;mouse undifferentiated carcinoma;broadmatch
mouse undifferentiated carcinoma;mouse carcinoma;broadmatch
mouse squamous cell carcinoma;mouse squamous cell neoplasm;broadmatch
mouse squamous cell carcinoma;mouse carcinoma;broadmatch
mouse carcinoid tumor;mouse epithelial cell neoplasms;broadmatch
mouse malignant mixed mesodermal tumor;mouse mixed mesodermal tumor;broadmatch
mouse mixed mesodermal tumor;mouse mixed neoplasm;broadmatch
mouse giant cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse leukemia;mouse neoplasms by morphology;broadmatch
mouse malignant mesenchymal neoplasm;mouse mesenchymal neoplasm;broadmatch
mouse mesothelioma;mouse malignant mesenchymal neoplasm;broadmatch
mouse plasmacytoma;mouse plasma cell dyscrasia;broadmatch
mouse mesothelioma;mouse epithelial cell neoplasms;broadmatch
mouse plasmacytoma;mouse b cell neoplasms;broadmatch
mouse t cell neoplasms;mouse lymph cell neoplasm;broadmatch
mouse t cell neoplasms;mouse lymphoma;broadmatch
mouse b cell neoplasms;mouse lymph cell neoplasm;broadmatch
mouse b cell neoplasms;mouse lymphoma;broadmatch
mouse plasma cell neoplasm;mouse neoplasms by cell type;broadmatch
mouse basal cell neoplasm;mouse epithelial cell neoplasms;broadmatch
mouse luminal carcinoma;mouse adenocarcinoma;broadmatch
mouse mixed neoplasm;mouse neoplasms by morphology;broadmatch
mouse myoepithelioma;mouse mixed neoplasm;broadmatch
mouse lipoma;mouse benign mesenchymal neoplasm;broadmatch
mouse fibroma;mouse neoplasms by morphology;broadmatch
mouse fibroma;mouse benign mesenchymal neoplasm;broadmatch
mouse leiomyoma;mouse benign mesenchymal neoplasm;broadmatch
mouse angioma;mouse benign mesenchymal neoplasm;broadmatch
subcellular process;biological process;broadmatch
thrombopoiesis;myelopoiesis;broadmatch
biosynthetic process;metabolic process;broadmatch
hif1a overexpression positive;elevated expression;broadmatch
chromosome 6 loss of heterozygosity;loss of heterozygosity;broadmatch
chromosome arm 5q loss of heterozygosity;loss of heterozygosity;broadmatch
chromosome arm 1p loss of heterozygosity;chromosome 1 abnormality;broadmatch
chromosome arm 1p loss of heterozygosity;loss of heterozygosity;broadmatch
variably-sized cysts filled with clear, serous, or gelatinous fluid;cystic change;broadmatch
short somatic mutation;somatic mutation;broadmatch
hif1a overexpression positive;positive laboratory test result;broadmatch
pi3k gene mutation;pi3k/mtor pathway mutation;broadmatch
afp level finding;laboratory test result;broadmatch
cdk gene mutation;gene abnormality;broadmatch
recurrent high risk non-muscle invasive bladder urothelial carcinoma;high risk non-muscle invasive bladder urothelial carcinoma;broadmatch
high risk non-muscle invasive bladder urothelial carcinoma;urinary system finding;broadmatch
feline histiocytic sarcoma;feline experimental organism diagnosis;broadmatch
resistance to second-generation androgen receptor axis-targeted agents;castration resistance;broadmatch
sdhaf2 gene mutation;gene variant;broadmatch
borderline resectable mass;resectable mass;broadmatch
chromosome 8 loss of heterozygosity;loss of heterozygosity;broadmatch
chromosome 10 loss of heterozygosity;loss of heterozygosity;broadmatch
chromosome 11 loss of heterozygosity;loss of heterozygosity;broadmatch
chromosome 15 loss of heterozygosity;loss of heterozygosity;broadmatch
marked thickening of the bladder urothelium present;morphologic finding;broadmatch
nf1 mutation positive malignant peripheral nerve sheath tumor;gene variant positive;broadmatch
nf1 mutation positive malignant peripheral nerve sheath tumor;biomarker positive malignant neoplasm;broadmatch
subcutaneous disorder;skin disorder;broadmatch
tsc2 monoallelic inactivation;tsc2 gene inactivation;broadmatch
tsc2 monoallelic inactivation;loss of heterozygosity;broadmatch
tsc2 monoallelic inactivation;monoallelic mutation;broadmatch
smooth muscle metaplasia;mesenchymal metaplasia;broadmatch
intra or intercytoplasmic lumina present;morphologic finding;broadmatch
malignant epithelial cells with cytoplasmic vacuoles or flocculent cytoplasmic inclusions containing wispy eosinophilic material present;abnormal cells present;broadmatch
microcystic growth pattern;morphologic architectural pattern;broadmatch
reticular growth pattern;morphologic architectural pattern;broadmatch
blasts 0.01 percent or more of bone marrow nucleated cells;blast cells increased in bone marrow;broadmatch
chromosome 22 loss of heterozygosity;loss of heterozygosity;broadmatch
chromosome 18 loss of heterozygosity;loss of heterozygosity;broadmatch
blasts 0.1 percent or more of bone marrow nucleated cells;blasts 0.01 percent or more of bone marrow nucleated cells;broadmatch
vitreoretinal area;eye part;broadmatch
platinum sensitivity;disease response;broadmatch
high risk chronic myelomonocytic leukemia;myeloid neoplasm finding;broadmatch
experimental organism endocardial schwannoma;experimental organism neoplasm;broadmatch
loss of immunohistochemical expression of succinate dehydrogenase (sdh) b;immunophenotypic finding;broadmatch
loss of immunohistochemical expression of succinate dehydrogenase (sdh) b;sdhb negative;broadmatch
malignant primitive cellular infiltrate;malignant cellular infiltrate;broadmatch
feline melanoma;feline experimental organism diagnosis;broadmatch
rara gene translocation;chromosomal translocation;broadmatch
rara gene translocation;chromosome 17 abnormality;broadmatch
high risk acute myeloid leukemia;high risk acute leukemia;broadmatch
prkaca gene mutation;gene variant;broadmatch
creb3l2/pparg fusion gene;fusion gene;broadmatch
receptor tyrosine kinase gene amplification;gene amplification abnormality;broadmatch
receptor tyrosine kinase gene rearrangement;gene rearrangement abnormality;broadmatch
myeloblasts present;blast cells present;broadmatch
blasts 2 percent or more of peripheral blood white cells;blasts 1 percent or more of peripheral blood white cells;broadmatch
etv6 gene rearrangement;chromosome 12 abnormality;broadmatch
etv6 gene rearrangement;gene rearrangement abnormality;broadmatch
experimental organism intramural schwannoma;experimental organism neoplasm;broadmatch
experimental organism ductal cell adenocarcinoma;experimental organism neoplasm;broadmatch
experimental organism ductal cell adenoma;experimental organism neoplasm;broadmatch
experimental organism brunner's gland carcinoma;experimental organism neoplasm;broadmatch
cacna1d gene mutation;gene variant;broadmatch
atp2b3 gene mutation;gene variant;broadmatch
atp1a1 gene mutation;gene variant;broadmatch
kcnj5 gene mutation;gene variant;broadmatch
medical condition;condition;broadmatch
malignant basal cell;malignant basaloid cell;broadmatch
sdhb negative;expression negative;broadmatch
acute monoblastic and monocytic leukemia in remission;acute myeloid leukemia in remission;broadmatch
acute myeloid leukemia with multilineage dysplasia in remission;acute myeloid leukemia in remission;broadmatch
peritoneum and retroperitoneum;other anatomic concept;broadmatch
non-neoplastic genitourinary system disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic genitourinary system disorder;genitourinary system disorder;broadmatch
genitourinary system disorder;disorder by site;broadmatch
experimental organism malignant thecoma;experimental organism neoplasm;broadmatch
experimental organism benign thecoma;experimental organism neoplasm;broadmatch
translocase gene;enzyme gene;broadmatch
lymphoma in remission;lymphoma finding;broadmatch
asph-positive neoplastic cells present;immunophenotypic finding;broadmatch
elevated ldh;abnormal blood chemistry and hematology test result;broadmatch
cd15 positive;expression positive;broadmatch
cd14 positive;expression positive;broadmatch
eno2 positive;expression positive;broadmatch
hla-dr negative;expression negative;broadmatch
progressive thyroid carcinoma;progressive neoplastic disease;broadmatch
increased fibroblast growth factor pathway activation;elevated test result;broadmatch
elevated ldh;elevated test result;broadmatch
her2/neu status;receptor status;broadmatch
plcb4 gene;esterase gene;broadmatch
estrogen receptor status;receptor status;broadmatch
progesterone receptor status;receptor status;broadmatch
oligometastatic disease;metastatic/recurrent disease;broadmatch
morphologic features resembling salivary gland adenocarcinoma;morphologic finding;broadmatch
canine thyroid gland medullary carcinoma;canine neoplasm;broadmatch
nasal vestibule;head and neck part;broadmatch
tubuloglandular pattern;morphologic architectural pattern;broadmatch
figo stage ib3;figo stage ib;broadmatch
figo stage iia1;figo stage iia;broadmatch
figo stage iia2;figo stage iia;broadmatch
hypermutated sample;genetic finding;broadmatch
normal karyotype intermediate risk acute myeloid leukemia;intermediate risk acute myeloid leukemia;broadmatch
non-m3 acute myeloid leukemia;leukemia finding;broadmatch
non-m3 acute myeloid leukemia;myeloid neoplasm finding;broadmatch
aging;aging-related process;broadmatch
atpase;protein family;broadmatch
intravascular myofibroblastic proliferation;vascular morphologic change;broadmatch
actin-binding protein;ligand binding protein;broadmatch
blasts 1 percent or more of bone marrow nucleated cells;blasts 0.1 percent or more of bone marrow nucleated cells;broadmatch
paratesticular region;body region;broadmatch
canine transmissible venereal tumor;canine neoplasm;broadmatch
refractory intermediate risk acute myeloid leukemia;intermediate risk acute myeloid leukemia;broadmatch
refractory high risk acute myeloid leukemia;high risk acute myeloid leukemia;broadmatch
intermediate risk acute myeloid leukemia;leukemia finding;broadmatch
intermediate risk acute myeloid leukemia;myeloid neoplasm finding;broadmatch
exonuclease;esterase;broadmatch
plcb4 gene mutation;gene variant;broadmatch
high risk meningioma;nervous system finding;broadmatch
non-hodgkin lymphoma in remission;lymphoma in remission;broadmatch
canine nephroblastoma;canine neoplasm;broadmatch
labyrinthine growth pattern;morphologic architectural pattern;broadmatch
proliferation of squamous nests with little stromal reaction;abnormal tissue present;broadmatch
rearrangement negative;negative test result;broadmatch
rearrangement detected;positive laboratory test result;broadmatch
primary site of disease;location description;broadmatch
braf exon 15 mutation;braf gene mutation;broadmatch
3q abnormality;cytogenetic abnormality;broadmatch
canine langerhans cell histiocytosis;canine neoplasm;broadmatch
urethra part;urinary system part;broadmatch
canine granular cell tumor;canine neoplasm;broadmatch
canine gastrointestinal stromal tumor;canine neoplasm;broadmatch
foxl2 gene mutation;gene variant;broadmatch
dense eosinophilic basement membrane deposit;deposit;broadmatch
11q23 abnormality;11q aberration;broadmatch
scattered neuroendocrine cells by immunohistochemistry present;cellular infiltrate;broadmatch
hodgkin lymphoma in remission;lymphoma in remission;broadmatch
fanconi anemia complementation group gene mutation;dna repair gene mutation;broadmatch
fa complementation group gene;dna repair gene;broadmatch
lung parenchyma tumor location;respiratory system finding;broadmatch
peripheral lung parenchyma tumor;lung parenchyma tumor location;broadmatch
cysltr2 gene mutation;gene variant;broadmatch
bladder diverticulum;urinary system finding;broadmatch
bladder diverticulum;diverticulum;broadmatch
chromosome 7 abnormality;cytogenetic abnormality;broadmatch
chromosome 5 abnormality;cytogenetic abnormality;broadmatch
growth phase;morphologic architectural pattern;broadmatch
diffuse large b-cell lymphoma in partial remission;non-hodgkin lymphoma in remission;broadmatch
diffuse large b-cell lymphoma in complete remission;non-hodgkin lymphoma in remission;broadmatch
kidney tumor, middle section;urinary system finding;broadmatch
kidney tumor, lower pole;urinary system finding;broadmatch
kidney tumor, upper pole;urinary system finding;broadmatch
acute bilineal leukemia in remission;acute leukemia in remission;broadmatch
small, stellate, or spindled cells present;abnormal cells present;broadmatch
renomedullary interstitial cell;interstitial cell;broadmatch
central lung parenchyma tumor;lung parenchyma tumor location;broadmatch
questionable invasive lesion;invasive lesion;broadmatch
cytoplasmic accumulation of black pigment;morphologic finding;broadmatch
black discoloration;discoloration;broadmatch
platinum resistance;disease response;broadmatch
refractory round cell liposarcoma;round cell liposarcoma;broadmatch
histone gene;structural protein gene;broadmatch
somatic kit gene mutation;kit gene mutation;broadmatch
somatic kit gene mutation;somatic mutation;broadmatch
hedgehog pathway mutation;gene abnormality;broadmatch
cd34 positive;expression positive;broadmatch
hormone resistance;endocrine system finding;broadmatch
sheep lung adenocarcinoma;experimental organism neoplasm by organism;broadmatch
canine mammary adenoma;canine neoplasm;broadmatch
progressive medulloblastoma, shh-activated;progressive medulloblastoma;broadmatch
progressive central nervous system neoplasm;progressive neoplastic disease;broadmatch
progressive central nervous system neoplasm;nervous system finding;broadmatch
progressive ependymoma;progressive central nervous system neoplasm;broadmatch
progressive medulloblastoma;progressive central nervous system neoplasm;broadmatch
chromogranin-positive neoplastic cells present;immunophenotypic finding;broadmatch
chromogranin-positive neoplastic cells present;chromogranin positive;broadmatch
metastatic round cell liposarcoma;round cell liposarcoma;broadmatch
bcl6 gene fusion;gene fusion abnormality;broadmatch
notch2 gene mutation;notch family gene mutation;broadmatch
notch2 gene mutation;gene variant;broadmatch
hmb45-positive cells present;immunophenotypic finding;broadmatch
hmb45-positive cells present;pmel positive;broadmatch
small aggregates of tumor cells present;abnormal cells present;broadmatch
fibrinous material present;abnormal finding;broadmatch
samd9 gene;regulatory gene;broadmatch
biomarker positive malignant neoplasm;positive laboratory test result;broadmatch
high grade myeloid neoplasm;myeloid neoplasm finding;broadmatch
castration-naive;male reproductive system finding;broadmatch
refractory soft tissue sarcoma, excluding rhabdomyosarcoma;soft tissue sarcoma, excluding rhabdomyosarcoma;broadmatch
recurrent soft tissue sarcoma, excluding rhabdomyosarcoma;soft tissue sarcoma, excluding rhabdomyosarcoma;broadmatch
soft tissue sarcoma, excluding rhabdomyosarcoma;musculoskeletal finding;broadmatch
pdgfr protein overexpression;protein deregulation;broadmatch
pdgfr gene amplification;receptor tyrosine kinase gene amplification;broadmatch
diffuse large b-cell lymphoma, not otherwise specified molecular subtypes;diffuse large b-cell lymphoma, not otherwise specified;broadmatch
cd79b gene mutation;gene variant;broadmatch
chromogranin positive;expression positive;broadmatch
blasts 1 percent or more of peripheral blood white cells;blast cells present in peripheral blood;broadmatch
intestinal polyposis syndrome;syndrome;broadmatch
activating akt1 gene mutation;akt1 gene mutation;broadmatch
vertebrata;animal;broadmatch
primate;mammalia;broadmatch
experimental organism benign mesoblastic nephroma;experimental organism neoplasm;broadmatch
mammalia;vertebrata;broadmatch
human;hominidae;broadmatch
c11orf95/mkl2 fusion gene;fusion gene;broadmatch
mrtfb gene;transcription coactivator gene;broadmatch
blasts more than 5 percent of bone marrow nucleated cells;blasts 5 percent or more of bone marrow nucleated cells;broadmatch
gnas protein variant;gene product sequence variation;broadmatch
animal;eukaryota;broadmatch
undifferentiated;histologic grade;broadmatch
diffuse;disease morphology qualifier;broadmatch
benign;disease morphology qualifier;broadmatch
well differentiated;histologic grade;broadmatch
villous;disease morphology qualifier;broadmatch
tubular;disease morphology qualifier;broadmatch
peribronchial proliferation of neoplastic cells present;abnormal cells present;broadmatch
inoperable disease;clinical course of disease;broadmatch
cysltr2 gene;g protein-coupled receptor gene;broadmatch
masaoka-koga stage;disease stage qualifier;broadmatch
cdkn2a protein variant;gene product sequence variation;broadmatch
tp53 protein variant;gene product sequence variation;broadmatch
mediastinal malignant germ cell tumor stage;disease stage qualifier;broadmatch
wt1 gene mutation;gene variant;broadmatch
human papillomavirus-16 negative;human papillomavirus negative;broadmatch
fgfr gene mutation;receptor tyrosine kinase gene mutation;broadmatch
blasts 30 percent or less of peripheral blood white cells;blast cells present in peripheral blood;broadmatch
myeloblasts 5 percent or more of bone marrow nucleated cells;immature myeloid cells increased in bone marrow;broadmatch
myeloblasts 5 percent or more of bone marrow nucleated cells;blasts 5 percent or more of bone marrow nucleated cells;broadmatch
blasts more than 5 percent of peripheral blood white cells;blasts 5 percent or more of peripheral blood white cells;broadmatch
rb1 gene deletion;chromosome 13q abnormality;broadmatch
rb1 gene deletion;gene deletion;broadmatch
blasts under 30 percent of peripheral blood white cells;blasts 30 percent or less of peripheral blood white cells;broadmatch
blasts under 15 percent of bone marrow nucleated cells;blasts under 20 percent of bone marrow nucleated cells;broadmatch
blasts under 15 percent of peripheral blood white cells;blasts under 20 percent of peripheral blood white cells;broadmatch
alk gene product;protein tyrosine kinase;broadmatch
blasts 5 percent or less of peripheral blood white cells;blasts under 10 percent of peripheral blood white cells;broadmatch
blasts more than 10 percent of peripheral blood white cells;blasts 10 percent or more of peripheral blood white cells;broadmatch
usp8 gene mutation;gene variant;broadmatch
experimental organism adenocarcinoma arising in fibroadenoma;experimental organism neoplasm;broadmatch
more than two separate tumor masses present in the same organ;tumor mass;broadmatch
two separate tumor masses present in the same organ;tumor mass;broadmatch
multihormonal immunoreactivity present in two or more cell types;multihormonal immunoreactivity present;broadmatch
multihormonal immunoreactivity present in a single cell type;multihormonal immunoreactivity present;broadmatch
mit family translocation;chromosomal translocation;broadmatch
tfeb protein overexpression;protein deregulation;broadmatch
crooke hyaline change;morphologic finding;broadmatch
cdh1 gene mutation;gene variant;broadmatch
neoplastic corticotroph cell with scarce secretory granules;neoplastic corticotroph cell;broadmatch
neoplastic corticotroph cell with abundant secretory granules;neoplastic corticotroph cell;broadmatch
histone h3 gene;histone gene;broadmatch
myeloblasts 5 percent or less of bone marrow nucleated cells;myeloblasts under 10 percent of bone marrow nucleated cells;broadmatch
myeloblasts 5 percent or less of bone marrow nucleated cells;blasts 5 percent or less of bone marrow nucleated cells;broadmatch
squamous dysplasia;dysplasia;broadmatch
blasts 20 percent or less of peripheral blood white cells;blasts under 30 percent of peripheral blood white cells;broadmatch
cytoplasmic alteration;morphologic finding;broadmatch
estrogen receptor positive;hormone receptor positive;broadmatch
estrogen receptor positive;estrogen receptor status;broadmatch
estrogen receptor negative;estrogen receptor status;broadmatch
bone marrow lymphoplasmacytic infiltrate;lymphoplasmacytic infiltrate;broadmatch
low grade neuroendocrine lesion;low grade lesion;broadmatch
poorly differentiated neuroendocrine lesion;poorly differentiated lesion;broadmatch
intermediate grade neuroendocrine lesion;intermediate grade lesion;broadmatch
well differentiated neuroendocrine lesion;well differentiated lesion;broadmatch
aerodigestive invasive malignancy;tumor mass;broadmatch
intrasellar region;sellar region;broadmatch
sellar region;body region;broadmatch
primitive mesenchymal stroma formation;stromal change;broadmatch
gain of chromosome 14q;chromosomal gain;broadmatch
progesterone receptor negative;expression negative;broadmatch
progesterone receptor negative;progesterone receptor status;broadmatch
progesterone receptor positive;progesterone receptor status;broadmatch
progesterone receptor positive;hormone receptor positive;broadmatch
estrogen receptor negative;expression negative;broadmatch
cd1a positive;expression positive;broadmatch
mgmt gene promoter methylation;genetic finding;broadmatch
xp11.2 translocation;chromosomal translocation;broadmatch
telomere maintenance gene mutation;gene abnormality;broadmatch
ankrd26 gene mutation;gene variant;broadmatch
ddx41 gene mutation;gene variant;broadmatch
med12 gene mutation;gene variant;broadmatch
activating flt3 gene mutation;flt3 gene mutation;broadmatch
hepatic steatosis;steatosis;broadmatch
muscle invasion;morphologic finding;broadmatch
bone marrow lymphoplasmacytic infiltration of less than 10%;abnormal cells present;broadmatch
serum igm monoclonal gammopathy of less than 30g/l;igm monoclonal gammopathy;broadmatch
chromosome 7 rearrangement;chromosomal rearrangement;broadmatch
chromosome 7 rearrangement;chromosome 7 abnormality;broadmatch
chromosome 5 rearrangement;chromosomal rearrangement;broadmatch
chromosome 5 rearrangement;chromosome 5 abnormality;broadmatch
cdkn1b gene mutation;gene variant;broadmatch
cdk4 gene mutation;gene variant;broadmatch
cdk4 gene mutation;cdk gene mutation;broadmatch
ddx41 gene;helicase gene;broadmatch
ankrd26 gene;regulatory gene;broadmatch
t-cell receptor gene rearrangement;gene rearrangement abnormality;broadmatch
blasts expressing b-lymphoid, t-lymphoid, and myeloid markers present;blasts of mixed phenotype present;broadmatch
pmel positive;expression positive;broadmatch
neoplastic plasma cells under 50 percent of bone marrow nucleated cells;neoplastic plasma cells present in bone marrow;broadmatch
locally advanced soft tissue sarcoma, excluding liposarcoma;metastatic soft tissue sarcoma, excluding liposarcoma;broadmatch
metastatic soft tissue sarcoma, excluding liposarcoma;soft tissue sarcoma, excluding liposarcoma;broadmatch
soft tissue sarcoma, excluding liposarcoma;musculoskeletal finding;broadmatch
castration-sensitive;male reproductive system finding;broadmatch
tfeb gene translocation;mit family translocation;broadmatch
tfe3 gene translocation;mit family translocation;broadmatch
tfe3 gene translocation;xp11.2 translocation;broadmatch
tfe3 gene translocation;tfe3 gene rearrangement;broadmatch
nutm1 gene rearrangement;gene rearrangement abnormality;broadmatch
homologous recombination repair gene;dna repair gene;broadmatch
fgfr gene rearrangement;receptor tyrosine kinase gene rearrangement;broadmatch
cd4 positive;expression positive;broadmatch
blasts expressing b-lymphoid and t-lymphoid markers present;blasts of mixed phenotype present;broadmatch
asph-positive neoplastic cells present;asph positive;broadmatch
cdkn2a-p16 status;laboratory test result;broadmatch
pax/foxo1 fusion gene;fusion gene;broadmatch
endogenous cushing syndrome;cushing syndrome;broadmatch
transformation;tumor initiation;broadmatch
transferase;enzyme;broadmatch
transcription;transcription process;broadmatch
rearrangement of 12p13.2;chromosomal rearrangement;broadmatch
rearrangement of 12p13.2;chromosome 12 abnormality;broadmatch
rearrangement of 11p15;chromosomal rearrangement;broadmatch
spermatogenesis;gametogenesis;broadmatch
signal transduction;cellular process;broadmatch
ntrk gene rearrangement;receptor tyrosine kinase gene rearrangement;broadmatch
signaling pathway;biochemical pathway;broadmatch
non-neoplastic endocrine pancreas disorder;non-neoplastic pancreatic disorder;broadmatch
non-neoplastic endocrine pancreas disorder;endocrine pancreas disorder;broadmatch
rna splicing;rna processing;broadmatch
central nervous system involvement in recurrent b acute lymphoblastic leukemia;leukemia finding;broadmatch
chromosome 13q abnormality;chromosome 13 abnormality;broadmatch
chromosome 12 abnormality;cytogenetic abnormality;broadmatch
tumor marker;disease marker;broadmatch
cutaneous epithelioid angiomatous nodule;reactive vascular proliferation;broadmatch
herpesvirus infection;viral infection;broadmatch
apc promoter 1b variant;apc gene mutation;broadmatch
abl1 gene;non-receptor tyrosine kinase gene;broadmatch
serine/threonine protein kinase;protein kinase;broadmatch
vaginal discharge;female reproductive system finding;broadmatch
fibroblast growth factor receptor family;receptor tyrosine kinase;broadmatch
focus of carcinoma cells measuring equal to or less than 2 cm present;morphologic finding;broadmatch
abrupt nuclear anaplasia;morphologic finding;broadmatch
phosphatidylinositol-4,5-bisphosphate 3-kinase;kinase;broadmatch
malat1/gli1 fusion gene;fusion gene;broadmatch
columnar cells with differentiation to chief cells and parietal cells present;morphologic finding;broadmatch
invasive focus of carcinoma cells measuring 1 mm or less present;morphologic finding;broadmatch
cellular granularity present;morphologic finding;broadmatch
wound repair;regeneration;broadmatch
germline apc promoter 1b variant;germline mutation;broadmatch
germline apc promoter 1b variant;apc promoter 1b variant;broadmatch
apc promoter 1b variant;chromosome 5 abnormality;broadmatch
chromosome 17p abnormality;chromosome 17 abnormality;broadmatch
ribonuclease;esterase;broadmatch
g1 phase process;interphase process;broadmatch
oxidation/reduction;biochemical reaction;broadmatch
protein kinase;phosphotransferase;broadmatch
phosphotransferase;transferase;broadmatch
phosphorylation process;biochemical reaction;broadmatch
phosphoprotein;protein, organized by structure;broadmatch
phosphatase;esterase;broadmatch
pathologic process;biological process;broadmatch
oxidoreductase;enzyme;broadmatch
left-sided breast carcinoma;reproductive system finding;broadmatch
actb/gli1 fusion gene;fusion gene;broadmatch
mutyh protein variant;gene product sequence variation;broadmatch
med12 protein variant;gene product sequence variation;broadmatch
sdhd protein variant;gene product sequence variation;broadmatch
sdhb protein variant;gene product sequence variation;broadmatch
rb1 protein variant;gene product sequence variation;broadmatch
ptpn11 protein variant;gene product sequence variation;broadmatch
ptch1 protein variant;gene product sequence variation;broadmatch
post-translational modification;post-translational regulation;broadmatch
protein tyrosine kinase;protein kinase;broadmatch
protein;gene product;broadmatch
prkd2 gene mutation;gene variant;broadmatch
"t(7;12)(p21-22;q13-15)";chromosomal translocation;broadmatch
"t(7;12)(p21-22;q13-15)";chromosome 12 abnormality;broadmatch
"t(7;12)(p21-22;q13-15)";chromosome 7 rearrangement;broadmatch
reproduction;reproductive process;broadmatch
rel gene;transcription factor gene;broadmatch
regeneration;multicellular process;broadmatch
dna recombination process;dna sequence rearrangement;broadmatch
lower alveolar ridge;alveolar ridge;broadmatch
upper alveolar ridge;alveolar ridge;broadmatch
fosl1 protein overexpression;protein deregulation;broadmatch
11q12 translocation;11q translocation;broadmatch
usp6 gene rearrangement;gene rearrangement abnormality;broadmatch
usp6 gene rearrangement;chromosome 17 abnormality;broadmatch
cell surface receptor;receptor;broadmatch
hras gene;ras family gene;broadmatch
oral verruca vulgaris;verruca vulgaris;broadmatch
tp53 gene;cell cycle gene;broadmatch
lateral pharyngeal space;body region;broadmatch
tall columnar adenocarcinoma cell with reversed polarity;tall columnar adenocarcinoma cell;broadmatch
foxo1 gene rearrangement;gene rearrangement abnormality;broadmatch
marked distention of terminal duct lobular units present;dilated terminal duct lobular units present;broadmatch
malignant cells with uniform nuclei present;abnormal cells present;broadmatch
tumor mass of the extremity;tumor mass;broadmatch
tumor mass of the extremity;ctrp disease finding;broadmatch
locally invasive lesion;invasive lesion;broadmatch
apc gene;signaling pathway gene;broadmatch
apoptosis;cell death process;broadmatch
retinal hamartoma;hamartoma;broadmatch
transcriptional activation;transcriptional regulation;broadmatch
smad4 gene mutation;gene variant;broadmatch
lacrimal drainage system;head and neck part;broadmatch
senescence;aging-related process;broadmatch
rous sarcoma;experimental organism neoplasm;broadmatch
g protein;signaling protein;broadmatch
experimental model;biological model;broadmatch
foxo1 gene rearrangement;chromosome 13q abnormality;broadmatch
intraductal cellular proliferation;morphologic finding;broadmatch
tumor progression;disease progression;broadmatch
tumor progression;tumor-associated process;broadmatch
acute lymphoblastic leukemia, susceptibility to, 3;hereditary neoplastic syndrome;broadmatch
melanoma-astrocytoma syndrome;hereditary neoplastic syndrome;broadmatch
canine sebaceous gland epithelioma;canine neoplasm;broadmatch
germline mutation;mutation abnormality;broadmatch
growth factor receptor;receptor;broadmatch
antigen presentation;immune response process;broadmatch
receptor tyrosine kinase;receptor;broadmatch
receptor tyrosine kinase;protein tyrosine kinase;broadmatch
locally recurrent disease;recurrent disease;broadmatch
experimental organism malignant pituicytoma;experimental organism neoplasm;broadmatch
experimental organism amphophilic vacuolar adenoma;experimental organism neoplasm;broadmatch
experimental organism amphophilic vacuolar carcinoma;experimental organism neoplasm;broadmatch
experimental organism benign mesovarial leiomyoma;experimental organism neoplasm;broadmatch
devil facial tumor disease 2;devil facial tumor disease;broadmatch
devil facial tumor disease 1;devil facial tumor disease;broadmatch
combined hamartoma of the retina and retinal pigment epithelium;retinal hamartoma;broadmatch
retinal hamartoma;non-neoplastic retinal disorder;broadmatch
rb1 gene;transcription factor gene;broadmatch
appendix disorder;digestive system disorder;broadmatch
ccnd1 gene rearrangement;rearrangement of 11q;broadmatch
ccnd1 gene translocation;ccnd1 gene rearrangement;broadmatch
ccnd1 gene translocation;11q translocation;broadmatch
p21 ras protein;ras superfamily protein;broadmatch
maxillofacial bone;bone;broadmatch
non-neoplastic appendix disorder;non-neoplastic digestive system disorder;broadmatch
non-neoplastic appendix disorder;appendix disorder;broadmatch
tonsillar disorder;oral cavity disorder;broadmatch
fos family gene;transcription factor gene;broadmatch
non-neoplastic gingival disorder;non-neoplastic oral cavity disorder;broadmatch
non-neoplastic gingival disorder;gingival disorder;broadmatch
gingival disorder;oral cavity disorder;broadmatch
tongue disorder;oral cavity disorder;broadmatch
horse transitional cell carcinoma;equine experimental organism diagnosis;broadmatch
tumor suppressor gene;cancer gene;broadmatch
rb1 gene;cell cycle gene;broadmatch
ctrp disease finding;other finding;broadmatch
cemento-osseous dysplasia;non-neoplastic dental disorder;broadmatch
focal cemento-osseous dysplasia;cemento-osseous dysplasia;broadmatch
s phase process;interphase process;broadmatch
eif1ax gene mutation;gene variant;broadmatch
"t(9;22)(q22;q12)";ewsr1 gene translocation;broadmatch
"t(12;22)(q13.3;q12)";ddit3 gene rearrangement;broadmatch
"t(12;22)(q13.3;q12)";ewsr1 gene translocation;broadmatch
"t(12;22)(q13.12;q12)";chromosome 12 abnormality;broadmatch
"t(12;22)(q13.12;q12)";ewsr1 gene translocation;broadmatch
fus gene rearrangement;gene rearrangement abnormality;broadmatch
ipsilateral nodule;neoplastic nodule;broadmatch
chronic inflammation;inflammation;broadmatch
protein tyrosine phosphatase;phosphoprotein phosphatase;broadmatch
stromal proliferation of nevus cells present;stromal change;broadmatch
nf2 gene;signaling pathway gene;broadmatch
nf1 gene;signaling pathway gene;broadmatch
xrcc family gene mutation;dna repair gene mutation;broadmatch
rna helicase;helicase;broadmatch
neovascularization;pathologic process;broadmatch
abnormal karyotype;cytogenetic abnormality;broadmatch
myc gene;myc family gene;broadmatch
mixture of melanocytic neoplastic components present;mixture of morphologic patterns;broadmatch
esterase;hydrolase;broadmatch
erythropoiesis;myelopoiesis;broadmatch
pten protein variant;gene product sequence variation;broadmatch
patient-specific neoantigen-positive;neoantigen-positive;broadmatch
enzyme;protein, organized by function;broadmatch
shared neoantigen-positive;neoantigen-positive;broadmatch
neoantigen-positive;positive laboratory test result;broadmatch
sinonasal tract and oral cavity;head and neck part;broadmatch
nutm1 gene translocation;chromosomal translocation;broadmatch
melanin-pigmented epithelioid cells present;melanin pigment present;broadmatch
hereditary colorectal cancer syndrome;hereditary neoplastic syndrome;broadmatch
energy metabolism process;intermediary metabolic process;broadmatch
endocytotic process;transmembrane transport;broadmatch
refractory very high risk myelodysplastic syndrome;very high risk myelodysplastic syndrome;broadmatch
recurrent very high risk myelodysplastic syndrome;very high risk myelodysplastic syndrome;broadmatch
very high risk myelodysplastic syndrome;myeloid neoplasm finding;broadmatch
bone marrow failure syndrome;syndrome;broadmatch
bone marrow failure syndrome;bone marrow failure;broadmatch
proximal stomach;digestive system part;broadmatch
skin with high degree of cumulative sun damage;integumentary system finding;broadmatch
gametogenesis;reproductive process;broadmatch
fertilization;reproductive process;broadmatch
second primary squamous cell carcinoma of the head and neck;head and neck finding;broadmatch
fgfr4 protein variant;gene product sequence variation;broadmatch
diffuse large b-cell lymphoma with associated monoclonal small b-cell population in bone marrow;lymphoma finding;broadmatch
hormone receptor negative;receptor status;broadmatch
hormone receptor negative;expression negative;broadmatch
mixed malignant epithelial cell population;mixed neoplastic epithelial cell population;broadmatch
atypical vascular lesion;reactive vascular proliferation;broadmatch
atypical vascular lesion;non-neoplastic skin disorder;broadmatch
cic/dux4l fusion gene;fusion gene;broadmatch
cic gene rearrangement;gene rearrangement abnormality;broadmatch
ewsr1 gene rearrangement;gene rearrangement abnormality;broadmatch
nail matrix;integumentary system part;broadmatch
excision repair;dna repair;broadmatch
upper aerodigestive invasive malignancy;aerodigestive invasive malignancy;broadmatch
nutm1 gene translocation;nutm1 gene rearrangement;broadmatch
morphogenesis;developmental process;broadmatch
intercellular communication process;multicellular process;broadmatch
cell survival;cell viability process;broadmatch
dysplasia negative;dysplasia;broadmatch
dysplasia negative;negative test result;broadmatch
cell motility;cell movement;broadmatch
cell growth;cell growth process;broadmatch
cell differentiation process;cellular process;broadmatch
cell cycle process;cell division process;broadmatch
cell aging;cellular process;broadmatch
expression negative;negative test result;broadmatch
biology;biological sciences;broadmatch
biological sciences;occupation or discipline;broadmatch
biomarker;diagnostic or prognostic factor;broadmatch
b16 malignant melanoma;experimental malignant melanoma;broadmatch
asph positive;expression positive;broadmatch
non-malignant neoplasm;neoplasm by special category;broadmatch
retropharyngeal space;body region;broadmatch
hodgkin's sarcoma;hodgkin's lymphoma (antiquated);broadmatch
apc protein variant;gene product sequence variation;broadmatch
abdominal neoplasm, excluding pancreas neoplasm;abdominal mass;broadmatch
abdominal neoplasm, excluding pancreas neoplasm;tumor mass;broadmatch
transcriptional repression;transcriptional regulation;broadmatch
trunk and extremities;body region;broadmatch
dna binding protein;ligand binding protein;broadmatch
dna replication;replication-associated process;broadmatch
dna repair;dna maintenance;broadmatch
cytoskeletal protein;structural protein;broadmatch
cytokinesis;m phase process;broadmatch
conception;reproductive process;broadmatch
cloudman s91 malignant melanoma;experimental malignant melanoma;broadmatch
dicer1 protein variant;gene product sequence variation;broadmatch
ctnnb1 protein variant;gene product sequence variation;broadmatch
cdc73 protein variant;gene product sequence variation;broadmatch
neuroendocrine and non-neuroendocrine neoplastic components present;mixture of morphologic patterns;broadmatch
pax3 gene rearrangement;gene rearrangement abnormality;broadmatch
brd4 gene translocation;chromosomal translocation;broadmatch
gene deletion;deletion mutation;broadmatch
gene expression;gene expression process;broadmatch
homeobox gene;transcription factor gene;broadmatch
methylation;alkylation process;broadmatch
mitosis;m phase process;broadmatch
microtubule associated protein;cytoskeletal protein;broadmatch
pigmented dendritic melanocytes present;abnormal cells present;broadmatch
liver fibrosis;fibrosis;broadmatch
squamous cell carcinoma of the mouse tongue;mouse squamous cell carcinoma;broadmatch
fus gene translocation;chromosomal translocation;broadmatch
fus gene translocation;fus gene rearrangement;broadmatch
metaphase process;m phase process;broadmatch
mhc class i gene;major histocompatibility complex gene;broadmatch
detoxification;metabolic process;broadmatch
membrane protein;protein, organized by location;broadmatch
experimental malignant melanoma;mouse neoplasms;broadmatch
major histocompatibility complex gene;gene;broadmatch
interphase process;cell cycle process;broadmatch
transmembrane protein;membrane protein;broadmatch
high risk plasma cell myeloma;plasma cell neoplasm finding;broadmatch
model;conceptual entity;broadmatch
myeloblasts 1 percent of peripheral blood white cells;myeloblasts 1 percent or less of peripheral blood white cells;broadmatch
bone marrow dysplasia present in less than 10 percent of myeloid cells;bone marrow dysplasia present;broadmatch
myeloblasts 1 percent or less of peripheral blood white cells;myeloblasts under 2 percent of peripheral blood white cells;broadmatch
gata2/mecom fusion gene;fusion gene;broadmatch
samd9l gene mutation;gene variant;broadmatch
samd9 gene mutation;gene variant;broadmatch
samd9l gene;regulatory gene;broadmatch
unresectable round cell liposarcoma;round cell liposarcoma;broadmatch
advanced round cell liposarcoma;metastatic round cell liposarcoma;broadmatch
thoracic region;spinal region;broadmatch
spinal region;body region;broadmatch
high risk acute lymphoblastic leukemia;high risk acute leukemia;broadmatch
very high risk prostate carcinoma;urinary system finding;broadmatch
high risk prostate carcinoma;urinary system finding;broadmatch
very high risk chronic myelogenous leukemia, bcr-abl1 positive;leukemia finding;broadmatch
very high risk chronic myelogenous leukemia, bcr-abl1 positive;myeloid neoplasm finding;broadmatch
high risk chronic myelogenous leukemia, bcr-abl1 positive;leukemia finding;broadmatch
high risk chronic myelogenous leukemia, bcr-abl1 positive;myeloid neoplasm finding;broadmatch
lymphoma finding;hematopoietic system finding;broadmatch
leukemia finding;hematopoietic system finding;broadmatch
myeloid neoplasm finding;hematopoietic system finding;broadmatch
neoplastic cells with bright cd56 expression present;cd56-positive neoplastic cells present;broadmatch
nf1 protein variant;gene product sequence variation;broadmatch
hydrolysis;biochemical reaction;broadmatch
hydrolase;enzyme;broadmatch
histone;structural protein;broadmatch
histone h3;histone;broadmatch
hematopoietic process;histogenic process;broadmatch
harding-passey malignant melanoma;experimental malignant melanoma;broadmatch
gtpase;hydrolase;broadmatch
embryogenesis;organismal process;broadmatch
tissue growth;developmental process;broadmatch
pancreatobiliary system;digestive system part;broadmatch
non-neoplastic musculoskeletal disorder;non-neoplastic connective and soft tissue disorder;broadmatch
non-neoplastic musculoskeletal disorder;musculoskeletal disorder;broadmatch
non-recurrent lung carcinoma;respiratory system finding;broadmatch
non-recurrent esophageal carcinoma;digestive system finding;broadmatch
notch1 protein variant;gene product sequence variation;broadmatch
neoplastic cells with cd45 dim-to-negative expression present;decreased expression;broadmatch
plasma cell neoplasm finding;hematopoietic system finding;broadmatch
neoplastic cells with cd45 dim-to-negative expression present;immunophenotypic finding;broadmatch
refractory high risk chronic myelomonocytic leukemia;high risk chronic myelomonocytic leukemia;broadmatch
recurrent high risk chronic myelomonocytic leukemia;high risk chronic myelomonocytic leukemia;broadmatch
recurrent non-muscle invasive bladder urothelial carcinoma (nmibc) with a prior history of low or intermediate risk nmibc;urinary system finding;broadmatch
blasts 2 percent or more of bone marrow nucleated cells;blasts 1 percent or more of bone marrow nucleated cells;broadmatch
mll gene translocation;11q translocation;broadmatch
mll gene translocation;mll gene rearrangement;broadmatch
sf3b1 protein variant;gene product sequence variation;broadmatch
humoral immunity;immunity;broadmatch
cell-mediated immunity;immunity;broadmatch
immunity;immune system process;broadmatch
inactivating brca gene mutation;dna repair gene mutation;broadmatch
hla-dr-negative neoplastic cells present;immunophenotypic finding;broadmatch
hla-dr-negative neoplastic cells present;hla-dr negative;broadmatch
neoplastic cells with cd38 dim-to-negative expression present;immunophenotypic finding;broadmatch
neoplastic cells with cd38 dim-to-negative expression present;decreased expression;broadmatch
newly diagnosed disease;clinical course of disease;broadmatch
metastatic/recurrent disease;clinical course of disease;broadmatch
cltc/alk fusion gene;fusion gene;broadmatch
rat respiratory system neoplasms;proliferative change of the rat respiratory system;broadmatch
gastrin-positive neoplastic cells present;immunophenotypic finding;broadmatch
periampullary region;body region;broadmatch
biliary obstruction;digestive system obstruction;broadmatch
rat neoplasms by morphology;rat neoplasms;broadmatch
rat special sensory organ neoplasms;rat nervous system and sensory organs neoplasms;broadmatch
rat urinary system neoplasms;proliferative change of the rat urinary system;broadmatch
rat soft tissue and musculoskeletal system neoplasms;proliferative change of the rat soft tissue and musculoskeletal system;broadmatch
rat male genital system neoplasms;rat genital system neoplasms;broadmatch
rat neoplasms by location;rat neoplasms;broadmatch
rat integumentary system neoplasms;proliferative change of the rat integumentary system;broadmatch
rat hematopoietic and mononuclear phagocytic system neoplasms;proliferative change of the rat hematopoietic and mononuclear phagocytic system;broadmatch
rat genital system neoplasms;proliferative change of the rat genital system;broadmatch
rat female genital system neoplasms;rat genital system neoplasms;broadmatch
rat endocrine system neoplasms;proliferative change of the rat endocrine system;broadmatch
rat digestive system neoplasms;proliferative change of the rat digestive system;broadmatch
rat nervous system and sensory organs neoplasms;proliferative change of the rat nervous system and sensory organs;broadmatch
somatostatin-positive neoplastic cells present;immunophenotypic finding;broadmatch
vip-positive neoplastic cells present;immunophenotypic finding;broadmatch
glucagon-like peptide positive neoplastic cells present;immunophenotypic finding;broadmatch
neuron-specific enolase positive neoplastic cells present;eno2 positive;broadmatch
rat female reproductive system part;rat reproductive system part;broadmatch
rat urinary system part;rat anatomy concepts;broadmatch
rat special sensory organ part;rat anatomy concepts;broadmatch
rat respiratory system part;rat anatomy concepts;broadmatch
rat reproductive system part;rat anatomy concepts;broadmatch
rat nervous system part;rat anatomy concepts;broadmatch
rat musculoskeletal system part;rat anatomy concepts;broadmatch
rat lymphohematopoietic system part;rat anatomy concepts;broadmatch
rat integument system part;rat anatomy concepts;broadmatch
rat endocrine system part;rat anatomy concepts;broadmatch
rat digestive system part;rat anatomy concepts;broadmatch
rat cardiovascular system part;rat anatomy concepts;broadmatch
absence of invasion of the muscularis externa;absence of muscle invasion;broadmatch
submucosal tumor growth;neoplastic growth or spread;broadmatch
neuron-specific enolase positive neoplastic cells present;immunophenotypic finding;broadmatch
rat cardiovascular system neoplasms;proliferative change of the rat cardiovascular system;broadmatch
enterochromaffin type granules present;ultrastructural finding;broadmatch
metaplasia of malignant cells present;morphologic finding;broadmatch
rat soft tissue;rat musculoskeletal system part;broadmatch
rat tongue;rat digestive system part;broadmatch
rat thyroid gland;rat endocrine system part;broadmatch
rat thymus;rat lymphohematopoietic system part;broadmatch
rat testis;rat male reproductive system part;broadmatch
rat sublingual gland;rat digestive system part;broadmatch
rat spinal meninx;rat nervous system part;broadmatch
rat spinal cord;rat nervous system part;broadmatch
rat skin/subcutaneous tissue;rat integument system part;broadmatch
enterochromaffin-like type granules present;ultrastructural finding;broadmatch
rat skeletal system;rat musculoskeletal system part;broadmatch
rat skeletal muscle;rat musculoskeletal system part;broadmatch
rat seminal vesicle;rat male reproductive system part;broadmatch
rat salivary gland;rat digestive system part;broadmatch
rat renal pelvis;rat urinary system part;broadmatch
rat prostate;rat male reproductive system part;broadmatch
rat preputial gland;rat male reproductive system part;broadmatch
rat tooth;rat digestive system part;broadmatch
rat trachea;rat respiratory system part;broadmatch
rat ureter;rat urinary system part;broadmatch
rat urethra;rat urinary system part;broadmatch
serotonin-positive neoplastic cells present;immunophenotypic finding;broadmatch
argentaffin positive neoplastic cells present;immunophenotypic finding;broadmatch
chromogranin-a positive neoplastic cells present;chromogranin-positive neoplastic cells present;broadmatch
malt1 gene;signaling pathway gene;broadmatch
rassf1 gene;cell cycle gene;broadmatch
malignant epithelial cell with vesicular nucleus, distinct nucleolus, and abundant pink cytoplasm;malignant epithelial large cell with vesicular nucleus and distinct nucleolus;broadmatch
intramucosal lesion;lesion by morphology;broadmatch
tenesmus;disturbance in bowel function;broadmatch
childhood lesion;lesion;broadmatch
adulthood lesion;lesion;broadmatch
rat zymbal gland;rat integument system part;broadmatch
rat vagina;rat female reproductive system part;broadmatch
rat uterus;rat female reproductive system part;broadmatch
rat uterine cervix;rat female reproductive system part;broadmatch
rat urinary bladder;rat urinary system part;broadmatch
rat male reproductive system part;rat reproductive system part;broadmatch
squamous metaplasia of malignant cells present;metaplasia of malignant cells present;broadmatch
rat pituitary gland;rat endocrine system part;broadmatch
alcohol toxicity;toxicity;broadmatch
entrapped respiratory epithelium present;epithelial component present;broadmatch
malignant round germ cell with glycogen-rich cytoplasm and round nucleus;malignant round germ cell;broadmatch
stage i retinoblastoma;cancer stage (antiquated);broadmatch
mutyh gene;dna repair gene;broadmatch
tobacco chewing toxicity;tobacco toxicity;broadmatch
cigarette smoking toxicity;tobacco toxicity;broadmatch
tobacco toxicity;toxicity;broadmatch
basophilic adenocarcinoma cell;adenocarcinoma cell;broadmatch
malignant epithelial small oval cell;malignant epithelial oval cell;broadmatch
prominent elastic tissue cores present;abnormal tissue present;broadmatch
multifocal epithelial proliferations less than 1mm in diameter present;epithelial component present;broadmatch
malignant epithelial medium-sized polygonal cell;neoplastic epithelial polygonal cell;broadmatch
malignant epithelial medium-sized polygonal cell;malignant epithelial cell;broadmatch
malignant epithelial large polygonal cell;neoplastic epithelial large polygonal cell;broadmatch
malignant epithelial large polygonal cell;malignant epithelial large cell;broadmatch
neoplastic epithelial large polygonal cell;neoplastic epithelial polygonal cell;broadmatch
sclerotic pattern;morphologic architectural pattern;broadmatch
hemorrhagic pattern;morphologic architectural pattern;broadmatch
stage ia retinoblastoma;stage i retinoblastoma;broadmatch
stage ib retinoblastoma;stage i retinoblastoma;broadmatch
proliferative change of the rat integumentary system;rat proliferative change by location;broadmatch
proliferative change of the rat hematopoietic and mononuclear phagocytic system;rat proliferative change by location;broadmatch
proliferative change of the rat genital system;rat proliferative change by location;broadmatch
proliferative change of the rat endocrine system;rat proliferative change by location;broadmatch
proliferative change of the rat digestive system;rat proliferative change by location;broadmatch
proliferative change of the rat cardiovascular system;rat proliferative change by location;broadmatch
rat proliferative change by location;rat histopathology diagnoses for proliferative changes;broadmatch
large adenocarcinoma cell with eosinophilic cytoplasm;adenocarcinoma cell with eosinophilic cytoplasm;broadmatch
large adenocarcinoma cell with eosinophilic cytoplasm;malignant cell with eosinophilic cytoplasm;broadmatch
stage iib retinoblastoma;stage ii retinoblastoma;broadmatch
non-specific glandular pattern;glandular pattern;broadmatch
absence of muscle invasion;absence of invasion;broadmatch
kidney and ureter;urinary system part;broadmatch
stage iia retinoblastoma;stage ii retinoblastoma;broadmatch
stage ii retinoblastoma;cancer stage (antiquated);broadmatch
malignant epithelial small oval cell;neoplastic epithelial small oval cell;broadmatch
neoplastic epithelial small oval cell;neoplastic epithelial oval cell;broadmatch
spindle cell metaplasia of malignant cells present;metaplasia of malignant cells present;broadmatch
cysts containing proteinaceous fluid present;abnormal tissue present;broadmatch
squamoid corpuscle;morphologic finding;broadmatch
lipase hypersecretion syndrome;syndrome;broadmatch
melanin pigment present;morphologic finding;broadmatch
malignant small round cell with scant amount of dark granular cytoplasm;malignant small round cell;broadmatch
small cuboidal cell resembling fetal hepatocyte;abnormal epithelial cell;broadmatch
proliferation of small ducts present;abnormal tissue present;broadmatch
distal common bile duct;common bile duct;broadmatch
anorectal fistula;digestive system fistula;broadmatch
malignant epithelial small polygonal cell;neoplastic epithelial small polygonal cell;broadmatch
anal mucosa;mucosa;broadmatch
malignant cutaneous basal cell;neoplastic cutaneous basal cell;broadmatch
malignant cutaneous basal cell;malignant basal cell;broadmatch
fibrovascular stalks present;abnormal tissue present;broadmatch
osseous metaplasia of malignant cells present;mesenchymal metaplasia of malignant cells present;broadmatch
cartilaginous metaplasia of malignant cells present;mesenchymal metaplasia of malignant cells present;broadmatch
mesenchymal metaplasia of malignant cells present;metaplasia of malignant cells present;broadmatch
ectopic thyroid tissue present;abnormal tissue present;broadmatch
single cell necrosis;necrotic change;broadmatch
cytoplasmic membrane-bound granules present;ultrastructural finding;broadmatch
microglandular pattern;glandular pattern;broadmatch
malignant epithelial small polygonal cell;malignant epithelial small cell;broadmatch
neoplastic epithelial small polygonal cell;neoplastic epithelial polygonal cell;broadmatch
malignant epithelial oval cell;neoplastic epithelial oval cell;broadmatch
malignant epithelial oval cell;malignant epithelial cell;broadmatch
neoplastic epithelial oval cell;neoplastic epithelial cell;broadmatch
myasthenia gravis;autoimmune nervous system disorder;broadmatch
widely invasive lesion;invasive lesion;broadmatch
minimally invasive lesion;invasive lesion;broadmatch
cuboidal neoplastic mesothelial cell;neoplastic mesothelial cell;broadmatch
flattened neoplastic mesothelial cell;neoplastic mesothelial cell;broadmatch
absence of invasion or limited invasion present;morphologic finding;broadmatch
dense collagenized tissue present;mesenchymal component present;broadmatch
histiocytoid differentiation;tissue differentiation;broadmatch
malignant spindle mesothelial cell;malignant spindle cell;broadmatch
malignant spindle mesothelial cell;malignant mesothelial cell;broadmatch
rat pleura;rat soft tissue;broadmatch
rat pineal gland;rat endocrine system part;broadmatch
rat endometrial stromal polyp;rat female genital system neoplasms;broadmatch
rat malignant melanoma;rat integumentary system neoplasms;broadmatch
rat malignant neuroendocrine cell tumor;rat neoplasms by morphology;broadmatch
rat malignant mixed tumor;rat neoplasms by morphology;broadmatch
rat malignant mixed sertoli-leydig cell tumor;rat male genital system neoplasms;broadmatch
rat malignant mixed muellerian tumor;rat female genital system neoplasms;broadmatch
rat malignant mixed glioma;rat nervous system and sensory organs neoplasms;broadmatch
rat malignant mesothelioma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat malignant mesenchymoma;rat urinary system neoplasms;broadmatch
rat malignant melanoma;rat nervous system and sensory organs neoplasms;broadmatch
rat malignant fibrous histiocytoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat malignant medullary tumor;rat endocrine system neoplasms;broadmatch
rat malignant mast cell tumor;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat malignant lymphoma;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat malignant intraocular schwannoma;rat special sensory organ neoplasms;broadmatch
rat malignant intraocular schwannoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat malignant hibernoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat malignant hemangiopericytoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat malignant neuromyoblastoma;rat nervous system and sensory organs neoplasms;broadmatch
rat malignant odontogenic tumor;rat digestive system neoplasms;broadmatch
rat malignant oligodendroglioma;rat nervous system and sensory organs neoplasms;broadmatch
rat malignant pinealoma;rat endocrine system neoplasms;broadmatch
rat odontogenic fibroma;rat benign odontogenic tumor;broadmatch
rat ocular dermoid;rat special sensory organ neoplasms;broadmatch
rat non-keratinizing epithelioma;rat respiratory system neoplasms;broadmatch
rat neuroendocrine cell hyperplasia;rat hyperplasia;broadmatch
rat nephroblastoma;rat urinary system neoplasms;broadmatch
rat myelolipoma;rat endocrine system neoplasms;broadmatch
rat meningeal sarcoma;rat nervous system and sensory organs neoplasms;broadmatch
rat medulloblastoma;rat nervous system and sensory organs neoplasms;broadmatch
rat malignant thymoma;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat malignant thecoma;rat female genital system neoplasms;broadmatch
rat malignant teratoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat malignant sertoli cell tumor;rat genital system neoplasms;broadmatch
rat malignant seminoma;rat male genital system neoplasms;broadmatch
rat malignant schwannoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat malignant reticulosis;rat nervous system and sensory organs neoplasms;broadmatch
rat malignant granulosa cell tumor;rat genital system neoplasms;broadmatch
rat malignant ependymoma;rat nervous system and sensory organs neoplasms;broadmatch
rat olfactory neuroblastoma;rat neuroblastoma;broadmatch
rat granulocytic leukemia;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat histiocytic sarcoma;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat hepatocholangiocellular carcinoma;rat hepatic neoplasm;broadmatch
rat hepatocholangiocellular adenoma;rat hepatic neoplasm;broadmatch
rat hepatocellular carcinoma;rat hepatic neoplasm;broadmatch
rat hepatocellular adenoma;rat hepatic neoplasm;broadmatch
rat hemangiosarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat hemangioma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat glandular polyp;rat female genital system neoplasms;broadmatch
rat malignant endocardial schwannoma;rat cardiovascular system neoplasms;broadmatch
rat follicular cell carcinoma;rat carcinoma;broadmatch
rat follicular cell adenoma;rat adenoma;broadmatch
rat fibrosarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat fibroma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat fibroadenoma;rat integumentary system neoplasms;broadmatch
rat erythroid leukemia;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
mucinous fibroplasia;abnormal tissue present;broadmatch
rat hyperplasia;rat histopathology diagnoses for proliferative changes;broadmatch
rat islet cell adenoma;rat endocrine system neoplasms;broadmatch
rat islet cell carcinoma;rat endocrine system neoplasms;broadmatch
rat keratinizing cystic epithelioma;rat respiratory system neoplasms;broadmatch
rat malignant craniopharyngioma;rat nervous system and sensory organs neoplasms;broadmatch
rat malignant chordoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat malignant atriocaval mesothelioma;rat cardiovascular system neoplasms;broadmatch
rat malignant astrocytoma;rat nervous system and sensory organs neoplasms;broadmatch
rat lymphangioma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat liposarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
adenocarcinoma cell with abundant cytoplasm;neoplastic large cell with abundant cytoplasm;broadmatch
adenocarcinoma cell with abundant cytoplasm;adenocarcinoma cell;broadmatch
rat lipoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat leydig cell carcinoma;rat male genital system neoplasms;broadmatch
rat leydig cell adenoma;rat male genital system neoplasms;broadmatch
rat leukemia;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat leiomyosarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat leiomyoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat keratoacanthoma;rat neoplasms by morphology;broadmatch
rat odontoma;rat benign odontogenic tumor;broadmatch
rat osteochondroma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat peritoneum;rat soft tissue;broadmatch
rat external ear;rat special sensory organ part;broadmatch
rat heart;rat cardiovascular system part;broadmatch
rat glandular stomach;rat digestive system part;broadmatch
rat forestomach;rat digestive system part;broadmatch
rat eyelid;rat special sensory organ part;broadmatch
rat eyeball;rat special sensory organ part;broadmatch
rat esophagus;rat digestive system part;broadmatch
rat epididymis;rat male reproductive system part;broadmatch
rat cranial nerve;rat nervous system part;broadmatch
rat adrenal gland;rat endocrine system part;broadmatch
rat conjunctiva;rat special sensory organ part;broadmatch
rat coagulating gland;rat male reproductive system part;broadmatch
rat clitoral gland;rat female reproductive system part;broadmatch
rat cerebral meninx;rat nervous system part;broadmatch
rat cerebellum;rat nervous system part;broadmatch
rat bronchus;rat respiratory system part;broadmatch
rat bronchiole;rat respiratory system part;broadmatch
rat hematopoietic tissue;rat lymphohematopoietic system part;broadmatch
rat joint;rat musculoskeletal system part;broadmatch
rat kidney;rat urinary system part;broadmatch
rat larynx;rat respiratory system part;broadmatch
rat pericardium;rat soft tissue;broadmatch
rat parotid gland;rat digestive system part;broadmatch
rat parathyroid gland;rat endocrine system part;broadmatch
rat paranasal sinus;rat respiratory system part;broadmatch
rat pancreas;rat digestive system part;broadmatch
rat oviduct;rat female reproductive system part;broadmatch
rat ovary;rat female reproductive system part;broadmatch
rat oral cavity;rat cavity;broadmatch
rat nasopharynx;rat respiratory system part;broadmatch
rat nasal cavity;rat respiratory system part;broadmatch
rat mononuclear phagocytic tissue;rat lymphohematopoietic system part;broadmatch
rat mandibular gland;rat digestive system part;broadmatch
rat mammary gland;rat integument system part;broadmatch
rat lung;rat respiratory system part;broadmatch
rat liver;rat digestive system part;broadmatch
rat brain;rat nervous system part;broadmatch
rat anatomy concepts;experimental organism anatomical concept;broadmatch
rat osteoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
lipoma of the rat kidney;rat urinary system neoplasms;broadmatch
rat sebaceous cell adenoma;rat adenoma;broadmatch
rat sarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat rhabdomyosarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat retinoblastoma;rat special sensory organ neoplasms;broadmatch
rat rete testis carcinoma;rat male genital system neoplasms;broadmatch
rat rete testis adenoma;rat male genital system neoplasms;broadmatch
liposarcoma of the rat kidney;rat urinary system neoplasms;broadmatch
rat pituicytoma;rat endocrine system neoplasms;broadmatch
neoplastic neuroendocrine small cell;neoplastic neuroendocrine cell;broadmatch
rat pars intermedia adenoma;rat endocrine system neoplasms;broadmatch
rat pars intermedia adenoma;rat adenoma;broadmatch
rat pars distalis carcinoma;rat carcinoma;broadmatch
rat pars distalis adenoma;rat endocrine system neoplasms;broadmatch
rat pars distalis adenoma;rat adenoma;broadmatch
rat papilloma;rat neoplasms by morphology;broadmatch
rat osteosarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat sebaceous cell carcinoma;rat carcinoma;broadmatch
rat squamous cell carcinoma;rat carcinoma;broadmatch
large neoplastic glands with branching and papillary infolding present;epithelial component present;broadmatch
rat squamous cell papilloma;rat digestive system neoplasms;broadmatch
polarization of nuclei towards the glandular lumen;morphologic finding;broadmatch
intraluminal masses of mucin present;morphologic finding;broadmatch
tall columnar adenocarcinoma cell;adenocarcinoma cell;broadmatch
rat yolk sac carcinoma;rat female genital system neoplasms;broadmatch
rat uveal leiomyoma;rat special sensory organ neoplasms;broadmatch
rat unclassifiable malignant tumor;rat neoplasms;broadmatch
rat unclassifiable benign tumor;rat neoplasms;broadmatch
adenocarcinoma cell with foamy cytoplasm;adenocarcinoma cell with abundant cytoplasm;broadmatch
rat tubulostromal adenoma;tubulostromal adenoma;broadmatch
rat tubulostromal adenoma;rat adenoma;broadmatch
rat tubulostromal adenocarcinoma;tubulostromal adenocarcinoma;broadmatch
rat tubulostromal adenocarcinoma;rat adenocarcinoma;broadmatch
rat transitional cell papilloma;rat urinary system neoplasms;broadmatch
rat transitional cell carcinoma;rat carcinoma;broadmatch
rat synovial sarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
proliferative change of the rat nervous system and sensory organs;rat proliferative change by location;broadmatch
proliferative change of the rat respiratory system;rat proliferative change by location;broadmatch
stage iic retinoblastoma;stage ii retinoblastoma;broadmatch
fenestrated pattern;morphologic architectural pattern;broadmatch
aflatoxins toxicity;toxicity;broadmatch
anterior visual pathway;peripheral nervous system part;broadmatch
anterior foramen magnum;skeletal system part;broadmatch
hypopituitarism;non-neoplastic endocrine disorder;broadmatch
epidermolytic ichthyosis;hyperkeratosis;broadmatch
tricholemmal differentiation;follicular differentiation;broadmatch
shadow cells present;abnormal cells present;broadmatch
follicular differentiation;adnexal differentiation;broadmatch
malignant eccrine cell;malignant epithelial cell;broadmatch
trichoblastic differentiation;follicular differentiation;broadmatch
stage iib nasopharyngeal keratinizing squamous cell carcinoma;cancer stage (antiquated);broadmatch
stage iia nasopharyngeal keratinizing squamous cell carcinoma;cancer stage (antiquated);broadmatch
compartmentalized pattern;morphologic architectural pattern;broadmatch
anastomosing cells connected to the basal layer of the epidermis present;epithelial component present;broadmatch
malignant apocrine cell;neoplastic apocrine cell;broadmatch
malignant apocrine cell;malignant epithelial cell;broadmatch
posterior foramen magnum;skeletal system part;broadmatch
upper clivus;skeletal system part;broadmatch
trigeminal ganglion;sensory ganglion;broadmatch
petrous apex;skeletal system part;broadmatch
adenocarcinoma of the rat sublingual gland;rat salivary gland neoplasm;broadmatch
adenocarcinoma of the rat salivary gland;rat salivary gland neoplasm;broadmatch
adenocarcinoma of the rat parotid gland;rat salivary gland neoplasm;broadmatch
adenocarcinoma of the rat mandibular gland;rat salivary gland neoplasm;broadmatch
rat acanthomatous ameloblastoma;rat malignant odontogenic tumor;broadmatch
rat compound odontoma;rat odontoma;broadmatch
rat complex odontoma;rat odontoma;broadmatch
rat cavity;rat anatomy concepts;broadmatch
flcn gene;candidate tumor suppressor gene;broadmatch
melanin;pigment;broadmatch
perivascular lymphocytic infiltrate;lymphocytic infiltrate;broadmatch
sphenocavernous region;body region;broadmatch
sphenoorbital region;body region;broadmatch
periocular region;body region;broadmatch
petroclival region;body region;broadmatch
malignant eccrine cell;neoplastic eccrine cell;broadmatch
eccrine adenocarcinoma cell;malignant eccrine cell;broadmatch
adenoma of the rat parotid gland;rat salivary gland neoplasm;broadmatch
fenestrating pattern;morphologic architectural pattern;broadmatch
small melanoma cell;melanoma cell;broadmatch
large melanoma cell;melanoma cell;broadmatch
actinic damage;integumentary system signs and symptoms;broadmatch
actinic damage;injury;broadmatch
dermo-epidermal junction;skin tissue;broadmatch
giant melanoma cell;large melanoma cell;broadmatch
melanoma cell with large nucleus and abundant pale cytoplasm;large melanoma cell;broadmatch
arborising network of cords of basaloid cells present;carcinomatous component present;broadmatch
eccrine adenocarcinoma cell;adenocarcinoma cell;broadmatch
fibrovascular stroma formation;stromal change;broadmatch
matrical differentiation;adnexal differentiation;broadmatch
slit-like stromal retraction present;abnormal tissue present;broadmatch
proliferation of basaloid cells parallel to the long axis of the epidermis present;epithelial component present;broadmatch
micronodular pattern;morphologic architectural pattern;broadmatch
infundibular-like structures present;abnormal tissue present;broadmatch
prominent keratin formation;morphologic finding;broadmatch
signet ring melanoma cell;signet ring cell;broadmatch
signet ring melanoma cell;melanoma cell;broadmatch
balloon melanoma cell;large melanoma cell;broadmatch
ionizing radiation toxicity;radiation toxicity;broadmatch
neoplastic eccrine cell;neoplastic glandular cell;broadmatch
neoplastic apocrine cell;neoplastic glandular cell;broadmatch
apocrine differentiation;adnexal differentiation;broadmatch
apocrine differentiation;glandular differentiation;broadmatch
pilar sheath;outer root sheath;broadmatch
outer root sheath;hair part;broadmatch
germinative follicular epithelium;epithelium;broadmatch
chest wall;body part;broadmatch
nests of nevus cells resembling nerve bundles present;abnormal tissue present;broadmatch
wedge-shaped growth pattern;morphologic architectural pattern;broadmatch
epidermal involvement;cutaneous involvement;broadmatch
area of depigmentation at the periphery of the dermal melanocytic infiltrate present;abnormal tissue present;broadmatch
melanocytes near the tips and sides of elongated rete ridges present;abnormal tissue present;broadmatch
lesion with diameter of 4 mm or more;lesion;broadmatch
flexural skin;skin;broadmatch
adenoma of the rat mandibular gland;rat salivary gland neoplasm;broadmatch
adenoma of the rat salivary gland;rat salivary gland neoplasm;broadmatch
proliferative change of the rat soft tissue and musculoskeletal system;rat proliferative change by location;broadmatch
squamous cell papilloma of the rat esophagus;rat intestinal neoplasm;broadmatch
acinar cell adenocarcinoma of the rat pancreas;rat digestive system neoplasms;broadmatch
ductal cell adenocarcinoma of the rat pancreas;rat digestive system neoplasms;broadmatch
acinar cell adenoma of the rat pancreas;rat digestive system neoplasms;broadmatch
ductal cell adenoma of the rat pancreas;rat digestive system neoplasms;broadmatch
gestational trophoblastic tumor by figo stage;neoplasm by obsolete classification;broadmatch
rat hepatic neoplasm;rat digestive system neoplasms;broadmatch
squamous cell papilloma of the rat forestomach;rat intestinal neoplasm;broadmatch
squamous cell carcinoma of the rat forestomach;rat intestinal neoplasm;broadmatch
basal cell carcinoma of the rat forestomach;rat intestinal neoplasm;broadmatch
squamous cell carcinoma of the rat esophagus;rat intestinal neoplasm;broadmatch
signet ring cell adenocarcinoma of the rat glandular stomach;rat intestinal neoplasm;broadmatch
neuroendocrine cell hyperplasia of the rat glandular stomach;rat neuroendocrine cell hyperplasia;broadmatch
malignant neuroendocrine cell tumor of the rat glandular stomach;rat intestinal neoplasm;broadmatch
exophytic squamous cell carcinoma of the rat esophagus;squamous cell carcinoma of the rat esophagus;broadmatch
endophytic squamous cell carcinoma of the rat esophagus;squamous cell carcinoma of the rat esophagus;broadmatch
benign neuroendocrine cell tumor of the rat glandular stomach;rat intestinal neoplasm;broadmatch
figo stage i gestational trophoblastic tumor;gestational trophoblastic tumor by figo stage;broadmatch
adenocarcinoma of the rat parathyroid gland;rat endocrine system neoplasms;broadmatch
adenoma of the rat parathyroid gland;rat endocrine system neoplasms;broadmatch
rat c-cell ganglioneuroma;rat endocrine system neoplasms;broadmatch
benign granulosa cell tumor of the rat ovary;rat female genital system neoplasms;broadmatch
adenosquamous carcinoma of the rat uterus;rat female genital system neoplasms;broadmatch
adenosquamous carcinoma of the rat uterine cervix;rat female genital system neoplasms;broadmatch
adenoma of the rat uterus;rat female genital system neoplasms;broadmatch
adenoma of the rat oviduct;rat female genital system neoplasms;broadmatch
adenoma of the rat clitoral gland;rat female genital system neoplasms;broadmatch
adenocarcinoma of the rat uterus;rat female genital system neoplasms;broadmatch
adenocarcinoma of the rat oviduct;rat female genital system neoplasms;broadmatch
figo stage ii gestational trophoblastic tumor;gestational trophoblastic tumor by figo stage;broadmatch
adenocarcinoma of the rat clitoral gland;rat female genital system neoplasms;broadmatch
figo stage ic gestational trophoblastic tumor;figo stage i gestational trophoblastic tumor;broadmatch
figo stage ib gestational trophoblastic tumor;figo stage i gestational trophoblastic tumor;broadmatch
figo stage ia gestational trophoblastic tumor;figo stage i gestational trophoblastic tumor;broadmatch
malignant medullary tumor of the rat adrenal gland;rat endocrine system neoplasms;broadmatch
benign medullary tumor of the rat adrenal gland;rat endocrine system neoplasms;broadmatch
benign basal cell tumor of the rat forestomach;rat intestinal neoplasm;broadmatch
basal cell carcinoma of the rat esophagus;rat intestinal neoplasm;broadmatch
adenoma of the rat sublingual gland;rat salivary gland neoplasm;broadmatch
squamous cell carcinoma of the rat mandibular gland;rat salivary gland neoplasm;broadmatch
squamous cell metaplasia of the rat sublingual gland;rat salivary gland neoplasm;broadmatch
squamous cell metaplasia of the rat salivary gland;rat salivary gland neoplasm;broadmatch
squamous cell metaplasia of the rat parotid gland;rat salivary gland neoplasm;broadmatch
squamous cell metaplasia of the rat mandibular gland;rat salivary gland neoplasm;broadmatch
squamous cell carcinoma of the rat sublingual gland;rat salivary gland neoplasm;broadmatch
squamous cell carcinoma of the rat salivary gland;rat salivary gland neoplasm;broadmatch
squamous cell carcinoma of the rat parotid gland;rat salivary gland neoplasm;broadmatch
malignant mixed tumor of the rat sublingual gland;rat salivary gland neoplasm;broadmatch
adenoma of the rat small intestine;rat intestinal neoplasm;broadmatch
malignant mixed tumor of the rat salivary gland;rat salivary gland neoplasm;broadmatch
malignant mixed tumor of the rat parotid gland;rat salivary gland neoplasm;broadmatch
malignant mixed tumor of the rat mandibular gland;rat salivary gland neoplasm;broadmatch
benign mixed tumor of the rat sublingual gland;rat salivary gland neoplasm;broadmatch
benign mixed tumor of the rat salivary gland;rat salivary gland neoplasm;broadmatch
benign mixed tumor of the rat parotid gland;rat salivary gland neoplasm;broadmatch
benign mixed tumor of the rat mandibular gland;rat salivary gland neoplasm;broadmatch
rat salivary gland neoplasm;rat digestive system neoplasms;broadmatch
rat intestinal neoplasm;rat digestive system neoplasms;broadmatch
adenocarcinoma of the rat cecum;rat intestinal neoplasm;broadmatch
adenocarcinoma of the rat colon;rat intestinal neoplasm;broadmatch
adenoma of the rat rectum;rat intestinal neoplasm;broadmatch
adenoma of the rat large intestine;rat intestinal neoplasm;broadmatch
adenoma of the rat jejunum;rat intestinal neoplasm;broadmatch
adenoma of the rat ileum;rat intestinal neoplasm;broadmatch
adenoma of the rat glandular stomach;rat intestinal neoplasm;broadmatch
adenoma of the rat duodenum;rat intestinal neoplasm;broadmatch
adenoma of the rat colon;rat intestinal neoplasm;broadmatch
adenoma of the rat cecum;rat intestinal neoplasm;broadmatch
adenocarcinoma of the rat small intestine;rat intestinal neoplasm;broadmatch
adenocarcinoma of the rat rectum;rat intestinal neoplasm;broadmatch
adenocarcinoma of the rat large intestine;rat intestinal neoplasm;broadmatch
adenocarcinoma of the rat jejunum;rat intestinal neoplasm;broadmatch
adenocarcinoma of the rat ileum;rat intestinal neoplasm;broadmatch
adenocarcinoma of the rat glandular stomach;rat intestinal neoplasm;broadmatch
adenocarcinoma of the rat duodenum;rat intestinal neoplasm;broadmatch
adnexal differentiation;epithelial differentiation;broadmatch
germ cell tumor (antiquated);neoplasm by obsolete classification;broadmatch
connective and soft tissue neoplasm (antiquated);neoplasm by obsolete classification;broadmatch
malignant sex cord-stromal cell;malignant cell;broadmatch
neoplastic small sex cord-stromal cell;neoplastic sex cord-stromal cell;broadmatch
lipid-rich neoplastic spindle cell;neoplastic sex cord-stromal cell;broadmatch
lipid-rich neoplastic spindle cell;neoplastic spindle cell;broadmatch
gonadal dysgenesis;non-neoplastic gonadal disorder;broadmatch
neoplastic sertoli cell with clear cytoplasm;neoplastic sertoli cell;broadmatch
neoplastic large polygonal sertoli cell;neoplastic sertoli cell;broadmatch
malignant sex cord-stromal cell;neoplastic sex cord-stromal cell;broadmatch
embryoid bodies present;abnormal tissue present;broadmatch
malignant round germ cell;malignant germ cell;broadmatch
seminomatous component present;abnormal tissue present;broadmatch
one germ layer present;abnormal tissue present;broadmatch
inconspicuous syncytiotrophoblastic cell component;morphologic finding;broadmatch
malignant intermediate type trophoblastic cell;malignant trophoblastic cell;broadmatch
malignant intermediate type trophoblastic cell;neoplastic intermediate type trophoblastic cell;broadmatch
radiation exposure;environmental and occupational exposure;broadmatch
polyvesicular vitelline pattern;morphologic architectural pattern;broadmatch
sclerosing peritonitis;peritonitis;broadmatch
neoplastic leutein cell;neoplastic sex cord-stromal cell;broadmatch
pseudolobular pattern;morphologic architectural pattern;broadmatch
amenorrhea;menstrual disorder;broadmatch
tissues derived from two or three embryonic layers present;abnormal tissue present;broadmatch
single type of tissue derived from one embryonic layer present;abnormal tissue present;broadmatch
thyrotoxicosis;hyperthyroidism;broadmatch
aberrant thyroid tissue present;abnormal tissue present;broadmatch
malignant component present;abnormal tissue present;broadmatch
fetiform mass;mass;broadmatch
annular tubules present;abnormal tissue present;broadmatch
small lesion;lesion;broadmatch
neoplastic sex cord-stromal cell resembling steroid hormone-secreting cell;neoplastic sex cord-stromal cell;broadmatch
ovarian hilus;female reproductive system part;broadmatch
retiform structures comprise more than 10% and less than 90% of the tumor;retiform structures present;broadmatch
retiform structures comprise 90% or more of the tumor;retiform structures present;broadmatch
retiform structures present;abnormal tissue present;broadmatch
sarcomatoid stroma formation;stromal change;broadmatch
hirsutism;reproductive system finding;broadmatch
testicular mass;mass;broadmatch
malignant small germ cell;malignant germ cell;broadmatch
mixed neoplastic glandular and squamous cell population;mixed neoplastic epithelial cell population;broadmatch
delicate vascular network formation;vascular morphologic change;broadmatch
stage iv retinoblastoma;cancer stage (antiquated);broadmatch
stage iiib retinoblastoma;stage iii retinoblastoma;broadmatch
renal tubular epithelial cell;epithelial cell;broadmatch
adenocarcinoma cell with eosinophilic cytoplasm;neoplastic epithelial cell with eosinophilic cytoplasm;broadmatch
adenocarcinoma cell with eosinophilic cytoplasm;adenocarcinoma cell;broadmatch
small adenocarcinoma cell with scant amount of cytoplasm;neoplastic small epithelial cell with scant amount of cytoplasm;broadmatch
small adenocarcinoma cell with scant amount of cytoplasm;adenocarcinoma cell;broadmatch
stage iiia retinoblastoma;stage iii retinoblastoma;broadmatch
malignant giant germ cell;malignant germ cell;broadmatch
stage iii retinoblastoma;cancer stage (antiquated);broadmatch
posterior portion of the urethra;urethra part;broadmatch
anterior portion of the urethra;urethra part;broadmatch
bulbomembranous urethra;urethra part;broadmatch
penile portion of the urethra;urethra part;broadmatch
skene gland;urethral gland;broadmatch
proliferative change of the rat urinary system;rat proliferative change by location;broadmatch
x-linked lymphoproliferative syndrome;immunodeficiency syndrome;broadmatch
nephrogenic blastemal cell;blastemal cell;broadmatch
blastemal cell;embryonic cell;broadmatch
blastemal pattern;morphologic architectural pattern;broadmatch
malignant giant germ cell;giant neoplastic germ cell;broadmatch
painless testicular mass;testicular mass;broadmatch
painless testicular mass;painless mass;broadmatch
tissue breakdown;tissue damage;broadmatch
uterine ligament;ligament;broadmatch
high plasma renin activity;elevated test result;broadmatch
high plasma renin activity;abnormal blood chemistry and hematology test result;broadmatch
neoplastic small epithelial cell with scant amount of cytoplasm;neoplastic epithelial cell;broadmatch
neoplastic epithelial cell with eosinophilic cytoplasm;neoplastic epithelial cell;broadmatch
tubular structures present;abnormal tissue present;broadmatch
malignant blastemal cell;neoplastic blastemal cell;broadmatch
malignant blastemal cell;malignant cell;broadmatch
serpentine blastemal pattern;blastemal pattern;broadmatch
nodular blastemal pattern;blastemal pattern;broadmatch
diffuse blastemal pattern;blastemal pattern;broadmatch
first trimester bleeding;female reproductive system finding;broadmatch
first trimester bleeding;reproductive system hemorrhage;broadmatch
generalized hydropic villous change;hydropic villous change;broadmatch
neoplastic columnar epithelial cell;neoplastic glandular cell;broadmatch
neoplastic apocrine cell with eosinophilic granular cytoplasm;neoplastic glandular cell with eosinophilic granular cytoplasm;broadmatch
apocrine carcinoma cell with eosinophilic granular cytoplasm;neoplastic apocrine cell with eosinophilic granular cytoplasm;broadmatch
apocrine carcinoma cell with eosinophilic granular cytoplasm;apocrine carcinoma cell;broadmatch
apocrine carcinoma cell with eosinophilic granular cytoplasm;adenocarcinoma cell with eosinophilic granular cytoplasm;broadmatch
paucicellular stroma present;stromal change;broadmatch
beaded anastomosing cords present;abnormal tissue present;broadmatch
canalicular pattern;morphologic architectural pattern;broadmatch
point mutation;mutation abnormality;broadmatch
localized hydropic villous change;hydropic villous change;broadmatch
malignant cuboidal epithelial cell;neoplastic cuboidal cell;broadmatch
malignant cuboidal epithelial cell;malignant epithelial cell;broadmatch
small to medium size adenocarcinoma cell with oval nucleus;adenocarcinoma cell;broadmatch
lobular pattern;morphologic architectural pattern;broadmatch
terminal duct cell;epithelial cell;broadmatch
dysplastic dentin formation;dentin formation;broadmatch
tumor droplets present;abnormal tissue present;broadmatch
neoplastic apocrine cell with eosinophilic granular cytoplasm;neoplastic apocrine cell;broadmatch
eccrine differentiation;glandular differentiation;broadmatch
eccrine differentiation;adnexal differentiation;broadmatch
extensive secretory changes present;abnormal tissue present;broadmatch
epithelial neoplasm (antiquated);neoplasm by obsolete classification;broadmatch
hyperplastic epithelial tissue present;hyperplastic tissue present;broadmatch
hyperplastic epithelial tissue present;epithelial component present;broadmatch
hyperplastic tissue present;abnormal tissue present;broadmatch
dilated terminal duct lobular units with acini lined by more than two layers of columnar epithelial cells present;dilated terminal duct lobular units present;broadmatch
dilated terminal duct lobular units with acini lined by one or two layers of columnar epithelial cells present;dilated terminal duct lobular units present;broadmatch
dilated terminal duct lobular units present;epithelial component present;broadmatch
spaces lined by one to three layers of monotonous atypical cells present;abnormal tissue present;broadmatch
malignant basaloid cell;malignant epithelial cell;broadmatch
malignant basaloid cell;neoplastic basaloid cell;broadmatch
juvenile lesion;lesion;broadmatch
subareolar region;body region;broadmatch
large mass;mass;broadmatch
pericanalicular growth pattern;morphologic architectural pattern;broadmatch
intraductal lesion;lesion by morphology;broadmatch
rosette-like configurations present;abnormal tissue present;broadmatch
duct-like structures present;abnormal tissue present;broadmatch
neoplastic ghost cell;neoplastic cell;broadmatch
malignant glandular epithelium resembling the endocervical epithelium present;carcinomatous component present;broadmatch
ciliated adenocarcinoma cell;adenocarcinoma cell;broadmatch
rete ovarii;female reproductive system part;broadmatch
degradation;biophysical process;broadmatch
myomatous stroma formation;stromal change;broadmatch
mixed neoplastic epithelial cell population;mixed cellular population;broadmatch
malignant hobnail cell;neoplastic hobnail cell;broadmatch
neoplastic glandular epithelium resembling the normal endometrium present;epithelial component present;broadmatch
atypical glandular epithelium resembling the normal endometrium present;neoplastic glandular epithelium resembling the normal endometrium present;broadmatch
malignant glandular epithelium resembling the normal endometrium present;atypical glandular epithelium resembling the normal endometrium present;broadmatch
malignant glandular epithelium resembling the normal endometrium present;carcinomatous component present;broadmatch
mural nodule;nodule;broadmatch
gastrointestinal type epithelium present;epithelial component present;broadmatch
endocervical type epithelium present;epithelial component present;broadmatch
ovarian surface epithelium;ovarian tissue;broadmatch
ovarian surface epithelium;epithelium;broadmatch
complex glandular pattern;morphologic architectural pattern;broadmatch
infiltrating ureter urothelial carcinoma with mixed differentiation;epithelial neoplasm (antiquated);broadmatch
extraosseous lesion;lesion;broadmatch
mesonephric remnants;epithelial tissue;broadmatch
intraosseous lesion;lesion;broadmatch
neoplastic epithelial cell with granular cytoplasm;neoplastic epithelial cell;broadmatch
anastomosing strands of tumor cells present;abnormal tissue present;broadmatch
islands of odontogenic epithelium present;epithelial component present;broadmatch
ciliated respiratory mucosa;mucosa;broadmatch
tissue of mullerian origin present;abnormal tissue present;broadmatch
fibromuscular stroma formation;stromal change;broadmatch
basal cell of the squamous epithelium;squamous cell;broadmatch
basal cell of the squamous epithelium;skin basal cell;broadmatch
prominent squamous eddies present;abnormal tissue present;broadmatch
female genitalia;genitalia;broadmatch
lipid;organic chemical;broadmatch
vaginal mass;mass;broadmatch
endometrial type glands and stroma present;abnormal tissue present;broadmatch
malignant hyperchromatic small epithelial cell;malignant hyperchromatic epithelial cell;broadmatch
rat endometrial stromal sarcoma;rat female genital system neoplasms;broadmatch
rat embryonal carcinoma;rat female genital system neoplasms;broadmatch
benign mixed muellerian tumor of the rat uterus;rat female genital system neoplasms;broadmatch
non-proliferating breast lesion;lesion by morphology;broadmatch
primary low grade b-cell dural lymphoma;low grade b-cell non-hodgkin's lymphoma;broadmatch
head skin;skin;broadmatch
metaphysis;skeletal system part;broadmatch
childhood acute lymphoblastic leukemia in complete remission;childhood acute lymphoblastic leukemia in remission;broadmatch
childhood acute lymphoblastic leukemia in partial remission;childhood acute lymphoblastic leukemia in remission;broadmatch
labium;female reproductive system part;broadmatch
benign ovarian partly luteinized thecoma;epithelial neoplasm (antiquated);broadmatch
hereditary multiple exostoses;hereditary connective tissue disorder;broadmatch
myopericyte;pericyte;broadmatch
hereditary multiple exostoses;hereditary neoplastic syndrome;broadmatch
hereditary multiple exostoses;exostosis;broadmatch
fh gene mutation;gene variant;broadmatch
flcn gene mutation;gene variant;broadmatch
malignant spindle-shaped to round cell;malignant connective and soft tissue cell;broadmatch
malignant spindle-shaped to round cell;neoplastic spindle-shaped to round cell;broadmatch
cd34-positive neoplastic cells present;immunophenotypic finding;broadmatch
dendritic melanoma cell;melanoma cell;broadmatch
skin of the extremity;skin;broadmatch
red papular lesion;papular lesion;broadmatch
epidermal hyperplasia;hyperplasia;broadmatch
malignant oval endothelial cell;malignant endothelial cell;broadmatch
malignant spindle endothelial cell;malignant endothelial cell;broadmatch
malignant spindle endothelial cell;spindle endothelial cell;broadmatch
malignant epithelioid endothelial cell;malignant endothelial cell;broadmatch
malignant epithelioid endothelial cell;epithelioid endothelial cell;broadmatch
blood vessel endothelium;blood vessel tissue;broadmatch
blood vessel endothelium;vascular endothelium;broadmatch
collagen bundles formation;morphologic finding;broadmatch
neoplastic plump endothelial cell;neoplastic endothelial cell;broadmatch
neoplastic plump endothelial cell;neoplastic hobnail cell;broadmatch
skin red dot;integumentary system signs and symptoms;broadmatch
skin red dot;lesion;broadmatch
congenital lesion;lesion;broadmatch
acquired lesion;lesion;broadmatch
spontaneous regression;regression;broadmatch
cd34-positive neoplastic cells present;cd34 positive;broadmatch
concentric perivascular arrangement of tumor cells;perivascular arrangement of tumor cells;broadmatch
rarely metastasizing lesion;lesion;broadmatch
alopecia;non-neoplastic hair disorder;broadmatch
tinnitus;alterations in hearing;broadmatch
lymphadenopathy;hematopoietic system finding;broadmatch
sore throat;head and neck finding;broadmatch
regurgitation;sign;broadmatch
nasal obstruction;obstruction;broadmatch
heart failure;non-neoplastic heart disorder;broadmatch
hearing impairment;hearing disorder;broadmatch
cancer other;abnormal finding;broadmatch
marked nuclear atypia present;nuclear atypia;broadmatch
airway obstruction;respiratory system finding;broadmatch
airway obstruction;obstruction;broadmatch
erosion;tissue breakdown;broadmatch
fluid and electrolyte manifestation;cardiovascular system finding;broadmatch
body substance discharge;sign;broadmatch
ventilation or perfusion signs and symptoms;sign or symptom;broadmatch
visual manifestations;sensory manifestations;broadmatch
tissue damage;injury;broadmatch
urinary retention;urinary system finding;broadmatch
abnormal vaginal discharge;vaginal discharge;broadmatch
visual disturbance;visual manifestations;broadmatch
lesion with diameter greater than 2 cm;lesion with diameter greater than 10 mm;broadmatch
deep lesion;lesion;broadmatch
capillary sized vascular channel formation;vascular channel formation;broadmatch
vascular channel formation with muscular walls;vascular channel formation;broadmatch
huge vascular channel formation;dilated vascular space formation;broadmatch
dilated vascular space formation;vascular channel formation;broadmatch
cell defense process;cellular process;broadmatch
regulation of cell death process;cell death process;broadmatch
disease response;clinical course of disease;broadmatch
stage iv splenic marginal zone lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
stage iii splenic marginal zone lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
stage ii splenic marginal zone lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
stage i splenic marginal zone lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
skin erosion;integumentary system finding;broadmatch
locally aggressive lesion;lesion;broadmatch
osseous differentiation;mesenchymal differentiation;broadmatch
sensory manifestations;neurological signs and symptoms;broadmatch
wreath-like multinucleated giant cell;giant cell;broadmatch
malignant cardiac hemangiopericytoma;malignant hemangiopericytoma;broadmatch
malignant cell with eosinophilic cytoplasm;neoplastic cell with eosinophilic cytoplasm;broadmatch
malignant cell with eosinophilic cytoplasm;malignant cell;broadmatch
spindle cell pattern;morphologic architectural pattern;broadmatch
cord-like pattern;morphologic architectural pattern;broadmatch
malignant polygonal cell with eosinophilic cytoplasm;malignant cell with eosinophilic cytoplasm;broadmatch
malignant polygonal cell with eosinophilic cytoplasm;neoplastic polygonal cell with eosinophilic cytoplasm;broadmatch
epithelioid component present;abnormal tissue present;broadmatch
luminal b breast carcinoma;breast carcinoma by gene expression profile;broadmatch
malignant spindle cell;neoplastic spindle cell;broadmatch
pseudoalveolar pattern;morphologic architectural pattern;broadmatch
pseudogranulomatous pattern;morphologic architectural pattern;broadmatch
spindle cell component present;abnormal tissue present;broadmatch
lipomatous component present;abnormal tissue present;broadmatch
epithelial component present;abnormal tissue present;broadmatch
tissue differentiation uncertain;pathology result;broadmatch
glucose metabolism disorder;non-neoplastic endocrine disorder;broadmatch
glucose metabolism disorder;carbohydrate metabolism disorder;broadmatch
intermediate filaments present;ultrastructural finding;broadmatch
malignant cell with large nucleus and abundant eosinophilic cytoplasm;malignant cell with eosinophilic cytoplasm;broadmatch
malignant small osteoblast;malignant small cell;broadmatch
large spaces filled with blood present;morphologic finding;broadmatch
new bone formation;abnormal tissue present;broadmatch
retroperitoneal hemangiopericytoma;hemangiopericytoma;broadmatch
lesion with diameter of 2 cm or less;lesion with diameter of 5 cm or less;broadmatch
osteoid formation;abnormal tissue present;broadmatch
nidus formation;abnormal tissue present;broadmatch
smooth muscle component present;abnormal tissue present;broadmatch
thick-walled vessels present;vascular morphologic change;broadmatch
neoplastic perivascular epithelioid cell;neoplastic epithelioid cell;broadmatch
gain of chromosome 12q13-14;chromosomal gain;broadmatch
gain of chromosome 12q13-14;chromosome 12 abnormality;broadmatch
intraluminal tumor growth;vascular morphologic change;broadmatch
arterial embolic tumor spread;neoplastic growth or spread;broadmatch
intracytoplasmic eosinophilic inclusion;cytoplasmic alteration;broadmatch
normal breast-like subtype of breast carcinoma;breast carcinoma by gene expression profile;broadmatch
luminal a breast carcinoma;breast carcinoma by gene expression profile;broadmatch
cartilaginous differentiation;mesenchymal differentiation;broadmatch
malignant chondrocyte;atypical chondrocyte;broadmatch
malignant chondrocyte with clear cytoplasm;malignant chondrocyte;broadmatch
well differentiated hyaline cartilage present;hyaline cartilage differentiation;broadmatch
malignant small round cell;neoplastic small round cell;broadmatch
malignant small round cell;malignant small cell;broadmatch
low grade cartilaginous component present;stromal change;broadmatch
high grade non cartilaginous sarcomatous stroma present;stromal change;broadmatch
malignant chondrocyte;malignant connective and soft tissue cell;broadmatch
hyaline cartilage differentiation;cartilaginous differentiation;broadmatch
breast carcinoma by gene expression profile;breast adenocarcinoma;broadmatch
neoplastic spindle-shaped chondrocyte;neoplastic chondrocyte;broadmatch
neoplastic spindle-shaped chondrocyte;neoplastic connective and soft tissue spindle cell;broadmatch
neoplastic stellate chondrocyte;neoplastic chondrocyte;broadmatch
neoplastic stellate chondrocyte;neoplastic stellate cell;broadmatch
medullary bone;bone tissue;broadmatch
chicken wire calcification;calcification;broadmatch
sign;sign or symptom;broadmatch
non-neoplastic esophageal disorder;non-neoplastic digestive system disorder;broadmatch
non-neoplastic esophageal disorder;esophageal disorder;broadmatch
non-neoplastic intestinal disorder;intestinal disorder;broadmatch
non-neoplastic intestinal disorder;non-neoplastic digestive system disorder;broadmatch
non-neoplastic liver and intrahepatic bile duct disorder;non-neoplastic hepatobiliary disorder;broadmatch
non-neoplastic liver and intrahepatic bile duct disorder;liver and intrahepatic bile duct disorder;broadmatch
non-neoplastic disorder by special category;non-neoplastic disorder;broadmatch
rare non-neoplastic disorder;non-neoplastic disorder by special category;broadmatch
rare non-neoplastic disorder;rare disorder;broadmatch
non-neoplastic vision disorder;non-neoplastic disorder by site;broadmatch
non-neoplastic vision disorder;vision disorder;broadmatch
non-neoplastic disorder by site;non-neoplastic disorder;broadmatch
non-neoplastic disorder;disease or disorder;broadmatch
benign orbit hemangiopericytoma;orbit hemangiopericytoma;broadmatch
benign orbit hemangiopericytoma;benign hemangiopericytoma;broadmatch
non-neoplastic pancreatic disorder;non-neoplastic digestive system disorder;broadmatch
non-neoplastic pancreatic disorder;pancreatic disorder;broadmatch
non-neoplastic stomach disorder;non-neoplastic digestive system disorder;broadmatch
non-neoplastic stomach disorder;stomach disorder;broadmatch
thin bands of collagen present;stromal change;broadmatch
motor manifestations;neurological signs and symptoms;broadmatch
glomerulations;abnormal tissue present;broadmatch
malignant spindle-shaped fibrohistiocytic cell;malignant spindle cell;broadmatch
xanthomatous fibrohistiocytic cell;xanthomatous cell;broadmatch
xanthomatous fibrohistiocytic cell;neoplastic fibrohistiocytic cell;broadmatch
neoplastic epithelioid fibrohistiocytic cell;neoplastic connective and soft tissue epithelioid cell;broadmatch
neoplastic epithelioid fibrohistiocytic cell;neoplastic fibrohistiocytic cell;broadmatch
neoplastic spindle-shaped fibrohistiocytic cell;neoplastic fibrohistiocytic cell;broadmatch
neoplastic spindle-shaped fibrohistiocytic cell;neoplastic connective and soft tissue spindle cell;broadmatch
malignant large hyperchromatic fibrohistiocytic cell;malignant fibrohistiocytic cell;broadmatch
malignant spindle-shaped fibrohistiocytic cell;neoplastic spindle-shaped fibrohistiocytic cell;broadmatch
malignant mesenchymal spindle cell;neoplastic connective and soft tissue spindle cell;broadmatch
malignant spindle-shaped fibrohistiocytic cell;malignant fibrohistiocytic cell;broadmatch
xanthomatous cell;abnormal cell;broadmatch
malignant ovoid to spindle-shaped fibrohistiocytic cell;malignant fibrohistiocytic cell;broadmatch
cellular pleomorphism;morphologic finding;broadmatch
malignant fibrohistiocytic cell;malignant connective and soft tissue cell;broadmatch
malignant fibrohistiocytic cell;neoplastic fibrohistiocytic cell;broadmatch
malignant mesenchymal spindle cell;malignant spindle cell;broadmatch
wide vessel-like spaces formation;morphologic finding;broadmatch
melanin-pigmented dendritic cells present;melanin pigment present;broadmatch
myofibroblastic differentiation;tissue differentiation;broadmatch
fibrosarcomatous component present;sarcomatous component present;broadmatch
malignant spindle-shaped smooth muscle cell;neoplastic spindle-shaped smooth muscle cell;broadmatch
intersecting sharply marginated clusters of spindle cells present;abnormal cells present;broadmatch
malignant smooth muscle cell;malignant connective and soft tissue cell;broadmatch
malignant smooth muscle cell;neoplastic smooth muscle cell;broadmatch
lipomatous metaplasia;mesenchymal metaplasia;broadmatch
alternative fascicle (bundle) pattern;morphologic architectural pattern;broadmatch
hydropic change;morphologic finding;broadmatch
neoplastic epithelioid smooth muscle cell;neoplastic connective and soft tissue epithelioid cell;broadmatch
neoplastic epithelioid smooth muscle cell;neoplastic smooth muscle cell;broadmatch
dartoic muscle;muscle;broadmatch
cavernous vascular space formation;dilated vascular space formation;broadmatch
slit-like vascular channel formation;vascular channel formation;broadmatch
venous type vascular channel formation;vascular channel formation;broadmatch
conventional dermatofibrosarcoma protuberans;connective and soft tissue neoplasm (antiquated);broadmatch
fibroblastoma-like differentiation;mesenchymal differentiation;broadmatch
malignant mesenchymal spindle cell;malignant stromal cell;broadmatch
neoplastic mononuclear stromal cell;neoplastic stromal cell;broadmatch
malignant spindle-shaped smooth muscle cell;malignant spindle cell;broadmatch
primitive mesenchymal round to oval cell;primitive mesenchymal cell;broadmatch
myeloid leukemia in remission;myeloid neoplasm finding;broadmatch
chronic leukemia in remission;leukemia in remission;broadmatch
acute leukemia in remission;leukemia in remission;broadmatch
leukemia in remission;leukemia finding;broadmatch
bladder wall;urinary system part;broadmatch
delicate arborizing vascular channel formation;arborizing vascular channel formation;broadmatch
primitive mesenchymal round to oval cell;primitive round to oval cell;broadmatch
non lipogenic sarcomatous stroma present;stromal change;broadmatch
neoplastic elongated mononuclear stromal cell;neoplastic mononuclear stromal cell;broadmatch
floret-like pattern;morphologic architectural pattern;broadmatch
neoplastic spindle-shaped adipocyte;neoplastic lipocyte;broadmatch
neoplastic spindle-shaped adipocyte;neoplastic connective and soft tissue spindle cell;broadmatch
intravascular fibrin thrombus formation;intravascular thrombus formation;broadmatch
painful mass;mass;broadmatch
painless mass;mass;broadmatch
neoplastic mature adipocyte;neoplastic lipocyte;broadmatch
myeloid leukemia in remission;leukemia in remission;broadmatch
lymphoid leukemia in remission;leukemia in remission;broadmatch
intracytoplasmic eosinophilic spherical inclusion;intracytoplasmic eosinophilic inclusion;broadmatch
numerous stromal mast cells present;stromal change;broadmatch
neoplastic ovoid mononuclear stromal cell;neoplastic mononuclear stromal cell;broadmatch
joint effusion;effusion;broadmatch
malignant histiocyte-like cell;malignant connective and soft tissue cell;broadmatch
malignant histiocyte-like cell;neoplastic histiocyte-like cell;broadmatch
curvilinear thin-walled vascular pattern;thin-walled branching vascular pattern;broadmatch
vacuolated malignant fibroblast;malignant fibroblast;broadmatch
malignant epithelioid fibroblast;malignant fibroblast;broadmatch
malignant fibroblast;malignant connective and soft tissue cell;broadmatch
malignant fibroblast;neoplastic fibroblast;broadmatch
inclusion-like nucleoli;morphologic finding;broadmatch
malignant spindle-shaped fibroblast;malignant spindle cell;broadmatch
malignant spindle-shaped fibroblast;malignant fibroblast;broadmatch
malignant spindle-shaped fibroblast;neoplastic spindle-shaped fibroblast;broadmatch
regional lymph node;lymph node;broadmatch
nuclear palisading;morphologic finding;broadmatch
malignant spindle-shaped smooth muscle cell;malignant smooth muscle cell;broadmatch
malignant epithelioid smooth muscle cell;neoplastic epithelioid smooth muscle cell;broadmatch
alterations in hearing;sensory manifestations;broadmatch
brain nucleus;brain part;broadmatch
spinal nerve plexus;nerve plexus;broadmatch
oral cavity epithelium;stratified squamous epithelium;broadmatch
vaginal fibroepithelial polyp;vaginal polyp;broadmatch
vaginal fibroepithelial polyp;fibroepithelial polyp;broadmatch
convoluted tubule;renal tubule;broadmatch
intestinal wall tissue;tissue;broadmatch
cerebral white matter;brain white matter;broadmatch
brain white matter;white matter;broadmatch
tongue epithelium;stratified squamous epithelium;broadmatch
brain white matter;brain part;broadmatch
retina layer;ocular tissue;broadmatch
pseudostratified columnar epithelium;pseudostratified epithelium;broadmatch
pseudostratified columnar epithelium;columnar epithelium;broadmatch
vaginal squamous epithelium;vaginal epithelium;broadmatch
vaginal squamous epithelium;stratified squamous epithelium;broadmatch
vaginal epithelium;epithelium;broadmatch
central nervous system vascular malformation;vascular malformation;broadmatch
central nervous system vascular malformation;non-neoplastic central nervous system disorder;broadmatch
central nervous system vascular malformation;congenital nervous system disorder;broadmatch
marginal zone;lymphoid tissue;broadmatch
integumentary system signs and symptoms;sign or symptom;broadmatch
genitourinary signs and symptoms;sign or symptom;broadmatch
disturbance in bowel function;digestive system signs and symptoms;broadmatch
high grade burkitt-like lymphoma;high grade b-cell non-hodgkin's lymphoma;broadmatch
recurrent high grade burkitt-like lymphoma;high grade burkitt-like lymphoma;broadmatch
refractory high grade burkitt-like lymphoma;high grade burkitt-like lymphoma;broadmatch
stage i high grade burkitt-like lymphoma;high grade burkitt-like lymphoma;broadmatch
stage ii high grade burkitt-like lymphoma;high grade burkitt-like lymphoma;broadmatch
stage iii high grade burkitt-like lymphoma;high grade burkitt-like lymphoma;broadmatch
stage iv high grade burkitt-like lymphoma;high grade burkitt-like lymphoma;broadmatch
stage i extragonadal seminoma;germ cell tumor (antiquated);broadmatch
occupational malignant neoplasm;malignant neoplasm;broadmatch
occupational malignant neoplasm;occupational neoplasm;broadmatch
aids-related disorder;immunodeficiency-related disorder;broadmatch
splenic marginal zone;marginal zone;broadmatch
gland of littre;urethral gland;broadmatch
hilar area of the lung;respiratory system part;broadmatch
malignant epithelioid smooth muscle cell;malignant smooth muscle cell;broadmatch
malignant rhabdomyoblast;malignant skeletal muscle cell;broadmatch
fibrovascular septa present;abnormal tissue present;broadmatch
primitive malignant skeletal muscle cell;primitive skeletal muscle cell;broadmatch
primitive malignant skeletal muscle cell;malignant rhabdomyoblast;broadmatch
primitive malignant skeletal spindle cell;primitive malignant skeletal muscle cell;broadmatch
primitive malignant skeletal spindle cell;primitive skeletal spindle cell;broadmatch
primitive skeletal muscle cell;primitive striated muscle cell;broadmatch
cambium layer;morphologic architectural pattern;broadmatch
malignant rhabdomyoblast;rhabdomyoblast;broadmatch
renal tubule epithelium;simple cuboidal epithelium;broadmatch
malignant skeletal muscle cell;neoplastic skeletal muscle cell;broadmatch
malignant skeletal muscle cell;malignant connective and soft tissue cell;broadmatch
primitive skeletal spindle cell;primitive skeletal muscle cell;broadmatch
neoplastic striated muscle cell with eosinophilic granular cytoplasm;rhabdomyoblast;broadmatch
neoplastic large striated muscle cell with clear cytoplasm;rhabdomyoblast;broadmatch
neoplastic skeletal muscle cell;neoplastic striated muscle cell;broadmatch
malignant smooth muscle cell with granular cytoplasmic change;malignant smooth muscle cell;broadmatch
cervix epithelium;epithelium;broadmatch
cervix squamous epithelium;stratified squamous epithelium;broadmatch
cervix squamous epithelium;cervix epithelium;broadmatch
esophageal epithelium;gut epithelium;broadmatch
renal tubule;kidney part;broadmatch
benign ovarian cyst;ovarian cyst;broadmatch
oropharynx epithelium;epithelium;broadmatch
nasopharynx epithelium;epithelium;broadmatch
nasal cavity epithelium;epithelium;broadmatch
lymphatic vessel endothelium;vascular endothelium;broadmatch
laryngeal epithelium;epithelium;broadmatch
laryngeal mucosa;mucosa;broadmatch
intestinal mucosa;mucosa;broadmatch
gingival epithelium;oral cavity epithelium;broadmatch
candidate tumor suppressor gene;tumor suppressor gene;broadmatch
gallbladder epithelium;simple columnar epithelium;broadmatch
esophageal squamous epithelium;esophageal epithelium;broadmatch
esophageal squamous epithelium;stratified squamous epithelium;broadmatch
esophageal epithelium;esophageal mucosa;broadmatch
malignant small osteoblast;malignant osteoblast;broadmatch
malignant spindle-shaped osteoblast;malignant osteoblast;broadmatch
spindle cell osteo-fibrous component present;spindle cell component present;broadmatch
stage i extrahepatic bile duct cancer;cancer stage (antiquated);broadmatch
stage ivb oral cavity verrucous carcinoma;stage iv oral cavity verrucous carcinoma;broadmatch
stage iva oral cavity verrucous carcinoma;stage iv oral cavity verrucous carcinoma;broadmatch
stage ivb extrahepatic bile duct cancer;stage iv extrahepatic bile duct cancer;broadmatch
stage iva extrahepatic bile duct cancer;stage iv extrahepatic bile duct cancer;broadmatch
stage iv extrahepatic bile duct cancer;cancer stage (antiquated);broadmatch
stage iii extrahepatic bile duct cancer;cancer stage (antiquated);broadmatch
stage ii extrahepatic bile duct cancer;cancer stage (antiquated);broadmatch
liver mesenchymal hamartoma;non-neoplastic liver and intrahepatic bile duct disorder;broadmatch
stage ivb esophageal cancer;cancer stage (antiquated);broadmatch
liver mesenchymal hamartoma;mesenchymal hamartoma;broadmatch
stage iva pancreatic cancer;cancer stage (antiquated);broadmatch
solid pseudopapillary carcinoma of the pancreas;epithelial neoplasm (antiquated);broadmatch
pancreatic intraductal papillary-mucinous carcinoma;epithelial neoplasm (antiquated);broadmatch
pancreatic intraductal papillary-mucinous neoplasm with intermediate grade dysplasia;epithelial neoplasm (antiquated);broadmatch
pancreatic mucinous cystadenoma;epithelial neoplasm (antiquated);broadmatch
pancreatic mucinous cystadenocarcinoma;epithelial neoplasm (antiquated);broadmatch
stage ivc oral cavity verrucous carcinoma;stage iv oral cavity verrucous carcinoma;broadmatch
stage 0 oral cavity verrucous carcinoma;epithelial neoplasm (antiquated);broadmatch
astler-coller b3 colon carcinoma;astler-coller b3 colorectal carcinoma;broadmatch
astler-coller b3 colon carcinoma;colon cancer by astler-coller stage;broadmatch
astler-coller c1 colorectal carcinoma;colorectal cancer by astler-coller stage;broadmatch
astler-coller c2 colorectal carcinoma;colorectal cancer by astler-coller stage;broadmatch
astler-coller c3 colorectal carcinoma;colorectal cancer by astler-coller stage;broadmatch
astler-coller b3 colorectal carcinoma;colorectal cancer by astler-coller stage;broadmatch
astler-coller a colorectal carcinoma;colorectal cancer by astler-coller stage;broadmatch
astler-coller a rectal carcinoma;rectal cancer by astler-coller stage;broadmatch
astler-coller a rectal carcinoma;astler-coller a colorectal carcinoma;broadmatch
astler-coller c2 rectal carcinoma;rectal cancer by astler-coller stage;broadmatch
astler-coller c2 rectal carcinoma;astler-coller c2 colorectal carcinoma;broadmatch
astler-coller c1 rectal carcinoma;rectal cancer by astler-coller stage;broadmatch
astler-coller c1 rectal carcinoma;astler-coller c1 colorectal carcinoma;broadmatch
astler-coller c3 rectal carcinoma;rectal cancer by astler-coller stage;broadmatch
astler-coller c3 rectal carcinoma;astler-coller c3 colorectal carcinoma;broadmatch
astler-coller b3 rectal carcinoma;rectal cancer by astler-coller stage;broadmatch
astler-coller b3 rectal carcinoma;astler-coller b3 colorectal carcinoma;broadmatch
stage iva esophageal cancer;cancer stage (antiquated);broadmatch
colorectal hyperplastic polyp;colorectal sporadic serrated polyp;broadmatch
stage iib nasopharyngeal carcinoma;cancer stage (antiquated);broadmatch
intracytoplasmic and extracytoplasmic eosinophilic material present;abnormal tissue present;broadmatch
central nervous system hamartoma;non-neoplastic central nervous system disorder;broadmatch
intracanalicular growth pattern;morphologic architectural pattern;broadmatch
sarcomatous component present;malignant component present;broadmatch
sarcomatous component present;mesenchymal component present;broadmatch
fibrotic stroma with finger-like projections present;fibrotic stroma formation;broadmatch
adenocarcinoma cell with abundant pale cytoplasm;adenocarcinoma cell with abundant cytoplasm;broadmatch
adenocarcinoma cell with abundant pale cytoplasm;neoplastic large cell with abundant pale cytoplasm;broadmatch
sebaceous differentiation;adnexal differentiation;broadmatch
colorectal hyperplastic polyp;hyperplastic polyp;broadmatch
malignant epithelial cells with abundant clear cytoplasm containing glycogen present;abnormal cells present;broadmatch
acinar cell differentiation;epithelial differentiation;broadmatch
malignant epithelial cells with abundant cytoplasmic neutral lipids present;abnormal cells present;broadmatch
mesenchymal metaplasia;metaplasia;broadmatch
spindle cell metaplasia;metaplasia;broadmatch
blood pressure finding;cardiovascular system finding;broadmatch
neoplastic syndrome;syndrome;broadmatch
central nervous system hamartoma;hamartoma;broadmatch
skin appendage hamartoma;non-neoplastic skin disorder;broadmatch
skin appendage hamartoma;hamartoma;broadmatch
eccrine sweat gland hamartoma;skin appendage hamartoma;broadmatch
colorectal juvenile polyp;colorectal hamartoma;broadmatch
colorectal juvenile polyp;juvenile polyp;broadmatch
colorectal polyp;gastrointestinal polyp;broadmatch
colorectal polyp;intestinal disorder;broadmatch
adult acute lymphoblastic leukemia in partial remission;adult acute lymphoblastic leukemia in remission;broadmatch
adult acute lymphoblastic leukemia in complete remission;adult acute lymphoblastic leukemia in remission;broadmatch
tubular structures of glycogen-rich non-ciliated cells present;tubular structures present;broadmatch
type ii cell differentiation;epithelial differentiation;broadmatch
club cell differentiation;epithelial differentiation;broadmatch
lepidic growth pattern;morphologic architectural pattern;broadmatch
solitary pulmonary nodule;pulmonary nodule;broadmatch
nuclear molding;morphologic finding;broadmatch
asbestos exposure;chemical exposure;broadmatch
pancoast syndrome;neoplastic syndrome;broadmatch
pilosebaceous hamartoma;skin appendage hamartoma;broadmatch
stage iia nasopharyngeal carcinoma;cancer stage (antiquated);broadmatch
laryngeal carcinoid tumor;epithelial neoplasm (antiquated);broadmatch
zonal pattern;morphologic architectural pattern;broadmatch
rat benign pinealoma;rat endocrine system neoplasms;broadmatch
rat bronchiolo-alveolar adenoma;rat respiratory system neoplasms;broadmatch
rat benign thymoma;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat benign thecoma;rat female genital system neoplasms;broadmatch
prostatic crystalloids present;morphologic finding;broadmatch
rat benign teratoma;rat neoplasms by morphology;broadmatch
rat benign sertoli cell tumor;rat male genital system neoplasms;broadmatch
rat benign schwannoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat benign oligodendroglioma;rat nervous system and sensory organs neoplasms;broadmatch
rat benign medullary tumor;rat endocrine system neoplasms;broadmatch
rat benign odontogenic tumor;rat digestive system neoplasms;broadmatch
rat benign neuroendocrine cell tumor;rat digestive system neoplasms;broadmatch
rat benign mixed tumor;rat neoplasms by morphology;broadmatch
rat benign mixed sex cord stromal tumor;rat female genital system neoplasms;broadmatch
rat benign mixed muellerian tumor;rat female genital system neoplasms;broadmatch
rat benign mixed glioma;rat nervous system and sensory organs neoplasms;broadmatch
rat benign mesothelioma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat bronchiolo-alveolar carcinoma;rat respiratory system neoplasms;broadmatch
rat carcinoma;rat neoplasms by morphology;broadmatch
rat carcinoma, nos;rat carcinoma;broadmatch
rat c-cell adenoma;rat endocrine system neoplasms;broadmatch
rat ductal cell adenoma;rat adenoma;broadmatch
rat ductal cell adenocarcinoma;rat adenocarcinoma;broadmatch
rat cystadenoma;rat adenoma;broadmatch
rat cystadenocarcinoma;rat adenocarcinoma;broadmatch
rat cortical carcinoma;rat endocrine system neoplasms;broadmatch
rat cortical adenoma;rat endocrine system neoplasms;broadmatch
rat choroid plexus papilloma;rat nervous system and sensory organs neoplasms;broadmatch
rat choroid plexus carcinoma;rat nervous system and sensory organs neoplasms;broadmatch
rat choriocarcinoma;rat carcinoma;broadmatch
rat chondrosarcoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat chondroma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat cholangioma;rat hepatic neoplasm;broadmatch
rat cholangiocarcinoma;rat hepatic neoplasm;broadmatch
absence of basal cell layer;morphologic finding;broadmatch
rat c-cell carcinoma;rat endocrine system neoplasms;broadmatch
rat benign meningioma;rat nervous system and sensory organs neoplasms;broadmatch
rat benign luteoma;rat female genital system neoplasms;broadmatch
malignant spindle transitional cell;malignant transitional cell;broadmatch
secretory adenocarcinoma cell;adenocarcinoma cell;broadmatch
rat acinar islet cell adenoma;rat endocrine system neoplasms;broadmatch
rat acinar islet cell adenoma;rat adenoma;broadmatch
rat acinar cell adenoma;rat adenoma;broadmatch
rat acinar cell adenocarcinoma;rat digestive system neoplasms;broadmatch
rat acinar cell adenocarcinoma;rat adenocarcinoma;broadmatch
tissue autolysed diagnosis not possible;rat histopathology diagnoses for proliferative changes;broadmatch
secretory adenocarcinoma cell;neoplastic acinar cell;broadmatch
serum prostate specific antigen increased;elevated test result;broadmatch
rat benign hibernoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
serum prostate specific antigen increased;abnormal blood chemistry and hematology test result;broadmatch
serum prostate specific antigen increased;psa progression;broadmatch
rat histopathology diagnoses for proliferative changes;murine experimental organism diagnosis;broadmatch
more than 10 mitoses per 10hpf;high mitotic activity;broadmatch
less than 2 mitoses per 10hpf;mitotic activity;broadmatch
two to 10 mitoses per 10hpf;mitotic activity;broadmatch
malignant spindle transitional cell;malignant epithelial spindle cell;broadmatch
rat adenocarcinoma;rat carcinoma;broadmatch
rat adenocarcinoma arising in fibroadenoma;rat integumentary system neoplasms;broadmatch
rat adenoma;rat neoplasms by morphology;broadmatch
rat adenosquamous carcinoma;rat carcinoma;broadmatch
rat benign hemangiopericytoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat benign hair follicle tumor;rat integumentary system neoplasms;broadmatch
rat benign granulosa cell tumor;rat genital system neoplasms;broadmatch
rat benign granular cell tumor;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat benign fibrous histiocytoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat benign ependymoma;rat nervous system and sensory organs neoplasms;broadmatch
rat benign endocardial schwannoma;rat cardiovascular system neoplasms;broadmatch
rat benign craniopharyngioma;rat endocrine system neoplasms;broadmatch
rat benign chordoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat benign basal cell tumor;rat neoplasms by morphology;broadmatch
rat benign atriocaval mesothelioma;rat cardiovascular system neoplasms;broadmatch
rat benign astrocytoma;rat nervous system and sensory organs neoplasms;broadmatch
rat basal cell carcinoma;rat carcinoma;broadmatch
rat ameloblastoma;rat benign odontogenic tumor;broadmatch
rat ameloblastic odontoma;rat odontoma;broadmatch
tumor replacement;tumor-associated process;broadmatch
mucinous tall columnar adenocarcinoma cell;tall columnar adenocarcinoma cell;broadmatch
mucinous tall columnar adenocarcinoma cell;adenocarcinoma cell with intracytoplasmic mucin;broadmatch
rathke pouch epithelium;epithelium;broadmatch
malignant germ cell;neoplastic germ cell;broadmatch
malignant germ cell;malignant cell;broadmatch
"undifferentiated ""fetal-type"" tissues present";tissue differentiation;broadmatch
"fully differentiated ""adult-type"" tissues present";tissue differentiation;broadmatch
germinal layer;embryonic tissue;broadmatch
abnormal germ cell;abnormal cell;broadmatch
parinaud syndrome;syndrome;broadmatch
cholesterol deposit;deposit;broadmatch
preexisting condition;medical condition;broadmatch
nodules of compact keratin present;keratin present;broadmatch
aggravated disease;clinical course of disease;broadmatch
neoplastic vacuolated stromal cell;neoplastic mononuclear stromal cell;broadmatch
polyhedral melanocyte;neoplastic melanocyte;broadmatch
fusiform melanocyte;neoplastic melanocyte;broadmatch
nevoid polygonal cell;neoplastic melanocyte;broadmatch
hereditary lesion;lesion;broadmatch
ectodermal differentiation;tissue differentiation;broadmatch
endodermal differentiation;tissue differentiation;broadmatch
mesodermal differentiation;tissue differentiation;broadmatch
sarcomatous or carcinomatous component present;malignant component present;broadmatch
mesenchymal component present;abnormal tissue present;broadmatch
medium size melanoma cell;melanoma cell;broadmatch
lesion with diameter greater than 15 mm;lesion with diameter greater than 10 mm;broadmatch
spindle b melanoma cell;spindle melanoma cell;broadmatch
spindle a melanoma cell;spindle melanoma cell;broadmatch
mixture of germ cell neoplastic components present;mixture of morphologic patterns;broadmatch
malignant large germ cell with abundant cytoplasm;neoplastic large germ cell;broadmatch
malignant large germ cell with abundant cytoplasm;malignant primitive germ cell;broadmatch
schiller-duval body;morphologic finding;broadmatch
sinusoidal growth pattern;morphologic architectural pattern;broadmatch
cytoplasmic hyaline globules present;cytoplasmic alteration;broadmatch
malignant syncytiotrophoblastic giant cell;malignant trophoblastic cell;broadmatch
malignant syncytiotrophoblastic giant cell;neoplastic syncytiotrophoblastic cell;broadmatch
malignant cytotrophoblastic cell;malignant trophoblastic cell;broadmatch
malignant cytotrophoblastic cell;neoplastic cytotrophoblastic cell;broadmatch
cerebellopontine angle;brain part;broadmatch
striated muscle component present;abnormal tissue present;broadmatch
round adenocarcinoma cell with abundant cytoplasm and vesicular nucleus;adenocarcinoma cell with abundant cytoplasm;broadmatch
cytoplasmic eosinophilic globules present;cytoplasmic alteration;broadmatch
neoplastic epithelioid stromal cell;neoplastic mononuclear stromal cell;broadmatch
neoplastic spindle stromal cell;neoplastic elongated mononuclear stromal cell;broadmatch
heparan sulfate;anticoagulant agent;broadmatch
endometrioid stromal cell;stromal cell;broadmatch
plexiform vasculature present;vascular proliferation;broadmatch
infiltrating tumor margins present;morphologic finding;broadmatch
pushing tumor margin;tumor margin configuration;broadmatch
malignant stellate cell;malignant cell;broadmatch
melanin-forming neuroepithelial cells present;morphologic finding;broadmatch
malignant neuroectodermal cell;neoplastic neuroepithelial cell;broadmatch
malignant neuroectodermal cell;malignant cell;broadmatch
primitive round to oval cell;malignant cell;broadmatch
neuroectodermal differentiation;tissue differentiation;broadmatch
non-hereditary lesion;lesion;broadmatch
blue bone formation;new bone formation;broadmatch
fibrous septa present;abnormal tissue present;broadmatch
lesion with diameter of 5 cm or less;lesion;broadmatch
lesion with diameter greater than 10 cm;lesion with diameter greater than 2 cm;broadmatch
five or less mitoses per 50hpf;mitotic activity;broadmatch
more than 5 mitoses per 50hpf;mitotic activity;broadmatch
malignant neuroectodermal small cell;malignant neuroectodermal cell;broadmatch
malignant neuroectodermal small cell;neoplastic small neuroepithelial cell;broadmatch
malignant neuroectodermal large cell;malignant neuroectodermal cell;broadmatch
malignant neuroectodermal round cell;malignant neuroectodermal cell;broadmatch
nodular, reticulin-free zones present;morphologic finding;broadmatch
malignant neuroectodermal cell with hyperchromatic nucleus and scanty cytoplasm;malignant neuroectodermal cell;broadmatch
pseudostratified tumor cells present;morphologic finding;broadmatch
pseudostratified neuroepithelial tumor cells present;pseudostratified tumor cells present;broadmatch
drop metastasis;metastatic lesion;broadmatch
nerve root;nervous system part;broadmatch
apple green dichromism present in polarized congo-red stained sections;morphologic finding;broadmatch
amorphous, eosinophilic, and acellular deposit;deposit;broadmatch
elastin fibers present;fibrotic stroma formation;broadmatch
dermal nodule;skin nodule;broadmatch
distortion of the hair follicle;morphologic finding;broadmatch
cartilaginous component present;abnormal tissue present;broadmatch
osseous component present;abnormal tissue present;broadmatch
carcinomatous component present;epithelial component present;broadmatch
transcription regulation gene;gene;broadmatch
intraluminal necrosis;necrotic change;broadmatch
round adenocarcinoma cell;adenocarcinoma cell;broadmatch
cervix glandular epithelium;cervix epithelium;broadmatch
cervix glandular epithelium;glandular epithelium;broadmatch
rassf1a gene inactivation;tumor-suppressor gene inactivation;broadmatch
cellular stratification;morphologic finding;broadmatch
malignant epithelial large cell with vesicular nucleus and distinct nucleolus;malignant epithelial large cell;broadmatch
odontoameloblastoma;neoplasm by obsolete classification;broadmatch
carcinomatous component present;malignant component present;broadmatch
odontogenic keratocyst;odontogenic cyst;broadmatch
odontogenic epithelium;odontogenic tissue;broadmatch
odontogenic epithelium;epithelium;broadmatch
sinonasal tract;head and neck part;broadmatch
rhinorrhea;respiratory system signs and symptoms;broadmatch
paranasal sinus epithelium;epithelium;broadmatch
throat;head and neck part;broadmatch
renal pelvis and ureter;urinary system part;broadmatch
single malignant cells present;morphologic finding;broadmatch
malignant transitional cell with large nucleus and small nucleolus;malignant transitional cell;broadmatch
malignant transitional cell with eccentrically placed large nucleus and small nucleolus;malignant transitional cell;broadmatch
round adenocarcinoma cell with abundant cytoplasm and vesicular nucleus;round adenocarcinoma cell;broadmatch
prominent in situ component present;malignant component present;broadmatch
prominent intraductal component present;prominent in situ component present;broadmatch
melanoma cells present;abnormal cells present;broadmatch
primary site unspecified;primary site of disease;broadmatch
synchronous lesion;lesion;broadmatch
malignant epithelial cell with ground glass cytoplasm;malignant epithelial cell;broadmatch
gastric hemorrhage;upper gastrointestinal hemorrhage;broadmatch
preserved nuclear polarity;morphologic finding;broadmatch
lipoblast-like malignant transitional cell;malignant transitional cell;broadmatch
malignant transitional cell with clear cytoplasm;malignant transitional cell;broadmatch
human chorionic gonadotropin-positive neoplastic cells present;immunophenotypic finding;broadmatch
heterologous elements present;abnormal tissue present;broadmatch
renal pelvis urothelial cell;urothelial cell;broadmatch
renal pelvis urothelium;urothelium;broadmatch
dome-shaped lesion;lesion;broadmatch
acantholysis;morphologic finding;broadmatch
windblown appearance of atypical keratinocytes;morphologic finding;broadmatch
crtc1-maml2 fusion protein expression;fusion protein expression;broadmatch
horny masses of keratin present;keratin present;broadmatch
early stromal invasion present;stromal change;broadmatch
urachal epithelium;epithelium;broadmatch
peripheral nuclear palisading;nuclear palisading;broadmatch
malignant hyperchromatic squamous cell;malignant hyperchromatic epithelial cell;broadmatch
malignant hyperchromatic squamous cell;malignant small squamous cell;broadmatch
malignant small squamous cell;malignant epithelial small cell;broadmatch
malignant small squamous cell;malignant squamous cell;broadmatch
endophytic tumor growth;morphologic finding;broadmatch
upper gingiva;gingiva;broadmatch
lower gingiva;gingiva;broadmatch
exophytic papillary lesion;lesion;broadmatch
colorectal region;body region;broadmatch
rectosigmoid region;body region;broadmatch
floor of mouth;head and neck part;broadmatch
"t(11;19)(q21;p13)";11q translocation;broadmatch
mucin-producing malignant epithelial cell;malignant epithelial cell;broadmatch
angiosarcoma-like areas present;abnormal tissue present;broadmatch
mucin-producing malignant epithelial cell;mucin-producing neoplastic epithelial cell;broadmatch
skin ulcer;skin erosion;broadmatch
skin ulcer;ulcer;broadmatch
solar radiation toxicity;radiation toxicity;broadmatch
malignant hyperchromatic epithelial cell;malignant epithelial cell;broadmatch
no evidence of radiologic finding;radiologic finding;broadmatch
no evidence of radiologic finding;negative test result;broadmatch
bronchial epithelial cell;columnar cell;broadmatch
mixture of morphologic patterns;morphologic architectural pattern;broadmatch
malignant large squamous cell;malignant squamous cell;broadmatch
lip and oral cavity;head and neck part;broadmatch
retromolar trigone;head and neck part;broadmatch
posterior wall of the pharynx;wall of the pharynx;broadmatch
postcricoid region;head and neck part;broadmatch
postcricoid region;body region;broadmatch
odontogenic cyst;oral cavity cyst;broadmatch
benign mixed muellerian tumor of the rat uterine cervix;rat female genital system neoplasms;broadmatch
figo stage iia gestational trophoblastic tumor;figo stage ii gestational trophoblastic tumor;broadmatch
unresectable mass;mass;broadmatch
fc-epsilon receptor i signaling pathway pid;immune response regulation pathway;broadmatch
glucocorticoid receptor regulatory network;glucocorticoid receptor signaling pathway;broadmatch
glucocorticoid receptor signaling pathway;signaling pathway;broadmatch
foxo transcription factor family signaling pathway;regulatory pathway;broadmatch
foxm1 transcription factor signaling pathway;regulatory pathway;broadmatch
foxa2 and foxa3 transcription factor signaling pathway;foxa transcription factor signaling pathway;broadmatch
foxa transcription factor signaling pathway;regulatory pathway;broadmatch
fgf signaling pathway;signaling pathway;broadmatch
fas signaling pathway pid;signaling pathway;broadmatch
ephrin a signaling pathway;signaling pathway;broadmatch
erbb2/erbb3 signaling pathway;signaling pathway;broadmatch
epidermal growth factor receptor downstream signaling pathway;epidermal growth factor receptor pathway;broadmatch
epidermal growth factor receptor family pathway;signaling pathway;broadmatch
erythropoietin signaling pathway;signaling pathway;broadmatch
ephrin b reverse signaling pathway;ephrin b signaling pathway;broadmatch
ephrin b forward signaling pathway;ephrin b signaling pathway;broadmatch
ephrin a2 forward signaling pathway;ephrin a signaling pathway;broadmatch
hedgehog signaling events mediated by gli family proteins;hedgehog family-mediated signaling pathway;broadmatch
hypoxia and oxygen homeostasis regulation of hif-1-alpha pathway;regulatory pathway;broadmatch
hif-1-alpha transcription factor pathway;hypoxia and oxygen homeostasis regulation of hif-1-alpha pathway;broadmatch
interferon-gamma signaling pathway;signaling pathway;broadmatch
n-cadherin signaling pathway;signaling pathway;broadmatch
mtor signaling pathway pid;signaling pathway;broadmatch
lysophosphatidic acid receptor signaling pathway;signaling pathway;broadmatch
internalization pathway for epidermal growth factor receptor;epidermal growth factor receptor pathway;broadmatch
integrin angiogenesis pathway;regulatory pathway;broadmatch
insulin-mediated glucose transport pathway;insulin pathway;broadmatch
insulin pathway;signaling pathway;broadmatch
il6-mediated signaling pathway;signaling pathway;broadmatch
il4-mediated signaling pathway;signaling pathway;broadmatch
il2/stat5 signaling pathway;il2-mediated signaling pathway;broadmatch
il2/pi3k signaling pathway;il2-mediated signaling pathway;broadmatch
il2-mediated signaling pathway;signaling pathway;broadmatch
il23-mediated signaling pathway;signaling pathway;broadmatch
il1-mediated signaling pathway;signaling pathway;broadmatch
igf1 pathway;signaling pathway;broadmatch
ephrin b signaling pathway;signaling pathway;broadmatch
egfr-dependent endothelin signaling pathway;endothelin pathway;broadmatch
nephrin signaling pathway in the kidney podocyte;cell differentiation or development pathway;broadmatch
angiopoietin-1 receptor signaling pathway;signaling pathway;broadmatch
bcr immune response signaling pathway;immune response regulation pathway;broadmatch
aurora a signaling pathway;aurora kinase signaling pathway;broadmatch
aurora kinase signaling pathway;cell cycle regulation pathway;broadmatch
aurora kinase signaling pathway;signaling pathway;broadmatch
atypical nf-kappab signaling pathway;signaling pathway;broadmatch
atf-2 transcription factor signaling pathway;regulatory pathway;broadmatch
arf6 pathway;signaling pathway;broadmatch
androgen-mediated signaling pathway;signaling pathway;broadmatch
endothelin pathway;signaling pathway;broadmatch
alpham/beta2 integrin signaling pathway;cell motility pathway;broadmatch
alpha6/beta1 and alpha6/beta4 integrin signaling pathway;cell motility pathway;broadmatch
hedgehog family-mediated signaling pathway;signaling pathway;broadmatch
wnt signaling pathway kegg;signaling pathway;broadmatch
endometrial cancer pathway;cancer pathway;broadmatch
epithelial cell signaling pathway in helicobacter pylori infection;infectious disease pathway;broadmatch
acute myeloid leukemia pathway;cancer pathway;broadmatch
t-cell receptor signaling pathway in naive cd4+ t cells;signaling pathway;broadmatch
t-cell receptor signaling pathway in naive cd4+ t cells;immune response regulation pathway;broadmatch
t-cell receptor signaling pathway in naive cd8+ t cells;signaling pathway;broadmatch
t-cell receptor signaling pathway in naive cd8+ t cells;immune response regulation pathway;broadmatch
epidermal growth factor receptor pathway;signaling pathway;broadmatch
adherens junction formation pathway;e-cadherin signaling pathway;broadmatch
e-cadherin signaling pathway in keratinocytes;e-cadherin signaling pathway;broadmatch
e-cadherin signaling pathway;signaling pathway;broadmatch
e2f transcription factor pathway;cell cycle regulation pathway;broadmatch
p53 effector pathway;p53 pathway for transcriptional regulation;broadmatch
p53 pathway for transcriptional regulation;regulatory pathway;broadmatch
cxcr4-mediated signaling pathway;signaling pathway;broadmatch
cxcr3-mediated signaling pathway;signaling pathway;broadmatch
coregulation pathway for androgen receptor activity;androgen-mediated signaling pathway;broadmatch
class i pi3k signaling pathway;signaling pathway;broadmatch
ceramide signaling pathway pid;signaling pathway;broadmatch
cd40/cd40l signaling pathway;signaling pathway;broadmatch
canonical wnt signaling pathway;wnt signaling pathway pid;broadmatch
wnt signaling pathway pid;signaling pathway;broadmatch
nectin adhesion pathway;signaling pathway;broadmatch
neurotrophic factor-mediated ntrk1 signaling pathway;signaling pathway;broadmatch
vegf signaling pathway;signaling pathway;broadmatch
cognitive disorder;psychiatric disorder;broadmatch
silicon granuloma;foreign body granuloma;broadmatch
hypertension-associated pregnancy disorder;pregnancy disorder;broadmatch
weight change;sign;broadmatch
systemic disease;clinical course of disease;broadmatch
non-hematologic malignancy;malignant neoplasm;broadmatch
esophagitis;non-neoplastic esophageal disorder;broadmatch
extraperitoneal space;body region;broadmatch
rat pars intermedia carcinoma;rat carcinoma;broadmatch
malaria pathway;infectious disease pathway;broadmatch
rat sertoliform tubular adenoma;rat adenoma;broadmatch
atf1 gene;creb family gene;broadmatch
stage ii non-contiguous adult diffuse mixed cell lymphoma;stage ii adult diffuse mixed cell lymphoma;broadmatch
stage ii non-contiguous adult diffuse small cleaved cell lymphoma;stage ii adult diffuse small cleaved cell lymphoma;broadmatch
fus gene;regulatory gene;broadmatch
homeostasis regulation pathway;regulatory pathway;broadmatch
drug pathway;biochemical pathway;broadmatch
endobronchial lesion;lesion;broadmatch
arid1a gene;transcription regulation gene;broadmatch
ddit3 gene;transcription regulation gene;broadmatch
recurrent malignant hemangiopericytoma;malignant hemangiopericytoma;broadmatch
stage iia bladder cancer;cancer stage (antiquated);broadmatch
location description;description;broadmatch
in-transit metastasis;metastasis;broadmatch
advanced stage;disease stage qualifier;broadmatch
psa failure;psa progression;broadmatch
inflammatory disorder;non-neoplastic disorder by special category;broadmatch
deleterious mutation;mutation abnormality;broadmatch
paratesticular soft tissue;soft tissue;broadmatch
pregnancy finding;female reproductive system finding;broadmatch
nutm1 gene;regulatory gene;broadmatch
brd4 gene;cell cycle gene;broadmatch
malat1 gene;cancer gene;broadmatch
microrna synthesis;rna synthesis;broadmatch
ependymal differentiation;glial differentiation;broadmatch
islands of neuropil-like matrix present;morphologic finding;broadmatch
amoebiasis pathway;infectious disease pathway;broadmatch
bacterial invasion of epithelial cell pathway;infectious disease pathway;broadmatch
nongenotropic androgen signaling pathway;androgen-mediated signaling pathway;broadmatch
syndecan-mediated signaling pathway;signaling pathway;broadmatch
retinoic acid receptor family-mediated signaling pathway;signaling pathway;broadmatch
telomerase regulation pathway;regulatory pathway;broadmatch
regulation of retinoblastoma protein pathway;cell cycle regulation pathway;broadmatch
regulation of nuclear smad2/3 signaling pathway;regulation of cytoplasmic and nuclear smad2/3 signaling pathway;broadmatch
regulation of cytoplasmic and nuclear smad2/3 signaling pathway;regulatory pathway;broadmatch
reelin signaling pathway pid;signaling pathway;broadmatch
ras signaling in the cd4+ tcr pathway;t-cell receptor signaling pathway in naive cd4+ t cells;broadmatch
presenilin action in notch and wnt signaling pathways;wnt signaling pathway pid;broadmatch
immune hemolytic anemia;acquired hemolytic anemia;broadmatch
plasma membrane estrogen receptor signaling pathway;signaling pathway;broadmatch
pdgfr-beta signaling pathway;signaling pathway;broadmatch
pdgfr-alpha signaling pathway;signaling pathway;broadmatch
nerve growth factor receptor signaling pathway;apoptosis regulation pathway;broadmatch
p38 mapk signaling pathway pid;signaling pathway;broadmatch
osteopontin-mediated signaling pathway;integrin angiogenesis pathway;broadmatch
sphingosine 1-phosphate signaling pathway;signaling pathway;broadmatch
sphingosine 1-phosphate receptor 2 signaling pathway;sphingosine 1-phosphate signaling pathway;broadmatch
sphingosine 1-phosphate receptor 3 signaling pathway;sphingosine 1-phosphate signaling pathway;broadmatch
hepatocyte growth factor receptor signaling pathway pid;signaling pathway;broadmatch
transport pathway;regulatory pathway;broadmatch
bowel obstruction;digestive system obstruction;broadmatch
vegfr3 lymphatic signaling pathway;signaling pathway;broadmatch
vegfr1 signaling pathway;vegfr1 and vegfr2 signaling;broadmatch
ntrk1/mapk signaling pathway;neurotrophic factor-mediated ntrk1 signaling pathway;broadmatch
ntrk1/pi3k/plc-gamma signaling pathway;neurotrophic factor-mediated ntrk1 signaling pathway;broadmatch
thromboxane a2 receptor family signaling pathway;signaling pathway;broadmatch
syndecan-3-mediated signaling pathway;syndecan-mediated signaling pathway;broadmatch
syndecan-2-mediated signaling pathway;syndecan-mediated signaling pathway;broadmatch
adherens junction stabilization pathway;e-cadherin signaling pathway;broadmatch
p38-alpha and p38-beta signaling pathway;p38 mapk signaling pathway pid;broadmatch
proto-oncogene tyrosine-protein kinase receptor ret signaling pathway;signaling pathway;broadmatch
vegfr1 and vegfr2 signaling;signaling pathway;broadmatch
mast/stem cell growth factor receptor signaling pathway;signaling pathway;broadmatch
ptpn1 signaling pathway;signaling pathway;broadmatch
chagas disease pathway;infectious disease pathway;broadmatch
vascular smooth muscle contraction pathway;homeostasis regulation pathway;broadmatch
tbxt gene;transcription factor gene;broadmatch
cancer stage (antiquated);epithelial neoplasm (antiquated);broadmatch
stage iii extragonadal mixed germ cell tumor;germ cell tumor (antiquated);broadmatch
stage i extragonadal mixed germ cell tumor;germ cell tumor (antiquated);broadmatch
stage iv hodgkin's disease lymphocyte predominance type;lymphocyte predominant type hodgkin's disease;broadmatch
stage iii hodgkin's disease lymphocyte predominance type;lymphocyte predominant type hodgkin's disease;broadmatch
refractory hodgkin's disease lymphocyte predominance type;lymphocyte predominant type hodgkin's disease;broadmatch
recurrent hodgkin's disease lymphocyte predominance type;lymphocyte predominant type hodgkin's disease;broadmatch
gpc3 gene;ligand binding protein gene;broadmatch
mucin-rich endometrial endometrioid adenocarcinoma;epithelial neoplasm (antiquated);broadmatch
stage ii extragonadal mixed germ cell tumor;germ cell tumor (antiquated);broadmatch
primary malignant hemangiopericytoma;malignant hemangiopericytoma;broadmatch
metastatic malignant hemangiopericytoma;malignant hemangiopericytoma;broadmatch
steatorrhea;digestive system signs and symptoms;broadmatch
stage iv gastric cancer with metastasis;cancer stage (antiquated);broadmatch
pure erythroid leukemia in remission;acute erythroid leukemia in remission;broadmatch
chronic myelomonocytic leukemia in remission;myeloid leukemia in remission;broadmatch
chronic myelomonocytic leukemia in remission;chronic leukemia in remission;broadmatch
stage i extragonadal non-seminomatous germ cell tumor;germ cell tumor (antiquated);broadmatch
stage ii extragonadal non-seminomatous germ cell tumor;germ cell tumor (antiquated);broadmatch
stage iii extragonadal non-seminomatous germ cell tumor;germ cell tumor (antiquated);broadmatch
stage iv extragonadal non-seminomatous germ cell tumor;germ cell tumor (antiquated);broadmatch
malignant lymphoma centroblastic, follicular;lymphoma/leukemia by kiel classification (antiquated);broadmatch
alveolar ridge;head and neck part;broadmatch
gna11 gene;heterotrimeric g protein subunit gene;broadmatch
gna11 gene mutation;gene variant;broadmatch
gnaq gene mutation;gene variant;broadmatch
cutaneous precancerous condition;precancerous condition by site;broadmatch
cutaneous precancerous condition;skin disorder;broadmatch
stage iv gastric cancer without metastasis;cancer stage (antiquated);broadmatch
eating disorder;psychiatric disorder;broadmatch
eating disorder;nutritional disorder;broadmatch
developmental disorder;pediatric disorder;broadmatch
pediatric disorder;disease or disorder;broadmatch
stage iv extragonadal seminoma;germ cell tumor (antiquated);broadmatch
stage iii extragonadal seminoma;germ cell tumor (antiquated);broadmatch
stage ii extragonadal seminoma;germ cell tumor (antiquated);broadmatch
myeloid sarcoma in remission;acute myeloid leukemia in remission;broadmatch
retro-orbital neoplasm;neoplasm by obsolete classification;broadmatch
malignant lymphoma follicular, large cleaved cell type;malignant lymphoma, large cell, cleaved;broadmatch
stage ii contiguous adult diffuse large cell lymphoma;stage ii adult diffuse large cell lymphoma;broadmatch
idh2 gene;idh gene family;broadmatch
palb2 gene;fa complementation group gene;broadmatch
nelson syndrome;rare non-neoplastic disorder;broadmatch
nelson syndrome;syndrome;broadmatch
muir-torre syndrome;rare neoplastic syndrome;broadmatch
marek disease;experimental organism non-neoplastic disorder;broadmatch
stage ii non-contiguous adult diffuse large cell lymphoma;stage ii adult diffuse large cell lymphoma;broadmatch
stage ii contiguous adult diffuse mixed cell lymphoma;stage ii adult diffuse mixed cell lymphoma;broadmatch
vulvar angiokeratoma;angiokeratoma;broadmatch
stage ii contiguous adult diffuse small cleaved cell lymphoma;stage ii adult diffuse small cleaved cell lymphoma;broadmatch
denys-drash syndrome;rare neoplastic syndrome;broadmatch
aniridia;rare non-neoplastic disorder;broadmatch
acromegaly;rare non-neoplastic disorder;broadmatch
acromegaly;syndrome;broadmatch
primary malignant neoplasm;malignant neoplasm;broadmatch
primary malignant neoplasm;primary neoplasm;broadmatch
neurofibromatosis 1 and 2 (nf1 and nf2);nervous system neoplasm (antiquated);broadmatch
isocitrate dehydrogenase [nadp], mitochondrial;oxidoreductase;broadmatch
chronic lymphoblastic lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
proteus syndrome;rare non-neoplastic disorder;broadmatch
lymphocyte predominant type hodgkin's disease;hodgkin's lymphoma (antiquated);broadmatch
acute myelomonocytic leukemia in remission;acute myeloid leukemia in remission;broadmatch
fanconi anemia complementation group protein;protein family;broadmatch
stage iic soft tissue sarcoma;cancer stage (antiquated);broadmatch
stage ivb pancreatic cancer;cancer stage (antiquated);broadmatch
stage iic adult soft tissue sarcoma;stage iic soft tissue sarcoma;broadmatch
erythroleukemia in remission;acute erythroid leukemia in remission;broadmatch
respiratory system signs and symptoms;respiratory system finding;broadmatch
respiratory system signs and symptoms;sign or symptom;broadmatch
47,xyy syndrome;rare non-neoplastic disorder;broadmatch
47,xyy syndrome;syndrome;broadmatch
progressive neoplastic disease;progressive disease;broadmatch
primary neoplasm;neoplasm by special category;broadmatch
positive axillary lymph node;positive lymph node;broadmatch
sinus histiocytosis;histiocytosis;broadmatch
malignant lymphoma follicular, large noncleaved cell type;malignant lymphoma, non-cleaved cell type;broadmatch
myd88 gene;adaptor signaling protein gene;broadmatch
notch signaling pathway;signaling pathway;broadmatch
endocytosis pathway;metabolic pathway;broadmatch
gonadotropin-releasing hormone signaling pathway;signaling pathway;broadmatch
glioblastoma multiforme pathway;cancer pathway;broadmatch
gap junction assembly pathway;regulatory pathway;broadmatch
melanoma pathway;cancer pathway;broadmatch
fc epsilon receptor i signaling pathway kegg;immune response regulation pathway;broadmatch
tight junction assembly pathway;regulatory pathway;broadmatch
pathogenic escherichia coli infection pathway;infectious disease pathway;broadmatch
mismatch repair pathway;dna repair pathway;broadmatch
bladder cancer pathway;cancer pathway;broadmatch
cytokine-cytokine receptor signaling pathway;signaling pathway;broadmatch
melanogenesis pathway;metabolic pathway;broadmatch
colorectal cancer pathway;cancer pathway;broadmatch
chronic myeloid leukemia pathway;cancer pathway;broadmatch
long-term depression pathway;homeostasis regulation pathway;broadmatch
adherens junction assembly pathway;signaling pathway;broadmatch
calcium-mediated signaling pathway;signaling pathway;broadmatch
long-term potentiation pathway;homeostasis regulation pathway;broadmatch
adipocytokine signaling pathway;signaling pathway;broadmatch
chemokine signaling pathway;immune response regulation pathway;broadmatch
insulin/insulin receptor signaling pathway;signaling pathway;broadmatch
jak-stat signaling pathway;signaling pathway;broadmatch
prostate cancer pathway;cancer pathway;broadmatch
hedgehog signaling pathway;signaling pathway;broadmatch
erbb family signaling pathway;signaling pathway;broadmatch
basal cell carcinoma pathway;cancer pathway;broadmatch
toll-like receptor signaling pathway;signaling pathway;broadmatch
aldosterone-regulated sodium reabsorption pathway;homeostasis regulation pathway;broadmatch
small cell lung cancer pathway;cancer pathway;broadmatch
renal cell carcinoma pathway;cancer pathway;broadmatch
fc gamma receptor-mediated phagocytosis pathway;transport pathway;broadmatch
fc gamma receptor-mediated phagocytosis pathway;immune response regulation pathway;broadmatch
papillary thyroid carcinoma pathway;cancer pathway;broadmatch
progesterone-mediated oocyte maturation pathway;cell differentiation or development pathway;broadmatch
leishmaniasis infection pathway;infectious disease pathway;broadmatch
type ii diabetes mellitus pathway;disease pathway;broadmatch
hematopoietic cell lineage pathway;immune response regulation pathway;broadmatch
base excision repair pathway;dna repair pathway;broadmatch
myeloid differentiation primary response protein myd88;adaptor signaling protein;broadmatch
low grade adult non-hodgkin's lymphoma;adult non-hodgkin's lymphoma grade;broadmatch
childhood acute myeloid leukemia in remission;childhood acute leukemia in remission;broadmatch
childhood acute myeloid leukemia in remission;acute myeloid leukemia in remission;broadmatch
high grade adult non-hodgkin's lymphoma;adult non-hodgkin's lymphoma grade;broadmatch
high grade adult non-hodgkin's lymphoma;high grade lymphoma;broadmatch
intermediate grade adult non-hodgkin's lymphoma;adult non-hodgkin's lymphoma grade;broadmatch
intermediate grade adult non-hodgkin's lymphoma;intermediate grade lymphoma;broadmatch
low grade adult non-hodgkin's lymphoma;low grade lymphoma;broadmatch
b cell receptor signaling pathway;immune response regulation pathway;broadmatch
childhood diffuse large cell lymphoma;childhood large cell lymphoma;broadmatch
ajcc v7 stage;disease stage qualifier;broadmatch
ajcc v6 stage;disease stage qualifier;broadmatch
fnclcc sarcoma grade 3;sarcoma by fnclcc grade;broadmatch
fnclcc sarcoma grade 2;sarcoma by fnclcc grade;broadmatch
fnclcc sarcoma grade 1;sarcoma by fnclcc grade;broadmatch
sarcoma by fnclcc grade;sarcoma;broadmatch
childhood acute myeloid leukemia in remission;childhood myeloid leukemia in remission;broadmatch
non-t non-b calla positive childhood acute lymphoblastic leukemia;childhood non-t non-b acute lymphoblastic leukemia;broadmatch
non-t non-b calla positive childhood acute lymphoblastic leukemia;calla positive lymphoblastic leukemia;broadmatch
axon guidance pathway;cell differentiation or development pathway;broadmatch
arrhythmogenic right ventricular cardiomyopathy pathway;disease pathway;broadmatch
spliceosome pathway;mrna biosynthesis pathway;broadmatch
t cell receptor signaling pathway kegg;immune response regulation pathway;broadmatch
pancreatic cancer pathway;cancer pathway;broadmatch
non-small cell lung cancer pathway;cancer pathway;broadmatch
neurotrophin signaling pathway;cell differentiation or development pathway;broadmatch
natural killer cell-mediated cytotoxicity pathway;immune response regulation pathway;broadmatch
non-t non-b calla positive adult acute lymphoblastic leukemia;calla positive lymphoblastic leukemia;broadmatch
non-t non-b calla positive adult acute lymphoblastic leukemia;adult non-t non-b acute lymphoblastic leukemia;broadmatch
leukocyte transendothelial migration pathway;immune response regulation pathway;broadmatch
cancer pathway;disease pathway;broadmatch
actin cytoskeleton regulation pathway;cell motility pathway;broadmatch
dorso-ventral axis formation pathway;cell differentiation or development pathway;broadmatch
mtor signaling pathway kegg;signaling pathway;broadmatch
stage iib bladder cancer;cancer stage (antiquated);broadmatch
stage iva bladder cancer;cancer stage (antiquated);broadmatch
stage ivb bladder cancer;cancer stage (antiquated);broadmatch
tumor mass;mass;broadmatch
braf nm_004333.4:c.1799_1800deltginsaa;braf exon 15 mutation;broadmatch
braf np_004324.2:p.v600e;braf np_004324.2:p.v600x;broadmatch
braf protein variant;gene product sequence variation;broadmatch
akt1 gene mutation;gene variant;broadmatch
akt1 gene mutation;akt family gene mutation;broadmatch
akt1 protein variant;gene product sequence variation;broadmatch
sf3b1 gene;regulatory gene;broadmatch
med12 gene;mediator complex component gene;broadmatch
tpm4 gene;cytoskeletal gene;broadmatch
ighg1 gene;immunoprotein gene;broadmatch
has2 gene;glycosyltransferase gene;broadmatch
breast solid neuroendocrine carcinoma;epithelial neoplasm (antiquated);broadmatch
gene product sequence variation;molecular sequence variation;broadmatch
gene variant;molecular genetic variation;broadmatch
molecular sequence variation;molecular abnormality;broadmatch
cic gene;transcription regulation gene;broadmatch
braf nm_004333.4:c.1799t>a;braf exon 15 mutation;broadmatch
egfr protein variant;gene product sequence variation;broadmatch
egfr gene mutation;receptor tyrosine kinase gene mutation;broadmatch
egfr gene mutation;gene variant;broadmatch
pml/rara fusion gene;fusion gene;broadmatch
neonatal disorder;pediatric disorder;broadmatch
connective and soft tissue injury;injury;broadmatch
connective and soft tissue injury;connective and soft tissue finding;broadmatch
congenital urinary system abnormality;congenital genitourinary abnormality;broadmatch
congenital urinary system abnormality;non-neoplastic urinary system disorder;broadmatch
zymbal's gland carcinoma;experimental organism neoplasm;broadmatch
zymbal's gland adenoma;experimental organism neoplasm;broadmatch
undetermined sertoli cell tumor;experimental organism neoplasm;broadmatch
experimental organism pituitary gland adenoma;experimental organism neoplasm;broadmatch
experimental organism benign melanocytoma;experimental organism neoplasm;broadmatch
benign histiocytoma;experimental organism neoplasm;broadmatch
pik3ca protein variant;gene product sequence variation;broadmatch
nras protein variant;gene product sequence variation;broadmatch
kras protein variant;gene product sequence variation;broadmatch
patz1 gene;transcription regulation gene;broadmatch
tpm3 gene;cytoskeletal gene;broadmatch
dek/nup214 fusion gene;fusion gene;broadmatch
crlf2 gene;receptor gene;broadmatch
kdm5a gene;oxidoreductase gene;broadmatch
mnx1 gene;homeobox gene;broadmatch
gata2 gene;transcription factor gene;broadmatch
ell gene;transcription regulation gene;broadmatch
fev gene;ets family gene;broadmatch
dux4 gene;homeobox gene;broadmatch
fip1l1 gene;regulatory gene;broadmatch
cd79b gene;immunoprotein gene;broadmatch
tfg gene;signaling pathway gene;broadmatch
cltc gene;structural protein gene;broadmatch
atic gene;transferase gene;broadmatch
atic gene;hydrolase gene;broadmatch
rnf213 gene;regulatory gene;broadmatch
hepatosplenomegaly;sign or symptom;broadmatch
intellectual property;conceptual entity;broadmatch
asxl1 gene;transcription regulation gene;broadmatch
lpp gene;regulatory gene;broadmatch
msn gene;cytoskeletal gene;broadmatch
myh9 gene;cytoskeletal gene;broadmatch
mlf1 gene;transcription factor gene;broadmatch
tcf12 gene;transcription factor gene;broadmatch
hnf1a gene;transcription factor gene;broadmatch
ssx4 gene;regulatory gene;broadmatch
ssx2 gene;regulatory gene;broadmatch
ssx1 gene;regulatory gene;broadmatch
ss18 gene;transcription regulation gene;broadmatch
sh3gl1 gene;regulatory gene;broadmatch
sdhd gene;regulatory gene;broadmatch
sdhc gene;regulatory gene;broadmatch
sdhb gene;oxidoreductase gene;broadmatch
sdhaf2 gene;regulatory gene;broadmatch
prkar1a gene;regulatory gene;broadmatch
phox2b gene;transcription factor gene;broadmatch
notch2 gene;receptor gene;broadmatch
map2k4 gene;kinase family gene;broadmatch
col1a1/pdgfb fusion gene;fusion gene;broadmatch
ewsr1/ddit3 fusion gene;fusion gene;broadmatch
childhood myeloid leukemia in remission;myeloid leukemia in remission;broadmatch
hmga2/lpp long fusion gene;fusion gene;broadmatch
tfe3/aspscr1 fusion gene;fusion gene;broadmatch
stat5b/rara fusion gene;fusion gene;broadmatch
tfg/nr4a3 fusion gene;fusion gene;broadmatch
mllt10/clp1 fusion gene;fusion gene;broadmatch
mll/sh3gl1 fusion gene;fusion gene;broadmatch
taf15/nr4a3 fusion gene;fusion gene;broadmatch
nup98/nsd1 fusion gene;fusion gene;broadmatch
hmga2/lpp short fusion gene;fusion gene;broadmatch
tfe3/prcc fusion gene;fusion gene;broadmatch
etv6/jak2 fusion gene;fusion gene;broadmatch
etv6/ntrk3 fusion gene;fusion gene;broadmatch
etv6/pdgfrb fusion gene;fusion gene;broadmatch
tcf12/nr4a3 fusion gene;fusion gene;broadmatch
pcm1/ret fusion gene;fusion gene;broadmatch
ss18/ssx4 fusion gene;fusion gene;broadmatch
ss18/ssx2 fusion gene;fusion gene;broadmatch
sfpq/tfe3 fusion gene;fusion gene;broadmatch
rbm15/mkl1 fusion gene;fusion gene;broadmatch
aspscr1/tfe3 fusion gene;fusion gene;broadmatch
jazf1/suz12 fusion gene;fusion gene;broadmatch
rnf213/alk fusion gene;fusion gene;broadmatch
ctnnb1/plag1 fusion gene;fusion gene;broadmatch
golga5/ret fusion gene;fusion gene;broadmatch
trim33/ret fusion gene;fusion gene;broadmatch
trim24/ret fusion gene;fusion gene;broadmatch
ncoa4/ret fusion gene;fusion gene;broadmatch
prkar1a/ret fusion gene;fusion gene;broadmatch
brd4/nutm1 fusion gene;fusion gene;broadmatch
malat1/tfeb fusion gene;fusion gene;broadmatch
fip1l1/pdgfra fusion gene;fusion gene;broadmatch
crtc1/maml2 fusion gene;fusion gene;broadmatch
eml4/alk fusion gene;fusion gene;broadmatch
erc1/ret fusion gene;fusion gene;broadmatch
nsd1/nup98 fusion gene;fusion gene;broadmatch
pax3/foxo1 fusion gene;pax/foxo1 fusion gene;broadmatch
ss18/ssx1 fusion gene;fusion gene;broadmatch
contralateral breast carcinoma;bilateral breast carcinoma;broadmatch
ewsr1/fli1 fusion gene;fusion gene;broadmatch
ewsr1/etv1 fusion gene;fusion gene;broadmatch
runx1/runx1t1 fusion gene;fusion gene;broadmatch
tcf3/pbx1 fusion gene;fusion gene;broadmatch
fus/creb3l2 fusion gene;fusion gene;broadmatch
fus/erg fusion gene;fusion gene;broadmatch
fus/ddit3 fusion gene;fusion gene;broadmatch
fus/atf1 fusion gene;fusion gene;broadmatch
ewsr1/etv4 fusion gene;fusion gene;broadmatch
ewsr1/nr4a3 fusion gene;fusion gene;broadmatch
tpm3/ntrk1 fusion gene;fusion gene;broadmatch
ewsr1/creb1 fusion gene;fusion gene;broadmatch
ewsr1/patz1 fusion gene;fusion gene;broadmatch
ewsr1/fev fusion gene;fusion gene;broadmatch
ewsr1/atf1 fusion gene;fusion gene;broadmatch
ewsr1/wt1 fusion gene;fusion gene;broadmatch
ewsr1/erg fusion gene;fusion gene;broadmatch
eye finding;eye and ear finding;broadmatch
runx1/mecom fusion gene;fusion gene;broadmatch
bcr/abl1 fusion gene p190;bcr/abl1 fusion gene;broadmatch
bcr/abl1 fusion gene p210;bcr/abl1 fusion gene;broadmatch
bcr/abl1 fusion gene p230;bcr/abl1 fusion gene;broadmatch
autoimmune nervous system disorder;autoimmune disease;broadmatch
autoimmune nervous system disorder;non-neoplastic nervous system disorder;broadmatch
prcc/tfe3 fusion gene;fusion gene;broadmatch
zbtb16/rara fusion gene;fusion gene;broadmatch
pax8/pparg fusion gene;fusion gene;broadmatch
pax7/foxo1 fusion gene;pax/foxo1 fusion gene;broadmatch
npm1/alk fusion gene;fusion gene;broadmatch
numa1/rara fusion gene;fusion gene;broadmatch
mll/mllt4 fusion gene;fusion gene;broadmatch
mll/mllt10 fusion gene;fusion gene;broadmatch
mll/mllt3 fusion gene;fusion gene;broadmatch
mll/mllt1 fusion gene;fusion gene;broadmatch
mll/aff1 fusion gene;fusion gene;broadmatch
bcr/pdgfra fusion gene;fusion gene;broadmatch
bcr/fgfr1 fusion gene;fusion gene;broadmatch
pbx1 gene;transcription factor gene;broadmatch
asxl1 gene mutation;gene variant;broadmatch
etv6 gene mutation;gene variant;broadmatch
tall papillae present;papillary pattern;broadmatch
gastric dysplasia;digestive system dysplasia;broadmatch
poorly cohesive malignant cellular infiltrate;malignant cellular infiltrate;broadmatch
second primary malignant neoplasm;primary malignant neoplasm;broadmatch
vaginal bleeding;female reproductive system finding;broadmatch
acinar cystic transformation of the pancreas;non-neoplastic pancreatic disorder;broadmatch
hemoglobin trait;hemoglobinopathy;broadmatch
thin-branching papillae present;papillary pattern;broadmatch
cellular changes resembling foveolar epithelium cells;abnormal cells present;broadmatch
stage iiic2;stage iiic;broadmatch
creb3l2 gene;creb family gene;broadmatch
creb3l1 gene;creb family gene;broadmatch
maml2 gene;transcription coactivator gene;broadmatch
crtc1 gene;transcription coactivator gene;broadmatch
internal auditory canal;ear part;broadmatch
digestive system dysplasia;dysplasia;broadmatch
fh gene;lyase gene;broadmatch
gastric non-neoplastic polyp;gastric polyp;broadmatch
gastric non-neoplastic polyp;non-neoplastic stomach disorder;broadmatch
gastric-type epithelial differentiation;glandular differentiation;broadmatch
foveolar-type epithelium present;glandular differentiation;broadmatch
figo stage ia;figo stage i;broadmatch
figo stage i;figo stage;broadmatch
stage iia cervix;stage ii cervix;broadmatch
stage iia cervix;stage iia;broadmatch
stage ii cervix;stage ii;broadmatch
stage ib cervix;stage ib;broadmatch
cystitis cystica and glandularis;non-infectious cystitis;broadmatch
cystitis cystica and glandularis;chronic cystitis;broadmatch
colorectal neuroendocrine tumor;colorectal neuroendocrine neoplasm;broadmatch
colorectal neuroendocrine tumor;intestinal neuroendocrine tumor;broadmatch
nr4a3 gene;nuclear receptor gene;broadmatch
taf15 gene;tbp-associated factor gene;broadmatch
di guglielmo syndrome;neoplastic syndrome;broadmatch
pancreatobiliary-type malignant cells present;abnormal cells present;broadmatch
kcnj5 gene;ion channel protein gene;broadmatch
prkd2 gene;serine/threonine protein kinase gene;broadmatch
stage iiic1;stage iiic;broadmatch
ezh2 gene mutation;gene variant;broadmatch
myxoid chondrosarcoma nci grade 2;chondrosarcoma nci grade 2;broadmatch
inflammatory malignant fibrous histiocytoma nci grade 3;connective and soft tissue neoplasm (antiquated);broadmatch
inflammatory malignant fibrous histiocytoma nci grade 2;connective and soft tissue neoplasm (antiquated);broadmatch
storiform-pleomorphic malignant fibrous histiocytoma nci grade 3;connective and soft tissue neoplasm (antiquated);broadmatch
storiform-pleomorphic malignant fibrous histiocytoma nci grade 2;connective and soft tissue neoplasm (antiquated);broadmatch
fibrosarcoma nci grade 2;connective and soft tissue neoplasm (antiquated);broadmatch
round cell liposarcoma nci grade 3;round cell liposarcoma;broadmatch
round cell liposarcoma nci grade 2;round cell liposarcoma;broadmatch
myxoid chondrosarcoma nci grade 1;connective and soft tissue neoplasm (antiquated);broadmatch
stage iia2;stage iia cervix;broadmatch
chondrosarcoma nci grade 1;connective and soft tissue neoplasm (antiquated);broadmatch
chondrosarcoma nci grade 2;connective and soft tissue neoplasm (antiquated);broadmatch
chondrosarcoma nci grade 3;connective and soft tissue neoplasm (antiquated);broadmatch
malignant hemangiopericytoma nci grade 3;hemangiopericytic neoplasm;broadmatch
malignant hemangiopericytoma nci grade 2;hemangiopericytic neoplasm;broadmatch
well differentiated malignant hemangiopericytoma;malignant hemangiopericytoma;broadmatch
sarcoma by nci grade;sarcoma;broadmatch
sarcoma by ajcc grade;sarcoma;broadmatch
conventional malignant hemangiopericytoma;malignant hemangiopericytoma;broadmatch
receptor status;laboratory test result;broadmatch
malignant pleural effusion;pleural effusion;broadmatch
stage iia1;stage iia cervix;broadmatch
chromosomal deletion;chromosomal rearrangement;broadmatch
familial isolated hyperparathyroidism;hereditary neoplastic syndrome;broadmatch
inherited bone marrow failure syndrome;hereditary neoplastic syndrome;broadmatch
inherited bone marrow failure syndrome;bone marrow failure syndrome;broadmatch
atypia;morphologic finding;broadmatch
multicentric lesion;lesion;broadmatch
tfeb gene;transcription factor gene;broadmatch
grade 2/3;disease grade qualifier;broadmatch
bcr/abl1 fusion gene;fusion gene;broadmatch
neoplastic eosinophilic spindle cell;neoplastic eosinophilic cell oncocyte;broadmatch
neoplastic eosinophilic spindle cell;neoplastic epithelial spindle cell;broadmatch
deposit;morphologic finding;broadmatch
chronic kidney disease, stage 5;chronic kidney disease;broadmatch
granuloma by site;granuloma;broadmatch
figo stage ia1;figo stage ia;broadmatch
figo stage ia2;figo stage ia;broadmatch
figo stage ib;figo stage i;broadmatch
non-neoplastic hepatobiliary disorder;hepatobiliary disorder;broadmatch
metabolic bone disorder;non-neoplastic bone disorder;broadmatch
basal cells with pale cytoplasm present;abnormal cells present;broadmatch
gallbladder mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia;epithelial neoplasm (antiquated);broadmatch
gallbladder intracholecystic papillary (tubular) neoplasm with intermediate grade intraepithelial neoplasia;epithelial neoplasm (antiquated);broadmatch
pdgfra gene amplification;oncogene deregulation;broadmatch
pdgfra gene amplification;pdgfr gene amplification;broadmatch
akt family gene mutation;gene abnormality;broadmatch
non-neoplastic hepatobiliary disorder;non-neoplastic digestive system disorder;broadmatch
figo stage ib1;figo stage ib;broadmatch
bile duct mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia;epithelial neoplasm (antiquated);broadmatch
thrombocyte differentiation;myeloid cell differentiation;broadmatch
erythrocyte differentiation;myeloid cell differentiation;broadmatch
myeloid cell differentiation;hematopoietic process;broadmatch
megakaryopoiesis;myelopoiesis;broadmatch
bile duct intraductal papillary neoplasm with intermediate grade intraepithelial neoplasia;epithelial neoplasm (antiquated);broadmatch
intrahepatic large bile duct;intrahepatic bile duct;broadmatch
metabolic bone disorder;metabolic disorder;broadmatch
hereditary connective tissue disorder;connective tissue disorder;broadmatch
benign lymphoid hyperplasia;lymphoid hyperplasia;broadmatch
carbohydrate metabolism disorder;metabolic disorder;broadmatch
mrtfa gene;transcription regulation gene;broadmatch
rbm15 gene;ligand binding protein gene;broadmatch
low vision;non-neoplastic vision disorder;broadmatch
congenital nervous system disorder;congenital systemic disorder;broadmatch
congenital nervous system disorder;non-neoplastic nervous system disorder;broadmatch
non-neoplastic brain disorder;brain disorder;broadmatch
non-neoplastic brain disorder;non-neoplastic central nervous system disorder;broadmatch
congenital systemic disorder;congenital abnormality;broadmatch
unmutated immunoglobulin heavy chain variable region gene;germline mutation;broadmatch
complex karyotype;abnormal karyotype;broadmatch
spinal cord disorder;central nervous system disorder;broadmatch
blindness;non-neoplastic vision disorder;broadmatch
nephrogenic metaplasia;epithelial metaplasia;broadmatch
calcium oxalate crystal deposition;crystal formation;broadmatch
lipodystrophy;metabolic disorder;broadmatch
hnf1a gene mutation;gene variant;broadmatch
bile duct disorder;biliary system disorder;broadmatch
bmpr1a gene mutation;gene variant;broadmatch
pik3ca gene mutation;gene variant;broadmatch
intracytoplasmic lipofuscin present;cytoplasmic alteration;broadmatch
figo stage ivb;figo stage iv;broadmatch
figo stage iva;figo stage iv;broadmatch
figo stage iv;figo stage;broadmatch
figo stage iiic2;figo stage iiic;broadmatch
figo stage iiic1;figo stage iiic;broadmatch
figo stage iiic;figo stage iii;broadmatch
figo stage iiib;figo stage iii;broadmatch
figo stage iiia;figo stage iii;broadmatch
figo stage iii;figo stage;broadmatch
figo stage iib;figo stage ii;broadmatch
figo stage iia;figo stage ii;broadmatch
figo stage ii;figo stage;broadmatch
figo stage ic;figo stage i;broadmatch
figo stage ib2;figo stage ib;broadmatch
perinuclear halo present;morphologic finding;broadmatch
mutyh gene mutation;gene variant;broadmatch
small cell component present;abnormal tissue present;broadmatch
mutyh gene mutation;dna repair gene mutation;broadmatch
colorectal cowden-associated polyp;colorectal hamartoma;broadmatch
gastrointestinal hamartoma;hamartomatous polyp;broadmatch
gastrointestinal hamartoma;gastrointestinal polyp;broadmatch
colorectal hamartoma;gastrointestinal hamartoma;broadmatch
colorectal hamartoma;colorectal polyp;broadmatch
colorectal hamartoma;non-neoplastic intestinal disorder;broadmatch
colorectal sporadic serrated polyp;colorectal polyp;broadmatch
villous projections of the neoplastic epithelium present;abnormal tissue present;broadmatch
appendix neuroma;neuroma;broadmatch
appendix neuroma;non-neoplastic appendix disorder;broadmatch
high grade appendix mucinous adenocarcinoma;epithelial neoplasm (antiquated);broadmatch
generalized dysplasia;dysplasia;broadmatch
brain disorder;central nervous system disorder;broadmatch
epithelial metaplasia;metaplasia;broadmatch
mllt10 gene;transcription factor gene;broadmatch
mental retardation;developmental disorder;broadmatch
benign sertoli cell tumor of the rat ovary;rat female genital system neoplasms;broadmatch
transitional cell papilloma of the rat urinary bladder;rat urinary system neoplasms;broadmatch
malignant tumor, small cell type;epithelial neoplasm (antiquated);broadmatch
malignant neoplasm, uncertain whether primary or metastatic;malignant neoplasm;broadmatch
fibroblastic liposarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
asynchronous multifocal osteosarcoma;multifocal osteosarcoma;broadmatch
teratoma of the rat ovary;rat female genital system neoplasms;broadmatch
squamous cell carcinoma of the rat tongue;rat digestive system neoplasms;broadmatch
squamous cell papilloma of the rat tongue;rat digestive system neoplasms;broadmatch
transitional cell papilloma of the rat urethra;rat urinary system neoplasms;broadmatch
squamous cell papilloma of the rat urinary bladder;rat urinary system neoplasms;broadmatch
transitional cell papilloma of the rat ureter;rat urinary system neoplasms;broadmatch
transitional cell papilloma of the rat renal pelvis;rat urinary system neoplasms;broadmatch
transitional cell carcinoma of the rat urinary bladder;rat urinary system neoplasms;broadmatch
transitional cell carcinoma of the rat urethra;rat urinary system neoplasms;broadmatch
transitional cell carcinoma of the rat ureter;rat urinary system neoplasms;broadmatch
transitional cell carcinoma of the rat renal pelvis;rat urinary system neoplasms;broadmatch
squamous cell papilloma of the rat skin;rat integumentary system neoplasms;broadmatch
clear cell malignant neoplasm;clear cell neoplasm;broadmatch
neoplasm, uncertain whether benign or malignant;neoplasm by special category;broadmatch
glassy cell carcinoma;epithelial neoplasm (antiquated);broadmatch
giant cell and spindle cell carcinoma;epithelial neoplasm (antiquated);broadmatch
extraskeletal osteoma;connective and soft tissue neoplasm (antiquated);broadmatch
multiple mucosal neuromas;neuroma;broadmatch
fibrous synovial sarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
minimal invasion present;morphologic finding;broadmatch
lung adenocarcinoma with mixed bronchioloalveolar and invasive components;lung adenocarcinoma, mixed subtype;broadmatch
carcinoid tumor of uncertain malignant potential;epithelial neoplasm (antiquated);broadmatch
carcinoma simplex;epithelial neoplasm (antiquated);broadmatch
malignant enteroglucagonoma;enteroglucagonoma;broadmatch
islet cell adenoma;epithelial neoplasm (antiquated);broadmatch
squamous cell carcinoma, clear cell type;squamous cell carcinoma;broadmatch
squamous cell carcinoma with horn formation;keratinizing squamous cell carcinoma;broadmatch
squamous cell carcinoma in situ with questionable stromal invasion;squamous cell carcinoma;broadmatch
keratin present;morphologic finding;broadmatch
tumorlet;respiratory system finding;broadmatch
polygonal cell carcinoma;epithelial neoplasm (antiquated);broadmatch
squamous cell carcinoma of the rat skin;rat integumentary system neoplasms;broadmatch
squamous cell papilloma of the rat urethra;rat urinary system neoplasms;broadmatch
mitogen;physiology-regulatory factor;broadmatch
olfactory neuroblastoma of the rat nasal cavity;rat respiratory system neoplasms;broadmatch
sebaceous cell adenoma of the rat skin;rat integumentary system neoplasms;broadmatch
rat myxolipomatous lipoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
rat angiolipomatous lipoma;rat soft tissue and musculoskeletal system neoplasms;broadmatch
papilloma of the rat trachea;rat respiratory system neoplasms;broadmatch
papilloma of the rat larynx;rat respiratory system neoplasms;broadmatch
papilloma of the rat bronchus;rat respiratory system neoplasms;broadmatch
papilloma of the rat bronchiole;rat respiratory system neoplasms;broadmatch
non-keratinizing epithelioma of the rat lung;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat trachea;rat respiratory system neoplasms;broadmatch
melanotic malignant melanoma of the rat skin;rat integumentary system neoplasms;broadmatch
malignant melanoma of the rat skin;rat integumentary system neoplasms;broadmatch
malignant neuroendocrine cell tumor of the rat trachea;rat respiratory system neoplasms;broadmatch
malignant mesothelioma of the rat pleura;rat respiratory system neoplasms;broadmatch
malignant mesothelioma of the rat peritoneum;rat respiratory system neoplasms;broadmatch
malignant mesothelioma of the rat pericardium;rat respiratory system neoplasms;broadmatch
malignant mesenchymal tumor of the rat kidney;rat urinary system neoplasms;broadmatch
sebaceous cell carcinoma of the rat skin;rat integumentary system neoplasms;broadmatch
squamous cell carcinoma of the rat bronchiole;rat respiratory system neoplasms;broadmatch
squamous cell carcinoma of the rat bronchus;rat respiratory system neoplasms;broadmatch
squamous cell carcinoma of the rat larynx;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat paranasal sinus;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat nasopharynx;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat nasal cavity;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat larynx;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat bronchus;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat bronchiole;rat respiratory system neoplasms;broadmatch
squamous cell carcinoma of the rat urinary bladder;rat urinary system neoplasms;broadmatch
squamous cell carcinoma of the rat urethra;rat urinary system neoplasms;broadmatch
squamous cell carcinoma of the rat ureter;rat urinary system neoplasms;broadmatch
squamous cell carcinoma of the rat trachea;rat respiratory system neoplasms;broadmatch
squamous cell carcinoma of the rat renal pelvis;rat urinary system neoplasms;broadmatch
squamous cell carcinoma of the rat paranasal sinus;rat respiratory system neoplasms;broadmatch
squamous cell carcinoma of the rat nasopharynx;rat respiratory system neoplasms;broadmatch
squamous cell carcinoma of the rat nasal cavity;rat respiratory system neoplasms;broadmatch
squamous cell carcinoma of the rat lung;rat respiratory system neoplasms;broadmatch
benign mediastinal hemangiopericytoma;benign hemangiopericytoma;broadmatch
malignant mediastinal hemangiopericytoma;malignant hemangiopericytoma;broadmatch
keratinizing cystic epithelioma of the rat lung;rat respiratory system neoplasms;broadmatch
unbalanced translocation;chromosomal translocation;broadmatch
malignant trophoblastic cell;malignant cell;broadmatch
double minutes;cytogenetic abnormality;broadmatch
homogeneously staining region;cytogenetic abnormality;broadmatch
derivative chromosome;cytogenetic abnormality;broadmatch
chromosomal insertion;chromosomal rearrangement;broadmatch
chromosomal inversion;chromosomal rearrangement;broadmatch
numerical chromosomal abnormality;cytogenetic abnormality;broadmatch
balanced chromosomal translocation;chromosomal translocation;broadmatch
pancreatic g-cell adenoma;islet cell adenoma;broadmatch
intermediate grade b-cell non-hodgkin's lymphoma;intermediate grade lymphoma;broadmatch
high grade b-cell non-hodgkin's lymphoma;high grade lymphoma;broadmatch
low grade b-cell non-hodgkin's lymphoma;low grade lymphoma;broadmatch
cystic neoplasm;neoplasm by special category;broadmatch
pituitary gland acidophil adenoma;pituitary gland neoplasm (antiquated);broadmatch
tdt negative acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
flt3 internal tandem duplication;activating flt3 gene mutation;broadmatch
malignant trophoblastic cell;neoplastic trophoblastic cell;broadmatch
hodgkin lymphoma by clinical course;hodgkin lymphoma;broadmatch
tdt positive acute lymphoblastic leukemia;leukemia (antiquated);broadmatch
neurotransmitter;physiology-regulatory factor;broadmatch
malignant intracranial neoplasm by morphology;malignant intracranial neoplasm;broadmatch
benign kidney hemangiopericytoma;kidney hemangiopericytoma;broadmatch
benign kidney hemangiopericytoma;benign hemangiopericytoma;broadmatch
postoperative spindle cell nodule of the bladder;postoperative spindle cell nodule;broadmatch
postoperative spindle cell nodule of the bladder;non-neoplastic bladder disorder;broadmatch
postoperative spindle cell nodule;non-neoplastic soft tissue disorder;broadmatch
thoracic spine;skeletal system part;broadmatch
lumbar spine;skeletal system part;broadmatch
cervical spine;skeletal system part;broadmatch
sclerosis;morphologic finding;broadmatch
hodgkin's granuloma;hodgkin's lymphoma (antiquated);broadmatch
pancreatic mucinous-cystic neoplasm with intermediate grade dysplasia;epithelial neoplasm (antiquated);broadmatch
oligodendroglial component present;abnormal tissue present;broadmatch
her2/neu negative;expression negative;broadmatch
her2/neu negative;her2/neu status;broadmatch
pancreatic delta cell adenoma;islet cell adenoma;broadmatch
pancreatic beta cell adenoma;islet cell adenoma;broadmatch
medullary carcinoma, not otherwise specified;epithelial neoplasm (antiquated);broadmatch
malignant trophoblastic teratoma;germ cell tumor (antiquated);broadmatch
spontaneously regressed retinoblastoma;neoplasm by obsolete classification;broadmatch
spongioneuroblastoma;nervous system neoplasm (antiquated);broadmatch
medulloepithelioma not otherwise specified;nervous system neoplasm (antiquated);broadmatch
cerebellar sarcoma;nervous system neoplasm (antiquated);broadmatch
oligodendroblastoma;nervous system neoplasm (antiquated);broadmatch
polar spongioblastoma;nervous system neoplasm (antiquated);broadmatch
benign hemangioendothelioma;connective and soft tissue neoplasm (antiquated);broadmatch
benign stromal tumor;connective and soft tissue neoplasm (antiquated);broadmatch
pancreatic alpha cell adenoma;islet cell adenoma;broadmatch
angiomyosarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
periosteal fibrosarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
giant cell sarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
clear cell neoplasm;neoplasm by obsolete classification;broadmatch
granulosa cell-theca cell tumor;neoplasm by obsolete classification;broadmatch
ovarian stromal tumor with minor sex cord elements;ovarian sex cord-stromal tumor;broadmatch
benign thymoma;epithelial neoplasm (antiquated);broadmatch
hemangioblastic meningioma;nervous system neoplasm (antiquated);broadmatch
nervous system neoplasm (antiquated);neoplasm by obsolete classification;broadmatch
hodgkin's disease, lymphocyte depletion, diffuse fibrosis;hodgkin's lymphoma (antiquated);broadmatch
hodgkin's disease, lymphocyte depletion, reticular;hodgkin's lymphoma (antiquated);broadmatch
pancreatic polypeptide tumor;epithelial neoplasm (antiquated);broadmatch
stage iva esophageal squamous cell carcinoma;stage iva esophageal cancer;broadmatch
stage ivb esophageal squamous cell carcinoma;stage ivb esophageal cancer;broadmatch
stage ivb esophageal adenocarcinoma;stage ivb esophageal cancer;broadmatch
stage iva esophageal adenocarcinoma;stage iva esophageal cancer;broadmatch
neurofibromatosis;phakomatosis;broadmatch
phosphaturia;abnormal urine test result;broadmatch
oncogenic osteomalacia;paraneoplastic syndrome;broadmatch
oncogenic osteomalacia;osteomalacia;broadmatch
epithelioid osteoblast;neoplastic osteoblast;broadmatch
enteroglucagonoma;epithelial neoplasm (antiquated);broadmatch
skin metatypical carcinoma;skin basal cell carcinoma;broadmatch
keratin horn pearls formation;keratin pearls formation;broadmatch
carotid body;capillary;broadmatch
diffuse hyperplastic perilobar nephroblastomatosis;urinary tract precancerous condition;broadmatch
keratoacanthoma of the rat skin;rat integumentary system neoplasms;broadmatch
epithelioid mesothelioma of the rat pericardium;rat respiratory system neoplasms;broadmatch
joint capsule;soft tissue;broadmatch
adenocarcinoma of the rat preputial gland;rat male genital system neoplasms;broadmatch
adenoma of the rat intraorbital lacrimal gland;rat nervous system and sensory organs neoplasms;broadmatch
adenoma of the rat harderian gland;rat nervous system and sensory organs neoplasms;broadmatch
adenoma of the rat extraorbital lacrimal gland;rat nervous system and sensory organs neoplasms;broadmatch
adenoma of the rat coagulating gland;rat male genital system neoplasms;broadmatch
adenolipoma of the rat mammary gland;rat integumentary system neoplasms;broadmatch
adenocarcinoma of the rat seminal vesicle;rat male genital system neoplasms;broadmatch
adenocarcinoma of the rat prostate;rat male genital system neoplasms;broadmatch
adenocarcinoma of the rat mammary gland;rat integumentary system neoplasms;broadmatch
yolk sac carcinoma of the rat uterine cervix;rat female genital system neoplasms;broadmatch
adenocarcinoma of the rat lacrimal gland;rat nervous system and sensory organs neoplasms;broadmatch
figo stage iiia gestational trophoblastic tumor;figo stage iii gestational trophoblastic tumor;broadmatch
adenocarcinoma of the rat intraorbital lacrimal gland;rat nervous system and sensory organs neoplasms;broadmatch
adenocarcinoma of the rat harderian gland;rat nervous system and sensory organs neoplasms;broadmatch
adenocarcinoma of the rat extraorbital lacrimal gland;rat nervous system and sensory organs neoplasms;broadmatch
adenocarcinoma of the rat coagulating gland;rat male genital system neoplasms;broadmatch
adenocarcinoma arising in fibroadenoma of the rat mammary gland;rat integumentary system neoplasms;broadmatch
figo stage iiib gestational trophoblastic tumor;figo stage iii gestational trophoblastic tumor;broadmatch
adenoma of the rat lacrimal gland;rat nervous system and sensory organs neoplasms;broadmatch
adenoma of the rat mammary gland;rat integumentary system neoplasms;broadmatch
adenoma of the rat preputial gland;rat male genital system neoplasms;broadmatch
carcinoma of the rat choroid plexus;rat nervous system and sensory organs neoplasms;broadmatch
benign oligodendroglioma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
benign mixed tumor of the rat mammary gland;rat integumentary system neoplasms;broadmatch
benign mixed glioma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
benign meningioma of the rat spinal meninx;rat nervous system and sensory organs neoplasms;broadmatch
benign meningioma of the rat cerebral meninx;rat nervous system and sensory organs neoplasms;broadmatch
benign granulosa cell tumor of the rat testis;rat male genital system neoplasms;broadmatch
benign ependymoma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
figo stage iiic gestational trophoblastic tumor;figo stage iii gestational trophoblastic tumor;broadmatch
benign ependymoma of the rat brain;rat nervous system and sensory organs neoplasms;broadmatch
benign astrocytoma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
benign astrocytoma of the rat brain;rat nervous system and sensory organs neoplasms;broadmatch
basal cell carcinoma of the rat preputial gland;rat male genital system neoplasms;broadmatch
adenoma of the rat seminal vesicle;rat male genital system neoplasms;broadmatch
adenoma of the rat prostate;rat male genital system neoplasms;broadmatch
yolk sac carcinoma of the rat uterus;rat female genital system neoplasms;broadmatch
yolk sac carcinoma of the rat oviduct;rat female genital system neoplasms;broadmatch
carcinosarcoma of the rat mammary gland;rat integumentary system neoplasms;broadmatch
decidual reaction of the rat uterus;rat female genital system neoplasms;broadmatch
keratoacanthoma of the rat vagina;rat female genital system neoplasms;broadmatch
keratoacanthoma of the rat uterine cervix;rat female genital system neoplasms;broadmatch
endometrial stromal sarcoma of the rat uterus;rat female genital system neoplasms;broadmatch
endometrial stromal sarcoma of the rat uterine cervix;rat female genital system neoplasms;broadmatch
endometrial stromal polyp of the rat uterus;rat female genital system neoplasms;broadmatch
endometrial stromal polyp of the rat uterine cervix;rat female genital system neoplasms;broadmatch
figo stage iib gestational trophoblastic tumor;figo stage ii gestational trophoblastic tumor;broadmatch
decidual reaction of the rat uterine cervix;rat female genital system neoplasms;broadmatch
yolk sac carcinoma of the rat ovary;rat female genital system neoplasms;broadmatch
cystadenoma of the rat ovary;rat female genital system neoplasms;broadmatch
cystadenocarcinoma of the rat ovary;rat female genital system neoplasms;broadmatch
choriocarcinoma of the rat uterus;rat female genital system neoplasms;broadmatch
choriocarcinoma of the rat uterine cervix;rat female genital system neoplasms;broadmatch
choriocarcinoma of the rat oviduct;rat female genital system neoplasms;broadmatch
choriocarcinoma of the rat ovary;rat female genital system neoplasms;broadmatch
benign thecoma of the rat ovary;rat female genital system neoplasms;broadmatch
malignant granulosa cell tumor of the rat ovary;rat female genital system neoplasms;broadmatch
malignant mixed muellerian tumor of the rat uterine cervix;rat female genital system neoplasms;broadmatch
malignant mixed muellerian tumor of the rat uterus;rat female genital system neoplasms;broadmatch
malignant sertoli cell tumor of the rat ovary;rat female genital system neoplasms;broadmatch
tubulostromal adenoma of the rat ovary;tubulostromal adenoma;broadmatch
tubulostromal adenoma of the rat ovary;rat female genital system neoplasms;broadmatch
figo stage iii gestational trophoblastic tumor;gestational trophoblastic tumor by figo stage;broadmatch
tubulostromal adenocarcinoma of the rat ovary;tubulostromal adenocarcinoma;broadmatch
tubulostromal adenocarcinoma of the rat ovary;rat female genital system neoplasms;broadmatch
squamous cell papilloma of the rat vagina;rat female genital system neoplasms;broadmatch
squamous cell papilloma of the rat uterus;rat female genital system neoplasms;broadmatch
squamous cell papilloma of the rat uterine cervix;rat female genital system neoplasms;broadmatch
squamous cell papilloma of the rat clitoral gland;rat female genital system neoplasms;broadmatch
squamous cell carcinoma of the rat vagina;rat female genital system neoplasms;broadmatch
squamous cell carcinoma of the rat uterus;rat female genital system neoplasms;broadmatch
squamous cell carcinoma of the rat uterine cervix;rat female genital system neoplasms;broadmatch
squamous cell carcinoma of the rat clitoral gland;rat female genital system neoplasms;broadmatch
malignant thecoma of the rat ovary;rat female genital system neoplasms;broadmatch
figo stage iic gestational trophoblastic tumor;figo stage ii gestational trophoblastic tumor;broadmatch
carcinoma of the rat rete testis;rat male genital system neoplasms;broadmatch
figo stage iv gestational trophoblastic tumor;gestational trophoblastic tumor by figo stage;broadmatch
carcinoma of the rat lung;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat external ear;rat nervous system and sensory organs neoplasms;broadmatch
adenocarcinoma of the rat nasopharynx;rat respiratory system neoplasms;broadmatch
adenocarcinoma of the rat nasal cavity;rat respiratory system neoplasms;broadmatch
adenocarcinoma of the rat larynx;rat respiratory system neoplasms;broadmatch
adenocarcinoma of the rat bronchus;rat respiratory system neoplasms;broadmatch
adenocarcinoma of the rat bronchiole;rat respiratory system neoplasms;broadmatch
squamous cell papilloma of the rat preputial gland;rat male genital system neoplasms;broadmatch
squamous cell papilloma of the rat eyelid;rat nervous system and sensory organs neoplasms;broadmatch
squamous cell papilloma of the rat conjunctiva;rat nervous system and sensory organs neoplasms;broadmatch
rat trichofolliculoma type benign follicle hair tumor;rat integumentary system neoplasms;broadmatch
squamous cell carcinoma of the rat zymbal gland;rat integumentary system neoplasms;broadmatch
squamous cell carcinoma of the rat preputial gland;rat male genital system neoplasms;broadmatch
squamous cell carcinoma of the rat eyelid;rat nervous system and sensory organs neoplasms;broadmatch
squamous cell carcinoma of the rat external ear;rat nervous system and sensory organs neoplasms;broadmatch
squamous cell carcinoma of the rat conjunctiva;rat nervous system and sensory organs neoplasms;broadmatch
sebaceous cell carcinoma of the rat zymbal gland;rat integumentary system neoplasms;broadmatch
sebaceous cell adenoma of the rat zymbal gland;rat integumentary system neoplasms;broadmatch
adenocarcinoma of the rat paranasal sinus;rat respiratory system neoplasms;broadmatch
adenocarcinoma of the rat trachea;rat respiratory system neoplasms;broadmatch
adenocarcinoma of the rat urinary bladder;rat urinary system neoplasms;broadmatch
adenoma of the rat kidney;rat urinary system neoplasms;broadmatch
carcinoma of the rat kidney;rat urinary system neoplasms;broadmatch
benign basosquamous tumor of the rat skin;rat integumentary system neoplasms;broadmatch
benign basal cell tumor of the rat skin;rat integumentary system neoplasms;broadmatch
benign mesothelioma of the rat pleura;rat respiratory system neoplasms;broadmatch
benign mesothelioma of the rat peritoneum;rat respiratory system neoplasms;broadmatch
benign mesothelioma of the rat pericardium;rat respiratory system neoplasms;broadmatch
basal cell carcinoma of the rat skin;rat integumentary system neoplasms;broadmatch
amelanotic malignant melanoma of the rat skin;rat integumentary system neoplasms;broadmatch
adenosquamous carcinoma of the rat paranasal sinus;rat respiratory system neoplasms;broadmatch
adenosquamous carcinoma of the rat nasopharynx;rat respiratory system neoplasms;broadmatch
adenosquamous carcinoma of the rat nasal cavity;rat respiratory system neoplasms;broadmatch
adenosquamous carcinoma of the rat lung;rat respiratory system neoplasms;broadmatch
adenoma of the rat paranasal sinus;rat respiratory system neoplasms;broadmatch
adenoma of the rat nasopharynx;rat respiratory system neoplasms;broadmatch
adenoma of the rat nasal cavity;rat respiratory system neoplasms;broadmatch
rat tricholemmoma type benign follicle hair tumor;rat integumentary system neoplasms;broadmatch
rat trichoepithelioma type benign follicle hair tumor;rat integumentary system neoplasms;broadmatch
fibroadenoma of the rat mammary gland;rat integumentary system neoplasms;broadmatch
malignant melanoma of the rat spinal meninx;rat nervous system and sensory organs neoplasms;broadmatch
malignant oligodendroglioma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
malignant oligodendroglioma of the rat brain;rat nervous system and sensory organs neoplasms;broadmatch
malignant neuromyoblastoma of the rat cranial nerve;rat nervous system and sensory organs neoplasms;broadmatch
malignant neuromyoblastoma of the rat brain;rat nervous system and sensory organs neoplasms;broadmatch
malignant mixed tumor of the rat mammary gland;rat integumentary system neoplasms;broadmatch
malignant mixed glioma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
figo stage iva gestational trophoblastic tumor;figo stage iv gestational trophoblastic tumor;broadmatch
malignant melanoma of the rat cerebral meninx;rat nervous system and sensory organs neoplasms;broadmatch
rat pleomorphic lymphoma;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
malignant intraocular schwannoma of the rat eyeball;rat nervous system and sensory organs neoplasms;broadmatch
malignant glioma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
malignant ependymoma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
malignant ependymoma of the rat brain;rat nervous system and sensory organs neoplasms;broadmatch
malignant astrocytoma of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
malignant astrocytoma of the rat brain;rat nervous system and sensory organs neoplasms;broadmatch
keratoacanthoma of the rat external ear;rat nervous system and sensory organs neoplasms;broadmatch
malignant reticulosis of the rat brain;rat nervous system and sensory organs neoplasms;broadmatch
malignant reticulosis of the rat spinal cord;rat nervous system and sensory organs neoplasms;broadmatch
malignant sertoli cell tumor of the rat testis;rat male genital system neoplasms;broadmatch
malignant uveal melanoma of the rat eyeball;rat special sensory organ neoplasms;broadmatch
rat plasmacytic lymphoma;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat pilomatricoma type benign follicle hair tumor;rat integumentary system neoplasms;broadmatch
rat neutrophilic leukemia;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
figo stage ivc gestational trophoblastic tumor;figo stage iv gestational trophoblastic tumor;broadmatch
rat malignant glioma;rat nervous system and sensory organs neoplasms;broadmatch
rat lymphocytic lymphoma;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat lymphoblastic lymphoma;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat large granular lymphocyte leukemia;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat eosinophilic leukemia;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
rat basophilic leukemia;rat hematopoietic and mononuclear phagocytic system neoplasms;broadmatch
papilloma of the rat choroid plexus;rat nervous system and sensory organs neoplasms;broadmatch
ocular dermoid of the rat eyeball;rat nervous system and sensory organs neoplasms;broadmatch
meningeal sarcoma of the rat spinal meninx;rat nervous system and sensory organs neoplasms;broadmatch
meningeal sarcoma of the rat cerebral meninx;rat nervous system and sensory organs neoplasms;broadmatch
figo stage ivb gestational trophoblastic tumor;figo stage iv gestational trophoblastic tumor;broadmatch
meningioma by site;meningioma;broadmatch
recurrent adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma;broadmatch
nucleic acids;nucleic acids, nucleosides, and nucleotides;broadmatch
stage iv adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma;broadmatch
recurrent high grade adult non-hodgkin's lymphoma;high grade adult non-hodgkin's lymphoma;broadmatch
recurrent adult diffuse large cell lymphoma;adult diffuse large cell lymphoma;broadmatch
recurrent adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma;broadmatch
recurrent intermediate grade adult non-hodgkin's lymphoma;intermediate grade adult non-hodgkin's lymphoma;broadmatch
recurrent low grade adult non-hodgkin's lymphoma;low grade adult non-hodgkin's lymphoma;broadmatch
stage iv high grade adult non-hodgkin's lymphoma;high grade adult non-hodgkin's lymphoma;broadmatch
stage iv adult diffuse large cell lymphoma;adult diffuse large cell lymphoma;broadmatch
stage iv adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma;broadmatch
stage iii low grade adult non-hodgkin's lymphoma;low grade adult non-hodgkin's lymphoma;broadmatch
stage iv intermediate grade adult non-hodgkin's lymphoma;intermediate grade adult non-hodgkin's lymphoma;broadmatch
stage iv low grade adult non-hodgkin's lymphoma;low grade adult non-hodgkin's lymphoma;broadmatch
stage iii high grade adult non-hodgkin's lymphoma;high grade adult non-hodgkin's lymphoma;broadmatch
stage iii adult diffuse large cell lymphoma;adult diffuse large cell lymphoma;broadmatch
stage iii adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma;broadmatch
stage iii adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma;broadmatch
elevated test result;abnormal laboratory test result;broadmatch
adult non-hodgkin's lymphoma grade;lymphoma by working formulation (antiquated);broadmatch
cytokeratin-positive neoplastic cells present;immunophenotypic finding;broadmatch
alk gene mutation;pi3k/mtor pathway mutation;broadmatch
alk gene mutation;receptor tyrosine kinase gene mutation;broadmatch
tmprss2-erg fusion protein expression;fusion protein expression;broadmatch
gata1 gene mutation;gene variant;broadmatch
sonic hedgehog/patch pathway activated;signaling pathway status;broadmatch
signaling pathway status;laboratory test result;broadmatch
blasts expressing cd56 and immature t-cell markers present;blasts of mixed phenotype present;broadmatch
blasts expressing t-lymphoid and myeloid markers present;blasts of mixed phenotype present;broadmatch
blasts expressing b-lymphoid and myeloid markers present;blasts of mixed phenotype present;broadmatch
blasts of mixed phenotype present;blast cells present;broadmatch
stage iv oral cavity verrucous carcinoma;epithelial neoplasm (antiquated);broadmatch
stage iii oral cavity verrucous carcinoma;epithelial neoplasm (antiquated);broadmatch
stage ii oral cavity verrucous carcinoma;epithelial neoplasm (antiquated);broadmatch
stage i oral cavity verrucous carcinoma;epithelial neoplasm (antiquated);broadmatch
nasal cavity and paranasal sinus lethal midline granuloma;granuloma by site;broadmatch
alk fusion protein expression;fusion protein expression;broadmatch
alk gene mutation;gene variant;broadmatch
stage iii intermediate grade adult non-hodgkin's lymphoma;intermediate grade adult non-hodgkin's lymphoma;broadmatch
stage ii high grade adult non-hodgkin's lymphoma;high grade adult non-hodgkin's lymphoma;broadmatch
erg gene rearrangement;rearrangement of 21q;broadmatch
hypodiploidy;hypoploidy;broadmatch
neoplastic nodule;nodule;broadmatch
tubulostromal adenocarcinoma;experimental organism neoplasm;broadmatch
malignant ito cell tumor;ito cell tumor;broadmatch
benign ito cell tumor;ito cell tumor;broadmatch
ito cell tumor;experimental organism neoplasm;broadmatch
cystic keratinizing epithelioma;experimental organism neoplasm;broadmatch
choristoma;tissue;broadmatch
hyperdiploidy;hyperploidy;broadmatch
stage ii adult diffuse large cell lymphoma;adult diffuse large cell lymphoma;broadmatch
recurrent genetic abnormalities present;genetic finding;broadmatch
poems syndrome;syndrome;broadmatch
ebv-transformed mature b-lymphocyte;mature b-lymphocyte;broadmatch
braf v600e mutation present;gene variant positive;broadmatch
binet stage c;binet stage;broadmatch
binet stage b;binet stage;broadmatch
binet stage a;binet stage;broadmatch
biological model;model;broadmatch
adult non-hodgkin's lymphoma stage;lymphoma by working formulation (antiquated);broadmatch
stage i low grade adult non-hodgkin's lymphoma;low grade adult non-hodgkin's lymphoma;broadmatch
bone marrow failure;bone marrow disorder;broadmatch
stage ii adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma;broadmatch
stage ii adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma;broadmatch
ribonucleic acid;nucleic acids;broadmatch
immunosuppression-related post-transplant toxicity;therapy-related toxicity;broadmatch
immunosuppression-related post-transplant toxicity;drug toxicity;broadmatch
stage ii intermediate grade adult non-hodgkin's lymphoma;intermediate grade adult non-hodgkin's lymphoma;broadmatch
ovarian monodermal and highly specialized teratoma;ovarian monodermal teratoma;broadmatch
childhood malignant mesenchymoma;malignant mesenchymoma;broadmatch
malignant childhood hemangiopericytoma;malignant hemangiopericytoma;broadmatch
stage ii low grade adult non-hodgkin's lymphoma;low grade adult non-hodgkin's lymphoma;broadmatch
stage i high grade adult non-hodgkin's lymphoma;high grade adult non-hodgkin's lymphoma;broadmatch
stage i adult diffuse large cell lymphoma;adult diffuse large cell lymphoma;broadmatch
stage i adult diffuse mixed cell lymphoma;adult diffuse mixed cell lymphoma;broadmatch
stage i adult diffuse small cleaved cell lymphoma;adult diffuse small cleaved cell lymphoma;broadmatch
stage i intermediate grade adult non-hodgkin's lymphoma;intermediate grade adult non-hodgkin's lymphoma;broadmatch
erg gene rearrangement;gene rearrangement abnormality;broadmatch
npm1 gene mutation;gene variant;broadmatch
neoplasm by special category;neoplasm;broadmatch
apocrine metaplasia;epithelial metaplasia;broadmatch
hamartomatous polyp;hamartoma;broadmatch
connective tissue nevus;non-neoplastic nevus;broadmatch
connective tissue nevus;hamartoma;broadmatch
severe dysplasia;dysplasia;broadmatch
moderate dysplasia;dysplasia;broadmatch
mild dysplasia;dysplasia;broadmatch
intestinal metaplasia;epithelial metaplasia;broadmatch
glandular metaplasia;epithelial metaplasia;broadmatch
severe cytologic atypia;cytologic atypia;broadmatch
atypical glandular hyperplasia;atypical hyperplasia;broadmatch
atypical glandular hyperplasia;glandular hyperplasia;broadmatch
koilocytotic atypia;cytologic atypia;broadmatch
microscopic finding;pathology result;broadmatch
malignant subcapsular adrenal tumor;subcapsular adrenal tumor;broadmatch
benign subcapsular adrenal tumor;subcapsular adrenal tumor;broadmatch
glandular cell atypia;cytologic atypia;broadmatch
hamartomatous polyp;polyp;broadmatch
florid cemento-osseous dysplasia;cemento-osseous dysplasia;broadmatch
squamous metaplasia of bladder;squamous metaplasia;broadmatch
tbxt gene duplication;oncogene deregulation;broadmatch
distant intracranial metastasis;metastatic lesion;broadmatch
yolk sac adenoma;experimental organism neoplasm;broadmatch
phakomatosis;hereditary neoplastic syndrome;broadmatch
microcalcification;calcification;broadmatch
fgfr1 gene rearrangement;fgfr gene rearrangement;broadmatch
pdgfrb gene rearrangement;receptor tyrosine kinase gene rearrangement;broadmatch
pdgfrb gene rearrangement;chromosome 5 rearrangement;broadmatch
pdgfra gene rearrangement;receptor tyrosine kinase gene rearrangement;broadmatch
renal benign mesenchymoma;benign mesenchymoma;broadmatch
jak2 gene mutation;gene variant;broadmatch
jak2 gene mutation;jak family gene mutation;broadmatch
leukoplakia of buccal mucosa;mouth mucous membrane leukoplakia;broadmatch
fgfr4 gene mutation;gene variant;broadmatch
fgfr4 gene mutation;fgfr gene mutation;broadmatch
tbxt gene duplication;gene amplification abnormality;broadmatch
squamous cell atypia;cytologic atypia;broadmatch
severe cytologic atypia;precancerous atypia;broadmatch
abnormal finding;clinical test result;broadmatch
odontogenesis;organogenesis;broadmatch
focal mammary duct ectasia;mammary duct ectasia;broadmatch
aids-related diffuse small cleaved cell lymphoma;aids-related lymphoma by working formulation;broadmatch
aids-related diffuse small cleaved cell lymphoma;diffuse malignant lymphoma;broadmatch
aids-related diffuse small cleaved cell lymphoma;malignant non-hodgkin lymphoma, cleaved cell;broadmatch
aids-related diffuse mixed cell lymphoma;diffuse mixed cell lymphoma;broadmatch
aids-related diffuse mixed cell lymphoma;aids-related lymphoma by working formulation;broadmatch
aids-related diffuse mixed cell lymphoma;diffuse malignant lymphoma;broadmatch
hyperchromasia;morphologic finding;broadmatch
moderate cytologic atypia;cytologic atypia;broadmatch
mild chronic inflammation;chronic inflammation;broadmatch
bone marrow involvement;bone marrow and extramedullary involvement;broadmatch
sexual dysfunction and infertility;genitourinary signs and symptoms;broadmatch
sexual dysfunction and infertility;reproductive system finding;broadmatch
cancer-related condition;disease or disorder;broadmatch
ptpn11 gene mutation;gene variant;broadmatch
unilineage dysplasia present;bone marrow dysplasia present;broadmatch
subcapsular adrenal tumor;experimental organism neoplasm;broadmatch
chronic hepatitis;hepatitis;broadmatch
chronic viral hepatitis;viral hepatitis;broadmatch
chronic viral hepatitis;chronic hepatitis;broadmatch
mild cytologic atypia;cytologic atypia;broadmatch
cytologic atypia;atypia;broadmatch
malignant cells with nuclei of various sizes and shapes present;abnormal cells present;broadmatch
fibrous polyp;polyp;broadmatch
childhood large cell lymphoma;malignant lymphoma, large cell type;broadmatch
recurrent childhood large cell lymphoma;childhood large cell lymphoma;broadmatch
stage iv childhood large cell lymphoma;childhood large cell lymphoma;broadmatch
stage iii childhood large cell lymphoma;childhood large cell lymphoma;broadmatch
stage ii childhood large cell lymphoma;childhood large cell lymphoma;broadmatch
stage i childhood large cell lymphoma;childhood large cell lymphoma;broadmatch
hypocellular tissue;morphologic finding;broadmatch
glandular hyperplasia;hyperplasia;broadmatch
small lymphocytic lymphoma variant;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
macrovesicular steatosis;hepatic steatosis;broadmatch
architectural distortion;morphologic finding;broadmatch
merkel cell polyomavirus infection;viral infection;broadmatch
chronic kidney disease;non-neoplastic kidney disorder;broadmatch
tubulostromal adenoma;experimental organism neoplasm;broadmatch
nephrogenic adenoma;non-neoplastic urinary system disorder;broadmatch
gastric precancerous condition;digestive system precancerous condition;broadmatch
gastric precancerous condition;stomach disorder;broadmatch
esophageal precancerous condition;digestive system precancerous condition;broadmatch
esophageal precancerous condition;esophageal disorder;broadmatch
precancerous condition by site;precancerous condition;broadmatch
bladder nephrogenic adenoma;nephrogenic adenoma;broadmatch
bladder nephrogenic adenoma;non-neoplastic bladder disorder;broadmatch
pancreatic precancerous condition;digestive system precancerous condition;broadmatch
diffuse intraductal papillomatosis;epithelial neoplasm (antiquated);broadmatch
pancreatic precancerous condition;pancreatic exocrine neoplasm;broadmatch
laryngeal precancerous condition;head and neck precancerous condition;broadmatch
laryngeal precancerous condition;laryngeal disorder;broadmatch
anal precancerous condition;digestive system precancerous condition;broadmatch
anal precancerous condition;anal disorder;broadmatch
ebv-positive neoplastic cells present;immunophenotypic finding;broadmatch
thyroid gland papillary and follicular carcinoma;epithelial neoplasm (antiquated);broadmatch
oral cavity and lip precancerous condition;head and neck precancerous condition;broadmatch
oral cavity and lip precancerous condition;oral disorder;broadmatch
pulmonary precancerous condition;lung disorder;broadmatch
pulmonary precancerous condition;precancerous condition by site;broadmatch
hepatobiliary precancerous condition;hepatobiliary disorder;broadmatch
breast intracystic papillary carcinoma;epithelial neoplasm (antiquated);broadmatch
nsd1 gene;methyltransferase gene;broadmatch
dysplastic nevus syndrome;hereditary neoplastic syndrome;broadmatch
nevus of ota;non-neoplastic nevus;broadmatch
foxl2 gene;transcription factor gene;broadmatch
col1a1 associated connective tissue disorder;hereditary connective tissue disorder;broadmatch
malignant esophageal neoplasm by topographic region;malignant esophageal neoplasm;broadmatch
malignant esophageal neoplasm by anatomic region;malignant esophageal neoplasm;broadmatch
paranasal sinus polyp;polyp;broadmatch
paranasal sinus polyp;paranasal sinus disorder;broadmatch
pigment;industrial aid;broadmatch
acute erythroid leukemia in remission;acute myeloid leukemia in remission;broadmatch
hybrid odontogenic fibroma;connective and soft tissue neoplasm (antiquated);broadmatch
granular cell odontogenic fibroma;connective and soft tissue neoplasm (antiquated);broadmatch
focal intraductal papillomatosis;epithelial neoplasm (antiquated);broadmatch
suz12 gene;methyltransferase gene;broadmatch
granular renal cell carcinoma;epithelial neoplasm (antiquated);broadmatch
nucleotide;nucleic acids, nucleosides, and nucleotides;broadmatch
subepidermal nodular fibrosis;non-neoplastic soft tissue disorder;broadmatch
plag1 gene;transcription factor gene;broadmatch
nono gene;transcription regulation gene;broadmatch
sfpq gene;transcription regulation gene;broadmatch
exaggerated placental site;non-neoplastic, non-molar trophoblastic disorder;broadmatch
prcc gene;transcription regulation gene;broadmatch
aspscr1 gene;regulatory gene;broadmatch
rectal cancer by astler-coller stage;colorectal cancer by astler-coller stage;broadmatch
jazf1 gene;transcription regulation gene;broadmatch
colon cancer by astler-coller stage;colorectal cancer by astler-coller stage;broadmatch
colorectal cancer by astler-coller stage;cancer stage (antiquated);broadmatch
nucleic acids, nucleosides, and nucleotides;organic chemical;broadmatch
hemangiopericytic neoplasm;connective and soft tissue neoplasm (antiquated);broadmatch
neoplastic polyp;neoplasm by special category;broadmatch
neoplastic polyp;polyp;broadmatch
t-cell chronic lymphocytic leukemia;leukemia (antiquated);broadmatch
pineal region dysgerminoma;germ cell tumor (antiquated);broadmatch
central nervous system neuroepithelial neoplasm of uncertain origin;nervous system neoplasm (antiquated);broadmatch
organic chemical;drug or chemical by structure;broadmatch
lymphoma by site;lymphoma;broadmatch
hematopoietic and lymphoid neoplasm (antiquated);neoplasm by obsolete classification;broadmatch
borderline ovarian serous surface papillary tumor;epithelial neoplasm (antiquated);broadmatch
ovarian dermoid cyst with secondary tumor;ovarian monodermal teratoma;broadmatch
borderline ovarian serous papillary cystic tumor;epithelial neoplasm (antiquated);broadmatch
mixed mucinous and non-mucinous bronchioloalveolar carcinoma;epithelial neoplasm (antiquated);broadmatch
non-hodgkin lymphoma with variable clinical course;non-hodgkin lymphoma by clinical course;broadmatch
non-hodgkin lymphoma by clinical course;non-hodgkin lymphoma;broadmatch
aids-related diffuse large cell lymphoma;aids-related lymphoma by working formulation;broadmatch
aids-related diffuse large cell lymphoma;malignant lymphoma, large cell type;broadmatch
aids-related diffuse large cell lymphoma;diffuse malignant lymphoma;broadmatch
t-zone variant peripheral t-cell lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
malignant histiocytosis;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
infrequent neoplasm;neoplasm by special category;broadmatch
non-burkitt's lymphoma;malignant lymphoma, non-cleaved cell type;broadmatch
lymphoma by working formulation (antiquated);hematopoietic and lymphoid neoplasm (antiquated);broadmatch
hepatobiliary precancerous condition;digestive system precancerous condition;broadmatch
intestinal precancerous condition;intestinal disorder;broadmatch
intestinal precancerous condition;digestive system precancerous condition;broadmatch
rearrangement of 11q;chromosomal rearrangement;broadmatch
adult acute lymphoblastic leukemia in remission;adult acute leukemia in remission;broadmatch
adult acute lymphoblastic leukemia in remission;acute lymphoblastic leukemia in remission;broadmatch
adult acute myeloid leukemia in remission;adult acute leukemia in remission;broadmatch
adult acute myeloid leukemia in remission;acute myeloid leukemia in remission;broadmatch
1p/19q codeletion;chromosome 1 abnormality;broadmatch
1p/19q codeletion;chromosomal loss;broadmatch
rearrangement of 21q;chromosomal rearrangement;broadmatch
rearrangement of 11q;11q aberration;broadmatch
digestive system precancerous condition;digestive system disorder;broadmatch
rearrangement of 3q;chromosomal rearrangement;broadmatch
rearrangement of 3q;3q abnormality;broadmatch
thyroid gland undifferentiated small cell carcinoma;epithelial neoplasm (antiquated);broadmatch
adult diffuse large cell lymphoma;malignant lymphoma, large cell type;broadmatch
adult diffuse large cell lymphoma;diffuse malignant lymphoma;broadmatch
wheezing;respiratory system signs and symptoms;broadmatch
adult diffuse mixed cell lymphoma;diffuse mixed cell lymphoma;broadmatch
childhood acute lymphoblastic leukemia in remission;acute lymphoblastic leukemia in remission;broadmatch
childhood acute lymphoblastic leukemia in remission;childhood acute leukemia in remission;broadmatch
body temperature associated symptom;symptom;broadmatch
malignant adult hemangiopericytoma;malignant hemangiopericytoma;broadmatch
tmprss2/erg fusion gene;tmprss2/ets family fusion gene;broadmatch
abnormal virilization;virilization;broadmatch
hominidae;primate;broadmatch
precocious puberty;endocrine system finding;broadmatch
precocious puberty;reproductive system finding;broadmatch
optic nerve disorder;cranial nerve disorder;broadmatch
ophthalmoplegia;eye finding;broadmatch
reproductive system hemorrhage;reproductive system finding;broadmatch
reproductive system hemorrhage;hemorrhage;broadmatch
digestive system perforation;perforation;broadmatch
digestive system perforation;digestive system injury;broadmatch
adult malignant mesenchymoma;malignant mesenchymoma;broadmatch
digestive system obstruction;digestive system finding;broadmatch
digestive system obstruction;obstruction;broadmatch
upper gastrointestinal hemorrhage;gastrointestinal hemorrhage;broadmatch
small intestinal infection;non-neoplastic intestinal disorder;broadmatch
small intestinal infection;digestive system infection;broadmatch
stage iv cutaneous t-cell non-hodgkin lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
stage ii cutaneous t-cell non-hodgkin lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
stage i cutaneous t-cell non-hodgkin lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
cranial cavity;body cavity;broadmatch
oral mucosa;mucosa;broadmatch
dna repair disorder;genetic disorder;broadmatch
peutz-jeghers polyp of the small intestine;peutz-jeghers polyp;broadmatch
peutz-jeghers polyp of the small intestine;small intestinal hamartoma;broadmatch
angiokeratoma of fordyce;skin angiokeratoma;broadmatch
mucous membrane leukoplakia;leukoplakia;broadmatch
mouth mucous membrane leukoplakia;mucous membrane leukoplakia;broadmatch
mouth mucous membrane leukoplakia;oral cavity leukoplakia;broadmatch
peau d'orange;integumentary system signs and symptoms;broadmatch
clinical test result;finding;broadmatch
precancerous atypia;atypia;broadmatch
digestive system precancerous condition;precancerous condition by site;broadmatch
stage iii cutaneous t-cell non-hodgkin lymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
non-infectious cystitis;cystitis;broadmatch
small intestinal obstruction;bowel obstruction;broadmatch
agent affecting blood or body fluid;pharmacologic substance;broadmatch
pleural infection;infectious disorder by site;broadmatch
pleural infection;non-neoplastic pleural disorder;broadmatch
pain in extremity;pain;broadmatch
lower gastrointestinal hemorrhage;gastrointestinal hemorrhage;broadmatch
decreased libido;sexual dysfunction;broadmatch
trochlear nerve disorder;cranial nerve disorder;broadmatch
intra-abdominal hemorrhage;hemorrhage;broadmatch
hepatic infection;non-neoplastic liver and intrahepatic bile duct disorder;broadmatch
hepatic infection;digestive system infection;broadmatch
hemoglobin increased;elevated test result;broadmatch
hemoglobin increased;abnormal blood chemistry and hematology test result;broadmatch
digestive system fistula;fistula;broadmatch
gastric infection;non-neoplastic stomach disorder;broadmatch
gastric infection;digestive system infection;broadmatch
gait disturbance;motor manifestations;broadmatch
clinical tnm finding;cancer tnm finding category;broadmatch
neoplastic lipoblast;neoplastic lipocyte;broadmatch
malignant lipocyte;malignant connective and soft tissue cell;broadmatch
neoplastic endocrine clear cell;neoplastic epithelial clear cell;broadmatch
neoplastic muscle cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic neuroendocrine spindle cell;neoplastic epithelial spindle cell;broadmatch
neoplastic neuroendocrine spindle cell;neoplastic neuroendocrine cell;broadmatch
neoplastic neuroendocrine polygonal cell;neoplastic epithelial polygonal cell;broadmatch
neoplastic neuroendocrine polygonal cell;neoplastic neuroendocrine cell;broadmatch
neoplastic adrenal cortical compact cell;neoplastic adrenal cortical cell;broadmatch
neoplastic endocrine clear cell;neoplastic endocrine cell;broadmatch
malignant endocrine cell;neoplastic endocrine cell;broadmatch
neoplastic lactotroph cell;neoplastic adenohypophysial cell;broadmatch
malignant endocrine cell;malignant epithelial cell;broadmatch
neoplastic glomerulosa cell;neoplastic adrenal cortical cell;broadmatch
neoplastic endocrine cell;neoplastic epithelial cell;broadmatch
neoplastic endocrine null cell;neoplastic adenohypophysial cell;broadmatch
neoplastic thyrotroph cell;neoplastic adenohypophysial cell;broadmatch
neoplastic gonadotroph cell;neoplastic adenohypophysial cell;broadmatch
neoplastic corticotroph cell;neoplastic adenohypophysial cell;broadmatch
neoplastic smooth muscle cell;neoplastic muscle cell;broadmatch
neoplastic oncocyte;neoplastic glandular cell;broadmatch
neoplastic oncocyte;neoplastic large cell with abundant cytoplasm;broadmatch
malignant oncocyte;neoplastic oncocyte;broadmatch
bizarre cell with evidence of skeletal muscle differentiation;malignant rhabdomyoblast;broadmatch
spindle cell myoblast;neoplastic connective and soft tissue spindle cell;broadmatch
spindle cell myoblast;rhabdomyoblast;broadmatch
round cell with primitive myoblastic differentiation;malignant rhabdomyoblast;broadmatch
round cell with primitive myoblastic differentiation;neoplastic round cell;broadmatch
round cell with primitive myoblastic differentiation;round striated muscle cell;broadmatch
round striated muscle cell;rhabdomyoblast;broadmatch
primitive striated muscle cell;rhabdomyoblast;broadmatch
strap-like skeletal muscle cell;neoplastic skeletal muscle cell;broadmatch
neoplastic striated muscle cell;neoplastic muscle cell;broadmatch
neoplastic spindle-shaped smooth muscle cell;neoplastic connective and soft tissue spindle cell;broadmatch
neoplastic spindle-shaped smooth muscle cell;neoplastic smooth muscle cell;broadmatch
malignant small undifferentiated cell;malignant small cell;broadmatch
neoplastic acinar cell;neoplastic glandular cell;broadmatch
malignant oncocyte;adenocarcinoma cell with abundant cytoplasm;broadmatch
neoplastic somatotroph cell;neoplastic adenohypophysial cell;broadmatch
atypical epithelial cell;abnormal epithelial cell;broadmatch
neoplastic connective and soft tissue spindle cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic langerhans cell;neoplastic dendritic cell;broadmatch
neoplastic sertoli cell;neoplastic sex cord-stromal cell;broadmatch
neoplastic granulosa cell;neoplastic sex cord-stromal cell;broadmatch
neoplastic follicular dendritic cell;neoplastic dendritic cell;broadmatch
neoplastic interdigitating dendritic cell;neoplastic dendritic cell;broadmatch
mucin-producing neoplastic epithelial cell;neoplastic epithelial cell;broadmatch
malignant langerhans cell;neoplastic langerhans cell;broadmatch
malignant langerhans cell;malignant cell;broadmatch
neoplastic histiocyte;neoplastic histiocytic and dendritic cell;broadmatch
primitive mesenchymal round cell;neoplastic round cell;broadmatch
neoplastic connective and soft tissue cell;abnormal connective and soft tissue cell;broadmatch
neoplastic connective and soft tissue cell;neoplastic cell;broadmatch
malignant polygonal cell with abundant granular cytoplasm;neoplastic polygonal cell with abundant granular cytoplasm;broadmatch
malignant polygonal cell with abundant granular cytoplasm;malignant cell;broadmatch
neoplastic glandular cell with eosinophilic granular cytoplasm;neoplastic cell with eosinophilic cytoplasm;broadmatch
neoplastic glandular cell with eosinophilic granular cytoplasm;neoplastic glandular cell;broadmatch
adenocarcinoma cell with eosinophilic granular cytoplasm;adenocarcinoma cell with eosinophilic cytoplasm;broadmatch
neoplastic leydig cell;neoplastic sex cord-stromal cell;broadmatch
malignant primitive germ cell;malignant germ cell;broadmatch
neoplastic sex cord-stromal cell;neoplastic cell;broadmatch
neoplastic stellate cell;neoplastic connective and soft tissue cell;broadmatch
primitive mesenchymal round cell;primitive mesenchymal cell;broadmatch
apocrine carcinoma cell;malignant apocrine cell;broadmatch
apocrine carcinoma cell;adenocarcinoma cell;broadmatch
primitive mesenchymal cell;malignant connective and soft tissue cell;broadmatch
neoplastic syncytiotrophoblastic cell;neoplastic trophoblastic cell;broadmatch
neoplastic syncytiotrophoblastic cell;abnormal syncytiotrophoblastic cell;broadmatch
neoplastic large germ cell;neoplastic large cell;broadmatch
neoplastic large germ cell;neoplastic germ cell;broadmatch
neoplastic germ cell;abnormal germ cell;broadmatch
neoplastic germ cell;neoplastic cell;broadmatch
signet ring stromal cell;neoplastic sex cord-stromal cell;broadmatch
signet ring stromal cell;signet ring cell;broadmatch
malignant osteoblast;malignant connective and soft tissue cell;broadmatch
malignant osteoblast;neoplastic osteoblast;broadmatch
neoplastic osteoblast;neoplastic connective and soft tissue cell;broadmatch
neoplastic connective and soft tissue spindle cell;neoplastic spindle cell;broadmatch
neoplastic spindle-shaped fibroblast;neoplastic connective and soft tissue spindle cell;broadmatch
lobular carcinoma cell;neoplastic lobular epithelial cell;broadmatch
neoplastic small cleaved follicle center cell;neoplastic centrocyte;broadmatch
neoplastic immunoblast;neoplastic large lymphocyte;broadmatch
neoplastic large lymphocyte;neoplastic large cell;broadmatch
neoplastic large lymphocyte;neoplastic lymphocyte;broadmatch
neoplastic medium-sized b-lymphocyte with eccentric basophilic cytoplasm;neoplastic medium-sized b-lymphocyte with basophilic cytoplasm;broadmatch
neoplastic medium-sized lymphocyte;neoplastic lymphocyte;broadmatch
neoplastic monocytoid b-lymphocyte;neoplastic b-lymphocyte;broadmatch
neoplastic small cleaved follicle center cell;neoplastic small b-lymphocyte;broadmatch
centrocyte-like cell;neoplastic b-lymphocyte;broadmatch
neoplastic medium-sized to large lymphocyte;neoplastic lymphocyte;broadmatch
lymphoplasmacytoid cell;neoplastic b-lymphocyte;broadmatch
neoplastic small lymphocyte with clumped chromatin;neoplastic small b-lymphocyte;broadmatch
neoplastic small lymphocyte;neoplastic lymphocyte;broadmatch
pleomorphic t-lymphocyte;neoplastic t-lymphocyte;broadmatch
pleomorphic t-lymphocyte;pleomorphic lymphocyte;broadmatch
pleomorphic lymphocyte;pleomorphic cell;broadmatch
pleomorphic lymphocyte;neoplastic lymphocyte;broadmatch
neoplastic b-immunoblast;neoplastic immunoblast;broadmatch
neoplastic b-immunoblast;neoplastic large b-lymphocyte;broadmatch
plasmablastic immunoblast;neoplastic b-immunoblast;broadmatch
neoplastic t-immunoblast;neoplastic immunoblast;broadmatch
neoplastic t-cell large granular lymphocyte;neoplastic large t-lymphocyte;broadmatch
anaplastic large lymphocyte;neoplastic large lymphocyte;broadmatch
anaplastic large lymphocyte;anaplastic cell;broadmatch
anaplastic large t-lymphocyte;anaplastic t-lymphocyte;broadmatch
anaplastic large t-lymphocyte;anaplastic large lymphocyte;broadmatch
anaplastic large t-lymphocyte;neoplastic large t-lymphocyte;broadmatch
neoplastic large t-lymphocyte;neoplastic t-lymphocyte;broadmatch
neoplastic large t-lymphocyte;neoplastic large lymphocyte;broadmatch
anaplastic large b-lymphocyte;anaplastic large lymphocyte;broadmatch
anaplastic large b-lymphocyte;neoplastic large b-lymphocyte;broadmatch
neoplastic centroblast;neoplastic follicle center b-cell;broadmatch
neoplastic centroblast;neoplastic large b-lymphocyte;broadmatch
neoplastic large b-lymphocyte;neoplastic b-lymphocyte;broadmatch
neoplastic large b-lymphocyte;neoplastic large lymphocyte;broadmatch
neoplastic t-immunoblast;neoplastic large t-lymphocyte;broadmatch
neoplastic natural killer cell;neoplastic t-lymphocyte and neoplastic natural killer cell;broadmatch
neoplastic small to medium-sized b-lymphocyte with pale cytoplasm;neoplastic b-lymphocyte;broadmatch
neoplastic spindle-shaped fibroblast;neoplastic fibroblast;broadmatch
malignant glomus cell;malignant connective and soft tissue cell;broadmatch
monovacuolated lipoblast;neoplastic lipoblast;broadmatch
multilobated lipoblast-like cell;neoplastic connective and soft tissue cell;broadmatch
pale brown fat cell;polygonal brown fat cell;broadmatch
eosinophilic brown fat cell;polygonal brown fat cell;broadmatch
multivacuolated brown fat cell;polygonal brown fat cell;broadmatch
polygonal brown fat cell;neoplastic lipocyte;broadmatch
polygonal brown fat cell;neoplastic polygonal cell;broadmatch
malignant glomus cell;glomus cell;broadmatch
neoplastic small to medium-sized b-lymphocyte with pale cytoplasm;neoplastic small to medium-sized lymphocyte;broadmatch
glomus cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic myoid cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic fusiform cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic fibrohistiocytic cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic histiocyte-like cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic fibroblast-like cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic spindle-shaped myofibroblast;neoplastic spindle-shaped fibroblast;broadmatch
multivacuolated lipoblast;neoplastic lipoblast;broadmatch
pleomorphic lipoblast;pleomorphic connective and soft tissue cell;broadmatch
pleomorphic lipoblast;malignant lipocyte;broadmatch
pleomorphic lipoblast;neoplastic lipoblast;broadmatch
neoplastic small to medium-sized lymphocyte;neoplastic lymphocyte;broadmatch
neoplastic lymphocyte;neoplastic hematopoietic and lymphoid cell;broadmatch
neoplastic lymphocyte;abnormal lymphocyte;broadmatch
neoplastic lymphocyte;malignant cell;broadmatch
abnormal hematopoietic and lymphoid cell;abnormal cell;broadmatch
neoplastic chondroblast;neoplastic cartilage cell;broadmatch
atypical chondrocyte;neoplastic chondrocyte;broadmatch
neoplastic chondrocyte;neoplastic cartilage cell;broadmatch
chondrocyte-like cell;neoplastic connective and soft tissue cell;broadmatch
ganglion-like cell;neoplastic connective and soft tissue cell;broadmatch
hyperchromatic stromal cell;neoplastic stromal cell;broadmatch
hyperchromatic adipocyte;atypical adipocyte;broadmatch
atypical adipocyte;neoplastic lipocyte;broadmatch
signet ring lipoblast;neoplastic lipoblast;broadmatch
signet ring lipoblast;malignant lipocyte;broadmatch
adenocarcinoma cell with eosinophilic granular cytoplasm;neoplastic glandular cell with eosinophilic granular cytoplasm;broadmatch
lobular carcinoma cell;adenocarcinoma cell;broadmatch
anaplastic cell;neoplastic large cell;broadmatch
neoplastic cutaneous basal cell;neoplastic basaloid cell;broadmatch
malignant epithelial clear cell;malignant epithelial cell;broadmatch
malignant epithelial clear cell;neoplastic epithelial clear cell;broadmatch
malignant non-cutaneous basaloid cell;malignant basaloid cell;broadmatch
malignant non-cutaneous basaloid cell;neoplastic non-cutaneous basaloid cell;broadmatch
malignant non-cutaneous basaloid cell;adenocarcinoma cell;broadmatch
neoplastic non-cutaneous basaloid cell;neoplastic glandular cell;broadmatch
neoplastic non-cutaneous basaloid cell;neoplastic basaloid cell;broadmatch
malignant myoepithelial cell;malignant epithelial cell;broadmatch
malignant spindle squamous cell;malignant squamous cell;broadmatch
malignant myoepithelial cell;neoplastic myoepithelial cell;broadmatch
malignant epithelial cell;dysplastic epithelial cell;broadmatch
malignant epithelial cell;malignant cell;broadmatch
malignant transitional cell;malignant epithelial cell;broadmatch
malignant transitional cell;neoplastic transitional cell;broadmatch
signet ring adenocarcinoma cell;adenocarcinoma cell with intracytoplasmic mucin;broadmatch
signet ring adenocarcinoma cell;signet ring cell;broadmatch
giant epithelial cell;giant cell;broadmatch
giant epithelial cell;abnormal epithelial cell;broadmatch
dysplastic squamous cell;neoplastic squamous cell;broadmatch
non-keratinizing malignant small squamous cell;non-keratinizing malignant squamous cell;broadmatch
neoplastic trophoblastic cell;neoplastic cell;broadmatch
abnormal intermediate type trophoblastic cell;abnormal trophoblastic cell;broadmatch
abnormal cytotrophoblastic cell;abnormal trophoblastic cell;broadmatch
abnormal syncytiotrophoblastic cell;abnormal trophoblastic cell;broadmatch
abnormal trophoblastic cell;abnormal cell;broadmatch
poorly differentiated adenocarcinoma cell;adenocarcinoma cell;broadmatch
malignant epithelial small cell;malignant small cell;broadmatch
malignant epithelial small cell;malignant epithelial cell;broadmatch
dysplastic glandular cell;dysplastic epithelial cell;broadmatch
dysplastic glandular cell;neoplastic glandular cell;broadmatch
non-keratinizing malignant large squamous cell;malignant large squamous cell;broadmatch
non-keratinizing malignant large squamous cell;non-keratinizing malignant squamous cell;broadmatch
non-keratinizing malignant squamous cell;malignant squamous cell;broadmatch
keratinizing malignant squamous cell;malignant squamous cell;broadmatch
non-keratinizing malignant small squamous cell;malignant small squamous cell;broadmatch
malignant spindle squamous cell;malignant epithelial spindle cell;broadmatch
multinucleated malignant squamous cell;malignant large squamous cell;broadmatch
dysplastic epithelial cell;neoplastic epithelial cell;broadmatch
neoplastic epithelial cell;abnormal epithelial cell;broadmatch
alteration in respiration;ventilation or perfusion signs and symptoms;broadmatch
neoplastic basaloid cell;neoplastic epithelial cell;broadmatch
neoplastic hobnail cell;neoplastic cell;broadmatch
neoplastic clear cell;neoplastic cell;broadmatch
neoplastic epithelial clear cell;neoplastic clear cell;broadmatch
neoplastic epithelial clear cell;neoplastic epithelial cell;broadmatch
paget cell;adenocarcinoma cell;broadmatch
neoplastic epithelial cell;neoplastic cell;broadmatch
multinucleated malignant squamous cell;malignant epithelial giant cell;broadmatch
large keratinocyte;neoplastic keratinocyte;broadmatch
neoplastic keratinocyte;abnormal keratinocyte;broadmatch
neoplastic keratinocyte;neoplastic squamous cell;broadmatch
abnormal epithelial cell;abnormal cell;broadmatch
rhabdomyoblast;neoplastic striated muscle cell;broadmatch
neoplastic centrocyte;neoplastic follicle center b-cell;broadmatch
spider cell;rhabdomyoblast;broadmatch
neoplastic squamous cell;abnormal squamous cell;broadmatch
neoplastic squamous cell;dysplastic epithelial cell;broadmatch
neoplastic neuroendocrine cell;neoplastic endocrine cell;broadmatch
neoplastic glandular cell;neoplastic epithelial cell;broadmatch
adenocarcinoma cell;dysplastic glandular cell;broadmatch
adenocarcinoma cell;malignant epithelial cell;broadmatch
abnormal squamous cell;abnormal epithelial cell;broadmatch
malignant squamous cell;dysplastic squamous cell;broadmatch
malignant squamous cell;malignant epithelial cell;broadmatch
neoplastic myoepithelial cell;abnormal myoepithelial cell;broadmatch
neoplastic myoepithelial cell;neoplastic epithelial cell;broadmatch
abnormal myoepithelial cell;abnormal epithelial cell;broadmatch
neoplastic transitional cell;abnormal transitional cell;broadmatch
neoplastic transitional cell;neoplastic epithelial cell;broadmatch
abnormal transitional cell;abnormal epithelial cell;broadmatch
abnormal keratinocyte;abnormal squamous cell;broadmatch
neoplastic glandular cell with clear cytoplasm;neoplastic glandular cell;broadmatch
abnormal glandular cell;abnormal epithelial cell;broadmatch
neoplastic glandular cell;abnormal glandular cell;broadmatch
neoplastic trophoblastic cell;abnormal trophoblastic cell;broadmatch
warthin-finkeldey polykaryocyte;giant cell;broadmatch
neoplastic lobular epithelial cell;neoplastic glandular cell;broadmatch
neoplastic polygonal cell;neoplastic large cell with abundant cytoplasm;broadmatch
mucin-producing adenocarcinoma cell;adenocarcinoma cell;broadmatch
malignant neuroendocrine polygonal cell;neoplastic neuroendocrine polygonal cell;broadmatch
malignant neuroendocrine polygonal cell;malignant neuroendocrine large cell;broadmatch
malignant neuroendocrine spindle cell;malignant epithelial spindle cell;broadmatch
malignant neuroendocrine spindle cell;neoplastic neuroendocrine spindle cell;broadmatch
malignant neuroendocrine spindle cell;malignant neuroendocrine cell;broadmatch
neoplastic polygonal cell with abundant granular cytoplasm;neoplastic polygonal cell;broadmatch
polygonal adenocarcinoma cell with eosinophilic cytoplasm;large adenocarcinoma cell with eosinophilic cytoplasm;broadmatch
giant astrocyte;neoplastic astrocyte;broadmatch
polygonal adenocarcinoma cell with eosinophilic cytoplasm;adenocarcinoma cell with abundant cytoplasm;broadmatch
polygonal adenocarcinoma cell with eosinophilic cytoplasm;malignant polygonal cell with eosinophilic cytoplasm;broadmatch
neoplastic epithelial spindle cell;neoplastic spindle cell;broadmatch
neoplastic epithelial spindle cell;neoplastic epithelial cell;broadmatch
anaplastic carcinoma cell;malignant epithelial large cell;broadmatch
anaplastic carcinoma cell;anaplastic cell;broadmatch
hemosiderin-laden macrophage;abnormal macrophage;broadmatch
mucin-producing adenocarcinoma cell;mucin-producing malignant epithelial cell;broadmatch
giant adenocarcinoma cell;adenocarcinoma cell;broadmatch
giant adenocarcinoma cell;malignant epithelial giant cell;broadmatch
ductal carcinoma cell;adenocarcinoma cell;broadmatch
neoplastic ductal epithelial cell;neoplastic glandular cell;broadmatch
spindle melanoma cell;malignant spindle cell;broadmatch
spindle melanoma cell;melanoma cell;broadmatch
melanoma cell;neoplastic melanocyte;broadmatch
melanoma cell;malignant cell;broadmatch
epithelioid melanoma cell;melanoma cell;broadmatch
epithelioid melanocyte;neoplastic melanocyte;broadmatch
spindle melanocyte;neoplastic melanocyte;broadmatch
spindle melanocyte;neoplastic spindle cell;broadmatch
atypical melanocyte;neoplastic melanocyte;broadmatch
balloon nevus cell;nevus cell;broadmatch
neoplastic melanocyte;neoplastic cell;broadmatch
malignant small hyperchromatic cell;malignant small cell;broadmatch
malignant small cell;malignant cell;broadmatch
ductal carcinoma cell;neoplastic ductal epithelial cell;broadmatch
abnormal connective and soft tissue cell;abnormal cell;broadmatch
giant astrocyte;neoplastic multinucleated giant cell;broadmatch
warthin-finkeldey polykaryocyte;abnormal lymphocyte;broadmatch
malignant neuroendocrine small cell;malignant epithelial small cell;broadmatch
neoplastic spindle cell;neoplastic cell;broadmatch
malignant epithelial large cell;neoplastic large cell;broadmatch
malignant epithelial large cell;malignant epithelial cell;broadmatch
malignant neuroendocrine large cell;malignant neuroendocrine cell;broadmatch
malignant neuroendocrine large cell;malignant epithelial large cell;broadmatch
malignant neuroendocrine small cell;neoplastic neuroendocrine small cell;broadmatch
malignant neuroendocrine small cell;malignant neuroendocrine cell;broadmatch
neoplastic multinucleated giant cell;neoplastic large cell;broadmatch
granular adenocarcinoma cell;adenocarcinoma cell;broadmatch
neoplastic multinucleated giant cell;giant cell;broadmatch
large osteoclastic giant cell;giant cell;broadmatch
adenocarcinoma clear cell;malignant epithelial clear cell;broadmatch
adenocarcinoma clear cell;adenocarcinoma cell;broadmatch
adenocarcinoma clear cell;neoplastic glandular cell with clear cytoplasm;broadmatch
malignant clear squamous cell;malignant epithelial clear cell;broadmatch
malignant clear squamous cell;malignant squamous cell;broadmatch
malignant epithelial giant cell;giant epithelial cell;broadmatch
malignant epithelial giant cell;neoplastic multinucleated giant cell;broadmatch
malignant epithelial giant cell;malignant epithelial large cell;broadmatch
malignant neuroendocrine cell;neoplastic neuroendocrine cell;broadmatch
malignant thyroid gland follicular cell;malignant endocrine cell;broadmatch
malignant thyroid gland follicular cell;neoplastic thyroid gland follicular cell;broadmatch
malignant thyroid gland follicular cell;adenocarcinoma cell;broadmatch
neoplastic thyroid gland follicular cell;neoplastic endocrine cell;broadmatch
neoplastic thyroid gland follicular cell;neoplastic glandular cell;broadmatch
tingible body macrophage;abnormal macrophage;broadmatch
lipid-laden macrophage;abnormal macrophage;broadmatch
abnormal macrophage;abnormal connective and soft tissue cell;broadmatch
malignant mesothelial cell;neoplastic mesothelial cell;broadmatch
malignant mesothelial cell;malignant cell;broadmatch
abnormal mesothelial cell;abnormal cell;broadmatch
giant cell with myoblastic differentiation;malignant rhabdomyoblast;broadmatch
giant cell with myoblastic differentiation;neoplastic multinucleated giant cell;broadmatch
osteoclast-like giant cell;giant cell;broadmatch
malignant neuroendocrine cell;malignant endocrine cell;broadmatch
neoplastic t-cell large granular lymphocyte;abnormal large granular lymphocyte;broadmatch
neoplastic t-cell large granular lymphocyte;leukemic lymphocyte;broadmatch
neoplastic large cleaved follicle center cell;neoplastic centrocyte;broadmatch
taf15-nr4a3 fusion protein expression;fusion protein expression;broadmatch
has2-plag1 fusion protein expression;fusion protein expression;broadmatch
col1a2-plag1 fusion protein expression;fusion protein expression;broadmatch
pax7-foxo1 fusion protein expression;fusion protein expression;broadmatch
pax3-foxo1 fusion protein expression;fusion protein expression;broadmatch
fus-ddit3 fusion protein expression;fusion protein expression;broadmatch
ewsr1-wt1 fusion protein expression;fusion protein expression;broadmatch
tcf12-nr4a3 fusion protein expression;fusion protein expression;broadmatch
ewsr1-nr4a3 fusion protein expression;fusion protein expression;broadmatch
pml-rara fusion protein expression;fusion protein expression;broadmatch
ewsr1-atf1 fusion protein expression;fusion protein expression;broadmatch
ewsr1-etv4 fusion protein expression;fusion protein expression;broadmatch
ewsr1-etv1 fusion protein expression;fusion protein expression;broadmatch
ewsr1-erg fusion protein expression;fusion protein expression;broadmatch
kmt2a-af4 fusion protein expression;fusion protein expression;broadmatch
etv6-runx1 fusion protein expression;fusion protein expression;broadmatch
tcf3-pbx1 fusion protein expression;fusion protein expression;broadmatch
etv6-ntrk3 fusion protein expression;fusion protein expression;broadmatch
fus-atf1 fusion protein expression;fusion protein expression;broadmatch
ss18-ssx1 fusion protein expression;ss18-ssx fusion protein expression;broadmatch
ss18-ssx2 fusion protein expression;ss18-ssx fusion protein expression;broadmatch
trisomy 17;trisomy;broadmatch
trisomy 17;chromosome 17 abnormality;broadmatch
pulmonary adenomatosis;epithelial neoplasm (antiquated);broadmatch
loss of chromosome 11q;chromosomal loss;broadmatch
loss of chromosome 11q;11q aberration;broadmatch
cardiovascular system signs and symptoms;cardiovascular system finding;broadmatch
cardiovascular system signs and symptoms;sign or symptom;broadmatch
hmga2-lpp fusion protein expression;fusion protein expression;broadmatch
ewsr1-patz1 fusion protein expression;fusion protein expression;broadmatch
"t(1;22)(p36.1;q12)";chromosome 1 abnormality;broadmatch
"t(1;22)(p36.1;q12)";chromosomal translocation;broadmatch
ewsr1-fev fusion protein expression;fusion protein expression;broadmatch
"t(2;22)(q33;q12)";chromosomal translocation;broadmatch
aspl-tfe3 fusion protein expression;fusion protein expression;broadmatch
ss18-ssx4 fusion protein expression;ss18-ssx fusion protein expression;broadmatch
ewsr1-fli1 fusion protein expression;fusion protein expression;broadmatch
numa1-rara fusion protein expression;fusion protein expression;broadmatch
tetrasomy 7;chromosome 7 abnormality;broadmatch
neoplastic monoblast;neoplastic myeloid blast;broadmatch
gain of chromosome 12q13;chromosomal gain;broadmatch
gain of chromosome 12q13;chromosome 12 abnormality;broadmatch
neoplastic t-prolymphocyte;neoplastic t-lymphocyte;broadmatch
neoplastic t-prolymphocyte;neoplastic prolymphocyte;broadmatch
neoplastic b-prolymphocyte;neoplastic b-lymphocyte;broadmatch
neoplastic b-prolymphocyte;neoplastic prolymphocyte;broadmatch
neoplastic prolymphocyte;leukemic lymphocyte;broadmatch
medium-sized neoplastic myeloblast with coarse cytoplasmic basophilic granules;neoplastic myeloblast;broadmatch
npm1-rara fusion protein expression;fusion protein expression;broadmatch
neoplastic myeloblast without azurophilic granules;neoplastic myeloblast;broadmatch
neoplastic myeloblast with azurophilic granules;neoplastic myeloblast;broadmatch
neoplastic medium-sized myeloblast with basophilic agranular cytoplasm;neoplastic myeloblast with basophilic cytoplasm;broadmatch
neoplastic myeloblast with abundant basophilic cytoplasm;neoplastic myeloblast with basophilic cytoplasm;broadmatch
neutrophil with pseudo chediak-higashi granules;neutrophil with abnormal cytoplasmic granulation;broadmatch
neutrophil with cytoplasmic hypogranularity;neutrophil with abnormal cytoplasmic granulation;broadmatch
neutrophil with abnormal cytoplasmic granulation;dysplastic neutrophil;broadmatch
del(6q25-27);chromosomal deletion;broadmatch
del(17q25);chromosome 17 abnormality;broadmatch
del(17q25);chromosomal deletion;broadmatch
"t(9;22)(q22-31;q12)";chromosomal translocation;broadmatch
zbtb16-rara fusion protein expression;fusion protein expression;broadmatch
oral cavity hairy leukoplakia;aids-related disorder;broadmatch
oral cavity hairy leukoplakia;oral cavity leukoplakia;broadmatch
cbfb-myh11 fusion protein expression;fusion protein expression;broadmatch
aml1-eto fusion protein expression;fusion protein expression;broadmatch
fip1l1-pdgfralpha fusion protein expression;fusion protein expression;broadmatch
cltc-alk fusion protein expression;alk fusion protein expression;broadmatch
"t(6;11)(p21;q12)";11q12 translocation;broadmatch
"t(6;11)(p21;q12)";tfeb gene translocation;broadmatch
rearrangement of 2p23;chromosomal rearrangement;broadmatch
zap70 messenger rna overexpression;messenger rna overexpression;broadmatch
"t(16;17)(q22;p13)";chromosomal translocation;broadmatch
"t(16;17)(q22;p13)";chromosome 17 abnormality;broadmatch
intravascular metastasis;metastasis;broadmatch
trisomy 11;trisomy;broadmatch
trisomy 16;trisomy;broadmatch
tetrasomy 7;tetrasomy;broadmatch
neoplastic large cleaved follicle center cell;neoplastic large b-lymphocyte;broadmatch
gnaq gene;heterotrimeric g protein subunit gene;broadmatch
immature t-lymphocyte;immature lymphocyte;broadmatch
immature t-lymphocyte;t-lymphocyte;broadmatch
mature cytotoxic t-lymphocyte;cytotoxic t-lymphocyte;broadmatch
peripheral epidermotropic t-lymphocyte;mature t-lymphocyte;broadmatch
marginal zone b-lymphocyte of nodal type;marginal zone b-lymphocyte;broadmatch
malaise;symptom;broadmatch
gnas gene;heterotrimeric g protein subunit gene;broadmatch
juvenile polyp;gastrointestinal hamartoma;broadmatch
cyclin d2 messenger rna overexpression;messenger rna overexpression;broadmatch
pseudolymphoma;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
lesion;finding;broadmatch
alk gene;receptor tyrosine kinase gene;broadmatch
bcl2 gene translocation;chromosomal translocation;broadmatch
bcl2 gene translocation;bcl2 gene rearrangement;broadmatch
cd44 messenger rna overexpression;messenger rna overexpression;broadmatch
irf4/mum1 messenger rna overexpression;messenger rna overexpression;broadmatch
immature peripheral gamma/delta cell of cytotoxic type;immature t-lymphocyte;broadmatch
immature peripheral gamma/delta cell of cytotoxic type;peripheral (post-thymic) t-lymphocyte;broadmatch
immature peripheral alpha/beta cell of cytotoxic type;immature t-lymphocyte;broadmatch
immature peripheral alpha/beta cell of cytotoxic type;peripheral (post-thymic) t-lymphocyte;broadmatch
ataxic gait;gait disturbance;broadmatch
postgerminal center memory b-lymphocyte;postgerminal center b-lymphocyte;broadmatch
postgerminal center memory b-lymphocyte;memory b-lymphocyte;broadmatch
naive pregerminal center b-lymphocyte;mature b-lymphocyte;broadmatch
interdigitating dendritic cell;dendritic cell;broadmatch
germinal center b-lymphocyte;mature b-lymphocyte;broadmatch
postgerminal center marginal zone b-lymphocyte;marginal zone b-lymphocyte;broadmatch
postgerminal center marginal zone b-lymphocyte;postgerminal center b-lymphocyte;broadmatch
activated b-lymphocyte;mature b-lymphocyte;broadmatch
activated b-lymphocyte;activated lymphocyte;broadmatch
peripheral b-lymphocyte of inner mantle zone;mature b-lymphocyte;broadmatch
intraepithelial t-lymphocyte;mature t-lymphocyte;broadmatch
peripheral b-lymphocyte;mature b-lymphocyte;broadmatch
thymic b-lymphocyte;mature b-lymphocyte;broadmatch
unfavorable clinical outcome;clinical course of disease;broadmatch
bcl2 gene mrna overexpression;messenger rna overexpression;broadmatch
pkcbeta1 messenger rna overexpression;messenger rna overexpression;broadmatch
"t(x;1)(p11.2;q21)";tfe3 gene translocation;broadmatch
"t(9;12)(q34;p13)";chromosome 12 abnormality;broadmatch
intestinal mass;abdominal mass;broadmatch
"t(9;22)(p24;q11)";chromosomal translocation;broadmatch
bcr-jak2 fusion protein expression;fusion protein expression;broadmatch
"t(9;12)(p24;p13)";chromosomal translocation;broadmatch
"t(9;12)(p24;p13)";etv6 gene rearrangement;broadmatch
tel-jak2 fusion protein expression;fusion protein expression;broadmatch
"t(9;12)(q34;p13)";chromosomal translocation;broadmatch
tel-abl fusion protein expression;fusion protein expression;broadmatch
lmo2 messenger rna overexpression;messenger rna overexpression;broadmatch
bcr-pdgfralpha fusion protein expression;fusion protein expression;broadmatch
"t(4;22)(q12;q11)";chromosomal translocation;broadmatch
bcr-fgfr1 fusion protein expression;fusion protein expression;broadmatch
"t(8;22)(p11;q11)";chromosomal translocation;broadmatch
"t(x;1)(p11.2;p34)";chromosome 1 abnormality;broadmatch
"t(x;1)(p11.2;p34)";tfe3 gene translocation;broadmatch
"t(x;1)(p11.2;q21)";chromosome 1 abnormality;broadmatch
gain of chromosome 14;chromosomal gain;broadmatch
constipation;disturbance in bowel function;broadmatch
cough;respiratory system signs and symptoms;broadmatch
dizziness;neurological signs and symptoms;broadmatch
a-myb messenger rna overexpression;messenger rna overexpression;broadmatch
bcl-6 messenger rna overexpression;messenger rna overexpression;broadmatch
cd10 messenger rna overexpression;messenger rna overexpression;broadmatch
male reproductive system precancerous condition;precancerous condition by site;broadmatch
male reproductive system precancerous condition;male reproductive system neoplasm;broadmatch
metachronous malignant neoplasm;malignant neoplasm;broadmatch
recurrent disease;clinical course of disease;broadmatch
malignant ascites;ascites;broadmatch
typhlitis;colitis;broadmatch
tremor;motor manifestations;broadmatch
pneumothorax;non-neoplastic pleural disorder;broadmatch
palpitation;cardiovascular system signs and symptoms;broadmatch
hypophosphatemia;abnormal blood chemistry and hematology test result;broadmatch
hypokalemia;abnormal blood chemistry and hematology test result;broadmatch
hypocalcemia;abnormal blood chemistry and hematology test result;broadmatch
hypolobated neutrophil;dysplastic neutrophil;broadmatch
pleomorphic adenocarcinoma cell;pleomorphic epithelial cell;broadmatch
pleomorphic adenocarcinoma cell;adenocarcinoma cell;broadmatch
neoplastic megakaryoblast;neoplastic myeloid blast;broadmatch
hypogranular promyelocyte;neoplastic promyelocyte;broadmatch
hypergranular promyelocyte;neoplastic promyelocyte;broadmatch
neoplastic promyelocyte;neoplastic granulocyte;broadmatch
neoplastic t-lymphoblast;neoplastic t-lymphocyte;broadmatch
neoplastic t-lymphoblast;neoplastic lymphoblast;broadmatch
neoplastic b-lymphoblast;neoplastic b-lymphocyte;broadmatch
neoplastic b-lymphoblast;neoplastic lymphoblast;broadmatch
neoplastic myeloid blast;neoplastic myeloid cell;broadmatch
neoplastic hematopoietic and lymphoid cell;abnormal hematopoietic and lymphoid cell;broadmatch
neoplastic myeloid blast;neoplastic blast;broadmatch
neoplastic myeloblast with basophilic cytoplasm;neoplastic myeloblast;broadmatch
neoplastic myeloblast;neoplastic granulocyte;broadmatch
neoplastic myeloblast;neoplastic myeloid blast;broadmatch
neoplastic blast;leukemic cell;broadmatch
immature malignant mast cell;neoplastic mast cell;broadmatch
immature malignant mast cell;malignant cell;broadmatch
neoplastic promonocyte;neoplastic myeloid cell;broadmatch
neoplastic neutrophilic precursor;neoplastic granulocyte;broadmatch
neoplastic plasma cell;neoplastic b-lymphocyte;broadmatch
pseudo-gaucher cell;neoplastic plasma cell;broadmatch
neoplastic thyroid gland oncocyte;neoplastic oncocyte;broadmatch
neoplastic thyroid gland oncocyte;neoplastic thyroid gland follicular cell;broadmatch
epithelioid endothelial cell;neoplastic endothelial cell;broadmatch
spindle endothelial cell;neoplastic endothelial cell;broadmatch
vacuolated endothelial cell;neoplastic endothelial cell;broadmatch
neoplastic endothelial cell;abnormal endothelial cell;broadmatch
neoplastic endothelial cell;neoplastic connective and soft tissue cell;broadmatch
abnormal endothelial cell;abnormal connective and soft tissue cell;broadmatch
undifferentiated carcinoma cell;malignant epithelial cell;broadmatch
hyperchromatic spindle cell;neoplastic spindle cell;broadmatch
pleomorphic plasma cell;neoplastic plasma cell;broadmatch
plasmablast;neoplastic plasma cell;broadmatch
anaplastic plasma cell;neoplastic plasma cell;broadmatch
flame cell;neoplastic plasma cell;broadmatch
mott cell;neoplastic plasma cell;broadmatch
neoplastic mast cell;neoplastic hematopoietic and lymphoid cell;broadmatch
neoplastic hematopoietic and lymphoid cell;neoplastic cell;broadmatch
pleomorphic epithelial cell;pleomorphic cell;broadmatch
dysplastic neutrophil;abnormal neutrophil;broadmatch
neoplastic monocyte;abnormal monocyte;broadmatch
abnormal monocyte;abnormal myeloid cell;broadmatch
large atypical platelet;abnormal platelet;broadmatch
abnormal platelet;abnormal hematopoietic and lymphoid cell;broadmatch
neoplastic epithelial polygonal cell;neoplastic polygonal cell;broadmatch
neoplastic epithelial polygonal cell;neoplastic epithelial cell;broadmatch
abnormal eosinophil;abnormal hematopoietic and lymphoid cell;broadmatch
toxic neutrophil;abnormal neutrophil;broadmatch
neoplastic large erythroblast;neoplastic erythroblast;broadmatch
abnormal neutrophil;abnormal hematopoietic and lymphoid cell;broadmatch
popcorn cell;reed-sternberg cell;broadmatch
hodgkin-like cell;neoplastic large lymphocyte;broadmatch
mummified cell;reed-sternberg cell;broadmatch
reed-sternberg-like cell;neoplastic large lymphocyte;broadmatch
lacunar reed-sternberg cell;reed-sternberg cell;broadmatch
hodgkin cell;reed-sternberg cell;broadmatch
neoplastic monocyte;neoplastic myeloid cell;broadmatch
abnormal myeloid cell;abnormal hematopoietic and lymphoid cell;broadmatch
abnormal megakaryocyte;abnormal myeloid cell;broadmatch
large megakaryocyte;abnormal megakaryocyte;broadmatch
ring sideroblast;sideroblast;broadmatch
abnormal erythroblast;abnormal erythroid precursor;broadmatch
dysplastic erythroblast;abnormal erythroblast;broadmatch
dysplastic erythroblast;dysplastic erythroid precursor;broadmatch
large multinucleated erythroid cell;dysplastic erythroid precursor;broadmatch
dysplastic erythroid precursor;abnormal erythroid precursor;broadmatch
abnormal erythroid precursor;abnormal myeloid cell;broadmatch
faggot cell;neoplastic granulocyte;broadmatch
dysplastic granulocyte;abnormal granulocyte;broadmatch
abnormal granulocyte;abnormal myeloid cell;broadmatch
hyperchromatic megakaryocyte;dysplastic megakaryocyte;broadmatch
monolobed megakaryocyte;hypolobated megakaryocyte;broadmatch
hypolobated megakaryocyte;dysplastic megakaryocyte;broadmatch
dysplastic megakaryocyte;abnormal megakaryocyte;broadmatch
giant megakaryocyte;abnormal megakaryocyte;broadmatch
malignant thyroid gland oncocyte;malignant thyroid gland follicular cell;broadmatch
malignant thyroid gland oncocyte;malignant oncocyte;broadmatch
malignant thyroid gland oncocyte;neoplastic thyroid gland oncocyte;broadmatch
neoplastic ganglion cell;neoplastic neuroepithelial cell;broadmatch
malignant stromal cell;neoplastic mononuclear stromal cell;broadmatch
malignant stromal cell;malignant connective and soft tissue cell;broadmatch
neoplastic perineurial-like cell;neoplastic perineural cell;broadmatch
neoplastic schwann cell;neoplastic perineural cell;broadmatch
neoplastic stromal cell;neoplastic connective and soft tissue cell;broadmatch
rhabdoid cell;neoplastic cell;broadmatch
neoplastic oligodendrocyte-like cell;neoplastic glial cell;broadmatch
neoplastic neuroblast;neoplastic neuroepithelial cell;broadmatch
neoplastic round cell;neoplastic cell;broadmatch
neoplastic elongated glial cell;neoplastic glial cell;broadmatch
neoplastic ependymal cell;neoplastic glial cell;broadmatch
neoplastic intermediate type trophoblastic cell;neoplastic trophoblastic cell;broadmatch
neoplastic intermediate type trophoblastic cell;abnormal intermediate type trophoblastic cell;broadmatch
neoplastic oligodendrocyte;neoplastic glial cell;broadmatch
neoplastic cytotrophoblastic cell;neoplastic trophoblastic cell;broadmatch
neoplastic cytotrophoblastic cell;abnormal cytotrophoblastic cell;broadmatch
neoplastic perineurial cell;neoplastic perineural cell;broadmatch
neoplastic meningothelial cell;neoplastic cell;broadmatch
spindle-shaped meningothelial cell;neoplastic meningothelial cell;broadmatch
meningothelial cell with elongated processes;neoplastic meningothelial cell;broadmatch
pleomorphic epithelial cell;malignant epithelial cell;broadmatch
multilobated neoplastic b-lymphocyte;neoplastic large b-lymphocyte;broadmatch
malignant eosinophilic cell oncocyte;large adenocarcinoma cell with eosinophilic cytoplasm;broadmatch
malignant eosinophilic cell oncocyte;neoplastic eosinophilic cell oncocyte;broadmatch
malignant eosinophilic cell oncocyte;malignant oncocyte;broadmatch
neoplastic eosinophilic cell oncocyte;neoplastic cell with eosinophilic cytoplasm;broadmatch
neoplastic eosinophilic cell oncocyte;neoplastic oncocyte;broadmatch
atypical lymphocyte;abnormal lymphocyte;broadmatch
neoplastic polygonal cell with eosinophilic cytoplasm;neoplastic cell with eosinophilic cytoplasm;broadmatch
neoplastic polygonal cell with eosinophilic cytoplasm;neoplastic polygonal cell;broadmatch
neoplastic large cell with abundant pale cytoplasm;neoplastic large cell with abundant cytoplasm;broadmatch
neoplastic large cell;neoplastic cell;broadmatch
small meningothelial cell;neoplastic meningothelial cell;broadmatch
meningothelial cell with clear cytoplasm;neoplastic meningothelial cell;broadmatch
eosinophilic meningothelial cell;neoplastic meningothelial cell;broadmatch
xanthomatous astrocyte;xanthomatous cell;broadmatch
xanthomatous astrocyte;neoplastic astrocyte;broadmatch
neoplastic piloid astrocyte;neoplastic astrocyte;broadmatch
serous adenocarcinoma cell;adenocarcinoma cell;broadmatch
pleomorphic connective and soft tissue cell;pleomorphic cell;broadmatch
pleomorphic connective and soft tissue cell;neoplastic connective and soft tissue cell;broadmatch
pleomorphic cell;neoplastic cell;broadmatch
compound odontoma;odontoma;broadmatch
malignant epithelial spindle cell;malignant spindle cell;broadmatch
malignant epithelial spindle cell;neoplastic epithelial spindle cell;broadmatch
malignant epithelial spindle cell;malignant epithelial cell;broadmatch
adenocarcinoma spindle cell;malignant epithelial spindle cell;broadmatch
adenocarcinoma spindle cell;adenocarcinoma cell;broadmatch
neoplastic large cell with abundant cytoplasm;neoplastic large cell;broadmatch
neoplastic large cell with abundant eosinophilic cytoplasm;neoplastic large cell with abundant cytoplasm;broadmatch
neoplastic large cell with abundant eosinophilic cytoplasm;neoplastic cell with eosinophilic cytoplasm;broadmatch
neoplastic cell with eosinophilic cytoplasm;neoplastic cell;broadmatch
neoplastic epithelioid cell;neoplastic cell;broadmatch
neoplastic small round cell;neoplastic round cell;broadmatch
neoplastic serous epithelial cell;neoplastic glandular cell;broadmatch
serous adenocarcinoma cell;neoplastic serous epithelial cell;broadmatch
poorly differentiated neoplastic astrocyte;neoplastic astrocyte;broadmatch
neoplastic epithelial cell with intracytoplasmic mucin;neoplastic glandular cell;broadmatch
anaplastic astrocyte;neoplastic astrocyte;broadmatch
neoplastic astrocyte with few flaccid processes;neoplastic astrocyte;broadmatch
giant neoplastic germ cell;neoplastic large germ cell;broadmatch
giant neoplastic germ cell;neoplastic multinucleated giant cell;broadmatch
gemistocytic neoplastic astrocyte;neoplastic astrocyte;broadmatch
fibrillary neoplastic astrocyte;neoplastic astrocyte;broadmatch
neoplastic astrocyte;neoplastic glial cell;broadmatch
neoplastic glial cell;neoplastic neuroepithelial cell;broadmatch
neoplastic neuroepithelial cell;neoplastic neuroepithelial cell and neoplastic perineural cell;broadmatch
neoplastic multinucleated stromal cell;neoplastic stromal cell;broadmatch
neoplastic spindle-shaped to round cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic blastemal cell;neoplastic cell;broadmatch
atypical epithelioid cell;neoplastic epithelioid cell;broadmatch
adenocarcinoma cell with intracytoplasmic mucin;neoplastic epithelial cell with intracytoplasmic mucin;broadmatch
adenocarcinoma cell with intracytoplasmic mucin;adenocarcinoma cell;broadmatch
physaliphorous cell;neoplastic connective and soft tissue cell;broadmatch
sea-blue histiocyte;abnormal macrophage;broadmatch
malignant lipocyte;atypical adipocyte;broadmatch
"t(2;13)(q35;q14)";chromosomal translocation;broadmatch
"t(9;15)(q22;q21)";chromosomal translocation;broadmatch
"t(9;17)(q22;q11)";chromosomal translocation;broadmatch
"t(9;17)(q22;q11)";chromosome 17 abnormality;broadmatch
"t(x;17)(p11.2;q25)";tfe3 gene translocation;broadmatch
"t(x;17)(p11.2;q25)";chromosome 17 abnormality;broadmatch
molecular genetic variation;molecular sequence variation;broadmatch
"t(x;18)(p11;q11)";chromosomal translocation;broadmatch
"t(2;13)(q35;q14)";foxo1 gene rearrangement;broadmatch
monosomy 13;chromosome 13 abnormality;broadmatch
"t(1;2)(p11;q35-36)";chromosome 1 abnormality;broadmatch
"t(1;2)(p11;q35-36)";chromosomal translocation;broadmatch
"t(12;15)(p13;q25)";chromosomal translocation;broadmatch
"t(12;15)(p13;q25)";chromosome 12 abnormality;broadmatch
chromosome 1 abnormality;cytogenetic abnormality;broadmatch
giant rod chromosome;cytogenetic abnormality;broadmatch
monosomy 16;monosomy;broadmatch
trisomy 8;trisomy;broadmatch
trisomy 20;trisomy;broadmatch
inv(22);chromosomal inversion;broadmatch
"t(5;12)(q33;p13)";chromosome 5 rearrangement;broadmatch
"t(5;12)(q31;p12)";chromosome 5 rearrangement;broadmatch
loss of chromosome 7q;chromosomal loss;broadmatch
loss of chromosome 7q;chromosome 7 abnormality;broadmatch
"inv(3)(q21.3;q26.2)";rearrangement of 3q;broadmatch
"inv(3)(q21.3;q26.2)";paracentric inversion;broadmatch
"inv(3)(q21.3;q26.2)";inv(3);broadmatch
"t(3;3)(q21.3;q26.2)";rearrangement of 3q;broadmatch
"t(3;3)(q21.3;q26.2)";chromosomal translocation;broadmatch
loss of chromosome 20q;chromosomal loss;broadmatch
"t(6;8)(q27;p11)";chromosomal translocation;broadmatch
"t(8;9)(p11;q32-34)";chromosomal translocation;broadmatch
"t(8;13)(p11;q11)";chromosomal translocation;broadmatch
"t(8;13)(p11;q11)";chromosome 13q abnormality;broadmatch
"t(5;12)(q33;p13)";chromosomal translocation;broadmatch
"t(5;12)(q33;p13)";chromosome 12 abnormality;broadmatch
monosomy 13;monosomy;broadmatch
"t(5;12)(q33;q13-15)";chromosomal translocation;broadmatch
"t(5;12)(q31;p12)";chromosomal translocation;broadmatch
"t(21;22)(q22;q12)";erg gene rearrangement;broadmatch
"t(11;19)(q23.3;p13.3)";mll gene translocation;broadmatch
"t(11;19)(q23;p13.1)";mll gene translocation;broadmatch
"t(9;11)(p21.3;q23.3)";mll gene translocation;broadmatch
"t(17;22)(q21;q12)";chromosome 17 abnormality;broadmatch
"t(17;22)(q21;q12)";ewsr1 gene translocation;broadmatch
"t(7;22)(p22;q12)";chromosomal translocation;broadmatch
"t(7;22)(p22;q12)";chromosome 7 rearrangement;broadmatch
"t(21;22)(q22;q12)";ewsr1 gene translocation;broadmatch
"t(5;12)(q33;q13-15)";chromosome 12 abnormality;broadmatch
"t(9;11)(q21;q23)";mll gene translocation;broadmatch
"t(4;11)(q21;q23)";mll gene translocation;broadmatch
"t(11;17)(q13;q21)";rara gene translocation;broadmatch
"t(11;17)(q13;q21)";11q translocation;broadmatch
"t(11;17)(q23;q21)";11q23 abnormality;broadmatch
"t(11;17)(q23;q21)";rara gene translocation;broadmatch
"t(11;17)(q23;q21)";11q translocation;broadmatch
"inv(16)(p13.1;q22)";inv(16);broadmatch
"inv(16)(p13.1;q22)";pericentric inversion;broadmatch
"t(12;22)(q13;q12)";ewsr1 gene translocation;broadmatch
"t(12;22)(q13;q12)";rearrangement of 12q13;broadmatch
"t(5;12)(q33;q13-15)";chromosome 5 rearrangement;broadmatch
"t(2;12)(q35-37;q13-15)";chromosomal translocation;broadmatch
"t(2;12)(q35-37;q13-15)";chromosome 12 abnormality;broadmatch
"t(2;12)(p22-24;q13-15)";chromosomal translocation;broadmatch
"t(2;12)(p22-24;q13-15)";chromosome 12 abnormality;broadmatch
"t(1;12)(p32-34;q13-15)";chromosome 1 abnormality;broadmatch
"t(1;12)(p32-34;q13-15)";chromosomal translocation;broadmatch
"t(1;12)(p32-34;q13-15)";chromosome 12 abnormality;broadmatch
"t(3;12)(q27-28;q13-15)";rearrangement of 3q;broadmatch
"t(3;12)(q27-28;q13-15)";chromosomal translocation;broadmatch
"t(3;12)(q27-28;q13-15)";chromosome 12 abnormality;broadmatch
"t(1;13)(p36;q14)";chromosome 1 abnormality;broadmatch
"t(1;13)(p36;q14)";chromosomal translocation;broadmatch
"t(1;13)(p36;q14)";foxo1 gene rearrangement;broadmatch
"t(11;22)(p13;q12)";ewsr1 gene translocation;broadmatch
"t(5;12)(q31;p12)";chromosome 12 abnormality;broadmatch
loss of chromosome 12p;chromosome 12 abnormality;broadmatch
"t(5;17)(q35;q21)";chromosome 5 rearrangement;broadmatch
clonal immunoglobulin light chain gene rearrangement;clonal immunoglobulin gene rearrangement;broadmatch
clonal bcl6 gene rearrangement;bcl6 gene rearrangement;broadmatch
clonal t-cell receptor gamma chain gene rearrangement;clonal t-cell receptor gene rearrangement;broadmatch
clonal t-cell receptor gamma chain gene rearrangement;chromosome 7 rearrangement;broadmatch
clonal t-cell receptor beta chain gene rearrangement;clonal t-cell receptor gene rearrangement;broadmatch
clonal t-cell receptor beta chain gene rearrangement;chromosome 7 rearrangement;broadmatch
clonal t-cell receptor gene rearrangement;clonal antigen receptor gene rearrangement;broadmatch
clonal t-cell receptor gene rearrangement;t-cell receptor gene rearrangement;broadmatch
clonal immunoglobulin heavy chain gene rearrangement;clonal immunoglobulin gene rearrangement;broadmatch
"inv(2)(p23;q35)";rearrangement of 2p23;broadmatch
clonal immunoglobulin gene rearrangement;clonal antigen receptor gene rearrangement;broadmatch
clonal bcl2 gene rearrangement;clonal gene rearrangement;broadmatch
clonal bcl2 gene rearrangement;bcl2 gene rearrangement;broadmatch
gain of chromosome 12q;chromosomal gain;broadmatch
gain of chromosome 12q;chromosome 12 abnormality;broadmatch
gain of chromosome 9p;chromosomal gain;broadmatch
gain of chromosome 2p;chromosomal gain;broadmatch
clonal bcl6 gene rearrangement;clonal gene rearrangement;broadmatch
clonal antigen receptor gene rearrangement;clonal gene rearrangement;broadmatch
clonal immunoglobulin kappa light chain gene rearrangement;clonal immunoglobulin light chain gene rearrangement;broadmatch
clonal immunoglobulin lambda light chain gene rearrangement;clonal immunoglobulin light chain gene rearrangement;broadmatch
gain of chromosome 17;chromosomal gain;broadmatch
gain of chromosome 17;chromosome 17 abnormality;broadmatch
gain of chromosome 15;chromosomal gain;broadmatch
gain of chromosome 12;chromosomal gain;broadmatch
gain of chromosome 12;chromosome 12 abnormality;broadmatch
gain of chromosome 9;chromosomal gain;broadmatch
monosomy 22;monosomy;broadmatch
gain of chromosome 3;chromosomal gain;broadmatch
gain of chromosome 22;chromosomal gain;broadmatch
gain of chromosome 19;chromosomal gain;broadmatch
gain of chromosome 8;chromosomal gain;broadmatch
gain of chromosome 7;chromosomal gain;broadmatch
gain of chromosome 7;chromosome 7 abnormality;broadmatch
gain of chromosome 7q;chromosomal gain;broadmatch
gain of chromosome 7q;chromosome 7 abnormality;broadmatch
chromosomal gain;numerical chromosomal abnormality;broadmatch
"inv(2)(p23;q35)";paracentric inversion;broadmatch
loss of chromosome 12p;chromosomal loss;broadmatch
"t(1;22)(p13.3;q13.1)";chromosome 1 abnormality;broadmatch
del(11q22q23);chromosomal deletion;broadmatch
del(11q22q23);rearrangement of 11q;broadmatch
del(11q22q23);11q23 abnormality;broadmatch
del(13q14);chromosomal deletion;broadmatch
del(13q14);chromosome 13q abnormality;broadmatch
trisomy 12;trisomy;broadmatch
trisomy 12;chromosome 12 abnormality;broadmatch
"t(1;22)(p13.3;q13.1)";chromosomal translocation;broadmatch
"t(2;3)(p23;q21)";rearrangement of 3q;broadmatch
"t(8;16)(p11;p13)";chromosomal translocation;broadmatch
"t(3;5)(q25;q34)";rearrangement of 3q;broadmatch
"t(3;5)(q25;q34)";chromosomal translocation;broadmatch
"t(3;5)(q25;q34)";chromosome 5 rearrangement;broadmatch
"ins(3;3)";chromosomal insertion;broadmatch
monosomy 7;monosomy;broadmatch
monosomy 7;chromosome 7 abnormality;broadmatch
del(6q21);chromosomal deletion;broadmatch
del(17p13);chromosome 17p abnormality;broadmatch
del(17p13);chromosomal deletion;broadmatch
trisomy 3;trisomy;broadmatch
"t(2;3)(p23;q21)";rearrangement of 2p23;broadmatch
"t(2;3)(p23;q21)";chromosomal translocation;broadmatch
"t(1;2)(q25;p23)";rearrangement of 2p23;broadmatch
"t(1;2)(q25;p23)";chromosome 1 abnormality;broadmatch
"t(1;2)(q25;p23)";chromosomal translocation;broadmatch
trisomy 5;trisomy;broadmatch
trisomy 5;chromosome 5 abnormality;broadmatch
i(7q);isochromosome;broadmatch
i(7q);chromosome 7 abnormality;broadmatch
apoptotic pathway deregulation;molecular pathway deregulation;broadmatch
del(12p13);chromosomal deletion;broadmatch
del(12p13);chromosome 12 abnormality;broadmatch
trisomy 8q;trisomy;broadmatch
"t(8;8)(p11-12;q12)";chromosomal translocation;broadmatch
inv(14);chromosomal inversion;broadmatch
"t(5;17)(q35;q21)";rara gene translocation;broadmatch
"t(x;14)(q28;11)";chromosomal translocation;broadmatch
touton giant cell;giant cell;broadmatch
myeloblasts under 5 percent of peripheral blood white cells;myeloblasts under 10 percent of peripheral blood white cells;broadmatch
myeloblasts under 1 percent of peripheral blood white cells;myeloblasts 1 percent or less of peripheral blood white cells;broadmatch
ring sideroblasts 15 percent or more of erythroid precursors;ring sideroblasts present;broadmatch
hemoglobin f increased;hemoglobin increased;broadmatch
myeloblasts under 20 percent of peripheral blood white cells;blasts under 20 percent of peripheral blood white cells;broadmatch
myeloblasts under 20 percent of peripheral blood white cells;myeloblasts present;broadmatch
myeloblasts 5-19 percent of peripheral blood white cells;blasts 5-19 percent of peripheral blood white cells;broadmatch
myeloblasts 5-19 percent of peripheral blood white cells;myeloblasts under 20 percent of peripheral blood white cells;broadmatch
blasts under 20 percent of peripheral blood white cells;blasts 20 percent or less of peripheral blood white cells;broadmatch
bone marrow fibrosis;fibrosis;broadmatch
myeloblasts under 10 percent of bone marrow nucleated cells;blasts under 10 percent of bone marrow nucleated cells;broadmatch
myeloblasts under 10 percent of bone marrow nucleated cells;myeloblasts under 20 percent of bone marrow nucleated cells;broadmatch
leukoerythroblastic reaction;abnormal hematology test result;broadmatch
myeloblasts under 20 percent of bone marrow nucleated cells;immature myeloid cells increased in bone marrow;broadmatch
myeloblasts under 20 percent of bone marrow nucleated cells;blasts under 20 percent of bone marrow nucleated cells;broadmatch
immature granulocytes in peripheral blood increased;blast cells present in peripheral blood;broadmatch
blasts 20 percent or more of bone marrow nucleated cells;blasts 10 percent or more of bone marrow nucleated cells;broadmatch
myeloblasts 5-19 percent of bone marrow nucleated cells;myeloblasts under 20 percent of bone marrow nucleated cells;broadmatch
myeloblasts 5-9 percent of bone marrow nucleated cells;myeloblasts 5-19 percent of bone marrow nucleated cells;broadmatch
myeloblasts 20 percent or more of bone marrow nucleated cells;myeloblasts 10 percent or more of bone marrow nucleated cells;broadmatch
myeloblasts 20 percent or more of bone marrow nucleated cells;blasts 20 percent or more of bone marrow nucleated cells;broadmatch
erythroid precursors 80 percent or more of bone marrow nucleated cells;erythroid precursors 50 percent or more of bone marrow nucleated cells;broadmatch
myeloblasts 20 percent or more of bone marrow non-erythroid cells;myeloblasts 20 percent or more of bone marrow nucleated cells;broadmatch
erythroid precursors 50 percent or more of bone marrow nucleated cells;immature myeloid cells increased in bone marrow;broadmatch
neoplastic promonocytes in bone marrow markedly increased;cells of monocytic lineage 80 percent or more of bone marrow leukemic cells;broadmatch
monoblasts 80 percent or more of bone marrow monocytic cells;cells of monocytic lineage 80 percent or more of bone marrow leukemic cells;broadmatch
monoblasts 80 percent or more of bone marrow monocytic cells;monoblasts 20 percent or more of bone marrow nucleated cells;broadmatch
monoblasts 20 percent or more of bone marrow nucleated cells;immature myeloid cells increased in bone marrow;broadmatch
monoblasts 20 percent or more of bone marrow nucleated cells;blasts 20 percent or more of bone marrow nucleated cells;broadmatch
neoplastic monocytes and precursors 20 percent or more of bone marrow cells;immature myeloid cells increased in bone marrow;broadmatch
promyelocytes, myelocytes, and mature neutrophils 10 percent or more of bone marrow cells;normal bone marrow test result;broadmatch
bone marrow dysplasia present in 10 percent or more of the cells of two or more myeloid cell lines;bone marrow dysplasia present;broadmatch
bone marrow dysplasia present in 50 percent or more of the cells of two cell lines;bone marrow dysplasia present;broadmatch
bone marrow dysplasia present;abnormal bone marrow test result;broadmatch
bone marrow eosinophilia;abnormal bone marrow test result;broadmatch
bone marrow eosinophilia;eosinophilia;broadmatch
blasts 20 percent or more of peripheral blood white cells;blasts more than 10 percent of peripheral blood white cells;broadmatch
myeloblasts 10-19 percent of peripheral blood white cells;myeloblasts 5-19 percent of peripheral blood white cells;broadmatch
megakaryoblasts 50 percent or more of bone marrow nucleated cells;immature myeloid cells increased in bone marrow;broadmatch
firm mass;mass;broadmatch
mesenchymal differentiation;tissue differentiation;broadmatch
fetal -epithelial differentiation;epithelial differentiation;broadmatch
multinodular mass;mass;broadmatch
thorotrast exposure;chemical exposure;broadmatch
globular hyaline body;morphologic finding;broadmatch
steatosis;morphologic finding;broadmatch
necrotic change;morphologic finding;broadmatch
solid growth pattern;morphologic architectural pattern;broadmatch
myeloblasts 10-19 percent of bone marrow nucleated cells;blasts 10-19 percent of bone marrow nucleated cells;broadmatch
micropapillary pattern;papillary pattern;broadmatch
multifocal lesion;lesion by focality;broadmatch
fibrotic stroma formation;stromal change;broadmatch
single-file linear pattern;morphologic architectural pattern;broadmatch
bilateral mass;mass;broadmatch
sweating;sign;broadmatch
resectable mass;mass;broadmatch
astler-coller c2 colon carcinoma;astler-coller c2 colorectal carcinoma;broadmatch
astler-coller c2 colon carcinoma;colon cancer by astler-coller stage;broadmatch
astler-coller c1 colon carcinoma;astler-coller c1 colorectal carcinoma;broadmatch
astler-coller c1 colon carcinoma;colon cancer by astler-coller stage;broadmatch
myeloblasts 10-19 percent of bone marrow nucleated cells;myeloblasts 5-19 percent of bone marrow nucleated cells;broadmatch
myeloblasts 10-19 percent of bone marrow nucleated cells;myeloblasts 10 percent or more of bone marrow nucleated cells;broadmatch
myeloblasts under 5 percent of bone marrow nucleated cells;myeloblasts 5 percent or less of bone marrow nucleated cells;broadmatch
myeloblasts under 5 percent of bone marrow nucleated cells;blasts under 5 percent of bone marrow nucleated cells;broadmatch
myeloblasts under 2 percent of peripheral blood white cells;myeloblasts under 5 percent of peripheral blood white cells;broadmatch
small intestinal hamartoma;gastrointestinal hamartoma;broadmatch
small intestinal hamartoma;non-neoplastic intestinal disorder;broadmatch
astler-coller b1 colorectal carcinoma;colorectal cancer by astler-coller stage;broadmatch
astler-coller b1 rectal carcinoma;rectal cancer by astler-coller stage;broadmatch
astler-coller b1 rectal carcinoma;astler-coller b1 colorectal carcinoma;broadmatch
astler-coller a colon carcinoma;colon cancer by astler-coller stage;broadmatch
astler-coller a colon carcinoma;astler-coller a colorectal carcinoma;broadmatch
astler-coller b2 colorectal carcinoma;colorectal cancer by astler-coller stage;broadmatch
astler-coller b2 rectal carcinoma;rectal cancer by astler-coller stage;broadmatch
astler-coller b2 rectal carcinoma;astler-coller b2 colorectal carcinoma;broadmatch
megakaryoblasts 50 percent or more of bone marrow nucleated cells;megakaryocytes increased in bone marrow;broadmatch
normal bone marrow test result;normal laboratory test result;broadmatch
"t(1;7)(p33;q35)";chromosome 1 abnormality;broadmatch
messenger rna overexpression;deregulation of protein and messenger rna expression;broadmatch
protein deregulation;deregulation of protein and messenger rna expression;broadmatch
oncogene deregulation;gene abnormality;broadmatch
tumor-suppressor pathway deregulation;molecular pathway deregulation;broadmatch
signal transduction pathway deregulation;molecular pathway deregulation;broadmatch
molecular pathway deregulation;molecular abnormality;broadmatch
retinal hemangioma;connective and soft tissue neoplasm (antiquated);broadmatch
cell cycle deregulation;molecular pathway deregulation;broadmatch
deregulation of protein and messenger rna expression;gene abnormality;broadmatch
"t(8;22)(q24;q11)";chromosomal translocation;broadmatch
tumor-suppressor gene inactivation;gene abnormality;broadmatch
clonal gene rearrangement;gene rearrangement abnormality;broadmatch
polysomy;numerical chromosomal abnormality;broadmatch
tp53 gene inactivation;tumor-suppressor gene inactivation;broadmatch
tp53 gene inactivation;tp53 gene mutation;broadmatch
rb1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
rb1 gene inactivation;rb1 gene mutation;broadmatch
fusion protein expression;protein deregulation;broadmatch
"t(1;14)(p32;q11)";chromosomal translocation;broadmatch
"t(1;14)(p32;q11)";chromosome 1 abnormality;broadmatch
"t(7;9)(q34;q34.3)";chromosome 7 rearrangement;broadmatch
"t(1;7)(p33;q35)";chromosomal translocation;broadmatch
"t(1;7)(p33;q35)";chromosome 7 rearrangement;broadmatch
"t(5;14)(q31.1;q32.3)";chromosomal translocation;broadmatch
"t(5;14)(q31.1;q32.3)";chromosome 5 rearrangement;broadmatch
"t(14;19)(q32;q13.1)";chromosomal translocation;broadmatch
"t(14;14)(q11;q32)";chromosomal translocation;broadmatch
"t(3;14)(q27;q32)";rearrangement of 3q;broadmatch
"t(3;14)(q27;q32)";chromosomal translocation;broadmatch
"t(7;10)(q34;q24)";chromosomal translocation;broadmatch
"t(7;10)(q34;q24)";chromosome 7 rearrangement;broadmatch
"t(10;14)(q24;q11)";chromosomal translocation;broadmatch
"t(11;14)(p13;q11)";chromosomal translocation;broadmatch
"t(11;14)(p15;q11)";chromosomal translocation;broadmatch
"t(11;14)(p15;q11)";rearrangement of 11p15;broadmatch
"t(7;9)(q34;q34.3)";chromosomal translocation;broadmatch
gene abnormality;molecular genetic variation;broadmatch
"t(8;14)(q24;q32)";chromosomal translocation;broadmatch
atypical lymphocytes present in bone marrow;abnormal bone marrow test result;broadmatch
oral cavity leukoplakia;oral leukoplakia;broadmatch
head and neck finding;finding by site or system;broadmatch
integumentary system finding;finding by site or system;broadmatch
nervous system finding;finding by site or system;broadmatch
digestive system finding;finding by site or system;broadmatch
finding by site or system;finding;broadmatch
monoclonal polymorphic post-transplant lymphoproliferative disorder;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
polyclonal polymorphic post-transplant lymphoproliferative disorder;hematopoietic and lymphoid neoplasm (antiquated);broadmatch
lymphatic spread;neoplastic growth or spread;broadmatch
microsatellite instability;genomic instability;broadmatch
bone marrow basophilia;abnormal bone marrow test result;broadmatch
bone marrow basophilia;basophilia;broadmatch
ineffective hematopoiesis;abnormal hematology test result;broadmatch
benzene exposure;chemical exposure;broadmatch
auer rods present;morphologic finding;broadmatch
atypical lymphocytes present in peripheral blood;atypical lymphocytes present;broadmatch
atypical lymphocytes present in bone marrow;atypical lymphocytes present;broadmatch
eye and ear finding;head and neck finding;broadmatch
reproductive system finding;finding by site or system;broadmatch
endocrine system finding;finding by site or system;broadmatch
urinary system finding;finding by site or system;broadmatch
"t(12;16)(q13;p11)";rearrangement of 12q13;broadmatch
"t(12;16)(q13;p11)";fus gene translocation;broadmatch
chromosomal loss;numerical chromosomal abnormality;broadmatch
lesion by stage;lesion;broadmatch
lesion by grade;lesion;broadmatch
lesion by grade;morphologic finding;broadmatch
regional lymph node involvement;lymph node involvement;broadmatch
other finding;finding;broadmatch
neoplastic growth or spread;clinical course of disease;broadmatch
laboratory test result;clinical test result;broadmatch
finding by cause;finding;broadmatch
chemical exposure;environmental and occupational exposure;broadmatch
hematopoietic system finding;finding by site or system;broadmatch
connective and soft tissue finding;finding by site or system;broadmatch
congenital or acquired anatomic abnormality;non-neoplastic disorder by special category;broadmatch
gain of chromosome 18;chromosomal gain;broadmatch
monosomy 10;monosomy;broadmatch
monosomy 21;monosomy;broadmatch
gain of chromosome 17q22-q24;chromosome 17 abnormality;broadmatch
erbb2 protein overexpression;protein deregulation;broadmatch
erbb2 gene amplification;oncogene deregulation;broadmatch
erbb2 gene amplification;receptor tyrosine kinase gene amplification;broadmatch
gain of chromosome 19q;chromosomal gain;broadmatch
loss of chromosome 9p;chromosomal loss;broadmatch
gain of chromosome 20q13;chromosomal gain;broadmatch
gain of chromosome 17q22-q24;chromosomal gain;broadmatch
gain of chromosome 6p;chromosomal gain;broadmatch
trisomy 18;trisomy;broadmatch
loss of chromosome 19;chromosomal loss;broadmatch
loss of chromosome 17;chromosomal loss;broadmatch
loss of chromosome 17;chromosome 17 abnormality;broadmatch
monosomy x;monosomy;broadmatch
vaginal leukoplakia;genital leukoplakia;broadmatch
monosomy 11;monosomy;broadmatch
monosomy 8;monosomy;broadmatch
vaginal polyp;vaginal non-neoplastic disorder;broadmatch
vaginal polyp;polyp;broadmatch
c-erbb2 messenger rna overexpression;messenger rna overexpression;broadmatch
myc gene amplification;oncogene deregulation;broadmatch
polysomy 3;polysomy;broadmatch
cdh1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
cdh1 gene inactivation;cdh1 gene mutation;broadmatch
ccnd1 gene amplification;gene amplification abnormality;broadmatch
ccnd1 gene amplification;oncogene deregulation;broadmatch
fgfr1 gene amplification;oncogene deregulation;broadmatch
fgfr1 gene amplification;fgfr gene amplification;broadmatch
egfr gene amplification;oncogene deregulation;broadmatch
egfr gene amplification;receptor tyrosine kinase gene amplification;broadmatch
loss of chromosome 11q atm gene locus;chromosomal deletion;broadmatch
loss of chromosome 11q atm gene locus;rearrangement of 11q;broadmatch
loss of chromosome 3p fhit gene locus;chromosomal deletion;broadmatch
loss of e-cadherin expression;protein deregulation;broadmatch
cyclin d1 messenger rna overexpression;messenger rna overexpression;broadmatch
myc gene amplification;gene amplification abnormality;broadmatch
monosomy 6;monosomy;broadmatch
uterine polyp;polyp;broadmatch
polysomy 17;chromosome 17 abnormality;broadmatch
increased nfkappab pathway activation;signaling pathway status;broadmatch
loss of chromosome y;chromosomal loss;broadmatch
loss of chromosome 18;chromosomal loss;broadmatch
loss of chromosome 1;chromosome 1 abnormality;broadmatch
loss of chromosome 1;chromosomal loss;broadmatch
gain of chromosome 6q;chromosomal gain;broadmatch
loss of chromosome 16p;chromosomal loss;broadmatch
del(6q21q25);chromosomal deletion;broadmatch
gain of chromosome 9q34;chromosomal gain;broadmatch
uterine polyp;uterine disorder;broadmatch
"t(x;2)(q11-12;p23)";rearrangement of 2p23;broadmatch
"t(x;2)(q11-12;p23)";chromosomal translocation;broadmatch
"t(2;17)(p23;q23)";rearrangement of 2p23;broadmatch
"t(2;17)(p23;q23)";chromosomal translocation;broadmatch
"t(2;17)(p23;q23)";chromosome 17 abnormality;broadmatch
rearrangement of 17p11-13;chromosomal rearrangement;broadmatch
rearrangement of 17p11-13;chromosome 17p abnormality;broadmatch
tetrasomy 12;chromosome 12 abnormality;broadmatch
tetrasomy 12;tetrasomy;broadmatch
tetrasomy;polysomy;broadmatch
"inv(14)(q11;q32.1)";paracentric inversion;broadmatch
"t(16;21)(p11;q22)";erg gene rearrangement;broadmatch
"t(16;21)(p11;q22)";fus gene translocation;broadmatch
"t(10;11)(p11;q23)";mll gene translocation;broadmatch
"t(6;11)(q27;q23)";mll gene translocation;broadmatch
"t(7;11)(p15;p15)";chromosomal translocation;broadmatch
"t(7;11)(p15;p15)";rearrangement of 11p15;broadmatch
"t(7;11)(p15;p15)";chromosome 7 rearrangement;broadmatch
"t(3;21)(q26;q22)";rearrangement of 21q;broadmatch
"t(3;21)(q26;q22)";rearrangement of 3q;broadmatch
"t(3;21)(q26;q22)";chromosomal translocation;broadmatch
i(19);isochromosome;broadmatch
del(9p21p22);chromosomal deletion;broadmatch
"t(7;9)(q34;q32)";chromosomal translocation;broadmatch
"t(7;9)(q34;q32)";chromosome 7 rearrangement;broadmatch
"inv(14)(q11;q32.1)";inv(14);broadmatch
polysomy 10;polysomy;broadmatch
polysomy 17;polysomy;broadmatch
del(6q25);chromosomal deletion;broadmatch
inactivating mlh1 gene mutation;mismatch repair gene inactivation;broadmatch
inactivating pms2 gene mutation;mismatch repair gene inactivation;broadmatch
inactivating pms2 gene mutation;pms2 gene mutation;broadmatch
pms1 gene inactivation;mismatch repair gene inactivation;broadmatch
pms1 gene inactivation;pms1 gene mutation;broadmatch
inactivating msh6 gene mutation;mismatch repair gene inactivation;broadmatch
inactivating msh6 gene mutation;msh6 gene mutation;broadmatch
mismatch repair gene inactivation;mismatch repair gene mutation;broadmatch
inactivating mlh1 gene mutation;mlh1 gene mutation;broadmatch
pten gene inactivation;tumor-suppressor gene inactivation;broadmatch
inactivating msh2 gene mutation;mismatch repair gene inactivation;broadmatch
inactivating msh2 gene mutation;msh2 gene mutation;broadmatch
tsc2 gene inactivation;tumor-suppressor gene inactivation;broadmatch
tsc2 gene inactivation;tsc2 gene mutation;broadmatch
lkb1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
lkb1 gene inactivation;stk11 gene mutation;broadmatch
smad4 gene inactivation;tumor-suppressor gene inactivation;broadmatch
fhit gene inactivation;tumor-suppressor gene inactivation;broadmatch
npm-alk fusion protein expression;alk fusion protein expression;broadmatch
tpm3-alk fusion protein expression;alk fusion protein expression;broadmatch
tfg-alk fusion protein expression;alk fusion protein expression;broadmatch
tear-drop red blood cell;abnormal red blood cell;broadmatch
abnormal lymphocyte;abnormal hematopoietic and lymphoid cell;broadmatch
neutrophil with pseudo pelger-huet nucleus;dysplastic neutrophil;broadmatch
giant platelet;abnormal platelet;broadmatch
sezary cell;leukemic lymphocyte;broadmatch
calcification;deposit;broadmatch
segmented neutrophil;abnormal neutrophil;broadmatch
sideroblast;abnormal erythroblast;broadmatch
bcr-abl1 fusion protein expression;fusion protein expression;broadmatch
p190 fusion protein expression;bcr-abl1 fusion protein expression;broadmatch
p230 fusion protein expression;bcr-abl1 fusion protein expression;broadmatch
p210 fusion protein expression;bcr-abl1 fusion protein expression;broadmatch
atic-alk fusion protein expression;alk fusion protein expression;broadmatch
injury;finding by cause;broadmatch
smad4 gene inactivation;smad4 gene mutation;broadmatch
pten gene inactivation;pten gene mutation;broadmatch
gain of chromosome xq;chromosomal gain;broadmatch
nmyc gene amplification;oncogene deregulation;broadmatch
mdm2 gene amplification;gene amplification abnormality;broadmatch
mdm2 gene amplification;oncogene deregulation;broadmatch
hras gene amplification;gene amplification abnormality;broadmatch
hras gene amplification;oncogene deregulation;broadmatch
fos gene amplification;gene amplification abnormality;broadmatch
fos gene amplification;oncogene deregulation;broadmatch
nmyc gene amplification;gene amplification abnormality;broadmatch
gain of chromosome 10;chromosomal gain;broadmatch
ptch gene inactivation;tumor-suppressor gene inactivation;broadmatch
gain of chromosome 16;chromosomal gain;broadmatch
loss of chromosome 4q;chromosomal loss;broadmatch
kras gene amplification;gene amplification abnormality;broadmatch
kras gene amplification;oncogene deregulation;broadmatch
transforming growth factor-beta overexpression;growth factor overexpression;broadmatch
growth factor overexpression;elevated expression;broadmatch
ctnnb1 gene mutation;gene variant;broadmatch
apc gene inactivation;apc gene mutation;broadmatch
apc gene inactivation;tumor-suppressor gene inactivation;broadmatch
wt1 gene inactivation;wt1 gene mutation;broadmatch
wt1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
ptch gene inactivation;ptch1 gene mutation;broadmatch
men1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
men1 gene inactivation;men1 gene mutation;broadmatch
brca2 gene inactivation;tumor-suppressor gene inactivation;broadmatch
brca2 gene inactivation;brca2 gene mutation;broadmatch
brca2 gene inactivation;inactivating brca gene mutation;broadmatch
brca1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
brca1 gene inactivation;brca1 gene mutation;broadmatch
brca1 gene inactivation;inactivating brca gene mutation;broadmatch
vhl gene inactivation;tumor-suppressor gene inactivation;broadmatch
vhl gene inactivation;vhl gene mutation;broadmatch
nf2 gene inactivation;nf2 gene mutation;broadmatch
nf2 gene inactivation;tumor-suppressor gene inactivation;broadmatch
nf1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
nf1 gene inactivation;nf1 gene mutation;broadmatch
loss of chromosome 3;chromosomal loss;broadmatch
loss of chromosome 10;chromosomal loss;broadmatch
loss of chromosome 9;chromosomal loss;broadmatch
monosomy 17;monosomy;broadmatch
"t(7;19)(q34;q13)";chromosome 7 rearrangement;broadmatch
"t(v;11q23.3)";mll gene translocation;broadmatch
loss of chromosome 10q;chromosomal loss;broadmatch
loss of chromosome 16q;chromosomal loss;broadmatch
del(5q22);chromosomal deletion;broadmatch
del(5q22);chromosome 5 rearrangement;broadmatch
loss of chromosome 10p;chromosomal loss;broadmatch
monosomy 17;chromosome 17 abnormality;broadmatch
loss of chromosome 17p;chromosomal loss;broadmatch
loss of chromosome 22q;chromosomal loss;broadmatch
loss of chromosome 11p;chromosomal loss;broadmatch
loss of chromosome 6;chromosomal loss;broadmatch
loss of chromosome 8p;chromosomal loss;broadmatch
loss of chromosome 3p;chromosomal loss;broadmatch
loss of chromosome 1p;chromosome 1 abnormality;broadmatch
loss of chromosome 1p;chromosomal loss;broadmatch
"t(7;19)(q34;q13)";chromosomal translocation;broadmatch
"t(7;14)(q35;q32.1)";chromosome 7 rearrangement;broadmatch
"t(7;14)(q35;q32.1)";chromosomal translocation;broadmatch
"t(17;22)(q22;q13)";chromosome 17 abnormality;broadmatch
trisomy 13;trisomy;broadmatch
trisomy 13;chromosome 13 abnormality;broadmatch
gain of chromosome 21;chromosomal gain;broadmatch
loss of chromosome 5;chromosomal loss;broadmatch
loss of chromosome 5;chromosome 5 abnormality;broadmatch
gain of chromosome 11;chromosomal gain;broadmatch
loss of chromosome 7;chromosomal loss;broadmatch
loss of chromosome 7;chromosome 7 abnormality;broadmatch
monosomy 5;monosomy;broadmatch
monosomy 5;chromosome 5 abnormality;broadmatch
gain of chromosome 13;chromosomal gain;broadmatch
gain of chromosome 13;chromosome 13 abnormality;broadmatch
partial trisomy 1q;chromosome 1 abnormality;broadmatch
partial trisomy 1q;trisomy;broadmatch
"t(17;22)(q22;q13)";chromosomal translocation;broadmatch
loss of chromosome 6p;chromosomal loss;broadmatch
loss of chromosome 17p;chromosome 17p abnormality;broadmatch
loss of chromosome 6q;chromosomal loss;broadmatch
i(17q);chromosome 17 abnormality;broadmatch
gain of chromosome 1q;chromosomal gain;broadmatch
gain of chromosome 1q;chromosome 1 abnormality;broadmatch
gain of chromosome 15q;chromosomal gain;broadmatch
gain of chromosome 20q;chromosomal gain;broadmatch
unbalanced translocation of chromosome 1;unbalanced translocation;broadmatch
unbalanced translocation of chromosome 1;chromosome 1 abnormality;broadmatch
i(17q);isochromosome;broadmatch
trisomy 7;trisomy;broadmatch
loss of chromosome 12q;chromosomal loss;broadmatch
trisomy 7;chromosome 7 abnormality;broadmatch
trisomy 6;trisomy;broadmatch
ring chromosome 1;chromosome 1 abnormality;broadmatch
ring chromosome 1;supernumerary circular chromosome;broadmatch
"der(15;21)(q10;q10)";derivative chromosome;broadmatch
del(19p12);chromosomal deletion;broadmatch
del(14q21);chromosomal deletion;broadmatch
gain of chromosome 9q;chromosomal gain;broadmatch
gain of chromosome 17q;chromosome 17 abnormality;broadmatch
gain of chromosome 17q;chromosomal gain;broadmatch
ccnd1 protein overexpression;protein deregulation;broadmatch
loss of chromosome 12q;chromosome 12 abnormality;broadmatch
loss of chromosome 13q;chromosomal loss;broadmatch
loss of chromosome 13q;chromosome 13q abnormality;broadmatch
loss of chromosome 18q;chromosomal loss;broadmatch
trisomy 2;trisomy;broadmatch
high-frequency microsatellite instability;microsatellite instability;broadmatch
loss of chromosome 22;chromosomal loss;broadmatch
loss of chromosome 14;chromosomal loss;broadmatch
gain of chromosome 5p;chromosomal gain;broadmatch
gain of chromosome 5p;chromosome 5 abnormality;broadmatch
gain of chromosome 8q;chromosomal gain;broadmatch
gain of chromosome 3q;chromosomal gain;broadmatch
gain of chromosome 3q;3q abnormality;broadmatch
gain of chromosome 5;chromosomal gain;broadmatch
gain of chromosome 5;chromosome 5 abnormality;broadmatch
trisomy 4;trisomy;broadmatch
"t(6;9)(p23;q34.1)";chromosomal translocation;broadmatch
del(11q23);11q23 abnormality;broadmatch
i(8)(q10);isochromosome;broadmatch
secondary hypertension;hypertension;broadmatch
del(1p36);chromosomal deletion;broadmatch
del(1p36);chromosome 1 abnormality;broadmatch
rearrangement of 6q25;chromosomal rearrangement;broadmatch
rearrangement of 6q13;chromosomal rearrangement;broadmatch
rearrangement of 8q21;chromosomal rearrangement;broadmatch
del(8q24.1);chromosomal deletion;broadmatch
"t(1;3)(p36;q23-25)";rearrangement of 3q;broadmatch
del(11q23);rearrangement of 11q;broadmatch
"t(1;3)(p36;q23-25)";chromosome 1 abnormality;broadmatch
"t(1;3)(p36;q23-25)";chromosomal translocation;broadmatch
rearrangement of 12q13;chromosomal rearrangement;broadmatch
rearrangement of 12q13;chromosome 12 abnormality;broadmatch
rearrangement of 1p11-q11;chromosomal rearrangement;broadmatch
rearrangement of 1p11-q11;chromosome 1 abnormality;broadmatch
del(11p15);chromosomal deletion;broadmatch
del(1p13-22);chromosome 1 abnormality;broadmatch
del(1p13-22);chromosomal deletion;broadmatch
loss of chromosome 4;chromosomal loss;broadmatch
del(5q13-31);chromosome 5 rearrangement;broadmatch
gain of chromosome 12q15-qter;chromosomal gain;broadmatch
gain of chromosome 12q15-qter;chromosome 12 abnormality;broadmatch
gain of chromosome 7p13-pter;chromosomal gain;broadmatch
gain of chromosome 7p13-pter;chromosome 7 abnormality;broadmatch
del(22q13);chromosomal deletion;broadmatch
loss of chromosome 18p;chromosomal loss;broadmatch
del(13q21-qter);chromosomal deletion;broadmatch
del(13q21-qter);chromosome 13q abnormality;broadmatch
del(11q25);chromosomal deletion;broadmatch
del(11q25);rearrangement of 11q;broadmatch
del(11p13-pter);chromosomal deletion;broadmatch
del(10q24-qter);chromosomal deletion;broadmatch
del(9p22-pter);chromosomal deletion;broadmatch
del(6q22-qter);chromosomal deletion;broadmatch
del(5q13-31);chromosomal deletion;broadmatch
del(11p15);rearrangement of 11p15;broadmatch
gain of chromosome 20;chromosomal gain;broadmatch
gain of chromosome 1;chromosomal gain;broadmatch
rearrangement of 1p11-13;chromosomal rearrangement;broadmatch
gain of chromosome 5q;chromosomal gain;broadmatch
gain of chromosome 5q;chromosome 5 abnormality;broadmatch
rearrangement of 11q13-21;rearrangement of 11q;broadmatch
loss of chromosome 16;chromosomal loss;broadmatch
chromosomal rearrangement;cytogenetic abnormality;broadmatch
rearrangement of 8q11-13;chromosomal rearrangement;broadmatch
gain of chromosome x;chromosomal gain;broadmatch
del(6q23);chromosomal deletion;broadmatch
loss of chromosome x;chromosomal loss;broadmatch
loss of chromosome 13;chromosomal loss;broadmatch
loss of chromosome 13;chromosome 13 abnormality;broadmatch
loss of chromosome 8;chromosomal loss;broadmatch
del(7q21-32);chromosomal deletion;broadmatch
del(7q21-32);chromosome 7 rearrangement;broadmatch
del(11q23);chromosomal deletion;broadmatch
rearrangement of 1p11-13;chromosome 1 abnormality;broadmatch
loss of chromosome 2p;chromosomal loss;broadmatch
gain of chromosome 1;chromosome 1 abnormality;broadmatch
loss of chromosome 2q;chromosomal loss;broadmatch
del(13q32-qter);chromosomal deletion;broadmatch
del(13q32-qter);chromosome 13q abnormality;broadmatch
del(13q12-13);chromosomal deletion;broadmatch
del(13q12-13);chromosome 13q abnormality;broadmatch
del(8p21-pter);chromosomal deletion;broadmatch
del(3p21-23);chromosomal deletion;broadmatch
gain of chromosome 1q21-31;chromosomal gain;broadmatch
gain of chromosome 1q21-31;chromosome 1 abnormality;broadmatch
gain of chromosome 1p31;chromosomal gain;broadmatch
gain of chromosome 1p31;chromosome 1 abnormality;broadmatch
gain of chromosome 7q32;chromosomal gain;broadmatch
gain of chromosome 7q32;chromosome 7 abnormality;broadmatch
gain of chromosome 7p;chromosomal gain;broadmatch
gain of chromosome 7p;chromosome 7 abnormality;broadmatch
loss of chromosome 11;chromosomal loss;broadmatch
postgerminal center b-lymphocyte;mature b-lymphocyte;broadmatch
postgerminal center b-lymphocyte of unknown differentiation stage;postgerminal center b-lymphocyte;broadmatch
postgerminal center b-lymphocyte of unknown differentiation stage;marginal zone b-lymphocyte;broadmatch
rapidly progressive clinical course;progressive clinical course;broadmatch
neoplastic histiocytic and dendritic cell;neoplastic hematopoietic and lymphoid cell;broadmatch
histiocytic and dendritic cell;hematopoietic and lymphoid cell;broadmatch
mature tissue histiocyte;histiocyte;broadmatch
neoplastic eosinophilic precursor;neoplastic granulocyte;broadmatch
mature neutrophils present;morphologic finding;broadmatch
neoplastic granulocyte;neoplastic myeloid cell;broadmatch
neoplastic granulocyte;abnormal granulocyte;broadmatch
bone marrow stem cell committed to the basophil lineage;bone marrow myeloid stem cell;broadmatch
myeloblasts 90 percent or more of bone marrow non-erythroid cells;myeloblasts 20 percent or more of bone marrow nucleated cells;broadmatch
trisomy 21;trisomy;broadmatch
bone marrow stem cell committed to the megakaryocytic lineage;bone marrow myeloid stem cell;broadmatch
bone marrow myeloid stem cell with some degree of commitment to the erythroid lineage;bone marrow myeloid stem cell;broadmatch
neoplastic medium to large size erythroblast;neoplastic erythroblast;broadmatch
neoplastic erythroblast;neoplastic myeloid blast;broadmatch
neoplastic erythroblast;abnormal erythroblast;broadmatch
complex odontoma;odontoma;broadmatch
large malignant histiocyte;neoplastic histiocyte;broadmatch
large multinucleated malignant histiocyte;large malignant histiocyte;broadmatch
unifocal disease;localized disease;broadmatch
multifocal unisystem disease;clinical course of disease;broadmatch
leukemic mast cell;neoplastic mast cell;broadmatch
leukemic mast cell;leukemic cell;broadmatch
paracortical involvement with residual follicles present;morphologic finding;broadmatch
neoplastic dendritic cell;neoplastic histiocytic and dendritic cell;broadmatch
cd35-positive neoplastic cells present;immunophenotypic finding;broadmatch
cd21-positive neoplastic cells present;immunophenotypic finding;broadmatch
hmb-45-positive neoplastic cells present;hmb45-positive cells present;broadmatch
cd1a-positive neoplastic cells present;immunophenotypic finding;broadmatch
cd1a-positive neoplastic cells present;cd1a positive;broadmatch
birbeck granules present;ultrastructural finding;broadmatch
ultrastructural finding;microscopic finding;broadmatch
monoclonal langerhans cells present;monoclonal cellular population present;broadmatch
diabetes insipidus;non-neoplastic endocrine disorder;broadmatch
multiple destructive bone lesions;bone lesion;broadmatch
bone lesion;lesion;broadmatch
malignant hemangiopericytoma;hemangiopericytoma;broadmatch
dek-nup214 fusion protein expression;fusion protein expression;broadmatch
serum total tryptase levels increased;elevated test result;broadmatch
sheet-like growth pattern;morphologic architectural pattern;broadmatch
chemotherapeutic agent toxicity;drug toxicity;broadmatch
neoplastic retinal ganglion cell;neoplastic ganglion cell;broadmatch
suprasellar region;sellar region;broadmatch
extraocular dissemination of disease;clinical course of disease;broadmatch
rb-e2f pathway deregulation;tumor-suppressor pathway deregulation;broadmatch
serrated glandular architecture;morphologic architectural pattern;broadmatch
chondroid hamartoma;hamartoma;broadmatch
pseudo-psammoma body formation;deposit;broadmatch
benign hemangiopericytoma;hemangiopericytoma;broadmatch
epithelial differentiation;tissue differentiation;broadmatch
ossified mass;mass;broadmatch
round cell liposarcoma;connective and soft tissue neoplasm (antiquated);broadmatch
giant congenital nevus;congenital melanocytic nevus;broadmatch
giant congenital nevus;pigmented nevus;broadmatch
precancerous melanosis;cutaneous precancerous condition;broadmatch
tissue differentiation;morphologic finding;broadmatch
chemotherapeutic agent toxicity;therapy-related toxicity;broadmatch
therapy-related toxicity;toxicity;broadmatch
premalignant lesion;lesion by morphology;broadmatch
benign mesenchymoma;mesenchymoma;broadmatch
intermediate immature teratoma;germ cell tumor (antiquated);broadmatch
dual population of bone marrow blasts present;blasts of mixed phenotype present;broadmatch
dual population of bone marrow blasts present;blast cells increased in bone marrow;broadmatch
neoplastic blast coexpressing myeloid and lymphoid lineage antigens;neoplastic blast;broadmatch
undifferentiated neoplastic blast;neoplastic blast;broadmatch
bone marrow stem cell with some commitment to monocytic differentiation;bone marrow myeloid stem cell;broadmatch
immature myeloid cells increased in bone marrow;blast cells increased in bone marrow;broadmatch
immature myeloid cells increased in bone marrow;myeloblasts present;broadmatch
neoplastic promyelocytes in bone marrow markedly increased;granulocytes increased in bone marrow;broadmatch
granulocyte-monocyte progenitor cell;bone marrow myeloid stem cell;broadmatch
abnormal eosinophilic granules present;morphologic finding;broadmatch
neoplastic granulocytes and precursors 20 percent or more of bone marrow cells;granulocytes increased in bone marrow;broadmatch
cells of monocytic lineage 80 percent or more of bone marrow leukemic cells;immature myeloid cells increased in bone marrow;broadmatch
bone marrow stem cell with potential to differentiate to granulocytic lineage;bone marrow myeloid stem cell;broadmatch
malignant mesenchymoma;mesenchymoma;broadmatch
serum total tryptase levels increased;abnormal blood chemistry and hematology test result;broadmatch
macular lesion;lesion;broadmatch
neoplastic maturing ganglion cell;neoplastic ganglion cell;broadmatch
hepatobiliary system;digestive system part;broadmatch
lamellar pattern;morphologic architectural pattern;broadmatch
extrahepatic bile duct epithelium;bile duct epithelium;broadmatch
intrahepatic bile duct epithelium;bile duct epithelium;broadmatch
bile duct epithelium;bile duct tissue;broadmatch
bile duct epithelium;glandular epithelium;broadmatch
bile duct tissue;hepatobiliary tissue;broadmatch
hepatobiliary tissue;tissue;broadmatch
gallbladder tubulopapillary adenoma;epithelial neoplasm (antiquated);broadmatch
pituitary tumor transforming gene overexpression;oncogene deregulation;broadmatch
gallbladder papillary adenoma;epithelial neoplasm (antiquated);broadmatch
gallbladder tubular adenoma;epithelial neoplasm (antiquated);broadmatch
myc gene mutation;gene variant;broadmatch
protoplasm;cell structure;broadmatch
neuroendocrine differentiation;epithelial differentiation;broadmatch
glandular differentiation;epithelial differentiation;broadmatch
cdc73 gene;transcription regulation gene;broadmatch
hilar portion of the hepatic duct;extrahepatic bile duct;broadmatch
hilar portion of the hepatic duct;hepatic duct;broadmatch
frontal sinus polyp;paranasal sinus polyp;broadmatch
gastric hamartomatous polyp;gastric non-neoplastic polyp;broadmatch
cockade nevus;benign skin melanocytic nevus;broadmatch
malignant skin hemangiopericytoma;skin hemangiopericytoma;broadmatch
malignant skin hemangiopericytoma;malignant hemangiopericytoma;broadmatch
skin hemangiopericytoma;hemangiopericytoma;broadmatch
skin angiokeratoma;angiokeratoma;broadmatch
cutaneous verruciform xanthoma;xanthoma;broadmatch
cutaneous verruciform xanthoma;non-neoplastic skin disorder;broadmatch
multiple self healing epithelioma of ferguson-smith;hereditary neoplastic syndrome;broadmatch
"t(3;14)(p14.1;q32)";chromosomal translocation;broadmatch
stage 0 extrahepatic bile duct cancer;cancer stage (antiquated);broadmatch
intravascular papillary endothelial hyperplasia;reactive vascular proliferation;broadmatch
bile pigment present;morphologic finding;broadmatch
neutral epithelial mucin present;morphologic finding;broadmatch
renal failure;non-neoplastic kidney disorder;broadmatch
gastric hamartomatous polyp;gastrointestinal hamartoma;broadmatch
pituitary tumor transforming gene overexpression;gene amplification abnormality;broadmatch
c-met gene amplification;oncogene deregulation;broadmatch
macular lesion;integumentary system signs and symptoms;broadmatch
ret gene mutation;gene variant;broadmatch
neoplastic connective and soft tissue epithelioid cell;neoplastic epithelioid cell;broadmatch
neoplastic connective and soft tissue epithelioid cell;neoplastic connective and soft tissue cell;broadmatch
ss18-ssx fusion protein expression;fusion protein expression;broadmatch
monosomy 3;monosomy;broadmatch
col1a1-pdgfbeta fusion protein expression;fusion protein expression;broadmatch
campylobacter jejuni infection;small intestinal infection;broadmatch
campylobacter jejuni infection;bacterial infection;broadmatch
ret gene mutation;receptor tyrosine kinase gene mutation;broadmatch
c-met gene amplification;receptor tyrosine kinase gene amplification;broadmatch
cdkn1c gene mutation;gene variant;broadmatch
monoclonal myeloid or lymphoid cells present;monoclonal cellular population present;broadmatch
unifocal disease at presentation;unifocal disease;broadmatch
mast cells 10 percent or more of peripheral blood white cells;abnormal hematology test result;broadmatch
mast cells 20 percent or more of bone marrow nucleated cells;abnormal bone marrow test result;broadmatch
peau chagrine lesion;integumentary system signs and symptoms;broadmatch
peau chagrine lesion;lesion;broadmatch
"t(3;8)(p12;q21)";chromosomal translocation;broadmatch
"t(3;8)(p12;q21)";rearrangement of 8q21;broadmatch
gain of chromosome 10p;chromosomal gain;broadmatch
trichoepithelial carcinoma;epithelial neoplasm (antiquated);broadmatch
epithelial stem cell;stem cell;broadmatch
multipotent stem cell;stem cell;broadmatch
diffuse centroblastic-centrocytic lymphoma;lymphoma/leukemia by kiel classification (antiquated);broadmatch
cdc73 gene mutation;gene variant;broadmatch
apocrine cell;glandular cell;broadmatch
eccrine cell;epithelial cell;broadmatch
glandular epithelium;glandular epithelial tissue;broadmatch
glandular epithelium;epithelium;broadmatch
anus;digestive system part;broadmatch
syringoacanthoma;epithelial neoplasm (antiquated);broadmatch
malignant sebocyte;neoplastic sebocyte;broadmatch
malignant sebocyte;adenocarcinoma cell;broadmatch
neoplastic sebocyte;neoplastic epithelial cell;broadmatch
sebocyte;glandular cell;broadmatch
trichofollicular carcinoma;epithelial neoplasm (antiquated);broadmatch
rare lesion;lesion;broadmatch
neoplastic round neuroepithelial cell;neoplastic neuroepithelial cell;broadmatch
jak-stat pathway deregulation;signal transduction pathway deregulation;broadmatch
malignant epithelioid cell;malignant cell;broadmatch
visual pathway;neural pathway;broadmatch
secondary lesion;lesion;broadmatch
nerve tissue and nerve sheaths;nerve tissue, neuroepithelial tissue, and nerve sheaths;broadmatch
perineurial cell;perineural cell;broadmatch
nerve sheath;nerve tissue and nerve sheaths;broadmatch
nerve sheath;soft tissue;broadmatch
malignant epithelioid cell;neoplastic epithelioid cell;broadmatch
malignant perineural cell;malignant connective and soft tissue cell;broadmatch
loss of merlin expression;protein deregulation;broadmatch
malignant perineural cell;neoplastic perineural cell;broadmatch
geographic necrosis;necrotic change;broadmatch
pseudoencapsulated mass;mass;broadmatch
thick-walled hyalinized vessels present;thick-walled vessels present;broadmatch
thick-walled hyalinized vessels present;hyalinized vessels present;broadmatch
absence of malignant features;morphologic finding;broadmatch
increased cellularity present;morphologic finding;broadmatch
subependymal tissue;ependyma and remnants of the central canal of the spinal cord;broadmatch
epidural spinal canal space;musculoskeletal system part;broadmatch
intradural extramedullary spinal canal space;musculoskeletal system part;broadmatch
neoplastic subependymal glial cell;neoplastic ependymal cell;broadmatch
dense intercellular reticulin network present;morphologic finding;broadmatch
multinodular lesion;nodular lesion;broadmatch
rosenthal fibers present;morphologic finding;broadmatch
macrocystic change;cystic change;broadmatch
eosinophilic granular bodies present;morphologic finding;broadmatch
hyalinized vessels present;vascular morphologic change;broadmatch
low cellularity present;morphologic finding;broadmatch
neoplastic protoplasmic astrocyte;neoplastic astrocyte;broadmatch
slow growing mass;mass;broadmatch
well-circumscribed lesion;lesion;broadmatch
microcystic change;cystic change;broadmatch
microvascular proliferation;vascular proliferation;broadmatch
cystic change;morphologic finding;broadmatch
infiltrative growth pattern;morphologic architectural pattern;broadmatch
subependymal cell;ependymal cell;broadmatch
nodular lesion;lesion;broadmatch
unicystic lesion;cystic lesion;broadmatch
neoplastic large ganglioid astrocyte;neoplastic astrocyte;broadmatch
nras gene mutation;ras family gene mutation;broadmatch
blasts 10-19 percent of bone marrow nucleated cells;blasts under 20 percent of bone marrow nucleated cells;broadmatch
blasts 5-19 percent of peripheral blood white cells;blasts under 20 percent of peripheral blood white cells;broadmatch
blasts under 5 percent of peripheral blood white cells;blasts 5 percent or less of peripheral blood white cells;broadmatch
blasts under 10 percent of bone marrow nucleated cells;blasts under 15 percent of bone marrow nucleated cells;broadmatch
blasts under 20 percent of bone marrow nucleated cells;blasts under 25 percent of bone marrow nucleated cells;broadmatch
etv6-pdgfrb fusion protein expression;fusion protein expression;broadmatch
nras gene mutation;gene variant;broadmatch
fgf6 gene amplification;oncogene deregulation;broadmatch
multilocular lesion;cystic lesion;broadmatch
fgf6 gene amplification;fgf gene amplification;broadmatch
fgf4 gene amplification;oncogene deregulation;broadmatch
fgf4 gene amplification;fgf gene amplification;broadmatch
del(3p25);chromosomal deletion;broadmatch
loss of chromosome 12;chromosomal loss;broadmatch
loss of chromosome 12;chromosome 12 abnormality;broadmatch
akt2 gene amplification;gene amplification abnormality;broadmatch
myeloblasts under 10 percent of peripheral blood white cells;myeloblasts under 20 percent of peripheral blood white cells;broadmatch
myeloblasts under 10 percent of peripheral blood white cells;blasts under 10 percent of peripheral blood white cells;broadmatch
elevated serum lysozyme;abnormal blood chemistry and hematology test result;broadmatch
elevated serum lysozyme;elevated test result;broadmatch
cystic lesion;lesion;broadmatch
vater-pacini corpuscles-like structures present;morphologic finding;broadmatch
perineural cell;supporting cell of the nervous system;broadmatch
melanosomes present;morphologic finding;broadmatch
pseudo-onion bulbs formation;morphologic finding;broadmatch
neoplastic perineural cell;neoplastic ganglion cell;broadmatch
neoplastic perineural cell;neoplastic connective and soft tissue cell;broadmatch
neuroepithelial cell;neuron, neuroepithelial cell, and supporting cell of the nervous system;broadmatch
neuroepithelial tissue;nerve tissue, neuroepithelial tissue, and nerve sheaths;broadmatch
neoplastic neuroepithelial cell and neoplastic perineural cell;neoplastic cell;broadmatch
perineural tissue;nerve sheath;broadmatch
nerve tissue, neuroepithelial tissue, and nerve sheaths;tissue;broadmatch
neuron, neuroepithelial cell, and supporting cell of the nervous system;cell;broadmatch
absence of bone marrow dysplasia;normal bone marrow test result;broadmatch
absence of bone marrow dysplasia;dysplasia negative;broadmatch
intracellular accumulation of lipids;morphologic finding;broadmatch
pituitary gland acidophil carcinoma;pituitary gland neoplasm (antiquated);broadmatch
lipomatous differentiation;mesenchymal differentiation;broadmatch
neuropil present;morphologic finding;broadmatch
ganglioneuroblastoma component present;abnormal tissue present;broadmatch
hemorrhagic neuroblastic nodules present;morphologic finding;broadmatch
schwannian stroma predominant component of the tumor volume;schwannian stroma more than 50 percent of the tumor volume;broadmatch
schwannian stroma more than 50 percent of the tumor volume;prominent schwannian stroma present;broadmatch
differentiating neuroblasts present;abnormal cells present;broadmatch
differentiating neuroblasts more than 5 percent of the tumor cells;differentiating neuroblasts present;broadmatch
differentiating neuroblasts under 5 percent of the tumor cells;differentiating neuroblasts present;broadmatch
neuroectodermal cell;neuroepithelial cell;broadmatch
neoplastic small immature neuroepithelial cell;neoplastic small neuroepithelial cell;broadmatch
neuroectodermal cell;ectoderm cell;broadmatch
prominent schwannian stroma present;stromal change;broadmatch
complex epithelial neoplasm;epithelial neoplasm (antiquated);broadmatch
regional disease;clinical course of disease;broadmatch
clusters and cords of gfap positive epithelioid tumor cells present;abnormal cells present;broadmatch
perivascular arrangement of tumor cells;morphologic architectural pattern;broadmatch
large pineocytomatous rosette formation;pineocytomatous rosette formation;broadmatch
ganglioneuroma component present;abnormal tissue present;broadmatch
mature schwannian stroma present;abnormal tissue present;broadmatch
ganglion cells present;morphologic finding;broadmatch
scattered collections of differentiating neuroblasts present;abnormal cells present;broadmatch
pale eosinophilic stroma formation;stromal change;broadmatch
cortical dysplasia;dysplasia;broadmatch
aggregates of poorly differentiated neuroepithelial cells present;morphologic finding;broadmatch
downward ocular deviation;strabismus;broadmatch
dysplastic ganglion cell;neoplastic ganglion cell;broadmatch
neoplastic mature ganglion cell;neoplastic ganglion cell;broadmatch
neuronal differentiation;tissue differentiation;broadmatch
neoplastic cuboidal cell;neoplastic epithelial cell;broadmatch
cauliflower-like mass;mass;broadmatch
choroid plexus epithelium;epithelium;broadmatch
lesion by morphology;lesion;broadmatch
lesion by morphology;morphologic finding;broadmatch
cellular infiltrate;morphologic finding;broadmatch
abnormal cells present;morphologic finding;broadmatch
abnormal tissue present;morphologic finding;broadmatch
neoplastic small mature neuroepithelial cell;neoplastic small neuroepithelial cell;broadmatch
neoplastic small neuroepithelial cell;neoplastic neuroepithelial cell;broadmatch
perivascular pseudopalisading;morphologic architectural pattern;broadmatch
cell movement process;cellular process;broadmatch
mixed cell adenocarcinoma;epithelial neoplasm (antiquated);broadmatch
water-clear cell adenocarcinoma;epithelial neoplasm (antiquated);broadmatch
resistance process;metabolic process;broadmatch
nucleotide biosynthesis process;nucleotide metabolic process;broadmatch
dna maintenance process;biochemical process;broadmatch
leukotriene activity induction;eicosanoid activity induction;broadmatch
eicosanoid activity induction;eicosanoid modulation;broadmatch
cell death process;cellular process;broadmatch
pineal parenchyma;neuroepithelial tissue;broadmatch
cell adhesion process;cellular process;broadmatch
circulatory process;organismal process;broadmatch
pituitary gland mixed acidophil-basophil carcinoma;pituitary gland neoplasm (antiquated);broadmatch
musculoskeletal process;organismal process;broadmatch
pituitary gland mixed acidophil-basophil adenoma;pituitary gland neoplasm (antiquated);broadmatch
collagenous stroma formation;stromal change;broadmatch
glial differentiation;tissue differentiation;broadmatch
neoplastic mesothelial cell;neoplastic cell;broadmatch
neoplastic mesothelial cell;abnormal mesothelial cell;broadmatch
endocrine-stromal cell;secretory cell;broadmatch
endocrine reproductive tissue;tissue;broadmatch
nests of tumor cell nuclei in a fibrillary matrix;abnormal tissue present;broadmatch
back pain;pain;broadmatch
pseudopalisading necrosis;necrotic change;broadmatch
papillary eccrine adenoma;epithelial neoplasm (antiquated);broadmatch
fascicles of spindly tumor cells present;abnormal cells present;broadmatch
clear perinuclear halo present;perinuclear halo present;broadmatch
perivascular pseudorosette formation;pseudorosette formation;broadmatch
protein kinase b;protein or riboprotein complex;broadmatch
remnants of the central canal of the spinal cord;ependyma and remnants of the central canal of the spinal cord;broadmatch
ependyma and remnants of the central canal of the spinal cord;neuroepithelial tissue;broadmatch
ependyma and remnants of the central canal of the spinal cord;membrane of the brain or spinal cord;broadmatch
cdkn2a gene deletion;gene deletion;broadmatch
extensive necrosis;necrotic change;broadmatch
precise histogenesis unknown;pathology result;broadmatch
mixed cellular population;cellular infiltrate;broadmatch
chlamydophila psittaci infection;bacterial infection;broadmatch
nevus spilus;benign skin melanocytic nevus;broadmatch
borrelia burgdorferi infection;bacterial infection;broadmatch
neoplastic thyroid gland follicular signet ring cell;signet ring cell;broadmatch
nesting (zellballen) growth pattern;nested pattern;broadmatch
malignant endothelial cell;malignant connective and soft tissue cell;broadmatch
malignant endothelial cell;neoplastic endothelial cell;broadmatch
neoplastic thyroid gland follicular cell with large and hyperchromatic nucleus;neoplastic thyroid gland follicular cell;broadmatch
neoplastic thyroid gland follicular clear cell;neoplastic endocrine clear cell;broadmatch
neoplastic thyroid gland follicular clear cell;neoplastic thyroid gland follicular cell;broadmatch
neoplastic thyroid gland follicular signet ring cell;neoplastic thyroid gland follicular cell;broadmatch
pseudostratified columnar tumor cells present;pseudostratified tumor cells present;broadmatch
macrofollicular structures present;follicular structures present;broadmatch
nuclear grooves;morphologic finding;broadmatch
nuclear clearing;morphologic finding;broadmatch
nuclear pseudoinclusion;nuclear inclusion;broadmatch
diffuse lesion;lesion;broadmatch
malignant thyroid gland follicular clear cell;neoplastic thyroid gland follicular clear cell;broadmatch
malignant thyroid gland follicular clear cell;malignant thyroid gland follicular cell;broadmatch
malignant thyroid gland follicular clear cell;adenocarcinoma clear cell;broadmatch
dementia;central nervous system degenerative disorder;broadmatch
dementia;cognitive disorder;broadmatch
deficiency of humoral immunity;immunodeficiency syndrome;broadmatch
central nervous system degenerative disorder;degenerative disorder;broadmatch
neoplastic parathyroid gland cell;neoplastic endocrine cell;broadmatch
neoplastic parathyroid gland cell;neoplastic glandular cell;broadmatch
perineural invasion;morphologic finding;broadmatch
hyperparathyroidism;endocrine system disorder;broadmatch
hyperparathyroidism;parathyroid gland disorder;broadmatch
parathyroid gland epithelial tissue;glandular epithelial tissue;broadmatch
parathyroid gland epithelial tissue;parathyroid gland tissue;broadmatch
parathyroid gland parenchymal cell;glandular cell;broadmatch
parathyroid gland parenchymal cell;endocrine cell;broadmatch
cancer tnm finding;finding;broadmatch
anogenital human papillomavirus infection;human papillomavirus infection;broadmatch
genomic instability;molecular genetic variation;broadmatch
lesion less than 10 mm in diameter;lesion with diameter of 10 mm or less;broadmatch
residual disease;clinical course of disease;broadmatch
central nervous system degenerative disorder;non-neoplastic central nervous system disorder;broadmatch
microfollicular structures present;follicular structures present;broadmatch
follicular structures present;morphologic finding;broadmatch
malignant parathyroid gland cell;malignant endocrine cell;broadmatch
sclerotic fibroma;connective tissue nevus;broadmatch
porokeratotic eccrine ostial and dermal duct nevus;eccrine sweat gland hamartoma;broadmatch
high grade t-cell lymphoma;high grade lymphoma;broadmatch
low grade t-cell lymphoma;low grade lymphoma;broadmatch
peutz-jeghers polyp;gastrointestinal hamartoma;broadmatch
neuropathy;nervous system disorder;broadmatch
interarytenoid leukoplakia;leukoplakia of vocal cords;broadmatch
eruptive collagenoma;connective tissue nevus;broadmatch
moniliform hamartoma;pilosebaceous hamartoma;broadmatch
follicular cell differentiation;epithelial differentiation;broadmatch
eccrine angiomatous hamartoma;eccrine sweat gland hamartoma;broadmatch
proliferative verrucous leukoplakia;oral leukoplakia;broadmatch
speckled oral leukoplakia;oral leukoplakia;broadmatch
ulcerated oral leukoplakia;oral leukoplakia;broadmatch
gingival fibroepithelial polyp;gingival polyp;broadmatch
gingival fibroepithelial polyp;fibroepithelial polyp;broadmatch
laryngeal keratosis;laryngeal precancerous condition;broadmatch
neoplasm by morphology;neoplasm;broadmatch
coccygeal body neoplasm;connective and soft tissue neoplasm (antiquated);broadmatch
basal cell nevus with comedones;pilosebaceous hamartoma;broadmatch
oral cavity cyst;cyst;broadmatch
non-neoplastic osteoclast-like giant cell;osteoclast-like giant cell;broadmatch
vocal cord paralysis;motor manifestations;broadmatch
hoarseness;sign;broadmatch
malignant goblet-like mucous cell;mucin-producing malignant epithelial cell;broadmatch
malignant cuboidal mucous cell;mucin-producing malignant epithelial cell;broadmatch
thyroid gland epithelial tissue;epithelial tissue;broadmatch
thyroid gland epithelial tissue;thyroid gland tissue;broadmatch
malignant squamoid cell;malignant epithelial cell;broadmatch
calcitonin positive neoplastic cells present;immunophenotypic finding;broadmatch
thyroglobulin-positive neoplastic cells present;immunophenotypic finding;broadmatch
malignant neuroendocrine small round cell;malignant neuroendocrine small cell;broadmatch
serum calcitonin level increased;elevated test result;broadmatch
serum calcitonin level increased;abnormal blood chemistry and hematology test result;broadmatch
neoplastic c-cell;neoplastic neuroendocrine cell;broadmatch
vulvar low grade squamous intraepithelial lesion;vulvar squamous intraepithelial lesion;broadmatch
malignant parathyroid gland cell;adenocarcinoma cell;broadmatch
malignant parathyroid gland cell;neoplastic parathyroid gland cell;broadmatch
collagen rosette formation;rosette formation;broadmatch
base of the heart;heart part;broadmatch
lesion by focality;lesion;broadmatch
focal pattern;morphologic architectural pattern;broadmatch
satellite nodule;nodule;broadmatch
ganglion cell-like elements present;morphologic finding;broadmatch
neoplastic schwann-like cell;neoplastic connective and soft tissue cell;broadmatch
neoplastic epithelioid neuroendocrine cell;neoplastic neuroendocrine cell;broadmatch
gastrointestinal hemorrhage;digestive system hemorrhage;broadmatch
slow growing painless mass;painless mass;broadmatch
neoplastic adrenal cortical oncocyte;neoplastic adrenal cortical cell;broadmatch
slow growing painless mass;slow growing mass;broadmatch
malignant chromaffin cell;neoplastic chromaffin cell;broadmatch
malignant chromaffin cell;malignant neuroendocrine cell;broadmatch
neoplastic chromaffin cell;neoplastic neuroendocrine cell;broadmatch
no evidence of metastatic disease;clinical course of disease;broadmatch
mild colon dysplasia;mild dysplasia;broadmatch
mild colon dysplasia;colon dysplasia;broadmatch
unifocal lesion;lesion by focality;broadmatch
neoplastic parathyroid gland water-clear cell;neoplastic parathyroid gland clear cell;broadmatch
neoplastic fibroblast;neoplastic connective and soft tissue cell;broadmatch
neoplastic lipocyte;neoplastic connective and soft tissue cell;broadmatch
cartilage-like elements present;abnormal tissue present;broadmatch
lumbosacral region;spinal region;broadmatch
jaw bone;skeletal system part;broadmatch
malignant connective and soft tissue cell;neoplastic connective and soft tissue cell;broadmatch
malignant connective and soft tissue cell;malignant cell;broadmatch
bone cell;connective and soft tissue cell;broadmatch
symptom;sign or symptom;broadmatch
reproductive system disorder;genitourinary system disorder;broadmatch
pathologic tnm finding;cancer tnm finding category;broadmatch
rare disorder;disease or disorder;broadmatch
cancer tnm finding category;cancer tnm finding;broadmatch
neoplastic cartilage cell;neoplastic connective and soft tissue cell;broadmatch
cartilage cell;connective and soft tissue cell;broadmatch
remnants of the notochord;connective and soft tissue;broadmatch
skeletal muscle cell;striated muscle cell;broadmatch
colon dysplasia;digestive system dysplasia;broadmatch
neoplastic adrenal cortical oncocyte;neoplastic oncocyte;broadmatch
neoplastic parathyroid gland chief cell;neoplastic parathyroid gland cell;broadmatch
malignant parathyroid gland oncocyte;malignant parathyroid gland cell;broadmatch
sdh complex gene mutation;gene abnormality;broadmatch
broad fibrous bands formation;fibrotic stroma formation;broadmatch
primary hyperparathyroidism;hyperparathyroidism;broadmatch
neoplastic parathyroid gland clear cell;neoplastic parathyroid gland cell;broadmatch
neoplastic parathyroid gland clear cell;neoplastic endocrine clear cell;broadmatch
neoplastic parathyroid gland clear cell;neoplastic glandular cell with clear cytoplasm;broadmatch
malignant parathyroid gland oncocyte;neoplastic parathyroid gland oncocyte;broadmatch
malignant parathyroid gland oncocyte;malignant oncocyte;broadmatch
neural crest-derived cell;neuroectodermal cell;broadmatch
neoplastic parathyroid gland oncocyte;neoplastic parathyroid gland cell;broadmatch
neoplastic parathyroid gland oncocyte;neoplastic oncocyte;broadmatch
malignant parathyroid gland clear cell;neoplastic parathyroid gland clear cell;broadmatch
malignant parathyroid gland clear cell;malignant parathyroid gland cell;broadmatch
malignant parathyroid gland clear cell;adenocarcinoma clear cell;broadmatch
malignant parathyroid gland chief cell;neoplastic parathyroid gland chief cell;broadmatch
malignant parathyroid gland chief cell;malignant parathyroid gland cell;broadmatch
sdhb gene mutation;sdh complex gene mutation;broadmatch
sdhb gene mutation;gene variant;broadmatch
sdhc gene mutation;sdh complex gene mutation;broadmatch
sdhc gene mutation;gene variant;broadmatch
neural crest-derived cell;neuroendocrine cell;broadmatch
neuroendocrine tissue;epithelial tissue;broadmatch
malignant adrenal cortical cell;neoplastic adrenal cortical cell;broadmatch
malignant adrenal cortical cell;malignant endocrine cell;broadmatch
malignant adrenal cortical cell;adenocarcinoma cell;broadmatch
neoplastic adrenal cortical clear cell;neoplastic adrenal cortical cell;broadmatch
neoplastic adrenal cortical clear cell;neoplastic endocrine clear cell;broadmatch
neoplastic adrenal cortical cell;neoplastic endocrine cell;broadmatch
neoplastic adrenal cortical cell;neoplastic glandular cell;broadmatch
adrenal cortical cell;glandular cell;broadmatch
adrenal cortical cell;endocrine cell;broadmatch
abundant intracytoplasmic lipofuscin present;intracytoplasmic lipofuscin present;broadmatch
primary site unknown;primary site of disease;broadmatch
sdhd gene mutation;gene variant;broadmatch
sdhd gene mutation;sdh complex gene mutation;broadmatch
laryngeal keratosis;leukoplakia;broadmatch
organoid nevus;hamartoma;broadmatch
central nervous system cyst;nervous system finding;broadmatch
fus-erg fusion protein expression;fusion protein expression;broadmatch
vascular ectasia;vascular malformation;broadmatch
reactive vascular proliferation;non-neoplastic vascular disorder;broadmatch
ewsr1-ddit3 fusion protein expression;fusion protein expression;broadmatch
orbit hemangiopericytoma;hemangiopericytoma;broadmatch
"t(3;9)(q11-12;q22)";rearrangement of 3q;broadmatch
"t(3;9)(q11-12;q22)";chromosomal translocation;broadmatch
tfg-nr4a3 fusion protein expression;fusion protein expression;broadmatch
myh9-alk fusion protein expression;alk fusion protein expression;broadmatch
malignant orbit hemangiopericytoma;malignant hemangiopericytoma;broadmatch
alo17-alk fusion protein expression;alk fusion protein expression;broadmatch
tpm4-alk fusion protein expression;alk fusion protein expression;broadmatch
"t(2;22)(p23;q11)";rearrangement of 2p23;broadmatch
"t(2;22)(p23;q11)";chromosomal translocation;broadmatch
"t(2;17)(p23;q35)";rearrangement of 2p23;broadmatch
"t(2;17)(p23;q35)";chromosomal translocation;broadmatch
"t(2;17)(p23;q35)";chromosome 17 abnormality;broadmatch
lung adenocarcinoma, mixed subtype;epithelial neoplasm (antiquated);broadmatch
lung signet ring cell carcinoma;epithelial neoplasm (antiquated);broadmatch
lung clear cell adenocarcinoma;epithelial neoplasm (antiquated);broadmatch
gain of chromosome 3q24-qter;3q abnormality;broadmatch
pleural mass;mass;broadmatch
pyothorax;pleural infection;broadmatch
pyothorax;empyema;broadmatch
industrial aid;drug, food, chemical or biomedical material;broadmatch
nf2 gene mutation;gene variant;broadmatch
gpc3 gene inactivation;tumor-suppressor gene inactivation;broadmatch
absence of invasion;morphologic finding;broadmatch
adenomatous hyperplasia of the ciliary body;hyperplasia;broadmatch
gene fusion abnormality;gene abnormality;broadmatch
gene duplication abnormality;gene amplification abnormality;broadmatch
gene amplification abnormality;gene abnormality;broadmatch
mutation abnormality;molecular genetic variation;broadmatch
intermediate grade lung neuroendocrine neoplasm;epithelial neoplasm (antiquated);broadmatch
low grade lung neuroendocrine neoplasm;epithelial neoplasm (antiquated);broadmatch
gain of chromosome 3q24-qter;chromosomal gain;broadmatch
malignant orbit hemangiopericytoma;orbit hemangiopericytoma;broadmatch
"t(2;19)(p23;p13)";rearrangement of 2p23;broadmatch
central nervous system cyst;cyst;broadmatch
neoplasm by obsolete classification;neoplasm by special category;broadmatch
cd56-positive neoplastic cells present;immunophenotypic finding;broadmatch
cd56-positive neoplastic cells present;ncam1 positive;broadmatch
cd4-positive neoplastic cells present;immunophenotypic finding;broadmatch
cd4-positive neoplastic cells present;cd4 positive;broadmatch
kidney hemangiopericytoma;hemangiopericytoma;broadmatch
precursor of plasmacytoid dendritic cell;myeloid cell;broadmatch
respiratory system finding;finding by site or system;broadmatch
diffuse large b-cell lymphoma, not otherwise specified by gene expression profile;diffuse large b-cell lymphoma, not otherwise specified;broadmatch
"t(2;19)(p23;p13)";chromosomal translocation;broadmatch
pdcd1lg2 gene overexpression;gene abnormality;broadmatch
poor collagen rosette formation;collagen rosette formation;broadmatch
fus-creb3l1 fusion protein expression;fusion protein expression;broadmatch
fus-creb3l2 fusion protein expression;fusion protein expression;broadmatch
"t(7;16)(q33;p11)";chromosomal translocation;broadmatch
"t(7;16)(q33;p11)";chromosome 7 rearrangement;broadmatch
prominent collagen rosette formation;collagen rosette formation;broadmatch
neoplastic small to medium-sized b-lymphocyte resembling a centrocyte;neoplastic small to medium-sized lymphocyte;broadmatch
neoplastic small to medium-sized b-lymphocyte resembling a centrocyte;neoplastic b-lymphocyte;broadmatch
neoplastic follicle center b-cell;neoplastic b-lymphocyte;broadmatch
confluent sheets of neoplastic b-lymphocytes present;abnormal cells present;broadmatch
pdcd1lg2 gene;immunoprotein gene;broadmatch
notch1 gene mutation;gene variant;broadmatch
notch1 gene mutation;notch family gene mutation;broadmatch
v-mll fusion protein expression;fusion protein expression;broadmatch
cd15-positive neoplastic cells present;immunophenotypic finding;broadmatch
cd15-positive neoplastic cells present;cd15 positive;broadmatch
multilocular thymic cyst;thymic cyst;broadmatch
activated mature gamma/delta t-lymphocyte with a cytotoxic phenotype;gamma/delta t-lymphocyte;broadmatch
rimming of adipose tissue cells present;morphologic finding;broadmatch
neoplastic immunoblast-like t-lymphocyte;neoplastic t-lymphocyte;broadmatch
papulovesicular lesion;integumentary system signs and symptoms;broadmatch
papulovesicular lesion;lesion;broadmatch
cd8-positive neoplastic cells present;immunophenotypic finding;broadmatch
cd8-positive neoplastic cells present;cd8 positive;broadmatch
dermal involvement;cutaneous involvement;broadmatch
ebv-transformed late germinal center/post-germinal center b-lymphocyte;ebv-transformed mature b-lymphocyte;broadmatch
thymic medullary epithelial cell;thymic epithelial cell;broadmatch
"t(15;22)(p11;q11)";chromosomal translocation;broadmatch
well developed rough endoplasmic reticulum present;ultrastructural finding;broadmatch
lesion with diameter of 10 mm or less;lesion with diameter of 2 cm or less;broadmatch
neoplastic adenohypophysial cell;neoplastic endocrine cell;broadmatch
neoplastic adenohypophysial cell;neoplastic glandular cell;broadmatch
multihormonal immunoreactivity present;immunophenotypic finding;broadmatch
giant mitochondria present;ultrastructural finding;broadmatch
no evidence of hormonal immunoreactivity present;negative test result;broadmatch
concentric aggregates of intermediate filaments present;intermediate filaments present;broadmatch
misplaced exocytosis present;ultrastructural finding;broadmatch
thymic epithelial cell capable of differentiating towards both cortical and medullary cell type;thymic epithelial cell;broadmatch
neoplastic lactotroph cell with small secretory granules;neoplastic lactotroph cell;broadmatch
neoplastic lactotroph cell with large secretory granules;neoplastic lactotroph cell;broadmatch
malignant lactotroph cell;malignant adenohypophysial cell;broadmatch
malignant lactotroph cell;neoplastic lactotroph cell;broadmatch
malignant thyrotroph cell;malignant adenohypophysial cell;broadmatch
malignant thyrotroph cell;neoplastic thyrotroph cell;broadmatch
malignant corticotroph cell;malignant adenohypophysial cell;broadmatch
lesion with diameter greater than 10 mm;lesion with diameter of 4 mm or more;broadmatch
malignant adenohypophysial cell;adenocarcinoma cell;broadmatch
malignant adenohypophysial cell;malignant endocrine cell;broadmatch
malignant adenohypophysial cell;neoplastic adenohypophysial cell;broadmatch
atypical endometrial hyperplasia;atypical glandular hyperplasia;broadmatch
atypical endometrial hyperplasia;endometrial hyperplasia;broadmatch
atypical endometrial hyperplasia;female reproductive system precancerous condition;broadmatch
malignant coccygeal body neoplasm;coccygeal body neoplasm;broadmatch
capsular invasion;morphologic finding;broadmatch
nonestrogen-dependent malignant neoplasm;malignant neoplasm;broadmatch
presymptomatic cancer;clinical course of disease;broadmatch
pparg gene rearrangement;gene rearrangement abnormality;broadmatch
ntrk1 gene rearrangement;chromosome 1 abnormality;broadmatch
ntrk1 gene rearrangement;ntrk gene rearrangement;broadmatch
ret/ptc rearrangement;receptor tyrosine kinase gene rearrangement;broadmatch
presence of a hormonal syndrome;endocrine system finding;broadmatch
absence of a hormonal syndrome;endocrine system finding;broadmatch
lesion less than 5 mm in diameter;lesion with diameter of 10 mm or less;broadmatch
fungating mass;mass;broadmatch
malignant corticotroph cell;neoplastic corticotroph cell;broadmatch
malignant somatotroph cell;malignant adenohypophysial cell;broadmatch
malignant somatotroph cell;neoplastic somatotroph cell;broadmatch
gain of chromosome 22q;chromosomal gain;broadmatch
gain of chromosome 13q;chromosome 13q abnormality;broadmatch
hamartoma of mature cardiac myocytes;non-neoplastic heart disorder;broadmatch
hamartoma of mature cardiac myocytes;hamartoma;broadmatch
pluripotent primordial germ cell;primordial germ cell;broadmatch
totipotent primordial germ cell;primordial germ cell;broadmatch
thymic epithelial stem cell;epithelial stem cell;broadmatch
thymic epithelial stem cell;thymic epithelial cell;broadmatch
brd4-nut fusion protein expression;fusion protein expression;broadmatch
"t(15;19)(q13;p13.1)";nutm1 gene translocation;broadmatch
"t(15;19)(q13;p13.1)";brd4 gene translocation;broadmatch
glandular epithelial tissue;epithelial tissue;broadmatch
epithelial tissue;tissue;broadmatch
thymic epithelial tissue;epithelial tissue;broadmatch
thymic epithelial tissue;thymic tissue;broadmatch
thymic epithelial cell capable of differentiating towards cortical cell type;thymic epithelial cell;broadmatch
gain of chromosome 13q;chromosomal gain;broadmatch
gain of chromosome 11q13;11q aberration;broadmatch
neoplastic somatotroph cell with scarce secretory granules;neoplastic somatotroph cell;broadmatch
gain of chromosome 11q13;chromosomal gain;broadmatch
neoplastic somatotroph cell with abundant secretory granules;neoplastic somatotroph cell;broadmatch
hras gene mutation;gene variant;broadmatch
hras gene mutation;ras family gene mutation;broadmatch
gain of chromosome 4q;chromosomal gain;broadmatch
gnas gene mutation;gene variant;broadmatch
pituitary gland neoplasm (antiquated);epithelial neoplasm (antiquated);broadmatch
adenohypophysial cell;glandular cell;broadmatch
adenohypophysial cell;endocrine cell;broadmatch
pituicyte;glial cell;broadmatch
pituitary stalk;brain part;broadmatch
tuberculum sellae;skeletal system part;broadmatch
del(18q21);chromosomal deletion;broadmatch
loss of chromosome 3q;chromosomal loss;broadmatch
loss of chromosome 3q;3q abnormality;broadmatch
gain of chromosome 4;chromosomal gain;broadmatch
akt2 gene amplification;oncogene deregulation;broadmatch
map2k4 gene inactivation;tumor-suppressor gene inactivation;broadmatch
drug exposure;chemical exposure;broadmatch
skeletal myogenesis pathway;cell differentiation or development pathway;broadmatch
igf-1 signaling pathway;signaling pathway;broadmatch
skeletal muscle hypertrophy pathway;disease pathway;broadmatch
ifn gamma signaling pathway;signaling pathway;broadmatch
hswi-snf pathway;regulatory pathway;broadmatch
hiv-i nef in apoptosis pathway;apoptosis regulation pathway;broadmatch
segmentation clock pathway;cell differentiation or development pathway;broadmatch
erbb2 signaling pathway;signaling pathway;broadmatch
human cytomegalovirus infection pathway;infectious disease pathway;broadmatch
fc epsilon receptor i signaling pathway biocarta;immune response regulation pathway;broadmatch
beta-catenin accumulation pathway;signaling pathway;broadmatch
inhibition of cellular proliferation by gleevec pathway;drug pathway;broadmatch
growth hormone signaling pathway;signaling pathway;broadmatch
corticosteroid cardioprotection pathway;drug pathway;broadmatch
gallbladder polyp;gastrointestinal polyp;broadmatch
gallbladder polyp;gallbladder disorder;broadmatch
g2/m checkpoint pathway;cell cycle regulation pathway;broadmatch
igf1r antiapoptosis pathway;apoptosis regulation pathway;broadmatch
il12 signaling pathway;signaling pathway;broadmatch
il22 signaling pathway;signaling pathway;broadmatch
il2rb pathway;immune response regulation pathway;broadmatch
nitric oxide pathway;signaling pathway;broadmatch
nerve growth factor pathway;signaling pathway;broadmatch
nfat pathway;disease pathway;broadmatch
nfat pathway;regulatory pathway;broadmatch
mtor signaling pathway biocarta;signaling pathway;broadmatch
hepatocyte growth factor receptor signaling pathway biocarta;signaling pathway;broadmatch
calpain-2 cell motility pathway;cell motility pathway;broadmatch
mapkinase signaling pathway;signaling pathway;broadmatch
longevity pathway;homeostasis regulation pathway;broadmatch
keratinocyte differentiation pathway;cell differentiation or development pathway;broadmatch
insulin signaling pathway;signaling pathway;broadmatch
il7 signaling pathway;signaling pathway;broadmatch
il6 signaling pathway;signaling pathway;broadmatch
il4 signaling pathway;signaling pathway;broadmatch
il3 signaling pathway;signaling pathway;broadmatch
g1/s checkpoint pathway;cell cycle regulation pathway;broadmatch
cyclin e degradation pathway;degradation pathway;broadmatch
notch proteolysis and signaling pathway;signaling pathway;broadmatch
cardiac hypertrophy pathway;disease pathway;broadmatch
creb activation signaling pathway;signaling pathway;broadmatch
apoptosis dna damage pathway;apoptosis regulation pathway;broadmatch
cyclin regulation of cell cycle pathway;cell cycle regulation pathway;broadmatch
cell to cell adhesion signaling pathway;signaling pathway;broadmatch
cell migration pathway;cell motility pathway;broadmatch
egf receptor downregulation by cbl pathway;regulatory pathway;broadmatch
estrogen receptor regulation by carm1 pathway;regulatory pathway;broadmatch
btg cell cycle regulation pathway;cell cycle regulation pathway;broadmatch
fas signaling pathway biocarta;apoptosis regulation pathway;broadmatch
bioactive peptide signaling pathway;signaling pathway;broadmatch
b-cell survival pathway;immune response regulation pathway;broadmatch
bard1 pathway;dna repair pathway;broadmatch
bad regulation pathway;regulatory pathway;broadmatch
cancer susceptibility pathway;disease pathway;broadmatch
atm signaling pathway;dna repair pathway;broadmatch
atm signaling pathway;signaling pathway;broadmatch
ctcf pathway;regulatory pathway;broadmatch
t-cell activation co-stimulatory signaling pathway;signaling pathway;broadmatch
t-cell activation co-stimulatory signaling pathway;immune response regulation pathway;broadmatch
dicer pathway;degradation pathway;broadmatch
fas signaling pathway biocarta;signaling pathway;broadmatch
electron transport pathway;energy metabolism pathway;broadmatch
erythrocyte differentiation pathway;cell differentiation or development pathway;broadmatch
erk1/erk2 mapk signaling pathway;signaling pathway;broadmatch
neuronal survival pathway;cell differentiation or development pathway;broadmatch
erbb3 receptor recycling pathway;protein cycling pathway;broadmatch
epo signaling pathway;signaling pathway;broadmatch
erythropoietin neuroprotection pathway;apoptosis regulation pathway;broadmatch
eif4 regulation pathway;regulatory pathway;broadmatch
map kinase inactivation of smrt corepressor pathway;regulatory pathway;broadmatch
egf signaling pathway;signaling pathway;broadmatch
efp cell cycle pathway;cell cycle regulation pathway;broadmatch
vesicle transport pathway;transport pathway;broadmatch
phospholipid signaling pathway;signaling pathway;broadmatch
extracellular matrix binding pathway;cell motility pathway;broadmatch
no2-dependent il12 pathway;immune response regulation pathway;broadmatch
p27 regulation pathway;cell cycle regulation pathway;broadmatch
gamma/delta t-lymphocyte;mature t-lymphocyte;broadmatch
ethmoid sinus polyp;paranasal sinus polyp;broadmatch
gingival polyp;polyp;broadmatch
gingival polyp;non-neoplastic gingival disorder;broadmatch
nevus comedonicus;pilosebaceous hamartoma;broadmatch
mongolian spot;non-neoplastic nevus;broadmatch
non-neoplastic nevus;non-neoplastic skin disorder;broadmatch
leukoplakia of vocal cords;laryngeal keratosis;broadmatch
sphenoid sinus polyp;paranasal sinus polyp;broadmatch
maxillary sinus polyp;paranasal sinus polyp;broadmatch
hhv8 infection;herpesvirus infection;broadmatch
cd4+/cd56+ neoplastic medium-sized cell;neoplastic hematopoietic and lymphoid cell;broadmatch
precursor natural killer cell;t-lymphocyte and natural killer cell;broadmatch
precursor natural killer cell;immature lymphocyte;broadmatch
opisthorchis viverrini infection;parasitic infection;broadmatch
schistosoma hematobium infection;schistosomiasis;broadmatch
helicobacter pylori infection;gastric infection;broadmatch
helicobacter pylori infection;bacterial infection;broadmatch
leukoplakia of lip;oral leukoplakia;broadmatch
hairy leukoplakia of tongue;oral cavity hairy leukoplakia;broadmatch
hairy leukoplakia of tongue;leukoplakia of tongue;broadmatch
esophageal leukoplakia;leukoplakia;broadmatch
t-lymphocyte with a post-thymic immunophenotype;mature t-lymphocyte;broadmatch
neoplastic cerebriform t-prolymphocyte;neoplastic t-prolymphocyte;broadmatch
neoplastic small t-prolymphocyte;neoplastic small t-lymphocyte;broadmatch
neoplastic small t-prolymphocyte;neoplastic t-prolymphocyte;broadmatch
cutaneous involvement;integumentary system finding;broadmatch
anal polyp;gastrointestinal polyp;broadmatch
anal polyp;anal disorder;broadmatch
cytoplasmic protrusions present;cytoplasmic alteration;broadmatch
peripheral (post-thymic) t-lymphocyte and natural killer cell;t-lymphocyte and natural killer cell;broadmatch
t-lymphocyte and natural killer cell;lymphocyte;broadmatch
neoplastic t-lymphocyte and neoplastic natural killer cell;neoplastic lymphocyte;broadmatch
coarse azurophilic granules present;morphologic finding;broadmatch
intestinal metaplasia of gastric mucosa;intestinal metaplasia;broadmatch
gastric polyp;gastrointestinal polyp;broadmatch
gastric polyp;stomach disorder;broadmatch
htlv-1 infection;viral infection;broadmatch
thrombin/protease-activated receptor signaling pathway;signaling pathway;broadmatch
hypoxia pathway;disease pathway;broadmatch
ptc1 regulation of cell cycle pathway;cell cycle regulation pathway;broadmatch
ras signaling pathway;signaling pathway;broadmatch
g1 to s transition pathway;cell cycle regulation pathway;broadmatch
ion channels in vascular endothelium pathway;homeostasis regulation pathway;broadmatch
rac1 cell motility signaling pathway;signaling pathway;broadmatch
pten-dependent cell cycle arrest and apoptosis pathway;cell cycle regulation pathway;broadmatch
pten-dependent cell cycle arrest and apoptosis pathway;apoptosis regulation pathway;broadmatch
phosphoinositide pathway;regulatory pathway;broadmatch
notch and wnt signaling pathway;signaling pathway;broadmatch
wnt signaling pathway biocarta;signaling pathway;broadmatch
ppar-alpha gene regulation pathway;regulatory pathway;broadmatch
cell cycle progression pathway;cell cycle regulation pathway;broadmatch
phospholipase c signaling pathway;signaling pathway;broadmatch
pitx2 transcription regulation pathway;regulatory pathway;broadmatch
pdgf signaling pathway;signaling pathway;broadmatch
p53 signaling pathway biocarta;cell cycle regulation pathway;broadmatch
p53 signaling pathway biocarta;signaling pathway;broadmatch
rb checkpoint signaling pathway;signaling pathway;broadmatch
rb checkpoint signaling pathway;cell cycle regulation pathway;broadmatch
dsrna induction pathway;immune response regulation pathway;broadmatch
sonic hedgehog pathway;signaling pathway;broadmatch
angiokeratoma of mibelli;skin angiokeratoma;broadmatch
angiogenesis pathway;regulatory pathway;broadmatch
trka receptor signaling pathway;signaling pathway;broadmatch
tpo signaling pathway;signaling pathway;broadmatch
tnfr1 signaling pathway;signaling pathway;broadmatch
interferon signaling modulation pathway;signaling pathway;broadmatch
tgf beta signaling pathway biocarta;signaling pathway;broadmatch
mucosal healing pathway;homeostasis regulation pathway;broadmatch
tert regulation pathway;regulatory pathway;broadmatch
terc regulation pathway;regulatory pathway;broadmatch
telomere pathway;genetic information processing pathway;broadmatch
t cell receptor signaling pathway biocarta;immune response regulation pathway;broadmatch
t cell receptor signaling pathway biocarta;signaling pathway;broadmatch
sprouty regulation of tyrosine kinase signaling pathway;signaling pathway;broadmatch
e2f1 degradation pathway;degradation pathway;broadmatch
angiotensin ii signaling pathway;signaling pathway;broadmatch
ribosomal biogenesis pathway;metabolic pathway;broadmatch
alk pathway;cell differentiation or development pathway;broadmatch
interleukin-10 overexpression;abnormal immunology test result;broadmatch
clonal bcl3 gene rearrangement;clonal gene rearrangement;broadmatch
colony-stimulating factor overexpression;abnormal immunology test result;broadmatch
colony-stimulating factor overexpression;elevated expression;broadmatch
lymphotoxin-alpha overexpression;abnormal immunology test result;broadmatch
lymphotoxin-alpha overexpression;elevated expression;broadmatch
interleukin-13 overexpression;abnormal immunology test result;broadmatch
interleukin-13 overexpression;elevated expression;broadmatch
interleukin-10 overexpression;elevated expression;broadmatch
interleukin-2 overexpression;abnormal immunology test result;broadmatch
interleukin-9 overexpression;abnormal immunology test result;broadmatch
interleukin-9 overexpression;elevated expression;broadmatch
interleukin-7 overexpression;abnormal immunology test result;broadmatch
interleukin-7 overexpression;elevated expression;broadmatch
interleukin-6 overexpression;abnormal immunology test result;broadmatch
interleukin-6 overexpression;elevated expression;broadmatch
interleukin-5 overexpression;abnormal immunology test result;broadmatch
api2-mlt fusion protein expression;fusion protein expression;broadmatch
hair part;integumentary system part;broadmatch
lymph node part;immune system part;broadmatch
interfollicular area of the lymph node;lymphoid tissue;broadmatch
tonsil part;immune system part;broadmatch
extremity part;body part;broadmatch
lower extremity part;extremity part;broadmatch
upper extremity part;extremity part;broadmatch
organ of special sense part;body part;broadmatch
integumentary system part;body part;broadmatch
head and neck part;body part;broadmatch
mental and behavioral signs and symptoms;sign or symptom;broadmatch
creb1 gene;creb family gene;broadmatch
creb family gene;transcription factor gene;broadmatch
tonsillar tissue;tonsil part;broadmatch
tonsillar tissue;tissue;broadmatch
spleen part;immune system part;broadmatch
constitutional symptom;symptom;broadmatch
interfollicular area of the lymph node;lymph node tissue;broadmatch
interleukin-5 overexpression;elevated expression;broadmatch
interleukin-2 overexpression;elevated expression;broadmatch
akt signaling pathway;signaling pathway;broadmatch
runx1 gene mutation;gene variant;broadmatch
stat5b-rara fusion protein expression;fusion protein expression;broadmatch
"t(17;17)(q21;q21)";rara gene translocation;broadmatch
rbm15-mkl1 fusion protein expression;fusion protein expression;broadmatch
cebpa gene mutation;gene variant;broadmatch
cebpa gene mutation;ccaat enhancer binding protein gene mutation;broadmatch
neurological signs and symptoms;nervous system finding;broadmatch
neurological signs and symptoms;sign or symptom;broadmatch
runx1 gene mutation;core binding factor complex mutation;broadmatch
abnormal immunology test result;abnormal laboratory test result;broadmatch
infertility;sexual dysfunction and infertility;broadmatch
del(4)(q12);chromosomal deletion;broadmatch
msn-alk fusion protein expression;alk fusion protein expression;broadmatch
pi3k-akt pathway deregulation;signal transduction pathway deregulation;broadmatch
myc pathway deregulation;signal transduction pathway deregulation;broadmatch
jun pathway deregulation;molecular pathway deregulation;broadmatch
ras-raf pathway deregulation;signal transduction pathway deregulation;broadmatch
aneuploid dysplastic oral leukoplakia;oral leukoplakia;broadmatch
"del(7)(q11;q36)";chromosome 7 rearrangement;broadmatch
"del(7)(q11;q36)";chromosomal deletion;broadmatch
del(20)(q11);chromosomal deletion;broadmatch
mature lymphocyte;lymphocyte;broadmatch
mature b-lymphocyte at the germinal center stage of differentiation;mature b-lymphocyte;broadmatch
peripheral (post-thymic) t-lymphocyte;peripheral (post-thymic) t-lymphocyte and natural killer cell;broadmatch
peripheral (post-thymic) t-lymphocyte;t-lymphocyte;broadmatch
pleomorphic reed-sternberg cell;reed-sternberg cell;broadmatch
prkaca gene;serine/threonine protein kinase gene;broadmatch
progressive transformation of germinal centers;morphologic finding;broadmatch
c-kit somatic point mutation;point mutation;broadmatch
c-kit somatic point mutation;short somatic mutation;broadmatch
c-kit somatic point mutation;somatic kit gene mutation;broadmatch
kmt2a-een fusion protein expression;fusion protein expression;broadmatch
kmt2a-ell fusion protein expression;fusion protein expression;broadmatch
kmt2a-enl fusion protein expression;fusion protein expression;broadmatch
mllt3-kmt2a fusion protein expression;fusion protein expression;broadmatch
kmt2a-af10 fusion protein expression;fusion protein expression;broadmatch
inv(22q12);paracentric inversion;broadmatch
inv(22q12);inv(22);broadmatch
delta cell of the pancreas;delta cell;broadmatch
squamoid differentiation;tissue differentiation;broadmatch
apoptosis pathway;apoptosis regulation pathway;broadmatch
amyotrophic lateral sclerosis pathway;neurodegenerative disorders pathway;broadmatch
alzheimer's disease pathway kegg;neurodegenerative disorders pathway;broadmatch
malignant neoplasms of mouse liver;mouse hepatic system neoplasm;broadmatch
benign neoplasms of mouse liver;mouse hepatic system neoplasm;broadmatch
squamous differentiation;epithelial differentiation;broadmatch
lymphocytic thyroiditis;thyroiditis;broadmatch
scaffolding protein;structural protein;broadmatch
delta cell of the pancreas;islet cell;broadmatch
ebv infection;herpesvirus infection;broadmatch
hepatocellular carcinoma of the mouse;malignant neoplasms of mouse liver;broadmatch
hepatocellular adenoma of the mouse;benign neoplasms of mouse liver;broadmatch
mouse liver disorder;mouse digestive system disorder;broadmatch
non-neoplastic proliferation of the mouse liver;mouse liver disorder;broadmatch
non-neoplastic proliferation of the mouse liver;mouse cancer-related conditions;broadmatch
mouse ito cell tumor, benign;benign neoplasms of mouse liver;broadmatch
cell cycle pathway;cell cycle regulation pathway;broadmatch
citrate cycle (tca cycle) pathway;carbohydrate metabolism pathway;broadmatch
leukoplakia of gingiva;oral cavity leukoplakia;broadmatch
huntington's disease pathway;neurodegenerative disorders pathway;broadmatch
agrin pathway;cell differentiation or development pathway;broadmatch
regulation of apoptosis pathway;apoptosis regulation pathway;broadmatch
isochromosome;cytogenetic abnormality;broadmatch
minimal residual disease;residual disease;broadmatch
leukoplakia of tongue;oral cavity leukoplakia;broadmatch
prion disease pathway;neurodegenerative disorders pathway;broadmatch
phosphatidylinositol signaling system pathway;signaling pathway;broadmatch
parkinson's disease pathway kegg;neurodegenerative disorders pathway;broadmatch
oxidative phosphorylation pathway;energy metabolism pathway;broadmatch
skin cyst;integumentary system finding;broadmatch
skin cyst;cyst;broadmatch
mrna biosynthesis pathway;genetic information processing pathway;broadmatch
mapk signaling pathway;signaling pathway;broadmatch
focal adhesion pathway;cell motility pathway;broadmatch
inositol phosphate metabolism pathway;carbohydrate metabolism pathway;broadmatch
mouse hepatocholangiocellular adenocarcinoma;malignant neoplasms of mouse liver;broadmatch
mouse hepatocholangiocellular adenoma;benign neoplasms of mouse liver;broadmatch
mouse cholangioma;benign neoplasms of mouse liver;broadmatch
transformed peripheral b-lymphocyte;peripheral b-lymphocyte;broadmatch
alk kinase overexpression;protein deregulation;broadmatch
bulky disease;clinical course of disease;broadmatch
bone marrow and blood involvement;bone marrow and extramedullary involvement;broadmatch
defective mu heavy chain present;defective heavy chain present;broadmatch
vacuolated plasma cells in the bone marrow;abnormal cells present;broadmatch
negative bone marrow and peripheral blood;negative test result;broadmatch
prolymphocytes exceed 55 percent of lymphoid cells in the peripheral blood;atypical lymphocytes present in peripheral blood;broadmatch
fried-egg appearance of the bone marrow;morphologic finding;broadmatch
tartrate resistant acid phosphatase positive cells present;abnormal hematology test result;broadmatch
bone pain;pain;broadmatch
extensive bone marrow and blood involvement;bone marrow and blood involvement;broadmatch
lymphoblasts 25 percent or less of bone marrow nucleated cells;atypical lymphocytes present in bone marrow;broadmatch
lymphoblasts 25 percent or less of bone marrow nucleated cells;blasts under 30 percent of bone marrow nucleated cells;broadmatch
neoplastic t-lymphocyte;neoplastic t-lymphocyte and neoplastic natural killer cell;broadmatch
neoplastic b-lymphocyte;neoplastic lymphocyte;broadmatch
neoplastic immunoblast-like b-lymphocyte;neoplastic large b-lymphocyte;broadmatch
neoplastic large b-lymphocyte with pale cytoplasm;neoplastic large b-lymphocyte;broadmatch
mouse cholangiocarcinoma;malignant neoplasms of mouse liver;broadmatch
pericardial cavity;body cavity;broadmatch
mouse hepatic system neoplasm;mouse liver disorder;broadmatch
mouse hepatic system neoplasm;mouse digestive system neoplasms;broadmatch
defective alpha heavy chain present;defective heavy chain present;broadmatch
villous atrophy;morphologic finding;broadmatch
lymphoepithelial lesion;lesion by morphology;broadmatch
marginal zone b-lymphocyte;mature b-lymphocyte;broadmatch
villous lymphocyte;neoplastic b-lymphocyte;broadmatch
nuclear pleomorphism;morphologic finding;broadmatch
neoplastic small b-lymphocyte;neoplastic b-lymphocyte;broadmatch
neoplastic small b-lymphocyte;neoplastic small lymphocyte;broadmatch
hyperviscosity;abnormal laboratory test result;broadmatch
widespread disease;clinical course of disease;broadmatch
polymorphic cellular infiltrate;cellular infiltrate;broadmatch
monomorphic cellular infiltrate;cellular infiltrate;broadmatch
chest pain;pain;broadmatch
fas apoptosis pathway deregulation;apoptotic pathway deregulation;broadmatch
serum soluble fas ligand level increased;abnormal blood chemistry and hematology test result;broadmatch
kras gene mutation;gene variant;broadmatch
cdk4 gene inactivation;cdk4 gene mutation;broadmatch
exophytic polypoid lesion;lesion;broadmatch
intraocular lesion;lesion;broadmatch
primary lesion;lesion;broadmatch
metastatic lesion;lesion;broadmatch
morphologic overlap;morphologic finding;broadmatch
composite lesion;lesion;broadmatch
cdk4 gene inactivation;tumor-suppressor gene inactivation;broadmatch
receptor binding;molecular interaction process;broadmatch
calcifying odontogenic cyst;odontogenic cyst;broadmatch
nucleic acid binding;molecular interaction process;broadmatch
leukotriene receptor binding;receptor binding;broadmatch
ion transport process;transport process;broadmatch
ion transport process;cellular process;broadmatch
cytokine receptor binding;receptor binding;broadmatch
chelating activity;molecular interaction process;broadmatch
antigen binding;molecular interaction process;broadmatch
transformed phase of disease;clinical course of disease;broadmatch
transformed neoplastic lymphocyte;neoplastic lymphocyte;broadmatch
rel gene amplification;oncogene deregulation;broadmatch
rel gene amplification;gene amplification abnormality;broadmatch
perforation;injury;broadmatch
cytoskeletal process;cellular process;broadmatch
cell membrane process;cellular process;broadmatch
intercellular communication induction;intercellular communication process;broadmatch
cell migration inhibition process;cellular migration process;broadmatch
negative regulation of cell death;regulation of cell death process;broadmatch
positive regulation of cell death;regulation of cell death process;broadmatch
xanthoma;non-neoplastic soft tissue disorder;broadmatch
ovarian endometriotic cyst;ovarian cyst;broadmatch
protein degradation inhibition;protein degradation process;broadmatch
ectopic hormone secretion syndrome associated with neoplasia;neoplastic syndrome;broadmatch
ectopic hormone secretion syndrome associated with neoplasia;endocrine syndrome;broadmatch
eicosanoid modulation;lipid metabolic process;broadmatch
enzyme inhibition;enzyme activity alteration;broadmatch
enzyme activity alteration;biochemical process;broadmatch
alkylation process;biochemical reaction;broadmatch
tsc1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
lipogranuloma;granuloma;broadmatch
"t(7;17)(p15;q21)";chromosome 17 abnormality;broadmatch
cervical glandular dysplasia;dysplasia;broadmatch
digit;extremity part;broadmatch
forebrain;brain part;broadmatch
non-neoplastic, non-molar trophoblastic disorder;placental non-neoplastic disorder;broadmatch
jazf1-suz12 fusion protein expression;fusion protein expression;broadmatch
"t(7;17)(p15;q21)";chromosomal translocation;broadmatch
"t(7;17)(p15;q21)";chromosome 7 rearrangement;broadmatch
pelvic pain;lower abdominal pain;broadmatch
tsc1 gene inactivation;tsc1 gene mutation;broadmatch
ovarian endometrioid adenocarcinofibroma;epithelial neoplasm (antiquated);broadmatch
ovarian dermoid cyst with prolactin secreting adenoma;ovarian dermoid cyst with secondary pituitary-type tumor;broadmatch
ovarian dermoid cyst with corticotropin secreting adenoma;ovarian dermoid cyst with secondary pituitary-type tumor;broadmatch
ovarian dermoid cyst with secondary pituitary-type tumor;ovarian dermoid cyst with secondary tumor;broadmatch
ovarian leydig cell tumor, not otherwise specified;ovarian leydig cell tumor;broadmatch
ovarian sex cord-stromal tumor of mixed or unclassified cell types;ovarian sex cord-stromal tumor;broadmatch
gain of chromosome 12p;chromosomal gain;broadmatch
endometrioid stromal sarcoma of the cervix;connective and soft tissue neoplasm (antiquated);broadmatch
cervical disorder;uterine disorder;broadmatch
endometrioid stromal sarcoma of the vagina;connective and soft tissue neoplasm (antiquated);broadmatch
hypospadias;congenital reproductive system abnormality;broadmatch
cerebral calcification;calcification;broadmatch
cafe au lait spot;skin patch;broadmatch
atm gene mutation;gene variant;broadmatch
potter syndrome;syndrome;broadmatch
braf gene mutation;gene variant;broadmatch
braf gene mutation;raf family gene mutation;broadmatch
mesenchymal hamartoma;hamartoma;broadmatch
cartilaginous hamartoma;mesenchymal hamartoma;broadmatch
protein cycling pathway;transport pathway;broadmatch
salivary gland myoepithelial cell;myoepithelial cell;broadmatch
breast hemangiopericytoma;hemangiopericytoma;broadmatch
hypertriploidy;hyperploidy;broadmatch
hypotriploidy;hypoploidy;broadmatch
hypospadias;congenital urinary system abnormality;broadmatch
hypospadias;penile non-neoplastic disorder;broadmatch
chromatin structural process;biochemical process;broadmatch
glucose transport induction;transport process;broadmatch
serum soluble fas ligand level increased;elevated test result;broadmatch
leukemic natural killer cell;neoplastic natural killer cell;broadmatch
intraepidermal epithelioma of jadassohn;epithelial neoplasm (antiquated);broadmatch
evi1-aml1 fusion protein expression;fusion protein expression;broadmatch
leukemic lymphocyte;neoplastic lymphocyte;broadmatch
leukemic lymphocyte;leukemic cell;broadmatch
leukemic plasma cell;leukemic lymphocyte;broadmatch
leukemic plasma cell;circulating plasma cell;broadmatch
leukemic natural killer cell;leukemic lymphocyte;broadmatch
leukemic medium-sized b-lymphocyte with basophilic cytoplasm;leukemic lymphocyte;broadmatch
multipotent bone marrow stem cell;bone marrow stem cell;broadmatch
leukemic medium-sized b-lymphocyte with basophilic cytoplasm;neoplastic medium-sized b-lymphocyte with basophilic cytoplasm;broadmatch
leukemic small lymphocyte with clumped chromatin;leukemic lymphocyte;broadmatch
leukemic small lymphocyte with clumped chromatin;neoplastic small lymphocyte with clumped chromatin;broadmatch
neoplastic myeloid cell;abnormal myeloid cell;broadmatch
neoplastic myeloid cell;leukemic cell;broadmatch
bone marrow stem cell at the earliest stage of myeloid differentiation;bone marrow myeloid stem cell;broadmatch
bone marrow stem cell with predominant neutrophil differentiation;bone marrow myeloid stem cell;broadmatch
hematopoietic and lymphatic system;organ system;broadmatch
hematopoietic and lymphatic system part;body part;broadmatch
hematopoietic and lymphoid tissue;tissue;broadmatch
immature granulocytes in peripheral blood under 10 percent;blasts under 10 percent of peripheral blood white cells;broadmatch
kras gene mutation;ras family gene mutation;broadmatch
electrocardiographic finding;cardiovascular system finding;broadmatch
superficial spreading adenocarcinoma;epithelial neoplasm (antiquated);broadmatch
pancreatic non-invasive mucinous cystadenocarcinoma;epithelial neoplasm (antiquated);broadmatch
granulocytes increased in bone marrow;immature myeloid cells increased in bone marrow;broadmatch
blasts under 10 percent of peripheral blood white cells;blasts under 15 percent of peripheral blood white cells;broadmatch
marked bone marrow fibrosis;bone marrow fibrosis;broadmatch
minimal reticulin fibrosis of the bone marrow;reticulin fibrosis of the bone marrow;broadmatch
osteosclerosis;morphologic finding;broadmatch
extramedullary hematopoiesis;morphologic finding;broadmatch
increased red cell mass;elevated test result;broadmatch
increased red cell mass;abnormal blood chemistry and hematology test result;broadmatch
charcot-leyden crystals formation;crystal formation;broadmatch
monoclonal cellular population present;positive laboratory test result;broadmatch
monoclonal eosinophils present;monoclonal cellular population present;broadmatch
multipotent bone marrow stem cell;multipotent stem cell;broadmatch
solitary mass;mass;broadmatch
signal transduction induction;signal transduction;broadmatch
massive sinusoidal histiocytic infiltrate;sinus histiocytosis;broadmatch
reactive germinal centers present;morphologic finding;broadmatch
atypical histiocyte;abnormal macrophage;broadmatch
immunophenotypic finding;pathology result;broadmatch
cd14-positive neoplastic cells present;immunophenotypic finding;broadmatch
cd14-positive neoplastic cells present;cd14 positive;broadmatch
cd68-positive neoplastic cells present;immunophenotypic finding;broadmatch
s-100-positive neoplastic cells present;immunophenotypic finding;broadmatch
plasmacytic infiltrate;cellular infiltrate;broadmatch
immunoglobulin heavy chain deposition;immunoglobulin deposition;broadmatch
small cell intermediate cell carcinoma;grade iii neuroendocrine carcinoma;broadmatch
cervical lymphadenopathy;lymphadenopathy;broadmatch
abnormal large granular lymphocyte;abnormal lymphocyte;broadmatch
dysplasia;morphologic finding;broadmatch
antimicrobial effect;host defense mechanism;broadmatch
lymphocyte activation process;immune cell activation process;broadmatch
hyperplastic polyp;gastrointestinal polyp;broadmatch
germinal centers with prominent hyalinized vessels present;morphologic finding;broadmatch
sheets of interfollicular plasma cells present;abnormal cells present;broadmatch
qualifier;property or attribute;broadmatch
verrucous papilloma;epithelial neoplasm (antiquated);broadmatch
immunoglobulin light chain deposition;immunoglobulin deposition;broadmatch
immunoglobulin deposition;deposit;broadmatch
solitary lytic metastatic bone lesion;lytic metastatic bone lesion;broadmatch
lytic bone lesion;bone lesion;broadmatch
lytic bone lesion;radiologic finding;broadmatch
localized lesion;lesion;broadmatch
neoplastic plasma cells under 20 percent of bone marrow nucleated cells;neoplastic plasma cells 30 percent or less of bone marrow nucleated cells;broadmatch
bone marrow-homing plasma cell;plasma cell;broadmatch
neoplastic plasma cells 10 percent or more of bone marrow nucleated cells;neoplastic plasma cells present in bone marrow;broadmatch
monoclonal paraproteinemia present in lower than myeloma levels;paraproteinemia;broadmatch
neoplastic plasma cells more than 30 percent of bone marrow nucleated cells;neoplastic plasma cells more than 20 percent of bone marrow nucleated cells;broadmatch
neoplastic plasma cells between 10 and 30 percent of bone marrow nucleated cells;neoplastic plasma cells 10 percent or more of bone marrow nucleated cells;broadmatch
neoplastic plasma cells under 10 percent of bone marrow nucleated cells;neoplastic plasma cells under 20 percent of bone marrow nucleated cells;broadmatch
neoplastic plasma cells present in bone marrow;abnormal bone marrow test result;broadmatch
osteosclerotic lesion;radiologic finding;broadmatch
gain of chromosome 12p;chromosome 12 abnormality;broadmatch
i(12p);isochromosome;broadmatch
i(12p);chromosome 12 abnormality;broadmatch
proliferation of follicular dendritic cells present;morphologic finding;broadmatch
flower-like t-lymphocyte;anaplastic t-lymphocyte;broadmatch
neoplastic small to medium-sized t-lymphocyte with irregular nucleus;neoplastic small to medium-sized t-lymphocyte;broadmatch
doughnut cell;anaplastic t-lymphocyte;broadmatch
hallmark cell;anaplastic t-lymphocyte;broadmatch
anaplastic t-lymphocyte;neoplastic t-lymphocyte;broadmatch
anaplastic t-lymphocyte;anaplastic cell;broadmatch
neoplastic t-lymphocyte with clear cytoplasm;neoplastic t-lymphocyte;broadmatch
proliferation of high endothelial venules present;microvascular proliferation;broadmatch
extracutaneous dissemination of disease;clinical course of disease;broadmatch
serpine1 gene;proteinase inhibitor gene;broadmatch
erythroderma;non-neoplastic skin disorder;broadmatch
mucinous degeneration;morphologic finding;broadmatch
cdkn2a gene inactivation;tumor-suppressor gene inactivation;broadmatch
cdkn2a gene inactivation;cdkn2a gene mutation;broadmatch
single cell exocytosis;morphologic finding;broadmatch
pautrier microabscess present;morphologic finding;broadmatch
signet ring-like neoplastic t-lymphocyte;neoplastic t-lymphocyte;broadmatch
activated skin-homing t-lymphocyte;activated lymphocyte;broadmatch
activated skin-homing t-lymphocyte;mature t-lymphocyte;broadmatch
activated mature cytotoxic t-lymphocyte;mature cytotoxic t-lymphocyte;broadmatch
degradation pathway;metabolic pathway;broadmatch
disease pathway;biochemical pathway;broadmatch
cell cycle regulation pathway;regulatory pathway;broadmatch
kidney cyst;urinary system finding;broadmatch
kidney cyst;cyst;broadmatch
apoptosis regulation pathway;regulatory pathway;broadmatch
immune response regulation pathway;regulatory pathway;broadmatch
extranodal disease;clinical course of disease;broadmatch
sarcomatoid features;mesenchymal differentiation;broadmatch
complete regression;regression;broadmatch
partial regression;regression;broadmatch
papular lesion;integumentary system signs and symptoms;broadmatch
papular lesion;lesion;broadmatch
multicentric cutaneous involvement;cutaneous involvement;broadmatch
localized skin lesion;localized lesion;broadmatch
epidermotropic lymphocytic infiltrate;lymphocytic infiltrate;broadmatch
skin plaque;integumentary system signs and symptoms;broadmatch
gain of chromosome y;chromosomal gain;broadmatch
neoplastic medium-sized t-lymphocyte;neoplastic medium-sized lymphocyte;broadmatch
pautrier-like microabscess present;morphologic finding;broadmatch
osteoclastic activity present;morphologic finding;broadmatch
pleomorphic medium-sized to large t-lymphocyte;neoplastic medium-sized to large t-lymphocyte;broadmatch
pleomorphic medium-sized to large t-lymphocyte;pleomorphic t-lymphocyte;broadmatch
pleomorphic small t-lymphocyte;neoplastic small t-lymphocyte;broadmatch
pleomorphic small t-lymphocyte;pleomorphic t-lymphocyte;broadmatch
neoplastic medium-sized t-lymphocyte;neoplastic t-lymphocyte;broadmatch
polylobated t-lymphocyte;pleomorphic t-lymphocyte;broadmatch
skin patch;integumentary system signs and symptoms;broadmatch
cebpa gene;transcription factor gene;broadmatch
prkcb gene;serine/threonine protein kinase gene;broadmatch
ccnd2 gene;cyclin gene;broadmatch
skin rash;integumentary system signs and symptoms;broadmatch
peripheral blood involvement;extramedullary involvement;broadmatch
hepatobiliary disorder;digestive system disorder;broadmatch
angioinvasion;tumor vascular invasion;broadmatch
neoplastic small t-lymphocyte;neoplastic small lymphocyte;broadmatch
neoplastic small t-lymphocyte;neoplastic t-lymphocyte;broadmatch
neoplastic small to medium-sized t-lymphocyte;neoplastic small to medium-sized lymphocyte;broadmatch
neoplastic small to medium-sized t-lymphocyte;neoplastic t-lymphocyte;broadmatch
skin patch;lesion;broadmatch
scaly skin eruption;integumentary system signs and symptoms;broadmatch
cerebriform lymphocyte;neoplastic t-lymphocyte;broadmatch
dermatopathic lymphadenopathy;lymphadenopathy;broadmatch
subcutaneous nodule;nodule;broadmatch
subcutaneous involvement;integumentary system finding;broadmatch
karyorrhexis;morphologic finding;broadmatch
sinusoidal infiltration;morphologic finding;broadmatch
neoplastic medium-sized to large t-lymphocyte;neoplastic t-lymphocyte;broadmatch
neoplastic medium-sized to large t-lymphocyte;neoplastic medium-sized to large lymphocyte;broadmatch
intraepithelial t-lymphocyte of the intestine;intraepithelial t-lymphocyte;broadmatch
intestinal ulcerated mass;intestinal mass;broadmatch
intestinal perforation;digestive system perforation;broadmatch
activated natural killer cell;natural killer cell;broadmatch
coagulative necrosis;ischemic necrosis;broadmatch
cell motility pathway;biochemical pathway;broadmatch
cell differentiation or development pathway;biochemical pathway;broadmatch
dna repair pathway;biochemical pathway;broadmatch
loss of chromosome 2;chromosomal loss;broadmatch
asymptomatic mass;mass;broadmatch
nono-tfe3 fusion protein expression;fusion protein expression;broadmatch
psf-tfe3 fusion protein expression;fusion protein expression;broadmatch
prcc-tfe3 fusion protein expression;fusion protein expression;broadmatch
"inv(x)(p11;q12)";pericentric inversion;broadmatch
sickle cell trait;hemoglobin trait;broadmatch
loss of chromosome 21;chromosomal loss;broadmatch
loss of chromosome 14q;chromosomal loss;broadmatch
cerebriform-like lymphocyte;neoplastic t-lymphocyte;broadmatch
"t(3;12)(q13;q24)";rearrangement of 3q;broadmatch
"t(3;12)(q13;q24)";chromosomal translocation;broadmatch
"t(3;12)(q13;q24)";chromosome 12 abnormality;broadmatch
"t(3;6)(p13;q25)";rearrangement of 6q25;broadmatch
"t(3;6)(p13;q25)";chromosomal translocation;broadmatch
"t(3;8)(p14;q24)";chromosomal translocation;broadmatch
met gene mutation;gene variant;broadmatch
type 1 renal papillary adenoma;epithelial neoplasm (antiquated);broadmatch
type 2 renal papillary adenoma;epithelial neoplasm (antiquated);broadmatch
"t(5;11)(q35;q13)";11q translocation;broadmatch
"t(5;11)(q35;q13)";chromosome 5 rearrangement;broadmatch
thrombocytopenia due to immune destruction;thrombocytopenia;broadmatch
gain of chromosome 18q;chromosomal gain;broadmatch
parathyroid hyperplasia;hyperplasia;broadmatch
fgfr3 gene mutation;gene variant;broadmatch
fgfr3 gene mutation;fgfr gene mutation;broadmatch
loss of chromosome 9q;chromosomal loss;broadmatch
urethral glandular metaplasia;urinary tract precancerous condition;broadmatch
cystitis glandularis;cystitis cystica and glandularis;broadmatch
urothelial dysplasia;dysplasia;broadmatch
intestinal metaplasia of bladder urachal epithelium;urinary tract precancerous condition;broadmatch
intestinal metaplasia of bladder urothelium;urinary tract precancerous condition;broadmatch
intestinal metaplasia of bladder urothelium;bladder disorder;broadmatch
urinary tract precancerous condition;precancerous condition by site;broadmatch
smarcb1 gene inactivation;tumor-suppressor gene inactivation;broadmatch
smarcb1 gene inactivation;smarcb1 gene mutation;broadmatch
met gene mutation;receptor tyrosine kinase gene mutation;broadmatch
multiple tumor masses;neoplastic growth or spread;broadmatch
bilateral disease;clinical course of disease;broadmatch
immunodeficiency;immune system finding;broadmatch
defective heavy chain present;abnormal blood chemistry and hematology test result;broadmatch
abundance of small lymphocytes;morphologic finding;broadmatch
classical reed-sternberg cell;reed-sternberg cell;broadmatch
pdgfralpha protein overexpression;pdgfr protein overexpression;broadmatch
pdgfra gene mutation;gene variant;broadmatch
pdgfra gene mutation;pdgfr family gene mutation;broadmatch
mdm2 gene mutation;gene variant;broadmatch
egfr protein overexpression;protein deregulation;broadmatch
cd30-positive neoplastic cells present;immunophenotypic finding;broadmatch
cd30-positive neoplastic cells present;tnfrsf8 positive;broadmatch
kit gene mutation;gene variant;broadmatch
kit gene mutation;receptor tyrosine kinase gene mutation;broadmatch
c-kit tyrosine kinase protein overexpression;protein deregulation;broadmatch
solitary skin tumor;integumentary system finding;broadmatch
confluent sheets of anaplastic t-lymphocytes present;abnormal cells present;broadmatch
immune system finding;finding by site or system;broadmatch
carbohydrate metabolism pathway;metabolic pathway;broadmatch
vulvar polyp;polyp;broadmatch
energy metabolism pathway;metabolic pathway;broadmatch
vulvar polyp;vulvar non-neoplastic disorder;broadmatch
non-contiguous disease;clinical course of disease;broadmatch
contiguous disease;clinical course of disease;broadmatch
below the diaphragm disease;clinical course of disease;broadmatch
above the diaphragm disease;clinical course of disease;broadmatch
cervical leukoplakia;genital leukoplakia;broadmatch
refractory disease;clinical course of disease;broadmatch
cervical atypia;atypia;broadmatch
lymphoblast-like neoplastic b-lymphocyte;neoplastic b-lymphocyte;broadmatch
myxoid changes present;abnormal tissue present;broadmatch
fascicular pattern;morphologic architectural pattern;broadmatch
negative peripheral blood;negative test result;broadmatch
infectious disease pathway;disease pathway;broadmatch
neurodegenerative disorders pathway;disease pathway;broadmatch
genetic information processing pathway;biochemical pathway;broadmatch
fusion gene;birc3/malt1 fusion gene;narrowmatch
